Citrus Sinensis ID: 017746

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360------
Protein Sequence
MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKFSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCLLDRIRVLAGDDERPNWSDSECWVTVR
Secondary Structure (PSIPRED)
ccEEEcccccccccccEEEcEEcccccccccEEEEEEEEcccccHHHHHHHHHHHHHcccccccEEEEcccccccccccEEEEEEEEcccccHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEccccccccccccccccccccccccccccccEEEccccccccccHHHHHHHHHHHHcccccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEcc
Secondary Structure Prediction (SSPRO)
cccEEEEEEccccccEEEEEEEccccEEEEEEEEEccEEEEccccHHHHHHHHHHHHHcccccEEEcccEEEEccccccEEEEEEEEccccHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEcccccccEccccccccEEEEEcccHHHHHHHHHHHccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHHcccHHHcccHHHHHccccHccccHHHHHHHHHHcccccccccccccHcccccccHHHccccccccccccccHHHccHHHccccccccHHHHHHHHHcccccccccccccccEEEEc
Coil and Loop (DISEMBL)
mewlrgdvighgsfgsvNLAKAskvssefpslmavkscadcppssvtlkNEKEALdqigicpqivrcfgddysfekGERFYNLLLEYASRGSLADRVKkqnngrlqesDVKRYTRSMLKGLRHihskgfvhcdiklqnvlvfdndeakiadfglakksscdgersqsfecrgtplymspesvneneyeapcdiWALGCAVVEmasgkpawnhkqdsnVFSLLIRIgvgdelpnipgdlseqGKDFLIKCFLKDPKRRWTAEMllnhpfvcaddqtgddggihihsssspslkgikdekfsqsprspfgfpewvsvqssssvtssinspsfdsflsSRDCLLDRIRVlagdderpnwsdsecwvtvr
Flexible Loop (DISEMBL)
mewlrgdvighgsfgsvNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASrgsladrvkkqnngrlqesdvkRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGlakksscdgersqsfecrgtplYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHsssspslkgiKDEKFSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCLLDRIRvlagdderpnwsdsecwvtvr
Low Complexity Region (SEG)
MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTgddggihihssssPSLKGIKDEKFSQSPRSPFGFPEWvsvqssssvtssinspsFDSFLSSRDCLLDRIRVLAGDDERPNWSDSECWVTVR
Disordered region (IsUnstruct)
*****GDVIGHGSFGSVNL**************AVKSCA************KEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRG*********************YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA******************************EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD***********************************************************FLSSRDCLLDRIRVLAGD*****W***ECWV***
Disordered Region (DISOPRED)
MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVK***************KEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS***********CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD**********************************************************************************WSDSECWVTVR
Disordered Region (DISEMBL)
MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK***********FECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKFSQSPRSPFGFPEWV**************PSFDSFLSSRDCLLDRIRVLAGDDERPNWSDSECWVTVR
Disordered Region (DISPRO)
MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKFSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCLLDRIRVL*******N**D*ECWVTV*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKFSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCLLDRIRVLAGDDERPNWSDSECWVTVR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	366	2.2.26 [Sep-21-2011]
O22042	651	Mitogen-activated protein	no	no	0.704	0.396	0.332	2e-38
Q39008	608	Mitogen-activated protein	no	no	0.674	0.406	0.378	2e-37
Q01389	1478	Serine/threonine-protein	yes	no	0.683	0.169	0.355	5e-37
Q9FZ36	651	Mitogen-activated protein	no	no	0.710	0.399	0.324	3e-36
O22040	666	Mitogen-activated protein	no	no	0.765	0.420	0.320	3e-35
Q54R82	942	Mitogen-activated protein	no	no	0.704	0.273	0.320	3e-35
P53349	1493	Mitogen-activated protein	yes	no	0.702	0.172	0.336	4e-35
Q13233	1512	Mitogen-activated protein	yes	no	0.702	0.169	0.336	7e-35
Q62925	1493	Mitogen-activated protein	yes	no	0.702	0.172	0.333	2e-34
Q0CL79	1342	Cytokinesis protein sepH	N/A	no	0.666	0.181	0.370	1e-33

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  160 bits (404), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/286 (33%), Positives = 156/286 (54%), Gaps = 28/286 (9%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNE---KEALDQ 57
           + W +G++IG G+FG V +     ++ +   L+A+K     P S+   K +   +E  ++
Sbjct: 66  IRWRKGELIGCGAFGRVYMG----MNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEE 121

Query: 58  IGIC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKR 112
           + +      P IVR  G     +      N+L+E+   GS++  ++K   G   E  +  
Sbjct: 122 VQLLKNLSHPNIVRYLGTVRESDS----LNILMEFVPGGSISSLLEK--FGSFPEPVIIM 175

Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK----SSCDGERSQSF 168
           YT+ +L GL ++H+ G +H DIK  N+LV +    ++ADFG +KK    ++ +G +S   
Sbjct: 176 YTKQLLLGLEYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSM-- 233

Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG 228
             +GTP +M+PE + +  +    DIW++GC V+EMA+GKP W+ +     F+ ++ IG  
Sbjct: 234 --KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQ--FAAVLHIGRT 289

Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
              P IP DLS + KDFL+KC  K+P  R +A  LL HPFV    Q
Sbjct: 290 KAHPPIPEDLSPEAKDFLMKCLHKEPSLRLSATELLQHPFVTGKRQ 335

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  157 bits (396), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 104/275 (37%), Positives = 151/275 (54%), Gaps = 28/275 (10%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           W +G ++G GSFGSV       +S +     AVK  +     S   +  ++   +I +  
Sbjct: 333 WQKGQLLGRGSFGSV----YEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLS 387

Query: 63  Q-----IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           Q     IVR  G   + + G   Y + LE  ++GSL   +K     +L++S V  YTR +
Sbjct: 388 QLQHQNIVRYRG---TAKDGSNLY-IFLELVTQGSL---LKLYQRYQLRDSVVSLYTRQI 440

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           L GL+++H KGF+H DIK  N+LV  N   K+ADFGLAK S  +  +S    C+GTP +M
Sbjct: 441 LDGLKYLHDKGFIHRDIKCANILVDANGAVKLADFGLAKVSKFNDIKS----CKGTPFWM 496

Query: 178 SPESVNENE---YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +PE +N  +   Y +P DIW+LGC V+EM +G+  ++   D      L RIG G  LP +
Sbjct: 497 APEVINRKDSDGYGSPADIWSLGCTVLEMCTGQIPYS---DLEPVQALFRIGRG-TLPEV 552

Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           P  LS   + F++KC   +P+ R TA  LLNHPFV
Sbjct: 553 PDTLSLDARLFILKCLKVNPEERPTAAELLNHPFV 587

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q01389|BCK1_YEAST Serine/threonine-protein kinase BCK1/SLK1/SSP31 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=BCK1 PE=1 SV=1

 Score =  155 bits (392), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 153/281 (54%), Gaps = 31/281 (11%)

Query: 3    WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSV----------TLKNEK 52
            W++G++IG GSFG+V L     ++     +MAVK   + P  S            L++E 
Sbjct: 1175 WMKGEMIGKGSFGAVYLC----LNVTTGEMMAVKQV-EVPKYSSQNEAILSTVEALRSEV 1229

Query: 53   EALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKR 112
              L  +     IV+  G    FE     Y+L LEY + GS+   ++    GR  E  +K 
Sbjct: 1230 STLKDLDHL-NIVQYLG----FENKNNIYSLFLEYVAGGSVGSLIRMY--GRFDEPLIKH 1282

Query: 113  YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
             T  +LKGL ++HSKG +H D+K  N+L+  +   KI+DFG+++KS  D   +     RG
Sbjct: 1283 LTTQVLKGLAYLHSKGILHRDMKADNLLLDQDGICKISDFGISRKSK-DIYSNSDMTMRG 1341

Query: 173  TPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
            T  +M+PE V+  + Y A  DIW+LGC V+EM +GK  W++ +   V + + +IG     
Sbjct: 1342 TVFWMAPEMVDTKQGYSAKVDIWSLGCIVLEMFAGKRPWSNLE---VVAAMFKIGKSKSA 1398

Query: 232  PNIPGD----LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
            P IP D    +S+ G++FL  CF  +P++R TA  LL+HPF
Sbjct: 1399 PPIPEDTLPLISQIGRNFLDACFEINPEKRPTANELLSHPF 1439

Serine/threonine protein kinase involved in a signal transduction pathway that play a role in yeast cell morphogenesis and cell growth. This pathway seems to starts by SMP3; then involve the kinase PKC1 that may act on this kinase. BCK1 probably phosphorylates MKK1 and MKK2 which themselves phosphorylate the MPK1 kinase.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  152 bits (385), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 89/274 (32%), Positives = 145/274 (52%), Gaps = 14/274 (5%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           + W +G +IG G+FG+V +   +  S E  ++  V   ++C     T  + +E  +++ +
Sbjct: 66  IRWRKGQLIGRGAFGTVYMG-MNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKL 124

Query: 61  C-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                 P IVR  G      + +   N+LLE+   GS++  ++K   G   ES V+ YT 
Sbjct: 125 LKNLSHPNIVRYLGT----VREDETLNILLEFVPGGSISSLLEK--FGAFPESVVRTYTN 178

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            +L GL ++H+   +H DIK  N+LV +    K+ADFG +K+ +     S +   +GTP 
Sbjct: 179 QLLLGLEYLHNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPY 238

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           +M+PE + +  +    DIW++GC V+EM +GK  W+  Q     + +  IG     P IP
Sbjct: 239 WMAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWS--QQYKEIAAIFHIGTTKSHPPIP 296

Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            ++S    DFL+KC  ++P  R TA  LL HPFV
Sbjct: 297 DNISSDANDFLLKCLQQEPNLRPTASELLKHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  149 bits (377), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 95/296 (32%), Positives = 153/296 (51%), Gaps = 16/296 (5%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           + W +G +IG G+FG+V +   +  S E  ++  V   A+      T  + +E  +++ +
Sbjct: 67  ISWRKGQLIGRGAFGTVYMG-MNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKL 125

Query: 61  C-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                 P IVR  G      + +   N+LLE+   GS++  ++K   G   ES V+ YTR
Sbjct: 126 LKNLSHPNIVRYLGT----VREDDTLNILLEFVPGGSISSLLEK--FGPFPESVVRTYTR 179

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            +L GL ++H+   +H DIK  N+LV +    K+ADFG +K+ +     + +   +GTP 
Sbjct: 180 QLLLGLEYLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPY 239

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           +M+PE + +  +    DIW++GC V+EM +GK  W+  Q     + +  IG     P IP
Sbjct: 240 WMAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWS--QQYKEVAAIFFIGTTKSHPPIP 297

Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA--DDQTGDDGGIHIHSSSSP 289
             LS   KDFL+KC  + P  R TA  LL HPFV     +    D G  +++ S+P
Sbjct: 298 DTLSSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESASTDLGSVLNNLSTP 353

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  149 bits (377), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/281 (32%), Positives = 147/281 (52%), Gaps = 23/281 (8%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSS--------VTLKNEK 52
           ++W +G ++G G +GSV L     ++ +   L AVK       +S        ++   E 
Sbjct: 168 IKWQKGQILGRGGYGSVYLG----LNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEI 223

Query: 53  EALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKR 112
           E +  +     IVR  G        + F ++ LEY   GS++  + K   G   E+ +K 
Sbjct: 224 EVMRSLR-HDNIVRYLGTSLD----QSFLSVFLEYIPGGSISSLLGK--FGAFSENVIKV 276

Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
           YT+ +L+GL  +H+   +H DIK  N+L+      K++DFG +K  S  G  SQ    +G
Sbjct: 277 YTKQILQGLSFLHANSIIHRDIKGANILIDTKGIVKLSDFGCSK--SFSGIVSQFKSMQG 334

Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
           TP +M+PE + +  +    DIW+LGC +VEMA+ +P W++  +  + +++  I   + +P
Sbjct: 335 TPYWMAPEVIKQTGHGRSSDIWSLGCVIVEMATAQPPWSNITE--LAAVMYHIASSNSIP 392

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           NIP  +S++  DFL  CF +DPK R  A  LL HPF+   D
Sbjct: 393 NIPSHMSQEAFDFLNLCFKRDPKERPDANQLLKHPFIMNLD 433

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P53349|M3K1_MOUSE Mitogen-activated protein kinase kinase kinase 1 OS=Mus musculus GN=Map3k1 PE=1 SV=3

 Score =  149 bits (375), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 145/276 (52%), Gaps = 19/276 (6%)

Query: 2    EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEAL-DQIGI 60
            EWL+G  IG G+F S   A+     +    LMAVK       +S   +   EAL ++I +
Sbjct: 1223 EWLKGQQIGLGAFSSCYQAQDVGTGT----LMAVKQVTYVRNTSSEQEEVVEALREEIRM 1278

Query: 61   C-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                  P I+R  G   + EK    YNL +E+ + GS+A  + K   G  +ES V  YT 
Sbjct: 1279 MGHLNHPNIIRMLG--ATCEKSN--YNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTE 1332

Query: 116  SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE-AKIADFGLAKKSSCDGERSQSFECR--G 172
             +L+GL ++H    +H D+K  N+L+    +  +IADFG A + +  G  +  F+ +  G
Sbjct: 1333 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLG 1392

Query: 173  TPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
            T  +M+PE +   +Y   CD+W++GCA++EMA  KP WN ++ SN  +L+ +I      P
Sbjct: 1393 TIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAP 1452

Query: 233  NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
            +IP  LS   +D  ++C    P+ R  +  LL HP 
Sbjct: 1453 SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPV 1488

Component of a protein kinase signal transduction cascade. Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4. Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q13233|M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4

 Score =  148 bits (373), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 145/276 (52%), Gaps = 19/276 (6%)

Query: 2    EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEAL-DQIGI 60
            EWL+G  IG G+F S   A+     +    LMAVK       +S   +   EAL ++I +
Sbjct: 1242 EWLKGQQIGLGAFSSCYQAQDVGTGT----LMAVKQVTYVRNTSSEQEEVVEALREEIRM 1297

Query: 61   C-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                  P I+R  G   + EK    YNL +E+ + GS+A  + K   G  +ES V  YT 
Sbjct: 1298 MSHLNHPNIIRMLG--ATCEKSN--YNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTE 1351

Query: 116  SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE-AKIADFGLAKKSSCDGERSQSFECR--G 172
             +L+GL ++H    +H D+K  N+L+    +  +IADFG A + +  G  +  F+ +  G
Sbjct: 1352 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLG 1411

Query: 173  TPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
            T  +M+PE +   +Y   CD+W++GCA++EMA  KP WN ++ SN  +L+ +I      P
Sbjct: 1412 TIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAP 1471

Query: 233  NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
            +IP  LS   +D  ++C    P+ R  +  LL HP 
Sbjct: 1472 SIPSHLSPGLRDVALRCLELQPQDRPPSRELLKHPV 1507

Component of a protein kinase signal transduction cascade. Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4. Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q62925|M3K1_RAT Mitogen-activated protein kinase kinase kinase 1 OS=Rattus norvegicus GN=Map3k1 PE=1 SV=1

 Score =  146 bits (369), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 144/276 (52%), Gaps = 19/276 (6%)

Query: 2    EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEAL-DQIGI 60
            EWL+G  IG G+F S   A+     +    LMAVK       +S   +   EAL ++I +
Sbjct: 1223 EWLKGQQIGLGAFSSCYQAQDVGTGT----LMAVKQVTYVRNTSSEQEEVVEALREEIRM 1278

Query: 61   C-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                  P I+R  G   + EK    YNL +E+ +  S+A  + K   G  +ES V  YT 
Sbjct: 1279 MSHLNHPNIIRMLG--ATCEKSN--YNLFIEWMAGASVAHLLSKY--GAFKESVVINYTE 1332

Query: 116  SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE-AKIADFGLAKKSSCDGERSQSFECR--G 172
             +L+GL ++H    +H D+K  N+L+    +  +IADFG A + +  G  +  F+ +  G
Sbjct: 1333 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLG 1392

Query: 173  TPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
            T  +M+PE +   +Y   CD+W++GCA++EMA  KP WN ++ SN  +L+ +I      P
Sbjct: 1393 TIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAP 1452

Query: 233  NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
            +IP  LS   +D  ++C    P+ R  +  LL HP 
Sbjct: 1453 SIPSHLSPGLRDVALRCLELQPQDRPPSRELLKHPV 1488

Component of a protein kinase signal transduction cascade. Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4. Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q0CL79|SEPH_ASPTN Cytokinesis protein sepH OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=sepH PE=3 SV=2

 Score =  144 bits (362), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 138/267 (51%), Gaps = 23/267 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC--ADCPPSSVTLKNEKEALDQIGICPQ 63
           GD +G G+FGSV  A    ++      +AVK    AD P S + L  E + L  +   P 
Sbjct: 64  GDCLGKGAFGSVYRA----LNWNTGETVAVKQIKLADLPKSELRL--EIDLLKNLD-HPN 116

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G    F K     N++LEY   GSL    K  N GR  E+ V  Y   +L GL +
Sbjct: 117 IVKYQG----FVKSAETLNIILEYCENGSLHSIAK--NFGRFPENLVGLYMSQVLHGLLY 170

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +H +G +H DIK  N+L       K+ADFG+A +++   E S      GTP +M+PE + 
Sbjct: 171 LHEQGVIHRDIKGANILTTKEGLVKLADFGVASRTTGLSESS----VVGTPYWMAPEVIE 226

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
            +      DIW+LGC V+E+  GKP + + Q       L RI V D+ P +P   S   K
Sbjct: 227 LSGATTASDIWSLGCTVIELLEGKPPYYNMQP---MPALFRI-VNDDHPPLPQGASPAVK 282

Query: 244 DFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           DFL++CF KDP  R +A  LL HP++ 
Sbjct: 283 DFLMQCFQKDPNLRVSARKLLKHPWIV 309

Required for early events during cytokinesis including localization of cytoskeletal components to the cytokinetic ring.

Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	366
449448312	740	PREDICTED: LOW QUALITY PROTEIN: uncharac	0.939	0.464	0.534	1e-100
449533290	350	PREDICTED: mitogen-activated protein kin	0.939	0.982	0.534	1e-100
255565216	358	ATP binding protein, putative [Ricinus c	0.959	0.980	0.541	2e-98
297819710	342	MAPKKK20 [Arabidopsis lyrata subsp. lyra	0.931	0.997	0.517	4e-97
224081672	347	predicted protein [Populus trichocarpa]	0.926	0.976	0.548	4e-97
297797667	344	MAPKKK19 [Arabidopsis lyrata subsp. lyra	0.934	0.994	0.535	1e-96
356496902	346	PREDICTED: mitogen-activated protein kin	0.931	0.985	0.525	1e-96
356504533	348	PREDICTED: mitogen-activated protein kin	0.937	0.985	0.509	5e-96
15240194	344	mitogen-activated protein kinase kinase	0.934	0.994	0.519	6e-96
356541799	346	PREDICTED: mitogen-activated protein kin	0.937	0.991	0.514	2e-95

>gi|449448312|ref|XP_004141910.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101215204 [Cucumis sativus]

 Score =  372 bits (956), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 199/372 (53%), Positives = 256/372 (68%), Gaps = 28/372 (7%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           M+W+RGD IG+GSF ++NLA +      FP LMAVKS       S +LKNEK+ LD +G 
Sbjct: 1   MDWVRGDEIGYGSFATINLATSCS-GDRFPPLMAVKSSGLV--CSASLKNEKQVLDLLGD 57

Query: 61  -CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
            CPQI+RCFGD  S E GE  YNL LEYAS GSLADR++ +  GRL E +V+RYTR++L+
Sbjct: 58  DCPQIIRCFGDSCSVENGEELYNLFLEYASGGSLADRIQSRG-GRLPEFEVRRYTRTILE 116

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD----GERSQSFECRGTPL 175
           GLR+IH KGFVHCD+K +N+LVF + +AKIADFGL+KK+  +    GE +  F+ RG+PL
Sbjct: 117 GLRYIHGKGFVHCDVKPRNILVFGDGDAKIADFGLSKKAGKNRVGTGEETGKFQLRGSPL 176

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           YMSPESVN+NEYE+PCDIWA+GCAVVEM +GKPAWN + +SNVF+LLI+IG+G+ELP IP
Sbjct: 177 YMSPESVNDNEYESPCDIWAVGCAVVEMLTGKPAWNCRPESNVFALLIKIGIGEELPEIP 236

Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIK 295
            DLSE+GKDFL KC +KDP +RWTA+MLL HPFV               S     L G+ 
Sbjct: 237 KDLSEEGKDFLKKCLVKDPLKRWTADMLLKHPFVA-------------ESGRCVPLAGV- 282

Query: 296 DEKFSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCL-LDRIRVLAGDDERP 354
            E+ S SPR PF F +W S+ S  S     N    + +L++  C   +R+  L G+    
Sbjct: 283 -EEVSTSPRCPFDFEDWASIHSQES--DPRNEEEANCWLNNWSCSPRERLLELVGNGAV- 338

Query: 355 NWSDSECWVTVR 366
            WS ++ WV VR
Sbjct: 339 EWSVTDNWVRVR 350

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449533290|ref|XP_004173609.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Cucumis sativus]

 Score =  370 bits (950), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 199/372 (53%), Positives = 256/372 (68%), Gaps = 28/372 (7%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           M+W+RGD IG+GSF ++NLA +      FP LMAVKS       S +LKNEK+ LD +G 
Sbjct: 1   MDWVRGDEIGYGSFATINLATSCS-GDRFPPLMAVKSSGLV--CSASLKNEKQVLDLLGD 57

Query: 61  -CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
            CPQI+RCFGD  S E GE  YNL LEYAS GSLADR++ +  GRL E +V+RYTR++L+
Sbjct: 58  DCPQIIRCFGDSCSVENGEELYNLFLEYASGGSLADRIQSRG-GRLPEFEVRRYTRTILE 116

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD----GERSQSFECRGTPL 175
           GLR+IH KGFVHCD+K +N+LVF + +AKIADFGL+KK+  +    GE +  F+ RG+PL
Sbjct: 117 GLRYIHGKGFVHCDVKPRNILVFGDGDAKIADFGLSKKAGKNRVGTGEETGKFQLRGSPL 176

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           YMSPESVN+NEYE+PCDIWA+GCAVVEM +GKPAWN + +SNVF+LLI+IG+G+ELP IP
Sbjct: 177 YMSPESVNDNEYESPCDIWAVGCAVVEMLTGKPAWNCRPESNVFALLIKIGIGEELPEIP 236

Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIK 295
            DLSE+GKDFL KC +KDP +RWTA+MLL HPFV               S     L G+ 
Sbjct: 237 KDLSEEGKDFLKKCLVKDPLKRWTADMLLKHPFVA-------------ESGRCVPLAGV- 282

Query: 296 DEKFSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCL-LDRIRVLAGDDERP 354
            E+ S SPR PF F +W S+ S  S     N    + +L++  C   +R+  L G+    
Sbjct: 283 -EEVSTSPRCPFDFEDWASIHSQES--DPRNEEEANCWLNNWSCSPRERLLELVGNGAV- 338

Query: 355 NWSDSECWVTVR 366
            WS ++ WV VR
Sbjct: 339 EWSVTDNWVRVR 350

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255565216|ref|XP_002523600.1| ATP binding protein, putative [Ricinus communis] gi|223537162|gb|EEF38795.1| ATP binding protein, putative [Ricinus communis]

 Score =  365 bits (937), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 202/373 (54%), Positives = 260/373 (69%), Gaps = 22/373 (5%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           M+W+RG+ IGHGSF +VNLA     S    SLMAVKSC      SV L+NEK+ LDQ+G 
Sbjct: 1   MDWVRGNSIGHGSFSTVNLAIPRNDSG--ASLMAVKSCD--VFDSVFLENEKDVLDQLGD 56

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
           C  I+RCFG + S E G R  NLLLEYA+ GSLA  VK  N G L+ESDV+ YTRS+LKG
Sbjct: 57  CEHIIRCFGSEESVENGHRLSNLLLEYAAGGSLAHWVK-NNGGCLRESDVRHYTRSVLKG 115

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L +IH+KGF HCD+KLQN+L+F++ E KIADFGLAKK    G++ +  + RGTPL M+PE
Sbjct: 116 LSYIHAKGFAHCDLKLQNLLLFEDGELKIADFGLAKKV---GQKLEGVQVRGTPLCMAPE 172

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
           SVNENEY++PCDIWALGCAVVEM +GKPAWN + D+N+ +LLI+IGV DELP IP +LS 
Sbjct: 173 SVNENEYDSPCDIWALGCAVVEMITGKPAWNCRADANIAALLIKIGVSDELPEIPQELSN 232

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKFS 300
           +GKDFL KCF+KDP+RRWTA+MLL+H FV   D   D+     +S+++ + K  K E  S
Sbjct: 233 EGKDFLSKCFVKDPQRRWTADMLLDHSFVA--DHYDDE----FNSTTTVTFKN-KKEVPS 285

Query: 301 QSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFL-------SSRDCLLDRIRVLAGDDER 353
            SPR PF F EW+S+ SSS  +   +    +S +       +     +DRI+ L  D + 
Sbjct: 286 SSPRCPFEFQEWISIPSSSPNSEVWSHRELESRIDWSSLSSTPSSSPVDRIQQLTSDHQG 345

Query: 354 PNWSDSECWVTVR 366
            NW+ S+ W+TVR
Sbjct: 346 CNWAFSDSWITVR 358

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297819710|ref|XP_002877738.1| MAPKKK20 [Arabidopsis lyrata subsp. lyrata] gi|297323576|gb|EFH53997.1| MAPKKK20 [Arabidopsis lyrata subsp. lyrata]

 Score =  360 bits (925), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 190/367 (51%), Positives = 247/367 (67%), Gaps = 26/367 (7%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           MEW+RG+ +G G+F +V++A  ++ S +FP++MAVKS      +S  L  EK  LD +G 
Sbjct: 1   MEWVRGETVGFGTFSTVSVATNTRDSGDFPAIMAVKSSDSYGAAS--LSKEKSVLDSLGD 58

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
           CP+IVRC+G+D + E GE+ +NLLLEYASRGSLA  VKK     L ES V+R+T S+L+G
Sbjct: 59  CPEIVRCYGEDLTVENGEKMHNLLLEYASRGSLATHVKKLGGEGLPESTVRRHTGSVLRG 118

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ-SFECRGTPLYMSP 179
           LRHIH+ GF HCDIKL N+L+F++   KIADFGLA++   D   S+ S E RGTPLYM+P
Sbjct: 119 LRHIHAIGFAHCDIKLGNILLFNDGAVKIADFGLARRVDGDLTPSKKSVEIRGTPLYMAP 178

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           ESVNENEY +  D+WALGCAVVEM SGK AW+ K+ S+  SLLIRIGVGDELP IP  LS
Sbjct: 179 ESVNENEYGSAADVWALGCAVVEMFSGKTAWSVKEGSHFMSLLIRIGVGDELPKIPEMLS 238

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKF 299
           E+GKDFL+KCF+KDP++RWTAEMLLNH FV  D        +  +      +K  ++EK 
Sbjct: 239 EEGKDFLLKCFVKDPEKRWTAEMLLNHSFVAVD--------LEDYHREDFVVKFKEEEKV 290

Query: 300 SQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCLLDRIRVLAGDDERPNWSDS 359
             SP+ PF F +W S  S S   +S++SP            ++R+  L      P+WS  
Sbjct: 291 LMSPKCPFEFHDWESFTSDSH--TSLDSP------------VERLGSLV-SGSSPDWSVG 335

Query: 360 ECWVTVR 366
             WVTVR
Sbjct: 336 GSWVTVR 342

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081672|ref|XP_002306473.1| predicted protein [Populus trichocarpa] gi|222855922|gb|EEE93469.1| predicted protein [Populus trichocarpa]

 Score =  360 bits (925), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 205/374 (54%), Positives = 254/374 (67%), Gaps = 35/374 (9%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           MEW+RG  IG GS   V+LA       + PS++AVKSCA+    S  L+NE+E + ++G 
Sbjct: 1   MEWVRGQCIGSGSSSRVHLATLK----QHPSVLAVKSCAE--SDSSLLENEREVVTELGY 54

Query: 61  CPQIVRCFGDDYSFE-KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           CPQI++ FGD ++ E K ER YNLLLEYA  GSL+ ++ K   G  QE DVK Y RS+LK
Sbjct: 55  CPQIIQYFGDSHTVEEKNERLYNLLLEYAKGGSLSQKLNK--FGCFQERDVKDYARSILK 112

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GLRHIH+KGFVHCD+KL N+L+F+N+E KIADFGLA+K+   G+     E RGTPLYM+P
Sbjct: 113 GLRHIHAKGFVHCDLKLDNILLFENEEVKIADFGLARKA---GKAQGRAEIRGTPLYMAP 169

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           ESVN+N YE+  DIWALGCAV+EM +GKPAW+ K  +N+F LLIRIG GDELP IP +LS
Sbjct: 170 ESVNDNVYESGVDIWALGCAVIEMLTGKPAWSCKPGTNMFVLLIRIGKGDELPTIPEELS 229

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKF 299
           +QGKDFL KCF+KDPKRRWTA+MLL HPFV AD   G          + P  + I  E  
Sbjct: 230 QQGKDFLSKCFVKDPKRRWTADMLLEHPFV-ADQGKG----------TVPLREEI--EVS 276

Query: 300 SQSPRSPFGFPEWVSVQSSSSVTSSINS-------PSFDSFLSSRDCLLDRIRVLAGDDE 352
           S SPR  F FP+WVS+QS S  +  ++        PS +S  SS     DRIR LA  D+
Sbjct: 277 STSPRCHFDFPDWVSIQSPSPRSEFLSDDGVGLVFPSLNS--SSWISASDRIRQLA-SDQ 333

Query: 353 RPNWSDSECWVTVR 366
             NWSDS  WV VR
Sbjct: 334 CCNWSDSGFWVAVR 347

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297797667|ref|XP_002866718.1| MAPKKK19 [Arabidopsis lyrata subsp. lyrata] gi|297312553|gb|EFH42977.1| MAPKKK19 [Arabidopsis lyrata subsp. lyrata]

 Score =  359 bits (922), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 197/368 (53%), Positives = 245/368 (66%), Gaps = 26/368 (7%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           MEW+RG+ IG+G+F +V+LA  S   S E P LMAVKS      +S  L+NEK  LD++G
Sbjct: 1   MEWIRGETIGYGTFSTVSLATPSNNDSGELPPLMAVKSADSYGAAS--LENEKSVLDKLG 58

Query: 60  I-CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
             C +IVRCFG+D + E GE  +NL LEYASRGSL   +KK     L ES V+R+T S+L
Sbjct: 59  DDCNEIVRCFGEDRTVENGEEMHNLFLEYASRGSLESYLKKLAGEGLPESTVRRHTGSVL 118

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
           +GLRHIH+ GF HCD+KL N+L F +   KIADFGLAK+       ++  + RGTPLYM+
Sbjct: 119 RGLRHIHANGFAHCDLKLGNILWFGDGAVKIADFGLAKRIGEVTAINEGVQIRGTPLYMA 178

Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           PESVN+NEY +  D+WALGCAVVEM SGK AW+ K+ SN  SLLIRIGVGDELP IP +L
Sbjct: 179 PESVNDNEYGSEGDVWALGCAVVEMFSGKTAWSLKEGSNFMSLLIRIGVGDELPMIPEEL 238

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEK 298
           SEQGKDFL KCF+KDPK+RWTAEMLL+HPFV  D     DG +         +  +K E+
Sbjct: 239 SEQGKDFLSKCFVKDPKKRWTAEMLLHHPFVAVDLDY--DGLVE----EEDFVVKLKTEE 292

Query: 299 FSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCLLDRIRVLAGDDERPNWSD 358
            S SPR PF FP+WVSV S S +   I+SP             +R+  L   D  P+WS 
Sbjct: 293 VSTSPRCPFEFPDWVSVSSGSQM---IDSPE------------ERVTSLV-TDLIPDWSV 336

Query: 359 SECWVTVR 366
           +  WVTVR
Sbjct: 337 TNSWVTVR 344

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356496902|ref|XP_003517304.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  359 bits (922), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 195/371 (52%), Positives = 257/371 (69%), Gaps = 30/371 (8%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           M W+RGD +G GSF +VN+A  +  S  FPS  AVKS +D   SS+ LKNEKE LD +G 
Sbjct: 1   MIWVRGDSLGTGSFATVNIAIPTNTSIHFPSPTAVKS-SDVHSSSM-LKNEKEILDCLGA 58

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +++CFG D++ E GE +YN+ LEYA+ GSLAD+VK+   GRL ES V+R TRS+++G
Sbjct: 59  SPYVIKCFGHDHTVENGEEYYNIFLEYAAGGSLADQVKRHG-GRLPESYVRRCTRSIVEG 117

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L+HIH  G+VHCD+KLQN+LVF+N + KIADFGLAK+    GE+  +FECRGTPL+MSPE
Sbjct: 118 LKHIHDNGYVHCDVKLQNILVFENGDVKIADFGLAKEK---GEKQGTFECRGTPLFMSPE 174

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
           SVN+NEYE+P DIWALGCAVVEM +GKPAW+  + SN++SLLIRIGVG+ELP IP +LSE
Sbjct: 175 SVNDNEYESPADIWALGCAVVEMLTGKPAWD-VRGSNIWSLLIRIGVGEELPKIPEELSE 233

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKFS 300
           +GKDFL+KCF+KDP +RW+AEMLL+HPFV       ++  +  H  +            S
Sbjct: 234 EGKDFLLKCFVKDPMKRWSAEMLLHHPFV-------NNEAVSFHKVNE------PLPLPS 280

Query: 301 QSPRSPFGFPEWVSVQSSSSVTSSI-NSPSFDSF----LSSRDCLLDRIRVLAGDDERPN 355
            SPR+ F    W     +S+VT+ + +SP  D +      S     +R R L  D    N
Sbjct: 281 PSPRTHFDLTHW-----ASTVTTWLPSSPDSDEWRMAEFGSSCSPENRFRRLLTDQTPAN 335

Query: 356 WSDSECWVTVR 366
           WS+S+ W +VR
Sbjct: 336 WSESDGWTSVR 346

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356504533|ref|XP_003521050.1| PREDICTED: mitogen-activated protein kinase kinase kinase 2-like [Glycine max]

 Score =  357 bits (916), Expect = 5e-96,   Method: Compositional matrix adjust.
 Identities = 189/371 (50%), Positives = 252/371 (67%), Gaps = 28/371 (7%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           M W+RG+ +G GSF +VN+A  +  S++F S  AVKS      +S  LKNEKE LD++G 
Sbjct: 1   MNWVRGESLGSGSFATVNIAIPTNTSTQFLSSTAVKSSH--VQTSSMLKNEKEILDRLGA 58

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P ++ CFGDD++ E GE +YN+ LEYA+ GSLAD+VKK   GRL ES V+R TRS+++G
Sbjct: 59  SPYVINCFGDDHTVENGEEYYNIFLEYAAGGSLADQVKKHG-GRLPESYVRRCTRSLVEG 117

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L+HIH  G+VHCD+KLQN+LVF N + KIADFGLAK+    GE+    ECRGTPL+MSPE
Sbjct: 118 LKHIHDNGYVHCDVKLQNILVFQNGDVKIADFGLAKEK---GEKPGKLECRGTPLFMSPE 174

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
           SVN+NEYE+P DIWALGCAVVEM +GKPAW+ +  SN++SLLIRIG G+ELP IP +LSE
Sbjct: 175 SVNDNEYESPADIWALGCAVVEMVTGKPAWDVR-GSNIWSLLIRIGAGEELPKIPEELSE 233

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKD---- 296
           +GKDFL+KCF+KDP +RW+AEMLLNHPFV  +               + S + + +    
Sbjct: 234 EGKDFLLKCFVKDPMKRWSAEMLLNHPFVNGE---------------TVSFQKVNEPLPL 278

Query: 297 EKFSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCLLD-RIRVLAGDDERPN 355
              S SPR+ F    W S   ++S+ SS +S  +  +     C  + R+R L       N
Sbjct: 279 PSPSPSPRTHFDLTHWASTL-TASLPSSPDSDEWRMWEFGSSCSPENRLRRLVTVQTPAN 337

Query: 356 WSDSECWVTVR 366
           WS+S+ W ++R
Sbjct: 338 WSESDGWTSIR 348

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15240194|ref|NP_201509.1| mitogen-activated protein kinase kinase kinase 19 [Arabidopsis thaliana] gi|10177595|dbj|BAB10942.1| protein kinase-like protein [Arabidopsis thaliana] gi|332010915|gb|AED98298.1| mitogen-activated protein kinase kinase kinase 19 [Arabidopsis thaliana]

 Score =  357 bits (915), Expect = 6e-96,   Method: Compositional matrix adjust.
 Identities = 191/368 (51%), Positives = 242/368 (65%), Gaps = 26/368 (7%)

Query: 1   MEWLRGDVIGHGSFGSVNLA-KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           MEW+RG+ IG+G+F +V+LA +++  S EFP LMAVKS      +S  L NEK  LD +G
Sbjct: 1   MEWIRGETIGYGTFSTVSLATRSNNDSGEFPPLMAVKSADSYGAAS--LANEKSVLDNLG 58

Query: 60  I-CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
             C +IVRCFG+D + E GE  +NL LEYASRGSL   +KK     + ES V+R+T S+L
Sbjct: 59  DDCNEIVRCFGEDRTVENGEEMHNLFLEYASRGSLESYLKKLAGEGVPESTVRRHTGSVL 118

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
           +GLRHIH+ GF HCD+KL N+L+F +   KIADFGLAK+       +   + RGTPLYM+
Sbjct: 119 RGLRHIHANGFAHCDLKLGNILLFGDGAVKIADFGLAKRIGDLTALNYGVQIRGTPLYMA 178

Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           PESVN+NEY +  D+WALGC VVEM SGK AW+ K+ SN  SLL+RIGVGDE+P IP +L
Sbjct: 179 PESVNDNEYGSEGDVWALGCVVVEMFSGKTAWSLKEGSNFMSLLLRIGVGDEVPMIPEEL 238

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEK 298
           SEQG+DFL KCF+KDPK+RWTAEMLLNHPFV  D          +       +  +K E 
Sbjct: 239 SEQGRDFLSKCFVKDPKKRWTAEMLLNHPFVTVDVDH------DVLVKEEDFVVNMKTED 292

Query: 299 FSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCLLDRIRVLAGDDERPNWSD 358
            S SPR PF FP+WVSV S S    +I+SP             +R+  L   D  P+WS 
Sbjct: 293 VSTSPRCPFEFPDWVSVSSGS---QTIDSPD------------ERVASLV-TDMIPDWSV 336

Query: 359 SECWVTVR 366
           +  WVTVR
Sbjct: 337 TNSWVTVR 344

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356541799|ref|XP_003539360.1| PREDICTED: mitogen-activated protein kinase kinase kinase 3-like [Glycine max]

 Score =  355 bits (912), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 190/369 (51%), Positives = 251/369 (68%), Gaps = 26/369 (7%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           M W+RG+ +G GSF +VN+A  +  S++F S  AVKS      +S  LKNEKE LD +G 
Sbjct: 1   MNWVRGEPLGSGSFATVNIAIPTNTSTQFLSSTAVKSSY--VHTSSMLKNEKEILDCLGA 58

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P ++ CFGDD++ E GE +YN+ LEYA+ GSLAD+VKK   GRL ES V+R TRS+++G
Sbjct: 59  SPYVINCFGDDHTVENGEEYYNIFLEYAAGGSLADQVKKHG-GRLPESYVRRCTRSLVEG 117

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L+HIH  G+VHCD+KLQN+LVF N + KIADFGLAK+    GE+    ECRGTPL+MSPE
Sbjct: 118 LKHIHDNGYVHCDVKLQNILVFQNGDVKIADFGLAKEK---GEKQGKLECRGTPLFMSPE 174

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
           SVN+NEYE+P DIWALGCAVVEM +GKPAW+ +  SN++SLLIRIG G+ELP IP +LSE
Sbjct: 175 SVNDNEYESPADIWALGCAVVEMLTGKPAWDVR-GSNIWSLLIRIGAGEELPKIPEELSE 233

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKD--EK 298
           +GKDFL+KCF+KDP +RW+AEMLLNHPFV  +               + S + + +    
Sbjct: 234 EGKDFLLKCFVKDPMKRWSAEMLLNHPFVNGE---------------TVSFQKVNEPLPL 278

Query: 299 FSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCLLD-RIRVLAGDDERPNWS 357
            S SPR+ F    W S   ++ + SS +S  +  + S   C  + R+R L       NWS
Sbjct: 279 PSPSPRTHFDLTHWAST-VTALLPSSPDSDEWRMWESGSSCSPENRLRRLVTVQTPANWS 337

Query: 358 DSECWVTVR 366
           +S+ W +VR
Sbjct: 338 ESDGWTSVR 346

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	366
TAIR|locus:2155568	344	MAPKKK19 "mitogen-activated pr	0.830	0.883	0.550	8.9e-92
TAIR|locus:2074835	342	MAPKKK20 "mitogen-activated pr	0.816	0.874	0.556	1.3e-90
TAIR|locus:2114990	336	MAPKKK21 "mitogen-activated pr	0.732	0.797	0.589	3.9e-89
TAIR|locus:2161690	448	MAPKKK15 "mitogen-activated pr	0.909	0.743	0.383	2.4e-53
TAIR|locus:2045658	463	MAPKKK14 "mitogen-activated pr	0.685	0.542	0.438	3.6e-50
TAIR|locus:2007337	499	MAPKKK13 "mitogen-activated pr	0.696	0.511	0.412	6.7e-49
TAIR|locus:2116417	444	MAPKKK16 "mitogen-activated pr	0.775	0.639	0.396	8.5e-49
TAIR|locus:2060246	372	MAPKKK17 "mitogen-activated pr	0.699	0.688	0.422	1.2e-47
TAIR|locus:2205523	339	MAPKKK18 "mitogen-activated pr	0.702	0.758	0.425	2.6e-47
TAIR|locus:2075246	376	AT3G46140 [Arabidopsis thalian	0.710	0.691	0.395	2.5e-42

TAIR|locus:2155568 MAPKKK19 "mitogen-activated protein kinase kinase kinase 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 858 (307.1 bits), Expect = 8.9e-92, Sum P(2) = 8.9e-92
 Identities = 173/314 (55%), Positives = 218/314 (69%)

Query:     1 MEWLRGDVIGHGSFGSVNLA-KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
             MEW+RG+ IG+G+F +V+LA +++  S EFP LMAVKS AD    + +L NEK  LD +G
Sbjct:     1 MEWIRGETIGYGTFSTVSLATRSNNDSGEFPPLMAVKS-ADSY-GAASLANEKSVLDNLG 58

Query:    60 I-CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
               C +IVRCFG+D + E GE  +NL LEYASRGSL   +KK     + ES V+R+T S+L
Sbjct:    59 DDCNEIVRCFGEDRTVENGEEMHNLFLEYASRGSLESYLKKLAGEGVPESTVRRHTGSVL 118

Query:   119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
             +GLRHIH+ GF HCD+KL N+L+F +   KIADFGLAK+       +   + RGTPLYM+
Sbjct:   119 RGLRHIHANGFAHCDLKLGNILLFGDGAVKIADFGLAKRIGDLTALNYGVQIRGTPLYMA 178

Query:   179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
             PESVN+NEY +  D+WALGC VVEM SGK AW+ K+ SN  SLL+RIGVGDE+P IP +L
Sbjct:   179 PESVNDNEYGSEGDVWALGCVVVEMFSGKTAWSLKEGSNFMSLLLRIGVGDEVPMIPEEL 238

Query:   239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTXXXXXXXXXXXXXPSLKGIKDEK 298
             SEQG+DFL KCF+KDPK+RWTAEMLLNHPFV  D                  +  +K E 
Sbjct:   239 SEQGRDFLSKCFVKDPKKRWTAEMLLNHPFVTVD------VDHDVLVKEEDFVVNMKTED 292

Query:   299 FSQSPRSPFGFPEW 312
              S SPR PF FP+W
Sbjct:   293 VSTSPRCPFEFPDW 306

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

TAIR|locus:2074835 MAPKKK20 "mitogen-activated protein kinase kinase kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 865 (309.6 bits), Expect = 1.3e-90, Sum P(2) = 1.3e-90
 Identities = 176/316 (55%), Positives = 223/316 (70%)

Query:     1 MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
             MEW+RG+ IG G+F +V+ A  S+ S +FP+L+AVKS  D    + +L NEK  LD +G 
Sbjct:     1 MEWVRGETIGFGTFSTVSTATKSRNSGDFPALIAVKS-TDAY-GAASLSNEKSVLDSLGD 58

Query:    61 CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             CP+I+RC+G+D + E GE  +NLLLEYASRGSLA  +KK     L ES V+R+T S+L+G
Sbjct:    59 CPEIIRCYGEDSTVENGEEMHNLLLEYASRGSLASYMKKLGGEGLPESTVRRHTGSVLRG 118

Query:   121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERS---QSFECRGTPLYM 177
             LRHIH+KGF HCDIKL N+L+F++   KIADFGLA +   DG+ +   +S E RGTPLYM
Sbjct:   119 LRHIHAKGFAHCDIKLANILLFNDGSVKIADFGLAMR--VDGDLTALRKSVEIRGTPLYM 176

Query:   178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
             +PE VN+NEY +  D+WALGCAVVEM SGK AW+ K+ S+  SLLIRIGVGDELP IP  
Sbjct:   177 APECVNDNEYGSAADVWALGCAVVEMFSGKTAWSVKEGSHFMSLLIRIGVGDELPKIPEM 236

Query:   238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTXXXXXXXXXXXXXPSLKGIKDE 297
             LSE+GKDFL KCF+KDP +RWTAEMLLNH FV  D +                +K +KDE
Sbjct:   237 LSEEGKDFLSKCFVKDPAKRWTAEMLLNHSFVTIDLEDDHRENFV--------VK-VKDE 287

Query:   298 -KFSQSPRSPFGFPEW 312
              K   SP+ PF F +W
Sbjct:   288 DKVLMSPKCPFEFDDW 303

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0048235 "pollen sperm cell differentiation" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0009409 "response to cold" evidence=IEP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0009651 "response to salt stress" evidence=IMP

TAIR|locus:2114990 MAPKKK21 "mitogen-activated protein kinase kinase kinase 21" [Arabidopsis thaliana (taxid:3702)]

 Score = 827 (296.2 bits), Expect = 3.9e-89, Sum P(2) = 3.9e-89
 Identities = 164/278 (58%), Positives = 205/278 (73%)

Query:     1 MEWLRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
             MEW+R + IGHGSF +V+LA  S  SS+ FPSLMAVKS       S  L+NE++ LD +G
Sbjct:     1 MEWIRRETIGHGSFSTVSLATTSGSSSKAFPSLMAVKSSGVV--CSAALRNERDVLDDLG 58

Query:    60 ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
              C +IVRCFG+  + E GE  YNL LEYAS GSLADR+K      L E +V+R+TRS++K
Sbjct:    59 DCSEIVRCFGEGRTVENGEEIYNLFLEYASGGSLADRIKSSGEA-LPEFEVRRFTRSIVK 117

Query:   120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
             GL HIH  GF HCDIKL+NVLVF + + KI+DFGLAK+ S  GE     E RGTPLYM+P
Sbjct:   118 GLCHIHGNGFTHCDIKLENVLVFGDGDVKISDFGLAKRRS--GE--VCVEIRGTPLYMAP 173

Query:   180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD--SNVFSLLIRIGVGDELPNIPGD 237
             ESVN  E+E+P DIWALGC+VVEM+SGK AW  +    +NV SLL+RIG GDE+P IP +
Sbjct:   174 ESVNHGEFESPADIWALGCSVVEMSSGKTAWCLEDGVMNNVMSLLVRIGSGDEVPRIPVE 233

Query:   238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQT 275
             LSE+GKDF+ KCF+K+   RWTAEMLL+HPF+  DD++
Sbjct:   234 LSEEGKDFVSKCFVKNAAERWTAEMLLDHPFLAVDDES 271

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2161690 MAPKKK15 "mitogen-activated protein kinase kinase kinase 15" [Arabidopsis thaliana (taxid:3702)]

 Score = 552 (199.4 bits), Expect = 2.4e-53, P = 2.4e-53
 Identities = 142/370 (38%), Positives = 199/370 (53%)

Query:     3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
             W+RG +IG GS  +V+L   +  S +F    AVKS A+   SS  L+ E+  L ++   P
Sbjct:     6 WIRGPIIGRGSTATVSLGITN--SGDF---FAVKS-AEFS-SSAFLQREQSILSKLS-SP 57

Query:    63 QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
              IV+  G + + E  +  YNLL+EY S GSL D +K  + G+L E  ++ YTR +LKGL 
Sbjct:    58 YIVKYIGSNVTKENDKLMYNLLMEYVSGGSLHDLIKN-SGGKLPEPLIRSYTRQILKGLM 116

Query:   123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV 182
             ++H +G VHCD+K QNV++   + AKI D G AK      E +++ E  GTP +MSPE  
Sbjct:   117 YLHDQGIVHCDVKSQNVMI-GGEIAKIVDLGCAKTV----EENENLEFSGTPAFMSPEVA 171

Query:   183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
                E   P D+WALGC V+EMA+G   W    D  V + + +IG   E P IP  LSE+G
Sbjct:   172 RGEEQSFPADVWALGCTVIEMATGSSPWPELND--VVAAIYKIGFTGESPVIPVWLSEKG 229

Query:   243 KDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTXXXXXXXXXXXXXPSLKGIKDEKF--- 299
             +DFL KC  KDPK+RWT E LL HPF+  +D               PS   + D++F   
Sbjct:   230 QDFLRKCLRKDPKQRWTVEELLQHPFLDEEDNDSDQTGNCLNSSS-PST--VLDQRFWDL 286

Query:   300 SQSPRSPFGFPEWXXXXXXXXXXXXXXXXXFDSFLSSRDCLL-DRIRVLAGDDE--RPNW 356
              ++ RS F   +                    +FL   D L  DRI+ LAGD+    P+W
Sbjct:   287 CETSRSRFIKEDHEDPFANST-----------NFLWDDDSLPGDRIKKLAGDESSGEPDW 335

Query:   357 SDSECWVTVR 366
              ++  W+ VR
Sbjct:   336 -ETNGWIEVR 344

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2045658 MAPKKK14 "mitogen-activated protein kinase kinase kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 522 (188.8 bits), Expect = 3.6e-50, P = 3.6e-50
 Identities = 121/276 (43%), Positives = 164/276 (59%)

Query:     3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC--ADCPPSSV-TLKNEKEALDQIG 59
             W+RG  +G G FG+V+ A  SK+      L AVKS   A C PS   +L+NE   L  + 
Sbjct:    17 WIRGSCVGRGCFGTVSKA-LSKIDG---GLFAVKSIDLATCLPSQAESLENEIVILRSMK 72

Query:    60 ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               P IVR  GDD S E    F NL LEY+  G +A      N G + E+ ++RY   ++ 
Sbjct:    73 SHPNIVRFLGDDVSKEGTASFRNLHLEYSPEGDVA------NGGIVNETLLRRYVWCLVS 126

Query:   120 GLRHIHSKGFVHCDIKLQNVLVFDNDEA-KIADFGLAKKSSCDGERSQ-SFECRGTPLYM 177
              L H+HS G VHCD+K +NVLVF+   + K+ADFG    S+ + E+S      RG+PL+M
Sbjct:   127 ALSHVHSNGIVHCDVKSKNVLVFNGGSSVKLADFG----SAVEFEKSTIHVSPRGSPLWM 182

Query:   178 SPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
             +PE V   EY+ P  D+W+LGC V+EM +GKPAW    + + F  L RIG  ++LP IP 
Sbjct:   183 APEVVRR-EYQGPESDVWSLGCTVIEMLTGKPAW----EDHGFDSLSRIGFSNDLPFIPV 237

Query:   237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
              LSE G+DFL KC  +D  +RW+ + LL HPF+C D
Sbjct:   238 GLSELGRDFLEKCLKRDRSQRWSCDQLLQHPFLCQD 273

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IMP

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

TAIR|locus:2007337 MAPKKK13 "mitogen-activated protein kinase kinase kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 510 (184.6 bits), Expect = 6.7e-49, P = 6.7e-49
 Identities = 111/269 (41%), Positives = 159/269 (59%)

Query:     3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
             W+RG  IG G FG+V+ A  SK + E  ++ +V      P  S +L+NE      +   P
Sbjct:    23 WVRGACIGRGCFGAVSTA-ISKTNGEVFAVKSVDLATSLPTQSESLENEISVFRSLKPHP 81

Query:    63 QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQ-ESDVKRYTRSMLKGL 121
              IV+  GD  S E    F NL LEY   G +A     +  G+++ E+ ++RYT  ++  L
Sbjct:    82 YIVKFLGDGVSKEGTTTFRNLYLEYLPNGDVASH---RAGGKIEDETLLQRYTACLVSAL 138

Query:   122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
             RH+HS+GFVHCD+K +N+LV  +   K+ADFG A +      R+     RG+PL+M+PE 
Sbjct:   139 RHVHSQGFVHCDVKARNILVSQSSMVKLADFGSAFRIHTP--RAL-ITPRGSPLWMAPEV 195

Query:   182 VNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
             +   EY+ P  D+W+LGC ++EM +GKPAW   +D  + SL  RI   DELP  P  LSE
Sbjct:   196 IRR-EYQGPESDVWSLGCTIIEMFTGKPAW---EDHGIDSLS-RISFSDELPVFPSKLSE 250

Query:   241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
              G+DFL KC  +DP +RW+ + LL HPF+
Sbjct:   251 IGRDFLEKCLKRDPNQRWSCDQLLQHPFL 279

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2116417 MAPKKK16 "mitogen-activated protein kinase kinase kinase 16" [Arabidopsis thaliana (taxid:3702)]

 Score = 509 (184.2 bits), Expect = 8.5e-49, P = 8.5e-49
 Identities = 121/305 (39%), Positives = 169/305 (55%)

Query:     1 MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
             + W RG +IG GS  +V++A +S  S E   L AVKS AD   SS+ L+ E+  L  +  
Sbjct:     3 INWTRGPIIGRGSTATVSIAISS--SGE---LFAVKS-ADLSSSSL-LQKEQSILSTLS- 54

Query:    61 CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              P +V+  G   + E     YN+L+EY S G+L D +K  + G+L E +++ YTR +L G
Sbjct:    55 SPHMVKYIGTGLTRESNGLVYNILMEYVSGGNLHDLIKN-SGGKLPEPEIRSYTRQILNG 113

Query:   121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
             L ++H +G VHCD+K  NVLV +N   KIAD G AK  S D  +S   E  GTP +M+PE
Sbjct:   114 LVYLHERGIVHCDLKSHNVLVEENGVLKIADMGCAK--SVD--KS---EFSGTPAFMAPE 166

Query:   181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
                  E   P D+WALGC ++EM +G   W    D  V + + +IG   E P IP  +S+
Sbjct:   167 VARGEEQRFPADVWALGCTMIEMMTGSSPWPELND--VVAAMYKIGFSGESPAIPAWISD 224

Query:   241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTXXXXXXXXXXXXXPSLKGIKDEKFS 300
             + KDFL  C  +D K+RWT E LL HPF+  DD+              PS   + D++F 
Sbjct:   225 KAKDFLKNCLKEDQKQRWTVEELLKHPFL-DDDEESQTSDCLKNKTSSPST--VLDQRFW 281

Query:   301 QSPRS 305
              S  S
Sbjct:   282 DSCES 286

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2060246 MAPKKK17 "mitogen-activated protein kinase kinase kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 498 (180.4 bits), Expect = 1.2e-47, P = 1.2e-47
 Identities = 115/272 (42%), Positives = 157/272 (57%)

Query:     1 MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
             MEW RG ++G GS  +V  A A   S E   ++AVKS ++   S   L+ E + L  +  
Sbjct:     1 MEWTRGRILGRGSTATV-YAAAGHNSDE---ILAVKS-SEVHRSEF-LQREAKILSSLS- 53

Query:    61 CPQIVRCFGDDYSFEK-GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
              P ++   G +   E  G   YNLL+EYA  G+L D   K + GR+ E+ V +YTR +LK
Sbjct:    54 SPYVIGYRGSETKRESNGVVMYNLLMEYAPYGTLTDAAAK-DGGRVDETRVVKYTRDILK 112

Query:   120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
             GL +IHSKG VHCD+K  NV++ +  EAKIADFG AK+     E        GTP +M+P
Sbjct:   113 GLEYIHSKGIVHCDVKGSNVVISEKGEAKIADFGCAKRVDPVFESP----VMGTPAFMAP 168

Query:   180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS--NVFSLLIRIGVGDELPNIPGD 237
             E     +     DIWA+GC ++EM +G P W  K DS  +  S+L R+G   E P +P  
Sbjct:   169 EVARGEKQGKESDIWAVGCTMIEMVTGSPPWT-KADSREDPVSVLYRVGYSSETPELPCL 227

Query:   238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             L+E+ KDFL KC  ++   RWTA  LLNHPF+
Sbjct:   228 LAEEAKDFLEKCLKREANERWTATQLLNHPFL 259

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205523 MAPKKK18 "mitogen-activated protein kinase kinase kinase 18" [Arabidopsis thaliana (taxid:3702)]

 Score = 474 (171.9 bits), Expect = 2.6e-47, Sum P(2) = 2.6e-47
 Identities = 117/275 (42%), Positives = 157/275 (57%)

Query:     1 MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
             M W RG  +G GS  +V+ A   + S E    +AVKS A+   S   L+ E + L  +  
Sbjct:     1 MNWTRGKTLGRGSTATVSAATCHE-SGE---TLAVKS-AEFHRSEF-LQREAKILSSLN- 53

Query:    61 CPQIVRCFGDDYSFE----KGERF-YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
              P ++   G + + E     GE   Y+LL+EYA  G+L D V  +N G + E+ V +YTR
Sbjct:    54 SPYVIGYRGCEITREPFHNNGEATTYSLLMEYAPYGTLTD-VATKNGGFIDEARVVKYTR 112

Query:   116 SMLKGLRHIH-SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
              +L GL +IH SKG  HCDIK  NVLV +N EAKIADFG AK    + E ++    RGTP
Sbjct:   113 QILLGLEYIHNSKGIAHCDIKGSNVLVGENGEAKIADFGCAKW--VEPEITEPV--RGTP 168

Query:   175 LYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
              +M+PE+          DIWA+GC V+EM +G   W     ++  S+L R+G   ELP +
Sbjct:   169 AFMAPEAARGERQGKESDIWAVGCTVIEMVTGSQPWIGADFTDPVSVLYRVGYLGELPEL 228

Query:   235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             P  L+EQ KDFL KC  K+   RWTA  LLNHPF+
Sbjct:   229 PCSLTEQAKDFLGKCLKKEATERWTASQLLNHPFL 263

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075246 AT3G46140 [Arabidopsis thaliana (taxid:3702)]

 Score = 448 (162.8 bits), Expect = 2.5e-42, P = 2.5e-42
 Identities = 111/281 (39%), Positives = 154/281 (54%)

Query:     3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
             W++ + +G GS+GSV LA + K  ++  + MA+KS A+   +S +L +E+  L ++   P
Sbjct:    96 WIKSEFLGRGSYGSVYLATSKKAKTK--TTMAIKS-AEISRAS-SLMDEERILTRLS-SP 150

Query:    63 QIVRCFGDDYSFEK----GERF-YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
              IVRC+G + + E+    GER  YNL+LEY S  SL D V   N G L E DVK   R +
Sbjct:   151 FIVRCYGHEIAREETLFGGERTNYNLILEYCSGKSLFDLVN-DNLGGLSEKDVKLLARDI 209

Query:   118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDE--------AKIADFGLA-KKSSCDGERSQSF 168
             L GL  IH    +HCDIK +N+ +   +         AKI DFGLA +K S + E++   
Sbjct:   210 LYGLDCIHRANIIHCDIKPENIFLTPVENRIRPSGYVAKIGDFGLALEKGSSEYEKASGH 269

Query:   169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG 228
               RGT  YMSPE +     +   D WA GC V+EM +G+  W    D       I IG  
Sbjct:   270 R-RGTTRYMSPELIRHGIVDYAVDTWAFGCTVLEMLTGQQVWGEHSDLGSVDWDILIGQS 328

Query:   229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
               +P IP  LSE+ + FL +C  +DP  RW    LLNHPF+
Sbjct:   329 CYIPYIPDWLSEEAQHFLSRCLKRDPASRWGIGALLNHPFL 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005739 "mitochondrion" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00050488 hypothetical protein (348 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	366
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-106
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-71
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-64
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-64
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-62
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-60
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-58
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-57
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-51
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-50
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-49
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-47
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-45
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-45
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-44
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-43
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-43
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-42
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-40
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-40
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-40
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-39
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-38
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-38
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-36
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-36
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-35
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-34
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-34
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-34
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-34
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-32
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-32
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-31
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-31
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-31
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-31
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-31
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-30
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-30
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-30
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-29
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-28
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-28
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-28
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-27
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-27
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-27
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-27
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-27
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-27
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-26
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-26
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-26
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-26
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-26
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-26
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-26
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-25
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-25
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-25
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-25
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-25
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-25
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-25
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-25
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-25
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-24
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-24
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-24
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-24
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-24
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-24
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-24
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-24
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-24
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-24
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-24
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-23
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-23
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-23
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-23
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-23
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-23
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-23
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-23
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-22
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-22
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-22
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-22
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-22
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-21
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-21
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-21
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-21
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-21
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-21
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-20
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-20
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-20
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-20
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-20
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-20
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-20
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-20
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-20
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-20
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-19
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-19
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-18
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-18
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-18
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-18
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-18
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-18
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-18
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-18
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-17
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-17
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-17
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-17
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-17
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-17
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-16
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-16
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-15
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-15
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-14
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-14
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-14
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-13
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-10
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-08
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-06
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-06
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	6e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	9e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	9e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	5e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	8e-04

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  311 bits (798), Expect = e-106
 Identities = 119/273 (43%), Positives = 160/273 (58%), Gaps = 18/273 (6%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCA---DCPPSSVTLKNEKEALDQI 58
           EW RG+++G GSFGSV LA    +  +   LMAVKS     D       L+ E   L  +
Sbjct: 1   EWTRGELLGRGSFGSVYLA----LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL 56

Query: 59  GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              P IVR +G +    + +   N+ LEY S GSL+  +KK   G+L E  +++YTR +L
Sbjct: 57  Q-HPNIVRYYGSERD--EEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQIL 111

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK--SSCDGERSQSFECRGTPLY 176
           +GL ++HS G VH DIK  N+LV  +   K+ADFG AK+      GE + S   RGTP +
Sbjct: 112 EGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV--RGTPYW 169

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           M+PE +   EY    DIW+LGC V+EMA+GKP W+     N  + L +IG   E P IP 
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL--GNPMAALYKIGSSGEPPEIPE 227

Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            LSE+ KDFL KC  +DPK+R TA+ LL HPF+
Sbjct: 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  222 bits (568), Expect = 3e-71
 Identities = 95/270 (35%), Positives = 144/270 (53%), Gaps = 19/270 (7%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC--ADCPPSSVTLKNEKEALDQIGI 60
           +   + +G GSFG V LA+  K + +   L+A+K             +  E + L ++  
Sbjct: 1   YEILEKLGEGSFGKVYLAR-DKKTGK---LVAIKVIKKKKIKKDRERILREIKILKKLK- 55

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IVR +     FE  ++ Y L++EY   G L D +KK   GRL E + + Y R +L  
Sbjct: 56  HPNIVRLYD---VFEDEDKLY-LVMEYCEGGDLFDLLKK--RGRLSEDEARFYLRQILSA 109

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L ++HSKG VH D+K +N+L+ ++   K+ADFGLA++    GE+  +F   GTP YM+PE
Sbjct: 110 LEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTF-V-GTPEYMAPE 166

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-ELPNIPGDLS 239
            +    Y    DIW+LG  + E+ +GKP +    D  +  L  +IG      P    D+S
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFPG--DDQLLELFKKIGKPKPPFPPPEWDIS 224

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            + KD + K  +KDP++R TAE  L HPF 
Sbjct: 225 PEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  205 bits (524), Expect = 1e-64
 Identities = 101/277 (36%), Positives = 147/277 (53%), Gaps = 30/277 (10%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG--- 59
           W +G+++G GSFGSV       ++ +     AVK  +            +EA+ Q+    
Sbjct: 2   WRKGELLGSGSFGSVYEG----LNLDDGDFFAVKEVSLADDGQTG----QEAVKQLEQEI 53

Query: 60  -----IC-PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
                +  P IV+  G     E+ E    + LE    GSLA  +KK   G   E  ++ Y
Sbjct: 54  ALLSKLQHPNIVQYLGT----EREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLY 107

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
           TR +L GL ++H +  VH DIK  N+LV  N   K+ADFG+AK+     E S +   +G+
Sbjct: 108 TRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV---EFSFAKSFKGS 164

Query: 174 PLYMSPESVN-ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
           P +M+PE +  +  Y    DIW+LGC V+EMA+GKP W+  +     + + +IG   ELP
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRSKELP 221

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            IP  LS++ KDF++KC  +DP  R TA  LL HPFV
Sbjct: 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  204 bits (521), Expect = 5e-64
 Identities = 107/281 (38%), Positives = 151/281 (53%), Gaps = 30/281 (10%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK---NEKEALDQI 58
            W RG+ IG G+FG V  A    V+ +   LMAVK          T+K   +E + L+ +
Sbjct: 1   RWQRGNKIGGGTFGKVYTA----VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL 56

Query: 59  GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR-LQESDVKRYTRSM 117
              P +V+ +G +   EK      + +EY S G+L + ++   +GR L E  ++ YT  +
Sbjct: 57  -KHPNLVKYYGVEVHREK----VYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQL 108

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD----GERSQSFECRGT 173
           L+GL ++HS G VH DIK  N+ +  N   K+ DFG A K   +    GE  QS    GT
Sbjct: 109 LEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL--AGT 166

Query: 174 PLYMSPESVNENE---YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE 230
           P YM+PE +   +   +    DIW+LGC V+EMA+GK  W  + D N F ++  +G G  
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW-SELD-NEFQIMFHVGAG-H 223

Query: 231 LPNIPG--DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            P IP    LS +GKDFL +C   DPK+R TA  LL HPFV
Sbjct: 224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  198 bits (506), Expect = 7e-62
 Identities = 93/275 (33%), Positives = 136/275 (49%), Gaps = 23/275 (8%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-- 60
           +     +G GSFG+V  AK            AVK        S   K ++ A  +I I  
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIV----AVKIL---KKRSEKSKKDQTARREIRILR 53

Query: 61  ---CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P IVR      +FE  +  Y L++EY   G L D + +   G L E + K+    +
Sbjct: 54  RLSHPNIVRLID---AFEDKDHLY-LVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQI 107

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           L+GL ++HS G +H D+K +N+L+ +N   KIADFGLAKK         +F   GTP YM
Sbjct: 108 LRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF--VGTPWYM 165

Query: 178 SPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PE +   N Y    D+W+LG  + E+ +GKP ++ +   +   L+ RI       + P 
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK 225

Query: 237 --DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
               SE+ KD + KC  KDP +R TAE +L HP+ 
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  194 bits (494), Expect = 4e-60
 Identities = 92/267 (34%), Positives = 140/267 (52%), Gaps = 20/267 (7%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSV-TLKNEKEALDQIGICP 62
           GD+IG G+FG V     +  + +F   +A+K  S       ++ ++  E + L  +   P
Sbjct: 5   GDLIGRGAFGVVYKG-LNLETGDF---VAIKQISLEKIKEEALKSIMQEIDLLKNLK-HP 59

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            IV+  G      +      ++LEYA  GSL   +KK   G   ES V  Y   +L+GL 
Sbjct: 60  NIVKYIG----SIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLA 113

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV 182
           ++H +G +H DIK  N+L   +   K+ADFG+A K   +          GTP +M+PE +
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVI 171

Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
             +      DIW+LGC V+E+ +G P +    D N  + L RI V D+ P +P  +S + 
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPPY---YDLNPMAALFRI-VQDDHPPLPEGISPEL 227

Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           KDFL++CF KDP  R TA+ LL HP++
Sbjct: 228 KDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  190 bits (484), Expect = 1e-58
 Identities = 92/274 (33%), Positives = 146/274 (53%), Gaps = 28/274 (10%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI- 60
            +   + IG G FG V  A+  K + +    +A+K          + + +++ +++I I 
Sbjct: 1   LFEILEKIGKGGFGEVYKAR-HKRTGK---EVAIKVIKL-----ESKEKKEKIINEIQIL 51

Query: 61  --C--PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
             C  P IV+ +G   S+ K +  + +++E+ S GSL D + K  N  L ES +    + 
Sbjct: 52  KKCKHPNIVKYYG---SYLKKDELW-IVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKE 106

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           +LKGL ++HS G +H DIK  N+L+  + E K+ DFGL+ + S D +   +    GTP +
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMV--GTPYW 163

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD--ELPNI 234
           M+PE +N   Y+   DIW+LG   +E+A GKP   +  +      L +I       L N 
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPP--YS-ELPPMKALFKIATNGPPGLRN- 219

Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P   S++ KDFL KC  K+P++R TAE LL HPF
Sbjct: 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  187 bits (476), Expect = 3e-57
 Identities = 89/269 (33%), Positives = 133/269 (49%), Gaps = 18/269 (6%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCA--DCPPSSVTLKNEKEALDQIGICP 62
           R  V+G GS G V   +       +    A+K             L  E + L +    P
Sbjct: 5   RVKVLGQGSSGVVYKVRHKPTGKIY----ALKKIHVDGDEEFRKQLLRELKTL-RSCESP 59

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            +V+C+G   +F K      ++LEY   GSLAD +KK   G++ E  +    R +LKGL 
Sbjct: 60  YVVKCYG---AFYKEGEIS-IVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLD 113

Query: 123 HIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           ++H+K   +H DIK  N+L+    E KIADFG++K      ++  +F   GT  YMSPE 
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPER 171

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL-SE 240
           +    Y    DIW+LG  ++E A GK  +      + F L+  I      P++P +  S 
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEFSP 230

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           + +DF+  C  KDPK+R +A  LL HPF+
Sbjct: 231 EFRDFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  169 bits (431), Expect = 3e-51
 Identities = 80/263 (30%), Positives = 124/263 (47%), Gaps = 52/263 (19%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           +G G FG+V LA+  K   +     A+K     D       L  E E L ++   P IV+
Sbjct: 1   LGEGGFGTVYLARDKKTGKKV----AIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVK 55

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            +G    FE     Y L++EY   GSL D +K+ N G+L E ++ R    +L+GL ++HS
Sbjct: 56  LYG---VFEDENHLY-LVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHS 110

Query: 127 KGFVHCDIKLQNVLVF-DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV-NE 184
            G +H D+K +N+L+  DN + K+ADFGL+K  + D    ++    GTP YM+PE +  +
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMAPEVLLGK 168

Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             Y    DIW+LG  + E+                                     + KD
Sbjct: 169 GYYSEKSDIWSLGVILYEL------------------------------------PELKD 192

Query: 245 FLIKCFLKDPKRRWTAEMLLNHP 267
            + K   KDP++R +A+ +L H 
Sbjct: 193 LIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  169 bits (429), Expect = 3e-50
 Identities = 94/283 (33%), Positives = 147/283 (51%), Gaps = 31/283 (10%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEK-----EALDQ 57
           W++G++IG G++G V LA    ++     +MAVK   + P +     + +     +AL  
Sbjct: 3   WVKGELIGKGTYGRVYLA----LNVTTGEMMAVKQ-VELPATIAGRHDSRQKDMVKALRS 57

Query: 58  -IGIC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVK 111
            I          IV+  G    FE  E + ++ LEY   GS+   ++    GR +E  V+
Sbjct: 58  EIETLKDLDHLNIVQYLG----FETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVR 111

Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR 171
            +T  +L+GL ++HSKG +H D+K  N+LV  +   KI+DFG++KKS    +  Q+   +
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 172 GTPLYMSPESVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
           G+  +M+PE ++     Y A  DIW+LGC V+EM +G+  W+   D    + + ++G   
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS---DEEAIAAMFKLGNKR 228

Query: 230 ELPNIPGD----LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
             P IP D    LS    DFL  CF  +P  R TA  LL HPF
Sbjct: 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  165 bits (419), Expect = 7e-49
 Identities = 87/275 (31%), Positives = 144/275 (52%), Gaps = 19/275 (6%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEAL-DQIGI 60
           EWL+G  +G G+F S   A+  K  +    LMAVK       +S   +   EAL  +I +
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGT----LMAVKQVTYVRNTSSEQEEVVEALRKEIRL 56

Query: 61  C-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                 P I+R  G   + E     +NL +E+ + GS++  + K   G  +E+ +  YT 
Sbjct: 57  MARLNHPHIIRMLGA--TCEDSH--FNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTE 110

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE-AKIADFGLAKKSSCDGERSQSFECR--G 172
            +L+GL ++H    +H D+K  N+L+    +  +IADFG A + +  G  +  F+ +  G
Sbjct: 111 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG 170

Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
           T  +M+PE +   +Y   CD+W++GC ++EMA+ KP WN ++ SN  +L+ +I      P
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHP 267
           +IP  LS   +D  ++C    P+ R  +  LL HP
Sbjct: 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  161 bits (409), Expect = 2e-47
 Identities = 97/280 (34%), Positives = 142/280 (50%), Gaps = 27/280 (9%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALD----QI 58
           W++G +IG GSFGSV L   +  S E   LMAVK       S+ +   ++  LD    +I
Sbjct: 2   WIKGALIGSGSFGSVYLG-MNASSGE---LMAVKQVELPSVSASSKDRKRSMLDALAREI 57

Query: 59  GIC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
            +        IV+  G            N+ LEY   GS+A  +   N G  +E+ V+ +
Sbjct: 58  ALLKELQHENIVQYLGSSLD----ADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNF 111

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK----SSCDGERSQSFE 169
            R +LKGL ++H++G +H DIK  N+LV +    KI+DFG++KK    S           
Sbjct: 112 VRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171

Query: 170 CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
            +G+  +M+PE V +  Y    DIW+LGC VVEM +GK  +    D      + +IG  +
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF---PDCTQLQAIFKIG-EN 227

Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             P IP ++S +  DFL K F  D  +R TA  LL HPF+
Sbjct: 228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  155 bits (394), Expect = 5e-45
 Identities = 86/273 (31%), Positives = 143/273 (52%), Gaps = 37/273 (13%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGI-----C 61
            IG GSFG V  A   K +++   ++A+K   D   +     +E E + Q I        
Sbjct: 8   CIGKGSFGEVYKA-IDKRTNQ---VVAIK-VIDLEEAE----DEIEDIQQEIQFLSQCRS 58

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P I + +G   SF KG + + +++EY   GS  D +K    G+L E+ +    R +L GL
Sbjct: 59  PYITKYYG---SFLKGSKLW-IIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGL 111

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR----GTPLYM 177
            ++H +G +H DIK  N+L+ +  + K+ADFG++      G+ + +   R    GTP +M
Sbjct: 112 EYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS------GQLTSTMSKRNTFVGTPFWM 165

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           +PE + ++ Y+   DIW+LG   +E+A G+P  +      V  L+ +    +  P++ G+
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK----NNPPSLEGN 221

Query: 238 L-SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             S+  KDF+  C  KDPK R +A+ LL H F+
Sbjct: 222 KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  154 bits (391), Expect = 7e-45
 Identities = 93/281 (33%), Positives = 144/281 (51%), Gaps = 35/281 (12%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGIC 61
           W RG ++G G+FG V L        E    +AVK     P S  T K E  AL+  I + 
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRE----LAVKQVPFDPDSPET-KKEVNALECEIQLL 58

Query: 62  -----PQIVRCFG---DDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
                 +IV+ +G   DD +        ++ +EY   GS+ D++K    G L E+  ++Y
Sbjct: 59  KNLQHERIVQYYGCLRDDETL-------SIFMEYMPGGSVKDQLKAY--GALTETVTRKY 109

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-----SSCDGERSQSF 168
           TR +L+G+ ++HS   VH DIK  N+L       K+ DFG +K+     SS  G +S + 
Sbjct: 110 TRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT- 168

Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG 228
              GTP +MSPE ++   Y    D+W++GC VVEM + KP W    +    + + +I   
Sbjct: 169 ---GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQ 222

Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
              P +P  +S   ++FL + F+++ K+R +AE LL H FV
Sbjct: 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  153 bits (388), Expect = 2e-44
 Identities = 76/270 (28%), Positives = 135/270 (50%), Gaps = 24/270 (8%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----C 61
             IG GSFG V L +  K   +   L  +K       S+++ K  ++AL+++ I      
Sbjct: 6   KQIGKGSFGKVYLVR-RKSDGK---LYVLKEI---DLSNMSEKEREDALNEVKILKKLNH 58

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN--NGRLQESDVKRYTRSMLK 119
           P I++ +    SFE+  +   +++EYA  G L+ ++KKQ        E  +  +   +  
Sbjct: 59  PNIIKYYE---SFEEKGKLC-IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            L+++HS+  +H DIK QN+ +  N   K+ DFG++K  S   + +++    GTP Y+SP
Sbjct: 115 ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-V-GTPYYLSP 172

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E      Y    DIW+LGC + E+ + K  +   +  N+  L ++I +  + P IP   S
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPF---EGENLLELALKI-LKGQYPPIPSQYS 228

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            + ++ +     KDP+ R +   +L  PF+
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  150 bits (382), Expect = 1e-43
 Identities = 82/272 (30%), Positives = 130/272 (47%), Gaps = 35/272 (12%)

Query: 9   IGHGSFGSVNLAK--------ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           +G GSFG V L +        A KV  +    +  +   +          E+  L +I  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKK--KKIIKRKEVEHT------LTERNILSRIN- 51

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV+     Y+F+  E+ Y L+LEYA  G L   + K+  GR  E   + Y   ++  
Sbjct: 52  HPFIVKLH---YAFQTEEKLY-LVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLA 105

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           L ++HS G ++ D+K +N+L  D D   K+ DFGLAK+ S +G R+ +F   GTP Y++P
Sbjct: 106 LEYLHSLGIIYRDLKPENIL-LDADGHIKLTDFGLAKELSSEGSRTNTFC--GTPEYLAP 162

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E +    Y    D W+LG  + EM +GKP +  +    ++  +++          P  LS
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP-----LRFPEFLS 217

Query: 240 EQGKDFLIKCFLKDPKRRWT---AEMLLNHPF 268
            + +D +     KDP +R     AE +  HPF
Sbjct: 218 PEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  151 bits (383), Expect = 3e-43
 Identities = 85/294 (28%), Positives = 132/294 (44%), Gaps = 51/294 (17%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTL---------KNEKEALD 56
           G +IG GSF +V LAK  + + E+    A+K           L         K EKE L 
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEY----AIKIL-----DKRQLIKEKKVKYVKIEKEVLT 56

Query: 57  QIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
           ++   P I++ +   Y+F+  E  Y  +LEYA  G L   ++K   G L E   + Y   
Sbjct: 57  RLNGHPGIIKLY---YTFQDEENLY-FVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAE 110

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK-------------KSSCDGE 163
           +L  L ++HSKG +H D+K +N+L+  +   KI DFG AK              ++    
Sbjct: 111 ILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 164 RSQSFECR-----GTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV 218
           + +    R     GT  Y+SPE +NE       D+WALGC + +M +GKP +    +   
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230

Query: 219 FSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEM----LLNHPF 268
           F  ++++       + P +     KD + K  + DP+ R         L  HPF
Sbjct: 231 FQKILKLEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  147 bits (372), Expect = 5e-42
 Identities = 86/276 (31%), Positives = 134/276 (48%), Gaps = 41/276 (14%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGI----- 60
           + +G GS+GSV   KA    +     +A+K      P    L+   KE    I I     
Sbjct: 9   EKLGEGSYGSV--YKAIHKETGQV--VAIKVV----PVEEDLQEIIKE----ISILKQCD 56

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV+ +G   S+ K    + +++EY   GS++D +K  N   L E ++       LKG
Sbjct: 57  SPYIVKYYG---SYFKNTDLW-IVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKG 111

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L ++HS   +H DIK  N+L+ +  +AK+ADFG++ + +    +  +    GTP +M+PE
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV--IGTPFWMAPE 169

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN------- 233
            + E  Y    DIW+LG   +EMA GKP ++         +         +PN       
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---------IPNKPPPTLS 220

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            P   S +  DF+ KC +KDP+ R +A  LL HPF+
Sbjct: 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  142 bits (360), Expect = 3e-40
 Identities = 81/285 (28%), Positives = 135/285 (47%), Gaps = 37/285 (12%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-------- 53
           EW +G+V+G G++G+V     ++       L+AVK       + +  + E E        
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTNQ-----GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDL 55

Query: 54  --ALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVK 111
             +L  + I   +  C  D+          ++ +E+   GS++  + +   G L E    
Sbjct: 56  LKSLKHVNIVQYLGTCLDDN--------TISIFMEFVPGGSISSILNR--FGPLPEPVFC 105

Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK---SSCDGERSQSF 168
           +YT+ +L G+ ++H+   VH DIK  NV++  N   K+ DFG A++       G  S   
Sbjct: 106 KYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165

Query: 169 EC-RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV--FSLLIRI 225
           +   GTP +M+PE +NE+ Y    DIW++GC V EMA+GKP       +++   + +  I
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL-----ASMDRLAAMFYI 220

Query: 226 GVGDEL-PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           G    L P +P   S    DF+  C  +D   R +A  LL H F+
Sbjct: 221 GAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  142 bits (360), Expect = 6e-40
 Identities = 88/268 (32%), Positives = 140/268 (52%), Gaps = 26/268 (9%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI---C-- 61
           + IG G+ G V  A       E    +A+K         +  +N++  +++I I   C  
Sbjct: 25  EKIGEGASGEVYKATDRATGKE----VAIKKM------RLRKQNKELIINEILIMKDCKH 74

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +    S+  G+  + +++EY   GSL D +  QN  R+ E  +    R +L+GL
Sbjct: 75  PNIVDYYD---SYLVGDELW-VVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGL 129

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++HS+  +H DIK  N+L+  +   K+ADFG A + + +  +  S    GTP +M+PE 
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV--GTPYWMAPEV 187

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSL-LIRIGVGDELPNIPGDLSE 240
           +   +Y    DIW+LG   +EMA G+P   + ++  + +L LI       L N P   S 
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP--YLREPPLRALFLITTKGIPPLKN-PEKWSP 244

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           + KDFL KC +KDP++R +AE LL HPF
Sbjct: 245 EFKDFLNKCLVKDPEKRPSAEELLQHPF 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  141 bits (356), Expect = 9e-40
 Identities = 90/276 (32%), Positives = 140/276 (50%), Gaps = 22/276 (7%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSS---VTLKNEKEALDQ 57
           + W RG ++G G+FG V L        E  +   V+   + P +S     L+ E + L  
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAA-KQVQFDPESPETSKEVSALECEIQLLKN 60

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           +    +IV+ +G     ++ E+   + +EY   GS+ D++K    G L ES  ++YTR +
Sbjct: 61  LQ-HERIVQYYG--CLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQI 115

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-----SSCDGERSQSFECRG 172
           L+G+ ++HS   VH DIK  N+L       K+ DFG +K+      S  G RS +    G
Sbjct: 116 LEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT----G 171

Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
           TP +MSPE ++   Y    D+W+LGC VVEM + KP W    +    + + +I      P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNP 228

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
            +P  +SE  +DFL  C   + + R +AE LL HPF
Sbjct: 229 QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  141 bits (357), Expect = 1e-39
 Identities = 81/272 (29%), Positives = 140/272 (51%), Gaps = 27/272 (9%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----C 61
             +G G+ G V+     + + +    MAVK+        +    +K+ L ++ I      
Sbjct: 7   GELGAGNSGVVSKVL-HRPTGKI---MAVKTI----RLEINEAIQKQILRELDILHKCNS 58

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  Y+   G+   ++ +EY   GSL D++ K+  GR+ E  + +   ++LKGL
Sbjct: 59  PYIVGFYGAFYN--NGD--ISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGL 113

Query: 122 RHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++H K   +H D+K  N+LV    + K+ DFG++ +       +++F   GT  YM+PE
Sbjct: 114 TYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--LAKTFV--GTSSYMAPE 169

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDS-NVFSLLIRIGVGDELPNIPGD- 237
            +  N+Y    DIW+LG +++E+A+G+ P          +F LL  I V +  P +P   
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGK 228

Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            S   +DF+  C +KDP+ R + + LL HPF+
Sbjct: 229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  141 bits (354), Expect = 2e-38
 Identities = 91/347 (26%), Positives = 146/347 (42%), Gaps = 25/347 (7%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
            +G GSFG V LA+  K+ +    ++A K  +           E + L  +   P IV+ 
Sbjct: 7   KLGEGSFGEVYLARDRKLVA--LKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKL 63

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKK-QNNGRLQESDVKRYTRSMLKGLRHIHS 126
           +     F+     Y L++EY   GSL D +KK    G L ES+       +L  L ++HS
Sbjct: 64  Y---DFFQDEGSLY-LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 127 KGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECR----GTPLYMSPES 181
           KG +H DIK +N+L+  D    K+ DFGLAK     G  S          GTP YM+PE 
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179

Query: 182 V---NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           +   +     +  DIW+LG  + E+ +G P +  +++S+  S  ++I +    P++   L
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239

Query: 239 SEQG--------KDFLIKCFLKDPKRRWTAEMLLNHPFV-CADDQTGDDGGIHIHSSSSP 289
           S            D L K   KDPK R ++   L+H  +     +  D   +     S+P
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAP 299

Query: 290 SLKGIKDEKFSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSS 336
               +     +              ++   S  S   +P+  S    
Sbjct: 300 LRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPH 346

Length = 384

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 8e-38
 Identities = 89/280 (31%), Positives = 138/280 (49%), Gaps = 48/280 (17%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGI---C--P 62
           IG G++G V  A+    + E   L+A+K         +   ++ E + Q I +   C  P
Sbjct: 11  IGSGTYGDVYKAR-DIATGE---LVAIKVI------KLEPGDDFEIIQQEISMLKECRHP 60

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            IV  FG   S+ + ++ + +++EY   GSL D + +   G L E  +    R  LKGL 
Sbjct: 61  NIVAYFG---SYLRRDKLW-IVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLA 115

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV 182
           ++H  G +H DIK  N+L+ ++ + K+ADFG++ + +    + +SF   GTP +M+PE  
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF--IGTPYWMAPEVA 173

Query: 183 NENE---YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSL-----LIRIGVGDELPNI 234
                  Y+  CDIWALG   +E+A  +P         +F L     L  I   +     
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPP--------MFDLHPMRALFLISKSNF---P 222

Query: 235 PGDLSEQGK------DFLIKCFLKDPKRRWTAEMLLNHPF 268
           P  L ++ K      DF+ KC  KDPK+R TA  LL HPF
Sbjct: 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  131 bits (330), Expect = 7e-36
 Identities = 79/264 (29%), Positives = 121/264 (45%), Gaps = 22/264 (8%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----PQ 63
           IG GSFG V      K      ++  +        S +  +  +EA+D+  +        
Sbjct: 8   IGKGSFGVVFKVV-RKADKRVYAMKQIDL------SKMNRREREEAIDEARVLAKLDSSY 60

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           I+R +  +   +KG+   N+++EYA  G L   +K Q    L E  V R+   +L GL H
Sbjct: 61  IIRYY--ESFLDKGK--LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HSK  +H DIK  N+ +   D  KI D G+AK  S +   + +    GTP Y+SPE   
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI--VGTPYYLSPELCE 174

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
           +  Y    D+WALG  + E  +GK    H  D+N    LI   +    P +    S+Q  
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGK----HPFDANNQGALILKIIRGVFPPVSQMYSQQLA 230

Query: 244 DFLIKCFLKDPKRRWTAEMLLNHP 267
             + +C  KD ++R     LL +P
Sbjct: 231 QLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  130 bits (330), Expect = 9e-36
 Identities = 79/279 (28%), Positives = 126/279 (45%), Gaps = 35/279 (12%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEAL-DQIGIC---- 61
           + IG GSFG+V   K  + S     ++  K   +    ++T K EK+ L  ++ I     
Sbjct: 6   ETIGKGSFGTVR--KVRRKSDGK--ILVWK---EIDYGNMTEK-EKQQLVSEVNILRELK 57

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSML 118
            P IVR +         +  Y +++EY   G LA  ++K  +    ++E  + R    +L
Sbjct: 58  HPNIVRYYDRIIDRSN-QTLY-IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115

Query: 119 KGLRHIHSKG-----FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
             L   H++       +H D+K  N+ +  N+  K+ DFGLAK      + S +    GT
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTYVGT 173

Query: 174 PLYMSPESVNENEYEAPCDIWALGCAVVEMASGKP---AWNHKQDSNVFSLLIRIGVGDE 230
           P YMSPE +N   Y+   DIW+LGC + E+ +  P   A N  Q      L  +I  G +
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ------LASKIKEG-K 226

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
              IP   S +  + +      DP +R + E LL  P +
Sbjct: 227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  130 bits (328), Expect = 1e-35
 Identities = 75/210 (35%), Positives = 120/210 (57%), Gaps = 12/210 (5%)

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK-KQNNGRLQESDVKRYTRSMLKGLR 122
           IV+  G D   E G  F+ + +E    GSL+  ++ K    +  E  +  YT+ +L+GL+
Sbjct: 67  IVQYLGSD--SENG--FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122

Query: 123 HIHSKGFVHCDIKLQNVLVFD-NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           ++H    VH DIK  NVLV   +   KI+DFG +K+ +     +++F   GT  YM+PE 
Sbjct: 123 YLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TGTLQYMAPEV 180

Query: 182 VNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +++    Y AP DIW+LGC +VEMA+GKP +    +    + + ++G+    P IP  LS
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGMFKIHPEIPESLS 238

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            + K+F+++CF  DP +R +A  LL  PF+
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  127 bits (320), Expect = 2e-34
 Identities = 74/269 (27%), Positives = 131/269 (48%), Gaps = 24/269 (8%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQI-- 64
             +G GS+GSV   K     ++F +L  V         S++ K  ++A+++I I   +  
Sbjct: 6   KKLGKGSYGSVYKVKRLS-DNQFYALKEVDL------GSMSQKEREDAVNEIRILASVNH 58

Query: 65  --VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR--LQESDVKRYTRSMLKG 120
             +  + +  +F  G +   +++EYA  G L+  + K+   R  + E ++ R    +L+G
Sbjct: 59  PNIISYKE--AFLDGNKLC-IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L+ +H +  +H D+K  N+L+  ND  KI D G++K    +  ++Q     GTP YM+PE
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPE 171

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
                 Y    DIW+LGC + EMA+  P +  +   +   L  ++  G + P IP   S+
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKVQRG-KYPPIPPIYSQ 227

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             ++F+       PK R   + +L  P V
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  127 bits (319), Expect = 3e-34
 Identities = 82/265 (30%), Positives = 142/265 (53%), Gaps = 20/265 (7%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQI 64
           + IG GSFG V       + +    ++A+K   D   +   +++ ++ +  +  C  P I
Sbjct: 10  ERIGKGSFGEV----YKGIDNRTKEVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
            R +G   S+ KG + + +++EY   GS  D +K    G L+E+ +    R +LKGL ++
Sbjct: 65  TRYYG---SYLKGTKLW-IIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYL 117

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HS+  +H DIK  NVL+ +  + K+ADFG+A + +    +  +F   GTP +M+PE + +
Sbjct: 118 HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQ 175

Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           + Y+   DIW+LG   +E+A G+P  +      V  L+ +    +  P + G  S+  K+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK----NSPPTLEGQYSKPFKE 231

Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFV 269
           F+  C  KDP+ R TA+ LL H F+
Sbjct: 232 FVEACLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  126 bits (317), Expect = 4e-34
 Identities = 95/278 (34%), Positives = 145/278 (52%), Gaps = 28/278 (10%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALD-QIGIC 61
           W  G ++G G+FG V L   +    E    +AVK     P S  T K E  AL+ +I + 
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRE----LAVKQVPFDPDSQETSK-EVNALECEIQLL 58

Query: 62  P-----QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                 +IV+ +G     E  E+  ++ +EY   GS+ D++K    G L E+  +RYTR 
Sbjct: 59  KNLRHDRIVQYYGCLRDPE--EKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQ 114

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-----SSCDGERSQSFECR 171
           +L+G+ ++HS   VH DIK  N+L       K+ DFG +K+      S  G +S +    
Sbjct: 115 ILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT---- 170

Query: 172 GTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           GTP +MSPE ++   Y    D+W++ C VVEM + KP W   +     + + +I      
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE---AMAAIFKIATQPTK 227

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           P +P  +S+  +DFL + F+++ KRR TAE LL HPFV
Sbjct: 228 PMLPDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  126 bits (317), Expect = 5e-34
 Identities = 91/278 (32%), Positives = 143/278 (51%), Gaps = 28/278 (10%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALD-QIGIC 61
           W  G ++G G+FG V L   +    E    +AVK     P S  T K E  AL+ +I + 
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRE----LAVKQVQFDPESPETSK-EVNALECEIQLL 58

Query: 62  P-----QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                 +IV+ +G     +  ER  ++ +E+   GS+ D++K    G L E+  ++YTR 
Sbjct: 59  KNLLHERIVQYYG--CLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQ 114

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS-----SCDGERSQSFECR 171
           +L+G+ ++HS   VH DIK  N+L       K+ DFG +K+      S  G +S +    
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---- 170

Query: 172 GTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           GTP +MSPE ++   Y    DIW++GC VVEM + KP W    +    + + +I      
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN 227

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           P +P  +S+  +DFL + F+ + K R +A+ LL H FV
Sbjct: 228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  123 bits (310), Expect = 1e-32
 Identities = 79/297 (26%), Positives = 127/297 (42%), Gaps = 51/297 (17%)

Query: 6   GDVIGHGSFGSVNLAK--------ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ 57
              IG G+ G V  AK        A K        +A++      P+      E +AL  
Sbjct: 5   LGRIGEGAHGIVFKAKDRETGETVALK-------KVALRRLEGGIPNQAL--REIKALQA 55

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P +V+       F  G  F  L++EY     L++ ++ +    L E+ VK Y R +
Sbjct: 56  CQ-HPYVVKLLD---VFPHGSGFV-LVMEYMPS-DLSEVLRDEERP-LPEAQVKSYMRML 108

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           LKG+ ++H+ G +H D+K  N+L+  +   KIADFGLA+  S +  R  S +   T  Y 
Sbjct: 109 LKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYR 167

Query: 178 SPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI-GVGDE----- 230
           +PE +    +Y+   D+WA+GC   E+ +G P +  + D    +++ R  G  +E     
Sbjct: 168 APELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227

Query: 231 -----------LPNIPG--------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                       P            D S +  D L    + DP +R +A   L HP+
Sbjct: 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  121 bits (305), Expect = 3e-32
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 26/268 (9%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGIC---- 61
           V+G G+FG   L +     +E  SL+  K  +           K  ++AL++I I     
Sbjct: 7   VLGKGAFGEATLYR----RTEDDSLVVWKEVNLTRLSE-----KERRDALNEIVILSLLQ 57

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I+  +     F        + +EYA+ G+L D++ +Q     +E  V  Y   ++  
Sbjct: 58  HPNIIAYYN---HFMDDNTLL-IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + +IH  G +H DIK  N+ +      K+ DFG++K    +   +++    GTP YMSPE
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPE 171

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
                +Y    DIWALGC + E+ + K  +     +N  +L+++I  G+  P +    S 
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTF---DATNPLNLVVKIVQGNYTP-VVSVYSS 227

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +    +     +DP++R TA+ +L+ P 
Sbjct: 228 ELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  120 bits (302), Expect = 1e-31
 Identities = 77/265 (29%), Positives = 140/265 (52%), Gaps = 20/265 (7%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQI 64
           + IG GSFG V       + +    ++A+K   D   +   +++ ++ +  +  C  P +
Sbjct: 10  ERIGKGSFGEV----FKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
            + +G   S+ KG + + +++EY   GS  D ++    G   E  +    + +LKGL ++
Sbjct: 65  TKYYG---SYLKGTKLW-IIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYL 117

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HS+  +H DIK  NVL+ +  + K+ADFG+A + +    +  +F   GTP +M+PE + +
Sbjct: 118 HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQQ 175

Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           + Y++  DIW+LG   +E+A G+P  +      V  L+ +    +  P + G+ S+  K+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK----NNPPTLTGEFSKPFKE 231

Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFV 269
           F+  C  KDP  R TA+ LL H F+
Sbjct: 232 FIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 1e-31
 Identities = 85/276 (30%), Positives = 136/276 (49%), Gaps = 38/276 (13%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALD---QIGI---C- 61
           +G G+FG V  A+      E     A K           +++E+E  D   +I I   C 
Sbjct: 13  LGDGAFGKVYKAQ----HKETGLFAAAKII--------QIESEEELEDFMVEIDILSECK 60

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV  + + Y +E       +L+E+   G+L   + +   G L E  ++   R ML+ 
Sbjct: 61  HPNIVGLY-EAYFYENK---LWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEA 115

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L  +HS   +H D+K  N+L+  + + K+ADFG++ K+    ++  +F   GTP +M+PE
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGTPYWMAPE 173

Query: 181 SVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI- 234
            V      +N Y+   DIW+LG  ++E+A  +P  +H  + N   +L++I   +  P + 
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEPP-HH--ELNPMRVLLKILKSEP-PTLD 229

Query: 235 -PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            P   S    DFL  C +KDP  R TA  LL HPFV
Sbjct: 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  119 bits (301), Expect = 1e-31
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 42/282 (14%)

Query: 7   DVIGHGSFGSVN----LAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIG 59
           +VIG G+   V     L    KV        A+K   D   C  S   L+ E +A+ Q  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKV--------AIK-RIDLEKCQTSVDELRKEVQAMSQCN 57

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK-KQNNGRLQESDVKRYTRSML 118
             P +V+ +    SF  G+  + L++ Y S GSL D +K     G L E+ +    + +L
Sbjct: 58  -HPNVVKYYT---SFVVGDELW-LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS--FECRGTPLY 176
           KGL ++HS G +H DIK  N+L+ ++   KIADFG++   +  G+R++       GTP +
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 177 MSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           M+PE + + + Y+   DIW+ G   +E+A+G   ++      V  L ++        N P
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ--------NDP 224

Query: 236 GDL---------SEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
             L         S+  +  +  C  KDP +R TAE LL H F
Sbjct: 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  119 bits (299), Expect = 2e-31
 Identities = 75/265 (28%), Positives = 126/265 (47%), Gaps = 20/265 (7%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           I  G+FGSV LAK       F   +  KS          +K E+  +   G  P + + +
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              YSF+  +  Y L++EY + G  A  +K    G L E   K+Y   ++ G+  +H +G
Sbjct: 64  ---YSFQSKDYLY-LVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG 117

Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
            +H DIK +N+L+      K+ DFGL++    +G  ++ F   GTP Y++PE++     +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSR----NGLENKKFV--GTPDYLAPETILGVGDD 171

Query: 189 APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI--RIGVGDELPNIPGDLSEQGKDFL 246
              D W+LGC + E   G P ++ +    VF  ++  RI   +E+       S +  D +
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEF---CSPEAVDLI 228

Query: 247 IKCFLKDPKRRWTA---EMLLNHPF 268
            +    DP +R  A   + + +HPF
Sbjct: 229 NRLLCMDPAKRLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  118 bits (298), Expect = 4e-31
 Identities = 65/211 (30%), Positives = 111/211 (52%), Gaps = 17/211 (8%)

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +    S+  G+  + +++E+   G+L D V    + R+ E  +     ++LK L
Sbjct: 76  PNIVEMYS---SYLVGDELW-VVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKAL 128

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
             +H++G +H DIK  ++L+  +   K++DFG   + S +  R +S    GTP +M+PE 
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPEV 186

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP---NIPGDL 238
           ++   Y    DIW+LG  V+EM  G+P + ++        + RI   D LP        +
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRI--RDNLPPKLKNLHKV 241

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + + FL +  ++DP +R TA  LLNHPF+
Sbjct: 242 SPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  118 bits (296), Expect = 7e-31
 Identities = 78/263 (29%), Positives = 141/263 (53%), Gaps = 20/263 (7%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           IG GSFG V       + +    ++A+K   D   +   +++ ++ +  +  C  P + +
Sbjct: 12  IGKGSFGEV----FKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            +G   S+ K  + + +++EY   GS  D ++    G L E+ +    R +LKGL ++HS
Sbjct: 67  YYG---SYLKDTKLW-IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS 119

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           +  +H DIK  NVL+ ++ E K+ADFG+A + +    +  +F   GTP +M+PE + ++ 
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQSA 177

Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y++  DIW+LG   +E+A G+P  +      V  L+ +    +  P + G+ S+  K+F+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK----NNPPTLEGNYSKPLKEFV 233

Query: 247 IKCFLKDPKRRWTAEMLLNHPFV 269
             C  K+P  R TA+ LL H F+
Sbjct: 234 EACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  116 bits (293), Expect = 2e-30
 Identities = 65/261 (24%), Positives = 122/261 (46%), Gaps = 25/261 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI----- 60
           G  +G G+FG V               +AVK+  +      + +  +E L +  I     
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA----SEQQIEEFLREARIMRKLD 59

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV+  G      + E    +++EY   G L D ++K     L  SD+  +   + +G
Sbjct: 60  HPNIVKLLGV---CTEEEPLM-IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YM 177
           + ++ SK F+H D+  +N LV +N   KI+DFGL++    D      ++ +G  L   +M
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWM 171

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PES+ E ++ +  D+W+ G  + E+ + G+  +    ++ V   L +   G  LP  P 
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK---GYRLP-KPP 227

Query: 237 DLSEQGKDFLIKCFLKDPKRR 257
           +   +    +++C+ +DP+ R
Sbjct: 228 NCPPELYKLMLQCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  116 bits (293), Expect = 2e-30
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 25/272 (9%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT--LKNEKEALDQIGICPQIVR 66
           I  G++G V LAK  K S+     + V   AD    +    +  E++ L Q    P +V+
Sbjct: 1   ISKGAYGRVFLAK--KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVK 57

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            +   YSF+  +  Y L++EY   G LA  ++  N G L E   + Y   ++  L ++HS
Sbjct: 58  LY---YSFQGKKNLY-LVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHS 111

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAK---KSSCDGERSQSFECR---GTPLYMSPE 180
            G +H D+K  N+L+  N   K+ DFGL+K               E +   GTP Y++PE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-ELPNIPGDLS 239
            +    +    D W+LGC + E   G P ++ +    +F     I  G  E P    ++S
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ---NILNGKIEWPEDV-EVS 227

Query: 240 EQGKDFLIKCFLKDPKRR---WTAEMLLNHPF 268
           ++  D + K  + DP++R    + E + NHPF
Sbjct: 228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 2e-30
 Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 57/293 (19%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
            +VIG G++G V  A+  K       L+A+K         +    E+E  ++      I+
Sbjct: 11  VEVIGEGTYGKVYKARHKKTGQ----LVAIKI------MDIIEDEEEEIKEEY----NIL 56

Query: 66  RCFGDDYSFEKG-ERFYN---------------LLLEYASRGSLADRVK--KQNNGRLQE 107
           R     YS       FY                L++E    GS+ D VK  ++   RL+E
Sbjct: 57  R----KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE 112

Query: 108 SDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS 167
             +    R  L+GL ++H    +H DIK QN+L+  N E K+ DFG++ +      R  +
Sbjct: 113 EWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172

Query: 168 FECRGTPLYMSPESVNENE-----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLL 222
               GTP +M+PE +  +E     Y+A  D+W+LG   +E+A GKP             +
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230

Query: 223 IRIGVGDELPNIPGDLSEQGK------DFLIKCFLKDPKRRWTAEMLLNHPFV 269
            R        N P  L           DF+ +C +K+ ++R   E LL HPF+
Sbjct: 231 PR--------NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (288), Expect = 8e-30
 Identities = 68/261 (26%), Positives = 124/261 (47%), Gaps = 26/261 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI----- 60
           G  +G G+FG V   K      +    +AVK+  +      + +  +E L +  I     
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA----SEQQIEEFLREARIMRKLD 59

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +V+  G      + E  Y +++EY   G L   ++K N  +L  SD+  +   + +G
Sbjct: 60  HPNVVKLLGVCT---EEEPLY-IVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARG 114

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YM 177
           + ++ SK F+H D+  +N LV +N   KI+DFGL++    D      +  RG  L   +M
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWM 170

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PES+ E ++ +  D+W+ G  + E+ + G+  +    +  V   L     G  LP  P 
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN---GYRLP-QPP 226

Query: 237 DLSEQGKDFLIKCFLKDPKRR 257
           +   +  D +++C+ +DP+ R
Sbjct: 227 NCPPELYDLMLQCWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  114 bits (288), Expect = 3e-29
 Identities = 77/276 (27%), Positives = 125/276 (45%), Gaps = 38/276 (13%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSC----------ADCPPSSVTLKNEKEALDQ 57
           V+G GSFG V LA+          L AVK             +C         EK  L  
Sbjct: 2   VLGKGSFGKVLLAELKGTDE----LYAVKVLKKDVILQDDDVECT------MTEKRVLAL 51

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
            G  P + +       F+  +R +  ++EY + G L   +  Q +GR  E   + Y   +
Sbjct: 52  AGKHPFLTQLHS---CFQTKDRLF-FVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAEI 105

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + GL+ +H +G ++ D+KL NVL+      KIADFG+ K+    G  + +F C GTP Y+
Sbjct: 106 VLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF-C-GTPDYI 163

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           +PE ++   Y    D WALG  + EM +G+  +    +  +F  ++     ++    P  
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL-----EDEVRYPRW 218

Query: 238 LSEQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
           LS++ K  L     K+P++R        + +  HPF
Sbjct: 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 9e-29
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 32/223 (14%)

Query: 74  FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCD 133
           F +  R Y L+ EY  R +L + ++    G L    V+ Y   +L+ + + HS   +H D
Sbjct: 69  FRRKGRLY-LVFEYVER-TLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCHSHNIIHRD 125

Query: 134 IKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES-VNENEYEAPCD 192
           IK +N+LV ++   K+ DFG A+          + +   T  Y +PE  V +  Y  P D
Sbjct: 126 IKPENILVSESGVLKLCDFGFARALRARPASPLT-DYVATRWYRAPELLVGDTNYGKPVD 184

Query: 193 IWALGCAVVEMASGKPAWNHKQDSNVFSLLIR-IG----------------VGDELPNI- 234
           +WA+GC + E+  G+P +    D +   L+ + +G                 G   P   
Sbjct: 185 VWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPS 244

Query: 235 ---------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                    PG +S    DFL  C   DPK R T + LL HP+
Sbjct: 245 QPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  111 bits (280), Expect = 1e-28
 Identities = 65/188 (34%), Positives = 99/188 (52%), Gaps = 9/188 (4%)

Query: 82  NLLLEYASRGSLADRVKK-QNNGRL-QESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNV 139
           N++LE A  G L+  +K  +   RL  E  + +Y   +   L H+HSK  +H DIK  NV
Sbjct: 78  NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANV 137

Query: 140 LVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCA 199
            +      K+ D GL +  S   + + +    GTP YMSPE ++EN Y    DIW+LGC 
Sbjct: 138 FITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 195

Query: 200 VVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPGD-LSEQGKDFLIKCFLKDPKRR 257
           + EMA+ + P +  K   N++SL  +I   D  P +P D  SE+ +D + +C   DP++R
Sbjct: 196 LYEMAALQSPFYGDKM--NLYSLCKKIEKCD-YPPLPADHYSEELRDLVSRCINPDPEKR 252

Query: 258 WTAEMLLN 265
                +L 
Sbjct: 253 PDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  111 bits (281), Expect = 2e-28
 Identities = 82/304 (26%), Positives = 131/304 (43%), Gaps = 72/304 (23%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVK-------SCADCPPSSVTLKNEKEALDQIGIC 61
           +G G+FGSV LA+ +K + E   L+A+K       S  +C    + L+ E ++L ++   
Sbjct: 7   LGDGTFGSVYLAR-NKETGE---LVAIKKMKKKFYSWEEC----MNLR-EVKSLRKLNEH 57

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV+    +   E  E +   + EY   G+L   +K +      ES ++     +L+GL
Sbjct: 58  PNIVKLK--EVFRENDELY--FVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS--FECRGTPLYMSP 179
            HIH  GF H D+K +N+LV   +  KIADFGLA++      RS+    +   T  Y +P
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI-----RSRPPYTDYVSTRWYRAP 167

Query: 180 ESV-NENEYEAPCDIWALGCAVVEMASGKP------------------------------ 208
           E +     Y +P DIWALGC + E+ + +P                              
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227

Query: 209 ----AWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
                   +      + L ++     +PN   +      D +      DPK+R TA   L
Sbjct: 228 KLASKLGFRFPQFAPTSLHQL-----IPNASPEAI----DLIKDMLRWDPKKRPTASQAL 278

Query: 265 NHPF 268
            HP+
Sbjct: 279 QHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  111 bits (278), Expect = 2e-28
 Identities = 82/267 (30%), Positives = 133/267 (49%), Gaps = 21/267 (7%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK-NEKEA--LDQIGICPQI 64
           V+G GS+G V+L +      ++     +K       S    K  E+EA  L Q+   P I
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQY----VIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNI 61

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V       S+E  +    +++ +   G L  ++K+Q    L E+ V  +   +   L+++
Sbjct: 62  VAY---RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK--KSSCDGERSQSFECRGTPLYMSPESV 182
           H K  +H D+K QNV +   +  K+ D G+A+  ++ CD     +    GTP YMSPE  
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD----MASTLIGTPYYMSPELF 174

Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
           +   Y    D+WALGC V EMA+ K A+N K D N  SL+ RI  G +LP +P D S + 
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMN--SLVYRIIEG-KLPPMPKDYSPEL 230

Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            + +     K P++R + + +L  P++
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 2e-27
 Identities = 79/271 (29%), Positives = 137/271 (50%), Gaps = 23/271 (8%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVT-LKNEKEALDQI--GI 60
           R ++IG G++G+V   K          ++A+K    D P   V+ ++ E   L Q+    
Sbjct: 5   RLELIGRGAYGAVYRGKHVPTGR----VVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I + +G   S+ KG R + +++EYA  GS+   +K    G + E  +    R +L  
Sbjct: 61  PPNITKYYG---SYLKGPRLW-IIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVA 113

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L++IH  G +H DIK  N+LV +    K+ DFG+A   + +  +  +F   GTP +M+PE
Sbjct: 114 LKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV--GTPYWMAPE 171

Query: 181 SVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD-L 238
            + E   Y+   DIW+LG  + EMA+G P ++         L+ +     + P +  +  
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK----SKPPRLEDNGY 227

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S+  ++F+  C  ++PK R +AE LL   ++
Sbjct: 228 SKLLREFVAACLDEEPKERLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  109 bits (273), Expect = 2e-27
 Identities = 83/270 (30%), Positives = 132/270 (48%), Gaps = 31/270 (11%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEK--EALDQIGICPQIVR 66
           IGHGSFG+V  A+  + +     ++A+K  +     S    NEK  + + ++    Q+  
Sbjct: 23  IGHGSFGAVYFARDVRTNE----VVAIKKMSYSGKQS----NEKWQDIIKEVRFLQQLRH 74

Query: 67  CFGDDYSFEKG----ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
               +Y   KG    E    L++EY   GS +D ++      LQE ++       L+GL 
Sbjct: 75  PNTIEY---KGCYLREHTAWLVMEYCL-GSASDILEVHKKP-LQEVEIAAICHGALQGLA 129

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-- 180
           ++HS   +H DIK  N+L+ +    K+ADFG A  S      + SF   GTP +M+PE  
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSA--SLVS--PANSFV--GTPYWMAPEVI 183

Query: 181 -SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
            +++E +Y+   D+W+LG   +E+A  KP      + N  S L  I   D       D S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNDSPTLSSNDWS 240

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           +  ++F+  C  K P+ R ++E LL H FV
Sbjct: 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  108 bits (271), Expect = 3e-27
 Identities = 79/273 (28%), Positives = 134/273 (49%), Gaps = 26/273 (9%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           +G G+FG     K  K  ++   ++A     D   S   L++    +D +  C  P IV+
Sbjct: 13  LGDGAFG-----KVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVK 66

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
              D + +E       +L+E+ + G++ D V  +    L E  ++   +  L+ L ++H 
Sbjct: 67  LL-DAFYYENN---LWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV---- 182
              +H D+K  N+L   + + K+ADFG++ K++   +R  SF   GTP +M+PE V    
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWMAPEVVMCET 179

Query: 183 -NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI--PGDLS 239
             +  Y+   D+W+LG  ++EMA  +P      + N   +L++I   +  P +  P   S
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPP---HHELNPMRVLLKIAKSEP-PTLAQPSRWS 235

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + KDFL KC  K+   RWT   LL HPFV  +
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  108 bits (271), Expect = 3e-27
 Identities = 83/276 (30%), Positives = 137/276 (49%), Gaps = 38/276 (13%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE------ALDQIGIC- 61
           +G G+FG V  AK    + E  +L A K         +  K+E+E       ++ +  C 
Sbjct: 20  LGDGAFGKVYKAK----NKETGALAAAKV--------IETKSEEELEDYMVEIEILATCN 67

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV+  G  Y   K      +++E+   G++ D +  + +  L E  ++   R ML+ 
Sbjct: 68  HPYIVKLLGAFYWDGK----LWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEA 122

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L+++HS   +H D+K  NVL+  + + K+ADFG++ K+    +R  SF   GTP +M+PE
Sbjct: 123 LQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF--IGTPYWMAPE 180

Query: 181 SV-----NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI- 234
            V      +  Y+   DIW+LG  ++EMA  +P      + N   +L++I   +  P + 
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP---HHELNPMRVLLKIAKSEP-PTLS 236

Query: 235 -PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            P   S + +DFL     K P+ R +A  LL HPFV
Sbjct: 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 3e-27
 Identities = 77/292 (26%), Positives = 121/292 (41%), Gaps = 48/292 (16%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+  K++ E   ++A+K          +    K AL +I    ++++  
Sbjct: 7   IGEGTYGVVYKAR-DKLTGE---IVAIKKIK---LRFESEGIPKTALREI----KLLKEL 55

Query: 69  GDDY------SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
                      F      Y L+ E+     L   +K +  G L ES +K Y   +L+GL 
Sbjct: 56  NHPNIIKLLDVFRHKGDLY-LVFEFMDT-DLYKLIKDRQRG-LPESLIKSYLYQLLQGLA 112

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES- 181
             HS G +H D+K +N+L+      K+ADFGLA+  S             T  Y +PE  
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELL 170

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI---------------- 225
           + +  Y  P DIW++GC   E+ S +P +  K + +    + R                 
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 226 ---------GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                      G  LP +  + S Q  D L +    DP +R TAE  L HP+
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  106 bits (267), Expect = 6e-27
 Identities = 76/268 (28%), Positives = 134/268 (50%), Gaps = 24/268 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G+FG V+L +  K   +   L+ +K     P   +T      A ++  +      P
Sbjct: 7   VVGRGAFGIVHLCR-RKADQK---LVIIK---QIPVEQMTKDERLAAQNECQVLKLLSHP 59

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+  + +++  +K      +++EYA  G+LA+ ++K+ N  L E  +  +   +L  L 
Sbjct: 60  NIIEYY-ENFLEDKA---LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDE-AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           H+H+K  +H D+K QN+L+  +    KI DFG++K  S    +S+++   GTP Y+SPE 
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPEL 172

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
                Y    DIWALGC + E+AS K A+   + +N+ +L+++I  G   P I    S  
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAF---EAANLPALVLKIMSGTFAP-ISDRYSPD 228

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            +  ++     DP +R     ++  P  
Sbjct: 229 LRQLILSMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  106 bits (266), Expect = 9e-27
 Identities = 80/264 (30%), Positives = 124/264 (46%), Gaps = 15/264 (5%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
            IG GSFG + LAKA K  SE   +  +             K E   L ++   P IV  
Sbjct: 7   KIGEGSFGKIYLAKA-KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTF 64

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F    SF++  R + +++EY   G L  R+ +Q      E  +  +   +  GL+HIH +
Sbjct: 65  FA---SFQENGRLF-IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 128 GFVHCDIKLQNVLVFDNDE-AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
             +H DIK QN+ +  N   AK+ DFG+A++ +   E + +  C GTP Y+SPE      
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNRP 178

Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGDELPNIPGDLSEQGKDF 245
           Y    DIW+LGC + E+ + K    H  + N    L+++I  G   P  P   S   +  
Sbjct: 179 YNNKTDIWSLGCVLYELCTLK----HPFEGNNLHQLVLKICQGYFAPISPN-FSRDLRSL 233

Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           + + F   P+ R +   +L  PF+
Sbjct: 234 ISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  106 bits (267), Expect = 1e-26
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 8/197 (4%)

Query: 73  SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHC 132
           S+  G+  + +++EY + GSL D V +     + E  +    R  L+ L  +HS   +H 
Sbjct: 84  SYLVGDELW-VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHR 139

Query: 133 DIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCD 192
           DIK  N+L+  +   K+ DFG   + +   E+S+     GTP +M+PE V    Y    D
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 193 IWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLK 252
           IW+LG   +EM  G+P + ++       L+   G   EL N P  LS   +DFL +C   
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQN-PEKLSAIFRDFLNRCLEM 255

Query: 253 DPKRRWTAEMLLNHPFV 269
           D ++R +A+ LL HPF+
Sbjct: 256 DVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  105 bits (265), Expect = 2e-26
 Identities = 66/258 (25%), Positives = 117/258 (45%), Gaps = 19/258 (7%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGI 60
           G  +G G+FG V             + +AVK+  +        +  +EA     L     
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS---- 59

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IVR  G      +GE  Y ++ EY   G L D ++K +  +L   D+ +    + KG
Sbjct: 60  HPNIVRLLG---VCTQGEPLY-IVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKG 114

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++ SK FVH D+  +N LV +N   KI+DFGL++    D    +    +    +M+PE
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174

Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           S+ + ++ +  D+W+ G  + E+ + G+  +    +  V  LL          N P +L 
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL- 233

Query: 240 EQGKDFLIKCFLKDPKRR 257
               + +++C+  DP+ R
Sbjct: 234 ---YELMLQCWAYDPEDR 248

Length = 258

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 42/285 (14%)

Query: 7   DVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI------- 58
           D +G G++GSV      KV        MA+K         + L+ ++   +QI       
Sbjct: 7   DELGKGNYGSV-----YKVLHRPTGVTMAMKE--------IRLELDESKFNQIIMELDIL 53

Query: 59  --GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRV--KKQNNGRLQESDVKRYT 114
              + P IV  +G    F +G  +    +EY   GSL D++         + E  ++R T
Sbjct: 54  HKAVSPYIVDFYGA--FFIEGAVYM--CMEYMDAGSL-DKLYAGGVATEGIPEDVLRRIT 108

Query: 115 RSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
            +++KGL+ +  +   +H D+K  NVLV  N + K+ DFG+    S +   S +    G 
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGC 164

Query: 174 PLYMSPESVNEN------EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV 227
             YM+PE +          Y    D+W+LG +++EMA G+  +  +  +N+F+ L  I  
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD 224

Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
           GD  P +P   S+  +DF+ KC  K P RR T   LL HP++   
Sbjct: 225 GDP-PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 53/210 (25%), Positives = 79/210 (37%), Gaps = 57/210 (27%)

Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS 158
            +  G L  + +K     +L+GL + HS   +H D+K QN+L+  +   K+ADFGLA+  
Sbjct: 89  DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR-- 146

Query: 159 SCDGERSQSFECRGTPL-YMSPESV-----------NENEYEAPCDIWALGCAVVEMASG 206
                   +F   G PL   + E V               Y    DIW++GC   EM +G
Sbjct: 147 --------AF---GIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195

Query: 207 KP------------------------AW----NHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           KP                        +W            F       +   LP     L
Sbjct: 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPR----L 251

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
             +G D L K    +P +R +A+  L HP+
Sbjct: 252 DPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  105 bits (262), Expect = 3e-26
 Identities = 81/265 (30%), Positives = 129/265 (48%), Gaps = 19/265 (7%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V   KA  V++    L A+K     P     +  ++  + +      IV  F
Sbjct: 17  IGSGTYGDV--YKARNVNTG--ELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72

Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G   S+ + ++ + + +E+   GSL D       G L ES +   +R  L+GL ++HSKG
Sbjct: 73  G---SYLRRDKLW-ICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV---NEN 185
            +H DIK  N+L+ DN   K+ADFG++ + +    + +SF   GTP +M+PE      + 
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF--IGTPYWMAPEVAAVERKG 184

Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL--SEQGK 243
            Y   CDIWA+G   +E+A  +P            L+ +     + P +   +  S    
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF--QPPKLKDKMKWSNSFH 242

Query: 244 DFLIKCFLKDPKRRWTAEMLLNHPF 268
            F+     K+PK+R TAE LL HPF
Sbjct: 243 HFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  105 bits (264), Expect = 5e-26
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 34/278 (12%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK------NEKEAL 55
           ++     +G GSFG V L +  K S ++    A+K  +      V LK      NEK  L
Sbjct: 2   DFEFIKTLGTGSFGRVMLVR-HKGSGKY---YALKILSKAK--IVKLKQVEHVLNEKRIL 55

Query: 56  DQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
             I   P +V  +G   SF+     Y L++EY   G L   ++K  +GR  E   + Y  
Sbjct: 56  QSIR-HPFLVNLYG---SFQDDSNLY-LVMEYVPGGELFSHLRK--SGRFPEPVARFYAA 108

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ++  L ++HS   V+ D+K +N+L+  +   KI DFG AK+      R+ +  C GTP 
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYTL-C-GTPE 163

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           Y++PE +    Y    D WALG  + EM +G P +       ++    +I +  ++   P
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE---KI-LEGKV-RFP 218

Query: 236 GDLSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
              S   KD +      D  +R          + NHP+
Sbjct: 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  105 bits (263), Expect = 6e-26
 Identities = 68/222 (30%), Positives = 114/222 (51%), Gaps = 25/222 (11%)

Query: 62  PQIVRCFGDDYSF-EKGERFYNLLLEYASRGSLADRVKKQ---NNGRLQESDVKRYTRSM 117
           P IV+ +G   +F ++      + +EY   GSL D + K+     GR+ E  + +   S+
Sbjct: 59  PYIVKYYG---AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESV 114

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR--GTPL 175
           LKGL ++HS+  +H DIK  N+L+    + K+ DFG++      GE   S      GT  
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS------GELVNSLAGTFTGTSF 168

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV-----FSLLIRIGVGDE 230
           YM+PE +    Y    D+W+LG  ++E+A  +  +  + +  +      S ++ +    E
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-PE 227

Query: 231 LPNIPGD---LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           L + PG+    SE+ KDF+ +C  KDP RR T   +L HP++
Sbjct: 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 6e-26
 Identities = 63/262 (24%), Positives = 116/262 (44%), Gaps = 22/262 (8%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA--LDQIGICPQI 64
             +G G+FG V   K      +  + +AVK+  +           KEA  + ++G  P +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGK-TTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNV 58

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNN-------GRLQESDVKRYTRSM 117
           VR  G     E+   +  L+LEY   G L D ++K            L   D+  +   +
Sbjct: 59  VRLLG--VCTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-Y 176
            KG+ ++ SK FVH D+  +N LV ++   KI+DFGL++    D +  +       P+ +
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY-DDDYYRKKTGGKLPIRW 173

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           M+PES+ +  + +  D+W+ G  + E+ + G   +    +  V   L +          P
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK----GYRLPKP 229

Query: 236 GDLSEQGKDFLIKCFLKDPKRR 257
               ++  + ++ C+  DP+ R
Sbjct: 230 EYCPDELYELMLSCWQLDPEDR 251

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  104 bits (261), Expect = 6e-26
 Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 20/197 (10%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L++E+   GS+ D VK      L+E  +    R +L+GL H+H+   +H DIK QNVL+ 
Sbjct: 96  LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT 155

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV--NEN---EYEAPCDIWALG 197
           +N E K+ DFG++ +      R  +F   GTP +M+PE +  +EN    Y+   DIW+LG
Sbjct: 156 ENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213

Query: 198 CAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL-----SEQGKDFLIKCFLK 252
              +EMA G P            L+ R        N P  L     S++  DF+  C +K
Sbjct: 214 ITAIEMAEGAPPLCDMHPMRALFLIPR--------NPPPKLKSKKWSKKFIDFIEGCLVK 265

Query: 253 DPKRRWTAEMLLNHPFV 269
           +   R + E LL HPF+
Sbjct: 266 NYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  104 bits (259), Expect = 9e-26
 Identities = 61/193 (31%), Positives = 99/193 (51%), Gaps = 12/193 (6%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L++E+   GS+ D +K      L+E  +    R +L+GL H+H    +H DIK QNVL+ 
Sbjct: 86  LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE-----YEAPCDIWALG 197
           +N E K+ DFG++ +      R  +F   GTP +M+PE +  +E     Y+   D+W+LG
Sbjct: 146 ENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203

Query: 198 CAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG-DLSEQGKDFLIKCFLKDPKR 256
              +EMA G P            L+ R    +  P +     S++ + F+  C +K+  +
Sbjct: 204 ITAIEMAEGAPPLCDMHPMRALFLIPR----NPAPRLKSKKWSKKFQSFIESCLVKNHSQ 259

Query: 257 RWTAEMLLNHPFV 269
           R T E L+ HPF+
Sbjct: 260 RPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  103 bits (259), Expect = 1e-25
 Identities = 87/269 (32%), Positives = 128/269 (47%), Gaps = 27/269 (10%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G++G V   KA  + +    L AVK     P    +L  ++  + +      IV  F
Sbjct: 17  VGSGTYGDV--YKARNLHTG--ELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72

Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G   S EK      + +EY   GSL D       G L E  +    R  L+GL ++HSKG
Sbjct: 73  GSYLSREK----LWICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE--SVNEN- 185
            +H DIK  N+L+ DN + K+ADFG+A K +    + +SF   GTP +M+PE  +V +N 
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF--IGTPYWMAPEVAAVEKNG 184

Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK-- 243
            Y   CDIWA+G   +E+A  +P            L+ +          P  L ++ K  
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ------PPKLKDKTKWS 238

Query: 244 ----DFLIKCFLKDPKRRWTAEMLLNHPF 268
               +F+     K+PK+R TAE LL H F
Sbjct: 239 STFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  104 bits (261), Expect = 1e-25
 Identities = 74/275 (26%), Positives = 133/275 (48%), Gaps = 35/275 (12%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI------CP 62
           IG G+ G V   +  K       +MAVK        +   +  K  L  + +      CP
Sbjct: 23  IGSGTCGQVYKMRFKKTGH----VMAVKQM----RRTGNKEENKRILMDLDVVLKSHDCP 74

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            IV+C+G  Y     + F  + L      +  D++ K+  G + E  + + T +++K L 
Sbjct: 75  YIVKCYG--YFITDSDVFICMEL----MSTCLDKLLKRIQGPIPEDILGKMTVAIVKALH 128

Query: 123 HIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           ++  K G +H D+K  N+L+  +   K+ DFG++ +      +++S  C     YM+PE 
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC---AAYMAPER 185

Query: 182 VNEN----EYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           ++      +Y+   D+W+LG ++VE+A+G+ P  N K +   F +L +I + +E P++P 
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKI-LQEEPPSLPP 241

Query: 237 D--LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           +   S     F+  C  KD ++R     LL HPF+
Sbjct: 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  104 bits (260), Expect = 1e-25
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 17/269 (6%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGI 60
           ++ R + IG G+ G+V  A       E    +A+K       P    + NE   + ++  
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQE----VAIKQINLQKQPKKELIINEILVMKELK- 74

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV  F D +    G+  + +++EY + GSL D V +     + E+ +    R  L+ 
Sbjct: 75  NPNIVN-FLDSFLV--GDELF-VVMEYLAGGSLTDVVTETC---MDEAQIAAVCRECLQA 127

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L  +H+   +H DIK  NVL+  +   K+ DFG   + +   E+S+     GTP +M+PE
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPE 185

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            V    Y    DIW+LG   +EM  G+P + ++       L+   G   EL N P  LS 
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQN-PEKLSP 243

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             +DFL +C   D ++R +A+ LL HPF+
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  103 bits (258), Expect = 2e-25
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 43/290 (14%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CPQ 63
           +G G+ GSV+  K     +    +MA K       SSV     K+ L ++ I      P 
Sbjct: 13  LGAGNGGSVSKVKHIPTGT----VMAKKVVHIGAKSSV----RKQILRELQIMHECRSPY 64

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV  +G   +F   E    + +E+   GSL DR+ K+  G +    + +   ++++GL +
Sbjct: 65  IVSFYG---AFLN-ENNICMCMEFMDCGSL-DRIYKKG-GPIPVEILGKIAVAVVEGLTY 118

Query: 124 IHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER----SQSFECRGTPLYMS 178
           +++    +H DIK  N+LV    + K+ DFG++      GE     + +F   GT  YMS
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS------GELINSIADTFV--GTSTYMS 170

Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN--------VFSLLIRIGVGDE 230
           PE +   +Y    D+W+LG +++E+A GK  +      +        +  LL +I V + 
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI-VQEP 229

Query: 231 LPNIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLL-NHPFVCADDQTGDD 278
            P +P  D  E  +DF+  C LKDP  R T + L    PF+ A   +  D
Sbjct: 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVD 279

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  101 bits (254), Expect = 4e-25
 Identities = 70/266 (26%), Positives = 126/266 (47%), Gaps = 22/266 (8%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----PQ 63
           IG GSFG   L K+ +   ++     +K       S    K  +E+  ++ +      P 
Sbjct: 8   IGEGSFGKAILVKSKEDGKQY----VIKEINISKMSP---KEREESRKEVAVLSNMKHPN 60

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+      SFE+    Y ++++Y   G L  ++  Q      E  +  +   +   L+H
Sbjct: 61  IVQY---QESFEENGNLY-IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKH 116

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +H +  +H DIK QN+ +  +   K+ DFG+A+  +   E +++  C GTP Y+SPE   
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICE 174

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    DIWALGC + EM + K A+   +  N+ +L+++I  G   P +    S   +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAF---EAGNMKNLVLKIIRG-SYPPVSSHYSYDLR 230

Query: 244 DFLIKCFLKDPKRRWTAEMLLNHPFV 269
           + + + F ++P+ R +   +L   F+
Sbjct: 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  102 bits (256), Expect = 4e-25
 Identities = 65/200 (32%), Positives = 108/200 (54%), Gaps = 14/200 (7%)

Query: 73  SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHC 132
           S+  GE  + +L+E+   G+L D V +    RL E  +     S+L+ L ++HS+G +H 
Sbjct: 86  SYLVGEELW-VLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHR 141

Query: 133 DIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCD 192
           DIK  ++L+  +   K++DFG   + S D  + +S    GTP +M+PE ++   Y    D
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVD 199

Query: 193 IWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG---KDFLIKC 249
           IW+LG  V+EM  G+P +    DS V   + R+   D  P    +  +     +DFL + 
Sbjct: 200 IWSLGIMVIEMVDGEPPYF--SDSPV-QAMKRL--RDSPPPKLKNAHKISPVLRDFLERM 254

Query: 250 FLKDPKRRWTAEMLLNHPFV 269
             ++P+ R TA+ LL+HPF+
Sbjct: 255 LTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  102 bits (254), Expect = 8e-25
 Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 16/208 (7%)

Query: 71  DYSFEKGERFYN---------LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           DY  E     YN         +++E+   G+L D V    + R+ E  +     ++LK L
Sbjct: 73  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKAL 129

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
             +H++G +H DIK  ++L+  +   K++DFG   + S +  R +S    GTP +M+PE 
Sbjct: 130 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPEL 187

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           ++   Y    DIW+LG  V+EM  G+P + ++        +IR  +  +L N+   +S  
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPKLKNLH-KVSPS 245

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            K FL +  ++DP +R TA  LL HPF+
Sbjct: 246 LKGFLDRLLVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  101 bits (252), Expect = 8e-25
 Identities = 81/268 (30%), Positives = 134/268 (50%), Gaps = 22/268 (8%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKN-EKEALDQIGICPQIV 65
           +G GSFG+V L K  K  +E   L  +K     +  P+     N E + L ++   P IV
Sbjct: 8   LGKGSFGTVYLVKDKKAVAE-ERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIV 65

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVK--KQNNGRLQESDVKRYTRSMLKGLRH 123
           +      SF + + F  ++ EY     L  +++  K     L E+ V  +   +L G+ +
Sbjct: 66  KFHA---SFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK--KSSCDGERSQSFECRGTPLYMSPES 181
           +H +  +H D+K +N+ +  N+  KI DFG+++    SCD   + +F   GTP YMSPE+
Sbjct: 122 MHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCD--LATTFT--GTPYYMSPEA 176

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           +    Y++  DIW+LGC + EM     A+   +  N  S+++RI  G   P++P   S Q
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAF---EGQNFLSVVLRIVEGPT-PSLPETYSRQ 232

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
               +     KDP  R +A  +L +PF+
Sbjct: 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 9e-25
 Identities = 81/302 (26%), Positives = 131/302 (43%), Gaps = 64/302 (21%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSV----TLKNEKEALDQIGIC 61
           IG G++G+V  A+    +  F +L  V+        P S++     LK     L+     
Sbjct: 7   IGEGAYGTVYKAR-DLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ----LESFE-H 60

Query: 62  PQIVR----CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           P IVR    C G        E    L+ E+  +  LA  + K     L    +K   R +
Sbjct: 61  PNIVRLLDVCHGPRTD---RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
           L+G+  +HS   VH D+K QN+LV  + + KIADFGLA+          SFE   T +  
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI--------YSFEMALTSVVV 168

Query: 176 ---YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN----VFSLLIRIGV- 227
              Y +PE + ++ Y  P D+W++GC   E+   +P +    +++    +F +   IG+ 
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDV---IGLP 225

Query: 228 -GDELPN--------------------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
             +E P                     +P ++ E+G D L K    +P +R +A   L H
Sbjct: 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVP-EICEEGLDLLKKMLTFNPHKRISAFEALQH 284

Query: 267 PF 268
           P+
Sbjct: 285 PY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  100 bits (251), Expect = 1e-24
 Identities = 62/180 (34%), Positives = 93/180 (51%), Gaps = 9/180 (5%)

Query: 82  NLLLEYASRGSLADRVK--KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNV 139
           N++LE A  G L+  +K  K+    + E  V +Y   +   + H+HS+  +H DIK  NV
Sbjct: 78  NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANV 137

Query: 140 LVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCA 199
            +      K+ D GL +  S     + S    GTP YMSPE ++EN Y    DIW+LGC 
Sbjct: 138 FITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCL 195

Query: 200 VVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD-LSEQGKDFLIKCFLKDPKRR 257
           + EMA+   P +  K   N+FSL  +I   D  P +P +  SE+ ++ +  C   DP +R
Sbjct: 196 LYEMAALQSPFYGDKM--NLFSLCQKIEQCD-YPPLPTEHYSEKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  101 bits (252), Expect = 2e-24
 Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 8/197 (4%)

Query: 73  SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHC 132
           S+  G+  + +++EY + GSL D V +     + E  +    R  L+ L  +HS   +H 
Sbjct: 84  SYLVGDELW-VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFLHSNQVIHR 139

Query: 133 DIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCD 192
           DIK  N+L+  +   K+ DFG   + +   E+S+     GTP +M+PE V    Y    D
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 193 IWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLK 252
           IW+LG   +EM  G+P + ++       L+   G   EL N P  LS   +DFL +C   
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQN-PERLSAVFRDFLNRCLEM 255

Query: 253 DPKRRWTAEMLLNHPFV 269
           D  RR +A+ LL HPF+
Sbjct: 256 DVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  101 bits (252), Expect = 3e-24
 Identities = 79/275 (28%), Positives = 127/275 (46%), Gaps = 35/275 (12%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN--------EKEALDQIG 59
           V+G GSFG V LA+      E   L AVK         V L++        EK  L    
Sbjct: 2   VLGKGSFGKVMLAR----LKESGRLYAVKVLK----KDVILQDDDVECTMTEKRILSLAR 53

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P + + +     F+  +R +  ++E+ + G L   ++K    R  E+  + Y   +  
Sbjct: 54  NHPFLTQLY---CCFQTPDRLF-FVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITS 107

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            L  +H KG ++ D+KL NVL+      K+ADFG+ K+   +G+ + +F C GTP Y++P
Sbjct: 108 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-C-GTPDYIAP 165

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + E  Y    D WA+G  + EM  G   +  + + ++F  ++     DE+   P  LS
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN----DEVV-YPTWLS 220

Query: 240 EQGKDFLIKCFLKDPKRRWTA------EMLLNHPF 268
           +   D L     K+P  R  +      E +L HPF
Sbjct: 221 QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  100 bits (250), Expect = 4e-24
 Identities = 67/226 (29%), Positives = 116/226 (51%), Gaps = 15/226 (6%)

Query: 49  KNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES 108
           + E++ L+ +  CP +V      Y+F+   + + L+L+Y + G L   + ++      ES
Sbjct: 52  RTERQVLEAVRRCPFLVTLH---YAFQTDTKLH-LILDYVNGGELFTHLYQR--EHFTES 105

Query: 109 DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD-GERSQS 167
           +V+ Y   ++  L H+H  G ++ DIKL+N+L+       + DFGL+K+   +  ER+ S
Sbjct: 106 EVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165

Query: 168 FECRGTPLYMSPESVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI 225
           F C GT  YM+PE +      ++   D W+LG    E+ +G   +    + N  S + R 
Sbjct: 166 F-C-GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR- 222

Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRW---TAEMLLNHPF 268
            +    P  P  +S + +DF+ K   KDPK+R     A+ + NHPF
Sbjct: 223 RILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =   99 bits (250), Expect = 4e-24
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 62/301 (20%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-----ALDQIGIC-- 61
           IG G++G V  A+ +K + E   L+A+K         + ++NEKE     A+ +I +   
Sbjct: 7   IGEGTYGQVYKAR-NKKTGE---LVALKK--------IRMENEKEGFPITAIREIKLLQK 54

Query: 62  ---PQIVRCFGDDYSFEKGERFYNLLLEYAS---RGSLADRVKKQNNGRLQESDVKRYTR 115
              P IVR      S  KG  +  ++ EY      G L          +  ES +K Y +
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIY--MVFEYMDHDLTGLLD-----SPEVKFTESQIKCYMK 107

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            +L+GL+++HS G +H DIK  N+L+ ++   K+ADFGLA+  +     S  +  R   L
Sbjct: 108 QLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYT--KRNSADYTNRVITL 165

Query: 176 -YMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI-------- 225
            Y  PE +     Y    D+W++GC + E+  GKP +    +      +  +        
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN 225

Query: 226 --GVGD-----------ELPNIPGD-----LSEQGKDFLIKCFLKDPKRRWTAEMLLNHP 267
             GV                    +     +     D L K    DPK+R +A+  L H 
Sbjct: 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285

Query: 268 F 268
           +
Sbjct: 286 Y 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  100 bits (249), Expect = 5e-24
 Identities = 86/273 (31%), Positives = 133/273 (48%), Gaps = 31/273 (11%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEK--EALDQIGICPQIVR 66
           IGHGSFG+V  A  S  +     ++AVK  +     S    NEK  + + ++    Q+  
Sbjct: 29  IGHGSFGAVYFATNSHTNE----VVAVKKMS----YSGKQTNEKWQDIIKEVKFLQQLKH 80

Query: 67  CFGDDYSFEKG----ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
               +Y   KG    E    L++EY   GS +D ++      LQE ++   T   L+GL 
Sbjct: 81  PNTIEY---KGCYLKEHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLA 135

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-- 180
           ++HS   +H DIK  N+L+ +  + K+ADFG A KSS     + SF   GTP +M+PE  
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFV--GTPYWMAPEVI 189

Query: 181 -SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
            +++E +Y+   D+W+LG   +E+A  KP      + N  S L  I   D       + +
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNDSPTLQSNEWT 246

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
           +  + F+  C  K P+ R  +  LL H FV  D
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  100 bits (251), Expect = 6e-24
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 22/235 (9%)

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P +V+C      F+       +LLE+   GSL              +DV    R +L G+
Sbjct: 132 PNVVKCHD---MFDHNGEI-QVLLEFMDGGSLEGT---HIADEQFLADV---ARQILSGI 181

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK--KSSCDGERSQSFECRGTPLYMSP 179
            ++H +  VH DIK  N+L+      KIADFG+++    + D   S      GT  YMSP
Sbjct: 182 AYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV----GTIAYMSP 237

Query: 180 ESVN----ENEYEAPC-DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           E +N       Y+    DIW+LG +++E   G+  +   +  +  SL+  I +    P  
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-PEA 296

Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSP 289
           P   S + + F+  C  ++P +RW+A  LL HPF+         GG ++H    P
Sbjct: 297 PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPP 351

Length = 353

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 99.7 bits (249), Expect = 7e-24
 Identities = 59/202 (29%), Positives = 82/202 (40%), Gaps = 39/202 (19%)

Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA-------- 155
           +L ES +K Y   +L+G+ ++H    +H DIK  N+L+ +    KIADFGLA        
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170

Query: 156 --KKSSCDGERSQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNH 212
             K     G R  +     T  Y  PE +  E  Y    DIW +GC   EM + +P    
Sbjct: 171 NPKGGGGGGTRKYT-NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229

Query: 213 KQDSNVFSLLIRIGVG----------DELPNIPGDLS----------------EQGKDFL 246
           K D +   L+ ++  G            LP   G  S                 +G D L
Sbjct: 230 KSDIDQLHLIFKL-CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLL 288

Query: 247 IKCFLKDPKRRWTAEMLLNHPF 268
            K    DP +R TA   L HP+
Sbjct: 289 SKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 99.9 bits (249), Expect = 8e-24
 Identities = 80/258 (31%), Positives = 132/258 (51%), Gaps = 29/258 (11%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN--------EKEALDQIG 59
           V+G GSFG V LA+  K ++EF ++ A+K         V L++        E+  L    
Sbjct: 2   VLGKGSFGKVMLAEL-KGTNEFFAIKALKK-------DVVLEDDDVECTMVERRVLALAW 53

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P +   F    +F+  E  +  ++EY + G L   +  Q++GR  E+  + Y   ++ 
Sbjct: 54  EHPFLTHLF---CTFQTKEHLF-FVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIIC 107

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL+ +H KG ++ D+KL NVL+  +   KIADFG+ K+ + +GE   S  C GTP Y++P
Sbjct: 108 GLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFC-GTPDYIAP 165

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E +   +Y    D W+ G  + EM  G+  + H +D +     I      + P+ P  +S
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPF-HGEDEDELFDSILN----DRPHFPRWIS 220

Query: 240 EQGKDFLIKCFLKDPKRR 257
           ++ KD L K F +DP +R
Sbjct: 221 KEAKDCLSKLFERDPTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 99.4 bits (247), Expect = 8e-24
 Identities = 63/197 (31%), Positives = 100/197 (50%), Gaps = 8/197 (4%)

Query: 73  SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHC 132
           S+  G+  + +++EY + GSL D V +     + E  +    R  L+ L  +HS   +H 
Sbjct: 85  SYLVGDELW-VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHR 140

Query: 133 DIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCD 192
           DIK  N+L+  +   K+ DFG   + +   E+S+     GTP +M+PE V    Y    D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 193 IWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLK 252
           IW+LG   +EM  G+P + ++       L+   G   EL N P  LS   +DFL +C   
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQN-PEKLSAIFRDFLNRCLDM 256

Query: 253 DPKRRWTAEMLLNHPFV 269
           D ++R +A+ LL H F+
Sbjct: 257 DVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 99.0 bits (247), Expect = 9e-24
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 35/219 (15%)

Query: 79  RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQN 138
           R  +L+ EY    ++ + ++K   G + E  +K+     L+ +   H    +H D+K +N
Sbjct: 73  RKLHLVFEYCDH-TVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPEN 130

Query: 139 VLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALG 197
           +L+    + K+ DFG A+  +  G      +   T  Y +PE  V + +Y  P D+WA+G
Sbjct: 131 ILITKQGQIKLCDFGFARILT--GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIG 188

Query: 198 CAVVEMASGKPAWNHKQDSNVFSL-LIRIGVGDELP---------------NIPG----- 236
           C   E+ +G+P W  K  S+V  L LIR  +GD +P               +IP      
Sbjct: 189 CVFAELLTGQPLWPGK--SDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETRE 246

Query: 237 -------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                  ++S     FL  C   DP  R + E LL HP+
Sbjct: 247 PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 99.6 bits (248), Expect = 9e-24
 Identities = 80/264 (30%), Positives = 128/264 (48%), Gaps = 19/264 (7%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK-NEKEALDQIGICPQIVRC 67
           IG GSFG V   +  + +    +L  ++       S VT    E+  L Q+  CP IV  
Sbjct: 1   IGKGSFGKVMQVR-KRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPL 58

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               +SF+  E+ Y L+L + + G L   ++++  GR   S  + YT  +L  L ++H  
Sbjct: 59  ---KFSFQSPEKLY-LVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKF 112

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             ++ D+K +N+L+       + DFGL K +  D +++ +F C GTP Y++PE +  + Y
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF-C-GTPEYLAPELLLGHGY 170

Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
               D W LG  + EM +G P +    D NV  +  +I + + L   P       KD LI
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPF---YDENVNEMYRKI-LQEPL-RFPDGFDRDAKDLLI 225

Query: 248 KCFLKDPKRRW---TAEMLLNHPF 268
               +DP RR     A+ + NHPF
Sbjct: 226 GLLSRDPTRRLGYNGAQEIKNHPF 249

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 98.2 bits (244), Expect = 2e-23
 Identities = 80/280 (28%), Positives = 132/280 (47%), Gaps = 26/280 (9%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           W   + IG G++G     K  KV+++   SL AVK           ++ E   L  +   
Sbjct: 24  WEIIETIGKGTYG-----KVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNH 78

Query: 62  PQIVRCFGDDYSFEK--GERFYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSM 117
           P +V+ +G  Y  +K  G + + L+LE  + GS+ + VK       RL E+ +       
Sbjct: 79  PNVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL-AKKSSCDGERSQSFECRGTPLY 176
           L GL+H+H+   +H D+K  N+L+      K+ DFG+ A+ +S    R+ S    GTP +
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---GTPFW 194

Query: 177 MSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           M+PE +      +  Y+A CD+W+LG   +E+  G P      D +    L +I   +  
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL---FDMHPVKTLFKIP-RNPP 250

Query: 232 PNI--PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           P +  P         F+ +C +KD + R +   LL HPF+
Sbjct: 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 97.4 bits (242), Expect = 2e-23
 Identities = 77/231 (33%), Positives = 114/231 (49%), Gaps = 23/231 (9%)

Query: 32  LMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSF-EKGERFYNLLLEYASR 90
           LM  K+ ADC         E + L Q+   P +++ +    SF E  E   N++LE A  
Sbjct: 40  LMDAKARADC-------IKEIDLLKQLN-HPNVIKYYA---SFIEDNE--LNIVLELADA 86

Query: 91  GSLADRVK--KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAK 148
           G L+  +K  K+    + E  V +Y   +   L H+HS+  +H DIK  NV +      K
Sbjct: 87  GDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVK 146

Query: 149 IADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GK 207
           + D GL +  S     + S    GTP YMSPE ++EN Y    DIW+LGC + EMA+   
Sbjct: 147 LGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204

Query: 208 PAWNHKQDSNVFSLLIRIGVGDELPNIPGD-LSEQGKDFLIKCFLKDPKRR 257
           P +  K   N++SL  +I   D  P +P D  SE+ +  +  C   DP++R
Sbjct: 205 PFYGDKM--NLYSLCKKIEQCD-YPPLPSDHYSEELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 98.3 bits (245), Expect = 3e-23
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 17/203 (8%)

Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           YSF+  +R    ++EYA+ G L   + ++      E   + Y   ++  L ++HS   V+
Sbjct: 62  YSFQTHDRLC-FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVY 118

Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            D+KL+N+++  +   KI DFGL K+   DG   ++F C GTP Y++PE + +N+Y    
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-C-GTPEYLAPEVLEDNDYGRAV 176

Query: 192 DIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCF 250
           D W LG  + EM  G+ P +N  QD      LI +    E+   P  LS + K  L    
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILME---EI-RFPRTLSPEAKSLLAGLL 230

Query: 251 LKDPKRRW-----TAEMLLNHPF 268
            KDPK+R       A+ ++ H F
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 97.6 bits (244), Expect = 3e-23
 Identities = 68/311 (21%), Positives = 113/311 (36%), Gaps = 73/311 (23%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           + +G  +G G++  V  A+  K +     ++A+K           +K  +    + GI  
Sbjct: 2   YEKGKKLGEGTYAVVYKAR-DKETGR---IVAIKK----------IKLGERKEAKDGINF 47

Query: 63  QIVR------------------CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR 104
             +R                   FG            NL+ E+     L ++V K  +  
Sbjct: 48  TALREIKLLQELKHPNIIGLLDVFGHK-------SNINLVFEFME-TDL-EKVIKDKSIV 98

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L  +D+K Y    L+GL ++HS   +H D+K  N+L+  +   K+ADFGLA+       +
Sbjct: 99  LTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158

Query: 165 --SQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAW----------- 210
              Q      T  Y +PE +     Y    D+W++GC   E+    P             
Sbjct: 159 MTHQVV----TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK 214

Query: 211 --------NHKQDSNVFSLLIRIGVGDELPNIPGD-----LSEQGKDFLIKCFLKDPKRR 257
                     +    V SL   +      P  P        S+   D L +    +P +R
Sbjct: 215 IFEALGTPTEENWPGVTSLPDYVEF-KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKR 273

Query: 258 WTAEMLLNHPF 268
            TA   L HP+
Sbjct: 274 ITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 85/271 (31%), Positives = 138/271 (50%), Gaps = 33/271 (12%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEK--EALDQIGICPQIVR 66
           IGHGSFG+V  A+  + +     ++A+K  +     S    NEK  + + ++    +I  
Sbjct: 33  IGHGSFGAVYFARDVRTNE----VVAIKKMSYSGKQS----NEKWQDIIKEVKFLQRIKH 84

Query: 67  CFGDDYSFEKG----ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
               +Y   KG    E    L++EY   GS +D ++      LQE ++   T   L+GL 
Sbjct: 85  PNSIEY---KGCYLREHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLA 139

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-- 180
           ++HS   +H DIK  N+L+ +  + K+ADFG A  +S     + SF   GTP +M+PE  
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANSFV--GTPYWMAPEVI 193

Query: 181 -SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG-DL 238
            +++E +Y+   D+W+LG   +E+A  KP      + N  S L  I   +E P +   + 
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIA-QNESPTLQSNEW 249

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S+  ++F+  C  K P+ R T+E LL H FV
Sbjct: 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 83/329 (25%), Positives = 129/329 (39%), Gaps = 62/329 (18%)

Query: 7   DVIGHGSFGSVNLAK--------ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI 58
            VIG G+FG V L +        A KV  +  S M  +           ++ E++ L   
Sbjct: 7   KVIGRGAFGEVWLVRDKDTGQVYAMKVLRK--SDMIKR------NQIAHVRAERDILADA 58

Query: 59  GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              P IV+ +   YSF+  E  Y L++EY   G L + + ++      E   + Y   ++
Sbjct: 59  -DSPWIVKLY---YSFQDEEHLY-LVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELV 111

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK------SSCDGERSQSFECR- 171
             L  +H  GF+H DIK  N+L+  +   K+ADFGL KK             S +   R 
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 172 --------------------GTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
                               GTP Y++PE +    Y   CD W+LG  + EM  G P + 
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231

Query: 212 HKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT-AEMLLNHPFVC 270
                  ++ +I        P  P  +S +  D + +  L DP+ R    E + +HPF  
Sbjct: 232 SDTLQETYNKIINWKESLRFPPDP-PVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFFK 289

Query: 271 ADDQTGDDGGIHIHSSSS---PSLKGIKD 296
             D        ++  +     P L    D
Sbjct: 290 GIDWE------NLRETKPPFVPELSSPLD 312

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 97.8 bits (243), Expect = 3e-23
 Identities = 77/275 (28%), Positives = 140/275 (50%), Gaps = 25/275 (9%)

Query: 8   VIGHGSFGSVNLAKASKVSS----EFPSLMAVKSCADCPPSSVT--LKNEKEALDQIGIC 61
           V+G G++G V L +  KVS     +  ++  +K       +  T   + E++ L+ I   
Sbjct: 7   VLGTGAYGKVFLVR--KVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 64

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P +V      Y+F+   + + L+L+Y + G L   + ++   R +E +V+ Y+  ++  L
Sbjct: 65  PFLVTL---HYAFQTDTKLH-LILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLAL 118

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG-ERSQSFECRGTPLYMSPE 180
            H+H  G ++ DIKL+N+L+  N    + DFGL+K+   D  ER+ SF C GT  YM+P+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF-C-GTIEYMAPD 176

Query: 181 SV--NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
            V   +  ++   D W++G  + E+ +G   +    + N  + + R  +  E P  P ++
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PPYPQEM 235

Query: 239 SEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
           S   KD + +  +KDPK+R       A+ +  HPF
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 97.5 bits (243), Expect = 4e-23
 Identities = 76/255 (29%), Positives = 116/255 (45%), Gaps = 58/255 (22%)

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL   +KK   GR+ E+ + + + ++L+GL
Sbjct: 59  PYIVGFYGAFYS--DGE--ISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGL 112

Query: 122 ---RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE----RSQSFECRGTP 174
              R  H    +H D+K  N+LV    E K+ DFG++      G+     + SF   GT 
Sbjct: 113 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFV--GTR 162

Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNHKQDSNVFS----------- 220
            YMSPE +    Y    DIW+LG ++VEMA G+   P  + K+   +F            
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222

Query: 221 -------------------LLIRIGVGDELPNIPGD-LSEQGKDFLIKCFLKDPKRRWTA 260
                              LL  I V +  P +P    S++ +DF+ KC  K+PK R   
Sbjct: 223 HRPVSGHPPDSPRPMAIFELLDYI-VNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL 281

Query: 261 EMLLNHPFVCADDQT 275
           + L  HPF+   +  
Sbjct: 282 KELTKHPFIKRAELE 296

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 97.6 bits (243), Expect = 5e-23
 Identities = 77/268 (28%), Positives = 130/268 (48%), Gaps = 21/268 (7%)

Query: 8   VIGHGSFGSVNLAK--ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           V+G GSFG V L +      + +  ++  +K         V  K E++ L ++   P IV
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIV 61

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           +     Y+F+   + Y L+L++   G L  R+ K+      E DVK Y   +   L H+H
Sbjct: 62  KL---HYAFQTEGKLY-LILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH 115

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
           S G ++ D+K +N+L+ +    K+ DFGL+K+S    +++ SF C GT  YM+PE VN  
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-C-GTVEYMAPEVVNRR 173

Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
            +    D W+ G  + EM +G   +  K      +++++  +G     +P  LS + +  
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG-----MPQFLSPEAQSL 228

Query: 246 LIKCFLKDPKRRWTA-----EMLLNHPF 268
           L   F ++P  R  A     E +  HPF
Sbjct: 229 LRALFKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 96.1 bits (239), Expect = 9e-23
 Identities = 75/272 (27%), Positives = 137/272 (50%), Gaps = 31/272 (11%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI---C-- 61
           +++GHG+ G+V   KA  + +    ++AVK      P  +T++ +K+ + ++ I   C  
Sbjct: 7   EILGHGNGGTV--YKAYHLLTR--RILAVKVI----PLDITVELQKQIMSELEILYKCDS 58

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P I+  +G  +     E   ++  E+   GSL          ++ E  + R   +++KGL
Sbjct: 59  PYIIGFYGAFFV----ENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGL 108

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++ S   +H D+K  N+LV    + K+ DFG++ +       S +    GT  YM+PE 
Sbjct: 109 TYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPER 164

Query: 182 VNENEYEAPCDIWALGCAVVEMASGK---PAWNHKQDSNVFSLLIRIGVGDELPNIP-GD 237
           ++  +Y    D+W+LG + +E+A G+   P     Q S +   L++  V ++ P +P G 
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224

Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            SE+   F+ +C  K PK R   E L++HPF+
Sbjct: 225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.1 bits (237), Expect = 1e-22
 Identities = 75/264 (28%), Positives = 112/264 (42%), Gaps = 16/264 (6%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V + +       F      K       S   + NE+  L ++   P +V  
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNL 65

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           +   YSF+  E  Y L+++    G L  R       +  E  VK +   ++  L ++HSK
Sbjct: 66  W---YSFQDEENMY-LVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
           G +H DIK  N+L+ +     I DF +A K + D   + +    GTP YM+PE +    Y
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGYMAPEVLCRQGY 176

Query: 188 EAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
               D W+LG    E   GK P   H   S      IR          P   S +  D +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGH---SRTIRDQIRAKQETADVLYPATWSTEAIDAI 233

Query: 247 IKCFLKDPKRRW--TAEMLLNHPF 268
            K   +DP++R     + L NHP+
Sbjct: 234 NKLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 95.9 bits (239), Expect = 1e-22
 Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 32/222 (14%)

Query: 74  FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCD 133
           F + +R Y L+ E+    ++ D ++K  NG L ES V++Y   +L+G+   HS   +H D
Sbjct: 69  FRRKKRLY-LVFEFVDH-TVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCHSHNIIHRD 125

Query: 134 IKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-SVNENEYEAPCD 192
           IK +N+LV  +   K+ DFG A+  +  GE    +    T  Y +PE  V + +Y    D
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV--ATRWYRAPELLVGDTKYGRAVD 183

Query: 193 IWALGCAVVEMASGKPAWNHKQDSNVFSLLIR-----------------IGVGDELPNI- 234
           IWA+GC V EM +G+P +    D +    +I+                 +  G  LP + 
Sbjct: 184 IWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVK 243

Query: 235 ---PGD-----LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
              P +     LS    D   +C   DP  R ++  LL+H F
Sbjct: 244 EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 94.3 bits (234), Expect = 7e-22
 Identities = 58/186 (31%), Positives = 97/186 (52%), Gaps = 10/186 (5%)

Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           Y+F+  +R    ++EYA+ G L   + ++      E   + Y   ++  L ++HS+  V+
Sbjct: 62  YAFQTHDRLC-FVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVY 118

Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            DIKL+N+++  +   KI DFGL K+   DG   ++F C GTP Y++PE + +N+Y    
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-C-GTPEYLAPEVLEDNDYGRAV 176

Query: 192 DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFL 251
           D W LG  + EM  G+  + ++    +F L++      E    P  LS + K  L     
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFPRTLSPEAKSLLAGLLK 231

Query: 252 KDPKRR 257
           KDPK+R
Sbjct: 232 KDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 9e-22
 Identities = 79/257 (30%), Positives = 121/257 (47%), Gaps = 33/257 (12%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSL--MAVKSCADCPPSSVTLK------NEKEALDQIGI 60
           +G G+FG V+L +  ++S  + +L  MA+       P  + LK      NEK  L ++  
Sbjct: 9   VGTGTFGRVHLVR-DRISEHYYALKVMAI-------PEVIRLKQEQHVHNEKRVLKEVS- 59

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I+R F      E  +RF  +L+EY   G L   ++  N+GR   S    Y   ++  
Sbjct: 60  HPFIIRLFWT----EHDQRFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCA 113

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L ++HSK  V+ D+K +N+L+      K+ DFG AKK      R +++   GTP Y++PE
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEYLAPE 168

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            +    +    D WALG  + EM  G P +    D N F +  +I  G      P  L  
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPPF---FDDNPFGIYEKILAGK--LEFPRHLDL 223

Query: 241 QGKDFLIKCFLKDPKRR 257
             KD + K  + D  RR
Sbjct: 224 YAKDLIKKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 93.3 bits (232), Expect = 9e-22
 Identities = 76/283 (26%), Positives = 134/283 (47%), Gaps = 31/283 (10%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI------CP 62
           +G G++G V+  K   V +   ++MAVK       ++V  + +K  L  + I      CP
Sbjct: 9   LGRGAYGVVD--KMRHVPTG--TIMAVKRI----RATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
             V  +G    F +G+ +  + +   S      +V  +    + E  + +   S++K L 
Sbjct: 61  YTVTFYGA--LFREGDVWICMEVMDTSLDKFYKKVYDKGL-TIPEDILGKIAVSIVKALE 117

Query: 123 HIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           ++HSK   +H D+K  NVL+  N + K+ DFG++        ++    C+  P YM+PE 
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCK--P-YMAPER 174

Query: 182 VN----ENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +N    +  Y+   D+W+LG  ++E+A+G+ P  + K     F  L ++ V +  P +P 
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK---TPFQQLKQV-VEEPSPQLPA 230

Query: 237 D-LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDD 278
           +  S + +DF+ KC  K+ K R     LL HPF         D
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTD 273

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 80/279 (28%), Positives = 131/279 (46%), Gaps = 24/279 (8%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           W   + IG G++G V      K  S+     AVK           ++ E   L  +   P
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSK----AAVKILDPIHDIDEEIEAEYNILKALSDHP 75

Query: 63  QIVRCFGDDYSFEK--GERFYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSML 118
            +V+ +G  Y  +   G++ + L+LE  + GS+ D VK   +   R++E  +       L
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL-AKKSSCDGERSQSFECRGTPLYM 177
            GL+H+H    +H D+K  N+L+      K+ DFG+ A+ +S    R+ S    GTP +M
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---GTPFWM 191

Query: 178 SPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
           +PE +      ++ Y+A CD+W+LG   +E+  G P      D +    L +I   +  P
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIP-RNPPP 247

Query: 233 NI--PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            +  P   S +  DF+ KC  KD ++R T   LL H F+
Sbjct: 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 77/263 (29%), Positives = 131/263 (49%), Gaps = 16/263 (6%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           ++G GSFG V LA+  K +++F ++ A+K         V     EK  L      P +  
Sbjct: 2   MLGKGSFGKVFLAEL-KGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            +    +F+  E  +  ++EY + G L   +  Q+  +        Y   ++ GL+ +HS
Sbjct: 61  LY---CTFQTKENLF-FVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHS 114

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           KG V+ D+KL N+L+  +   KIADFG+ K++     ++ +F C GTP Y++PE +   +
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF-C-GTPDYIAPEILLGQK 172

Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y    D W+ G  + EM  G+  + H  D       IR+    + P  P  L+ + KD L
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPF-HGHDEEELFQSIRM----DNPCYPRWLTREAKDIL 227

Query: 247 IKCFLKDPKRRWTAEM-LLNHPF 268
           +K F+++P+RR   +  +  HPF
Sbjct: 228 VKLFVREPERRLGVKGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 75/265 (28%), Positives = 121/265 (45%), Gaps = 19/265 (7%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G +G V LAK  K + E  +L    KS          +  E++ L        +V+ 
Sbjct: 9   VGQGGYGQVFLAK-KKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+  E  Y L +EY   G    R    N G L E   + Y   M + +  +H  
Sbjct: 67  L---YAFQDDEYLY-LAMEYVPGGDF--RTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
           G++H D+K +N L+  +   K+ DFGL+K     G  + +    G+P YM+PE +    Y
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGY 175

Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP--NIPG-DLSEQGKD 244
           +   D W+LGC + E   G P ++    +  +  L       + P  + P  +LS++  D
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235

Query: 245 FLIKCFLKDPKRRWTA-EMLLNHPF 268
            + K  + DP RR+ + E + NHPF
Sbjct: 236 LITKL-INDPSRRFGSLEDIKNHPF 259

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 93.6 bits (232), Expect = 1e-21
 Identities = 82/272 (30%), Positives = 135/272 (49%), Gaps = 33/272 (12%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEK--EALDQIGICPQIVR 66
           IGHGSFG+V  A+  + +SE   ++A+K  +     S    NEK  + + ++    ++  
Sbjct: 23  IGHGSFGAVYFARDVR-NSE---VVAIKKMS----YSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 67  CFGDDYSFEKG----ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
                Y   +G    E    L++EY   GS +D ++      LQE ++   T   L+GL 
Sbjct: 75  PNTIQY---RGCYLREHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAVTHGALQGLA 129

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-- 180
           ++HS   +H D+K  N+L+ +    K+ DFG A   +     +  F   GTP +M+PE  
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANXFV--GTPYWMAPEVI 183

Query: 181 -SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD-L 238
            +++E +Y+   D+W+LG   +E+A  KP      + N  S L  I   +E P +     
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIA-QNESPALQSGHW 239

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           SE  ++F+  C  K P+ R T+E+LL H FV 
Sbjct: 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 92.6 bits (230), Expect = 2e-21
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 18/226 (7%)

Query: 50  NEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESD 109
           NEK+ L+++     IV      Y+FE  +    L++   + G L   +         E+ 
Sbjct: 42  NEKKILEKVS-SRFIV-SLA--YAFETKDDL-CLVMTLMNGGDLKYHIYNVGEPGFPEAR 96

Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
              Y   ++ GL H+H +  V+ D+K +NVL+ D+   +I+D GLA     + +  +  +
Sbjct: 97  AIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA----VELKGGKKIK 152

Query: 170 CR-GTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGV 227
            R GTP YM+PE +    Y+   D +ALGC + EM +G+ P    K+      L  R   
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--T 210

Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
            +     P   S + KD       KDP++R      +A+ +  HP 
Sbjct: 211 LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPL 256

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 92.4 bits (229), Expect = 2e-21
 Identities = 60/200 (30%), Positives = 106/200 (53%), Gaps = 14/200 (7%)

Query: 73  SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHC 132
           S+  G+  + +++E+   G+L D V    + R+ E  +     S+L+ L ++H++G +H 
Sbjct: 87  SYLVGDELW-VVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142

Query: 133 DIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCD 192
           DIK  ++L+  +   K++DFG   + S +  + +S    GTP +M+PE ++   Y    D
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV--GTPYWMAPEVISRLPYGTEVD 200

Query: 193 IWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL---SEQGKDFLIKC 249
           IW+LG  V+EM  G+P + ++        + RI   D LP    D    S   + FL   
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPP---LQAMRRI--RDNLPPRVKDSHKVSSVLRGFLDLM 255

Query: 250 FLKDPKRRWTAEMLLNHPFV 269
            +++P +R TA+ LL HPF+
Sbjct: 256 LVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 24/207 (11%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-------LKNEKEALDQIGIC 61
           +G G FG V L K  K  +   +L  VK         +        + +EKE L++    
Sbjct: 1   LGVGGFGRVELVK-VKSKNRTFALKCVKK------RHIVETGQQEHIFSEKEILEECN-H 52

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV+ +    +F+  +  Y +L+EY   G L   ++    G   E   + Y   ++   
Sbjct: 53  PFIVKLYR---TFKDKKYIY-MLMEYCLGGELWTILRD--RGLFDEYTARFYIACVVLAF 106

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++H++G ++ D+K +N+L+  N   K+ DFG AKK    G+++ +F C GTP Y++PE 
Sbjct: 107 EYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-GQKTWTF-C-GTPEYVAPEI 163

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKP 208
           +    Y+   D W+LG  + E+ +G+P
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRP 190

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 75/264 (28%), Positives = 122/264 (46%), Gaps = 41/264 (15%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVK-------------SCADCPPSSVTLKNEKEA 54
           V+G GSFG V LA+  K + E   L A+K              C       + L  +   
Sbjct: 7   VLGKGSFGKVMLAE-RKGTDE---LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62

Query: 55  LDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYT 114
           L Q+  C            F+  +R Y  ++EY + G L   +  Q  G+ +E     Y 
Sbjct: 63  LTQLHSC------------FQTMDRLY-FVMEYVNGGDLMYHI--QQVGKFKEPHAVFYA 107

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
             +  GL  +HSKG ++ D+KL NV++      KIADFG+ K++   G+ +++F C GTP
Sbjct: 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF-C-GTP 165

Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
            Y++PE +    Y    D WA G  + EM +G+P ++ + +  +F       + +   + 
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-----SIMEHNVSY 220

Query: 235 PGDLSEQGKDFLIKCFL-KDPKRR 257
           P  LS++    + K  L K P +R
Sbjct: 221 PKSLSKEAVS-ICKGLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 92.3 bits (229), Expect = 4e-21
 Identities = 75/274 (27%), Positives = 136/274 (49%), Gaps = 24/274 (8%)

Query: 8   VIGHGSFGSVNLAKASKVS----SEFPSLMAVKSCADCPPSSVT--LKNEKEALDQIGIC 61
           V+G G++G V L +  KV+     +  ++  ++  A    +      + E+  L+ +   
Sbjct: 7   VLGTGAYGKVFLVR--KVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQS 64

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P +V      Y+F+   + + L+L+Y S G +   + +++N    E +V+ Y+  ++  L
Sbjct: 65  PFLVTL---HYAFQTEAKLH-LILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILAL 118

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS-SCDGERSQSFECRGTPLYMSPE 180
            H+H  G V+ DIKL+N+L+       + DFGL+K+  S + ER+ SF C GT  YM+PE
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF-C-GTIEYMAPE 176

Query: 181 SV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
            +  +  +    D W+LG  + E+ +G   +  + + N  S + R  +  + P  P  + 
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD-PPFPSFIG 235

Query: 240 EQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
            + +D L K   KDPK+R       A  +  HPF
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 91.5 bits (227), Expect = 7e-21
 Identities = 79/272 (29%), Positives = 129/272 (47%), Gaps = 34/272 (12%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVK----------SCADCPPSSVTLKNEKEALDQ 57
           V+G GSFG V LA+  K   E+ ++ A+K           C       + L  E   L  
Sbjct: 2   VLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           +  C           +F+  E  +  ++E+ + G L   +  Q+ GR        Y   +
Sbjct: 61  L-YC-----------TFQTKEHLF-FVMEFLNGGDLMFHI--QDKGRFDLYRATFYAAEI 105

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + GL+ +HSKG ++ D+KL NV++  +   KIADFG+ K++     R+ +F C GTP Y+
Sbjct: 106 VCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF-C-GTPDYI 163

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           +PE +   +Y    D W+ G  + EM  G+  + H  D +     IR+    + P+ P  
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF-HGDDEDELFESIRV----DTPHYPRW 218

Query: 238 LSEQGKDFLIKCFLKDPKRRW-TAEMLLNHPF 268
           ++++ KD L K F +DP RR      +  HPF
Sbjct: 219 ITKESKDILEKLFERDPTRRLGVVGNIRGHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 89.6 bits (222), Expect = 1e-20
 Identities = 75/261 (28%), Positives = 126/261 (48%), Gaps = 21/261 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQIVR 66
           V+G GSFG   L +      ++    A+K       SS    + KEA+    +  P IV 
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKY----AMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV- 61

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            F +  SFE     Y +++EY   G L  ++K Q      E  + ++   M  G++HIH 
Sbjct: 62  AFKE--SFEADGHLY-IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR--GTPLYMSPESVNE 184
           K  +H DIK +N+ +  N + K+ DFG A+  +  G    ++ C   GTP Y+ PE    
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG----AYACTYVGTPYYVPPEIWEN 174

Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGDELPNIPGDLSEQGK 243
             Y    DIW+LGC + E+ + K    H   +N + +L++++  G   P +P   S + +
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLK----HPFQANSWKNLILKVCQGSYKP-LPSHYSYELR 229

Query: 244 DFLIKCFLKDPKRRWTAEMLL 264
             + + F ++P+ R +A  +L
Sbjct: 230 SLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 77/269 (28%), Positives = 121/269 (44%), Gaps = 23/269 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSV-TLKNEKEALDQIGIC--PQI 64
           V+G G FG V LA+  K + E  ++ A+K         V +L  EK   +       P +
Sbjct: 6   VLGRGHFGKVLLAE-YKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V  F     F+  +     ++EYA+ G L   +         E     Y   ++ GL+++
Sbjct: 65  VNLFA---CFQTEDHVC-FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYL 117

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           H    V+ D+KL N+L+      KIADFGL K+    G+R+ +F C GTP +++PE + E
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF-C-GTPEFLAPEVLTE 175

Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             Y    D W LG  + EM  G+  +    +  VF  +    V DE    P  LS +   
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI----VNDE-VRYPRFLSREAIS 230

Query: 245 FLIKCFLKDPKRRW-----TAEMLLNHPF 268
            + +   ++P+RR       AE +   PF
Sbjct: 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 28/197 (14%)

Query: 100 QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS 159
           ++   L +  ++ +   +L+GL+++HS   +H D+K  N+LV  N + KI DFGLA+   
Sbjct: 95  KSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154

Query: 160 CDGERSQSF-ECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN 217
            D +      E   T  Y +PE + + + Y    DIW++GC   E+ + KP +  +   +
Sbjct: 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214

Query: 218 VFSLLIR-IGVGDE-----------------LPNIPG--------DLSEQGKDFLIKCFL 251
             +L++  +G   E                 LP  P           S +  D L K  +
Sbjct: 215 QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLV 274

Query: 252 KDPKRRWTAEMLLNHPF 268
            DPK+R TA+  L HP+
Sbjct: 275 FDPKKRITADEALAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 72/260 (27%), Positives = 120/260 (46%), Gaps = 33/260 (12%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVK----------SCADCPPSSVTLKNEKEALDQ 57
           V+G GSFG V LA+  K + E  ++  +K           C       + L+++   L Q
Sbjct: 7   VLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQ 65

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           +  C Q V            +R Y  ++EY + G L   +  Q  G+ +E     Y   +
Sbjct: 66  LHSCFQTV------------DRLY-FVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEI 110

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
             GL  +H +G ++ D+KL NV++      KIADFG+ K+   DG  +++F C GTP Y+
Sbjct: 111 SVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF-C-GTPDYI 168

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           +PE +    Y    D WA G  + EM +G+P ++ + +  +F  ++   V     + P  
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-----SYPKS 223

Query: 238 LSEQGKDFLIKCFLKDPKRR 257
           LS++          K P +R
Sbjct: 224 LSKEAVSICKGLMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 35/274 (12%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVK--------SCADCPPSSVTLKNEKEALDQIG 59
           ++G G+FG V L +  K S ++ ++  +K          A     S  LKN +       
Sbjct: 2   LLGKGTFGKVILVR-EKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH------ 54

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P +       YSF+  +R    ++EY + G L   + ++      E   + Y   ++ 
Sbjct: 55  --PFLTSL---KYSFQTKDRLC-FVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVS 106

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            L ++HS   V+ D+KL+N+++  +   KI DFGL K+   D    ++F C GTP Y++P
Sbjct: 107 ALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF-C-GTPEYLAP 164

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +N+Y    D W LG  + EM  G+  + ++    +F L++      E    P  LS
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EDIKFPRTLS 219

Query: 240 EQGKDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
              K  L    +KDP +R       A+ ++ H F
Sbjct: 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 75/254 (29%), Positives = 119/254 (46%), Gaps = 21/254 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICP---Q 63
           V+G GSFG V LA+  K + E  ++  +K         V     EK  L   G  P   Q
Sbjct: 7   VLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +  CF      +  +R Y  ++EY + G L  ++  Q  GR +E     Y   +  GL  
Sbjct: 66  LHSCF------QTMDRLY-FVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFF 116

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HSKG ++ D+KL NV++      KIADFG+ K++  DG  +++F C GTP Y++PE + 
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF-C-GTPDYIAPEIIA 174

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WA G  + EM +G+  +  + +  +F  ++   V       P  +S++  
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-----YPKSMSKEAV 229

Query: 244 DFLIKCFLKDPKRR 257
                   K P +R
Sbjct: 230 AICKGLMTKHPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 30/272 (11%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G G+FG V L K  K +  + ++  +K         V     +  + Q    P +   
Sbjct: 2   LLGKGTFGKVILVK-EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-- 58

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSL-----ADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
               YSF+  +R    ++EYA+ G L      +RV  ++  R        Y   ++  L 
Sbjct: 59  -ALKYSFQTHDRLC-FVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALD 109

Query: 123 HIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           ++HS K  V+ D+KL+N+++  +   KI DFGL K+   DG   ++F C GTP Y++PE 
Sbjct: 110 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-C-GTPEYLAPEV 167

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           + +N+Y    D W LG  + EM  G+  + ++    +F L++      E    P  LS +
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFPRTLSPE 222

Query: 242 GKDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
            K  L     KDPK+R       A+ ++ H F
Sbjct: 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 72/269 (26%), Positives = 122/269 (45%), Gaps = 22/269 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK-NEKEALDQIGICPQIVR 66
           V+G GSFG V LA+  K + E  ++  +K         V     EK  L      P +  
Sbjct: 2   VLGKGSFGKVMLAE-LKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                  F+  +R +  ++EY + G L  ++++    +  E   + Y   +   L  +H 
Sbjct: 61  LHC---CFQTKDRLF-FVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHR 114

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
            G ++ D+KL N+L+      K+ADFG+ K+   +G  + +F C GTP Y++PE + E E
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF-C-GTPDYIAPEILQELE 172

Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y    D WALG  + EM +G+P +    + ++F  ++   V       P  LS++    L
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-----LYPVWLSKEAVSIL 227

Query: 247 IKCFLKDPKRRW-------TAEMLLNHPF 268
                K+P +R          + +  HPF
Sbjct: 228 KAFMTKNPNKRLGCVASQGGEDAIKQHPF 256

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 12/253 (4%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG GS+  V L +  K    +   +  K           ++ EK   +Q    P +V  
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV-- 59

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G    F+   R + L++EY + G L   +++Q   +L E   + Y   +   L  +H +
Sbjct: 60  -GLHSCFQTTSRLF-LVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHER 115

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
           G ++ D+KL NVL+  +   K+ D+G+ K+    G+ + +F C GTP Y++PE +   EY
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF-C-GTPNYIAPEILRGEEY 173

Query: 188 EAPCDIWALGCAVVEMASGKPAWN---HKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
               D WALG  + EM +G+  ++      D N    L ++ + ++   IP  LS +   
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASH 232

Query: 245 FLIKCFLKDPKRR 257
            L     KDPK R
Sbjct: 233 VLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 30/275 (10%)

Query: 9   IGHGSFGSVN--LAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICPQI 64
           IG G+FG+VN  L K S        +MAVK             L  + + + +   CP I
Sbjct: 12  IGRGAFGTVNKMLHKPSGT------IMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V+ +G    F +G+ +  + L   S       V +     + E  + +   + +K L ++
Sbjct: 66  VKFYG--ALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123

Query: 125 HSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
             +   +H D+K  N+L+  N   K+ DFG++ +      +++   CR  P YM+PE ++
Sbjct: 124 KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCR--P-YMAPERID 180

Query: 184 ENE---YEAPCDIWALGCAVVEMASGK---PAWNHKQDSNVFSLLIRIGVGDE---LPNI 234
            +    Y+   D+W+LG  + E+A+GK   P WN     +VF  L ++  GD      + 
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDPPILSNSE 235

Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             + S    +F+  C +KD  +R   + LL HPF+
Sbjct: 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 88.6 bits (219), Expect = 8e-20
 Identities = 69/255 (27%), Positives = 119/255 (46%), Gaps = 14/255 (5%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG GS+  V L +  K    +   +  K   +       ++ EK   +Q    P +V  
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV-- 59

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G    F+   R +  ++EY + G L   +++Q   +L E   + Y+  +   L ++H +
Sbjct: 60  -GLHSCFQTESRLF-FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER 115

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
           G ++ D+KL NVL+      K+ D+G+ K+    G+ + +F C GTP Y++PE +   +Y
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-C-GTPNYIAPEILRGEDY 173

Query: 188 EAPCDIWALGCAVVEMASGKPAWN-----HKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               D WALG  + EM +G+  ++        D N    L ++ +  ++  IP  LS + 
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKA 232

Query: 243 KDFLIKCFLKDPKRR 257
              L     KDPK R
Sbjct: 233 ASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 81/309 (26%), Positives = 128/309 (41%), Gaps = 65/309 (21%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-----ALDQIGIC 61
             IG G++G V  A+  K + E  +L  V+           L NEKE     A+ +I I 
Sbjct: 13  GQIGEGTYGQVYKAR-DKDTGELVALKKVR-----------LDNEKEGFPITAIREIKIL 60

Query: 62  PQ-----------IVRCFGDDYSFEKGERFYNLLLEYASR---GSLADRVKKQNNGRLQE 107
            Q           IV    D   F+K +  + L+ EY      G L   +   +     E
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS-----E 115

Query: 108 SDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS 167
             +K + + +L+GL + H K F+H DIK  N+L+ +  + K+ADFGLA+  + +  R  +
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Query: 168 FECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG 226
            +   T  Y  PE  + E  Y    D+W+ GC + E+ + KP +   Q+     L+ R+ 
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL- 233

Query: 227 VGDELPNIPGDLSE--------------------------QGKDFLIKCFLKDPKRRWTA 260
            G   P +  D+ +                             D L      DP +R TA
Sbjct: 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA 293

Query: 261 EMLLNHPFV 269
           E  LN P++
Sbjct: 294 EEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 18/210 (8%)

Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           Y+F+ G + Y L+LEY S G L   ++++  G   E     Y   +   L H+H +G ++
Sbjct: 67  YAFQTGGKLY-LILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIY 123

Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            D+K +N+L+      K+ DFGL K+S  +G  + +F C GT  YM+PE +  + +    
Sbjct: 124 RDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF-C-GTIEYMAPEILMRSGHGKAV 181

Query: 192 DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFL 251
           D W+LG  + +M +G P +  +        +++  +     N+P  L+ + +D L K   
Sbjct: 182 DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-----NLPPYLTPEARDLLKKLLK 236

Query: 252 KDPKRRW-----TAEMLLNHPF---VCADD 273
           ++P  R       A  + +HPF   V  DD
Sbjct: 237 RNPSSRLGAGPGDAAEVQSHPFFRHVNWDD 266

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 6/197 (3%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV L +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-HDNIVKY 70

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K +  RL    +  Y   + KG+ ++ SK
Sbjct: 71  KGVCYS--AGRRNLRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSK 127

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            +VH D+  +N+LV   +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187

Query: 187 YEAPCDIWALGCAVVEM 203
           +    D+W+ G  + E+
Sbjct: 188 FSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 7/200 (3%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVT-LKNEKEALDQIGICPQIVR 66
           +G G FG V L +   +       +AVKS          +  + E E L  +     IV+
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVK 70

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
             G     + G R   L++EY   GSL D +++  + ++    +  ++  + KG+ ++ S
Sbjct: 71  YKG--VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGS 127

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNEN 185
           + ++H D+  +N+LV   D  KI+DFGLAK    D +     E   +P+ + +PE +  +
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 186 EYEAPCDIWALGCAVVEMAS 205
           ++ +  D+W+ G  + E+ +
Sbjct: 188 KFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.9 bits (213), Expect = 3e-19
 Identities = 65/260 (25%), Positives = 111/260 (42%), Gaps = 24/260 (9%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGICPQ 63
           +G GSFG V   + S    +   + AVK       S +     KEA     LD       
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPV-AVKCLKSDKLSDIMDDFLKEAAIMHSLDH----EN 57

Query: 64  IVRCFGD--DYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           ++R +G    +          ++ E A  GSL DR++K   G    S +  Y   +  G+
Sbjct: 58  LIRLYGVVLTHPLM-------MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGM 110

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPE 180
           R++ SK F+H D+  +N+L+  +D+ KI DFGL +    + +     E    P  + +PE
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170

Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           S+    +    D+W  G  + EM + G+  W     S +   + + G   E    P    
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG---ERLERPEACP 227

Query: 240 EQGKDFLIKCFLKDPKRRWT 259
           +   + +++C+  +P  R T
Sbjct: 228 QDIYNVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.0 bits (213), Expect = 3e-19
 Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 31/267 (11%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGIC 61
           + +G G+FG V   +         +L+A+K      P+    K E++      + ++ I 
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQ---NLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62

Query: 62  ------PQIVRCFGDDYSFEKGERFYNL--LLEYASRGSLADRVKKQNNGRLQESDVKRY 113
                 P IVR +    +F + +R Y +  L+E A  G   + +K++   R  E  +   
Sbjct: 63  KEQLRHPNIVRYYK---TFLENDRLYIVMDLIEGAPLGEHFNSLKEKK-QRFTEERIWNI 118

Query: 114 TRSMLKGLRHIH-SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
              M+  LR++H  K  VH D+   N+++ ++D+  I DFGLAK+       S+     G
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK---QPESKLTSVVG 175

Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI--GVGDE 230
           T LY  PE V    Y    D+WA GC + +M + +P +     +N+ SL  +I   V + 
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF---YSTNMLSLATKIVEAVYEP 232

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           LP   G  SE   D +  C   D + R
Sbjct: 233 LPE--GMYSEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 83/293 (28%), Positives = 126/293 (43%), Gaps = 37/293 (12%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQ 63
           + IG G++G V  A+  K + +  +L   +   D    PP+++    E   L  +     
Sbjct: 7   EKIGEGTYGKVYKAR-DKNTGKLVALKKTRLEMDEEGIPPTAL---REISLLQMLSESIY 62

Query: 64  IVRCFGDDYSFEK-GERFYNLLLEYASRG--SLADRVKKQNNGRLQESDVKRYTRSMLKG 120
           IVR    ++  EK G+    L+ EY         D   +     L    +K +   +LKG
Sbjct: 63  IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA-KIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           + H H  G +H D+K QN+LV       KIAD GL +  S    +S + E   T  Y +P
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP-VKSYTHEIV-TLWYRAP 180

Query: 180 ES-VNENEYEAPCDIWALGCAVVEMASGKPAW----NHKQDSNVFSLL------IRIGVG 228
           E  +    Y  P DIW++GC   EM+  +P +      +Q  ++F LL      +  GV 
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240

Query: 229 D-----ELPNIPG--------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                 E P            DLS +G D L K    DP +R +A+  L HP+
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 38/221 (17%)

Query: 78  ERFYNLLLEYASRGSLADRVKK--QNNGRLQE-SDVKRYTRSMLKGLRHIHSKGFVHCDI 134
           ER   L+ EY     L   +K+   N G L    +VK +   +L+GL + H +  +H D+
Sbjct: 75  ERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL 129

Query: 135 KLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV--NENEYEAPCD 192
           K QN+L+ +  E K+ADFGLA+  S     ++++      L+  P  V     EY  P D
Sbjct: 130 KPQNLLINEKGELKLADFGLARAKSVP---TKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186

Query: 193 IWALGCAVVEMASGKPAW---NHKQDSNVFSLLIRIGVGDELPNIPGD------------ 237
           +W +GC + EMA+G+P +     K++ ++   L+     +  P I  +            
Sbjct: 187 MWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYR 246

Query: 238 ----------LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                     L   G D L    L + K R +AE  L H +
Sbjct: 247 AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 81/291 (27%), Positives = 127/291 (43%), Gaps = 41/291 (14%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           IG G++G V  A+  K    F +L  V+         ++   E   L  +     P +VR
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 67  CFGDDYSFEKGERFYNLLL--EYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
            F D  +  + +R   L L  E+  +  L   + K     +    +K     +L+GL  +
Sbjct: 69  LF-DVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-----YMSP 179
           HS   VH D+K QN+LV  + + K+ADFGLA        R  SF+   T +     Y +P
Sbjct: 127 HSHRVVHRDLKPQNILVTSSGQIKLADFGLA--------RIYSFQMALTSVVVTLWYRAP 178

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR-IGVGDE-------- 230
           E + ++ Y  P D+W++GC   EM   KP +    D +    ++  IG+  E        
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Query: 231 LP-------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           LP                 D+ E GKD L+KC   +P +R +A   L+HP+
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 27/273 (9%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G G FG V + +  K + +  ++  +K        +V+   E+  +  I   P I + 
Sbjct: 8   LVGRGHFGEVQVVR-EKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+  +  Y L++EY   G L   + +    +  E   + Y   ++  +  +H  
Sbjct: 67  ---QYAFQDKDNLY-LVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM 121

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE---SVN- 183
           G+VH DIK +NVL+      K+ADFG A + + +   +      GTP Y++PE   ++N 
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNG 180

Query: 184 --ENEYEAPCDIWALGCAVVEMASGKPAWN----HKQDSNVFSLLIRIGVGDELPNIPGD 237
             +  Y   CD W+LG    EM  G+  ++     K  +N+ +              P D
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF-------QRFLKFPED 233

Query: 238 L--SEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
              S    D LI+  L   K R   E L  HPF
Sbjct: 234 PKVSSDFLD-LIQSLLCGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 22/273 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG GS+  V L +  K    +   +  K   +       ++ EK   +     P +V  
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV-- 59

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G    F+   R +  ++E+ S G L   +++Q   +L E   + Y+  +   L  +H +
Sbjct: 60  -GLHSCFQTESRLF-FVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER 115

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
           G ++ D+KL NVL+      K+ D+G+ K+    G+ + +F C GTP Y++PE +   +Y
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF-C-GTPNYIAPEILRGEDY 173

Query: 188 EAPCDIWALGCAVVEMASGKPAW-----NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               D WALG  + EM +G+  +     +   D N    L ++ + ++   IP  LS + 
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV-ILEKQIRIPRSLSVKA 232

Query: 243 KDFLIKCFL-KDPKRRWTAEM------LLNHPF 268
              L K FL KDPK R           + +HPF
Sbjct: 233 SSVL-KGFLNKDPKERLGCHPQTGFRDIKSHPF 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 58/213 (27%)

Query: 95  DRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL 154
           D              +K Y   +L+G+ + HS   +H D+K QN+L+      K+ADFGL
Sbjct: 89  DSSPLTGLDPPL---IKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGL 145

Query: 155 AKKSSCDGERSQSFECRGTPL-----------YMSPES-VNENEYEAPCDIWALGCAVVE 202
           A+          +F   G P+           Y +PE  +   +Y  P DIW++GC   E
Sbjct: 146 AR----------AF---GVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192

Query: 203 MASGKPAWNHKQDSNV---FSLLIRIGVGDE--------LPN----------------IP 235
           M + +P +    DS +   F +   +G  DE        LP+                +P
Sbjct: 193 MVNRRPLF--PGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVP 250

Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
             L E G D L K  + DP +R +A+  L HP+
Sbjct: 251 N-LDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 54/179 (30%), Positives = 81/179 (45%), Gaps = 29/179 (16%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           +L+GL++IHS   +H D+K  N+L+  N + KI DFGLA+ +S  G+     E   T  Y
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWY 174

Query: 177 MSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR-IGVGDE---- 230
            +PE + N +EY    D+W++GC   E+   KP +  K   +   L+   +G   E    
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234

Query: 231 -------------LPNIPG--------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                        LP  P           +    D L K  + DP +R T E  L HP+
Sbjct: 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 74/270 (27%), Positives = 120/270 (44%), Gaps = 26/270 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQI 64
           G+ +G GSFG V +AK  K + E+ ++  +K         V  +  EK  L ++   P I
Sbjct: 23  GETLGTGSFGRVRIAK-HKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFI 80

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V       SF+   R Y  LLE+   G L   ++K   GR      K Y   ++    ++
Sbjct: 81  VNMM---CSFQDENRVY-FLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYL 134

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  ++ D+K +N+L+ +    K+ DFG AKK        ++F   GTP Y++PE +  
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-----PDRTFTLCGTPEYLAPEVIQS 189

Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             +    D W +G  + E  +G P +    D   F +  +I  G      P     + +D
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPPF---FDDTPFRIYEKILAGRLK--FPNWFDGRARD 244

Query: 245 FLIKCFLK-DPKRRWTA-----EMLLNHPF 268
            L+K  L+ D  +R          + NHP+
Sbjct: 245 -LVKGLLQTDHTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 29/195 (14%)

Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE 163
            L ++  + +   +L GL++IHS   +H D+K  N+LV  + E KI DFGLA+  S +  
Sbjct: 101 PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160

Query: 164 RSQSF--ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHK----QDS 216
            +  F  E   T  Y +PE  ++   Y    D+W++GC + E+   KP +  K    Q +
Sbjct: 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220

Query: 217 NVFSLL--------IRIG------VGDELPNIPG--------DLSEQGKDFLIKCFLKDP 254
            +  +L         RIG          LPNIP         + +    D L K    DP
Sbjct: 221 QILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDP 280

Query: 255 KRRWTAEMLLNHPFV 269
            +R + E  L HP++
Sbjct: 281 TKRISVEEALEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 62/191 (32%), Positives = 87/191 (45%), Gaps = 32/191 (16%)

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L E  V+     ML GL++IHS G +H D+K  N+ V ++ E KI DFGLA+    D E 
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM 171

Query: 165 SQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI 223
           +     R    Y +PE + N   Y    DIW++GC + EM +GK  +  K   +  + ++
Sbjct: 172 TGYVVTR---WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228

Query: 224 RI-GV-GDE----------------LPNIP-GDLS-------EQGKDFLIKCFLKDPKRR 257
           ++ GV G E                LP  P  D S        Q  D L K    D  +R
Sbjct: 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKR 288

Query: 258 WTAEMLLNHPF 268
            TA   L HP+
Sbjct: 289 LTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 83.4 bits (207), Expect = 4e-18
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 46/206 (22%)

Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS 158
           +       +S+VK     +L G+ H+H    +H D+K  N+L+ +    KI DFGLA++ 
Sbjct: 97  ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156

Query: 159 SCDGERSQSFECRGTPL-----YMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNH 212
              G   + +    T L     Y +PE +    EY    D+W++GC   E+ + KP +  
Sbjct: 157 ---GSPLKPY----TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209

Query: 213 K----QDSNVFSLLIRIGVGDE--------LPNI------------------PGDLSEQG 242
           K    Q + +F LL   G   E        LP                       LS+ G
Sbjct: 210 KSEIDQLNKIFKLL---GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNG 266

Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPF 268
            D L +    DP +R +AE  L HP+
Sbjct: 267 FDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 76/273 (27%), Positives = 122/273 (44%), Gaps = 33/273 (12%)

Query: 8   VIGHGSFGSVNLAK--------ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           VIG GSFG V LAK        A KV  +   L   +        +V LKN K       
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH------ 55

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P +V   G  YSF+  E+ Y  +L+Y + G L   ++++      E   + Y   +  
Sbjct: 56  --PFLV---GLHYSFQTAEKLY-FVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVAS 107

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            + ++HS   ++ D+K +N+L+       + DFGL K+     E + +F C GTP Y++P
Sbjct: 108 AIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF-C-GTPEYLAP 165

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +  Y+   D W LG  + EM  G P +  +  S ++       +  +   +PG  +
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD-----NILHKPLQLPGGKT 220

Query: 240 EQGKDFLIKCFLKDPKRRWTAEM----LLNHPF 268
               D L+    KD +RR  A+     + NH F
Sbjct: 221 VAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 82.5 bits (204), Expect = 7e-18
 Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 55/198 (27%)

Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           VK Y   +L+G+   HS+  +H D+K QN+L+ +    K+ADFGLA+          +F 
Sbjct: 103 VKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR----------AF- 151

Query: 170 CRGTPL-----------YMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN 217
             G P+           Y +PE +     Y  P DIW++G    EMA+ KP ++   DS 
Sbjct: 152 --GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH--GDSE 207

Query: 218 VFSLLIRI-------------GV--------------GDELPNIPGDLSEQGKDFLIKCF 250
           +   L RI             GV                 L +   +L E G D L K  
Sbjct: 208 I-DQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKML 266

Query: 251 LKDPKRRWTAEMLLNHPF 268
           + DP +R +A+  LNHP+
Sbjct: 267 IYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 73/281 (25%), Positives = 123/281 (43%), Gaps = 49/281 (17%)

Query: 8   VIGHGSFGSVNLAK--------ASKVSS--------EFPSLMAVKSCADCPPSSVTLKNE 51
           VIG GSFG V LAK        A KV          E   +MA ++        V LKN 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERN--------VLLKNV 53

Query: 52  KEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVK 111
           K         P +V   G  YSF+  ++ Y  +L+Y + G L   ++++      E   +
Sbjct: 54  KH--------PFLV---GLHYSFQTADKLY-FVLDYVNGGELFFHLQRER--SFPEPRAR 99

Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR 171
            Y   +   L ++HS   ++ D+K +N+L+       + DFGL K+   +  ++ S  C 
Sbjct: 100 FYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG-IEHSKTTSTFC- 157

Query: 172 GTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           GTP Y++PE + +  Y+   D W LG  + EM  G P +  +  + ++  ++     ++ 
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL-----NKP 212

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTA----EMLLNHPF 268
             +  ++S   +  L     KD  +R  A      + NH F
Sbjct: 213 LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 84/297 (28%), Positives = 131/297 (44%), Gaps = 54/297 (18%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSS----VTLKNEKEALDQIGICP 62
           IG G++G+V  A+    S  F +L +V+  +  D  P S    V L    EA D     P
Sbjct: 8   IGVGAYGTVYKAR-DPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH----P 62

Query: 63  QIVRCFGDDYSFEKGER--FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            IVR   D  +  + +R     L+ E+  +  L   + K     L    +K   R  L+G
Sbjct: 63  NIVRLM-DVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL----- 175
           L  +H+   VH D+K +N+LV    + K+ADFGLA+  SC        +   TP+     
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--------QMALTPVVVTLW 172

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAW--NHKQDS--NVFSLLIRIGVGDEL 231
           Y +PE + ++ Y  P D+W++GC   EM   KP +  N + D    +F  LI +   D+ 
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD-LIGLPPEDDW 231

Query: 232 PN--------------------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P                     +P ++ E G   L++    +P +R +A   L HPF
Sbjct: 232 PRDVTLPRGAFSPRGPRPVQSVVP-EIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 57/201 (28%), Positives = 86/201 (42%), Gaps = 48/201 (23%)

Query: 103 GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG 162
             L++  ++ +   +L+GL+++HS G VH D+K  N+L+ +N + KI DFGLA       
Sbjct: 103 RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA------- 155

Query: 163 ERSQSFECRG---TPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV 218
            R Q  +  G   T  Y +PE  +   +Y+   DIW+ GC   EM  GKP +  K   N 
Sbjct: 156 -RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214

Query: 219 FSLLIRIGVGDELPNIPGD-------------------------------LSEQGKDFLI 247
           FS++      D L   P D                                     D L 
Sbjct: 215 FSIIT-----DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLE 269

Query: 248 KCFLKDPKRRWTAEMLLNHPF 268
           K  + DP++R +A   L HP+
Sbjct: 270 KMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 46/220 (20%)

Query: 83  LLLEYASR--GSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVL 140
           L++EY  +   SL D +         ES VK     +L+GL+++H    +H D+K+ N+L
Sbjct: 85  LVMEYCEQDLASLLDNMPTP----FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLL 140

Query: 141 VFDNDEAKIADFGLAKKSSCDGERSQSFECRG-TP-----LYMSPESV-NENEYEAPCDI 193
           + D    KIADFGLA        R+     +  TP      Y +PE +     Y    D+
Sbjct: 141 LTDKGCLKIADFGLA--------RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDM 192

Query: 194 WALGCAVVEMASGKPAWNHKQDSNVFSLLI--------RIGVG-DELPNI--------P- 235
           WA+GC + E+ + KP    K +     L+I         I  G  +LP +        P 
Sbjct: 193 WAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPY 252

Query: 236 -------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                    LSE G   L    + DPK+R TAE  L   +
Sbjct: 253 NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 37/232 (15%)

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           ++  F  D S ++   FY L++ +       D  K   + +L E  ++     MLKGL++
Sbjct: 79  LLDVFTPDLSLDRFHDFY-LVMPFMG----TDLGKLMKHEKLSEDRIQFLVYQMLKGLKY 133

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV- 182
           IH+ G +H D+K  N+ V ++ E KI DFGLA+++  D E +     R    Y +PE + 
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT--DSEMTGYVVTR---WYRAPEVIL 188

Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG-----------VGDEL 231
           N   Y    DIW++GC + EM +GKP +      +    ++++              ++ 
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248

Query: 232 PNIPGDLSE-QGKDF--------------LIKCFLKDPKRRWTAEMLLNHPF 268
            N    L   + KDF              L K  + D + R TA   L HP+
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 74/265 (27%), Positives = 121/265 (45%), Gaps = 36/265 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEA-----LDQIG 59
           G  IG G FG V   +   +S E   + +AVK+C +C   SV  K  +EA      D   
Sbjct: 11  GRCIGEGQFGDVY--QGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH-- 66

Query: 60  ICPQIVRCFG---DDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
             P IV+  G   ++  +        +++E A  G L   ++  N   L  + +  Y+  
Sbjct: 67  --PHIVKLIGVITENPVW--------IVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQ 115

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           +   L ++ SK FVH DI  +NVLV   D  K+ DFGL++    D    ++ + +    +
Sbjct: 116 LSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKW 174

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP--- 232
           M+PES+N   + +  D+W  G  + E+   G   +   ++++V     RI  G+ LP   
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG---RIENGERLPMPP 231

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
           N P  L       + KC+  DP +R
Sbjct: 232 NCPPTLY----SLMTKCWAYDPSKR 252

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 71/307 (23%), Positives = 115/307 (37%), Gaps = 69/307 (22%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNE-------KEALDQIGI 60
           ++G G  G V L +       F    A+K         V  K E       K  L +  I
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLF----ALK---------VLDKKEMIKRNKVKRVLTEQEI 54

Query: 61  C-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                 P +   +    SF+       L+++Y   G L   +++Q    L E   + Y  
Sbjct: 55  LATLDHPFLPTLYA---SFQTETYLC-LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC--------------- 160
            +L  L ++H  G V+ D+K +N+L+ ++    ++DF L+K+S                 
Sbjct: 111 EVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 161 --------------DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASG 206
                            RS SF   GT  Y++PE ++ + + +  D W LG  + EM  G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFV--GTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Query: 207 KPAWNHKQDSNVFSLLIRIGVGD-ELPNIPGDLSEQGKDFLIKCFLKDPKRR---WT-AE 261
              +        FS    I   +   P  P   S   +D + K  +KDP +R      A 
Sbjct: 229 TTPFKGSNRDETFS---NILKKEVTFPGSPPV-SSSARDLIRKLLVKDPSKRLGSKRGAA 284

Query: 262 MLLNHPF 268
            +  HPF
Sbjct: 285 EIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 83/304 (27%), Positives = 117/304 (38%), Gaps = 58/304 (19%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ----- 63
           +G GS G V     S V S+    +AVK      P SV     K AL +I I  +     
Sbjct: 13  LGCGSNGLV----FSAVDSDCDKRVAVKKIVLTDPQSV-----KHALREIKIIRRLDHDN 63

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSL--------ADRVKKQNNGRLQESDVKRYTR 115
           IV+ +  +     G      +       S+         D       G L E   + +  
Sbjct: 64  IVKVY--EVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMY 121

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA-KIADFGLAK----KSSCDGERSQSFEC 170
            +L+GL++IHS   +H D+K  NV +   D   KI DFGLA+      S  G  S+    
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 171 RGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR-IGVG 228
             T  Y SP  + + N Y    D+WA GC   EM +GKP +    +     L++  + V 
Sbjct: 181 --TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238

Query: 229 DE------LPNIPGDLSEQGK------------------DFLIKCFLKDPKRRWTAEMLL 264
            E      L  IP  +   G                   DFL +    +P  R TAE  L
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298

Query: 265 NHPF 268
            HP+
Sbjct: 299 MHPY 302

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 77/287 (26%), Positives = 122/287 (42%), Gaps = 38/287 (13%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 8   IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 65

Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
            D    E   + Y L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 66  -DVIHTEN--KLY-LVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES-VNENEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE  +    Y
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 178

Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNV---FSLLIRIGVGDE--------LPNIPG 236
               DIW+LGC   EM + +  +    DS +   F +   +G  DE        LP+   
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALF--PGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236

Query: 237 D---------------LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                           L E G+D L +    DP +R +A+  L HPF
Sbjct: 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 80.0 bits (197), Expect = 4e-17
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)

Query: 51  EKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDV 110
           EKE L+++   P IV      Y+FE       L++   + G L   +       L+   V
Sbjct: 43  EKEILEKVN-SPFIVNL---AYAFESKTHLC-LVMSLMNGGDLKYHIYNVGERGLEMERV 97

Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
             Y+  +  G+ H+HS   V+ D+K +NVL+ D    +++D GLA +       +Q    
Sbjct: 98  IHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR--- 154

Query: 171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGD 229
            GT  YM+PE + E  Y  P D +A+GC++ EM +G+ P  +HK+      L  R  + D
Sbjct: 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT-LED 213

Query: 230 ELPNIPGDLSEQGKDFLIKCFL-KDPKRR 257
           E+     + +E+ KD + + FL K P+ R
Sbjct: 214 EVKFEHQNFTEESKD-ICRLFLAKKPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 62/199 (31%), Positives = 81/199 (40%), Gaps = 49/199 (24%)

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L E  VK Y   +LK L H+H  G  H DIK +N+L+  +D  K+ADFG     SC G  
Sbjct: 97  LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI-KDDILKLADFG-----SCRGIY 150

Query: 165 S-QSF-ECRGTPLYMSPESVNENEYEAP-CDIWALGCAVVEMASGKP------------- 208
           S   + E   T  Y +PE +  + Y  P  DIWA+GC   E+ S  P             
Sbjct: 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK 210

Query: 209 -----------------AWNHKQDSNVFSLLIRIGVGDE--LPNIPGDLSEQGKDFLIKC 249
                               H      ++   + G G    LPN     S +G D L K 
Sbjct: 211 IHDVLGTPDAEVLKKFRKSRHMN----YNFPSKKGTGLRKLLPN----ASAEGLDLLKKL 262

Query: 250 FLKDPKRRWTAEMLLNHPF 268
              DP  R TA+  L HP+
Sbjct: 263 LAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 5e-17
 Identities = 71/263 (26%), Positives = 118/263 (44%), Gaps = 37/263 (14%)

Query: 9   IGHGSFGSVNLAK-ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC------ 61
           +GHG+FGSV       K   E    +AVK          TLK E  A  +          
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVE--VAVK----------TLKQEHIAAGKKEFLREASVM 50

Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P IVR  G      KGE    L++E A  G L   +KK     +  SD+K     
Sbjct: 51  AQLDHPCIVRLIG----VCKGEPLM-LVMELAPLGPLLKYLKK--RREIPVSDLKELAHQ 103

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           +  G+ ++ SK FVH D+  +NVL+ +  +AKI+DFG+++      +  ++      PL 
Sbjct: 104 VAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK 163

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           + +PE +N  ++ +  D+W+ G  + E  S G   +   + + V ++L     G+ LP  
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES---GERLPR- 219

Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P +  ++    ++ C+   P+ R
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDR 242

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 80.6 bits (199), Expect = 8e-17
 Identities = 84/298 (28%), Positives = 134/298 (44%), Gaps = 40/298 (13%)

Query: 8   VIGHGSFGSVNLAK--------ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           VIG G+FG V L +        A K+ S+F   M  +S       S     E++ +    
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE--MIKRS------DSAFFWEERDIMAHAN 101

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               IV+     Y+F+  +++  +++EY   G   D V   +N  + E   + YT  ++ 
Sbjct: 102 -SEWIVQLH---YAFQD-DKYLYMVMEYMPGG---DLVNLMSNYDIPEKWARFYTAEVVL 153

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE-RSQSFECRGTPLYMS 178
            L  IHS GF+H D+K  N+L+  +   K+ADFG   K   +G  R  +    GTP Y+S
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGTPDYIS 211

Query: 179 PESV----NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           PE +     +  Y   CD W++G  + EM  G   +        +S ++        P+ 
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271

Query: 235 PGDLSEQGKDFLIKCFLKD-PKR--RWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSP 289
             ++S+Q KD LI  FL D   R  R   + + +HPF   D  T D+    I  + +P
Sbjct: 272 I-EISKQAKD-LICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDN----IRETVAP 323

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 80.0 bits (197), Expect = 9e-17
 Identities = 74/255 (29%), Positives = 113/255 (44%), Gaps = 13/255 (5%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V + K       +   +  K        +   + E+  L   G C  I   
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GDCQWITTL 66

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+     Y L+++Y   G L   + K  + RL E   + Y   M+  +  IH  
Sbjct: 67  ---HYAFQDENYLY-LVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQL 121

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE- 186
            +VH DIK  NVL+  N   ++ADFG   K + DG   QS    GTP Y+SPE +   E 
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMED 180

Query: 187 ----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               Y   CD W+LG  + EM  G+  +  +     +  ++      + P+   D+SE+ 
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240

Query: 243 KDFLIKCFLKDPKRR 257
           KD LI+  +   +RR
Sbjct: 241 KD-LIQRLICSRERR 254

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 73/253 (28%), Positives = 116/253 (45%), Gaps = 56/253 (22%)

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL D+V K+   R+ E  + + + ++L+GL
Sbjct: 63  PYIVGFYGAFYS--DGE--ISICMEHMDGGSL-DQVLKEAK-RIPEEILGKVSIAVLRGL 116

Query: 122 RHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++ +       + SF   GT  YMSPE
Sbjct: 117 AYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSFV--GTRSYMSPE 172

Query: 181 SVNENEYEAPCDIWALGCAVVEMA------------------------------------ 204
            +    Y    DIW++G ++VE+A                                    
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232

Query: 205 ---SGKPAWNHKQDSN----VFSLLIRIGVGDELPNIP-GDLSEQGKDFLIKCFLKDPKR 256
               G+P   H  DS     +F LL  I V +  P +P G  +   ++F+ KC +K+P  
Sbjct: 233 PRPPGRPVSGHGMDSRPAMAIFELLDYI-VNEPPPKLPNGVFTPDFQEFVNKCLIKNPAE 291

Query: 257 RWTAEMLLNHPFV 269
           R   +ML+NH F+
Sbjct: 292 RADLKMLMNHTFI 304

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 77.4 bits (190), Expect = 3e-16
 Identities = 69/264 (26%), Positives = 127/264 (48%), Gaps = 32/264 (12%)

Query: 9   IGHGSFGSVNLA---KASKVSSEF--PSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +G G FG V +     ++KV+ +   P  M+V++  +      TL+++K           
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDK----------- 62

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +VR +       K E  Y ++ EY ++GSL D +K    G++    +  ++  + +G+ +
Sbjct: 63  LVRLYA---VVTKEEPIY-IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 118

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           I  K ++H D++  NVLV ++   KIADFGLA+    D E +     +    + +PE++N
Sbjct: 119 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAIN 177

Query: 184 ENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP---NIPGDLS 239
              +    D+W+ G  + E+ + GK  +    +S+V S L R   G  +P   N P +L 
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR---GYRMPRMENCPDELY 234

Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
               D +  C+ +  + R T + L
Sbjct: 235 ----DIMKTCWKEKAEERPTFDYL 254

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 72/251 (28%), Positives = 114/251 (45%), Gaps = 54/251 (21%)

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL   +KK   GR+ E  + + + +++KGL
Sbjct: 63  PYIVGFYGAFYS--DGE--ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 116

Query: 122 RHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++ +       + SF   GT  YMSPE
Sbjct: 117 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSFV--GTRSYMSPE 172

Query: 181 SVNENEYEAPCDIWALGCAVVEMA------------------------------------ 204
            +    Y    DIW++G ++VEMA                                    
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232

Query: 205 -SGKPAWNHKQDSN----VFSLLIRIGVGDELPNIP-GDLSEQGKDFLIKCFLKDPKRRW 258
             G+P  ++  DS     +F LL  I V +  P +P G    + +DF+ KC +K+P  R 
Sbjct: 233 PPGRPLSSYGPDSRPPMAIFELLDYI-VNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERA 291

Query: 259 TAEMLLNHPFV 269
             + L+ H F+
Sbjct: 292 DLKQLMVHAFI 302

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 59/199 (29%), Positives = 87/199 (43%), Gaps = 44/199 (22%)

Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE 163
           +L +  ++     +L+GL++IHS G +H D+K  N+ V ++ E KI DFGLA        
Sbjct: 114 KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-------- 165

Query: 164 RSQSFECRG---TPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
           R    E  G   T  Y +PE + N   Y    DIW++GC + E+ +GK  +     S+  
Sbjct: 166 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF---PGSDHI 222

Query: 220 SLLIRI----GVGDE-----------------LPNIP--------GDLSEQGKDFLIKCF 250
             L RI    G  DE                 LP +P           +    D L K  
Sbjct: 223 DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKML 282

Query: 251 LKDPKRRWTAEMLLNHPFV 269
           + DP +R TA   L HP++
Sbjct: 283 VLDPDKRITAAEALAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 76/273 (27%), Positives = 122/273 (44%), Gaps = 33/273 (12%)

Query: 8   VIGHGSFGSVNLAK--------ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           VIG GSFG V LAK        A KV  +   L   +        +V LKN K       
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH------ 55

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P +V   G  YSF+  E+ Y  +L++ + G L   ++++ +    E   + Y   +  
Sbjct: 56  --PFLV---GLHYSFQTTEKLY-FVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIAS 107

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            L ++HS   V+ D+K +N+L+       + DFGL K+     + + +F C GTP Y++P
Sbjct: 108 ALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF-C-GTPEYLAP 165

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +  Y+   D W LG  + EM  G P +  +  + ++  ++       L   PG  S
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH----KPLVLRPG-AS 220

Query: 240 EQGKDFLIKCFLKDPKRRWTAE----MLLNHPF 268
                 L +   KD +RR  A+     +  HPF
Sbjct: 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQEHPF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 41/224 (18%)

Query: 78  ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQ 137
           ++   L+ EY     L   +     G L   +V+ +   +L+GL + H +  +H D+K Q
Sbjct: 75  KKTLTLVFEYLDT-DLKQYMDDCGGG-LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQ 132

Query: 138 NVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV--NENEYEAPCDIWA 195
           N+L+ +  E K+ADFGLA+  S     S+++      L+  P  V     EY    D+W 
Sbjct: 133 NLLISERGELKLADFGLARAKSVP---SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWG 189

Query: 196 LGCAVVEMASGKPAWNHKQDSN-----VFSLLIRIGVGDE-----LPNIPG--------- 236
           +GC   EMA+G+P +    D       +F +L   G   E     + + P          
Sbjct: 190 VGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL---GTPTEETWPGVSSNPEFKPYSFPFY 246

Query: 237 ------------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                       D    G++  +K    +PK+R +A   + HP+
Sbjct: 247 PPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 19/214 (8%)

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV   G  +SF+     Y L+ +Y S G L   ++K+  GR  E   K Y   ++  
Sbjct: 55  SPFIV---GLKFSFQTDSDLY-LVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLA 108

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L H+H    V+ D+K +N+L+       + DFGL+K +  D + + +F C GT  Y++PE
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF-C-GTTEYLAPE 166

Query: 181 S-VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-ELPNIPGDL 238
             ++E  Y    D W+LG  V EM  G   W+     +   +   I  G    P     L
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFPK--NVL 221

Query: 239 SEQGKDFLIKCFLKDPKRRW----TAEMLLNHPF 268
           S++G+ F+     ++P+ R      A  L  HPF
Sbjct: 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 45/128 (35%), Positives = 69/128 (53%), Gaps = 7/128 (5%)

Query: 100 QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS 159
           Q+ G L   +V+ +   +L+GL +IH +  +H D+K QN+L+    E K+ADFGLA+  S
Sbjct: 95  QHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154

Query: 160 CDGERSQSFECRGTPLYMSPESV--NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN 217
                SQ++      L+  P  V     +Y +  DIW  GC  +EM  G+PA+     S+
Sbjct: 155 IP---SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF--PGVSD 209

Query: 218 VFSLLIRI 225
           VF  L +I
Sbjct: 210 VFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 33/199 (16%)

Query: 102 NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD 161
           +  L E  ++ +   +L+GL++IHS   +H D+K  N+LV ++ E +I DFG+A+  S  
Sbjct: 101 DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160

Query: 162 GERSQSF--ECRGTPLYMSPE---SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS 216
               + F  E   T  Y +PE   S+   EY    D+W++GC   EM   +  +  K   
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSL--PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218

Query: 217 NVFSLLI------------RIGVG------DELPNIPG--------DLSEQGKDFLIKCF 250
           +   L++            RIG          LP              S +  D L +  
Sbjct: 219 HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQML 278

Query: 251 LKDPKRRWTAEMLLNHPFV 269
             DP+ R T E  L HPF+
Sbjct: 279 QFDPEERITVEQALQHPFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 77.1 bits (190), Expect = 5e-16
 Identities = 79/301 (26%), Positives = 125/301 (41%), Gaps = 66/301 (21%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-----ALDQIGIC-- 61
           IG G++G+V  AK    + E   ++A+K         V L ++ E     AL +I +   
Sbjct: 8   IGEGTYGTVFKAK----NRETHEIVALKR--------VRLDDDDEGVPSSALREICLLKE 55

Query: 62  ---PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKK---QNNGRLQESDVKRYTR 115
                IVR     Y     ++   L+ EY  +      +KK     NG +    VK +  
Sbjct: 56  LKHKNIVRL----YDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMF 106

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            +LKGL   HS   +H D+K QN+L+  N E K+ADFGLA+     G   + +      L
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVRCYSAEVVTL 163

Query: 176 YMSPESV--NENEYEAPCDIWALGCAVVEMA-SGKPAWNHKQDSNVFSLLIRI------- 225
           +  P  V      Y    D+W+ GC   E+A +G+P +      +    + R+       
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 223

Query: 226 ---GVGDELPNIP---------------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHP 267
              GV  +LP+                   L+  G+D L    + +P +R +AE  L HP
Sbjct: 224 SWPGV-SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282

Query: 268 F 268
           +
Sbjct: 283 Y 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 18/275 (6%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V L +  K + +  ++  +        S      E+  +      P +V+ 
Sbjct: 50  VIGRGAFGEVQLVR-HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F   Y+F+  +R+  +++EY   G   D V   +N  + E   + YT  ++  L  IHS 
Sbjct: 109 F---YAFQD-DRYLYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN---- 183
           GF+H D+K  N+L+  +   K+ADFG   K + +G   +     GTP Y+SPE +     
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGG 220

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
           +  Y   CD W++G  + EM  G   +        +S ++        P+   D+S++ K
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-DNDISKEAK 279

Query: 244 DFLIKCFLKDPKRRW---TAEMLLNHPFVCADDQT 275
           + LI  FL D + R      E +  H F   D   
Sbjct: 280 N-LICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 313

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 74/268 (27%), Positives = 114/268 (42%), Gaps = 18/268 (6%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           V+G G FG V   +       +    +  K        S+ L NEK+ L+++    Q V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMAL-NEKQILEKVN--SQFVV 63

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                Y++E  +    L+L   + G L   +    N   +E     Y   +L GL  +H 
Sbjct: 64  NLA--YAYETKDALC-LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR-GTPLYMSPESVNEN 185
           +  V+ D+K +N+L+ D    +I+D GLA K   +GE   S   R GT  YM+PE +N  
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIP-EGE---SIRGRVGTVGYMAPEVLNNQ 176

Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
            Y    D W LGC + EM  G+  +  +++  V    +   V +         SE+ K  
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-KVKREEVDRRVLETEEVYSAKFSEEAKSI 235

Query: 246 LIKCFLKDPKRRW-----TAEMLLNHPF 268
                 KDPK+R       A  +  HPF
Sbjct: 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPF 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 58/197 (29%), Positives = 89/197 (45%), Gaps = 45/197 (22%)

Query: 111 KRY-TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCDGERSQSF 168
           KRY    +LK L++IHS   +H D+K  N+L+ ++D   K+ADFGLA+ S  + E +   
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILL-NSDCRVKLADFGLAR-SLSELEENPEN 166

Query: 169 ----ECRGTPLYMSPES-VNENEYEAPCDIWALGCAVVEMASGKPAW------NH----- 212
               +   T  Y +PE  +    Y    D+W++GC + EM  GKP +      N      
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226

Query: 213 -------KQD-----SNVFSLLIRIGVGDELPNIP--------GDLSEQGKDFLIKCFLK 252
                   +D     S   + ++     D LP+ P           S+   D L K  + 
Sbjct: 227 EVIGPPSAEDIESIKSPFAATML-----DSLPSRPRKPLDELLPKASDDALDLLKKLLVF 281

Query: 253 DPKRRWTAEMLLNHPFV 269
           +P +R TAE  L HP+V
Sbjct: 282 NPNKRLTAEEALEHPYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 71/234 (30%), Positives = 115/234 (49%), Gaps = 32/234 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEK----EALDQIGIC 61
           G++IG+GSFG V  A     S +    +A+K     P      KN +    + L+ I I 
Sbjct: 71  GNIIGNGSFGVVYEAICIDTSEK----VAIKKVLQDP----QYKNRELLIMKNLNHINII 122

Query: 62  PQIVRCFGDDY----SFEKGER--FYNLLLEYASRGSLADRVK--KQNNGRLQESDVKRY 113
                 F  DY     F+K E+  F N+++E+  + ++   +K   +NN  L    VK Y
Sbjct: 123 ------FLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLY 175

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA-KIADFGLAKKSSCDGERSQSFECRG 172
           +  + + L +IHSK   H D+K QN+L+  N    K+ DFG A K+   G+RS S+ C  
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA-KNLLAGQRSVSYIC-- 232

Query: 173 TPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI 225
           +  Y +PE  +    Y    D+W+LGC + EM  G P ++ +   +    +I++
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286

Length = 440

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 28/181 (15%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF-ECRGTPL 175
           +L+GL++IHS   +H D+K  N+L+  N + KI DFGLA+ +  + + +    E   T  
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 176 YMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN----HKQDSNVFSLLIRIGVGD- 229
           Y +PE  +N   Y    DIW++GC + EM S +P +       Q + +  +L      D 
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234

Query: 230 -------------ELPNIPG--------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                         LP  P         +   +  D L K    +P +R T E  L HP+
Sbjct: 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Query: 269 V 269
           +
Sbjct: 295 L 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 36/277 (12%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK-------NEKEALDQI-- 58
           +IG G FG V   + +         M    C D     + +K       NE+  L  +  
Sbjct: 1   IIGRGGFGEVYGCRKADTGK-----MYAMKCLD--KKRIKMKQGETLALNERIMLSLVST 53

Query: 59  GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
           G CP IV C    Y+F   ++  + +L+  + G L   + +  +G   E++++ Y   ++
Sbjct: 54  GDCPFIV-CM--SYAFHTPDKL-SFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEII 107

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            GL H+H++  V+ D+K  N+L+ ++   +I+D GLA    CD  + +     GT  YM+
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMA 163

Query: 179 PESVNEN-EYEAPCDIWALGCAVVEMASG-KPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           PE + +   Y++  D ++LGC + ++  G  P   HK         I          +P 
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMAVELPD 220

Query: 237 DLSEQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
             S + +  L     +D  RR       A+ +  HPF
Sbjct: 221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 44/283 (15%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS----SVTLKNEKEALDQI------ 58
           +G G FG V L +           +AVKS    P S       LK E E L  +      
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEILRNLYHENIV 69

Query: 59  ---GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
              GIC             E G     L++E+   GSL + + + N  ++      +Y  
Sbjct: 70  KYKGICT------------EDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAV 116

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            + KG+ ++ S+ +VH D+  +NVLV    + KI DFGL K    D E     +   +P+
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176

Query: 176 Y-MSPESVNENEYEAPCDIWALGCAVVEM-----ASGKPAW--------NHKQDSNVFSL 221
           +  +PE + ++++    D+W+ G  + E+     +   P           H Q   V  L
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ-MTVTRL 235

Query: 222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
           +  +  G  LP  P +  E+    + KC+   P +R T + L+
Sbjct: 236 VRVLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 57/215 (26%), Positives = 106/215 (49%), Gaps = 14/215 (6%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR- 66
           VIG GSFG V LA+  K   +F ++  ++  A      +  K EK  + +  +  + V+ 
Sbjct: 2   VIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKA-----ILKKKEEKHIMSERNVLLKNVKH 55

Query: 67  --CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
               G  +SF+  ++ Y  +L+Y + G L   ++++      E   + Y   +   L ++
Sbjct: 56  PFLVGLHFSFQTADKLY-FVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYL 112

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HS   V+ D+K +N+L+       + DFGL K++      + +F C GTP Y++PE +++
Sbjct: 113 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF-C-GTPEYLAPEVLHK 170

Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
             Y+   D W LG  + EM  G P +  +  + ++
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 70/270 (25%), Positives = 114/270 (42%), Gaps = 26/270 (9%)

Query: 5   RGDVIGHGSFGSV--NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-- 60
           +  V+G G+FG+V   +        + P  +A+K   +        K  KE LD+  +  
Sbjct: 11  KIKVLGSGAFGTVYKGVWIPEGEKVKIP--VAIKVLREETSP----KANKEILDEAYVMA 64

Query: 61  ---CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P +VR  G         +   L+ +    G L D V+  +   +    +  +   +
Sbjct: 65  SVDHPHVVRLLG----ICLSSQV-QLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQI 118

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-Y 176
            KG+ ++  K  VH D+  +NVLV      KI DFGLAK    D E+    E    P+ +
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD-EKEYHAEGGKVPIKW 177

Query: 177 MSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           M+ ES+    Y    D+W+ G  V E M  G   +       +  LL +   G+ LP  P
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK---GERLPQ-P 233

Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
              +      L+KC++ D + R T + L+N
Sbjct: 234 PICTIDVYMVLVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 83/306 (27%), Positives = 128/306 (41%), Gaps = 62/306 (20%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-----ALDQIGICPQ 63
           IG G+FG V  A+  K + +    +A+K         V ++NEKE     AL +I I   
Sbjct: 20  IGQGTFGEVFKAR-HKKTKQI---VALKK--------VLMENEKEGFPITALREIKILQL 67

Query: 64  -----------IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKR 112
                      I R     Y+  KG  FY L+ E+     LA  +    N +   S++K+
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGS-FY-LVFEFCEH-DLA-GLLSNKNVKFTLSEIKK 123

Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFECR 171
             + +L GL +IH    +H D+K  N+L+  +   K+ADFGLA+  S     +   +  R
Sbjct: 124 VMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183

Query: 172 GTPL-YMSPES-VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI---- 225
              L Y  PE  + E +Y  P D+W  GC + EM +  P      + +  +L+ ++    
Sbjct: 184 VVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243

Query: 226 ------GVGD-------ELPN-----IPGDL-----SEQGKDFLIKCFLKDPKRRWTAEM 262
                 GV         ELP      +   L          D + K  + DP +R  A+ 
Sbjct: 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303

Query: 263 LLNHPF 268
            LNH F
Sbjct: 304 ALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 8e-15
 Identities = 54/192 (28%), Positives = 82/192 (42%), Gaps = 11/192 (5%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+L   + G L   +    N    E     Y   +  GL  +H +  V+ D+K +N+L+ 
Sbjct: 77  LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD 136

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECR-GTPLYMSPESVNENEYEAPCDIWALGCAVV 201
           D    +I+D GLA +   +GE  +    R GT  YM+PE V    Y    D W LGC + 
Sbjct: 137 DYGHIRISDLGLAVEIP-EGETIRG---RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIY 192

Query: 202 EMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPK-----R 256
           EM  GK  +  +++      + R  V ++        SE  +    +   KDP      R
Sbjct: 193 EMIEGKSPFRQRKEKVKREEVERR-VKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCR 251

Query: 257 RWTAEMLLNHPF 268
              AE +  HPF
Sbjct: 252 GEGAEEVKAHPF 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 73.3 bits (180), Expect = 8e-15
 Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 8/174 (4%)

Query: 100 QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS 159
           + N    E     YT  ++ GL H+H +  ++ D+K +NVL+ ++   +I+D GLA +  
Sbjct: 89  EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK 148

Query: 160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
               +++ +   GTP +M+PE +   EY+   D +ALG  + EM + +  +  + +  V 
Sbjct: 149 DGQSKTKGYA--GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-KVE 205

Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
           +  ++  + ++    P   S   K F      KDP++R        + L  HP 
Sbjct: 206 NKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 73.3 bits (180), Expect = 9e-15
 Identities = 55/194 (28%), Positives = 82/194 (42%), Gaps = 29/194 (14%)

Query: 101 NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC 160
             G L  + VK +T  +LKG+   H    +H D+K QN+L+    E K+ADFGLA+    
Sbjct: 93  VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF-- 150

Query: 161 DGERSQSFECRGTPLYMSPESV--NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV 218
            G    +F      L+     V      Y    DIW++GC + EM +G+P +    + + 
Sbjct: 151 -GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209

Query: 219 FSLLIRI-GVGDE--------LPNI--------PGDLSE-------QGKDFLIKCFLKDP 254
              + RI G   E        LP          P DL +        G D L +    +P
Sbjct: 210 LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNP 269

Query: 255 KRRWTAEMLLNHPF 268
           + R +A   L HP+
Sbjct: 270 ELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 5/115 (4%)

Query: 103 GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG 162
           G L   +VK +   +L+GL +IH +  +H D+K QN+L+ D  E K+ADFGLA+  S   
Sbjct: 98  GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP- 156

Query: 163 ERSQSFECRGTPLYMSPESV--NENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
             S ++      L+  P  V     EY    D+W +GC  VEM  G  A+   +D
Sbjct: 157 --SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 50/217 (23%)

Query: 6   GDVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           G  IG G FG V L   +  KV        AVK           LK++  A         
Sbjct: 11  GATIGKGEFGDVMLGDYRGQKV--------AVK----------CLKDDSTAAQA------ 46

Query: 64  IVRCFGDDYSFEKGERFYNL---------------LLEYASRGSLADRVKKQNNGRLQES 108
               F  + S     R  NL               + EY ++GSL D ++ +    +  +
Sbjct: 47  ----FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA 102

Query: 109 DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
               +   + +G+ ++  K FVH D+  +NVLV ++  AK++DFGLAK+ +  G+ S   
Sbjct: 103 QQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE-ASQGQDSGKL 161

Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
             + T    +PE++ E ++    D+W+ G  + E+ S
Sbjct: 162 PVKWT----APEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 74/280 (26%), Positives = 113/280 (40%), Gaps = 28/280 (10%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V + K       F   +  K        +   + E++ L            
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN---------- 57

Query: 68  FGDD-------YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            GD+       Y+F+     Y L+++Y   G L   + K  + RL E   + Y   M+  
Sbjct: 58  -GDNQWITTLHYAFQDENNLY-LVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIA 114

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +  +H   +VH DIK  N+L+  N   ++ADFG   K   DG   QS    GTP Y+SPE
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPE 173

Query: 181 SVNENE-----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
            +   E     Y   CD W+LG  + EM  G+  +  +     +  ++      + P   
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233

Query: 236 GDLSEQGKDFLIKCFLKDPKR--RWTAEMLLNHPFVCADD 273
            D+SE  KD + +       R  +   E    HPF    D
Sbjct: 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 10/204 (4%)

Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           Y+F+     Y L+++Y   G L   + K  + RL E   + Y   M+  +  +H  G+VH
Sbjct: 68  YAFQDENNLY-LVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVLAIDSVHQLGYVH 125

Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE----- 186
            DIK  NVL+  N   ++ADFG   +   DG   QS    GTP Y+SPE +   E     
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGR 184

Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y   CD W+LG  + EM  G+  +  +     +  ++      + P    D+SE+ KD +
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLI 244

Query: 247 IKCFLKDPKR--RWTAEMLLNHPF 268
            +       R  R   +   +HPF
Sbjct: 245 RRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 31/222 (13%)

Query: 73  SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHC 132
           +F +  + Y L+ EY  +  L + +++  NG   E  V+ Y   ++K +   H    VH 
Sbjct: 68  AFRRRGKLY-LVFEYVEKNML-ELLEEMPNGVPPEK-VRSYIYQLIKAIHWCHKNDIVHR 124

Query: 133 DIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCD 192
           DIK +N+L+  ND  K+ DFG A+  S +G  +   E   T  Y SPE +    Y    D
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAVD 183

Query: 193 IWALGCAVVEMASGKPAWNHKQD-SNVFSLLIRIG----------------VGDELPNIP 235
           +W++GC + E++ G+P +  + +   +F++   +G                 G   P + 
Sbjct: 184 MWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVN 243

Query: 236 ----------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHP 267
                     G LS    D +      +P  R+  E  LNHP
Sbjct: 244 HPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 63/231 (27%), Positives = 93/231 (40%), Gaps = 51/231 (22%)

Query: 78  ERFYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIK 135
             F NL+++      +A  +KK      RL ES VK     +L GL  +H   F+H D+ 
Sbjct: 92  GDFINLVMDI-----MASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLS 146

Query: 136 LQNVLVFDNDEAKIADFGLAKKSSCD--------GERSQSFECRGTP-----LYMSPESV 182
             N+ +      KIADFGLA++             E  Q  E   T       Y +PE +
Sbjct: 147 PANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE-EMTSKVVTLWYRAPELL 205

Query: 183 -NENEYEAPCDIWALGCAVVEMASGKPAW---NH-KQDSNVFSLLIRIGVGDE------- 230
               +Y    D+W++GC   E+ +GKP +   N   Q   +F LL   G  +E       
Sbjct: 206 MGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL---GTPNEDNWPQAK 262

Query: 231 -LPNIPGDLSEQGKDF-------------LIKCFLK-DPKRRWTAEMLLNH 266
            LP        + KD              L++  LK +P  R +A+  L H
Sbjct: 263 KLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313

Length = 335

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 71.8 bits (177), Expect = 2e-14
 Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 23/196 (11%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+++Y   G L D +KK   G+L E++VK+  R +++ L  +H    +H DIKL+NVL  
Sbjct: 86  LIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143

Query: 143 DN-DEAKIADFGLAK---KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
              D   + D+GL K     SC           GT  Y SPE +  + Y+   D WA+G 
Sbjct: 144 RAKDRIYLCDYGLCKIIGTPSCY---------DGTLDYFSPEKIKGHNYDVSFDWWAVGV 194

Query: 199 AVVEMASGK-PAWNHKQDS-NVFSLLIRIGVGDELPNIPGDLSEQGKDFLIK--CFLKDP 254
              E+ +GK P    + +  ++ SLL R     +      ++S+   DF+     +  + 
Sbjct: 195 LTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQSMLKYNIN- 250

Query: 255 KRRWTAEMLLNHPFVC 270
            R      ++ HPF+ 
Sbjct: 251 YRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 47/187 (25%), Positives = 82/187 (43%), Gaps = 30/187 (16%)

Query: 109 DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
           +VK +   +L+GL + H +  +H D+K QN+L+ +  E K+ADFGLA+  S     ++++
Sbjct: 105 NVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTY 161

Query: 169 ECRGTPLYMSPESV--NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI- 225
                 L+  P  +     +Y    D+W +GC   EM++G+P +           + RI 
Sbjct: 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221

Query: 226 ---------GV---------------GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAE 261
                    G+                D L N    L   G + L K    + ++R +AE
Sbjct: 222 GTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE 281

Query: 262 MLLNHPF 268
             + HP+
Sbjct: 282 EAMKHPY 288

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 56/188 (29%), Positives = 84/188 (44%), Gaps = 34/188 (18%)

Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSF 168
           +K Y   +L+G+ + HS   +H D+K QN+L+    +  K+ADFGLA+       R+ + 
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VRTFTH 162

Query: 169 ECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV---FSLLIR 224
           E   T  Y +PE +     Y  P DIW++GC   EM + KP +    DS +   F +   
Sbjct: 163 EVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF--PGDSEIDELFKIFRI 219

Query: 225 IGVGDE--------LPN----------------IPGDLSEQGKDFLIKCFLKDPKRRWTA 260
           +G  +E        LP+                +P  L   G D L K    DP +R TA
Sbjct: 220 LGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITA 278

Query: 261 EMLLNHPF 268
              L H +
Sbjct: 279 RAALEHEY 286

Length = 294

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 67/261 (25%), Positives = 113/261 (43%), Gaps = 21/261 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVT--LKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +S     + +AVK       SS    L +E + +  +G   
Sbjct: 40  GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE 99

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            IV   G   +   G     ++ EY   G L + ++++    L   D+  ++  + KG+ 
Sbjct: 100 NIVNLLG---ACTIGGPIL-VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT---PL-YMS 178
            + SK  +H D+  +NVL+      KI DFGLA+    D     ++  +G    P+ +M+
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDSNYVVKGNARLPVKWMA 211

Query: 179 PESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           PES+    Y    D+W+ G  + E+ S    P      DS  + L+     G  +   P 
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE---GYRMAQ-PE 267

Query: 237 DLSEQGKDFLIKCFLKDPKRR 257
               +  D +  C+  DP +R
Sbjct: 268 HAPAEIYDIMKTCWDADPLKR 288

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.5 bits (175), Expect = 5e-14
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 17/203 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICP---- 62
           V+G G FG V+L      +     ++AVK+   +C       +N      +I I      
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-----QNTSGWKKEINILKTLYH 65

Query: 63  -QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
             IV+  G     E+G +   L++EY   GSL D + K      Q   +  + + + +G+
Sbjct: 66  ENIVKYKG--CCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ---LLLFAQQICEGM 120

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPE 180
            ++HS+ ++H D+  +NVL+ ++   KI DFGLAK      E  +  E   +P++  + E
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 181 SVNENEYEAPCDIWALGCAVVEM 203
            + EN++    D+W+ G  + E+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 71.0 bits (174), Expect = 5e-14
 Identities = 67/256 (26%), Positives = 117/256 (45%), Gaps = 26/256 (10%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK--NEKEALDQIGICPQIVR 66
           IG G+FG V             + +AVK+C    P  +  K   E E L Q    P IV+
Sbjct: 3   IGKGNFGDVYKGVLKG-----NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVK 56

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
             G     +K +  Y +++E    GSL   ++K    RL    + + +     G+ ++ S
Sbjct: 57  LIG--VCVQK-QPIY-IVMELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNEN 185
           K  +H D+  +N LV +N+  KI+DFG++++    G  + S   +  P+ + +PE++N  
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 186 EYEAPCDIWALGCAVVEMASGK----PAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
            Y +  D+W+ G  + E  S      P  +++Q         RI  G  +P  P    E+
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE------RIESGYRMPA-PQLCPEE 223

Query: 242 GKDFLIKCFLKDPKRR 257
               +++C+  DP+ R
Sbjct: 224 IYRLMLQCWAYDPENR 239

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 60/270 (22%), Positives = 113/270 (41%), Gaps = 35/270 (12%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEA--LDQIGICPQIV 65
           +G GSFG V    A  V    P   +A+K+  +       ++   EA  + +   C  +V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN-CHHVV 72

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML------- 118
           R  G       G+    +++E  ++G L   ++ +   R +  +        L       
Sbjct: 73  RLLG---VVSTGQPTL-VVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQKFIQMA 125

Query: 119 ----KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
                G+ ++ +K FVH D+  +N +V ++   KI DFG+ +    D   +  +   G  
Sbjct: 126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKG 181

Query: 175 L----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD 229
           L    +M+PES+ +  +    D+W+ G  + EMA+  +  +    +  V   +I  G  D
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241

Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWT 259
              N P    ++  + +  C+  +PK R T
Sbjct: 242 LPENCP----DKLLELMRMCWQYNPKMRPT 267

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 38/119 (31%), Positives = 64/119 (53%), Gaps = 5/119 (4%)

Query: 109 DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
           +VK +   +L+GL + H +  +H D+K QN+L+ +  E K+ADFGLA+  S     ++++
Sbjct: 105 NVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP---TKTY 161

Query: 169 ECRGTPLYMSPESV--NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI 225
                 L+  P  V    +EY    D+W +GC   EMASG+P +      +   L+ R+
Sbjct: 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 70.5 bits (172), Expect = 7e-14
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 7/193 (3%)

Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G+ ++    +VH
Sbjct: 67  YAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125

Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE+     +    
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 192 DIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCF 250
           D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  E   D + +C+
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECPESLHDLMCQCW 240

Query: 251 LKDPKRRWTAEML 263
            K+P+ R T E L
Sbjct: 241 RKEPEERPTFEYL 253

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 72.2 bits (177), Expect = 8e-14
 Identities = 78/271 (28%), Positives = 129/271 (47%), Gaps = 22/271 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-LDQIGICP--QI 64
           V+G G+ G+V  AK  +VS   P   AVK   D    S   KN  +A +  +  C    I
Sbjct: 39  VLGSGATGTVLCAK--RVSDGEP--FAVK-VVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 65  VRCFGD----DYSFEKGERFYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSML 118
           V+C  D    D    +      L+L+YA+ G L   +K   + N   +E +       +L
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK--KSSCDGERSQSFECRGTPLY 176
             + H+HSK  +H DIK  N+L+  N   K+ DFG +K   ++   +  ++F C GTP Y
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-C-GTPYY 211

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           ++PE      Y    D+++LG  + E+ + K  ++     N+  ++ +   G   P +P 
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEVMHKTLAGRYDP-LPP 267

Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHP 267
            +S + ++ +      DPKRR ++  LLN P
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 72.5 bits (177), Expect = 8e-14
 Identities = 77/260 (29%), Positives = 117/260 (45%), Gaps = 53/260 (20%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG+G FG V L K  K + EF    A+        S   LK  +++  Q+ I   ++R  
Sbjct: 21  IGNGRFGEVFLVK-HKRTQEFFCWKAI--------SYRGLKEREKS--QLVIEVNVMREL 69

Query: 69  GDDYSFEKGERFYN-------LLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSMLK 119
                    +RF N       +L+E+   G L+  ++K  +  G+++E  +   TR +L 
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129

Query: 120 GLRHIHS-------KGFVHCDIKLQNVLVFDNDE-----------------AKIADFGLA 155
            L + H+       +  +H D+K QN+ +                      AKI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 156 KKSSCDGERSQSFECRGTPLYMSPESV--NENEYEAPCDIWALGCAVVEMASGKPAWNHK 213
           K     G  S +  C GTP Y SPE +      Y+   D+WALGC + E+ SGK  + HK
Sbjct: 190 KNI---GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF-HK 245

Query: 214 QDSNVFSLLI-RIGVGDELP 232
             +N FS LI  +  G +LP
Sbjct: 246 --ANNFSQLISELKRGPDLP 263

Length = 1021

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 29/221 (13%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           DVIG G+FG V  A   K   +  + + +               E E L ++G  P I+ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESD----------------- 109
             G   + E     Y + +EYA  G+L D ++K    R+ E+D                 
Sbjct: 68  LLG---ACENRGYLY-IAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTASTLTSQQ 120

Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + ++   +  G++++  K F+H D+  +NVLV +N  +KIADFGL++      +++    
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG-- 178

Query: 170 CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKP 208
            R    +M+ ES+N + Y    D+W+ G  + E+ S  G P
Sbjct: 179 -RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 66/251 (26%), Positives = 108/251 (43%), Gaps = 31/251 (12%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGIC-- 61
               +GHG+FG V          +   L +AVK+     P S + ++E + L +  I   
Sbjct: 10  LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL----PESCSEQDESDFLMEALIMSK 65

Query: 62  ---PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLA-----DRVKKQNNGRLQESDVKRY 113
                IVR  G   SFE+  RF  +LLE  + G L      +R + +    L   D+   
Sbjct: 66  FNHQNIVRLIG--VSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFEC 170
            R + KG +++    F+H DI  +N L+        AKIADFG+A+    D  R+  +  
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRK 177

Query: 171 RGTPL----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
            G  +    +M PE+  +  + +  D+W+ G  + E+ S G   +  + +  V   +   
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237

Query: 226 GVGDELPNIPG 236
           G  D     PG
Sbjct: 238 GRLDPPKGCPG 248

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 23/261 (8%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ- 63
           +  VIG G FG V      K+       +A+K+         T K  ++ L +  I  Q 
Sbjct: 9   KQKVIGAGEFGEV-FRGILKMPGRKEVAVAIKTLK----PGYTEKQRQDFLSEASIMGQF 63

Query: 64  ----IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               I+R  G    F+       ++ EY   G+L D+  + ++G      +    R +  
Sbjct: 64  SHHNIIRLEGVVTKFKPAM----IITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAA 118

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMS 178
           G++++    +VH D+  +N+LV  N E K++DFGL++    D E + +      P+ + +
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 179 PESVNENEYEAPCDIWALGCAVVE-MASG-KPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           PE++   ++ +  D+W+ G  + E M+ G +P W    D +   ++  I  G  LP  P 
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW----DMSNHEVMKAINDGFRLPA-PM 233

Query: 237 DLSEQGKDFLIKCFLKDPKRR 257
           D        +++C+ +D  RR
Sbjct: 234 DCPSAVYQLMLQCWQQDRARR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 14/210 (6%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI--GICPQIV 65
           +IG G FG V   + +     +      K             NE+  L  +  G CP IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
            C    Y+F   ++    +L+  + G L   + +  +G   E +++ Y   ++ GL H+H
Sbjct: 61  -CM--TYAFHTPDKLC-FILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMH 114

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE- 184
           ++  V+ D+K  N+L+ ++   +I+D GLA    CD  + +     GT  YM+PE + + 
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 170

Query: 185 NEYEAPCDIWALGCAVVEMASG-KPAWNHK 213
             Y++  D ++LGC + ++  G  P   HK
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 74/297 (24%), Positives = 122/297 (41%), Gaps = 56/297 (18%)

Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 80

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 81  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 131

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATR---WYRAP 186

Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG---------- 228
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG          
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 245

Query: 229 ---------DELPNIPG--------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                      L  +P           +    D L K  + D  +R TA   L H +
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 23/217 (10%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCADCPPSS--VTLKNEKEALDQIGI 60
           G  +G G FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G   +  +    Y +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 80  HKNIINLLG---ACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135

Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 61/256 (23%), Positives = 117/256 (45%), Gaps = 25/256 (9%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA--LDQIGICPQIVR 66
           IG G+FG V   +    ++     +AVKSC +  P  +  K  +EA  L Q    P IVR
Sbjct: 3   IGRGNFGEVFSGRLRADNT----PVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVR 57

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
             G      + +  Y +++E    G     ++ +   RL+  ++ +   +   G+ ++ S
Sbjct: 58  LIG---VCTQKQPIY-IVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLES 112

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNEN 185
           K  +H D+  +N LV + +  KI+DFG++++   DG  + +   +  P+ + +PE++N  
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 186 EYEAPCDIWALGCAVVEM----ASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
            Y +  D+W+ G  + E     A      +++Q        +R+   +  P+    L E+
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMER 231

Query: 242 GKDFLIKCFLKDPKRR 257
                  C+  DP +R
Sbjct: 232 -------CWEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 12/185 (6%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ EY S+GSL D +K      L+  ++      +  G+ +I    ++H D++  N+LV 
Sbjct: 77  IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG 136

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVE 202
           D    KIADFGLA+    D E +     +    + +PE+     +    D+W+ G  + E
Sbjct: 137 DGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 195

Query: 203 MAS-GK---PAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRW 258
           + + G+   P  N+++      +L ++  G  +P  P D      + +++C+ KDP+ R 
Sbjct: 196 LVTKGRVPYPGMNNRE------VLEQVERGYRMP-CPQDCPISLHELMLQCWKKDPEERP 248

Query: 259 TAEML 263
           T E L
Sbjct: 249 TFEYL 253

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 71/298 (23%), Positives = 121/298 (40%), Gaps = 47/298 (15%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V L +       +   +  K+          ++ E++ L +      +V+ 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKM 66

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F   YSF+     Y L++E+   G +   + K++   L E   + Y    +  +  IH  
Sbjct: 67  F---YSFQDKRNLY-LIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL 120

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLA-------------------------------- 155
           GF+H DIK  N+L+      K++DFGL                                 
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 156 KKSSCDGERSQ-SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQ 214
           K  +    R Q ++   GTP Y++PE   +  Y   CD W+LG  + EM  G P +  + 
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 215 DSNVFSLLIRIGVGDEL-PNIPGDLSEQGKDFLIKCFLKDPKRRW---TAEMLLNHPF 268
               +  ++         P +P  +SE+ KD +++ F  D + R      E + +HPF
Sbjct: 241 PQETYRKVMNWKETLVFPPEVP--ISEKAKDLILR-FCTDSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 72/303 (23%), Positives = 116/303 (38%), Gaps = 52/303 (17%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V L +       +      KS          ++ E++ L +    P +V+ 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKL 66

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           +   YSF+     Y L++EY   G +   + K++     E + + Y    +  +  IH  
Sbjct: 67  Y---YSFQDENYLY-LIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL 120

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERS-------------QSFECR--- 171
           G++H DIK  N+L+      K++DFGL                          F  +   
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 172 --------------------GTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
                               GTP Y++PE   +  Y   CD W+LG  + EM  G P + 
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 212 HKQDSNVFSLLIRIGVGDELPNIPGD--LSEQGKDFLIKCFLKDPKRR---WTAEMLLNH 266
              D+   +    I   + L   P +  LS + KD LIK    + +RR        + +H
Sbjct: 241 --SDNPQETYRKIINWKETLQ-FPDEVPLSPEAKD-LIKRLCCEAERRLGNNGVNEIKSH 296

Query: 267 PFV 269
           PF 
Sbjct: 297 PFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 2/105 (1%)

Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE 163
            L    VK +   +L+GL+++HS G +H DIK  N+LV  N   KI DFGLA+    D  
Sbjct: 99  PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158

Query: 164 RSQSFECRGTPLYMSPES-VNENEYEAPCDIWALGCAVVEMASGK 207
           +  + E   T  Y +PE  +    Y +  DIW++GC   E+   +
Sbjct: 159 KHMTQEVV-TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 78/280 (27%), Positives = 120/280 (42%), Gaps = 22/280 (7%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V L +  K S +  ++  +        S      E+  +      P +V+ 
Sbjct: 50  VIGRGAFGEVQLVR-HKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F    +F+  +  Y +++EY   G   D V   +N  + E   K YT  ++  L  IHS 
Sbjct: 109 F---CAFQDDKYLY-MVMEYMPGG---DLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN---- 183
           G +H D+K  N+L+  +   K+ADFG   K    G   +     GTP Y+SPE +     
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGG 220

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD--LSEQ 241
           +  Y   CD W++G  + EM  G   +        +S   +I       N P D  +S+ 
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS---KIMDHKNSLNFPEDVEISKH 277

Query: 242 GKDFLIKCFLKDPKRRW---TAEMLLNHPFVCADDQTGDD 278
            K+ LI  FL D + R      E +  HPF   D    D+
Sbjct: 278 AKN-LICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDN 316

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 67.8 bits (165), Expect = 6e-13
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 29/221 (13%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           DVIG G+FG V  A+  K      + +                 E E L ++G  P I+ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESD----------------- 109
             G   + E     Y L +EYA  G+L D ++K    R+ E+D                 
Sbjct: 61  LLG---ACEHRGYLY-LAIEYAPHGNLLDFLRKS---RVLETDPAFAIANSTASTLSSQQ 113

Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           +  +   + +G+ ++  K F+H D+  +N+LV +N  AKIADFGL++      +++    
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG-- 171

Query: 170 CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKP 208
            R    +M+ ES+N + Y    D+W+ G  + E+ S  G P
Sbjct: 172 -RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 33/223 (14%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSS--VTLKNEKEALDQIGICPQI 64
           DVIG G+FG V  A+  K      +  A+K   +            E E L ++G  P I
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDA--AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESD----VKRYTRSML-- 118
           +   G   + E     Y L +EYA  G+L D ++K    R+ E+D    +   T S L  
Sbjct: 71  INLLG---ACEHRGYLY-LAIEYAPHGNLLDFLRKS---RVLETDPAFAIANSTASTLSS 123

Query: 119 -----------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS 167
                      +G+ ++  K F+H D+  +N+LV +N  AKIADFGL++      +++  
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 183

Query: 168 FECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKP 208
              R    +M+ ES+N + Y    D+W+ G  + E+ S  G P
Sbjct: 184 ---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 40/190 (21%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +  +   +     R    Y
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR---YY 188

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGK---------PAWNHKQDS---------NV 218
            +PE +    Y+   DIW++GC + E+  G            WN   +          N 
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248

Query: 219 FSLLIR-----------IGVGDELPN--IPGDL------SEQGKDFLIKCFLKDPKRRWT 259
               +R           I   +  P+   P +       + Q +D L K  + DP +R +
Sbjct: 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS 308

Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 309 VDEALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 61/251 (24%), Positives = 100/251 (39%), Gaps = 11/251 (4%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G G FG V   +       +      K             NEK+ L+++    + V  
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN--SRFVVS 64

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y++E  +    L+L   + G L   +        +E     Y   +  GL  +H +
Sbjct: 65  LA--YAYETKDALC-LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR-GTPLYMSPESVNENE 186
             V+ D+K +N+L+ D+   +I+D GLA          Q+ + R GT  YM+PE V    
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVP----EGQTIKGRVGTVGYMAPEVVKNER 177

Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y    D WALGC + EM +G+  +  ++       + R+ V +         S   +   
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-VKEVQEEYSEKFSPDARSLC 236

Query: 247 IKCFLKDPKRR 257
                KDPK R
Sbjct: 237 KMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 59/261 (22%), Positives = 120/261 (45%), Gaps = 27/261 (10%)

Query: 9   IGHGSFGSVNLAKASK-----VSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +G G FG V +A  +K     V +  P  M+V++         TL+++K           
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDK----------- 62

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+     ++    E  Y ++ E+ ++GSL D +K     +     +  ++  + +G+  
Sbjct: 63  LVKL----HAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           I  + ++H D++  N+LV  +   KIADFGLA+    D E +     +    + +PE++N
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAIN 176

Query: 184 ENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              +    D+W+ G  ++E+ + G+  +    +  V   L R   G  +P    +  E+ 
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---GYRMPRPE-NCPEEL 232

Query: 243 KDFLIKCFLKDPKRRWTAEML 263
            + +++C+   P+ R T E +
Sbjct: 233 YNIMMRCWKNRPEERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 54/203 (26%), Positives = 82/203 (40%), Gaps = 65/203 (32%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +             GT   
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-------------GTSFM 173

Query: 177 MSPESVNENEYEAP-----------CDIWALGCAVVEMASGK---PAWNH-KQDSNVFSL 221
           M+P  V    Y AP            DIW++GC + EM  G    P  +H  Q + +   
Sbjct: 174 MTPYVVTR-YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ 232

Query: 222 L--------------IRIGVGDELPNIPG---------DL------------SEQGKDFL 246
           L              +R  V +  P   G          L            + Q +D L
Sbjct: 233 LGTPSDEFMSRLQPTVRNYV-ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLL 291

Query: 247 IKCFLKDPKRRWTAEMLLNHPFV 269
            K  + DP++R + +  L HP++
Sbjct: 292 SKMLVIDPEKRISVDDALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 47/277 (16%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT--LKNEKEALDQIGICPQIV 65
           VIG G+FG V L +       +   M +   AD         ++ E++ L +      +V
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYA--MKILRKADMLEKEQVGHIRAERDILVEADSL-WVV 64

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + F   YSF+     Y L++E+   G +   + K++   L E + + Y    +  +  IH
Sbjct: 65  KMF---YSFQDKLNLY-LIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIH 118

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGL------------------------------A 155
             GF+H DIK  N+L+      K++DFGL                              +
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 156 KKSSCDGERSQ---SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNH 212
           K+ +   +R++   +F   GTP Y++PE   +  Y   CD W+LG  + EM  G P +  
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 213 KQDSNVFSLLIRIGVGDEL-PNIPGDLSEQGKDFLIK 248
           +     +  ++         P +P  +SE+ KD +++
Sbjct: 239 ETPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILR 273

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 38/105 (36%), Positives = 60/105 (57%), Gaps = 6/105 (5%)

Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE 163
           +L +  V+     +L+GL++IHS G +H D+K  NV V ++ E +I DFGLA+++  D E
Sbjct: 114 KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA--DDE 171

Query: 164 RSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGK 207
            +     R    Y +PE  +N   Y    DIW++GC + E+  GK
Sbjct: 172 MTGYVATR---WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 26/264 (9%)

Query: 8   VIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-PQIV 65
            +G G FG V LAKA  +      +L+ VK+       ++  +  +E      +    +V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSL-------ADRVKKQNNGRLQESDVKRYTRSML 118
           R  G      + E  Y ++LEY   G L         + +K     L           + 
Sbjct: 72  RLLG---LCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT--PL- 175
            G+ H+ +  FVH D+  +N LV    E K++   L+K    D   S+ ++ R    PL 
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNALIPLR 183

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEM-ASGKPAWNHKQDSNVFSLLIRIGVGD-ELPN 233
           +++PE+V E+++    D+W+ G  + E+   G+  +    D  V   L R+  G  ELP 
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LNRLQAGKLELP- 239

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRR 257
           +P     +    + +C+  +PK R
Sbjct: 240 VPEGCPSRLYKLMTRCWAVNPKDR 263

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 46/199 (23%), Positives = 95/199 (47%), Gaps = 30/199 (15%)

Query: 75  EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDI 134
           EKG  +  ++ EY ++GSL D ++ +    L    + +++  + + + ++ +  FVH D+
Sbjct: 71  EKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDL 128

Query: 135 KLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENEYEAPCDI 193
             +NVLV +++ AK++DFGL K++S   +  +       P+ + +PE++ E ++    D+
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPVKWTAPEALREKKFSTKSDV 182

Query: 194 WALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNI--------PGDLSEQGKD 244
           W+ G  + E+ S G+  +             RI + D +P +        P        D
Sbjct: 183 WSFGILLWEIYSFGRVPYP------------RIPLKDVVPRVEKGYKMDAPDGCPPVVYD 230

Query: 245 FLIKCFLKDPKRRWTAEML 263
            + +C+  D   R +   L
Sbjct: 231 VMKQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 27/212 (12%)

Query: 6   GDVIGHGSFGSVNLAKA-SKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICP 62
           G  +G G+FG V  A+A    +    S +AVK   D         L +E E +  IG   
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSL-----ADRVKKQNN---------GRLQES 108
            I+   G     ++G  +  +++EYA+ G+L     A R   +             L + 
Sbjct: 77  NIINLLG--VCTQEGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 109 DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQS 167
           D+  +   + +G+  + SK  +H D+  +NVLV ++   KIADFGLA+     D  R  +
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 168 FECRG-TPL-YMSPESVNENEYEAPCDIWALG 197
               G  P+ +M+PE++ +  Y    D+W+ G
Sbjct: 193 ---NGRLPVKWMAPEALFDRVYTHQSDVWSFG 221

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 23/217 (10%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G FG V +A+A  +  + P+    +AVK   D         L +E E +  IG 
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK--------------KQNNGRLQ 106
              I+   G   +  +    Y +L+EYAS+G+L + ++              K    +L 
Sbjct: 77  HKNIINLLG---ACTQDGPLY-VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132

Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ S+  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 60/233 (25%), Positives = 93/233 (39%), Gaps = 28/233 (12%)

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P +V  F    SFE  +R   +++EY   G  A  +K  N G L     + Y    +  L
Sbjct: 61  PFVVSMFC---SFET-KRHLCMVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLAL 114

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS-------------SCDGERSQSF 168
            ++H+ G VH D+K  N+L+      K+ DFGL+K                 D       
Sbjct: 115 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174

Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG 228
           +  GTP Y++PE +    Y  P D WA+G  + E   G   +       +F  +I     
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI----S 230

Query: 229 DELPNIPGD--LSEQGKDFLIKCFLKDPKRRW---TAEMLLNHPFVCADDQTG 276
           D++    GD  L    +D + +   ++P  R     A  +  H F    D  G
Sbjct: 231 DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 24/237 (10%)

Query: 46  VTLKNEKEA------LDQIGICPQ--IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRV 97
           V L +E++A      L  +  C    IV+ F DD+   K +    L++EY S G L  ++
Sbjct: 101 VMLNDERQAAYARSELHCLAACDHFGIVKHF-DDF---KSDDKLLLIMEYGSGGDLNKQI 156

Query: 98  KKQNNGRL--QESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA 155
           K++    L  QE +V      ++  L  +HS+  +H D+K  N+ +      K+ DFG +
Sbjct: 157 KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS 216

Query: 156 KK--SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNH 212
           K+   S   + + SF C GTP Y++PE      Y    D+W+LG  + E+ +  +P    
Sbjct: 217 KQYSDSVSLDVASSF-C-GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274

Query: 213 KQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            Q      ++ ++  G   P  P  +S   K  L     K+P  R T + LL+  F+
Sbjct: 275 SQR----EIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL 326

Length = 478

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 63/251 (25%), Positives = 98/251 (39%), Gaps = 11/251 (4%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G G FG V   +       +      K             NEK  L+++    + V  
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN--SRFVVS 64

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y++E  +    L+L   + G L   +    N    E     Y   +  GL  +  +
Sbjct: 65  LA--YAYETKDALC-LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             V+ D+K +N+L+ D    +I+D GLA +   +GE  +     GT  YM+PE +N  +Y
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIP-EGETVRGRV--GTVGYMAPEVINNEKY 178

Query: 188 EAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
               D W LGC + EM  G+ P    K+      +  R+    E        SE  K   
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSEKFSEDAKSIC 236

Query: 247 IKCFLKDPKRR 257
                K+PK R
Sbjct: 237 RMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 62/268 (23%), Positives = 122/268 (45%), Gaps = 35/268 (13%)

Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CP 62
           +G GSFG V    A  V  + P + +A+K+  +    + +++   E L++  +     C 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCH 69

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR-- 115
            +VR  G      +G+    +++E  +RG L       R + +NN       +K+  +  
Sbjct: 70  HVVRLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125

Query: 116 -SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
             +  G+ ++++  FVH D+  +N +V ++   KI DFG+ +    D   +  +   G  
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKG 181

Query: 175 L----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD 229
           L    +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241

Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           +  N P  L E     +  C+  +PK R
Sbjct: 242 KPDNCPDMLFE----LMRMCWQYNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 49/186 (26%), Positives = 88/186 (47%), Gaps = 14/186 (7%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ EY   GSL D +K     +L  + +      + +G+  I  K ++H D++  N+LV 
Sbjct: 77  IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS 136

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENEYEAPCDIWALGCAVV 201
           +    KIADFGLA+    +   ++  E    P+ + +PE++N   +    D+W+ G  + 
Sbjct: 137 ETLCCKIADFGLARLIEDNEYTAR--EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLT 194

Query: 202 EMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP---NIPGDLSEQGKDFLIKCFLKDPKRR 257
           E+ + G+  +    +  V   L R   G  +P   N P +L E     +  C+ + P+ R
Sbjct: 195 EIVTYGRIPYPGMTNPEVIQNLER---GYRMPRPDNCPEELYE----LMRLCWKEKPEER 247

Query: 258 WTAEML 263
            T E L
Sbjct: 248 PTFEYL 253

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 38/272 (13%)

Query: 9   IGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPPSSVTLKN---EKEALDQIGICPQI 64
           +G G+FG V LA+   +S ++   L+AVK+  D  P+    K+   E E L  +     I
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQ-HEHI 69

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSL--------------ADRVKKQNNGRLQESDV 110
           V+ +G       G+    ++ EY   G L               D   +Q  G L  S +
Sbjct: 70  VKFYG---VCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
                 +  G+ ++ S+ FVH D+  +N LV  N   KI DFG+++    D   +  +  
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV 181

Query: 171 RGTPL----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
            G  +    +M PES+   ++    D+W+ G  + E+ + GK  W    ++ V   + + 
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ- 240

Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           G   E P +     ++  D ++ C+ ++P++R
Sbjct: 241 GRVLERPRV---CPKEVYDIMLGCWQREPQQR 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 39/147 (26%), Positives = 76/147 (51%), Gaps = 5/147 (3%)

Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR 171
           R+   +  G+ ++ SK F+H D+  +N ++ +N    +ADFGL+KK        Q    +
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 172 GTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDE 230
               +++ ES+ +N Y    D+WA G  + E+ + G+  +   ++S +++ LI+   G+ 
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK---GNR 233

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           L   P D  E   + + +C+  +PK R
Sbjct: 234 LKQ-PPDCLEDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 47/277 (16%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEA--LDQIGICPQI 64
            +G G+FG V L +   +  E    L+AVK+  +   +      E+EA  L        I
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-HENI 70

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------------KQNNGRLQESDVKR 112
           V+ +G      +G+    ++ EY   G L   ++                G L  S + +
Sbjct: 71  VKFYG---VCTEGDPPI-MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126

Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFECR 171
               +  G+ ++ S+ FVH D+  +N LV  +   KI DFG+++   + D      +   
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD-----YYRVG 181

Query: 172 GTPL----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFS------ 220
           G  +    +M PES+   ++    D+W+ G  + E+ + GK  W    +  V        
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241

Query: 221 LLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           LL R          P     +  D ++ C+ +DP++R
Sbjct: 242 LLQR----------PRTCPSEVYDIMLGCWKRDPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.4 bits (151), Expect = 4e-11
 Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 7/193 (3%)

Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           Y+    E  Y ++ E+  +GSL D +K+ +   L+   +      +  G+ +I    ++H
Sbjct: 67  YAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125

Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            D++  N+LV DN   KIADFGLA+    D E +     +    + +PE+     +    
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 192 DIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCF 250
           D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P    E   + +  C+
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVER---GYRMP-CPQGCPESLHELMKLCW 240

Query: 251 LKDPKRRWTAEML 263
            KDP  R T E +
Sbjct: 241 KKDPDERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 59/252 (23%), Positives = 111/252 (44%), Gaps = 15/252 (5%)

Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G+FG+V         SE   ++  +K+  + P     L  E   + Q+   P IVR 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRM 61

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G      + E +  L++E A  G L   ++K  N  + E ++      +  G++++   
Sbjct: 62  IG----ICEAESWM-LVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET 114

Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENE 186
            FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ + +PE +N  +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 187 YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           + +  D+W+ G  + E  S G+  +   + + V  ++     G+ +   P     +  D 
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES---GERM-ECPQRCPPEMYDL 230

Query: 246 LIKCFLKDPKRR 257
           +  C+      R
Sbjct: 231 MKLCWTYGVDER 242

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 53/195 (27%), Positives = 98/195 (50%), Gaps = 19/195 (9%)

Query: 76  KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIK 135
           + E  Y ++ EY S+GSL D +K     +L+   +      + +G+ ++ S+ ++H D+ 
Sbjct: 72  EEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLA 130

Query: 136 LQNVLVFDNDEAKIADFGLAKK------SSCDGERSQSFECRGTPLYMSPESVNENEYEA 189
            +N+LV +N   KIADFGLA+       ++ +G +   F  + T    +PE+ N   +  
Sbjct: 131 ARNILVGENLVCKIADFGLARLIEDDEYTAREGAK---FPIKWT----APEAANYGRFTI 183

Query: 190 PCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIK 248
             D+W+ G  + E +  G+  +    +  V   + R   G  +P  P +  E+  D +++
Sbjct: 184 KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER---GYRMP-RPPNCPEELYDLMLQ 239

Query: 249 CFLKDPKRRWTAEML 263
           C+ KDP+ R T E L
Sbjct: 240 CWDKDPEERPTFEYL 254

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 31/182 (17%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF--ECRGTP 174
           +L+ L++IH+    H D+K +N+L   + + KI DFGLA+ +  D   +  F  +   T 
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP-TAIFWTDYVATR 170

Query: 175 LYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI------- 225
            Y +PE      ++Y    DIW++GC   E+ +GKP +  K   +   L+  +       
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230

Query: 226 ---GVGDE---------LPNIPGDLSEQ--GKDFLIKCFLK-----DPKRRWTAEMLLNH 266
               V +E             P   S++    D L    L+     DPK R TAE  L  
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290

Query: 267 PF 268
           P+
Sbjct: 291 PY 292

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 7e-11
 Identities = 56/214 (26%), Positives = 80/214 (37%), Gaps = 51/214 (23%)

Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF-DNDE---AKIADFGLAKKSS 159
            +  S VK     +L G+ ++HS   +H D+K  N+LV  +  E    KI D GLA+   
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-- 161

Query: 160 CDGERSQSFECRG---TPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
            +       +      T  Y +PE +     Y    DIWA+GC   E+ + +P +  ++ 
Sbjct: 162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221

Query: 216 ----SNVFSL--LIRI----GVGDE--------LP-----------------------NI 234
               SN F    L RI    G   E        +P                         
Sbjct: 222 KIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEK 281

Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                 QG D L K    DP +R TAE  L HP+
Sbjct: 282 HKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 66/278 (23%), Positives = 125/278 (44%), Gaps = 35/278 (12%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G FG V  A A ++      + +AVK   +   SS    L +E   L Q+   P
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HP 63

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK--------------KQNNGRLQES 108
            +++ +G   +  +      L++EYA  GSL   ++               +N+  L   
Sbjct: 64  HVIKLYG---ACSQDGPLL-LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 109 DVKRYTRSML--------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC 160
           D +  T   L        +G++++     VH D+  +NVLV +  + KI+DFGL++    
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVF 219
           +    +  + R    +M+ ES+ ++ Y    D+W+ G  + E+ + G   +       +F
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239

Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           +LL + G   E P    + SE+  + ++ C+ ++P +R
Sbjct: 240 NLL-KTGYRMERPE---NCSEEMYNLMLTCWKQEPDKR 273

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 72/317 (22%), Positives = 122/317 (38%), Gaps = 57/317 (17%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G+FG V LA+     + +      K           +K E++ L +      +VR +
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLY 67

Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              YSF+  +  Y  +++Y   G +   + +   G   E   + Y   +   +  +H  G
Sbjct: 68  ---YSFQDKDNLY-FVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG 121

Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLA------------------KKSSCD--------- 161
           F+H DIK  N+L+  +   K+ DFGL                   ++ S D         
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181

Query: 162 ----GERSQSFECR--------------GTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
               G+R +  E R              GTP Y++PE +    Y   CD W++G  + EM
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241

Query: 204 ASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRW---TA 260
             G+P +  +        +I       +P     LS +  D +IK   + P+ R     A
Sbjct: 242 LVGQPPFLAQTPLETQMKVINWQTSLHIP-PQAKLSPEASDLIIK-LCRGPEDRLGKNGA 299

Query: 261 EMLLNHPFVCADDQTGD 277
           + +  HPF    D + D
Sbjct: 300 DEIKAHPFFKTIDFSSD 316

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 40/190 (21%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YY 191

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL---------- 222
            +PE +    Y+   DIW++GC + EM  G    P  +H  Q + V   L          
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251

Query: 223 ----IRIGVGDE-----------LPNI--PGDL------SEQGKDFLIKCFLKDPKRRWT 259
               +R  V +             P++  P D       + Q +D L K  + D  +R +
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311

Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 312 VDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 64/257 (24%), Positives = 109/257 (42%), Gaps = 22/257 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CP 62
           V+G G+FG+V               +A+K   +    + + K  KE LD+  +      P
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRE----NTSPKANKEILDEAYVMAGVGSP 69

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            + R  G         +    L+ Y   G L D V+ +N  R+   D+  +   + KG+ 
Sbjct: 70  YVCRLLG--ICLTSTVQLVTQLMPY---GCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMS 123

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++     VH D+  +NVLV   +  KI DFGLA+    D E     +    P+ +M+ ES
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID-ETEYHADGGKVPIKWMALES 182

Query: 182 VNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
           +    +    D+W+ G  V E M  G   ++      +  LL +   G+ LP  P   + 
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK---GERLPQ-PPICTI 238

Query: 241 QGKDFLIKCFLKDPKRR 257
                ++KC++ D + R
Sbjct: 239 DVYMIMVKCWMIDSECR 255

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 49/192 (25%), Positives = 81/192 (42%), Gaps = 44/192 (22%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    Y
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YY 184

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNHKQDSNVFSLLIRIGV------ 227
            +PE +    Y+   DIW++GC + EM   K   P  ++    N   ++ ++G       
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTPCPEFM 242

Query: 228 ------------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRR 257
                             G   P +      P D       + Q +D L K  + DP +R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302

Query: 258 WTAEMLLNHPFV 269
            + +  L HP++
Sbjct: 303 ISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 58/237 (24%), Positives = 94/237 (39%), Gaps = 43/237 (18%)

Query: 2   EWLRGDV-----IGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSSVTLKNEKEA- 54
           E+ R ++     IG G+FG V  A+A  +    P  M AVK   +   + +    ++EA 
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 55  ----LDQIGICPQIVR----C--------------FGDDYSFEKGERFYNLLLEYASRGS 92
                D     P IV+    C              +GD   F +            S  +
Sbjct: 61  LMAEFDH----PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRA--QCSLSHST 114

Query: 93  LADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADF 152
            + R    N   L  ++     + +  G+ ++  + FVH D+  +N LV +N   KIADF
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 174

Query: 153 GLAKK----SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
           GL++            + +   R    +M PES+  N Y    D+WA G  + E+ S
Sbjct: 175 GLSRNIYSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 23/217 (10%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP---SLMAVKSC-ADCPPSSVT-LKNEKEALDQIGI 60
           G  +G G FG V +A+A  +  E P   + +AVK   +D     ++ L +E E +  IG 
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN--------------NGRLQ 106
              I+   G     + G  +  +++EYAS+G+L + ++ +                 +L 
Sbjct: 83  HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138

Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 139 FKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198

Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 41/177 (23%), Positives = 88/177 (49%), Gaps = 12/177 (6%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           +++E  S+G+L + ++ +    +    + +++  + +G+ ++ SK  VH D+  +N+LV 
Sbjct: 75  IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS 134

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENEYEAPCDIWALGCAVV 201
           ++  AK++DFGLA+  S   + S+       P+ + +PE++   ++ +  D+W+ G  + 
Sbjct: 135 EDGVAKVSDFGLARVGSMGVDNSK------LPVKWTAPEALKHKKFSSKSDVWSYGVLLW 188

Query: 202 EMASGKPAWNHKQDSNVFSLLIRIGVGDELPN-IPGDLSEQGKDFLIKCFLKDPKRR 257
           E+ S   A   K         +  G   E P   P D+       +  C+  +PK+R
Sbjct: 189 EVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV----LMTSCWETEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 60.5 bits (146), Expect = 2e-10
 Identities = 61/267 (22%), Positives = 116/267 (43%), Gaps = 31/267 (11%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPS-LMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVR 66
           +G G+FG V LA+   +  E    L+AVK+  D   ++      E E L  +     IV+
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVK 71

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNG-----------RLQESDVKRYTR 115
            +G      +G+    ++ EY   G L   ++                 L +S +    +
Sbjct: 72  FYG---VCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            +  G+ ++ S+ FVH D+  +N LV +N   KI DFG+++    D   +  +   G  +
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTM 183

Query: 176 ----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDE 230
               +M PES+   ++    D+W+LG  + E+ + GK  W    ++ V   + +  V   
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR 243

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRR 257
               P ++ +     ++ C+ ++P  R
Sbjct: 244 PRTCPKEVYD----LMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 26/265 (9%)

Query: 2   EWLRGDVIGHGSFGSV--NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           E+ +  V+G G+FG+V   L        + P  +     A  P      K  KE LD+  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP------KANKEILDEAY 61

Query: 60  IC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYT 114
           +      P + R  G         +    L+ +   G L D V+ ++   +    +  + 
Sbjct: 62  VMASVDNPHVCRLLG--ICLTSTVQLITQLMPF---GCLLDYVR-EHKDNIGSQYLLNWC 115

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
             + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    D E+    E    P
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD-EKEYHAEGGKVP 174

Query: 175 L-YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
           + +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLP 231

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
             P   +      ++KC++ D   R
Sbjct: 232 Q-PPICTIDVYMIMVKCWMIDADSR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP---SLMAVKSCADCPPSS--VTLKNEKEALDQIGI 60
           G  +G G FG V  A+A  +    P     +AVK   D         L +E E +  IG 
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSL-----ADR---------VKKQNNGRLQ 106
              I+   G     ++G  +  +++EYA++G+L     A R         + K    +L 
Sbjct: 77  HKNIINLLG--VCTQEGPLY--VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132

Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ S+  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 53/202 (26%), Positives = 102/202 (50%), Gaps = 16/202 (7%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA--LDQIGICPQI 64
           +++G G+FG V      K + +  + +AVK+C +  P  + +K   EA  L Q    P I
Sbjct: 1   ELLGKGNFGEV-----FKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNI 54

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V+  G      + +  Y +++E    G     ++K+ +  L+   + ++      G+ ++
Sbjct: 55  VKLIG---VCTQRQPIY-IVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYL 109

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVN 183
            SK  +H D+  +N LV +N+  KI+DFG++++   DG  S S   +  P+ + +PE++N
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSS-GLKQIPIKWTAPEALN 167

Query: 184 ENEYEAPCDIWALGCAVVEMAS 205
              Y +  D+W+ G  + E  S
Sbjct: 168 YGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 74/312 (23%), Positives = 126/312 (40%), Gaps = 69/312 (22%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-------EKEALDQIGIC 61
           IG G+FG V L    KV +   +L A+K+      + V ++N       E++ L +    
Sbjct: 9   IGIGAFGEVCLV--RKVDTN--ALYAMKTLRK---ADVLMRNQAAHVKAERDILAEAD-N 60

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
             +V+ +   YSF+  +  Y  +++Y   G +   + +   G  +E   + Y   +   +
Sbjct: 61  EWVVKLY---YSFQDKDNLY-FVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAI 114

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA-------------------------- 155
             +H  GF+H DIK  N+L+  +   K+ DFGL                           
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 156 -KKSSCDGERSQSFECR--------------GTPLYMSPESVNENEYEAPCDIWALGCAV 200
            + S  D  R +  E R              GTP Y++PE +    Y   CD W++G  +
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234

Query: 201 VEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--GDLSEQGKDFLIKCFLKDPKR-- 256
            EM  G+P +    D+   + L  I     L +IP    LS +  D +++       R  
Sbjct: 235 YEMLVGQPPFL--ADTPAETQLKVINWETTL-HIPSQAKLSREASDLILRLCCGAEDRLG 291

Query: 257 RWTAEMLLNHPF 268
           +  A+ +  HPF
Sbjct: 292 KNGADEIKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 44/206 (21%), Positives = 79/206 (38%), Gaps = 42/206 (20%)

Query: 101 NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC 160
            +  L         + +L+GLR++H++  +H D+K +N+ + D D+  I D G A+    
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ---F 206

Query: 161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM-----------ASGKPA 209
                      GT    +PE +  ++Y +  DIW+ G  + EM            S    
Sbjct: 207 PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266

Query: 210 WNHKQDSNVFSLLIRIGVG-DELPNIPG---------------------------DLSEQ 241
           +     S++  ++  + V  +E P  PG                           +L   
Sbjct: 267 YVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPID 326

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHP 267
           G+  + K    D   R +AE +LN+P
Sbjct: 327 GEFLVHKMLTFDAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 59.5 bits (144), Expect = 4e-10
 Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 20/215 (9%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC----- 61
           +VIG G FG V   +  K+  +    +A+K+      S  T K  ++ L +  I      
Sbjct: 10  EVIGAGEFGEVCRGRL-KLPGKREIFVAIKTLK----SGYTEKQRRDFLSEASIMGQFDH 64

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P I+   G         R   ++ E+   G+L D   +QN+G+     +    R +  G+
Sbjct: 65  PNIIHLEG----VVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGM 119

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK---KSSCDGERSQSFECRGTPLYMS 178
           +++    +VH D+  +N+LV  N   K++DFGL++     + D   + S   +    + +
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 179 PESVNENEYEAPCDIWALGCAVVEMAS--GKPAWN 211
           PE++   ++ +  D+W+ G  + E+ S   +P W+
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 39/156 (25%), Positives = 64/156 (41%), Gaps = 13/156 (8%)

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV       S E        + EY    +L + +    +G L   +  R    +L  L
Sbjct: 38  PNIVALLD---SGEAPPGLLFAVFEYVPGRTLREVL--AADGALPAGETGRLMLQVLDAL 92

Query: 122 RHIHSKGFVHCDIKLQNVLVFDND---EAKIADFGLAKKSSCDGER-----SQSFECRGT 173
              H++G VH D+K QN++V        AK+ DFG+        +      +++ E  GT
Sbjct: 93  ACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152

Query: 174 PLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPA 209
           P Y +PE +         D++A G   +E  +G+  
Sbjct: 153 PTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 47/196 (23%), Positives = 92/196 (46%), Gaps = 21/196 (10%)

Query: 76  KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIK 135
             E  Y ++ E    GSL + ++      L+   +      +  G+ ++ ++ ++H D+ 
Sbjct: 72  LEEPIY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130

Query: 136 LQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR-GTPL---YMSPESVNENEYEAPC 191
            +NVLV +N+  K+ADFGLA+       +   +E R G      + +PE+   N +    
Sbjct: 131 ARNVLVGENNICKVADFGLARVI-----KEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 192 DIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
           D+W+ G  + E+ + G+   P   + +      +L ++  G  +P  PG   ++  D ++
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNAE------VLQQVDQGYRMPCPPG-CPKELYDIML 238

Query: 248 KCFLKDPKRRWTAEML 263
            C+ +DP  R T E L
Sbjct: 239 DCWKEDPDDRPTFETL 254

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.8 bits (142), Expect = 6e-10
 Identities = 46/179 (25%), Positives = 87/179 (48%), Gaps = 11/179 (6%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ EY   GSL D   ++++G+     +    R +  G++++   G+VH D+  +N+LV 
Sbjct: 82  IVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN 140

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENEYEAPCDIWALGCAVV 201
            N   K++DFGL++    D E + +      P+ + +PE++   ++ +  D+W+ G  + 
Sbjct: 141 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 200

Query: 202 EMAS--GKPAWN-HKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           E+ S   +P W    QD     ++  I  G  LP  P D        ++ C+ KD   R
Sbjct: 201 EVMSYGERPYWEMSNQD-----VIKAIEEGYRLPA-PMDCPAALHQLMLDCWQKDRNER 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 68/276 (24%), Positives = 124/276 (44%), Gaps = 42/276 (15%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK---NEKEALDQIGIC--- 61
           VIG G FG V   +  K+  +    +A+K          TLK   ++K+ LD +      
Sbjct: 11  VIGGGEFGEVCRGRL-KLPGKKEIDVAIK----------TLKAGSSDKQRLDFLTEASIM 59

Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P I+R  G      K      ++ EY   GSL D+  ++N+G+     +    R 
Sbjct: 60  GQFDHPNIIRLEG---VVTKSRPVM-IITEYMENGSL-DKFLRENDGKFTVGQLVGMLRG 114

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG--TP 174
           +  G++++    +VH D+  +N+LV  N   K++DFGL   S    +   ++  +G   P
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL---SRRLEDSEATYTTKGGKIP 171

Query: 175 L-YMSPESVNENEYEAPCDIWALGCAVVE-MASG-KPAWN-HKQDSNVFSLLIRIGVGDE 230
           + + +PE++   ++ +  D+W+ G  + E M+ G +P W+   QD     ++  +  G  
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-----VIKAVEDGYR 226

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           LP  P D        ++ C+ KD   R T   +++ 
Sbjct: 227 LPP-PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 58.3 bits (141), Expect = 7e-10
 Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 27/194 (13%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+L++A  G L   + K  N  + E  VKR+   M+  L  +H +G V  D+   N+L+ 
Sbjct: 62  LVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119

Query: 143 DNDEAKIADFG--LAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAV 200
           D    ++  F      + SCDGE  ++       +Y +PE    +E    CD W+LG  +
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDGEAVEN-------MYCAPEVGGISEETEACDWWSLGAIL 172

Query: 201 VEMASGKP-AWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT 259
            E+ +GK     H    N  + L          NIP  +SE+ +  L +    +P  R  
Sbjct: 173 FELLTGKTLVECHPSGINTHTTL----------NIPEWVSEEARSLLQQLLQFNPTERLG 222

Query: 260 A-----EMLLNHPF 268
           A     E + +HPF
Sbjct: 223 AGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 14/159 (8%)

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L   D+  +T  + +G+  + SK  VH D+  +NVL+      KI DFGLA+    D   
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMH 289

Query: 165 SQSFECRGTPL----YMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNV 218
             ++  +G+      +M+PES+ +N Y    D+W+ G  + E+ S  G P      DS  
Sbjct: 290 DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349

Query: 219 FSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           ++   +I  G  +   P   +++  D ++KC+  +P++R
Sbjct: 350 YN---KIKSGYRMAK-PDHATQEVYDIMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 58.2 bits (141), Expect = 9e-10
 Identities = 41/183 (22%), Positives = 86/183 (46%), Gaps = 7/183 (3%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ EY + G L + ++ +  G+L    +      + + + ++ S GF+H D+  +N LV 
Sbjct: 76  IVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG 134

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVE 202
           +++  K++DFGLA +   D + + S   +    +  PE  + + + +  D+W+ G  + E
Sbjct: 135 EDNVVKVSDFGLA-RYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWE 193

Query: 203 MAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAE 261
           + S GK  +    +S V   +  +  G  L   P     +    +  C+ + P+ R   +
Sbjct: 194 VFSEGKMPYERFSNSEV---VESVSAGYRLYR-PKLAPTEVYTIMYSCWHEKPEDRPAFK 249

Query: 262 MLL 264
            LL
Sbjct: 250 KLL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 66/270 (24%), Positives = 122/270 (45%), Gaps = 35/270 (12%)

Query: 9   IGHGSFGSVNLAKASK-VSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CP 62
           +G GSFG V    A   +  E  + +AVK+  +    S +L+   E L++  +     C 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 69

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNN-GRLQES--DVKRYT 114
            +VR  G      KG+    +++E  + G L       R + +NN GR   +  ++ +  
Sbjct: 70  HVVRLLG---VVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
             +  G+ ++++K FVH D+  +N +V  +   KI DFG+ +    D   +  +   G  
Sbjct: 126 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKG 181

Query: 175 L----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD 229
           L    +M+PES+ +  +    D+W+ G  + E+ S  +  +    +  V   ++  G  D
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241

Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWT 259
           +  N P    E+  D +  C+  +PK R T
Sbjct: 242 QPDNCP----ERVTDLMRMCWQFNPKMRPT 267

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 39/147 (26%), Positives = 74/147 (50%), Gaps = 9/147 (6%)

Query: 80  FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNV 139
           FY ++ E+ + G+L D +++ N   +    +      +   + ++  K F+H D+  +N 
Sbjct: 77  FY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135

Query: 140 LVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNENEYEAPCDIWAL 196
           LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N++    D+WA 
Sbjct: 136 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFSIKSDVWAF 191

Query: 197 GCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           G  + E+A+ G   +     S V+ LL
Sbjct: 192 GVLLWEIATYGMSPYPGIDLSQVYELL 218

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 38/129 (29%), Positives = 67/129 (51%), Gaps = 4/129 (3%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L++E AS G L   +  + +  +  S+V      +  G++++  K FVH D+  +NVL+ 
Sbjct: 71  LVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV 129

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENEYEAPCDIWALGCAVV 201
           +   AKI+DFGL+K    D    ++      PL + +PE +N  ++ +  D+W+ G  + 
Sbjct: 130 NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMW 189

Query: 202 EMAS--GKP 208
           E  S   KP
Sbjct: 190 EAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 62/269 (23%), Positives = 110/269 (40%), Gaps = 33/269 (12%)

Query: 9   IGHGSFGSVNLAKASKVSSEF-PSLMAVKSCADCPPSS-VTLKNEKEALDQIGICPQIVR 66
           +G G+FG V LA+   +  E    L+AVK+  +   S+    + E E L  +     IVR
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ-HQHIVR 71

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSL-------------ADRVKKQNNGRLQESDVKRY 113
            +G      +G     ++ EY   G L                 +    G+L    +   
Sbjct: 72  FYG---VCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
              +  G+ ++ S  FVH D+  +N LV      KI DFG+++    D   +  +   G 
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGR 183

Query: 174 PL----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVG 228
            +    +M PES+   ++    DIW+ G  + E+ + GK  W    ++     + +   G
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ---G 240

Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            EL   P     +    +  C+ ++P++R
Sbjct: 241 RELER-PRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 58/273 (21%), Positives = 106/273 (38%), Gaps = 38/273 (13%)

Query: 9   IGHGSFGSVNLAKASKV--SSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGIC 61
           +G G+FG V    A+ +      P  +AVK+           +  KEA      +   I 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSL-----ADRVKKQNNGRLQESDVKRYTRS 116
             +  C  ++  +        +++E    G L       RV++     L   ++      
Sbjct: 63  KLLGVCLLNEPQY--------IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA-----KIADFGLAKKSSCDGERSQSFECR 171
           + KG  ++    F+H D+  +N LV +         KI DFGLA+    D  +S  +   
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKE 170

Query: 172 GTPL----YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIG 226
           G  L    +M+PES+ + ++    D+W+ G  + E +  G+  +    +  V   +   G
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG 230

Query: 227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT 259
              +  N P  +       +  C+ +DP  R T
Sbjct: 231 RLQKPENCPDKI----YQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 60/277 (21%), Positives = 117/277 (42%), Gaps = 28/277 (10%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
           G ++G G FGSV   + S+       + AVK+        +   +E E       C    
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMK----LDIHTYSEIEEFLSEAACMKDF 58

Query: 62  --PQIVRCFGDDYSFEKGERFYN--LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
             P +++  G  +     ++     ++L +   G L   +      RL     K   +++
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS---RLGGLPEKLPLQTL 115

Query: 118 LK-------GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
           LK       G+ ++ ++ F+H D+  +N ++ ++    +ADFGL+KK        Q    
Sbjct: 116 LKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD 229
           +    +++ ES+ +  Y +  D+WA G  + E+A+ G+  +   ++  ++  L     G+
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH---GN 232

Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
            L   P D  ++  D +  C+  DPK R T   L   
Sbjct: 233 RL-KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 90/387 (23%), Positives = 141/387 (36%), Gaps = 97/387 (25%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG-------- 59
           VIG G+FG V L +          + A+K+          LK+E    DQ+         
Sbjct: 8   VIGKGAFGEVRLVQKKDTGK----IYAMKT---------LLKSEMFKKDQLAHVKAERDV 54

Query: 60  ----ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKR-YT 114
                 P +V  +   YSF+  +  Y L++E+   G L   + K +       DV R Y 
Sbjct: 55  LAESDSPWVVSLY---YSFQDAQYLY-LIMEFLPGGDLMTMLIKYD---TFSEDVTRFYM 107

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL-------------------- 154
              +  +  +H  GF+H DIK  N+L+      K++DFGL                    
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167

Query: 155 AKKSSCDGERSQ-------------------------SFECRGTPLYMSPESVNENEYEA 189
           + K+  D   S                          ++   GTP Y++PE   +  Y  
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227

Query: 190 PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD--LSEQGKDFLI 247
            CD W+LG  + E   G P +  +     +  +I      E    P D  LS + +D LI
Sbjct: 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINW---RETLYFPDDIHLSVEAED-LI 283

Query: 248 KCFLKDPKR---RWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKD------EK 298
           +  + + +    R  A  + +HPF    D    D    I +   P LK I D      ++
Sbjct: 284 RRLITNAENRLGRGGAHEIKSHPFFRGVDW---DTIRQIRAPFIPQLKSITDTSYFPTDE 340

Query: 299 FSQSPRSPFGFPEWVSVQSSSSVTSSI 325
             Q P +P    +    Q   SV   +
Sbjct: 341 LEQVPEAP-ALKQAAPAQQEESVELDL 366

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 6/184 (3%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+ + +  GSL D V+ Q+   L    +  +   + KG+ ++     VH ++  +N+L+ 
Sbjct: 85  LVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK 143

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVE 202
            +   +IADFG+A     D ++    E +    +M+ ES+    Y    D+W+ G  V E
Sbjct: 144 SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWE 203

Query: 203 MAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAE 261
           M S G   +   +   V  LL +   G+ L   P   +      ++KC++ D   R T +
Sbjct: 204 MMSYGAEPYAGMRPHEVPDLLEK---GERLAQ-PQICTIDVYMVMVKCWMIDENVRPTFK 259

Query: 262 MLLN 265
            L N
Sbjct: 260 ELAN 263

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 29/90 (32%), Positives = 49/90 (54%)

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
           R +L+ L ++H +G +H D+K +N+ + + + A + DFG A K     +  Q +   GT 
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTL 251

Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMA 204
              SPE +  + Y A  DIW+ G  + EM+
Sbjct: 252 ETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 4/156 (2%)

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L   D+  Y+  + +G+  + S+  +H D+  +N+L+ +N+  KI DFGLA+    D + 
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230

Query: 165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLI 223
            +    R    +M+PES+ +  Y    D+W+ G  + E+ S G   +   Q +  F   +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290

Query: 224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT 259
           + G     P      + +    ++ C+  DPK R T
Sbjct: 291 KDGTRMRAPENA---TPEIYRIMLACWQGDPKERPT 323

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 20/203 (9%)

Query: 81  YNLLLEYASRGSLADRVKKQNNGRLQESD---VKRYTRSMLKGLRHIHSKGFVHCDIKLQ 137
           Y L+LE+   G L + ++       Q +    ++R    +  GL  +H   F+H D+ L+
Sbjct: 70  YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALR 129

Query: 138 NVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNE-------NEYEA 189
           N  +  +   KI D+GLA       +   + +C   PL +++PE V          +   
Sbjct: 130 NCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTK 188

Query: 190 PCDIWALGCAVVEM--ASGKPAWNHKQDSNVFSLLIR-IGVGDELPNIPGDLSEQGKDFL 246
             +IW+LG  + E+  A+ +P  +   D  V   ++R   +    P +    S++  + +
Sbjct: 189 KSNIWSLGVTMWELFTAADQPYPDL-SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVM 247

Query: 247 IKCFLKDPKRRWTAE---MLLNH 266
             C+L DP+ R TAE    LL +
Sbjct: 248 QFCWL-DPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 61/272 (22%), Positives = 120/272 (44%), Gaps = 25/272 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
           G  +G G FGSV   + ++  S     +     A C       ++E E      +C    
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT------RSEMEDFLSEAVCMKEF 57

Query: 62  --PQIVRCFGDDYSFEKGERFYN--LLLEYASRGSLADRVKKQNNGR----LQESDVKRY 113
             P ++R  G      + E + +  ++L +   G L   +     G     L    + ++
Sbjct: 58  DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
              +  G+ ++ SK F+H D+  +N ++ +N    +ADFGL+KK   +G+  +       
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY-NGDYYRQGRIAKM 176

Query: 174 PL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL 231
           P+ +++ ES+ +  Y    D+W+ G  + E+A+ G+  +   ++S ++  L +   G+ L
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ---GNRL 233

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEML 263
              P D  +     +  C+L +PK R + E L
Sbjct: 234 KQ-PPDCLDGLYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 44/194 (22%)

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD----GERSQSFEC 170
           + +L  L +IHSKGF+H  +K  ++L+  + +  ++      + S      G+R +    
Sbjct: 108 KDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL----RYSVSMIKHGKRQRVVHD 163

Query: 171 RGTPL-----YMSPESVNEN--EYEAPCDIWALGCAVVEMASGKPAWNHKQDS------- 216
                     ++SPE + +N   Y    DI+++G    E+A+G   +     +       
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV 223

Query: 217 --NVFSLL--------------IRIGVGDELPNIPGD------LSEQGKDFLIKCFLKDP 254
              V  LL               R            D       SE    F+  C  +DP
Sbjct: 224 RGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDP 283

Query: 255 KRRWTAEMLLNHPF 268
           + R +A  LLNH F
Sbjct: 284 ESRPSASQLLNHSF 297

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 37/155 (23%), Positives = 75/155 (48%), Gaps = 4/155 (2%)

Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
           Y+  + KG+  + S+  +H D+  +N+L+ +N+  KI DFGLA+    D +  +  + R 
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL 231
              +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G     
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 304 PDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 49/211 (23%), Positives = 99/211 (46%), Gaps = 13/211 (6%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G FG V L             +A+K+  +   S      E + + ++   P++V+ +
Sbjct: 12  IGSGQFGLVWLG-----YWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLS-HPKLVQLY 65

Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G     E+      L+ E+   G L+D ++ Q  G+  +  +      + +G+ ++ S  
Sbjct: 66  G--VCTERSPIC--LVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
            +H D+  +N LV +N   K++DFG+  +   D + + S   +    + SPE  + ++Y 
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMT-RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179

Query: 189 APCDIWALGCAVVEMAS-GKPAWNHKQDSNV 218
           +  D+W+ G  + E+ S GK  + ++ +S V
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 39/223 (17%)

Query: 9   IGHGSFGSVNLAKASKV-------SSEF---PSLMAVKSCADCPPSSVTLKNEKEALDQI 58
           +G G FG V+L +A  +       + EF   P L+AVK       + VT     + L +I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR----ADVTKTARNDFLKEI 68

Query: 59  GIC-----PQIVR----CFGDD------YSFEKGERFYNLLLEYASRGSLADRVKKQNN- 102
            I      P I+R    C  DD         E G+     L ++ S+  +       NN 
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD-----LNQFLSQREIESTFTHANNI 123

Query: 103 GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCD 161
             +  +++      +  G++++ S  FVH D+  +N LV ++   KIADFG+++   S D
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183

Query: 162 GERSQSFECRGTPL-YMSPESVNENEYEAPCDIWALGCAVVEM 203
             R Q       P+ +M+ ES+   ++    D+WA G  + EM
Sbjct: 184 YYRIQGRAV--LPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 57/255 (22%), Positives = 99/255 (38%), Gaps = 55/255 (21%)

Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           YSF+  +  Y  +++Y   G +   + +       E   + Y   +   +  +H  GF+H
Sbjct: 68  YSFQDKDNLY-FVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIH 124

Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKK------------------------------SSCD 161
            DIK  N+L+  +   K+ DFGL                                 S+C 
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184

Query: 162 -GERSQSFECR--------------GTPLYMSPESVNENEYEAPCDIWALGCAVVEMASG 206
            G+R ++ E R              GTP Y++PE +    Y   CD W++G  + EM  G
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244

Query: 207 KPAWNHKQDSNVFSLLIRIGVGDELPNIPGD--LSEQGKDFLIK--CFLKDPKRRWTAEM 262
           +P +     +      +++   +   +IP    LS +  D + K  C  ++   R  A+ 
Sbjct: 245 QPPFLAPTPTET---QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301

Query: 263 LLNHPFVCADDQTGD 277
           +  HPF    D + D
Sbjct: 302 IKAHPFFSEVDFSSD 316

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 32/101 (31%), Positives = 52/101 (51%)

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L   D+ R++  + +G+  + SK  +H D+  +NVL+ D   AKI DFGLA+    D   
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268

Query: 165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
                 R    +M+PES+ +  Y    D+W+ G  + E+ S
Sbjct: 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 43/180 (23%), Positives = 83/180 (46%), Gaps = 7/180 (3%)

Query: 86  EYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND 145
           E+   G L + ++ Q  G+L +  +    + + +G+ ++    F+H D+  +N LV    
Sbjct: 79  EFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG 137

Query: 146 EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
             K++DFG+  +   D E + S   +    +  PE  N ++Y +  D+W+ G  + E+ +
Sbjct: 138 VVKVSDFGMT-RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Query: 206 -GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
            GK  +  K +  V  ++ R   G  L   P   S    + +  C+ + P+ R T   LL
Sbjct: 197 EGKMPFEKKSNYEVVEMISR---GFRLYR-PKLASMTVYEVMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 34/232 (14%)

Query: 2   EWLRGDVIGHGSFGSV-NLAKASKVSSEFPSLMAVKSCADCPPSSVTL------------ 48
           EW    +IG G FG V     AS       ++  +++  +      TL            
Sbjct: 13  EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIA 72

Query: 49  --KNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN-LLLE--YASRGSLADRVKKQNNG 103
             KN    +D +GI P+   C     SF++   +Y  +LLE    +   +  R+K +N  
Sbjct: 73  LWKNIHN-IDHLGI-PKYYGC----GSFKRCRMYYRFILLEKLVENTKEIFKRIKCKN-- 124

Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE 163
              +  +K   + ML  L +IH  G  H DIK +N++V  N+   I D+G+A      G+
Sbjct: 125 ---KKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGK 181

Query: 164 -----RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAW 210
                + Q    RGT  Y   ++ N        D+ +LG  +++ A  K  W
Sbjct: 182 HIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233

Length = 294

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 8/103 (7%)

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L   D+  ++  +  G+  + SK  VH D+  +NVL+ +    KI DFGLA+    D  R
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR----DIMR 291

Query: 165 SQSFECRGT---PL-YMSPESVNENEYEAPCDIWALGCAVVEM 203
             ++  +G+   PL +M+PES+  N Y    D+W+ G  + E+
Sbjct: 292 DSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 52.7 bits (127), Expect = 9e-08
 Identities = 77/296 (26%), Positives = 123/296 (41%), Gaps = 67/296 (22%)

Query: 9   IGHGSFGSVNLAKA-------SKVSSEF-----PSLMAVKSCADCPPSSVTLKNE--KEA 54
           +G G FG V+L +A        K  +E      P L+AVK     P +S   + +  KE 
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLR--PDASDNAREDFLKEV 70

Query: 55  --LDQIGICPQIVR----CFGDDYSFEKGERFYNLLLEYASRGSLADRVKK---QNNGRL 105
             L ++   P I R    C  D            +++EY   G L   ++K   + +G  
Sbjct: 71  KILSRLS-DPNIARLLGVCTVDPPLC--------MIMEYMENGDLNQFLQKHVAETSGLA 121

Query: 106 QESDVKRYTRSMLK--------GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK 157
              + K  + S L         G+R++ S  FVH D+  +N LV  N   KIADFG+++ 
Sbjct: 122 --CNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179

Query: 158 S-SCDGERSQSFECRG-TPL---YMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAW 210
             S D      +  +G  PL   +M+ ESV   ++    D+WA G  + E+ +   +  +
Sbjct: 180 LYSSD-----YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234

Query: 211 NHKQDSNVFSLLIRIGVGDEL-------PNIPGDLSEQGKDFLIKCFLKDPKRRWT 259
            H  D  V          D         PN P D+ E     +++C+ +D + R T
Sbjct: 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYE----LMLECWRRDEEDRPT 286

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 28/100 (28%), Positives = 45/100 (45%), Gaps = 16/100 (16%)

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK----------------KSSCDGE 163
            + ++HSKG +H D+K  N+L+    E  I D+G A                 ++ C   
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 164 RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
            +   +  GTP YM+PE +         DI+ALG  + +M
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 47/183 (25%), Positives = 89/183 (48%), Gaps = 7/183 (3%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ EY S G L + +++    R Q S +    + + +G+ ++ SK F+H D+  +N LV 
Sbjct: 76  IVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD 134

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVE 202
           D    K++DFGL+ +   D E + S   +    +  PE +  +++ +  D+WA G  + E
Sbjct: 135 DQGCVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193

Query: 203 MAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAE 261
           + S GK  +    +S     + ++  G  L   P   SE+    +  C+ +  + R T +
Sbjct: 194 VYSLGKMPYERFNNSET---VEKVSQGLRLYR-PHLASEKVYAIMYSCWHEKAEERPTFQ 249

Query: 262 MLL 264
            LL
Sbjct: 250 QLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 27/104 (25%), Positives = 50/104 (48%), Gaps = 1/104 (0%)

Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE 163
            +   D+    RS+L+ ++++H    +H DIK +N+ +    +  + DFG A     D  
Sbjct: 178 NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDIN 236

Query: 164 RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGK 207
            ++ +   GT    +PE +  + Y    DIW+ G  + EMA+  
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 35/273 (12%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-----IGICPQ 63
           IG+G FG V L++    +    + + VK       ++ + K + E L Q     I   P 
Sbjct: 3   IGNGWFGKVLLSEIYTDTG--VARVVVKELK----ANASSKEQNEFLQQGDPYRILQHPN 56

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNN--GRLQESDVKRYTRSMLKGL 121
           I++C G           Y L+ EY   G L   + ++       Q   ++R    +  G+
Sbjct: 57  ILQCLGQCVEAIP----YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA----KKSSCDGERSQSFECRGTPLYM 177
            H+H   F+H D+ L+N  +  +   K+ D+G+     K+   + E  +    R    ++
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WL 168

Query: 178 SPESVNE-------NEYEAPCDIWALGCAVVEM-ASGKPAWNHKQDSNVFSLLIR-IGVG 228
           +PE V E        E   P ++WALG  + E+  +    ++H  D  V + +I+   V 
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228

Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAE 261
              P +    SE+  + L  C+L  P++R TAE
Sbjct: 229 LFKPQLELPYSERWYEVLQFCWLS-PEKRATAE 260

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 28/97 (28%), Positives = 54/97 (55%)

Query: 109 DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
           D+  Y+  + +G+  + S+  +H D+  +N+L+ +N+  KI DFGLA+    D +  +  
Sbjct: 174 DLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233

Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
           + R    +M+PES+ +  Y    D+W+ G  + E+ S
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 29/269 (10%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQI 64
           +G GSFG V LA     + +FP + A+K               + +E++ L+ I   P  
Sbjct: 38  LGTGSFGRVILATYK--NEDFPPV-AIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFC 93

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V  +G   SF K E +  L+LE+   G     +++  N R        Y   ++    ++
Sbjct: 94  VNLYG---SF-KDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYL 147

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
            S   V+ D+K +N+L+  +   K+ DFG AK        ++++   GTP Y++PE +  
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TRTYTLCGTPEYIAPEILLN 202

Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             +    D W LG  + E+  G P +   +      LLI   + + +   P  L    K 
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPFYANE-----PLLIYQKILEGIIYFPKFLDNNCKH 257

Query: 245 FLIKCFLKDPKRRW-----TAEMLLNHPF 268
            + K    D  +R+      A+ +  HP+
Sbjct: 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 60/261 (22%), Positives = 116/261 (44%), Gaps = 18/261 (6%)

Query: 2   EWLRGDVIGHGSFGSV--NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           E  R  V+G G+FG+V   +      + + P  + + +    P ++V   +E   +  + 
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P +VR  G   S         L+ +    G L D V +  +  +    +  +   + K
Sbjct: 68  -HPHLVRLLGVCLS-----PTIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAK 120

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMS 178
           G+ ++  +  VH D+  +NVLV   +  KI DFGLA+    D E+  + +    P+ +M+
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMA 179

Query: 179 PESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
            E ++  ++    D+W+ G  + E+ +  GKP ++      +  LL +   G+ LP  P 
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKP-YDGIPTREIPDLLEK---GERLPQ-PP 234

Query: 237 DLSEQGKDFLIKCFLKDPKRR 257
             +      ++KC++ D   R
Sbjct: 235 ICTIDVYMVMVKCWMIDADSR 255

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 46/227 (20%)

Query: 9   IGHGSFGSVNLAKAS------------KVSSEFPSLMAVKSC-ADCPPSSVTLKNEK-EA 54
           +G G FG V+L +A              VS   P L+AVK    D        KN + + 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN------KNARNDF 66

Query: 55  LDQIGIC-----PQIVR----CFGDD------YSFEKGERFYNLLLEYASRGSLADRVKK 99
           L +I I      P I+R    C   D         E G+     L ++ SR    +  +K
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD-----LNQFLSRHEPQEAAEK 121

Query: 100 QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-S 158
            +   +  S +      +  G++++ S  FVH D+  +N LV  N   KIADFG+++   
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 159 SCDGERSQSFECRGT-PL-YMSPESVNENEYEAPCDIWALGCAVVEM 203
           S D  R Q    R   P+ +MS ES+   ++    D+WA G  + E+
Sbjct: 182 SGDYYRIQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 15/146 (10%)

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL--- 175
           KG+ ++ SK FVH D+  +N ++ ++   K+ADFGLA +   D E        G  L   
Sbjct: 109 KGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLA-RDIYDKEYYSVHNHTGAKLPVK 167

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPN- 233
           +M+ ES+   ++    D+W+ G  + E M  G P +    D + F + + +  G  L   
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVDSFDITVYLLQGRRLLQP 224

Query: 234 --IPGDLSEQGKDFLIKCFLKDPKRR 257
              P  L E     ++ C+   P+ R
Sbjct: 225 EYCPDPLYE----VMLSCWHPKPEMR 246

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 25/93 (26%), Positives = 48/93 (51%), Gaps = 12/93 (12%)

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK-----KSSCDGERSQSFECRGT 173
            G+ ++H +G +H DI  +N ++ +  + KI D  L++        C G+     E R  
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN----ENR-- 181

Query: 174 PL-YMSPESVNENEYEAPCDIWALGCAVVEMAS 205
           P+ +M+ ES+   EY +  D+W+ G  + E+ +
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 29/101 (28%), Positives = 48/101 (47%)

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L   D+  ++  + KG+  + SK  +H D+  +N+L+      KI DFGLA+    D   
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270

Query: 165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
                 R    +M+PES+    Y    D+W+ G  + E+ S
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 36/128 (28%), Positives = 60/128 (46%), Gaps = 8/128 (6%)

Query: 96  RVKKQNNGRLQ--ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF----DNDEAKI 149
           R  K N   +Q   S VK     +L G+ ++H+   +H D+K  N+LV     +    KI
Sbjct: 94  RASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 153

Query: 150 ADFGLAKKSSCDGERSQSFE-CRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGK 207
           AD G A+  +   +     +    T  Y +PE +     Y    DIWA+GC   E+ + +
Sbjct: 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Query: 208 PAWNHKQD 215
           P ++ +Q+
Sbjct: 214 PIFHCRQE 221

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 8/90 (8%)

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS-SCDGERSQSFECRGTPL--- 175
           G+ ++ S  FVH D+  +N LV +    KI+DFGL++   S D  R QS     + L   
Sbjct: 136 GMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS----KSLLPVR 191

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMAS 205
           +M PE++   ++    DIW+ G  + E+ S
Sbjct: 192 WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 8/104 (7%)

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC--DG 162
           L  + V    R +L  + +IH +G +H DIK +NVLV   ++  + DFG A    C   G
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA----CFARG 312

Query: 163 ERSQSFE--CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMA 204
             S  F     GT    +PE +  + Y    DIW+ G  + E A
Sbjct: 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 35/141 (24%), Positives = 68/141 (48%), Gaps = 9/141 (6%)

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFECRGTPL-YM 177
           G+ ++ S  FVH D+  +N+L+ +    KI+D GL+++  S D  R Q       P+ +M
Sbjct: 136 GMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL--LPIRWM 193

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
            PE++   ++ +  DIW+ G  + E+ S G   +    +  V  ++ +     +L     
Sbjct: 194 PPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK----RQLLPCSE 249

Query: 237 DLSEQGKDFLIKCFLKDPKRR 257
           D   +    + +C+ + P RR
Sbjct: 250 DCPPRMYSLMTECWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 22/88 (25%), Positives = 44/88 (50%), Gaps = 6/88 (6%)

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK--KSSCDGERSQSFECRGTPLYM 177
           G+ ++  +  +H D+  +N+LV ++   K+ADFGLA+  K        +    + T    
Sbjct: 116 GMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT---- 171

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS 205
           +PE+ +   +    D+W+ G  + EM +
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 13/158 (8%)

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L+ +D       +  G+  + S   VH D+  +NVLVFD    KI+D GL ++       
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA---- 176

Query: 165 SQSFECRGTPL----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVF 219
           +  ++  G  L    +MSPE++   ++    DIW+ G  + E+ S G   +    + +V 
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236

Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            ++    V   LP  P D        +++C+ + P RR
Sbjct: 237 EMIRNRQV---LP-CPDDCPAWVYTLMLECWNEFPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 19/198 (9%)

Query: 81  YNLLLEYASRGSLADRVKKQNNGRLQESD---VKRYTRSMLKGLRHIHSKGFVHCDIKLQ 137
           Y L++E+   G L   ++      L   D   ++R    +  GL H+H   F+H D+ L+
Sbjct: 70  YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALR 129

Query: 138 NVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNE-------NEYEA 189
           N L+  +   KI D+GL+     +       +    PL +++PE V+E        +   
Sbjct: 130 NCLLTADLTVKIGDYGLSHNKYKEDYYVTP-DQLWVPLRWIAPELVDEVHGNLLVVDQTK 188

Query: 190 PCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIR---IGVGDELPNIPGDLSEQGKDF 245
             ++W+LG  + E+   G   + H  D  V +  +R   + +      +P  LS++  + 
Sbjct: 189 ESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP--LSDRWYEV 246

Query: 246 LIKCFLKDPKRRWTAEML 263
           +  C+L+ P++R +AE +
Sbjct: 247 MQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 28/73 (38%), Positives = 36/73 (49%), Gaps = 1/73 (1%)

Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           +K   R +L GLR +H  G VH DIK +N+LV  + + KI DFG A    C G       
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG-AAVDMCTGINFNPLY 369

Query: 170 CRGTPLYMSPESV 182
               P Y  PE +
Sbjct: 370 GMLDPRYSPPEEL 382

Length = 507

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.0 bits (111), Expect = 6e-06
 Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 8/128 (6%)

Query: 96  RVKKQNNGRLQ--ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF----DNDEAKI 149
           R  K N   +Q     VK     +L G+ ++H+   +H D+K  N+LV     +    KI
Sbjct: 94  RASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 153

Query: 150 ADFGLAKKSSCDGERSQSFE-CRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGK 207
           AD G A+  +   +     +    T  Y +PE +     Y    DIWA+GC   E+ + +
Sbjct: 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Query: 208 PAWNHKQD 215
           P ++ +Q+
Sbjct: 214 PIFHCRQE 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.7 bits (106), Expect = 9e-06
 Identities = 24/118 (20%), Positives = 39/118 (33%), Gaps = 23/118 (19%)

Query: 45  SVTLKNEKEALD----QIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQ 100
               + E   L     +    P+++       S E     Y LL+E+   G   D V ++
Sbjct: 35  GADREREVAILQLLARKGLPVPKVL------ASGESDGWSY-LLMEWIE-GETLDEVSEE 86

Query: 101 NNGRLQESDVKRYTRSMLKGLRHIHS---KGFVHCDIKLQNVLVFDNDEAKIADFGLA 155
               + E  +          L  +H        H D+   N+LV D     I D+  A
Sbjct: 87  EKEDIAE-QLAEL-------LAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 40/181 (22%), Positives = 84/181 (46%), Gaps = 17/181 (9%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ EY S G+L D   +++ G+L    +      +  G++++   G+VH  +    VLV 
Sbjct: 83  IVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN 141

Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVE 202
            +   KI+ F   ++   +   + +   +   L+ +PE++  + + +  D+W+ G  + E
Sbjct: 142 SDLVCKISGFRRLQEDKSEAIYT-TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWE 200

Query: 203 -MASG-KPAWN-HKQDSNVFSLLIRIGVGDELP---NIPGDLSEQGKDFLIKCFLKDPKR 256
            M+ G +P W+   QD     ++  +  G  LP   N P  L +     ++ C+ K+   
Sbjct: 201 VMSYGERPYWDMSGQD-----VIKAVEDGFRLPAPRNCPNLLHQ----LMLDCWQKERGE 251

Query: 257 R 257
           R
Sbjct: 252 R 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 3/96 (3%)

Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER-SQSFE 169
           +   + +L  + +IH K  +H DIKL+N+ +  + +  + DFG A     + ER +  + 
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA--MPFEKEREAFDYG 327

Query: 170 CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
             GT    SPE +  + Y    DIW+ G  +++M S
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 58/236 (24%), Positives = 100/236 (42%), Gaps = 52/236 (22%)

Query: 9   IGHGSFGSVNLAKASK----VSSEFPS--------LMAVKSCADCPPSSVTLKNEKEALD 56
           +G G FG V+L +        + +FP         L+AVK     P ++   +N+   L 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR--PDANKNARND--FLK 68

Query: 57  QIGIC-----PQIVR-----------CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQ 100
           ++ I      P I+R           C   +Y  E G+     L ++ S   L D+ +  
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEY-MENGD-----LNQFLSSHHLDDKEENG 122

Query: 101 NNGRLQESDVKRYTRSML--------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADF 152
           N+       +   + S L         G++++ S  FVH D+  +N LV +N   KIADF
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADF 182

Query: 153 GLAKK-SSCDGERSQSFECRGT-PL-YMSPESVNENEYEAPCDIWALGCAVVEMAS 205
           G+++   + D  R Q    R   P+ +M+ E +   ++    D+WA G  + E+  
Sbjct: 183 GMSRNLYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 54/203 (26%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC--DGERSQ------SF 168
           +LK L +IH  G+VH  +K  ++L+  + + K+   GL    S    G+R +       +
Sbjct: 110 VLKALDYIHHMGYVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKY 167

Query: 169 ECRGTPLYMSPESVNEN--EYEAPCDIWALGCAVVEMASGK------PAWN---HKQDSN 217
             +  P ++SPE + +N   Y+A  DI+++G    E+A+G       PA      K +  
Sbjct: 168 SVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 226

Query: 218 VFSLL------------------IRIGVGDELP-----NIPGD---------LSEQGKDF 245
           V  LL                     G+G+           G+          S     F
Sbjct: 227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286

Query: 246 LIKCFLKDPKRRWTAEMLLNHPF 268
           + +C  ++P  R +A  LLNH F
Sbjct: 287 VEQCLQRNPDARPSASTLLNHSF 309

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 41/170 (24%), Positives = 68/170 (40%), Gaps = 23/170 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  +G G+FG V  A      S+      +K   +     + + NE+        C   V
Sbjct: 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWM-NERVRRACPNSCADFV 195

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN-----------------NGRLQES 108
             F +  S +K + ++ L+  Y    +LAD ++ +                   G  +E+
Sbjct: 196 YGFLEPVSSKKEDEYW-LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLEREN 254

Query: 109 D-VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLA 155
             ++   R +L  L  +HS G VH D+K QN++ F       KI D G A
Sbjct: 255 KIIQTIMRQILFALDGLHSTGIVHRDVKPQNII-FSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.4 bits (97), Expect = 6e-04
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 15/152 (9%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSC--ADCPPSSVT--LKNEKEALDQIGICPQI 64
           I  G+FG V L +    S     L AVK    AD    ++   ++ E++AL  +   P I
Sbjct: 12  ISRGAFGKVYLGRKKNNSK----LYAVKVVKKADMINKNMVHQVQAERDAL-ALSKSPFI 66

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V  +   YS +     Y L++EY   G +   +     G   E    +Y   +   L ++
Sbjct: 67  VHLY---YSLQSANNVY-LVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYL 120

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK 156
           H  G +H D+K  N+L+ +    K+ DFGL+K
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 39.9 bits (94), Expect = 8e-04
 Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 8/71 (11%)

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +H  G VH D+   N++V D+    I DFGL       G+ S   E +   L++   S+ 
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDDKLYLI-DFGL-------GKYSDEIEDKAVDLHVLKRSLE 157

Query: 184 ENEYEAPCDIW 194
               +   +++
Sbjct: 158 STHPDKAEELF 168

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	366
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.89
PRK10345	210	hypothetical protein; Provisional	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
smart00090	237	RIO RIO-like kinase.	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.59
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
KOG1243	690	consensus Protein kinase [General function predict	99.36
KOG3087	229	consensus Serine/threonine protein kinase [General	99.23
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.22
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.21
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.13
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.12
PRK09902	216	hypothetical protein; Provisional	99.0
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.0
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.98
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.92
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.77
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.73
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.61
PF01636	239	APH: Phosphotransferase enzyme family This family	98.52
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.49
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.38
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.34
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.33
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.23
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.13
PLN02876	822	acyl-CoA dehydrogenase	98.11
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.09
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.06
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.0
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.98
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.97
PRK10593	297	hypothetical protein; Provisional	97.83
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.82
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.8
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.67
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.67
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.66
PRK05231	319	homoserine kinase; Provisional	97.61
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.59
PLN02236	344	choline kinase	97.4
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.3
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.25
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.18
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.08
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.88
PLN02756	418	S-methyl-5-thioribose kinase	96.77
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.74
COG2334	331	Putative homoserine kinase type II (protein kinase	96.73
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.69
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.64
PTZ00384	383	choline kinase; Provisional	96.64
PRK12396	409	5-methylribose kinase; Reviewed	96.46
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.16
PRK06148	1013	hypothetical protein; Provisional	96.06
PRK11768	325	serine/threonine protein kinase; Provisional	95.98
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.8
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.8
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.18
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.13
PHA03111	444	Ser/Thr kinase; Provisional	94.78
KOG2270	520	consensus Serine/threonine protein kinase involved	94.78

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-60  Score=433.45  Aligned_cols=255  Identities=31%  Similarity=0.453  Sum_probs=215.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--------chhhHHHHHHHHHHcCCCCceeEeecceee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--------SSVTLKNEKEALDQIGICPQIVRCFGDDYS   73 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~   73 (366)
                      .|.+.+.||+|+||.|-+|..+.+++    .||+|++.+...        .....++|+++|++|+ |||||++++    
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk----~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d----  243 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGK----QVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKD----  243 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCc----EEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEee----
Confidence            37889999999999999999999877    677776655211        2334679999999999 999999998    


Q ss_pred             ccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC---CceEEE
Q 017746           74 FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN---DEAKIA  150 (366)
Q Consensus        74 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~  150 (366)
                      +.+....+||||||++||+|.+.+-.  ++.+.+..-+.+++||+.||.|||++||+||||||+|||+..+   ..+||+
T Consensus       244 ~f~~~ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  244 FFEVPDSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             eeecCCceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEec
Confidence            44445566799999999999999976  4679999999999999999999999999999999999999766   679999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCC---CccchhhhHHHHHHHHhCCCCCCCCCcch-HHHHHHHhh
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE---APCDIWALGCAVVEMASGKPAWNHKQDSN-VFSLLIRIG  226 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~emltg~~pf~~~~~~~-~~~~~~~~~  226 (366)
                      |||+|+...   +.....+.||||.|.|||++.++.+.   .++|||||||+||-|++|.+||....... ..+++.+..
T Consensus       322 DFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~  398 (475)
T KOG0615|consen  322 DFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR  398 (475)
T ss_pred             ccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence            999999874   34444577999999999999876533   47899999999999999999998775554 555555544


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       227 ~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +. ..|.....+++++++||.+||..||++||+++++|+||||+.
T Consensus       399 y~-f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~  442 (475)
T KOG0615|consen  399 YA-FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD  442 (475)
T ss_pred             cc-ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence            43 344556779999999999999999999999999999999964

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-59  Score=441.98  Aligned_cols=256  Identities=29%  Similarity=0.520  Sum_probs=228.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.++++||+|||+.||.+++..+++.++.|++-|+..........+.+|+++.++|+ |||||++++   .|++ ....
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~---~FED-s~nV   93 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYH---FFED-SNNV   93 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeee---Eeec-CCce
Confidence            5999999999999999999998888866666666666667778899999999999999 999999998   3444 4456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      |||+|+|+.++|..++++  .+.++|.+++.|++||+.||.|||+++|+|||||..|++|+++.+|||+|||+|..+..+
T Consensus        94 YivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            699999999999999985  368999999999999999999999999999999999999999999999999999988644


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .  ....+.||||.|+|||++....++..+||||+||+||.||+|++||+...-.+++..+....+     .+|..+|.+
T Consensus       172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-----~~P~~ls~~  244 (592)
T KOG0575|consen  172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-----SMPSHLSAE  244 (592)
T ss_pred             c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-----ccccccCHH
Confidence            3  344577999999999999999999999999999999999999999998877777777776554     456689999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +++||.++|++||.+|||+++++.|+||..
T Consensus       245 A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  245 AKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            999999999999999999999999999944

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-59  Score=421.65  Aligned_cols=260  Identities=31%  Similarity=0.526  Sum_probs=226.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.++++||+|+||+||+++.+++++.|+.++.-|..............|..+|.+++ ||.||+++   ++|+..+.. 
T Consensus        26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~---ysFQt~~kL-  100 (357)
T KOG0598|consen   26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLI---YSFQTEEKL-  100 (357)
T ss_pred             heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeE---EecccCCeE-
Confidence            5889999999999999999999999877777776665555567788999999999998 99999997   467776655 


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      |||+||+.||+|+..|++  .+.++|..++.|+++|+.||.|||++|||||||||+||||+.+|+++|+|||+++..-..
T Consensus       101 ylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            599999999999999976  368999999999999999999999999999999999999999999999999999975433


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      +.  .+.+.|||+.|||||++.+..|+.++|+||||+++|||++|.+||.+.+.....+.+.+..    .+..|..++.+
T Consensus       179 ~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k----~~~~p~~ls~~  252 (357)
T KOG0598|consen  179 GD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK----LPLPPGYLSEE  252 (357)
T ss_pred             CC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc----CCCCCccCCHH
Confidence            22  3345799999999999999999999999999999999999999999887766666655432    35556679999


Q ss_pred             HHHHHHHhcccCCCCCC----CHHHHHcCCCcccCCC
Q 017746          242 GKDFLIKCFLKDPKRRW----TAEMLLNHPFVCADDQ  274 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~----t~~~ll~hp~~~~~~~  274 (366)
                      ++++|.++|.+||++|.    ++++|.+||||..-.+
T Consensus       253 ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW  289 (357)
T KOG0598|consen  253 ARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW  289 (357)
T ss_pred             HHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence            99999999999999996    6899999999976544

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-59  Score=419.87  Aligned_cols=256  Identities=33%  Similarity=0.528  Sum_probs=220.4

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeec--CCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCA--DCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~--~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      -..+..||+|..|+||+++|+.+++    .+|+|.+.  ..+....++.+|+++++..+ |||||.+||.++.  .+. .
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~----i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~--~~~-~  152 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGK----IYALKVILLNIDPALQKQILRELEILRSCQ-SPYIVGFYGAFYS--NGE-E  152 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCe----EEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEe--CCc-e
Confidence            3567899999999999999998876    77888773  34456678899999999997 9999999997653  222 5


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      +.++||||.+|+|.+++.+.  ++++|..+..++.+|++||.|||+ ++||||||||+|||++..|+|||||||.++.+.
T Consensus       153 isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            77999999999999999864  689999999999999999999996 899999999999999999999999999998864


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCC--CcchHHHHHHHhhcCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHK--QDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ..    ...+++||..|||||.+.++.|+.++||||||+.++||++|+.||...  .....++.+..+ .....|.+|..
T Consensus       231 nS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I-v~~ppP~lP~~  305 (364)
T KOG0581|consen  231 NS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI-VDEPPPRLPEG  305 (364)
T ss_pred             hh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH-hcCCCCCCCcc
Confidence            21    345678999999999999999999999999999999999999999774  233444444443 44567888887


Q ss_pred             -CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          238 -LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       238 -~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                       +|+++++||..||++||.+||++.||++|||+....
T Consensus       306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence             999999999999999999999999999999996543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-58  Score=434.63  Aligned_cols=263  Identities=30%  Similarity=0.526  Sum_probs=236.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|..|+.||.|+|++|++|+.+.++++|+.||.-|.....+........|..+|.+|.+||.|+++|-   +|++.... 
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~---TFQD~~sL-  149 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYF---TFQDEESL-  149 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEE---Eeecccce-
Confidence            68999999999999999999999999888888888887777888999999999999988999999985   67766654 


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      |+|+||+++|+|.++|.+.  |.|++..++.|++||+.||+|||++|||||||||+||||+++|++||+|||.|+.+...
T Consensus       150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            5999999999999999885  68999999999999999999999999999999999999999999999999999976532


Q ss_pred             CCC---------ccc--ccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          162 GER---------SQS--FECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       162 ~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      ...         ...  ..++||..|.+||++.....++.+|||+||||||+|+.|.+||.+.++-.+++.|+...+   
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y---  304 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY---  304 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc---
Confidence            211         112  457899999999999999999999999999999999999999999888888888887765   


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCCCC
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQT  275 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~~~  275 (366)
                        .+|..+++.+.|||+++|..||.+|+|+.+|..||||..-+..
T Consensus       305 --~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~  347 (604)
T KOG0592|consen  305 --EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE  347 (604)
T ss_pred             --cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence              5677889999999999999999999999999999999765443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-58  Score=422.69  Aligned_cols=263  Identities=46%  Similarity=0.778  Sum_probs=223.8

Q ss_pred             CCccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            1 MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         1 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      ++|..++.||+|+||+||++.+.+++.    ..|||....... ....+.+|+.+|.+|+ |||||+++|.....+.  .
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~----~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~--~   89 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGE----LMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSREN--D   89 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCc----ceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccC--e
Confidence            469999999999999999999987644    778888776311 1456899999999999 9999999994322222  4


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-CCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-NDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~  158 (366)
                      .++++|||+++|+|.+++.+..+ .++|..++.+++||++||+|||++|||||||||+|||++. ++.+||+|||+++..
T Consensus        90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            78899999999999999998543 8999999999999999999999999999999999999999 799999999999876


Q ss_pred             CCCCC-CcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          159 SCDGE-RSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       159 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ..... ........||+.|||||++..+ ....++|||||||++.||+||++||...  .+....+.+++.....|.+|.
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P~ip~  246 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLPEIPD  246 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCCCCCc
Confidence            53111 1223456899999999999863 3345999999999999999999999874  345566777787778899999


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                      .+|.++++||.+||.+||++|||+++||+|||.....
T Consensus       247 ~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  247 SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            9999999999999999999999999999999995543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-57  Score=397.85  Aligned_cols=256  Identities=28%  Similarity=0.498  Sum_probs=221.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.++||.|+||.|.+++++.++..++.++.-|.-.......+...+|..+|+.+. ||.++++++.   +.+ ...+
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t---~~d-~~~l  119 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGT---FKD-NSNL  119 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEe---ecc-CCeE
Confidence            5889999999999999999999987755555444433223345667888999999999 9999999983   333 4456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +|||||++||.|+.++++.  +++++..++.|++||+.||+|||+++|++|||||+||||+.+|.+||+|||+|+...  
T Consensus       120 ymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--  195 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--  195 (355)
T ss_pred             EEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence            7999999999999999873  689999999999999999999999999999999999999999999999999999873  


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                         ..+.+.||||.|+|||++..++|+.++|+|||||++|||+.|++||...+...+++.|.....     .+|..++.+
T Consensus       196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-----~fP~~fs~~  267 (355)
T KOG0616|consen  196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-----KFPSYFSSD  267 (355)
T ss_pred             ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-----cCCcccCHH
Confidence               225678999999999999999999999999999999999999999999888777777665433     567889999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHcCCCcccCCC
Q 017746          242 GKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCADDQ  274 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~~~  274 (366)
                      ++|||.++|++|-.+|.     ...+|.+||||+.-.+
T Consensus       268 ~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W  305 (355)
T KOG0616|consen  268 AKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW  305 (355)
T ss_pred             HHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence            99999999999999994     6789999999975444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-56  Score=406.70  Aligned_cols=256  Identities=29%  Similarity=0.539  Sum_probs=220.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||+||+|+++.++.    .||||.+....   ...+.+..|+.+|+.++ |||||++++    +....
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~----~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d----~~~~~   81 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGT----EVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLD----CIEDD   81 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCc----eEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEE----EEecC
Confidence            68899999999999999999998764    78888877642   24566889999999999 999999997    34445


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC------CceEEEec
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN------DEAKIADF  152 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~------~~vkl~DF  152 (366)
                      .+++||||||.||||.+||+++  +.++|.+++.++.||+.||++||+++||||||||+||||+..      -.+||+||
T Consensus        82 ~~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   82 DFIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             CeEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            5788999999999999999874  579999999999999999999999999999999999999865      35899999


Q ss_pred             CCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          153 GLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       153 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      |+|+.+..   .....+.||+|.|||||+++.++|+.++|+||+|+|+|+|++|++||+..+..+.+..+.+..  ...|
T Consensus       160 GfAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~--~~~~  234 (429)
T KOG0595|consen  160 GFARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN--EIVP  234 (429)
T ss_pred             chhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc--cccC
Confidence            99999853   333446789999999999999999999999999999999999999999888777666444322  3445


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                      .++..++....+++...|+.+|.+|.+..+-..|+++....
T Consensus       235 ~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  235 VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            66677888889999999999999999999999999986544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.9e-56  Score=418.41  Aligned_cols=265  Identities=27%  Similarity=0.507  Sum_probs=226.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|..+..||+||||.||+|+.+.+|..++.+++-|..............|..+|.... +|+||++|   |+|++.+ ++
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLy---YsFQD~~-~L  216 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLY---YSFQDKE-YL  216 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEE---EEecCCC-ee
Confidence            6889999999999999999999998865555555554445567788999999999966 89999998   4666655 55


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ||||||++|||+..+|.+.  +.|++..++.|+++++.||+.||+.|+|||||||+|+||+..|++||+||||+..+.+.
T Consensus       217 YLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            6999999999999999763  68999999999999999999999999999999999999999999999999999632210


Q ss_pred             ---------------------CCCc------------------------ccccccCCCCCCCccccCCcCCCCccchhhh
Q 017746          162 ---------------------GERS------------------------QSFECRGTPLYMSPESVNENEYEAPCDIWAL  196 (366)
Q Consensus       162 ---------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  196 (366)
                                           ....                        ..+..+|||.|||||++.+..|+..+|+|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 0000                        0124579999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCCCcccCC
Q 017746          197 GCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT---AEMLLNHPFVCADD  273 (366)
Q Consensus       197 G~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t---~~~ll~hp~~~~~~  273 (366)
                      |||+||||.|.+||.+.++.+++..|.........|.- ..++++++|||.+||. ||++|..   ++||..||||+.-.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~-~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE-VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc-CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence            99999999999999999999999998887655555543 3478999999999999 9999985   99999999998766


Q ss_pred             CC
Q 017746          274 QT  275 (366)
Q Consensus       274 ~~  275 (366)
                      +.
T Consensus       453 W~  454 (550)
T KOG0605|consen  453 WD  454 (550)
T ss_pred             cc
Confidence            55

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-54  Score=409.22  Aligned_cols=253  Identities=28%  Similarity=0.488  Sum_probs=216.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----C--CchhhHHHHHHHHHHcCCCCceeEeecceeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----P--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~   75 (366)
                      +|.+++.||+|+||+|++|.+..++.    ++|+|.....    .  .....+.+|+.+++.+..||||++++.+.    
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~----~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~----   89 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGE----KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF----   89 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCC----eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE----
Confidence            58999999999999999999988774    7777755542    1  23556778999999999899999999843    


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC-CceEEEecCC
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN-DEAKIADFGL  154 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~  154 (366)
                      .....+++|||||.||+|++++.+  .+++.|..++.+++||++|++|||++||+||||||+|||++.+ +++||+|||+
T Consensus        90 ~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   90 ATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             ecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            233447899999999999999987  4689999999999999999999999999999999999999999 9999999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCCcC-CC-CccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNENE-YE-APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      +....  .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+.......+.+.     ..
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-----~~  240 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-----EF  240 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-----Cc
Confidence            99873  2233345679999999999999988 87 5899999999999999999999986655555543332     23


Q ss_pred             CCCCCC-CHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          233 NIPGDL-SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       233 ~~~~~~-s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+|..+ |.++++|+.+||..||.+|+++.++++||||+.
T Consensus       241 ~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  241 KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            567778 999999999999999999999999999999976

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-54  Score=381.98  Aligned_cols=256  Identities=27%  Similarity=0.497  Sum_probs=216.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|..+.++|+|+||+||+++++++|+    .||+|++..++.   ...-..+|+++|++|+ |||+|.+++++    ...
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~Tgq----IVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVF----rrk   73 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQ----IVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVF----RRK   73 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCccc----EEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHH----Hhc
Confidence            58899999999999999999999876    899999887544   2345788999999999 99999999843    335


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..++||+|||+. ++.+.+++..+ .+++..++.|+.|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+
T Consensus        74 rklhLVFE~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   74 RKLHLVFEYCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             ceeEEEeeecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhh
Confidence            567799999988 88888887554 4899999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh-----------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG-----------  226 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~-----------  226 (366)
                      ..++..  ...++.|.+|.|||.+.+ .+|+.++||||+||++.||++|.+.|.+..+.++...|.+..           
T Consensus       152 ~~pgd~--YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF  229 (396)
T KOG0593|consen  152 SAPGDN--YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF  229 (396)
T ss_pred             cCCcch--hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence            643333  345689999999999988 789999999999999999999999999999888877776531           


Q ss_pred             ------cCCCCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          227 ------VGDELPNIP---------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       227 ------~~~~~~~~~---------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                            .+..+|...         ..++.-+.||+.+||..||.+|++.+|++.||||.
T Consensus       230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence                  111111111         13567789999999999999999999999999993

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-54  Score=414.38  Aligned_cols=255  Identities=28%  Similarity=0.495  Sum_probs=220.1

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      |.+|+.||.|+-|.|-+|++..+|+..+.|++.|.....+.....+++|+-+|+.|. ||||+++|++    -++...+|
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydV----we~~~~ly   88 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDV----WENKQHLY   88 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeee----eccCceEE
Confidence            899999999999999999999999866666666655445566778999999999999 9999999984    34456677


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +|+||++||.|++++.++  |++++.++..+++||+.|+.|||..+|+||||||+|+||+..+++||+|||+|..-..+ 
T Consensus        89 lvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-  165 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-  165 (786)
T ss_pred             EEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence            999999999999999874  68999999999999999999999999999999999999999999999999999865322 


Q ss_pred             CCcccccccCCCCCCCccccCCcCCC-CccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYE-APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                        ....+.||+|.|.|||++.+.+|+ .++||||+|||||.||||++||++.   ++...+.+...+..  .+|..++.+
T Consensus       166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLlKV~~G~f--~MPs~Is~e  238 (786)
T KOG0588|consen  166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLLKVQRGVF--EMPSNISSE  238 (786)
T ss_pred             --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHHHHHcCcc--cCCCcCCHH
Confidence              223456899999999999999997 4899999999999999999999854   44445555443332  567889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +++||.+||..||++|+|.+||++|||+...
T Consensus       239 aQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  239 AQDLLRRMLDVDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             HHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence            9999999999999999999999999999543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-54  Score=414.50  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=226.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|...++||+|+||+|++|..+.+++.|+.|++-|.........+....|..|+..+..||.+++++.   +|+..+ .+
T Consensus       369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~---~fQT~~-~l  444 (694)
T KOG0694|consen  369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS---CFQTKE-HL  444 (694)
T ss_pred             ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc---ccccCC-eE
Confidence            58889999999999999999999988666666555555566788899999999999999999999998   455544 55


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+.||++..++.   .+.|++..++.|+++|+.||.|||++||||||||.+|||||.+|++||+|||+++.--..
T Consensus       445 ~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            69999999999555543   357999999999999999999999999999999999999999999999999999975422


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                        ...+.+.||||.|||||++.+..|+.++|+|||||+||||+.|..||.+.+.++.+..|....     +.+|..+|.+
T Consensus       522 --g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~-----~~yP~~ls~e  594 (694)
T KOG0694|consen  522 --GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE-----VRYPRFLSKE  594 (694)
T ss_pred             --CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-----CCCCCcccHH
Confidence              234567799999999999999999999999999999999999999999999888888877643     4678889999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHcCCCcccCCC
Q 017746          242 GKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCADDQ  274 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~~~  274 (366)
                      +.++++++|++||++|..     +++|..||||+.-++
T Consensus       595 a~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w  632 (694)
T KOG0694|consen  595 AIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW  632 (694)
T ss_pred             HHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence            999999999999999985     589999999976554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-55  Score=380.67  Aligned_cols=246  Identities=29%  Similarity=0.494  Sum_probs=209.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.++||+|+||+||++.+..++.    .+|.|.+..   .......+..|+.+|++|+ |||||++++.  .|.++.
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~----l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~--~f~~~~   92 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGK----LVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQYYAH--SFIEDN   92 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcc----hhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHHHHH--hhhccc
Confidence            48899999999999999999988865    667776653   3335567889999999999 9999999983  456666


Q ss_pred             eEEEEEeecCCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--cEecCCCCCcEEeccCCceEEEec
Q 017746           79 RFYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSMLKGLRHIHS--KG--FVHCDIKLQNVLVFDNDEAKIADF  152 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~--~g--ivHrDlkp~NILl~~~~~vkl~DF  152 (366)
                      ..+++|||||.+|||...|+.  +....++|.+++.++.|++.||.+||.  ..  |+||||||.||+|+.+|.|||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            668899999999999999974  234569999999999999999999999  44  999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          153 GLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       153 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      |+++.+...  .......+|||.||+||.+.+.+|+.++|||||||++|||+.-++||.+.   +..+...++..+ ..|
T Consensus       173 GL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qg-d~~  246 (375)
T KOG0591|consen  173 GLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQG-DYP  246 (375)
T ss_pred             hhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcC-CCC
Confidence            999998633  23334568999999999999999999999999999999999999999987   344444444444 556


Q ss_pred             CCC-CCCCHHHHHHHHHhcccCCCCCCCH
Q 017746          233 NIP-GDLSEQGKDFLIKCFLKDPKRRWTA  260 (366)
Q Consensus       233 ~~~-~~~s~~~~~ll~~cL~~dp~~R~t~  260 (366)
                      .+| ...|.++..+|..|+..||+.||+.
T Consensus       247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  247 PLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            667 6789999999999999999999985

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-53  Score=384.43  Aligned_cols=266  Identities=23%  Similarity=0.388  Sum_probs=225.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|+.++.||+|.-|+||++..+.++..++.||+.|..........+.+.|.+||..+. ||.++++|..    .+.+.++
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~----fet~~~~  152 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYAS----FETDKYS  152 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhhe----eecccee
Confidence            3678899999999999999999988655555555544444556678889999999999 9999999984    2346688


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      |++||||+||+|..+++++.++.|++..++.|+++|+.||+|||-+|||+|||||+||||.++|++.|+||.++......
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999988532110


Q ss_pred             ---------------------------------CC---------------------CcccccccCCCCCCCccccCCcCC
Q 017746          162 ---------------------------------GE---------------------RSQSFECRGTPLYMSPESVNENEY  187 (366)
Q Consensus       162 ---------------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  187 (366)
                                                       ..                     ...+..++||-.|+|||+++++..
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                             00                     011234679999999999999999


Q ss_pred             CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHH
Q 017746          188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT----AEML  263 (366)
Q Consensus       188 ~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t----~~~l  263 (366)
                      +.++|+|+|||++|||++|..||.+.+..+++..+....  ..+|..+ .++.+++|||+++|.+||++|..    +.||
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~--l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP--LKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC--CcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            999999999999999999999999999888877766533  2344443 57899999999999999999998    9999


Q ss_pred             HcCCCcccCCCC
Q 017746          264 LNHPFVCADDQT  275 (366)
Q Consensus       264 l~hp~~~~~~~~  275 (366)
                      .+||||..-.+.
T Consensus       390 K~HpFF~gVnWa  401 (459)
T KOG0610|consen  390 KRHPFFEGVNWA  401 (459)
T ss_pred             hcCccccCCChh
Confidence            999999766554

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-53  Score=399.42  Aligned_cols=253  Identities=30%  Similarity=0.508  Sum_probs=219.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      .|..-..||+|+.|.||.|+...+++    .||+|.+... ....+.+.+|+.+|+..+ |+|||+++..+.  ..  ..
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~----~VaiK~m~l~~Q~~keLilnEi~Vm~~~~-H~NiVnfl~Syl--v~--de  344 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQ----EVAIKRMDLRKQPKKELLLNEILVMRDLH-HPNIVNFLDSYL--VG--DE  344 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCc----eEEEEEEEeccCCchhhhHHHHHHHHhcc-chHHHHHHHHhc--cc--ce
Confidence            46778899999999999999988765    5899988864 446677899999999999 999999998542  22  34


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||++||+|.|.+.+   ..++|.+++.+.++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+..
T Consensus       345 LWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  345 LWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             eEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            6699999999999999976   3599999999999999999999999999999999999999999999999999998864


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ...  ...+.+|||+|||||++....|++++||||||++++||+-|++||...++...+..+...+..  .-..+..+|.
T Consensus       422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P--~lk~~~klS~  497 (550)
T KOG0578|consen  422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--KLKNPEKLSP  497 (550)
T ss_pred             ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCC--CcCCccccCH
Confidence            433  445678999999999999999999999999999999999999999987666555555544332  2245678999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      +++|||.+||+.|+++|+++.+||.||||+
T Consensus       498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  498 ELKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             HHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence            999999999999999999999999999994

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-53  Score=392.73  Aligned_cols=262  Identities=28%  Similarity=0.474  Sum_probs=219.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||.|.||.||+|+.+.++.    .||+|++...-.  ....-.+|++.|++|+.||||+++++.   +.+...
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~----~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Ev---i~d~~~   83 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGE----LVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEV---IRDNDR   83 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCc----eeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHH---hhccCc
Confidence            68999999999999999999988876    588888776433  233457899999999999999999984   334444


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++|||||+. +|+++++.+ +..|++..++.|+.||++||+|+|.+|+.|||+||+|||+..+..+||+|||+|+...
T Consensus        84 ~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   84 ILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence            78899999987 999999985 7789999999999999999999999999999999999999988999999999999884


Q ss_pred             CCCCCcccccccCCCCCCCcccc-CCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh------------
Q 017746          160 CDGERSQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG------------  226 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~------------  226 (366)
                         .......++.|.+|.|||++ +..-|+.++||||+|||++|+.+-++.|.+..+.++...|-.+.            
T Consensus       162 ---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  162 ---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence               44455677899999999987 55679999999999999999999999999887666555444321            


Q ss_pred             -----cCCCCCCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCCCC
Q 017746          227 -----VGDELPNIP--------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQT  275 (366)
Q Consensus       227 -----~~~~~~~~~--------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~~~  275 (366)
                           ....+|..+        ..++.++.++|.+||..||++|||+.|+++||||+.....
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                 112222222        2378999999999999999999999999999999765443

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-54  Score=368.44  Aligned_cols=258  Identities=25%  Similarity=0.442  Sum_probs=220.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeE-EeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMA-VKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~a-vK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+.+.||+|.|+.|++..+..++++++.+++ +|++  +....+.+++|+.+.+.|+ ||||+++..    ....+.+
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~--~~~~~e~l~rEarIC~~Lq-HP~IvrL~~----ti~~~~~   84 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQ-HPNIVRLHD----SIQEESF   84 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh--ccccHHHHHHHHHHHHhcC-CCcEeehhh----hhcccce
Confidence            477889999999999999999988875544422 2222  2347788999999999999 999999987    3445667


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC---CceEEEecCCccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN---DEAKIADFGLAKK  157 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a~~  157 (366)
                      .|||+|++.|++|..-|-++  .-++|..+..+++||+.||.|||.+||||||+||+|+|+-..   --+||+|||+|..
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             eEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            78999999999998777653  358999999999999999999999999999999999999543   3599999999999


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      +.   ........+|||.|||||+++..+|+.++|||+.|||||-|+.|++||.+.+....++.|....+....|. .+.
T Consensus       163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~-w~~  238 (355)
T KOG0033|consen  163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE-WDT  238 (355)
T ss_pred             eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc-cCc
Confidence            86   22334566899999999999999999999999999999999999999999888888888887776555444 457


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +++++++|+.+||..||.+|+|+.|.|+|||++..
T Consensus       239 is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  239 VTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             CCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            99999999999999999999999999999999653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.8e-52  Score=359.98  Aligned_cols=258  Identities=26%  Similarity=0.364  Sum_probs=219.1

Q ss_pred             CCccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            1 MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         1 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      .+|...+.||+|.||+||+|++..+++    .||+|++...+.   ......+|++.|+.++ |+||+.+++++-   . 
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~----~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F~---~-   72 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGK----RVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVFP---H-   72 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCc----EEEEEEeeccccccCccHHHHHHHHHHHHcc-Ccchhhhhhhcc---C-
Confidence            379999999999999999999998876    789998876433   3677899999999999 999999998432   2 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+.||+||++. +|+..|+. ..-.++..+++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.
T Consensus        73 ~~~l~lVfEfm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   73 KSNLSLVFEFMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARF  150 (318)
T ss_pred             CCceEEEEEeccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhc
Confidence            3345699999998 99999987 456799999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC---
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN---  233 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---  233 (366)
                      +.........  .+-|.+|.|||.+.| ..|+..+||||.|||+.||+.|.+-|.+.++-++...+.+.--......   
T Consensus       151 f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  151 FGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             cCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence            8654443332  268999999998876 5799999999999999999999999999999888887776431111111   


Q ss_pred             --------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          234 --------------------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       234 --------------------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                          +....+.++.||+.+||..||.+|+++.|+++|+||..
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence                                11236788899999999999999999999999999965

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.6e-53  Score=396.10  Aligned_cols=251  Identities=30%  Similarity=0.474  Sum_probs=216.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||+||+|+.+.+.+    .||+|.+.+...   ....+.+|+++++.|+ ||||+.+++    +.+..
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~----~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~e----sfEt~   73 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQ----VVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLE----SFETS   73 (808)
T ss_pred             chhHHHHhcCCccceeeeccccccee----EEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHH----hhccc
Confidence            68999999999999999999988765    777887766322   3456899999999999 999999997    44455


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++|.|||.| +|+.++..  .+.++|+.++.++.+++.||.|||+++|+|||+||.|||+..+|.+|+||||+|+.+
T Consensus        74 ~~~~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   74 AHLWVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             ceEEEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence            667799999988 99999976  467999999999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ..+  ........|||.|||||++.+++|+..+|+||||||+|||++|++||......   +.+..+..  +.+..|..+
T Consensus       151 ~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---~Lv~~I~~--d~v~~p~~~  223 (808)
T KOG0597|consen  151 STN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---QLVKSILK--DPVKPPSTA  223 (808)
T ss_pred             ccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---HHHHHHhc--CCCCCcccc
Confidence            642  33344567999999999999999999999999999999999999999876443   33333333  234556789


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +..+..|++.+|.+||.+|.+..+|+.|||++.
T Consensus       224 S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  224 SSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             cHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence            999999999999999999999999999999854

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-51  Score=384.62  Aligned_cols=260  Identities=26%  Similarity=0.404  Sum_probs=219.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      .|..++.||+|.||.||+|++..+++    .||+|++....   .......+|+.+|++|. ||||+++.+...  +...
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgk----ivALKKvr~d~~~~~~~~t~~REI~ILr~l~-HpNIikL~eivt--~~~~  190 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGK----IVALKKVRFDNEKEGFPITAIREIKILRRLD-HPNIIKLEEIVT--SKLS  190 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCc----EEEEEEeecccCCCcchHHHHHHHHHHHhcC-CCcccceeeEEE--ecCC
Confidence            47889999999999999999998876    88999887633   34567899999999999 999999999543  2334


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+|||+|||+. ||.-++.. .+-.|++.+++.|+.||+.||+|||.+||+|||||.+||||+.+|.+||+|||||+.+
T Consensus       191 ~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  191 GSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             ceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence            567899999998 99999976 5667999999999999999999999999999999999999999999999999999977


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC-----CCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-----ELP  232 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~-----~~~  232 (366)
                      ....... ....+-|.+|.|||++.+. .|+.++|+||.||||.||++|++.|.+.++.++...|.+.--..     ...
T Consensus       269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            5443332 3445689999999998774 69999999999999999999999999999988888887642110     000


Q ss_pred             CCC-------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          233 NIP-------------------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       233 ~~~-------------------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+|                   ..+++.+.+|+..+|..||.+|.|+.++|.|+||..
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            111                   137889999999999999999999999999999943

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-52  Score=358.55  Aligned_cols=256  Identities=27%  Similarity=0.440  Sum_probs=224.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|-||.||+|+.+.++-..+.+|+.|.-.........+.+|+++-..|+ ||||+++||++.    +....
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fh----d~~ri   97 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFH----DSKRI   97 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhhee----cccee
Confidence            5889999999999999999999887644444444443333345677899999999999 999999999543    34556


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ||++||..+|+|+..+.....+++++..+..|+.|++.||.|||..+||||||||+|+|++..|.+||+|||.+...+  
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            799999999999999987677789999999999999999999999999999999999999999999999999987753  


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                        .....+.|||..|.+||.+.+..++..+|+|++|++.||++.|.+||......+++..|.+...     .+|..++.+
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-----~~p~~is~~  248 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-----KFPSTISGG  248 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-----cCCcccChh
Confidence              3334567999999999999999999999999999999999999999999888888888877654     456789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +.|+|.+||.++|.+|.+..|++.|||+..
T Consensus       249 a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  249 AADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            999999999999999999999999999854

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=383.97  Aligned_cols=260  Identities=28%  Similarity=0.433  Sum_probs=225.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .|.+++.||+|.||.||+++.+.+++.++.+++.|...........+.+|+++|+++.+|||||.+++.    .+....+
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~----~e~~~~~  111 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA----FEDPDSV  111 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE----EEcCCeE
Confidence            488999999999999999999999886666666665554444567899999999999999999999983    3334467


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC----CceEEEecCCccc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN----DEAKIADFGLAKK  157 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~----~~vkl~DFG~a~~  157 (366)
                      ++|||+|.||+|++.|.+.   .++|..+..++.||+.|++|||+.||+||||||+|+|+...    +.+|++|||+|..
T Consensus       112 ~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            7999999999999999874   39999999999999999999999999999999999999643    4799999999998


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+.......+.+.......+.+ ..
T Consensus       189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w-~~  264 (382)
T KOG0032|consen  189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW-DD  264 (382)
T ss_pred             ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc-cc
Confidence            753   33445678999999999999999999999999999999999999999999887777777666554444443 45


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ++..+++||.+||..||.+|+|+.++|.|||+...
T Consensus       265 is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  265 ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            79999999999999999999999999999999654

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-50  Score=381.79  Aligned_cols=248  Identities=27%  Similarity=0.472  Sum_probs=205.7

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      ++||+|+||.||+|+++.+++    .+|+|.+..    .......+.+|+.++++++ ||||+++++.   +.. ...++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~---~~~-~~~~~   71 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGK----YYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYS---FQT-HDRLC   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEE---EEc-CCEEE
Confidence            579999999999999987765    677776653    1223456778999999998 9999999873   223 44677


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||+++|+|.+++.+  .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        72 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          72 FVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence            99999999999999976  3579999999999999999999999999999999999999999999999999997642211


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..     ....++..++.++
T Consensus       150 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-----~~~~~p~~~~~~~  222 (323)
T cd05571         150 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFPRTLSPEA  222 (323)
T ss_pred             --CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCHHH
Confidence              122345799999999999999999999999999999999999999987654444333322     1235567789999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHHHHcCCCcccC
Q 017746          243 KDFLIKCFLKDPKRRW-----TAEMLLNHPFVCAD  272 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~  272 (366)
                      .+||.+||.+||++||     ++.++++||||...
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             HHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999999999     89999999999653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2e-50  Score=381.06  Aligned_cols=249  Identities=25%  Similarity=0.441  Sum_probs=210.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+++|.+...    ......+.+|+.++++++ ||||+++++.+   .. 
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~---~~-   89 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGE----YYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSF---QD-   89 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEE---Ec-
Confidence            58889999999999999999987765    6777766531    233456889999999998 99999999843   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            34567999999999999999763  5789999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....     ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..     ....+|..
T Consensus       168 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-----~~~~~p~~  237 (329)
T PTZ00263        168 VPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-----GRLKFPNW  237 (329)
T ss_pred             cCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc-----CCcCCCCC
Confidence            6321     2234799999999999999999999999999999999999999987655444443332     12345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~  271 (366)
                      ++..+++||.+||..||++|++     +++|++||||..
T Consensus       238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            8999999999999999999997     799999999965

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.7e-50  Score=355.85  Aligned_cols=260  Identities=26%  Similarity=0.368  Sum_probs=216.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---hhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|..+..|++|+||.||+|+++.++.    .||+|++......   ...-.+|+.+|.+++ |||||.+..+...  .+-
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~e----IVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG--~~~  149 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDE----IVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVVG--SNM  149 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcce----eEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEec--ccc
Confidence            47889999999999999999998875    8999988764332   345688999999999 9999999885443  233


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+|+|||||+. ||..++... ..+|...+++.++.|+++||+|||.+.|+||||||+|+|+...|.+||+|||+|+.+
T Consensus       150 d~iy~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  150 DKIYIVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             ceeeeeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence            347799999998 999999874 468999999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC--------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD--------  229 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~--------  229 (366)
                      ......  ....+-|.+|.|||++.+ ..|+.++|+||+|||+.||+++++-|.+....++...|.+..-..        
T Consensus       228 gsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  228 GSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             cCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            654332  334567999999999877 569999999999999999999999999998777776666532000        


Q ss_pred             ---------CCC---------CCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          230 ---------ELP---------NIPGD-LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       230 ---------~~~---------~~~~~-~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                               .++         .++.. +++.+.+|+..+|..||.+|.|++|.|+|.||...
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                     000         11111 66899999999999999999999999999999553

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-52  Score=380.13  Aligned_cols=253  Identities=31%  Similarity=0.516  Sum_probs=219.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      .|...++||+|+||.||+|.+..+++    .||+|.+...  ......+++|+.+|.++. ++||.++||.++.    +.
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k----~vAiKii~Le~~~deIediqqei~~Ls~~~-~~~it~yygsyl~----g~   84 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKK----VVAIKIIDLEEAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLK----GT   84 (467)
T ss_pred             ccccchhccccccceeeeeeeccccc----eEEEEEechhhcchhhHHHHHHHHHHHhcC-cchHHhhhhheee----cc
Confidence            58888999999999999999988765    7899988763  335578999999999999 8999999995442    34


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+.++||||.||++.+.++.  +..+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+-.+.
T Consensus        85 ~LwiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             cHHHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee
Confidence            46699999999999999964  4456999999999999999999999999999999999999999999999999998876


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      .....  ..+++|||.|||||+++...|+.++||||||++.+||++|.+||....+...+..|    -...+|.+.+.++
T Consensus       163 ~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----pk~~PP~L~~~~S  236 (467)
T KOG0201|consen  163 NTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----PKSAPPRLDGDFS  236 (467)
T ss_pred             chhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----cCCCCCccccccC
Confidence            43333  36779999999999999999999999999999999999999999877664332222    2245677778899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +.+++||..||.+||+.||+|.+||+|+|++.
T Consensus       237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  237 PPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            99999999999999999999999999999965

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=373.71  Aligned_cols=246  Identities=26%  Similarity=0.428  Sum_probs=208.1

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---hhhHHHHHHHHHHcCCCCceeEeecceeeccCCee-E
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER-F   80 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~-~   80 (366)
                      ..+.||+|+||+||+|......     .+|+|.+......   ...+.+|+.+|.+++ |||||+++|.+    .+.. .
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~-----~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~----~~~~~~  114 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTD-----VVAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYGAC----TSPPGS  114 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCce-----eEEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEEEE----cCCCCc
Confidence            4567999999999999987642     3899988763322   458999999999999 99999999943    2232 5


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCCCcEEeccCC-ceEEEecCCcccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG-FVHCDIKLQNVLVFDND-EAKIADFGLAKKS  158 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NILl~~~~-~vkl~DFG~a~~~  158 (366)
                      +++||||+++|+|.+++.+.....++...+..++.||++||+|||+++ ||||||||+|||++.++ ++||+|||+++..
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            679999999999999998744568999999999999999999999999 99999999999999998 9999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccC--CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVN--ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ....  .......||+.|||||++.  ...|+.++||||||+++|||+||+.||.+.....   ...........|.+|.
T Consensus       195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~~v~~~~~Rp~~p~  269 (362)
T KOG0192|consen  195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VASAVVVGGLRPPIPK  269 (362)
T ss_pred             cccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhcCCCCCCCc
Confidence            4221  2222257999999999999  5699999999999999999999999998876633   3344444566778888


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+++.+..++.+||..||++||++.+++.
T Consensus       270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  270 ECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            89999999999999999999999999975

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-50  Score=367.54  Aligned_cols=258  Identities=27%  Similarity=0.459  Sum_probs=214.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC--CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~--~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.++||.|..++||+|+....+    ..||+|++..  ++.....+.+|+..|+.++ ||||++++..+   .. +.
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~----e~VAIK~inLEkc~~~ld~l~kE~~~msl~~-HPNIv~~~~sF---vv-~~   97 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTN----EVVAIKIINLEKCNNDLDALRKEVQTMSLID-HPNIVTYHCSF---VV-DS   97 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccC----CEEEEEEeehhhhhhhHHHHHHHHHHhhhcC-CCCcceEEEEE---Ee-cc
Confidence            5889999999999999999998765    4899999876  4455788999999999999 99999998743   32 34


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||.||.+|++.++++......++|..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            56799999999999999988655569999999999999999999999999999999999999999999999999987765


Q ss_pred             CCCCCcc-c-ccccCCCCCCCccccCC--cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC---
Q 017746          160 CDGERSQ-S-FECRGTPLYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP---  232 (366)
Q Consensus       160 ~~~~~~~-~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~---  232 (366)
                      ..+.... . .+.+|||.|||||++..  ..|+.++||||||++..||++|..||....+...   +..... ..+|   
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv---Ll~tLq-n~pp~~~  253 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV---LLLTLQ-NDPPTLL  253 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH---HHHHhc-CCCCCcc
Confidence            5443222 2 45689999999999644  5699999999999999999999999987755432   222221 1222   


Q ss_pred             --CCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          233 --NIP----GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       233 --~~~----~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                        .++    ..++..++.++..||.+||++|||+++|++|+||+..
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~  299 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA  299 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence              111    2357788999999999999999999999999999654

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-50  Score=366.00  Aligned_cols=260  Identities=29%  Similarity=0.425  Sum_probs=217.1

Q ss_pred             CCccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC-ee
Q 017746            1 MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG-ER   79 (366)
Q Consensus         1 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~-~~   79 (366)
                      |+|.-.+++|+|+||.||+|+..+++    ..+|+|+...   +...-.+|.++|+.+. |||||++.-+++.-.+. +-
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~----~~vAIKKv~~---d~r~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETE----EEVAIKKVLQ---DKRYKNRELQIMRKLD-HPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCC----ceeEEEEecC---CCCcCcHHHHHHHhcC-CcCeeeEEEEEEecCCCchh
Confidence            46888999999999999999998874    4899998874   3345678999999998 99999999766544444 45


Q ss_pred             EEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC-CceEEEecCCcc
Q 017746           80 FYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN-DEAKIADFGLAK  156 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~  156 (366)
                      +.++||||++. +|.++++..  .+.+++...++-|+.||++||.|||+.||+||||||.|+|++.+ |.+||||||.|+
T Consensus        96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            67899999997 999999842  34579999999999999999999999999999999999999966 899999999999


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc--------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV--------  227 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~--------  227 (366)
                      .+..+..   ...+..|..|.|||.+.+ .+|+.+.||||.||++.||+-|++-|.+.+..++...+.+.--        
T Consensus       175 ~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  175 VLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             eeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            9854332   345568999999998866 6799999999999999999999999999888777777665320        


Q ss_pred             -------CCCCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          228 -------GDELPN---------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       228 -------~~~~~~---------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                             ....|.         +....++++.+|+.++|..+|++|.++.|++.||||..-
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence                   011111         234578999999999999999999999999999999553

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-50  Score=372.35  Aligned_cols=258  Identities=27%  Similarity=0.445  Sum_probs=209.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---------------CchhhHHHHHHHHHHcCCCCceeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---------------PSSVTLKNEKEALDQIGICPQIVR   66 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---------------~~~~~~~~E~~~l~~l~~~p~Iv~   66 (366)
                      +|.+++.||+|.||.|-+|++..+++    .+|+|++.+..               ...+...+|+.+|+++. |||||+
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~----l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~  172 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGK----LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVK  172 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCc----EEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeE
Confidence            69999999999999999999988876    67777665421               12357889999999999 899999


Q ss_pred             eecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC
Q 017746           67 CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR-LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND  145 (366)
Q Consensus        67 ~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~-l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~  145 (366)
                      ++++--  ......+|||+|||..|.+...-   ..++ +++.+++.|++.++.||+|||.+|||||||||+|+||+++|
T Consensus       173 LiEvLD--DP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  173 LIEVLD--DPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEEeec--CcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence            998432  23344577999999998886543   2344 99999999999999999999999999999999999999999


Q ss_pred             ceEEEecCCccccCCCCC---CcccccccCCCCCCCccccCCcC---C-CCccchhhhHHHHHHHHhCCCCCCCCCcchH
Q 017746          146 EAKIADFGLAKKSSCDGE---RSQSFECRGTPLYMSPESVNENE---Y-EAPCDIWALGCAVVEMASGKPAWNHKQDSNV  218 (366)
Q Consensus       146 ~vkl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~DiwslG~il~emltg~~pf~~~~~~~~  218 (366)
                      +|||+|||.+..+.....   .......+|||.|||||.+.++.   | +.+.||||+||+||.|+.|+.||.+....+.
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            999999999986633211   11223368999999999987733   3 4589999999999999999999988877666


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          219 FSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +..|.....  .+|..+ .+.+.++|||.+||.+||++|++..+|..|||+...
T Consensus       328 ~~KIvn~pL--~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  328 FDKIVNDPL--EFPENP-EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHhcCcc--cCCCcc-cccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            666665433  233333 478999999999999999999999999999999554

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.6e-49  Score=367.44  Aligned_cols=258  Identities=24%  Similarity=0.332  Sum_probs=210.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      .|...+.||+|+||+||+|.+..+++    .+|+|.+...    ......+.+|+.++++++ |+||+++++.+   .. 
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~---~~-   71 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAY---ET-   71 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCc----eEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEE---cc-
Confidence            37889999999999999999987765    6777776532    122345678999999998 99999998732   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            34577999999999999988764445699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ......++..
T Consensus       152 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~  227 (285)
T cd05631         152 IPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-KEDQEEYSEK  227 (285)
T ss_pred             cCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-hcccccCCcc
Confidence            53221   1224469999999999999999999999999999999999999998765443333332222 1222345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~  272 (366)
                      ++.++.+|+.+||..||++||+     ++++++||||...
T Consensus       228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            8999999999999999999997     8999999999553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.3e-51  Score=354.06  Aligned_cols=261  Identities=25%  Similarity=0.394  Sum_probs=216.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-----chhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      .|...+.||+|..++|-+..++.++++++.+++.-.......     -.+.-.+|+.+|+++.+||+|+++.+    +.+
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D----~ye   93 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD----VYE   93 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee----ecc
Confidence            367788999999999999999998876555444333222111     12345679999999999999999987    566


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ...++++|+|.|+.|.|+|++...  -.++|+..+.|++||+.|++|||.++||||||||+|||++++.++||+|||+|.
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence            677888999999999999999763  569999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC------cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      .+..+..   ....||||+|+|||.+..      ..|+..+|+|++|||||.|+.|.+||......-....+....+...
T Consensus       172 ~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~  248 (411)
T KOG0599|consen  172 QLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR  248 (411)
T ss_pred             ccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence            8854433   345689999999999843      4688899999999999999999999987755444455555455544


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .|. ..++++..+|||.+||+.||.+|.|++|+|.||||..-
T Consensus       249 spe-Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  249 SPE-WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             Ccc-hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            444 45689999999999999999999999999999999543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-50  Score=370.01  Aligned_cols=249  Identities=29%  Similarity=0.465  Sum_probs=211.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|.++.+++    .+|+|.+....    .....+.+|+.++++++ ||||+++++.    ..+
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~----~~~   72 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEH----YYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWT----EHD   72 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCC----EEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhh----hcc
Confidence            68899999999999999999987665    67888765421    23456788999999998 9999999873    233


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++|+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          73 QRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            45677999999999999999763  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....     ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...     .+.++..
T Consensus       151 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-----~~~~~~~  220 (291)
T cd05612         151 LRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-----KLEFPRH  220 (291)
T ss_pred             ccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----CcCCCcc
Confidence            5321     22346999999999999999999999999999999999999999887655544444332     2345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~  271 (366)
                      ++..+++||.+||..||.+|++     ++++++||||..
T Consensus       221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            8999999999999999999995     999999999954

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.9e-49  Score=363.65  Aligned_cols=255  Identities=27%  Similarity=0.422  Sum_probs=205.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||.|+||.||+|.++.++.    .+++|.+...  ......+.+|+.++++++ ||||+++++..    ..+.
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~----~~~~   76 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVTLHDII----HTER   76 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCC----EEEEEEecccccCCcchhHHHHHHHHHhCC-CCCEeeEEEEE----cCCC
Confidence            58999999999999999999887654    6788876542  223456778999999998 99999999843    2344


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++ +|.+++.. .+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        77 ~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          77 CLTLVFEYLDS-DLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             eEEEEEeCCCc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            67799999986 99999976 34468999999999999999999999999999999999999999999999999997653


Q ss_pred             CCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC----------
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG----------  228 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~----------  228 (366)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+....+.+....          
T Consensus       155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         155 VPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             CCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            221  11223468999999999865 56899999999999999999999999877655544444332100          


Q ss_pred             -------CCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          229 -------DELPN--------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       229 -------~~~~~--------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                             ...|.        ....++.++++||.+||+.||.+|||++|+++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                   00111        112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-50  Score=359.68  Aligned_cols=264  Identities=28%  Similarity=0.409  Sum_probs=216.2

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcCCCCceeEeecceee-ccCCe
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYS-FEKGE   78 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~-~~~~~   78 (366)
                      |...+.||+|+||.|..|.++.++    ..||+|++..   ......+..+|+++|+.++ |+||+.++..... ..+.-
T Consensus        24 y~~~~~iG~GAyGvVcsA~~~~t~----~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   24 YVLIEPIGRGAYGVVCSAKDKRTG----EKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             ecccccccCcceeeEEEEEEcCCC----CEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccccccc
Confidence            555789999999999999999887    4899998873   2234567889999999999 9999999886543 22333


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      +-+|+|+|+|+. +|...|+.  +..+++..+..++.||++||+|+|+.||+||||||.|+|++.++.+||+|||+|+..
T Consensus        99 ~DvYiV~elMet-DL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen   99 NDVYLVFELMET-DLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             ceeEEehhHHhh-HHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence            456799999965 99999975  345999999999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCCcccccccCCCCCCCcccc-CCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh-----------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG-----------  226 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~-----------  226 (366)
                      ........-..++.|.+|.|||++ ....|+.++||||+|||+.||++|++-|.+.+..++...+....           
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            644222223567899999999987 45789999999999999999999999999887776666655421           


Q ss_pred             -------cCCCCCCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCCC
Q 017746          227 -------VGDELPNIP--------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ  274 (366)
Q Consensus       227 -------~~~~~~~~~--------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~~  274 (366)
                             +-...|..|        ...++.+.||+.+||..||.+|+|++|+|.|||+..-..
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence                   111112211        357899999999999999999999999999999965433

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.6e-49  Score=376.92  Aligned_cols=259  Identities=23%  Similarity=0.375  Sum_probs=205.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      .|..++.||+|+||+||+|+++.+++    .+|+|.+...    ......+.+|+.+++.++ ||||+++++.+   .. 
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~----~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~---~~-   72 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHA----LYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSF---QD-   72 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEE---ec-
Confidence            58899999999999999999987765    6777776542    223456788999999998 99999999743   23 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||+||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          73 KDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            34577999999999999999763  4699999999999999999999999999999999999999999999999999864


Q ss_pred             cCCCCC---------------------------------------------CcccccccCCCCCCCccccCCcCCCCccc
Q 017746          158 SSCDGE---------------------------------------------RSQSFECRGTPLYMSPESVNENEYEAPCD  192 (366)
Q Consensus       158 ~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  192 (366)
                      ......                                             .......+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD  230 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence            311000                                             00012347999999999999999999999


Q ss_pred             hhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHh--cccCCCCCCCHHHHHcCCCcc
Q 017746          193 IWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKC--FLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       193 iwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c--L~~dp~~R~t~~~ll~hp~~~  270 (366)
                      ||||||++|||++|++||......+....+.........|. ...+++++.+||.+|  +..+|..|++++++++||||.
T Consensus       231 iwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~  309 (381)
T cd05626         231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP-QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS  309 (381)
T ss_pred             eeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCC-CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccC
Confidence            99999999999999999987765444433332221112221 224799999999994  455666699999999999996


Q ss_pred             cC
Q 017746          271 AD  272 (366)
Q Consensus       271 ~~  272 (366)
                      ..
T Consensus       310 ~~  311 (381)
T cd05626         310 EV  311 (381)
T ss_pred             CC
Confidence            53

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-50  Score=365.02  Aligned_cols=249  Identities=27%  Similarity=0.479  Sum_probs=214.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.++||.|.||.|-+|.....++    .||+|.+.+    .+.+...+.+|+++|..|+ ||||+.+|.    +.++
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR----~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyE----VFEN  124 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGR----EVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYE----VFEN  124 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCc----EeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhh----hhcC
Confidence            68999999999999999999877665    677776654    4456778999999999999 999999998    3344


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+.+||||..+|+|+||+.++  +.|+|.+++.+++||++|+.|||.++++|||||.+||||+.|+++||+|||++..
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNL  202 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhh
Confidence            55677999999999999999874  5799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCC-CccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYE-APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      +.   ...-..++||+|.|.+||++.+.+|. +.+|-|||||+||.|+.|.+||++.+......+|.+..+..  |    
T Consensus       203 y~---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P----  273 (668)
T KOG0611|consen  203 YA---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--P----  273 (668)
T ss_pred             hc---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--C----
Confidence            64   23334567999999999999999996 58999999999999999999999987666655555444322  1    


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      .-+.++..||+.||..||++|.|++++.+|-|++
T Consensus       274 ~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  274 ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence            2356788899999999999999999999999984

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.3e-50  Score=374.97  Aligned_cols=255  Identities=27%  Similarity=0.441  Sum_probs=224.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|..++++|+|+||.+++++++.++.    .+++|++...   ........+|..++.++. |||||.+++   .|..++
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~----~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~d---s~~~~~   76 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDK----LYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKD---SFEEDG   76 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCc----eEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeecc---chhcCC
Confidence            68999999999999999999988765    7888887653   234557799999999998 999999998   567777


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ...+|||+||+||+|.+.|.++.+..++|+.+..|+.||+.|+.|||+++|+|||||+.||+++.++.|||.|||+|+.+
T Consensus        77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            77889999999999999999987788999999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ....  ....+.+|||.||.||++.+.+|+.++|||||||++|||++-+++|...+.......+.+..    ...+|...
T Consensus       157 ~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~----~~Plp~~y  230 (426)
T KOG0589|consen  157 NPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL----YSPLPSMY  230 (426)
T ss_pred             CCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc----CCCCCccc
Confidence            6433  23456689999999999999999999999999999999999999998876555444443322    45677889


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      +.+++.+|..||.++|+.||++.+||.+|.+.
T Consensus       231 s~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  231 SSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             cHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence            99999999999999999999999999999875

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-49  Score=369.05  Aligned_cols=246  Identities=28%  Similarity=0.476  Sum_probs=204.0

Q ss_pred             eeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            9 IGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         9 lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ||+|+||.||+|++..+++    .+|+|.+..    .......+.+|+.++.+++ ||||+++++.+   . ....+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~----~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---~-~~~~~~lv   71 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQR----IYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSF---Q-SPEKLYLV   71 (312)
T ss_pred             CCcCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEE---e-cCCeEEEE
Confidence            7999999999999987765    677776643    2234456778999999998 99999998732   2 34456799


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||+++|+|.+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus        72 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--  147 (312)
T cd05585          72 LAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--  147 (312)
T ss_pred             EcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--
Confidence            999999999999976  3579999999999999999999999999999999999999999999999999998643221  


Q ss_pred             cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHH
Q 017746          165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD  244 (366)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  244 (366)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..     ....++..+++++.+
T Consensus       148 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  222 (312)
T cd05585         148 DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ-----EPLRFPDGFDRDAKD  222 (312)
T ss_pred             CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----CCCCCCCcCCHHHHH
Confidence            122345799999999999999999999999999999999999999987655444333322     233556778999999


Q ss_pred             HHHHhcccCCCCCC---CHHHHHcCCCcccC
Q 017746          245 FLIKCFLKDPKRRW---TAEMLLNHPFVCAD  272 (366)
Q Consensus       245 ll~~cL~~dp~~R~---t~~~ll~hp~~~~~  272 (366)
                      ||.+||..||++||   ++.++++||||...
T Consensus       223 li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         223 LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            99999999999997   57999999999653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-49  Score=373.77  Aligned_cols=254  Identities=24%  Similarity=0.411  Sum_probs=212.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|++..+++    .+|+|.+...    ......+.+|+.++..++ ||||+++++.+   . .
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~---~-~   72 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGE----IVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAF---Q-D   72 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCC----EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEE---E-c
Confidence            58999999999999999999987765    6777776542    123456788999999998 99999998732   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          73 DEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            4456799999999999999975  34699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC--
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--  235 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  235 (366)
                      ...     ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.........|...  
T Consensus       151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  225 (333)
T cd05600         151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP  225 (333)
T ss_pred             ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcc
Confidence            532     2234579999999999999999999999999999999999999998876665555554433222222222  


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 -GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 -~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                       ..+++++.+||.+||..+|++||+++++++||||..
T Consensus       226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence             246899999999999999999999999999999964

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.1e-49  Score=369.23  Aligned_cols=248  Identities=26%  Similarity=0.436  Sum_probs=205.5

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.||+|+||.||+|+++.+++    .+|+|.+..    ..........|.+++..+..||||+++++.+   .. ...++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~---~~-~~~~~   72 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDE----VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF---QT-KDRLF   72 (321)
T ss_pred             CccccCCCeEEEEEEECCCCC----EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE---Ec-CCeEE
Confidence            479999999999999987665    677776653    2233455678899998887799999999843   22 34567


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||+++|+|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        73 lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          73 FVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            999999999999999763  469999999999999999999999999999999999999999999999999987643222


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...     ....|..++.++
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-----~~~~p~~~~~~~  223 (321)
T cd05591         151 V--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-----DVLYPVWLSKEA  223 (321)
T ss_pred             c--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCHHH
Confidence            1  223457999999999999999999999999999999999999999887665554444332     123456689999


Q ss_pred             HHHHHHhcccCCCCCC-------CHHHHHcCCCccc
Q 017746          243 KDFLIKCFLKDPKRRW-------TAEMLLNHPFVCA  271 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~-------t~~~ll~hp~~~~  271 (366)
                      .++|.+||.+||++|+       +++++++||||..
T Consensus       224 ~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         224 VSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             HHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            9999999999999999       8999999999954

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.1e-48  Score=367.66  Aligned_cols=261  Identities=26%  Similarity=0.448  Sum_probs=208.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||++++... ......+++|.+...     ......+.+|+.+++.++.||||+++++.   +. 
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~---~~-   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTG-HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA---FQ-   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEccc-CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE---Ee-
Confidence            589999999999999999987432 123457788876531     12345678899999999879999999863   23 


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            344567999999999999999763  469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ....... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+..... ...+.++
T Consensus       154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~  231 (332)
T cd05614         154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-KCDPPFP  231 (332)
T ss_pred             cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-cCCCCCC
Confidence            6532221 222345799999999999875 478899999999999999999999975433222222222211 2234566


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      ..++..+.+||.+||..||++||     +++++++||||..
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            77899999999999999999999     8899999999965

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.7e-49  Score=375.65  Aligned_cols=258  Identities=24%  Similarity=0.421  Sum_probs=206.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||+||+|.++.+++    .+|+|.+...    ......+.+|+.++.+++ ||||+++++.   +.+ 
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~---~~~-   72 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGH----VYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYS---FQD-   72 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCC----EEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEE---Eec-
Confidence            68999999999999999999987765    6777776531    223456788999999998 9999999873   233 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||+||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          73 KLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             CCeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            44567999999999999999763  5799999999999999999999999999999999999999999999999999975


Q ss_pred             cCCCCC---------------------------------CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHH
Q 017746          158 SSCDGE---------------------------------RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMA  204 (366)
Q Consensus       158 ~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~eml  204 (366)
                      ......                                 .......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            432110                                 00012457999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCC---CCCCHHHHHcCCCcccC
Q 017746          205 SGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPK---RRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       205 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~---~R~t~~~ll~hp~~~~~  272 (366)
                      +|+.||.+....+....+.........|.. ..++++++++|.+++. +|+   .||++++|++||||...
T Consensus       231 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         231 IGYPPFCSETPQETYKKVMNWKETLIFPPE-VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             hCCCCCCCCCHHHHHHHHHcCcCcccCCCc-CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            999999887665555554432222222221 2378999999998664 444   46899999999999654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-48  Score=360.20  Aligned_cols=261  Identities=27%  Similarity=0.429  Sum_probs=207.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcC--CCCceeEeecceeecc-
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIG--ICPQIVRCFGDDYSFE-   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~--~~p~Iv~~~g~~~~~~-   75 (366)
                      +|.+.+.||+|+||+||+|++..++.   ..+|+|.+...   ........+|+.+++.+.  .||||+++++.+.... 
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGG---RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCC---eEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            69999999999999999999865432   36778876542   123345677888888774  4999999998543211 


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      .....+++||||+.+ +|.+++.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          79 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            234457799999974 9999997754556899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC---C--
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD---E--  230 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~---~--  230 (366)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|+|++|++||.+..+.+....+.......   .  
T Consensus       158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            875422   22234569999999999999999999999999999999999999998876655555444321100   0  


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          231 -----------------LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       231 -----------------~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                                       ...+...+++.+++|+.+||+.||++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             001123468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.2e-49  Score=369.99  Aligned_cols=247  Identities=26%  Similarity=0.468  Sum_probs=204.5

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.||+|+||.||++.++.+++    .+|+|.+..    .......+.+|+.+++.+. ||||+++++.   +. ....++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~---~~-~~~~~~   71 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGK----YYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYS---FQ-TKDRLC   71 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEE---EE-cCCEEE
Confidence            479999999999999987765    677776653    2234456788999999998 9999999873   22 344567


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||+++|+|.+++...  +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        72 lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-  148 (328)
T cd05593          72 FVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-  148 (328)
T ss_pred             EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-
Confidence            999999999999998653  46999999999999999999999999999999999999999999999999998764221 


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                       .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..     ....+|..++.++
T Consensus       149 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-----~~~~~p~~~~~~~  222 (328)
T cd05593         149 -AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EDIKFPRTLSADA  222 (328)
T ss_pred             -ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-----CCccCCCCCCHHH
Confidence             1122345799999999999999999999999999999999999999987655443333321     2234567789999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          243 KDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      .+||.+||.+||++|+     ++.++++||||..
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            9999999999999997     8999999999954

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.4e-48  Score=364.92  Aligned_cols=249  Identities=27%  Similarity=0.455  Sum_probs=205.6

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      ++||+|+||.||+|+++.++.    .+|+|.+...    .........|..++..+..||||+++++.+   . ....++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~---~-~~~~~~   72 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGE----YFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF---Q-TKEHLF   72 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE---E-eCCEEE
Confidence            579999999999999987765    6777776542    234456777888888776699999998732   2 344677


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||+++|+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        73 lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          73 FVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             EEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            999999999999999763  569999999999999999999999999999999999999999999999999987532211


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.........+.+..     ..+.++..++.++
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~  223 (316)
T cd05620         151 N--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-----DTPHYPRWITKES  223 (316)
T ss_pred             C--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----CCCCCCCCCCHHH
Confidence            1  22345799999999999999999999999999999999999999987765444443322     2345667789999


Q ss_pred             HHHHHHhcccCCCCCCCH-HHHHcCCCcccC
Q 017746          243 KDFLIKCFLKDPKRRWTA-EMLLNHPFVCAD  272 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t~-~~ll~hp~~~~~  272 (366)
                      ++||.+||..||++|+++ +++++||||...
T Consensus       224 ~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         224 KDILEKLFERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             HHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence            999999999999999997 589999999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-48  Score=367.21  Aligned_cols=248  Identities=27%  Similarity=0.453  Sum_probs=205.1

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.||+|+||.||+++++.+++    .+|+|.+..    .......+.+|+.+++.++ ||||+++++.+   .. ...++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~---~~-~~~~~   71 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGR----YYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAF---QT-HDRLC   71 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEE---ec-CCEEE
Confidence            579999999999999987765    677776653    2233455678999999998 99999998743   22 34567


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||+++|+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        72 lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          72 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence            999999999999998753  469999999999999999999999999999999999999999999999999987542211


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...     ...+|..+++++
T Consensus       150 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----~~~~p~~~~~~~  222 (323)
T cd05595         150 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----EIRFPRTLSPEA  222 (323)
T ss_pred             --CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----CCCCCCCCCHHH
Confidence              1122357999999999999999999999999999999999999999876655444443321     234566789999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHHHHcCCCcccC
Q 017746          243 KDFLIKCFLKDPKRRW-----TAEMLLNHPFVCAD  272 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~  272 (366)
                      .++|.+||..||++|+     ++.++++||||...
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             HHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999999998     89999999999653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.3e-48  Score=368.02  Aligned_cols=254  Identities=27%  Similarity=0.437  Sum_probs=209.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+|+|.+..    .......+..|..++..+..+++|+++++.   +.. 
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~---~~~-   72 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDE----LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC---FQT-   72 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEE---EEc-
Confidence            58999999999999999999887765    677776653    223445677899999999866778888763   222 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++...  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          73 MDRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            34567999999999999999763  4689999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+..     ..+.++..
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-----~~~~~~~~  223 (324)
T cd05587         151 NIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME-----HNVSYPKS  223 (324)
T ss_pred             cCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc-----CCCCCCCC
Confidence            322111  22345799999999999999999999999999999999999999987765544444432     22345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH-----HHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTA-----EMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~-----~~ll~hp~~~~~  272 (366)
                      ++.++.+++.+||.+||.+|++.     +++++||||...
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         224 LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            89999999999999999999986     899999999653

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2e-48  Score=365.50  Aligned_cols=249  Identities=28%  Similarity=0.501  Sum_probs=204.7

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      ++||+|+||.||+|++..+++    .+|+|.+..    ..........|..++..+..||||+++++.+   . ....++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~---~-~~~~~~   72 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNE----FFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF---Q-TKEHLF   72 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE---E-cCCEEE
Confidence            479999999999999987765    677776653    1233445667788888776799999998732   2 234677


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||++||+|.+++...  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        73 lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          73 FVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            999999999999999763  479999999999999999999999999999999999999999999999999998643222


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+.     ...+.++..++.++
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~-----~~~~~~~~~~~~~~  223 (316)
T cd05592         151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL-----NDRPHFPRWISKEA  223 (316)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCHHH
Confidence              22234579999999999999999999999999999999999999998776554444332     23455677789999


Q ss_pred             HHHHHHhcccCCCCCCCH-HHHHcCCCcccC
Q 017746          243 KDFLIKCFLKDPKRRWTA-EMLLNHPFVCAD  272 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t~-~~ll~hp~~~~~  272 (366)
                      .+||.+||..||++||++ .++++||||...
T Consensus       224 ~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         224 KDCLSKLFERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             HHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence            999999999999999986 588899999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-48  Score=369.17  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=209.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||+||+|+++.+++    .+|+|.+...    ......+.+|+.+++.++ ||||+++++.   +.. 
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~---~~~-   72 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGD----IYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYA---FQD-   72 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeE---Eec-
Confidence            58899999999999999999987765    6777776542    224456788999999887 9999999873   222 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++|+|.+++.+. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          73 KDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             CCeEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeE
Confidence            34577999999999999999873 35799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccC------CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVN------ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      ....... ......||+.|+|||++.      ...++.++|||||||++|+|++|+.||...........+.........
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~  230 (330)
T cd05601         152 LTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKF  230 (330)
T ss_pred             CCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCC
Confidence            6432221 222346999999999986      456889999999999999999999999877655554444433222222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      |.. ..++.++.+||.+||. +|++||+++++++||||...
T Consensus       231 ~~~-~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         231 PED-PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CCC-CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            222 2478999999999998 99999999999999999653

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.4e-49  Score=368.34  Aligned_cols=248  Identities=28%  Similarity=0.466  Sum_probs=206.2

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.||+|+||+||+|+++.+++    .+|+|.+..    .......+..|+.++..+..||||+++++.+   . ....++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~---~-~~~~~~   72 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGR----LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF---Q-TPDRLF   72 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCC----EEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE---E-cCCEEE
Confidence            479999999999999987765    677776653    2234456778889998887799999999742   2 234567


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||+++|+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        73 iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          73 FVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             EEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            999999999999999763  469999999999999999999999999999999999999999999999999987643222


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..     ..+..+..++.++
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~~  223 (320)
T cd05590         151 K--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYPTWLSQDA  223 (320)
T ss_pred             C--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-----CCCCCCCCCCHHH
Confidence            1  22334799999999999999999999999999999999999999987765555444432     1234566789999


Q ss_pred             HHHHHHhcccCCCCCCCH------HHHHcCCCccc
Q 017746          243 KDFLIKCFLKDPKRRWTA------EMLLNHPFVCA  271 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t~------~~ll~hp~~~~  271 (366)
                      .+||.+||++||++|+++      +++++||||..
T Consensus       224 ~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         224 VDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             HHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence            999999999999999998      99999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.7e-49  Score=372.71  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=209.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|+++..+.   ..+++|.+..    .......+.+|+.+++.++ ||||+++++.+   . .
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~---~-~  102 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDF---PPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSF---K-D  102 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCC---eEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEE---E-e
Confidence            58889999999999999998765432   3678887653    2234456788999999998 99999999843   2 2


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++|+|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            44677999999999999999763  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....     ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+...     ...+|..
T Consensus       181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-----~~~~p~~  250 (340)
T PTZ00426        181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG-----IIYFPKF  250 (340)
T ss_pred             cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC-----CCCCCCC
Confidence            5321     23457999999999999999999999999999999999999999877554444443321     2245667


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      ++.++.++|.+||+.||++|+     +++++++||||..
T Consensus       251 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        251 LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            899999999999999999996     8999999999954

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-49  Score=377.34  Aligned_cols=251  Identities=32%  Similarity=0.593  Sum_probs=220.4

Q ss_pred             eeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEee
Q 017746            8 VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLE   86 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E   86 (366)
                      +||+|.||+||.|++..+.    ..+|+|.+... ......+..|++.-++|+ |.|||+++|.   +.+ ++++-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tq----vrIaIKEIpekdsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs---~se-nGf~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQ----VRIAIKEIPEKDSREVQPLHEEIALHSTLR-HKNIVRYLGS---VSE-NGFFKIFME  652 (1226)
T ss_pred             EeecCceeEEEeeccccce----eEEEeeecccccchhhccHHHHHHHHHHHh-hHhHHHHhhc---cCC-CCeEEEEee
Confidence            7999999999999998875    47899988763 345667889999999999 9999999994   333 346779999


Q ss_pred             cCCCCCHHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-CCceEEEecCCccccCCCCC
Q 017746           87 YASRGSLADRVKKQNNGRL--QESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-NDEAKIADFGLAKKSSCDGE  163 (366)
Q Consensus        87 ~~~~g~L~~~l~~~~~~~l--~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~~~  163 (366)
                      -++||+|.++++. .-|++  +|.++..|.+||++||.|||++.|||||||.+||||+. .|.+||+|||-++++.  +.
T Consensus       653 qVPGGSLSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--gi  729 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GI  729 (1226)
T ss_pred             cCCCCcHHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc--cC
Confidence            9999999999987 45677  89999999999999999999999999999999999964 6899999999999875  44


Q ss_pred             CcccccccCCCCCCCccccCCc--CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          164 RSQSFECRGTPLYMSPESVNEN--EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      ...+.++.||..|||||++..+  .|+.++|||||||++.||.||++||....  .....+.+.+.-..-|.+|..++.+
T Consensus       730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg--spqAAMFkVGmyKvHP~iPeelsae  807 (1226)
T KOG4279|consen  730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG--SPQAAMFKVGMYKVHPPIPEELSAE  807 (1226)
T ss_pred             CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC--ChhHhhhhhcceecCCCCcHHHHHH
Confidence            4445566799999999999765  58899999999999999999999997653  4456788888888889999999999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ++.||.+|+.+||.+||++.+||..||++..
T Consensus       808 ak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  808 AKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            9999999999999999999999999999765

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1e-48  Score=376.06  Aligned_cols=257  Identities=23%  Similarity=0.449  Sum_probs=207.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|+++.+++    .+|+|.+...    ......+.+|+.++++++ ||||+++++.   +.. 
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~---~~~-   72 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNA----LYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYS---FQD-   72 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCC----EEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEE---EEc-
Confidence            58999999999999999999987755    6788876531    234456788999999998 9999999873   233 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +..+++|||||++|+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus        73 ~~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          73 KDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            44677999999999999999763  4689999999999999999999999999999999999999999999999999853


Q ss_pred             cCCCC-----------------------------------------CCcccccccCCCCCCCccccCCcCCCCccchhhh
Q 017746          158 SSCDG-----------------------------------------ERSQSFECRGTPLYMSPESVNENEYEAPCDIWAL  196 (366)
Q Consensus       158 ~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  196 (366)
                      +....                                         ........+||+.|||||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            21000                                         0000113479999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCCCccc
Q 017746          197 GCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRW---TAEMLLNHPFVCA  271 (366)
Q Consensus       197 G~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~---t~~~ll~hp~~~~  271 (366)
                      ||++|+|++|+.||......+....+.........+. ...++.++.++|.+|+ .+|.+|+   ++.++++||||..
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS-QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCC-CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            9999999999999987765544443332222212221 2357999999999976 5999999   9999999999964

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-48  Score=373.99  Aligned_cols=257  Identities=24%  Similarity=0.442  Sum_probs=205.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|.++.+++    .+|+|.+...    ......+.+|+.+++.++ ||||+++++.+   . +
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~---~-~   72 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGK----IYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSF---Q-D   72 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCC----EEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEE---E-c
Confidence            68999999999999999999988765    6777765431    223456788999999998 99999998732   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++..  .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          73 AQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             CCeeEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            4467799999999999999975  35699999999999999999999999999999999999999999999999999964


Q ss_pred             cCCCCC-------------C--------------------------------cccccccCCCCCCCccccCCcCCCCccc
Q 017746          158 SSCDGE-------------R--------------------------------SQSFECRGTPLYMSPESVNENEYEAPCD  192 (366)
Q Consensus       158 ~~~~~~-------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D  192 (366)
                      ......             .                                ......+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            321000             0                                0001246999999999999999999999


Q ss_pred             hhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHHcCCCc
Q 017746          193 IWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR---WTAEMLLNHPFV  269 (366)
Q Consensus       193 iwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R---~t~~~ll~hp~~  269 (366)
                      ||||||++|||++|.+||......+....+.........|. ...++.++++||.+||. +|.+|   +++.+++.||||
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~  308 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF  308 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence            99999999999999999987665544444433221112221 12478999999999997 77765   599999999999


Q ss_pred             cc
Q 017746          270 CA  271 (366)
Q Consensus       270 ~~  271 (366)
                      ..
T Consensus       309 ~~  310 (377)
T cd05629         309 RG  310 (377)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-48  Score=372.22  Aligned_cols=258  Identities=24%  Similarity=0.468  Sum_probs=208.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||+||+|++..+++    .+|+|.+...    ......+.+|+.++..++ ||||+++++.+   . .
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~---~-~   72 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGH----IYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSF---Q-D   72 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEE---E-c
Confidence            68999999999999999999987765    6788877542    223456788999999998 99999998732   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||+||+|.+++.+  ++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          73 ENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             CCeEEEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence            4467799999999999999976  34699999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCC------------------------------------cccccccCCCCCCCccccCCcCCCCccchhhhHHHHH
Q 017746          158 SSCDGER------------------------------------SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVV  201 (366)
Q Consensus       158 ~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  201 (366)
                      +......                                    ......+||+.|+|||++.+..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            4321100                                    0111346999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCCCcccC
Q 017746          202 EMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT---AEMLLNHPFVCAD  272 (366)
Q Consensus       202 emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t---~~~ll~hp~~~~~  272 (366)
                      +|++|.+||......+....+.........|. ...+++++++||.+||. +|.+|++   +++++.||||...
T Consensus       231 el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            99999999987765544444333221112221 12478999999999996 9999998   9999999999653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.7e-48  Score=358.04  Aligned_cols=256  Identities=24%  Similarity=0.367  Sum_probs=203.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+++|.+...   ......+.+|+.+++.++ ||||+++++.+   . ..
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---~-~~   72 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKE----IVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAF---R-RR   72 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCc----EEEEEEEecccccccchhhHHHHHHHHHhCC-CccccchhhhE---e-cC
Confidence            68999999999999999999987665    6777776542   223456788999999998 99999998843   2 23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||++++.|..+..  ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        73 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          73 GKLYLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             CEEEEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            45679999999976665543  2356999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC----------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG----------  228 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~----------  228 (366)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|++||...........+......          
T Consensus       151 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             ccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            43221 1222356999999999999999999999999999999999999999876544333222221100          


Q ss_pred             -------CCCC----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          229 -------DELP----------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       229 -------~~~~----------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                             ...+          .....++.++.+||.+||++||++|||++++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                   0001          0112368889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.7e-48  Score=366.95  Aligned_cols=253  Identities=27%  Similarity=0.430  Sum_probs=209.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+|+|.+...    .........|..++..+..||+|+++++.   +.. 
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~---~~~-   72 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDE----LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSC---FQT-   72 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEE---Eec-
Confidence            58899999999999999999987765    6677765532    22334567788888888778999999873   222 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++|+|.+++...  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          73 MDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             CCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            34567999999999999999763  4699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...     ...+|..
T Consensus       151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-----~~~~p~~  223 (323)
T cd05616         151 NMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----NVAYPKS  223 (323)
T ss_pred             cCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----CCCCCCc
Confidence            43222  1223457999999999999999999999999999999999999999877655554444332     2345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH-----HHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTA-----EMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~-----~~ll~hp~~~~  271 (366)
                      ++.++.+++.+||++||++|+++     .++++||||..
T Consensus       224 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         224 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            89999999999999999999984     89999999964

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-49  Score=372.30  Aligned_cols=258  Identities=27%  Similarity=0.472  Sum_probs=212.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+...    ......+..|+.++..+. ||||+++++.+   . .
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~---~-~   72 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQ----VYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSF---Q-D   72 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCC----EEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhhe---e-c
Confidence            68999999999999999999987765    6777776532    234566888999999998 99999998742   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++|+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          73 EEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             CCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            44677999999999999999763  5799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC---------------------------CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCC
Q 017746          158 SSCDG---------------------------ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAW  210 (366)
Q Consensus       158 ~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf  210 (366)
                      .....                           .........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            64332                           001123456999999999999999999999999999999999999999


Q ss_pred             CCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHcCCCcccC
Q 017746          211 NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT-AEMLLNHPFVCAD  272 (366)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t-~~~ll~hp~~~~~  272 (366)
                      ...........+.........|..+ .+++++.+||.+||. ||.+|++ ++++++||||...
T Consensus       231 ~~~~~~~~~~~i~~~~~~~~~p~~~-~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         231 YSDTLQETYNKIINWKESLRFPPDP-PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             CCCCHHHHHHHHhccCCcccCCCCC-CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            8876555444444322222333322 369999999999997 9999999 9999999999653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=9.4e-49  Score=377.11  Aligned_cols=257  Identities=25%  Similarity=0.444  Sum_probs=206.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|..++.||+|+||+||+|++..+++    .+|+|.+...    ......+.+|+.++++++ ||||+++++.+   .. 
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~----~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~---~~-   72 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKA----LYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSF---QD-   72 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCC----EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEE---Ee-
Confidence            58899999999999999999987765    6777776542    123456888999999998 99999999843   33 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||++|+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            34577999999999999999763  4689999999999999999999999999999999999999999999999999753


Q ss_pred             cCCCCC---------------------------------------------CcccccccCCCCCCCccccCCcCCCCccc
Q 017746          158 SSCDGE---------------------------------------------RSQSFECRGTPLYMSPESVNENEYEAPCD  192 (366)
Q Consensus       158 ~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  192 (366)
                      ......                                             .......+||+.|+|||++.+..|+.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            210000                                             00012347999999999999999999999


Q ss_pred             hhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCCCc
Q 017746          193 IWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT---AEMLLNHPFV  269 (366)
Q Consensus       193 iwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t---~~~ll~hp~~  269 (366)
                      ||||||++|||++|++||......+....+.........|. ...+++++.++|.+|+ .+|++|++   ++++++||||
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f  308 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP-QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFF  308 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC-cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCc
Confidence            99999999999999999987765444333332222222222 2357999999999976 59999997   9999999999


Q ss_pred             cc
Q 017746          270 CA  271 (366)
Q Consensus       270 ~~  271 (366)
                      ..
T Consensus       309 ~~  310 (382)
T cd05625         309 KT  310 (382)
T ss_pred             CC
Confidence            65

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.2e-48  Score=350.24  Aligned_cols=263  Identities=26%  Similarity=0.411  Sum_probs=214.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCc-eeEeecceeecc--
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQ-IVRCFGDDYSFE--   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~-Iv~~~g~~~~~~--   75 (366)
                      .|..++.||+|+||+||+|+.+.+++    .||+|++.....   .-....+|+.+|+.|+ |+| ||++++..++..  
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~----~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGK----FVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCC----EEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccc
Confidence            47788899999999999999998874    899998876433   3455789999999999 888 999999665433  


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecC
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNN--GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                      .....+++|+||+.. +|.+++.....  ..++...++.+++||+.||+|||++||+||||||.||||+++|.+||+|||
T Consensus        87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence            223467799999987 99999987432  247789999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC---
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD---  229 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~---  229 (366)
                      +|+...-+...  ....++|.+|.|||++.+. .|+..+||||+|||++||+++++.|.+..+.++...+.+..-..   
T Consensus       166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            99976433222  3345799999999999887 79999999999999999999999999988766666555432110   


Q ss_pred             -------------CCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          230 -------------ELPNIP---------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       230 -------------~~~~~~---------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                   ..+...         ...+.++.+++.+||+.+|.+|.|++.++.||||...
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence                         111111         1134588999999999999999999999999999654

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.4e-48  Score=367.87  Aligned_cols=247  Identities=28%  Similarity=0.480  Sum_probs=203.5

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.||+|+||.||++.+..+++    .+++|.+..    .......+.+|++++..++ ||||+++++.   +. ....++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~---~~-~~~~~~   71 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGR----YYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYS---FQ-THDRLC   71 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEE---EE-cCCEEE
Confidence            579999999999999987765    667776653    2223456678999999998 9999999873   22 234577


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus        72 lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          72 FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  149 (325)
T ss_pred             EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999998653  469999999999999999999997 79999999999999999999999999998754322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      ..  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..     ....++..++++
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-----~~~~~p~~~~~~  222 (325)
T cd05594         150 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFPRTLSPE  222 (325)
T ss_pred             Cc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-----CCCCCCCCCCHH
Confidence            11  12234699999999999999999999999999999999999999987665444443322     223456678999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          242 GKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      +.+||.+||..||++|+     ++.++++||||..
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             HHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence            99999999999999997     8999999999964

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.2e-48  Score=380.63  Aligned_cols=258  Identities=26%  Similarity=0.381  Sum_probs=205.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc----CC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE----KG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~----~~   77 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+|+|.+...   .....+|+.+++.++ ||||+++++.++...    ..
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~----~vAiK~i~~~---~~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSE----KVAIKKVLQD---PQYKNRELLIMKNLN-HINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCC----EEEEEEEecC---cchHHHHHHHHHhcC-CCCCcceeeeEeecccccCCC
Confidence            58999999999999999999877654    7888876542   234567999999998 999999988554321    22


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-ceEEEecCC
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGL  154 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~  154 (366)
                      ..++++||||+++ +|.+++...  .+..+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence            3467799999986 888877532  345799999999999999999999999999999999999998665 799999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC-----
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG-----  228 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~-----  228 (366)
                      |+......   ......||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+....+....+.+....     
T Consensus       218 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        218 AKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             chhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            98764322   2234578999999999866 46999999999999999999999999887655444443322100     


Q ss_pred             ----------CCCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          229 ----------DELP---------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       229 ----------~~~~---------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                ...|         .+|...++++.+||.+||..||.+|||+.|+++||||..
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence                      0011         133457889999999999999999999999999999954

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.6e-48  Score=364.90  Aligned_cols=251  Identities=28%  Similarity=0.439  Sum_probs=205.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcC--CCCceeEeecceeeccC
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIG--ICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~--~~p~Iv~~~g~~~~~~~   76 (366)
                      |.+.+.||+|+||.||+|.++.+++    .+|+|.+...    ......+.+|+.++..++  .||||+++++.+   . 
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~---~-   72 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGE----LYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF---Q-   72 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE---E-
Confidence            7789999999999999999987765    6777776531    223456777777665443  299999999843   2 


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||++||+|..++.+   +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        73 ~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          73 TEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            23456799999999999988854   469999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...     .+..+.
T Consensus       150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----~~~~p~  222 (324)
T cd05589         150 EGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-----EVRYPR  222 (324)
T ss_pred             cCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----CCCCCC
Confidence            542211  1223457999999999999999999999999999999999999999877655544443332     234566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      .++.++.++|.+||..||++||     ++.++++||||..
T Consensus       223 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         223 FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence            7899999999999999999999     7999999999965

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-49  Score=365.58  Aligned_cols=254  Identities=26%  Similarity=0.445  Sum_probs=223.0

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      |.+-+.||+|.|++|-+|++.-+|.    +||||.+++..-   ....+.+|+.-|+..+ |||||++|+    +-+.+.
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGe----kVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYE----ViDTQT   90 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGE----KVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYE----VIDTQT   90 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccc----eeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeee----hhcccc
Confidence            6677899999999999999987654    888888876432   4467899999999999 999999998    445566


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec-cCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF-DNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-~~~~vkl~DFG~a~~~  158 (366)
                      .+|||+|+-.+|+|+|||-++. ..+.|+.+++|++||+.|+.|||+..+|||||||+||++. +-|-|||.|||++..+
T Consensus        91 KlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            7789999999999999999854 4599999999999999999999999999999999999875 5689999999999877


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCC-ccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ..+..   ..+.||+..|-|||++.+..|+. ++||||||||||-|++|++||...++.++...|..-.+     .+|..
T Consensus       170 ~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-----tvPsh  241 (864)
T KOG4717|consen  170 QPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-----TVPSH  241 (864)
T ss_pred             CCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-----cCchh
Confidence            54333   34568999999999999999996 78999999999999999999999999998888876554     56888


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCCC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ  274 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~~  274 (366)
                      ++.++++||..||..||++|.+.++|.+|+|++..+.
T Consensus       242 vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  242 VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             hhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            9999999999999999999999999999999976544

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-47  Score=361.69  Aligned_cols=251  Identities=25%  Similarity=0.428  Sum_probs=205.7

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      ++.||+|+||.||+++.... ......+|+|.+...     ......+.+|+.+++.++ ||||+++++.+   .. +..
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~---~~-~~~   74 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTG-ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAF---QT-GGK   74 (323)
T ss_pred             CceeeecCCeEEEEEEEccc-CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEE---ec-CCe
Confidence            47899999999999987432 123457888876531     123345678999999998 99999998743   22 345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++|+|.+++.+  .+.+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          75 LYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             EEEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            6799999999999999976  35689999999999999999999999999999999999999999999999999875432


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...     ...++..+++
T Consensus       153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~  225 (323)
T cd05584         153 EGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-----KLNLPPYLTP  225 (323)
T ss_pred             CCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCH
Confidence            221  223457999999999999999999999999999999999999999877654444433321     2345667899


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          241 QGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      ++.+||.+||.+||++||     +++++++||||..
T Consensus       226 ~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         226 EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             HHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence            999999999999999999     8999999999964

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.2e-48  Score=358.59  Aligned_cols=257  Identities=27%  Similarity=0.385  Sum_probs=200.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||+||+|+++.+++    .+|+|.+....  .......+|+.+++.++ ||||+++++.+   . ...
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~---~-~~~   76 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGK----LVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDII---H-TKE   76 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCC----EEEEEEeccccccccchhHHHHHHHHhhCC-CCCcCeEEEEE---e-cCC
Confidence            68999999999999999999987654    67888765422  23345778999999998 99999998843   2 234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+. ++|.+++.+ ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        77 ~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          77 TLTLVFEYVH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             eEEEEEECCC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            5779999996 589888876 34569999999999999999999999999999999999999999999999999997643


Q ss_pred             CCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcch-HHHHHHHhhcCC--------
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN-VFSLLIRIGVGD--------  229 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~-~~~~~~~~~~~~--------  229 (366)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..+.. ....+.......        
T Consensus       155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         155 VPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             CCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence            221  12233468999999999865 458889999999999999999999998754321 111121110000        


Q ss_pred             -CCCC---------CC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 -ELPN---------IP---------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 -~~~~---------~~---------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                       ..+.         .+         ...+.++.+||.+||+.||++|||+.++++||||..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~  293 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD  293 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence             0000         00         024567899999999999999999999999999954

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.7e-48  Score=366.55  Aligned_cols=252  Identities=27%  Similarity=0.426  Sum_probs=202.8

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.||+|+||.||+|+++.+++    .+|+|.+..    .......+..|..++..+..||||+++++.+   . ....++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~---~-~~~~~~   72 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRR----IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF---Q-TESRLF   72 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE---E-cCCEEE
Confidence            479999999999999987765    677776654    2223456788999999997799999998832   2 234567


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +|||||+||+|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        73 lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          73 FVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence            999999999999998753  579999999999999999999999999999999999999999999999999987532111


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc-----hHHHHHHHhhcCCCCCCCCCC
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS-----NVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  237 (366)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......     .....+..... .....+|..
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~  227 (329)
T cd05588         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-EKQIRIPRS  227 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-cCCCCCCCC
Confidence              1223457999999999999999999999999999999999999999632111     11111111111 223356677


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC------HHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWT------AEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t------~~~ll~hp~~~~  271 (366)
                      ++.++.++|.+||..||.+|++      ++++++||||..
T Consensus       228 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            8999999999999999999987      789999999954

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-49  Score=344.99  Aligned_cols=255  Identities=24%  Similarity=0.371  Sum_probs=212.5

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEee
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLE   86 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E   86 (366)
                      ++||-|-.|.|-.+.++.+++    ++|+|.+..    .....+|++.--....|||||.+++.+.-...+..++.+|||
T Consensus        68 qvLG~GinGkV~~C~~k~T~e----kfALKvL~D----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE  139 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQE----KFALKVLLD----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME  139 (400)
T ss_pred             hhhccccCCceEEEEeccchh----hhHHHHHhc----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence            689999999999999999876    566666543    456788888888888899999999876555566788889999


Q ss_pred             cCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC---CceEEEecCCccccCCCCC
Q 017746           87 YASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN---DEAKIADFGLAKKSSCDGE  163 (366)
Q Consensus        87 ~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a~~~~~~~~  163 (366)
                      .++||+|+..|+.+....++|.++..|++||..|+.|||+.+|.||||||+|+|.+.+   ..+||+|||+|+....   
T Consensus       140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---  216 (400)
T KOG0604|consen  140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---  216 (400)
T ss_pred             cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC---
Confidence            9999999999998877889999999999999999999999999999999999999754   4699999999998643   


Q ss_pred             CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchH---HHHHHHhhcCCCCCCCCCCCCH
Q 017746          164 RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV---FSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .....+.|-||+|.|||++..+.|+..+|+||+||++|-|++|++||+......+   +..-++.+.-.....-++.+|+
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe  296 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE  296 (400)
T ss_pred             CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH
Confidence            2333456789999999999999999999999999999999999999986644221   2222222322222223456899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +++|+|+.+|..+|.+|.|++++++|||+...
T Consensus       297 ~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  297 AAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             HHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            99999999999999999999999999999543

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.6e-48  Score=371.42  Aligned_cols=257  Identities=26%  Similarity=0.444  Sum_probs=208.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+|+|.+..    .......+.+|+.+++.++ ||||+++++.   + ..
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~---~-~~  114 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQ----VYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYA---F-QD  114 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEE---E-ec
Confidence            58889999999999999999987765    677777653    1233445778999999998 9999999873   2 23


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         115 DKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            4567799999999999999865   3589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCc----CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNEN----EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      ...... ......+||+.|+|||++.+.    .++.++|||||||++|+|++|++||...........+.........|.
T Consensus       192 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  270 (370)
T cd05596         192 MDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD  270 (370)
T ss_pred             ccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence            542221 122345799999999998654    478899999999999999999999988766555555443222222222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCCcccC
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKR--RWTAEMLLNHPFVCAD  272 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~--R~t~~~ll~hp~~~~~  272 (366)
                       ...++.++.+||.+||..+|++  |++++++++||||...
T Consensus       271 -~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         271 -DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             -cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence             1247999999999999999988  9999999999999653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.5e-48  Score=363.54  Aligned_cols=248  Identities=24%  Similarity=0.398  Sum_probs=200.0

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHH-HHHcCCCCceeEeecceeeccCCeeEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEA-LDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~-l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      ++||+|+||+||+|+++.+++    .+++|.+...    ......+..|..+ ++.++ ||||+++++.+   .. ...+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~---~~-~~~~   71 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGK----FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSF---QT-ADKL   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEE---Ee-CCEE
Confidence            579999999999999987765    6778876531    1222344455554 46676 99999998732   22 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++.+  ++.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        72 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          72 YFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH  149 (323)
T ss_pred             EEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence            799999999999999975  357999999999999999999999999999999999999999999999999998754221


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+...     ...++..++.+
T Consensus       150 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~  222 (323)
T cd05575         150 S--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-----PLRLKPNISVS  222 (323)
T ss_pred             C--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCHH
Confidence            1  1223457999999999999999999999999999999999999999877554444443322     22345567999


Q ss_pred             HHHHHHHhcccCCCCCCCH----HHHHcCCCcccC
Q 017746          242 GKDFLIKCFLKDPKRRWTA----EMLLNHPFVCAD  272 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~----~~ll~hp~~~~~  272 (366)
                      +.++|.+||++||++||++    .++++||||...
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         223 ARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             HHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999999999987    699999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-47  Score=362.66  Aligned_cols=262  Identities=25%  Similarity=0.357  Sum_probs=204.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeecc-CC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~   77 (366)
                      +|.+.+.||+|+||.||+|+++.++.    .+++|.+...   ......+.+|+.+++.++ ||||+++++.+.... ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   75 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE   75 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCC----EEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCC
Confidence            68999999999999999999987765    7788876532   223446788999999998 999999998543322 12


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||. ++|.+++.+  +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          76 FKDIYVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             CceEEEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            234679999996 599999975  34699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCC-cccccccCCCCCCCccccCC--cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh--------
Q 017746          158 SSCDGER-SQSFECRGTPLYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG--------  226 (366)
Q Consensus       158 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~--------  226 (366)
                      ....... .......||+.|+|||++.+  ..++.++|||||||++|+|++|++||.+.........+....        
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            4322211 11234579999999999876  678999999999999999999999997765433222211100        


Q ss_pred             --------------cCCCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          227 --------------VGDELP----NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       227 --------------~~~~~~----~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                    .....+    .....+++++.++|.+||..||++||+++++++||||..
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence                          000000    011236788999999999999999999999999999954

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-49  Score=395.84  Aligned_cols=264  Identities=30%  Similarity=0.459  Sum_probs=224.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.++++||+|+||.|.+++++.+++.|+.+++-|--.........+..|..+|.--. .+.|++++   |.|++ +.++
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~Lh---yAFQD-~~~L  150 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLH---YAFQD-ERYL  150 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHH---HHhcC-ccce
Confidence            6899999999999999999999998866555554432233456677888888888777 89999987   35555 4566


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      |+||||++||||-.++.+. + +++++.+++|++.|+.||.-||+.|+|||||||+||||+.+|++||+|||.+-.+..+
T Consensus       151 YlVMdY~pGGDlltLlSk~-~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKF-D-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             EEEEecccCchHHHHHhhc-C-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            7999999999999999884 3 8999999999999999999999999999999999999999999999999999888755


Q ss_pred             CCCcccccccCCCCCCCccccCC-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          162 GERSQSFECRGTPLYMSPESVNE-----NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      +... +...+|||.|++||+++.     +.|+..+|+||+||++|||++|..||+...-.+++..|.+......+|... 
T Consensus       229 G~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~-  306 (1317)
T KOG0612|consen  229 GTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDET-  306 (1317)
T ss_pred             CcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccc-
Confidence            5443 345689999999999943     569999999999999999999999999998889999998887666666433 


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC---HHHHHcCCCcccCCCC
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWT---AEMLLNHPFVCADDQT  275 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t---~~~ll~hp~~~~~~~~  275 (366)
                      .+|+++++||.+.+. +|+.|..   ++++.+||||....+.
T Consensus       307 ~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  307 DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence            499999999998765 5889988   9999999999877664

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.2e-48  Score=364.66  Aligned_cols=252  Identities=27%  Similarity=0.443  Sum_probs=201.7

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.||+|+||.||+|+++.+++    .+|+|.+..    .......+.+|+.++.++..||||+++++.+   .. ...++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~---~~-~~~~~   72 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTER----IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF---QT-ESRLF   72 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCC----EEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE---Ee-CCEEE
Confidence            579999999999999988765    566666543    2233456778999999886799999999843   22 34567


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||+++|+|..++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        73 lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          73 FVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            999999999999998653  469999999999999999999999999999999999999999999999999987542211


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCC-----cchHHHHHHHhhcCCCCCCCCCC
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQ-----DSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....     .......+..... .....+|..
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~  227 (329)
T cd05618         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRS  227 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCCCC
Confidence              12234579999999999999999999999999999999999999995311     1111112222111 122346677


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC------HHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWT------AEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t------~~~ll~hp~~~~  271 (366)
                      ++.++.++|.+||..||++||+      ++++++||||..
T Consensus       228 ~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         228 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            8999999999999999999998      589999999955

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.1e-47  Score=352.98  Aligned_cols=260  Identities=26%  Similarity=0.419  Sum_probs=206.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcC--CCCceeEeecceeecc-
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIG--ICPQIVRCFGDDYSFE-   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~--~~p~Iv~~~g~~~~~~-   75 (366)
                      +|.+.+.||+|+||+||+|.++.+++    .+++|.+....   .......+|+.+++.+.  .||||+++++.+.... 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~   76 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGH----FVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT   76 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCc----EEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence            68999999999999999999988765    67777665421   22335667888887774  4999999998654322 


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      .....++++|||+.+ +|.+++.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            234557799999985 9999997654456899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC---C--
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD---E--  230 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~---~--  230 (366)
                      +......   ......||+.|+|||++.+..++.++|||||||++|+|++|++||...........+.......   .  
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8764221   1223468999999999999999999999999999999999999998765544443333211000   0  


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          231 -----------------LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       231 -----------------~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                                       .......++..+.++|.+||..||++|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                             001123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.9e-48  Score=370.34  Aligned_cols=257  Identities=26%  Similarity=0.434  Sum_probs=206.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+|+|.+..    .......+.+|+.+++.++ ||||+++++.+   . .
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~---~-~  114 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQK----VYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAF---Q-D  114 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEE---E-c
Confidence            58899999999999999999987765    566666543    2233456778999999998 99999999732   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +..+++|||||+||+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence            4567799999999999999965   3589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcC----CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENE----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      ...... ......+||+.|+|||++.+..    ++.++|||||||++|+|++|++||...........+.........|.
T Consensus       192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  270 (370)
T cd05621         192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE  270 (370)
T ss_pred             cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC
Confidence            642221 1223457999999999997643    78899999999999999999999987766555555443222222222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCCcccC
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKR--RWTAEMLLNHPFVCAD  272 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~--R~t~~~ll~hp~~~~~  272 (366)
                       ...++..+++++.+||..++.+  |++++++++||||...
T Consensus       271 -~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         271 -DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             -cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence             1246999999999999866544  8999999999999653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-47  Score=360.79  Aligned_cols=249  Identities=29%  Similarity=0.483  Sum_probs=206.2

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.||+|+||+||+|.++.+++    .+|+|.+..    .......+.+|+.++..+..||||+++++.+   . ....++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~---~-~~~~~~   72 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDE----LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF---Q-TKDRLF   72 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE---E-cCCEEE
Confidence            579999999999999987765    677776653    2234456778999999987799999999842   2 234577


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||++||+|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        73 lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          73 FVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             EEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            999999999999999763  479999999999999999999999999999999999999999999999999987532211


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..     ..+.++..++.++
T Consensus       151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~~  223 (318)
T cd05570         151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-----DEVRYPRWLSKEA  223 (318)
T ss_pred             --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-----CCCCCCCcCCHHH
Confidence              122334699999999999999999999999999999999999999987665444433332     2234566789999


Q ss_pred             HHHHHHhcccCCCCCCCH-----HHHHcCCCcccC
Q 017746          243 KDFLIKCFLKDPKRRWTA-----EMLLNHPFVCAD  272 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t~-----~~ll~hp~~~~~  272 (366)
                      .+||.+||..||++||++     .++++||||...
T Consensus       224 ~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         224 KSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             HHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999999999     999999999653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=365.65  Aligned_cols=247  Identities=25%  Similarity=0.432  Sum_probs=209.3

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      ..++.||+|-||+|++|..+.+.     ++++|.+....-....+.+|+++|++|+ |++||+++|++    ..+.-++|
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~-----~vavk~ik~~~m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~----~~~~piyI  278 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGST-----KVAVKTIKEGSMSPEAFLREAQIMKKLR-HEKLVKLYGVC----TKQEPIYI  278 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCC-----cccceEEeccccChhHHHHHHHHHHhCc-ccCeEEEEEEE----ecCCceEE
Confidence            46789999999999999998753     6788887765556677889999999999 99999999943    22335779


Q ss_pred             EeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCC
Q 017746           84 LLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE  163 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  163 (366)
                      |||||+.|+|.++|+...++.+...+...++.||++|++||+++++|||||.+.||||+++..+||+|||+|+... ++.
T Consensus       279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~  357 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDE  357 (468)
T ss_pred             EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC-CCc
Confidence            9999999999999998667789999999999999999999999999999999999999999999999999999543 223


Q ss_pred             CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          164 RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                      ........-..-|.|||.+....++.++|||||||+||||+| |+.||.+.+..+..+.+.   .+..+|. |..+|+++
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le---~GyRlp~-P~~CP~~v  433 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE---RGYRLPR-PEGCPDEV  433 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh---ccCcCCC-CCCCCHHH
Confidence            222222234567999999999999999999999999999998 999999987766655544   3445543 66799999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHc
Q 017746          243 KDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+++..||..+|++|||++.|..
T Consensus       434 Y~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  434 YELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHHhhCCcccCCCHHHHHH
Confidence            99999999999999999998764

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-47  Score=360.20  Aligned_cols=260  Identities=27%  Similarity=0.421  Sum_probs=207.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+++++.+++    .+|+|.+..    .......+.+|+.++..++ ||||+++++.   +. .
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~---~~-~   72 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQ----VYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYA---FQ-D   72 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEE---Ee-c
Confidence            68999999999999999999987765    677777653    1223455788999999987 9999999873   22 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +..+++||||++||+|.+++.+ .+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          73 ENNLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             CCeEEEEEecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence            4567799999999999999976 345799999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE-----NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      ....... .....+||+.|+|||++..     ..++.++|||||||++|+|++|+.||......+....+.........+
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  230 (331)
T cd05597         152 LLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP  230 (331)
T ss_pred             cCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence            5432221 1223469999999999863     457889999999999999999999998766555544444333222333


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCCcccC
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKR--RWTAEMLLNHPFVCAD  272 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~--R~t~~~ll~hp~~~~~  272 (366)
                      .....+++++++||.+||..++++  |++++++++||||...
T Consensus       231 ~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            334458999999999988654443  7899999999999553

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-47  Score=361.93  Aligned_cols=258  Identities=25%  Similarity=0.388  Sum_probs=204.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|.+.... ......+|+|.+....  .....+.+|+.++..+..||||+++++.+   ....
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~---~~~~   84 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC---TKPN   84 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe---cCCC
Confidence            5889999999999999999864322 1223468888876422  23456889999999996699999999843   2233


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC---------------------------------------------------------
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN---------------------------------------------------------  101 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~---------------------------------------------------------  101 (366)
                      ..+++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            45679999999999999997521                                                         


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCC
Q 017746          102 ---NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS  178 (366)
Q Consensus       102 ---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a  178 (366)
                         ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence               12477889999999999999999999999999999999999999999999999986543222222223456788999


Q ss_pred             ccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 017746          179 PESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR  257 (366)
Q Consensus       179 PE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R  257 (366)
                      ||++.+..++.++|||||||++|||++ |..||.+....+........   ...+..+..+++++.+++.+||..||++|
T Consensus       245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD---GTRMRAPENATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc---CCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999999999999999999999997 99999876544333322222   22334456789999999999999999999


Q ss_pred             CCHHHHHc
Q 017746          258 WTAEMLLN  265 (366)
Q Consensus       258 ~t~~~ll~  265 (366)
                      ||+.+|++
T Consensus       322 Ps~~el~~  329 (338)
T cd05102         322 PTFSALVE  329 (338)
T ss_pred             cCHHHHHH
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-47  Score=353.40  Aligned_cols=257  Identities=25%  Similarity=0.354  Sum_probs=211.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      .|++.++||+|+||+||++.+..++.    .+|+|.+....    .....+.+|+.+++.++ ||||+++++.+   .. 
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---~~-   71 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAY---ET-   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCc----eEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeee---cC-
Confidence            48899999999999999999877654    67888765421    22345678999999998 99999998732   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +..+++||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++..
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            34677999999999999998764445699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.......+.+.... ....+.++..
T Consensus       152 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~  227 (285)
T cd05605         152 IPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV-KEDQEEYSEK  227 (285)
T ss_pred             cCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh-hhcccccCcc
Confidence            54222   1223469999999999999999999999999999999999999998765544333333221 1223345566


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      ++..+.+|+.+||..||++||     +++++++||||..
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            899999999999999999999     8999999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-47  Score=360.71  Aligned_cols=247  Identities=26%  Similarity=0.423  Sum_probs=198.0

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHH-HHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKE-ALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~-~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      ++||+|+||.||+|++..+++    .+++|.+...    ......+..|+. +++.++ ||||+++++.+   .. ...+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~---~~-~~~~   71 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGS----FYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSF---QT-AEKL   71 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEE---Ec-CCEE
Confidence            479999999999999987765    6677765431    122334555554 566776 99999998732   22 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|..++.+  ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        72 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          72 YFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP  149 (321)
T ss_pred             EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence            799999999999998865  356899999999999999999999999999999999999999999999999998753211


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..     ....++...+.+
T Consensus       150 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~  222 (321)
T cd05603         150 E--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-----KPLQLPGGKTVA  222 (321)
T ss_pred             C--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc-----CCCCCCCCCCHH
Confidence            1  122345799999999999999999999999999999999999999987654443333322     123456678899


Q ss_pred             HHHHHHHhcccCCCCCCCH----HHHHcCCCccc
Q 017746          242 GKDFLIKCFLKDPKRRWTA----EMLLNHPFVCA  271 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~----~~ll~hp~~~~  271 (366)
                      +.++|.+||++||.+|+++    .++++|+||..
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         223 ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             HHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence            9999999999999999875    59999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-47  Score=361.19  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=209.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|...+.||+|+||.||+|.++.+++    .+|+|.+..    .......+..|..++..+.+|++|+++++.   +.. 
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~---~~~-   72 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDE----LYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC---FQT-   72 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE---Eec-
Confidence            47888999999999999999988765    677776653    223345577889999999877888888763   233 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+.  +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          73 VDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence            34567999999999999999763  5699999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....     ..+|..
T Consensus       151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----~~~p~~  223 (323)
T cd05615         151 HMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----VSYPKS  223 (323)
T ss_pred             cCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----CCCCcc
Confidence            43222  12234569999999999999999999999999999999999999998776555444444322     245567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~  272 (366)
                      ++.++.+++.+||.++|.+|++     .+++++||||...
T Consensus       224 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         224 LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            8999999999999999999997     4799999999653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.2e-47  Score=360.19  Aligned_cols=249  Identities=27%  Similarity=0.463  Sum_probs=204.4

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.||+|+||+||+|++..+++    .+|+|.+...    .........|..++..+..||||+++++.+   .. ...++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~---~~-~~~~~   72 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQ----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF---QT-KENLF   72 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE---Ee-CCEEE
Confidence            579999999999999987765    6777776542    233455677888888776699999998743   22 34577


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||++||+|.+++.+.  ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        73 lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          73 FVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            999999999999999763  468999999999999999999999999999999999999999999999999987542211


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..     ..+.++..++.++
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~~  223 (316)
T cd05619         151 A--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-----DNPCYPRWLTREA  223 (316)
T ss_pred             C--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----CCCCCCccCCHHH
Confidence            1  22345799999999999999999999999999999999999999987665444443322     1234566789999


Q ss_pred             HHHHHHhcccCCCCCCCHH-HHHcCCCcccC
Q 017746          243 KDFLIKCFLKDPKRRWTAE-MLLNHPFVCAD  272 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t~~-~ll~hp~~~~~  272 (366)
                      .+||.+||.+||++||++. +++.||||...
T Consensus       224 ~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         224 KDILVKLFVREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             HHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence            9999999999999999996 99999999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.7e-47  Score=363.21  Aligned_cols=253  Identities=28%  Similarity=0.439  Sum_probs=202.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|..++.||+|+||.||+|++..+++    .+++|.+.....  ....+.+|+++++.++ |+||+++++.+    ....
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~----~~~~  145 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGR----LYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMF----DHNG  145 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCC----EEEEEEEecCCcHHHHHHHHHHHHHHHhCC-CCCcceeeeEe----ccCC
Confidence            47788999999999999999887665    788887754222  2456889999999998 99999999832    3344


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+..      ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       146 ~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            567999999999986532      35788889999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCC-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE-----NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ....  ......||..|+|||++..     ...+.++|||||||++|||++|+.||...........+.... ....+..
T Consensus       220 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~  296 (353)
T PLN00034        220 QTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEA  296 (353)
T ss_pred             cccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCC
Confidence            2211  1223479999999998743     234568999999999999999999997544333333333322 2233455


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +..++.++++||.+||..||++||++.|+++||||...
T Consensus       297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        297 PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            66789999999999999999999999999999999553

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.3e-48  Score=368.48  Aligned_cols=258  Identities=26%  Similarity=0.453  Sum_probs=207.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|...+.||+|+||.||+|.++.+++    .+|+|.+..    .......+.+|+.++.+++ ||+|+++++.   +. .
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~---~~-~   72 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGH----IYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYS---FQ-D   72 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEE---EE-c
Confidence            58899999999999999999987765    677777643    2234556788999999998 8999999873   23 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||+||+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          73 KRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             CCEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            44677999999999999999763  4699999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCCC---------------------------------CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHH
Q 017746          158 SSCDGE---------------------------------RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMA  204 (366)
Q Consensus       158 ~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~eml  204 (366)
                      ......                                 .......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            421100                                 00112357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCCCcccC
Q 017746          205 SGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRW---TAEMLLNHPFVCAD  272 (366)
Q Consensus       205 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~---t~~~ll~hp~~~~~  272 (366)
                      +|++||...........+.........|.. ..+++++++||.+|+. ||.+|+   +++++++||||...
T Consensus       231 tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         231 IGYPPFCSETPQETYRKVMNWKETLVFPPE-VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCceecCCC-CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            999999887665555444432211122211 2378999999999874 999998   48999999999653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2e-47  Score=352.49  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=202.2

Q ss_pred             eeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            9 IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         9 lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ||+|+||+||++.++.+++    .+++|.+....    .....+..|+.+++.++ ||||+++.+.   +. ....+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~---~~-~~~~~~lv   71 (280)
T cd05608           1 LGKGGFGEVSACQMRATGK----LYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYA---FQ-TKTDLCLV   71 (280)
T ss_pred             CCCCCceeEEEEEEccCCc----EEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEE---Ec-CCCeEEEE
Confidence            7999999999999987765    67777765421    12245678999999998 9999999873   22 23456799


Q ss_pred             eecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           85 LEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      |||+++|+|.+++...  .+..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  151 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ  151 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC
Confidence            9999999999888542  23469999999999999999999999999999999999999999999999999998764322


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... .....++..++.++
T Consensus       152 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  228 (280)
T cd05608         152 S--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-NDSVTYPDKFSPAS  228 (280)
T ss_pred             c--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc-ccCCCCcccCCHHH
Confidence            2  22334799999999999999999999999999999999999999976543322222222222 12234556789999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          243 KDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      .+++.+||+.||++||     +++++++||||+.
T Consensus       229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         229 KSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            9999999999999999     8899999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-47  Score=361.38  Aligned_cols=248  Identities=25%  Similarity=0.395  Sum_probs=198.9

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHH-HHHcCCCCceeEeecceeeccCCeeEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEA-LDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~-l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +.||+|+||+||+|+++.+++    .+++|.+...    ......+..|..+ ++.++ ||||+++++.   +.. ...+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~---~~~-~~~~   71 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGK----CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYS---FQT-TEKL   71 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEE---Eec-CCEE
Confidence            579999999999999987765    6777766431    1233445556554 55566 9999999873   222 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++.+  .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        72 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~  149 (325)
T cd05604          72 YFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence            799999999999999865  357999999999999999999999999999999999999999999999999998754211


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                        .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...     ...++...+..
T Consensus       150 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~  222 (325)
T cd05604         150 --SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----PLVLRPGASLT  222 (325)
T ss_pred             --CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----CccCCCCCCHH
Confidence              11223457999999999999999999999999999999999999999877655444443321     12334457899


Q ss_pred             HHHHHHHhcccCCCCCCCH----HHHHcCCCcccC
Q 017746          242 GKDFLIKCFLKDPKRRWTA----EMLLNHPFVCAD  272 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~----~~ll~hp~~~~~  272 (366)
                      +.++|.+||.+||.+||++    .++++||||...
T Consensus       223 ~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         223 AWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             HHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            9999999999999999976    599999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.8e-47  Score=359.95  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=207.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+++++.+++    .+|+|.+..    .......+.+|..++..+. |++|+++++.+   . .
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~---~-~   72 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTER----IYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAF---Q-D   72 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEE---E-c
Confidence            68999999999999999999987765    567776643    1123345777888988887 99999998732   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+ .++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        73 ~~~~~lv~Ey~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          73 ENYLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence            4567799999999999999976 345799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE-----NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      ....... .....+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||......+....+.........|
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p  230 (331)
T cd05624         152 MNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP  230 (331)
T ss_pred             ccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence            6432221 1223469999999999876     568889999999999999999999998766555444444332222334


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCCccc
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKR--RWTAEMLLNHPFVCA  271 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~--R~t~~~ll~hp~~~~  271 (366)
                      .....++++++++|.+||..++++  |++++++++||||..
T Consensus       231 ~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         231 SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            434457999999999999876654  568999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-47  Score=362.24  Aligned_cols=248  Identities=27%  Similarity=0.428  Sum_probs=196.0

Q ss_pred             eeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcC--CCCceeEeecceeeccCCeeEEE
Q 017746            9 IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIG--ICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         9 lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~--~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      ||+|+||+||+|+++.+++    .+|+|.+...    .........|..++..+.  .||||+++++.   +.. ...++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~---~~~-~~~~~   72 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRR----IYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFS---FQT-DSDLY   72 (330)
T ss_pred             CCCCCceEEEEEEECCCCC----EEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEE---Eec-CCeEE
Confidence            7999999999999987765    6777776431    122233455667776654  69999999873   222 34567


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||+++|+|.+++.+  .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        73 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          73 LVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             EEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            99999999999999975  3579999999999999999999999999999999999999999999999999997643222


Q ss_pred             CCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                        ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.....  ..+  ...++++
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~--~~~~~~~  224 (330)
T cd05586         151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--RFP--KNVLSDE  224 (330)
T ss_pred             --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--CCC--CccCCHH
Confidence              122345799999999998765 489999999999999999999999987655444333322111  111  2347899


Q ss_pred             HHHHHHHhcccCCCCCC----CHHHHHcCCCcccC
Q 017746          242 GKDFLIKCFLKDPKRRW----TAEMLLNHPFVCAD  272 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~----t~~~ll~hp~~~~~  272 (366)
                      +.+||.+||.+||++||    +++++++||||...
T Consensus       225 ~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         225 GRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             HHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            99999999999999998    79999999999643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.3e-47  Score=363.60  Aligned_cols=256  Identities=27%  Similarity=0.451  Sum_probs=214.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC-----CceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----PQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~-----p~Iv~~~g~~~~~~~   76 (366)
                      +|.+.++||+|+||.|.+|.+..+++    .||+|++.....-......|+.+|..|+.|     -|+|+++++++.   
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e----~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f---  259 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGE----IVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF---  259 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCc----EEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc---
Confidence            68999999999999999999998865    899999988767777888899999999843     589999996554   


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC--ceEEEecCC
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND--EAKIADFGL  154 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~--~vkl~DFG~  154 (366)
                       .++.|||+|++.- +|+++|+...-..|+...++.++.||+.||.+||+.||||+|||||||||...+  .|||+|||.
T Consensus       260 -r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  260 -RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             -ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence             4567899999976 999999876555699999999999999999999999999999999999997543  799999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh--------
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG--------  226 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~--------  226 (366)
                      |....     ...++++.+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+....+++..|....        
T Consensus       338 Sc~~~-----q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  338 SCFES-----QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             ccccC-----CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            98752     22236678999999999999999999999999999999999999999988877777666421        


Q ss_pred             ---------cC--CCCC----------------------------CCC-C----------CCCHHHHHHHHHhcccCCCC
Q 017746          227 ---------VG--DELP----------------------------NIP-G----------DLSEQGKDFLIKCFLKDPKR  256 (366)
Q Consensus       227 ---------~~--~~~~----------------------------~~~-~----------~~s~~~~~ll~~cL~~dp~~  256 (366)
                               +.  ...+                            ..| +          .-...+.|||.+||+.||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence                     00  0000                            011 0          11245689999999999999


Q ss_pred             CCCHHHHHcCCCccc
Q 017746          257 RWTAEMLLNHPFVCA  271 (366)
Q Consensus       257 R~t~~~ll~hp~~~~  271 (366)
                      |+|+.++++|||+..
T Consensus       493 R~tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  493 RITPAQALNHPFLTG  507 (586)
T ss_pred             cCCHHHHhcCccccc
Confidence            999999999999964

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.7e-47  Score=350.13  Aligned_cols=251  Identities=26%  Similarity=0.400  Sum_probs=200.8

Q ss_pred             eeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            9 IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         9 lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ||+|+||.||++..+.+++    .+++|.+...    .........|++++++++ ||||+++++.   ++ ....+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~---~~-~~~~~~lv   71 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGK----MYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYA---FE-SKTHLCLV   71 (277)
T ss_pred             CCCCCceEEEEEEEccCCc----EEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEE---Ee-cCCeEEEE
Confidence            7999999999999987765    6777766431    122344567999999998 9999999873   22 34567799


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||++|++|.+++.......+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.......  
T Consensus        72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--  149 (277)
T cd05607          72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--  149 (277)
T ss_pred             EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--
Confidence            999999999999876444468999999999999999999999999999999999999999999999999998764221  


Q ss_pred             cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHH
Q 017746          165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD  244 (366)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  244 (366)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.+.......+.....++.++++
T Consensus       150 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (277)
T cd05607         150 -TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKD  228 (277)
T ss_pred             -eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHH
Confidence             1223469999999999999999999999999999999999999997654322222333322222222223457999999


Q ss_pred             HHHHhcccCCCCCCCH----HHHHcCCCccc
Q 017746          245 FLIKCFLKDPKRRWTA----EMLLNHPFVCA  271 (366)
Q Consensus       245 ll~~cL~~dp~~R~t~----~~ll~hp~~~~  271 (366)
                      +|.+||.+||++||++    +++++||||+.
T Consensus       229 li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         229 ICRLFLAKKPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             HHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence            9999999999999999    67889999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.7e-47  Score=359.51  Aligned_cols=253  Identities=28%  Similarity=0.433  Sum_probs=203.0

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      ++||+|+||+||+|++..+++    .+++|.+..    .......+.+|+.++.++..||+|+++++.   +.. ...++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~---~~~-~~~~~   72 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQ----IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSC---FQT-TSRLF   72 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEE---EEe-CCEEE
Confidence            479999999999999987765    566776653    223345678899999999879999999873   222 34577


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||++||+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        73 lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          73 LVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            999999999999998753  469999999999999999999999999999999999999999999999999987532211


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc---hHHHHHHHhhcCCCCCCCCCCCC
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS---NVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .....+...... ....+|..++
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~  227 (327)
T cd05617         151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KPIRIPRFLS  227 (327)
T ss_pred             --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CCCCCCCCCC
Confidence              1223457999999999999999999999999999999999999999643211   111122222111 2234667789


Q ss_pred             HHHHHHHHHhcccCCCCCCC------HHHHHcCCCcccC
Q 017746          240 EQGKDFLIKCFLKDPKRRWT------AEMLLNHPFVCAD  272 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t------~~~ll~hp~~~~~  272 (366)
                      ..+.++|.+||.+||++|++      ++++++||||...
T Consensus       228 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            99999999999999999997      5799999999653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.5e-47  Score=360.48  Aligned_cols=259  Identities=27%  Similarity=0.420  Sum_probs=207.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+++++.+++    .+++|.+..    .......+..|+.++..++ |++|+++++.   +. .
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~---~~-~   72 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADK----VFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYA---FQ-D   72 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCC----EEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEE---Ee-c
Confidence            68899999999999999999987655    667776543    1223345778888998887 8999999873   22 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++|+|.+++.+ .+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          73 ENNLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             CCEEEEEEeccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence            4456799999999999999976 345799999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      ...... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||......+....+.........|
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p  230 (332)
T cd05623         152 LMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP  230 (332)
T ss_pred             cccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCC
Confidence            532222 1122347999999999986     3468899999999999999999999998776555555444333223344


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCCccc
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKR--RWTAEMLLNHPFVCA  271 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~--R~t~~~ll~hp~~~~  271 (366)
                      .....++.++++||.+||..++++  |++++++++||||..
T Consensus       231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            444568999999999999665444  689999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.5e-47  Score=365.73  Aligned_cols=257  Identities=26%  Similarity=0.441  Sum_probs=205.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+|+|.+..    .......+.+|+.+++.++ ||||+++++.+   . .
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~----~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~---~-~  114 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHKSTRK----VYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAF---Q-D  114 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEECCCCc----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEE---E-c
Confidence            58899999999999999999988765    667776543    1223445778899999998 99999999732   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            4567799999999999999965   3589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcC----CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENE----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      ...... ......+||+.|+|||++.+..    ++.++|||||||++|+|++|++||...........+.........|.
T Consensus       192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  270 (371)
T cd05622         192 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD  270 (371)
T ss_pred             cCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence            643221 1223457999999999987643    78899999999999999999999987765555555443222222222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCCcccC
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKR--RWTAEMLLNHPFVCAD  272 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~--R~t~~~ll~hp~~~~~  272 (366)
                       ...++..++++|.+||..++.+  |++++++++||||...
T Consensus       271 -~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         271 -DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             -cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence             2358999999999999854443  7899999999999653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.4e-47  Score=356.70  Aligned_cols=255  Identities=27%  Similarity=0.421  Sum_probs=205.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||++++..++.    .+++|......  .....+.+|++++++++ ||||+++++.+.   . ..
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~---~-~~   76 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKPSGL----IMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFY---S-DG   76 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECCCCc----EEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEE---E-CC
Confidence            68899999999999999999987654    67777765421  23456889999999998 999999998432   2 33


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      .+++||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          77 EISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             EEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            567999999999999999763  4689999999999999999999986 6999999999999999999999999999765


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHH--------------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR--------------  224 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~--------------  224 (366)
                      ...    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..              
T Consensus       155 ~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (331)
T cd06649         155 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS  230 (331)
T ss_pred             ccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence            321    12234699999999999999999999999999999999999999976543332221111              


Q ss_pred             ----------------------------hhcCCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          225 ----------------------------IGVGDELPNI-PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       225 ----------------------------~~~~~~~~~~-~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                                  .......+.. ...++.++++||.+||..||++|||+++|++||||+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~  306 (331)
T cd06649         231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR  306 (331)
T ss_pred             cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence                                        0000111111 1246889999999999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.1e-47  Score=357.90  Aligned_cols=248  Identities=24%  Similarity=0.401  Sum_probs=198.6

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHH-HHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKE-ALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~-~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +.||+|+||+||+|+++.+++    .+++|.+...    ......+..|.. +++.+. ||||+++++.+   .. ...+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~---~~-~~~~   71 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEK----FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSF---QT-ADKL   71 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEE---Ec-CCeE
Confidence            479999999999999987765    5667765431    122234444544 456666 99999998732   22 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++.+  .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        72 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~  149 (325)
T cd05602          72 YFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  149 (325)
T ss_pred             EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence            799999999999999976  346899999999999999999999999999999999999999999999999999754221


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .  ......+||+.|+|||++.+..++.++|||||||++|+|++|++||......+....+....     ..++..++..
T Consensus       150 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~  222 (325)
T cd05602         150 N--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-----LQLKPNITNS  222 (325)
T ss_pred             C--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-----cCCCCCCCHH
Confidence            1  12234579999999999999999999999999999999999999998776555444443321     2344568999


Q ss_pred             HHHHHHHhcccCCCCCCCHH----HHHcCCCcccC
Q 017746          242 GKDFLIKCFLKDPKRRWTAE----MLLNHPFVCAD  272 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~----~ll~hp~~~~~  272 (366)
                      +.++|.+||++||.+|+++.    ++++|+||...
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         223 ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence            99999999999999999875    89999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-47  Score=358.28  Aligned_cols=251  Identities=29%  Similarity=0.464  Sum_probs=205.3

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      ++.||+|+||.||++++... ...+..+++|.+...   ........+|++++.+++ ||||+++++.+   .. ...++
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~---~~-~~~~~   74 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITG-PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYAF---QT-EGKLY   74 (318)
T ss_pred             CceeeeCCCEEEEEEEEecc-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC-CCCcccEEEEE---Ec-CCEEE
Confidence            46899999999999986421 123457888877642   123445678999999998 99999998742   22 34567


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          75 LILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            999999999999999653  469999999999999999999999999999999999999999999999999998653221


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...     ...++..++.++
T Consensus       153 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~-----~~~~p~~~~~~~  225 (318)
T cd05582         153 --KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA-----KLGMPQFLSPEA  225 (318)
T ss_pred             --CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCHHH
Confidence              2223457999999999999999999999999999999999999999877655444443322     224566789999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHHcCCCccc
Q 017746          243 KDFLIKCFLKDPKRRWT-----AEMLLNHPFVCA  271 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~  271 (366)
                      .+||.+||++||++||+     ++++++||||..
T Consensus       226 ~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         226 QSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            99999999999999999     788999999964

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.8e-47  Score=374.01  Aligned_cols=256  Identities=21%  Similarity=0.335  Sum_probs=210.0

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      |.+.+.||+|+||.||+|....+..   .++++|....... ....+.+|+.++..++ ||||+++++.+   .. ...+
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~---~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~---~~-~~~~  140 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPK---EKVVAKFVMLNDERQAAYARSELHCLAACD-HFGIVKHFDDF---KS-DDKL  140 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCC---eEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEE---EE-CCEE
Confidence            8889999999999999999876532   3677776544322 3345778999999998 99999999843   22 3456


Q ss_pred             EEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           82 NLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ++||||++||+|.+++...  ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            7999999999999988642  23568999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      ...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..    ...+..+..++
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~s  296 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY----GKYDPFPCPVS  296 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCCccCC
Confidence            33222223445799999999999999999999999999999999999999987654443333322    22234556789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      .++.+||.+||.+||++||++++++.|+|+.
T Consensus       297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~  327 (478)
T PTZ00267        297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLK  327 (478)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence            9999999999999999999999999999984

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.9e-47  Score=373.97  Aligned_cols=261  Identities=25%  Similarity=0.373  Sum_probs=213.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeecc---
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE---   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~---   75 (366)
                      +|.+.+.||+|+||+||+|++..+++    .+|+|.+....   .....+.+|+..+..+. |+||+++++.+....   
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGE----PFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCC----EEEEEEEecccCCHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccC
Confidence            69999999999999999999887765    78888775432   23456788999999998 999999887543221   


Q ss_pred             -CCeeEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEec
Q 017746           76 -KGERFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADF  152 (366)
Q Consensus        76 -~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF  152 (366)
                       .....+++||||+++|+|.+++..+  ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence             1123467999999999999999753  2346899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          153 GLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       153 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      |+++..............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||......+....+..    ...+
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~----~~~~  263 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA----GRYD  263 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc----CCCC
Confidence            999875432222223445799999999999999999999999999999999999999987654433333222    2233


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .++..+++++.+++.+||..||++||++.++++|||+..
T Consensus       264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            456778999999999999999999999999999999753

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.5e-46  Score=342.85  Aligned_cols=259  Identities=27%  Similarity=0.456  Sum_probs=210.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccC--Cee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK--GER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~--~~~   79 (366)
                      .|...+.||+|+||.||+|....++.    .+++|...........+.+|+.+++++..||||+++++.+.....  ...
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~----~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQ----LAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCc----EEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            47888999999999999999877654    788888876556667889999999999669999999996543221  134


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .++++|||+++|+|.+++....+..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            67799999999999999987444578999999999999999999999999999999999999999999999999998653


Q ss_pred             CCCCCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ...  .......|++.|+|||++.     +..++.++|||||||++|+|++|+.||...........+..   .......
T Consensus       163 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~  237 (272)
T cd06637         163 RTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPAPRLK  237 (272)
T ss_pred             ccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CCCCCCC
Confidence            221  1223456999999999986     34588899999999999999999999976544332222221   1122222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +..++.++.+|+.+||..||.+||++.++++||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            34578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-48  Score=355.95  Aligned_cols=263  Identities=25%  Similarity=0.383  Sum_probs=221.6

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      |+.-++||+|+||.||-++.+.+|+-|+.+.+-|+-.+.........+|..+|.+++ .+.||.+-   |.++. ...++
T Consensus       187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVsla---YAfeT-kd~LC  261 (591)
T KOG0986|consen  187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLA---YAFET-KDALC  261 (591)
T ss_pred             eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEe---eeecC-CCceE
Confidence            567789999999999999999999877777777665555566777889999999999 79999885   33443 44577


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      |||..|+||||.-+|....+..|++..+..|+++|+.||++||+.+||+|||||+|||||+.|++.|+|.|+|..+..+.
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            99999999999999988655679999999999999999999999999999999999999999999999999999886443


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                      ..   ...+||.+|||||++.++.|+..+|+|||||++|||+.|+.||.......-.+.+.+..... .-.+++.+|+++
T Consensus       342 ~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-~~ey~~kFS~ea  417 (591)
T KOG0986|consen  342 PI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-PEEYSDKFSEEA  417 (591)
T ss_pred             cc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-hhhcccccCHHH
Confidence            32   23379999999999999999999999999999999999999997665443343344333322 235678899999


Q ss_pred             HHHHHHhcccCCCCCC-----CHHHHHcCCCcccCCC
Q 017746          243 KDFLIKCFLKDPKRRW-----TAEMLLNHPFVCADDQ  274 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~~~  274 (366)
                      ++++..+|++||++|.     +++++..||||+.-+.
T Consensus       418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw  454 (591)
T KOG0986|consen  418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW  454 (591)
T ss_pred             HHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence            9999999999999997     5679999999976444

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-47  Score=359.93  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=206.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .|.+++.||+||.+.||++...+.+..+..++..+..  .......+.+|++.|.+|++|.+|+++++    ++-++.++
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~--D~qtl~gy~nEI~lL~KLkg~~~IIqL~D----YEv~d~~l  435 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA--DNQTLDGYRNEIALLNKLKGHDKIIQLYD----YEVTDGYL  435 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc--CHHHHHHHHHHHHHHHHhcCCceEEEEee----eeccCceE
Confidence            5899999999999999999876554322222222222  23456778999999999999999999998    44457789


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ||||||-+. ||..+|++. ...++...++.|..||+.|+.++|.+||||.||||.|+|+- .|.+||+|||+|..+..+
T Consensus       436 YmvmE~Gd~-DL~kiL~k~-~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  436 YMVMECGDI-DLNKILKKK-KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             EEEeecccc-cHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            999998766 999999874 34455568999999999999999999999999999999995 478999999999998877


Q ss_pred             CCCcccccccCCCCCCCccccCCcC-----------CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh---c
Q 017746          162 GERSQSFECRGTPLYMSPESVNENE-----------YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG---V  227 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~---~  227 (366)
                      .........+||+.||+||.+....           .+.++||||||||||+|+.|++||.....  ....+..+.   .
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAITDPNH  590 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhhcCCCc
Confidence            7777777789999999999885433           45789999999999999999999965532  233333332   2


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..++|.++..  .++.++++.||..||++||++.+||+|||+..
T Consensus       591 ~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  591 EIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             cccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            2345555542  34999999999999999999999999999854

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.2e-46  Score=356.57  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=200.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+.+.||+|+||.||++.+..++.    .+++|.+...   ......+.+|+.+++.++ ||||+++++.+....  .
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          22 RYQQLKPIGSGAQGIVCAAFDTVLGI----NVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             ceEEEEEeecCCCEEEEEEEEcCCCc----eeEEEEecccccchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCcc
Confidence            68999999999999999999887654    6788876532   223456778999999998 999999998543211  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||+.+ +|.+.+..    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            12346799999976 77777643    48899999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh----------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG----------  226 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~----------  226 (366)
                      .....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....          
T Consensus       172 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         172 TACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             ccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            64321   12233468999999999999999999999999999999999999998765433222111100          


Q ss_pred             ----------cCCCCC-----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          227 ----------VGDELP-----------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       227 ----------~~~~~~-----------------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                .....+                 ......++++++||.+||..||++|||+.|+++||||..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                      000000                 011124678899999999999999999999999999953

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-46  Score=361.16  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=198.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+|+|...     ...+.+|++++++++ ||||+++++.+.   . ....
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~----~vaiK~~~-----~~~~~~E~~il~~l~-HpnIv~~~~~~~---~-~~~~  158 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCE----HVVIKAGQ-----RGGTATEAHILRAIN-HPSIIQLKGTFT---Y-NKFT  158 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCC----EEEEechh-----hhhhHHHHHHHHhCC-CCCCCCEeEEEE---E-CCee
Confidence            58999999999999999999987765    78888633     345789999999998 999999998432   2 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++|||++. ++|..++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus       159 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        159 CLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             EEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            79999996 5999998663  46899999999999999999999999999999999999999999999999999753221


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCc-------chHHHHHHHh-hc------
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD-------SNVFSLLIRI-GV------  227 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~-------~~~~~~~~~~-~~------  227 (366)
                       ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.....       ......+.+. +.      
T Consensus       236 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        236 -NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             -cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence             11122345799999999999999999999999999999999999988754321       1111111110 00      


Q ss_pred             -----------------CCCCCC-CC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          228 -----------------GDELPN-IP-----GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       228 -----------------~~~~~~-~~-----~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                       ....+. .+     ..++.++.+||.+||..||++|||++|+++||||..
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~  381 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD  381 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence                             000000 00     124668899999999999999999999999999954

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-48  Score=342.87  Aligned_cols=259  Identities=27%  Similarity=0.463  Sum_probs=224.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|..+++||+|.||.|-+++.+.+++.|+.+++-|.+.........-..|-.+|.... ||.+..+.   |+|+... .+
T Consensus       169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LK---YsFQt~d-rl  243 (516)
T KOG0690|consen  169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLK---YSFQTQD-RL  243 (516)
T ss_pred             hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhh---hhhccCc-eE
Confidence            5778899999999999999999999877777666655555566677788999999998 99988775   3565544 46


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      |+||||+.||.|+-++.+.  ..++|..++.|...|+.||.|||+++||+||||.+|.|++++|++||+|||+++.--..
T Consensus       244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            6999999999999999763  45999999999999999999999999999999999999999999999999999874322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      +  ....+.||||.|+|||++....|+.++|+|.+||++|||++|+.||.+.+....++.|.....     .+|..++++
T Consensus       322 g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~-----kFPr~ls~e  394 (516)
T KOG0690|consen  322 G--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL-----KFPRTLSPE  394 (516)
T ss_pred             c--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-----cCCccCCHH
Confidence            2  234567999999999999999999999999999999999999999999988888887776543     567889999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHcCCCcccCCC
Q 017746          242 GKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCADDQ  274 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~~~  274 (366)
                      ++.|+..+|.+||.+|.     .+.++.+|+||....+
T Consensus       395 AktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W  432 (516)
T KOG0690|consen  395 AKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW  432 (516)
T ss_pred             HHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence            99999999999999997     5899999999966544

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.4e-46  Score=346.15  Aligned_cols=257  Identities=24%  Similarity=0.347  Sum_probs=207.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      .|+..+.||+|+||.||++.+..+++    .+++|.+....    .....+.+|+.++++++ |++|+++++.+   .. 
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~---~~-   71 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAY---ET-   71 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCc----eEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEE---ec-
Confidence            47889999999999999999988765    67777765421    12345678999999998 89999998743   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus        72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05630          72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVH  151 (285)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence            34677999999999999999764444699999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................. ......+..
T Consensus       152 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~  227 (285)
T cd05630         152 VPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEK  227 (285)
T ss_pred             cCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCcc
Confidence            53222   12234699999999999999999999999999999999999999986543222222211111 111234556


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~  271 (366)
                      +++++.+|+.+||+.||++|||     ++++++||||..
T Consensus       228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            8899999999999999999999     899999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-46  Score=370.28  Aligned_cols=255  Identities=20%  Similarity=0.277  Sum_probs=198.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCC-----CCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~-----~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+.+.||+|+||+||+|.+..+++    .||+|.+............|+.+++.+..     ++++++++++   +..
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~---~~~  202 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKE----YCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY---FQN  202 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCe----EEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE---EEc
Confidence            58899999999999999999877654    78888876433344556778888888862     3457777763   334


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCC----------
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDND----------  145 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~----------  145 (366)
                      ....+++|||++ |++|.+++.+.  +.+++..+..|+.||+.||+|||+ .|||||||||+|||++.++          
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            445678999998 66999999763  579999999999999999999998 5999999999999998765          


Q ss_pred             ------ceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHH
Q 017746          146 ------EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF  219 (366)
Q Consensus       146 ------~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~  219 (366)
                            .+||+|||++....     ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+....+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             cCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                  49999999876432     1223457999999999999999999999999999999999999999877655444


Q ss_pred             HHHHHhhcC----------------------CCCCCCC---------------CCCCHHHHHHHHHhcccCCCCCCCHHH
Q 017746          220 SLLIRIGVG----------------------DELPNIP---------------GDLSEQGKDFLIKCFLKDPKRRWTAEM  262 (366)
Q Consensus       220 ~~~~~~~~~----------------------~~~~~~~---------------~~~s~~~~~ll~~cL~~dp~~R~t~~~  262 (366)
                      ..+.+....                      ...+...               ...++.+.|||.+||..||++|||++|
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence            433322100                      0000000               001456779999999999999999999


Q ss_pred             HHcCCCccc
Q 017746          263 LLNHPFVCA  271 (366)
Q Consensus       263 ll~hp~~~~  271 (366)
                      +++||||..
T Consensus       435 ~L~Hp~~~~  443 (467)
T PTZ00284        435 MTTHPYVLK  443 (467)
T ss_pred             HhcCccccc
Confidence            999999954

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.4e-46  Score=349.95  Aligned_cols=257  Identities=25%  Similarity=0.408  Sum_probs=205.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||+|+||.||+|+++.+++    .+++|.+....  .....+.+|+.++++++ ||||+++++.+   . .+.
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---~-~~~   77 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIV---H-TDK   77 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCC----eEEEEEeeccccCCcchhHHHHHHHHHhCC-CCCcceEEEEE---e-eCC
Confidence            58999999999999999999877654    67888765422  23345778999999998 99999999843   2 234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++ +|.+++.+ .+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          78 SLTLVFEYLDK-DLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             eEEEEEeCCCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence            56799999986 99998876 34568999999999999999999999999999999999999999999999999997653


Q ss_pred             CCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC----------
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG----------  228 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~----------  228 (366)
                      ....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.+....          
T Consensus       156 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         156 VPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             CCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            2221  1223468999999998865 46889999999999999999999999877655544444321100          


Q ss_pred             -------CCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          229 -------DELPN--------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       229 -------~~~~~--------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                             ...+.        ....++.++++||.+||..||.+|||++|+++||||..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  291 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS  291 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence                   00011        11246889999999999999999999999999999954

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-48  Score=394.79  Aligned_cols=258  Identities=34%  Similarity=0.610  Sum_probs=217.7

Q ss_pred             CCccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            1 MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         1 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      |+|..+..||.|.||.||-|....+|.    ..|+|.+...+   .......+|..+|..++ |||+|++||+..+    
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGe----llAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvH---- 1305 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGE----LLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVH---- 1305 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccc----hhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCceeec----
Confidence            689999999999999999999988765    67777666543   34566889999999999 9999999995433    


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ....+|.||||+||+|.+.++.  ++..+|...+.|..|++.||.|||++|||||||||+||+|+.+|.+|++|||.|..
T Consensus      1306 Rekv~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeE
Confidence            3345699999999999999964  45678888899999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCCc--ccccccCCCCCCCccccCCc---CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          158 SSCDGERS--QSFECRGTPLYMSPESVNEN---EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       158 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      +.......  ......|||.|||||++.+.   ....++|||||||++.||+||+.||...+.+  +..+.+.+. ...|
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~-gh~P 1460 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAA-GHKP 1460 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhc-cCCC
Confidence            75432111  12356899999999999664   4667999999999999999999999876543  444555544 4668


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ++|..+|.+++|||.+||+.||++||++.||+.|.|-+..
T Consensus      1461 q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1461 QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            8999999999999999999999999999999999997544

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6e-46  Score=348.35  Aligned_cols=257  Identities=24%  Similarity=0.346  Sum_probs=194.2

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEe
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      ++.||+|+||+||+|+++...  ....+++|..... .......+|+.++++++ ||||+++++.+.  ......++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~--~~~~~aiK~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGK--DDRDYALKQIEGT-GISMSACREIALLRELK-HPNVISLQKVFL--SHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCC--CCceEEEEEECCC-CCcHHHHHHHHHHHhcC-CCCCcceeeeEe--cCCCcEEEEEE
Confidence            678999999999999976432  2347888887643 33456789999999998 999999988542  23345677999


Q ss_pred             ecCCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe----ccCCceEEEecCC
Q 017746           86 EYASRGSLADRVKKQN-------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV----FDNDEAKIADFGL  154 (366)
Q Consensus        86 E~~~~g~L~~~l~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~~~vkl~DFG~  154 (366)
                      ||+.+ +|.+++....       ...+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            99975 9999886421       1258999999999999999999999999999999999999    4557899999999


Q ss_pred             ccccCCCCCC-cccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcc---------hHHHHHH
Q 017746          155 AKKSSCDGER-SQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDS---------NVFSLLI  223 (366)
Q Consensus       155 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~---------~~~~~~~  223 (366)
                      ++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||......         .....+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            9876432221 11234578999999999877 45899999999999999999999999754321         1111111


Q ss_pred             Hhhc-C--------CCCC------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          224 RIGV-G--------DELP------------------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       224 ~~~~-~--------~~~~------------------------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      .... .        ...+                        ......+.++.+||.+||+.||++|||++|+++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            1000 0        0000                        0011235678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-45  Score=335.64  Aligned_cols=254  Identities=32%  Similarity=0.583  Sum_probs=209.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC------chhhHHHHHHHHHHcCCCCceeEeecceeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP------SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~   75 (366)
                      .|.++++||+|+||.||.|.+..+++    ++++|.......      ....+.+|+.++++++ ||||+++++.+   .
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~----~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~---~   74 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGR----ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCL---R   74 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCc----EEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEE---c
Confidence            58899999999999999999877655    677776543211      2346788999999998 99999999843   2


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      . ....++||||+++++|.+++.+.  +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus        75 ~-~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          75 D-DETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             c-CCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            2 33677999999999999999763  46899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCcc-cccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          156 KKSSCDGERSQ-SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       156 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      +.......... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+...   ...+.......+.+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~  228 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIFKIATQPTNPQL  228 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHHHHhccCCCCCC
Confidence            76532211111 123468899999999999999999999999999999999999997654433   22333333344566


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +..++.++.++|.+||..+|++||++.++++||||
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         229 PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            77789999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.4e-45  Score=334.91  Aligned_cols=254  Identities=27%  Similarity=0.466  Sum_probs=211.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||.|+||.||+++++.+++    .+++|......   .....+.+|++++++++ |||++++++.   +....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~---~~~~~   72 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGK----QYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVAYRES---WEGED   72 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCc----EEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-CCCeeeeeee---ecCCC
Confidence            58999999999999999999877654    68888775422   23456788999999998 9999999873   33344


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..++++|||+++++|.+++....+..+++.++..++.||+.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus        73 ~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          73 GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence            56779999999999999998754556999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      .....  ......|++.|+|||++.+..++.++|||||||++++|++|+.||...+.......+.    ....+..+..+
T Consensus       153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  226 (257)
T cd08223         153 ENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII----EGKLPPMPKDY  226 (257)
T ss_pred             cccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----hcCCCCCcccc
Confidence            43222  2233468999999999999999999999999999999999999998665433322222    22334556678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ++++.+|+.+||..||++||++.++++||||
T Consensus       227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         227 SPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1e-45  Score=353.75  Aligned_cols=257  Identities=22%  Similarity=0.318  Sum_probs=202.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+++|.+...   ......+.+|+.+++.++ ||||+++++.+....  .
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAILER----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECCCCc----EEEEEEeCccccCchhHHHHHHHHHHHHhcC-CCCccccceeeccccccc
Confidence            68899999999999999999877654    6788877542   223456778999999998 999999988543211  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||+++ +|.+++..    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         100 EFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             ccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            22356799999976 88888754    48899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC--------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG--------  228 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~--------  228 (366)
                      .....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......        
T Consensus       175 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         175 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             ccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            65321   1223346999999999999999999999999999999999999999876554443333221000        


Q ss_pred             ---------CCCC--------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          229 ---------DELP--------------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       229 ---------~~~~--------------------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                               ...|                    ......+.++++||.+||..||++|||++++++||||..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                     0000                    011123567899999999999999999999999999953

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.2e-46  Score=355.14  Aligned_cols=257  Identities=22%  Similarity=0.306  Sum_probs=201.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+.+.||+|+||.||+|.+..+++    .+++|.+....   .....+.+|+.+++.++ ||||+++++.+....  .
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDR----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCc----eEEEEEeCCcccChHHHHHHHHHHHHHHHhC-CCchhceeeeeecccccc
Confidence            68899999999999999999876654    67888776422   23456778999999998 999999998543211  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||+++ +|.+.+..    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            22346799999976 78777754    48899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC--------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG--------  228 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~--------  228 (366)
                      .....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......        
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             cCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            65322   1223457999999999999999999999999999999999999999876543332222111000        


Q ss_pred             -----------------CCC------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          229 -----------------DEL------------PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       229 -----------------~~~------------~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                       ...            ...+...+.++++||.+||..||++|||+.|+++||||..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence                             000            0011224567899999999999999999999999999953

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-46  Score=360.73  Aligned_cols=256  Identities=23%  Similarity=0.259  Sum_probs=202.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||++......  ...++++|.....    ....+|+.++++++ ||||+++++.+   . ....+
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~--~~~~v~vK~~~~~----~~~~~E~~il~~l~-h~~iv~~~~~~---~-~~~~~  161 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDE--QRKKVIVKAVTGG----KTPGREIDILKTIS-HRAIINLIHAY---R-WKSTV  161 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCc--cceeEEEEecccc----ccHHHHHHHHHhcC-CCCccceeeeE---e-eCCEE
Confidence            6999999999999999999865432  2457888876542    34578999999998 99999998742   2 23456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++||++. ++|.+++..  .+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       162 ~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            79999996 599999954  357999999999999999999999999999999999999999999999999999876433


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh---------------
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG---------------  226 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~---------------  226 (366)
                      ..........||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+..+.               
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            33333345679999999999999999999999999999999999999997654322111111100               


Q ss_pred             -----------cCCCCC-CCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          227 -----------VGDELP-NIP-----GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       227 -----------~~~~~~-~~~-----~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                 .....+ ..+     ..++.++.+||.+||..||++||++.++++||||..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence                       000000 011     235678899999999999999999999999999954

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.5e-46  Score=350.93  Aligned_cols=256  Identities=27%  Similarity=0.414  Sum_probs=204.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|.+..++.    .+++|......  .....+.+|++++++++ ||||+++++.+.   . ..
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~----~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~---~-~~   76 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGL----IMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFY---S-DG   76 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCc----EEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCcccceeEEEE---E-CC
Confidence            68999999999999999999987654    67777665421  23356889999999998 999999998532   2 34


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      .+++||||+++|+|.+++.+.  +.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          77 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            577999999999999999763  4689999999999999999999985 7999999999999999999999999998765


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHH---------------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI---------------  223 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~---------------  223 (366)
                      ...    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.               
T Consensus       155 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         155 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence            321    1123469999999999999999999999999999999999999997654322211110               


Q ss_pred             -------------------------HhhcCCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          224 -------------------------RIGVGDELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       224 -------------------------~~~~~~~~~~~~-~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                               ........+..+ ..++.++++||.+||++||++|||+++++.||||+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                     000111112222 2367889999999999999999999999999999643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-45  Score=340.57  Aligned_cols=259  Identities=28%  Similarity=0.443  Sum_probs=210.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc--CCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--KGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~~~~   79 (366)
                      .|.+.+.||.|+||.||+|.+..+++    .+++|...........+..|+.++.++..||||+++++.+....  ....
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~----~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   92 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQ----LAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD   92 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCc----EEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence            47888999999999999999977654    78888876654455678899999999977999999998654221  2345


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .++++|||+++|+|.+++....+..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....
T Consensus        93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~  172 (282)
T cd06636          93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence            67899999999999999987555678999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCCCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ..  ........|++.|+|||.+.     ...++.++|||||||++|+|++|..||...........+.   ........
T Consensus       173 ~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~  247 (282)
T cd06636         173 RT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPPKLK  247 (282)
T ss_pred             cc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh---hCCCCCCc
Confidence            21  11223456999999999886     3468889999999999999999999997654433222221   11122222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ...++.++.+||.+||..||.+||++.+|++||||
T Consensus       248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            34578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.2e-46  Score=342.93  Aligned_cols=258  Identities=26%  Similarity=0.355  Sum_probs=210.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      .|+..+.||.|+||+||+|.+..+++    .+|+|.+....    .....+.+|+++++.++ |+||+++.+.+   .. 
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~---~~-   71 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGK----MYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAY---ET-   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCc----EEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEE---ec-
Confidence            47889999999999999999987765    67777765421    22345678999999998 99999998732   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +...+++|||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~  151 (285)
T cd05632          72 KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK  151 (285)
T ss_pred             CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence            34567999999999999998764445699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....   ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+..... ...+.++..
T Consensus       152 ~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~  227 (285)
T cd05632         152 IPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL-ETEEVYSAK  227 (285)
T ss_pred             cCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhh-ccccccCcc
Confidence            53221   12234699999999999999999999999999999999999999987654433333333222 112344566


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~  272 (366)
                      ++.++.+|+.+||..||++||+     +.++++|+||+..
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            8899999999999999999999     8899999999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-47  Score=358.76  Aligned_cols=249  Identities=31%  Similarity=0.459  Sum_probs=209.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      |.-++.||.|+||.||-|++..+..    .||+|++..+-    ..-..+..|+.+|+++. |||++.+.|++.-    +
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~e----vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLr----e   98 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLR----E   98 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccc----eeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeec----c
Confidence            5567889999999999999988764    89999887532    23456889999999999 9999999995432    3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ...+||||||-| +-.|++.- ..+++.+.++..|+.+.+.||+|||+++.||||||+.||||++.|.|||+|||.|...
T Consensus        99 ~TaWLVMEYClG-SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen   99 HTAWLVMEYCLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             chHHHHHHHHhc-cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc
Confidence            345699999976 99999876 3468999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCcccccccCCCCCCCcccc---CCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      .      ....++|||+|||||++   ..++|+-++||||||++..||...++|..+.+   .+..+..+.....+..-.
T Consensus       177 ~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN---AMSALYHIAQNesPtLqs  247 (948)
T KOG0577|consen  177 A------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPTLQS  247 (948)
T ss_pred             C------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch---HHHHHHHHHhcCCCCCCC
Confidence            3      22356899999999997   45789999999999999999999999998764   455666665544333233


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ...|+.+..|+..||++-|.+|||.+++++|+|+..
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence            457899999999999999999999999999999954

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9.8e-46  Score=354.88  Aligned_cols=262  Identities=23%  Similarity=0.319  Sum_probs=206.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeecc-CC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~   77 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+|+|.+....   .....+.+|+.+++.++ ||||+++++.+.... ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   75 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGK----RVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDP   75 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCC----EEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccc
Confidence            58899999999999999999877654    78888765421   23356788999999998 999999998543211 11


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ....++||||+.+ +|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~~~~lv~e~~~~-~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          76 FEEIYVVTELMQS-DLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             cceEEEEeecccc-CHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceee
Confidence            1256799999975 89888854  35799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh----------
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG----------  226 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~----------  226 (366)
                      ...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.........+....          
T Consensus       153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            532221 112234689999999998774 57899999999999999999999998776554443332210          


Q ss_pred             -----------cCCCCC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          227 -----------VGDELP------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       227 -----------~~~~~~------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                 .....+      .+....++++.+||.+||..||++|||+.++++||||...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                       001111      1233468899999999999999999999999999999653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-45  Score=360.82  Aligned_cols=254  Identities=21%  Similarity=0.268  Sum_probs=199.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .|.+.+.||+|+||.||+|.+...++    .+++|...     .....+|+++|++++ ||||+++++.+.    .....
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~----~vavK~~~-----~~~~~~E~~iL~~L~-HpnIv~l~~~~~----~~~~~  235 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQ----RVVVKAGW-----YASSVHEARLLRRLS-HPAVLALLDVRV----VGGLT  235 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCC----EEEEeccc-----ccCHHHHHHHHHHCC-CCCCCcEEEEEE----ECCEE
Confidence            58899999999999999999887654    78888632     335678999999998 999999998432    23456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++|||++. ++|.+++.. ....+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus       236 ~lv~e~~~-~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        236 CLVLPKYR-SDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEEEccC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            69999996 599999876 3347999999999999999999999999999999999999999999999999999875432


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCc--------chHHHHHHHhhcC-CCCC
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD--------SNVFSLLIRIGVG-DELP  232 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~--------~~~~~~~~~~~~~-~~~~  232 (366)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|..|+.....        ......+...... ...+
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            222222345799999999999999999999999999999999998876543211        1122222221110 0001


Q ss_pred             C---------------------CC-------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          233 N---------------------IP-------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       233 ~---------------------~~-------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .                     ..       ..++.++.+||.+||+.||++|||+.|||+||||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            0                     00       124568899999999999999999999999999953

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.6e-45  Score=334.18  Aligned_cols=253  Identities=36%  Similarity=0.626  Sum_probs=207.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc----------hhhHHHHHHHHHHcCCCCceeEeecce
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS----------SVTLKNEKEALDQIGICPQIVRCFGDD   71 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~----------~~~~~~E~~~l~~l~~~p~Iv~~~g~~   71 (366)
                      +|.++..||.|+||.||+|.+..+++    .+++|.+......          ...+.+|+.++++++ ||||+++++.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGE----LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSS   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCc----EEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEE
Confidence            69999999999999999999876554    6777766542211          245788999999998 99999999843


Q ss_pred             eeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEe
Q 017746           72 YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        72 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D  151 (366)
                          ......+++|||+++++|.+++...  +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|
T Consensus        76 ----~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~d  149 (267)
T cd06628          76 ----LDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISD  149 (267)
T ss_pred             ----EeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecc
Confidence                2234567999999999999999763  5689999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCCCCc----ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc
Q 017746          152 FGLAKKSSCDGERS----QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV  227 (366)
Q Consensus       152 FG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~  227 (366)
                      ||+++.........    ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||........   +.....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~  226 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---IFKIGE  226 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---HHHHhc
Confidence            99998764221111    11234588999999999998999999999999999999999999986544322   222222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                       ...+.++..++.++.++|.+||+.||++||++.++++||||
T Consensus       227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         227 -NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence             33455667789999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=361.34  Aligned_cols=253  Identities=29%  Similarity=0.485  Sum_probs=210.1

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC-CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD-CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~-~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      |.++..||.|+||.||+|..+.++-    .-|-|.+.. .......+.-|++||..+. ||+||++++.+|.    ++.+
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~----lAAaKvIetkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~----enkL  104 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKL----LAAAKVIETKSEEELEDYLVEIEILAECD-HPVIVKLLSAYYF----ENKL  104 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchh----hhhhhhhcccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhc----cCce
Confidence            8889999999999999999887654    334444443 2345677888999999999 9999999996543    2345


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++.|||.||-+...+.. -+..|.+.++..+.+|++.||.|||+++|||||||+.|||++-+|.++|+|||.+....  
T Consensus       105 wiliEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--  181 (1187)
T KOG0579|consen  105 WILIEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--  181 (1187)
T ss_pred             EEEEeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch--
Confidence            699999999999999887 45679999999999999999999999999999999999999999999999999876532  


Q ss_pred             CCCcccccccCCCCCCCcccc-----CCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC-CCC
Q 017746          162 GERSQSFECRGTPLYMSPESV-----NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP-NIP  235 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  235 (366)
                      ........+.|||+|||||++     ...+|++++||||||++|.||..+.+|-...   ..+..+.++.....+. .-|
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel---npMRVllKiaKSePPTLlqP  258 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL---NPMRVLLKIAKSEPPTLLQP  258 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc---chHHHHHHHhhcCCCcccCc
Confidence            222334456899999999987     4568999999999999999999999997544   4566677766544322 234


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      ...+..+.||+.+||.+||..||++++|++||||.
T Consensus       259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            56788999999999999999999999999999996

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-45  Score=349.67  Aligned_cols=256  Identities=24%  Similarity=0.372  Sum_probs=202.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+|+|.+....   .....+.+|+.++++++ ||||+++++.+....  .
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQ----KVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCC----EEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccccccc
Confidence            68899999999999999999877654    78888776421   22345778999999998 999999998543211  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....++++||++ +++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccce
Confidence            223467999998 6799988853   469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC-------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG-------  228 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~-------  228 (366)
                      .....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......       
T Consensus       167 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         167 QADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             ecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            75321     224479999999999877 56899999999999999999999999776543333332221100       


Q ss_pred             -----------CCCCCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          229 -----------DELPNIP--------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       229 -----------~~~~~~~--------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                 ...+..+        ...++.+.+||.+||..||++|||+.++++||||..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence                       0011111        235677899999999999999999999999999954

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.3e-45  Score=330.66  Aligned_cols=253  Identities=28%  Similarity=0.423  Sum_probs=211.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||.||+|+++.++.    .+++|.....   ......+.+|+++++.++ ||||+++++.+   . ..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~---~-~~   71 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKR----VYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESF---L-DK   71 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCc----EEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-CCCeehheeee---c-cC
Confidence            58889999999999999999987654    6778876542   234567888999999998 99999999843   2 23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+++++|.+++....+..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++..
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence            46779999999999999998754567999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ......  .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+    .....+.++..+
T Consensus       152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~  225 (256)
T cd08529         152 SDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI----IRGVFPPVSQMY  225 (256)
T ss_pred             cCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HcCCCCCCcccc
Confidence            432221  22346899999999999999999999999999999999999999876543322222    223345566678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +.++.+++.+||+.+|++||++.+++.|||+
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         226 SQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            9999999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-48  Score=342.25  Aligned_cols=253  Identities=28%  Similarity=0.493  Sum_probs=214.4

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      |.+++.||+|+||.||+|.++++|.    .+|+|++... .+...+..|+.++.++. .|++|++||.++  -  ..-++
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~----v~AIK~VPV~-sDLQEIIKEISIMQQC~-S~yVVKYYGSYF--K--~sDLW  104 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGH----VLAIKKVPVD-TDLQEIIKEISIMQQCK-SKYVVKYYGSYF--K--HSDLW  104 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCc----EEEEEecCcc-chHHHHHHHHHHHHHcC-Cchhhhhhhhhc--c--CCceE
Confidence            4577899999999999999998865    8999998763 67788999999999999 899999999543  2  22356


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +|||||..|++.+.++. ++++|+|.++..+++..+.||+|||...-||||||+.||||+.+|.+||+|||.|..+..  
T Consensus       105 IVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--  181 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--  181 (502)
T ss_pred             eehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--
Confidence            99999999999999987 567899999999999999999999999999999999999999999999999999987642  


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC--CCCCCH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI--PGDLSE  240 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~  240 (366)
                      ......+..|||.|||||++..-.|+..+||||||++..||..|++||....+.   ..+..+.. ..+|.+  |...|.
T Consensus       182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT-~PPPTF~KPE~WS~  257 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPT-KPPPTFKKPEEWSS  257 (502)
T ss_pred             hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccC-CCCCCCCChHhhhh
Confidence            223344668999999999999999999999999999999999999999766443   33333222 122222  334688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ++.||++.||.++|++|.|+-+|+.|||++..
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            99999999999999999999999999999653

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-45  Score=351.02  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=193.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|++..++.    .+++|....     .....|+.++++++ ||||+++++.+.   . ....
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~valK~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~---~-~~~~  132 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPD----PVVLKIGQK-----GTTLIEAMLLQNVN-HPSVIRMKDTLV---S-GAIT  132 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCc----eEEEEeCCc-----cccHHHHHHHHhCC-CCCCcChhheEE---e-CCee
Confidence            58999999999999999999877654    678886432     23467999999998 999999998432   2 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+.+ +|.+++.+ ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus       133 ~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-  209 (357)
T PHA03209        133 CMVLPHYSS-DLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-  209 (357)
T ss_pred             EEEEEccCC-cHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc-
Confidence            699999964 99999876 445799999999999999999999999999999999999999999999999999975421 


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcch-----------HHHHHHHhhc-CC
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN-----------VFSLLIRIGV-GD  229 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~-----------~~~~~~~~~~-~~  229 (366)
                        ........||+.|+|||++.+..++.++|||||||++|||+++..|+....+..           ....+...+. ..
T Consensus       210 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        210 --APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             --CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence              122234569999999999999999999999999999999998655443222111           0011111110 00


Q ss_pred             CCCC---------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          230 ELPN---------------------------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       230 ~~~~---------------------------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      ..+.                           ....++.++.+||.+||+.||++|||+.|+++||||.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~  355 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA  355 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence            0000                           0013567788899999999999999999999999995

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.5e-45  Score=332.53  Aligned_cols=258  Identities=32%  Similarity=0.624  Sum_probs=212.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-------chhhHHHHHHHHHHcCCCCceeEeecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-------SSVTLKNEKEALDQIGICPQIVRCFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~   74 (366)
                      +|..++.||+|+||.||+|.+..+++    .+++|.......       ....+.+|++++++++ ||||+++++.+   
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~----~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~---   72 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGT----LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGAT---   72 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCc----EEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhcee---
Confidence            58999999999999999999877654    677777654221       2456889999999998 99999999842   


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-ceEEEecC
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFG  153 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG  153 (366)
                      . ....+++||||+++++|.+++.+.  +.+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||
T Consensus        73 ~-~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          73 C-EDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             c-cCCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence            2 334567999999999999999763  4689999999999999999999999999999999999998776 59999999


Q ss_pred             CccccCCCCCCc--ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          154 LAKKSSCDGERS--QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       154 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      ++..........  ......||..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  229 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA  229 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC
Confidence            998764332111  112346899999999999889999999999999999999999999765544444444444444445


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      +..+..++.++.+++.+||..+|++||++.++++||||.
T Consensus       230 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         230 PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            667777899999999999999999999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.7e-45  Score=340.65  Aligned_cols=257  Identities=24%  Similarity=0.410  Sum_probs=204.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||+|+||.||+|+++.+++    .+++|.+...  ......+.+|+.+++.++ ||||+++++.+   . ...
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~---~-~~~   77 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDN----LVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDII---H-TEK   77 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCc----EEEEEEEecccccCchhHHHHHHHHHHhcC-CCCcceEEEEE---e-cCC
Confidence            58999999999999999999877654    6788876542  223346778999999998 99999999843   2 344


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+.+ +|.+++.+ .+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        78 ~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          78 SLTLVFEYLDK-DLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             eEEEEEecccc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            57799999985 99999876 34568999999999999999999999999999999999999999999999999997653


Q ss_pred             CCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC----------
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG----------  228 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~----------  228 (366)
                      ....  ......+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+....+......          
T Consensus       156 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         156 IPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            2211  11223578999999988654 5788999999999999999999999876554443333221100          


Q ss_pred             -------CCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          229 -------DELPN--------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       229 -------~~~~~--------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                             ...+.        ....++.++++||.+||..||.+|||++++++||||..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                   00111        11346889999999999999999999999999999954

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-45  Score=334.20  Aligned_cols=260  Identities=29%  Similarity=0.454  Sum_probs=209.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc--CCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--KGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~~~~   79 (366)
                      +|.+.+.||+|+||.||+|.++.+++    .+++|...........+.+|+.+++++..||||+++++.+....  ....
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQ----LVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCc----EEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            68999999999999999999876654    78888877655556778999999999966999999999654322  2345


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQN--NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      .+++||||+++++|.+++....  +..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            6779999999999999987533  46799999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE-----NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      .....  .......|++.|+|||++..     ..++.++|||||||++|+|++|++||...........+....  ....
T Consensus       163 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~  238 (275)
T cd06608         163 LDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--PPTL  238 (275)
T ss_pred             cccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC--CCCC
Confidence            53222  12233468999999998754     346788999999999999999999997654333322222211  1111


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ..+...+.++.+||.+||..||++|||+.++++|||+
T Consensus       239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            1123367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.7e-46  Score=338.80  Aligned_cols=254  Identities=30%  Similarity=0.469  Sum_probs=204.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhh---HHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT---LKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~---~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      |+.++.||+|+||+||++++..+++    .+|+|...........   ..+|+.++++++ ||||+++++....    ..
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~----~~   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQ----KVAVKIIDKSEIEEEEREENIREIKILRRLR-HPNIVQILDVFQD----DN   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTE----EEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEE----SS
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCe----EEEEEEeccccccccccchhhhhhhcccccc-ccccccccccccc----cc
Confidence            7899999999999999999988764    7888988875433332   345999999996 9999999884332    44


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+++++|.+++.+.  ..+++..+..++.||++||++||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        72 ~~~~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred             ccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            566999999999999999842  468999999999999999999999999999999999999999999999999997642


Q ss_pred             CCCCCcccccccCCCCCCCccccC-CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC--CCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVN-ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN--IPG  236 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~  236 (366)
                        ..........||+.|+|||++. +..++.++||||||+++|+|++|..||...........+.+.........  ...
T Consensus       150 --~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T PF00069_consen  150 --ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR  227 (260)
T ss_dssp             --STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT
T ss_pred             --ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc
Confidence              1222333457899999999998 88899999999999999999999999987633333333332221110000  011


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ..+..+.++|.+||+.||++||++.++++||||
T Consensus       228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  228 EKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             TSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             hhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            124889999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.2e-45  Score=334.75  Aligned_cols=254  Identities=30%  Similarity=0.442  Sum_probs=202.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+.+.||+|+||.||+|++..+++    .+++|...... .....+.+|+.+++.++ ||||+++++.+   . ....
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~---~-~~~~   80 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGE----LAAIKVIKLEPGEDFAVVQQEIIMMKDCK-HSNIVAYFGSY---L-RRDK   80 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCc----EEEEEEEecCchhHHHHHHHHHHHHHhCC-CCCeeeEEEEE---E-eCCE
Confidence            57888999999999999999887665    67888765432 23345788999999998 99999999843   2 2345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|.+++...  +.+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            67999999999999999753  4799999999999999999999999999999999999999999999999999876532


Q ss_pred             CCCCcccccccCCCCCCCccccC---CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESVN---ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .  ........||+.|+|||++.   ...++.++|+|||||++|+|++|..||...........................
T Consensus       159 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06645         159 T--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK  236 (267)
T ss_pred             c--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence            2  11223346999999999874   456888999999999999999999999765433322222221111111111124


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                      ++..+.+|+.+||..+|++||++++|++|||
T Consensus       237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            6789999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.7e-45  Score=335.15  Aligned_cols=259  Identities=29%  Similarity=0.465  Sum_probs=206.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc-CCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~~~~   80 (366)
                      +|.+.+.||+|+||.||+|++..+++    .+++|...........+.+|+.+++.+..||||+++++.+.... .....
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGS----KAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCc----eeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            68999999999999999999887654    67788765433445678889999999966999999998654322 23456


Q ss_pred             EEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           81 YNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      +++||||+++++|.+++...  .+..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++...
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  174 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL  174 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence            77999999999999988642  2356899999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC-CCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE-----NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-ELP  232 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~-~~~  232 (366)
                      ....  .......|++.|+|||++..     ..++.++|||||||++|+|++|+.||........   +....... ...
T Consensus       175 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~  249 (286)
T cd06638         175 TSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---LFKIPRNPPPTL  249 (286)
T ss_pred             ccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---HhhccccCCCcc
Confidence            4221  12233469999999999853     4578899999999999999999999976543322   22211111 111


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ..+..++.++.+++.+||..||++||++.++++|+||
T Consensus       250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            2334468899999999999999999999999999996

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.1e-45  Score=351.59  Aligned_cols=257  Identities=25%  Similarity=0.344  Sum_probs=203.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC-CCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++...+. .....+|+|.+.....  ....+.+|+++++.+..||||+++++.+   . ..
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~---~-~~  114 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC---T-HG  114 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe---c-CC
Confidence            47899999999999999999765432 2334689998765322  2346788999999995599999999843   2 23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC---------------------------------------------------------
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN---------------------------------------------------------  101 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~---------------------------------------------------------  101 (366)
                      ..+++|||||++|+|.+++.+..                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            45679999999999999996521                                                         


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccc
Q 017746          102 -----------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC  170 (366)
Q Consensus       102 -----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~  170 (366)
                                 ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..............
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                       124788999999999999999999999999999999999999999999999999865433222122223


Q ss_pred             cCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHh
Q 017746          171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKC  249 (366)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  249 (366)
                      .+++.|||||++.+..++.++|||||||++|+|++ |+.||...........+....   ..+..+..++.++.+++.+|
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~c  351 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG---YQMSRPDFAPPEIYSIMKMC  351 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc---cCccCCCCCCHHHHHHHHHH
Confidence            45678999999999999999999999999999997 999998765443333333222   22334556789999999999


Q ss_pred             cccCCCCCCCHHHHHc
Q 017746          250 FLKDPKRRWTAEMLLN  265 (366)
Q Consensus       250 L~~dp~~R~t~~~ll~  265 (366)
                      |..||++||++.++++
T Consensus       352 l~~dp~~RPs~~~l~~  367 (374)
T cd05106         352 WNLEPTERPTFSQISQ  367 (374)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.3e-45  Score=335.76  Aligned_cols=256  Identities=28%  Similarity=0.399  Sum_probs=201.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|++..++.    .+++|.+....   .....+.+|+.+++++. ||||+++++.+.    .+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~   71 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQ----IVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLM----QE   71 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCc----EEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEe----eC
Confidence            58999999999999999999877654    68888765421   23456888999999998 999999998432    24


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN-NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ..+++||||++ ++|.+++.... +..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  150 (285)
T cd07861          72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA  150 (285)
T ss_pred             CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence            46679999998 59999986533 25699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc---------
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV---------  227 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~---------  227 (366)
                      .....  .......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.........+.....         
T Consensus       151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
T cd07861         151 FGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG  228 (285)
T ss_pred             cCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence            53221  111223578999999988654 578899999999999999999999986543322221111000         


Q ss_pred             ---------------CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          228 ---------------GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       228 ---------------~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                                     ..........++.++.+||.+||..||++|||+.+|++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                           000001123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.2e-45  Score=349.66  Aligned_cols=258  Identities=24%  Similarity=0.339  Sum_probs=201.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.++++||+|+||.||+|+.... .......+|+|.+....  .....+.+|+.++..+..||||+++++.+    ...
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~----~~~  111 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC----TVG  111 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee----ccC
Confidence            588899999999999999985321 12234578999876432  23456788999999996699999999843    223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC---------------------------------------------------------
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN---------------------------------------------------------  101 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~---------------------------------------------------------  101 (366)
                      ...++|||||++|+|.+++.+..                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            34669999999999999996521                                                         


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCc
Q 017746          102 ----------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERS  165 (366)
Q Consensus       102 ----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  165 (366)
                                      +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                            1247888999999999999999999999999999999999999999999999998764332222


Q ss_pred             ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHH
Q 017746          166 QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD  244 (366)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  244 (366)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |..||...............+.   .+..+...+.++.+
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~  348 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY---RMLSPECAPSEMYD  348 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc---cCCCCCCCCHHHHH
Confidence            2222345678999999999999999999999999999998 8999977644333333333222   22334557889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcC
Q 017746          245 FLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       245 ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      |+.+||..||++||++.+|++.
T Consensus       349 li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         349 IMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.5e-45  Score=333.18  Aligned_cols=254  Identities=30%  Similarity=0.425  Sum_probs=201.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|...... .....+.+|+.++++++ ||||+++++.+.    .+..
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~----~~aik~~~~~~~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~----~~~~   80 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGE----LAAVKIIKLEPGDDFSLIQQEIFMVKECK-HCNIVAYFGSYL----SREK   80 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCe----EEEEEEEecCccchHHHHHHHHHHHHhcC-CCCeeeeeEEEE----eCCE
Confidence            58999999999999999999877654    67777765432 23456788999999998 999999998432    2345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|.+++.+  ++.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          81 LWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            6799999999999999965  34689999999999999999999999999999999999999999999999999987632


Q ss_pred             CCCCcccccccCCCCCCCccccC---CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESVN---ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...  ......|++.|+|||.+.   ...++.++|||||||++|+|++|+.||...........+...............
T Consensus       159 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06646         159 TIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK  236 (267)
T ss_pred             ccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccc
Confidence            211  122346899999999884   345778999999999999999999999755433222222111111111112234


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                      ++..+.+||.+||..+|++||++++|++|+|
T Consensus       237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             cCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            6889999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.5e-44  Score=330.38  Aligned_cols=257  Identities=33%  Similarity=0.603  Sum_probs=207.8

Q ss_pred             CCccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC------CchhhHHHHHHHHHHcCCCCceeEeecceeec
Q 017746            1 MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP------PSSVTLKNEKEALDQIGICPQIVRCFGDDYSF   74 (366)
Q Consensus         1 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~------~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~   74 (366)
                      ++|..++.||+|+||.||+|.+..++.    .+++|......      .....+.+|+.++++++ ||||+++++.+.  
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--   74 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGR----ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLR--   74 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCc----EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEE--
Confidence            479999999999999999999887665    67777654321      12346788999999998 999999998432  


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCC
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                      ......++++|||+++++|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        75 ~~~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~  152 (266)
T cd06651          75 DRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGA  152 (266)
T ss_pred             cCCCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCC
Confidence            22345667999999999999999753  4689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC-CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          155 AKKSSCDGE-RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       155 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      ++....... ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......   .+.........+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~  229 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AIFKIATQPTNPQ  229 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---HHHHHhcCCCCCC
Confidence            986532111 111123458899999999999999999999999999999999999997654332   2333333334466


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      ++..+++.+++++ +||..+|++||+++++++||||+
T Consensus       230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         230 LPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            6777889999998 68888999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-45  Score=360.99  Aligned_cols=256  Identities=23%  Similarity=0.317  Sum_probs=208.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC-CCCchhhHHHHHHHHHHcCCCCceeEeecceeecc--CC-
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD-CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--KG-   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~-~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~~-   77 (366)
                      +.++.+.|.+|||+.||+|.+...+    .++|+|+... .+.....+.+|+.+|+.|++|+|||.+++......  .+ 
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~----~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGG----KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCC----ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            4577889999999999999987754    4788887665 34567789999999999999999999999433322  22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEeccCCceEEEecCCc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG--FVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      .-.+.|+||||.||.|-|++.++...+|+|.++.+|+.++++|+.+||...  |||||||-|||||..+|+.||||||.|
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            345679999999999999999766667999999999999999999999998  999999999999999999999999999


Q ss_pred             cccCCCCCCcc-------cccccCCCCCCCcccc---CCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHh
Q 017746          156 KKSSCDGERSQ-------SFECRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI  225 (366)
Q Consensus       156 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~  225 (366)
                      ...........       .....-|+.|.|||++   .+.+.+.++|||+|||+||.|+....||+......    |...
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Ilng  269 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILNG  269 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEec
Confidence            75332221111       1123479999999987   67889999999999999999999999998663322    2222


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       226 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                      .  ..+|.. ..++..+++||..||+.||++||++-|++.+-+
T Consensus       270 ~--Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  270 N--YSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             c--ccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            2  234443 357999999999999999999999999987543

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6e-45  Score=341.27  Aligned_cols=259  Identities=24%  Similarity=0.333  Sum_probs=194.2

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      ..+..||+|+||+||+|+++...  ....+++|..... .....+.+|+.++++++ ||||+++++.+.  ......+++
T Consensus         4 ~~g~~lG~G~~g~Vy~~~~~~~~--~~~~~a~k~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~~~l   77 (317)
T cd07867           4 YEGCKVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGT-GISMSACREIALLRELK-HPNVIALQKVFL--SHSDRKVWL   77 (317)
T ss_pred             eeceEeccCCCeeEEEEEecCCC--ccceEEEEEecCC-CCcHHHHHHHHHHHhCC-CCCeeeEEEEEe--ccCCCeEEE
Confidence            34578999999999999976432  2357888877643 33456789999999998 999999998543  233456779


Q ss_pred             EeecCCCCCHHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe----ccCCceEEEec
Q 017746           84 LLEYASRGSLADRVKKQ-------NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV----FDNDEAKIADF  152 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~~~vkl~DF  152 (366)
                      ||||+.+ +|.+++...       ....+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+||
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9999976 888888532       12248899999999999999999999999999999999999    45678999999


Q ss_pred             CCccccCCCCCC-cccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcch---------HHHH
Q 017746          153 GLAKKSSCDGER-SQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN---------VFSL  221 (366)
Q Consensus       153 G~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~---------~~~~  221 (366)
                      |+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|+||++||.......         ....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            999876432221 11234568999999999876 458899999999999999999999997543211         0000


Q ss_pred             HHHh-hc-----------CC---------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          222 LIRI-GV-----------GD---------------------ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       222 ~~~~-~~-----------~~---------------------~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                      +... +.           ..                     .........+..+.+||.+||..||.+|||++|+++|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            0000 00           00                     000011123567889999999999999999999999999


Q ss_pred             c
Q 017746          269 V  269 (366)
Q Consensus       269 ~  269 (366)
                      |
T Consensus       317 f  317 (317)
T cd07867         317 F  317 (317)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-44  Score=328.49  Aligned_cols=254  Identities=30%  Similarity=0.550  Sum_probs=206.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-------chhhHHHHHHHHHHcCCCCceeEeecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-------SSVTLKNEKEALDQIGICPQIVRCFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~   74 (366)
                      +|..++.||+|+||+||+|... ++    ..+++|.+.....       ....+.+|+.++++++ |+||+++++.+   
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~----~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~---   71 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QG----QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTC---   71 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CC----CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEe---
Confidence            6999999999999999999863 33    3678887654221       1245788999999998 89999999843   


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCC
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                       .....++++|||+++++|.+++.+.  +.+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|||+
T Consensus        72 -~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~  148 (265)
T cd06631          72 -LDDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGC  148 (265)
T ss_pred             -ecCCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchh
Confidence             2235677999999999999999763  4689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC----CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          155 AKKSSCDGE----RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       155 a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      +........    ........|+..|+|||++.+..++.++|||||||++|+|++|..||...........+  ......
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~~~~  226 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--GAHRGL  226 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh--hhccCC
Confidence            876432111    11122346899999999999999999999999999999999999999765433222111  112234


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      .+..+..++.++.+||.+||.++|++||++.++++||||
T Consensus       227 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            456677789999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.1e-45  Score=336.56  Aligned_cols=250  Identities=27%  Similarity=0.451  Sum_probs=210.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||++.+..+++    .+++|.....    ......+.+|+++++++. ||||+++++.+   . .
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~---~-~   72 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGK----YYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSF---Q-D   72 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEE---E-c
Confidence            58899999999999999999987654    6777776532    233466888999999999 99999999843   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++++|.+++.+.  +.+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..
T Consensus        73 ~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          73 DSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             CCeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            44567999999999999999763  5799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....     .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+.     ...+.++..
T Consensus       151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~  220 (290)
T cd05580         151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-----EGKVRFPSF  220 (290)
T ss_pred             cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-----cCCccCCcc
Confidence            6432     234468999999999988889999999999999999999999998765433333322     122345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~  272 (366)
                      ++..++++|.+||..||.+|+     +++++++||||...
T Consensus       221 ~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence            899999999999999999999     99999999999543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-44  Score=333.91  Aligned_cols=255  Identities=26%  Similarity=0.399  Sum_probs=199.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||.||+|+++.+++    .+++|.+...   ......+.+|++++++++ ||||+++++.+    .+.
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~----~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~----~~~   71 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHE----IVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVL----HSD   71 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCc----EEEEEEeecccccccCccchhHHHHHHHhcC-CCCeeeHHHHh----ccC
Confidence            58899999999999999999987765    6777776542   123356788999999998 99999999843    234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..++++|||+.+ +|.+++.+ .++.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        72 ~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          72 KKLTLVFEYCDQ-DLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             CceEEEEecCCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence            467799999975 89888876 3467999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCc-chHHHHHHHhh----------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQD-SNVFSLLIRIG----------  226 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~-~~~~~~~~~~~----------  226 (366)
                      .....  ......+++.|+|||++.+. .++.++|||||||++|+|++|..||..... .+....+.+..          
T Consensus       150 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07839         150 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG  227 (284)
T ss_pred             CCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH
Confidence            32211  11233578999999998765 478899999999999999999888644322 22222222110          


Q ss_pred             -----cCCCCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          227 -----VGDELPN---------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       227 -----~~~~~~~---------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                           .....+.         ....+++++.+||.+||..||.+|||++++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                 0000111         112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.6e-45  Score=335.03  Aligned_cols=256  Identities=22%  Similarity=0.331  Sum_probs=208.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|.....+ ......+++|.......  ....+.+|+.++.+++ ||||+++++.+    ...
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~----~~~   80 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVC----TKE   80 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC-CcccceEEEEE----cCC
Confidence            4788999999999999999986654 22345788888764322  2356788999999998 99999999842    223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN--------------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN  144 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~  144 (366)
                      ...+++|||+++|+|.+++.+...              ..+++..+..++.||+.||.|||++|++||||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            456799999999999999976321              458889999999999999999999999999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 017746          145 DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLI  223 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~  223 (366)
                      +.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999986543332222333457889999999998999999999999999999998 999998776555444333


Q ss_pred             HhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .    ...+..+..++.++.+|+.+||..||++||++.+++++
T Consensus       241 ~----~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         241 S----RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             c----CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2    23345567789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-44  Score=337.89  Aligned_cols=259  Identities=20%  Similarity=0.278  Sum_probs=200.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC------------CCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS------------EFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRC   67 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~------------~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~   67 (366)
                      +|.+.+.||+|+||.||+|.+.....            .....+|+|.+.....  ....+.+|+.++.+++ ||||+++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~   84 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK-DPNIIRL   84 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC-CCCeeEE
Confidence            58899999999999999998654321            1234689998765322  2346889999999998 9999999


Q ss_pred             ecceeeccCCeeEEEEEeecCCCCCHHHHHHHhC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q 017746           68 FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN-----------------NGRLQESDVKRYTRSMLKGLRHIHSKGFV  130 (366)
Q Consensus        68 ~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~~~~qi~~aL~~LH~~giv  130 (366)
                      ++.+.   . ....++||||+++|+|.+++....                 ...+++..+..++.||+.||.|||++||+
T Consensus        85 ~~~~~---~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          85 LGVCV---D-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             EEEEe---c-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            98432   2 234679999999999999996521                 12367788999999999999999999999


Q ss_pred             ecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh--CCC
Q 017746          131 HCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKP  208 (366)
Q Consensus       131 HrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt--g~~  208 (366)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986543222222223456889999999999999999999999999999986  678


Q ss_pred             CCCCCCcchHHHHHHHhh---cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          209 AWNHKQDSNVFSLLIRIG---VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       209 pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ||................   .....+..+..++..+.+|+.+||..||++|||+.+|..
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            887765544433332211   111122234567899999999999999999999999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.6e-44  Score=332.16  Aligned_cols=261  Identities=28%  Similarity=0.458  Sum_probs=207.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccC-CeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK-GERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~-~~~~   80 (366)
                      +|.+.+.||+|+||.||+|..+.+++    .+++|...........+.+|+.+++++..|||++++++.+..... ....
T Consensus        23 ~y~~~~~l~~g~~~~vy~~~~~~~~~----~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          23 TWEIIETIGKGTYGKVYKVTNKKDGS----LAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCC----EEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            58889999999999999999877654    678887765444556788899999999669999999986543221 2245


Q ss_pred             EEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           81 YNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      +++||||+++|+|.+++...  .+..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~  178 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL  178 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence            77999999999999998642  3457899999999999999999999999999999999999999999999999998875


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcC-----CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENE-----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      ......  .....|+..|+|||++....     ++.++|||||||++|+|++|++||...........+.+..  .....
T Consensus       179 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~  254 (291)
T cd06639         179 TSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP--PPTLL  254 (291)
T ss_pred             cccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC--CCCCC
Confidence            422211  12346899999999986543     6789999999999999999999997664433322222111  11112


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      .+...+..+.++|.+||..+|++||++.+++.||||+
T Consensus       255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            2345678899999999999999999999999999983

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.9e-44  Score=333.35  Aligned_cols=243  Identities=21%  Similarity=0.260  Sum_probs=200.7

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc----hhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS----SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      ...||+|++|.||+|...+      ..+|+|.+......    ...+.+|+.+|++++ ||||++++|.+.....+...+
T Consensus        25 ~~~i~~g~~~~v~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         25 SVLIKENDQNSIYKGIFNN------KEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             CeEEeeCCceEEEEEEECC------EEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCce
Confidence            3679999999999999842      37888887654333    356679999999998 999999999654433444567


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      ++||||+++|+|.+++.+.  ..+++.....++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++....
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            7999999999999999763  468999999999999999999998 4999999999999999999999999999986532


Q ss_pred             CCCCcccccccCCCCCCCccccCC--cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      .     .....||+.|+|||++.+  ..++.++|||||||++|||++|+.||......+....+....   ..+.++..+
T Consensus       176 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~  247 (283)
T PHA02988        176 P-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN---NSLKLPLDC  247 (283)
T ss_pred             c-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC---CCCCCCCcC
Confidence            1     123468999999999976  689999999999999999999999998776555444443322   234455568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++++++|+.+||+.||++|||++++++
T Consensus       248 ~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        248 PLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             cHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            999999999999999999999999985

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-44  Score=342.80  Aligned_cols=259  Identities=24%  Similarity=0.370  Sum_probs=205.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|....++ ......+++|.+.....  ....+.+|+.++.++..||||+++++.+.   ..+
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~---~~~   84 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT---KPG   84 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe---cCC
Confidence            5889999999999999999865442 22345789998764222  23457789999999966999999998432   233


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC--------------------------------------------------------
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN--------------------------------------------------------  102 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~--------------------------------------------------------  102 (366)
                      ..++++|||+++|+|.+++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            456799999999999999964221                                                        


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCc
Q 017746          103 ---GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP  179 (366)
Q Consensus       103 ---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP  179 (366)
                         ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.............++..|+||
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence               25889999999999999999999999999999999999999999999999999876433322222334567889999


Q ss_pred             cccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 017746          180 ESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRW  258 (366)
Q Consensus       180 E~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~  258 (366)
                      |++.+..++.++|||||||++|+|++ |..||.+....+........+   ..+..+...++++.+++.+||+.+|++||
T Consensus       245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~~p~~RP  321 (337)
T cd05054         245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG---TRMRAPEYATPEIYSIMLDCWHNNPEDRP  321 (337)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc---CCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence            99999999999999999999999998 999997754433332222222   22344556789999999999999999999


Q ss_pred             CHHHHHcC
Q 017746          259 TAEMLLNH  266 (366)
Q Consensus       259 t~~~ll~h  266 (366)
                      ++++|++|
T Consensus       322 s~~ell~~  329 (337)
T cd05054         322 TFSELVEI  329 (337)
T ss_pred             CHHHHHHH
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-44  Score=328.13  Aligned_cols=258  Identities=30%  Similarity=0.443  Sum_probs=208.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||.|+||+||+|....++.    .+++|......  .....+.+|+++++.++ |+||+++++..   .. ..
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~---~~-~~   72 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNE----KVAIKRIDLEKCQTSVDELRKEVQAMSQCN-HPNVVKYYTSF---VV-GD   72 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCc----EEEEEEeccCCcchHHHHHHHHHHHHHhcC-CCCEEEEEEEE---ee-CC
Confidence            68999999999999999999876544    67888775422  24567889999999998 99999998743   22 34


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNN-GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      .+++|||++++++|.+++..... ..+++..+..++.||+.||+|||++|++||||||+||++++++.+||+|||++...
T Consensus        73 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            56799999999999999976432 46899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCc--ccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          159 SCDGERS--QSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       159 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      .......  ......|+..|+|||++... .++.++|+|||||++|+|++|+.||................. ...+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  231 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-PSLETGA  231 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-CCcCCcc
Confidence            5433221  22345689999999998777 788999999999999999999999977654433333222211 1111111


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          236 --GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       236 --~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                        ..++.++.+++.+||..||++||++++|++||||
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence              2578899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.4e-44  Score=329.77  Aligned_cols=255  Identities=35%  Similarity=0.647  Sum_probs=203.7

Q ss_pred             CCccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-----------chhhHHHHHHHHHHcCCCCceeEeec
Q 017746            1 MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-----------SSVTLKNEKEALDQIGICPQIVRCFG   69 (366)
Q Consensus         1 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-----------~~~~~~~E~~~l~~l~~~p~Iv~~~g   69 (366)
                      ++|...+.||.|+||.||+|....+++    .+++|.+.....           ....+.+|+.+++.++ ||||+++++
T Consensus         1 ~~~~~~~~lg~g~~~~vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~   75 (272)
T cd06629           1 FKWVKGELIGKGTYGRVYLALNVTTGE----MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLG   75 (272)
T ss_pred             CceeecceecccCceEEEEEeecCCCc----eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEE
Confidence            479999999999999999999877654    677776543111           1235778999999998 999999998


Q ss_pred             ceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEE
Q 017746           70 DDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKI  149 (366)
Q Consensus        70 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl  149 (366)
                      .+    .....+++||||+++++|.+++.+.  +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||
T Consensus        76 ~~----~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l  149 (272)
T cd06629          76 FE----TTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKI  149 (272)
T ss_pred             Ee----ccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEE
Confidence            32    2344667999999999999999763  57999999999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCCCCCcccccccCCCCCCCccccCCcC--CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc
Q 017746          150 ADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV  227 (366)
Q Consensus       150 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~  227 (366)
                      +|||+++...............|+..|+|||.+....  ++.++|+||||+++|+|++|..||.......   .+.....
T Consensus       150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~  226 (272)
T cd06629         150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---AMFKLGN  226 (272)
T ss_pred             eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH---HHHHhhc
Confidence            9999998653222122223346899999999987755  7889999999999999999999996543322   2222211


Q ss_pred             CCCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          228 GDELPN----IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       228 ~~~~~~----~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ....+.    ....++.++.++|.+||..+|++||+++++++|||+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            111122    223468999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=328.63  Aligned_cols=255  Identities=31%  Similarity=0.478  Sum_probs=207.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|...+.||.|+||.||+|.+..++.    .+++|...... .....+.+|+.++++++ ||||+++++..    .....
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~----~~~~~   74 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGE----LVAIKVIKLEPGDDFEIIQQEISMLKECR-HPNIVAYFGSY----LRRDK   74 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCC----EEEEEEEEcCchhhHHHHHHHHHHHHhCC-CCChhceEEEE----EeCCE
Confidence            58899999999999999999877654    57777766532 24567899999999998 99999999843    22445


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      ++++|||+++++|.+++.. ....+++.++..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus        75 ~~l~~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            7799999999999999976 335799999999999999999999999999999999999999999999999999986542


Q ss_pred             CCCCcccccccCCCCCCCccccCCc---CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESVNEN---EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...  ......|+..|+|||.+.+.   .++.++|+|||||++|+|++|++||...........+............+..
T Consensus       154 ~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd06613         154 TIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK  231 (262)
T ss_pred             hhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence            211  12234689999999999777   8899999999999999999999999876654443333332222111122334


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                      .+.++.+|+.+||..+|.+||++.+++.|+|
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            6788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.2e-44  Score=332.08  Aligned_cols=256  Identities=28%  Similarity=0.453  Sum_probs=205.4

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      |.+.+.||+|+||.||+|.+..++.    .+++|...... .....+.+|+++++.+. ||||+++++.+.   . ...+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~---~-~~~~   77 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGV----LAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFY---Y-ENNL   77 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCe----EEEEEEeCCCCHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEe---e-CCEE
Confidence            6788999999999999999877654    66777765422 23456788999999998 999999998432   2 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++++|..++.+ ....+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus        78 ~~v~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          78 WILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             EEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            799999999999998865 3457999999999999999999999999999999999999999999999999998765322


Q ss_pred             CCCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          162 GERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      .  .......||+.|+|||++.     +..++.++|||||||++|+|++|++||......+....+....  ......+.
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~  232 (282)
T cd06643         157 I--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPTLAQPS  232 (282)
T ss_pred             c--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC--CCCCCCcc
Confidence            1  1122346899999999984     4557889999999999999999999998765443333332211  11122345


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .++.++.+||.+||..||++||+++++++||||...
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            678999999999999999999999999999999643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.4e-44  Score=332.58  Aligned_cols=256  Identities=29%  Similarity=0.437  Sum_probs=205.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      .|++++.||.|+||.||+|++..++.    .+++|...... .....+.+|+.+++.++ ||||+++++.+.    .+..
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~   83 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGA----LAAAKVIETKSEEELEDYMVEIEILATCN-HPYIVKLLGAFY----WDGK   83 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCc----eEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEE----eCCe
Confidence            48899999999999999999887664    67777765432 23456788999999999 999999998432    2346


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|..++.+. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          84 LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            77999999999999988663 35699999999999999999999999999999999999999999999999999876432


Q ss_pred             CCCCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      .  ........|++.|+|||++.     ...++.++|||||||++|+|++|.+||...........+..  ........+
T Consensus       163 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~  238 (292)
T cd06644         163 T--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--SEPPTLSQP  238 (292)
T ss_pred             c--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc--CCCccCCCC
Confidence            1  11122346899999999984     34578899999999999999999999976654332222211  111111234


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..++.++.++|.+||..||++||+++++++||||..
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            567889999999999999999999999999999954

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.3e-44  Score=334.75  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=207.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|...+.||+|+||.||+|++..+++    .+++|...... .....+.+|+.+++.+. ||||+++++.+.   . ...
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~v~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~---~-~~~   91 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQ----EVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYL---V-GDE   91 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCc----EEEEEEEecCCcchHHHHHHHHHHHHhCC-CCCEeeEEEEEE---e-CCE
Confidence            68899999999999999999877654    67777766432 33466888999999998 999999998432   2 335


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|.+++..   ..+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        92 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             EEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            6799999999999999864   3589999999999999999999999999999999999999999999999999876532


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ...  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...............  .......+..++.
T Consensus       169 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  244 (296)
T cd06654         169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN--GTPELQNPEKLSA  244 (296)
T ss_pred             ccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC--CCCCCCCccccCH
Confidence            211  122346899999999999888999999999999999999999999766543322222211  1111223456788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .+.+++.+||..+|++||++.++++||||...
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            99999999999999999999999999999543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.6e-44  Score=331.31  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=200.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...++||+|+||.||+|++..+++    .+++|......  .....+.+|++++.++. ||||+++++.+..    ..
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----~~   72 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRR----ILAVKVIPLDITVELQKQIMSELEILYKCD-SPYIIGFYGAFFV----EN   72 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCc----EEEEEEEecCCChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEE----CC
Confidence            57889999999999999999877654    67888765431  23356788999999998 9999999984332    33


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++++|..+.      .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus        73 ~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          73 RISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             EEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            466999999999996542      47899999999999999999999999999999999999999999999999998653


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcch----HHHHHHHhhcCCCCCCC-
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN----VFSLLIRIGVGDELPNI-  234 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~-  234 (366)
                      ..    ......||..|+|||++.+..++.++|+|||||++|+|++|+.||.......    ......... ....+.. 
T Consensus       147 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  221 (279)
T cd06619         147 NS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLP  221 (279)
T ss_pred             cc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCC
Confidence            21    1223479999999999999999999999999999999999999996533211    111111111 1111222 


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ....++++.+|+.+||..+|++||+++++++||||...
T Consensus       222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            23478899999999999999999999999999999543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-44  Score=369.89  Aligned_cols=257  Identities=27%  Similarity=0.414  Sum_probs=203.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++..++.    .+++|.+...   ......+..|+.++.+|. |||||++++.+.  ....
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~----~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~--de~~   86 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQE----FFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFL--NKAN   86 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCe----EEEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEE--ecCC
Confidence            68999999999999999999987654    6667765532   233456888999999999 999999998543  2334


Q ss_pred             eEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CcEecCCCCCcEEecc------
Q 017746           79 RFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSK-------GFVHCDIKLQNVLVFD------  143 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-------givHrDlkp~NILl~~------  143 (366)
                      ..++|||||+++|+|.++|...  ..+.+++..++.|+.||+.||.|||+.       +||||||||+||||+.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            5677999999999999999753  235799999999999999999999995       4999999999999964      


Q ss_pred             -----------CCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCC--cCCCCccchhhhHHHHHHHHhCCCCC
Q 017746          144 -----------NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKPAW  210 (366)
Q Consensus       144 -----------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~emltg~~pf  210 (366)
                                 .+.+||+|||++......   .......||+.|+|||++.+  ..++.++||||||||||+|++|+.||
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             cccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                       234899999999876322   12234579999999999864  45889999999999999999999999


Q ss_pred             CCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          211 NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .............  ......+  ....+.++.+||..||..+|.+||++.|+|.|||+...
T Consensus       244 ~~~~~~~qli~~l--k~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        244 HKANNFSQLISEL--KRGPDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CcCCcHHHHHHHH--hcCCCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            7654433222221  1111111  13468999999999999999999999999999999644

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-44  Score=330.71  Aligned_cols=254  Identities=31%  Similarity=0.529  Sum_probs=210.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||.|+||.||+|++..++.    .+++|......  .....+.+|+.+++.++ ||||+++++.+.   + ..
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~-~~   72 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQ----VVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-SPYITKYYGSFL---K-GS   72 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCe----EEEEEEeeccccchHHHHHHHHHHHHHHcC-CCCeeeeeEEEE---E-CC
Confidence            68899999999999999999887654    77888776532  23456889999999999 999999998432   2 35


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++|+||+++++|.+++..   .++++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++...
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          73 KLWIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             eEEEEEEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            67799999999999999975   278999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC-C
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD-L  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (366)
                      ...  .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+..    ...+.++.. +
T Consensus       150 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~  223 (274)
T cd06609         150 STM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK----NNPPSLEGNKF  223 (274)
T ss_pred             ccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----cCCCCCccccc
Confidence            332  122334689999999999998999999999999999999999999976553332222221    223344444 7


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                      +.++.+++.+||..+|++||+++++++||||....
T Consensus       224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            89999999999999999999999999999996543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.3e-44  Score=333.77  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=210.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|..++.||.|+||.||+|.+..+++    .+++|.+... ......+.+|+.+++.++ ||||+++++.+   . ....
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~---~-~~~~   90 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQ----EVAIKQINLQKQPKKELIINEILVMKELK-NPNIVNFLDSF---L-VGDE   90 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCc----EEEEEEEecccCchHHHHHHHHHHHHhcC-CCceeeeeeeE---e-cCce
Confidence            48889999999999999999877665    6788877543 234567788999999998 99999999843   2 2345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|.+++.+   ..+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        91 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          91 LFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            7799999999999999865   3589999999999999999999999999999999999999999999999999886543


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ...  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+....  ......+..++.
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  243 (296)
T cd06655         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG--TPELQNPEKLSP  243 (296)
T ss_pred             ccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CcccCCcccCCH
Confidence            221  1223468999999999999889999999999999999999999998775544333332211  112234556889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .+.+||.+||..||++||++.+++.||||+..
T Consensus       244 ~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            99999999999999999999999999999653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.7e-44  Score=331.73  Aligned_cols=262  Identities=28%  Similarity=0.411  Sum_probs=204.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccC-C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK-G   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~-~   77 (366)
                      +|.+.+.||+|+||.||+|.+..+++    .+++|......   .....+.+|+.+++.+..||||+++++.+..... +
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~----~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGK----LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCc----EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            58899999999999999999987665    67888765422   2335678899999999878999999985543222 2


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-CCceEEEecC
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQN---NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-NDEAKIADFG  153 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG  153 (366)
                      ...+++||||+++ +|.+++....   +..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus        78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            3346799999986 8999887532   235899999999999999999999999999999999999998 8899999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC---
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD---  229 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~---  229 (366)
                      ++........  ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+..+......+.......   
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9986532211  1122357889999998865 457899999999999999999999998765443333222210000   


Q ss_pred             ------------CCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          230 ------------ELP--------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       230 ------------~~~--------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                                  ..+        .....++.++.+||.+||..||.+||++++++.||||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                        000        01124788999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-44  Score=338.02  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=207.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||+|+||.||+|++..++.....++++|......  .....+.+|+.+++.+. ||||++++|.+..   +  
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~---~--   81 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT---S--   81 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcC---C--
Confidence            68999999999999999999877776666678999876432  23456888999999998 9999999985432   1  


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++++||+++|+|.+++.+ ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             CceeeeecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            24599999999999999986 34568999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+ ..   ...+..+..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~---~~~~~~~~~~  236 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EK---GERLPQPPIC  236 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hC---CCCCCCCCCC
Confidence            3332222222345678999999999999999999999999999997 99999876544433222 21   1222334567


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +.++.+++.+||..+|++||++.+++.+
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5e-44  Score=324.27  Aligned_cols=252  Identities=27%  Similarity=0.487  Sum_probs=208.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||.||+|....+++    .+++|.....   ......+.+|++++++++ ||||+++++.+   . ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~---~-~~   71 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQK----LVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENF---L-ED   71 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCc----EEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeeeE---e-cC
Confidence            58999999999999999999877654    6777776542   223557889999999998 99999998843   2 34


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-ceEEEecCCccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKK  157 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~  157 (366)
                      ..+++||||+++++|.+++.+..+..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (256)
T cd08220          72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI  151 (256)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence            4567999999999999999875555689999999999999999999999999999999999998654 689999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....   ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..    ...+.++..
T Consensus       152 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  224 (256)
T cd08220         152 LSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS----GTFAPISDR  224 (256)
T ss_pred             cCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh----cCCCCCCCC
Confidence            64322   22234689999999999988899999999999999999999999987654433332222    223345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ++.++.+++.+||..+|++|||+.+++.||||
T Consensus       225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            89999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-44  Score=341.44  Aligned_cols=258  Identities=21%  Similarity=0.274  Sum_probs=198.2

Q ss_pred             ccCeeeec--CCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            5 RGDVIGHG--SFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         5 ~~~~lG~G--~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      ++++||+|  +||+||+++++.+++    .+|+|.+....   .....+++|+.+++.++ ||||+++++.+.   . +.
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~---~-~~   72 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGE----YVTVRRINLEACTNEMVTFLQGELHVSKLFN-HPNIVPYRATFI---A-DN   72 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCc----EEEEEEechhhccHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE---E-CC
Confidence            56889999  778999999988765    78888876532   23356788999999998 999999998432   2 34


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+....
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~  152 (327)
T cd08227          73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  152 (327)
T ss_pred             EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccc
Confidence            56799999999999999976544569999999999999999999999999999999999999999999999998754432


Q ss_pred             CCCCCc-----ccccccCCCCCCCccccCC--cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC---
Q 017746          160 CDGERS-----QSFECRGTPLYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD---  229 (366)
Q Consensus       160 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~---  229 (366)
                      ......     ......++..|+|||++.+  ..|+.++|||||||++|+|++|+.||...................   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence            111110     1112357788999999976  468999999999999999999999997654322211111000000   


Q ss_pred             ------------------------------C--------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 ------------------------------E--------LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 ------------------------------~--------~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                                    .        .......+++++.+||.+||+.||++|||++++++||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                                          0        00011235678999999999999999999999999999954

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=338.77  Aligned_cols=258  Identities=24%  Similarity=0.415  Sum_probs=210.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|...+.||+|+||.||+|.+..+++    .+++|.......    ....+.+|+++++.++ ||||+++++.+    ..
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~----~~   72 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGK----LFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASF----QT   72 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCc----EEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeee----ec
Confidence            68899999999999999999887654    778887765322    3356788999999999 99999999742    23


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ....++||||+.|++|.+++.+..+..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          73 ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            44677999999999999999865556799999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCC---------------------------cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCC
Q 017746          158 SSCDGER---------------------------SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAW  210 (366)
Q Consensus       158 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf  210 (366)
                      .......                           .......||..|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4322110                           0111346899999999999999999999999999999999999999


Q ss_pred             CCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHHcCCCccc
Q 017746          211 NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT----AEMLLNHPFVCA  271 (366)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t----~~~ll~hp~~~~  271 (366)
                      .+.........+....  ...+. ...++.++.++|.+||..||++||+    ++++++||||..
T Consensus       233 ~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         233 KGSNRDETFSNILKKE--VTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             CCCchHHHHHHHhcCC--ccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            8776554443333211  11111 1226899999999999999999999    999999999954

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=336.39  Aligned_cols=261  Identities=27%  Similarity=0.438  Sum_probs=224.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|..+.+||.|+||.|.+|..+.+..-|+.+++-|-+.....+.+--..|.++|.....-|.++++.-   +|+.-+. +
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS---cFQTmDR-L  425 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS---CFQTMDR-L  425 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH---Hhhhhhh-e
Confidence            57788999999999999999999887666666666555555667777889999988887788888876   3454444 4


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      |+||||+.||+|--.|+..  |++-|..+..|+++|+-||-+||++|||+||||.+||||+.+|++||+|||+++.--.+
T Consensus       426 yFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            5999999999999999764  67999999999999999999999999999999999999999999999999999864322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                        ...+.+.||||.|+|||++..++|+.++|+||+||+||||+.|++||++.+..+.+..|.....     .+|..+|.+
T Consensus       504 --~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-----syPKslSkE  576 (683)
T KOG0696|consen  504 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-----SYPKSLSKE  576 (683)
T ss_pred             --CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC-----cCcccccHH
Confidence              2344567999999999999999999999999999999999999999999998888888876543     567789999


Q ss_pred             HHHHHHHhcccCCCCCCCH-----HHHHcCCCcccCCCC
Q 017746          242 GKDFLIKCFLKDPKRRWTA-----EMLLNHPFVCADDQT  275 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~-----~~ll~hp~~~~~~~~  275 (366)
                      +.+++...|.+.|.+|...     .++..||||+.-++.
T Consensus       577 Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe  615 (683)
T KOG0696|consen  577 AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE  615 (683)
T ss_pred             HHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence            9999999999999999754     789999999765543

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7e-44  Score=323.71  Aligned_cols=253  Identities=26%  Similarity=0.429  Sum_probs=211.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||.|+||.||.++...+++    .+++|.+...   ......+.+|+.++++++ |+||+++++.+   .+ .
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~---~~-~   71 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDS----LVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNHF---MD-D   71 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCc----EEEEEEEeecccchhHHHHHHHHHHHHHhCC-CCCeeEEEeEE---ec-C
Confidence            68999999999999999999887654    6777866542   234456889999999998 99999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ...+++|||+++|+|.+++.+..+..+++.++..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            45679999999999999998754567999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      .....  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||......+....+..   . ..+..+..+
T Consensus       152 ~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~  225 (256)
T cd08221         152 GSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ---G-NYTPVVSVY  225 (256)
T ss_pred             ccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---C-CCCCCcccc
Confidence            43221  22334689999999999988899999999999999999999999987655444333332   2 223344667


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +.++.+++.+||.++|++||+++++++|||+
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         226 SSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            8999999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-44  Score=331.60  Aligned_cols=257  Identities=29%  Similarity=0.447  Sum_probs=208.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|.+..++.    .+++|.+....  .....+.+|+.++.++. ||||+++++.+.    ...
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~----~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~----~~~   72 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGV----TMAMKEIRLELDESKFNQIIMELDILHKAV-SPYIVDFYGAFF----IEG   72 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCc----EEEEEEeecccCHHHHHHHHHHHHHHHhcC-CCcHHhhhhhee----cCC
Confidence            68899999999999999999886654    67777665421  22456888999999998 999999998432    245


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQN-NGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      .+++||||+++++|..++.... .+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++..
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  152 (286)
T cd06622          73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN  152 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence            6779999999999999986521 2368999999999999999999997 5999999999999999999999999999876


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCc------CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNEN------EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      ....    ......|++.|+|||.+.+.      .++.++|||||||++|+|++|+.||...........+..... ...
T Consensus       153 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~  227 (286)
T cd06622         153 LVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-GDP  227 (286)
T ss_pred             ccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh-cCC
Confidence            5321    12234688999999998554      357899999999999999999999976655444444333332 334


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +.++..++.++.+||.+||..+|++||+++++++||||...
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            55666789999999999999999999999999999999554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.3e-44  Score=325.08  Aligned_cols=253  Identities=26%  Similarity=0.472  Sum_probs=210.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||.||+++...+++    .+++|.....   ......+.+|+.++++++ ||||+++++.+   . ..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~---~-~~   71 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGK----QYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESF---E-EN   71 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCC----EEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEeee---c-CC
Confidence            68999999999999999999887655    6788876532   223457889999999998 99999998842   2 34


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+++++|.+++.......+++.++..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            46779999999999999997644456899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      .....  ......|++.|+|||++.+..++.++|+|||||++++|++|+.||......+....+.    ....+..+..+
T Consensus       152 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  225 (256)
T cd08218         152 NSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII----RGSYPPVSSHY  225 (256)
T ss_pred             Ccchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh----cCCCCCCcccC
Confidence            43221  1223468999999999999999999999999999999999999997664443333222    22334556678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +.++.++|.+||..+|++||++.++++||||
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            9999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.9e-44  Score=325.83  Aligned_cols=253  Identities=31%  Similarity=0.499  Sum_probs=207.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|...+.||+|+||.||+|+...+++    .+++|....... ...+.+|++++++++ ||||+++++.+.   . ...+
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~-~~~~~~e~~~~~~l~-~~~i~~~~~~~~---~-~~~~   73 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQ----VVAIKVVPVEED-LQEIIKEISILKQCD-SPYIVKYYGSYF---K-NTDL   73 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCc----EEEEEEeecHHH-HHHHHHHHHHHHhCC-CCcEeeeeeeee---c-CCcE
Confidence            58899999999999999999877543    678887765322 678999999999997 999999998432   2 3567


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++++||+++++|.+++.. .+..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus        74 ~l~~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          74 WIVMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEEEecCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            799999999999999976 3457899999999999999999999999999999999999999999999999999876432


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      ..  ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+..  ........+..++.+
T Consensus       153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  228 (256)
T cd06612         153 MA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--KPPPTLSDPEKWSPE  228 (256)
T ss_pred             cc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc--CCCCCCCchhhcCHH
Confidence            21  12234589999999999999999999999999999999999999986644332222111  111111233457889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +.+++.+||+.||++||++.+++.||||
T Consensus       229 ~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         229 FNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.4e-44  Score=330.99  Aligned_cols=256  Identities=20%  Similarity=0.308  Sum_probs=206.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|++.+.||+|+||.||+|.....+......+++|.......  ....+.+|+.++++++ ||||+++++..   . ...
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~---~-~~~   80 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIVCLLGVV---T-QEQ   80 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEE---e-cCC
Confidence            478889999999999999997655555567899998864322  2346888999999998 99999999842   2 233


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQN---------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN  144 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~---------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~  144 (366)
                      ..++||||+++++|.+++....               ...+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            4679999999999999996421               1247889999999999999999999999999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 017746          145 DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLI  223 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~  223 (366)
                      +.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |.+||.+.......+.+.
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~  240 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR  240 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999987643322222233456778999999998899999999999999999998 999998765444333332


Q ss_pred             HhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .    ...+..+..+++.+.+++.+||..||++||++.+|+++
T Consensus       241 ~----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         241 K----RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             c----CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            2    22334566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1e-43  Score=324.59  Aligned_cols=255  Identities=33%  Similarity=0.548  Sum_probs=207.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC------CchhhHHHHHHHHHHcCCCCceeEeecceeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP------PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~------~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~   75 (366)
                      +|.+++.||+|+||.||+|.+..++.    .+++|......      .....+.+|+.+++++. ||||+++++.+.  .
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~----~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~   75 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGR----ELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLR--D   75 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCc----EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEec--c
Confidence            68999999999999999999887665    67787664321      12346788999999998 999999998422  2


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      .....++++|||+++++|.+++.+.  +.+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence            2234677999999999999999763  46899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCC-cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          156 KKSSCDGER-SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       156 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ......... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......   .+.........+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~  230 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---AIFKIATQPTNPVL  230 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---HHHHHhcCCCCCCC
Confidence            865321111 11223468999999999988889999999999999999999999997653332   22333333344556


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +..++..+.++|.+||. +|++||++++++.|||+
T Consensus       231 ~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         231 PPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV  264 (265)
T ss_pred             chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence            67788999999999995 99999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.8e-44  Score=323.99  Aligned_cols=251  Identities=39%  Similarity=0.688  Sum_probs=209.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC------CchhhHHHHHHHHHHcCCCCceeEeecceeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP------PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~------~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~   75 (366)
                      +|..++.||+|+||.||+|....++.    .+++|......      .....+.+|+.+++.++ ||||+++++.+    
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~----   71 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGD----FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTE----   71 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCc----EEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeE----
Confidence            68999999999999999999876655    67777654422      13456889999999998 99999999832    


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      .....++++|||+++++|.+++.+.  +.+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~  149 (258)
T cd06632          72 REEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMA  149 (258)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence            2334567999999999999999763  46899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcC-CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      .......   ......|++.|+|||.+.... ++.++|+|||||++|+|++|+.||.....   ...+.........+.+
T Consensus       150 ~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~  223 (258)
T cd06632         150 KQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRSKELPPI  223 (258)
T ss_pred             eeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHHHhcccCCCc
Confidence            8754322   122346899999999987776 89999999999999999999999976542   2333333333455667


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +..+++++.+|+.+||..+|++||++.+++.|||+
T Consensus       224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            77889999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=331.99  Aligned_cols=255  Identities=29%  Similarity=0.457  Sum_probs=206.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+.+.||.|+||.||+|.+..++.    .+++|...... .....+.+|+.++++++ ||||+++++.+.    ....
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~   76 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGL----FAAAKIIQIESEEELEDFMVEIDILSECK-HPNIVGLYEAYF----YENK   76 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCc----EEEEEEEeeCCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEe----cCCe
Confidence            58899999999999999999876543    67888776432 23346778999999999 999999998432    2445


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|.+++.+ .+..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          77 LWILIEFCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EEEEeeccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            6799999999999999976 345799999999999999999999999999999999999999999999999999876532


Q ss_pred             CCCCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC-CCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE-LPNI  234 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  234 (366)
                      ...  ......||+.|+|||++.     ...++.++|||||||++|+|++|++||...........+   ..... ....
T Consensus       156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~  230 (280)
T cd06611         156 TLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI---LKSEPPTLDQ  230 (280)
T ss_pred             ccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH---hcCCCCCcCC
Confidence            221  222346899999999975     345778999999999999999999999776443332222   21111 1123


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +..++.++.++|.+||..+|.+||+++++++|||+..
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence            4467899999999999999999999999999999954

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.4e-44  Score=324.54  Aligned_cols=255  Identities=27%  Similarity=0.455  Sum_probs=210.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||.|+||.||+|.+..++.    .+++|.....   ......+.+|++++++++ ||||+++++.+.  ....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~   73 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGK----ILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRII--DRSN   73 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCC----EEEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeee--cCCC
Confidence            58899999999999999999887654    6777766532   223456778999999999 999999988432  2334


Q ss_pred             eEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCcEecCCCCCcEEeccCCceEEEe
Q 017746           79 RFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIH-----SKGFVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH-----~~givHrDlkp~NILl~~~~~vkl~D  151 (366)
                      ...+++|||+++++|.+++...  .+..+++..+..++.||+.||.|||     +.+++|+||||+||+++.++.+||+|
T Consensus        74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d  153 (265)
T cd08217          74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGD  153 (265)
T ss_pred             CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEec
Confidence            5567999999999999999753  2457999999999999999999999     89999999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          152 FGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       152 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      ||++.........  .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+    .....
T Consensus       154 ~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~  227 (265)
T cd08217         154 FGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI----KEGKF  227 (265)
T ss_pred             ccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH----hcCCC
Confidence            9999876533221  22346899999999999989999999999999999999999999876533322222    22334


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +.++..++.++.+++.+||..+|++||++.+|++|||+
T Consensus       228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            55667789999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.7e-44  Score=334.45  Aligned_cols=255  Identities=29%  Similarity=0.441  Sum_probs=208.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+++|...... .....+.+|+.+++.++ ||||+++++.+   .. ...
T Consensus        20 ~y~~~~~lg~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~---~~-~~~   90 (297)
T cd06656          20 KYTRFEKIGQGASGTVYTAIDIATGQ----EVAIKQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSY---LV-GDE   90 (297)
T ss_pred             hceeeeeeccCCCeEEEEEEECCCCC----EEEEEEEecCccchHHHHHHHHHHHHhCC-CCCEeeEEEEE---ec-CCE
Confidence            68999999999999999999877665    67888776432 34456788999999998 99999999843   22 345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|.+++.+   ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus        91 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             EEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            6799999999999999965   3589999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ...  ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+..  ........+..++.
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  243 (297)
T cd06656         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NGTPELQNPERLSA  243 (297)
T ss_pred             Ccc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc--CCCCCCCCccccCH
Confidence            221  12234689999999999999999999999999999999999999976654332221111  11112234556788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .+++|+.+||..+|++||+++++++||||...
T Consensus       244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence            99999999999999999999999999999543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.8e-44  Score=330.56  Aligned_cols=256  Identities=28%  Similarity=0.414  Sum_probs=205.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++..++.    .+++|.+....   .....+.+|+.++++++ ||||+++++.+.    ..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~----~~   71 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGE----TVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFP----HG   71 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCc----eEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEe----cC
Confidence            68999999999999999999877654    67778766432   23457889999999998 999999998432    24


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+ +++|.+++... ...+++.++..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        72 ~~~~~v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~  149 (286)
T cd07832          72 SGFVLVMEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLF  149 (286)
T ss_pred             CeeEEEeccc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence            5677999999 99999999763 357999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC--------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD--------  229 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~--------  229 (366)
                      ..... .......|+..|+|||.+.+. .++.++|||||||++|+|++|.+||....+......+.......        
T Consensus       150 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         150 SEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             cCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhc
Confidence            53322 112234689999999998654 46889999999999999999999987765544433333211000        


Q ss_pred             -------------C----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          230 -------------E----LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       230 -------------~----~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                                   .    ........+..+.+||.+||..+|++||+++++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence                         0    001112457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-44  Score=327.80  Aligned_cols=252  Identities=26%  Similarity=0.409  Sum_probs=209.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||.|+||.||+|.+..++.    .+++|.+....    .....+.+|++++++++ ||||+++++.   + .+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~---~-~~   71 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKK----MFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYS---F-QD   71 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCc----EEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHh---h-cC
Confidence            58899999999999999999887665    57777665421    34567889999999998 9999999873   2 33


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ....++||||+.|++|.+++.+.  ..+++..+..++.||+.||.|||++|++|+||||+||++++++.++|+|||++..
T Consensus        72 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          72 EENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            44577999999999999999763  5799999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||............ ..... ..+..+..
T Consensus       150 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~-~~~~~~~~  224 (258)
T cd05578         150 VTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-AKQET-ADVLYPAT  224 (258)
T ss_pred             cCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-HHhcc-ccccCccc
Confidence            64322   223346899999999999888999999999999999999999999877543222222 22111 34456667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH--HHHHcCCCc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTA--EMLLNHPFV  269 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~--~~ll~hp~~  269 (366)
                      ++.++.++|.+||..||.+||++  .|+++||||
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         225 WSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             CcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            89999999999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=347.87  Aligned_cols=236  Identities=23%  Similarity=0.438  Sum_probs=203.6

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEe
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      ++-||+|+.|.||+|+...      ..||||++..      .-+.+++-|++|+ ||||+.+.|    +.....+|++||
T Consensus       129 LeWlGSGaQGAVF~Grl~n------etVAVKKV~e------lkETdIKHLRkLk-H~NII~FkG----VCtqsPcyCIiM  191 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHN------ETVAVKKVRE------LKETDIKHLRKLK-HPNIITFKG----VCTQSPCYCIIM  191 (904)
T ss_pred             hhhhccCcccceeeeeccC------ceehhHHHhh------hhhhhHHHHHhcc-CcceeeEee----eecCCceeEEee
Confidence            4568999999999999764      4789997553      4567899999999 999999999    445567899999


Q ss_pred             ecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCc
Q 017746           86 EYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERS  165 (366)
Q Consensus        86 E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  165 (366)
                      |||..|.|...|+.  +..+.......|..+|+.|+.|||.++|||||||.-||||..+..|||+|||-++...   ...
T Consensus       192 EfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~---~~S  266 (904)
T KOG4721|consen  192 EFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS---DKS  266 (904)
T ss_pred             eccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh---hhh
Confidence            99999999999976  3579999999999999999999999999999999999999999999999999999874   234


Q ss_pred             ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHH
Q 017746          166 QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF  245 (366)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  245 (366)
                      ....++||..|||||++++++.+.++|||||||+|||||||..||.+...   ...|...+.....-.+|..+++-++-|
T Consensus       267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---sAIIwGVGsNsL~LpvPstcP~GfklL  343 (904)
T KOG4721|consen  267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---SAIIWGVGSNSLHLPVPSTCPDGFKLL  343 (904)
T ss_pred             hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch---heeEEeccCCcccccCcccCchHHHHH
Confidence            44567899999999999999999999999999999999999999965532   233444444444445678899999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcC
Q 017746          246 LIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       246 l~~cL~~dp~~R~t~~~ll~h  266 (366)
                      |++||.-.|..||++.+++.|
T Consensus       344 ~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  344 LKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             HHHHHhcCCCCCccHHHHHHH
Confidence            999999999999999999988

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.8e-44  Score=334.43  Aligned_cols=255  Identities=28%  Similarity=0.414  Sum_probs=204.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||++.+..++.    .+++|.......  ....+.+|++++.+++ ||||+++++.+   .. +.
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~----~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---~~-~~   72 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGL----IMARKLIHLEIKPAIRNQIIRELKVLHECN-SPYIVGFYGAF---YS-DG   72 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCe----EEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE---ee-CC
Confidence            68899999999999999999887654    677777654211  2345788999999998 99999999843   22 34


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      .+++||||+++++|.+++.+.  +.+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||++...
T Consensus        73 ~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          73 EISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             EEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            567999999999999999763  568999999999999999999998 59999999999999999999999999998765


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHh-------------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI-------------  225 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~-------------  225 (366)
                      ...    ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+...             
T Consensus       151 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         151 IDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             ccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence            321    122346899999999998888999999999999999999999999755432222111110             


Q ss_pred             -------------------hcCCCCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          226 -------------------GVGDELPNIPG-DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       226 -------------------~~~~~~~~~~~-~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                         ......|..+. .++.++++|+.+||..||++||++.++++||||..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                               00111122222 36788999999999999999999999999999954

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7e-44  Score=328.56  Aligned_cols=253  Identities=24%  Similarity=0.324  Sum_probs=205.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|++++.||+|+||+||+|+...++.....++++|.......  ....+..|+..+.++. ||||+++++.+    .+. 
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~----~~~-   81 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD-HAYIVRLLGIC----PGA-   81 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCC-CCCcceEEEEE----CCC-
Confidence            578899999999999999999877776667888888764322  2245667777888888 99999999842    222 


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++++||+++|+|.+++.. ..+.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            34589999999999999976 34579999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............|+..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+ .   ....+..+..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~---~~~~~~~~~~~  236 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-E---KGERLAQPQIC  236 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-H---CCCcCCCCCCC
Confidence            3322222233457788999999998999999999999999999998 99999876544333322 2   12233344557


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +.++.+++.+||..||++||++.++++
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            888999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.3e-44  Score=327.62  Aligned_cols=252  Identities=18%  Similarity=0.291  Sum_probs=202.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|.++..+ .....+++|.......  ....+.+|+.++.+++ ||||++++|.+   . ...
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~---~-~~~   79 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPS-KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSNIVRLEGVI---T-RGN   79 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCC-CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEE---e-cCC
Confidence            4788999999999999999875432 2346788888765322  2346788999999997 99999999843   2 234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+++|+|.+++.+ ..+.+++..+..++.||+.||+|||++|++||||||+|||++.++.+|++|||.+....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            56799999999999999976 34579999999999999999999999999999999999999999999999999876542


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      .... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+....+.   .. ..+..+..+
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---~~-~~~~~~~~~  233 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE---DG-FRLPAPRNC  233 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH---CC-CCCCCCCCC
Confidence            2111 11222346778999999999999999999999999999775 999998776554434332   22 223356678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +..+.+++.+||..+|++||++++|++
T Consensus       234 ~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         234 PNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=345.18  Aligned_cols=262  Identities=23%  Similarity=0.402  Sum_probs=223.9

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      ..++.+||-||||.|=++..+.....++.+++-|+-.......+.+..|..+|.+.. +|.||++|.   +| .+.++.|
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYr---Tf-rd~kyvY  496 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYR---TF-RDSKYVY  496 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHH---Hh-ccchhhh
Confidence            457789999999999999887654434445444433334456678899999999999 899999997   33 3456778


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      ++||-|-||+|...++++  +.|++.+++.|+.++++|++|||++|||+|||||+|.+|+.+|-+||.|||+|+.+.   
T Consensus       497 mLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---  571 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---  571 (732)
T ss_pred             hhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---
Confidence            999999999999999873  689999999999999999999999999999999999999999999999999999984   


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                      ....+.++||||.|.|||++.++..+.++|.||||+++|||++|.+||.+.++..++..|.+-.   ..-.+|..++..+
T Consensus       572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi---d~i~~Pr~I~k~a  648 (732)
T KOG0614|consen  572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI---DKIEFPRRITKTA  648 (732)
T ss_pred             cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh---hhhhcccccchhH
Confidence            3444667899999999999999999999999999999999999999999998877777776643   3345667899999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHHcCCCcccCCCCCC
Q 017746          243 KDFLIKCFLKDPKRRWT-----AEMLLNHPFVCADDQTGD  277 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~~~~~~  277 (366)
                      .++|+++..-+|.+|..     +.+|.+|.||...++.+-
T Consensus       649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl  688 (732)
T KOG0614|consen  649 TDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL  688 (732)
T ss_pred             HHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence            99999999999999985     899999999977666543

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.4e-44  Score=324.39  Aligned_cols=250  Identities=25%  Similarity=0.432  Sum_probs=206.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC--CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~--~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||.|+||.||++.+..+++    .+++|.+..  .......+.+|+.+++.++ ||||+++++.+   . ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~---~-~~~   71 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQ----KYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-HPNIVAFKESF---E-ADG   71 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCc----eEEEEEEEcCcchHHHHHHHHHHHHHHhCC-CCCcceEEEEE---E-ECC
Confidence            58899999999999999999887665    677777643  2234567788999999998 99999998842   2 344


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .++++|||+++|+|.+++....+..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus        72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeec
Confidence            67799999999999999976555678999999999999999999999999999999999999999999999999998664


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      ....  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...........+..    ...+..+..++
T Consensus       152 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~  225 (255)
T cd08219         152 SPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ----GSYKPLPSHYS  225 (255)
T ss_pred             cccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc----CCCCCCCcccC
Confidence            3222  12234689999999999999999999999999999999999999986654333332221    22334566788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+.+||.+||..||++||++.++++-
T Consensus       226 ~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         226 YELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.2e-44  Score=343.88  Aligned_cols=257  Identities=25%  Similarity=0.357  Sum_probs=203.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC-CCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++...+. .....+|+|.+.....  ....+.+|++++..+..||||+++++.+    ...
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----~~~  113 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----TKS  113 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE----ccC
Confidence            47789999999999999999754432 2234789998864322  3456889999999997799999999843    223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC---------------------------------------------------------
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN---------------------------------------------------------  101 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~---------------------------------------------------------  101 (366)
                      ..+++|||||++|+|.+++.+..                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            45679999999999999986521                                                         


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC
Q 017746          102 -------------------------------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN  144 (366)
Q Consensus       102 -------------------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~  144 (366)
                                                           ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~  273 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence                                                 1247888899999999999999999999999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 017746          145 DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLI  223 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~  223 (366)
                      +.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~  353 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI  353 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence            9999999999986543322222233457888999999999999999999999999999997 999997654333322222


Q ss_pred             HhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ..+   ..+..+..++.++.+++.+||..||++||++.+|.+
T Consensus       354 ~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         354 KSG---YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             hcC---CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            222   223345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.5e-44  Score=327.89  Aligned_cols=256  Identities=26%  Similarity=0.392  Sum_probs=203.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||.|+||.||+|+++.+++    .+++|......   .....+.+|++++++++ ||||+++++.+    .+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~----~~~   71 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGE----VVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVI----HTE   71 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCC----EEEEEEccccccccccchHHHHHHHHHHhcC-CCCCcchhhhc----ccC
Confidence            48899999999999999999887654    67888765422   23356889999999998 99999999843    234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+. ++|.+++....+..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            45679999996 58999997655567999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcC-CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC--------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD--------  229 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~--------  229 (366)
                      ....  .......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||...........+.......        
T Consensus       151 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         151 GVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             ccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence            3221  1122235788999999887644 6889999999999999999999998765443333322211100        


Q ss_pred             --------CCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          230 --------ELP--------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       230 --------~~~--------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                              ..+        .+...++.+++++|.+||..||++|||++++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                    000        1122468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-43  Score=323.82  Aligned_cols=250  Identities=33%  Similarity=0.596  Sum_probs=201.0

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      -..||+|+||.||+|++..++    ..+++|....... ....+.+|+.+++.++ |+||+++++.+    ..+..+++|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~----~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~----~~~~~~~lv   83 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQ----VRIAIKEIPERDSRYVQPLHEEIALHSYLK-HRNIVQYLGSD----SENGFFKIF   83 (268)
T ss_pred             eEEEecCCceEEEEeEecCCC----cEEEEEEecCCCHHHHHHHHHHHHHHHhcC-CCCeeeeeeee----ccCCEEEEE
Confidence            357999999999999987654    3788887665322 4457889999999998 99999999843    223467799


Q ss_pred             eecCCCCCHHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-CCceEEEecCCccccCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRL--QESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-NDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l--~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~  161 (366)
                      |||+++++|.+++... .+.+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          84 MEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             EecCCCCCHHHHHHHh-cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            9999999999999763 2345  88999999999999999999999999999999999976 679999999998765322


Q ss_pred             CCCcccccccCCCCCCCccccCCcC--CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          162 GERSQSFECRGTPLYMSPESVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      ..  ......|++.|+|||++.+..  ++.++||||||+++|+|++|+.||........  ...........+.++..++
T Consensus       163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06624         163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFKIHPEIPESLS  238 (268)
T ss_pred             CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhccCCCCCcccC
Confidence            21  122335899999999986644  78899999999999999999999976533221  2222222234456677789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +++.+|+.+||..+|++|||+.+++.||||
T Consensus       239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.2e-43  Score=322.50  Aligned_cols=248  Identities=22%  Similarity=0.359  Sum_probs=202.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|..+..     ..+++|...........+.+|+.++++++ ||||+++++.+    .....+
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~-----~~~a~K~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~~~   74 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQ-----IKVAIKAINEGAMSEEDFIEEAKVMMKLS-HPKLVQLYGVC----TQQKPL   74 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccC-----ceEEEEecccCCccHHHHHHHHHHHHHCC-CCCceeEEEEE----ccCCCE
Confidence            478899999999999999987542     36888887654455667889999999998 99999999832    223456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++... .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        75 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            7999999999999999763 346899999999999999999999999999999999999999999999999998865322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......++..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+...    ..+..+...+.
T Consensus       154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~----~~~~~~~~~~~  228 (256)
T cd05114         154 EY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG----FRLYRPKLASM  228 (256)
T ss_pred             ce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC----CCCCCCCCCCH
Confidence            11 11122345678999999998899999999999999999999 99999876554444443321    12233455788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.+++.+||..+|++||+++++++
T Consensus       229 ~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         229 TVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8e-44  Score=327.57  Aligned_cols=255  Identities=22%  Similarity=0.366  Sum_probs=205.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|++.... ......+++|.+.....  ....+.+|+++++.++ ||||+++++.+.   . .
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~---~-~   80 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-HENIVKFYGVCT---E-G   80 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC-CCCchheeeEEe---c-C
Confidence            4788899999999999999875431 22345788998765333  2467889999999998 999999998432   2 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE  146 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~  146 (366)
                      ...++||||+++++|.+++....            ...+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            45679999999999999997531            134789999999999999999999999999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHh
Q 017746          147 AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI  225 (366)
Q Consensus       147 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~  225 (366)
                      +||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.  
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~--  238 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT--  238 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--
Confidence            99999999976532222111223346788999999999999999999999999999998 999998766554444333  


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       226 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                        ....+..+..++..+.+++.+||..||++||++.|+++
T Consensus       239 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 --QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             --cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence              22233445678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.1e-44  Score=326.52  Aligned_cols=257  Identities=22%  Similarity=0.339  Sum_probs=203.3

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccC--C
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK--G   77 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~--~   77 (366)
                      +.+++.||+|+||.||+|....++.  ...+++|.....   ......+.+|.++++.++ ||||+++++.+.....  .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~--~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDS--ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCC--eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccC
Confidence            4678999999999999999876543  346888876543   223456788999999998 9999999985433221  2


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecC
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQ----NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                      ....+++|||+++|+|.+++...    ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence            23467999999999999988532    12348899999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      +++...............+++.|+|||++.+..++.++|||||||++|+|++ |+.||...........+..    ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~----~~~~  233 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ----GNRL  233 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----CCCC
Confidence            9987643222111222346778999999999999999999999999999999 8999987655444443332    1223


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+..++..+.++|.+||..||++|||+.+|+++
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         234 KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3455688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-45  Score=322.07  Aligned_cols=260  Identities=25%  Similarity=0.425  Sum_probs=206.3

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEe
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      .+.||+|+||.|--++...++.+|+++++-|...   ..+.+..+|++++.+.++|+||+++++   .|+++.+ +||||
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLie---fFEdd~~-FYLVf  155 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIE---FFEDDTR-FYLVF  155 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHH---Hhcccce-EEEEE
Confidence            4689999999999999988888666666555511   356789999999999999999999998   3445444 55999


Q ss_pred             ecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC---ceEEEecCCccccCCCC
Q 017746           86 EYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND---EAKIADFGLAKKSSCDG  162 (366)
Q Consensus        86 E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~DFG~a~~~~~~~  162 (366)
                      |-|.||.|...|.++  ..|+|.++..+++.|+.||.|||.+||.||||||+|||-....   -||||||.+..-.....
T Consensus       156 EKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             ecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            999999999999875  4699999999999999999999999999999999999997654   49999999886432221


Q ss_pred             -----CCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc---------------h
Q 017746          163 -----ERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS---------------N  217 (366)
Q Consensus       163 -----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg~~pf~~~~~~---------------~  217 (366)
                           ......+.+|+..|||||++.     ...|+.++|.||||||+|-||+|++||.+.-..               .
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK  313 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence                 122334568999999999872     345899999999999999999999999654321               1


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCCCC
Q 017746          218 VFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQT  275 (366)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~~~  275 (366)
                      .++.|.. +.-..+.+-+..+|.+++|++..+|.+|+.+|.++.++++|||+......
T Consensus       314 LFesIQE-GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  314 LFESIQE-GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHHhc-cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            1222222 22122222335689999999999999999999999999999999665443

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-43  Score=326.73  Aligned_cols=255  Identities=25%  Similarity=0.469  Sum_probs=202.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||.||+|+++.+++    .+++|......   .....+.+|+.+++++. ||||+++++.+   .. .
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~---~~-~   72 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQ----IVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVF---RR-K   72 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCc----EEEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeEE---ee-C
Confidence            58899999999999999999887655    67777665321   23345788999999998 99999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+++++|..++..  ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        73 ~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          73 RKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             CEEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceec
Confidence            456799999999888877754  346999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC---------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG---------  228 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~---------  228 (366)
                      .....  ......++..|+|||++.+ ..++.++|||||||++|+|++|++||.+....+....+......         
T Consensus       151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         151 TGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            43322  1223358899999999876 55888999999999999999999999876654443333221100         


Q ss_pred             --------CCCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          229 --------DELPN---------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       229 --------~~~~~---------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                              ...|.         ....++..+.+|+.+||..+|++||++.+++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                    00000         012467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1e-43  Score=324.32  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=205.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|..+.++.    .+++|...........+.+|+++++++. ||||+++++.+    ..+..+
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~~~   77 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVC----TREPPF   77 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCc----eEEEEEecCCchHHHHHHHHHHHHHhCC-CCChhheEEEE----cCCCCc
Confidence            47788899999999999999876554    6888887665445667889999999998 99999999842    223456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+++++|.+++.......+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            79999999999999997644456899999999999999999999999999999999999999999999999999876432


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+..    ...+..+..++.
T Consensus       158 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  232 (263)
T cd05052         158 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----GYRMERPEGCPP  232 (263)
T ss_pred             ee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----CCCCCCCCCCCH
Confidence            11 11112234678999999999999999999999999999998 9999987655444333322    223445667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.+++.+||..||++||++.++++
T Consensus       233 ~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         233 KVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3e-43  Score=320.66  Aligned_cols=254  Identities=37%  Similarity=0.629  Sum_probs=207.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|.+..+++    .+++|.......   ....+.+|+.+++.++ |+||+++++.    ....
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~----~~~~   71 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGE----LMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGV----EVHR   71 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCc----EEEEEEEECcccchHHHHHHHHHHHHHHhCC-CCChhheeee----EecC
Confidence            69999999999999999999876654    677787665433   4567899999999998 9999999983    2234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++|+||+++++|.+++.+  +..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~  149 (264)
T cd06626          72 EKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL  149 (264)
T ss_pred             CEEEEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence            456799999999999999975  246899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcc--cccccCCCCCCCccccCCcC---CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          159 SCDGERSQ--SFECRGTPLYMSPESVNENE---YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       159 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      ........  .....|++.|+|||++.+..   ++.++||||||+++|+|++|+.||........  ....... ...+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~~~~-~~~~~  226 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFHVGA-GHKPP  226 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHHHhc-CCCCC
Confidence            43322211  11346889999999998766   88999999999999999999999976543222  2222222 23344


Q ss_pred             CCCC--CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          234 IPGD--LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       234 ~~~~--~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ++..  ++..+.+||.+||+.+|++||++++++.|||+
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            4444  48999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=314.95  Aligned_cols=253  Identities=25%  Similarity=0.448  Sum_probs=203.3

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      ..+..||.|+-|+|++++.+.++.    .+|||......+  ...++...+.++..-..+|+||+|+|++..   +. ..
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~----iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~---n~-dV  166 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGH----IIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT---NT-DV  166 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccce----EEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee---Cc-hH
Confidence            345679999999999999988764    899999877433  445667777777777779999999996543   11 23


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      .+.||.|.. .+..++++ ..++++|..+-.+...++.||.||-++ ||+|||+||+|||+++.|++||||||++-++..
T Consensus       167 ~IcMelMs~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  167 FICMELMST-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHHHHH-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence            378999853 55555554 567899999999999999999999985 899999999999999999999999999988743


Q ss_pred             CCCCcccccccCCCCCCCccccCCc---CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESVNEN---EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ..   ......|-+.|||||.+...   .|+.++||||||++|+||+||+.||.+...+  ++.+.++.. .+.|.++..
T Consensus       245 Sk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln-~ePP~L~~~  318 (391)
T KOG0983|consen  245 SK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLN-EEPPLLPGH  318 (391)
T ss_pred             cc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHh-cCCCCCCcc
Confidence            22   22334688999999998654   6899999999999999999999999876433  334444433 444665543


Q ss_pred             --CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          238 --LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       238 --~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                        +|+++.+|+..||++|+.+||...+||+|||+...
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence              79999999999999999999999999999999554

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-43  Score=323.62  Aligned_cols=249  Identities=24%  Similarity=0.463  Sum_probs=205.0

Q ss_pred             eeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            9 IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         9 lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ||.|+||.||+|++..+++    .+++|.+....    .....+.+|+.+++.++ ||||+++++.+   . .+..++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~---~-~~~~~~lv   71 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNR----TFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTF---K-DKKYIYML   71 (262)
T ss_pred             CCCCCceEEEEEEECCCCc----EEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeE---E-cCCccEEE
Confidence            6999999999999987654    67777765422    33467889999999998 99999999832   2 34456799


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||+++++|.+++.+.  ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.......  
T Consensus        72 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--  147 (262)
T cd05572          72 MEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--  147 (262)
T ss_pred             EecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence            9999999999999763  468999999999999999999999999999999999999999999999999998764322  


Q ss_pred             cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHH
Q 017746          165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD  244 (366)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  244 (366)
                       ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ..............+..|...++++.+
T Consensus       148 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (262)
T cd05572         148 -KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYNDILKGNGKLEFPNYIDKAAKD  225 (262)
T ss_pred             -ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHHHhccCCCCCCCcccCHHHHH
Confidence             223346899999999998888999999999999999999999999876531 222233322223345566667899999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHHcCCCcccC
Q 017746          245 FLIKCFLKDPKRRWT-----AEMLLNHPFVCAD  272 (366)
Q Consensus       245 ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~  272 (366)
                      +|.+||..+|++||+     ++|+++||||...
T Consensus       226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             HHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence            999999999999999     9999999999653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-43  Score=325.76  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=205.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||+|+||+||+|++..++.....++++|.......  ....+.+|+.++..+. ||||+++++.+..    . 
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~----~-   81 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG-SPYVCRLLGICLT----S-   81 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC----C-
Confidence            578899999999999999998777766566789998764222  3456788999999998 9999999984421    2 


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..+++|||+++|+|.+++.. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            24589999999999999976 34579999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+..    ...+..+..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~  236 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK----GERLPQPPIC  236 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----CCcCCCCccC
Confidence            3222211222345678999999999999999999999999999998 9999976654433333222    2223335568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +.++.+++.+||..||++||++.+++.
T Consensus       237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         237 TIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-43  Score=325.57  Aligned_cols=256  Identities=27%  Similarity=0.407  Sum_probs=199.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+|+|.......  ....+..|+.++.+...||||+++++.+.    ...
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~----~~~   73 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGT----IMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF----REG   73 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCc----EEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe----cCC
Confidence            58899999999999999999987764    788887665322  23455567776555555999999998432    233


Q ss_pred             EEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           80 FYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ..+++|||++ |+|.+++...  .+..+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus        74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            4679999997 4998888652  234689999999999999999999998 99999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC----cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE----NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      ......   ......|+..|+|||.+.+    ..++.++|+|||||++|+|++|+.||......  .+.+..... ...+
T Consensus       153 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~-~~~~  226 (283)
T cd06617         153 YLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVE-EPSP  226 (283)
T ss_pred             cccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHh-cCCC
Confidence            653211   1122458999999998865    45788999999999999999999999654321  222222211 1222


Q ss_pred             CCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          233 NIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       233 ~~~-~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .++ ..++.++.+||.+||..+|++||+++++++||||...
T Consensus       227 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         227 QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            332 3578999999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.4e-43  Score=318.06  Aligned_cols=257  Identities=45%  Similarity=0.756  Sum_probs=215.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|++|.||+|.+..+++    .+++|......   .....+.+|+.++++++ ||||+++++...  ....
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~   73 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGE----LMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSER--DEEK   73 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEe--cCCC
Confidence            58899999999999999999987654    77888776543   34677899999999999 999999998432  2212


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..++++|||+++++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+...
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          74 NTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             CeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            5677999999999999999763  37999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      .............++..|+|||.+.+..++.++||||||+++|+|++|..||....  .....+.........+.++..+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEPPEIPEHL  229 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccCCCcCCCccc
Confidence            54332111233468999999999998889999999999999999999999998765  2333444444344556777788


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +..+.+|+.+||..||++||++.+++.||||
T Consensus       230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.3e-43  Score=326.51  Aligned_cols=261  Identities=21%  Similarity=0.361  Sum_probs=204.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|..+.. .......+++|.......  ....+.+|+.+++.++ ||||+++++.+   .. .
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~---~~-~   81 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CHHVVRLLGVV---SK-G   81 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEE---cC-C
Confidence            588999999999999999986542 112234788998764322  2335678999999998 99999999842   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEE
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN--------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIA  150 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~  150 (366)
                      ...++||||+++|+|.+++.+..        ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence            35679999999999999997532        1235677889999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+..    .
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~----~  237 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----G  237 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----C
Confidence            9999986543222222222346778999999999999999999999999999998 7999987655444333322    2


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc------CCCccc
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN------HPFVCA  271 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~------hp~~~~  271 (366)
                      ..+..+..+++.+.+++.+||..||++||++.++++      ||||..
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            233445567899999999999999999999999987      888743

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.6e-43  Score=322.38  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=204.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|.....     ..+++|...........+.+|+.+++.++ ||||+++++..    ......
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~~~   76 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYNNS-----TKVAVKTLKPGTMSVQAFLEEANLMKTLQ-HDKLVRLYAVV----TKEEPI   76 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEecCC-----ceEEEEEccCCchhHHHHHHHHHHHHhCC-CCCeeeEEEEE----cCCCCc
Confidence            588999999999999999986542     36888887654445677889999999998 99999998732    233446


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+++|+|.+++.+..+..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            79999999999999998765667899999999999999999999999999999999999999999999999999876432


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+..   .... ..+..++.
T Consensus       157 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~-~~~~~~~~  231 (261)
T cd05072         157 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR---GYRM-PRMENCPD  231 (261)
T ss_pred             ce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc---CCCC-CCCCCCCH
Confidence            21 11122346778999999998899999999999999999998 9999987655444443332   2222 23346889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.+++.+||..+|++||+++++.+
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         232 ELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.7e-43  Score=330.22  Aligned_cols=257  Identities=24%  Similarity=0.370  Sum_probs=206.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|...+.||+|+||.||++.+..+++    .+++|......    .....+.+|+.+++.++ ||||+++++.+   . .
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~---~-~   72 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQ----RFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSF---E-T   72 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCc----EEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEE---e-c
Confidence            58899999999999999999987754    67777665421    23346778999999998 99999999742   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++|++|.+++...  +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          73 KRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            44667999999999999999763  5699999999999999999999999999999999999999999999999999874


Q ss_pred             cCCCCC-------------CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 017746          158 SSCDGE-------------RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       158 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~  224 (366)
                      ......             ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+.......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~  230 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  230 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            211000             0011123578899999999988999999999999999999999999987665544443333


Q ss_pred             hhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCCCccc
Q 017746          225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT---AEMLLNHPFVCA  271 (366)
Q Consensus       225 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t---~~~ll~hp~~~~  271 (366)
                      ..  ...|.....++.++.++|.+||..||++||+   +.++++||||..
T Consensus       231 ~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         231 DD--IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             cc--cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            22  1223333457899999999999999999998   799999999954

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-43  Score=322.02  Aligned_cols=258  Identities=20%  Similarity=0.330  Sum_probs=205.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeecc--CC
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--KG   77 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~~   77 (366)
                      |.+++.||+|+||.||.|....++. ....+++|.+.....   ....+.+|+..++.++ ||||+++++......  ..
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDG-SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCC-CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence            6789999999999999999865432 235788888764322   2346788999999998 999999998543211  12


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecC
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQN----NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                      ....+++|||+++|+|.+++....    ...+++..+..++.||+.||.|||++|++||||||+||++++++.+||+|||
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcc
Confidence            234679999999999999986532    2358999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      +++...............++..|+|||.+.+..++.++|||||||++|||++ |.+||......+....+..    ...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~----~~~~  234 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH----GNRL  234 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CCCC
Confidence            9987643322222222345678999999998999999999999999999999 9999987665544433332    2334


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+..++.++.+++.+||..||++||++.+++++
T Consensus       235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-43  Score=321.30  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=202.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|.++. +    ..+++|...........+.+|+++++.++ ||||+++++.+    ......
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~-~----~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~----~~~~~~   74 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRG-K----IDVAIKMIREGAMSEDDFIEEAKVMMKLS-HPNLVQLYGVC----TKQRPI   74 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecC-C----ccEEEEEeccCCCCHHHHHHHHHHHHhCC-CCCEEEEEEEE----cCCCce
Confidence            68899999999999999998753 2    25788877654445567888999999998 99999998732    233456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||++|++|.+++... .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          75 FIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             EEEEecCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence            7999999999999999763 347899999999999999999999999999999999999999999999999999865322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........++..|+|||.+.+..++.++|||||||++|+|++ |+.||....+.+....+..    ...+..+..++.
T Consensus       154 ~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  228 (256)
T cd05059         154 Q-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA----GYRLYRPKLAPT  228 (256)
T ss_pred             c-ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc----CCcCCCCCCCCH
Confidence            1 111111224457999999999999999999999999999999 8999987665544433322    122334556899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++.+++.+||..+|++|||+.++++.
T Consensus       229 ~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         229 EVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-43  Score=320.32  Aligned_cols=255  Identities=33%  Similarity=0.580  Sum_probs=208.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC------CCchhhHHHHHHHHHHcCCCCceeEeecceeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC------PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~------~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~   75 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+++|.....      ......+++|++++++++ ||||+++++..  ..
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~--~~   75 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGR----ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCL--RD   75 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCC----EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEE--Ec
Confidence            69999999999999999999887655    6777765421      123357888999999998 99999999843  22


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      .....++++|||+++++|.+++...  +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence            3344567999999999999999753  46899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC-CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          156 KKSSCDGE-RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       156 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      +....... ........|+..|+|||++.+..++.++|+|||||++|+|++|+.||.....   ...+.+.......+.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~  230 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQPTKPML  230 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHHcCCCCCCC
Confidence            86532111 1111234689999999999998899999999999999999999999976533   2333444444445667


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      |..+++++.+++.+||. +|..||++.++++|||+
T Consensus       231 p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         231 PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            88899999999999999 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-43  Score=326.64  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=202.9

Q ss_pred             eeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            9 IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         9 lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ||+|+||+||+|.+..+++    .+++|.+...    ......+.+|++++++++ ||||+++++.+   .. ...+++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~---~~-~~~~~lv   71 (277)
T cd05577           1 LGKGGFGEVCACQVKATGK----MYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAF---ET-KDDLCLV   71 (277)
T ss_pred             CCCCCceeEEEEEEcCCCc----EEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEE---ec-CCeEEEE
Confidence            6999999999999887765    5677766431    123445678999999998 99999998732   22 3456799


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||+++++|.+++.+.....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....   .
T Consensus        72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~  148 (277)
T cd05577          72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---G  148 (277)
T ss_pred             EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---C
Confidence            9999999999999775444699999999999999999999999999999999999999999999999999876532   1


Q ss_pred             cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHH
Q 017746          165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD  244 (366)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  244 (366)
                      .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ......+..+++++.+
T Consensus       149 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  227 (277)
T cd05577         149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSPEAKD  227 (277)
T ss_pred             CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccccCCccCCHHHHH
Confidence            112234588899999999888899999999999999999999999977654222333333222 2233455668999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHHcCCCcccC
Q 017746          245 FLIKCFLKDPKRRW-----TAEMLLNHPFVCAD  272 (366)
Q Consensus       245 ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~  272 (366)
                      +|.+||+.||++||     ++.++++||||...
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         228 LCEALLQKDPEKRLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             HHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence            99999999999999     88999999999543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.4e-43  Score=327.54  Aligned_cols=258  Identities=24%  Similarity=0.389  Sum_probs=204.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC------chhhHHHHHHHHHHcCCCCceeEeecceeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP------SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~   75 (366)
                      +|.+.+.||+|+||.||+|.+..+++    .+++|.+.....      ....+..|++++++++ |+||+++++.+.   
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~---   72 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGR----IVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFG---   72 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCc----EEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheee---
Confidence            58899999999999999999887654    778887765322      2345678999999999 999999998432   


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      . ....++||||+ +|+|.+++... ...+++..+..++.||++||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus        73 ~-~~~~~lv~e~~-~~~L~~~i~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~  149 (298)
T cd07841          73 H-KSNINLVFEFM-ETDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA  149 (298)
T ss_pred             c-CCEEEEEEccc-CCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceee
Confidence            2 45677999999 88999999763 236999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC-----
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-----  229 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~-----  229 (366)
                      .........  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||....+.+....+.......     
T Consensus       150 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (298)
T cd07841         150 RSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW  227 (298)
T ss_pred             eeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence            876432221  122357889999998855 467889999999999999999999988766544433332211000     


Q ss_pred             -------------CCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          230 -------------ELP-----NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       230 -------------~~~-----~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                   ..+     ......+.++.+||.+||.+||++|||+.+++.||||...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence                         000     0112357889999999999999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-43  Score=321.08  Aligned_cols=253  Identities=28%  Similarity=0.468  Sum_probs=208.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|..++.||+|+||.||+|..+.++.    .+++|.....   ......+.+|+.+++.++ ||||+++++.+   . ..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~---~-~~   71 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSE----HCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASF---Q-EN   71 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCc----eEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhhee---c-cC
Confidence            58899999999999999999987765    5788876542   234457789999999998 99999999842   2 24


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-ceEEEecCCccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKK  157 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~  157 (366)
                      ..+++|+||+++++|.+++.+..+..+++..+..++.||+.||.|||+++++|+||||+||++++++ .+||+|||.+..
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (257)
T cd08225          72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ  151 (257)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchh
Confidence            4667999999999999999775445689999999999999999999999999999999999999886 469999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ......  ......|++.|+|||++.+..++.++|+|||||++++|++|..||...+.......+.    ....+..+..
T Consensus       152 ~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~  225 (257)
T cd08225         152 LNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC----QGYFAPISPN  225 (257)
T ss_pred             ccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh----cccCCCCCCC
Confidence            643221  1223468999999999988889999999999999999999999997664433322221    2233444556


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ++.++.++|.+||..+|++|||+.++++||||
T Consensus       226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         226 FSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            78999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-43  Score=326.25  Aligned_cols=248  Identities=24%  Similarity=0.404  Sum_probs=193.2

Q ss_pred             eeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHc--CCCCceeEeecceeeccCCeeEE
Q 017746            8 VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQI--GICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l--~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .||+|+||.||++.+..+++    .+++|.+....    .......+|..+++.+  ..||||+.+++.+   .. +..+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~---~~-~~~~   72 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF---HT-PDKL   72 (279)
T ss_pred             CcccCCCeEEEEEEECCCCc----EEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE---ec-CCeE
Confidence            48999999999999887665    67777664321    1222344455444444  2489999987732   22 3356


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++..+  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        73 ~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          73 CFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            7999999999999999763  46999999999999999999999999999999999999999999999999998765322


Q ss_pred             CCCcccccccCCCCCCCccccC-CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVN-ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .    .....||+.|+|||.+. +..++.++||||+||++|+|++|..||......... .+..... ...+.++..++.
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~  224 (279)
T cd05633         151 K----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL-TVNVELPDSFSP  224 (279)
T ss_pred             C----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh-cCCcCCccccCH
Confidence            1    12346999999999886 456899999999999999999999999765433222 2222221 122345667899


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          241 QGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      ++.++|.+||..||++|+     ++.++++||||..
T Consensus       225 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         225 ELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            999999999999999999     6999999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.6e-43  Score=324.26  Aligned_cols=255  Identities=29%  Similarity=0.422  Sum_probs=199.6

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      |.+.+.||+|+||.||+|.+..+++    .+++|.....  ........+|+.++.++..||||+++++.+.  ......
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~----~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGK----YYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLF--DRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCc----EEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEe--cCCCCc
Confidence            6788999999999999999887665    6777776542  1223344578999999987999999998543  222245


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++ +|.+.+... .+.+++..+..++.||+.||+|||++|++||||||+||+++. +.+||+|||+++....
T Consensus        75 ~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          75 LALVFELMDM-NLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             EEEEEecCCc-cHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            7799999975 888888763 357899999999999999999999999999999999999999 9999999999987642


Q ss_pred             CCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc------------
Q 017746          161 DGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV------------  227 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~------------  227 (366)
                      ...   .....+++.|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+....+.....            
T Consensus       152 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         152 KPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             CCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence            221   123458999999997644 5578899999999999999999999987655443333322110            


Q ss_pred             ----CCCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          228 ----GDELP--------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       228 ----~~~~~--------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                          ....+        .+...++.++.++|.+||.++|++||++++++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                00001        0112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.1e-43  Score=324.68  Aligned_cols=256  Identities=20%  Similarity=0.351  Sum_probs=202.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|.++... ......+++|.......  ....+.+|+.+++.++ ||||+++++.+   . ..
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~---~-~~   81 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVV---S-QG   81 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEE---c-CC
Confidence            5889999999999999999875421 12245788988754222  2345778999999998 99999999842   2 33


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEE
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN--------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIA  150 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~  150 (366)
                      ...++||||+++|+|.+++.+...        ..+++..+..++.|++.||+|||+.|++||||||+||++++++.+||+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            456799999999999999975321        235778899999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      |||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..    .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~----~  237 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME----G  237 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----C
Confidence            9999986543222222222346788999999999999999999999999999999 7899987655444333322    2


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+..+..++..+.+++.+||+.||++||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2344566788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-43  Score=335.84  Aligned_cols=259  Identities=24%  Similarity=0.366  Sum_probs=203.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC-CCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|.+...+. .....+|+|.+....  .....+.+|+.++.++..||||+++++.+.   ...
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---~~~   84 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---KPG   84 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee---cCC
Confidence            58999999999999999998654322 234578999876432  234567889999999977999999998432   223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC--------------------------------------------------------
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN--------------------------------------------------------  102 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~--------------------------------------------------------  102 (366)
                      ..++++||||++|+|.+++....+                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            456799999999999999965211                                                        


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCC
Q 017746          103 ---------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT  173 (366)
Q Consensus       103 ---------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt  173 (366)
                               ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++................++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence                     23678888999999999999999999999999999999999999999999999875332222222233467


Q ss_pred             CCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhccc
Q 017746          174 PLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLK  252 (366)
Q Consensus       174 ~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~  252 (366)
                      +.|+|||.+.+..++.++|||||||++|+|++ |..||...............+   ..+..+...++++.+++.+||..
T Consensus       245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~cl~~  321 (343)
T cd05103         245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---TRMRAPDYTTPEMYQTMLDCWHG  321 (343)
T ss_pred             cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc---CCCCCCCCCCHHHHHHHHHHccC
Confidence            78999999999999999999999999999997 999997654433222222222   22334555788999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q 017746          253 DPKRRWTAEMLLNH  266 (366)
Q Consensus       253 dp~~R~t~~~ll~h  266 (366)
                      ||++||++.+|++|
T Consensus       322 ~p~~Rps~~eil~~  335 (343)
T cd05103         322 EPSQRPTFSELVEH  335 (343)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.8e-43  Score=321.77  Aligned_cols=246  Identities=24%  Similarity=0.391  Sum_probs=194.0

Q ss_pred             ccccCee--eecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            3 WLRGDVI--GHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         3 y~~~~~l--G~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      |.+.+.+  |+|+||.||++.++.++.    .+++|........    ..|......+..||||+++++.+.   . ...
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~k~~~~~~~~----~~e~~~~~~~~~h~~iv~~~~~~~---~-~~~   83 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQK----LFVQKIIKAKNFN----AIEPMVHQLMKDNPNFIKLYYSVT---T-LKG   83 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCc----EEEEEEEehhhcc----hhhHHHHHHhhcCCCEEEEEEEEe---c-CCe
Confidence            4455555  999999999999887765    6777776542111    123333444446999999998432   2 335


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-ceEEEecCCccccC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSS  159 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~  159 (366)
                      +++||||+++++|.+++...  ..+++.++..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            77999999999999999763  3799999999999999999999999999999999999999988 99999999988653


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchH-HHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV-FSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ..      ....|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ...+....  ......+..+
T Consensus       162 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  233 (267)
T PHA03390        162 TP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNV  233 (267)
T ss_pred             CC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCccccc
Confidence            21      123589999999999999999999999999999999999999985544332 12222222  2223344568


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-HHHHHcCCCcc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWT-AEMLLNHPFVC  270 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t-~~~ll~hp~~~  270 (366)
                      +..+.+||.+||+.+|.+||+ ++++++||||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             CHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            999999999999999999996 69999999995

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3e-43  Score=329.02  Aligned_cols=258  Identities=28%  Similarity=0.373  Sum_probs=204.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|.++.++.    .+++|.......   ......+|+.++++++ |+||+++++.+.  ....
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~   80 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGE----IVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVV--GKHL   80 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCc----EEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEe--cCCC
Confidence            58899999999999999999987665    677887654222   2234568999999998 999999998432  2223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+.+ +|.+++.. ....+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~lv~e~~~~-~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          81 DSIFLVMEYCEQ-DLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             CeEEEEEecCCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            456799999975 89999876 3357999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC--------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD--------  229 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~--------  229 (366)
                      .....  ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+.......        
T Consensus       159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            43221  1122346888999999865 568899999999999999999999998876655554444321100        


Q ss_pred             ---------CCCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          230 ---------ELPNI--------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       230 ---------~~~~~--------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                               ..+..        ....++++.+||.+||..||++|||++++++||||.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                     00000        012578899999999999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-43  Score=324.26  Aligned_cols=255  Identities=20%  Similarity=0.355  Sum_probs=205.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|..+... ......+++|.......  ....+.+|+.++..++ ||||+++++.+   . ..
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~---~-~~   81 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN-CHHVVRLLGVV---S-TG   81 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC-CCceeEEEEEE---c-CC
Confidence            5888999999999999999986543 22345789998764322  2345778999999998 99999999843   2 23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEE
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN--------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIA  150 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~  150 (366)
                      ...++||||+++|+|.+++....        ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence            45679999999999999997532        1247888999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      |||+++...............+|..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.    ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~----~~  237 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI----DG  237 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh----cC
Confidence            9999986543222222233457889999999998899999999999999999998 999998766555444333    22


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ..+..+..++.++.+++.+||..+|++|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            334556678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.5e-44  Score=324.62  Aligned_cols=255  Identities=29%  Similarity=0.489  Sum_probs=208.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||+|+||.||+|.++.+++    .+++|.+....  .....+.+|+++++++. ||||+++++.+.    ...
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~----~~~   72 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGK----IMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFY----NNG   72 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCc----EEEEEEEecccChHHHHHHHHHHHHHHHCC-CCchhhhheeee----cCC
Confidence            57888999999999999999987665    67888766532  23456888999999999 999999998432    235


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      .++++|||+++++|.+++... ...+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.+||+|||.+...
T Consensus        73 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          73 DISICMEYMDGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             EEEEEEEecCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            677999999999999999763 3579999999999999999999999 99999999999999999999999999998765


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCC--cchHHHHHHHhhcCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQ--DSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      .....    ....|+..|+|||.+.+..++.++|||||||++|+|++|+.||....  .......+.... ....+..+.
T Consensus       152 ~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  226 (265)
T cd06605         152 VNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPS  226 (265)
T ss_pred             HHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCCh
Confidence            32111    11568999999999999999999999999999999999999996542  122223332222 223344444


Q ss_pred             C-CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          237 D-LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       237 ~-~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      . ++.++.++|.+||..||++|||+.+++.||||..
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            4 8899999999999999999999999999999954

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.4e-43  Score=327.17  Aligned_cols=261  Identities=25%  Similarity=0.397  Sum_probs=201.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeecc---
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE---   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~---   75 (366)
                      +|.+.+.||+|+||.||+|++..+++    .+++|......   .......+|++++++++ ||||+++++.+....   
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   87 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQ----IVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPY   87 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCc----EEEEEEEeccCCcCCchhHHHHHHHHHHhCC-CCCccceEEEEecccccc
Confidence            58899999999999999999887654    77888765421   22335578999999998 999999998544322   


Q ss_pred             -CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCC
Q 017746           76 -KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        76 -~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                       .....+++||||+.+ +|.+++.. .+..+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+
T Consensus        88 ~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          88 NRYKGSFYLVFEFCEH-DLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             cCCCceEEEEEcCCCc-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence             123456799999975 89988876 345699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCC--cccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC-
Q 017746          155 AKKSSCDGER--SQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE-  230 (366)
Q Consensus       155 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~-  230 (366)
                      +.........  .......++..|+|||.+.+. .++.++||||||+++|+|++|++||...........+........ 
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9865432221  111234578899999988664 478899999999999999999999987655443333333211000 


Q ss_pred             ----------------CCC-----C-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          231 ----------------LPN-----I-----PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       231 ----------------~~~-----~-----~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                                      .+.     .     +...+..+.+||.+||..||++|||++++++||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                            000     0     01135678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-43  Score=321.71  Aligned_cols=254  Identities=21%  Similarity=0.344  Sum_probs=204.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|..+..+. ....+++|.......  ....+.+|+.++++++ ||||+++++..    ....
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~   78 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGK-KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNIIRLEGVV----TKSR   78 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCC-CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCcceEeEEE----ecCC
Confidence            48899999999999999999865432 234688887764322  3356788999999998 99999999832    2334


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..+++|||+++++|.+++.. ..+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            56799999999999999976 34579999999999999999999999999999999999999999999999999998774


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..   . ..+..+..+
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---~-~~~~~~~~~  233 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED---G-YRLPPPMDC  233 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc---C-CCCCCCCCC
Confidence            2222212222345678999999999999999999999999999998 9999977655544333322   1 122334568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++.+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         234 PSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-43  Score=324.72  Aligned_cols=255  Identities=26%  Similarity=0.444  Sum_probs=198.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+++|......  .......+|+.++++++ ||||+++++.+    ....
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~----~~~~   76 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQ----LVALKEIRLEHEEGAPFTAIREASLLKDLK-HANIVTLHDII----HTKK   76 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCc----EEEEEEEecccccCCchhHHHHHHHHhhCC-CcceeeEEEEE----ecCC
Confidence            58899999999999999999876654    68888775422  22345678999999998 99999999842    2345


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+.+ +|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        77 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          77 TLTLVFEYLDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             eEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            67799999985 999999763 3478999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCc-chHHHHHHHhhcC---CC----
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQD-SNVFSLLIRIGVG---DE----  230 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~-~~~~~~~~~~~~~---~~----  230 (366)
                      ....  ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+....+.+....   ..    
T Consensus       155 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         155 VPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             CCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence            2111  1122347889999999875 4588999999999999999999999976542 1112211111000   00    


Q ss_pred             ----------CC--------CCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          231 ----------LP--------NIPGDLS--EQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       231 ----------~~--------~~~~~~s--~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                                .+        .....++  .++.+++.+||..+|++|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                      00        0001233  788999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-43  Score=323.13  Aligned_cols=248  Identities=19%  Similarity=0.291  Sum_probs=205.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||.|+||.||+|.+.. +    ..+++|.+..... ....+.+|+.+++.++ ||||+++++.+    .....
T Consensus         7 ~y~~~~~ig~g~~~~vy~~~~~~-~----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~----~~~~~   76 (261)
T cd05148           7 EFTLERKLGSGYFGEVWEGLWKN-R----VRVAIKILKSDDLLKQQDFQKEVQALKRLR-HKHLISLFAVC----SVGEP   76 (261)
T ss_pred             HHHHhhhhccCCCccEEEeEecC-C----CcEEEEeccccchhhHHHHHHHHHHHhcCC-CcchhheeeeE----ecCCC
Confidence            58899999999999999999876 3    3677887765433 4567889999999998 99999998732    23445


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++|+|.+++.+..+..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            67999999999999999875566799999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      .....  ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+..    ...+..+..++
T Consensus       157 ~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~  230 (261)
T cd05148         157 DVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA----GYRMPCPAKCP  230 (261)
T ss_pred             ccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh----CCcCCCCCCCC
Confidence            22111  13346778999999998899999999999999999998 8999987665554444332    12234456789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +.+.+++.+||..||++|||+.+|++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         231 QEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.5e-43  Score=325.84  Aligned_cols=252  Identities=29%  Similarity=0.507  Sum_probs=208.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      .|...+.||.|+||.||+|.+..++.    .+++|......  .....+.+|+.+++++. ||||+++++.+.    +..
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~   75 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQ----VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYL----KGT   75 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCE----EEEEEEEeccccHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE----ECC
Confidence            37788999999999999999877654    78888766432  23456888999999998 999999998432    244


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||++||+|.+++..   +.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          76 KLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            67799999999999999864   468999999999999999999999999999999999999999999999999997754


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      ...  .......++..|+|||++.+..++.++|+|||||++|+|++|..||...........+    .....+.++..++
T Consensus       153 ~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~  226 (277)
T cd06640         153 DTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI----PKNNPPTLTGEFS  226 (277)
T ss_pred             CCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh----hcCCCCCCchhhh
Confidence            222  1122346889999999999889999999999999999999999999866544333222    1223455566788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..+.+++.+||..+|++||+++++++|+||..
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06640         227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVK  258 (277)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence            99999999999999999999999999999954

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.8e-43  Score=319.11  Aligned_cols=245  Identities=21%  Similarity=0.330  Sum_probs=195.7

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      +.||+|+||.||+|+++.+++    .+++|......  .....+.+|++++++++ ||||+++++.+.    ....+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~----~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~~lv   71 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNT----PVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCT----QKQPIYIV   71 (252)
T ss_pred             CccCcccCccEEEEEEecCCc----eEEEEecCccCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc----CCCCeEEE
Confidence            479999999999999977654    67888765422  23456889999999998 999999998432    23456799


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||+++++|.+++.+ .+..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus        72 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          72 MELVQGGDFLTFLRT-EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             EeeccCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc
Confidence            999999999999976 3456899999999999999999999999999999999999999999999999998764321111


Q ss_pred             cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHH
Q 017746          165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK  243 (366)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  243 (366)
                      .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+..    ...+..+..++.++.
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  226 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ----GVRLPCPELCPDAVY  226 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc----CCCCCCcccCCHHHH
Confidence            11111123456999999999999999999999999999998 9999976654443333322    222344566789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHc
Q 017746          244 DFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       244 ~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +|+.+||..+|++||++.+++.
T Consensus       227 ~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         227 RLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-43  Score=329.31  Aligned_cols=254  Identities=26%  Similarity=0.391  Sum_probs=205.0

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      |.....||+|+||.||++.+..++.    .+++|...... .....+.+|+.+++.++ ||||+++++.+.    ....+
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~----~~~~~   94 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGK----QVAVKKMDLRKQQRRELLFNEVVIMRDYH-HENVVDMYNSYL----VGDEL   94 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCC----EEEEEEEecchHHHHHHHHHHHHHHHhCC-CCcHHHHHHhee----cCCeE
Confidence            4556789999999999999876654    78888765422 23456789999999998 999999998432    23456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++++|.+++..   +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        95 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          95 WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            799999999999998854   46899999999999999999999999999999999999999999999999998765322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+.. ...... .....++..
T Consensus       172 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~  247 (292)
T cd06658         172 V--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRV-KDSHKVSSV  247 (292)
T ss_pred             c--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCcc-ccccccCHH
Confidence            2  122334689999999999988999999999999999999999999987655443333222 111111 122346889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +.+|+.+||..||++|||++++++||||...
T Consensus       248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         248 LRGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence            9999999999999999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-44  Score=345.07  Aligned_cols=251  Identities=27%  Similarity=0.430  Sum_probs=215.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      .|.+.++||+|.|+.|.+|++..++.    .||+|.+++...   ....+.+|+++|..|. |||||+++.    +.+.+
T Consensus        57 ~y~i~~tig~g~f~~V~La~~~~t~~----~VaiK~idkt~ln~~~~~k~~rev~imk~l~-HPnIvkl~~----v~~t~  127 (596)
T KOG0586|consen   57 LYVIIKTIGKGNFAKVKLARHILTGT----EVAIKIIDKTQLNPSKRQKLGREVDIMKSLN-HPNIVKLFS----VIETE  127 (596)
T ss_pred             ceeeeeeeccceeEEEEeeEecCCCc----eEEEEEehhcccChHHHHHHHHHHHHHHhcC-Ccceeeeee----eeeec
Confidence            37889999999999999999988865    677787766332   3355899999999999 999999998    33445


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+|+||||+.+|++++++.+.  +++.+..++.++.|+++|++|||+++|||||||++||||+.+.++||+|||++..+
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceee
Confidence            5677999999999999999874  57888999999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCC-CccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYE-APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ..   .....+.||++.|.|||++.+.+|+ +.+|+||||+++|.|+.|.+||++..-.+.........+     .+|-.
T Consensus       206 ~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~-----rIp~~  277 (596)
T KOG0586|consen  206 DY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY-----RIPFY  277 (596)
T ss_pred             cc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee-----cccce
Confidence            53   3334567899999999999999886 589999999999999999999998765544433333222     45556


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ++.++.++|+++|..+|.+|++.+++++|.|...
T Consensus       278 ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  278 MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             eechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence            8999999999999999999999999999999854

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.6e-43  Score=322.39  Aligned_cols=256  Identities=23%  Similarity=0.323  Sum_probs=199.7

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      ...+.||+|+||+||++............+++|.......  ....+.+|+++++.++ ||||+++++.+.  ......+
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~~   83 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-HENIVKYKGCCS--EQGGKGL   83 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe--cCCCceE
Confidence            7889999999999999875443333455789998765322  3566788999999998 999999998432  2334456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+++|+|.+++..   ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            799999999999999965   35999999999999999999999999999999999999999999999999999876432


Q ss_pred             CCCcc-cccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchH-----------HHHHHHhhcCC
Q 017746          162 GERSQ-SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV-----------FSLLIRIGVGD  229 (366)
Q Consensus       162 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~-----------~~~~~~~~~~~  229 (366)
                      ..... .....++..|+|||++.+..++.++|||||||++|+|++|..||........           ...+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            22111 1122466779999999989999999999999999999999999864432100           00000000111


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ..+..+..++.++.+++.+||..+|++||++++++.
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            222345667899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.9e-44  Score=328.40  Aligned_cols=251  Identities=31%  Similarity=0.512  Sum_probs=206.9

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      |...+.||+|+||.||+|.+..++.    .+++|......  .....+.+|+.++++++ ||||+++++.+    .....
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~~   76 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKE----VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYITRYYGSY----LKGTK   76 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCe----EEEEEEeccccchHHHHHHHHHHHHHHcCC-CCccHhhhccc----ccCCc
Confidence            6778899999999999999876553    68888766422  23456889999999998 99999999843    23445


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|.+++..   +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          77 LWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             eEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            7799999999999999854   4689999999999999999999999999999999999999999999999999987542


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ..  .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...........+.    ....+.++..++.
T Consensus       154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~  227 (277)
T cd06642         154 TQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----KNSPPTLEGQYSK  227 (277)
T ss_pred             cc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh----cCCCCCCCcccCH
Confidence            21  11223458899999999999999999999999999999999999997654433322221    1223455566889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ++.+++.+||..+|++||++.++++||||..
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         228 PFKEFVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence            9999999999999999999999999999854

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6e-43  Score=323.57  Aligned_cols=258  Identities=29%  Similarity=0.455  Sum_probs=205.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||.|++|.||++.+..+++    .+++|.......  ....+.+|++++++++ ||||+++++.+.  .....
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~   74 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGM----IFALKTITTDPNPDLQKQILRELEINKSCK-SPYIVKYYGAFL--DESSS   74 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCe----EEEEEEEecCCchHHHHHHHHHHHHHHhCC-CCCeeeeeeEEE--ccCCC
Confidence            58889999999999999999977654    678887764322  4466889999999998 999999998543  23344


Q ss_pred             EEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      .+++||||+++++|.+++...  ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence            567999999999999987642  345689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCc--chHHHHHHHhhcCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD--SNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ......    ....++..|+|||.+.+..++.++|||||||++|+|++|+.||.....  ....+...... ....+.++
T Consensus       155 ~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  229 (287)
T cd06621         155 LVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELK  229 (287)
T ss_pred             cccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhc
Confidence            532211    133578899999999999999999999999999999999999976522  11122222111 11111111


Q ss_pred             ------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 ------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                            ...++.+.+||.+||..+|++|||+.|++.||||..
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~  271 (287)
T cd06621         230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA  271 (287)
T ss_pred             cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence                  134678999999999999999999999999999944

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-44  Score=354.65  Aligned_cols=264  Identities=21%  Similarity=0.229  Sum_probs=191.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCC---------------CceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEF---------------PSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR   66 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~---------------~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~   66 (366)
                      +|.+++.||+|+||+||++..+......               ..+++.|...........+++|+.+|++++ ||||++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~  227 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HENILK  227 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-CCCcCc
Confidence            5899999999999999998765432111               111122322222233456789999999998 999999


Q ss_pred             eecceeeccCCeeEEEEEeecCCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc
Q 017746           67 CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN---NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD  143 (366)
Q Consensus        67 ~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~  143 (366)
                      +++.+   . .....++|||++.+ +|.+++....   ........+..++.||+.||+|||++|||||||||+|||++.
T Consensus       228 l~~~~---~-~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        228 IEEIL---R-SEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             EeEEE---E-ECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence            99843   2 23345699999965 8888875421   123446778899999999999999999999999999999999


Q ss_pred             CCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 017746          144 NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI  223 (366)
Q Consensus       144 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~  223 (366)
                      ++.+||+|||+++.+..... .......||+.|+|||++.+..|+.++|||||||++|||++|..++...........+.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999999987643221 22234579999999999999999999999999999999999876443222211111111


Q ss_pred             Hhhc-----CCCCCC----------------C---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          224 RIGV-----GDELPN----------------I---------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       224 ~~~~-----~~~~~~----------------~---------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +...     ....|.                .         ...++.++.++|.+||..||++|||+.|++.||||...
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            1100     000000                0         01256678889999999999999999999999999553

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-43  Score=317.96  Aligned_cols=250  Identities=25%  Similarity=0.401  Sum_probs=206.7

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc--hhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS--SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      +.||+|+||.||+|...... .....+++|........  ...+.+|+++++.++ |+||+++++.+.    ....+++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~----~~~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD-GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCT----EEEPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCC-CCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeec----CCCceEEE
Confidence            57999999999999987541 12357888887764333  578889999999999 999999998432    25567799


Q ss_pred             eecCCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           85 LEYASRGSLADRVKKQN-------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      |||+++++|.+++....       +..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||.+..
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence            99999999999998631       36799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ..............+++.|+|||.+....++.++|||||||++|+|++ |..||......+....+..    ......+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~  230 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK----GYRLPKPE  230 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCCCc
Confidence            754332222334468899999999998899999999999999999999 6999988765554444433    23334566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .++.++.+++.+||..+|++||++.+++++
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         231 YCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4e-43  Score=327.38  Aligned_cols=257  Identities=25%  Similarity=0.342  Sum_probs=205.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|..... .......+++|.......  ....+.+|+++++++..||||+++++.+    ...
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----~~~  111 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC----TIG  111 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE----ecC
Confidence            578899999999999999986432 223456789998765322  2356889999999996599999999843    223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ...+++|||+++|+|.+++.......+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++..
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            35679999999999999997644445899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .............+++.|+|||.+.+..++.++|||||||++|+|++ |..||...............+   ..+..+..
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~  268 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG---YRMAQPEH  268 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC---CcCCCCCC
Confidence            43322111222346788999999999999999999999999999998 999998765444333333322   22234456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+.++.+|+.+||.++|++||++.+++.
T Consensus       269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         269 APAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            7899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-43  Score=329.50  Aligned_cols=257  Identities=24%  Similarity=0.382  Sum_probs=203.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC---CCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS---EFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~---~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|++...++   .....+++|......  .....+.+|+.+++.+..||||+++++.+    .
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~----~   94 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC----T   94 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE----e
Confidence            58899999999999999998754322   223468888876532  23346778999999996699999999843    2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF  142 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  142 (366)
                      ....+++||||+++|+|.+++.++.              ...+++.++..++.||+.||+|||++|++||||||+|||++
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence            2345679999999999999997632              12488899999999999999999999999999999999999


Q ss_pred             cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHH
Q 017746          143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSL  221 (366)
Q Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~  221 (366)
                      .++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~  254 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  254 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            999999999999876532211111122235578999999999999999999999999999998 8999976654443333


Q ss_pred             HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +..    ...+..+..++.++.+++.+||..+|++||++.+++++
T Consensus       255 ~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         255 LKE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHc----CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            322    22334556789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.8e-43  Score=319.59  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=202.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|.....     ..+++|...........+.+|+.++++++ ||||+++++.+    .....+
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~-----~~~aik~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~~~   74 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQ-----YDVAIKMIKEGSMSEDEFIEEAKVMMKLS-HEKLVQLYGVC----TKQRPI   74 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCC-----CcEEEEEcCCCcccHHHHHHHHHHHhcCC-CCCeeeEEEEE----ccCCCc
Confidence            488899999999999999987542     24888877654445667899999999998 99999999843    223346


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+.+|+|.+++... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++.....
T Consensus        75 ~lv~e~~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          75 YIVTEYMSNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            7999999999999999763 346899999999999999999999999999999999999999999999999998865332


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+..    ...+..+...+.
T Consensus       154 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  228 (256)
T cd05113         154 EY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ----GLRLYRPHLASE  228 (256)
T ss_pred             ce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc----CCCCCCCCCCCH
Confidence            21 11222345678999999998889999999999999999998 9999977655444333322    122233455789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .+.+++.+||..||++||++.+|+.+
T Consensus       229 ~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         229 KVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.7e-43  Score=325.15  Aligned_cols=255  Identities=22%  Similarity=0.390  Sum_probs=203.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||++..... .......+++|...... .....+.+|+.++++++ ||||+++++.+    ....
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~   80 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVC----VEGD   80 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC-CCCcceEEEEE----ecCC
Confidence            578899999999999999986432 12223467888776432 23456889999999998 99999999843    2344


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceE
Q 017746           80 FYNLLLEYASRGSLADRVKKQN-----------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAK  148 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vk  148 (366)
                      .+++||||+++++|.+++..+.           ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+|
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            5679999999999999997532           12489999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhc
Q 017746          149 IADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV  227 (366)
Q Consensus       149 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~  227 (366)
                      |+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+..   
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~---  237 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ---  237 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---
Confidence            999999986543222222223346788999999999999999999999999999998 9999977655444333322   


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                       ...+..+..++.++.+|+.+||..||.+|||+.+++.
T Consensus       238 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 -GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             -CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             2223445568899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.7e-43  Score=329.94  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=199.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|.++.++.  ...+++|.....  ......+.+|+.++.++..||||+++++.+    ....
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~----~~~~   81 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGL--RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC----EHRG   81 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCc--eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE----CCCC
Confidence            47788999999999999999876654  234566665432  223456788999999996699999999842    2234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC
Q 017746           80 FYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND  145 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~  145 (366)
                      .+++||||+++|+|.+++.+..              +..+++.++..++.||+.||+|||++|++||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            5779999999999999997532              13588999999999999999999999999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 017746          146 EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       146 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~  224 (366)
                      .+||+|||++.....   ........++..|+|||++.+..++.++|||||||++|+|++ |.+||......+....+. 
T Consensus       162 ~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-  237 (303)
T cd05088         162 VAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-  237 (303)
T ss_pred             cEEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-
Confidence            999999999864321   111112234677999999988889999999999999999998 999997665544333321 


Q ss_pred             hhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       225 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                         ....+..+..++.++.+|+.+||..+|++||++++++.+
T Consensus       238 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         238 ---QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             ---cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               111223445578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-44  Score=344.33  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=208.5

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC--CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~--~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      ...+||+|+|-+||+|.+..++-+. ++-.+|.-..  .+....++..|+++|+.|+ ||||+++|..+.+.  ....++
T Consensus        44 ~~evLGrGafKtVYka~De~~giEV-AWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~--~n~~in  119 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEV-AWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDT--DNKTIN  119 (632)
T ss_pred             hhhhcccccceeeeeccccccchhh-HHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecC--CCceee
Confidence            3568999999999999997776543 3334444333  3345589999999999999 99999999976543  346788


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEeccC-CceEEEecCCccccC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG--FVHCDIKLQNVLVFDN-DEAKIADFGLAKKSS  159 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~-~~vkl~DFG~a~~~~  159 (366)
                      +|+|++..|+|..|+++.  ++++...++.|++||+.||.|||++.  |||||||.+||+|+.+ |.|||+|+|+|....
T Consensus       120 ~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            999999999999999985  46999999999999999999999995  9999999999999865 899999999999864


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                          ......+.|||.|||||+.- +.|+..+||||||++|+||+|+..||...+...  +...+...+..+..+..--.
T Consensus       198 ----~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QIYKKV~SGiKP~sl~kV~d  270 (632)
T KOG0584|consen  198 ----KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QIYKKVTSGIKPAALSKVKD  270 (632)
T ss_pred             ----ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HHHHHHHcCCCHHHhhccCC
Confidence                22223368999999999875 899999999999999999999999997665432  23333333333333333447


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCCC
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ  274 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~~  274 (366)
                      +++++||.+||.. .++|+|+.|||.||||..+..
T Consensus       271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  271 PEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             HHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence            8999999999999 999999999999999977644

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.1e-43  Score=324.43  Aligned_cols=255  Identities=21%  Similarity=0.306  Sum_probs=203.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||.|+||.||+|.+..+. ......+++|.......  ....+.+|+.++..++ ||||+++++.+    ...
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~----~~~   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-HPNIVCLLGVV----TKE   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEE----cCC
Confidence            4778899999999999999876542 22345789998775322  2356788999999998 99999999843    223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQ--------------NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN  144 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~  144 (366)
                      ...++++||+.+++|.+++...              ....+++..+..++.|++.||.|||++||+||||||+|||++++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            3466999999999999998531              12358889999999999999999999999999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 017746          145 DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLI  223 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~  223 (366)
                      +.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999887543222222223346789999999988899999999999999999998 889998765554444433


Q ss_pred             HhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .    ...+.++..++..+.+|+.+||+.+|++||++.+|+.
T Consensus       241 ~----~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         241 N----RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             c----CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            2    2233456778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-43  Score=318.30  Aligned_cols=249  Identities=20%  Similarity=0.293  Sum_probs=202.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|.....     ..+++|...........+.+|+.++++++ ||||+++++.+    ......
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~~~   76 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWNNT-----TPVAVKTLKPGTMDPKDFLAEAQIMKKLR-HPKLIQLYAVC----TLEEPI   76 (261)
T ss_pred             heeeEEEecccCCccEEEEEecCC-----eEEEEEeeCCCcccHHHHHHHHHHHHHCC-CCCccceeEEE----ecCCCe
Confidence            478889999999999999986542     35888988765555677889999999998 99999999832    223446


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+++++|.+++....+..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            79999999999999997654456899999999999999999999999999999999999999999999999999876422


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+.+.   . ....+..++.
T Consensus       157 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~-~~~~~~~~~~  231 (261)
T cd05068         157 IY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG---Y-RMPCPPGCPK  231 (261)
T ss_pred             cc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---C-CCCCCCcCCH
Confidence            11 11111223457999999999999999999999999999999 99999876554444433221   1 1233456789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+.+++.+||..+|++||++.+|+.
T Consensus       232 ~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         232 ELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHHH
Confidence            9999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.1e-43  Score=322.55  Aligned_cols=254  Identities=27%  Similarity=0.407  Sum_probs=205.3

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      |...+.||+|++|.||++.+..+++    .+++|...... .....+.+|+.+++.++ ||||+++++.+.    .....
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~----~~~~~   91 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGR----QVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYL----VGDEL   91 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCC----EEEEEEEeccchhHHHHHHHHHHHHHHcC-CCChheEEEEEE----cCCeE
Confidence            4556799999999999999876654    67888765422 23455788999999998 999999998432    23456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++++||+++++|.+++..   +++++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus        92 ~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             EEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            799999999999999965   46899999999999999999999999999999999999999999999999998765322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .  .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+....  ......+..++..
T Consensus       169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  244 (285)
T cd06648         169 V--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL--PPKLKNLHKVSPR  244 (285)
T ss_pred             C--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC--CCCCcccccCCHH
Confidence            1  11223468999999999999899999999999999999999999998765544433333221  1111122347889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +.+|+.+||..+|++||++.++++||||...
T Consensus       245 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  275 (285)
T cd06648         245 LRSFLDRMLVRDPAQRATAAELLNHPFLAKA  275 (285)
T ss_pred             HHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence            9999999999999999999999999999553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-42  Score=316.76  Aligned_cols=256  Identities=34%  Similarity=0.531  Sum_probs=213.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||.|++|.||+|++..+++    .+++|.......  ....+.+|+.++.+++ ||||+++++.+    ....
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~----~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~----~~~~   72 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGK----IYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVVKCYGAF----YKEG   72 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCc----EEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCeeeEEEEE----ccCC
Confidence            58899999999999999999987654    788888766432  3567889999999999 99999999842    2235


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      .+++||||+++++|.+++...  ..+++..+..++.||++||.|||+ +|++||||+|+||+++.++.++|+|||++...
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          73 EISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence            677999999999999999763  579999999999999999999999 99999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC-
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD-  237 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (366)
                      ......  .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||................ ....+..+.. 
T Consensus       151 ~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  227 (264)
T cd06623         151 ENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEE  227 (264)
T ss_pred             ccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCccc
Confidence            432222  123468899999999999999999999999999999999999997764323333333332 3334455555 


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ++..+.++|.+||..+|++||++.++++|||++.
T Consensus       228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         228 FSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence            8899999999999999999999999999999953

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-42  Score=322.09  Aligned_cols=253  Identities=27%  Similarity=0.406  Sum_probs=196.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|.+..+++    .+++|.+....  .....+.+|+.+++.++ |+||+++++.+   . ...
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~---~-~~~   76 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQ----LVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDII---H-TKE   76 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCc----EEEEEEecccCcCCCcHHHHHHHHHHHhcC-CCCEeEEEEEE---e-cCC
Confidence            58999999999999999999887765    67888765432  22345678999999998 99999999843   2 234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+. ++|.+++... .+.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        77 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          77 TLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             eEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            5679999996 5888877653 3468899999999999999999999999999999999999999999999999997643


Q ss_pred             CCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh--cC--------
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG--VG--------  228 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~--~~--------  228 (366)
                      ....  ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||....+.  .+.+....  .+        
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         155 IPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             CCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhh
Confidence            2221  12233579999999998764 5788999999999999999999999765432  12211110  00        


Q ss_pred             ------C---C-C----C----CCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          229 ------D---E-L----P----NIP--GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       229 ------~---~-~----~----~~~--~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                            .   . .    +    ...  ...+.++.+++.+||..||++|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                  0   0 0    0    000  0135688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.8e-43  Score=326.54  Aligned_cols=252  Identities=24%  Similarity=0.379  Sum_probs=199.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|..+.++..  ..+++|.....  ......+.+|+.++.++..||||+++++.+    ....
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~--~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~----~~~~   76 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLK--MNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC----ENRG   76 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCc--ceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE----ccCC
Confidence            588999999999999999998776542  23566655431  123356788999999996699999999842    2234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC
Q 017746           80 FYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND  145 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~  145 (366)
                      .++++|||+++|+|.+++.+..              ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence            5679999999999999997532              13488999999999999999999999999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 017746          146 EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       146 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~  224 (366)
                      .+||+|||++......   ........+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..
T Consensus       157 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         157 ASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             eEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            9999999998643211   11111223557999999999999999999999999999997 9999987655444333321


Q ss_pred             hhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       225 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                          ...+..+..++..+.+|+.+||..+|.+||++++++..
T Consensus       234 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 ----GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                22334456689999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-43  Score=321.38  Aligned_cols=254  Identities=28%  Similarity=0.497  Sum_probs=206.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcC--CCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIG--ICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~--~~p~Iv~~~g~~~~~~~~   77 (366)
                      .|...+.||+|+||.||+|.+..+++    .+++|.....  ......+.+|+.+++++.  .|||++++++.+.    .
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~----~   73 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGR----VVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL----K   73 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCc----EEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee----e
Confidence            37889999999999999999877654    6788876542  234556888999999997  5899999998432    2


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +..+++||||+++++|.+++..   +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          74 GPRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             CCEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            3456799999999999999865   3689999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ......  ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+   . ....+.++.
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---~-~~~~~~~~~  224 (277)
T cd06917         151 LNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---P-KSKPPRLED  224 (277)
T ss_pred             cCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc---c-cCCCCCCCc
Confidence            653322  1223468999999998865 45788999999999999999999999765433222211   1 123344444


Q ss_pred             C-CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          237 D-LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       237 ~-~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      . ++.++.+++.+||..||++||++.++++|+||...
T Consensus       225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         225 NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            3 78899999999999999999999999999999553

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.1e-43  Score=327.36  Aligned_cols=253  Identities=28%  Similarity=0.409  Sum_probs=204.8

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      |.....||+|+||.||+|.+..+++    .+++|..... ......+.+|+.+++.+. ||||+++++.+.    .+..+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~----~~~~~   93 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGR----QVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HQNVVEMYKSYL----VGEEL   93 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCC----EEEEEEEEecccchHHHHHHHHHHHHhCC-CCchhhhhhhee----eCCeE
Confidence            3455689999999999999876654    6778876542 234456888999999998 999999998432    23456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+++++|.+++..   ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        94 ~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             EEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            799999999999998854   36899999999999999999999999999999999999999999999999998765322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      ..  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+...  .......+..++..
T Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  246 (297)
T cd06659         171 VP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS--PPPKLKNAHKISPV  246 (297)
T ss_pred             cc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc--CCCCccccCCCCHH
Confidence            21  122356999999999999989999999999999999999999999866544433332221  11122233457889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +.++|.+||..+|++||+++++++||||..
T Consensus       247 l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~  276 (297)
T cd06659         247 LRDFLERMLTREPQERATAQELLDHPFLLQ  276 (297)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence            999999999999999999999999999954

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.7e-43  Score=325.62  Aligned_cols=255  Identities=25%  Similarity=0.398  Sum_probs=200.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||+|+||.||++.+..+++    .+++|......  .....+.+|+.++.++..||||+++++...   . +.
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~---~-~~   76 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGT----IMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF---R-EG   76 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCC----EEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe---c-CC
Confidence            35667899999999999999987654    78888776432  234567889999999987999999998432   2 33


Q ss_pred             EEEEEeecCCCCCHHHHH---HHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           80 FYNLLLEYASRGSLADRV---KKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l---~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      ..+++|||+.. +|.++.   .....+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++
T Consensus        77 ~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          77 DCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             cEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence            45699999875 665543   222345799999999999999999999985 9999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCc---CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNEN---EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      .......   ......|++.|+|||++.+.   .++.++|||||||++|+|++|+.||....  .....+.+... ...+
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~-~~~~  229 (288)
T cd06616         156 GQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVK-GDPP  229 (288)
T ss_pred             HHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcC-CCCC
Confidence            7653221   11233589999999999776   68999999999999999999999997653  23333333221 1122


Q ss_pred             CC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          233 NI----PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       233 ~~----~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+    +..++.++.+|+.+||.+||++||+++++++||||..
T Consensus       230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            22    2347899999999999999999999999999999954

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.1e-43  Score=323.41  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=203.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||.||+|++..+++    .+++|.+....   .....+.+|+.++++++ ||||+++++.+.  ....
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~--~~~~   78 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGE----IVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVV--GSNL   78 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCc----EEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEE--ecCC
Confidence            58889999999999999999877654    67777765422   22334678999999999 999999998533  2223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ...++||||+.+ +|.+++... ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        79 ~~~~lv~e~~~~-~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          79 DKIYMVMEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             CcEEEEehhcCc-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            567799999985 999999763 346999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc----------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----------  227 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~----------  227 (366)
                      ....  .......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...........+.....          
T Consensus       157 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         157 GSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             cCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            4322  112234578999999998764 468899999999999999999999987655444333322100          


Q ss_pred             ----------------CCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          228 ----------------GDELPNIPGD-LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       228 ----------------~~~~~~~~~~-~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                                      ......++.. +++.+.++|.+||..+|++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                            0000112222 58889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1e-42  Score=317.02  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=203.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|.....     ..+++|...........+.+|+.++++++ ||||+++++..   ..  ...
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~---~~--~~~   75 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGN-----TKVAVKTLKPGTMSPESFLEEAQIMKKLR-HDKLVQLYAVV---SE--EPI   75 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCC-----ceeEEEEecCCCCCHHHHHHHHHHHHhcC-CCceEEEEeEE---CC--CCc
Confidence            588999999999999999987542     25788887765555677899999999998 99999998732   22  235


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+++++|.+++.+.....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            69999999999999997644456899999999999999999999999999999999999999999999999999875432


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ... ......++..|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+..    ...+..+...+.
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  230 (260)
T cd05070         156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER----GYRMPCPQDCPI  230 (260)
T ss_pred             ccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCCCCcCCH
Confidence            211 1122345678999999988899999999999999999999 9999987655544444332    122345567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+.+|+.+||.++|++|||++++.+
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=337.73  Aligned_cols=252  Identities=26%  Similarity=0.427  Sum_probs=211.4

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      .++||+|-||+||-|+++.+|+.    ||||.+++   .......+.+|+++|+.+. ||.||.+.-    ..+....++
T Consensus       569 devLGSGQFG~VYgg~hRktGrd----VAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~----M~ET~ervF  639 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRD----VAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLEC----MFETPERVF  639 (888)
T ss_pred             HhhccCCcceeeecceecccCce----eeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEE----eecCCceEE
Confidence            47899999999999999999874    55555443   2345678999999999999 999999865    233344566


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC---ceEEEecCCccccC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND---EAKIADFGLAKKSS  159 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~DFG~a~~~~  159 (366)
                      +|||-+.| +..+.|.....++|++..-+.++.||+.||+|||-+||+|+||||+|||+....   ++||||||+|+.+ 
T Consensus       640 VVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI-  717 (888)
T KOG4236|consen  640 VVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII-  717 (888)
T ss_pred             EEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec-
Confidence            99999976 776766666778999999999999999999999999999999999999997543   7999999999998 


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                        ++..-....+|||.|+|||+++++.|+..-|+||+|||+|.-++|..||...  +++..+|.+..+-. .|.-...++
T Consensus       718 --gEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMy-Pp~PW~eis  792 (888)
T KOG4236|consen  718 --GEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMY-PPNPWSEIS  792 (888)
T ss_pred             --chhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhcccccc-CCCchhhcC
Confidence              4444455678999999999999999999999999999999999999999754  45566666655533 234446799


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                      +++.|||..+|+..-.+|.+++..+.|||++...
T Consensus       793 ~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  793 PEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            9999999999999999999999999999996543

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-43  Score=319.55  Aligned_cols=249  Identities=26%  Similarity=0.452  Sum_probs=199.0

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      ++.||.|+||.||+|.+..+++    .+++|......    .....+..|..++.....||||+++++.+   . ....+
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~---~-~~~~~   72 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGD----YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF---Q-SKDYL   72 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCC----eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE---E-cCCeE
Confidence            3679999999999999877654    68888765421    11233455666665555699999999843   2 23467


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++++|.+++...  +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||+++.... 
T Consensus        73 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-  149 (260)
T cd05611          73 YLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-  149 (260)
T ss_pred             EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-
Confidence            7999999999999999763  4689999999999999999999999999999999999999999999999999876432 


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                           .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+...... ..+.....++.+
T Consensus       150 -----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  223 (260)
T cd05611         150 -----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-WPEEVKEFCSPE  223 (260)
T ss_pred             -----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC-CCCcccccCCHH
Confidence                 12335889999999998888999999999999999999999999877655444443322211 122333457899


Q ss_pred             HHHHHHHhcccCCCCCC---CHHHHHcCCCccc
Q 017746          242 GKDFLIKCFLKDPKRRW---TAEMLLNHPFVCA  271 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~---t~~~ll~hp~~~~  271 (366)
                      +.+++.+||..||++||   +++|+++||||..
T Consensus       224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         224 AVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             HHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence            99999999999999999   5589999999954

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.1e-43  Score=318.47  Aligned_cols=248  Identities=22%  Similarity=0.348  Sum_probs=202.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|++..+.     .+++|...........+.+|+++++.++ ||||+++++..   ..  ...
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~-----~valK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~---~~--~~~   75 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTT-----RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVV---SE--EPI   75 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCc-----eEEEEecccCccCHHHHHHHHHHHHhCC-CCCcceEEEEE---CC--CCc
Confidence            5889999999999999999876542     5888888764455567899999999998 99999998732   22  235


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++.+..+..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            69999999999999998644456899999999999999999999999999999999999999999999999999866432


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..   .. ....+..++.
T Consensus       156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~---~~-~~~~~~~~~~  230 (262)
T cd05071         156 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GY-RMPCPPECPE  230 (262)
T ss_pred             cc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc---CC-CCCCccccCH
Confidence            21 11223346778999999998999999999999999999999 8999987655444333221   11 2233456889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+.+++.+||++||++||++.+++.
T Consensus       231 ~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         231 SLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.6e-43  Score=323.87  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=205.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC-CCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||.||++....... .....+++|.......  ....+.+|+.+++++..||||+++++.+    ...
T Consensus        13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----~~~   88 (293)
T cd05053          13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC----TQE   88 (293)
T ss_pred             HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----cCC
Confidence            57888999999999999999865431 2235788887764322  2345788999999996699999999843    223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQ--------------NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN  144 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~  144 (366)
                      ..++++|||+++|+|.+++..+              ....+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED  168 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence            4567999999999999999652              23568999999999999999999999999999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 017746          145 DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLI  223 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~  223 (366)
                      +.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus       169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  248 (293)
T cd05053         169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK  248 (293)
T ss_pred             CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999987643222222222345678999999999999999999999999999997 999998765544444332


Q ss_pred             HhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .    ...+..+..++.++.+|+.+||..||++|||+.+++++
T Consensus       249 ~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         249 E----GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             c----CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            2    22334556788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6e-43  Score=326.19  Aligned_cols=257  Identities=25%  Similarity=0.387  Sum_probs=204.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCC---CCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV---SSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~---~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|++...   .......+++|.....  ......+.+|+.+++.+..||||+++++.+    .
T Consensus        16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----~   91 (304)
T cd05101          16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC----T   91 (304)
T ss_pred             HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE----e
Confidence            588999999999999999986431   2223457888887642  223457889999999996699999999842    2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF  142 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  142 (366)
                      .....+++|||+++|+|.+++.+..              ...++..++..++.||+.||.|||++||+||||||+|||++
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~  171 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence            2345679999999999999997632              12477888999999999999999999999999999999999


Q ss_pred             cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHH
Q 017746          143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSL  221 (366)
Q Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~  221 (366)
                      .++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  251 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  251 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence            999999999999987643322222223346788999999999999999999999999999998 8899987655544443


Q ss_pred             HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +..    ......+..++.++++|+.+||..+|++||++.++++.
T Consensus       252 ~~~----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         252 LKE----GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHc----CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            322    12233456689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.5e-43  Score=323.67  Aligned_cols=253  Identities=31%  Similarity=0.507  Sum_probs=209.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|+...+++    .+++|....    .......+.+|.++++++..||||+++++.    ..+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~----~~~   73 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNK----EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT----FQD   73 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCC----EEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH----hcC
Confidence            68999999999999999999987665    566676554    223346688899999999879999999883    233


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++++|.+++.+.  +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~  151 (280)
T cd05581          74 EENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKV  151 (280)
T ss_pred             CceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccc
Confidence            44667999999999999999763  4699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCC------------------cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHH
Q 017746          158 SSCDGER------------------SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF  219 (366)
Q Consensus       158 ~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~  219 (366)
                      .......                  .......|+..|+|||++.+..++.++||||||+++++|++|+.||.........
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  231 (280)
T cd05581         152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF  231 (280)
T ss_pred             cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            5432211                  1122345889999999998888999999999999999999999999877544333


Q ss_pred             HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCCCc
Q 017746          220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTA----EMLLNHPFV  269 (366)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~----~~ll~hp~~  269 (366)
                      ..+..     ....++..+++.+.+||.+||+.+|++||++    +++++||||
T Consensus       232 ~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         232 QKILK-----LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHh-----cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            33321     1224456678999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-43  Score=323.76  Aligned_cols=252  Identities=24%  Similarity=0.384  Sum_probs=200.0

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.+.||.|+||.||+|............|+||.+.....  ....+.+|++.+++++ ||||++++|.+.   . ...++
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~---~-~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCI---E-NEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEE---S-SSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc-cccccccccccc---c-ccccc
Confidence            567999999999999999843344467899999865322  3578899999999996 999999999544   2 22266


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +|||||++|+|.+++.......+++..+..++.||+.||.|||+++++|+||+++|||+++++.+||+|||++.......
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999988535679999999999999999999999999999999999999999999999999998763222


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .........+...|+|||.+....++.++||||||+++|||++ |+.||......+....+...    ..+..+..++..
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~  233 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG----QRLPIPDNCPKD  233 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT----EETTSBTTSBHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccceeccchhHH
Confidence            2222333457788999999999999999999999999999999 78999877655544444222    223456678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +.++|..||..||++||++.+|++
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.6e-43  Score=326.78  Aligned_cols=256  Identities=24%  Similarity=0.380  Sum_probs=202.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC---CCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS---EFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~---~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|++.....   .....+++|.......  ....+.+|+.+++++..||||+++++.+    .
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----~   88 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC----T   88 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE----c
Confidence            57889999999999999998643221   1234678887664222  2346788999999997699999999843    2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF  142 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  142 (366)
                      ....++++|||+++|+|.+++....              ...+++.++..++.||+.||.|||++|++||||||+|||++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence            3345779999999999999997632              23588999999999999999999999999999999999999


Q ss_pred             cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHH
Q 017746          143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSL  221 (366)
Q Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~  221 (366)
                      .++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~  248 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL  248 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999986542221111122235568999999999999999999999999999999 8999987655544444


Q ss_pred             HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +..    ...+..+..++.++.+++.+||..+|++||++.++++
T Consensus       249 ~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         249 LRE----GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHc----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            332    2223445678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.9e-43  Score=330.77  Aligned_cols=263  Identities=23%  Similarity=0.330  Sum_probs=206.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|+++.++.    .+++|.+....   .....+.+|+.++++++ ||||+++++.+.......
T Consensus         6 ~y~~~~~lg~g~~g~v~~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           6 RYKPIENIGSGAYGVVCSAIDTRSGK----KVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADF   80 (334)
T ss_pred             ceeeeeeeecCCCeEEEEEEEcCCCC----EEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCC
Confidence            58899999999999999999887765    67788765421   23456778999999999 999999988543333344


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+. |+|.+++..  ++.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            56789999996 599999864  346999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCc--ccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc--------
Q 017746          159 SCDGERS--QSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV--------  227 (366)
Q Consensus       159 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~--------  227 (366)
                      .......  ......|+..|+|||.+.+ ..++.++|||||||++|+|++|++||...........+.....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            4322211  1123478999999999865 5688999999999999999999999977654333222221100        


Q ss_pred             -------------CCCCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          228 -------------GDELPN-----IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       228 -------------~~~~~~-----~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                   ....+.     +....++++.++|.+||+.+|++||++++++.||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence                         000001     113468899999999999999999999999999999643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.6e-43  Score=325.34  Aligned_cols=261  Identities=27%  Similarity=0.429  Sum_probs=202.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeecc---
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE---   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~---   75 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+++|......   .......+|+++++.++ ||||+++++......   
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGR----VVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCc----EEEEEEEEeccCCCCcchhHHHHHHHHHhcC-CCCccchhhheecccccc
Confidence            68999999999999999999887765    56777664321   22345688999999998 999999988543222   


Q ss_pred             -CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCC
Q 017746           76 -KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        76 -~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                       .....+++||||+.+ +|...+.. .+..+++..+..++.||++||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence             123456799999976 78887765 345799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCc---------ccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 017746          155 AKKSSCDGERS---------QSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       155 a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~  224 (366)
                      +..........         ......|++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.........+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            98654322111         1123457899999998765 4588999999999999999999999987765544444333


Q ss_pred             hhcCCCC---------C---------CCC-------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          225 IGVGDEL---------P---------NIP-------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       225 ~~~~~~~---------~---------~~~-------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      .......         +         ..+       ..++..+.+||.+||..||++|||+.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            2111000         0         000       1345678899999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-42  Score=314.32  Aligned_cols=253  Identities=27%  Similarity=0.464  Sum_probs=212.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||.||++.+..++.    .+++|......   .....+.+|+++++.++ |||++++++..   ..+ 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~---~~~-   71 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGK----LYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESF---EEK-   71 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCc----EEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEE---ecC-
Confidence            68899999999999999999976654    78888776532   34566889999999999 99999998843   222 


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN--NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ..+++||||+++++|.+++.+..  +..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~  151 (258)
T cd08215          72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISK  151 (258)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCcccee
Confidence            56679999999999999998743  4679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ......  .......|++.|+|||.+.+..++.++|+||+|+++++|++|+.||...........+.    ....+.++.
T Consensus       152 ~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~  225 (258)
T cd08215         152 VLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL----KGQYPPIPS  225 (258)
T ss_pred             ecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh----cCCCCCCCC
Confidence            764332  12233468999999999999999999999999999999999999997765433333322    233455666


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      .++.++.+++.+||..+|++||++.++++||||
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         226 QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            789999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-43  Score=322.86  Aligned_cols=254  Identities=28%  Similarity=0.424  Sum_probs=204.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||+||++.+..+++    .+++|.....  ......+.+|+++++.++ ||||+++++.+.    ...
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~----~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~----~~~   76 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGT----VMAKKVVHIGAKSSVRKQILRELQIMHECR-SPYIVSFYGAFL----NEN   76 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCc----EEEEEEEEecCcchHHHHHHHHHHHHHHcC-CCCcceEeeeEe----cCC
Confidence            58889999999999999999877654    5677765432  233567889999999998 999999998432    234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      .+++||||+++++|.+++.+.  +.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++...
T Consensus        77 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          77 NICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             EEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            677999999999999998763  569999999999999999999997 69999999999999999999999999998754


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc--------hHHHHHHHhhcCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS--------NVFSLLIRIGVGDE  230 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~--------~~~~~~~~~~~~~~  230 (366)
                      ....    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......        .....+... ....
T Consensus       155 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  229 (284)
T cd06620         155 INSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI-VQEP  229 (284)
T ss_pred             hhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH-hhcc
Confidence            2211    12346899999999998889999999999999999999999999765431        111222221 1222


Q ss_pred             CCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          231 LPNIPG-DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       231 ~~~~~~-~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+.++. .++.++.+|+.+||..||++||+++++++|+||..
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            233333 37889999999999999999999999999999954

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.1e-43  Score=332.74  Aligned_cols=258  Identities=22%  Similarity=0.320  Sum_probs=201.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|...+.||+|+||.||+|++..+++    .+++|.+...   ......+.+|+.++++++ ||||+++++.+..-.  .
T Consensus        17 ~y~~~~~lg~g~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          17 RYQNLKPIGSGAQGIVCAAYDTVTGQ----NVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             ceEEEEEeccCCCEEEEEEEECCCCC----EEEEEecCccccChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCcc
Confidence            58889999999999999999987765    6788876532   223346778999999998 999999998543211  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      +....++||||+.+ +|.+.+..    .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          92 EFQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             ccCcEEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            22346799999975 99998864    28999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC--------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG--------  228 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~--------  228 (366)
                      ......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+......        
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         167 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            764221   122346899999999999999999999999999999999999999766433322222110000        


Q ss_pred             ---------CCCC------------C---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          229 ---------DELP------------N---------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       229 ---------~~~~------------~---------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                               ...+            .         .+...++++++||.+||..||++|||+.+++.||||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence                     0000            0         011246678999999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.3e-43  Score=321.25  Aligned_cols=256  Identities=21%  Similarity=0.301  Sum_probs=201.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|.+... +......+++|.......  ....+.+|+.+++.++ |+||+++++.+.    ..
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~   81 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-HQNIVRLIGVSF----ER   81 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc----cC
Confidence            478889999999999999998652 112345788887764322  2345788999999998 999999998432    22


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC---ceEEE
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN-----GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND---EAKIA  150 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~  150 (366)
                      ..+++||||++|++|.+++.....     ..+++..+..++.||+.||+|||++|++||||||+||+++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            345699999999999999976421     2589999999999999999999999999999999999998765   59999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      |||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..    .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~----~  237 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG----G  237 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----C
Confidence            9999987632211111112234567999999999999999999999999999997 9999987765554443332    2


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+..+..++.++.+++.+||..+|++||++.++++|
T Consensus       238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2234456789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-43  Score=321.48  Aligned_cols=256  Identities=28%  Similarity=0.467  Sum_probs=204.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|.+..+++    .+++|.+...   ......+.+|+++++.+. |+||+++++.+..    .
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----~   72 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGE----IVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFRR----K   72 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCc----EEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEEE----C
Confidence            68999999999999999999887654    7888876542   223467889999999999 9999999985432    3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..++++|||++++.|..++.+  ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        73 ~~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          73 GRLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             CEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            456799999998766665543  345899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc----------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----------  227 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~----------  227 (366)
                      ...... ......|+..|+|||++.+. .++.++||||||+++|+|++|++||.+....+....+.....          
T Consensus       151 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         151 RARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             CCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence            433221 22335689999999999888 889999999999999999999999986644333222221110          


Q ss_pred             -------CCCCC----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          228 -------GDELP----------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       228 -------~~~~~----------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                             ....+          ..+..++.++.+||.+||..+|++||+++++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                   00000          1223358899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-42  Score=319.86  Aligned_cols=251  Identities=30%  Similarity=0.520  Sum_probs=207.0

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      |...+.||.|+||.||+|.+..++.    .+++|......  .....+.+|+.+++++. ||||+++++.+   . ....
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~---~-~~~~   76 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQK----VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSY---L-KDTK   76 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCc----EEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCEeEEEEEE---E-eCCe
Confidence            6788999999999999999876653    78888765432  23356788999999998 99999999843   2 2345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|.+++..   +.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        77 ~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          77 LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            6799999999999999864   4689999999999999999999999999999999999999999999999999876542


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ...  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+    .....+.++..++.
T Consensus       154 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~  227 (277)
T cd06641         154 TQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI----PKNNPPTLEGNYSK  227 (277)
T ss_pred             chh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH----hcCCCCCCCcccCH
Confidence            211  112346889999999998888999999999999999999999999765443332222    12234456667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ++.+++.+||..+|++||++.++++||||..
T Consensus       228 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~  258 (277)
T cd06641         228 PLKEFVEACLNKEPSFRPTAKELLKHKFIVR  258 (277)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence            9999999999999999999999999999954

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-43  Score=330.42  Aligned_cols=261  Identities=24%  Similarity=0.342  Sum_probs=202.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeecc-CCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~~   78 (366)
                      +|.+.+.||+|+||.||+|++..+++    .+++|.....  ......+.+|+.++++++ ||||+++++...... ...
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGV----KVAIKKISPFEHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFESF   80 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCC----eEEEEEecccccchhHHHHHHHHHHHHhCC-CCCcCchhheeeccccccc
Confidence            68999999999999999999887764    6888876532  223455778999999999 999999998533211 122


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ...+++|||+.+ +|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          81 NDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             ceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            346799999975 99888854   46999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCCc-ccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc---------
Q 017746          159 SCDGERS-QSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV---------  227 (366)
Q Consensus       159 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~---------  227 (366)
                      ....... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.........+.....         
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            4322211 1123468999999998754 5688999999999999999999999976543322222111000         


Q ss_pred             ------------CCCCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          228 ------------GDELPN-----IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       228 ------------~~~~~~-----~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                  ....+.     .....+.++.+||.+||+.||++|||+.++++||||..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~  297 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ  297 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence                        000000     11235788999999999999999999999999999954

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.7e-43  Score=319.19  Aligned_cols=253  Identities=27%  Similarity=0.415  Sum_probs=201.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|+.+.+++    .+++|.....    ......+.+|+.+++.++ ||||+++++.+.   . 
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~-   73 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRK----PVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFI---E-   73 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCC----EEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEE---E-
Confidence            68999999999999999999887665    6777765431    123345788999999998 999999998432   2 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      ...++++|||+++|+|.+++...  ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence            34567999999999999988642  2345899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... ..............+..+
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  230 (267)
T cd08228         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIEQCDYPPLPT  230 (267)
T ss_pred             eeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHHhcCCCCCCCh
Confidence            87642221  112346899999999999889999999999999999999999999654322 222222222222223333


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ...+..+.+++.+||..+|++||++.++++.
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            4678899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-42  Score=315.88  Aligned_cols=248  Identities=21%  Similarity=0.325  Sum_probs=202.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|.+....     .+++|...........+.+|+.++++++ |||++++++..   ..  ...
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~lK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~---~~--~~~   75 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTT-----KVAIKTLKPGTMMPEAFLQEAQIMKKLR-HDKLVPLYAVV---SE--EPI   75 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCc-----eEEEEEcccCCccHHHHHHHHHHHHhCC-CCCeeeEEEEE---cC--CCc
Confidence            5788999999999999999876532     5788877655455567889999999998 99999998732   22  235


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+++|+|.+++.+..+..+++..+..++.||+.||.|||++|++||||||+||++++++.+||+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            69999999999999997644456899999999999999999999999999999999999999999999999999865322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+....+....+..    ...+..+...+.
T Consensus       156 ~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  230 (260)
T cd05069         156 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER----GYRMPCPQGCPE  230 (260)
T ss_pred             cc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CCCCCCCcccCH
Confidence            21 11222346778999999998899999999999999999999 9999987665544443322    122334556889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+.+++.+||.+||++||+++++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         231 SLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.2e-43  Score=324.64  Aligned_cols=255  Identities=28%  Similarity=0.446  Sum_probs=206.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+.+.||+|+||.||++....++.    .+++|..... ......+.+|+.+++.++ ||||+++++.+.   . ...
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~---~-~~~   90 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQ----EVAIKQMNLQQQPKKELIINEILVMRENK-HPNIVNYLDSYL---V-GDE   90 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCC----EEEEEEeccccchHHHHHHHHHHHHhhcC-CCCeeehhheee---e-CCc
Confidence            68899999999999999999876654    6788876542 234466788999999998 999999998432   2 345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++|+||+++++|.+++.+   ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        91 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            6799999999999999965   3588999999999999999999999999999999999999999999999999876542


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ...  ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+....  ......+..++.
T Consensus       168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  243 (293)
T cd06647         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG--TPELQNPEKLSA  243 (293)
T ss_pred             ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC--CCCCCCccccCH
Confidence            221  1223468999999999988889999999999999999999999997665433222221111  111112345788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .+++++.+||..+|++||++++++.|+||...
T Consensus       244 ~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~  275 (293)
T cd06647         244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA  275 (293)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence            89999999999999999999999999999544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-42  Score=315.77  Aligned_cols=244  Identities=23%  Similarity=0.361  Sum_probs=200.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||++...+      ..+++|..... .....+.+|+.++++++ |+|++++++..  +. ....+
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~------~~~~~k~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~--~~-~~~~~   75 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKND-ATAQAFLAEASVMTQLR-HSNLVQLLGVI--VE-EKGGL   75 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEcC------CcEEEEEeCCC-chHHHHHHHHHHHHhCC-CCCeeeEEEEE--Ec-CCCce
Confidence            57889999999999999997653      36788876542 34557889999999998 99999999843  22 23346


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+++++|.+++.+.....+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            79999999999999998744445899999999999999999999999999999999999999999999999998865321


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .     ....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+.+    ...+..+..++.
T Consensus       156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  226 (256)
T cd05082         156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----GYKMDAPDGCPP  226 (256)
T ss_pred             C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc----CCCCCCCCCCCH
Confidence            1     12245678999999999999999999999999999997 9999976654433333322    223345567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+.+++.+||..+|++|||+.++++
T Consensus       227 ~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         227 VVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.9e-42  Score=310.73  Aligned_cols=250  Identities=34%  Similarity=0.553  Sum_probs=207.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|...+.||+|+||.||++.+..+++    .+++|....... ....+.+|+++++++. ||||+++++.+   .. ...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~---~~-~~~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGK----EVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYYGSY---LK-KDE   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCc----EEEEEEecccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEE---ec-CCe
Confidence            58899999999999999999876554    788888766433 5577899999999999 99999999843   22 245


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++++||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            67999999999999999763 25799999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC--C
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD--L  238 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  238 (366)
                      ...   .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..............    ...+..+..  +
T Consensus       151 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  223 (253)
T cd05122         151 TKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----NGPPGLRNPEKW  223 (253)
T ss_pred             ccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cCCCCcCccccc
Confidence            221   2344689999999999988899999999999999999999999987644333333222    222233333  3


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                      +..+.++|.+||..||++|||+.+++.|||
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            889999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.1e-43  Score=323.84  Aligned_cols=255  Identities=28%  Similarity=0.439  Sum_probs=202.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||.||+|.++.+++    .+++|.......   ....+.+|+++++.++ ||||+++++.+    ..+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~   72 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQ----IVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEVF----RRK   72 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCC----EEEEEeHhhccCcchhhHHHHHHHHHHHhcC-CcchhhHHHhc----ccC
Confidence            58899999999999999999876654    677887654222   3456788999999998 99999999843    334


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+++++|.++...  ...+++..+..++.||+.||.|||++|++|+||+|+||++++++.+||+|||++...
T Consensus        73 ~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          73 KRLYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             CeEEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            567799999999988887754  245899999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC---------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG---------  228 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~---------  228 (366)
                      .....  ......|+..|+|||++.+ ..++.++|||||||++|+|++|++||......+....+......         
T Consensus       151 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         151 AAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             cCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence            43221  1223468899999999875 44778999999999999999999999765543332222211100         


Q ss_pred             --------CCCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          229 --------DELPN---------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       229 --------~~~~~---------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                              ...+.         ....++..+.+|+.+||..+|++||++.+++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                    00111         123468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.6e-42  Score=319.46  Aligned_cols=249  Identities=24%  Similarity=0.445  Sum_probs=193.2

Q ss_pred             eeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHc--CCCCceeEeecceeeccCCeeEE
Q 017746            8 VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQI--GICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l--~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +||+|+||.||+|.+..+++    .+++|.+....    ........|..+++.+  ..||+|+++++.   +.. ...+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~---~~~-~~~~   72 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA---FHT-PDKL   72 (278)
T ss_pred             CcccCCCeEEEEEEEecCCC----EEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeee---eec-CCEE
Confidence            48999999999999877655    67777665421    1112233444433333  248999998873   222 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||++||+|.+++.+  .+.+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++......
T Consensus        73 ~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          73 SFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            799999999999999865  357999999999999999999999999999999999999999999999999998765321


Q ss_pred             CCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                          ......|+..|+|||++.+. .++.++||||+||++|+|++|+.||............ .... ...+.++..++.
T Consensus       151 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~-~~~~~~~~~~s~  224 (278)
T cd05606         151 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTL-TMAVELPDSFSP  224 (278)
T ss_pred             ----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhh-ccCCCCCCcCCH
Confidence                12234699999999998754 6899999999999999999999999876433222221 1111 123455666899


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHHcCCCcccC
Q 017746          241 QGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCAD  272 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~  272 (366)
                      ++.+++.+||..+|.+||     ++.++++||||...
T Consensus       225 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             HHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            999999999999999999     99999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-42  Score=318.21  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=206.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|..+.++......+++|.......  ....+.+|+.++.+++ ||||+++++.+..     .
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~   81 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVVRLLGICLS-----S   81 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-----C
Confidence            588899999999999999998877765566788888765432  3356788999999998 9999999985432     3


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            46699999999999999976 34569999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............++..|+|||.+....++.++|+|||||++||+++ |+.||......+....+..    ......+...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~  236 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK----GERLPQPPIC  236 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC----CCCCCCCCCC
Confidence            3222222222234678999999988899999999999999999998 9999987765544433332    1223344567


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +.++.+++.+||..||++||++.++++
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-43  Score=335.95  Aligned_cols=258  Identities=26%  Similarity=0.469  Sum_probs=208.5

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      |..++.||-|+||+|.++...++..    .+|.|.+.+    ........+.|..||.... ++.||++|   |+|++.+
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~----lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLy---ySFQDkd  702 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRA----LYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLY---YSFQDKD  702 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhh----HHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEE---EEeccCC
Confidence            6778999999999999999888765    555555443    3356677889999999998 79999998   4677665


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      . +|+||||++||++-.+|-+.  |-|.|..+++|++++.+|+++.|.+|+|||||||+|||||.+|++||.||||+.-+
T Consensus       703 n-LYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  703 N-LYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             c-eEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccc
Confidence            5 45999999999999999774  67999999999999999999999999999999999999999999999999999633


Q ss_pred             CCC--------CCC--------------------------------cccccccCCCCCCCccccCCcCCCCccchhhhHH
Q 017746          159 SCD--------GER--------------------------------SQSFECRGTPLYMSPESVNENEYEAPCDIWALGC  198 (366)
Q Consensus       159 ~~~--------~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  198 (366)
                      ...        +.+                                ......+||+.|+|||++....|+..||+||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            211        000                                0011357999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCCCcccCC
Q 017746          199 AVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRW---TAEMLLNHPFVCADD  273 (366)
Q Consensus       199 il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~---t~~~ll~hp~~~~~~  273 (366)
                      |||||+.|++||-..+..++...++.......++. -..+|.++.++|.+++ .+++.|.   .++++..||||+..+
T Consensus       860 il~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~-~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPY-QGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcceeeeeehhhcccccc-ccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccc
Confidence            99999999999988888776655544333223322 2568999999988743 4577886   478899999997643

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-42  Score=321.93  Aligned_cols=259  Identities=23%  Similarity=0.303  Sum_probs=204.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCC------------CCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSE------------FPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRC   67 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~------------~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~   67 (366)
                      +|.+++.||+|+||.||+|.+...+..            ....+++|.......  ....+.+|++++.++. ||||+++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~   84 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS-DPNIARL   84 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC-CCCEeEE
Confidence            689999999999999999998764432            224688888765322  3456788999999998 9999999


Q ss_pred             ecceeeccCCeeEEEEEeecCCCCCHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCc
Q 017746           68 FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN---------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQN  138 (366)
Q Consensus        68 ~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N  138 (366)
                      ++.+   . .+..++++|||+++++|.+++.+..         ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus        85 ~~~~---~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          85 LGVC---T-VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EEEE---e-cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9843   2 2345679999999999999997632         1258999999999999999999999999999999999


Q ss_pred             EEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh--CCCCCCCCCcc
Q 017746          139 VLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDS  216 (366)
Q Consensus       139 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt--g~~pf~~~~~~  216 (366)
                      |+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986543322222333457789999999998899999999999999999998  78898776554


Q ss_pred             hHHHHHHHhh---cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          217 NVFSLLIRIG---VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       217 ~~~~~~~~~~---~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .....+....   ........+..++.++.+++.+||..||++|||+.+|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            4444333220   011111223456789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2e-42  Score=315.19  Aligned_cols=248  Identities=23%  Similarity=0.358  Sum_probs=204.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|..+. +    ..+++|...........+.+|+.++++++ ||||+++++..   .  ...+
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~-~----~~~a~K~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~---~--~~~~   75 (260)
T cd05067           7 TLKLVKKLGAGQFGEVWMGYYNG-H----TKVAIKSLKQGSMSPEAFLAEANLMKQLQ-HPRLVRLYAVV---T--QEPI   75 (260)
T ss_pred             HceeeeeeccCccceEEeeecCC-C----ceEEEEEecCCCCcHHHHHHHHHHHHhcC-CcCeeeEEEEE---c--cCCc
Confidence            58889999999999999998653 2    36899988765556678899999999998 99999998732   2  2346


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+++++|.+++.+..+..+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            79999999999999997755567999999999999999999999999999999999999999999999999999765422


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......++..|+|||++....++.++||||||+++|+|++ |++||.+....+....+..    ...+..+...+.
T Consensus       156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  230 (260)
T cd05067         156 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER----GYRMPRPDNCPE  230 (260)
T ss_pred             Cc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc----CCCCCCCCCCCH
Confidence            11 11122346778999999999999999999999999999999 9999987665444333322    122344566889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.+++.+||..+|++||+++++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1e-42  Score=320.94  Aligned_cols=255  Identities=22%  Similarity=0.367  Sum_probs=201.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      ++...+.||+|+||.||++..... .......+++|...... .....+.+|+++++.++ ||||+++++.+   . ...
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~---~-~~~   80 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ-HQHIVRFYGVC---T-EGR   80 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC-CCCCceEEEEE---e-cCC
Confidence            467889999999999999975432 12223467888765422 23457889999999998 99999998832   2 234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNN-------------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE  146 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~  146 (366)
                      .++++|||+++|+|.+++.....             ..+++..+..++.||+.||+|||++|++||||||+|||+++++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence            56799999999999999976321             24889999999999999999999999999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHh
Q 017746          147 AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI  225 (366)
Q Consensus       147 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~  225 (366)
                      +||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+.. 
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-  239 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ-  239 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc-
Confidence            99999999976532222111223346788999999999999999999999999999998 9999976655444333322 


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       226 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                        . ..+..+..+++.+.+++.+||..||++||++++|+.
T Consensus       240 --~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         240 --G-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             --C-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              1 223445668899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=319.36  Aligned_cols=255  Identities=27%  Similarity=0.417  Sum_probs=201.6

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      |.+.+.||.|++|.||+|.++.++.    .+++|......   .....+.+|+++++.++ ||||+++++.+.    +..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~----~~~   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGE----IVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDVVH----SEN   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCC----EEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhheec----cCC
Confidence            6788999999999999999887654    67888765432   23356788999999998 999999998432    335


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..+++|||++ ++|.+++.......+++..+..++.||+.||+|||+++++||||+|+||+++.++.+||+|||++....
T Consensus        72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            6779999996 599999976443468999999999999999999999999999999999999999999999999997653


Q ss_pred             CCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc-----------
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV-----------  227 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~-----------  227 (366)
                      ....  ......+++.|+|||++.+. .++.++|||||||++|+|++|++||...++......+.+...           
T Consensus       151 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07835         151 VPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT  228 (283)
T ss_pred             CCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence            2211  11223578899999988664 578899999999999999999999987654333222221100           


Q ss_pred             -----C--------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          228 -----G--------DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       228 -----~--------~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                           .        .........++.++.++|.+||+.||++||++++++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                 0        00111223567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.8e-42  Score=319.23  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=202.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||.|++|.||+|++..++.    .+++|......  .....+.+|+.++++++ ||||+++++.+.   . ..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~-~~   71 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGE----IVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLHDVIH---T-EN   71 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCe----EEEEEEecccccccchHHHHHHHHHHHhhc-CCCEeeeeeeEe---e-CC
Confidence            58899999999999999999977654    67888776532  23456778999999998 999999998432   2 33


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQN-NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      .+++||||+++ +|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||++++++.+||+|||++...
T Consensus        72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~  150 (284)
T cd07836          72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF  150 (284)
T ss_pred             cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence            46799999986 9999887532 246899999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc----------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----------  227 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~----------  227 (366)
                      .....  ......+|+.|++||++.+. .++.++|||||||++|+|++|+.||.+....+....+.....          
T Consensus       151 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07836         151 GIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI  228 (284)
T ss_pred             cCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence            32211  11234578999999988664 578899999999999999999999987765544443332210          


Q ss_pred             ------CCCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          228 ------GDELPN--------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       228 ------~~~~~~--------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                            ....+.        +...++..+.+++.+||+.||.+||++.++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                  000110        112357888999999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.7e-42  Score=321.21  Aligned_cols=255  Identities=23%  Similarity=0.383  Sum_probs=203.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC-CCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|....... .....+++|....... ....+.+|+.++++++ ||||+++++.+    ....
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~   80 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEHIVKFYGVC----GDGD   80 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC-CCCcceEEEEE----ccCC
Confidence            57888999999999999998654321 2234577777654322 2356889999999998 99999999843    2334


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC
Q 017746           80 FYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND  145 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~  145 (366)
                      ..++||||+++++|.+++....              .+.+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            5679999999999999997532              23488999999999999999999999999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 017746          146 EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       146 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~  224 (366)
                      .+||+|||++................|+..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+. 
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-  239 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-  239 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-
Confidence            999999999986543322222233457889999999999999999999999999999998 999997765544433322 


Q ss_pred             hhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       225 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                         ....+..+..++..+.+++.+||..||++||++.++++
T Consensus       240 ---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         240 ---QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             ---CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence               22233445567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-43  Score=329.92  Aligned_cols=253  Identities=25%  Similarity=0.419  Sum_probs=195.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc-hhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS-SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.....||+|+||.||+|...+.     ..+|||........ ...+.+|+.++.+++ |||+|+++|++.  +.++ .
T Consensus        76 ~Fs~~~~ig~Ggfg~VYkG~l~~~-----~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~--e~~~-~  146 (361)
T KOG1187|consen   76 NFSESNLIGEGGFGTVYKGVLSDG-----TVVAVKRLSSNSGQGEREFLNEVEILSRLR-HPNLVKLLGYCL--EGGE-H  146 (361)
T ss_pred             CCchhcceecCCCeEEEEEEECCC-----CEEEEEEecCCCCcchhHHHHHHHHHhcCC-CcCcccEEEEEe--cCCc-e
Confidence            356678999999999999998653     47999987765444 567999999999999 999999999543  3332 4


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG---FVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ..||+||+++|+|.+++....+..++|.+..+|+.++++||+|||+..   ||||||||+|||||++.++||+|||+|+.
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~  226 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL  226 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence            559999999999999997633227999999999999999999999964   99999999999999999999999999976


Q ss_pred             cCCCCCCcccccc-cCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCC---cchHHHHH---HHhh--cC
Q 017746          158 SSCDGERSQSFEC-RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQ---DSNVFSLL---IRIG--VG  228 (366)
Q Consensus       158 ~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~---~~~~~~~~---~~~~--~~  228 (366)
                      ....  ....... .||.+|+|||++..+..+.++|||||||+|.||+||+.|.+...   ........   ...+  ..
T Consensus       227 ~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~e  304 (361)
T KOG1187|consen  227 GPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLRE  304 (361)
T ss_pred             CCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhh
Confidence            5421  1111122 79999999999999999999999999999999999999887543   11112211   1111  00


Q ss_pred             CCCCCCC-CCCC--HH---HHHHHHHhcccCCCCCCCHHHHHc
Q 017746          229 DELPNIP-GDLS--EQ---GKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       229 ~~~~~~~-~~~s--~~---~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ...|.+. ...+  .+   +..+..+|++.+|++||++.|+++
T Consensus       305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            1112222 2223  23   445678899999999999999864

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-42  Score=319.31  Aligned_cols=260  Identities=24%  Similarity=0.351  Sum_probs=201.9

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      |.+.+.||+|+||.||+++....+......+++|......  .....+.+|+.+++.++ ||||+++++.+.  ..+...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   82 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICT--EDGGNG   82 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEe--cCCCCc
Confidence            6788999999999999998755444456689999876432  23457889999999998 999999998432  232345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||++|++|.+++.+. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            67999999999999999763 34689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCc-----------chHHHHHHHhhcC
Q 017746          161 DGERS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD-----------SNVFSLLIRIGVG  228 (366)
Q Consensus       161 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~-----------~~~~~~~~~~~~~  228 (366)
                      ..... ......|+..|+|||++.+..++.++|||||||++|+|+++..|+.....           .............
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            32211 11234577889999999988999999999999999999998776532211           0001111111111


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       229 ~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ......+..++.++.+|+.+||..||++||++++++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            12223455689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-42  Score=311.57  Aligned_cols=251  Identities=34%  Similarity=0.582  Sum_probs=210.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|++|.||+|++..+++    .+++|......   .....+.+|+++++++. |||++++++..    .+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~----~~~   71 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGD----FVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSI----ETS   71 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCc----EEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEEE----EeC
Confidence            58899999999999999999876654    67888776543   24567889999999998 99999998743    223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..++++|||+++++|.+++...  +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  149 (254)
T cd06627          72 DSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKL  149 (254)
T ss_pred             CEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence            5677999999999999999763  57999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ......  .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........   .. ....+.++..+
T Consensus       150 ~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~---~~-~~~~~~~~~~~  223 (254)
T cd06627         150 NDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR---IV-QDDHPPLPEGI  223 (254)
T ss_pred             CCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---Hh-ccCCCCCCCCC
Confidence            433221  2334689999999999888899999999999999999999999976653322222   22 23345566778


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +..+.+++.+||..+|++||++.++++||||
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         224 SPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-42  Score=318.08  Aligned_cols=260  Identities=25%  Similarity=0.376  Sum_probs=200.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+.+.||+|+||.||++.....+......+++|....... ....+.+|++++++++ ||||+++++.++  ..+...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~   81 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-HDNIVKYKGVCY--SAGRRN   81 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEc--cCCCCc
Confidence            578899999999999999986543333456889998765322 3456789999999998 999999998543  233445


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++|+|.+++.+ ..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             eEEEEEecCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            7799999999999999976 345689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCcc-cccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcch------------HHHHHHHhhc
Q 017746          161 DGERSQ-SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN------------VFSLLIRIGV  227 (366)
Q Consensus       161 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~------------~~~~~~~~~~  227 (366)
                      ...... .....++..|+|||++.+..++.++|||||||++|||++|..|+.......            ....+.....
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            222111 111224456999999999999999999999999999999887764332110            0001111111


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ....+..+..++.++.+|+.+||..+|++|||+.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11222334568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.1e-42  Score=313.47  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=196.6

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      +.||+|+||.||+|......  ....+++|.......   ....+.+|+.+++.+. ||||+++++.+    .++ .+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~-~~~l   72 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKK--SEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGIC----EAE-SWML   72 (257)
T ss_pred             CcCCCcCCcceEEeEEecCC--CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC-CCCcceEEEEE----cCC-CcEE
Confidence            36899999999999764322  234788887754322   2456788999999998 99999999832    222 3569


Q ss_pred             EeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCC
Q 017746           84 LLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE  163 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  163 (366)
                      ||||+++|+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||.||+++.++.+||+|||++........
T Consensus        73 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~  150 (257)
T cd05116          73 VMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN  150 (257)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence            99999999999999753  4689999999999999999999999999999999999999999999999999987643322


Q ss_pred             Cc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          164 RS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .. ......++..|+|||.+....++.++|||||||++|||++ |..||...........+.+    ...+..+..++++
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~----~~~~~~~~~~~~~  226 (257)
T cd05116         151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES----GERMECPQRCPPE  226 (257)
T ss_pred             eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC----CCCCCCCCCCCHH
Confidence            11 1122235678999999988889999999999999999998 9999987655444443332    2234566778999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +.++|.+||..||++||++++|..
T Consensus       227 l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         227 MYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHHHHHhccCchhCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.5e-42  Score=319.82  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=202.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC-CCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|+...... .....+++|.......  ....+.+|+.+++.+. ||||+++++.+   . ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---~-~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHVIKLYGAC---S-QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCCEeeEEEEE---e-cC
Confidence            58899999999999999998754322 1224577777654322  2356888999999998 99999999842   2 23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN----------------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKL  136 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp  136 (366)
                      ...+++|||+.+|+|.+++....                      ...+++..+..++.|++.||+|||++|++||||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp  155 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA  155 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence            34669999999999999986521                      12478899999999999999999999999999999


Q ss_pred             CcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCc
Q 017746          137 QNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQD  215 (366)
Q Consensus       137 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~  215 (366)
                      +|||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999986543322222223356778999999988899999999999999999998 9999987765


Q ss_pred             chHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          216 SNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ......+...    ..+..+..++.++.+|+.+||+.+|++||++.++++
T Consensus       236 ~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         236 ERLFNLLKTG----YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHhCC----CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            5544433221    123345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=324.49  Aligned_cols=262  Identities=26%  Similarity=0.350  Sum_probs=200.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|.++..  .....+++|.+...    ......+.+|+.++..++ ||||+++++.+.  ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~--~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~   75 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG--KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFL--EHA   75 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC--CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEe--CCC
Confidence            588999999999999999998762  11347888877652    233456788999999998 999999998543  232


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc----CCceEEE
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQN---NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD----NDEAKIA  150 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~----~~~vkl~  150 (366)
                      ...+++||||+++ +|.+++....   ...+++..+..++.||+.||.|||++||+||||||+||+++.    ++.+||+
T Consensus        76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence            3567899999976 7888775422   236899999999999999999999999999999999999999    8999999


Q ss_pred             ecCCccccCCCCC-CcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcch---------HH
Q 017746          151 DFGLAKKSSCDGE-RSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN---------VF  219 (366)
Q Consensus       151 DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~---------~~  219 (366)
                      |||++........ ........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.....         ..
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            9999987543222 112234468999999998866 458899999999999999999999997654332         00


Q ss_pred             HHHHHh-h--------------------cCCCCCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 017746          220 SLLIRI-G--------------------VGDELPNIP-----------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHP  267 (366)
Q Consensus       220 ~~~~~~-~--------------------~~~~~~~~~-----------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp  267 (366)
                      ..+... +                    ........+           ...+.++.+++.+||..||++|||+.++++||
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~  314 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP  314 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence            000000 0                    000001111           14577899999999999999999999999999


Q ss_pred             Cc
Q 017746          268 FV  269 (366)
Q Consensus       268 ~~  269 (366)
                      ||
T Consensus       315 ~f  316 (316)
T cd07842         315 YF  316 (316)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.1e-42  Score=333.95  Aligned_cols=258  Identities=24%  Similarity=0.344  Sum_probs=203.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++... .......+|+|.+.....  ....+.+|+.+|.++..||||+++++.+.   . .
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~---~-~  113 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT---K-G  113 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc---c-C
Confidence            367789999999999999997643 222345789998875322  23467889999999987999999998432   2 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC--------------------------------------------------------
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN--------------------------------------------------------  102 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~--------------------------------------------------------  102 (366)
                      ...++|||||++|+|.+++.+...                                                        
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            356799999999999999975211                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec
Q 017746          103 ----------------------------------------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF  142 (366)
Q Consensus       103 ----------------------------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  142 (366)
                                                              ..+++..+..++.||+.||+|||++|++||||||+|||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC  273 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence                                                    1356778899999999999999999999999999999999


Q ss_pred             cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHH
Q 017746          143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSL  221 (366)
Q Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~  221 (366)
                      +++.+||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++ |..||......+....
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~  353 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN  353 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence            999999999999986532222222223457889999999999899999999999999999998 8999976544443322


Q ss_pred             HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ....+   ..+..+..++.++.+++.+||..+|.+||++++|++.
T Consensus       354 ~~~~~---~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         354 AIKRG---YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHcC---CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            22222   2334566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-42  Score=317.74  Aligned_cols=252  Identities=27%  Similarity=0.427  Sum_probs=201.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|..+.+++    .+++|......    .....+.+|+.+++.++ ||||+++++.+.   . 
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~---~-   73 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGV----PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFI---E-   73 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCc----eEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeE---e-
Confidence            58899999999999999999877664    67777654321    23356788999999998 999999998432   2 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      ...++++|||+++++|.+++...  ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence            34567999999999999998642  2346899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ..............+..+
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  230 (267)
T cd08229         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPPLPS  230 (267)
T ss_pred             hccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhcCCCCCCCc
Confidence            86543221  122346899999999999999999999999999999999999999755332 222222222222222233


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ..+++++.+++.+||..||++|||+.+|+.
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         231 DHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            457899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=339.76  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=202.5

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      ..+++.||+|.||+||+|.+.+       .||||.+...   +...+.+++|+.++++-+ |-||+=+.|++.    ...
T Consensus       394 v~l~~rIGsGsFGtV~Rg~whG-------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~----~p~  461 (678)
T KOG0193|consen  394 VLLGERIGSGSFGTVYRGRWHG-------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFMGACM----NPP  461 (678)
T ss_pred             hhccceeccccccceeeccccc-------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeeehhhc----CCc
Confidence            3578899999999999999876       5888888763   335678999999999999 999999999432    233


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      . .+|..+|+|-+|+.+|.-. ...|...+...|++||++|+.|||.++|||||||..||+|.+++.|||+|||++....
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             e-eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            3 6999999999999999763 3579999999999999999999999999999999999999999999999999997644


Q ss_pred             CCCCCcccccccCCCCCCCccccCC---cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC---C
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE---NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP---N  233 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~  233 (366)
                      ............|...|||||+++-   .+|++.+|||||||++|||++|..||.....   .+.|...+.+...|   .
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIifmVGrG~l~pd~s~  616 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQIIFMVGRGYLMPDLSK  616 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheEEEecccccCccchh
Confidence            3333333344568899999999964   4689999999999999999999999983322   23444455553333   3


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +...++.++++|+..||..++++||.+.+|+.
T Consensus       617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            44567889999999999999999999999986

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.9e-42  Score=325.79  Aligned_cols=266  Identities=24%  Similarity=0.341  Sum_probs=205.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||++++.....  ...+++|.+....   .....+.+|+.+++++..||||+++++.........
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   78 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSE--EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF   78 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCc--CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence            58899999999999999999876511  2468888765421   124467789999999977999999998654333334


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..++++|||+. ++|.+++..  +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        79 ~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          79 NELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             CcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            45679999996 599999864  356999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCc--ccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh---------
Q 017746          159 SCDGERS--QSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG---------  226 (366)
Q Consensus       159 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~---------  226 (366)
                      .......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+....         
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4322211  1223468999999998765 568999999999999999999999997654333222211110         


Q ss_pred             ---------------c--CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          227 ---------------V--GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       227 ---------------~--~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                     .  ....+......+..+.+|+.+||..||++|||+.+++.|||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                           0  000111222357889999999999999999999999999999543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-42  Score=313.52  Aligned_cols=249  Identities=24%  Similarity=0.381  Sum_probs=204.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|.....     ..+++|.+.........+.+|+.++++++ ||||+++++.+    .....+
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~~~   76 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWNGT-----TKVAVKTLKPGTMSPEAFLQEAQIMKKLR-HDKLVQLYAVC----SEEEPI   76 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEcCC-----ceEEEEEecCCccCHHHHHHHHHHHhhCC-CCCEeeeeeee----ecCCce
Confidence            588999999999999999987542     35888988765566678999999999999 99999999832    233456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++++|.+++.+..+..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            79999999999999998754457999999999999999999999999999999999999999999999999999876421


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+.......+..   . .....+...+.
T Consensus       157 ~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~---~-~~~~~~~~~~~  231 (261)
T cd05034         157 E-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER---G-YRMPRPPNCPE  231 (261)
T ss_pred             h-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---C-CCCCCCCCCCH
Confidence            1 111112235678999999999999999999999999999998 9999987655444443322   1 12233455689


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.+++.+||..+|++||++++++.
T Consensus       232 ~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         232 ELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=337.32  Aligned_cols=250  Identities=25%  Similarity=0.388  Sum_probs=206.5

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +++.||+|+||.||+|+.+..+......||+|.....    ......+.+|.++|++++ |||||++||+    ...+.-
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGV----a~~~~P  235 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGV----AVLEEP  235 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEE----EcCCCc
Confidence            4589999999999999987654422333899987742    235677899999999999 9999999993    333445


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++|||+|.||+|.++|++. ++.++..+...++.+.++||+|||++++|||||-++|+|++.++.+||+|||+++....
T Consensus       236 l~ivmEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence            77999999999999999984 44699999999999999999999999999999999999999999999999999876431


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                        .........-...|+|||.+...-|+.++|||||||++||+.+ |..||.+.+..+....+...++...   .+...+
T Consensus       315 --~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~---~~~~~p  389 (474)
T KOG0194|consen  315 --YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP---IPSKTP  389 (474)
T ss_pred             --eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC---CCCCCH
Confidence              1111111224568999999999999999999999999999998 8999999988776666655555443   344678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .++..++.+|+..+|++||++.++.+
T Consensus       390 ~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  390 KELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHHhccCChhhccCHHHHHH
Confidence            89999999999999999999999875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-43  Score=348.89  Aligned_cols=253  Identities=24%  Similarity=0.376  Sum_probs=210.2

Q ss_pred             cccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      ...+.||+|+||+||+|...+-. ......||||.+.....  ...++++|++++..|+ |||||+++|.+    ..+.-
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC----~~~~P  563 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ-HPNIVRLLGVC----REGDP  563 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEE----ccCCe
Confidence            35678999999999999865432 33456899999876433  4678999999999999 99999999943    33445


Q ss_pred             EEEEeecCCCCCHHHHHHHhC--------C----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceE
Q 017746           81 YNLLLEYASRGSLADRVKKQN--------N----GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAK  148 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~--------~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vk  148 (366)
                      ++||+|||..|||.++|+.+.        +    .+|+..+...|+.||+.|++||-++.+|||||..+|+||.++..||
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence            669999999999999998532        1    2388999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhc
Q 017746          149 IADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV  227 (366)
Q Consensus       149 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~  227 (366)
                      |+|||+++.....+-........-...||+||.+..+.|+.++||||+||+|||+++ |+.||.+..+++..+.+...  
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g--  721 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG--  721 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC--
Confidence            999999997543322222111223578999999999999999999999999999997 99999999888776665542  


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                       .. -..|..++.++.+|+..||+.+|++||++.||-.
T Consensus       722 -~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  722 -QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             -Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence             22 4568889999999999999999999999999854

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.4e-42  Score=319.40  Aligned_cols=258  Identities=26%  Similarity=0.375  Sum_probs=200.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||+||+|+++.+++    .+++|......   .....+.+|++++++++ ||||+++++.+   . ..
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~---~-~~   73 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNE----TIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVV---H-SE   73 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCc----EEEEEehhhccccccchHHHHHHHHHHHhcc-CCCEeeEEEEE---e-cC
Confidence            58899999999999999999877654    67888765422   23356788999999998 99999999843   2 34


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-CCceEEEecCCccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-NDEAKIADFGLAKK  157 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~  157 (366)
                      ..+++||||+++ +|.+++.......+++..+..++.||+.||+|||++|++||||||+||+++. ++.+||+|||++..
T Consensus        74 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         74 KRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             CeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            467799999965 8988887644444789999999999999999999999999999999999985 45799999999976


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC--------
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG--------  228 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~--------  228 (366)
                      .....  .......|++.|+|||++.+ ..++.++|||||||++|+|++|++||......+....+......        
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        153 FGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             cCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            53221  11123357899999998866 45788999999999999999999999876543333222211000        


Q ss_pred             --------CCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          229 --------DELPN--------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       229 --------~~~~~--------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                              ...+.        ....++.++.+++.+||..+|++||++.++++||||..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence                    00000        11246888999999999999999999999999999954

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.9e-42  Score=312.38  Aligned_cols=249  Identities=24%  Similarity=0.390  Sum_probs=202.4

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      +.||+|+||.||+|.+...+. ....+++|.......  ....+.+|+.++++++ ||||+++++...   .  ..+++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~---~--~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGG-KVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRLYGVVL---T--HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCCC-CceEEEEeecCCcccHHHHHHHHHHHHHHhhcC-CCCccceeEEEc---C--CeEEEE
Confidence            478999999999999866322 234688888776433  3457889999999998 999999998432   2  567799


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||+++|+|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99999999999998743256899999999999999999999999999999999999999999999999999876432221


Q ss_pred             c-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          165 S-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       165 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                      . ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||......+....+....   .....+..++..+
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  230 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG---ERLERPEACPQDI  230 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---CcCCCCccCCHHH
Confidence            1 1112457889999999999999999999999999999998 999998766555444444322   2233455678999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHc
Q 017746          243 KDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+++.+||..+|++||++.+++.
T Consensus       231 ~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         231 YNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHCCCCcccCCCHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-42  Score=315.28  Aligned_cols=259  Identities=26%  Similarity=0.398  Sum_probs=203.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcC--CCCceeEeecceeeccC-
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIG--ICPQIVRCFGDDYSFEK-   76 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~--~~p~Iv~~~g~~~~~~~-   76 (366)
                      |.+.+.||+|+||.||+|+++.+++    .+++|.......   ....+.+|+.+++++.  .||||+++++.+..... 
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   76 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGR----FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD   76 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCC----EEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence            6788999999999999999976554    678887764222   2345667888887774  38999999996543221 


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      +...++++|||+.+ +|.+++.+.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus        77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence            23347799999985 89999876444469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC--------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG--------  228 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~--------  228 (366)
                      .......   .....++..|+|||++.+..++.++|+|||||++|+|++|++||......+....+......        
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            7643221   22335889999999999999999999999999999999999999877655544444321100        


Q ss_pred             ----------CCC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          229 ----------DEL----PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       229 ----------~~~----~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                                ...    ......++..+.++|.+||..||++||++++++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                      000    00011346788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-42  Score=326.75  Aligned_cols=260  Identities=25%  Similarity=0.378  Sum_probs=203.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeecc-CC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~   77 (366)
                      +|.+.+.||+|+||+||+|++..++.    .+++|.....   ......+.+|+.+++.++ ||||+++++.+.... ..
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNE----KVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA   80 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCC----eEEEEEecccccccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence            68999999999999999999887654    6777776531   223456778999999998 999999998543221 11


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ....++||||+. ++|.+++.+  ++.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            234679999996 599999865  35799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc---------
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV---------  227 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~---------  227 (366)
                      ......  ......||..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+.....         
T Consensus       158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         158 TSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            643221  1223468999999998765 5688999999999999999999999976543332222221100         


Q ss_pred             ---------------CC--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          228 ---------------GD--ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       228 ---------------~~--~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                     ..  ........++.++.+||.+||+.+|++|||++++++||||..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence                           00  000112357889999999999999999999999999999954

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5e-42  Score=320.54  Aligned_cols=250  Identities=29%  Similarity=0.454  Sum_probs=200.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|...+.||+|+||.||+|++..+++    .+++|.+.....    ....+.+|+++++.++ ||||+++++.+.    .
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~----~   86 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYL----R   86 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCc----EEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEE----e
Confidence            58889999999999999999877654    678887653211    2345788999999998 999999998432    2


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ....++||||+.| +|.+++.. ....+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++..
T Consensus        87 ~~~~~lv~e~~~g-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~  164 (307)
T cd06607          87 EHTAWLVMEYCLG-SASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL  164 (307)
T ss_pred             CCeEEEEHHhhCC-CHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCccee
Confidence            3346699999975 88888765 345699999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCcccccccCCCCCCCccccC---CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVN---ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ....      ....|++.|+|||++.   ...++.++||||||+++|+|++|++||.+.........+.   .. ..+..
T Consensus       165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~---~~-~~~~~  234 (307)
T cd06607         165 VSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QN-DSPTL  234 (307)
T ss_pred             cCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---cC-CCCCC
Confidence            5321      1335889999999874   4568889999999999999999999997665433322222   11 12222


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          235 -PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       235 -~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                       +..++.++.++|.+||..||++||++.+++.||||...
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence             23468899999999999999999999999999999553

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3e-42  Score=325.93  Aligned_cols=258  Identities=25%  Similarity=0.392  Sum_probs=203.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCC---CCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSE---FPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~---~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|.+...++.   ....+++|......  .....+.+|+++++++..||||+++++.+   . 
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---~-   88 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC---T-   88 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE---c-
Confidence            588999999999999999987543321   22357888766422  23457889999999996699999999843   2 


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF  142 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  142 (366)
                      .....+++|||+++|+|.+++.+..              ...++..++..++.||+.||.|||++|++||||||+|||++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~  168 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence            2335679999999999999997632              12477888999999999999999999999999999999999


Q ss_pred             cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHH
Q 017746          143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSL  221 (366)
Q Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~  221 (366)
                      .++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999999986542221111222335678999999999999999999999999999998 8999987655444433


Q ss_pred             HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 017746          222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHP  267 (366)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp  267 (366)
                      +..    ...+..+..++.++.+++.+||..+|++||++.+++++-
T Consensus       249 ~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         249 LKE----GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHc----CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            322    223344566789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=336.82  Aligned_cols=243  Identities=23%  Similarity=0.378  Sum_probs=203.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.....+|.|+|+.|..+.+..+++.+.    +|.+...   .....+|+.++.....||||+++.+    ...+....
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~----vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~----v~~~~~~~  391 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPA----VKIISKR---ADDNQDEIPISLLVRDHPNIVKSHD----VYEDGKEI  391 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchh----heecccc---ccccccccchhhhhcCCCcceeecc----eecCCcee
Confidence            47778889999999999999998877554    4444432   3456778888888888999999987    45556677


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe-ccCCceEEEecCCccccCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl-~~~~~vkl~DFG~a~~~~~  160 (366)
                      ++|||++.|+.|.+.+.+.   +.....+..|+++|+.|+.|||++|||||||||+|||+ +..|+++|+|||.++....
T Consensus       392 ~~v~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             eeeehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            8999999999999998763   23348888999999999999999999999999999999 5889999999999987643


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .     ..+.+-|..|.|||++...+|+.+|||||||++||+||+|+.||......  .+.+.++.    .+.+...+|+
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~----~~~~s~~vS~  537 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQ----MPKFSECVSD  537 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhc----CCccccccCH
Confidence            2     23346789999999999999999999999999999999999999877655  22333332    2344477999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ++++||.+||+.||.+|+++.++..|||+
T Consensus       538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  538 EAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHHHHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999999999

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.7e-42  Score=318.34  Aligned_cols=260  Identities=27%  Similarity=0.384  Sum_probs=204.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeecc---
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE---   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~---   75 (366)
                      +|.+.+.||+|+||.||+|.++.+++    .+++|.+...   ......+.+|++++++++ ||||+++++.+....   
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGE----LVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCc----EEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhh
Confidence            58899999999999999999987654    6777776542   223356778999999998 999999998543321   


Q ss_pred             ---CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEec
Q 017746           76 ---KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADF  152 (366)
Q Consensus        76 ---~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF  152 (366)
                         .....+++||||+++ +|.+.+... ...+++..+..++.||+.||.|||++||+||||||+||++++++.+||+||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence               123367899999987 888887653 346999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          153 GLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       153 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      |++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...........+.........
T Consensus       161 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         161 GLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             cccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            999876433221 1122346888999998865 45788999999999999999999999876655544444442111100


Q ss_pred             ---C----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          232 ---P----------------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       232 ---~----------------------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                         |                      .....++..+.+++.+||..||++||++++++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence               0                      0112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.5e-42  Score=314.37  Aligned_cols=251  Identities=23%  Similarity=0.366  Sum_probs=191.1

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      +.||+|+||.||+|.....  .....+++|.......  ....+.+|+.+++.++ ||||+++++.+   . ....+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~---~-~~~~~~lv   73 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYRELN-HPNVLQCLGQC---I-ESIPYLLV   73 (269)
T ss_pred             CcCCccCCceEEEEEEecC--CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCC-CCCcceEEEEE---C-CCCceEEE
Confidence            4699999999999975432  2245788887654322  2345778999999998 99999999843   2 23456799


Q ss_pred             eecCCCCCHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           85 LEYASRGSLADRVKKQNN---GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      |||+++|+|.+++.+...   ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  153 (269)
T cd05042          74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE  153 (269)
T ss_pred             EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccc
Confidence            999999999999976322   23568889999999999999999999999999999999999999999999998754322


Q ss_pred             CCCcccccccCCCCCCCccccCC-------cCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhh-cCCCCC
Q 017746          162 GERSQSFECRGTPLYMSPESVNE-------NEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIG-VGDELP  232 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~  232 (366)
                      ..........+++.|+|||++..       ..++.++|||||||++|+|++ |..||....+.+......... .....+
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP  233 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence            21111223346778999998743       456789999999999999999 889997765544333332222 222234


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .++..++....+++..|+ .||++||++++|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            455678899999999998 59999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-42  Score=310.97  Aligned_cols=244  Identities=24%  Similarity=0.401  Sum_probs=202.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|...+      ..+++|...........+.+|+.++++++ |+||+++++...   . ....
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~~------~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~---~-~~~~   75 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYRG------QKVAVKCLKDDSTAAQAFLAEASVMTTLR-HPNLVQLLGVVL---Q-GNPL   75 (256)
T ss_pred             hccceeeeecCCCceEEEEEecC------cEEEEEEeccchhHHHHHHHHHHHHHhcC-CcceeeeEEEEc---C-CCCe
Confidence            57889999999999999998752      36899988765444667889999999998 999999998432   2 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            79999999999999998754446999999999999999999999999999999999999999999999999999876322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ..     ...++..|+|||.+....++.++||||||+++|+|++ |..||...........+..    ...+..+..+++
T Consensus       156 ~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  226 (256)
T cd05039         156 QD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK----GYRMEAPEGCPP  226 (256)
T ss_pred             cc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc----CCCCCCccCCCH
Confidence            11     2235667999999998899999999999999999997 9999977654443333322    122344566889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.++|.+||..+|++||+++++++
T Consensus       227 ~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         227 EVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.9e-42  Score=320.77  Aligned_cols=254  Identities=21%  Similarity=0.319  Sum_probs=204.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||+|+||.||+|.+..++.....++++|.......  ....+.+|+.+++.+. ||||++++|.+.   . . 
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~---~-~-   81 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD-HPHLVRLLGVCL---S-P-   81 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEc---C-C-
Confidence            578899999999999999999877776666788988765322  2235788999999998 999999998432   1 2 


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++++||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             CceeeehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence            24589999999999999976 34468999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+. .   ...+..+..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~---~~~~~~~~~~  236 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-K---GERLPQPPIC  236 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-C---CCCCCCCCCC
Confidence            3322222223346788999999999999999999999999999997 999997764433333322 1   1222334557


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +.++.+++.+||..+|++||++++++..
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.3e-42  Score=311.37  Aligned_cols=245  Identities=23%  Similarity=0.359  Sum_probs=196.2

Q ss_pred             eeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEe
Q 017746            8 VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      .||+|+||.||+|.....+.  ...+++|.......  ....+.+|+.++++++ ||||+++++.+   + . ..+++||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~--~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~---~-~-~~~~lv~   73 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKK--QIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMIGVC---E-A-EALMLVM   73 (257)
T ss_pred             ccCCCCcccEEEEEEecCCC--ceeEEEEEcccccChHHHHHHHHHHHHHHhcC-CCCeEEEEEEE---c-C-CCeEEEE
Confidence            48999999999998754332  23588887765322  2356889999999998 99999999842   2 2 2456999


Q ss_pred             ecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCc
Q 017746           86 EYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERS  165 (366)
Q Consensus        86 E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  165 (366)
                      ||+++|+|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus        74 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          74 EMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             EeCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            99999999999975 34579999999999999999999999999999999999999999999999999998654332211


Q ss_pred             c-cccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHH
Q 017746          166 Q-SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK  243 (366)
Q Consensus       166 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  243 (366)
                      . .....++..|+|||.+....++.++|||||||++|+|++ |..||...........+..    ...+..+..+++++.
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~  228 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ----GKRLDCPAECPPEMY  228 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC----CCCCCCCCCCCHHHH
Confidence            1 111234678999999988889999999999999999996 9999987655443333322    223456677899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHc
Q 017746          244 DFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       244 ~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +++.+||..+|++||++.++.+
T Consensus       229 ~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         229 ALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8e-42  Score=311.71  Aligned_cols=251  Identities=28%  Similarity=0.456  Sum_probs=201.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|.+..+++    .+++|.+..    .......+.+|++++++++ |+||+++++.+   .. 
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~---~~-   73 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGR----VVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASF---IE-   73 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCC----EEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeee---ec-
Confidence            58899999999999999999986665    567776542    1223567889999999998 99999999843   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      ...+++||||+++|+|.+++...  .+..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          74 NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEecccee
Confidence            34567999999999999998642  2345899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ........  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... .......... ...+..+
T Consensus       154 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~  229 (267)
T cd08224         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEK-CDYPPLP  229 (267)
T ss_pred             eeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhc-CCCCCCC
Confidence            86532211  122346899999999999999999999999999999999999999655322 2222222211 2223333


Q ss_pred             C-CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          236 G-DLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       236 ~-~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      . .++.++.++|.+||..+|++||++.+|++
T Consensus       230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3 67889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.4e-42  Score=314.18  Aligned_cols=247  Identities=28%  Similarity=0.508  Sum_probs=202.4

Q ss_pred             eeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            9 IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         9 lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ||.|+||.||++++..+++    .+++|......    .....+.+|+.++++++ ||||+++++..    .....++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~----~~~~~~~lv   71 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGD----IYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSF----QGKKNLYLV   71 (265)
T ss_pred             CCCCCceEEEEEEECCCCC----EEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHhe----ecCcEEEEE
Confidence            6899999999999987654    77888765432    24567888999999998 99999998732    334566799


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||+++++|.+++.+.  +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.........
T Consensus        72 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          72 MEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            9999999999999763  37999999999999999999999999999999999999999999999999998865432211


Q ss_pred             ------cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC-
Q 017746          165 ------SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD-  237 (366)
Q Consensus       165 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (366)
                            .......++..|+|||.+.+..++.++||||||+++|+|++|..||...........+...   .  ...+.. 
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---~--~~~~~~~  224 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG---K--IEWPEDV  224 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C--cCCCccc
Confidence                  1223346889999999998888999999999999999999999999877655444443321   1  112222 


Q ss_pred             -CCHHHHHHHHHhcccCCCCCCCH---HHHHcCCCccc
Q 017746          238 -LSEQGKDFLIKCFLKDPKRRWTA---EMLLNHPFVCA  271 (366)
Q Consensus       238 -~s~~~~~ll~~cL~~dp~~R~t~---~~ll~hp~~~~  271 (366)
                       ++..+.+|+.+||..+|++|||+   .++++||||..
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence             48999999999999999999999   99999999953

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.5e-42  Score=312.70  Aligned_cols=251  Identities=22%  Similarity=0.379  Sum_probs=191.0

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      +.||+|+||.||+|......  ....+++|.......  ....+.+|+.++++++ ||||+++++.+.    ....+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~----~~~~~~lv   73 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGY--TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCT----EVTPYLLV   73 (269)
T ss_pred             CcccccCCceEEEEEEcCCC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc----CCCCcEEE
Confidence            46999999999999875422  245688887765322  2346788999999998 999999998432    23346799


Q ss_pred             eecCCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           85 LEYASRGSLADRVKKQN---NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      |||+++|+|.+++....   ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence            99999999999997532   124677888899999999999999999999999999999999999999999999754322


Q ss_pred             CCCcccccccCCCCCCCccccCCc-------CCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHh-hcCCCCC
Q 017746          162 GERSQSFECRGTPLYMSPESVNEN-------EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI-GVGDELP  232 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~-~~~~~~~  232 (366)
                      ..........|++.|+|||++.+.       .++.++|||||||++|+|++ |+.||......+........ ......|
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP  233 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence            222222234578899999998643       35789999999999999996 99999776544433222211 1222223


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+....++.+.+++.+|+ .+|++|||+++|+.
T Consensus       234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            334457888999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.2e-43  Score=311.52  Aligned_cols=267  Identities=27%  Similarity=0.363  Sum_probs=209.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      .|.....||+|.||.||+|..++++......+|+|++....   ..+...-+|+..++.|+ ||||+.+..++..+   +
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~---d  100 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLSH---D  100 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhcc---C
Confidence            58889999999999999998777665555678899887632   35677899999999999 99999998865433   5


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC----CceEEEe
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN---NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN----DEAKIAD  151 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~----~~vkl~D  151 (366)
                      ...+|++||.+. +|...|+-++   ...++...+++|+.||+.|+.|||++=|+||||||.|||+..+    |.|||+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            567799999998 9999997432   2358999999999999999999999999999999999999877    8999999


Q ss_pred             cCCccccCCCCCCc-ccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcc------hHHHHHH
Q 017746          152 FGLAKKSSCDGERS-QSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------NVFSLLI  223 (366)
Q Consensus       152 FG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~------~~~~~~~  223 (366)
                      ||+|+.+...-... .....+-|.+|.|||.+.+ ..|+.++||||.|||+.||++-.+-|.+....      ....++.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999876443322 2334567999999999877 56999999999999999999999888654211      1112222


Q ss_pred             Hhh----c--CCCCC---CCCC--------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          224 RIG----V--GDELP---NIPG--------------------------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       224 ~~~----~--~~~~~---~~~~--------------------------~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                      ++-    .  ....|   .+|.                          .-++.+.+|+.++|+.||.+|+|+++.++|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            211    0  00000   1111                          12455889999999999999999999999999


Q ss_pred             cccCC
Q 017746          269 VCADD  273 (366)
Q Consensus       269 ~~~~~  273 (366)
                      |..+.
T Consensus       340 F~~d~  344 (438)
T KOG0666|consen  340 FTEDP  344 (438)
T ss_pred             cccCC
Confidence            97653

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4e-42  Score=312.99  Aligned_cols=255  Identities=27%  Similarity=0.480  Sum_probs=202.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||++++...+..... .++|....   ..........|+.+++.++ ||||+++++.+   .. .
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~---~~-~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERL-KVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASF---LE-R   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceE-EEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHH---hc-C
Confidence            689999999999999999998765443222 23333222   1223445678899999998 99999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ..+++||||+++++|.+++.+.  .+..+++..+..++.|++.||.|||++|++|+||||+||+++. +.+||+|||++.
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~  153 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSR  153 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCcee
Confidence            3467999999999999998642  3456999999999999999999999999999999999999975 579999999987


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      .......  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||........   .... .....+..+.
T Consensus       154 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~  227 (260)
T cd08222         154 LLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV---VLRI-VEGPTPSLPE  227 (260)
T ss_pred             ecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHH-HcCCCCCCcc
Confidence            7542222  12234589999999999888899999999999999999999999976543322   2222 2234555667


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      .++.++.++|.+||..+|++||++.++++||||
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             hhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            789999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-42  Score=314.71  Aligned_cols=255  Identities=28%  Similarity=0.439  Sum_probs=201.3

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      |.+.+.||+|+||+||+|+...+++    .+++|.......  ......+|+..++++.+||||+++++.+.   . +..
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~---~-~~~   72 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGE----LVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR---E-NDE   72 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCc----EEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh---c-CCc
Confidence            7789999999999999999877654    678887654322  23345678999999987999999998432   2 445


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      .++||||+ +|+|.+++....+..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        73 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          73 LYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            67999999 77999999775445789999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCcccccccCCCCCCCccccC-CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC-----------
Q 017746          161 DGERSQSFECRGTPLYMSPESVN-ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG-----------  228 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~-----------  228 (366)
                      ...   .....|+..|+|||++. ...++.++|+||||+++++|++|++||...........+......           
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         152 RPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            222   22346899999999874 456789999999999999999999999776554433322211100           


Q ss_pred             ------CCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          229 ------DELP--------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       229 ------~~~~--------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                            ...+        ......+..+.+||.+||..+|++||+++|++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                  0000        0111236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-42  Score=319.12  Aligned_cols=259  Identities=20%  Similarity=0.275  Sum_probs=200.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC----------CCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS----------EFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFG   69 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~----------~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g   69 (366)
                      +|.+.+.||+|+||.||++++...+.          .....+++|......  .....+.+|++++++++ ||||+++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~   84 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK-NPNIIRLLG   84 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCcCeEEE
Confidence            68899999999999999998754321          123458888876432  22346888999999998 999999998


Q ss_pred             ceeeccCCeeEEEEEeecCCCCCHHHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcE
Q 017746           70 DDYSFEKGERFYNLLLEYASRGSLADRVKKQN----------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNV  139 (366)
Q Consensus        70 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI  139 (366)
                      .+    ......++||||+++++|.+++....          ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus        85 ~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          85 VC----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             EE----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            43    23345679999999999999996521          01368889999999999999999999999999999999


Q ss_pred             EeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh--CCCCCCCCCcch
Q 017746          140 LVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSN  217 (366)
Q Consensus       140 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt--g~~pf~~~~~~~  217 (366)
                      +++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999986543222111222345778999999999999999999999999999988  678887765544


Q ss_pred             HHHHHHHhh---cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          218 VFSLLIRIG---VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       218 ~~~~~~~~~---~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .........   ........+..+++.+.+|+.+||..||++||+++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            333322211   111122334457899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.5e-42  Score=314.39  Aligned_cols=253  Identities=20%  Similarity=0.337  Sum_probs=201.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|.++.+++. ...+++|.....  ......+..|+.+++++. ||||+++++.+    ..+.
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~----~~~~   78 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKR-EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVV----TKSR   78 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCC-ceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CcCcceEEEEE----CCCC
Confidence            478899999999999999998776542 346888887642  223457888999999998 99999998832    2334


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+++.. ..+.+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            56699999999999999976 34578999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCCCccccc---ccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          160 CDGERSQSFE---CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       160 ~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ..........   ..++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+.   ..... ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~~~~~-~~~  233 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---QDYRL-PPP  233 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cCCcC-CCc
Confidence            3222111111   112457999999999999999999999999999886 999998765544433332   11222 234


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ..++..+.+++.+||..+|++||++++|+.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         234 MDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.3e-42  Score=316.34  Aligned_cols=256  Identities=18%  Similarity=0.225  Sum_probs=203.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|.+..++......+++|......  .....+.+|..+++.++ ||||+++++..  +.. ..
T Consensus         7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~--~~~-~~   82 (280)
T cd05043           7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS-HQNILPILHVC--IED-GE   82 (280)
T ss_pred             heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE--ecC-CC
Confidence            58889999999999999999876443334578888765422  23456788999999997 99999999843  222 33


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNN------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                      ..++++||+++|+|.+++.....      ..+++.++..++.||+.||+|||++|++||||||+||++++++.+||+|||
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g  162 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA  162 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence            45699999999999999976322      358999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      +++.+.............++..|+|||++.+..++.++|||||||++|++++ |++||......+....+..   . ..+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~-~~~  238 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD---G-YRL  238 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc---C-CCC
Confidence            9986543222211222346778999999998999999999999999999999 9999987654433332222   1 222


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ..+..+++++.+++.+||..||++|||+.+++.
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            334557899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-43  Score=311.08  Aligned_cols=265  Identities=26%  Similarity=0.421  Sum_probs=221.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.++++||+|+|+.|.+++++.+.+.|+.+++.|.+...+....-.+.|..+..+..++|.+|-+..   +|+.+. .+
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs---cfqtes-rl  326 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS---CFQTES-RL  326 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh---hhcccc-eE
Confidence            57889999999999999999999998888887777777677778889999999999999999999886   344444 45


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++|.||++||+|--.+++++  +++|+.++.|...|+.||.|||++|||+||||.+||||+..|++||.|+|+++.--.+
T Consensus       327 ffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            59999999999999997753  6999999999999999999999999999999999999999999999999999874333


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCC----CCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNH----KQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~----~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      +.  .+.++||||.|+|||++++..|+..+|+|+|||+++||+.|+.||+-    ..+.++...+.++..... -.+|..
T Consensus       405 gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-iriprs  481 (593)
T KOG0695|consen  405 GD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-IRIPRS  481 (593)
T ss_pred             Cc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-ccccce
Confidence            32  34467999999999999999999999999999999999999999962    222333333333332222 246777


Q ss_pred             CCHHHHHHHHHhcccCCCCCC------CHHHHHcCCCcccCCCC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRW------TAEMLLNHPFVCADDQT  275 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~------t~~~ll~hp~~~~~~~~  275 (366)
                      +|-.+..+++.-|.+||.+|.      .+.++..|+||..-++.
T Consensus       482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd  525 (593)
T KOG0695|consen  482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD  525 (593)
T ss_pred             eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence            888899999999999999996      57899999999755443

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.6e-42  Score=310.80  Aligned_cols=248  Identities=22%  Similarity=0.368  Sum_probs=201.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|.....     ..+++|...........+.+|+.++++++ |+||+++++...   .  ..+
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~~~-----~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~---~--~~~   75 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYNKH-----TKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT---K--EPI   75 (260)
T ss_pred             ceeEEeEecCccceEEEEEEecCC-----ccEEEEecCCChhHHHHHHHHHHHHHhcC-CCCcceEEEEEc---C--CCe
Confidence            588999999999999999986542     25788877654445567889999999998 999999987432   2  346


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+++++|.+++.+..+..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            69999999999999998755566889999999999999999999999999999999999999999999999999865422


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......++..|+|||++....++.++|+|||||++|+|++ |+.||...........+..   . .....+...+.
T Consensus       156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~-~~~~~~~~~~~  230 (260)
T cd05073         156 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---G-YRMPRPENCPE  230 (260)
T ss_pred             Cc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---C-CCCCCcccCCH
Confidence            11 11122346678999999998899999999999999999999 9999987655443333322   1 22233456889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.+++.+||..+|++||++.++++
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=340.84  Aligned_cols=258  Identities=30%  Similarity=0.509  Sum_probs=222.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc-CCeeEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KGERFY   81 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~~~~~   81 (366)
                      |++.++||.|.+|.||+++.+.+++    ..|+|+........+.++.|.++|+.+..|||++.++|+++-.. .+...+
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~----~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQ----LAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCc----eeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            7899999999999999999988765    78888888877888899999999999999999999999776333 345567


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +||||||.||+..|+++...+.++.|+.+..|.+.++.||.+||.+.++|||||-.|||++.++.|||+|||.+..+.  
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld--  174 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--  174 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee--
Confidence            799999999999999998778899999999999999999999999999999999999999999999999999998775  


Q ss_pred             CCCcccccccCCCCCCCccccCCc-----CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC--
Q 017746          162 GERSQSFECRGTPLYMSPESVNEN-----EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI--  234 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  234 (366)
                      .+.....++.|||.|||||++...     .|+.++|+||||++..||.-|.+|+-+..+..   .+..+.. ..+|.+  
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF~IpR-NPPPkLkr  250 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIPR-NPPPKLKR  250 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhccCCC-CCCccccc
Confidence            344455677899999999999654     37789999999999999999999997775543   3443332 222222  


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      |...+.++.+||..||.+|.++||+..+++.|||+.
T Consensus       251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            345688999999999999999999999999999996

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.8e-42  Score=313.01  Aligned_cols=253  Identities=22%  Similarity=0.346  Sum_probs=202.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|.++.++. ....+++|......  .....+.+|+.++++++ ||||+++++.+   . ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~---~-~~~   78 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGK-REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVV---T-KSK   78 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCC-CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEE---e-cCC
Confidence            58899999999999999999865543 22467888765422  23457888999999998 99999999843   2 334


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+++++|.+++.+ ..+.+++.++..++.||+.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            56799999999999999976 34578999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcc-cccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          160 CDGERSQ-SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       160 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||......+....+..   ... +..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~---~~~-~~~~~~  233 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE---GYR-LPAPMD  233 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC---CCc-CCCCCC
Confidence            3222111 111224568999999999999999999999999999886 9999987655444333322   112 233456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +++.+.+++.+||+++|++||++.++++
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         234 CPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            7899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=354.41  Aligned_cols=253  Identities=25%  Similarity=0.382  Sum_probs=208.9

Q ss_pred             cccCeeeecCCeeEEEEEECCCCC-CCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      .+++.||+|+||.||.|....... .....+|+|.+...  ......+.+|..+|..++ |||||+++|.+.  .  ...
T Consensus       695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l--~--~~~  769 (1025)
T KOG1095|consen  695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCL--D--SGP  769 (1025)
T ss_pred             EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CcceeeEEEeec--C--CCC
Confidence            357899999999999999765533 23667999988764  445678999999999999 999999999543  3  334


Q ss_pred             EEEEeecCCCCCHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           81 YNLLLEYASRGSLADRVKKQN-----NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      +++++|||+||+|..+|++.+     ...++..+...++.+|++|+.||+++++|||||.++|+||++...|||+|||+|
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence            569999999999999998731     345899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      +.+....-........-...|||||.+....++.++|||||||++||++| |..||.+....+.+......+   .+ ..
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---RL-~~  925 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---RL-DP  925 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---cc-CC
Confidence            95432222211111123357999999999999999999999999999998 999999887776665444443   33 34


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      |..+++.+.++|..||+.+|++||++..|++
T Consensus       926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            6779999999999999999999999999997

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-41  Score=308.07  Aligned_cols=253  Identities=24%  Similarity=0.407  Sum_probs=206.0

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +.+++.||+|+||.||++++...+......+++|.......  ....+..|+.+++.++ ||||+++++.+.   . ...
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~---~-~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD-HPNIVKLLGVCT---E-EEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC-CCchheEEEEEc---C-CCe
Confidence            35788999999999999999876544456889998875433  4567889999999996 999999998432   2 245


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      ++++|||+++++|.+++.......+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            77999999999999999764332389999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      ....... ...+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+..    ...+..+..++
T Consensus       156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~  230 (258)
T smart00219      156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK----GYRLPKPENCP  230 (258)
T ss_pred             ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc----CCCCCCCCcCC
Confidence            3222111 2237889999999988889999999999999999998 8999987655444443332    22334455689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .++.+++.+||..||++|||+.++++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      231 PEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            99999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-42  Score=324.19  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=209.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeecc-CC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~   77 (366)
                      +|.+.+.||+|+||.||+|++..+++    .+++|.+...   ......+.+|+.+++.++ ||||+++++.+.... ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   75 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGR----KVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPED   75 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCc----EEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCccc
Confidence            68999999999999999999876654    6788876652   234467888999999998 999999998543321 12


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...++++|||+++ +|.+++.+  +..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..
T Consensus        76 ~~~~~lv~e~~~~-~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          76 FNDVYIVTELMET-DLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             ccceEEEecchhh-hHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            2356799999985 89999865  34799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCC-cccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC-----
Q 017746          158 SSCDGER-SQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE-----  230 (366)
Q Consensus       158 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~-----  230 (366)
                      ....... .......||+.|+|||++.+. .++.++|+|||||++|+|++|++||......+....+........     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            6543210 112234689999999999888 789999999999999999999999987765544443333211000     


Q ss_pred             ---------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          231 ---------------------LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       231 ---------------------~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                           .......++.++.+||.+||.++|++||++++++.||||...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence                                 001122368889999999999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-42  Score=314.67  Aligned_cols=246  Identities=26%  Similarity=0.409  Sum_probs=194.2

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      +.||+|+||.||+|+.+.++.  ...+++|.....  ......+.+|++++.++..||||+++++.+    .....+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----~~~~~~~lv   74 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGL--RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC----EHRGYLYLA   74 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCC--eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE----ecCCCceEE
Confidence            479999999999999877654  234677766532  223456788999999996699999999843    223456799


Q ss_pred             eecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEE
Q 017746           85 LEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIA  150 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~  150 (366)
                      |||+++|+|.+++.+..              ...+++.++..++.||+.||+|||++|++||||||+|||+++++.+||+
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence            99999999999997532              1247899999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      |||++.....   .........+..|+|||++....++.++|||||||++|+|++ |..||...........+..    .
T Consensus       155 dfgl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~----~  227 (270)
T cd05047         155 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----G  227 (270)
T ss_pred             CCCCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC----C
Confidence            9999864321   111112234667999999998999999999999999999997 9999977654443333321    1


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .....+..++.++.+++.+||..||.+||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            222344567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7e-42  Score=323.76  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=203.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+|.+..++.    .+++|....   .......+.+|+.+++++..||||+++++.+  ...+.
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~--~~~~~   81 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKE----VVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVI--KAEND   81 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCe----EEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeee--ccCCC
Confidence            58899999999999999999876654    677776643   1233456778999999994499999999843  22334


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+.+ +|.+++.+   +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        82 ~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          82 KDIYLVFEYMET-DLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             ceEEEEeccccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            456799999985 99999865   26899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCC---cccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc-------
Q 017746          159 SCDGER---SQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV-------  227 (366)
Q Consensus       159 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~-------  227 (366)
                      ......   .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+....+.....       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            433221   12233568999999998755 5578899999999999999999999976654433222211100       


Q ss_pred             -------------------CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          228 -------------------GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       228 -------------------~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                         ..........++.++.+||.+||+.||++|||+.++++|||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                               000011122368899999999999999999999999999999553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=284.54  Aligned_cols=256  Identities=26%  Similarity=0.423  Sum_probs=209.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...++||+|.||+||+|+..++++    .||+|.....+.   .-....+|+-+|+.++ |.|||++++    +-..+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~e----ivalkrvrlddddegvpssalreicllkelk-hknivrl~d----vlhsd   73 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHE----IVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHD----VLHSD   73 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccc----eEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhh----hhccC
Confidence            57788999999999999999887754    888988765332   3356789999999999 999999987    34445


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      +.+.+|+|||.. +|..+... .+|.++.+.+++++.|+++||.|||++++.||||||.|.||+.+|.+||+|||+|+.+
T Consensus        74 kkltlvfe~cdq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   74 KKLTLVFEFCDQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             ceeEEeHHHhhH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence            566799999977 99999987 5678999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCC-------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD-------  229 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~-------  229 (366)
                      .-+-.  -....+-|.+|.+|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+..++...+.+..-..       
T Consensus       152 gipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             CCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence            42211  11223568999999999875 48899999999999999986 888898887777666666532110       


Q ss_pred             --------CCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          230 --------ELPNIP---------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       230 --------~~~~~~---------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                              ..|.+|         ..++...+|+++++|..+|.+|++++..++||||.
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~  287 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS  287 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence                    111111         12566789999999999999999999999999994

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.2e-41  Score=315.07  Aligned_cols=262  Identities=26%  Similarity=0.466  Sum_probs=206.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+.+.||.|+||.||+|...... ..+..+++|.+...     ......+.+|+.+++++.+|+||+++++.   +..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~-~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~---~~~   76 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA---FQT   76 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC-CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeE---eec
Confidence            4889999999999999999875321 12346888876541     12345678899999999779999999863   333


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                       +..+++||||+++++|.+++...  ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.
T Consensus        77 -~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          77 -DTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence             34567999999999999999763  468999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCc--CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNEN--EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ....... .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||...........+...... ..+.+
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~  231 (290)
T cd05613         154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPY  231 (290)
T ss_pred             ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCC
Confidence            7543221 122345689999999998753  4778999999999999999999999754332222223222211 22345


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCcccC
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCAD  272 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~  272 (366)
                      +..++..+.+++.+||..||++||     +++++++||||...
T Consensus       232 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            667899999999999999999997     89999999999654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-41  Score=322.05  Aligned_cols=259  Identities=25%  Similarity=0.389  Sum_probs=200.9

Q ss_pred             Ccc-ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---------------hhhHHHHHHHHHHcCCCCcee
Q 017746            2 EWL-RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---------------SVTLKNEKEALDQIGICPQIV   65 (366)
Q Consensus         2 ~y~-~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---------------~~~~~~E~~~l~~l~~~p~Iv   65 (366)
                      +|. +.+.||+|+||+||+|.++.+++    .+++|........               ...+.+|+++++++. ||||+
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv   83 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGK----IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIM   83 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCC----eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Cccee
Confidence            465 45789999999999999877654    6777776542211               124678999999998 99999


Q ss_pred             EeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC
Q 017746           66 RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND  145 (366)
Q Consensus        66 ~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~  145 (366)
                      ++++.+    ..+...++||||+. |+|.+++..  ...+++..+..++.||+.||+|||++|++|+||||+||+++.++
T Consensus        84 ~~~~~~----~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~  156 (335)
T PTZ00024         84 GLVDVY----VEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG  156 (335)
T ss_pred             eeeEEE----ecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC
Confidence            999843    23446779999997 499999965  34699999999999999999999999999999999999999999


Q ss_pred             ceEEEecCCccccCCCC------------CCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCC
Q 017746          146 EAKIADFGLAKKSSCDG------------ERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNH  212 (366)
Q Consensus       146 ~vkl~DFG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~  212 (366)
                      .+||+|||++.......            .........+++.|+|||++.+. .++.++|||||||++|+|++|++||..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999997654111            01111223578899999998764 468899999999999999999999987


Q ss_pred             CCcchHHHHHHHhhcCCCC-----------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          213 KQDSNVFSLLIRIGVGDEL-----------------------PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ..+.+....+.........                       .......+.++.++|.+||..+|++||++++++.||||
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            7665544433321110000                       01112357889999999999999999999999999999


Q ss_pred             ccC
Q 017746          270 CAD  272 (366)
Q Consensus       270 ~~~  272 (366)
                      ...
T Consensus       317 ~~~  319 (335)
T PTZ00024        317 KSD  319 (335)
T ss_pred             CCC
Confidence            654

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=309.19  Aligned_cols=246  Identities=27%  Similarity=0.404  Sum_probs=197.8

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      +.||+|+||.||+|+....+. ....+++|.......  ....+.+|+.+++++. ||||+++++.+    .+. .+++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~----~~~-~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSG-KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRLIGVC----KGE-PLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccCC-CcceEEEEecccccchHHHHHHHHHHHHHHhcC-CCCeeeEEEEE----cCC-ceEEE
Confidence            579999999999998755432 234788888775433  3456888999999998 99999999832    222 35699


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||+++|+|.+++.+.  +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++........
T Consensus        74 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          74 MELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999999999763  36899999999999999999999999999999999999999999999999999876433221


Q ss_pred             cc-cccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHH
Q 017746          165 SQ-SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG  242 (366)
Q Consensus       165 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  242 (366)
                      .. .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+..    ......+..++..+
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l  227 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES----GERLPRPEECPQEI  227 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc----CCcCCCCCCCCHHH
Confidence            11 111224568999999999999999999999999999998 9999987655443333322    12234556788999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHc
Q 017746          243 KDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++++.+||..+|++||++.++++
T Consensus       228 ~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         228 YSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.1e-42  Score=317.37  Aligned_cols=259  Identities=20%  Similarity=0.288  Sum_probs=198.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC------------CCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS------------SEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRC   67 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~------------~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~   67 (366)
                      +|.+.+.||+|+||.||++.+....            ......+++|......  .....+.+|+.+++.++ ||||+++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~   84 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK-DPNIIRL   84 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceE
Confidence            5889999999999999999754321            1223468888876432  23456889999999998 9999999


Q ss_pred             ecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCc
Q 017746           68 FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNN---------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQN  138 (366)
Q Consensus        68 ~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N  138 (366)
                      ++.+   . .....+++|||+++|+|.+++.+...         ..+++.++..++.||+.||+|||++|++||||||+|
T Consensus        85 ~~~~---~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          85 LAVC---I-TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             EEEE---e-cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9843   2 23346799999999999999976321         236778999999999999999999999999999999


Q ss_pred             EEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh--CCCCCCCCCcc
Q 017746          139 VLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDS  216 (366)
Q Consensus       139 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt--g~~pf~~~~~~  216 (366)
                      ||++.++.+||+|||+++...............+++.|+|||+..+..++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999986533222111222345678999999888899999999999999999998  78999766544


Q ss_pred             hHHHHHHHh---hcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          217 NVFSLLIRI---GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       217 ~~~~~~~~~---~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +........   .........+..++..+.+|+.+||..||++||++.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            433222111   0011111234457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.8e-42  Score=309.02  Aligned_cols=251  Identities=27%  Similarity=0.414  Sum_probs=208.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||.||+++++.+++    .+++|.....   ......+.+|+.+++.++ ||||+++++.+.   . .
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~---~-~   71 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQ----FYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFL---D-G   71 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCC----EEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhc---c-C
Confidence            58899999999999999999877654    6777776542   223456778999999998 999999987432   2 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ..+++||||+++++|.+++.+.  .+..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~  151 (256)
T cd08530          72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISK  151 (256)
T ss_pred             CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchh
Confidence            5677999999999999998652  13468999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      .....    ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+    .....+..+.
T Consensus       152 ~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~  223 (256)
T cd08530         152 VLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV----QRGKYPPIPP  223 (256)
T ss_pred             hhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hcCCCCCCch
Confidence            76433    122345899999999999999999999999999999999999999876544332222    2233445556


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      .++.++.+++.+||..+|++||++.+++.||++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         224 IYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             hhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.6e-42  Score=324.70  Aligned_cols=261  Identities=26%  Similarity=0.365  Sum_probs=200.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccC----
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK----   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~----   76 (366)
                      +|.+.+.||.|+||.||+|.++.+++    .+++|...... .....+.+|+++++.++ ||||+++++....-..    
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~----~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSAVDSDCDK----RVAVKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             ceEEEEEecCCCCEEEEEEEECCCCc----EEEEEEEecCCCchHHHHHHHHHHHHhcC-CCcchhhHhhhccccccccc
Confidence            68999999999999999999987765    67787765532 34456888999999998 9999999874322111    


Q ss_pred             ------CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-CCceEE
Q 017746           77 ------GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-NDEAKI  149 (366)
Q Consensus        77 ------~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~vkl  149 (366)
                            ....+++||||+.+ +|.+++..   +.+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          81 DVGSLTELNSVYIVQEYMET-DLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccccccceEEEEeecccc-cHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence                  11346799999975 99988854   46999999999999999999999999999999999999974 557999


Q ss_pred             EecCCccccCCCCCCc-ccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc
Q 017746          150 ADFGLAKKSSCDGERS-QSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV  227 (366)
Q Consensus       150 ~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~  227 (366)
                      +|||+++......... ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||...........+.....
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999998653221111 1122358899999998654 5688899999999999999999999976654333322221100


Q ss_pred             --------------------CCCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          228 --------------------GDELP-----NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       228 --------------------~~~~~-----~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                          ....+     .+...++.++.+||.+||..||++|||++++++||||..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                                00000     112347888999999999999999999999999999953

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=9.4e-42  Score=315.19  Aligned_cols=256  Identities=30%  Similarity=0.490  Sum_probs=208.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .|...+.||+|+||.||+|.+..++.    .+++|...........+.+|++++++++ |+||+++++.+..    ....
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----~~~~   90 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGK----EVAIKKMRLRKQNKELIINEILIMKDCK-HPNIVDYYDSYLV----GDEL   90 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCc----EEEEEEEecCchhHHHHHHHHHHHHHCC-CCCeeEEEEEEEE----CCEE
Confidence            47778899999999999999876554    6788887764344667889999999998 8999999984332    2456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++++||+++++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            79999999999999998742 37999999999999999999999999999999999999999999999999998765422


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      ..  ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+...... . ...+..++.+
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~  245 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-P-LKNPEKWSPE  245 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-C-CcchhhCCHH
Confidence            21  122335889999999999889999999999999999999999999866544333332221111 1 1112237889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +.+||.+||+.+|.+||++.++++|+||..
T Consensus       246 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         246 FKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            999999999999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.3e-42  Score=313.11  Aligned_cols=250  Identities=20%  Similarity=0.336  Sum_probs=197.1

Q ss_pred             CeeeecCCeeEEEEEECCCC--CCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVS--SEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~--~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.||+|+||.||+|+.+...  ......+++|......  .....+.+|+.+++.++ ||||+++++.+.    .....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCL----LNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC-CCCeeeEeeeec----CCCCeE
Confidence            46999999999999986543  2223467777765432  34567888999999998 999999998432    233467


Q ss_pred             EEeecCCCCCHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-----ceEEEec
Q 017746           83 LLLEYASRGSLADRVKKQN-----NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-----EAKIADF  152 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-----~vkl~DF  152 (366)
                      +||||+++++|.+++.+..     ...+++.++..++.||+.||+|||+.+++|+||||+||+++.++     .+||+||
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence            9999999999999997532     23478899999999999999999999999999999999999877     8999999


Q ss_pred             CCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          153 GLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       153 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      |+++...............++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+.   . ...
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~-~~~  231 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT---A-GGR  231 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh---c-CCc
Confidence            99986543222222223346788999999999999999999999999999998 999997665443333222   1 222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +..+..++..+.+++.+||.++|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3445668899999999999999999999999975

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=301.21  Aligned_cols=257  Identities=25%  Similarity=0.359  Sum_probs=201.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeecc-CCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~~~   79 (366)
                      ||++.+.||+|||+-||+++...++.    .+|+|++.-.. .+.+...+|++..++++ |||+++++.+...-+ ++..
T Consensus        22 Ryri~~~LgeGGfsfv~LV~~~s~~~----~YAlKkI~c~~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   22 RYRIQRLLGEGGFSFVDLVKGLSTGH----LYALKKILCHSQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             eEEEeeeecCCCceeeeeecccCccc----chhhheeeccchHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCce
Confidence            79999999999999999999777765    66777665533 56678899999999999 899999998665333 3566


Q ss_pred             EEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEeccCCceEEEecCCc
Q 017746           80 FYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKG--FVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      ..|++++|...|+|.+.++..  .+..++|.++..|+.+|++||++||+..  ++||||||.|||+.+.+.++|.|||.+
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence            788999999999999999753  3346999999999999999999999998  999999999999999999999999998


Q ss_pred             cccCCCCCCcc-------cccccCCCCCCCccccCC---cCCCCccchhhhHHHHHHHHhCCCCCCCCCc--chHHHHHH
Q 017746          156 KKSSCDGERSQ-------SFECRGTPLYMSPESVNE---NEYEAPCDIWALGCAVVEMASGKPAWNHKQD--SNVFSLLI  223 (366)
Q Consensus       156 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~emltg~~pf~~~~~--~~~~~~~~  223 (366)
                      ....-.-....       ...-..|..|.|||.+.-   ...+.++|||||||+||+|+.|..||+-.-.  ....-.+.
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~  256 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ  256 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence            76432111110       112347999999998854   4567899999999999999999999953211  00000000


Q ss_pred             HhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .  .....|.- ..+|+.+.++|..||+.||.+||++.+|+.+
T Consensus       257 n--~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  257 N--AQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             c--cccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            0  01122222 2389999999999999999999999999875

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-42  Score=313.75  Aligned_cols=254  Identities=28%  Similarity=0.427  Sum_probs=203.5

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      |...+.||+|++|.||+|.+..+++    .+++|.......   ....+.+|+.++++++ ||||+++++..    ....
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~----~~~~   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGE----IVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVF----RHKG   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCc----EEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhh----ccCC
Confidence            6788999999999999999876654    678887664322   3457888999999998 99999999843    2235


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++ +|.+++... .+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+....
T Consensus        72 ~~~~v~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          72 DLYLVFEFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             CEEEEEeccCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence            56799999986 999988763 3579999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC---------
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD---------  229 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~---------  229 (366)
                      ...  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.......         
T Consensus       150 ~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd05118         150 SPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT  227 (283)
T ss_pred             CCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccch
Confidence            332  111223588899999998776 78899999999999999999999998766544433332211000         


Q ss_pred             ----------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          230 ----------------ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       230 ----------------~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                                      ........++.++.+||.+||..||.+||++.++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                            0011123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.3e-42  Score=323.86  Aligned_cols=257  Identities=23%  Similarity=0.354  Sum_probs=202.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccC--
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK--   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~--   76 (366)
                      +|.+++.||+|+||.||+|.+..++.    .+++|.......   ....+.+|+.+++.++ ||||+++++.+.....  
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGA----KVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCc----EEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCcccc
Confidence            68899999999999999999877654    788887754211   2345788999999998 9999999985432111  


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||+ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence            113467999999 6799988854   469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC-------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG-------  228 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~-------  228 (366)
                      .....     .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||...........+.+....       
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         167 QTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             ccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            65321     123357999999999876 45888999999999999999999999866543333222221100       


Q ss_pred             -------------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          229 -------------------DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       229 -------------------~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                         .....+...++.++.++|.+||..||++|||+.+++.||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                               00011223578889999999999999999999999999999654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.1e-42  Score=352.01  Aligned_cols=253  Identities=21%  Similarity=0.206  Sum_probs=195.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||.||+|++..+++    .+|+|.+.....    ....+.+|++++.+++ ||||+++++.+    ..
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~----~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~----~d   73 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSR----RVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSIC----SD   73 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCc----EEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEE----ee
Confidence            69999999999999999999887655    788887764221    2356788999999999 99999999732    22


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceE
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQN---------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAK  148 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~---------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vk  148 (366)
                      ....+++|||++||+|.+++....         ...++...+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        74 ~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         74 GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEE
Confidence            345679999999999999996421         12355677889999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCCCC----------------CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCC
Q 017746          149 IADFGLAKKSSCDGE----------------RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNH  212 (366)
Q Consensus       149 l~DFG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~  212 (366)
                      |+|||+++.......                .......+||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999986521110                0011234699999999999999999999999999999999999999976


Q ss_pred             CCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          213 KQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ......... ......... .....+++.+.+++.+||..||++|++..+.+.
T Consensus       234 ~~~~ki~~~-~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        234 KKGRKISYR-DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             cchhhhhhh-hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            543322111 111110011 111357889999999999999999987655543

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-41  Score=314.86  Aligned_cols=262  Identities=27%  Similarity=0.484  Sum_probs=205.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+.+.||+|+||.||+++..... .....+++|.+...     ......+.+|++++.++.+||||+++++.   +..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~---~~~   76 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA---FQT   76 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccc-cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee---eec
Confidence            5889999999999999999865322 12346778876531     12345678899999999779999999873   333


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                       ...+++||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++
T Consensus        77 -~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          77 -DTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             -CCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence             34567999999999999999752  468999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcC--CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ........ ......|+..|+|||.+.+..  ++.++||||||+++|+|++|..||...........+.+.... ..+..
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~  231 (288)
T cd05583         154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPF  231 (288)
T ss_pred             cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cCCCC
Confidence            75432211 122346899999999987665  778999999999999999999999644322222222222222 22345


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCCCcccC
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWT---AEMLLNHPFVCAD  272 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t---~~~ll~hp~~~~~  272 (366)
                      +..++..+.++|.+||+.||++|||   +.++++||||+..
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            6678899999999999999999998   5778999999654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-41  Score=309.16  Aligned_cols=249  Identities=21%  Similarity=0.316  Sum_probs=193.8

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      +.||+|+||.||+|.....+ .....+++|......  .....+.+|+.+++.++ ||||+++++.+.  .. +...+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~-~~~~~lv   75 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD-GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICL--PS-EGSPLVV   75 (262)
T ss_pred             CcccccCCceEEEEEEecCC-CceEEEEEEecCccCCHHHHHHHHHHHHHHccCC-CCCcceEEEEee--cC-CCCcEEE
Confidence            47899999999999975432 234578899875422  23456778999999998 999999998432  22 3345699


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||+.+|+|.+++.+. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++........
T Consensus        76 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          76 LPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             EecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999999999999763 345778888999999999999999999999999999999999999999999999765322111


Q ss_pred             --cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          165 --SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                        .......++..|+|||.+.+..++.++|||||||++|||++ |.+||......+....+    .....+..+..++..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  230 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL----LQGRRLLQPEYCPDP  230 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----hcCCCCCCCCcCCHH
Confidence              11112346778999999988899999999999999999999 56677655433322222    222333445567899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +.+++.+||..+|++||++.++++
T Consensus       231 ~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         231 LYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-41  Score=310.98  Aligned_cols=253  Identities=21%  Similarity=0.347  Sum_probs=202.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||+|+||.||+|+++.+++. ...+++|......  .....+.+|+++++++. ||||+++++.+   . ...
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~---~-~~~   79 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRK-EVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRLEGVV---T-KFK   79 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCC-ceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CCCeeEEEEEE---c-cCC
Confidence            477889999999999999998765432 3468888876532  23456788999999998 99999999843   2 233


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+++++|.+++.+ ..+.+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          80 PAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            46699999999999999976 34579999999999999999999999999999999999999999999999999998664


Q ss_pred             CCCCCcc-cccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          160 CDGERSQ-SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       160 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....... ......++.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+..   .... ..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~---~~~~-~~~~~  234 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND---GFRL-PAPMD  234 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc---CCCC-CCCCC
Confidence            3221111 111223457999999998899999999999999999997 9999977665544444432   2222 23446


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.++.+++.+||..+|++||++.++++
T Consensus       235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         235 CPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            7899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.5e-41  Score=309.59  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=201.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|.+...+ .....+++|......  .....+.+|+.+++++. ||||+++++.+   .. . 
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~---~~-~-   79 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPE-NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGVI---TE-N-   79 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCC-CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCchhceeEEE---cC-C-
Confidence            4788899999999999999976542 123467888776532  23457889999999998 99999999843   22 2 


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+++|+|.+++.+. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            345999999999999999763 3468999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ....... ....++..|+|||.+....++.++|||||||++|+|++ |..||......+....+.   .. ..+..+..+
T Consensus       159 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~---~~-~~~~~~~~~  233 (270)
T cd05056         159 DESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE---NG-ERLPMPPNC  233 (270)
T ss_pred             cccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---cC-CcCCCCCCC
Confidence            3322111 12235568999999988899999999999999999996 999998776544433332   22 223445678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +.++.+++.+||..+|++|||+.+++..
T Consensus       234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         234 PPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.2e-41  Score=307.33  Aligned_cols=249  Identities=22%  Similarity=0.355  Sum_probs=201.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|.+.. +    ..+++|...........+.+|+++++++. ||||+++++.+    .....+
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~-~----~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~----~~~~~~   74 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLE-K----RKVAIKTIREGAMSEEDFIEEAQVMMKLS-HPKLVQLYGVC----TERSPI   74 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeC-C----CeEEEEECCCCCCCHHHHHHHHHHHHhCC-CCCeeeEEEEE----ccCCce
Confidence            57888999999999999998753 2    25788877665455667899999999998 99999998832    223456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++++|.+++.. ..+.++++.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus        75 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          75 CLVFEFMEHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             EEEEEcCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence            799999999999999976 3456899999999999999999999999999999999999999999999999998765322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+...    ..+..+...+.
T Consensus       154 ~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~  228 (256)
T cd05112         154 Q-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG----FRLYKPRLASQ  228 (256)
T ss_pred             c-ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC----CCCCCCCCCCH
Confidence            1 111122235678999999998999999999999999999998 99999876554444333221    11122444689


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .+.+|+.+||..+|++||++.+++++
T Consensus       229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         229 SVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHHHcccChhhCCCHHHHHHh
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1e-41  Score=316.41  Aligned_cols=252  Identities=28%  Similarity=0.430  Sum_probs=203.0

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      ....||+|+||.||++..+.++.    .+++|...... .....+.+|+.+++.++ ||||+++++.+   .. ....++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~---~~-~~~~~l   94 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGK----LVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSY---LV-GDELWV   94 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCe----EEEEEEecccchhHHHHHHHHHHHHHhcC-CcchhheeeEE---Ee-CCEEEE
Confidence            34579999999999999887654    78888765422 24456888999999998 89999999843   22 345679


Q ss_pred             EeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCC
Q 017746           84 LLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE  163 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  163 (366)
                      ||||+++++|.+++..   +.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++....... 
T Consensus        95 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-  170 (292)
T cd06657          95 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  170 (292)
T ss_pred             EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-
Confidence            9999999999998754   368999999999999999999999999999999999999999999999999987654322 


Q ss_pred             CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHH
Q 017746          164 RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK  243 (366)
Q Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  243 (366)
                       .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+. ......... ...++..+.
T Consensus       171 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~l~  247 (292)
T cd06657         171 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPPKLKN-LHKVSPSLK  247 (292)
T ss_pred             -ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hhCCcccCC-cccCCHHHH
Confidence             11223468999999999988889999999999999999999999998765443333322 222222222 235788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          244 DFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       244 ~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +++.+||..+|.+||++.++++||||...
T Consensus       248 ~li~~~l~~~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         248 GFLDRLLVRDPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             HHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence            99999999999999999999999999543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=311.83  Aligned_cols=257  Identities=27%  Similarity=0.428  Sum_probs=202.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      |.+.+.||+|+||.||+|+...+++    .+++|.+...   ......+.+|+.+++++. |||++++++.+..  ....
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~   73 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGE----LVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTS--KGKG   73 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCe----EEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEec--CCCC
Confidence            6788999999999999999987654    6777777653   223456788999999999 9999999984322  2135


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++|++|+||||+||++++++.+||+|||++....
T Consensus        74 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~  151 (287)
T cd07840          74 SIYMVFEYMDH-DLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYT  151 (287)
T ss_pred             cEEEEeccccc-cHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence            67799999986 99999876 33579999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC---CCC---
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD---ELP---  232 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~---~~~---  232 (366)
                      ..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.......   ..+   
T Consensus       152 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         152 KRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             CCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence            33211 1222357889999998765 457889999999999999999999998766544444333311100   000   


Q ss_pred             --------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          233 --------------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       233 --------------------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                                          .+...++.++.+++.+||..+|++||++++++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                                0011138889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=311.50  Aligned_cols=254  Identities=28%  Similarity=0.423  Sum_probs=202.9

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      |...+.||+|+||.||+|+...+++    .+++|.....   ......+.+|+.+++++. ||||+++++.+.    +..
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~----~~~   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGE----IVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVIH----TER   71 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCc----EEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhhh----cCC
Confidence            6788999999999999999987655    6788877653   233456788999999998 999999998432    235


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++ +|.+++.+. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus        72 ~~~~v~e~~~~-~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          72 KLYLVFEYCDM-DLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             ceEEEecCcCc-CHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccC
Confidence            67799999985 999999873 2469999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh------------
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG------------  226 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~------------  226 (366)
                      ....  ......++..|+|||.+.+. .++.++|||||||++|+|++|++||...........+....            
T Consensus       150 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07829         150 IPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT  227 (282)
T ss_pred             CCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhc
Confidence            3221  12223467889999998776 78999999999999999999999998765444433332211            


Q ss_pred             ----cCCCCCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          227 ----VGDELPNI--------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       227 ----~~~~~~~~--------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                          .....+..        ...++.++.++|.+||..||++||+++++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                00111111        11247789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-41  Score=308.21  Aligned_cols=240  Identities=16%  Similarity=0.243  Sum_probs=192.4

Q ss_pred             CeeeecCCeeEEEEEECCCC------CCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            7 DVIGHGSFGSVNLAKASKVS------SEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~------~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +.||+|+||.||+|.+..++      ......+++|...........+.+|+.+++.++ ||||+++++.+..     ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS-HKHLVKLYGVCVR-----DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCC-CcchhheeeEEec-----CC
Confidence            57999999999999998765      334456788876654333677889999999998 9999999985432     23


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-------ceEEEecC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-------EAKIADFG  153 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-------~vkl~DFG  153 (366)
                      .++||||+++|+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            46999999999999999873 33689999999999999999999999999999999999999887       79999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCCc--CCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNEN--EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      ++.....      .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||......+......   ....
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~  224 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHR  224 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCC
Confidence            9987532      1123577889999999877  78899999999999999999 688887664333222221   1111


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                         .+.....++.+++.+||..+|++||++.++++
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         225 ---LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ---CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence               12223478999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1e-41  Score=321.55  Aligned_cols=257  Identities=19%  Similarity=0.284  Sum_probs=194.1

Q ss_pred             Ceeeec--CCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            7 DVIGHG--SFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         7 ~~lG~G--~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      ..||+|  +||+||+|++..+++    .+++|.......   ....+.+|+.+++.++ ||||+++++.+   .. +..+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~---~~-~~~~   74 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGT----LVTVRITDLENCTEEHLKALQNEVVLSHFFR-HPNIMTSWTVF---TT-GSWL   74 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCc----EEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEeeeE---ec-CCce
Confidence            456666  999999999987765    788887764322   2356788999988888 99999999843   22 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+.+++|.+++.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++||+.+......
T Consensus        75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~  154 (328)
T cd08226          75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN  154 (328)
T ss_pred             EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence            79999999999999998754446899999999999999999999999999999999999999999999999865433221


Q ss_pred             CCCcc-----cccccCCCCCCCccccCCc--CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc-------
Q 017746          162 GERSQ-----SFECRGTPLYMSPESVNEN--EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV-------  227 (366)
Q Consensus       162 ~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~-------  227 (366)
                      .....     .....++..|+|||++.+.  .++.++|||||||++|+|++|++||.................       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            11110     1112356779999999764  478899999999999999999999976543322211111000       


Q ss_pred             -----------------------------------CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          228 -----------------------------------GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       228 -----------------------------------~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                                         .......+..++.++.+||.+||..||++|||++++++||||...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                               000001122356789999999999999999999999999999543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-41  Score=320.49  Aligned_cols=256  Identities=24%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+++|.......   ....+.+|+.++++++ ||||+++++.+....  .
T Consensus        18 ~y~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~~   92 (345)
T cd07877          18 RYQNLSPVGSGAYGSVCAAFDTKTGL----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE   92 (345)
T ss_pred             ceEEEEEeeecCCeEEEEEEEcCCCe----EEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeeccccc
Confidence            68899999999999999999876654    788887764221   2356778999999998 999999998543211  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....++++++++ +++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        93 ~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          93 EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence            223466888887 6799988854   369999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc--------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV--------  227 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~--------  227 (366)
                      ....     ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+.+...        
T Consensus       169 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T cd07877         169 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  243 (345)
T ss_pred             cccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            6532     1223468999999999866 5688899999999999999999999976554333322221110        


Q ss_pred             -------------CCCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          228 -------------GDELP-----NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       228 -------------~~~~~-----~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                   ....+     ......++++.+||.+||..||.+||++.++++||||..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~  305 (345)
T cd07877         244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  305 (345)
T ss_pred             hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence                         00000     011235788999999999999999999999999999964

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.6e-42  Score=319.28  Aligned_cols=260  Identities=23%  Similarity=0.303  Sum_probs=194.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      .|.+++.+|.|++  ||.++...+++    .+|+|.....   ......+.+|+.++++++ ||||+++++.+   .. .
T Consensus         3 ~~~i~~~~~~~~~--v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~---~~-~   71 (314)
T cd08216           3 LTLIGKCFEDLMI--VHLAKHKPTNT----LVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSF---IV-D   71 (314)
T ss_pred             hhhhhHhhcCCce--EEEEEecCCCC----EEEEEEEeccccchhHHHHHHHHHHHHHhcC-Ccchhhhhhee---ec-C
Confidence            3455555555555  55555554444    7888876542   234567899999999998 99999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..++++|||+++|+|.+++.+..+..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+...
T Consensus        72 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          72 SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             CeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceee
Confidence            44679999999999999998755566999999999999999999999999999999999999999999999999998755


Q ss_pred             CCCCCC-----cccccccCCCCCCCccccCC--cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc----
Q 017746          159 SCDGER-----SQSFECRGTPLYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----  227 (366)
Q Consensus       159 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~----  227 (366)
                      ......     .......++..|+|||++..  ..++.++|||||||++|+|++|+.||.................    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (314)
T cd08216         152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLL  231 (314)
T ss_pred             ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccc
Confidence            322211     11123357888999999876  4588999999999999999999999986543322111110000    


Q ss_pred             -CCCCC------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          228 -GDELP------------------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       228 -~~~~~------------------------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                       ....+                        .....++.++.+|+.+||..||++|||++++++||||...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence             00000                        0111245678899999999999999999999999999643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4e-41  Score=315.45  Aligned_cols=249  Identities=30%  Similarity=0.459  Sum_probs=198.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      |...+.||+|+||+||+|++..++.    .+++|.......    ....+.+|+++++.++ |||++++++.+.    +.
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~----~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~----~~   93 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNE----VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYL----KE   93 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCc----EEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEE----eC
Confidence            4456789999999999999876654    677887654211    2245788999999998 999999998432    23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ...++||||+.+ +|.+++.. ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        94 ~~~~lv~e~~~~-~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633          94 HTAWLVMEYCLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             CEEEEEEecCCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            456799999965 88888865 3457999999999999999999999999999999999999999999999999998653


Q ss_pred             CCCCCCcccccccCCCCCCCccccC---CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVN---ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ..      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...........+..   ........
T Consensus       172 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~  242 (313)
T cd06633         172 SP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NDSPTLQS  242 (313)
T ss_pred             CC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---cCCCCCCc
Confidence            21      12346899999999984   46688899999999999999999999977654333333222   11212223


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..++..+++|+.+||+.+|++||++.++++||||..
T Consensus       243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~  278 (313)
T cd06633         243 NEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR  278 (313)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            356788999999999999999999999999999954

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-41  Score=305.20  Aligned_cols=244  Identities=24%  Similarity=0.359  Sum_probs=195.9

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      +.||+|+||.||+|.+.. ++    .+++|.......  ....+.+|+.+++++. ||||+++++.+    ......++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~----~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~----~~~~~~~~v   70 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NT----EVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLIGVC----VQKQPIYIV   70 (251)
T ss_pred             CccccCCCceEEEEEEeC-CC----cEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeEEEEEEE----ecCCCeEEE
Confidence            479999999999999865 43    678887665322  3457889999999998 99999998832    233456799


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||+++++|.+++.+ ....+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.........
T Consensus        71 ~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          71 MELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             EEcCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence            999999999999976 3456899999999999999999999999999999999999999999999999999865322111


Q ss_pred             cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHH
Q 017746          165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK  243 (366)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  243 (366)
                      .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+..   . .....+..++.++.
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~  225 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES---G-YRMPAPQLCPEEIY  225 (251)
T ss_pred             eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc---C-CCCCCCccCCHHHH
Confidence            11112234667999999998899999999999999999999 8999977655443333322   1 12234566889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHc
Q 017746          244 DFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       244 ~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +++.+||..+|++||++.++++
T Consensus       226 ~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         226 RLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-41  Score=309.85  Aligned_cols=242  Identities=16%  Similarity=0.216  Sum_probs=187.7

Q ss_pred             CeeeecCCeeEEEEEECCCC--------CCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            7 DVIGHGSFGSVNLAKASKVS--------SEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~--------~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +.||+|+||.||+|+.....        .....++++|....... ....+..|..++..++ ||||+++++.+.    .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~----~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS-HKHIVLLYGVCV----R   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEe----c
Confidence            47899999999999854321        12345688887654322 3346777889999998 999999998432    2


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc-------eEEE
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE-------AKIA  150 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~-------vkl~  150 (366)
                      ....++||||+++|+|..++.+ ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.       +|++
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            3345699999999999999876 3457999999999999999999999999999999999999987664       8999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccC-CcCCCCccchhhhHHHHHHHH-hCCCCCCCCCcchHHHHHHHhhcC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVN-ENEYEAPCDIWALGCAVVEMA-SGKPAWNHKQDSNVFSLLIRIGVG  228 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~eml-tg~~pf~~~~~~~~~~~~~~~~~~  228 (366)
                      |||++......      ....|+..|+|||++. +..++.++|||||||++|+|+ .|..||......+.. ......  
T Consensus       155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~--  225 (262)
T cd05077         155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ--  225 (262)
T ss_pred             CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC--
Confidence            99998764211      1335888999999886 567899999999999999998 589998765433322 111111  


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       229 ~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                        . ......+.++.+|+.+||..||++||++.+|+++
T Consensus       226 --~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 --C-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             --c-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence              1 1223356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-43  Score=304.42  Aligned_cols=263  Identities=26%  Similarity=0.391  Sum_probs=211.1

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe-
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE-   78 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~-   78 (366)
                      |....++|+|.||+||+|+.+.+++    +|++|+....   ..--....+|+.+|..|+ |+|++.+++.+.++.... 
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~k----kvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGK----KVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTN   93 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccc----hhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCcc
Confidence            6778899999999999999988776    5677765542   223356788999999999 999999998776655443 


Q ss_pred             ---eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           79 ---RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        79 ---~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                         ..+|+||.+|+. +|+-++.. ...+++..+++.++.+++.||.|+|.+.|+|||+||+|+||+.+|.+||+|||++
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence               347899999998 99999965 4467999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC--CcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC----
Q 017746          156 KKSSCDGE--RSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG----  228 (366)
Q Consensus       156 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~----  228 (366)
                      +.+.....  .......+-|.+|.+||.+.+ .+|+++.|||..|||+.||.||.+-+.+.+...+...|...--.    
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            87643222  122223456999999998866 57999999999999999999999999998877766665542100    


Q ss_pred             -------------CCCCCCCC-------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          229 -------------DELPNIPG-------------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       229 -------------~~~~~~~~-------------~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                   .+.+.++.             .-++++.||+.++|..||.+|++++++++|.||..+
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence                         00011111             124578899999999999999999999999999654

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.5e-41  Score=308.69  Aligned_cols=251  Identities=23%  Similarity=0.374  Sum_probs=190.7

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      +.||+|+||.||++.......  ...+++|......  .....+.+|+.+++.++ ||||+++++.+.    ....+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~----~~~~~~lv   73 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTG--VARVVVKELKANASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCV----EAIPYLLV   73 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCC--cceEEEEEecCCCChHHHHHHHHHHHHHhccC-CcchhheEEEec----CCCccEEE
Confidence            469999999999998654332  3345666655422  23457888999999998 999999998432    23456799


Q ss_pred             eecCCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           85 LEYASRGSLADRVKKQN--NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      |||+++|+|.+++.+..  ...+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||++.......
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch
Confidence            99999999999997632  2346777889999999999999999999999999999999999999999999986432211


Q ss_pred             CCcccccccCCCCCCCccccCC-------cCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhh-cCCCCCC
Q 017746          163 ERSQSFECRGTPLYMSPESVNE-------NEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIG-VGDELPN  233 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~  233 (366)
                      .........|+..|+|||++..       ..++.++|||||||++|||++ |..||......+....+.+.. .....|.
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ  233 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence            1112223468899999998753       245779999999999999997 577887665554444433322 2223345


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++..+++.+.+++..|| .+|++||++++|++
T Consensus       234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            55568899999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.7e-41  Score=312.47  Aligned_cols=255  Identities=24%  Similarity=0.316  Sum_probs=200.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||.||+|.+.... ......+++|.......  ....+.+|+.++.++. ||||+++++.+   .. .
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~---~~-~   80 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-HPNIVKLLGVC---AV-G   80 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC-CCchheEEEEE---cC-C
Confidence            5888999999999999999875310 11234788888764322  2356888999999998 99999999832   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN--------------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQN  138 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N  138 (366)
                      ..++++|||+++|+|.+++....                    ...+++..+..++.||+.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            34679999999999999997521                    1237888999999999999999999999999999999


Q ss_pred             EEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcch
Q 017746          139 VLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSN  217 (366)
Q Consensus       139 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~  217 (366)
                      |+++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876532222111222345678999999999999999999999999999997 889997665544


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          218 VFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ....+..    ...+..+..++.++.+|+.+||..+|++||++.|+++
T Consensus       241 ~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         241 VIYYVRD----GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHhc----CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            3333222    2223345668899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.1e-41  Score=310.62  Aligned_cols=260  Identities=22%  Similarity=0.347  Sum_probs=204.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc--hhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS--SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|...+.||+|+||.||+|+....+......+++|........  ...+.+|+++++.+. ||||+++++.+  ...+..
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~--~~~~~~   81 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVKYKGVC--EKPGGR   81 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC-CCChheEEeee--ecCCCC
Confidence            4677899999999999999986554445668999988764443  567899999999998 99999998843  223345


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..+++|||+++++|.+++.+. ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            677999999999999999763 3469999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcc-cccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcch-----------HHHHHHHhhc
Q 017746          160 CDGERSQ-SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN-----------VFSLLIRIGV  227 (366)
Q Consensus       160 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~-----------~~~~~~~~~~  227 (366)
                      ....... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.......           ....+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            2222111 112235667999999988899999999999999999999999986543221           0111111111


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .......+..++.++.+++.+||..+|++||++.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11222234567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.6e-41  Score=315.55  Aligned_cols=249  Identities=29%  Similarity=0.448  Sum_probs=200.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      |...+.||+|+||.||+|++..++.    .+++|.......    ....+.+|+++++.++ |||++++++.+.    ..
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~----~~   97 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNE----VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYL----RE   97 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCc----EEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe----eC
Confidence            6778899999999999999877654    778887654211    2346788999999998 999999998432    23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ...++||||+.| +|.+.+.. ....+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        98 ~~~~lv~e~~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635          98 HTAWLVMEYCLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             CeEEEEEeCCCC-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            456699999975 88888765 3457999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCCCCcccccccCCCCCCCccccC---CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVN---ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ...      ....|++.|+|||.+.   ...++.++|||||||++|+|++|+.||...........+...   ...+...
T Consensus       176 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~  246 (317)
T cd06635         176 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---ESPTLQS  246 (317)
T ss_pred             CCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc---cCCCCCC
Confidence            321      2335899999999873   456889999999999999999999999776444333333322   2222233


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ...+..+.+++.+||..+|.+||++.++++|+|+..
T Consensus       247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            457889999999999999999999999999999844

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.1e-41  Score=317.51  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=200.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||.|+||.||+|.++.+++    .+++|.+..   .......+.+|+.+++.++ ||||+++++.+   ....
T Consensus        11 ~y~~~~~ig~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~---~~~~   82 (328)
T cd07856          11 RYVDLQPVGMGAFGLVCSARDQLTGQ----NVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIF---ISPL   82 (328)
T ss_pred             ceEEEEeecccCCeEEEEEEECCCCC----EEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeE---ecCC
Confidence            68899999999999999999887765    677776543   1234467788999999998 99999999843   2223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..++++|||+ +++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            3466999998 4599988854   46899999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh-----------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG-----------  226 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~-----------  226 (366)
                      ...     .....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...........+.+..           
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            321     123467899999998765 578999999999999999999999997664432222221110           


Q ss_pred             -------------cCCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          227 -------------VGDELP--NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       227 -------------~~~~~~--~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                                   .....|  .....++.++.++|.+||..+|++||++++++.||||....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence                         000000  11124678999999999999999999999999999995543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.6e-41  Score=303.54  Aligned_cols=243  Identities=21%  Similarity=0.349  Sum_probs=194.6

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ++||+|+||.||+|.... +    ..+++|.......  ....+.+|+.++++++ ||||+++++.+    .....+++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~-~----~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~~~~lv   70 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKD-K----TPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKLIGVC----TQRQPIYIV   70 (250)
T ss_pred             CccCCCCCceEEEEEecC-C----cEEEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEE----ecCCccEEE
Confidence            479999999999998643 3    3678887665322  2345788999999998 99999999843    223456799


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ 
T Consensus        71 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  148 (250)
T cd05085          71 MELVPGGDFLSFLRK-KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-  148 (250)
T ss_pred             EECCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-
Confidence            999999999999976 345689999999999999999999999999999999999999999999999999876432211 


Q ss_pred             cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHH
Q 017746          165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK  243 (366)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  243 (366)
                      .......++..|+|||++.+..++.++||||||+++|+|++ |..||...........+..    ......+..++.++.
T Consensus       149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  224 (250)
T cd05085         149 SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK----GYRMSCPQKCPDDVY  224 (250)
T ss_pred             ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc----CCCCCCCCCCCHHHH
Confidence            11112235677999999998899999999999999999998 9999987655443333322    222344566889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHc
Q 017746          244 DFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       244 ~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +++.+||..+|++||++.++++
T Consensus       225 ~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         225 KVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             HHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.2e-41  Score=313.40  Aligned_cols=254  Identities=26%  Similarity=0.455  Sum_probs=199.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|.+..+++    .+++|......  .....+..|+.++..+..||||+++++.+.    ...
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~----~~~   87 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGH----VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI----TDS   87 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCe----EEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee----cCC
Confidence            57889999999999999999987654    67888776432  233455667777777777999999998432    234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++|||+.+ +|.+++... .+.+++..+..++.||+.||.|||+ +||+||||||+||++++++.+||+|||++...
T Consensus        88 ~~~~v~e~~~~-~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          88 DVFICMELMST-CLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             eEEEEeeccCc-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            56799999865 888887663 4579999999999999999999997 59999999999999999999999999999765


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcC----CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENE----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      .....   .....|++.|+|||.+.+..    ++.++||||||+++|+|++|+.||......  .+.+.+.... ..+..
T Consensus       166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~-~~~~~  239 (296)
T cd06618         166 VDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQE-EPPSL  239 (296)
T ss_pred             cCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcC-CCCCC
Confidence            32221   12235888999999987654    888999999999999999999999754322  2222222211 12222


Q ss_pred             C--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          235 P--GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       235 ~--~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +  ..++.++.+|+.+||..||++||++++++.||||..
T Consensus       240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence            2  246889999999999999999999999999999954

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-41  Score=320.09  Aligned_cols=256  Identities=26%  Similarity=0.364  Sum_probs=199.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|...+.||+|+||.||+|++..++.    .+++|.....   ......+.+|+.+++.+. ||||+++++.+....  .
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGE----KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCc----EEEEEEecCccccccchhHHHHHHHHHHhcC-CCCccchhheecccccCC
Confidence            58889999999999999999877654    7788876542   223345788999999998 999999998543221  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||+.. +|..++.    ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus        91 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          91 EFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             CCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            12345799999975 7877652    358999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc--------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV--------  227 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~--------  227 (366)
                      .....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....        
T Consensus       166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         166 HADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            65321     123468899999999876 4688999999999999999999999987654333332222100        


Q ss_pred             ----------CCCCCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          228 ----------GDELPNI--------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       228 ----------~~~~~~~--------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                ....+..        ....+.++.+||.+||+.||++||++++++.||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                      0000111        12367889999999999999999999999999999654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.8e-41  Score=307.88  Aligned_cols=256  Identities=21%  Similarity=0.347  Sum_probs=202.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC-CCCceeEEeeecCCCCc--hhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADCPPS--SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~avK~~~~~~~~--~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|...+.||+|+||.||+|+.+.+.. .....+++|........  ...+.+|+++++++. ||||+++++.+    ...
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~----~~~   80 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNVVRLLGLC----REA   80 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC-CcceeeeEEEE----CCC
Confidence            57889999999999999999865532 22346888877653332  457899999999998 99999999832    233


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEe
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN-------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D  151 (366)
                      ...++||||+++|+|.+++.....       ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            456799999999999999976431       1589999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          152 FGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       152 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      ||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....+......+.   ....
T Consensus       161 ~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~---~~~~  236 (275)
T cd05046         161 LSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ---AGKL  236 (275)
T ss_pred             cccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH---cCCc
Confidence            99987543211 111223356778999999988889999999999999999999 889997655443333222   1111


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ....+..++..+.+++.+||..+|++||++.+++.+
T Consensus       237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            122345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=305.00  Aligned_cols=243  Identities=31%  Similarity=0.525  Sum_probs=201.8

Q ss_pred             eeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            9 IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         9 lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ||+|+||.||++.+..+++    .+++|.......    ....+.+|+.++++++ ||||+++++.    ...+..++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~----~~~~~~~~~v   71 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGK----LYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYA----FQTEEKLYLV   71 (250)
T ss_pred             CCCCCceEEEEEEECCCCc----EEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHH----eecCCeeEEE
Confidence            6999999999999876554    677777654222    3457888999999999 9999999873    2345567799


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      |||+++++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......  
T Consensus        72 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--  147 (250)
T cd05123          72 LEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--  147 (250)
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--
Confidence            9999999999999763  368999999999999999999999999999999999999999999999999998764321  


Q ss_pred             cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHH
Q 017746          165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD  244 (366)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  244 (366)
                      .......|+..|+|||.+.+...+.++|+||||+++|+|++|..||...........+..     ....++..++..+.+
T Consensus       148 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~  222 (250)
T cd05123         148 SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-----DPLRFPEFLSPEARD  222 (250)
T ss_pred             CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----CCCCCCCCCCHHHHH
Confidence            122344689999999999988899999999999999999999999976654333232222     224566677999999


Q ss_pred             HHHHhcccCCCCCCCH---HHHHcCCCc
Q 017746          245 FLIKCFLKDPKRRWTA---EMLLNHPFV  269 (366)
Q Consensus       245 ll~~cL~~dp~~R~t~---~~ll~hp~~  269 (366)
                      ++.+||..||++||++   +++++||||
T Consensus       223 ~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         223 LISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            9999999999999999   999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.9e-42  Score=311.51  Aligned_cols=242  Identities=17%  Similarity=0.256  Sum_probs=190.0

Q ss_pred             CeeeecCCeeEEEEEECCCCC---CCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSS---EFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~---~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.||+|+||.||+|.+...+.   ....++++|...... .....+..|..+++.+. ||||+++++.+.   . ....+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~---~-~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS-HKHLVLNYGVCV---C-GDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCC-CCChhheeeEEE---e-CCCcE
Confidence            479999999999999865432   234567778765432 23356788999999998 999999998543   2 23456


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc--------eEEEecCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE--------AKIADFGL  154 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~--------vkl~DFG~  154 (366)
                      +||||+++|+|.+++.+ .+..+++..+..++.||+.||+|||++||+||||||+|||++.++.        +|++|||+
T Consensus        76 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          76 MVQEYVKFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             EEEecCCCCcHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999999999976 3346899999999999999999999999999999999999987764        69999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhC-CCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASG-KPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg-~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      +.....      .....|++.|+|||++.+ ..++.++|||||||++|+|++| .+||........... ..     ..+
T Consensus       155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~-----~~~  222 (258)
T cd05078         155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YE-----DRH  222 (258)
T ss_pred             ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HH-----ccc
Confidence            865421      112358899999999976 4588999999999999999998 466655443322221 11     123


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .++...+.++.+++.+||+.||++|||+++|++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         223 QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            4555677899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-41  Score=311.47  Aligned_cols=241  Identities=15%  Similarity=0.229  Sum_probs=186.9

Q ss_pred             eeeecCCeeEEEEEECCCC--------------------CCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeE
Q 017746            8 VIGHGSFGSVNLAKASKVS--------------------SEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVR   66 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~--------------------~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~   66 (366)
                      .||+|+||.||+|....++                    ......+++|....... ....+.+|+.++++++ ||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~-h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS-HIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC-CCCeee
Confidence            6999999999999854321                    11234588887764322 2345677888999998 999999


Q ss_pred             eecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-
Q 017746           67 CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-  145 (366)
Q Consensus        67 ~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-  145 (366)
                      +++++.    .....++||||+++|+|..++.+ ..+.+++..+..++.||+.||+|||++||+||||||+|||++..+ 
T Consensus        81 ~~~~~~----~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          81 VHGVCV----RGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEE----eCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence            998432    23345699999999999999976 345789999999999999999999999999999999999997654 


Q ss_pred             ------ceEEEecCCccccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHH-hCCCCCCCCCcch
Q 017746          146 ------EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMA-SGKPAWNHKQDSN  217 (366)
Q Consensus       146 ------~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~eml-tg~~pf~~~~~~~  217 (366)
                            .+|++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  3899999987653211      12357888999998865 56899999999999999995 7999998765544


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          218 VFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ....+..      ....+...+.++.++|.+||..+|++||++.+++++
T Consensus       230 ~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 KERFYEK------KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHHHh------ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            3222211      112334456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.7e-41  Score=312.23  Aligned_cols=256  Identities=20%  Similarity=0.215  Sum_probs=185.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCch--h----------hHHHHHHHHHHcCCCCceeEeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSS--V----------TLKNEKEALDQIGICPQIVRCFG   69 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~--~----------~~~~E~~~l~~l~~~p~Iv~~~g   69 (366)
                      +|.+.+.||+|+||.||+|.+..++. ....+++|.........  +          ....+...+..+. |++|+++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~   90 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHC-INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPKYYG   90 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcc-cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCcEEE
Confidence            69999999999999999999876522 12245555433221110  0          0111222334445 899999998


Q ss_pred             ceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEE
Q 017746           70 DDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKI  149 (366)
Q Consensus        70 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl  149 (366)
                      ++........+.+++||++.. ++.+.+...  ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            544322333345688998865 787777652  34688999999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCCCCC-----cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHH---
Q 017746          150 ADFGLAKKSSCDGER-----SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSL---  221 (366)
Q Consensus       150 ~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~---  221 (366)
                      +|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|++||.+.........   
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            999999876422211     111234699999999999999999999999999999999999999987633222111   


Q ss_pred             ---HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          222 ---LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       222 ---~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                         +.+.... . .. ...++.++.+++..|+..+|++||++++|++
T Consensus       248 ~~~~~~~~~~-~-~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEG-K-IK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHhhhh-h-hc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence               1111111 1 11 2346789999999999999999999999975

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.2e-41  Score=305.40  Aligned_cols=242  Identities=21%  Similarity=0.373  Sum_probs=197.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||++...  +    ..+++|..... .....+.+|+.+++.++ ||||+++++...   .+  ..
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~--~----~~~~iK~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~---~~--~~   73 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEYT--G----QKVAVKNIKCD-VTAQAFLEETAVMTKLH-HKNLVRLLGVIL---HN--GL   73 (254)
T ss_pred             HceeeeeeccCCCCceEecccC--C----CceEEEeecCc-chHHHHHHHHHHHHhCC-CCCcCeEEEEEc---CC--Cc
Confidence            5889999999999999998642  2    35788876542 34457889999999998 999999998432   22  24


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      +++|||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence            69999999999999998754456899999999999999999999999999999999999999999999999998764321


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                           ......+..|+|||.+.+..++.++|+|||||++|+|++ |++||......+....+.+   . ..+..+..+++
T Consensus       154 -----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~-~~~~~~~~~~~  224 (254)
T cd05083         154 -----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK---G-YRMEPPEGCPA  224 (254)
T ss_pred             -----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC---C-CCCCCCCcCCH
Confidence                 112234668999999998999999999999999999997 9999987655444333322   1 22233556889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+.+++.+||..+|++||++++++.
T Consensus       225 ~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         225 DVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-41  Score=321.49  Aligned_cols=257  Identities=23%  Similarity=0.362  Sum_probs=202.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+.+.||+|+||.||+|++..+++    .+++|.+...   ......+.+|+.+++++. ||||+++++.+..-.  .
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGR----KVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCc----EEEEEecccccchhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcccccc
Confidence            58889999999999999999987654    6788876542   123355678999999997 999999987432211  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++|+||+ +++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence            123467999999 5699999864   469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD------  229 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~------  229 (366)
                      .....     .....+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.......      
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            75322     223468999999999865 367889999999999999999999998765544333332211000      


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          230 --------------------ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       230 --------------------~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                          ........++.++.+||.+||..||++|||+.+|++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence                                0001112358899999999999999999999999999999643

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.8e-41  Score=306.55  Aligned_cols=258  Identities=22%  Similarity=0.357  Sum_probs=201.3

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe-
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE-   78 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~-   78 (366)
                      |.+.++||+|+||.||+|.....+ .....+++|......   .....+.+|+.++++++ ||||+++++......... 
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSED-GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccC-CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence            678899999999999999876532 234588999876532   23446788999999998 999999998543322211 


Q ss_pred             -eEEEEEeecCCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecC
Q 017746           79 -RFYNLLLEYASRGSLADRVKKQN----NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        79 -~~~~lv~E~~~~g~L~~~l~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                       ...++++||+.+|+|.+++....    ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccc
Confidence             23468999999999998875321    1247899999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      +++...............+++.|++||.+....++.++|||||||++|+|++ |++||......+....+...    ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~----~~~  234 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG----NRL  234 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC----CcC
Confidence            9987643222222223346778999999999999999999999999999999 89999766544433333221    122


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+...+..+.+++.+||..+|++||++.+++.+
T Consensus       235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3345678999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7.7e-41  Score=301.08  Aligned_cols=229  Identities=23%  Similarity=0.318  Sum_probs=185.1

Q ss_pred             cCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEeecCCCC
Q 017746           12 GSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRG   91 (366)
Q Consensus        12 G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g   91 (366)
                      |.||.||+++++.+++    .+++|.+....    ...+|...+.... ||||+++++.+.    ....++++|||++||
T Consensus         4 g~~~~v~~~~~~~~~~----~~~~K~i~~~~----~~~~~~~~~~~~~-~~~i~~~~~~~~----~~~~~~lv~e~~~~~   70 (237)
T cd05576           4 GVIDKVLLVMDTRTQQ----TFILKGLRKSS----EYSRERLTIIPHC-VPNMVCLHKYIV----SEDSVFLVLQHAEGG   70 (237)
T ss_pred             cccceEEEEEEccCCc----EEEEEeecchh----hhhhHHHHHHhcC-CCceeehhhhee----cCCeEEEEEecCCCC
Confidence            8999999999988765    67888766421    2344555555555 899999998432    234567999999999


Q ss_pred             CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCccccccc
Q 017746           92 SLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR  171 (366)
Q Consensus        92 ~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~  171 (366)
                      +|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+......     .....
T Consensus        71 ~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~  143 (237)
T cd05576          71 KLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEA  143 (237)
T ss_pred             CHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCC
Confidence            999999764  35999999999999999999999999999999999999999999999999988665321     12235


Q ss_pred             CCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcc
Q 017746          172 GTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFL  251 (366)
Q Consensus       172 gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~  251 (366)
                      ++..|+|||.+.+..++.++|+||+||++|+|++|+.||......     +    .......++..++++++++|.+||+
T Consensus       144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~----~~~~~~~~~~~~~~~~~~li~~~l~  214 (237)
T cd05576         144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I----NTHTTLNIPEWVSEEARSLLQQLLQ  214 (237)
T ss_pred             cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c----ccccccCCcccCCHHHHHHHHHHcc
Confidence            678899999998888999999999999999999999988643211     0    0011123456689999999999999


Q ss_pred             cCCCCCCCH-----HHHHcCCCc
Q 017746          252 KDPKRRWTA-----EMLLNHPFV  269 (366)
Q Consensus       252 ~dp~~R~t~-----~~ll~hp~~  269 (366)
                      .||++||++     +++++||||
T Consensus       215 ~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         215 FNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCHHHhcCCCccchHHHHcCCCC
Confidence            999999986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9.7e-41  Score=312.10  Aligned_cols=251  Identities=29%  Similarity=0.456  Sum_probs=199.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      .|...+.||+|+||.||+|+++.++.    .+++|.....    ......+.+|+++++.++ |||++++++.+.    .
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~   86 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYL----R   86 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCc----EEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEE----c
Confidence            36677899999999999999877654    6777776532    112345678999999998 999999998432    2


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+. |+|.+++.. .+..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus        87 ~~~~~lv~e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          87 EHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             CCeeEEEEEccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCccccee
Confidence            345679999997 588888765 345689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCcccccccCCCCCCCccccC---CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVN---ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ....      ....|++.|+|||.+.   ...++.++|||||||++|+|++|..||......+....+..   .......
T Consensus       165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~  235 (308)
T cd06634         165 MAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NESPALQ  235 (308)
T ss_pred             ecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh---cCCCCcC
Confidence            5321      2345899999999874   35688899999999999999999999976543333222222   1122222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ...++..+.+||.+||..+|++||+++++++|||+...
T Consensus       236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            34578899999999999999999999999999999553

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.2e-41  Score=344.23  Aligned_cols=144  Identities=27%  Similarity=0.421  Sum_probs=123.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+|+|.+....    .....+..|+.++..++ ||||+++++.+    ..
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~----~~   75 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSK----LYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSL----QS   75 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCc----EEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEE----EE
Confidence            68999999999999999999987665    67777765421    12356888999999998 99999998632    22


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ...+++||||+.|++|.+++...  +.+++..++.|+.||+.||+|||.+|||||||||+||||+.++.+||+|||+++
T Consensus        76 ~~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          76 ANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            34677999999999999999753  468999999999999999999999999999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.3e-40  Score=300.04  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=198.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-----------CchhhHHHHHHHHHHcCCCCceeEeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-----------PSSVTLKNEKEALDQIGICPQIVRCFGD   70 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-----------~~~~~~~~E~~~l~~l~~~p~Iv~~~g~   70 (366)
                      .|.+.+.||+|+||.||+|.+..++.   ..+++|......           .....+.+|+.++.+...||||+++++.
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~---~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~   77 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQ---NLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKT   77 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCC---ceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEee
Confidence            48899999999999999999876322   367777654311           1234466788888765459999999984


Q ss_pred             eeeccCCeeEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCce
Q 017746           71 DYSFEKGERFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEA  147 (366)
Q Consensus        71 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~v  147 (366)
                      +    ......+++|||++|++|.+++...  ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+
T Consensus        78 ~----~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          78 F----LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             E----ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcE
Confidence            3    2344667999999999999988542  34569999999999999999999996 789999999999999999999


Q ss_pred             EEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc
Q 017746          148 KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV  227 (366)
Q Consensus       148 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~  227 (366)
                      ||+|||++.......   ......|+..|+|||.+.+..++.++|+||||+++|+|++|++||...........+..   
T Consensus       154 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---  227 (269)
T cd08528         154 TITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE---  227 (269)
T ss_pred             EEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh---
Confidence            999999998764332   22344689999999999998899999999999999999999999976544333332222   


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ....+......+.++.+++.+||..||++||++.++..+
T Consensus       228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         228 AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            112222233578999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=308.23  Aligned_cols=259  Identities=21%  Similarity=0.349  Sum_probs=204.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--------chhhHHHHHHHHHHcCCCCceeEeecceee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--------SSVTLKNEKEALDQIGICPQIVRCFGDDYS   73 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~   73 (366)
                      +|..+.+||+|||+.||+|.+...++    .+|+|+-.....        -.....+|..+-+.|. ||.||++|++   
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqR----YvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDy---  535 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQR----YVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDY---  535 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhh----eeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeee---
Confidence            58889999999999999999887655    577776544222        2234567899999998 9999999984   


Q ss_pred             ccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCCCcEEecc---CCceE
Q 017746           74 FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK--GFVHCDIKLQNVLVFD---NDEAK  148 (366)
Q Consensus        74 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NILl~~---~~~vk  148 (366)
                      |.-+...+|-|+|||+|.+|.-|++.+  ..++|++++.|+.||+.||.||.+.  .|||.||||.||||..   .|.+|
T Consensus       536 fslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  536 FSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             eeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence            344455677999999999999999764  4699999999999999999999998  4999999999999953   47899


Q ss_pred             EEecCCccccCCCCCCc-----ccccccCCCCCCCccccCC----cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHH
Q 017746          149 IADFGLAKKSSCDGERS-----QSFECRGTPLYMSPESVNE----NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF  219 (366)
Q Consensus       149 l~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~  219 (366)
                      |.|||+++.+..+....     .+....||.+|++||++.-    ...+.++||||+|||+|.++.|+.||.........
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI  693 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI  693 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence            99999999886543321     1334679999999998743    34788999999999999999999999766432211


Q ss_pred             ---HHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          220 ---SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       220 ---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                         ..|.+... -.+|.- ..++.++++||++||+..-++|..+.+|..||||...
T Consensus       694 LqeNTIlkAtE-VqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  694 LQENTILKATE-VQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             Hhhhchhccee-ccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence               11111111 122322 3479999999999999999999999999999999653

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.6e-40  Score=329.33  Aligned_cols=265  Identities=21%  Similarity=0.242  Sum_probs=176.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceee-c-cCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYS-F-EKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~-~-~~~~~   79 (366)
                      +|.+++.||+|+||.||+|++..+.......+++|++....  ......+.. ++... +.++..+...+.. . .....
T Consensus       133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e~-l~~~~-~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNER-VRRAC-PNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHHH-HHhhc-hhhHHHHHHhhhcccccccCC
Confidence            58899999999999999999987744445689999865421  111111111 12211 2222222211110 1 13344


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe
Q 017746           80 FYNLLLEYASRGSLADRVKKQNN------------------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV  141 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl  141 (366)
                      .+++||||+.+++|.+++.....                  ....+..+..++.||+.||+|||++||+||||||+|||+
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl  288 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF  288 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence            56799999999999999975210                  012244577899999999999999999999999999999


Q ss_pred             cc-CCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCc----------------------CCCCccchhhhHH
Q 017746          142 FD-NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN----------------------EYEAPCDIWALGC  198 (366)
Q Consensus       142 ~~-~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslG~  198 (366)
                      +. ++.+||+|||+|+.+..... .......||+.|||||.+...                      .++.++|||||||
T Consensus       289 ~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        289 SEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             eCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            86 57999999999986543222 222345799999999965322                      2345679999999


Q ss_pred             HHHHHHhCCCCCCCCCcchHHHHHHHhhc----------CCCCC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 017746          199 AVVEMASGKPAWNHKQDSNVFSLLIRIGV----------GDELP------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEM  262 (366)
Q Consensus       199 il~emltg~~pf~~~~~~~~~~~~~~~~~----------~~~~~------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~  262 (366)
                      +||||+++..|+..... .....+...+.          ....+      .+.+.....+++||.+||++||++|||+.+
T Consensus       368 iL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e  446 (566)
T PLN03225        368 IFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA  446 (566)
T ss_pred             HHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence            99999998777543211 11111111100          00000      011112345679999999999999999999


Q ss_pred             HHcCCCcccC
Q 017746          263 LLNHPFVCAD  272 (366)
Q Consensus       263 ll~hp~~~~~  272 (366)
                      +++||||...
T Consensus       447 ~L~Hpff~~~  456 (566)
T PLN03225        447 ALAHPYFDRE  456 (566)
T ss_pred             HhCCcCcCCC
Confidence            9999999654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-42  Score=296.63  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=202.8

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      +..||.|+||+|++..++.+++    .+|||.+....  ....++..|.....+-..+||||++||..  |.++  ..++
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~----~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~--F~EG--dcWi  140 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGK----LMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL--FSEG--DCWI  140 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCc----EEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh--hcCC--ceee
Confidence            4579999999999999998765    89999886532  34567788888888888899999999954  4443  3558


Q ss_pred             EeecCCCCCHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           84 LLEYASRGSLADRVKK---QNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .||+|.- +|..+.+.   .....++|..+..|+...+.||.||-+. +||||||||+||||+..|.+||||||++-.+.
T Consensus       141 CMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  141 CMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             eHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            9999975 77655432   2234699999999999999999999975 89999999999999999999999999987653


Q ss_pred             CCCCCcccccccCCCCCCCccccCC--cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC--
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--  235 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  235 (366)
                         .......-+|-..|||||.+..  ..|+-++|+||||++|||+.||+.|+..-..  .++++.....+..+-...  
T Consensus       220 ---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~  294 (361)
T KOG1006|consen  220 ---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDK  294 (361)
T ss_pred             ---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCcc
Confidence               1122223468889999999854  4589999999999999999999999987643  566666655544322111  


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCCC
Q 017746          236 --GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ  274 (366)
Q Consensus       236 --~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~~  274 (366)
                        -..+..+..||..||.+|-+.||...+|+++||+.....
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence              126889999999999999999999999999999965443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.5e-40  Score=334.67  Aligned_cols=256  Identities=24%  Similarity=0.374  Sum_probs=196.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeec-----
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSF-----   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~-----   74 (366)
                      +|..++.||+||||.||+++.+-+|+    .||+|++...  ......+.+|+..|.+|+ |||||++|..+..-     
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr----~YAIKKIpl~~s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGR----EYAIKKIPLKASDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccch----hhhhhhccCchHHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCccc
Confidence            57788999999999999999998887    5677777654  345567899999999999 99999976522100     


Q ss_pred             -------------------------------------------------c---------C--------------------
Q 017746           75 -------------------------------------------------E---------K--------------------   76 (366)
Q Consensus        75 -------------------------------------------------~---------~--------------------   76 (366)
                                                                       .         .                    
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0         0                    


Q ss_pred             ------------------------Ce--------eEEEEEeecCCCCCHHHHHHHhCCCCC-CHHHHHHHHHHHHHHHHH
Q 017746           77 ------------------------GE--------RFYNLLLEYASRGSLADRVKKQNNGRL-QESDVKRYTRSMLKGLRH  123 (366)
Q Consensus        77 ------------------------~~--------~~~~lv~E~~~~g~L~~~l~~~~~~~l-~~~~~~~~~~qi~~aL~~  123 (366)
                                              .+        ..+|+=||||+.-+|.+++.+.  ... ....++.+++||+.||.|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--~~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--HFNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--ccchhhHHHHHHHHHHHHHHHH
Confidence                                    01        4578999999997777777652  222 478899999999999999


Q ss_pred             HHHCCcEecCCCCCcEEeccCCceEEEecCCccccC----------C------CCCCcccccccCCCCCCCccccCCcC-
Q 017746          124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS----------C------DGERSQSFECRGTPLYMSPESVNENE-  186 (366)
Q Consensus       124 LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~----------~------~~~~~~~~~~~gt~~y~aPE~~~~~~-  186 (366)
                      +|++|||||||||.||+|++++.|||+|||+|....          .      ..........+||..|+|||++.+.. 
T Consensus       713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            999999999999999999999999999999998611          0      01111234568999999999997655 


Q ss_pred             --CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHH
Q 017746          187 --YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI---PGDLSEQGKDFLIKCFLKDPKRRWTAE  261 (366)
Q Consensus       187 --~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~ll~~cL~~dp~~R~t~~  261 (366)
                        |+.++|+||||++++||+.   ||...  .+....+.... ...+|..   ...--+.-..+|.+||.+||++|||+.
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~  866 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT  866 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence              9999999999999999996   56433  33333343332 2222322   222334456799999999999999999


Q ss_pred             HHHcCCCcc
Q 017746          262 MLLNHPFVC  270 (366)
Q Consensus       262 ~ll~hp~~~  270 (366)
                      |||++.|+.
T Consensus       867 eLL~s~llp  875 (1351)
T KOG1035|consen  867 ELLNSELLP  875 (1351)
T ss_pred             HHhhccCCC
Confidence            999999996

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-41  Score=303.25  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=201.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC-Cc----eeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-PQ----IVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~-p~----Iv~~~g~~~~~~~   76 (366)
                      +|.++.++|+|.||.|-...+..++    ..+|+|++..-..-.+...-|+++|.++..+ |+    +|.+.+    +.+
T Consensus        90 Ry~i~~~lGeGtFGkV~ec~D~~~~----~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~----wFd  161 (415)
T KOG0671|consen   90 RYEIVDLLGEGTFGKVVECWDRETK----EHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD----WFD  161 (415)
T ss_pred             ceehhhhhcCCcccceEEEeecCCC----ceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh----hhh
Confidence            6899999999999999999988763    4778887765445566778899999999543 22    455544    334


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-------------
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-------------  143 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-------------  143 (366)
                      -.+..++|+|.+ |-++++++.+..-.+++-..++.+++||+.+++|||+++++|-||||+|||+.+             
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence            456678999998 559999998865567999999999999999999999999999999999999942             


Q ss_pred             -------CCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc
Q 017746          144 -------NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS  216 (366)
Q Consensus       144 -------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~  216 (366)
                             +-.|||+|||.|.....   .  ....+.|..|.|||++.+-+++.++||||+||||+|+++|...|+...+.
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e---~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHE---H--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ceeccCCCcceEEEecCCcceecc---C--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                   22489999999987532   1  24557899999999999999999999999999999999999999988877


Q ss_pred             hHHHHHHHhhcCCCCCC------------------CC-------------------------CCCCHHHHHHHHHhcccC
Q 017746          217 NVFSLLIRIGVGDELPN------------------IP-------------------------GDLSEQGKDFLIKCFLKD  253 (366)
Q Consensus       217 ~~~~~~~~~~~~~~~~~------------------~~-------------------------~~~s~~~~~ll~~cL~~d  253 (366)
                      +.+..+.++..  .+|.                  ++                         +..-.++.|||++||..|
T Consensus       316 EHLaMMerIlG--p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  316 EHLAMMERILG--PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             HHHHHHHHhhC--CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            75544443321  1110                  00                         001235678999999999


Q ss_pred             CCCCCCHHHHHcCCCccc
Q 017746          254 PKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       254 p~~R~t~~~ll~hp~~~~  271 (366)
                      |.+|+|+.|++.||||..
T Consensus       394 P~~RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  394 PARRITLREALSHPFFAR  411 (415)
T ss_pred             ccccccHHHHhcCHHhhc
Confidence            999999999999999943

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=320.54  Aligned_cols=247  Identities=26%  Similarity=0.416  Sum_probs=189.5

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC--CCCchhhHHHHHHHHHHcCCCCceeEeecceeecc--CCe
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--KGE   78 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~--~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~~~   78 (366)
                      |...+.||+||||.||+++++.+|+    .||||.+..  .....+..-+|+++|++|+ |||||++++....-.  .-.
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~----~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGR----LVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             eeehhhhcCCccceeeeeccccccc----chhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccc
Confidence            7778999999999999999998876    777777665  2345677889999999999 999999998443221  002


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec--cCC--ceEEEecC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN-NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF--DND--EAKIADFG  153 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~--~~~--~vkl~DFG  153 (366)
                      ..-.+|||||.||||+.++++-. ...|+|.++..++..+..||.|||++|||||||||.||++.  ++|  .-||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            23359999999999999997521 23499999999999999999999999999999999999984  334  47999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcch----HHHHH-HHhh-
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN----VFSLL-IRIG-  226 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~----~~~~~-~~~~-  226 (366)
                      .|+.+..+.   .....+||+.|++||++-. +.|+..+|.|||||++|+++||..||.......    ....+ .+.. 
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS  246 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence            999986443   4456689999999999984 789999999999999999999999996543321    11111 1110 


Q ss_pred             ---------------cCCCCCCCCCCCCHH----HHHHHHHhcccCCCCCC
Q 017746          227 ---------------VGDELPNIPGDLSEQ----GKDFLIKCFLKDPKRRW  258 (366)
Q Consensus       227 ---------------~~~~~~~~~~~~s~~----~~~ll~~cL~~dp~~R~  258 (366)
                                     ....+|. |..++..    +...+..+|..+|++|+
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ceeEeeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                           1111222 3334433    34567889999999999

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.2e-40  Score=280.46  Aligned_cols=254  Identities=21%  Similarity=0.325  Sum_probs=202.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.+|+|-|++||.|....++.    ++++|.+..  -....+.+|+.+|+.|.++|||+++++...+  ......
T Consensus        39 dYeivrk~GRGKYSEVFeg~~~~~~e----K~ViKiLKP--VkkkKIkREikIL~nL~gg~NIi~L~DiV~D--p~Sktp  110 (338)
T KOG0668|consen   39 DYEIVRKVGRGKYSEVFEGINITNNE----KCVIKILKP--VKKKKIKREIKILQNLRGGPNIIKLLDIVKD--PESKTP  110 (338)
T ss_pred             hHHHHHHHcCccHhhHhcccccCCCc----eEEEeeech--HHHHHHHHHHHHHHhccCCCCeeehhhhhcC--ccccCc
Confidence            58899999999999999999877654    778887765  5567899999999999999999999985433  333456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC-CceEEEecCCccccCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN-DEAKIADFGLAKKSSC  160 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~  160 (366)
                      .|++||+.+-+...+..     .++...++.++.||+.||.|||++||+|||+||.|++|+.. ..++|+|+|+|.+...
T Consensus       111 aLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            69999999977776654     38899999999999999999999999999999999999864 5799999999998865


Q ss_pred             CCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCc-chHHHHHHHhh-----------c
Q 017746          161 DGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQD-SNVFSLLIRIG-----------V  227 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~-~~~~~~~~~~~-----------~  227 (366)
                      +.+...   .+.+..|--||.+.. +.|+..-|+|||||++..|+..+-||....+ .++.-.+.+..           +
T Consensus       186 ~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  186 GKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             Cceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            544443   347888999998855 5699999999999999999999999865433 22222222210           0


Q ss_pred             CC-CCCCC--------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          228 GD-ELPNI--------------------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       228 ~~-~~~~~--------------------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .. ..|.+                    ..-.++++.||+.++|..|..+|+|+.|.+.||||..
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence            00 01110                    0125789999999999999999999999999999954

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=312.68  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=209.4

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC--CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~--~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      ..++||.|-||.||.|......+.....||||.+..  .....+.+..|..+|+.+. ||||++++|.+.     +.-.+
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfd-HphIikLIGv~~-----e~P~W  466 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCV-----EQPMW  466 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCC-Ccchhheeeeee-----cccee
Confidence            467899999999999998766555567799999886  3345678999999999999 999999999432     22355


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG  162 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~  162 (366)
                      +|||+++-|.|..|++. +...++......|..||+.||.|||+.++|||||..+|||+....-|||+|||+++.+..+.
T Consensus       467 ivmEL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             EEEecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            99999999999999987 45579999999999999999999999999999999999999999999999999999886543


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      -...+ ...-..-|||||.+.-..++.++|||-|||++||++. |..||.+..+.+..   .++..+.. +..|+.+++.
T Consensus       546 yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---~~iEnGeR-lP~P~nCPp~  620 (974)
T KOG4257|consen  546 YYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---GHIENGER-LPCPPNCPPA  620 (974)
T ss_pred             hhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---EEecCCCC-CCCCCCCChH
Confidence            33322 2233566999999999999999999999999999986 99999988776543   33334444 4567889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +..++.+||..+|.+||++.+|..
T Consensus       621 LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  621 LYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHHHhccCcccCCcHHHHHH
Confidence            999999999999999999987754

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=314.03  Aligned_cols=252  Identities=24%  Similarity=0.376  Sum_probs=209.6

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .++++||+|.||.|++|.++..+. ..+.||||.+.....  ....+.+|+.+|.+|. |||++++||...+     .-.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psg-k~V~VAVKclr~d~l~~~mddflrEas~M~~L~-H~hliRLyGvVl~-----qp~  185 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSG-KHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-----QPA  185 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCC-cEEeEEEEeccCCccchhHHHHHHHHHHHHhcc-CcceeEEeeeecc-----chh
Confidence            467899999999999999987543 456899998876332  5678999999999999 9999999995332     335


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      .||||+++.|+|.+.|.+.....|....+..|+.||+.||.||..+++|||||...|+||-....|||+|||+.+.+..+
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            69999999999999998855567889999999999999999999999999999999999999999999999999988644


Q ss_pred             CCCcccc-cccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          162 GERSQSF-ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       162 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      ....... ...-...|+|||.++...++.++|||++||++|||++ |..||.+.....++   .++..+..++ -|..++
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL---~~iD~~erLp-RPk~cs  341 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL---KNIDAGERLP-RPKYCS  341 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH---HhccccccCC-CCCCCh
Confidence            4332211 1123456999999999999999999999999999998 89999988665444   4444333443 367899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +++.+++..||..+|.+|||+..|...
T Consensus       342 edIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  342 EDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             HHHHHHHHHhccCCccccccHHHHHHh
Confidence            999999999999999999999998643

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-40  Score=308.96  Aligned_cols=253  Identities=20%  Similarity=0.271  Sum_probs=207.7

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .+++.||+|-||.|.++....     +.++|||++.....  ....+.+|+++|.+|+ ||||++++|++..    +.-+
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg-----~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~----DePi  610 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEG-----PLKVAVKILRPDATKNARNDFLKEIKILSRLK-HPNIVELLGVCVQ----DDPL  610 (807)
T ss_pred             ehhhhhcCcccceeEEEEecC-----ceEEEEeecCcccchhHHHHHHHHHHHHhccC-CCCeeEEEeeeec----CCch
Confidence            568899999999999998654     57999999876333  4568999999999997 9999999995432    3457


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++.++.-..+.-+...+|+.||+.||+||.+.++|||||.+.|+|+++++++||+|||+++.+..+
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence            79999999999999998853323455666779999999999999999999999999999999999999999999977655


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHH--hCCCCCCCCCcchHHHHHHHhh---cCCCCCCCCC
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMA--SGKPAWNHKQDSNVFSLLIRIG---VGDELPNIPG  236 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~eml--tg~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~  236 (366)
                      .....-...+-...|||||.+..++++.++|+|+||+++||++  +...||...+++...+......   -....+..|.
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence            5444433445678899999999999999999999999999976  5789998877766554433321   2222334566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      -++..+.+++.+||..+-++||++++|..|
T Consensus       771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  771 ACPQGLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             cCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence            789999999999999999999999998654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=319.96  Aligned_cols=252  Identities=23%  Similarity=0.392  Sum_probs=212.2

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC--CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~--~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .+-++||.|.||+|+.|+.+..++.. ..||+|.++.  .+.....+..|..||-++. ||||+++.|    +....+-.
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre-~~VAIKTLK~GytekqrrdFL~EAsIMGQFd-HPNIIrLEG----VVTks~Pv  705 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKRE-ITVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIRLEG----VVTKSKPV  705 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcc-eeEEEeeeccCccHHHHhhhhhhhhhcccCC-CCcEEEEEE----EEecCcee
Confidence            35679999999999999998877643 5789998876  3456778999999999999 999999999    34445567


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++|.|||++|+|..+|++ +.|.|...++.-+++.|+.|++||-++|+|||||.++|||++.+-.+|++|||+++.+.++
T Consensus       706 MIiTEyMENGsLDsFLR~-~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             EEEhhhhhCCcHHHHHhh-cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            799999999999999998 4567999999999999999999999999999999999999999999999999999987655


Q ss_pred             CCCccc-ccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          162 GERSQS-FECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       162 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      .+...+ ....-...|.|||.+....++.++||||+|++|||.++ |..||-+..+.+....   +..+..+|. |-+++
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka---Ie~gyRLPp-PmDCP  860 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA---IEQGYRLPP-PMDCP  860 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH---HHhccCCCC-CCCCc
Confidence            422211 11112367999999999999999999999999999765 9999988776655444   444555554 45799


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+.+|+..||++|-.+||++.||+++
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999999999873

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=304.67  Aligned_cols=268  Identities=21%  Similarity=0.219  Sum_probs=184.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC------------CCCCceeEEeeecCCCCc---------------hhhHHHHHHH
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS------------SEFPSLMAVKSCADCPPS---------------SVTLKNEKEA   54 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~------------~~~~~~~avK~~~~~~~~---------------~~~~~~E~~~   54 (366)
                      +|.+.++||+|+||+||+|.....+            ......|+||.+......               ......|+.+
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            5889999999999999999763322            122346899987642211               1223346777


Q ss_pred             HHHcCCCC----ceeEeecceeecc----CCeeEEEEEeecCCCCCHHHHHHHhCC----------------------CC
Q 017746           55 LDQIGICP----QIVRCFGDDYSFE----KGERFYNLLLEYASRGSLADRVKKQNN----------------------GR  104 (366)
Q Consensus        55 l~~l~~~p----~Iv~~~g~~~~~~----~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------------~~  104 (366)
                      +.++++++    +++++++++....    ..+...+|||||+++|+|.+++....+                      ..
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            77776332    2355666432211    112345699999999999999864211                      12


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCC
Q 017746          105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE  184 (366)
Q Consensus       105 l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  184 (366)
                      +++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........ .......+|+.|+|||.+..
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~  384 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVM  384 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcC
Confidence            45678899999999999999999999999999999999999999999999976533221 11122345899999998854


Q ss_pred             cC--------------------CC--CccchhhhHHHHHHHHhCCC-CCCCCCcchHH--------HHHHHh-hcCCCCC
Q 017746          185 NE--------------------YE--APCDIWALGCAVVEMASGKP-AWNHKQDSNVF--------SLLIRI-GVGDELP  232 (366)
Q Consensus       185 ~~--------------------~~--~~~DiwslG~il~emltg~~-pf~~~~~~~~~--------~~~~~~-~~~~~~~  232 (366)
                      ..                    |+  .+.||||+||++|+|++|.. ||.........        ...... ...... 
T Consensus       385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~-  463 (507)
T PLN03224        385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF-  463 (507)
T ss_pred             CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc-
Confidence            32                    22  24799999999999999986 77532111100        000000 011111 


Q ss_pred             CCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHHcCCCccc
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDP---KRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp---~~R~t~~~ll~hp~~~~  271 (366)
                      ...+..++.++||+.+||.++|   .+|+|++|+|+||||..
T Consensus       464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            1234578999999999999876   68999999999999943

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=315.57  Aligned_cols=249  Identities=25%  Similarity=0.342  Sum_probs=196.7

Q ss_pred             cccCeeeecCCee-EEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            4 LRGDVIGHGSFGS-VNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         4 ~~~~~lG~G~fg~-Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      .--+.+|.|+.|+ ||+|...+      ..||||.+..  .-....++|+..|+.-..|||||++|+    .+.+..+.|
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye~------R~VAVKrll~--e~~~~A~rEi~lL~eSD~H~NviRyyc----~E~d~qF~Y  579 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYEG------REVAVKRLLE--EFFDFAQREIQLLQESDEHPNVIRYYC----SEQDRQFLY  579 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeCC------ceehHHHHhh--HhHHHHHHHHHHHHhccCCCceEEEEe----eccCCceEE
Confidence            3446789999985 99998754      3789998765  455578999999999999999999987    677888999


Q ss_pred             EEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc---C--CceEEEecCCc
Q 017746           83 LLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD---N--DEAKIADFGLA  155 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~--~~vkl~DFG~a  155 (366)
                      +..|.|.- +|.++++..  ...............|++.||++||+.+||||||||.||||+.   +  ..++|+|||++
T Consensus       580 IalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls  658 (903)
T KOG1027|consen  580 IALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS  658 (903)
T ss_pred             EEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence            99999987 999999873  1111122456789999999999999999999999999999976   3  36999999999


Q ss_pred             cccCCCCCCc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhC-CCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          156 KKSSCDGERS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASG-KPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       156 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      +.+..+...- ...+..||-+|+|||++.....+.++||+||||++|+.++| ..||...-.  ....|....+.  +-.
T Consensus       659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~--L~~  734 (903)
T KOG1027|consen  659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYT--LVH  734 (903)
T ss_pred             cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccc--eee
Confidence            9986554322 24456899999999999999989999999999999999996 899965422  12222222111  111


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +......++.|||.+||.++|..||++.++|+||||
T Consensus       735 L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF  770 (903)
T KOG1027|consen  735 LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF  770 (903)
T ss_pred             eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence            111112289999999999999999999999999999

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=299.25  Aligned_cols=246  Identities=22%  Similarity=0.349  Sum_probs=208.8

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ...+||-|.||.||.|.++.    +...||||.+....-....+..|..+|+.++ |||+|+++|+|    .-+.-+|||
T Consensus       271 MkhKLGGGQYGeVYeGvWKk----yslTvAVKtLKEDtMeveEFLkEAAvMKeik-HpNLVqLLGVC----T~EpPFYIi  341 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKK----YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVC----THEPPFYII  341 (1157)
T ss_pred             eeeccCCCcccceeeeeeec----cceeeehhhhhhcchhHHHHHHHHHHHHhhc-CccHHHHhhhh----ccCCCeEEE
Confidence            34689999999999999975    5578999998876667889999999999999 99999999954    334456799


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      .|||..|+|.+||++.....++.-.+..++.||.+|++||..+++|||||.+.|+|+.++..|||+|||+++.+..+ ..
T Consensus       342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TY  420 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TY  420 (1157)
T ss_pred             EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC-ce
Confidence            99999999999999866666888888999999999999999999999999999999999999999999999987533 22


Q ss_pred             cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHH
Q 017746          165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK  243 (366)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  243 (366)
                      .......-..-|.|||.+....++.++|||+|||+|||+.| |-.||.+.+..+.+..+.+ ++..   .-|..|++.+.
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-gyRM---~~PeGCPpkVY  496 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-GYRM---DGPEGCPPKVY  496 (1157)
T ss_pred             ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-cccc---cCCCCCCHHHH
Confidence            22222223456999999999999999999999999999997 8899999877776665543 3433   33567999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHH
Q 017746          244 DFLIKCFLKDPKRRWTAEMLL  264 (366)
Q Consensus       244 ~ll~~cL~~dp~~R~t~~~ll  264 (366)
                      +|+..||+.+|.+||++.|+-
T Consensus       497 eLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  497 ELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHHhcCCcccCccHHHHH
Confidence            999999999999999998874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-36  Score=271.69  Aligned_cols=239  Identities=34%  Similarity=0.566  Sum_probs=194.1

Q ss_pred             CCeeEEEEEECCCCCCCCceeEEeeecCCCCc--hhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEeecCCC
Q 017746           13 SFGSVNLAKASKVSSEFPSLMAVKSCADCPPS--SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASR   90 (366)
Q Consensus        13 ~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~   90 (366)
                      +||.||+|+...++.    .+++|........  ...+.+|++.+++++ |+||+++++.+..    ....+++|||+++
T Consensus         1 ~~g~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~----~~~~~l~~e~~~~   71 (244)
T smart00220        1 SFGKVYLARDKKTGK----LVAIKVIKKEKIKKKRERILREISILKKLK-HPNIVRLYDVFED----EDKLYLVMEYCDG   71 (244)
T ss_pred             CceEEEEEEECCCCc----EEEEEEecccccccHHHHHHHHHHHHHhCC-CCcHHHHHhheee----CCEEEEEEeCCCC
Confidence            689999999987554    7788887653222  578899999999996 9999999984322    2456799999999


Q ss_pred             CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccc
Q 017746           91 GSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC  170 (366)
Q Consensus        91 g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~  170 (366)
                      ++|.+++....  .+++..+..++.+++.+|.|||+.|++|+||+|.||+++.++.++|+|||.+.......   .....
T Consensus        72 ~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~  146 (244)
T smart00220       72 GDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTF  146 (244)
T ss_pred             CCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccc
Confidence            99999997632  38999999999999999999999999999999999999999999999999998764332   22334


Q ss_pred             cCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcch-HHHHHHHhhcCCCCCCCCC--CCCHHHHHHHH
Q 017746          171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN-VFSLLIRIGVGDELPNIPG--DLSEQGKDFLI  247 (366)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~s~~~~~ll~  247 (366)
                      .|+..|++||.+.+..++.++||||||+++++|++|..||....... ....+..    ...+....  .++.++.+++.
T Consensus       147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~  222 (244)
T smart00220      147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK----PKPPFPPPEWKISPEAKDLIR  222 (244)
T ss_pred             cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc----cCCCCccccccCCHHHHHHHH
Confidence            68899999999998889999999999999999999999997732222 2222211    11111111  17889999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCc
Q 017746          248 KCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       248 ~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +||..+|++||++.++++||||
T Consensus       223 ~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      223 KLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHccCCchhccCHHHHhhCCCC
Confidence            9999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.9e-38  Score=296.48  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=205.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCC-----CCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~-----~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+....|+|-|++|..|.+...+.    .||||++...+.-...-..|+++|++|+.     --|.++++-+++.   
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~----~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h---  505 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQ----EVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH---  505 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCC----eeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh---
Confidence            57888889999999999999877654    89999988755555666889999999973     2578888775433   


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC-CceEEEecCC
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQN-NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN-DEAKIADFGL  154 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~  154 (366)
                       .+.+|||+|-+.- +|.++|++.. +-.|....++.|+.||..||..|-..||+|+||||+|||+++. ..+||||||.
T Consensus       506 -knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  506 -KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             -cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence             5678899999965 9999999852 2238889999999999999999999999999999999999876 4699999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC--
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP--  232 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~--  232 (366)
                      |.....+...    .+.-+..|.|||++.+.+|+++.|+||+||+||||.||+..|.+.++..++...+...-  .+|  
T Consensus       584 A~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG--k~p~K  657 (752)
T KOG0670|consen  584 ASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG--KFPNK  657 (752)
T ss_pred             cccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC--CCcHH
Confidence            9887543322    22346789999999999999999999999999999999999999988877665553210  000  


Q ss_pred             ----------------------------------------------------CCCCC---CCHHHHHHHHHhcccCCCCC
Q 017746          233 ----------------------------------------------------NIPGD---LSEQGKDFLIKCFLKDPKRR  257 (366)
Q Consensus       233 ----------------------------------------------------~~~~~---~s~~~~~ll~~cL~~dp~~R  257 (366)
                                                                          .+|+.   +-.++++||.+||..||++|
T Consensus       658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence                                                                01111   12357889999999999999


Q ss_pred             CCHHHHHcCCCcc
Q 017746          258 WTAEMLLNHPFVC  270 (366)
Q Consensus       258 ~t~~~ll~hp~~~  270 (366)
                      .|+.++|.||||.
T Consensus       738 it~nqAL~HpFi~  750 (752)
T KOG0670|consen  738 ITVNQALKHPFIT  750 (752)
T ss_pred             CCHHHHhcCCccc
Confidence            9999999999994

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-38  Score=276.91  Aligned_cols=255  Identities=23%  Similarity=0.344  Sum_probs=200.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcCCCCceeEeecceeec--cC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSF--EK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~--~~   76 (366)
                      +|..++.+|.|+- .|.-|.+.-.++    .+++|+...   ......+..+|...+..+. |+||++++..+.-.  .+
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~----~v~ikk~~~pf~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGR----PVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccC----ceehhhhcCccccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHH
Confidence            6788888999998 777777665554    566666543   2234567889999999999 99999999854321  12


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      .-...|+|||||.. +|...+.-    .++-+++..++.|+++|++|||+.||+||||||+||++..++.+||.|||+|+
T Consensus        92 ~~~e~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   92 EFQEVYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHhHHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence            22345699999976 99999963    48899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh----------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG----------  226 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~----------  226 (366)
                      ....+   .....++.|..|.|||++.+-.|...+||||+||++.||++|...|.+...-+++..+....          
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            75422   23345678999999999999999999999999999999999999998776555444443210          


Q ss_pred             -------------------cCCCCCC--CC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          227 -------------------VGDELPN--IP------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       227 -------------------~~~~~~~--~~------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                                         +...+|.  ++      ..-+..+++++.+||..||++|.+++++|+|||++
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                               0000010  00      01245688999999999999999999999999996

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=301.77  Aligned_cols=252  Identities=23%  Similarity=0.372  Sum_probs=214.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      .+.+++||+|+||+||+|...-.++.+..+|++|.+....  .....+..|.-+|.++. |||+++++|.+...     .
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s-----~  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD-HPNLLRLLGVCMLS-----T  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccc-----h
Confidence            3567899999999999999987788899999999887643  34778999999999999 99999999955431     2


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      ..||++|+++|+|.++++. +...+.......|..||++||.|||++++|||||-.+|||+.+-..+||.|||+|+.+..
T Consensus       772 ~qlvtq~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHHHhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            5699999999999999998 456899999999999999999999999999999999999999999999999999998866


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      +..........-.+-|||=|.+....|+.++||||+||++||++| |..|+++....++...+.+ +  .++ ..|..++
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-g--eRL-sqPpiCt  926 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-G--ERL-SQPPICT  926 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-c--ccC-CCCCCcc
Confidence            555443333334566999999999999999999999999999998 9999998877665554443 2  223 3456689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      -++.-++.+||..|+..||+++++..
T Consensus       927 iDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHHHHH
Confidence            99999999999999999999998864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=282.19  Aligned_cols=136  Identities=24%  Similarity=0.284  Sum_probs=117.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC-------CceeEeecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-------PQIVRCFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~-------p~Iv~~~g~~~~~   74 (366)
                      +|.+.++||.|.|++||+|.+....+    .||+|+......-.+....|+++|+++..+       .+||++++++...
T Consensus        79 RY~v~rKLGWGHFSTVWLawDtq~~r----~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   79 RYHVQRKLGWGHFSTVWLAWDTQNKR----YVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             eEEEEEeccccccceeEEEeeccCCe----EEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            68999999999999999999988765    677777665545566788899999999643       4799999988777


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEec
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVF  142 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~  142 (366)
                      ..++..++||+|++ |.+|..+|.+..-..++...++.|++||+.||.|||+. ||||.||||+|||+.
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            77888999999999 56999999886555699999999999999999999986 999999999999994

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=305.36  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=203.4

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCC---CCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSE---FPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~---~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      .+.+.||+|+||.|++|........   ....+|||......  .....+..|+++|..++.||||+.++|.+..    .
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~----~  374 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ----D  374 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----C
Confidence            3566999999999999986544332   25689999877532  3467899999999999999999999995433    4


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC-------C-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN-------N-------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN  144 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~-------~-------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~  144 (366)
                      ...++|+|||..|+|.+++++.+       .       ..++..+...++.||+.|++||++.++|||||-++|||++++
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~  454 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN  454 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence            45669999999999999998743       0       138899999999999999999999999999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCcccccccC--CCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCC-cchHHH
Q 017746          145 DEAKIADFGLAKKSSCDGERSQSFECRG--TPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQ-DSNVFS  220 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~-~~~~~~  220 (366)
                      ..+||+|||+|+.......... ....|  ...|||||.+....|+.++||||+||+|||+++ |..||.+.. ..+..+
T Consensus       455 ~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~  533 (609)
T KOG0200|consen  455 KVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE  533 (609)
T ss_pred             CEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence            9999999999996432222111 11123  234999999999999999999999999999998 899998754 333333


Q ss_pred             HHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          221 LLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                       ..+.+..   ...|..++.++.++++.||..+|++||++.++..
T Consensus       534 -~l~~G~r---~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  534 -FLKEGNR---MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             -HHhcCCC---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence             3333333   3446778999999999999999999999999875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.8e-36  Score=322.40  Aligned_cols=240  Identities=20%  Similarity=0.287  Sum_probs=181.8

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +...+.||+|+||.||+|+++.++.    .+|+|......   .....|++++++++ |||||+++|++.    ....++
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~---~~~~~~~~~l~~l~-HpnIv~~~~~~~----~~~~~~  759 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGM----QFVVKEINDVN---SIPSSEIADMGKLQ-HPNIVKLIGLCR----SEKGAY  759 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCc----EEEEEEccCCc---cccHHHHHHHhhCC-CCCcceEEEEEE----cCCCCE
Confidence            4456789999999999999876654    78888876422   22345789999998 999999999542    233467


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH---SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      +||||+++|+|.++++.     +++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.+....
T Consensus       760 lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        760 LIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             EEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            99999999999999953     789999999999999999999   6699999999999999998888876 66654332


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc--hHHHHHHHhhcC-----CCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS--NVFSLLIRIGVG-----DELP  232 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~--~~~~~~~~~~~~-----~~~~  232 (366)
                      .      .....||+.|||||++.+..|+.++|||||||++|||++|+.||+.....  ............     ...|
T Consensus       834 ~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  907 (968)
T PLN00113        834 T------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP  907 (968)
T ss_pred             c------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence            1      12236899999999999999999999999999999999999999543211  111111100000     0001


Q ss_pred             CCCC------CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          233 NIPG------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       233 ~~~~------~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .+..      ....++.+++.+||..||++||++.|+++.
T Consensus       908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            1111      122356788999999999999999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=252.33  Aligned_cols=207  Identities=25%  Similarity=0.396  Sum_probs=165.8

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      -+..||+|++|.|=+.++..++.    .+|+|.+...-  ....++.+|+.+..+...||.+|++||..  +.+  ...+
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~----imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~--~re--gdvw  121 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGT----IMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL--FRE--GDVW  121 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCe----EEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh--hcc--ccEE
Confidence            35689999999999999988764    89999887633  34566778888888888899999999943  223  3356


Q ss_pred             EEeecCCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           83 LLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      +.||.|.. +|..+-++  ..++.++|..+-+|+..++.||.|||++ .+||||+||+||||+.+|+||+||||++-.+.
T Consensus       122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            89999976 88776653  2577899999999999999999999997 89999999999999999999999999998763


Q ss_pred             CCCCCcccccccCCCCCCCccccCC----cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHh
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE----NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI  225 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~  225 (366)
                      .   .....-..|-..|||||.+..    ..|+-++||||||+++.||.+++.||+....  .++++...
T Consensus       201 d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t--pF~qLkqv  265 (282)
T KOG0984|consen  201 D---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT--PFQQLKQV  265 (282)
T ss_pred             h---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC--HHHHHHHH
Confidence            2   111122357788999998844    4799999999999999999999999976532  34444443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=278.63  Aligned_cols=245  Identities=28%  Similarity=0.395  Sum_probs=190.2

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcC-CCCceeEeecceeeccCCeeEEEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG-ICPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~-~~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      ..++||+|.||.||+|...+      ..||||++..  .....+++|.++..... .|+||+++++....-......|.|
T Consensus       214 l~eli~~Grfg~V~KaqL~~------~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLDN------RLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             hHHHhhcCccceeehhhccC------ceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            56789999999999999865      4899999987  56677888888877764 399999999854433333456889


Q ss_pred             EeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEecCCCCCcEEeccCCceEEEecCC
Q 017746           84 LLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK---------GFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---------givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                      |+||.+.|+|.+||+.   ..+++....+++..|++||+|||+.         .|+|||||..||||..++++-|+|||+
T Consensus       286 Vt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9999999999999976   3699999999999999999999983         499999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCCcC-CC-----CccchhhhHHHHHHHHhCC------------CCCC-----
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNENE-YE-----APCDIWALGCAVVEMASGK------------PAWN-----  211 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~il~emltg~------------~pf~-----  211 (366)
                      |..+..+.........+||..|||||++.+.- +.     .+.||||+|.+||||++..            +||.     
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            99887555544445568999999999986531 22     3689999999999999743            2332     


Q ss_pred             CCCcchHHHHHHHhhcCCCCCCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHH
Q 017746          212 HKQDSNVFSLLIRIGVGDELPNIPGD-----LSEQGKDFLIKCFLKDPKRRWTAEML  263 (366)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~s~~~~~ll~~cL~~dp~~R~t~~~l  263 (366)
                      ..+-++......+...   .|.+|+.     -..-+.+.+..||..||+.|.|+.=+
T Consensus       443 hPt~e~mq~~VV~kK~---RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQ---RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CCCHHHHHHHHHhhcc---CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            1122333334444333   3444432     23456788999999999999997433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=293.28  Aligned_cols=257  Identities=31%  Similarity=0.477  Sum_probs=210.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|..+..+|.|.||.||+|+++.+++    ..|+|.++... .....++.|+-+++..+ ||||+.++|....    ...
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~e----laavkvVkLep~dd~~~iqqei~~~~dc~-h~nivay~gsylr----~dk   86 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGE----LAAVKVVKLEPGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLR----RDK   86 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCc----hhhheeeeccCCccccccccceeeeecCC-CcChHHHHhhhhh----hcC
Confidence            68899999999999999999998876    44555554432 34566889999999999 9999999994322    223


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      .++.||||.||+|.+.-.  .-++++|.++....+..++||+|||++|=+|||||-.|||+++.|.+|++|||.+..+. 
T Consensus        87 lwicMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit-  163 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT-  163 (829)
T ss_pred             cEEEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh-
Confidence            459999999999998874  34789999999999999999999999999999999999999999999999999987664 


Q ss_pred             CCCCcccccccCCCCCCCcccc---CCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                       ........+.|||.|||||+.   +...|...+|||++|++..|+-.-++|-....+......+.+-++....-+-+..
T Consensus       164 -ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~k  242 (829)
T KOG0576|consen  164 -ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTK  242 (829)
T ss_pred             -hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCcc
Confidence             233334556899999999986   5678999999999999999999999998766655544444444433322233345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .++.+.+|++.||.++|++||+++-+|.|||+..
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            7889999999999999999999999999999843

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=268.62  Aligned_cols=258  Identities=24%  Similarity=0.337  Sum_probs=200.3

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeecc-CCee
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KGER   79 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~~~   79 (366)
                      ...+.||-|+||.||-+++..+++    .++.|++..-   ......+.+|+++|..++ |.|++..++.-.--. +--.
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgr----rvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGK----RVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCcc----chhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHH
Confidence            446789999999999999988876    5666665531   124567889999999999 999988766321100 0001


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+|++.|++.. +|...|-.  ...++.+.++-+..||++||+|||+.||.||||||.|.|++.|..+||||||+|+...
T Consensus       131 EiYV~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  131 ELYVLTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc
Confidence            24689999977 99988854  3579999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh------------
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG------------  226 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~------------  226 (366)
                      .+.....+ ..+-|.+|.|||++.+ ..|+.++||||.|||+.|++-.+..|....+.+..+.|....            
T Consensus       208 ~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  208 QRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            43333222 2356889999999987 469999999999999999999999998877766666554321            


Q ss_pred             ---------cCCCCCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          227 ---------VGDELPNI--------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       227 ---------~~~~~~~~--------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                               .....|..        +..-..+..+++.++|..||++|.+.++.+.|++..
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~  347 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE  347 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence                     11111211        123345678899999999999999999999999973

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=8.9e-35  Score=266.76  Aligned_cols=259  Identities=28%  Similarity=0.429  Sum_probs=196.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .|...+.||.|.|++||+|++... ......+|+|.+... +...++.+|+++|..++++.||+++.+   ++..++. .
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~-~~~~~~valk~i~~t-s~p~ri~~El~~L~~~gG~~ni~~~~~---~~rnnd~-v  110 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQ-DTKRRYVALKAIYRT-SSPSRILNELEMLYRLGGSDNIIKLNG---CFRNNDQ-V  110 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhh-ccccceEeeeecccc-cCchHHHHHHHHHHHhccchhhhcchh---hhccCCe-e
Confidence            377889999999999999998762 122358899987764 445679999999999999999999988   3444443 4


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-CCceEEEecCCccccCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-NDEAKIADFGLAKKSSC  160 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~  160 (366)
                      .+||||++..+-.++...     ++-.+++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|.|||+|.....
T Consensus       111 ~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             EEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence            599999999888888854     678999999999999999999999999999999999974 46789999999972100


Q ss_pred             C------------------------------------------CCCcccccccCCCCCCCccccCC-cCCCCccchhhhH
Q 017746          161 D------------------------------------------GERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALG  197 (366)
Q Consensus       161 ~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG  197 (366)
                      .                                          ..........||++|.|||++.. ...++++||||.|
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence            0                                          00001112459999999999855 5688899999999


Q ss_pred             HHHHHHHhCCCCCCCCCcch-HHHHHHHh-------------hc---C--CCCC--------------------------
Q 017746          198 CAVVEMASGKPAWNHKQDSN-VFSLLIRI-------------GV---G--DELP--------------------------  232 (366)
Q Consensus       198 ~il~emltg~~pf~~~~~~~-~~~~~~~~-------------~~---~--~~~~--------------------------  232 (366)
                      ||+.-+++++.||....++- ....+..+             +.   .  ...+                          
T Consensus       266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~  345 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE  345 (418)
T ss_pred             ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence            99999999999995433221 11111100             00   0  0000                          


Q ss_pred             --CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          233 --NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       233 --~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                        ...+..+..+.||+.+||+.||.+|.|++++|+||||..
T Consensus       346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence              011224567899999999999999999999999999964

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=265.30  Aligned_cols=250  Identities=26%  Similarity=0.360  Sum_probs=190.6

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHH--HcCCCCceeEeecceeeccCCeeEE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALD--QIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~--~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .+.+.||+|.||+||+|...+      ..||||++...+  .....+|.++.+  -|+ |+||+.+++....-...-..+
T Consensus       214 ~L~e~IGkGRyGEVwrG~wrG------e~VAVKiF~srd--E~SWfrEtEIYqTvmLR-HENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  214 VLQEIIGKGRFGEVWRGRWRG------EDVAVKIFSSRD--ERSWFRETEIYQTVMLR-HENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             EEEEEecCccccceeeccccC------CceEEEEecccc--hhhhhhHHHHHHHHHhc-cchhhhhhhccccCCCceEEE
Confidence            467899999999999999875      479999998744  445555555555  456 999999999766555555678


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCCCCcEEeccCCceEEEecC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK--------GFVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                      +||.+|.+.|+|+|||.+   ..++.+.+.+++..+++||+|||-.        .|.|||||..|||+.++|.+-|+|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            899999999999999976   4799999999999999999999973        39999999999999999999999999


Q ss_pred             CccccCCCC--CCcccccccCCCCCCCccccCCcC----CC--CccchhhhHHHHHHHHh----------CCCCCCCCCc
Q 017746          154 LAKKSSCDG--ERSQSFECRGTPLYMSPESVNENE----YE--APCDIWALGCAVVEMAS----------GKPAWNHKQD  215 (366)
Q Consensus       154 ~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~DiwslG~il~emlt----------g~~pf~~~~~  215 (366)
                      +|-....+.  ........+||..|||||++...-    +.  ..+||||||.++||++.          -++||.+..+
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            997654432  122344568999999999986532    22  36899999999999985          2478876544


Q ss_pred             chH-HHHHHHhhc-CCCCCCCCCCC-C----HHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          216 SNV-FSLLIRIGV-GDELPNIPGDL-S----EQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       216 ~~~-~~~~~~~~~-~~~~~~~~~~~-s----~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+. ++.+.+.-. ....|.+|... +    ..+..+++.||..||.-|.|+--+.+
T Consensus       442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            332 333443322 22334444332 1    23456889999999999999876654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-35  Score=253.32  Aligned_cols=255  Identities=22%  Similarity=0.372  Sum_probs=199.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .|.+.+.||+|.||.+-++.|+.++.    .+++|.+.........+.+|..---.|+.|.||+.-|+.  .|+..+ +|
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t----~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v--aFqt~d-~Y   97 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKT----RIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEV--AFQTSD-AY   97 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCce----EEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHH--HhhcCc-eE
Confidence            47888999999999999999988764    788998887667788899998888888889999998873  344444 77


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc--CCceEEEecCCccccC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD--NDEAKIADFGLAKKSS  159 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~~~vkl~DFG~a~~~~  159 (366)
                      .++|||++.|+|..-+..   ..+.|...+.++.|+++||+|||+.++||||||.+||||-.  .-.|||||||+.+...
T Consensus        98 vF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             EEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            899999999999999865   24889999999999999999999999999999999999943  2379999999987653


Q ss_pred             CCCCCcccccccCCCCCCCccccCC---c--CCCCccchhhhHHHHHHHHhCCCCCCCCCc--chHHHHHHHh-hcCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE---N--EYEAPCDIWALGCAVVEMASGKPAWNHKQD--SNVFSLLIRI-GVGDEL  231 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il~emltg~~pf~~~~~--~~~~~~~~~~-~~~~~~  231 (366)
                      ..   ...  .--+..|.+||++..   +  ..++.+|||.||+++|.++||++||.....  ....+.+... ......
T Consensus       175 ~t---V~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  175 TT---VKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL  249 (378)
T ss_pred             ce---ehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence            21   111  124567999997633   2  256789999999999999999999974322  2222222221 122244


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHHcCCCccc
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRR---WTAEMLLNHPFVCA  271 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R---~t~~~ll~hp~~~~  271 (366)
                      |.....+++.+..+.++-|.++|++|   +++..-....|...
T Consensus       250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            44445689999999999999999999   77777777778743

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=271.72  Aligned_cols=197  Identities=26%  Similarity=0.400  Sum_probs=167.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---------CCCchhhHHHHHHHHHHcCC--CCceeEeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---------CPPSSVTLKNEKEALDQIGI--CPQIVRCFGD   70 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---------~~~~~~~~~~E~~~l~~l~~--~p~Iv~~~g~   70 (366)
                      +|...+.||.|+||.|++|.++.+..    .|++|.+.+         .+........|+++|..|+.  |+||++++. 
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~----eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd-  636 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNY----EVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD-  636 (772)
T ss_pred             cceeeeeccccccceEEEeeecccce----EEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh-
Confidence            58889999999999999999998754    566666554         22344556789999999974  799999997 


Q ss_pred             eeeccCCeeEEEEEeecCC-CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEE
Q 017746           71 DYSFEKGERFYNLLLEYAS-RGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKI  149 (366)
Q Consensus        71 ~~~~~~~~~~~~lv~E~~~-~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl  149 (366)
                         |.+++.+|||+||-.. |-+|+++|..+  ..++|.+++.|++||+.|+++||++||||||||-+||.++.+|-+||
T Consensus       637 ---fFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  637 ---FFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             ---eeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEE
Confidence               4555667889999764 56999999864  46999999999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCCCCCcccccccCCCCCCCccccCCcCCC-CccchhhhHHHHHHHHhCCCCCCC
Q 017746          150 ADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE-APCDIWALGCAVVEMASGKPAWNH  212 (366)
Q Consensus       150 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~emltg~~pf~~  212 (366)
                      +|||.|.....    .....++||..|.|||++.+..|- .+-|||+||++||.++....||++
T Consensus       712 idfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  712 IDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99999887532    233456899999999999999986 478999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=8.5e-32  Score=234.68  Aligned_cols=211  Identities=36%  Similarity=0.572  Sum_probs=179.2

Q ss_pred             eeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEee
Q 017746            9 IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLE   86 (366)
Q Consensus         9 lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E   86 (366)
                      ||+|++|.||++....+++    .+++|.......  ....+.+|+..++.+. +++|+++++...    .....+++||
T Consensus         1 l~~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~----~~~~~~~~~e   71 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGK----KVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFE----DENHLYLVME   71 (215)
T ss_pred             CCcCCceEEEEEEecCCCc----EEEEEEeccccchhHHHHHHHHHHHHHhcC-CCCeeeEeeeee----cCCeEEEEEe
Confidence            6899999999999876443    788888776433  2467999999999998 799999998432    2245669999


Q ss_pred             cCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-CCceEEEecCCccccCCCCCCc
Q 017746           87 YASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-NDEAKIADFGLAKKSSCDGERS  165 (366)
Q Consensus        87 ~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~  165 (366)
                      ++.|++|.+++... ...+++..+..++.+++++|.+||++|++|+||+|.||+++. ++.++|+|||.+........  
T Consensus        72 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--  148 (215)
T cd00180          72 YCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--  148 (215)
T ss_pred             cCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--
Confidence            99999999999763 246899999999999999999999999999999999999998 89999999999987643221  


Q ss_pred             ccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHH
Q 017746          166 QSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD  244 (366)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  244 (366)
                      ......+...|++||.+... .++.+.|+|+||+++++|                                    ..+.+
T Consensus       149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------~~~~~  192 (215)
T cd00180         149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------PELKD  192 (215)
T ss_pred             hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------HHHHH
Confidence            12223578899999999887 888999999999999999                                    56889


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCC
Q 017746          245 FLIKCFLKDPKRRWTAEMLLNHP  267 (366)
Q Consensus       245 ll~~cL~~dp~~R~t~~~ll~hp  267 (366)
                      ++.+||..||++||+++++++|+
T Consensus       193 ~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         193 LIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHhhCCcccCcCHHHHhhCC
Confidence            99999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=2e-33  Score=293.84  Aligned_cols=184  Identities=17%  Similarity=0.197  Sum_probs=137.4

Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC--------------
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND--------------  145 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~--------------  145 (366)
                      .++++|||+. ++|.++|.. ....+++.++..|+.||++||+|||++||+||||||+||||+..|              
T Consensus        54 ~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~  131 (793)
T PLN00181         54 SIVRALECED-VSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG  131 (793)
T ss_pred             hhhhhhccCC-ccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence            4568899884 599999975 345699999999999999999999999999999999999996544              


Q ss_pred             -----ceEEEecCCccccCCCCC--------------CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhC
Q 017746          146 -----EAKIADFGLAKKSSCDGE--------------RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASG  206 (366)
Q Consensus       146 -----~vkl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg  206 (366)
                           .+||+|||+++.......              .......+||+.|||||++.+..|+.++|||||||+||||++|
T Consensus       132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~  211 (793)
T PLN00181        132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP  211 (793)
T ss_pred             ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence                 456666666653210000              0001124689999999999999999999999999999999999


Q ss_pred             CCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          207 KPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+|+....  .....+....   ..+... .......+++.+||.++|.+||++.|+++||||..
T Consensus       212 ~~~~~~~~--~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        212 VSSREEKS--RTMSSLRHRV---LPPQIL-LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             CCchhhHH--HHHHHHHHhh---cChhhh-hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence            99875432  1222222111   111111 12456678999999999999999999999999954

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.98  E-value=3e-32  Score=233.66  Aligned_cols=164  Identities=24%  Similarity=0.333  Sum_probs=130.9

Q ss_pred             CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccc
Q 017746           91 GSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC  170 (366)
Q Consensus        91 g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~  170 (366)
                      |+|.+++.+ .+..+++.++..++.||+.||.|||+++      ||+|||++.++.+|+  ||+++.....       ..
T Consensus         1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~   64 (176)
T smart00750        1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QS   64 (176)
T ss_pred             CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cC
Confidence            699999986 3457999999999999999999999999      999999999999999  9999875321       12


Q ss_pred             cCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc-hHHHHHHHhhcCCCCC--CCCCCCCH--HHHHH
Q 017746          171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS-NVFSLLIRIGVGDELP--NIPGDLSE--QGKDF  245 (366)
Q Consensus       171 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~s~--~~~~l  245 (366)
                      .||+.|||||++.+..|+.++|||||||++|||++|+.||...... .....+..........  ..+..++.  +++++
T Consensus        65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            5899999999999999999999999999999999999999765332 2222222221111100  11222333  68999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          246 LIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       246 l~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      +.+||..||++||++.+++.|+|+.
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHH
Confidence            9999999999999999999999974

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.4e-30  Score=230.70  Aligned_cols=199  Identities=32%  Similarity=0.530  Sum_probs=167.5

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      |.+++.||.|++|.||++.+..+++    .+++|.......  ....+.+|++.++.++ |+|++++++..    .....
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~----~~~~~   71 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGE----LVAVKVLKKEKTEKQREEFLREIRILKKLK-HPNIVKLYGVF----EDPEP   71 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCc----EEEEEeeccccchHHHHHHHHHHHHHHhCC-CCChhhheeee----ecCCc
Confidence            6788999999999999999876544    788888776433  4678889999999997 89999998832    22345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++++||+++++|.+++.... ..+++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++.....
T Consensus        72 ~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       72 LYLVMEYCEGGDLFDYLRKKG-GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             eEEEEeccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            679999999999999997632 2289999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCcccccccCCCCCCCcccc-CCcCCCCccchhhhHHHHHHHHhCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNH  212 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~emltg~~pf~~  212 (366)
                      .... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       151 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      151 DLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            3211 12234688899999998 677788899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=241.01  Aligned_cols=255  Identities=16%  Similarity=0.204  Sum_probs=197.5

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCC-ceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~-~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      ++...++-+|.||.||.|.+.+...... ..+.+|.....  +-+...+..|--.+..+. |||+..+.|..  .++.. 
T Consensus       286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s-H~nll~V~~V~--ie~~~-  361 (563)
T KOG1024|consen  286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS-HPNLLSVLGVS--IEDYA-  361 (563)
T ss_pred             eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc-CCCccceeEEE--eeccC-
Confidence            4556678899999999997765432222 24667766542  224556778888888888 99999999854  33333 


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecC
Q 017746           80 FYNLLLEYASRGSLADRVKKQN------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                      ..++++.++.-|+|..++...+      ...++..+...++.|++.|++|||++||||.||.++|.+|++.-++||+|=.
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence            3448899999999999998321      1237777888999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      +++.+...+-+-..........||+||.+.+..|+.++|+|||||+||||+| |+.|+...++.+... ..+.++..   
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-ylkdGyRl---  517 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-YLKDGYRL---  517 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-HHhcccee---
Confidence            9987643322221111123556999999999999999999999999999998 999998777665544 44444433   


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .-|-.+++++..++.-||...|++||+++|+..
T Consensus       518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            335679999999999999999999999999874

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-28  Score=231.21  Aligned_cols=258  Identities=24%  Similarity=0.214  Sum_probs=197.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcC---CCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIG---ICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~---~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||++.+...+   ...+|+|...... .....+..|..++..+.   ..+++.+++..+.   ..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~---~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~---~~   92 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK---NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR---ST   92 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC---CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc---CC
Confidence            6999999999999999999987764   2346666555421 12227899999999997   2457777776321   34


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC-----CceEEEec
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN-----DEAKIADF  152 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-----~~vkl~DF  152 (366)
                      +.+.++||+.+ |.+|.++......+.++..++..++.|++.+|++||+.|++||||||.|+++...     ..+.|.||
T Consensus        93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            55677999998 6799998876555789999999999999999999999999999999999999754     46999999


Q ss_pred             CCcc--ccCCCCC----Ccc--cccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 017746          153 GLAK--KSSCDGE----RSQ--SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       153 G~a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~  224 (366)
                      |+|+  .......    ...  .....||..|+++.+..+.+.+.+.|+||++.++.+++.|..||...........+..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~  251 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK  251 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence            9998  3221111    111  2235699999999999999999999999999999999999999987765444444444


Q ss_pred             hhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       225 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..............+.++.++...+-..+...+|....+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            333222222233456778888888888899999998888654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.8e-31  Score=264.04  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=193.4

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCce-eEEeeecCCCCch---hhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSS---VTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~-~avK~~~~~~~~~---~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      ....+|.|++|.|+.+......+.++.+ +.+| ........   ..+..|.-+-..+. |||++..+...   .+....
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~---~~~~~~  396 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIV---QEIDGI  396 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHH---hhcccc
Confidence            5678999999988888876655433333 2222 11111111   11444555556666 89987766522   222222


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      + -+||||++ +|+.++..  .+.+...++..++.||+.|++|||++||.||||||+|+++..+|.+||+|||.+.....
T Consensus       397 ~-~~mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  397 L-QSMEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             h-hhhhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence            2 34999999 99999975  35799999999999999999999999999999999999999999999999999988766


Q ss_pred             CCCC--cccccccCCCCCCCccccCCcCCCC-ccchhhhHHHHHHHHhCCCCCCCCCcchHHH-HHHH---hhcCCCCCC
Q 017746          161 DGER--SQSFECRGTPLYMSPESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFS-LLIR---IGVGDELPN  233 (366)
Q Consensus       161 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~emltg~~pf~~~~~~~~~~-~~~~---~~~~~~~~~  233 (366)
                      +.+.  ......+|+..|+|||++.+.+|++ .+||||.|++++.|++|+.||......+... ....   .........
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~  552 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR  552 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence            6555  4456678999999999999999998 6899999999999999999997654433221 1110   001111112


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +...++...+.+|.+||+.||.+|.|+++|++.+||+..
T Consensus       553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            234578889999999999999999999999999999653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=6e-28  Score=215.71  Aligned_cols=252  Identities=22%  Similarity=0.243  Sum_probs=201.4

Q ss_pred             CCccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            1 MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         1 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +.|++|++||+|+||++++|+..-+++    .||+|.-... ...-.+..|....+.|.+.++|...|-    |...+.+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne----~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYY----FGqeG~~   98 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNE----PVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYY----FGQEGKY   98 (449)
T ss_pred             ccceeccccccCcceeeecccccccCc----eEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceee----eccccch
Confidence            369999999999999999999876654    8999986653 455678999999999999999988763    5555555


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-----ceEEEecCCc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-----EAKIADFGLA  155 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-----~vkl~DFG~a  155 (366)
                      -.||||++ |-+|.|+..- .+.+|+.+++.-++.|++.-++|+|++.+|+|||||+|+||...+     .+.|+|||+|
T Consensus        99 NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen   99 NILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            56999998 6699999986 566899999999999999999999999999999999999996443     5999999999


Q ss_pred             cccCCCCCCc-----ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          156 KKSSCDGERS-----QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       156 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      +...+..+..     ......||..||+--...+.+.+.+.|+-|||-++++.|-|.+||.+.......+...+++....
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr  256 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR  256 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence            9876554432     23345799999999999999999999999999999999999999998877666666666665443


Q ss_pred             CCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 017746          231 LPNI---PGDLSEQGKDFLIKCFLKDPKRRWTAEML  263 (366)
Q Consensus       231 ~~~~---~~~~s~~~~~ll~~cL~~dp~~R~t~~~l  263 (366)
                      ...+   -..++.++...+...=..+-.+-|..+-+
T Consensus       257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl  292 (449)
T KOG1165|consen  257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL  292 (449)
T ss_pred             cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence            3221   13466676666665555555566665443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=1.2e-26  Score=214.64  Aligned_cols=258  Identities=31%  Similarity=0.449  Sum_probs=198.4

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      |...+.||.|+||.||++.+.       ..+++|.+.....    ....+.+|..++..+..+++|++++..+    ...
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~----~~~   70 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF----QDE   70 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE----ecC
Confidence            677889999999999999987       3566666654222    3567899999999999444899998844    222


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-ceEEEecCCcc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN-GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAK  156 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~  156 (366)
                      ...+++++++.+++|.+++..... ..+.+..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||+++
T Consensus        71 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          71 GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            236699999999999977765211 2689999999999999999999999999999999999999988 79999999998


Q ss_pred             ccCCCCCCc----ccccccCCCCCCCccccCC---cCCCCccchhhhHHHHHHHHhCCCCCCCCCc----chHHHHHHHh
Q 017746          157 KSSCDGERS----QSFECRGTPLYMSPESVNE---NEYEAPCDIWALGCAVVEMASGKPAWNHKQD----SNVFSLLIRI  225 (366)
Q Consensus       157 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~emltg~~pf~~~~~----~~~~~~~~~~  225 (366)
                      .........    ......||..|+|||.+.+   ..+....|+||+|++++++++|..||.....    ......+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  230 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL  230 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence            654333221    2345679999999999988   5788899999999999999999999877653    2233333322


Q ss_pred             hcCCCCCCCCCCC----CHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          226 GVGDELPNIPGDL----SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       226 ~~~~~~~~~~~~~----s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ......+......    .....+++.+|+..+|..|.+..+...+++...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             CCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            2210111222211    257889999999999999999999998877643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.5e-29  Score=239.35  Aligned_cols=244  Identities=25%  Similarity=0.421  Sum_probs=194.0

Q ss_pred             eeeecCCeeEEEEEECC---CCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            8 VIGHGSFGSVNLAKASK---VSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~---~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ++|.|+||.|++++...   .+.-++.++.-|..... ........|..++...+.+|.+|++.-   .++... ..+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~-~~~~~t~~er~il~~~~~~~f~v~lhy---afqt~~-kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKV-RDRTHTKQERIILAFVHNTPFLVKLHY---AFQTDG-KLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccc-ccccccccHHHHHhhccCCCceeeeee---eecccc-chhHh
Confidence            47999999999886422   23333333333332222 222266778999999998999999975   444444 34599


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER  164 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~  164 (366)
                      +++..||+|...+.+.  ..+.+...+.+...++.|++++|+.||+|||+|++||+++.+|++|+.|||+++..-.... 
T Consensus        76 ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             hhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            9999999999999763  4689999999999999999999999999999999999999999999999999987632221 


Q ss_pred             cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHH
Q 017746          165 SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD  244 (366)
Q Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  244 (366)
                           .|||..|||||+++  ....++|.||+|+++++|+||..||..    ++...|.+..     +.+|..++..+++
T Consensus       153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-----~~~p~~l~~~a~~  216 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-----LEMPRELSAEARS  216 (612)
T ss_pred             -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----cCCchhhhHHHHH
Confidence                 18999999999998  677899999999999999999999977    4444444322     3567789999999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHHcCCCcccCCCC
Q 017746          245 FLIKCFLKDPKRRWT-----AEMLLNHPFVCADDQT  275 (366)
Q Consensus       245 ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~~~~  275 (366)
                      ++..++.++|..|..     +.++++|+||......
T Consensus       217 ~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  217 LFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            999999999999974     5899999999765443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=2.8e-27  Score=223.17  Aligned_cols=172  Identities=22%  Similarity=0.250  Sum_probs=129.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC------CCchhhHHHHHHHHHHcCCCCceeE-eecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC------PPSSVTLKNEKEALDQIGICPQIVR-CFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~------~~~~~~~~~E~~~l~~l~~~p~Iv~-~~g~~~~~   74 (366)
                      +|..++.||+|+||+||+|.++.++.   ..+|+|.....      ......+.+|+++|++++ |+||+. ++.    .
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~----~   90 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPG---TARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLA----T   90 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCC---eEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEE----c
Confidence            59999999999999999999876332   24688875432      112456899999999999 889885 433    1


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC-CCCcEEeccCCceEEEecC
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDI-KLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDl-kp~NILl~~~~~vkl~DFG  153 (366)
                        +  ..++||||++|++|.. +..     ..   ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||
T Consensus        91 --~--~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 --G--KDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             --C--CcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence              1  2569999999999973 211     11   1468899999999999999999999 9999999999999999999


Q ss_pred             CccccCCCCCCcc------cccccCCCCCCCccccCCcCC------CCccchh
Q 017746          154 LAKKSSCDGERSQ------SFECRGTPLYMSPESVNENEY------EAPCDIW  194 (366)
Q Consensus       154 ~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~------~~~~Diw  194 (366)
                      +|+.+...+....      .....|++.|+|||.+..++-      +...|-|
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9997654332111      134568999999999866542      3346666

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2e-26  Score=197.73  Aligned_cols=251  Identities=20%  Similarity=0.198  Sum_probs=192.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .|.+++.||+|+||.+|+|....++.    .||+|.-.. ......+..|..+.+.|++...|..+.-    +..+..+-
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge----~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~----y~~e~~yn   86 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGE----EVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRH----YGTEKDYN   86 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCc----eEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhh----hccccccc
Confidence            58899999999999999999988765    788887543 2445568889999999987677766653    33344455


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc---CCceEEEecCCcccc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKS  158 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~~~  158 (366)
                      .+|||++ |.+|.+++.- ...+++.+++.-++-|++.-++|+|.+++|||||||+|+|+.-   ...+.|+|||+|+..
T Consensus        87 vlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             eeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            6999998 6799999875 3457999999999999999999999999999999999999953   346999999999976


Q ss_pred             CCCCCCc-----ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHh---hcCCC
Q 017746          159 SCDGERS-----QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI---GVGDE  230 (366)
Q Consensus       159 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~---~~~~~  230 (366)
                      .+..+..     ......||..|.+--...+.+.+.+.|+-|+|.+|.+...|..||.+.......+...++   .....
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            5432221     123456999999988888888999999999999999999999999987654433333332   22222


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEML  263 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~l  263 (366)
                      +..+-..+|.++.-.+..|=..--++-|....|
T Consensus       245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl  277 (341)
T KOG1163|consen  245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL  277 (341)
T ss_pred             HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence            222334578888888888887777777775443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=2.5e-26  Score=231.16  Aligned_cols=224  Identities=25%  Similarity=0.405  Sum_probs=169.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|..+++|-.|+||.||+++|+.+.+.    ++.|. .+    ...+.            .||.++.|.       . + 
T Consensus        84 df~~IklisngAygavylvrh~~trqr----fa~ki-Nk----q~lil------------Rnilt~a~n-------p-f-  133 (1205)
T KOG0606|consen   84 DFNTIKLISNGAYGAVYLVRHKETRQR----FAMKI-NK----QNLIL------------RNILTFAGN-------P-F-  133 (1205)
T ss_pred             ccceeEeeccCCCCceeeeeccccccc----hhhcc-cc----cchhh------------hccccccCC-------c-c-
Confidence            578899999999999999999987664    44433 11    11111            113333221       0 1 


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                       +|      ||-.+.++.  -+.++...        +.|++|||+-||+|||+||+|.||+.-|++|+.|||+++.....
T Consensus       134 -vv------gDc~tllk~--~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  134 -VV------GDCATLLKN--IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -ee------chhhhhccc--CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence             22      566666643  23454433        88999999999999999999999999999999999998752111


Q ss_pred             CC-------------CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC
Q 017746          162 GE-------------RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG  228 (366)
Q Consensus       162 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~  228 (366)
                      ..             .-.....||||.|+|||++..+.|+.++|+|++|+|+||.+.|..||.+.++++.+..+......
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence            00             01123568999999999999999999999999999999999999999999999988888775542


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCCCcccCCC
Q 017746          229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRW---TAEMLLNHPFVCADDQ  274 (366)
Q Consensus       229 ~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~---t~~~ll~hp~~~~~~~  274 (366)
                        .|.-...++++++++|.++|+.+|..|.   .+-++.+|+||..-++
T Consensus       277 --wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  277 --WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             --ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence              3343556889999999999999999995   5788889999965443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=1.5e-24  Score=196.67  Aligned_cols=236  Identities=23%  Similarity=0.323  Sum_probs=147.8

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCC---------C-----C-c
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGI---------C-----P-Q   63 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~---------~-----p-~   63 (366)
                      ..+++.||.|+|+.||.+++.++++    .+++|.....    ....+.+++|.-....+.+         +     | -
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~----~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d   89 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGE----EFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTE----EEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred             EEEccccccCCceEEEEEEEccCCc----eEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence            4578899999999999999998876    6666655432    2233444444433333221         1     1 1


Q ss_pred             eeEeecceeeccCC--eeEE-----EEEeecCCCCCHHHHHHH---hCCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 017746           64 IVRCFGDDYSFEKG--ERFY-----NLLLEYASRGSLADRVKK---QNNG--RLQESDVKRYTRSMLKGLRHIHSKGFVH  131 (366)
Q Consensus        64 Iv~~~g~~~~~~~~--~~~~-----~lv~E~~~~g~L~~~l~~---~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givH  131 (366)
                      ++++-+....+...  ...+     +++|+-+.+ ||.+++..   ....  .+.......++.|+++.+++||..|++|
T Consensus        90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH  168 (288)
T PF14531_consen   90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH  168 (288)
T ss_dssp             EEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence            33333322222211  1222     588998865 99988753   1111  1222233466699999999999999999


Q ss_pred             cCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCC--------cCCCCccchhhhHHHHHHH
Q 017746          132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE--------NEYEAPCDIWALGCAVVEM  203 (366)
Q Consensus       132 rDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~em  203 (366)
                      +||||+|++++.+|.++|+||+......   .....  ...+..|.+||....        -.++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g---~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAG---TRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETT---EEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecC---ceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            9999999999999999999999877652   22211  235678999997643        2578899999999999999


Q ss_pred             HhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 017746          204 ASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR  257 (366)
Q Consensus       204 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R  257 (366)
                      .||..||...........        .+..+. .+++.+++||..+|+.||.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~--------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW--------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG--------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc--------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999986543321111        222444 689999999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.2e-24  Score=194.14  Aligned_cols=195  Identities=19%  Similarity=0.338  Sum_probs=147.4

Q ss_pred             CCCceeEeecceeec-----------------------cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHH
Q 017746           60 ICPQIVRCFGDDYSF-----------------------EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS  116 (366)
Q Consensus        60 ~~p~Iv~~~g~~~~~-----------------------~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~q  116 (366)
                      .|||||++++.+.+.                       ......+|+||-..+. +|..++-.+   ..+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence            489999988855321                       1224567899999987 999999763   4788888999999


Q ss_pred             HHHHHHHHHHCCcEecCCCCCcEEec--cCC--ceEEEecCCccccCCCCC----CcccccccCCCCCCCccccCCcC--
Q 017746          117 MLKGLRHIHSKGFVHCDIKLQNVLVF--DND--EAKIADFGLAKKSSCDGE----RSQSFECRGTPLYMSPESVNENE--  186 (366)
Q Consensus       117 i~~aL~~LH~~givHrDlkp~NILl~--~~~--~vkl~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~--  186 (366)
                      +++|+.|||.+||.|||+|.+||||.  .++  .+.|+|||++-....-+-    .......-|...-||||+...-+  
T Consensus       350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            99999999999999999999999994  333  589999998854321111    11112334888899999985432  


Q ss_pred             ---CC-CccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 017746          187 ---YE-APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAE  261 (366)
Q Consensus       187 ---~~-~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~  261 (366)
                         .+ .++|.|+.|.+.||++....||+...... .+  .+.-....+|.+|+.+++.+++++..+|+.||++|++..
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~--~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LD--TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ec--hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence               22 37999999999999999999998742211 11  111223467889999999999999999999999999854

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=8.3e-24  Score=182.87  Aligned_cols=187  Identities=18%  Similarity=0.182  Sum_probs=139.5

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchh-----hHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSV-----TLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      .....|++|+||+||++...+      .+++.+.+........     .+.+|+++|++|+++++|+++++.        
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~------~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--------   70 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGE------RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--------   70 (218)
T ss_pred             ccceeecCCCcceEEEeecCC------ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--------
Confidence            457899999999999876522      3677666655444223     578999999999877889998762        


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC-CCCcEEeccCCceEEEecCCccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDI-KLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDl-kp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||+.|.+|.+.+..        . ...++.|++.+|++||++||+|||| ||+|||++.+|.++|+|||+|..
T Consensus        71 ~~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         71 DGRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             cCEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            113599999999999755421        1 1357889999999999999999999 79999999999999999999986


Q ss_pred             cCCCCCC----c-c------cccccCCCCCCCccccCCc-CCC-CccchhhhHHHHHHHHhCCCCCCCC
Q 017746          158 SSCDGER----S-Q------SFECRGTPLYMSPESVNEN-EYE-APCDIWALGCAVVEMASGKPAWNHK  213 (366)
Q Consensus       158 ~~~~~~~----~-~------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~emltg~~pf~~~  213 (366)
                      .......    . .      ..-..+++.|+.|+.-.-. ..+ .+.++++.|+-+|.++|+..++-+.
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            5433210    0 0      1112367888888854332 233 4678889999999999999987544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1.4e-23  Score=185.11  Aligned_cols=171  Identities=17%  Similarity=0.135  Sum_probs=127.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhh----------HHHHHHHHHHcCCCCceeEeecce
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT----------LKNEKEALDQIGICPQIVRCFGDD   71 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~----------~~~E~~~l~~l~~~p~Iv~~~g~~   71 (366)
                      +|+..++||.|+||.||++.. . +    .++++|.+.........          +++|+..+.++. ||+|.......
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~-~-~----~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~  104 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT-D-Y----GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFY  104 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec-C-C----CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEee
Confidence            688999999999999999754 2 2    26888987643222222          578999999997 89998887643


Q ss_pred             eeccC----CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCce
Q 017746           72 YSFEK----GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA  147 (366)
Q Consensus        72 ~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~v  147 (366)
                      .....    .....+++|||++|.+|.++..      +++.    ...+|+.+|..||+.|++|||+||+||+++.+| +
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence            32111    1234669999999999988742      3332    456999999999999999999999999999988 9


Q ss_pred             EEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHH
Q 017746          148 KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMA  204 (366)
Q Consensus       148 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~eml  204 (366)
                      +|+|||...........              ..++....|+.++|+|+||+++....
T Consensus       174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988654211100              11445667888999999999987654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=2.4e-24  Score=217.26  Aligned_cols=240  Identities=23%  Similarity=0.317  Sum_probs=171.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHH-HHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEAL-DQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l-~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      ++...+.||++.|=+|.+|++.+ |     .++||.+.+..  -....+.++++.. ..+..+||.+.+.-    +...+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-----~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk----~~~t~   93 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-----LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQK----VLVTD   93 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-----eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHH----HHHhh
Confidence            35667899999999999998764 2     35555554422  1222333322222 33445899998865    34445


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      +..|||-+|..+ +|+|.|..+  .-+...+.+.|+.||+.||..||..||+|+|||.+||||+.-+-+.|+||..-+..
T Consensus        94 kAAylvRqyvkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen   94 KAAYLVRQYVKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             HHHHHHHHHHhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCc
Confidence            566799999988 999999653  34778889999999999999999999999999999999999999999999887754


Q ss_pred             CCCCCCccccc-----ccCCCCCCCccccCCc----------C-CCCccchhhhHHHHHHHHh-CCCCCCCCC-------
Q 017746          159 SCDGERSQSFE-----CRGTPLYMSPESVNEN----------E-YEAPCDIWALGCAVVEMAS-GKPAWNHKQ-------  214 (366)
Q Consensus       159 ~~~~~~~~~~~-----~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~emlt-g~~pf~~~~-------  214 (366)
                      .-+......+.     ...-..|+|||.+...          . .+++.||||+||+++|+++ |++||.-.+       
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~  250 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG  250 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc
Confidence            33333322221     1223359999987441          1 5678999999999999987 799995221       


Q ss_pred             -cchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          215 -DSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       215 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                       .......+.         .++   +..++.+|..|++.||++|.++++.|+-
T Consensus       251 ~~~~~e~~Le---------~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  251 NADDPEQLLE---------KIE---DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CccCHHHHHH---------hCc---CccHHHHHHHHHccCchhccCHHHHHHh
Confidence             011111111         111   3467899999999999999999999974

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=3e-23  Score=180.09  Aligned_cols=138  Identities=17%  Similarity=0.158  Sum_probs=104.5

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---c-------h-----------------hhHHHHHHHHHHc
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---S-------S-----------------VTLKNEKEALDQI   58 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~-------~-----------------~~~~~E~~~l~~l   58 (366)
                      ...||+|+||.||+|.+. +++    .+|+|.......   .       .                 ....+|.+.+.++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~----~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   76 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGE----ERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL   76 (190)
T ss_pred             CCccccccceEEEEEECC-CCC----EEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            578999999999999986 444    788887754211   1       1                 1223489999999


Q ss_pred             CCCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEecCCCCC
Q 017746           59 GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI-HSKGFVHCDIKLQ  137 (366)
Q Consensus        59 ~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~givHrDlkp~  137 (366)
                      . ++++.....  +..  ..  .+|||||++|++|...+.+  .+.+++..+..++.||+.+|.|| |+.||+||||||+
T Consensus        77 ~-~~~v~~p~~--~~~--~~--~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~  147 (190)
T cd05147          77 V-TAGIPCPEP--ILL--KS--HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEY  147 (190)
T ss_pred             H-HCCCCCCcE--EEe--cC--CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence            7 565532221  111  11  2599999999887765433  25799999999999999999999 7999999999999


Q ss_pred             cEEeccCCceEEEecCCcccc
Q 017746          138 NVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus       138 NILl~~~~~vkl~DFG~a~~~  158 (366)
                      |||++ ++.++|+|||+|...
T Consensus       148 NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         148 NLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             HEEEE-CCcEEEEEccccccC
Confidence            99998 478999999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.1e-22  Score=175.06  Aligned_cols=140  Identities=18%  Similarity=0.169  Sum_probs=106.7

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---------------------------hhhHHHHHHHHHH
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---------------------------SVTLKNEKEALDQ   57 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---------------------------~~~~~~E~~~l~~   57 (366)
                      +.+.||+|+||.||+|++. +++    .+|+|........                           ....++|.+.+.+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~----~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGE----ELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR   75 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCC----EEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            3678999999999999976 443    7888877653211                           1123578899999


Q ss_pred             cCCCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCC
Q 017746           58 IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKL  136 (366)
Q Consensus        58 l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp  136 (366)
                      +. +++|.......  ..  .  .+|||||++|+++......  ...+++..+..++.|++.+|.+||. +||+||||||
T Consensus        76 l~-~~~i~~p~~~~--~~--~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP  146 (190)
T cd05145          76 LY-EAGVPVPEPIL--LK--K--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSE  146 (190)
T ss_pred             HH-hCCCCCceEEE--ec--C--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCh
Confidence            98 67764332211  11  1  2599999999865544222  2468899999999999999999999 9999999999


Q ss_pred             CcEEeccCCceEEEecCCccccC
Q 017746          137 QNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus       137 ~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      +|||++ ++.++|+|||+|....
T Consensus       147 ~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         147 YNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             hhEEEE-CCCEEEEEcccceecC
Confidence            999998 7899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.89  E-value=8.2e-24  Score=200.25  Aligned_cols=253  Identities=20%  Similarity=0.233  Sum_probs=169.8

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeeccee---ecc----CC
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDY---SFE----KG   77 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~---~~~----~~   77 (366)
                      .+..++.+++.++......+ ......+..+...... .......+++-.+.-...|+..+.+--...   .+-    ..
T Consensus       249 ~k~~~~~~~~~~~~~q~~~~-~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~  327 (516)
T KOG1033|consen  249 SKSSERVSSGIVFEKQGKNN-SSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGK  327 (516)
T ss_pred             cccccccccCCchhhhhccc-chhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccc
Confidence            34455555665555543322 1112334444433322 233445555555555554555443320000   011    11


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQ-NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ..++|+.|++|.-.+|.++|..+ .+...+......++.|++.|++|   +|.+|||+||.||++..++++||.|||+..
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence            33578999999999999999742 33457788999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCC----CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          157 KSSCDGE----RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       157 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      .......    ........||..||+||.+.++.|+.++||||||+||+|++. -..+|      +....+..+..+...
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~~d~r~g~ip  478 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF------ERIATLTDIRDGIIP  478 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH------HHHHhhhhhhcCCCC
Confidence            7654441    112334579999999999999999999999999999999997 33333      222333333333333


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      |.+..+.+ +-.+|+.++|.+.|.+||++.+.--|.|.
T Consensus       479 ~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  479 PEFLQDYP-EEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hHHhhcCc-HHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            33333333 34689999999999999987777777664

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=4e-22  Score=175.00  Aligned_cols=142  Identities=15%  Similarity=0.156  Sum_probs=106.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcC----CCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIG----ICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~----~~p~Iv~~~g~~~~~~~   76 (366)
                      +....+.||+|+||.||.  +..+..    + ++|+.... ......+.+|+.+++.+.    .||||++++|.+.+-..
T Consensus         3 ~L~~~~~LG~G~~~~Vy~--hp~~~~----k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g   75 (210)
T PRK10345          3 RLSEQSPLGTGRHRKCYA--HPEDAQ----R-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG   75 (210)
T ss_pred             ecCCcceecCCCceEEEE--CCCCcC----e-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence            455678999999999995  554432    4 57766542 234567899999999994    37999999996544222


Q ss_pred             CeeEEEEEeec--CCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHH-HHHHHCCcEecCCCCCcEEeccC----CceEE
Q 017746           77 GERFYNLLLEY--ASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL-RHIHSKGFVHCDIKLQNVLVFDN----DEAKI  149 (366)
Q Consensus        77 ~~~~~~lv~E~--~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL-~~LH~~givHrDlkp~NILl~~~----~~vkl  149 (366)
                      ....+.+||||  +.+|+|.+++++   +.+++.  ..++.|++.++ +|||+++|+||||||+|||++.+    +.++|
T Consensus        76 ~g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         76 TGYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             CeEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence            23335589999  558999999965   246666  46688888888 99999999999999999999743    37999


Q ss_pred             EecCCc
Q 017746          150 ADFGLA  155 (366)
Q Consensus       150 ~DFG~a  155 (366)
                      +||+-+
T Consensus       151 iDg~G~  156 (210)
T PRK10345        151 CDNIGE  156 (210)
T ss_pred             EECCCC
Confidence            995543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4e-23  Score=180.43  Aligned_cols=236  Identities=17%  Similarity=0.282  Sum_probs=185.2

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      .-+|.+...|+.|+|+..++.      ++.|++..   ....+..+..|.-.|+.+. ||||+.++|.+.    ......
T Consensus       195 ~tkl~e~hsgelwrgrwqgnd------ivakil~vr~~t~risrdfneefp~lrifs-hpnilpvlgacn----sppnlv  263 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGND------IVAKILNVREVTARISRDFNEEFPALRIFS-HPNILPVLGACN----SPPNLV  263 (448)
T ss_pred             hhhhccCCCcccccccccCcc------hhhhhhhhhhcchhhcchhhhhCcceeeec-CCchhhhhhhcc----CCCCce
Confidence            346778888999999987653      33444332   3356677888999999998 999999999543    334456


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cE-ecCCCCCcEEeccCCceEEE--ecCCcccc
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG-FV-HCDIKLQNVLVFDNDEAKIA--DFGLAKKS  158 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g-iv-HrDlkp~NILl~~~~~vkl~--DFG~a~~~  158 (366)
                      ++..||+.|+|+..+..+.+...+..++.+++..|++|++|||+.. ++ ---|....|+|+++.+++|.  |--++-  
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--  341 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--  341 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--
Confidence            9999999999999998766666889999999999999999999974 33 33688999999999876664  322211  


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCC---CccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYE---APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                             +.....-.|.||+||.++..+-+   .++|+|||.+++||+.|...||....+   ++.-.++......+.+|
T Consensus       342 -------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp---mecgmkialeglrv~ip  411 (448)
T KOG0195|consen  342 -------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP---MECGMKIALEGLRVHIP  411 (448)
T ss_pred             -------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc---hhhhhhhhhccccccCC
Confidence                   11122357899999999877654   379999999999999999999977654   44555666666778889


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLL  264 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll  264 (366)
                      ..++..+..++.-|+..||.+||.+++++
T Consensus       412 pgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  412 PGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            99999999999999999999999998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=4.8e-24  Score=213.76  Aligned_cols=263  Identities=26%  Similarity=0.378  Sum_probs=205.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      .|...+.||+|+|+.|-++....+..   ..+++|......   ........|..+-..+..|+|++.+++    .....
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~---~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~----~~~~~   93 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPE---SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIE----PSSSP   93 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCc---ceeeccCCCCCCCccchhhhcCccccccccccccccccccCC----ccCCC
Confidence            57888999999999999887655433   456666655432   233455568888888887999999998    34455


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCCCcEEeccCC-ceEEEecCCcc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH-SKGFVHCDIKLQNVLVFDND-EAKIADFGLAK  156 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NILl~~~~-~vkl~DFG~a~  156 (366)
                      ..+++++||..|+++++.+........+...+..++.|+..+|.|+| ..++.||||||+|.+++.++ .+|++|||+|.
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence            66779999999999999994213225788899999999999999999 99999999999999999999 99999999999


Q ss_pred             ccCC-CCCCcccccccC-CCCCCCccccCCcC-CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          157 KSSC-DGERSQSFECRG-TPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       157 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      .... .+........+| ++.|+|||...+.. ..+..|+||.|+++..|++|..||...........-...........
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL  253 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC
Confidence            8766 444444555678 99999999998865 45689999999999999999999976654332111111111111123


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ....++....+++.++|..+|..|.+.+++..+||+..
T Consensus       254 ~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  254 PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            34568889999999999999999999999999999965

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=9.6e-22  Score=201.52  Aligned_cols=196  Identities=24%  Similarity=0.277  Sum_probs=153.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .|.+-+.||+|+||.||+|.+.+     +.++|+|.-...  ..-.+.--.+++.+|+  |.+...+-..++..-..+.-
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~-----~~~~alK~e~P~--~~WEfYI~~q~~~RLk--~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSN-----GKLVALKVEKPP--NPWEFYICLQVMERLK--PQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCC-----CcEEEEEeecCC--CceeeeehHHHHHhhc--hhhhcchHHHHHHHccCCcc
Confidence            47788999999999999999865     358999986653  3333444455666665  44444433322222222233


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-------CCceEEEecCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-------NDEAKIADFGL  154 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-------~~~vkl~DFG~  154 (366)
                      +||+||.+-|+|.+++.  ..+.+++..+..++.|++..+++||.++|||+||||+|.||..       +--++|+|||.
T Consensus       770 ~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            49999999999999997  4567999999999999999999999999999999999999942       23599999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCC
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKP  208 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~  208 (366)
                      +-.+..-.........++|-.+-.+|...|.+.++.+|.|.|..+++-||.|+.
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            976543334444455689999999999999999999999999999999999874

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=2.3e-20  Score=167.50  Aligned_cols=142  Identities=18%  Similarity=0.168  Sum_probs=108.9

Q ss_pred             CccccCeeeecCCeeEEEEE-ECCCCCCCCceeEEeeecCCCCc-------------------------hhhHHHHHHHH
Q 017746            2 EWLRGDVIGHGSFGSVNLAK-ASKVSSEFPSLMAVKSCADCPPS-------------------------SVTLKNEKEAL   55 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~-~~~~~~~~~~~~avK~~~~~~~~-------------------------~~~~~~E~~~l   55 (366)
                      -|.+.+.||+|+||.||+|. +..++    ..+++|........                         ...+++|...+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L  104 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSG----KERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL  104 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCC----cEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence            37789999999999999998 54444    47888877643210                         12356899999


Q ss_pred             HHcCC-CCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecC
Q 017746           56 DQIGI-CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG-FVHCD  133 (366)
Q Consensus        56 ~~l~~-~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrD  133 (366)
                      .++.. ...+.++++    .  .  ..++||||++|++|......  ...+...++..++.||+.+|.+||.+| |+|||
T Consensus       105 ~~L~~~~i~~p~~~~----~--~--~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~D  174 (237)
T smart00090      105 QRLYEAGVPVPKPIA----W--R--RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGD  174 (237)
T ss_pred             HHHHhcCCCCCeeeE----e--c--CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCC
Confidence            99973 123344443    1  1  13599999999888776533  235677778899999999999999999 99999


Q ss_pred             CCCCcEEeccCCceEEEecCCcccc
Q 017746          134 IKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus       134 lkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      |||+||+++ ++.++|+|||.|...
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999 889999999998754

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=1.9e-19  Score=173.42  Aligned_cols=204  Identities=21%  Similarity=0.288  Sum_probs=153.6

Q ss_pred             HHcCCCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-EecCC
Q 017746           56 DQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGF-VHCDI  134 (366)
Q Consensus        56 ~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi-vHrDl  134 (366)
                      +.+. |.|+.+++|...  ..  ..+++|.+||..|+|.|.+.. ..-.+++.....+++.|+.||.|||.-.| .|+.+
T Consensus         2 ~~l~-h~n~~~f~g~~~--~~--~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l   75 (484)
T KOG1023|consen    2 RQLD-HDNLNKFIGASV--DG--PEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL   75 (484)
T ss_pred             cccc-hhhhhhheeeEe--cC--CceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence            4566 899999999543  22  456699999999999999987 45578999999999999999999999865 99999


Q ss_pred             CCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcC-------CCCccchhhhHHHHHHHHhCC
Q 017746          135 KLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE-------YEAPCDIWALGCAVVEMASGK  207 (366)
Q Consensus       135 kp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~emltg~  207 (366)
                      +..|.+++..-.+||+|||+.................-...|.|||.++...       -+.+.||||+|++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            9999999999999999999987653211111111112345699999997742       355799999999999999999


Q ss_pred             CCCCCCCcc----hHHHHHHHhhcCCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          208 PAWNHKQDS----NVFSLLIRIGVGDELPNIPG--DLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       208 ~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~--~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      -||......    +....+.+.+.....|.+..  .+.+++..++..||..+|++||+++++..
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            999763322    22223222122223344331  35567889999999999999999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=5.9e-19  Score=154.42  Aligned_cols=135  Identities=20%  Similarity=0.190  Sum_probs=103.2

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-----------------------chhhHHHHHHHHHHcC
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-----------------------SSVTLKNEKEALDQIG   59 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-----------------------~~~~~~~E~~~l~~l~   59 (366)
                      |.+.+.||+|+||.||++... ++    ..+++|.......                       .......|..++..+.
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   91 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DG----NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY   91 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CC----CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence            778899999999999999874 33    3788886543211                       1123567888888886


Q ss_pred             CCC--ceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCC
Q 017746           60 ICP--QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQ  137 (366)
Q Consensus        60 ~~p--~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~  137 (366)
                       ++  .+...++    .    ...++||||++|++|.+...        ......++.+|+.++.++|+.||+||||||+
T Consensus        92 -~~~i~v~~~~~----~----~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~  154 (198)
T cd05144          92 -EEGFPVPKPID----W----NRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEF  154 (198)
T ss_pred             -HcCCCCCceee----c----CCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcc
Confidence             45  3444433    1    12359999999999976542        1345678899999999999999999999999


Q ss_pred             cEEeccCCceEEEecCCccccC
Q 017746          138 NVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus       138 NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ||++++++.++|+|||++....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=9.4e-19  Score=154.44  Aligned_cols=134  Identities=16%  Similarity=0.183  Sum_probs=103.5

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---------chhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---------SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      .+.||+|++|.||+|...  +    ..+++|.......         ....+.+|+.++..+. +++|......+.  ..
T Consensus         1 ~~~l~~G~~~~vy~~~~~--~----~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~--~~   71 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDFL--G----IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFV--DP   71 (211)
T ss_pred             CcccccCceEEEEEEeeC--C----CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEE--eC
Confidence            368999999999999873  2    3567776443211         1235678999999998 677655443211  12


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                        ...+++|||++|++|.+++...     .. ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||++.
T Consensus        72 --~~~~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~  142 (211)
T PRK14879         72 --ENFIIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE  142 (211)
T ss_pred             --CCCEEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence              2345999999999999998652     12 8889999999999999999999999999999999 7899999999987


Q ss_pred             c
Q 017746          157 K  157 (366)
Q Consensus       157 ~  157 (366)
                      .
T Consensus       143 ~  143 (211)
T PRK14879        143 F  143 (211)
T ss_pred             C
Confidence            5

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1e-18  Score=175.27  Aligned_cols=138  Identities=20%  Similarity=0.247  Sum_probs=103.2

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      |...+.||+|+||+||++.......  ..++.+++.....     .....+.+|+++++.++ +++++......  ... 
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~~--v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~--~~~-  408 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRDA--VIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYD--VDP-  408 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCccc--eeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEE--EeC-
Confidence            4567899999999999998754321  2222222111110     11245788999999998 78887765422  222 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                       ...++||||++|++|.+++.          ....++.|++.+|.|||++|++||||||+|||+ .++.++|+|||+++.
T Consensus       409 -~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        409 -EEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             -CCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence             22459999999999999885          346789999999999999999999999999999 678999999999876


Q ss_pred             c
Q 017746          158 S  158 (366)
Q Consensus       158 ~  158 (366)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            4

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=1.4e-18  Score=151.91  Aligned_cols=130  Identities=21%  Similarity=0.260  Sum_probs=97.0

Q ss_pred             eeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---------chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            8 VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---------SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      .||+|+||.||+|...+      ..+++|.......         ....+.+|.++++.+. ++++......  ....  
T Consensus         1 ~ig~G~~~~vy~~~~~~------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~--~~~~--   69 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLG------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVY--DVDP--   69 (199)
T ss_pred             CCCCCceEEEEEeecCC------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEE--EEEC--
Confidence            48999999999998432      3567776443211         1245678999999998 5554322221  1222  


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ...++||||++|++|.+++... .  .      .++.|++.+|.+||+.|++|+|+||.||+++ ++.++++|||++...
T Consensus        70 ~~~~lv~e~~~g~~l~~~~~~~-~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        70 DNKTIVMEYIEGKPLKDVIEEG-N--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCCEEEEEEECCccHHHHHhhc-H--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            2235999999999999988541 1  1      8899999999999999999999999999999 789999999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.74  E-value=3.8e-18  Score=172.69  Aligned_cols=264  Identities=21%  Similarity=0.312  Sum_probs=194.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      +.+.+-+-+|+|+.++.+.-...+...+.++..+.-.........+..+-.++..-. +|-+++..-   .+-.... .+
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~---s~~~rsP-~~  880 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFP---SFPCRSP-LP  880 (1205)
T ss_pred             ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccC---CCCCCCC-cc
Confidence            345567788999999998876666433333332222222223333444444333333 466665543   2222222 45


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC-
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD-  161 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~-  161 (366)
                      |+|+|+.|++|...+..  .+..+++.++.+...+..+++|||...++|||++|.|+|+..+|..+++|||.......- 
T Consensus       881 L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             hhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            99999999999999965  346889999999999999999999999999999999999999999999999844321110 


Q ss_pred             ----------------------------CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 017746          162 ----------------------------GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHK  213 (366)
Q Consensus       162 ----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~  213 (366)
                                                  ..........||+.|.+||.+.+......+|+|++|++++|.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                        0001123457999999999999999999999999999999999999999998


Q ss_pred             CcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHHcCCCcccCCCC
Q 017746          214 QDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAE---MLLNHPFVCADDQT  275 (366)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~---~ll~hp~~~~~~~~  275 (366)
                      +.+..++.+.+...  ..|.-+...+.++++++.+.|..+|.+|..+.   ++..|+||+..++.
T Consensus      1039 tpq~~f~ni~~~~~--~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDI--PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred             chhhhhhccccCCC--CCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence            88777766554332  33455566899999999999999999999887   89999999776554

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=4.8e-17  Score=146.27  Aligned_cols=139  Identities=14%  Similarity=0.131  Sum_probs=101.5

Q ss_pred             cCeee-ecCCeeEEEEEECCCCCCCCceeEEeeecCC--------------CCchhhHHHHHHHHHHcCCCCce--eEee
Q 017746            6 GDVIG-HGSFGSVNLAKASKVSSEFPSLMAVKSCADC--------------PPSSVTLKNEKEALDQIGICPQI--VRCF   68 (366)
Q Consensus         6 ~~~lG-~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--------------~~~~~~~~~E~~~l~~l~~~p~I--v~~~   68 (366)
                      +..|| .|+.|+||.+...+      ..+++|.+...              ........+|++++..|. +++|  ++.+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~------~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl  108 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPG------VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPI  108 (239)
T ss_pred             CceeecCCCCccEEEEEeCC------ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeE
Confidence            45788 89999999997742      25666665321              122346788999999998 6664  5555


Q ss_pred             cceeeccCCeeEEEEEeecCCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCce
Q 017746           69 GDDYSFEKGERFYNLLLEYASR-GSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA  147 (366)
Q Consensus        69 g~~~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~v  147 (366)
                      +....-.......++|||+++| .+|.+++..   ..+++..    +.||+.+|.+||++||+||||||+|||++.++.+
T Consensus       109 ~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        109 AARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             eeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCE
Confidence            5322111111112499999997 699999854   3466543    5789999999999999999999999999998999


Q ss_pred             EEEecCCcccc
Q 017746          148 KIADFGLAKKS  158 (366)
Q Consensus       148 kl~DFG~a~~~  158 (366)
                      +|+|||.+...
T Consensus       182 ~LIDfg~~~~~  192 (239)
T PRK01723        182 WLIDFDRGELR  192 (239)
T ss_pred             EEEECCCcccC
Confidence            99999988653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=3.4e-17  Score=141.71  Aligned_cols=137  Identities=22%  Similarity=0.208  Sum_probs=95.4

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCch---hh----------------------HHHHHHHHHHcC
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSS---VT----------------------LKNEKEALDQIG   59 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~---~~----------------------~~~E~~~l~~l~   59 (366)
                      +++.||+|+||.||+|.+. ++    ..+++|.........   ..                      ...|...+..+.
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   75 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DG----EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY   75 (187)
T ss_pred             CCcccccccceeEEEEECC-CC----CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence            3678999999999999876 33    378888765422111   11                      134555666664


Q ss_pred             CC-CceeEeecceeeccCCeeEEEEEeecCCCCCHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCC
Q 017746           60 IC-PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-RVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKL  136 (366)
Q Consensus        60 ~~-p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp  136 (366)
                      .. -.+.++++.    .    ..++||||++++++.. .+.. .   .....+..++.+++.++.++|. +||+||||||
T Consensus        76 ~~~~~~~~~~~~----~----~~~lv~e~~~g~~~~~~~l~~-~---~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p  143 (187)
T cd05119          76 EAGVPVPKPIDL----N----RHVLVMEFIGGDGIPAPRLKD-V---RLLEDPEELYDQILELMRKLYREAGLVHGDLSE  143 (187)
T ss_pred             HcCCCCCceEec----C----CCEEEEEEeCCCCccChhhhh-h---hhcccHHHHHHHHHHHHHHHhhccCcCcCCCCh
Confidence            22 123444331    1    1359999999965432 2211 1   1116788999999999999999 9999999999


Q ss_pred             CcEEeccCCceEEEecCCccccC
Q 017746          137 QNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus       137 ~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      +||+++ ++.++|+|||.+....
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             hhEEEE-CCcEEEEECccccccc
Confidence            999999 8899999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=2.7e-16  Score=130.03  Aligned_cols=133  Identities=17%  Similarity=0.191  Sum_probs=106.2

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC-CceeEeecceeeccCCeeEEEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-PQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~-p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      +.+.||+|.++.||++...+      ..+++|....... ...+.+|..+++.+..+ ++++++++.    .......++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~------~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~----~~~~~~~~~   70 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD------EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLAS----GESDGWSYL   70 (155)
T ss_pred             cceecccccccceEEEEecC------CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEE----cCCCCccEE
Confidence            46789999999999999754      2678887665322 46789999999999744 577777652    222245679


Q ss_pred             EeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           84 LLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK---GFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +|||++|+.+..+         +......++.+++.+|++||..   +++|+|+||+||++++.+.+++.|||.+..
T Consensus        71 v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          71 LMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9999999777643         4566677899999999999995   799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=2.8e-15  Score=144.92  Aligned_cols=255  Identities=24%  Similarity=0.216  Sum_probs=188.7

Q ss_pred             ccccCeeee--cCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            3 WLRGDVIGH--GSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         3 y~~~~~lG~--G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +-+...+|.  |.+|.||.+....  .....++++|....   .......-.+|.....++..|++.++.+.    .-++
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~--~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~----~~e~  189 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTN--SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP----AWEG  189 (524)
T ss_pred             cccccccccCCCCCceeecccCCc--ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc----cccc
Confidence            445678899  9999999998722  23345778877443   22344556778888888888899998544    2334


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH----HHHHHHHCCcEecCCCCCcEEeccC-CceEEEec
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK----GLRHIHSKGFVHCDIKLQNVLVFDN-DEAKIADF  152 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~----aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DF  152 (366)
                      ....++-+|+|. .+|.++... ....+++..++.++.+...    ||.++|..+++|-|+||.||++..+ ..+++.||
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             CCcceeeecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence            445568899986 589888866 3445889999999999999    9999999999999999999999999 88999999


Q ss_pred             CCccccCCCCCCcc---cccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC
Q 017746          153 GLAKKSSCDGERSQ---SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       153 G~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      |+...+........   .....|...|++||.. ..-++...||++||.++.+..+|..++........ ..+.+. +  
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~-~--  342 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQG-Y--  342 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-cccccc-c--
Confidence            99998765543222   1223578889999975 45688899999999999999998766643311111 111110 0  


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      ....+-...+.++...+..+++.+|..|+++..+++|+++.
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence            11122233466667789999999999999999999999985

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.58  E-value=6.6e-15  Score=132.44  Aligned_cols=206  Identities=21%  Similarity=0.277  Sum_probs=147.4

Q ss_pred             HHHcCCCCceeEeecceeecc-CCeeEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC--Cc
Q 017746           55 LDQIGICPQIVRCFGDDYSFE-KGERFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSK--GF  129 (366)
Q Consensus        55 l~~l~~~p~Iv~~~g~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~--gi  129 (366)
                      |.++- |.|||+++.++.+.. ++.....++.||+..|+|..+|++.  ....+.....++|+.||+.||.|||+.  -|
T Consensus       121 llqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  121 LLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            34444 789999888655433 2444566899999999999999863  345688999999999999999999998  49


Q ss_pred             EecCCCCCcEEeccCCceEEEecCCccccCCC--CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCC
Q 017746          130 VHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD--GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGK  207 (366)
Q Consensus       130 vHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~  207 (366)
                      +|+++..+-|++..+|-+|+.--.....-..-  ..........|-++|.|||.=...+.+.++|||++|....+|..|.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            99999999999999998887532211100000  0000111224778999999866667778999999999999999987


Q ss_pred             CCC-CCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          208 PAW-NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       208 ~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      .-- ......+....+.+..++...        .--++++.+||+..|..||++.+++.||..
T Consensus       280 iq~tnseS~~~~ee~ia~~i~~len--------~lqr~~i~kcl~~eP~~rp~ar~llfHpll  334 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANVIIGLEN--------GLQRGSITKCLEGEPNGRPDARLLLFHPLL  334 (458)
T ss_pred             eccCCCcceeehhhhhhhheeeccC--------ccccCcCcccccCCCCCCcchhhhhcCcee
Confidence            653 333333333344433332221        112468999999999999999999999986

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=6.5e-14  Score=136.55  Aligned_cols=139  Identities=21%  Similarity=0.267  Sum_probs=93.0

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhh--------------------------------------
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT--------------------------------------   47 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~--------------------------------------   47 (366)
                      -+.||.|++|.||+|+.+. |    ..||||....  .....                                      
T Consensus       122 ~~plasaSigQVh~A~l~~-G----~~VaVKv~rp--~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l  194 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVD-G----KEVAVKVLRP--GIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL  194 (437)
T ss_pred             CcceeeeehhheEEEEecC-C----CEEEEEeeCC--CcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence            4679999999999999753 3    4799998654  21122                                      


Q ss_pred             -----HHHHHHHHHHcC----CCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHH
Q 017746           48 -----LKNEKEALDQIG----ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML  118 (366)
Q Consensus        48 -----~~~E~~~l~~l~----~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~  118 (366)
                           +.+|...+.++.    +++++ .+-..+... .+  ..+|||||++|++|.++...... ..   ....++.+++
T Consensus       195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~-~~--~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~  266 (437)
T TIGR01982       195 RRELDLRREAANASELGENFKNDPGV-YVPEVYWDR-TS--ERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLA  266 (437)
T ss_pred             HHHHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhh-cC--CceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHH
Confidence                 233333333332    22332 211111111 11  23599999999999988754211 12   2345666666


Q ss_pred             H-HHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746          119 K-GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus       119 ~-aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      . .+..+|..|++|+|+||.||+++.+|.++|+|||++..+.
T Consensus       267 ~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       267 RSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            5 4789999999999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=9.2e-14  Score=118.05  Aligned_cols=129  Identities=15%  Similarity=0.100  Sum_probs=94.7

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEe
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      .+.|+.|.++.||+++..      ...+++|............++|..+++.+.....+.+++.    +....  .++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~------~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~----~~~~~--~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA------NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYY----FDPET--GVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEEC------CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEE----EeCCC--CeEEE
Confidence            467899999999999864      2378899876543234567899999999864322344443    12212  24999


Q ss_pred             ecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----EecCCCCCcEEeccCCceEEEecCCccc
Q 017746           86 EYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGF-----VHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        86 E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi-----vHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ||++|.++.+.  .        .....++.+++.+|+.||..++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        71 e~i~G~~l~~~--~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          71 EFIEGSELLTE--D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EecCCCccccc--c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99999887643  0        1123456899999999999985     9999999999998 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=7.4e-14  Score=138.02  Aligned_cols=139  Identities=17%  Similarity=0.186  Sum_probs=88.5

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-----------------------------------ch------
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-----------------------------------SS------   45 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-----------------------------------~~------   45 (366)
                      +.||+|++|.||+|+.+.+|+    .||||.....-.                                   -.      
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~----~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E  200 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGR----EVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE  200 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCC----EEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence            689999999999999987654    788887754210                                   00      


Q ss_pred             hhHHHHHHHHHHcCC---CCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCC----CCCHHHHHHHHHHHH
Q 017746           46 VTLKNEKEALDQIGI---CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNG----RLQESDVKRYTRSML  118 (366)
Q Consensus        46 ~~~~~E~~~l~~l~~---~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~----~l~~~~~~~~~~qi~  118 (366)
                      ..+.+|...+.++..   +...+.+-..+..+   ....+|||||+.|+.|.++-.-...+    .+.+..+..++.||+
T Consensus       201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             hCHHHHHHHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            112333333333321   11112111111111   12234999999999998753211122    255555556666654


Q ss_pred             HHHHHHHHCCcEecCCCCCcEEeccCC----ceEEEecCCccccC
Q 017746          119 KGLRHIHSKGFVHCDIKLQNVLVFDND----EAKIADFGLAKKSS  159 (366)
Q Consensus       119 ~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~DFG~a~~~~  159 (366)
                             ..|++|+|+||.||+++.+|    +++++|||++..++
T Consensus       278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                   58999999999999999888    99999999998764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=7.7e-14  Score=135.03  Aligned_cols=246  Identities=25%  Similarity=0.221  Sum_probs=178.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|..+..||.|.|+.|+.......+   ..++++|......   .....-..|+.+...+..|.++++++..+   ....
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~---~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W---~~~r  339 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEG---DCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW---SQLR  339 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCC---CceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc---cccc
Confidence            5677889999999999988744222   2467777655421   23344567888888888899999987643   3334


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC-CceEEEecCCccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN-DEAKIADFGLAKK  157 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~~  157 (366)
                      +.| +=.|||+++++...+.-  ...+++...+....|++.|+.++|+..++|+|+||+||++..+ +..++.|||+...
T Consensus       340 ~~~-ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  340 QGY-IPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             ccc-CchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence            333 88999999998877632  2358899999999999999999999999999999999999876 7899999999875


Q ss_pred             cCCCCCCcccccccCCCCCC--CccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYM--SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      +...   ..  ...++-.++  +++......+..++|++|||..+.+.++|.+--...+..   ..+    .....|..+
T Consensus       417 ~~~~---~~--~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i----~~~~~p~~~  484 (524)
T KOG0601|consen  417 LAFS---SG--VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI----RSGDTPNLP  484 (524)
T ss_pred             ccee---cc--cccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eee----ecccccCCC
Confidence            3211   11  112333344  555555667888999999999999999987543222111   111    122334555


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      ... .++..+.+.+...++..|+.+.++..|.=|
T Consensus       485 ~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  485 GLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             chH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            444 788889999999999999999999887655

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=5.1e-12  Score=109.28  Aligned_cols=142  Identities=14%  Similarity=0.212  Sum_probs=97.3

Q ss_pred             cCeeeecCCeeEEEEEECCC--CCCCCceeEEeeecCCC-----------------------CchhhH----HHHHHHHH
Q 017746            6 GDVIGHGSFGSVNLAKASKV--SSEFPSLMAVKSCADCP-----------------------PSSVTL----KNEKEALD   56 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~--~~~~~~~~avK~~~~~~-----------------------~~~~~~----~~E~~~l~   56 (366)
                      ..+||.|--+.||.|.....  +......+|+|....+.                       .....+    ++|...|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            46799999999999985431  00113467888654311                       001122    37888888


Q ss_pred             HcCCC-CceeEeecceeeccCCeeEEEEEeecCCCCCHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEecC
Q 017746           57 QIGIC-PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-RVKKQNNGRLQESDVKRYTRSMLKGLRHI-HSKGFVHCD  133 (366)
Q Consensus        57 ~l~~~-p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~givHrD  133 (366)
                      ++... -++.+.++    +  ..  -+|||||+.++.+.. .++.   ..++++++..+..+++.+|..| |..|+||+|
T Consensus        82 rl~~~Gv~vP~pi~----~--~~--~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVV----L--KK--HVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEE----e--cC--CEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            88632 23444443    1  11  239999998754532 2322   2466677888899999999999 899999999


Q ss_pred             CCCCcEEeccCCceEEEecCCccccC
Q 017746          134 IKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus       134 lkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      |++.|||+. ++.+.|+|||.|-...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999996 4689999999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.36  E-value=2.1e-11  Score=119.62  Aligned_cols=160  Identities=22%  Similarity=0.292  Sum_probs=119.3

Q ss_pred             ceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHH
Q 017746           31 SLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESD  109 (366)
Q Consensus        31 ~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~  109 (366)
                      .++.|........ ......+-++.|+.++ ||+|++++.   +++. +...|||+|-+.  -|..++++     +....
T Consensus        38 ~~vsVF~~~~~~~~~~~~~~~A~k~lKtlR-HP~Il~yL~---t~e~-~~~~ylvTErV~--Pl~~~lk~-----l~~~~  105 (690)
T KOG1243|consen   38 GPVSVFVYKRSNGEVTELAKRAVKRLKTLR-HPNILSYLD---TTEE-EGTLYLVTERVR--PLETVLKE-----LGKEE  105 (690)
T ss_pred             CceEEEEEeCCCchhhHHHHHHHHHhhhcc-Cchhhhhhh---hhcc-cCceEEEeeccc--cHHHHHHH-----hHHHH
Confidence            3566665555333 2345788899999999 999999997   3333 336679999985  78888876     34888


Q ss_pred             HHHHHHHHHHHHHHHH-HCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCC
Q 017746          110 VKRYTRSMLKGLRHIH-SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE  188 (366)
Q Consensus       110 ~~~~~~qi~~aL~~LH-~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  188 (366)
                      +..-+.||+.||.||| +.+++|++|.-..|+++..|..||++|.++............  ..---.|..|+.+....  
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~--~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS--LYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc--chhhhcccChhhcCccc--
Confidence            8899999999999998 568999999999999999999999999988765322211111  11122366666543332  


Q ss_pred             CccchhhhHHHHHHHHhC
Q 017746          189 APCDIWALGCAVVEMASG  206 (366)
Q Consensus       189 ~~~DiwslG~il~emltg  206 (366)
                      ...|.|-|||++++++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            457999999999999999

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.23  E-value=1.2e-10  Score=97.67  Aligned_cols=142  Identities=15%  Similarity=0.195  Sum_probs=99.2

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---------CCchhhHHHHHHHHHHcCCC-CceeEeecceeec
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---------PPSSVTLKNEKEALDQIGIC-PQIVRCFGDDYSF   74 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---------~~~~~~~~~E~~~l~~l~~~-p~Iv~~~g~~~~~   74 (366)
                      ....|-+|+-+.|+++....      ...++|.-...         .-...+..+|.+.|.++... -...+++-    .
T Consensus        11 ~l~likQGAEArv~~~~~~G------e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~----~   80 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSG------EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF----I   80 (229)
T ss_pred             cceeeeccceeeEeeeccCC------ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE----E
Confidence            35678899999999998754      24455543221         11345677888888887521 11122221    1


Q ss_pred             cCCeeEEEEEeecCCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC---ceEEE
Q 017746           75 EKGERFYNLLLEYASR-GSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND---EAKIA  150 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~  150 (366)
                      ....+.  ++|||.+| -++.+++...............++.+|-+.|.-||.++|||+||..+||+|..+|   .+.++
T Consensus        81 D~~~~~--i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lI  158 (229)
T KOG3087|consen   81 DTYGGQ--IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILI  158 (229)
T ss_pred             ecCCCe--EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEE
Confidence            122222  88999987 5889999876544444455578999999999999999999999999999997665   35899


Q ss_pred             ecCCcccc
Q 017746          151 DFGLAKKS  158 (366)
Q Consensus       151 DFG~a~~~  158 (366)
                      |||++...
T Consensus       159 dfgls~~s  166 (229)
T KOG3087|consen  159 DFGLSSVS  166 (229)
T ss_pred             eecchhcc
Confidence            99998653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.22  E-value=7.2e-10  Score=105.96  Aligned_cols=217  Identities=19%  Similarity=0.170  Sum_probs=157.3

Q ss_pred             eeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEeecCCC-CC
Q 017746           15 GSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASR-GS   92 (366)
Q Consensus        15 g~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~-g~   92 (366)
                      .+.|++..+.+|.    .+++|.+..... .....-.-+++++++. |+|+|++..++.+.-.++..+++|++|.++ ++
T Consensus       290 ~Ttyk~~s~~DG~----~YvLkRlhg~r~~~~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  290 ITTYKATSNVDGN----AYVLKRLHGDRDQSTNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ceeEeeeeccCCc----eeeeeeeccccccCcccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            4789999888775    677777643211 1123344588999999 999999999877656667778899999997 68


Q ss_pred             HHHHHHHh-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           93 LADRVKKQ-------------NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        93 L~~~l~~~-------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      |.++-...             .+...+|..++.|+.||..||.++|+.|+.-+-|.|.+||++.+.+++|+--|+...+.
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            88766421             13347889999999999999999999999999999999999998888988777766654


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      .+.         +       |.+..   ..+-|.=.||.++..|.||..--. ..+......+..         +....+
T Consensus       445 ~d~---------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~-~~d~~~~s~~~~---------I~~~yS  495 (655)
T KOG3741|consen  445 EDP---------T-------EPLES---QQQNDLRDLGLLLLALATGTENSN-RTDSTQSSHLTR---------ITTTYS  495 (655)
T ss_pred             CCC---------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccc-cccchHHHHHHH---------hhhhhh
Confidence            332         0       11111   124577789999999999965421 112111111222         233578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .+++++|......++++ -++.+++.|
T Consensus       496 ~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  496 TDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            99999999999999987 688888864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=1.5e-10  Score=97.40  Aligned_cols=130  Identities=18%  Similarity=0.240  Sum_probs=90.6

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---------chhhHHHHHHHHHHcCCC-CceeEeecceeeccC
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---------SSVTLKNEKEALDQIGIC-PQIVRCFGDDYSFEK   76 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---------~~~~~~~E~~~l~~l~~~-p~Iv~~~g~~~~~~~   76 (366)
                      ..+++|+-+.+|.+...+      ..+++|.-....-         ...+..+|..++.++... -+...++.    +..
T Consensus         2 ~~i~~GAEa~i~~~~~~g------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d----vD~   71 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD----VDP   71 (204)
T ss_pred             chhhCCcceeEEeeeccC------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE----EcC
Confidence            468899999999995532      2455554332111         234556788888887521 12222222    333


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ...  .++|||.+|..|.+++...         ...++..+-.-+.-||.+||||+||.++||++...+ +.++|||++.
T Consensus        72 ~~~--~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          72 DNG--LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             CCC--EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            332  3999999999999899652         255677788888899999999999999999997654 9999999987


Q ss_pred             cc
Q 017746          157 KS  158 (366)
Q Consensus       157 ~~  158 (366)
                      ..
T Consensus       140 ~s  141 (204)
T COG3642         140 FS  141 (204)
T ss_pred             cc
Confidence            53

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.21  E-value=1.1e-10  Score=103.34  Aligned_cols=143  Identities=18%  Similarity=0.178  Sum_probs=102.0

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCC-CceeEeecceeeccCCeeEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGIC-PQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~-p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      .+.|+.|.++.||++...+     +..+++|.......  ....+.+|.+++..+..+ ..+.+++..... .......+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-----g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~-~~~~~~~~   76 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-----GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCED-PSVLGTPF   76 (223)
T ss_pred             ceecCCCccceEEEEEecC-----CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCC-CCccCCce
Confidence            4678999999999998743     23688888665332  356789999999999742 234445442111 00012346


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS------------------------------------  126 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~------------------------------------  126 (366)
                      +||||++|.+|.+.+..   ..+++.....++.+++++|..||+                                    
T Consensus        77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999999988776531   246777777778888888888774                                    


Q ss_pred             --------------------CCcEecCCCCCcEEecc--CCceEEEecCCccc
Q 017746          127 --------------------KGFVHCDIKLQNVLVFD--NDEAKIADFGLAKK  157 (366)
Q Consensus       127 --------------------~givHrDlkp~NILl~~--~~~vkl~DFG~a~~  157 (366)
                                          ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                23699999999999998  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=1.4e-11  Score=121.24  Aligned_cols=156  Identities=20%  Similarity=0.280  Sum_probs=115.8

Q ss_pred             HHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCc-------ccccccCCCCCCCccccCCcC
Q 017746          115 RSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERS-------QSFECRGTPLYMSPESVNENE  186 (366)
Q Consensus       115 ~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~  186 (366)
                      .+++.||.|+|.. ++||++|.|++|.++.+|..||+.|+++.....+....       ...-..-...|.|||++.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            3444999999987 89999999999999999999999999886543321110       001122456799999999988


Q ss_pred             CCCccchhhhHHHHHHHH-hCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          187 YEAPCDIWALGCAVVEMA-SGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       187 ~~~~~DiwslG~il~eml-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+.++|++||||++|.+. .|+.-+........+. ..........-.....++.++++=|.++|..++..||++.+++.
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence            899999999999999999 5666665443332222 22222222222344678999999999999999999999999999


Q ss_pred             CCCccc
Q 017746          266 HPFVCA  271 (366)
Q Consensus       266 hp~~~~  271 (366)
                      -|||..
T Consensus       265 ~~ff~D  270 (700)
T KOG2137|consen  265 IPFFSD  270 (700)
T ss_pred             ccccCC
Confidence            999943

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.13  E-value=3.6e-09  Score=99.00  Aligned_cols=241  Identities=16%  Similarity=0.186  Sum_probs=153.2

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeE--------eecceeeccC
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR--------CFGDDYSFEK   76 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~--------~~g~~~~~~~   76 (366)
                      .++.||+|+-+.+|-.-.-.+   ...    |++..  .-...-..-++.|...-.||-+-.        ++|    - .
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d---~VA----KIYh~--Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G----~-~   80 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD---QVA----KIYHA--PPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHG----G-R   80 (637)
T ss_pred             CCccccCCccceeeecchhhc---hhh----eeecC--CCchHHHHHHHHhccCCCCcchhhhhcccHHHhhC----C-C
Confidence            467899999999996643221   122    33332  222223334455555544554332        333    1 2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHH-----HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEe
Q 017746           77 GERFYNLLLEYASRGSLADRVK-----KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~-----~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D  151 (366)
                      ....+.++|..+.|..--..+.     ++......+..+.+.++.|+.|.+-||+.|.+-+|+.++|+|+.+++.|.|.|
T Consensus        81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence            2233678999998853222221     22333478999999999999999999999999999999999999999999987


Q ss_pred             cCCccccCCCCCCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhC-CCCCCCCCc----chHHH-
Q 017746          152 FGLAKKSSCDGERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASG-KPAWNHKQD----SNVFS-  220 (366)
Q Consensus       152 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg-~~pf~~~~~----~~~~~-  220 (366)
                      =..-..- .++.  .....+|.+.|.+||...     +..-+...|.|.||+++++++.| +.||.+...    ....+ 
T Consensus       161 sDsfqi~-~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         161 SDSFQIN-ANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             ccceeec-cCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            5432221 1111  122336999999999754     44566789999999999999987 999965421    11122 


Q ss_pred             HHHH----------hhcCCCCCCCC-CCCCHHHHHHHHHhccc--CCCCCCCHHH
Q 017746          221 LLIR----------IGVGDELPNIP-GDLSEQGKDFLIKCFLK--DPKRRWTAEM  262 (366)
Q Consensus       221 ~~~~----------~~~~~~~~~~~-~~~s~~~~~ll~~cL~~--dp~~R~t~~~  262 (366)
                      .|..          .+.......+| .-+++++..+..+|++.  ++.-||+++.
T Consensus       238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            1111          11111111111 23688899999999986  4678998754

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.12  E-value=1.9e-09  Score=98.30  Aligned_cols=108  Identities=15%  Similarity=0.070  Sum_probs=79.7

Q ss_pred             hHHHHHHHHHHcCC----CCceeEeecceeeccCC-eeEEEEEeecCCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHH
Q 017746           47 TLKNEKEALDQIGI----CPQIVRCFGDDYSFEKG-ERFYNLLLEYASRG-SLADRVKKQNNGRLQESDVKRYTRSMLKG  120 (366)
Q Consensus        47 ~~~~E~~~l~~l~~----~p~Iv~~~g~~~~~~~~-~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~~~~qi~~a  120 (366)
                      ...+|...+.+|..    .|.+|-+..   ..... ....+||||++++- +|.+++........++.....++.+++..
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e---~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~  150 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGE---RGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATM  150 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEE---ecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHH
Confidence            36788888888742    243333321   11111 22345999999986 89999864323456777888999999999


Q ss_pred             HHHHHHCCcEecCCCCCcEEecc-------CCceEEEecCCccc
Q 017746          121 LRHIHSKGFVHCDIKLQNVLVFD-------NDEAKIADFGLAKK  157 (366)
Q Consensus       121 L~~LH~~givHrDlkp~NILl~~-------~~~vkl~DFG~a~~  157 (366)
                      +.-||..||+|+|+++.|||++.       +..+.|+||+.+..
T Consensus       151 i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        151 VRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99999999999999999999975       45799999998753

>PRK09902 hypothetical protein; Provisional

Probab=99.00  E-value=1.6e-08  Score=87.87  Aligned_cols=142  Identities=13%  Similarity=0.117  Sum_probs=103.4

Q ss_pred             eeecCCeeEEEEEECCCCCCCCceeEEeeecC-------CCCchhhHHHHHHHHHHcCC--CCceeEeecceeeccCCee
Q 017746            9 IGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD-------CPPSSVTLKNEKEALDQIGI--CPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         9 lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~-------~~~~~~~~~~E~~~l~~l~~--~p~Iv~~~g~~~~~~~~~~   79 (366)
                      -|+||-+.|+.....+.      .+.+|....       -+.....+.+|...+.+|..  .| +.+.............
T Consensus        26 ~~rgG~SgV~r~~~~g~------~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pvf~~~~k~~~~~   98 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK------KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIVFGEAVKIEGEW   98 (216)
T ss_pred             cCCCCcceEEEEEeCCc------EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccceeeeeccCCce
Confidence            36789999998876442      577887652       13456789999999998863  23 3333321111222333


Q ss_pred             EEEEEeecCCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc--eEEEecCCcc
Q 017746           80 FYNLLLEYASR-GSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE--AKIADFGLAK  156 (366)
Q Consensus        80 ~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~--vkl~DFG~a~  156 (366)
                      .-.||+|-+.| -+|.+++....-.+.++.....+..+++..|.-||..|+.|+|+-+.||+++.+|.  ++++||.-++
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            45699998764 59999986533335678888899999999999999999999999999999987777  9999998765


Q ss_pred             c
Q 017746          157 K  157 (366)
Q Consensus       157 ~  157 (366)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.00  E-value=2.7e-09  Score=91.93  Aligned_cols=100  Identities=24%  Similarity=0.342  Sum_probs=66.8

Q ss_pred             hhHHHHHHHHHHcCCC-CceeEeecceeeccCCeeEEEEEeecCC--CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHH
Q 017746           46 VTLKNEKEALDQIGIC-PQIVRCFGDDYSFEKGERFYNLLLEYAS--RGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR  122 (366)
Q Consensus        46 ~~~~~E~~~l~~l~~~-p~Iv~~~g~~~~~~~~~~~~~lv~E~~~--~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~  122 (366)
                      ...++|.+.|.++... -++.+.+.    +..    -.|||||++  |..+..+...    .++.+....++.+++..+.
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~----~~~----~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~  120 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYD----YNR----NVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEII  120 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEE----EET----TEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEE----EeC----CEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHH
Confidence            3467799999999743 24555543    222    139999999  6555444322    2335667788888888665


Q ss_pred             H-HHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746          123 H-IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus       123 ~-LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      . +|..||+|+||.+.|||++++ .+.|+|||.+...
T Consensus       121 ~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  121 KMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             HHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             HHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence            5 579999999999999999877 8999999988765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=1.4e-08  Score=89.26  Aligned_cols=109  Identities=20%  Similarity=0.235  Sum_probs=82.2

Q ss_pred             hhhHHHHHHHHHHcCC----CCceeEeecceeeccCCeeEEEEEeecCCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHH
Q 017746           45 SVTLKNEKEALDQIGI----CPQIVRCFGDDYSFEKGERFYNLLLEYASRG-SLADRVKKQNNGRLQESDVKRYTRSMLK  119 (366)
Q Consensus        45 ~~~~~~E~~~l~~l~~----~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~~~~qi~~  119 (366)
                      .....+|...+..|..    .|..+-+.   ..-.......++|+|++++. +|.+++....  .++......++.+++.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~---~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYG---ERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALAR  129 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEE---EEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHH
Confidence            3457778887777742    23333332   22122223456999999984 8999997632  2678888999999999


Q ss_pred             HHHHHHHCCcEecCCCCCcEEeccCC---ceEEEecCCcccc
Q 017746          120 GLRHIHSKGFVHCDIKLQNVLVFDND---EAKIADFGLAKKS  158 (366)
Q Consensus       120 aL~~LH~~givHrDlkp~NILl~~~~---~vkl~DFG~a~~~  158 (366)
                      .+.-||++||+|+|+++.|||++.++   .+.|+||+-++..
T Consensus       130 ~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  130 LIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.92  E-value=8.3e-09  Score=91.93  Aligned_cols=136  Identities=23%  Similarity=0.213  Sum_probs=99.6

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-----------------------CchhhHHHHHHHHHHcC
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-----------------------PSSVTLKNEKEALDQIG   59 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-----------------------~~~~~~~~E~~~l~~l~   59 (366)
                      +.++..||-|--+.||.|.+..     +.++++|.-....                       -.....++|.++|.+|.
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~-----g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~  167 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPK-----GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY  167 (304)
T ss_pred             HhhccccccCccceEEEEECCC-----CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence            3578899999999999999763     2478888543210                       12345788999999997


Q ss_pred             CC-CceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCc
Q 017746           60 IC-PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQN  138 (366)
Q Consensus        60 ~~-p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N  138 (366)
                      .. -.+.+.++        .+.-.+||||++|-.|...       +++.+.+..++..|++-+.-+-..|+||+|+.+-|
T Consensus       168 ~~G~~VP~P~~--------~nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefN  232 (304)
T COG0478         168 PEGVKVPKPIA--------WNRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFN  232 (304)
T ss_pred             hcCCCCCCccc--------cccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchhe
Confidence            43 24555544        1223499999999666533       23455666677777777777779999999999999


Q ss_pred             EEeccCCceEEEecCCcccc
Q 017746          139 VLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus       139 ILl~~~~~vkl~DFG~a~~~  158 (366)
                      |+++++|.+.++||--+...
T Consensus       233 IlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EEEecCCCEEEEeCcccccC
Confidence            99999999999999876543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.77  E-value=3.6e-08  Score=102.46  Aligned_cols=209  Identities=22%  Similarity=0.266  Sum_probs=146.6

Q ss_pred             hhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 017746           46 VTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH  125 (366)
Q Consensus        46 ~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH  125 (366)
                      ...+.|...+..+. |+|++.++++...-...+-...+.-|+|..-++...++.  -+.++..+++.+..++++||.|+|
T Consensus       227 ~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHH
Confidence            44566777888888 899999988443222222123466789999999999965  357899999999999999999999


Q ss_pred             HCCcEecCCCCC---cEEeccCCceEEE--ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCc--cchhhhHH
Q 017746          126 SKGFVHCDIKLQ---NVLVFDNDEAKIA--DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAP--CDIWALGC  198 (366)
Q Consensus       126 ~~givHrDlkp~---NILl~~~~~vkl~--DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwslG~  198 (366)
                      +....|.-+...   +-..+..+.+.++  ||+.++.......   .....-+..+.+||......+..+  .|+|.+|.
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHH
Confidence            996555555444   3334455667766  9998887643322   222234567889998877777764  79999999


Q ss_pred             HHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCCC
Q 017746          199 AVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ  274 (366)
Q Consensus       199 il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~~  274 (366)
                      ++..+..|..+-...   .....+           ++........+++.+|+.-++++|+.+.+++.|+|.+....
T Consensus       381 l~~~~~~~~~i~~~~---~~~~~~-----------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~  442 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKS---AVPVSL-----------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD  442 (1351)
T ss_pred             HHhhhhhcCcccccc---cchhhh-----------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence            999999877553211   111111           11112226778999999999999999999999999865433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.73  E-value=2.3e-09  Score=104.92  Aligned_cols=236  Identities=21%  Similarity=0.248  Sum_probs=161.6

Q ss_pred             eeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCc-eeEeecceeeccCCeeEEEEEee
Q 017746            8 VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ-IVRCFGDDYSFEKGERFYNLLLE   86 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~-Iv~~~g~~~~~~~~~~~~~lv~E   86 (366)
                      -.++|+++.+++.+...+.     ....+.+..    .....-++++|.+++ ||| .+..++    .++.+.+..++|+
T Consensus       249 ~fvK~altknpKkRptaek-----lL~h~fvs~----~l~~rl~~eLLdK~n-~P~~~v~~~~----d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEK-----LLQHPFVSQ----TLSRRLAIELLDKVN-NPNPVVRYLE----DYDGEDYLWIPMR  314 (829)
T ss_pred             HHHHHHhcCCCccCCChhh-----heeceeecc----chhhHHHHHHHHHcc-CCCCcccccc----cCCcccccchhhh
Confidence            4578889999988765432     122333332    256677899999999 899 666655    3455667789999


Q ss_pred             cCCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCc
Q 017746           87 YASRG-SLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERS  165 (366)
Q Consensus        87 ~~~~g-~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  165 (366)
                      ++.++ +-...+.. ..-.+.+-+...+.+.-+++|+++|+.-=+|||    ||+..+ +..|..||+.+..+....   
T Consensus       315 i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---  385 (829)
T KOG0576|consen  315 ICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---  385 (829)
T ss_pred             hhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc---
Confidence            99987 22222211 112355556666777778899999998778998    888765 678999999988764322   


Q ss_pred             ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC---CCCHHH
Q 017746          166 QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG---DLSEQG  242 (366)
Q Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~  242 (366)
                      ......+|+.++|||+.....+....|.|++|+--.+|.-|-+|-....     .....++.+...+.+.+   +-+..-
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~-----~~~~~~g~~p~s~~L~~~~aw~~~~~  460 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP-----AVLPMIGNGPNSPMLTDKSAWSPVFH  460 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc-----cccCCCCCCCCccccchhhhcCcccc
Confidence            3345579999999999999999999999999998888888888864421     11222222221111111   001111


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          243 KDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .++...|+..-|..|+.....+.|.+|..
T Consensus       461 ~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  461 RDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             cCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            25778899999999999999999888854

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.61  E-value=7.6e-07  Score=77.84  Aligned_cols=68  Identities=28%  Similarity=0.431  Sum_probs=54.0

Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ..+.|+|||++|..|.+...      +++    .+...|.++|.-||+.|++|+|.+|.|++++.+ .+++.||+..+.
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             eEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECccccc
Confidence            34569999999988876542      333    244667788999999999999999999999865 499999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.52  E-value=5.8e-07  Score=79.83  Aligned_cols=144  Identities=18%  Similarity=0.181  Sum_probs=82.5

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC-CceeEeecceeeccCCeeEEEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-PQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~-p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ++.|+.|..+.||++...+ +     .+++|..... .....+.+|..+++.+..+ ..+.+++.... ........+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~-----~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~-~~~~~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-G-----RYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDT-SDEFNGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-S-----EEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEE-ETEETSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-c-----EEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecc-cccccccceEE
Confidence            4678999999999998765 2     7888886653 3456788999999888633 22445554221 12222346799


Q ss_pred             eecCCCCCHHH----------------HHHHh--C---CCCCCHHH---------HHHH------------HHHHHH-HH
Q 017746           85 LEYASRGSLAD----------------RVKKQ--N---NGRLQESD---------VKRY------------TRSMLK-GL  121 (366)
Q Consensus        85 ~E~~~~g~L~~----------------~l~~~--~---~~~l~~~~---------~~~~------------~~qi~~-aL  121 (366)
                      |++++|..+..                .+.+.  .   ...+....         ....            ...+.. .+
T Consensus        74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            99999988887                11110  0   01111000         0000            011122 23


Q ss_pred             HHHHH-------CCcEecCCCCCcEEec-cCCceEEEecCCccc
Q 017746          122 RHIHS-------KGFVHCDIKLQNVLVF-DNDEAKIADFGLAKK  157 (366)
Q Consensus       122 ~~LH~-------~givHrDlkp~NILl~-~~~~vkl~DFG~a~~  157 (366)
                      ..+++       ..++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            33332       3599999999999999 666678999997653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.49  E-value=1.8e-06  Score=77.06  Aligned_cols=136  Identities=15%  Similarity=0.104  Sum_probs=77.4

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCC-ceeEeecceeeccCCeeEEEEEe
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP-QIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p-~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      ..||+|..+.||+..    +    ..+++|..... .....+.+|.++++.+.... .+.+.++    +......+.+||
T Consensus         7 ~~i~~G~t~~~y~~~----~----~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~----~~~~~~~~glv~   73 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----T----GKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFD----LVEDGGRLGLIY   73 (226)
T ss_pred             eeecCCCCcceeEec----C----CCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEE----EEecCCeeeeee
Confidence            578999999999731    2    24677776542 34456899999999986321 1233333    222223355899


Q ss_pred             ecCCCCC-HH--------------HHHH----HhCCC---CCCH-HHHHHHHHHH----------HH-HHHHHHH----C
Q 017746           86 EYASRGS-LA--------------DRVK----KQNNG---RLQE-SDVKRYTRSM----------LK-GLRHIHS----K  127 (366)
Q Consensus        86 E~~~~g~-L~--------------~~l~----~~~~~---~l~~-~~~~~~~~qi----------~~-aL~~LH~----~  127 (366)
                      |+++|.+ +.              ..+.    +-+..   .... .....+..++          .. ...+|..    .
T Consensus        74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            9999963 11              1111    11110   0110 0011111111          11 1122221    2


Q ss_pred             CcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746          128 GFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus       128 givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      .++|+|+.|.||++++++ +.|+||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            478999999999999888 9999999765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.38  E-value=3.3e-06  Score=76.08  Aligned_cols=138  Identities=14%  Similarity=0.077  Sum_probs=80.6

Q ss_pred             CeeeecCC-eeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEe
Q 017746            7 DVIGHGSF-GSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         7 ~~lG~G~f-g~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      +.|-.|.+ +.||+....+      .++++|......  ...+.+|.++++.+..+--+.++++..   ..+ ...++||
T Consensus         4 ~~~~~g~~~~~v~~~~~~~------~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~---~~~-~~~~lv~   71 (244)
T cd05150           4 ERVTEGQSGATVYRLDGKN------PGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYG---SDD-GRAWLLT   71 (244)
T ss_pred             eecCCCCCcCeEEEEcCCC------CcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEE---ecC-CccEEEE
Confidence            44566777 6789986532      267888765432  346788999999997553344555421   111 2345899


Q ss_pred             ecCCCCCHHHHH----------------HHhCC-----CCCCHH---HHHHHHH-------------------HHHHHHH
Q 017746           86 EYASRGSLADRV----------------KKQNN-----GRLQES---DVKRYTR-------------------SMLKGLR  122 (366)
Q Consensus        86 E~~~~g~L~~~l----------------~~~~~-----~~l~~~---~~~~~~~-------------------qi~~aL~  122 (366)
                      |+++|.+|....                .+-+.     ..+...   .......                   .+...+.
T Consensus        72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (244)
T cd05150          72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA  151 (244)
T ss_pred             EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence            999998776442                11111     011100   0000000                   0111122


Q ss_pred             HHH-------HCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746          123 HIH-------SKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus       123 ~LH-------~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      .|-       ...++|+|+.|.|||+++++.+.|+||+.|.
T Consensus       152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            221       1349999999999999988778999999765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.34  E-value=8e-06  Score=70.59  Aligned_cols=100  Identities=19%  Similarity=0.204  Sum_probs=79.1

Q ss_pred             HHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHH---HHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 017746           49 KNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADR---VKKQNNGRLQESDVKRYTRSMLKGLRHIH  125 (366)
Q Consensus        49 ~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~---l~~~~~~~l~~~~~~~~~~qi~~aL~~LH  125 (366)
                      ..|.-+++.+.+.+++.+++|.+-.       + +|.||...+++...   +..  -...++.....++.++++.+++|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~-------~-~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR-------F-YVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC-------E-EEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHh
Confidence            4588888899877899999995421       2 78999987766421   111  013589999999999999999999


Q ss_pred             H---CCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746          126 S---KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus       126 ~---~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      .   ..+.-+|++|+|+-++++|++|++|...+...
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            8   35888999999999999999999999977543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.33  E-value=2.5e-06  Score=84.36  Aligned_cols=74  Identities=20%  Similarity=0.410  Sum_probs=54.2

Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHH-HHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG-LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~a-L~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .|+|||++|-.+.+...... ..++.+.+.   ..++++ +..+-..|+.|.|.+|.||++..+|.+-+.|||+...++
T Consensus       242 VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         242 VLTMEWIDGIKISDIAALKS-AGIDRKELA---ELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             EEEEEeeCCEecccHHHHHh-cCCCHHHHH---HHHHHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            39999999999988853322 235533332   222222 344555899999999999999999999999999988764

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.23  E-value=9e-06  Score=80.32  Aligned_cols=73  Identities=27%  Similarity=0.370  Sum_probs=52.3

Q ss_pred             EEEeecCCCCCHHHH--HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc----CCceEEEecCCc
Q 017746           82 NLLLEYASRGSLADR--VKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD----NDEAKIADFGLA  155 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~--l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~----~~~vkl~DFG~a  155 (366)
                      .|+||||+|..+.|.  |++   ..++...+...+.+..  ++.|-..|++|+|-+|.||+++.    ++.+.+.|||+.
T Consensus       278 VLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~  352 (538)
T KOG1235|consen  278 VLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLY  352 (538)
T ss_pred             EEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccc
Confidence            499999999877654  443   2366664444333322  34455678999999999999984    568999999998


Q ss_pred             cccC
Q 017746          156 KKSS  159 (366)
Q Consensus       156 ~~~~  159 (366)
                      ..+.
T Consensus       353 ~~is  356 (538)
T KOG1235|consen  353 AVIS  356 (538)
T ss_pred             cccc
Confidence            8764

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.13  E-value=2.3e-05  Score=69.49  Aligned_cols=134  Identities=21%  Similarity=0.257  Sum_probs=85.4

Q ss_pred             eeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCch-------------------------hhHHHHHHHHHHcCC-C
Q 017746            8 VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSS-------------------------VTLKNEKEALDQIGI-C   61 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~-------------------------~~~~~E~~~l~~l~~-~   61 (366)
                      +|..|--+.||+|....     ...+|+|++......-                         .-...|..-|.++.. .
T Consensus        55 ~istGKEA~Vy~a~~~~-----~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAG  129 (268)
T COG1718          55 CISTGKEANVYLAETGD-----GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG  129 (268)
T ss_pred             eecCCcceEEEeeccCC-----CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcC
Confidence            45566667899997632     2478888776521110                         112335555555541 1


Q ss_pred             CceeEeecceeeccCCeeEEEEEeecCCCCC-HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcE
Q 017746           62 PQIVRCFGDDYSFEKGERFYNLLLEYASRGS-LADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNV  139 (366)
Q Consensus        62 p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~-L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NI  139 (366)
                      -.+.+-++    +..    -.|||||+.... -.-.|   ....+..+++..+..++++.+.-|-. .|+||+||..=||
T Consensus       130 VrvP~Pi~----~~~----nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNi  198 (268)
T COG1718         130 VRVPEPIA----FRN----NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNI  198 (268)
T ss_pred             CCCCCcee----ecC----CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhhe
Confidence            12222222    111    139999997631 11111   11234445788899999999998887 8999999999999


Q ss_pred             EeccCCceEEEecCCcccc
Q 017746          140 LVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus       140 Ll~~~~~vkl~DFG~a~~~  158 (366)
                      |+. ++.+.|+|||-|...
T Consensus       199 L~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         199 LVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             EEE-CCeEEEEECcccccc
Confidence            998 789999999988764

>PLN02876 acyl-CoA dehydrogenase

Probab=98.11  E-value=2.4e-05  Score=82.80  Aligned_cols=149  Identities=18%  Similarity=0.261  Sum_probs=86.3

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCce--eEeecceeeccCCeeEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQI--VRCFGDDYSFEKGERFY   81 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~I--v~~~g~~~~~~~~~~~~   81 (366)
                      .+.++.|.++.+|+......+.  ...+++|+.....  .....+.+|.++|+.+..++++  .++++.+.... .....
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~--~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~-v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGS--VKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS-VIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCc--ceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC-cCCCc
Confidence            5678889999999987643221  1256677654322  2335688999999999645544  55554221111 11234


Q ss_pred             EEEeecCCCCCHHH--------------------HHHHhCC-----------C-C--CCHHHHHHHHHH-----------
Q 017746           82 NLLLEYASRGSLAD--------------------RVKKQNN-----------G-R--LQESDVKRYTRS-----------  116 (366)
Q Consensus        82 ~lv~E~~~~g~L~~--------------------~l~~~~~-----------~-~--l~~~~~~~~~~q-----------  116 (366)
                      ++||||++|..+.+                    .+.+-+.           + +  ....++..|..+           
T Consensus       120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~  199 (822)
T PLN02876        120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP  199 (822)
T ss_pred             eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence            59999999864321                    1111111           0 0  111233332222           


Q ss_pred             ----HHHHHHHHHH-----------CCcEecCCCCCcEEeccC-C-ceEEEecCCccc
Q 017746          117 ----MLKGLRHIHS-----------KGFVHCDIKLQNVLVFDN-D-EAKIADFGLAKK  157 (366)
Q Consensus       117 ----i~~aL~~LH~-----------~givHrDlkp~NILl~~~-~-~vkl~DFG~a~~  157 (366)
                          +...+++|..           ..+||+|+++.|||++.+ + .+-|.||+++..
T Consensus       200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence                2233556643           249999999999999853 3 367999999864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.09  E-value=6.7e-07  Score=95.31  Aligned_cols=214  Identities=15%  Similarity=0.003  Sum_probs=140.4

Q ss_pred             HHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH
Q 017746           49 KNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN--NGRLQESDVKRYTRSMLKGLRHIHS  126 (366)
Q Consensus        49 ~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~  126 (366)
                      ..|...++++. |+++...+.-....+.  ..-+.+++||.+|.+++.|-+..  ...+.+.-+.....+.+.+..-+|+
T Consensus      1277 l~e~de~~~~~-h~~~~~~p~rI~ps~s--~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1277 LSERDELREAK-HYLTEVDPLRIPPSES--TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             hhhhhhhhhhh-ceeeecccccCCCCCC--hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            33444555556 7888776542221122  22348999999999999997621  1235555555555665888888887


Q ss_pred             CC-----cEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHH
Q 017746          127 KG-----FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVV  201 (366)
Q Consensus       127 ~g-----ivHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  201 (366)
                      ..     .+|+++|+-|.+|..+.++|+.++|+.+...  ....-.....+++.|++|++...-.++.++|+|..|+.+|
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            52     8999999999999999999999999998432  1122223456889999999998889999999999999999


Q ss_pred             HHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          202 EMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       202 emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +..-|..+|.....    ..+...........++.-.|.++-.....+|-..-..||.-...+.-+.+..
T Consensus      1432 ~rs~~n~~fi~flq----~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFFLQ----PALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred             HHhcccHHHHHHHH----HHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence            99999998842211    1111111111111222222333333344444455568899888888777733

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.06  E-value=3.8e-05  Score=64.61  Aligned_cols=129  Identities=15%  Similarity=0.125  Sum_probs=89.0

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      ..+.||.|.+|.||++.....      .+++|.-.. +.....++.|.++|..+...---.+++.+..        -++.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~~~------~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~--------~~i~   90 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWRGG------EVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGE--------DFIR   90 (201)
T ss_pred             hhhhhhcccccEEEEeeccCc------eEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEech--------hhhh
Confidence            356899999999999987642      567776443 4667789999999999985333334443211        1266


Q ss_pred             eecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC-CCcEEeccCCceEEEecCCccc
Q 017746           85 LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIK-LQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        85 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlk-p~NILl~~~~~vkl~DFG~a~~  157 (366)
                      |||+.|-.|.+.-..   +  +...    ...++.+-.-|-..||-|..|. |..++|..++.+.|+||.-|+.
T Consensus        91 me~i~G~~L~~~~~~---~--~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          91 MEYIDGRPLGKLEIG---G--DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhcCcchhhhhhc---c--cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            999999888776532   1  2222    3345555556677899999986 5555565666999999998874

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.00  E-value=3.7e-05  Score=68.96  Aligned_cols=78  Identities=9%  Similarity=0.039  Sum_probs=45.9

Q ss_pred             cCeeeecCCee-EEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC--CceeEeecceeeccCCeeEEE
Q 017746            6 GDVIGHGSFGS-VNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         6 ~~~lG~G~fg~-Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~--p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      ++.|+.|+... ||+..     .    .+++|.... ......+.+|.++++.+..+  -.+.++++... ..+.....+
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~----~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~-~~~~~~~~~   70 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----D----DMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGE-PGEGYPWPW   70 (235)
T ss_pred             ceeccCCCcccceEEcC-----C----ceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCC-CccCCCcce
Confidence            45678777774 88762     1    356676543 23445799999999998642  12333333111 111112335


Q ss_pred             EEeecCCCCCHH
Q 017746           83 LLLEYASRGSLA   94 (366)
Q Consensus        83 lv~E~~~~g~L~   94 (366)
                      ++||+++|.++.
T Consensus        71 ~l~~~i~G~~l~   82 (235)
T cd05155          71 SVYRWLEGETAT   82 (235)
T ss_pred             EEEEeecCCCCC
Confidence            889999997663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.98  E-value=0.00011  Score=63.74  Aligned_cols=128  Identities=23%  Similarity=0.295  Sum_probs=87.6

Q ss_pred             CccccCeeeecCC-eeEEEEEECCCCCCCCceeEEeee---cCCC-------------------CchhhHHHHHHHHHHc
Q 017746            2 EWLRGDVIGHGSF-GSVNLAKASKVSSEFPSLMAVKSC---ADCP-------------------PSSVTLKNEKEALDQI   58 (366)
Q Consensus         2 ~y~~~~~lG~G~f-g~Vy~a~~~~~~~~~~~~~avK~~---~~~~-------------------~~~~~~~~E~~~l~~l   58 (366)
                      ++..++.||.|.- |.||++...+      ..+|+|..   ....                   .....+..|.++.-+|
T Consensus        38 ~I~flefLg~g~~~~~V~kv~I~g------~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL  111 (207)
T PF13095_consen   38 DIEFLEFLGHGSHDGYVFKVEIDG------RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL  111 (207)
T ss_pred             cEeeeeecCCCCceeEEEEEEECC------eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence            3567889999999 9999999864      37788872   1110                   0123466788777777


Q ss_pred             CCC--Cce--eEeecceeecc--------------CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHH
Q 017746           59 GIC--PQI--VRCFGDDYSFE--------------KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG  120 (366)
Q Consensus        59 ~~~--p~I--v~~~g~~~~~~--------------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~a  120 (366)
                      +.+  .++  |+|+|...-..              .....+.+|.||++...           .+..    .-+.+|++-
T Consensus       112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~d  176 (207)
T PF13095_consen  112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRD  176 (207)
T ss_pred             HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHH
Confidence            643  345  99999553211              11234568888887633           1233    344678888


Q ss_pred             HHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746          121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus       121 L~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      |..+|..||+-+|+|+.|..     .-||+|||.+
T Consensus       177 l~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  177 LKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999999999987     3499999964

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.97  E-value=8.8e-05  Score=66.32  Aligned_cols=77  Identities=9%  Similarity=0.097  Sum_probs=48.1

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEe
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      .+.|..|-...+|+.......   ...+++|............++|..+++.+....-..++++   .. .+    .++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~---~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~---~~-~~----~~l~   71 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDN---QDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYA---TF-QN----GLIY   71 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCC---CCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEE---Ee-CC----cEEE
Confidence            456777888899998754200   1367788765433333455689999999864433444443   11 11    2799


Q ss_pred             ecCCCCCH
Q 017746           86 EYASRGSL   93 (366)
Q Consensus        86 E~~~~g~L   93 (366)
                      ||++|.++
T Consensus        72 e~i~G~~l   79 (235)
T cd05157          72 EFIPGRTL   79 (235)
T ss_pred             EeeCCCcC
Confidence            99999765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.83  E-value=0.00026  Score=65.88  Aligned_cols=80  Identities=14%  Similarity=0.033  Sum_probs=52.4

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC--CceeEeecceeeccCCeeEEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~--p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      .+.||.|..+.||.....+ +     ++++|.... ......+..|.+.|+.|...  ..+.++++.+. .....+..++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~-~-----~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~-~~~~~g~~~L   90 (297)
T PRK10593         19 VECISEQPYAALWALYDSQ-G-----NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMT-HEQSPGPDVL   90 (297)
T ss_pred             eeecCCccceeEEEEEcCC-C-----CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEec-cCCcCCCeEE
Confidence            4578999999999986433 1     455565332 12345889999999999754  35667765322 1222233459


Q ss_pred             EeecCCCCCH
Q 017746           84 LLEYASRGSL   93 (366)
Q Consensus        84 v~E~~~~g~L   93 (366)
                      |||+++|+++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.82  E-value=0.00045  Score=62.73  Aligned_cols=135  Identities=13%  Similarity=0.128  Sum_probs=77.0

Q ss_pred             eeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCch-hhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEee
Q 017746            8 VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSS-VTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLE   86 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E   86 (366)
                      .+..|-.+.+|+....  +    .++++|......... ....+|..+++.+..+.-..++++    ...  .  ++|||
T Consensus         3 ~~~~G~tn~~y~~~~~--~----~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~----~~~--~--~~v~e   68 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHP--G----ISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPIL----VNE--H--WLLVE   68 (256)
T ss_pred             cCCCcCcCCeEEEEeC--C----ccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEE----EeC--C--EEEEE
Confidence            4566778899988632  2    367788755422221 356889999999974321223332    111  1  38999


Q ss_pred             cCCCCCHHH--------------HHHHhCC-----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCc
Q 017746           87 YASRGSLAD--------------RVKKQNN-----GRLQE-SDVKRYTRSM---------LKGLRHIHS--------KGF  129 (366)
Q Consensus        87 ~~~~g~L~~--------------~l~~~~~-----~~l~~-~~~~~~~~qi---------~~aL~~LH~--------~gi  129 (366)
                      |++|..+..              .+.+-+.     .+++. ..+..+..++         ...++.+-.        ..+
T Consensus        69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  148 (256)
T TIGR02721        69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP  148 (256)
T ss_pred             eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence            999866532              1122111     11221 1222222222         111222222        248


Q ss_pred             EecCCCCCcEEeccCCceEEEecCCccc
Q 017746          130 VHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       130 vHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +|+|+.|.||++++++ +.|+||+.|..
T Consensus       149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       149 LHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999999877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.80  E-value=0.00038  Score=60.54  Aligned_cols=129  Identities=19%  Similarity=0.196  Sum_probs=83.0

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-----------------CchhhHHHHHHHHHHcC-----CCC
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-----------------PSSVTLKNEKEALDQIG-----ICP   62 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-----------------~~~~~~~~E~~~l~~l~-----~~p   62 (366)
                      -...||+|+.=.||.=  ..+.     ...||+.....                 .......+|+.-..++.     .+.
T Consensus         5 ~~~~i~~G~~R~cy~H--P~dp-----~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~   77 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--PDDP-----NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWS   77 (199)
T ss_pred             CCcccccCCCceEEEC--CCCC-----CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccc
Confidence            3568999999999953  3332     23455554422                 23456667777666665     257


Q ss_pred             ceeEeecceeeccCCeeEEEEEeecCCC------CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCC
Q 017746           63 QIVRCFGDDYSFEKGERFYNLLLEYASR------GSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKL  136 (366)
Q Consensus        63 ~Iv~~~g~~~~~~~~~~~~~lv~E~~~~------g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp  136 (366)
                      +|.+++|...+   +.+ ..+|+|.+.+      -+|.+++++   +.+++    .+...+-+-.+||-+++|+.+||+|
T Consensus        78 ~i~r~~G~veT---~~G-~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~  146 (199)
T PF10707_consen   78 HIPRFYGFVET---NLG-LGLVVELIRDADGNISPTLEDYLKE---GGLTE----ELRQALDEFKRYLLDHHIVIRDLNP  146 (199)
T ss_pred             ccccEeEEEec---CCc-eEEEEEEEECCCCCcCccHHHHHHc---CCccH----HHHHHHHHHHHHHHHcCCeecCCCc
Confidence            88999994332   222 3467776653      378888854   34655    2333444556788999999999999


Q ss_pred             CcEEeccCC----ceEEEe
Q 017746          137 QNVLVFDND----EAKIAD  151 (366)
Q Consensus       137 ~NILl~~~~----~vkl~D  151 (366)
                      .||++..+.    .+.|+|
T Consensus       147 ~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             ccEEEEecCCCceEEEEEe
Confidence            999996432    477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.67  E-value=0.00093  Score=64.38  Aligned_cols=77  Identities=18%  Similarity=0.200  Sum_probs=50.9

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--------CCchhhHHHHHHHHHHcCCC--CceeEeecceeecc
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--------PPSSVTLKNEKEALDQIGIC--PQIVRCFGDDYSFE   75 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--------~~~~~~~~~E~~~l~~l~~~--p~Iv~~~g~~~~~~   75 (366)
                      .+.||.|.+..||++...+.+    ..++||.....        +....+...|.+.|+.+...  .++.+++.    +.
T Consensus        31 ~~elggGn~N~VyrV~~~~g~----~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~----~D  102 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGG----KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYH----YD  102 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCC----eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEE----EC
Confidence            357899999999999975321    25788875421        12345678888999887543  34666665    22


Q ss_pred             CCeeEEEEEeecCCCCC
Q 017746           76 KGERFYNLLLEYASRGS   92 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~   92 (366)
                      . + ..++||||+++..
T Consensus       103 ~-~-~~~lVME~L~~~~  117 (401)
T PRK09550        103 E-E-LAVTVMEDLSDHK  117 (401)
T ss_pred             C-C-CCEEEEecCCCcc
Confidence            2 2 2449999998744

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.67  E-value=0.00037  Score=64.59  Aligned_cols=144  Identities=15%  Similarity=0.111  Sum_probs=82.6

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC-CceeEeeccee--eccCCeeEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-PQIVRCFGDDY--SFEKGERFY   81 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~-p~Iv~~~g~~~--~~~~~~~~~   81 (366)
                      ..+.|..|....+|+....+      ..+++|....  .....+..|.+++..|..+ -.+.+++....  .+....+..
T Consensus        18 ~i~~i~~G~~n~~y~v~~~~------~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          18 SFEGISAGIENTNYFVTTDS------GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             heecccCccccceEEEEeCC------CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            35567778878999886432      1577787654  3445678888888888532 12444433110  011112345


Q ss_pred             EEEeecCCCCCHHH-----------HHHHhC----C--CC-----C-CHHHH----------HHHHHHHHHHHHHHHH--
Q 017746           82 NLLLEYASRGSLAD-----------RVKKQN----N--GR-----L-QESDV----------KRYTRSMLKGLRHIHS--  126 (366)
Q Consensus        82 ~lv~E~~~~g~L~~-----------~l~~~~----~--~~-----l-~~~~~----------~~~~~qi~~aL~~LH~--  126 (366)
                      ++|+++++|..+..           .+.+-+    +  ..     . .+...          ......+..++.++.+  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            69999999876421           111100    0  00     0 00000          0111223344455543  


Q ss_pred             -----CCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746          127 -----KGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus       127 -----~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                           .+++|+|+.|.|||+++++.+.|.||+.+.
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                 379999999999999988777999999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.66  E-value=0.0008  Score=62.85  Aligned_cols=144  Identities=15%  Similarity=0.082  Sum_probs=80.1

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC-CceeEeeccee--eccCCeeEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-PQIVRCFGDDY--SFEKGERFYN   82 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~-p~Iv~~~g~~~--~~~~~~~~~~   82 (366)
                      .+.++.|....+|+.... ++     ++++|..... .....+..|.+++..|..+ -.+.+++....  ......+..+
T Consensus        27 i~~~~~G~~n~~y~v~t~-~~-----~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-VG-----RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ccccCCccccceEEEEeC-CC-----cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            456777777899988642 22     4667765432 2345667788888887421 11344433110  0111123456


Q ss_pred             EEeecCCCCCHH-----------HHHHHhC--CCCC--------CHH---HH--H----------HHHHHHHHHHHHHHH
Q 017746           83 LLLEYASRGSLA-----------DRVKKQN--NGRL--------QES---DV--K----------RYTRSMLKGLRHIHS  126 (366)
Q Consensus        83 lv~E~~~~g~L~-----------~~l~~~~--~~~l--------~~~---~~--~----------~~~~qi~~aL~~LH~  126 (366)
                      ++|||++|.++.           ..+.+.+  ...+        ...   ..  .          .....+...++++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999985431           1111100  0000        000   00  0          011123345555543


Q ss_pred             -------CCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746          127 -------KGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus       127 -------~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                             .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                   579999999999999988877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.61  E-value=0.0014  Score=61.44  Aligned_cols=31  Identities=29%  Similarity=0.418  Sum_probs=26.3

Q ss_pred             CCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       127 ~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      .++||+|++|.|||++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3899999999999998665568999998653

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.59  E-value=0.00073  Score=62.87  Aligned_cols=80  Identities=13%  Similarity=0.120  Sum_probs=48.6

Q ss_pred             CeeeecCCeeEEEEEECCC--CCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKV--SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~--~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv   84 (366)
                      +.|..|-...+|+......  .+..+..+++|.............+|.+++..+...--..++++.   + .+    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~---~-~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGI---F-PN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEE---e-CC----Cch
Confidence            4556666678998875431  111234788888765434446778899999998743223344431   1 11    268


Q ss_pred             eecCCCCCHH
Q 017746           85 LEYASRGSLA   94 (366)
Q Consensus        85 ~E~~~~g~L~   94 (366)
                      +||++|.++.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=97.40  E-value=0.0012  Score=62.62  Aligned_cols=142  Identities=14%  Similarity=0.191  Sum_probs=81.1

Q ss_pred             eeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEeec
Q 017746            8 VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEY   87 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~   87 (366)
                      .|-.|-...+|++...........++++|.............+|..+++.+..+.--.++++   .+..+     .|.||
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~---~~~~g-----~v~ef  114 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLG---RFPNG-----RVEEF  114 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEE---EECCc-----eEEEe
Confidence            44446667899987543222223578889877644444456889999999875422334444   12222     57888


Q ss_pred             CCCCCHHHH--------------HHHhCCCC-------CCHHHHHHHHHHHH-----------------HHHHHH----H
Q 017746           88 ASRGSLADR--------------VKKQNNGR-------LQESDVKRYTRSML-----------------KGLRHI----H  125 (366)
Q Consensus        88 ~~~g~L~~~--------------l~~~~~~~-------l~~~~~~~~~~qi~-----------------~aL~~L----H  125 (366)
                      +++.+|...              +.+-+...       .....+..+..++.                 ..+..|    .
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            887665311              11111111       11233334332221                 111112    1


Q ss_pred             ----HCCcEecCCCCCcEEecc-CCceEEEecCCccc
Q 017746          126 ----SKGFVHCDIKLQNVLVFD-NDEAKIADFGLAKK  157 (366)
Q Consensus       126 ----~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~  157 (366)
                          ...++|+|+++.|||+++ ++.+.|+||..|..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence                225899999999999986 46899999998753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.30  E-value=0.00027  Score=65.13  Aligned_cols=134  Identities=13%  Similarity=0.139  Sum_probs=89.1

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-----------------C------chhhHHHHHHHHHHcC
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-----------------P------SSVTLKNEKEALDQIG   59 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-----------------~------~~~~~~~E~~~l~~l~   59 (366)
                      +..|+.||-|--+.||.+.+.. +.    ..++|.-....                 .      .+....+|...|+.|.
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~-G~----~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~  168 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE-GN----PLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY  168 (465)
T ss_pred             hhhccccccccccceEEEecCC-CC----chhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence            4678999999999999998753 22    44455321100                 0      1234566888888887


Q ss_pred             CCCc-eeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCc
Q 017746           60 ICPQ-IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQN  138 (366)
Q Consensus        60 ~~p~-Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N  138 (366)
                      .+-. +.+.++        ....++|||++.|-.|...-.-     .+..++   ...+..-+--|-.+|+||+|..-=|
T Consensus       169 e~gfpVPkpiD--------~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~l---y~~lm~~Iv~la~~GlIHgDFNEFN  232 (465)
T KOG2268|consen  169 ERGFPVPKPID--------HNRHCVVMELVDGYPLRQVRHV-----EDPPTL---YDDLMGLIVRLANHGLIHGDFNEFN  232 (465)
T ss_pred             HcCCCCCCccc--------ccceeeHHHhhcccceeeeeec-----CChHHH---HHHHHHHHHHHHHcCceecccchhe
Confidence            5432 222222        1234599999999887655321     233333   3445555667889999999999999


Q ss_pred             EEeccCCceEEEecCCccc
Q 017746          139 VLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       139 ILl~~~~~vkl~DFG~a~~  157 (366)
                      |++++++.++++||--+-.
T Consensus       233 imv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  233 IMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             eEEecCCCEEEeechHhhc
Confidence            9999999999999975543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.25  E-value=0.00085  Score=65.37  Aligned_cols=167  Identities=19%  Similarity=0.252  Sum_probs=104.1

Q ss_pred             chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Q 017746           44 SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH  123 (366)
Q Consensus        44 ~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~  123 (366)
                      ....+.....+++.+. |+|...++..-   ........+|||++.- +|++.+..+.   +-..   .+.         
T Consensus        25 ~s~~ilgr~~~lktl~-~~~l~~yl~~~---r~~~~r~IVV~e~~~~-Sled~~~~~~---l~~~---s~~---------   84 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQ-HDNLCQYLDFS---RGKHERVIVVMEHYTM-SLEDILKTGN---LKDE---SLL---------   84 (725)
T ss_pred             cHHHHhhhhHHHHhhc-CccceeeEeee---cCccceEEEEehhhcc-chHHHHHhcc---cchh---hhc---------
Confidence            4556777888999998 89998887621   1222235699999965 9999997632   1111   111         


Q ss_pred             HHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHH
Q 017746          124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM  203 (366)
Q Consensus       124 LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~em  203 (366)
                        .+|+.|     -||       ++++| -++..      .              |-.     ..+++||||+|.++.++
T Consensus        85 --~~~~~~-----~~~-------~~~td-~~~t~------~--------------~~~-----~~pKsdVwsl~~i~~el  124 (725)
T KOG1093|consen   85 --AHGVLH-----LNI-------IYITD-HFLTK------Y--------------PSP-----IGPKSDVWSLGFIILEL  124 (725)
T ss_pred             --ccccce-----ehh-------hhccc-ccccc------C--------------CCC-----CCcchhhhhHHHHHHHH
Confidence              223322     222       33444 11100      0              111     11499999999999999


Q ss_pred             HhCCCCCCCCCcchHHHHHHHhhcCCCCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          204 ASGKPAWNHKQDSNVFSLLIRIGVGDELPN-------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       204 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      ..|...|......+....+.+....+.-..       +-..++....+++.+|+...|..||...++.+++-|.
T Consensus       125 ~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~  198 (725)
T KOG1093|consen  125 YLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT  198 (725)
T ss_pred             HHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence            999988876666665555555433221110       0012455667788999999999999999999988774

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.18  E-value=0.0051  Score=58.26  Aligned_cols=80  Identities=21%  Similarity=0.202  Sum_probs=49.1

Q ss_pred             eeeecCCeeEEEEEECCCCCCCCceeEEeeecC-----C---CCchhhHHHHHHHHHHcCCC-C-ceeEeecceeeccCC
Q 017746            8 VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD-----C---PPSSVTLKNEKEALDQIGIC-P-QIVRCFGDDYSFEKG   77 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~-----~---~~~~~~~~~E~~~l~~l~~~-p-~Iv~~~g~~~~~~~~   77 (366)
                      .||-|...-||++.....    ..-++||....     .   +-...+..-|...|+..+.. | ++.+++.    +.. 
T Consensus         2 EigdGnlN~VfrV~~~~g----~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~----~D~-   72 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEG----DRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH----FDT-   72 (370)
T ss_pred             cCCCCceEEEEEEEcCCC----CeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE----Ecc-
Confidence            578899999999986421    12578886543     1   22345567788888887643 4 4555654    222 


Q ss_pred             eeEEEEEeecCCCC-CHHHHH
Q 017746           78 ERFYNLLLEYASRG-SLADRV   97 (366)
Q Consensus        78 ~~~~~lv~E~~~~g-~L~~~l   97 (366)
                      + ...+|||+++.. .|.+.+
T Consensus        73 e-~~~~vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        73 E-MAVTVMEDLSHHKIARKGL   92 (370)
T ss_pred             c-cceehHhhCccchHHHHHH
Confidence            2 334999999643 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.08  E-value=0.0013  Score=57.80  Aligned_cols=119  Identities=19%  Similarity=0.225  Sum_probs=60.5

Q ss_pred             ceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEeecCCCCCHHH-------HHH-----
Q 017746           31 SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-------RVK-----   98 (366)
Q Consensus        31 ~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~-------~l~-----   98 (366)
                      .+++++............+.|..+++.+..+-.-.++++.   + .+.    .|.||++|.+|..       .+.     
T Consensus         3 ~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~---~-~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~   74 (211)
T PF01633_consen    3 EKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYF---F-ENG----RVEEFIEGRTLSPEDFRNPEILKRIAKL   74 (211)
T ss_dssp             SEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEE---E-TTE----EEEE--SSEE--CGGGGSHHHHHHHHHH
T ss_pred             CEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEE---c-CCC----cEEEEecccccChhhccChHHHHHHHHH
Confidence            4788888877656667888899999988743333444431   2 121    5668887665422       111     


Q ss_pred             --HhCC--------CCCCHHHHHHH----------------------HHHHHHHHHHHHH--------CCcEecCCCCCc
Q 017746           99 --KQNN--------GRLQESDVKRY----------------------TRSMLKGLRHIHS--------KGFVHCDIKLQN  138 (366)
Q Consensus        99 --~~~~--------~~l~~~~~~~~----------------------~~qi~~aL~~LH~--------~givHrDlkp~N  138 (366)
                        +.+.        ..--...+..|                      +..+..-+..+.+        .-++|+|+.|.|
T Consensus        75 l~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~N  154 (211)
T PF01633_consen   75 LAKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGN  154 (211)
T ss_dssp             HHHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGG
T ss_pred             HHHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCcccc
Confidence              1000        00011222222                      1111222222221        249999999999


Q ss_pred             EEe-ccCCceEEEecCCccc
Q 017746          139 VLV-FDNDEAKIADFGLAKK  157 (366)
Q Consensus       139 ILl-~~~~~vkl~DFG~a~~  157 (366)
                      ||+ ..++.++|+||..|..
T Consensus       155 il~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  155 ILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEETSSSSCEEE--GTT-EE
T ss_pred             EEeccCCCeEEEecHHHHhh
Confidence            999 7889999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.88  E-value=0.0065  Score=55.86  Aligned_cols=30  Identities=23%  Similarity=0.364  Sum_probs=25.3

Q ss_pred             CcEecCCCCCcEEeccCCc-eEEEecCCccc
Q 017746          128 GFVHCDIKLQNVLVFDNDE-AKIADFGLAKK  157 (366)
Q Consensus       128 givHrDlkp~NILl~~~~~-vkl~DFG~a~~  157 (366)
                      .++|+|++|.|||+++++. .-|.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.77  E-value=0.021  Score=55.16  Aligned_cols=80  Identities=15%  Similarity=0.162  Sum_probs=48.9

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC-----CC---CchhhHHHHHHHHHHcCCC--CceeEeecceeecc
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD-----CP---PSSVTLKNEKEALDQIGIC--PQIVRCFGDDYSFE   75 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~-----~~---~~~~~~~~E~~~l~~l~~~--p~Iv~~~g~~~~~~   75 (366)
                      .+.||-|....||+.....  +    .++||....     ..   ....+...|.+.|+.+...  .++.+++.    +.
T Consensus        37 ~~eiggGn~N~VyrV~~~~--~----svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~----~d  106 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSS--G----SFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYH----FD  106 (418)
T ss_pred             EEEcCCCceeeEEEEEcCC--c----cEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEE----EC
Confidence            4567888888899987632  1    478887662     11   1345556677777777532  35666765    22


Q ss_pred             CCeeEEEEEeecCCC--CCHHHHH
Q 017746           76 KGERFYNLLLEYASR--GSLADRV   97 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~--g~L~~~l   97 (366)
                      .+.  .+++||++++  ..+.+.+
T Consensus       107 ed~--~vlvME~L~~~~~ilr~~L  128 (418)
T PLN02756        107 RTM--ALIGMRYLEPPHIILRKGL  128 (418)
T ss_pred             CCC--CEEEEeecCCcceehhhhh
Confidence            222  3488999987  3454444

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.74  E-value=0.022  Score=53.70  Aligned_cols=75  Identities=19%  Similarity=0.282  Sum_probs=58.4

Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCC
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                      ++..+.|++|++. |+.|. .++     .-..+++..++.+.+..++-+..+ .+-|||+.-.||||+ +|+|.|+||-+
T Consensus       296 de~~y~yl~~kdh-gt~is-~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         296 DETLYLYLHFKDH-GTPIS-IIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             CCceEEEEEEecC-Cceee-eee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeee
Confidence            4456677888885 44554 222     245788888999888877777665 699999999999999 89999999999


Q ss_pred             cccc
Q 017746          155 AKKS  158 (366)
Q Consensus       155 a~~~  158 (366)
                      ++.-
T Consensus       368 sRl~  371 (488)
T COG5072         368 SRLS  371 (488)
T ss_pred             eecc
Confidence            9843

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.73  E-value=0.026  Score=53.17  Aligned_cols=136  Identities=19%  Similarity=0.212  Sum_probs=82.8

Q ss_pred             CCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC------CceeEeecceeeccCCeeEEEEEee
Q 017746           13 SFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC------PQIVRCFGDDYSFEKGERFYNLLLE   86 (366)
Q Consensus        13 ~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~------p~Iv~~~g~~~~~~~~~~~~~lv~E   86 (366)
                      .-..||+....+ +     .+++|..... .....+..|.+.|.-|..+      | +...=|.....-.+..+.+-+++
T Consensus        37 ~eN~~f~~~~~~-g-----~~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~P-l~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          37 EENSNFRVQTED-G-----RYILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAP-LPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             ccCceEEEEecC-C-----CeEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCC-ccCCCcchhhhccCCceeEEEEE
Confidence            345688887543 2     3488888876 6778899999999999643      2 33333322111111136678999


Q ss_pred             cCCCCCHHH-----HHH-------H-----------hCCC--CCCHH----H---------HHHHHHHHHHHHHHHHH--
Q 017746           87 YASRGSLAD-----RVK-------K-----------QNNG--RLQES----D---------VKRYTRSMLKGLRHIHS--  126 (366)
Q Consensus        87 ~~~~g~L~~-----~l~-------~-----------~~~~--~l~~~----~---------~~~~~~qi~~aL~~LH~--  126 (366)
                      |++|..+..     .+.       +           +.+.  ...+.    .         -.....++...++.+.+  
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999987772     111       0           0000  11111    0         01123444455555554  


Q ss_pred             ------CC--cEecCCCCCcEEeccCCc-eEEEecCCcc
Q 017746          127 ------KG--FVHCDIKLQNVLVFDNDE-AKIADFGLAK  156 (366)
Q Consensus       127 ------~g--ivHrDlkp~NILl~~~~~-vkl~DFG~a~  156 (366)
                            .+  +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                  23  999999999999998875 8999999764

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.69  E-value=0.012  Score=54.84  Aligned_cols=30  Identities=23%  Similarity=0.320  Sum_probs=27.6

Q ss_pred             CcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       128 givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      .++|+|+++.||+++..+-+=|.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            389999999999999988899999999875

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.64  E-value=0.048  Score=51.48  Aligned_cols=142  Identities=11%  Similarity=0.149  Sum_probs=78.2

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEee
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLE   86 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E   86 (366)
                      +.|..|-...+|+....+... ....+++|.............+|..+++.+..+.--.++++.   +. ++    +|.+
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~-~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~---~~-~G----~i~~   90 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENG-NEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGV---FG-NG----MIQS   90 (330)
T ss_pred             EEeCCcccceEEEEEecCCCC-CCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEE---eC-Cc----Eeeh
Confidence            344445566788886543211 123688888765434445568899999988743222334431   21 11    5788


Q ss_pred             cCCCCCHHH--------------HHHHhCCCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 017746           87 YASRGSLAD--------------RVKKQNNGR------L-QESDVKRYTRSM----------------------LKGLRH  123 (366)
Q Consensus        87 ~~~~g~L~~--------------~l~~~~~~~------l-~~~~~~~~~~qi----------------------~~aL~~  123 (366)
                      |++|.+|..              .+++-+...      . -...+..+..++                      ..-+..
T Consensus        91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  170 (330)
T PLN02421         91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE  170 (330)
T ss_pred             hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence            888765421              112211111      1 122333333222                      111111


Q ss_pred             ----HHHCC----cEecCCCCCcEEecc-CCceEEEecCCccc
Q 017746          124 ----IHSKG----FVHCDIKLQNVLVFD-NDEAKIADFGLAKK  157 (366)
Q Consensus       124 ----LH~~g----ivHrDlkp~NILl~~-~~~vkl~DFG~a~~  157 (366)
                          +...+    ++|+|+.+.|||+++ ++.++++||..|..
T Consensus       171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11122    899999999999975 46899999998743

>PTZ00384 choline kinase; Provisional

Probab=96.64  E-value=0.026  Score=54.41  Aligned_cols=81  Identities=11%  Similarity=0.121  Sum_probs=47.2

Q ss_pred             cCeeeecCCeeEEEEEECCCC-CCCCc-eeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVS-SEFPS-LMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~-~~~~~-~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      .+.|..|-...+|++...... ..+.. .|+++............++|..+++.+..+---.++++.   +..     ++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~---f~~-----g~  126 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGR---FGD-----FT  126 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEe---cCC-----EE
Confidence            345555777889998754332 12222 245554333323334557799999999754444555552   211     28


Q ss_pred             EeecCCCCCHH
Q 017746           84 LLEYASRGSLA   94 (366)
Q Consensus        84 v~E~~~~g~L~   94 (366)
                      +.||++|.+|.
T Consensus       127 l~efIeGr~l~  137 (383)
T PTZ00384        127 IQEWVEGNTMG  137 (383)
T ss_pred             EEEEeccccCC
Confidence            89999987664

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.46  E-value=0.02  Score=55.00  Aligned_cols=82  Identities=18%  Similarity=0.182  Sum_probs=51.5

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----C---CCchhhHHHHHHHHHHcCCC-C-ceeEeecceeeccC
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----C---PPSSVTLKNEKEALDQIGIC-P-QIVRCFGDDYSFEK   76 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~---~~~~~~~~~E~~~l~~l~~~-p-~Iv~~~g~~~~~~~   76 (366)
                      .+.||-|.-.-||++.+...+    .-++||....    .   +-...+..-|.++|+.++.. | ++.+++.    + +
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~----~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~----~-D  104 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKN----ISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL----F-D  104 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCC----ceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE----E-C
Confidence            567899999999999874212    2577886543    1   22456677788999888643 4 4555654    2 2


Q ss_pred             CeeEEEEEeecCCCC-CHHHHH
Q 017746           77 GERFYNLLLEYASRG-SLADRV   97 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g-~L~~~l   97 (366)
                       .....+|||+++.. .|.+.+
T Consensus       105 -~e~~~~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        105 -SVMNCCVMEDLSDHTILRTAL  125 (409)
T ss_pred             -cHHhhHHHHhCcccHHHHHHH
Confidence             22334899999643 344444

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.16  E-value=0.067  Score=49.94  Aligned_cols=30  Identities=20%  Similarity=0.220  Sum_probs=27.6

Q ss_pred             CcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       128 givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +++|+|+.+.|||+++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK06148 hypothetical protein; Provisional

Probab=96.06  E-value=0.094  Score=57.01  Aligned_cols=140  Identities=19%  Similarity=0.238  Sum_probs=76.8

Q ss_pred             cCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCC------CCceeEee-ccee-ec--cCCeeEE
Q 017746           12 GSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI------CPQIVRCF-GDDY-SF--EKGERFY   81 (366)
Q Consensus        12 G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~------~p~Iv~~~-g~~~-~~--~~~~~~~   81 (366)
                      |..-.+|+..... +    ..+++|+.... .....+..|.++|..|..      .|.+++-. |... ..  .++...+
T Consensus        35 s~~d~nf~v~~~~-g----~~yVLKi~~~~-~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         35 GERDLNFRLTTDD-G----ADYILKIVNPS-EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             CcCCceEEEEeCC-C----CeEEEEEcCCc-cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            3456778876432 2    26888887753 334455666677765542      34545433 2211 11  1233356


Q ss_pred             EEEeecCCCCCHHHH-------HH-------H------hCC-----CCCCH-----------------HHHHHHHHHHHH
Q 017746           82 NLLLEYASRGSLADR-------VK-------K------QNN-----GRLQE-----------------SDVKRYTRSMLK  119 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~-------l~-------~------~~~-----~~l~~-----------------~~~~~~~~qi~~  119 (366)
                      +.+|+|++|..|.+.       +.       +      ...     ..+.|                 ...+.++.+++.
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            688999999877651       11       0      000     00111                 111222233333


Q ss_pred             HHH-----HHH--HCCcEecCCCCCcEEeccCC--ceE-EEecCCccc
Q 017746          120 GLR-----HIH--SKGFVHCDIKLQNVLVFDND--EAK-IADFGLAKK  157 (366)
Q Consensus       120 aL~-----~LH--~~givHrDlkp~NILl~~~~--~vk-l~DFG~a~~  157 (366)
                      ...     .+.  ..++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            222     121  14799999999999998775  555 999998764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.98  E-value=0.26  Score=46.39  Aligned_cols=71  Identities=13%  Similarity=0.043  Sum_probs=41.2

Q ss_pred             CeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC--CceeE---eecceeeccCCeeEEEEEeecC
Q 017746           14 FGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR---CFGDDYSFEKGERFYNLLLEYA   88 (366)
Q Consensus        14 fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~--p~Iv~---~~g~~~~~~~~~~~~~lv~E~~   88 (366)
                      -..||+....+ +    ..+++|...........+..|.+++..|..+  | ++.   .-|...  ..-++.++.+++++
T Consensus        38 eN~vy~v~~~~-~----~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gip-v~~p~~~~G~~~--~~~~g~~~~l~~~~  109 (325)
T PRK11768         38 ENRVYQFGDED-G----RRVVAKFYRPERWSDAQILEEHAFALELAEAEIP-VVAPLAFNGQTL--HEHQGFRFALFPRR  109 (325)
T ss_pred             cceEEEEecCC-C----CEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCC-CCCCccCCCCEE--EEECCEEEEEEeee
Confidence            34688886532 2    2578887654333566788899888888532  2 222   222111  11123566899999


Q ss_pred             CCCC
Q 017746           89 SRGS   92 (366)
Q Consensus        89 ~~g~   92 (366)
                      +|..
T Consensus       110 ~G~~  113 (325)
T PRK11768        110 GGRA  113 (325)
T ss_pred             CCCC
Confidence            8864

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.80  E-value=0.041  Score=52.64  Aligned_cols=60  Identities=28%  Similarity=0.275  Sum_probs=46.2

Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEecCCCCCcEEeccC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI-HSKGFVHCDIKLQNVLVFDN  144 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~givHrDlkp~NILl~~~  144 (366)
                      .|+-+|..|-++..+++..   ..+|+..+.++.-.+.||--| --.+++|.|+.|.||++.-+
T Consensus       321 vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             eeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            3788899999999999763   345667777777777776544 44689999999999999643

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.80  E-value=0.059  Score=47.43  Aligned_cols=100  Identities=18%  Similarity=0.180  Sum_probs=67.5

Q ss_pred             eeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHH
Q 017746           32 LMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESD  109 (366)
Q Consensus        32 ~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~  109 (366)
                      ..++|++...+-  ....+.++..++.++.   .|+++..      ++...|.+++|+|--              .....
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh---GilrL~N------Dn~~~yGvIlE~Cy~--------------~~i~~  143 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH---GILRLKN------DNNYKYGVILERCYK--------------IKINF  143 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh---heeEeec------CCCceeEEEEeeccC--------------cccch
Confidence            344555443222  3456688888888875   4788864      244457799999953              11111


Q ss_pred             HHHHHHHHHHHHHHHHH--CCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746          110 VKRYTRSMLKGLRHIHS--KGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus       110 ~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      .-.+++. +.+|.-.|+  .+.+|+|-.|+||+-++.|.+||.|-+..
T Consensus       144 ~N~i~ag-i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  144 SNFITAG-IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             hHHHHHh-HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            2222222 567888894  37999999999999999999999998853

The function of this family is unknown.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.18  E-value=0.12  Score=47.68  Aligned_cols=74  Identities=15%  Similarity=0.142  Sum_probs=41.2

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCC--CCceeEeecceeeccCCeeEEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI--CPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~--~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      .+.|+-|....+|...  .++    ..+++|.-..  .....+..|.+-|+.|..  .-.+.+.++....  .+.  -+|
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~----~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~--~fL   89 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDG----GSYFVKVNSE--SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDD--AFL   89 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-----EEEEEEEEG--GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSC--CEE
T ss_pred             eEecCCCChhheEEEE--CCC----ccEEEEecCh--hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCC--ceE
Confidence            4567778888888877  222    3788887663  445678999999999942  2345566553221  222  259


Q ss_pred             EeecCCCC
Q 017746           84 LLEYASRG   91 (366)
Q Consensus        84 v~E~~~~g   91 (366)
                      ||||++.+
T Consensus        90 lle~l~~~   97 (288)
T PF03881_consen   90 LLEFLEMG   97 (288)
T ss_dssp             EEE-----
T ss_pred             EEEeecCC
Confidence            99999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.13  E-value=0.043  Score=51.09  Aligned_cols=29  Identities=34%  Similarity=0.659  Sum_probs=25.4

Q ss_pred             CCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746          127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus       127 ~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47999999999999987 678999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.78  E-value=0.032  Score=51.81  Aligned_cols=53  Identities=28%  Similarity=0.409  Sum_probs=37.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHHH----CCcEecCCCCCcEEeccCCc------------------eEEEecCCcccc
Q 017746          106 QESDVKRYTRSMLKGLRHIHS----KGFVHCDIKLQNVLVFDNDE------------------AKIADFGLAKKS  158 (366)
Q Consensus       106 ~~~~~~~~~~qi~~aL~~LH~----~givHrDlkp~NILl~~~~~------------------vkl~DFG~a~~~  158 (366)
                      -.+-++.++.||+.-.-.+-+    .+++|-||||+|||+-....                  ++|.||.++...
T Consensus       277 ~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  351 (444)
T PHA03111        277 LVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA  351 (444)
T ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence            455677788888765544433    46999999999999954432                  567777777654

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.78  E-value=0.2  Score=47.56  Aligned_cols=136  Identities=18%  Similarity=0.237  Sum_probs=85.8

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----------------------CCc-----hhhHHHHHHHHHHcC
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----------------------PPS-----SVTLKNEKEALDQIG   59 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----------------------~~~-----~~~~~~E~~~l~~l~   59 (366)
                      .+|..|--+.||.|+... |.    .+|+|++..+                      ...     ..-.+.|..-|.++.
T Consensus       150 GCiSTGKEANVYHat~~d-G~----~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~  224 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEED-GS----EFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN  224 (520)
T ss_pred             cccccCccceeEeeecCC-Cc----eEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence            466778888999997543 44    3666655431                      000     112455777777775


Q ss_pred             CCCceeEeecceeeccCCeeEEEEEeecCCCCCH-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCC
Q 017746           60 ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQ  137 (366)
Q Consensus        60 ~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~  137 (366)
                      . ..| ++-...+     -..-.|||+|+....- .-.|   ....++...+..+-.|++.-+.-|-. .++||.||.-=
T Consensus       225 ~-aGI-P~PePIl-----Lk~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEf  294 (520)
T KOG2270|consen  225 N-AGI-PCPEPIL-----LKNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEF  294 (520)
T ss_pred             h-cCC-CCCCcee-----eecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhh
Confidence            2 221 1111000     0112399999964222 2222   23458888888888899888887765 59999999999


Q ss_pred             cEEeccCCceEEEecCCcccc
Q 017746          138 NVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus       138 NILl~~~~~vkl~DFG~a~~~  158 (366)
                      |+|+. +|.+.|+|.+-+...
T Consensus       295 N~Lyh-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  295 NLLYH-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             hheEE-CCEEEEEEccccccC
Confidence            99985 578999999977543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	366
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-28
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-27
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-27
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-27
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-27
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-27
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-27
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-25
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-25
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-25
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-25
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-25
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-25
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-24
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-24
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-24
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-23
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-23
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-23
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-23
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-23
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-23
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-23
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-23
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-23
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-23
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-23
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-23
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-23
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-23
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-23
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-23
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-23
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-23
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-23
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-23
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-23
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-23
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-23
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-23
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-23
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-23
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-23
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-23
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-23
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-23
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-23
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-23
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-22
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-22
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-22
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-22
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-22
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-22
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-22
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-22
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-22
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-22
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-22
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-22
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-22
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-22
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-22
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-22
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-21
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-21
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-21
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-21
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-21
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-21
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-21
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-21
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-21
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-21
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-21
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-21
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-21
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-21
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-21
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-21
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-21
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-21
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-21
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-21
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-20
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-20
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-20
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-20
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-20
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-20
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-20
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-20
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-20
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-20
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-20
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-20
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-20
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-20
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-20
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-20
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-20
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-20
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-20
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-20
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-20
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-20
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-20
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-20
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-20
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-20
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-20
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-20
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-20
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-20
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-20
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-20
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-20
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-20
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-20
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-20
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-19
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-19
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-19
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-19
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-19
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-19
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-19
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-19
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-19
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-19
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-19
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-19
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-19
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-19
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-19
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-19
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-19
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-19
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-19
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-19
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-19
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-19
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-19
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-19
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-19
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-19
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-19
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-19
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-19
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-19
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-19
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-19
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-19
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-19
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-19
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-19
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-19
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-19
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-19
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-19
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-19
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-19
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-19
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-19
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-19
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-19
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-19
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-19
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-19
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-19
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-19
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-19
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-19
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-19
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-18
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-18
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-18
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-18
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-18
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-18
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-18
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-18
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-18
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-18
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-18
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-18
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-18
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-18
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-18
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-18
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-18
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-18
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-18
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-18
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-18
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-18
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-18
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-18
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-18
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-18
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-18
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-18
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-18
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-18
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-18
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-18
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-18
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-18
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-18
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-18
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-18
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-18
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-18
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-18
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-18
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-18
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-18
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-18
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-18
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-18
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-18
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-18
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-17
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-17
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-17
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-17
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-17
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-17
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-17
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-17
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-17
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-17
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-17
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-17
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-17
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-17
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-17
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-17
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-17
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-17
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-17
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-17
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-17
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-17
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-17
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-17
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-17
3soa_A	444	Full-Length Human Camkii Length = 444		5e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-17
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-17
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-17
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-17
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-17
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-17
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-17
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-16
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-16
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-16
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-16
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-16
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-16
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-16
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-16
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-16
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-16
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-16
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-16
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-16
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-16
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-16
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-16
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-16
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-16
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-15
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-15
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-15
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-15
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-15
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-15
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-15
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-15
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-14
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-14
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-14
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-14
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-14
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-14
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-14
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-14
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-14
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-14
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-14
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-14
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-13
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-13
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-13
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-13
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-13
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-12
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-12
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-12
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-11
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-10
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-09
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-09
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-09
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-09
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-09
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-09
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-09
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-09
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-09
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-09
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-09
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-09
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-09
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-09
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-09
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-09
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-09
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-09
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-09
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-09
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-09
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-09
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-09
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-08
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		2e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-08

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 140/266 (52%), Gaps = 20/266 (7%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQI 64
           D IG GSFG V       + +    ++A+K   D   +   +++ ++ +  +  C  P I
Sbjct: 25  DRIGKGSFGEV----YKGIDNHTKEVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
            R FG   S+ K  + + +++EY   GS  D +K    G L+E+ +    R +LKGL ++
Sbjct: 80  TRYFG---SYLKSTKLW-IIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYL 132
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HS+  +H DIK  NVL+ +  + K+ADFG+A + +    +   F   GTP +M+PE + +
Sbjct: 133 HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXF--VGTPFWMAPEVIKQ 190
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           + Y+   DIW+LG   +E+A G+P  +      V  L+ +    +  P + G  S+  K+
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK----NSPPTLEGQHSKPFKE 246
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVC 270
           F+  C  KDP+ R TA+ LL H F+ 
Sbjct: 247 FVEACLNKDPRFRPTAKELLKHKFIT 272

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 141/264 (53%), Gaps = 20/264 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           IG GSFG V       + +    ++A+K   D   +   +++ ++ +  +  C  P + +
Sbjct: 35  IGKGSFGEV----FKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 89
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            +G   S+ K  + + +++EY   GS  D ++    G L E+ +    R +LKGL ++HS
Sbjct: 90  YYG---SYLKDTKLW-IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS 142
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           +  +H DIK  NVL+ ++ E K+ADFG+A + +    +  +F   GTP +M+PE + ++ 
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIKQSA 200
Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y++  DIW+LG   +E+A G+P  +      V  L+ +    +  P + G+ S+  K+F+
Sbjct: 201 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK----NNPPTLEGNYSKPLKEFV 256
Query: 247 IKCFLKDPKRRWTAEMLLNHPFVC 270
             C  K+P  R TA+ LL H F+ 
Sbjct: 257 EACLNKEPSFRPTAKELLKHKFIL 280

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 141/264 (53%), Gaps = 20/264 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           IG GSFG V       + +    ++A+K   D   +   +++ ++ +  +  C  P + +
Sbjct: 15  IGKGSFGEV----FKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 69
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            +G   S+ K  + + +++EY   GS  D ++    G L E+ +    R +LKGL ++HS
Sbjct: 70  YYG---SYLKDTKLW-IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS 122
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           +  +H DIK  NVL+ ++ E K+ADFG+A + +    +  +F   GTP +M+PE + ++ 
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIKQSA 180
Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y++  DIW+LG   +E+A G+P  +      V  L+ +    +  P + G+ S+  K+F+
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK----NNPPTLEGNYSKPLKEFV 236
Query: 247 IKCFLKDPKRRWTAEMLLNHPFVC 270
             C  K+P  R TA+ LL H F+ 
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFIL 260

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 140/264 (53%), Gaps = 20/264 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           IG GSFG V       + +    ++A+K   D   +   +++ ++ +  +  C  P + +
Sbjct: 30  IGKGSFGEV----FKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            +G   S+ K  + + +++EY   GS  D ++    G L E+ +    R +LKGL ++HS
Sbjct: 85  YYG---SYLKDTKLW-IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS 137
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           +  +H DIK  NVL+ ++ E K+ADFG+A + +    +   F   GTP +M+PE + ++ 
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF--VGTPFWMAPEVIKQSA 195
Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y++  DIW+LG   +E+A G+P  +      V  L+ +    +  P + G+ S+  K+F+
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK----NNPPTLEGNYSKPLKEFV 251
Query: 247 IKCFLKDPKRRWTAEMLLNHPFVC 270
             C  K+P  R TA+ LL H F+ 
Sbjct: 252 EACLNKEPSFRPTAKELLKHKFIL 275

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 140/264 (53%), Gaps = 20/264 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           IG GSFG V       + +    ++A+K   D   +   +++ ++ +  +  C  P + +
Sbjct: 15  IGKGSFGEV----FKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 69
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            +G   S+ K  + + +++EY   GS  D ++    G L E+ +    R +LKGL ++HS
Sbjct: 70  YYG---SYLKDTKLW-IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS 122
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           +  +H DIK  NVL+ ++ E K+ADFG+A + +    +   F   GTP +M+PE + ++ 
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF--VGTPFWMAPEVIKQSA 180
Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y++  DIW+LG   +E+A G+P  +      V  L+ +    +  P + G+ S+  K+F+
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK----NNPPTLEGNYSKPLKEFV 236
Query: 247 IKCFLKDPKRRWTAEMLLNHPFVC 270
             C  K+P  R TA+ LL H F+ 
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFIL 260

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 135/269 (50%), Gaps = 31/269 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----PQ 63
           +G GS+GSV  A    +  E   ++A+K     P  S    + +E + +I I      P 
Sbjct: 37  LGEGSYGSVYKA----IHKETGQIVAIKQV---PVES----DLQEIIKEISIMQQCDSPH 85
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+ +G   S+ K    + +++EY   GS++D ++ +N   L E ++    +S LKGL +
Sbjct: 86  VVKYYG---SYFKNTDLW-IVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEY 140
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +H    +H DIK  N+L+     AK+ADFG+A         ++     GTP +M+PE + 
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVIQ 198
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI---PGDLSE 240
           E  Y    DIW+LG   +EMA GKP +     +++  +     +    P     P   S+
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPY-----ADIHPMRAIFMIPTNPPPTFRKPELWSD 253
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
              DF+ +C +K P++R TA  LL HPFV
Sbjct: 254 NFTDFVKQCLVKSPEQRATATQLLQHPFV 282

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           IG GSFG V       + +    ++A+K   D   +   +++ ++ +  +  C    + +
Sbjct: 31  IGKGSFGEV----FKGIDNRTQQVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSSYVTK 85
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            +G   S+ KG + + +++EY   GS  D ++    G   E  +    + +LKGL ++HS
Sbjct: 86  YYG---SYLKGSKLW-IIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS 138
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           +  +H DIK  NVL+ +  + K+ADFG+A + +    +  +F   GTP +M+PE + ++ 
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIQQSA 196
Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y++  DIW+LG   +E+A G+P  +      V  L+ +    +  P + GD ++  K+F+
Sbjct: 197 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK----NNPPTLVGDFTKSFKEFI 252
Query: 247 IKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
             C  KDP  R TA+ LL H F+  + +
Sbjct: 253 DACLNKDPSFRPTAKELLKHKFIVKNSK 280

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 134/273 (49%), Gaps = 26/273 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           +G G+FG     K  K  ++  S++A     D   S   L++    +D +  C  P IV+
Sbjct: 45  LGDGAFG-----KVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVK 98
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
              D + +E       +L+E+ + G++ D V  +    L ES ++   +  L  L ++H 
Sbjct: 99  LL-DAFYYENN---LWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV---- 182
              +H D+K  N+L   + + K+ADFG++ K++   +R  SF   GTP +M+PE V    
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSF--IGTPYWMAPEVVMCET 211
Query: 183 -NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI--PGDLS 239
             +  Y+   D+W+LG  ++EMA  +P      + N   +L++I    E P +  P   S
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPP---HHELNPMRVLLKIA-KSEPPTLAQPSRWS 267
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
              KDFL KC  K+   RWT   LL HPFV  D
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 300

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 134/273 (49%), Gaps = 26/273 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           +G G+FG     K  K  ++  S++A     D   S   L++    +D +  C  P IV+
Sbjct: 45  LGDGAFG-----KVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVK 98
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
              D + +E       +L+E+ + G++ D V  +    L ES ++   +  L  L ++H 
Sbjct: 99  LL-DAFYYENN---LWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV---- 182
              +H D+K  N+L   + + K+ADFG++ K++   +R  SF   GTP +M+PE V    
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWMAPEVVMCET 211
Query: 183 -NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI--PGDLS 239
             +  Y+   D+W+LG  ++EMA  +P      + N   +L++I    E P +  P   S
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPP---HHELNPMRVLLKIA-KSEPPTLAQPSRWS 267
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
              KDFL KC  K+   RWT   LL HPFV  D
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 300

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 134/271 (49%), Gaps = 20/271 (7%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQI 64
           DV+G G+F  V LA+  +       L+A+K  A         +++NE   L +I   P I
Sbjct: 24  DVLGTGAFSEVILAEDKRTQK----LVAIKCIAKEALEGKEGSMENEIAVLHKIK-HPNI 78
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V     D  +E G   Y L+++  S G L DR+ ++  G   E D  R    +L  ++++
Sbjct: 79  VAL---DDIYESGGHLY-LIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYL 132
Query: 125 HSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           H  G VH D+K +N+L +  DE     I+DFGL+K    D     S  C GTP Y++PE 
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTAC-GTPGYVAPEV 189
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           + +  Y    D W++G     +  G P +  + D+ +F  +++     + P    D+S+ 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-DDISDS 248
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            KDF+     KDP++R+T E  L HP++  D
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 134/271 (49%), Gaps = 20/271 (7%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQI 64
           DV+G G+F  V LA+  +       L+A+K  A         +++NE   L +I   P I
Sbjct: 24  DVLGTGAFSEVILAEDKRTQK----LVAIKCIAKEALEGKEGSMENEIAVLHKIK-HPNI 78
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V     D  +E G   Y L+++  S G L DR+ ++  G   E D  R    +L  ++++
Sbjct: 79  VAL---DDIYESGGHLY-LIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYL 132
Query: 125 HSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           H  G VH D+K +N+L +  DE     I+DFGL+K    D     S  C GTP Y++PE 
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTAC-GTPGYVAPEV 189
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           + +  Y    D W++G     +  G P +  + D+ +F  +++     + P    D+S+ 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-DDISDS 248
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            KDF+     KDP++R+T E  L HP++  D
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 134/271 (49%), Gaps = 20/271 (7%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQI 64
           DV+G G+F  V LA+  +       L+A+K  A         +++NE   L +I   P I
Sbjct: 24  DVLGTGAFSEVILAEDKRTQK----LVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNI 78
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V     D  +E G   Y L+++  S G L DR+ ++  G   E D  R    +L  ++++
Sbjct: 79  VAL---DDIYESGGHLY-LIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYL 132
Query: 125 HSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           H  G VH D+K +N+L +  DE     I+DFGL+K    D     S  C GTP Y++PE 
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTAC-GTPGYVAPEV 189
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           + +  Y    D W++G     +  G P +  + D+ +F  +++     + P    D+S+ 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-DDISDS 248
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            KDF+     KDP++R+T E  L HP++  D
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 134/271 (49%), Gaps = 20/271 (7%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQI 64
           DV+G G+F  V LA+  +       L+A+K  A         +++NE   L +I   P I
Sbjct: 24  DVLGTGAFSEVILAEDKRTQK----LVAIKCIAKEALEGKEGSMENEIAVLHKIK-HPNI 78
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V     D  +E G   Y L+++  S G L DR+ ++  G   E D  R    +L  ++++
Sbjct: 79  VAL---DDIYESGGHLY-LIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYL 132
Query: 125 HSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           H  G VH D+K +N+L +  DE     I+DFGL+K    D     S  C GTP Y++PE 
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTAC-GTPGYVAPEV 189
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           + +  Y    D W++G     +  G P +  + D+ +F  +++     + P    D+S+ 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-DDISDS 248
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            KDF+     KDP++R+T E  L HP++  D
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 133/273 (48%), Gaps = 26/273 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           +G G+FG     K  K  ++  S++A     D   S   L++    +D +  C  P IV+
Sbjct: 45  LGDGAFG-----KVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVK 98
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
              D + +E       +L+E+ + G++ D V  +    L ES ++   +  L  L ++H 
Sbjct: 99  LL-DAFYYENN---LWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV---- 182
              +H D+K  N+L   + + K+ADFG++ K++   +R   F   GTP +M+PE V    
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXF--IGTPYWMAPEVVMCET 211
Query: 183 -NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI--PGDLS 239
             +  Y+   D+W+LG  ++EMA  +P      + N   +L++I    E P +  P   S
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPP---HHELNPMRVLLKIA-KSEPPTLAQPSRWS 267
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
              KDFL KC  K+   RWT   LL HPFV  D
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 300

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 130/269 (48%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 95
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 96  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH 149
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F+ +I++       + P     + +D 
Sbjct: 210 SAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-----DFPEKFFPKARDL 264
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 95
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 96  KLY---FTFQDDEKLY-FGLSYAKNGCLLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 149
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 210 SASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 264
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 130/269 (48%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 95
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 96  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH 149
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F+ +I++       + P     + +D 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-----DFPEKFFPKARDL 264
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 137/284 (48%), Gaps = 24/284 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLA----KASKVSSEFPSL--MAVKSCADCPPSSVTLKNEKEAL 55
           E++    +G G+ G V LA       KV+ +  S    A+ S  +  P+ + ++ E E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPA-LNVETEIEIL 69
Query: 56  DQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
            ++   P I++      +F   E +Y ++LE    G L D+V    N RL+E+  K Y  
Sbjct: 70  KKLN-HPCIIKI----KNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFY 121
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRG 172
            ML  ++++H  G +H D+K +NVL+   +E    KI DFG    S   GE S      G
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG---HSKILGETSLMRTLCG 178
Query: 173 TPLYMSPE---SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
           TP Y++PE   SV    Y    D W+LG  +    SG P ++  +        I  G  +
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
            +P +  ++SE+  D + K  + DPK R+T E  L HP++  +D
Sbjct: 239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 40  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 98
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 99  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 152
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 153 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 213 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPAAFFPKARDL 267
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 268 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 296

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 137/284 (48%), Gaps = 24/284 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLA----KASKVSSEFPSL--MAVKSCADCPPSSVTLKNEKEAL 55
           E++    +G G+ G V LA       KV+ +  S    A+ S  +  P+ + ++ E E L
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPA-LNVETEIEIL 75
Query: 56  DQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
            ++   P I++      +F   E +Y ++LE    G L D+V    N RL+E+  K Y  
Sbjct: 76  KKLN-HPCIIKI----KNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFY 127
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRG 172
            ML  ++++H  G +H D+K +NVL+   +E    KI DFG    S   GE S      G
Sbjct: 128 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG---HSKILGETSLMRTLCG 184
Query: 173 TPLYMSPE---SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
           TP Y++PE   SV    Y    D W+LG  +    SG P ++  +        I  G  +
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 244
Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
            +P +  ++SE+  D + K  + DPK R+T E  L HP++  +D
Sbjct: 245 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 288

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 137/284 (48%), Gaps = 24/284 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLA----KASKVSSEFPSL--MAVKSCADCPPSSVTLKNEKEAL 55
           E++    +G G+ G V LA       KV+ +  S    A+ S  +  P+ + ++ E E L
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPA-LNVETEIEIL 68
Query: 56  DQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
            ++   P I++      +F   E +Y ++LE    G L D+V    N RL+E+  K Y  
Sbjct: 69  KKLN-HPCIIKI----KNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFY 120
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRG 172
            ML  ++++H  G +H D+K +NVL+   +E    KI DFG    S   GE S      G
Sbjct: 121 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG---HSKILGETSLMRTLCG 177
Query: 173 TPLYMSPE---SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
           TP Y++PE   SV    Y    D W+LG  +    SG P ++  +        I  G  +
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 237
Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
            +P +  ++SE+  D + K  + DPK R+T E  L HP++  +D
Sbjct: 238 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 281

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 135/285 (47%), Gaps = 24/285 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLM------AVKSCADCPPSSVTLKNEKEAL 55
           E++    +G G+ G V LA   K   +    +      A+ S  +  P+ + ++ E E L
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPA-LNVETEIEIL 208
Query: 56  DQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
            ++   P I++      +F   E +Y ++LE    G L D+V    N RL+E+  K Y  
Sbjct: 209 KKLN-HPCIIKI----KNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFY 260
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRG 172
            ML  ++++H  G +H D+K +NVL+   +E    KI DFG    S   GE S      G
Sbjct: 261 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG---HSKILGETSLMRTLCG 317
Query: 173 TPLYMSPE---SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
           TP Y++PE   SV    Y    D W+LG  +    SG P ++  +        I  G  +
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 377
Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
            +P +  ++SE+  D + K  + DPK R+T E  L HP++  +D 
Sbjct: 378 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 422

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 137/284 (48%), Gaps = 24/284 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLA----KASKVSSEFPSL--MAVKSCADCPPSSVTLKNEKEAL 55
           E++    +G G+ G V LA       KV+ +  S    A+ S  +  P+ + ++ E E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPA-LNVETEIEIL 69
Query: 56  DQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
            ++   P I++      +F   E +Y ++LE    G L D+V    N RL+E+  K Y  
Sbjct: 70  KKLN-HPCIIKI----KNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFY 121
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRG 172
            ML  ++++H  G +H D+K +NVL+   +E    KI DFG    S   GE S      G
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG---HSKILGETSLMRTLCG 178
Query: 173 TPLYMSPE---SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
           TP Y++PE   SV    Y    D W+LG  +    SG P ++  +        I  G  +
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
            +P +  ++SE+  D + K  + DPK R+T E  L HP++  +D
Sbjct: 239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 137/284 (48%), Gaps = 24/284 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLA----KASKVSSEFPSL--MAVKSCADCPPSSVTLKNEKEAL 55
           E++    +G G+ G V LA       KV+ +  S    A+ S  +  P+ + ++ E E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPA-LNVETEIEIL 69
Query: 56  DQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
            ++   P I++      +F   E +Y ++LE    G L D+V    N RL+E+  K Y  
Sbjct: 70  KKLN-HPCIIKI----KNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFY 121
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRG 172
            ML  ++++H  G +H D+K +NVL+   +E    KI DFG    S   GE S      G
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG---HSKILGETSLMRTLCG 178
Query: 173 TPLYMSPE---SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
           TP Y++PE   SV    Y    D W+LG  +    SG P ++  +        I  G  +
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
            +P +  ++SE+  D + K  + DPK R+T E  L HP++  +D
Sbjct: 239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 135/284 (47%), Gaps = 24/284 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLM------AVKSCADCPPSSVTLKNEKEAL 55
           E++    +G G+ G V LA   K   +    +      A+ S  +  P+ + ++ E E L
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPA-LNVETEIEIL 194
Query: 56  DQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
            ++   P I++      +F   E +Y ++LE    G L D+V    N RL+E+  K Y  
Sbjct: 195 KKLN-HPCIIKI----KNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFY 246
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRG 172
            ML  ++++H  G +H D+K +NVL+   +E    KI DFG    S   GE S      G
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG---HSKILGETSLMRTLCG 303
Query: 173 TPLYMSPE---SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
           TP Y++PE   SV    Y    D W+LG  +    SG P ++  +        I  G  +
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363
Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
            +P +  ++SE+  D + K  + DPK R+T E  L HP++  +D
Sbjct: 364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 71
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 72  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 125
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 240
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 15  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 73
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 74  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 127
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 128 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 242
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 243 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 271

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 14  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 72
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 73  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 126
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 127 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 241
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 242 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 270

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 12  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 70
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 71  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 124
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 239
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 240 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 268

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 92
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 93  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 146
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 261
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 290

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 19  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 77
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 78  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 131
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 132 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 192 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 246
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 247 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 275

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 95
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 96  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 149
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 264
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 92
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 93  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 146
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 261
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 290

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 95
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 96  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 149
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 264
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 96
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 97  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 150
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 265
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 294

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 93
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 94  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 147
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 262
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 96
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 97  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 150
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 265
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 294

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 95
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 96  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 149
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 264
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 93
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 94  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 147
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 262
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 93
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 94  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 147
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 262
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 128/270 (47%), Gaps = 13/270 (4%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G+++G GSF  V  A++     E    M  K           ++NE +   Q+   P I+
Sbjct: 16  GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSIL 74
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
                 Y++ +   +  L+LE    G + +R  K       E++ + +   ++ G+ ++H
Sbjct: 75  EL----YNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
           S G +H D+ L N+L+  N   KIADFGLA +     E+  +  C GTP Y+SPE    +
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-C-GTPNYISPEIATRS 187
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
            +    D+W+LGC    +  G+P ++     N  +   ++ + D    +P  LS + KD 
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---KVVLADY--EMPSFLSIEAKDL 242
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFVCADDQT 275
           + +   ++P  R +   +L+HPF+  +  T
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSRNSST 272

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 137/266 (51%), Gaps = 16/266 (6%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G G++G V   +   +S++    +A+K   +         +E+ AL +      IV+ 
Sbjct: 15  VLGKGTYGIVYAGR--DLSNQV--RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVK-KQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            G   SF +   F  + +E    GSL+  ++ K    +  E  +  YT+ +L+GL+++H 
Sbjct: 71  LG---SFSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 126
Query: 127 KGFVHCDIKLQNVLVFDNDEA-KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
              VH DIK  NVL+       KI+DFG +K+ +     +++F   GT  YM+PE +++ 
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMAPEIIDKG 184
Query: 186 E--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    DIW+LGC ++EMA+GKP +    +    + + ++G+    P IP  +S + K
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAMFKVGMFKVHPEIPESMSAEAK 242
Query: 244 DFLIKCFLKDPKRRWTAEMLLNHPFV 269
            F++KCF  DP +R  A  LL   F+
Sbjct: 243 AFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 8/194 (4%)
Query: 80  FYNLLLEYASRGSLADRVK-KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQN 138
           F  + +E    GSL+  ++ K    +  E  +  YT+ +L+GL+++H    VH DIK  N
Sbjct: 93  FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDN 152
Query: 139 VLVFDNDEA-KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE--YEAPCDIWA 195
           VL+       KI+DFG +K+ +     +++F   GT  YM+PE +++    Y    DIW+
Sbjct: 153 VLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMAPEIIDKGPRGYGKAADIWS 210
Query: 196 LGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPK 255
           LGC ++EMA+GKP +    +    + + ++G+    P IP  +S + K F++KCF  DP 
Sbjct: 211 LGCTIIEMATGKPPFYELGEPQ--AAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPD 268
Query: 256 RRWTAEMLLNHPFV 269
           +R  A  LL   F+
Sbjct: 269 KRACANDLLVDEFL 282

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 24/273 (8%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQI-- 64
           + +G G+F  V LA+          L AVK    C P       E    ++I +  +I  
Sbjct: 28  ETLGTGAFSEVVLAEEKATGK----LFAVK----CIPKKALKGKESSIENEIAVLRKIKH 79
Query: 65  --VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
             +    D Y  E     Y L+++  S G L DR+ ++  G   E D     R +L  + 
Sbjct: 80  ENIVALEDIY--ESPNHLY-LVMQLVSGGELFDRIVEK--GFYTEKDASTLIRQVLDAVY 134
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAK---IADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           ++H  G VH D+K +N+L +  DE     I+DFGL+K    +G+        GTP Y++P
Sbjct: 135 YLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSK---MEGKGDVMSTACGTPGYVAP 191
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +  Y    D W++G     +  G P +  + DS +F  +++     + P    D+S
Sbjct: 192 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSP-YWDDIS 250
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
           +  KDF+     KDP +R+T E    HP++  D
Sbjct: 251 DSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGD 283

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 131/273 (47%), Gaps = 21/273 (7%)
Query: 8   VIGHGSFGSVNLAK--ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           V+G GSFG V L K  +   + +  ++  +K         V  K E++ L ++   P IV
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIV 89
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           +     Y+F+   + Y L+L++   G L  R+ K+      E DVK Y   +   L H+H
Sbjct: 90  KL---HYAFQTEGKLY-LILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH 143
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
           S G ++ D+K +N+L+ +    K+ DFGL+K+S    +++ SF C GT  YM+PE VN  
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-C-GTVEYMAPEVVNRR 201
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
            +    D W+ G  + EM +G   +  K      +++++  +G     +P  LS + +  
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-----MPQFLSPEAQSL 256
Query: 246 LIKCFLKDPKRRWTA-----EMLLNHPFVCADD 273
           L   F ++P  R  A     E +  H F    D
Sbjct: 257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSS----EFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           V+G GSFG V L K  K+S     +  ++  +K         V  K E++ L ++   P 
Sbjct: 32  VLGQGSFGKVFLVK--KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPF 88
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+     Y+F+   + Y L+L++   G L  R+ K+      E DVK Y   +   L H
Sbjct: 89  IVKL---HYAFQTEGKLY-LILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDH 142
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS G ++ D+K +N+L+ +    K+ DFGL+K+S    +++ SF C GT  YM+PE VN
Sbjct: 143 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-C-GTVEYMAPEVVN 200
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              +    D W+ G  + EM +G   +  K      +++++  +G     +P  LS + +
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-----MPQFLSPEAQ 255
Query: 244 DFLIKCFLKDPKRRWTA-----EMLLNHPFVCADD 273
             L   F ++P  R  A     E +  H F    D
Sbjct: 256 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 290

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 131/273 (47%), Gaps = 21/273 (7%)
Query: 8   VIGHGSFGSVNLAK--ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           V+G GSFG V L K  +   + +  ++  +K         V  K E++ L ++   P IV
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIV 89
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           +     Y+F+   + Y L+L++   G L  R+ K+      E DVK Y   +   L H+H
Sbjct: 90  KL---HYAFQTEGKLY-LILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH 143
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
           S G ++ D+K +N+L+ +    K+ DFGL+K+S    +++ SF C GT  YM+PE VN  
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-C-GTVEYMAPEVVNRR 201
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
            +    D W+ G  + EM +G   +  K      +++++  +G     +P  LS + +  
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-----MPQFLSPEAQSL 256
Query: 246 LIKCFLKDPKRRWTA-----EMLLNHPFVCADD 273
           L   F ++P  R  A     E +  H F    D
Sbjct: 257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 111/198 (56%), Gaps = 10/198 (5%)
Query: 73  SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHC 132
           S+  GE  + +L+E+   G+L D V   +  RL E  +     ++L+ L ++H++G +H 
Sbjct: 110 SYLVGEELW-VLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 133 DIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCD 192
           DIK  ++L+  +   K++DFG   + S D  + +     GTP +M+PE ++ + Y    D
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV--GTPYWMAPEVISRSLYATEVD 223
Query: 193 IWALGCAVVEMASGKPAWNHKQDSNVFSL-LIRIGVGDELPNIPGDLSEQGKDFLIKCFL 251
           IW+LG  V+EM  G+P +    DS V ++  +R     +L N    +S   +DFL +  +
Sbjct: 224 IWSLGIMVIEMVDGEPPYF--SDSPVQAMKRLRDSPPPKLKN-SHKVSPVLRDFLERMLV 280
Query: 252 KDPKRRWTAEMLLNHPFV 269
           +DP+ R TA+ LL+HPF+
Sbjct: 281 RDPQERATAQELLDHPFL 298

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 129/275 (46%), Gaps = 26/275 (9%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           +++G+G++G V   +  K       L A+K           +K E   L +      I  
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQ----LAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 67  CFGDDYSFEKG------ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            +G   +F K       ++ + L++E+   GS+ D +K      L+E  +    R +L+G
Sbjct: 86  YYG---AFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L H+H    +H DIK QNVL+ +N E K+ DFG++ +      R  +F   GTP +M+PE
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPE 199
Query: 181 SV--NEN---EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
            +  +EN    Y+   D+W+LG   +EMA G P            L+ R    +  P + 
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----NPAPRLK 255
Query: 236 G-DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
               S++ + F+  C +K+  +R   E L+ HPF+
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 128/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +V LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 42  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 100
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   + F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 101 KLY---FCFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 154
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 155 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 215 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 269
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 270 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 298

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 128/269 (47%), Gaps = 18/269 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G GSF +  LA+    S E+   +  K           +  E++ + ++   P  V
Sbjct: 35  GKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFV 93
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L ++H
Sbjct: 94  KLY---FTFQDDEKLY-FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 147
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE + E 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
                 D+WALGC + ++ +G P +    +  +F  +I++       + P     + +D 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFPEKFFPKARDL 262
Query: 246 LIKCFLKDPKRRWTAEM------LLNHPF 268
           + K  + D  +R   E       L  HPF
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 21/273 (7%)
Query: 8   VIGHGSFGSVNLAKASKV--SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           V+G GSFG V L +      S    ++  +K         V  K E++ L  +   P +V
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN-HPFVV 93
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           +     Y+F+   + Y L+L++   G L  R+ K+      E DVK Y   +  GL H+H
Sbjct: 94  KL---HYAFQTEGKLY-LILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALGLDHLH 147
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
           S G ++ D+K +N+L+ +    K+ DFGL+K++    +++ SF C GT  YM+PE VN  
Sbjct: 148 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSF-C-GTVEYMAPEVVNRQ 205
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
            +    D W+ G  + EM +G   +  K      +L+++  +G     +P  LS + +  
Sbjct: 206 GHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLG-----MPQFLSTEAQSL 260
Query: 246 LIKCFLKDPKRRW-----TAEMLLNHPFVCADD 273
           L   F ++P  R       AE +  H F    D
Sbjct: 261 LRALFKRNPANRLGSGPDGAEEIKRHVFYSTID 293

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 137/272 (50%), Gaps = 26/272 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           +G G+FG V  AK    + E  +L A K       S   L++    ++ +  C  P IV+
Sbjct: 19  LGDGAFGKVYKAK----NKETGALAAAKVIET--KSEEELEDYIVEIEILATCDHPYIVK 72
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
             G  Y    G+ +  +++E+   G++ D +  + +  L E  ++   R ML+ L  +HS
Sbjct: 73  LLGAYY--HDGKLW--IMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV---- 182
           K  +H D+K  NVL+    + ++ADFG++ K+    ++  SF   GTP +M+PE V    
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF--IGTPYWMAPEVVMCET 185
Query: 183 -NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI--PGDLS 239
             +  Y+   DIW+LG  ++EMA  +P      + N   +L++I   D  P +  P   S
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMAQIEPP---HHELNPMRVLLKIAKSDP-PTLLTPSKWS 241
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA 271
            + +DFL     K+P+ R +A  LL HPFV +
Sbjct: 242 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 273

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 18/266 (6%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           +V+G G+F  V L K  +++ +  +L  +K       SS  L+NE   L +I    + + 
Sbjct: 15  EVLGSGAFSEVFLVK-QRLTGKLFALKCIKKSPAFRDSS--LENEIAVLKKIK--HENIV 69
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
              D Y   +    Y L+++  S G L DR+ ++  G   E D     + +L  ++++H 
Sbjct: 70  TLEDIY---ESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHE 124
Query: 127 KGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
            G VH D+K +N+L     +N +  I DFGL+K    +G  S +  C GTP Y++PE + 
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTA--C-GTPGYVAPEVLA 180
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
           +  Y    D W++G     +  G P +  + +S +F   I+ G  +       D+SE  K
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK-IKEGYYEFESPFWDDISESAK 239
Query: 244 DFLIKCFLKDPKRRWTAEMLLNHPFV 269
           DF+     KDP  R+T E  L+HP++
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 137/272 (50%), Gaps = 26/272 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           +G G+FG V  AK    + E  +L A K       S   L++    ++ +  C  P IV+
Sbjct: 27  LGDGAFGKVYKAK----NKETGALAAAKVIET--KSEEELEDYIVEIEILATCDHPYIVK 80
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
             G  Y    G+ +  +++E+   G++ D +  + +  L E  ++   R ML+ L  +HS
Sbjct: 81  LLGAYY--HDGKLW--IMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV---- 182
           K  +H D+K  NVL+    + ++ADFG++ K+    ++  SF   GTP +M+PE V    
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF--IGTPYWMAPEVVMCET 193
Query: 183 -NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI--PGDLS 239
             +  Y+   DIW+LG  ++EMA  +P      + N   +L++I   D  P +  P   S
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPP---HHELNPMRVLLKIAKSDP-PTLLTPSKWS 249
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA 271
            + +DFL     K+P+ R +A  LL HPFV +
Sbjct: 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 71  DYSFEKGERFYN---------LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           DY  E     YN         +++E+   G+L D V    + R+ E  +     ++L+ L
Sbjct: 84  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQAL 140
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
             +H++G +H DIK  ++L+  +   K++DFG   + S +  R +     GTP +M+PE 
Sbjct: 141 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPEL 198
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           ++   Y    DIW+LG  V+EM  G+P + ++        +IR  +   L N+   +S  
Sbjct: 199 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNL-HKVSPS 256
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            K FL +  ++DP +R TA  LL HPF+ 
Sbjct: 257 LKGFLDRLLVRDPAQRATAAELLKHPFLA 285

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 71  DYSFEKGERFYN---------LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           DY  E     YN         +++E+   G+L D V    + R+ E  +     ++L+ L
Sbjct: 82  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQAL 138
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
             +H++G +H DIK  ++L+  +   K++DFG   + S +  R +     GTP +M+PE 
Sbjct: 139 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPEL 196
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           ++   Y    DIW+LG  V+EM  G+P + ++        +IR  +   L N+   +S  
Sbjct: 197 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNL-HKVSPS 254
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            K FL +  ++DP +R TA  LL HPF+ 
Sbjct: 255 LKGFLDRLLVRDPAQRATAAELLKHPFLA 283

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 71  DYSFEKGERFYN---------LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           DY  E     YN         +++E+   G+L D V    + R+ E  +     ++L+ L
Sbjct: 204 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQAL 260
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
             +H++G +H DIK  ++L+  +   K++DFG   + S +  R +     GTP +M+PE 
Sbjct: 261 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPEL 318
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           ++   Y    DIW+LG  V+EM  G+P + ++        +IR  +   L N+   +S  
Sbjct: 319 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNL-HKVSPS 376
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            K FL +  ++DP +R TA  LL HPF+ 
Sbjct: 377 LKGFLDRLLVRDPAQRATAAELLKHPFLA 405

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 71  DYSFEKGERFYN---------LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           DY  E     YN         +++E+   G+L D V    + R+ E  +     ++L+ L
Sbjct: 77  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQAL 133
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
             +H++G +H DIK  ++L+  +   K++DFG   + S +  R +     GTP +M+PE 
Sbjct: 134 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPEL 191
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           ++   Y    DIW+LG  V+EM  G+P + ++        +IR  +   L N+   +S  
Sbjct: 192 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNL-HKVSPS 249
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            K FL +  ++DP +R TA  LL HPF+ 
Sbjct: 250 LKGFLDRLLVRDPAQRATAAELLKHPFLA 278

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 71  DYSFEKGERFYN---------LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           DY  E     YN         +++E+   G+L D V    + R+ E  +     ++L+ L
Sbjct: 73  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQAL 129
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
             +H++G +H DIK  ++L+  +   K++DFG   + S +  R +     GTP +M+PE 
Sbjct: 130 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPEL 187
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           ++   Y    DIW+LG  V+EM  G+P + ++        +IR  +   L N+   +S  
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNL-HKVSPS 245
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            K FL +  ++DP +R TA  LL HPF+ 
Sbjct: 246 LKGFLDRLLVRDPAQRATAAELLKHPFLA 274

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 71  DYSFEKGERFYN---------LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           DY  E     YN         +++E+   G+L D V    + R+ E  +     ++L+ L
Sbjct: 127 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQAL 183
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
             +H++G +H DIK  ++L+  +   K++DFG   + S +  R +     GTP +M+PE 
Sbjct: 184 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPEL 241
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           ++   Y    DIW+LG  V+EM  G+P + ++        +IR  +   L N+   +S  
Sbjct: 242 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNL-HKVSPS 299
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            K FL +  ++DP +R TA  LL HPF+ 
Sbjct: 300 LKGFLDRLLVRDPAQRATAAELLKHPFLA 328

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 127/251 (50%), Gaps = 15/251 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVR 66
           ++G GSFG V LA+  K +++F ++ A+K         V     EK  L      P +  
Sbjct: 25  MLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            F    +F+  E  +  ++EY + G L   +  Q+  +   S    Y   ++ GL+ +HS
Sbjct: 84  MFC---TFQTKENLF-FVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS 137
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           KG V+ D+KL N+L+  +   KIADFG+ K++     ++  F C GTP Y++PE +   +
Sbjct: 138 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEF-C-GTPDYIAPEILLGQK 195
Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y    D W+ G  + EM  G+  + H QD       IR+    + P  P  L ++ KD L
Sbjct: 196 YNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRM----DNPFYPRWLEKEAKDLL 250
Query: 247 IKCFLKDPKRR 257
           +K F+++P++R
Sbjct: 251 VKLFVREPEKR 261

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 130/257 (50%), Gaps = 15/257 (5%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGI 60
           +++   ++G GSFG V LA+  K +++F ++ A+K         V     EK  L     
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +   F    +F+  E  +  ++EY + G L   +  Q+  +   S    Y   ++ G
Sbjct: 77  HPFLTHMFC---TFQTKENLF-FVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILG 130
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L+ +HSKG V+ D+KL N+L+  +   KIADFG+ K++     ++  F C GTP Y++PE
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXF-C-GTPDYIAPE 188
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            +   +Y    D W+ G  + EM  G+  + H QD       IR+    + P  P  L +
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRM----DNPFYPRWLEK 243
Query: 241 QGKDFLIKCFLKDPKRR 257
           + KD L+K F+++P++R
Sbjct: 244 EAKDLLVKLFVREPEKR 260

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 131/256 (51%), Gaps = 14/256 (5%)
Query: 8   VIGHGSFGSVNLAK--ASKVSSEFPSLMAVKSCADCPPSSVT--LKNEKEALDQIGICPQ 63
           V+G G++G V L +  +   + +  ++  +K       +  T   + E++ L+ I   P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V      Y+F+   + + L+L+Y + G L   + ++   R  E +V+ Y   ++  L H
Sbjct: 121 LVTL---HYAFQTETKLH-LILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEH 174
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV- 182
           +H  G ++ DIKL+N+L+  N    + DFGL+K+   D E  ++++  GT  YM+P+ V 
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTIEYMAPDIVR 233
Query: 183 -NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
             ++ ++   D W+LG  + E+ +G   +    + N  + + R  +  E P  P ++S  
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PPYPQEMSAL 292
Query: 242 GKDFLIKCFLKDPKRR 257
            KD + +  +KDPK+R
Sbjct: 293 AKDLIQRLLMKDPKKR 308

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 14  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 72  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 125
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     SC    S+     GT  Y+ PE +  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SCHAPSSRRTTLSGTLDYLPPEMIEG 181
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 236
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 18  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA RG +   ++K +  +  E     Y   +   L + 
Sbjct: 76  LRLYG---YFHDATRVY-LILEYAPRGEVYKELQKLS--KFDEQRTATYITELANALSYC 129
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLXGTLDYLPPEMIEG 185
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 240
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 129/274 (47%), Gaps = 22/274 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           +++R   IG GSFG   L K+++   ++          +   S ++ K  +E+  ++ + 
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQY-------VIKEINISRMSSKEREESRREVAVL 77
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P IV+      SFE+    Y ++++Y   G L  R+  Q     QE  +  +   
Sbjct: 78  ANMKHPNIVQY---RESFEENGSLY-IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ 133
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           +   L+H+H +  +H DIK QN+ +  +   ++ DFG+A+  +   E +++  C GTP Y
Sbjct: 134 ICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYY 191
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +SPE      Y    DIWALGC + E+ + K A+      N   L+++I +    P +  
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLKI-ISGSFPPVSL 247
Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
             S   +  + + F ++P+ R +   +L   F+ 
Sbjct: 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 126/269 (46%), Gaps = 17/269 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGI 60
           ++ R + IG G+ G+V  A       E    +A++       P    + NE   + +   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQE----VAIRQMNLQQQPKKELIINEILVMRE-NK 75
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV       S+  G+  + +++EY + GSL D V +     + E  +    R  L+ 
Sbjct: 76  NPNIVNYLD---SYLVGDELW-VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQA 128
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L  +HS   +H DIK  N+L+  +   K+ DFG    +    E+S+  E  GTP +M+PE
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSEMVGTPYWMAPE 186
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            V    Y    DIW+LG   +EM  G+P + ++       L+   G   EL N P  LS 
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQN-PEKLSA 244
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             +DFL +C   D ++R +A+ LL H F+
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 120/250 (48%), Gaps = 14/250 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G G+FG V L +  K +  + ++  ++         V     +  + Q    P +   
Sbjct: 12  LLGKGTFGKVILVR-EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+  +R    ++EYA+ G L   + ++      E   + Y   ++  L ++HS+
Sbjct: 71  ---KYAFQTHDRL-CFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR 124
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             V+ DIKL+N+++  +   KI DFGL K+   DG   ++F C GTP Y++PE + +N+Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-C-GTPEYLAPEVLEDNDY 182
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
               D W LG  + EM  G+  + ++    +F L++      E    P  LS + K  L 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFPRTLSPEAKSLLA 237
Query: 248 KCFLKDPKRR 257
               KDPK+R
Sbjct: 238 GLLKKDPKQR 247

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 120/250 (48%), Gaps = 14/250 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G G+FG V L +  K +  + ++  ++         V     +  + Q    P +   
Sbjct: 12  LLGKGTFGKVILVR-EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+  +R    ++EYA+ G L   + ++      E   + Y   ++  L ++HS+
Sbjct: 71  ---KYAFQTHDRL-CFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR 124
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             V+ DIKL+N+++  +   KI DFGL K+   DG   ++F C GTP Y++PE + +N+Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-C-GTPEYLAPEVLEDNDY 182
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
               D W LG  + EM  G+  + ++    +F L++      E    P  LS + K  L 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFPRTLSPEAKSLLA 237
Query: 248 KCFLKDPKRR 257
               KDPK+R
Sbjct: 238 GLLKKDPKQR 247

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 120/250 (48%), Gaps = 14/250 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G G+FG V L +  K +  + ++  ++         V     +  + Q    P +   
Sbjct: 15  LLGKGTFGKVILVR-EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+  +R    ++EYA+ G L   + ++      E   + Y   ++  L ++HS+
Sbjct: 74  ---KYAFQTHDRL-CFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR 127
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             V+ DIKL+N+++  +   KI DFGL K+   DG   ++F C GTP Y++PE + +N+Y
Sbjct: 128 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-C-GTPEYLAPEVLEDNDY 185
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
               D W LG  + EM  G+  + ++    +F L++      E    P  LS + K  L 
Sbjct: 186 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFPRTLSPEAKSLLA 240
Query: 248 KCFLKDPKRR 257
               KDPK+R
Sbjct: 241 GLLKKDPKQR 250

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 20/267 (7%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G GSFG V   K      E+   +  K+ A    +S  L+ E E L ++   P I++ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLD-HPNIMKL 86
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F      E    FY ++ E  + G L D + K+   R  E D  R  + +  G+ ++H  
Sbjct: 87  FE---ILEDSSSFY-IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH 140
Query: 128 GFVHCDIKLQNVLVFDND---EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
             VH D+K +N+L+   +   + KI DFGL   S+C  + ++  +  GT  Y++PE V  
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGL---STCFQQNTKMKDRIGTAYYIAPE-VLR 196
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG--DLSEQG 242
             Y+  CD+W+ G  +  + SG P +  K   N + +L R+  G    ++P    +S+  
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           KD + K     P  R TA   L HP++
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 14/250 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G G+FG V L +  K +  + ++  ++         V     +  + Q    P +   
Sbjct: 12  LLGKGTFGKVILVR-EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+  +R    ++EYA+ G L   + ++      E   + Y   ++  L ++HS+
Sbjct: 71  ---KYAFQTHDRL-CFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR 124
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             V+ DIKL+N+++  +   KI DFGL K+   DG   + F C GTP Y++PE + +N+Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-C-GTPEYLAPEVLEDNDY 182
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
               D W LG  + EM  G+  + ++    +F L++      E    P  LS + K  L 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFPRTLSPEAKSLLA 237
Query: 248 KCFLKDPKRR 257
               KDPK+R
Sbjct: 238 GLLKKDPKQR 247

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 14/250 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G G+FG V L +  K +  + ++  ++         V     +  + Q    P +   
Sbjct: 17  LLGKGTFGKVILVR-EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+  +R    ++EYA+ G L   + ++      E   + Y   ++  L ++HS+
Sbjct: 76  ---KYAFQTHDRL-CFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR 129
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             V+ DIKL+N+++  +   KI DFGL K+   DG   + F C GTP Y++PE + +N+Y
Sbjct: 130 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-C-GTPEYLAPEVLEDNDY 187
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
               D W LG  + EM  G+  + ++    +F L++      E    P  LS + K  L 
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFPRTLSPEAKSLLA 242
Query: 248 KCFLKDPKRR 257
               KDPK+R
Sbjct: 243 GLLKKDPKQR 252

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 20/267 (7%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G GSFG V   K      E+   +  K+ A    +S  L+ E E L ++   P I++ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLD-HPNIMKL 86
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F      E    FY ++ E  + G L D + K+   R  E D  R  + +  G+ ++H  
Sbjct: 87  FE---ILEDSSSFY-IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH 140
Query: 128 GFVHCDIKLQNVLVFDND---EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
             VH D+K +N+L+   +   + KI DFGL   S+C  + ++  +  GT  Y++PE V  
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGL---STCFQQNTKMKDRIGTAYYIAPE-VLR 196
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG--DLSEQG 242
             Y+  CD+W+ G  +  + SG P +  K   N + +L R+  G    ++P    +S+  
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           KD + K     P  R TA   L HP++
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 13  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 71  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 124
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+  E  GT  Y+ PE +  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTELCGTLDYLPPEMIEG 180
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 235
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 18  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA RG +   ++K +  +  E     Y   +   L + 
Sbjct: 76  LRLYG---YFHDATRVY-LILEYAPRGEVYKELQKLS--KFDEQRTATYITELANALSYC 129
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 240
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 14/250 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G G+FG V L +  K +  + ++  ++         V     +  + Q    P +   
Sbjct: 12  LLGKGTFGKVILVR-EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+  +R    ++EYA+ G L   + ++      E   + Y   ++  L ++HS+
Sbjct: 71  ---KYAFQTHDRL-CFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR 124
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             V+ DIKL+N+++  +   KI DFGL K+   DG   + F C GTP Y++PE + +N+Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-C-GTPEYLAPEVLEDNDY 182
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
               D W LG  + EM  G+  + ++    +F L++      E    P  LS + K  L 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFPRTLSPEAKSLLA 237
Query: 248 KCFLKDPKRR 257
               KDPK+R
Sbjct: 238 GLLKKDPKQR 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 14/250 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G G+FG V L +  K +  + ++  ++         V     +  + Q    P +   
Sbjct: 12  LLGKGTFGKVILVR-EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+  +R    ++EYA+ G L   + ++      E   + Y   ++  L ++HS+
Sbjct: 71  ---KYAFQTHDRL-CFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR 124
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             V+ DIKL+N+++  +   KI DFGL K+   DG   + F C GTP Y++PE + +N+Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-C-GTPEYLAPEVLEDNDY 182
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
               D W LG  + EM  G+  + ++    +F L++      E    P  LS + K  L 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFPRTLSPEAKSLLA 237
Query: 248 KCFLKDPKRR 257
               KDPK+R
Sbjct: 238 GLLKKDPKQR 247

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 20/267 (7%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G GSFG V   K      E+   +  K+ A    +S  L+ E E L ++   P I++ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLD-HPNIMKL 86
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F      E    FY ++ E  + G L D + K+   R  E D  R  + +  G+ ++H  
Sbjct: 87  FE---ILEDSSSFY-IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH 140
Query: 128 GFVHCDIKLQNVLVFDND---EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
             VH D+K +N+L+   +   + KI DFGL   S+C  + ++  +  GT  Y++PE V  
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGL---STCFQQNTKMKDRIGTAYYIAPE-VLR 196
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG--DLSEQG 242
             Y+  CD+W+ G  +  + SG P +  K   N + +L R+  G    ++P    +S+  
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           KD + K     P  R TA   L HP++
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 21/274 (7%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
            E++R  V+G GSFG V LA+  +    +   +  K              EK  L     
Sbjct: 25  FEFIR--VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P + + F     F+  +R +  ++E+ + G L   ++K    R  E+  + Y   ++  
Sbjct: 83  HPFLTQLFC---CFQTPDRLF-FVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISA 136
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L  +H KG ++ D+KL NVL+      K+ADFG+ K+  C+G  + +F C GTP Y++PE
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF-C-GTPDYIAPE 194
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            + E  Y    D WA+G  + EM  G   +  + + ++F  ++     DE+   P  L E
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL----NDEVV-YPTWLHE 249
Query: 241 QGKDFLIKCFLKDPKRRWTA------EMLLNHPF 268
                L     K+P  R  +        +L HPF
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 123/261 (47%), Gaps = 30/261 (11%)
Query: 9   IGHGSFGSVNLAK--------ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           IG G F  V  A         A K    F  LM  K+ ADC         E + L Q+  
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIF-DLMDAKARADC-------IKEIDLLKQLN- 90
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK--KQNNGRLQESDVKRYTRSML 118
            P +++ +    SF +     N++LE A  G L+  +K  K+    + E  V +Y   + 
Sbjct: 91  HPNVIKYYA---SFIEDNEL-NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
             L H+HS+  +H DIK  NV +      K+ D GL +  S     + S    GTP YMS
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMS 204
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           PE ++EN Y    DIW+LGC + EMA+ + P +  K   N++SL  +I   D  P +P D
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEQCD-YPPLPSD 261
Query: 238 -LSEQGKDFLIKCFLKDPKRR 257
             SE+ +  +  C   DP++R
Sbjct: 262 HYSEELRQLVNMCINPDPEKR 282

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 125/269 (46%), Gaps = 17/269 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGI 60
           ++ R + IG G+ G+V  A       E    +A++       P    + NE   + +   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQE----VAIRQMNLQQQPKKELIINEILVMRE-NK 75
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV       S+  G+  + +++EY + GSL D V +     + E  +    R  L+ 
Sbjct: 76  NPNIVNYLD---SYLVGDELW-VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQA 128
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L  +HS   +H DIK  N+L+  +   K+ DFG    +    E+S+     GTP +M+PE
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSXMVGTPYWMAPE 186
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            V    Y    DIW+LG   +EM  G+P + ++       L+   G   EL N P  LS 
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQN-PEKLSA 244
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             +DFL +C   D ++R +A+ LL H F+
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/221 (33%), Positives = 117/221 (52%), Gaps = 20/221 (9%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL   +KK   GR+ E  + + + +++KGL
Sbjct: 64  PYIVGFYGAFYS--DGE--ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 117
Query: 122 RHIHSKG-FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++ +       + SF   GT  YMSPE
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSF--VGTRSYMSPE 173
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGK---PAWNHKQDSN----VFSLLIRIGVGDELPN 233
            +    Y    DIW++G ++VEMA G+   P  + K+DS     +F LL  I V +  P 
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYI-VNEPPPK 232
Query: 234 IP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           +P G  S + +DF+ KC +K+P  R   + L+ H F+   D
Sbjct: 233 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 273

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 117/218 (53%), Gaps = 22/218 (10%)
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
           CP IV+CFG   +        ++ +     G+ A+++KK+  G + E  + + T +++K 
Sbjct: 83  CPYIVQCFGTFITNT------DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 121 LRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           L ++  K G +H D+K  N+L+ +  + K+ DFG++ +   D  + +S  C     YM+P
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA---YMAP 193
Query: 180 ESVN-----ENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPN 233
           E ++     + +Y+   D+W+LG ++VE+A+G+ P  N K D  V + +++    +E P 
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ----EEPPL 249
Query: 234 IPGDLSEQG--KDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           +PG +   G  + F+  C  KD ++R     LL H F+
Sbjct: 250 LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 125/269 (46%), Gaps = 17/269 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGI 60
           ++ R + IG G+ G+V  A       E    +A++       P    + NE   + +   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQE----VAIRQMNLQQQPKKELIINEILVMRE-NK 75
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV       S+  G+  + +++EY + GSL D V +     + E  +    R  L+ 
Sbjct: 76  NPNIVNYLD---SYLVGDELW-VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQA 128
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L  +HS   +H DIK  N+L+  +   K+ DFG    +    E+S+     GTP +M+PE
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPE 186
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            V    Y    DIW+LG   +EM  G+P + ++       L+   G   EL N P  LS 
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQN-PEKLSA 244
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             +DFL +C   D ++R +A+ LL H F+
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 13  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 71  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 124
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+  +  GT  Y+ PE +  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 235
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 18  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 76  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 129
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+  +  GT  Y+ PE +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEMIEG 185
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 240
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 17/269 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGI 60
           ++ R + IG G+ G+V  A       E    +A++       P    + NE   + +   
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQE----VAIRQMNLQQQPKKELIINEILVMRE-NK 76
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV       S+  G+  + +++EY + GSL D V +     + E  +    R  L+ 
Sbjct: 77  NPNIVNYLD---SYLVGDELW-VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQA 129
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L  +HS   +H DIK  N+L+  +   K+ DFG    +    E+S+     GTP +M+PE
Sbjct: 130 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSXMVGTPYWMAPE 187
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            V    Y    DIW+LG   +EM  G+P + ++       L+   G   EL N P  LS 
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQN-PEKLSA 245
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             +DFL +C   D ++R +A+ L+ H F+
Sbjct: 246 IFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 14  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 72  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 125
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+  +  GT  Y+ PE +  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 236
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 18  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 76  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 129
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEXIEG 185
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 186 RXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 240
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 241 LISRLLKHNPSQRPXLREVLEHPWITAN 268

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 13  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 71  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 124
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+  +  GT  Y+ PE +  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 235
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 13  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 71  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 124
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLCGTLDYLPPEMIEG 180
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 235
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 16  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 74  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 127
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLCGTLDYLPPEMIEG 183
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 238
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 113/215 (52%), Gaps = 14/215 (6%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL   +KK   GR+ E  + + + +++KGL
Sbjct: 83  PYIVGFYGAFYS--DGE--ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 136
Query: 122 RHIHSKG-FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++ +       + SF   GT  YMSPE
Sbjct: 137 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSF--VGTRSYMSPE 192
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIP-GDL 238
            +    Y    DIW++G ++VEMA G+ P  +      +F LL  I V +  P +P G  
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYI-VNEPPPKLPSGVF 251
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           S + +DF+ KC +K+P  R   + L+ H F+   D
Sbjct: 252 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 286

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 12  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 69
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 70  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 123
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 124 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 179
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 180 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 234
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 235 LISRLLKHNPSQRPMLREVLEHPWITAN 262

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 13  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 71  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 124
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTXLCGTLDYLPPEMIEG 180
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 235
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 17  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 75  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 128
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 129 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 239
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 240 LISRLLKHNPSQRPMLREVLEHPWITAN 267

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 13  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 71  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 124
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 180
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 235
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 16  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 74  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 127
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 238
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 15  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 73  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 126
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLCGTLDYLPPEMIEG 182
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 237
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 238 LISRLLKHNPSQRPMLREVLEHPWITAN 265

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 16  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 74  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 127
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 238
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 18  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 76  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 129
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 240
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+    +S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 13  GRPLGKGKFGNVYLAREK--NSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 71  LRLYG---YFHDSTRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 124
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 125 HSKKVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRAALCGTLDYLPPEMIEG 180
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +      + +  + R+         P  ++E  +D
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEF-----TFPDFVTEGARD 235
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 16  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 74  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 127
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+  +  GT  Y+ PE +  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRDDLCGTLDYLPPEMIEG 183
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 238
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 13  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 71  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 124
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRAALCGTLDYLPPEMIEG 180
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 235
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 39  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 97  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 150
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 206
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 261
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 262 LISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 30  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 87
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 88  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 141
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 142 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 197
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 198 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 252
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 253 LISRLLKHNPSQRPMLREVLEHPWITAN 280

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 39  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 97  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 150
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+  +  GT  Y+ PE +  
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRDDLCGTLDYLPPEMIEG 206
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 261
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 262 LISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 16  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 74  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 127
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRAALCGTLDYLPPEMIEG 183
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 238
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 14  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 72  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 125
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRDTLCGTLDYLPPEMIEG 181
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 236
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 119/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V        + V  +  +E   Q  +  P I
Sbjct: 17  GRPLGKGKFGNVYLARERQ--SKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  R  E     Y   +   L + 
Sbjct: 75  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--RFDEQRTATYITELANALSYC 128
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+  N E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   G P +        +  + R+         P  ++E  +D
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF-----TFPDFVTEGARD 239
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +  +R T   +L HP++ A+
Sbjct: 240 LISRLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 8   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-XINKML 62
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 63  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 118/254 (46%), Gaps = 21/254 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCA----DCPPSSVTLKNEKEALDQIGICPQ 63
           V+G GSFG V LA   K + E  ++  +K       D    ++  K     LD+     Q
Sbjct: 26  VLGKGSFGKVMLAD-RKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQ 84
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +  CF      +  +R Y  ++EY + G L   +  Q  G+ +E     Y   +  GL  
Sbjct: 85  LHSCF------QTVDRLY-FVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISIGLFF 135
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +H +G ++ D+KL NV++      KIADFG+ K+   DG  ++ F C GTP Y++PE + 
Sbjct: 136 LHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREF-C-GTPDYIAPEIIA 193
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WA G  + EM +G+P ++ + +  +F  ++   V     + P  LS++  
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-----SYPKSLSKEAV 248
Query: 244 DFLIKCFLKDPKRR 257
                   K P +R
Sbjct: 249 SICKGLMTKHPAKR 262

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 99/190 (52%), Gaps = 13/190 (6%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           +++E+   G+L D V    + R+ E  +     S+L+ L ++H++G +H DIK  ++L+ 
Sbjct: 119 VVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 175
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVE 202
            +   K++DFG   + S +  + +     GTP +M+PE ++   Y    DIW+LG  V+E
Sbjct: 176 SDGRIKLSDFGFCAQVSKEVPKRKXLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 233
Query: 203 MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL---SEQGKDFLIKCFLKDPKRRWT 259
           M  G+P + ++             + D LP    DL   S   + FL    +++P +R T
Sbjct: 234 MIDGEPPYFNEPPLQAMR-----RIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRAT 288
Query: 260 AEMLLNHPFV 269
           A+ LL HPF+
Sbjct: 289 AQELLGHPFL 298

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 17/269 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGI 60
           ++ R + IG G+ G+V  A       E    +A++       P    + NE   + +   
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQE----VAIRQMNLQQQPKKELIINEILVMRE-NK 76
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV       S+  G+  + +++EY + GSL D V +     + E  +    R  L+ 
Sbjct: 77  NPNIVNYLD---SYLVGDELW-VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQA 129
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L  +HS   +H +IK  N+L+  +   K+ DFG    +    E+S+     GTP +M+PE
Sbjct: 130 LEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPE 187
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            V    Y    DIW+LG   +EM  G+P + ++       L+   G   EL N P  LS 
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQN-PEKLSA 245
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             +DFL +C   D ++R +A+ L+ H F+
Sbjct: 246 IFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-XINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR+  + +  + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           + F +   F  ++LE   R SL +  K++    L E + + Y R ++ G +++H    +H
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            D+KL N+ + ++ E KI DFGLA K   DGER ++  C GTP Y++PE +++  +    
Sbjct: 141 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-C-GTPNYIAPEVLSKKGHSFEV 198
Query: 192 DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFL 251
           D+W++GC +  +  GKP +   + S +    +RI   +   +IP  ++      + K   
Sbjct: 199 DVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQ 253
Query: 252 KDPKRRWTAEMLLNHPFVCA 271
            DP  R T   LLN  F  +
Sbjct: 254 TDPTARPTINELLNDEFFTS 273

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           + F +   F  ++LE   R SL +  K++    L E + + Y R ++ G +++H    +H
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIH 144
Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            D+KL N+ + ++ E KI DFGLA K   DGER ++  C GTP Y++PE +++  +    
Sbjct: 145 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-C-GTPNYIAPEVLSKKGHSFEV 202
Query: 192 DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFL 251
           D+W++GC +  +  GKP +   + S +    +RI   +   +IP  ++      + K   
Sbjct: 203 DVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQ 257
Query: 252 KDPKRRWTAEMLLNHPFVCA 271
            DP  R T   LLN  F  +
Sbjct: 258 TDPTARPTINELLNDEFFTS 277

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 127/290 (43%), Gaps = 39/290 (13%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           IG G++G V  A+  K    F +L  V+         ++   E   L  +     P +VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGS-LADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
            F D  +  + +R   L L +      L   + K     +    +K     +L+GL  +H
Sbjct: 79  LF-DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-----YMSPE 180
           S   VH D+K QN+LV  + + K+ADFGLA        R  SF+   T +     Y +PE
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLA--------RIYSFQMALTSVVVTLWYRAPE 189
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGV-GDE-------L 231
            + ++ Y  P D+W++GC   EM   KP +    D +    +L  IG+ G+E       L
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 232 P-------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P                 D+ E GKD L+KC   +P +R +A   L+HP+
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           + F +   F  ++LE   R SL +  K++    L E + + Y R ++ G +++H    +H
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            D+KL N+ + ++ E KI DFGLA K   DGER ++  C GTP Y++PE +++  +    
Sbjct: 141 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-C-GTPNYIAPEVLSKKGHSFEV 198
Query: 192 DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFL 251
           D+W++GC +  +  GKP +   + S +    +RI   +   +IP  ++      + K   
Sbjct: 199 DVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQ 253
Query: 252 KDPKRRWTAEMLLNHPFVCA 271
            DP  R T   LLN  F  +
Sbjct: 254 TDPTARPTINELLNDEFFTS 273

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR+  + +  + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 16  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 74  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 127
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIA+FG     S     S+     GT  Y+ PE +  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIANFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 238
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 20/272 (7%)
Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNE---KEALDQIG 59
           ++RG  +G G F              F   +  KS    P     +  E    ++LD   
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN-- 101
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P +V   G    F + + F  ++LE   R SL +  K++    + E + + + R  ++
Sbjct: 102 --PHVVGFHG----FFEDDDFVYVVLEICRRRSLLELHKRRKA--VTEPEARYFMRQTIQ 153
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G++++H+   +H D+KL N+ + D+ + KI DFGLA K   DGER ++  C GTP Y++P
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL-C-GTPNYIAP 211
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +  +    DIW+LGC +  +  GKP +   + S +    IRI   +   ++P  ++
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPF---ETSCLKETYIRIKKNEY--SVPRHIN 266
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA 271
                 + +    DP  R +   LL   F  +
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 129/277 (46%), Gaps = 22/277 (7%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
            E+L+  ++G G+FG V L K  K +  + ++  +K         V     +  + Q   
Sbjct: 150 FEYLK--LLGKGTFGKVILVK-EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +       YSF+  +R    ++EYA+ G L   + ++      E   + Y   ++  
Sbjct: 207 HPFLTAL---KYSFQTHDRL-CFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSA 260
Query: 121 LRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           L ++HS K  V+ D+KL+N+++  +   KI DFGL K+   DG   ++F C GTP Y++P
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-C-GTPEYLAP 318
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +N+Y    D W LG  + EM  G+  + ++    +F L++      E    P  L 
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFPRTLG 373
Query: 240 EQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA 271
            + K  L     KDPK+R       A+ ++ H F   
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 127/290 (43%), Gaps = 39/290 (13%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           IG G++G V  A+  K    F +L  V+         ++   E   L  +     P +VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGS-LADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
            F D  +  + +R   L L +      L   + K     +    +K     +L+GL  +H
Sbjct: 79  LF-DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-----YMSPE 180
           S   VH D+K QN+LV  + + K+ADFGLA        R  SF+   T +     Y +PE
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLA--------RIYSFQMALTSVVVTLWYRAPE 189
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGV-GDE-------L 231
            + ++ Y  P D+W++GC   EM   KP +    D +    +L  IG+ G+E       L
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 232 P-------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P                 D+ E GKD L+KC   +P +R +A   L+HP+
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 119/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +   +F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 10  GRPLGKGKFGNVYLAREKQ--RKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 67
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 68  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 121
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 177
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 178 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 232
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 233 LISRLLKHNPSQRPMLREVLEHPWITAN 260

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V   A    + V  +  +E   Q  +  P I
Sbjct: 15  GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  +  E     Y   +   L + 
Sbjct: 73  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYC 126
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+    E KIA+FG     S     S+     GT  Y+ PE +  
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGELKIANFGW----SVHAPSSRRTTLCGTLDYLPPEMIEG 182
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   GKP +        +  + R+         P  ++E  +D
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGARD 237
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +P +R     +L HP++ A+
Sbjct: 238 LISRLLKHNPSQRPMLREVLEHPWITAN 265

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 129/277 (46%), Gaps = 22/277 (7%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
            E+L+  ++G G+FG V L K  K +  + ++  +K         V     +  + Q   
Sbjct: 153 FEYLK--LLGKGTFGKVILVK-EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 209
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +       YSF+  +R    ++EYA+ G L   + ++      E   + Y   ++  
Sbjct: 210 HPFLTAL---KYSFQTHDRL-CFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSA 263
Query: 121 LRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           L ++HS K  V+ D+KL+N+++  +   KI DFGL K+   DG   ++F C GTP Y++P
Sbjct: 264 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-C-GTPEYLAP 321
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +N+Y    D W LG  + EM  G+  + ++    +F L++      E    P  L 
Sbjct: 322 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFPRTLG 376
Query: 240 EQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA 271
            + K  L     KDPK+R       A+ ++ H F   
Sbjct: 377 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 413

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 125/290 (43%), Gaps = 39/290 (13%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           IG G++G V  A+  K    F +L  V+         ++   E   L  +     P +VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGS-LADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
            F D  +  + +R   L L +      L   + K     +    +K     +L+GL  +H
Sbjct: 79  LF-DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-----YMSPE 180
           S   VH D+K QN+LV  + + K+ADFGLA        R  SF+   T +     Y +PE
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLA--------RIYSFQMALTSVVVTLWYRAPE 189
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGDE--------L 231
            + ++ Y  P D+W++GC   EM   KP +    D +    +L  IG+  E        L
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 232 P-------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P                 D+ E GKD L+KC   +P +R +A   L+HP+
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 119/268 (44%), Gaps = 18/268 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G  +G G FG+V LA+  +  S+F   + V        + V  +  +E   Q  +  P I
Sbjct: 17  GRPLGKGKFGNVYLARERQ--SKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +G    F    R Y L+LEYA  G++   ++K +  R  E     Y   +   L + 
Sbjct: 75  LRLYG---YFHDATRVY-LILEYAPLGTVYRELQKLS--RFDEQRTATYITELANALSYC 128
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HSK  +H DIK +N+L+  N E KIADFG     S     S+     GT  Y+ PE +  
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGW----SVHAPSSRRDTLCGTLDYLPPEMIEG 184
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
             ++   D+W+LG    E   G P +        +  + R+         P  ++E  +D
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF-----TFPDFVTEGARD 239
Query: 245 FLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            + +    +  +R T   +L HP++ A+
Sbjct: 240 LISRLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 131/271 (48%), Gaps = 31/271 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEK--EALDQIGICPQIVR 66
           IGHGSFG+V  A+  + S     ++A+K  +     S    NEK  + + ++    ++  
Sbjct: 23  IGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQS----NEKWQDIIKEVRFLQKLRH 74
Query: 67  CFGDDYSFEKG----ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
                Y   +G    E    L++EY   GS +D ++      LQE ++   T   L+GL 
Sbjct: 75  PNTIQY---RGCYLREHTAWLVMEYC-LGSASDLLEVHKKP-LQEVEIAAVTHGALQGLA 129
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-- 180
           ++HS   +H D+K  N+L+ +    K+ DFG    S+     +  F   GTP +M+PE  
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANXF--VGTPYWMAPEVI 183
Query: 181 -SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
            +++E +Y+   D+W+LG   +E+A  KP      + N  S L  I   +      G  S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESPALQSGHWS 240
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           E  ++F+  C  K P+ R T+E+LL H FV 
Sbjct: 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 131/271 (48%), Gaps = 31/271 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEK--EALDQIGICPQIVR 66
           IGHGSFG+V  A+  + S     ++A+K  +     S    NEK  + + ++    ++  
Sbjct: 62  IGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQS----NEKWQDIIKEVRFLQKLRH 113
Query: 67  CFGDDYSFEKG----ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
                Y   +G    E    L++EY   GS +D ++      LQE ++   T   L+GL 
Sbjct: 114 PNTIQY---RGCYLREHTAWLVMEYC-LGSASDLLEVHKKP-LQEVEIAAVTHGALQGLA 168
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-- 180
           ++HS   +H D+K  N+L+ +    K+ DFG    S+     +  F   GTP +M+PE  
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANXF--VGTPYWMAPEVI 222
Query: 181 -SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
            +++E +Y+   D+W+LG   +E+A  KP      + N  S L  I   +      G  S
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESPALQSGHWS 279
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           E  ++F+  C  K P+ R T+E+LL H FV 
Sbjct: 280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 119/255 (46%), Gaps = 14/255 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG GS+  V L +  K    +   +  K   +       ++ EK   +Q    P +V  
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV-- 116
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G    F+   R +  ++EY + G L   +++Q   +L E   + Y+  +   L ++H +
Sbjct: 117 -GLHSCFQTESRLF-FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER 172
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
           G ++ D+KL NVL+      K+ D+G+ K+    G+ + +F C GTP Y++PE +   +Y
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-C-GTPNYIAPEILRGEDY 230
Query: 188 EAPCDIWALGCAVVEMASGKPAWN-----HKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               D WALG  + EM +G+  ++        D N    L ++ +  ++  IP  LS + 
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKA 289
Query: 243 KDFLIKCFLKDPKRR 257
              L     KDPK R
Sbjct: 290 ASVLKSFLNKDPKER 304

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 20/272 (7%)
Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNE---KEALDQIG 59
           ++RG  +G G F              F   +  KS    P     +  E    ++LD   
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN-- 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P +V   G    F + + F  ++LE   R SL +  K++    + E + + + R  ++
Sbjct: 86  --PHVVGFHG----FFEDDDFVYVVLEICRRRSLLELHKRRKA--VTEPEARYFMRQTIQ 137
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G++++H+   +H D+KL N+ + D+ + KI DFGLA K   DGER +   C GTP Y++P
Sbjct: 138 GVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-C-GTPNYIAP 195
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +  +    DIW+LGC +  +  GKP +   + S +    IRI   +   ++P  ++
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPF---ETSCLKETYIRIKKNEY--SVPRHIN 250
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA 271
                 + +    DP  R +   LL   F  +
Sbjct: 251 PVASALIRRMLHADPTLRPSVAELLTDEFFTS 282

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 22/277 (7%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
            E+L+  ++G G+FG V L K  K +  + ++  +K         V     +  + Q   
Sbjct: 12  FEYLK--LLGKGTFGKVILVK-EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 68
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +       YSF+  +R    ++EYA+ G L   + ++      E   + Y   ++  
Sbjct: 69  HPFLTAL---KYSFQTHDRL-CFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSA 122
Query: 121 LRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           L ++HS K  V+ D+KL+N+++  +   KI DFGL K+   DG   + F C GTP Y++P
Sbjct: 123 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF-C-GTPEYLAP 180
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +N+Y    D W LG  + EM  G+  + ++    +F L++      E    P  L 
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFPRTLG 235
Query: 240 EQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA 271
            + K  L     KDPK+R       A+ ++ H F   
Sbjct: 236 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 272

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 22/277 (7%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
            E+L+  ++G G+FG V L K  K +  + ++  +K         V     +  + Q   
Sbjct: 11  FEYLK--LLGKGTFGKVILVK-EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 67
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +       YSF+  +R    ++EYA+ G L   + ++      E   + Y   ++  
Sbjct: 68  HPFLTAL---KYSFQTHDRL-CFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSA 121
Query: 121 LRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           L ++HS K  V+ D+KL+N+++  +   KI DFGL K+   DG   + F C GTP Y++P
Sbjct: 122 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF-C-GTPEYLAP 179
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +N+Y    D W LG  + EM  G+  + ++    +F L++      E    P  L 
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFPRTLG 234
Query: 240 EQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA 271
            + K  L     KDPK+R       A+ ++ H F   
Sbjct: 235 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 271

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 20/272 (7%)
Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNE---KEALDQIG 59
           ++RG  +G G F              F   +  KS    P     +  E    ++LD   
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN-- 101
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P +V   G    F + + F  ++LE   R SL +  K++    + E + + + R  ++
Sbjct: 102 --PHVVGFHG----FFEDDDFVYVVLEICRRRSLLELHKRRKA--VTEPEARYFMRQTIQ 153
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G++++H+   +H D+KL N+ + D+ + KI DFGLA K   DGER +   C GTP Y++P
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL-C-GTPNYIAP 211
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +  +    DIW+LGC +  +  GKP +   + S +    IRI   +   ++P  ++
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPF---ETSCLKETYIRIKKNEY--SVPRHIN 266
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA 271
                 + +    DP  R +   LL   F  +
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 22/277 (7%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
            E+L+  ++G G+FG V L K  K +  + ++  +K         V     +  + Q   
Sbjct: 10  FEYLK--LLGKGTFGKVILVK-EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 66
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +       YSF+  +R    ++EYA+ G L   + ++      E   + Y   ++  
Sbjct: 67  HPFLTAL---KYSFQTHDRL-CFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSA 120
Query: 121 LRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           L ++HS K  V+ D+KL+N+++  +   KI DFGL K+   DG   + F C GTP Y++P
Sbjct: 121 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF-C-GTPEYLAP 178
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +N+Y    D W LG  + EM  G+  + ++    +F L++      E    P  L 
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFPRTLG 233
Query: 240 EQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA 271
            + K  L     KDPK+R       A+ ++ H F   
Sbjct: 234 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 270

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 9/200 (4%)
Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           + F +   F  ++LE   R SL +  K++    L E + + Y R ++ G +++H    +H
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIH 162
Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            D+KL N+ + ++ E KI DFGLA K   DGER +   C GTP Y++PE +++  +    
Sbjct: 163 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-C-GTPNYIAPEVLSKKGHSFEV 220
Query: 192 DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFL 251
           D+W++GC +  +  GKP +   + S +    +RI   +   +IP  ++      + K   
Sbjct: 221 DVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQ 275
Query: 252 KDPKRRWTAEMLLNHPFVCA 271
            DP  R T   LLN  F  +
Sbjct: 276 TDPTARPTINELLNDEFFTS 295

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-XINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 20/272 (7%)
Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNE---KEALDQIG 59
           ++RG  +G G F              F   +  KS    P     +  E    ++LD   
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN-- 101
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P +V   G    F + + F  ++LE   R SL +  K++    + E + + + R  ++
Sbjct: 102 --PHVVGFHG----FFEDDDFVYVVLEICRRRSLLELHKRRKA--VTEPEARYFMRQTIQ 153
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G++++H+   +H D+KL N+ + D+ + KI DFGLA K   DGER +   C GTP Y++P
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-C-GTPNYIAP 211
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +  +    DIW+LGC +  +  GKP +   + S +    IRI   +   ++P  ++
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPF---ETSCLKETYIRIKKNEY--SVPRHIN 266
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA 271
                 + +    DP  R +   LL   F  +
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           + F +   F  ++LE   R SL +  K++    L E + + Y R ++ G +++H    +H
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIH 138
Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            D+KL N+ + ++ E KI DFGLA K   DGER +   C GTP Y++PE +++  +    
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-C-GTPNYIAPEVLSKKGHSFEV 196
Query: 192 DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFL 251
           D+W++GC +  +  GKP +   + S +    +RI   +   +IP  ++      + K   
Sbjct: 197 DVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQ 251
Query: 252 KDPKRRWTAEMLLNHPF 268
            DP  R T   LLN  F
Sbjct: 252 TDPTARPTINELLNDEF 268

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 118/255 (46%), Gaps = 14/255 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG GS+  V L +  K    +   +  K   +       ++ EK   +Q    P +V  
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV-- 69
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G    F+   R +  ++EY + G L   +++Q   +L E   + Y+  +   L ++H +
Sbjct: 70  -GLHSCFQTESRLF-FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER 125
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
           G ++ D+KL NVL+      K+ D+G+ K+    G+ +  F C GTP Y++PE +   +Y
Sbjct: 126 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF-C-GTPNYIAPEILRGEDY 183
Query: 188 EAPCDIWALGCAVVEMASGKPAWN-----HKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               D WALG  + EM +G+  ++        D N    L ++ +  ++  IP  LS + 
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKA 242
Query: 243 KDFLIKCFLKDPKRR 257
              L     KDPK R
Sbjct: 243 ASVLKSFLNKDPKER 257

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 9/200 (4%)
Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           + F +   F  ++LE   R SL +  K++    L E + + Y R ++ G +++H    +H
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIH 164
Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            D+KL N+ + ++ E KI DFGLA K   DGER +   C GTP Y++PE +++  +    
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-C-GTPNYIAPEVLSKKGHSFEV 222
Query: 192 DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFL 251
           D+W++GC +  +  GKP +   + S +    +RI   +   +IP  ++      + K   
Sbjct: 223 DVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQ 277
Query: 252 KDPKRRWTAEMLLNHPFVCA 271
            DP  R T   LLN  F  +
Sbjct: 278 TDPTARPTINELLNDEFFTS 297

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 118/255 (46%), Gaps = 14/255 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG GS+  V L +  K    +   +  K   +       ++ EK   +Q    P +V  
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV-- 73
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G    F+   R +  ++EY + G L   +++Q   +L E   + Y+  +   L ++H +
Sbjct: 74  -GLHSCFQTESRLF-FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER 129
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
           G ++ D+KL NVL+      K+ D+G+ K+    G+ +  F C GTP Y++PE +   +Y
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF-C-GTPNYIAPEILRGEDY 187
Query: 188 EAPCDIWALGCAVVEMASGKPAWN-----HKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               D WALG  + EM +G+  ++        D N    L ++ +  ++  IP  LS + 
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKA 246
Query: 243 KDFLIKCFLKDPKRR 257
              L     KDPK R
Sbjct: 247 ASVLKSFLNKDPKER 261

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 8   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 62
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 63  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR+  + +  + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 6   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 60
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR+  + +  + E D +R+   ++ 
Sbjct: 61  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMA 114
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR+  + +  + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 8   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 62
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 63  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 8   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 62
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 63  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 8   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 62
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 63  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 8   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 62
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 63  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   IG GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      K+ADFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 138/288 (47%), Gaps = 44/288 (15%)
Query: 7   DVIGHGSFGSVNLA----KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC- 61
           +VIG G+   V  A    K  KV+ +  +L        C  S   L  E +A+ Q   C 
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINL------EKCQTSMDELLKEIQAMSQ---CH 71
Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------KQNNGRLQESDVKRYT 114
            P IV  +    SF   +  + L+++  S GS+ D +K      +  +G L ES +    
Sbjct: 72  HPNIVSYYT---SFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR--- 171
           R +L+GL ++H  G +H D+K  N+L+ ++   +IADFG++   +  G+ +++   +   
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 172 GTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR------ 224
           GTP +M+PE + +   Y+   DIW+ G   +E+A+G   ++      V  L ++      
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 225 -IGVGDELPNIPGDLSEQGKDF---LIKCFLKDPKRRWTAEMLLNHPF 268
             GV D+       L + GK F   +  C  KDP++R TA  LL H F
Sbjct: 248 ETGVQDK-----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 8   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 62
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 63  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 138/288 (47%), Gaps = 44/288 (15%)
Query: 7   DVIGHGSFGSVNLA----KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC- 61
           +VIG G+   V  A    K  KV+ +  +L        C  S   L  E +A+ Q   C 
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINL------EKCQTSMDELLKEIQAMSQ---CH 66
Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------KQNNGRLQESDVKRYT 114
            P IV  +    SF   +  + L+++  S GS+ D +K      +  +G L ES +    
Sbjct: 67  HPNIVSYYT---SFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR--- 171
           R +L+GL ++H  G +H D+K  N+L+ ++   +IADFG++   +  G+ +++   +   
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 172 GTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR------ 224
           GTP +M+PE + +   Y+   DIW+ G   +E+A+G   ++      V  L ++      
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 242
Query: 225 -IGVGDELPNIPGDLSEQGKDF---LIKCFLKDPKRRWTAEMLLNHPF 268
             GV D+       L + GK F   +  C  KDP++R TA  LL H F
Sbjct: 243 ETGVQDK-----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 285

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 118/255 (46%), Gaps = 14/255 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG GS+  V L +  K    +   +  K   +       ++ EK   +Q    P +V  
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV-- 84
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G    F+   R +  ++EY + G L   +++Q   +L E   + Y+  +   L ++H +
Sbjct: 85  -GLHSCFQTESRLF-FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER 140
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
           G ++ D+KL NVL+      K+ D+G+ K+    G+ +  F C GTP Y++PE +   +Y
Sbjct: 141 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF-C-GTPNYIAPEILRGEDY 198
Query: 188 EAPCDIWALGCAVVEMASGKPAWN-----HKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               D WALG  + EM +G+  ++        D N    L ++ +  ++  IP  +S + 
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSMSVKA 257
Query: 243 KDFLIKCFLKDPKRR 257
              L     KDPK R
Sbjct: 258 ASVLKSFLNKDPKER 272

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 116/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EYA  G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+++      K+ DFGLAK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 127/267 (47%), Gaps = 28/267 (10%)
Query: 2   EWLRGDVIGHGSFGSV------NLAKASKVSSE--FPSLMAVKSCADCPPSSVTLKNEKE 53
           E LR  V+G G +G V        A   K+ +       M V++  D   +    K E+ 
Sbjct: 20  ELLR--VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT----KAERN 73
Query: 54  ALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
            L+++   P IV      Y+F+ G + Y L+LEY S G L  +++++  G   E     Y
Sbjct: 74  ILEEVK-HPFIVDLI---YAFQTGGKLY-LILEYLSGGELFMQLERE--GIFMEDTACFY 126
Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
              +   L H+H KG ++ D+K +N+++      K+ DFGL K+S  DG  + +F C GT
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF-C-GT 184
Query: 174 PLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN 233
             YM+PE +  + +    D W+LG  + +M +G P +  +        +++  +     N
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-----N 239
Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTA 260
           +P  L+++ +D L K   ++   R  A
Sbjct: 240 LPPYLTQEARDLLKKLLKRNAASRLGA 266

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E  ++  V  K   DCP +      +KE      
Sbjct: 8   DWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENI-----KKEICINAM 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +  + V  F   Y   +      L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 62  LNHENVVKF---YGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   IG GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYMPGGDMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      K+ADFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   IG GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYMPGGDMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      K+ADFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 135/274 (49%), Gaps = 27/274 (9%)
Query: 5   RGDVIGHGSFGSVN----LAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           + +++G G FG V+     A   K++++      +K   +       +KNE   ++Q+  
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE-------VKNEISVMNQLD- 144
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              +++ +    +FE       L++EY   G L DR+  ++   L E D   + + + +G
Sbjct: 145 HANLIQLYD---AFESKNDIV-LVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEG 199
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDND--EAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
           +RH+H    +H D+K +N+L  + D  + KI DFGLA++     +   +F   GTP +++
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLA 256
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI--RIGVGDELPNIPG 236
           PE VN +    P D+W++G     + SG   +    D+   + ++  R  + DE      
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ--- 313
Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           D+SE+ K+F+ K  +K+   R +A   L HP++ 
Sbjct: 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 19/273 (6%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPH 72
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 124 IHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L      N   K+ DFG AK+++     S +  C  TP Y++PE
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCY-TPYYVAPE 189
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    +
Sbjct: 190 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 249
Query: 238 LSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           +SE+ K  LI+  LK +P +R T    +NHP++
Sbjct: 250 VSEEVK-MLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 19/273 (6%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP 
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPH 71
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 72  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 131
Query: 124 IHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L      N   K+ DFG AK+++     S +  C  TP Y++PE
Sbjct: 132 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCY-TPYYVAPE 188
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    +
Sbjct: 189 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 248
Query: 238 LSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           +SE+ K  LI+  LK +P +R T    +NHP++
Sbjct: 249 VSEEVK-MLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + F   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    +YSF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EYSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + F   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    +YSF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EYSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 19/273 (6%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP 
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPH 77
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 78  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 137
Query: 124 IHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L      N   K+ DFG AK+++     S +  C  TP Y++PE
Sbjct: 138 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCY-TPYYVAPE 194
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    +
Sbjct: 195 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 254
Query: 238 LSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           +SE+ K  LI+  LK +P +R T    +NHP++
Sbjct: 255 VSEEVK-MLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + F   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    +YSF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EYSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 19/273 (6%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP 
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPH 78
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 79  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 138
Query: 124 IHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L      N   K+ DFG AK+++     S +  C  TP Y++PE
Sbjct: 139 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCY-TPYYVAPE 195
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    +
Sbjct: 196 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 255
Query: 238 LSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           +SE+ K  LI+  LK +P +R T    +NHP++
Sbjct: 256 VSEEVK-MLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 127/270 (47%), Gaps = 19/270 (7%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
            V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP IVR
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPHIVR 89
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                 +   G +   +++E    G L  R++ + +    E +     +S+ + ++++HS
Sbjct: 90  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 149
Query: 127 KGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
               H D+K +N+L      N   K+ DFG AK+++     S +  C  TP Y++PE + 
Sbjct: 150 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCY-TPYYVAPEVLG 206
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GDLSE 240
             +Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    ++SE
Sbjct: 207 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 266
Query: 241 QGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           + K  LI+  LK +P +R T    +NHP++
Sbjct: 267 EVK-MLIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 19/273 (6%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPH 70
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 71  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 130
Query: 124 IHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L      N   K+ DFG AK+++     S +  C  TP Y++PE
Sbjct: 131 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCY-TPYYVAPE 187
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    +
Sbjct: 188 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 247
Query: 238 LSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           +SE+ K  LI+  LK +P +R T    +NHP++
Sbjct: 248 VSEEVK-MLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 19/273 (6%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP 
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPH 76
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 77  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 136
Query: 124 IHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L      N   K+ DFG AK+++     S +  C  TP Y++PE
Sbjct: 137 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCY-TPYYVAPE 193
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    +
Sbjct: 194 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 253
Query: 238 LSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           +SE+ K  LI+  LK +P +R T    +NHP++
Sbjct: 254 VSEEVK-MLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 128/273 (46%), Gaps = 19/273 (6%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPH 70
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 71  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 130
Query: 124 IHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L      N   K+ DFG AK+++     ++   C  TP Y++PE
Sbjct: 131 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEP--CY-TPYYVAPE 187
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    +
Sbjct: 188 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 247
Query: 238 LSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           +SE+ K  LI+  LK +P +R T    +NHP++
Sbjct: 248 VSEEVK-MLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 19/273 (6%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPH 72
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 124 IHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L      N   K+ DFG AK+++     S +  C  TP Y++PE
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCY-TPYYVAPE 189
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    +
Sbjct: 190 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 249
Query: 238 LSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           +SE+ K  LI+  LK +P +R T    +NHP++
Sbjct: 250 VSEEVK-MLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 112/214 (52%), Gaps = 16/214 (7%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL   +KK   GR+ E  + + + +++KGL
Sbjct: 67  PYIVGFYGAFYS--DGE--ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 120
Query: 122 RHIHSKG-FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++ +     E +  F   GT  YMSPE
Sbjct: 121 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDEMANEF--VGTRSYMSPE 176
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL-S 239
            +    Y    DIW++G ++VEMA G+     +    +F LL  I V +  P +P  + S
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP---RPPMAIFELLDYI-VNEPPPKLPSAVFS 232
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
            + +DF+ KC +K+P  R   + L+ H F+   D
Sbjct: 233 LEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 266

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  + Q    P 
Sbjct: 46  RIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKR-IQQAVNFPF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y ++LEYA  G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LVKL---EFSFKDNSNLY-MVLEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      K+ADFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 19/273 (6%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP 
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPH 122
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 123 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 182
Query: 124 IHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L      N   K+ DFG AK+++     S +  C  TP Y++PE
Sbjct: 183 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCY-TPYYVAPE 239
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    +
Sbjct: 240 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 299
Query: 238 LSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           +SE+ K  LI+  LK +P +R T    +NHP++
Sbjct: 300 VSEEVK-MLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EYA  G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LVKL---EFSFKDNSNLY-MVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+++      K+ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 19/273 (6%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPH 116
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 124 IHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L      N   K+ DFG AK+++     S +  C  TP Y++PE
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCY-TPYYVAPE 233
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    +
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 238 LSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           +SE+ K  LI+  LK +P +R T    +NHP++
Sbjct: 294 VSEEVK-MLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 2   EWLRGDVIGHGSFGSV------NLAKASKVSSE--FPSLMAVKSCADCPPSSVTLKNEKE 53
           E LR  V+G G +G V        A   K+ +       M V++  D   +    K E+ 
Sbjct: 20  ELLR--VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT----KAERN 73
Query: 54  ALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
            L+++   P IV      Y+F+ G + Y L+LEY S G L  +++++  G   E     Y
Sbjct: 74  ILEEVK-HPFIVDLI---YAFQTGGKLY-LILEYLSGGELFMQLERE--GIFMEDTACFY 126
Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
              +   L H+H KG ++ D+K +N+++      K+ DFGL K+S  DG  +  F C GT
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXF-C-GT 184
Query: 174 PLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN 233
             YM+PE +  + +    D W+LG  + +M +G P +  +        +++  +     N
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-----N 239
Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTA 260
           +P  L+++ +D L K   ++   R  A
Sbjct: 240 LPPYLTQEARDLLKKLLKRNAASRLGA 266

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 120/274 (43%), Gaps = 23/274 (8%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSV-----TLKNEKEALDQIGIC 61
           DVIG G    V          EF   +   +     P  +       + E   L Q+   
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P I+    D Y   +   F  L+ +   +G L D + ++    L E + +   RS+L+ +
Sbjct: 160 PHIITLI-DSY---ESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAV 213
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF-ECRGTPLYMSPE 180
             +H+   VH D+K +N+L+ DN + +++DFG     SC  E  +   E  GTP Y++PE
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGF----SCHLEPGEKLRELCGTPGYLAPE 269
Query: 181 ----SVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
               S++E    Y    D+WA G  +  + +G P + H++   +  +++        P  
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329
Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
             D S   KD + +    DP+ R TAE  L HPF
Sbjct: 330 -DDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 116/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EYA  G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+++      ++ DFGLAK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EYA  G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+++      K+ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLXGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EYA  G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYAPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+++      K+ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 14/218 (6%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAV--KSCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G+ G V LA  ++V+ E  ++  V  K   DCP +   +K E   ++++ 
Sbjct: 7   DWDLVQTLGEGAAGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN---IKKEI-CINKML 61
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++      + E D +R+   ++ 
Sbjct: 62  NHENVVKFYGHR---REGNIQY-LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 115
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDS 216
           E +   E+ A P D+W+ G  +  M +G+  W+   DS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLAGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 116/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 32  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 89
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 90  LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 143
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+ +    ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 144 LHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 198
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 253
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 254 DLLRNLLQVDLTKRF 268

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 19/273 (6%)
Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           + R   +G G++G V L K     +E    +  KS      +S  L +E   L Q+   P
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD-HP 81
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I++     Y F + +R Y L++E    G L D +  +   +  E D     + +L G  
Sbjct: 82  NIMKL----YEFFEDKRNYYLVMEVYRGGELFDEIILRQ--KFSEVDAAVIMKQVLSGTT 135
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           ++H    VH D+K +N+L+         KI DFGL+      G+  +     GT  Y++P
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL---GTAYYIAP 192
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--GD 237
           E V   +Y+  CD+W+ G  +  +  G P +  + D  +   L R+  G    + P    
Sbjct: 193 E-VLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEI---LKRVEKGKFSFDPPDWTQ 248
Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           +S++ K  +      +P +R +AE  LNHP++ 
Sbjct: 249 VSDEAKQLVKLMLTYEPSKRISAEEALNHPWIV 281

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 19/273 (6%)
Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           + R   +G G++G V L K     +E    +  KS      +S  L +E   L Q+   P
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD-HP 64
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I++     Y F + +R Y L++E    G L D +  +   +  E D     + +L G  
Sbjct: 65  NIMKL----YEFFEDKRNYYLVMEVYRGGELFDEIILRQ--KFSEVDAAVIMKQVLSGTT 118
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           ++H    VH D+K +N+L+         KI DFGL+      G+  +     GT  Y++P
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL---GTAYYIAP 175
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--GD 237
           E V   +Y+  CD+W+ G  +  +  G P +  + D  +   L R+  G    + P    
Sbjct: 176 E-VLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEI---LKRVEKGKFSFDPPDWTQ 231
Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           +S++ K  +      +P +R +AE  LNHP++ 
Sbjct: 232 VSDEAKQLVKLMLTYEPSKRISAEEALNHPWIV 264

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EYA  G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+++      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 40  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 97
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 98  LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEY 151
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 152 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 206
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 261
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 262 DLLRNLLQVDLTKRF 276

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 38  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 95
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 96  LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEY 149
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 204
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 259
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 260 DLLRNLLQVDLTKRF 274

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 38  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 95
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 96  LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 149
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 204
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 259
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 260 DLLRNLLQVDLTKRF 274

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           + +    ++SF+     Y +++EYA  G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LTKL---EFSFKDNSNLY-MVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+++      K+ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 13/250 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G GSFG V L++       +   +  K              EK  L   G  P + + 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
                 F+  +R Y  ++EY + G L   +  Q  GR +E     Y   +  GL  + SK
Sbjct: 87  HS---CFQTMDRLY-FVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
           G ++ D+KL NV++      KIADFG+ K++  DG  ++ F C GTP Y++PE +    Y
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXF-C-GTPDYIAPEIIAYQPY 198
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
               D WA G  + EM +G+  +  + +  +F  ++   V       P  +S++      
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-----YPKSMSKEAVAICK 253
Query: 248 KCFLKDPKRR 257
               K P +R
Sbjct: 254 GLMTKHPGKR 263

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           + +    ++SF+     Y +++EYA  G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LTKL---EFSFKDNSNLY-MVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+++      K+ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           + +    ++SF+     Y +++EYA  G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LTKL---EFSFKDNSNLY-MVMEYAPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+++      K+ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 31  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 88
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 89  LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 142
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 143 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYLAPEIIL 197
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 252
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 253 DLLRNLLQVDLTKRF 267

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 22/265 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
            +G GSFG V+L + S+ +  + ++  +K         V   N++  +  I   P I+R 
Sbjct: 13  TLGTGSFGRVHLIR-SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           +G   +F+  ++ + ++++Y   G L   ++K    R      K Y   +   L ++HSK
Sbjct: 72  WG---TFQDAQQIF-MIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK 125
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             ++ D+K +N+L+  N   KI DFG AK          ++   GTP Y++PE V+   Y
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYXLCGTPDYIAPEVVSTKPY 180
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
               D W+ G  + EM +G   +    DSN      +I +  EL   P   +E  KD L 
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPF---YDSNTMKTYEKI-LNAEL-RFPPFFNEDVKDLLS 235
Query: 248 KCFLKDPKRRW-----TAEMLLNHP 267
           +   +D  +R        E + NHP
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHP 260

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG GS+           + EF   +  KS  D  P+      E E L + G  P I+   
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD--PT-----EEIEILLRYGQHPNII-TL 81
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
            D Y  + G+  Y ++ E    G L D++ +Q     +E+    +T  + K + ++H++G
Sbjct: 82  KDVY--DDGKYVY-VVTELMKGGELLDKILRQKFFSEREASAVLFT--ITKTVEYLHAQG 136
Query: 129 FVHCDIKLQNVLVFDN----DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
            VH D+K  N+L  D     +  +I DFG AK+     E         T  +++PE +  
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLMTPCYTANFVAPEVLER 194
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG----DLSE 240
             Y+A CDIW+LG  +  M +G   + +  D     +L RIG G    ++ G     +S+
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF--SLSGGYWNSVSD 252
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
             KD + K    DP +R TA ++L HP++   DQ
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 123
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 124 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEY 177
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 232
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 287
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 288 DLLRNLLQVDLTKRF 302

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 16/269 (5%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  +G G FG+V LA+  +        +  KS  +       L+ E E    +   P I+
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNIL 78
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           R +     F   +R Y L+LE+A RG L   +  Q +GR  E     +   +   L + H
Sbjct: 79  RMYN---YFHDRKRIY-LMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCH 132
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            +  +H DIK +N+L+    E KIADFG +  +     R       GT  Y+ PE +   
Sbjct: 133 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGK 188
Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
            ++   D+W  G    E   G P ++    +     ++ + +       P  LS+  KD 
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-----KFPPFLSDGSKDL 243
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
           + K     P +R   + ++ HP+V A+ +
Sbjct: 244 ISKLLRYHPPQRLPLKGVMEHPWVKANSR 272

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 123/266 (46%), Gaps = 16/266 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPS--LMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           +G G F  V    +     E+ +  L   +   DC      + +E   L+    CP+++ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC---RAEILHEIAVLELAKSCPRVIN 93
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                  +E       L+LEYA+ G +      +    + E+DV R  + +L+G+ ++H 
Sbjct: 94  LHE---VYENTSEII-LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 127 KGFVHCDIKLQNVL---VFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
              VH D+K QN+L   ++   + KI DFG+++K    G   +  E  GTP Y++PE +N
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMGTPEYLAPEILN 206
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
            +      D+W +G     + +    +  + +   +  + ++ V D        +S+   
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV-DYSEETFSSVSQLAT 265
Query: 244 DFLIKCFLKDPKRRWTAEMLLNHPFV 269
           DF+    +K+P++R TAE+ L+H ++
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSHSWL 291

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFAEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 103
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 104 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 157
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYLAPEIIL 212
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 267
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 268 DLLRNLLQVDLTKRF 282

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 123
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 124 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 177
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 232
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 287
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 288 DLLRNLLQVDLTKRF 302

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 21/268 (7%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G GSFG V L K      E    +  K          +L  E + L Q+   P I++ 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKL 91
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y F + + ++ L+ E  + G L D +  +   R  E D  R  R +L G+ ++H  
Sbjct: 92  ----YEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN 145
Query: 128 GFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECR-GTPLYMSPESVN 183
             VH D+K +N+L+    +    +I DFGL    S   E S+  + + GT  Y++PE V 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGL----STHFEASKKMKDKIGTAYYIAPE-VL 200
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--GDLSEQ 241
              Y+  CD+W+ G  +  + SG P +N    +N + +L ++  G     +P    +SE 
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFN---GANEYDILKKVEKGKYTFELPQWKKVSES 257
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            KD + K     P  R +A   L+H ++
Sbjct: 258 AKDLIRKMLTYVPSMRISARDALDHEWI 285

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 21/268 (7%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G GSFG V L K      E    +  K          +L  E + L Q+   P I++ 
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKL 97
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y F + + ++ L+ E  + G L D +  +   R  E D  R  R +L G+ ++H  
Sbjct: 98  ----YEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN 151
Query: 128 GFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECR-GTPLYMSPESVN 183
             VH D+K +N+L+    +    +I DFGL    S   E S+  + + GT  Y++PE V 
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGL----STHFEASKKMKDKIGTAYYIAPE-VL 206
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--GDLSEQ 241
              Y+  CD+W+ G  +  + SG P +N    +N + +L ++  G     +P    +SE 
Sbjct: 207 HGTYDEKCDVWSTGVILYILLSGCPPFN---GANEYDILKKVEKGKYTFELPQWKKVSES 263
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            KD + K     P  R +A   L+H ++
Sbjct: 264 AKDLIRKMLTYVPSMRISARDALDHEWI 291

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY   G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 21/268 (7%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G GSFG V L K      E    +  K          +L  E + L Q+   P I++ 
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKL 114
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y F + + ++ L+ E  + G L D +  +   R  E D  R  R +L G+ ++H  
Sbjct: 115 ----YEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN 168
Query: 128 GFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECR-GTPLYMSPESVN 183
             VH D+K +N+L+    +    +I DFGL    S   E S+  + + GT  Y++PE V 
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGL----STHFEASKKMKDKIGTAYYIAPE-VL 223
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--GDLSEQ 241
              Y+  CD+W+ G  +  + SG P +N    +N + +L ++  G     +P    +SE 
Sbjct: 224 HGTYDEKCDVWSTGVILYILLSGCPPFN---GANEYDILKKVEKGKYTFELPQWKKVSES 280
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            KD + K     P  R +A   L+H ++
Sbjct: 281 AKDLIRKMLTYVPSMRISARDALDHEWI 308

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 13/250 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G GSFG V L++       +   +  K              EK  L   G  P + + 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
                 F+  +R Y  ++EY + G L   +  Q  GR +E     Y   +  GL  + SK
Sbjct: 408 HS---CFQTMDRLY-FVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
           G ++ D+KL NV++      KIADFG+ K++  DG  ++ F C GTP Y++PE +    Y
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXF-C-GTPDYIAPEIIAYQPY 519
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
               D WA G  + EM +G+  +  + +  +F  ++   V       P  +S++      
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-----YPKSMSKEAVAICK 574
Query: 248 KCFLKDPKRR 257
               K P +R
Sbjct: 575 GLMTKHPGKR 584

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 80
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 81  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 137
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 197
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 198 FSVASDVWSFGVVLYELFT 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 74
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 75  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 131
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 191
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 192 FSVASDVWSFGVVLYELFT 210

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 21/268 (7%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G GSFG V L K      E    +  K          +L  E + L Q+   P I++ 
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKL 115
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y F + + ++ L+ E  + G L D +  +   R  E D  R  R +L G+ ++H  
Sbjct: 116 ----YEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN 169
Query: 128 GFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECR-GTPLYMSPESVN 183
             VH D+K +N+L+    +    +I DFGL    S   E S+  + + GT  Y++PE V 
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGL----STHFEASKKMKDKIGTAYYIAPE-VL 224
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--GDLSEQ 241
              Y+  CD+W+ G  +  + SG P +N    +N + +L ++  G     +P    +SE 
Sbjct: 225 HGTYDEKCDVWSTGVILYILLSGCPPFN---GANEYDILKKVEKGKYTFELPQWKKVSES 281
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            KD + K     P  R +A   L+H ++
Sbjct: 282 AKDLIRKMLTYVPSMRISARDALDHEWI 309

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 75
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 76  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 132
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 192
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 193 FSVASDVWSFGVVLYELFT 211

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 16/214 (7%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IVR    D   E+G  F+ L+ +  + G L + +  +      E+D       +L+ +
Sbjct: 90  PNIVRL--HDSISEEG--FHYLVFDLVTGGELFEDIVARE--YYSEADASHCIHQILESV 143
Query: 122 RHIHSKGFVHCDIKLQNVLVFDN---DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            HIH    VH D+K +N+L+         K+ADFGLA +    GE+   F   GTP Y+S
Sbjct: 144 NHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIE--VQGEQQAWFGFAGTPGYLS 201
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           PE + ++ Y  P DIWA G  +  +  G P  W+  +D +     I+ G  D  P+   D
Sbjct: 202 PEVLRKDPYGKPVDIWACGVILYILLVGYPPFWD--EDQHKLYQQIKAGAYD-FPSPEWD 258
Query: 238 -LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            ++ + K+ + +    +P +R TA+  L HP+VC
Sbjct: 259 TVTPEAKNLINQMLTINPAKRITADQALKHPWVC 292

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 107
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 108 KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 164
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 224
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 225 FSVASDVWSFGVVLYELFT 243

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 123
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 124 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 177
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      +  ++   GTP Y++PE + 
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGATWTLCGTPEYLAPEIIL 232
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 287
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 288 DLLRNLLQVDLTKRF 302

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 76
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 77  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 133
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 81
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 82  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 138
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 198
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 199 FSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 83
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 84  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 140
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 200
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 201 FSVASDVWSFGVVLYELFT 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 76
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 77  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 133
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 94
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 95  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 151
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 212 FSVASDVWSFGVVLYELFT 230

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 122/255 (47%), Gaps = 16/255 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGI-CPQ 63
           G  IG G FG V+  +   +S E P+L +A+K+C +C   SV  K  +EAL       P 
Sbjct: 15  GRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G        E    +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 73  IVKLIG-----VITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 126
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV  ND  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 127 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 185
Query: 184 ENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E +  G   +   ++++V     RI  G+ LP +P +     
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLP-MPPNCPPTL 241
Query: 243 KDFLIKCFLKDPKRR 257
              + KC+  DP RR
Sbjct: 242 YSLMTKCWAYDPSRR 256

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 82
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 83  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 139
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 199
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 200 FSVASDVWSFGVVLYELFT 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 94
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 95  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 151
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 212 FSVASDVWSFGVVLYELFT 230

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IVR    D   E+G  F+ L+ +  + G L + +  +      E+D     + +L+ +
Sbjct: 63  PNIVRL--HDSISEEG--FHYLVFDLVTGGELFEDIVARE--YYSEADASHCIQQILESV 116
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            H H  G VH D+K +N+L+    +    K+ADFGLA +    G++   F   GTP Y+S
Sbjct: 117 NHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--VQGDQQAWFGFAGTPGYLS 174
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           PE + ++ Y  P D+WA G  +  +  G P  W+  +D +     I+ G  D  P+   D
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD--EDQHRLYQQIKAGAYD-FPSPEWD 231
Query: 238 -LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            ++ + KD + K    +P +R TA   L HP++C
Sbjct: 232 TVTPEAKDLINKMLTINPAKRITASEALKHPWIC 265

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+++      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIII 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 114/266 (42%), Gaps = 16/266 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG+V LA+  +        +  KS  +       L+ E E    +   P I+R +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMY 80
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
                F   +R Y L+LE+A RG L   +  Q +GR  E     +   +   L + H + 
Sbjct: 81  N---YFHDRKRIY-LMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
            +H DIK +N+L+    E KIADFG +  +     R       GT  Y+ PE +    ++
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTHD 190
Query: 189 APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIK 248
              D+W  G    E   G P ++    +     ++ + +       P  LS+  KD + K
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-----KFPPFLSDGSKDLISK 245
Query: 249 CFLKDPKRRWTAEMLLNHPFVCADDQ 274
                P +R   + ++ HP+V A+ +
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKANSR 271

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 79
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 80  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 136
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 197 FSVASDVWSFGVVLYELFT 215

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 122/255 (47%), Gaps = 16/255 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGI-CPQ 63
           G  IG G FG V+  +   +S E P+L +A+K+C +C   SV  K  +EAL       P 
Sbjct: 12  GRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G        E    +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 70  IVKLIG-----VITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 123
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV  ND  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 182
Query: 184 ENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E +  G   +   ++++V     RI  G+ LP +P +     
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLP-MPPNCPPTL 238
Query: 243 KDFLIKCFLKDPKRR 257
              + KC+  DP RR
Sbjct: 239 YSLMTKCWAYDPSRR 253

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 122/255 (47%), Gaps = 16/255 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGI-CPQ 63
           G  IG G FG V+  +   +S E P+L +A+K+C +C   SV  K  +EAL       P 
Sbjct: 20  GRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G        E    +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 78  IVKLIG-----VITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 131
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV  ND  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 190
Query: 184 ENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E +  G   +   ++++V     RI  G+ LP +P +     
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLP-MPPNCPPTL 246
Query: 243 KDFLIKCFLKDPKRR 257
              + KC+  DP RR
Sbjct: 247 YSLMTKCWAYDPSRR 261

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 122/255 (47%), Gaps = 16/255 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGI-CPQ 63
           G  IG G FG V+  +   +S E P+L +A+K+C +C   SV  K  +EAL       P 
Sbjct: 43  GRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 100
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G        E    +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 101 IVKLIG-----VITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 154
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV  ND  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 155 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 213
Query: 184 ENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E +  G   +   ++++V     RI  G+ LP +P +     
Sbjct: 214 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLP-MPPNCPPTL 269
Query: 243 KDFLIKCFLKDPKRR 257
              + KC+  DP RR
Sbjct: 270 YSLMTKCWAYDPSRR 284

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IVR    D   E+G  F+ L+ +  + G L + +  +      E+D     + +L+ +
Sbjct: 63  PNIVRL--HDSISEEG--FHYLVFDLVTGGELFEDIVAREY--YSEADASHCIQQILESV 116
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            H H  G VH D+K +N+L+    +    K+ADFGLA +    G++   F   GTP Y+S
Sbjct: 117 NHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--VQGDQQAWFGFAGTPGYLS 174
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           PE + ++ Y  P D+WA G  +  +  G P  W+  +D +     I+ G  D  P+   D
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD--EDQHRLYQQIKAGAYD-FPSPEWD 231
Query: 238 -LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            ++ + KD + K    +P +R TA   L HP++C
Sbjct: 232 TVTPEAKDLINKMLTINPAKRITASEALKHPWIC 265

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + +MA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 111/243 (45%), Gaps = 19/243 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFL 246
           D L
Sbjct: 267 DLL 269

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 115/255 (45%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   +   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 122/255 (47%), Gaps = 16/255 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGI-CPQ 63
           G  IG G FG V+  +   +S E P++ +A+K+C +C   SV  K  +EAL       P 
Sbjct: 15  GRCIGEGQFGDVH--QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G        E    +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 73  IVKLIG-----VITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 126
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV  ND  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 127 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 185
Query: 184 ENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E +  G   +   ++++V     RI  G+ LP +P +     
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLP-MPPNCPPTL 241
Query: 243 KDFLIKCFLKDPKRR 257
              + KC+  DP RR
Sbjct: 242 YSLMTKCWAYDPSRR 256

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 122/255 (47%), Gaps = 16/255 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGI-CPQ 63
           G  IG G FG V+  +   +S E P+L +A+K+C +C   SV  K  +EAL       P 
Sbjct: 18  GRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 75
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G        E    +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 76  IVKLIG-----VITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 129
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV  ND  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 130 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 188
Query: 184 ENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E +  G   +   ++++V     RI  G+ LP +P +     
Sbjct: 189 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLP-MPPNCPPTL 244
Query: 243 KDFLIKCFLKDPKRR 257
              + KC+  DP RR
Sbjct: 245 YSLMTKCWAYDPSRR 259

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 129/290 (44%), Gaps = 45/290 (15%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G++G V  AK S+      +L  ++  A+      T   E   L ++   P IV   
Sbjct: 29  VGEGTYGVVYKAKDSQ--GRIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLI 85
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              +S    ER   L+ E+  +     +V  +N   LQ+S +K Y   +L+G+ H H   
Sbjct: 86  DVIHS----ERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV-NENEY 187
            +H D+K QN+L+  +   K+ADFGLA+       RS + E   T  Y +P+ +    +Y
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVV-TLWYRAPDVLMGSKKY 197
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSN----VFSLLIRIGVGD--------ELP--- 232
               DIW++GC   EM +GKP +    D +    +FS+L   G  +        ELP   
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL---GTPNPREWPQVQELPLWK 254
Query: 233 --------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                          IPG   ++G D L      DP +R +A   +NHP+
Sbjct: 255 QRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 122/255 (47%), Gaps = 16/255 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGI-CPQ 63
           G  IG G FG V+  +   +S E P+L +A+K+C +C   SV  K  +EAL       P 
Sbjct: 17  GRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 74
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G        E    +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 75  IVKLIG-----VITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 128
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV  ND  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 129 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 187
Query: 184 ENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E +  G   +   ++++V     RI  G+ LP +P +     
Sbjct: 188 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLP-MPPNCPPTL 243
Query: 243 KDFLIKCFLKDPKRR 257
              + KC+  DP RR
Sbjct: 244 YSLMTKCWAYDPSRR 258

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  S G L D + ++ +  L E +  ++ + +L G+ ++HSK   H D+K +N+++ 
Sbjct: 85  LILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL 142
Query: 143 D----NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D    N   K+ DFG+A K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 143 DKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 199
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +    KQ++      +     +E  +   + SE  KDF+ +  +KDPKR
Sbjct: 200 ITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS---NTSELAKDFIRRLLVKDPKR 256
Query: 257 RWTAEMLLNHPFVCA 271
           R T    L H ++ A
Sbjct: 257 RMTIAQSLEHSWIKA 271

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 129/290 (44%), Gaps = 45/290 (15%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G++G V  AK S+      +L  ++  A+      T   E   L ++   P IV   
Sbjct: 29  VGEGTYGVVYKAKDSQ--GRIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLI 85
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              +S    ER   L+ E+  +     +V  +N   LQ+S +K Y   +L+G+ H H   
Sbjct: 86  DVIHS----ERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV-NENEY 187
            +H D+K QN+L+  +   K+ADFGLA+       RS + E   T  Y +P+ +    +Y
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVV-TLWYRAPDVLMGSKKY 197
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSN----VFSLLIRIGVGD--------ELP--- 232
               DIW++GC   EM +GKP +    D +    +FS+L   G  +        ELP   
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL---GTPNPREWPQVQELPLWK 254
Query: 233 --------------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                          IPG   ++G D L      DP +R +A   +NHP+
Sbjct: 255 QRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 122/255 (47%), Gaps = 16/255 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGI-CPQ 63
           G  IG G FG V+  +   +S E P++ +A+K+C +C   SV  K  +EAL       P 
Sbjct: 15  GRCIGEGQFGDVH--QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G        E    +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 73  IVKLIG-----VITENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAY 126
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV  ND  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 127 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPESIN 185
Query: 184 ENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E +  G   +   ++++V     RI  G+ LP +P +     
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLP-MPPNCPPTL 241
Query: 243 KDFLIKCFLKDPKRR 257
              + KC+  DP RR
Sbjct: 242 YSLMTKCWAYDPSRR 256

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 76
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 77  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 133
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP Y++P  + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPAIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 131/272 (48%), Gaps = 20/272 (7%)
Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           + R   +G G++G V L +  KV+    ++  ++  +    S+  L  E   L  +   P
Sbjct: 39  YQRVKKLGSGAYGEVLLCR-DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HP 96
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I++     Y F + +R Y L++E    G L D +   +  +  E D     + +L G+ 
Sbjct: 97  NIMKL----YDFFEDKRNYYLVMECYKGGELFDEII--HRMKFNEVDAAVIIKQVLSGVT 150
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           ++H    VH D+K +N+L+   ++    KI DFGL   S+    + +  E  GT  Y++P
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL---SAVFENQKKMKERLGTAYYIAP 207
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--GD 237
           E V   +Y+  CD+W++G  +  + +G P +  + D  +   L ++  G    + P   +
Sbjct: 208 E-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI---LRKVEKGKYTFDSPEWKN 263
Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           +SE  KD + +    D +RR +A+  L HP++
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 77
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 78  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 134
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H ++  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 194
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 195 FSVASDVWSFGVVLYELFT 213

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 125/280 (44%), Gaps = 25/280 (8%)
Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           ++  + IG GS+           + E+   +  KS  D  PS      E E L + G  P
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRD--PS-----EEIEILLRYGQHP 81
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+    D Y  + G+  Y L+ E    G L D++ +Q      E +      ++ K + 
Sbjct: 82  NII-TLKDVY--DDGKHVY-LVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVE 135
Query: 123 HIHSKGFVHCDIKLQNVLVFD---NDE-AKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
           ++HS+G VH D+K  N+L  D   N E  +I DFG AK+     E         T  +++
Sbjct: 136 YLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAENGLLMTPCYTANFVA 193
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG-- 236
           PE +    Y+  CDIW+LG  +  M +G   + +        +L RIG G     + G  
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKF--TLSGGN 251
Query: 237 --DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
              +SE  KD + K    DP +R TA+ +L HP+V   D+
Sbjct: 252 WNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDK 291

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 125/280 (44%), Gaps = 25/280 (8%)
Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           ++  + IG GS+           + E+   +  KS  D  PS      E E L + G  P
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRD--PS-----EEIEILLRYGQHP 81
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+    D Y  + G+  Y L+ E    G L D++ +Q      E +      ++ K + 
Sbjct: 82  NII-TLKDVY--DDGKHVY-LVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVE 135
Query: 123 HIHSKGFVHCDIKLQNVLVFD---NDE-AKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
           ++HS+G VH D+K  N+L  D   N E  +I DFG AK+     E         T  +++
Sbjct: 136 YLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAENGLLMTPCYTANFVA 193
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG-- 236
           PE +    Y+  CDIW+LG  +  M +G   + +        +L RIG G     + G  
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKF--TLSGGN 251
Query: 237 --DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
              +SE  KD + K    DP +R TA+ +L HP+V   D+
Sbjct: 252 WNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDK 291

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 127/274 (46%), Gaps = 25/274 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG GS+           + EF   +  KS  D  P+      E E L + G  P I+   
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRD--PT-----EEIEILLRYGQHPNII-TL 81
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
            D Y  + G+  Y ++ E    G L D++ +Q     +E+    +T  + K + ++H++G
Sbjct: 82  KDVY--DDGKYVY-VVTELXKGGELLDKILRQKFFSEREASAVLFT--ITKTVEYLHAQG 136
Query: 129 FVHCDIKLQNVLVFDN----DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
            VH D+K  N+L  D     +  +I DFG AK+   +     +  C  T  +++PE +  
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT-PCY-TANFVAPEVLER 194
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG----DLSE 240
             Y+A CDIW+LG  +    +G   + +  D     +L RIG G    ++ G     +S+
Sbjct: 195 QGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKF--SLSGGYWNSVSD 252
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
             KD + K    DP +R TA ++L HP++   DQ
Sbjct: 253 TAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQ 286

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 21/260 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIV 65
            IG G+F  V LA+      E    +AVK       +S +L+     +  + +   P IV
Sbjct: 21  TIGKGNFAKVKLARHILTGKE----VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + F       + E+   L++EYAS G + D +    +GR++E + +   R ++  +++ H
Sbjct: 77  KLF----EVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCH 130
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            K  VH D+K +N+L+  +   KIADFG + + +  G +  +F C G+P Y +PE     
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDTF-C-GSPPYAAPELFQGK 187
Query: 186 EYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           +Y+ P  D+W+LG  +  + SG   ++     N+  L  R+  G     IP  +S   ++
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGKY--RIPFYMSTDCEN 242
Query: 245 FLIKCFLKDPKRRWTAEMLL 264
            L K  + +P +R T E ++
Sbjct: 243 LLKKFLILNPSKRGTLEQIM 262

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 21/260 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIV 65
            IG G+F  V LA+      E    +AVK       +S +L+     +  + +   P IV
Sbjct: 21  TIGKGNFAKVKLARHILTGKE----VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + F       + E+   L++EYAS G + D +    +GR++E + +   R ++  +++ H
Sbjct: 77  KLF----EVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCH 130
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            K  VH D+K +N+L+  +   KIADFG + + +  G +  +F C G+P Y +PE     
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDTF-C-GSPPYAAPELFQGK 187
Query: 186 EYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           +Y+ P  D+W+LG  +  + SG   ++     N+  L  R+  G     IP  +S   ++
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGKY--RIPFYMSTDCEN 242
Query: 245 FLIKCFLKDPKRRWTAEMLL 264
            L K  + +P +R T E ++
Sbjct: 243 LLKKFLILNPSKRGTLEQIM 262

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 130/265 (49%), Gaps = 17/265 (6%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
            IG G+F  V LA+      E    + +       P+S+     +  + +I   P IV+ 
Sbjct: 19  TIGKGNFAKVKLARHILTGREVA--IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 76
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F       + E+   L++EYAS G + D +    +GR++E + +   R ++  +++ H K
Sbjct: 77  F----EVIETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK 130
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             VH D+K +N+L+  +   KIADFG + + +  G +  +F C G+P Y +PE     +Y
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDTF-C-GSPPYAAPELFQGKKY 187
Query: 188 EAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           + P  D+W+LG  +  + SG   ++ +   N+  L  R+  G     IP  +S   ++ L
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQ---NLKELRERVLRGKY--RIPFYMSTDCENLL 242
Query: 247 IKCFLKDPKRRWTAEMLLNHPFVCA 271
            +  + +P +R T E ++   ++ A
Sbjct: 243 KRFLVLNPIKRGTLEQIMKDRWINA 267

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 121/268 (45%), Gaps = 21/268 (7%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G GSFG V L K      E    +  K          +L  E + L Q+   P I + 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIXKL 91
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y F + + ++ L+ E  + G L D +  +   R  E D  R  R +L G+ + H  
Sbjct: 92  ----YEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYXHKN 145
Query: 128 GFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECR-GTPLYMSPESVN 183
             VH D+K +N+L+    +    +I DFGL    S   E S+  + + GT  Y++PE V 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGL----STHFEASKKXKDKIGTAYYIAPE-VL 200
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--GDLSEQ 241
              Y+  CD+W+ G  +  + SG P +N    +N + +L ++  G     +P    +SE 
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFN---GANEYDILKKVEKGKYTFELPQWKKVSES 257
Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            KD + K     P  R +A   L+H ++
Sbjct: 258 AKDLIRKXLTYVPSXRISARDALDHEWI 285

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IVR    D   E+G  +  L+ +  + G L + +  +      E+D     + +L+ +
Sbjct: 81  PNIVRL--HDSISEEGHHY--LIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAV 134
Query: 122 RHIHSKGFVHCDIKLQNVLV---FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            H H  G VH D+K +N+L+         K+ADFGLA +   +GE+   F   GTP Y+S
Sbjct: 135 LHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGYLS 192
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           PE + ++ Y  P D+WA G  +  +  G P  W+  +D +     I+ G  D  P+   D
Sbjct: 193 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD--EDQHRLYQQIKAGAYD-FPSPEWD 249
Query: 238 -LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            ++ + KD + K    +P +R TA   L HP++
Sbjct: 250 TVTPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 79
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++EY   GSL D ++     R+    + +YT  + KG+ ++ +K
Sbjct: 80  KGVCYS--AGRRNLKLIMEYLPYGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYLGTK 136
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 197 FSVASDVWSFGVVLYELFT 215

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 127/260 (48%), Gaps = 21/260 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIV 65
            IG G+F  V LA+      E    +AVK       +S +L+     +  + +   P IV
Sbjct: 21  TIGKGNFAKVKLARHILTGKE----VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + F       + E+   L++EYAS G + D +    +GR++E + +   R ++  +++ H
Sbjct: 77  KLF----EVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCH 130
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            K  VH D+K +N+L+  +   KIADFG + + +  G +  +F C G P Y +PE     
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDAF-C-GAPPYAAPELFQGK 187
Query: 186 EYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           +Y+ P  D+W+LG  +  + SG   ++     N+  L  R+  G     IP  +S   ++
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGKY--RIPFYMSTDCEN 242
Query: 245 FLIKCFLKDPKRRWTAEMLL 264
            L K  + +P +R T E ++
Sbjct: 243 LLKKFLILNPSKRGTLEQIM 262

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 6/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVRC 67
           +G G+FGSV + +   +      ++AVK         +   + E E L  +     IV+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKY 79
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G  YS   G R   L++E+   GSL + ++K    R+    + +YT  + KG+ ++ +K
Sbjct: 80  KGVCYS--AGRRNLKLIMEFLPYGSLREYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 136
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P++  +PES+ E++
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 197 FSVASDVWSFGVVLYELFT 215

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 129/260 (49%), Gaps = 21/260 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIV 65
            IG G+F  V LA+      E    +AV+       +S +L+     +  + +   P IV
Sbjct: 21  TIGKGNFAKVKLARHILTGKE----VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + F       + E+   L++EYAS G + D +    +GR++E + +   R ++  +++ H
Sbjct: 77  KLF----EVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCH 130
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            K  VH D+K +N+L+  +   KIADFG + + +  G +  +F C G+P Y +PE     
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDTF-C-GSPPYAAPELFQGK 187
Query: 186 EYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           +Y+ P  D+W+LG  +  + SG   ++ +   N+  L  R+  G     IP  +S   ++
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQ---NLKELRERVLRGKY--RIPFYMSTDCEN 242
Query: 245 FLIKCFLKDPKRRWTAEMLL 264
            L K  + +P +R T E ++
Sbjct: 243 LLKKFLILNPSKRGTLEQIM 262

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPAFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 263 RMTIQDSLQHPWIKPKD 279

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 14/195 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  S G L D + ++ +  L E +  ++ + +L G+ ++HSK   H D+K +N+++ 
Sbjct: 92  LILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL 149
Query: 143 D----NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D    N   K+ DFG+A K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 150 DKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +    KQ++      +     +E  +   + SE  KDF+ +  +KDPKR
Sbjct: 207 ITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS---NTSELAKDFIRRLLVKDPKR 263
Query: 257 RWTAEMLLNHPFVCA 271
           R      L H ++ A
Sbjct: 264 RMXIAQSLEHSWIKA 278

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 14/195 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  S G L D + ++ +  L E +  ++ + +L G+ ++HSK   H D+K +N+++ 
Sbjct: 106 LILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL 163
Query: 143 D----NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D    N   K+ DFG+A K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 164 DKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 220
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +    KQ++      +     +E  +   + SE  KDF+ +  +KDPKR
Sbjct: 221 ITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS---NTSELAKDFIRRLLVKDPKR 277
Query: 257 RWTAEMLLNHPFVCA 271
           R      L H ++ A
Sbjct: 278 RMXIAQSLEHSWIKA 292

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           R   +G GSFG V L K  +  + +   ++  +          TL NEK  L  +   P 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNF-PF 102
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+    ++SF+     Y +++EY + G +   +++   GR  E   + Y   ++    +
Sbjct: 103 LVKL---EFSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP  ++PE + 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEALAPEIIL 211
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    D WALG  + EMA+G P +   Q   ++  ++   V       P   S   K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSSDLK 266
Query: 244 DFLIKCFLKDPKRRW 258
           D L      D  +R+
Sbjct: 267 DLLRNLLQVDLTKRF 281

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 122/255 (47%), Gaps = 16/255 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGI-CPQ 63
           G  IG G FG V+  +   +S E P++ +A+K+C +C   SV  K  +EAL       P 
Sbjct: 395 GRCIGEGQFGDVH--QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G        E    +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 453 IVKLIG-----VITENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAY 506
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV  ND  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 565
Query: 184 ENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E +  G   +   ++++V     RI  G+ LP +P +     
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLP-MPPNCPPTL 621
Query: 243 KDFLIKCFLKDPKRR 257
              + KC+  DP RR
Sbjct: 622 YSLMTKCWAYDPSRR 636

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 263 RMTIQDSLQHPWIKPKD 279

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 263 RMTIQDSLQHPWIKPKD 279

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 90  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 147
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 148 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 204
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 205 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 261
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 262 RMTIQDSLQHPWIKPKD 278

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 263 RMTIQDSLQHPWIKPKD 279

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 90  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 147
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 148 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 204
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 205 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 261
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 262 RMTIQDSLQHPWIKPKD 278

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 263 RMTIQDSLQHPWIKPKD 279

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 128/265 (48%), Gaps = 17/265 (6%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
            IG G+F  V LA+      E    + +       P+S+     +  + +I   P IV+ 
Sbjct: 22  TIGKGNFAKVKLARHILTGREVA--IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F       + E+   L++EYAS G + D +    +GR++E + +   R ++  +++ H K
Sbjct: 80  F----EVIETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             VH D+K +N+L+  +   KIADFG + + +  G +  +F C G P Y +PE     +Y
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF-C-GAPPYAAPELFQGKKY 190
Query: 188 EAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           + P  D+W+LG  +  + SG   ++     N+  L  R+  G     IP  +S   ++ L
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGKY--RIPFYMSTDCENLL 245
Query: 247 IKCFLKDPKRRWTAEMLLNHPFVCA 271
            +  + +P +R T E ++   ++ A
Sbjct: 246 KRFLVLNPIKRGTLEQIMKDRWINA 270

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 263 RMTIQDSLQHPWIKPKD 279

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 263 RMTIQDSLQHPWIKPKD 279

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 120/270 (44%), Gaps = 23/270 (8%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR-- 66
           +G G+FG V+          F   +A       P    T+KNE   ++Q+   P+++   
Sbjct: 59  LGSGAFGVVHRCVEKATGRVF---VAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLH 114
Query: 67  -CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
             F D Y          L+LE+ S G L DR+  ++  ++ E++V  Y R   +GL+H+H
Sbjct: 115 DAFEDKYEM-------VLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH 166
Query: 126 SKGFVHCDIKLQNVL--VFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
               VH DIK +N++         KI DFGLA K + D     +     T  + +PE V+
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIVD 223
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG-VGDELPNIPGDLSEQG 242
                   D+WA+G     + SG   +  + D      + R     DE  +    +S + 
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--DAFSSVSPEA 281
Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
           KDF+     K+P++R T    L HP++  D
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 263 RMTIQDSLQHPWIKPKD 279

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 121/255 (47%), Gaps = 16/255 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGI-CPQ 63
           G  IG G FG V+  +   +S E P++ +A+K+C +C   SV  K  +EAL       P 
Sbjct: 15  GRCIGEGQFGDVH--QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G        E    +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 73  IVKLIG-----VITENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAY 126
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV   D  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 127 LESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 185
Query: 184 ENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E +  G   +   ++++V     RI  G+ LP +P +     
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLP-MPPNCPPTL 241
Query: 243 KDFLIKCFLKDPKRR 257
              + KC+  DP RR
Sbjct: 242 YSLMTKCWAYDPSRR 256

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 78  ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQ 137
           E F+ L+ +  + G L + +  +      E+D     + +L+ + H H  G VH D+K +
Sbjct: 75  EGFHYLVFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVVHRDLKPE 132
Query: 138 NVLVFDN---DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIW 194
           N+L+         K+ADFGLA +    G++   F   GTP Y+SPE + +  Y  P DIW
Sbjct: 133 NLLLASKCKGAAVKLADFGLAIE--VQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIW 190
Query: 195 ALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGDELPNIPGD-LSEQGKDFLIKCFLK 252
           A G  +  +  G P  W+  +D +     I+ G  D  P+   D ++ + K+ + +    
Sbjct: 191 ACGVILYILLVGYPPFWD--EDQHKLYQQIKAGAYD-FPSPEWDTVTPEAKNLINQMLTI 247
Query: 253 DPKRRWTAEMLLNHPFVC 270
           +P +R TA   L HP+VC
Sbjct: 248 NPAKRITAHEALKHPWVC 265

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 263 RMTIQDSLQHPWIKPKD 279

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 37/279 (13%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI------CP 62
           IG G++GSVN      V      +MAVK       S+V  K +K+ L  + +      CP
Sbjct: 30  IGRGAYGSVN----KMVHKPSGQIMAVKRIR----STVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            IV+ +G    F +G+ +  + L   S       V    +  + E  + + T + +K L 
Sbjct: 82  YIVQFYGA--LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 123 HIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           H+      +H DIK  N+L+  +   K+ DFG++ +      +++   CR    YM+PE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP---YMAPER 196
Query: 182 VNENE----YEAPCDIWALGCAVVEMASGK---PAWNHKQDSNVFSLLIRIGVGDELPNI 234
           ++ +     Y+   D+W+LG  + E+A+G+   P WN     +VF  L ++  GD  P +
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN-----SVFDQLTQVVKGDP-PQL 250
Query: 235 PG----DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
                 + S    +F+  C  KD  +R   + LL HPF+
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IVR    D   E+G  +  L+ +  + G L + +  +      E+D     + +L+ +
Sbjct: 70  PNIVRL--HDSISEEGHHY--LIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAV 123
Query: 122 RHIHSKGFVHCDIKLQNVLV---FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            H H  G VH ++K +N+L+         K+ADFGLA +   +GE+   F   GTP Y+S
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGYLS 181
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           PE + ++ Y  P D+WA G  +  +  G P  W+  +D +     I+ G  D  P+   D
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD--EDQHRLYQQIKAGAYD-FPSPEWD 238
Query: 238 -LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            ++ + KD + K    +P +R TA   L HP++
Sbjct: 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 128/260 (49%), Gaps = 21/260 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIV 65
            IG G+F  V LA+      E    +AV+       +S +L+     +  + +   P IV
Sbjct: 21  TIGKGNFAKVKLARHILTGKE----VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + F       + E+   L++EYAS G + D +    +GR++E + +   R ++  +++ H
Sbjct: 77  KLF----EVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCH 130
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            K  VH D+K +N+L+  +   KIADFG + + +  G +   F C G+P Y +PE     
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDEF-C-GSPPYAAPELFQGK 187
Query: 186 EYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           +Y+ P  D+W+LG  +  + SG   ++ +   N+  L  R+  G     IP  +S   ++
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQ---NLKELRERVLRGKY--RIPFYMSTDCEN 242
Query: 245 FLIKCFLKDPKRRWTAEMLL 264
            L K  + +P +R T E ++
Sbjct: 243 LLKKFLILNPSKRGTLEQIM 262

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 14/193 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFV 269
           R T +  L HP++
Sbjct: 263 RMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 14/193 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFV 269
           R T +  L HP++
Sbjct: 263 RMTIQDSLQHPWI 275

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 125/259 (48%), Gaps = 22/259 (8%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKN-EKEALDQIGICPQ 63
           D +G G   +V LA+ + ++ +    +A+K+    PP     TLK  E+E  +   +  Q
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIK----VAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
            +    D    ++ +  Y L++EY    +L++ +  +++G L       +T  +L G++H
Sbjct: 72  NIVSMID---VDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKH 126
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
            H    VH DIK QN+L+  N   KI DFG+AK  S +   +Q+    GT  Y SPE   
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAK 185
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG----DLS 239
               +   DI+++G  + EM  G+P +N        S+ I+  + D +PN+      D+ 
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFN---GETAVSIAIK-HIQDSVPNVTTDVRKDIP 241
Query: 240 EQGKDFLIKCFLKDPKRRW 258
           +   + +++   KD   R+
Sbjct: 242 QSLSNVILRATEKDKANRY 260

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 117/231 (50%), Gaps = 23/231 (9%)
Query: 47  TLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQ 106
           TLK E + L ++   P I++   D Y   +   F+ L+ +   +G L D + ++    L 
Sbjct: 57  TLK-EVDILRKVSGHPNIIQ-LKDTY---ETNTFFFLVFDLMKKGELFDYLTEKVT--LS 109
Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
           E + ++  R++L+ +  +H    VH D+K +N+L+ D+   K+ DFG     SC  +  +
Sbjct: 110 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF----SCQLDPGE 165
Query: 167 SF-ECRGTPLYMSPE----SVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
              E  GTP Y++PE    S+N+N   Y    D+W+ G  +  + +G P + H++   + 
Sbjct: 166 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 225
Query: 220 SLLIRIGVGDELPNIP--GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
            +++    G+     P   D S+  KD + +  +  P++R+TAE  L HPF
Sbjct: 226 RMIMS---GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 273

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 120/233 (51%), Gaps = 27/233 (11%)
Query: 47  TLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQ 106
           TLK E + L ++   P I++   D Y   +   F+ L+ +   +G L D + ++    L 
Sbjct: 70  TLK-EVDILRKVSGHPNIIQ-LKDTY---ETNTFFFLVFDLMKKGELFDYLTEKVT--LS 122
Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD---GE 163
           E + ++  R++L+ +  +H    VH D+K +N+L+ D+   K+ DFG     SC    GE
Sbjct: 123 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF----SCQLDPGE 178
Query: 164 RSQSFECRGTPLYMSPE----SVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSN 217
           + +S  C GTP Y++PE    S+N+N   Y    D+W+ G  +  + +G P + H++   
Sbjct: 179 KLRSV-C-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 218 VFSLLIRIGVGDELPNIP--GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  +++    G+     P   D S+  KD + +  +  P++R+TAE  L HPF
Sbjct: 237 MLRMIMS---GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 17/272 (6%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKXLQDCPKA----RREVELHWRASQCPH 116
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   ++ E    G L  R++ + +    E +     +S+ + +++
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQY 176
Query: 124 IHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L      N   K+ DFG AK+++     S +  C  TP Y++PE
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCY-TPYYVAPE 233
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD W+LG     +  G P +       +      RI  G  E PN    +
Sbjct: 234 VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSE 293
Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           +SE+ K  +      +P +R T     NHP++
Sbjct: 294 VSEEVKXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 117/231 (50%), Gaps = 23/231 (9%)
Query: 47  TLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQ 106
           TLK E + L ++   P I++   D Y   +   F+ L+ +   +G L D + ++    L 
Sbjct: 70  TLK-EVDILRKVSGHPNIIQ-LKDTY---ETNTFFFLVFDLMKKGELFDYLTEKVT--LS 122
Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
           E + ++  R++L+ +  +H    VH D+K +N+L+ D+   K+ DFG     SC  +  +
Sbjct: 123 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF----SCQLDPGE 178
Query: 167 SF-ECRGTPLYMSPE----SVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
              E  GTP Y++PE    S+N+N   Y    D+W+ G  +  + +G P + H++   + 
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 220 SLLIRIGVGDELPNIP--GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
            +++    G+     P   D S+  KD + +  +  P++R+TAE  L HPF
Sbjct: 239 RMIMS---GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 106/216 (49%), Gaps = 14/216 (6%)
Query: 62  PQIVRCFGDDY-SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
           P IV C  D Y +   G+R   +++E    G L  R++++ +    E +     R +   
Sbjct: 82  PHIV-CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           ++ +HS    H D+K +N+L    ++    K+ DFG AK+++ +  ++  +    TP Y+
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY----TPYYV 196
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGDE-LPNIP 235
           +PE +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G    PN  
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 236 -GDLSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
             ++SE  K  LI+  LK DP  R T    +NHP++
Sbjct: 257 WSEVSEDAKQ-LIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 129/270 (47%), Gaps = 24/270 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAK----ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ 57
            ++ GD +G G+FG V + +      KV+ +  +   ++S          ++N K     
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK----- 66
Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           +   P I++     Y        + +++EY S G L D + K  +GR++E + +R  + +
Sbjct: 67  LFRHPHIIKL----YQVISTPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQI 120
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           L  + + H    VH D+K +NVL+  +  AKIADFGL+   S DGE  ++  C G+P Y 
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRT-SC-GSPNYA 177
Query: 178 SPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PE ++   Y  P  DIW+ G  +  +  G   ++   D +V +L  +I  G  +  IP 
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD---DEHVPTLFKKIRGG--VFYIPE 232
Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
            L+      L+     DP +R T + +  H
Sbjct: 233 YLNRSVATLLMHMLQVDPLKRATIKDIREH 262

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 106/216 (49%), Gaps = 14/216 (6%)
Query: 62  PQIVRCFGDDY-SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
           P IV C  D Y +   G+R   +++E    G L  R++++ +    E +     R +   
Sbjct: 63  PHIV-CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 121
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           ++ +HS    H D+K +N+L    ++    K+ DFG AK+++ +  ++  +    TP Y+
Sbjct: 122 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY----TPYYV 177
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGDE-LPNIP 235
           +PE +   +Y+  CD+W+LG  +  +  G P +       +   +  RI +G    PN  
Sbjct: 178 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 237
Query: 236 -GDLSEQGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
             ++SE  K  LI+  LK DP  R T    +NHP++
Sbjct: 238 WSEVSEDAKQ-LIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 111/254 (43%), Gaps = 12/254 (4%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V + K       +   +  K        +   + E++ L   G C  I   
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN-GDCQWITAL 139
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+     Y L+++Y   G L   + K  + +L E   + Y   M+  +  IH  
Sbjct: 140 ---HYAFQDENHLY-LVMDYYVGGDLLTLLSKFED-KLPEDMARFYIGEMVLAIDSIHQL 194
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE- 186
            +VH DIK  NVL+  N   ++ADFG   K + DG   QS    GTP Y+SPE +   E 
Sbjct: 195 HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-TVQSSVAVGTPDYISPEILQAMED 253
Query: 187 ----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               Y   CD W+LG  + EM  G+  +  +     +  ++      + P+   D+SE+ 
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 313
Query: 243 KDFLIKCFLKDPKR 256
           KD + +      +R
Sbjct: 314 KDLIQRLICSRERR 327

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 111/254 (43%), Gaps = 12/254 (4%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V + K       +   +  K        +   + E++ L   G C  I   
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN-GDCQWITAL 155
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+     Y L+++Y   G L   + K  + +L E   + Y   M+  +  IH  
Sbjct: 156 ---HYAFQDENHLY-LVMDYYVGGDLLTLLSKFED-KLPEDMARFYIGEMVLAIDSIHQL 210
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE- 186
            +VH DIK  NVL+  N   ++ADFG   K + DG   QS    GTP Y+SPE +   E 
Sbjct: 211 HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-TVQSSVAVGTPDYISPEILQAMED 269
Query: 187 ----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               Y   CD W+LG  + EM  G+  +  +     +  ++      + P+   D+SE+ 
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 329
Query: 243 KDFLIKCFLKDPKR 256
           KD + +      +R
Sbjct: 330 KDLIQRLICSRERR 343

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 128/270 (47%), Gaps = 24/270 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAK----ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ 57
            ++ GD +G G+FG V + +      KV+ +  +   ++S          ++N K     
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK----- 66
Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           +   P I++     Y        + +++EY S G L D + K  +GR++E + +R  + +
Sbjct: 67  LFRHPHIIKL----YQVISTPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQI 120
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           L  + + H    VH D+K +NVL+  +  AKIADFGL+   S DGE  +   C G+P Y 
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRD-SC-GSPNYA 177
Query: 178 SPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PE ++   Y  P  DIW+ G  +  +  G   ++   D +V +L  +I  G  +  IP 
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD---DEHVPTLFKKIRGG--VFYIPE 232
Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
            L+      L+     DP +R T + +  H
Sbjct: 233 YLNRSVATLLMHMLQVDPLKRATIKDIREH 262

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 121/255 (47%), Gaps = 16/255 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEALDQIGI-CPQ 63
           G  IG G FG V+  +   +S E P++ +A+K+C +C   SV  K  +EAL       P 
Sbjct: 395 GRCIGEGQFGDVH--QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G        E    +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 453 IVKLIG-----VITENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAY 506
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV   D  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 507 LESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 565
Query: 184 ENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E +  G   +   ++++V     RI  G+ LP +P +     
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENGERLP-MPPNCPPTL 621
Query: 243 KDFLIKCFLKDPKRR 257
              + KC+  DP RR
Sbjct: 622 YSLMTKCWAYDPSRR 636

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 127/259 (49%), Gaps = 21/259 (8%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVR 66
           IG G+F  V LA+      E    +AVK       +S +L+     +  + +   P IV+
Sbjct: 15  IGKGNFAKVKLARHILTGKE----VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 70
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            F       + E+   L++EYAS G + D +    +G ++E + +   R ++  +++ H 
Sbjct: 71  LF----EVIETEKTLYLVMEYASGGEVFDYLVA--HGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           K  VH D+K +N+L+  +   KIADFG + + +  G +  +F C G+P Y +PE     +
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDTF-C-GSPPYAAPELFQGKK 181
Query: 187 YEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           Y+ P  D+W+LG  +  + SG   ++     N+  L  R+  G     IP  +S   ++ 
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGKY--RIPFYMSTDCENL 236
Query: 246 LIKCFLKDPKRRWTAEMLL 264
           L K  + +P +R T E ++
Sbjct: 237 LKKFLILNPSKRGTLEQIM 255

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 117/288 (40%), Gaps = 39/288 (13%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG GS+G V   + ++ + +  ++       D P        E   L Q+   P +V   
Sbjct: 11  IGEGSYGVVFKCR-NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLL 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
                F +  R + L+ EY     L +  + Q    + E  VK  T   L+ +   H   
Sbjct: 69  E---VFRRKRRLH-LVFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKHN 122
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES-VNENEY 187
            +H D+K +N+L+  +   K+ DFG A+  +  G      +   T  Y SPE  V + +Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLT--GPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 188 EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP--------------- 232
             P D+WA+GC   E+ SG P W  K D +    LIR  +GD +P               
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LIRKTLGDLIPRHQQVFSTNQYFSGV 239
Query: 233 NIPG------------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
            IP             ++S      L  C   DP  R T E LL+HP+
Sbjct: 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 124/277 (44%), Gaps = 22/277 (7%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSV---TLKNEKEALDQIGICP 62
           G+ +G G F  V   +      E+ +    K  +      V    ++ E   L Q+ + P
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHP 75
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+    D Y   +      L+LE  S G L D + ++ +  L E +   + + +L G+ 
Sbjct: 76  NII-TLHDVY---ENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVN 129
Query: 123 HIHSKGFVHCDIKLQNVLVFDND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
           ++H+K   H D+K +N+++ D +      K+ DFGLA +     E    F   GTP +++
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVA 186
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPG 236
           PE VN        D+W++G     + SG   +  + KQ++      +     +E  +   
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS--- 243
Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
             SE  KDF+ K  +K+ ++R T +  L HP++   D
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAK----ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ 57
            ++ GD +G G+FG V + K      KV+ +  +   ++S          ++N K     
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK----- 71
Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           +   P I++     Y          +++EY S G L D + K  NGRL E + +R  + +
Sbjct: 72  LFRHPHIIKL----YQVISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQI 125
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           L G+ + H    VH D+K +NVL+  +  AKIADFGL+   S DGE  +   C G+P Y 
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRX-SC-GSPNYA 182
Query: 178 SPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PE ++   Y  P  DIW+ G  +  +  G   ++   D +V +L  +I   D +   P 
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD---DDHVPTLFKKI--CDGIFYTPQ 237
Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
            L+      L      DP +R T + +  H
Sbjct: 238 YLNPSVISLLKHMLQVDPMKRATIKDIREH 267

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+ E  + G L D + ++ +  L E +   + + +L G+ ++HS    H D+K +N+++ 
Sbjct: 91  LIGELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      KI DFGLA K     E    F   GTP +++PE VN        D+W++G 
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     DE  +   + S   KDF+ +  +KDPK+
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKK 262
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 263 RMTIQDSLQHPWIKPKD 279

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 15/254 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V L +       +   +  K        S     E++ +      P +V+ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVVQL 139
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F   Y+F+  +R+  +++EY   G L   V   +N  + E   + YT  ++  L  IHS 
Sbjct: 140 F---YAFQD-DRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN---- 183
           GF+H D+K  N+L+  +   K+ADFG   K + +G   +     GTP Y+SPE +     
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGG 251
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
           +  Y   CD W++G  + EM  G   +        +S ++        P+   D+S++ K
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-DNDISKEAK 310
Query: 244 DFLIKCFLKDPKRR 257
           + LI  FL D + R
Sbjct: 311 N-LICAFLTDREVR 323

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 15/254 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V L +       +   +  K        S     E++ +      P +V+ 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVVQL 134
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F   Y+F+  +R+  +++EY   G L   V   +N  + E   + YT  ++  L  IHS 
Sbjct: 135 F---YAFQD-DRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN---- 183
           GF+H D+K  N+L+  +   K+ADFG   K + +G   +     GTP Y+SPE +     
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGG 246
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
           +  Y   CD W++G  + EM  G   +        +S ++        P+   D+S++ K
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-DNDISKEAK 305
Query: 244 DFLIKCFLKDPKRR 257
           + LI  FL D + R
Sbjct: 306 N-LICAFLTDREVR 318

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G+FGSV L +   +     +L+AVK      P       +++   +I    QI++  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD-----QQRDFQREI----QILKAL 68
Query: 69  GDDY-------SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
             D+       S+  G +   L++EY   G L D +++ +  RL  S +  Y+  + KG+
Sbjct: 69  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGM 127
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPE 180
            ++ S+  VH D+  +N+LV      KIADFGLAK    D +     E   +P++  +PE
Sbjct: 128 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 187
Query: 181 SVNENEYEAPCDIWALGCAVVEM 203
           S+++N +    D+W+ G  + E+
Sbjct: 188 SLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G+FGSV L +   +     +L+AVK      P       +++   +I    QI++  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD-----QQRDFQREI----QILKAL 69
Query: 69  GDDY-------SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
             D+       S+  G +   L++EY   G L D +++ +  RL  S +  Y+  + KG+
Sbjct: 70  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGM 128
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPE 180
            ++ S+  VH D+  +N+LV      KIADFGLAK    D +     E   +P++  +PE
Sbjct: 129 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 188
Query: 181 SVNENEYEAPCDIWALGCAVVEM 203
           S+++N +    D+W+ G  + E+
Sbjct: 189 SLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 123/278 (44%), Gaps = 24/278 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQI- 64
           G+ +G G F  V   +      E+ +    K  +      V+    +E   ++ I  Q+ 
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVS---REEIEREVSILRQVL 73
Query: 65  ---VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
              V    D Y   +      L+LE  S G L D + ++ +  L E +   + + +L G+
Sbjct: 74  HHNVITLHDVY---ENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGV 128
Query: 122 RHIHSKGFVHCDIKLQNVLVFDND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
            ++H+K   H D+K +N+++ D +      K+ DFGLA +     E    F   GTP ++
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFV 185
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIP 235
           +PE VN        D+W++G     + SG   +  + KQ++      +     +E  +  
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS-- 243
Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
              SE  KDF+ K  +K+ ++R T +  L HP++   D
Sbjct: 244 -QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 15/254 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V L +       +   +  K        S     E++ +      P +V+ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVVQL 139
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F   Y+F+  +R+  +++EY   G L   V   +N  + E   + YT  ++  L  IHS 
Sbjct: 140 F---YAFQD-DRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN---- 183
           GF+H D+K  N+L+  +   K+ADFG   K + +G   +     GTP Y+SPE +     
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGG 251
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
           +  Y   CD W++G  + EM  G   +        +S ++        P+   D+S++ K
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-DNDISKEAK 310
Query: 244 DFLIKCFLKDPKRR 257
           + LI  FL D + R
Sbjct: 311 N-LICAFLTDREVR 323

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G+FGSV L +   +     +L+AVK      P       +++   +I    QI++  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD-----QQRDFQREI----QILKAL 81
Query: 69  GDDY-------SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
             D+       S+  G +   L++EY   G L D +++ +  RL  S +  Y+  + KG+
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGM 140
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPE 180
            ++ S+  VH D+  +N+LV      KIADFGLAK    D +     E   +P++  +PE
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 181 SVNENEYEAPCDIWALGCAVVEM 203
           S+++N +    D+W+ G  + E+
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  S G L D + ++ +  L E +   + + +L G+ ++H+K   H D+K +N+++ 
Sbjct: 92  LILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      K+ DFGLA +     E    F   GTP +++PE VN        D+W++G 
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     +E  +     SE  KDF+ K  +K+ ++
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS---QTSELAKDFIRKLLVKETRK 263
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 264 RLTIQEALRHPWITPVD 280

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
            IG G+F  V LA+      E    +  K+  +  P+S+     +  + +I   P IV+ 
Sbjct: 22  TIGKGNFAKVKLARHVLTGREVAVKIIDKTQLN--PTSLQKLFREVRIMKILNHPNIVKL 79
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F       + E+   L++EYAS G + D +    +GR++E + +   R ++  +++ H K
Sbjct: 80  F----EVIETEKTLYLVMEYASGGEVFDYLVA--HGRMKEKEARAKFRQIVSAVQYCHQK 133
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY 187
             VH D+K +N+L+  +   KIADFG + + +  G +  +F C G+P Y +PE     +Y
Sbjct: 134 YIVHRDLKAENLLLDGDMNIKIADFGFSNEFTV-GNKLDTF-C-GSPPYAAPELFQGKKY 190
Query: 188 EAP-CDIWALGCAVVEMASG 206
           + P  D+W+LG  +  + SG
Sbjct: 191 DGPEVDVWSLGVILYTLVSG 210

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G+FGSV L +   +     +L+AVK      P       +++   +I    QI++  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD-----QQRDFQREI----QILKAL 65
Query: 69  GDDY-------SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
             D+       S+  G     L++EY   G L D +++ +  RL  S +  Y+  + KG+
Sbjct: 66  HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGM 124
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPE 180
            ++ S+  VH D+  +N+LV      KIADFGLAK    D +     E   +P++  +PE
Sbjct: 125 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE 184
Query: 181 SVNENEYEAPCDIWALGCAVVEM 203
           S+++N +    D+W+ G  + E+
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 21/259 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN--EKEALDQIGICPQIV 65
            IG G+F  V LA+      E    +AVK       +S +L+    +  + ++   P IV
Sbjct: 21  TIGKGNFAKVKLARHILTGKE----VAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIV 76
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + F       + E+   L+ EYAS G + D +    +GR +E + +   R ++  +++ H
Sbjct: 77  KLF----EVIETEKTLYLVXEYASGGEVFDYLVA--HGRXKEKEARAKFRQIVSAVQYCH 130
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            K  VH D+K +N+L+  +   KIADFG + + +  G +  +F C G P Y +PE     
Sbjct: 131 QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTF-GNKLDAF-C-GAPPYAAPELFQGK 187
Query: 186 EYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           +Y+ P  D+W+LG  +  + SG   ++     N+  L  R+  G     IP   S   ++
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGKY--RIPFYXSTDCEN 242
Query: 245 FLIKCFLKDPKRRWTAEML 263
            L K  + +P +R T E +
Sbjct: 243 LLKKFLILNPSKRGTLEQI 261

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 123/278 (44%), Gaps = 24/278 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQI- 64
           G+ +G G F  V   +      E+ +    K  +      V+    +E   ++ I  Q+ 
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVS---REEIEREVSILRQVL 73
Query: 65  ---VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
              V    D Y   +      L+LE  S G L D + ++ +  L E +   + + +L G+
Sbjct: 74  HHNVITLHDVY---ENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGV 128
Query: 122 RHIHSKGFVHCDIKLQNVLVFDND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
            ++H+K   H D+K +N+++ D +      K+ DFGLA +     E    F   GTP ++
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFV 185
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIP 235
           +PE VN        D+W++G     + SG   +  + KQ++      +     +E  +  
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS-- 243
Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
              SE  KDF+ K  +K+ ++R T +  L HP++   D
Sbjct: 244 -HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  S G L D + ++ +  L E +   + + +L G+ ++H+K   H D+K +N+++ 
Sbjct: 92  LILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      K+ DFGLA +     E    F   GTP +++PE VN        D+W++G 
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     +E  +     SE  KDF+ K  +K+ ++
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS---HTSELAKDFIRKLLVKETRK 263
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 264 RLTIQEALRHPWITPVD 280

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 118/266 (44%), Gaps = 24/266 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G+FG V+L +      E       K  +  P   +  + E E L  +   P I++ F
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI--EAEIEVLKSLD-HPNIIKIF 86
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADR-VKKQNNGR-LQESDVKRYTRSMLKGLRHIHS 126
                FE     Y +++E    G L +R V  Q  G+ L E  V    + M+  L + HS
Sbjct: 87  E---VFEDYHNMY-IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 127 KGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +  VH D+K +N+L  D   +   KI DFGLA+    D     S    GT LYM+PE V 
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTALYMAPE-VF 198
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD---LSE 240
           + +    CDIW+ G  +  + +G   +       V     +     + PN   +   L+ 
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-----QQKATYKEPNYAVECRPLTP 253
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNH 266
           Q  D L +   KDP+RR +A  +L+H
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHH 279

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 18/276 (6%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           +VIG G+F  V      +   +F   ++ V      P  S      + ++  +   P IV
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLA-DRVKKQNNGRL-QESDVKRYTRSMLKGLRH 123
               + YS    +    ++ E+     L  + VK+ + G +  E+    Y R +L+ LR+
Sbjct: 90  ELL-ETYS---SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECR-GTPLYMSP 179
            H    +H D+K +NVL+   + +   K+ DFG+A +    GE       R GTP +M+P
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL---GESGLVAGGRVGTPHFMAP 202
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASG-KPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E V    Y  P D+W  G  +  + SG  P +  K+   +F  +I+ G     P     +
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIK-GKYKMNPRQWSHI 259
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
           SE  KD + +  + DP  R T    LNHP++   D+
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 117/253 (46%), Gaps = 52/253 (20%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL   +KK   GR+ E  + + + +++KGL
Sbjct: 64  PYIVGFYGAFYS--DGE--ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 117
Query: 122 RHIHSKG-FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++ +       + SF   GT  YMSPE
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSF--VGTRSYMSPE 173
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGK---PAWNHKQ----------------------- 214
            +    Y    DIW++G ++VEMA G+   P  + K+                       
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 215 ---------DSN----VFSLLIRIGVGDELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTA 260
                    DS     +F LL  I V +  P +P G  S + +DF+ KC +K+P  R   
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYI-VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 261 EMLLNHPFVCADD 273
           + L+ H F+   D
Sbjct: 293 KQLMVHAFIKRSD 305

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 117/253 (46%), Gaps = 52/253 (20%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL   +KK   GR+ E  + + + +++KGL
Sbjct: 64  PYIVGFYGAFYS--DGE--ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 117
Query: 122 RHIHSKG-FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++ +       + SF   GT  YMSPE
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSF--VGTRSYMSPE 173
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGK---PAWNHKQ----------------------- 214
            +    Y    DIW++G ++VEMA G+   P  + K+                       
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 215 ---------DSN----VFSLLIRIGVGDELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTA 260
                    DS     +F LL  I V +  P +P G  S + +DF+ KC +K+P  R   
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYI-VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 261 EMLLNHPFVCADD 273
           + L+ H F+   D
Sbjct: 293 KQLMVHAFIKRSD 305

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L+LE  S G L D + ++ +  L E +   + + +L G+ ++H+K   H D+K +N+++ 
Sbjct: 92  LILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 143 DND----EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
           D +      K+ DFGLA +     E    F   GTP +++PE VN        D+W++G 
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 199 AVVEMASGKPAW--NHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
               + SG   +  + KQ++      +     +E  +     SE  KDF+ K  +K+ ++
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS---HTSELAKDFIRKLLVKETRK 263
Query: 257 RWTAEMLLNHPFVCADD 273
           R T +  L HP++   D
Sbjct: 264 RLTIQEALRHPWITPVD 280

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 117/253 (46%), Gaps = 52/253 (20%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL   +KK   GR+ E  + + + +++KGL
Sbjct: 64  PYIVGFYGAFYS--DGE--ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 117
Query: 122 RHIHSKG-FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++ +       + SF   GT  YMSPE
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSF--VGTRSYMSPE 173
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGK---PAWNHKQ----------------------- 214
            +    Y    DIW++G ++VEMA G+   P  + K+                       
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 215 ---------DSN----VFSLLIRIGVGDELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTA 260
                    DS     +F LL  I V +  P +P G  S + +DF+ KC +K+P  R   
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYI-VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 261 EMLLNHPFVCADD 273
           + L+ H F+   D
Sbjct: 293 KQLMVHAFIKRSD 305

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 17/214 (7%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IVR     +   + E F+ L+ +  + G L + +  +      E+D     + +L+ +
Sbjct: 65  PNIVRL----HDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESI 118
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            + HS G VH ++K +N+L+    +    K+ADFGLA + + D E    F   GTP Y+S
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA--GTPGYLS 175
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           PE + ++ Y  P DIWA G  +  +  G P  W+  +D +     I+ G  D  P+   D
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIKAGAYD-YPSPEWD 232
Query: 238 -LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            ++ + K  +      +PK+R TA+  L  P++C
Sbjct: 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 117/253 (46%), Gaps = 52/253 (20%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL   +KK   GR+ E  + + + +++KGL
Sbjct: 64  PYIVGFYGAFYS--DGE--ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 117
Query: 122 RHIHSKG-FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++ +       + SF   GT  YMSPE
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSF--VGTRSYMSPE 173
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGK---PAWNHKQ----------------------- 214
            +    Y    DIW++G ++VEMA G+   P  + K+                       
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 215 ---------DSN----VFSLLIRIGVGDELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTA 260
                    DS     +F LL  I V +  P +P G  S + +DF+ KC +K+P  R   
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYI-VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 261 EMLLNHPFVCADD 273
           + L+ H F+   D
Sbjct: 293 KQLMVHAFIKRSD 305

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IVR     +   + E F+ L+ +  + G L + +  +      E+D     + +L+ +
Sbjct: 64  PNIVRL----HDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESI 117
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            + HS G VH ++K +N+L+    +    K+ADFGLA + + D E    F   GTP Y+S
Sbjct: 118 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA--GTPGYLS 174
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           PE + ++ Y  P DIWA G  +  +  G P  W+  +D +     I+ G  D        
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIKAGAYDYPSPEWDT 232
Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           ++ + K  +      +PK+R TA+  L  P++C
Sbjct: 233 VTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 265

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 116/253 (45%), Gaps = 52/253 (20%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL   +KK   GR+ E  + + + +++KGL
Sbjct: 91  PYIVGFYGAFYS--DGE--ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 144
Query: 122 RHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++         + SF   GT  YMSPE
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSF--VGTRSYMSPE 200
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGK---PAWNHKQ----------------------- 214
            +    Y    DIW++G ++VEMA G+   P  + K+                       
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 215 ---------DSN----VFSLLIRIGVGDELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTA 260
                    DS     +F LL  I V +  P +P G  S + +DF+ KC +K+P  R   
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYI-VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 319
Query: 261 EMLLNHPFVCADD 273
           + L+ H F+   D
Sbjct: 320 KQLMVHAFIKRSD 332

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IVR     +   + E F+ L+ +  + G L + +  +      E+D     + +L+ +
Sbjct: 65  PNIVRL----HDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESI 118
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            + HS G VH ++K +N+L+    +    K+ADFGLA + + D E    F   GTP Y+S
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA--GTPGYLS 175
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           PE + ++ Y  P DIWA G  +  +  G P  W+  +D +     I+ G  D        
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIKAGAYDYPSPEWDT 233
Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           ++ + K  +      +PK+R TA+  L  P++C
Sbjct: 234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 67/119 (56%), Gaps = 3/119 (2%)
Query: 85  LEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN 144
           +E+  +G+L   ++K+   +L +         + KG+ +IHSK  +H D+K  N+ + D 
Sbjct: 113 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDT 172
Query: 145 DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
            + KI DFGL      DG+R++S   +GT  YMSPE ++  +Y    D++ALG  + E+
Sbjct: 173 KQVKIGDFGLVTSLKNDGKRTRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 98/188 (52%), Gaps = 21/188 (11%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           L++E  + G L +R+KK+ +    E++     R ++  + H+H  G VH D+K +N+L  
Sbjct: 83  LVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFT 140
Query: 143 D---NDEAKIADFGLAKKSSCDGE--RSQSFECRGTPLYMSPESVNENEYEAPCDIWALG 197
           D   N E KI DFG A+    D +  ++  F    T  Y +PE +N+N Y+  CD+W+LG
Sbjct: 141 DENDNLEIKIIDFGFARLKPPDNQPLKTPCF----TLHYAAPELLNQNGYDESCDLWSLG 196
Query: 198 CAVVEMASGK-PAWNHKQD---SNVFSLLIRIGVGDELPNIPGD----LSEQGKDFLIKC 249
             +  M SG+ P  +H +    ++   ++ +I  GD   +  G+    +S++ KD +   
Sbjct: 197 VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF--SFEGEAWKNVSQEAKDLIQGL 254
Query: 250 FLKDPKRR 257
              DP +R
Sbjct: 255 LTVDPNKR 262

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 13/190 (6%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           +++EYAS G L +R+   N GR  E + + + + ++ G+ + H+    H D+KL+N L+ 
Sbjct: 92  IVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLL- 148
Query: 143 DNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAP-CDIWALGC 198
           D   A   KIADFG +K S      SQ     GTP Y++PE + + EY+    D+W+ G 
Sbjct: 149 DGSPAPRLKIADFGYSKASVL---HSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGV 205
Query: 199 AVVEMASGKPAWNHKQDSNVFSLLIR--IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
            +  M  G   +   ++   F   I   + V   +P+    +S + +  + + F+ DP +
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY-VHISPECRHLISRIFVADPAK 264
Query: 257 RWTAEMLLNH 266
           R +   + NH
Sbjct: 265 RISIPEIRNH 274

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 17/214 (7%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IVR     +   + E F+ L+ +  + G L + +  +      E+D     + +L+ +
Sbjct: 88  PNIVRL----HDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESI 141
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            + HS G VH ++K +N+L+    +    K+ADFGLA + + D E    F   GTP Y+S
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA--GTPGYLS 198
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           PE + ++ Y  P DIWA G  +  +  G P  W+  +D +     I+ G  D  P+   D
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIKAGAYD-YPSPEWD 255
Query: 238 -LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            ++ + K  +      +PK+R TA+  L  P++C
Sbjct: 256 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR- 66
           VIG GSFG V LA+  K    F ++  ++  A      +  K EK  + +  +  + V+ 
Sbjct: 45  VIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKA-----ILKKKEEKHIMSERNVLLKNVKH 98
Query: 67  --CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
               G  +SF+  ++ Y  +L+Y + G L   ++++      E   + Y   +   L ++
Sbjct: 99  PFLVGLHFSFQTADKLY-FVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYL 155
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           HS   V+ D+K +N+L+       + DFGL K++      + +F C GTP Y++PE +++
Sbjct: 156 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF-C-GTPEYLAPEVLHK 213
Query: 185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
             Y+   D W LG  + EM  G P +  +  + ++
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 112/273 (41%), Gaps = 14/273 (5%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V + K       F   +  K        +   + E++ L   G    I   
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTL 139
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y+F+     Y L+++Y   G L   + K  + RL E   + Y   M+  +  +H  
Sbjct: 140 ---HYAFQDDNNLY-LVMDYYVGGDLLTLLSKFED-RLPEEMARFYLAEMVIAIDSVHQL 194
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE- 186
            +VH DIK  N+L+  N   ++ADFG   K   DG   QS    GTP Y+SPE +   E 
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEG 253
Query: 187 ----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               Y   CD W+LG  + EM  G+  +  +     +  ++      + P    D+SE  
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 243 KDFLIKCFLKDPKR--RWTAEMLLNHPFVCADD 273
           KD + +       R  +   E    HPF    D
Sbjct: 314 KDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 52/253 (20%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL   +KK   GR+ E  + + + +++KGL
Sbjct: 126 PYIVGFYGAFYS--DGE--ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 179
Query: 122 RHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++ +       + SF   GT  YMSPE
Sbjct: 180 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSF--VGTRSYMSPE 235
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGK---PAWNHKQ----------------------- 214
            +    Y    DIW++G ++VEMA G+   P  + K+                       
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 295
Query: 215 ---------DSN----VFSLLIRIGVGDELPNIPGDL-SEQGKDFLIKCFLKDPKRRWTA 260
                    DS     +F LL  I V +  P +P  + S + +DF+ KC +K+P  R   
Sbjct: 296 GRPLSSYGMDSRPPMAIFELLDYI-VNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADL 354
Query: 261 EMLLNHPFVCADD 273
           + L+ H F+   D
Sbjct: 355 KQLMVHAFIKRSD 367

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 130/271 (47%), Gaps = 27/271 (9%)
Query: 3   WLRGDVIGHGSFGSVNLAK----ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-ALDQ 57
           ++  + +G GSFG V LA       KV+ +F S   +K       S + ++ E+E +  +
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK------SDMHMRVEREISYLK 64
Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           +   P I++     Y          +++EYA  G L D + ++   R+ E + +R+ + +
Sbjct: 65  LLRHPHIIKL----YDVITTPTDIVMVIEYAG-GELFDYIVEKK--RMTEDEGRRFFQQI 117
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           +  + + H    VH D+K +N+L+ DN   KIADFGL+   + DG   ++  C G+P Y 
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKT-SC-GSPNYA 174
Query: 178 SPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PE +N   Y  P  D+W+ G  +  M  G+  ++ +   N+F       V   +  +P 
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-----KVNSCVYVMPD 229
Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHP 267
            LS   +  + +  + DP +R T + +   P
Sbjct: 230 FLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 88/192 (45%), Gaps = 32/192 (16%)
Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE 163
           +  E  ++     MLKGL++IHS G VH D+K  N+ V ++ E KI DFGLA+ +  D E
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA--DAE 179
Query: 164 RSQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLL 222
            +     R    Y +PE + +   Y    DIW++GC + EM +GK  +  K   +  + +
Sbjct: 180 MTGYVVTRW---YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236
Query: 223 IRI-GV-GDE----------------LPNIPGD--------LSEQGKDFLIKCFLKDPKR 256
           +++ GV G E                LP  P           S Q  D L K    D  +
Sbjct: 237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 296
Query: 257 RWTAEMLLNHPF 268
           R TA   L HPF
Sbjct: 297 RLTAAQALTHPF 308

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 87/189 (46%), Gaps = 32/189 (16%)
Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
           E  ++     MLKGL++IHS G VH D+K  N+ V ++ E KI DFGLA+ +  D E + 
Sbjct: 143 EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTG 200
Query: 167 SFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI 225
               R    Y +PE + +   Y    DIW++GC + EM +GK  +  K   +  + ++++
Sbjct: 201 YVVTR---WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 257
Query: 226 -GV-GDE----------------LPNIPGD--------LSEQGKDFLIKCFLKDPKRRWT 259
            GV G E                LP  P           S Q  D L K    D  +R T
Sbjct: 258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317
Query: 260 AEMLLNHPF 268
           A   L HPF
Sbjct: 318 AAQALTHPF 326

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 90/190 (47%), Gaps = 7/190 (3%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ E+ S G L ++V  ++N ++ E +   Y R + KGL H+H   +VH D+K +N++  
Sbjct: 231 MIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 289
Query: 143 D--NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAV 200
              ++E K+ DFGL   +  D ++S      GT  + +PE           D+W++G   
Sbjct: 290 TKRSNELKLIDFGLT--AHLDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
Query: 201 VEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTA 260
             + SG   +  + D      +       +     G +SE GKDF+ K  L DP  R T 
Sbjct: 347 YILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG-ISEDGKDFIRKLLLADPNTRMTI 405
Query: 261 EMLLNHPFVC 270
              L HP++ 
Sbjct: 406 HQALEHPWLT 415

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 90/190 (47%), Gaps = 7/190 (3%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ E+ S G L ++V  ++N ++ E +   Y R + KGL H+H   +VH D+K +N++  
Sbjct: 125 MIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 183
Query: 143 D--NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAV 200
              ++E K+ DFGL   +  D ++S      GT  + +PE           D+W++G   
Sbjct: 184 TKRSNELKLIDFGLT--AHLDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 240
Query: 201 VEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTA 260
             + SG   +  + D      +       +     G +SE GKDF+ K  L DP  R T 
Sbjct: 241 YILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG-ISEDGKDFIRKLLLADPNTRMTI 299
Query: 261 EMLLNHPFVC 270
              L HP++ 
Sbjct: 300 HQALEHPWLT 309

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 3/158 (1%)
Query: 100 QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS 159
           ++N   QE     YT  ++ GL H+H +  ++ D+K +NVL+ D+   +I+D GLA +  
Sbjct: 281 EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
               +++ +   GTP +M+PE +   EY+   D +ALG  + EM + +  +  + +  V 
Sbjct: 341 AGQTKTKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-KVE 397
Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           +  ++  V ++    P   S   KDF      KDP++R
Sbjct: 398 NKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 3/158 (1%)
Query: 100 QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS 159
           ++N   QE     YT  ++ GL H+H +  ++ D+K +NVL+ D+   +I+D GLA +  
Sbjct: 281 EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
               +++ +   GTP +M+PE +   EY+   D +ALG  + EM + +  +  + +  V 
Sbjct: 341 AGQTKTKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-KVE 397
Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           +  ++  V ++    P   S   KDF      KDP++R
Sbjct: 398 NKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 127/268 (47%), Gaps = 30/268 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQIVRC 67
           IG G+FG   L +  K S+E   L+AVK        +  +K  +E ++   +  P IVR 
Sbjct: 27  IGSGNFGVARLMR-DKQSNE---LVAVKYIERGEKIAANVK--REIINHRSLRHPNIVR- 79
Query: 68  FGDDYSFEK---GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
                 F++         +++EYAS G L +R+   N GR  E + + + + ++ G+ + 
Sbjct: 80  ------FKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYC 131
Query: 125 HSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           H+    H D+KL+N L+ D   A   KI DFG +K S      SQ     GTP Y++PE 
Sbjct: 132 HAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEV 187
Query: 182 VNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR--IGVGDELPNIPGDL 238
           + + EY+    D+W+ G  +  M  G   +   ++   F   I   + V   +P+    +
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY-VHI 246
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           S + +  + + F+ DP +R +   + NH
Sbjct: 247 SPECRHLISRIFVADPAKRISIPEIRNH 274

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 130/303 (42%), Gaps = 53/303 (17%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVK------SCADCPPSSV---TLKNEKEALDQIG 59
           IG G++G+V  A+    S  F +L +V+           P S+V    L    EA +   
Sbjct: 17  IGVGAYGTVYKARDPH-SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH-- 73
Query: 60  ICPQIVRCFGDDYSFEKGER--FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
             P +VR   D  +  + +R     L+ E+  +  L   + K     L    +K   R  
Sbjct: 74  --PNVVRLM-DVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
           L+GL  +H+   VH D+K +N+LV      K+ADFGLA        R  S++   TP+  
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA--------RIYSYQMALTPVVV 181
Query: 176 ---YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAW--NHKQDS--NVFSLL------ 222
              Y +PE + ++ Y  P D+W++GC   EM   KP +  N + D    +F L+      
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241
Query: 223 -----IRIGVGDELPNIP-------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
                + +  G   P  P        ++ E G   L++    +P +R +A   L H ++ 
Sbjct: 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
Query: 271 ADD 273
            D+
Sbjct: 302 KDE 304

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 3/158 (1%)
Query: 100 QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS 159
           ++N   QE     YT  ++ GL H+H +  ++ D+K +NVL+ D+   +I+D GLA +  
Sbjct: 281 EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
               +++ +   GTP +M+PE +   EY+   D +ALG  + EM + +  +  + +  V 
Sbjct: 341 AGQTKTKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-KVE 397
Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           +  ++  V ++    P   S   KDF      KDP++R
Sbjct: 398 NKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 3/158 (1%)
Query: 100 QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS 159
           ++N   QE     YT  ++ GL H+H +  ++ D+K +NVL+ D+   +I+D GLA +  
Sbjct: 281 EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
               +++ +   GTP +M+PE +   EY+   D +ALG  + EM + +  +  + +  V 
Sbjct: 341 AGQTKTKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-KVE 397
Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           +  ++  V ++    P   S   KDF      KDP++R
Sbjct: 398 NKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 40/295 (13%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSC---ADCPPSSV---TLKNEKEALDQIGICP 62
           IG G++G+V  A+    S  F +L +V+        P S+V    L    EA +     P
Sbjct: 12  IGVGAYGTVYKARDPH-SGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH----P 66
Query: 63  QIVRCFGDDYSFEKGER--FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            +VR   D  +  + +R     L+ E+  +  L   + K     L    +K   R  L+G
Sbjct: 67  NVVRLM-DVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L  +H+   VH D+K +N+LV      K+ADFGLA+  S    +   F    T  Y +PE
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVVVTLWYRAPE 181
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAW--NHKQDS--NVFSLL-----------IRI 225
            + ++ Y  P D+W++GC   EM   KP +  N + D    +F L+           + +
Sbjct: 182 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 226 GVGDELPNIP-------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
             G   P  P        ++ E G   L++    +P +R +A   L H ++  D+
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 296

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           M  L  +++G G++  V  A + +   E+   +  K       S   +  E E L Q   
Sbjct: 13  MYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGH---SRSRVFREVETLYQCQG 69
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              I+        FE   RFY L+ E    GS+   ++KQ +    E +  R  R +   
Sbjct: 70  NKNILELIE---FFEDDTRFY-LVFEKLQGGSILAHIQKQKH--FNEREASRVVRDVAAA 123
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADF----GLAKKSSCDGERSQSFECR-G 172
           L  +H+KG  H D+K +N+L    ++    KI DF    G+   +SC    +       G
Sbjct: 124 LDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCG 183
Query: 173 TPLYMSPESV-----NENEYEAPCDIWALGCAVVEMASGKP----------AWNHKQDSN 217
           +  YM+PE V         Y+  CD+W+LG  +  M SG P           W+  +   
Sbjct: 184 SAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCR 243
Query: 218 VFS--LLIRIGVGD-ELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           V    L   I  G  E P+     +S + KD + K  ++D K+R +A  +L HP+V
Sbjct: 244 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 117/277 (42%), Gaps = 32/277 (11%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-PQI 64
           G  +G G FG+V LA+  K  S F   + V   +      V  +  +E   Q  +  P I
Sbjct: 28  GRPLGKGKFGNVYLAREKK--SHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNI 85
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +R +  +Y +++  R Y L+LEYA RG L   ++K       E         +   L + 
Sbjct: 86  LRLY--NYFYDR-RRIY-LILEYAPRGELYKELQKSCT--FDEQRTATIMEELADALMYC 139
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFG-------LAKKSSCDGERSQSFECRGTPLYM 177
           H K  +H DIK +N+L+    E KIADFG       L +K+ C           GT  Y+
Sbjct: 140 HGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC-----------GTLDYL 188
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
            PE +    +    D+W +G    E+  G P +     +  +  ++++ +       P  
Sbjct: 189 PPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDL-----KFPAS 243
Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
           +    +D + K    +P  R     +  HP+V A+ +
Sbjct: 244 VPTGAQDLISKLLRHNPSERLPLAQVSAHPWVRANSR 280

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 125/275 (45%), Gaps = 27/275 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN----EKEALDQIGIC--- 61
           +G G++G V L K     SE    +  KS  D    S   KN     +E  ++I +    
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 62  --PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P I++ F     FE  + FY L+ E+   G L +++   N  +  E D     + +L 
Sbjct: 104 DHPNIIKLFD---VFEDKKYFY-LVTEFYEGGELFEQI--INRHKFDECDAANIMKQILS 157
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDND---EAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           G+ ++H    VH DIK +N+L+ + +     KI DFGL+   S D +        GT  Y
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL---GTAYY 214
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP- 235
           ++PE V + +Y   CD+W+ G  +  +  G P +  + D ++     ++  G    +   
Sbjct: 215 IAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK---KVEKGKYYFDFND 270
Query: 236 -GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             ++S++ K+ +      D  +R TAE  LN  ++
Sbjct: 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 115/265 (43%), Gaps = 17/265 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G+++G G    V+LA+  ++  +    +     A  P  S  L+  +EA +   +  P I
Sbjct: 17  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP--SFYLRFRREAQNAAALNHPAI 74
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V  +    +         +++EY    +L D V  +  G +             + L   
Sbjct: 75  VAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFS 132
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER-SQSFECRGTPLYMSPESVN 183
           H  G +H D+K  N+++   +  K+ DFG+A+  +  G   +Q+    GT  Y+SPE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG----DLS 239
            +  +A  D+++LGC + E+ +G+P +      +V    +R     E P  P      LS
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-----EDPIPPSARHEGLS 247
Query: 240 EQGKDFLIKCFLKDPKRRW--TAEM 262
                 ++K   K+P+ R+   AEM
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 111/270 (41%), Gaps = 35/270 (12%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVK---SCADCPPSSVTLKNEKEALDQIGICPQIV 65
           +GHGS+G V   +    S E   L AVK   S    P        E  + +++G  P  V
Sbjct: 65  LGHGSYGEVFKVR----SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV 120
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           R    + ++E+G   Y   L+    G    +  +     L E+ V  Y R  L  L H+H
Sbjct: 121 RL---EQAWEEGGILY---LQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
           S+G VH D+K  N+ +      K+ DFGL  +    G         G P YM+PE + + 
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ---EGDPRYMAPELL-QG 230
Query: 186 EYEAPCDIWALGCAVVEMA------SGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
            Y    D+++LG  ++E+A       G   W   +             G   P     LS
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ------------GYLPPEFTAGLS 278
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            + +  L+     DPK R TAE LL  P +
Sbjct: 279 SELRSVLVMMLEPDPKLRATAEALLALPVL 308

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR--LQESDVKRYTRSMLK 119
           P IVR +  D   ++      +++EY   G LA  + K    R  L E  V R    +  
Sbjct: 65  PNIVRYY--DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 120 GLRHIHSKG-----FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
            L+  H +       +H D+K  NV +      K+ DFGLA+  + D   +++F   GTP
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTP 180
Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMASGKP---AWNHKQDSNVFSLLIRIGVGDEL 231
            YMSPE +N   Y    DIW+LGC + E+ +  P   A++ K+ +      IR G   + 
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK----IREG---KF 233
Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             IP   S++  + + +        R + E +L +P +
Sbjct: 234 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           M++   ++IG G FG V  AK  ++  +   +  VK   +     V        LD + I
Sbjct: 11  MDFKEIELIGSGGFGQVFKAK-HRIDGKTYVIKRVKYNNEKAEREV---KALAKLDHVNI 66
Query: 61  CPQIVRCFGDDYSFEKGERFYN--------LLLEYASRGSLADRVKKQNNGRLQESDVKR 112
                   G DY  E   +  +        + +E+  +G+L   ++K+   +L +     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
               + KG+ +IHSK  ++ D+K  N+ + D  + KI DFGL      DG+R +S   +G
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS---KG 183
Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           T  YMSPE ++  +Y    D++ALG  + E+
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 13/190 (6%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           +++EYAS G L +R+   N GR  E + + + + ++ G+ + H+    H D+KL+N L+ 
Sbjct: 91  IVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL- 147
Query: 143 DNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAP-CDIWALGC 198
           D   A   KI DFG +K S      SQ     GTP Y++PE + + EY+    D+W+ G 
Sbjct: 148 DGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGV 204
Query: 199 AVVEMASGKPAWNHKQDSNVFSLLIR--IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
            +  M  G   +   ++   F   I   + V   +P+    +S + +  + + F+ DP +
Sbjct: 205 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY-VHISPECRHLISRIFVADPAK 263
Query: 257 RWTAEMLLNH 266
           R +   + NH
Sbjct: 264 RISIPEIRNH 273

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI------CP 62
           +G G++G V   K   V S    +MAVK       ++V  + +K  L  + I      CP
Sbjct: 15  LGRGAYGVVE--KMRHVPSG--QIMAVKRIR----ATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
             V  +G    F +G+ +  + L   S      +V  +    + E  + +   S++K L 
Sbjct: 67  FTVTFYG--ALFREGDVWICMELMDTSLDKFYKQVIDKGQ-TIPEDILGKIAVSIVKALE 123
Query: 123 HIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           H+HSK   +H D+K  NVL+    + K+ DFG++     D  +     C+    YM+PE 
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP---YMAPER 180
Query: 182 VN----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           +N    +  Y    DIW+LG  ++E+A  +  + +      F  L ++ V +  P +P D
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQV-VEEPSPQLPAD 237
Query: 238 -LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
             S +  DF  +C  K+ K R T   L+ HPF
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR--LQESDVKRYTRSMLK 119
           P IVR +  D   ++      +++EY   G LA  + K    R  L E  V R    +  
Sbjct: 65  PNIVRYY--DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 120 GLRHIHSKG-----FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
            L+  H +       +H D+K  NV +      K+ DFGLA+  + D   +++F   GTP
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV--GTP 180
Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMASGKP---AWNHKQDSNVFSLLIRIGVGDEL 231
            YMSPE +N   Y    DIW+LGC + E+ +  P   A++ K+ +      IR G   + 
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK----IREG---KF 233
Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             IP   S++  + + +        R + E +L +P +
Sbjct: 234 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 56/253 (22%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +G  YS   GE   ++ +E+   GSL D+V K+   R+ E  + + + ++L+GL
Sbjct: 74  PYIVGFYGAFYS--DGE--ISICMEHMDGGSL-DQVLKEAK-RIPEEILGKVSIAVLRGL 127
Query: 122 RHIHSKG-FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
            ++  K   +H D+K  N+LV    E K+ DFG++ +       + SF   GT  YM+PE
Sbjct: 128 AYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSF--VGTRSYMAPE 183
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGK--------------------------------- 207
            +    Y    DIW++G ++VE+A G+                                 
Sbjct: 184 RLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 243
Query: 208 ------PAWNHKQDSN----VFSLLIRIGVGDELPNIP-GDLSEQGKDFLIKCFLKDPKR 256
                 P   H  DS     +F LL  I V +  P +P G  +   ++F+ KC +K+P  
Sbjct: 244 PRPPGRPVSGHGMDSRPAMAIFELLDYI-VNEPPPKLPNGVFTPDFQEFVNKCLIKNPAE 302
Query: 257 RWTAEMLLNHPFV 269
           R   +ML NH F+
Sbjct: 303 RADLKMLTNHTFI 315

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 115/265 (43%), Gaps = 17/265 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G+++G G    V+LA+  ++  +    +     A  P  S  L+  +EA +   +  P I
Sbjct: 34  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP--SFYLRFRREAQNAAALNHPAI 91
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V  +    +         +++EY    +L D V  +  G +             + L   
Sbjct: 92  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFS 149
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER-SQSFECRGTPLYMSPESVN 183
           H  G +H D+K  N+++   +  K+ DFG+A+  +  G   +Q+    GT  Y+SPE   
Sbjct: 150 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 209
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG----DLS 239
            +  +A  D+++LGC + E+ +G+P +      +V    +R     E P  P      LS
Sbjct: 210 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-----EDPIPPSARHEGLS 264
Query: 240 EQGKDFLIKCFLKDPKRRW--TAEM 262
                 ++K   K+P+ R+   AEM
Sbjct: 265 ADLDAVVLKALAKNPENRYQTAAEM 289

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 115/265 (43%), Gaps = 17/265 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G+++G G    V+LA+  ++  +    +     A  P  S  L+  +EA +   +  P I
Sbjct: 17  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP--SFYLRFRREAQNAAALNHPAI 74
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V  +    +         +++EY    +L D V  +  G +             + L   
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFS 132
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER-SQSFECRGTPLYMSPESVN 183
           H  G +H D+K  N+++   +  K+ DFG+A+  +  G   +Q+    GT  Y+SPE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG----DLS 239
            +  +A  D+++LGC + E+ +G+P +      +V    +R     E P  P      LS
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-----EDPIPPSARHEGLS 247
Query: 240 EQGKDFLIKCFLKDPKRRW--TAEM 262
                 ++K   K+P+ R+   AEM
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 50/300 (16%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSC---ADCPPSSV---TLKNEKEALDQIGICP 62
           IG G++G+V  A+    S  F +L +V+        P S+V    L    EA +     P
Sbjct: 12  IGVGAYGTVYKARDPH-SGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH----P 66
Query: 63  QIVRCFGDDYSFEKGER--FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            +VR   D  +  + +R     L+ E+  +  L   + K     L    +K   R  L+G
Sbjct: 67  NVVRLM-DVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL----- 175
           L  +H+   VH D+K +N+LV      K+ADFGLA        R  S++    P+     
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA--------RIYSYQMALAPVVVTLW 176
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAW--NHKQDS--NVFSLL--------- 222
           Y +PE + ++ Y  P D+W++GC   EM   KP +  N + D    +F L+         
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 236
Query: 223 --IRIGVGDELPNIP-------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
             + +  G   P  P        ++ E G   L++    +P +R +A   L H ++  D+
Sbjct: 237 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 296

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR--LQESDVKRYTRSMLK 119
           P IVR +  D   ++      +++EY   G LA  + K    R  L E  V R    +  
Sbjct: 65  PNIVRYY--DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 120 GLRHIHSKG-----FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
            L+  H +       +H D+K  NV +      K+ DFGLA+  + D + ++ F   GTP
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV--GTP 180
Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMASGKP---AWNHKQDSNVFSLLIRIGVGDEL 231
            YMSPE +N   Y    DIW+LGC + E+ +  P   A++ K+ +      IR G   + 
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK----IREG---KF 233
Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             IP   S++  + + +        R + E +L +P +
Sbjct: 234 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 29/263 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G GSFG V      +   + PS   V     C    V   ++ EA+D        +R  
Sbjct: 16  LGDGSFGVVR-----RGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDF------IREV 62
Query: 69  GDDYSFEKGE--RFYNLLL--------EYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              +S +     R Y ++L        E A  GSL DR++K + G      + RY   + 
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVA 121
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YM 177
           +G+ ++ SK F+H D+  +N+L+   D  KI DFGL +    + +     E R  P  + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PES+    +    D W  G  + EM + G+  W     S +   + +   G+ LP  P 
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--EGERLPR-PE 238
Query: 237 DLSEQGKDFLIKCFLKDPKRRWT 259
           D  +   + +++C+   P+ R T
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 50/300 (16%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSC---ADCPPSSV---TLKNEKEALDQIGICP 62
           IG G++G+V  A+    S  F +L +V+        P S+V    L    EA +     P
Sbjct: 12  IGVGAYGTVYKARDPH-SGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH----P 66
Query: 63  QIVRCFGDDYSFEKGER--FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            +VR   D  +  + +R     L+ E+  +  L   + K     L    +K   R  L+G
Sbjct: 67  NVVRLM-DVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL----- 175
           L  +H+   VH D+K +N+LV      K+ADFGLA        R  S++    P+     
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA--------RIYSYQMALDPVVVTLW 176
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAW--NHKQDS--NVFSLL--------- 222
           Y +PE + ++ Y  P D+W++GC   EM   KP +  N + D    +F L+         
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 236
Query: 223 --IRIGVGDELPNIP-------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
             + +  G   P  P        ++ E G   L++    +P +R +A   L H ++  D+
Sbjct: 237 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 296

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 29/263 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G GSFG V      +   + PS   V     C    V   ++ EA+D        +R  
Sbjct: 26  LGDGSFGVVR-----RGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDF------IREV 72
Query: 69  GDDYSFEKGE--RFYNLLL--------EYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              +S +     R Y ++L        E A  GSL DR++K + G      + RY   + 
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVA 131
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YM 177
           +G+ ++ SK F+H D+  +N+L+   D  KI DFGL +    + +     E R  P  + 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PES+    +    D W  G  + EM + G+  W     S +   + +   G+ LP  P 
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--EGERLPR-PE 248
Query: 237 DLSEQGKDFLIKCFLKDPKRRWT 259
           D  +   + +++C+   P+ R T
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 29/263 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G GSFG V      +   + PS   V     C    V   ++ EA+D        +R  
Sbjct: 16  LGDGSFGVVR-----RGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDF------IREV 62
Query: 69  GDDYSFEKGE--RFYNLLL--------EYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              +S +     R Y ++L        E A  GSL DR++K + G      + RY   + 
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVA 121
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YM 177
           +G+ ++ SK F+H D+  +N+L+   D  KI DFGL +    + +     E R  P  + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PES+    +    D W  G  + EM + G+  W     S +   + +   G+ LP  P 
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--EGERLPR-PE 238
Query: 237 DLSEQGKDFLIKCFLKDPKRRWT 259
           D  +   + +++C+   P+ R T
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 124/272 (45%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI------CP 62
           +G G++G V   K   V S    +MAVK       ++V  + +K  L  + I      CP
Sbjct: 59  LGRGAYGVVE--KMRHVPSG--QIMAVKRIR----ATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
             V  +G    F +G+ +  + L   S      +V  +    + E  + +   S++K L 
Sbjct: 111 FTVTFYG--ALFREGDVWICMELMDTSLDKFYKQVIDKGQ-TIPEDILGKIAVSIVKALE 167
Query: 123 HIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           H+HSK   +H D+K  NVL+    + K+ DFG++        ++    C+    YM+PE 
Sbjct: 168 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKP---YMAPER 224
Query: 182 VN----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           +N    +  Y    DIW+LG  ++E+A  +  + +      F  L ++ V +  P +P D
Sbjct: 225 INPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQV-VEEPSPQLPAD 281
Query: 238 -LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
             S +  DF  +C  K+ K R T   L+ HPF
Sbjct: 282 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 313

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 29/263 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G GSFG V      +   + PS   V     C    V   ++ EA+D        +R  
Sbjct: 16  LGDGSFGVVR-----RGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDF------IREV 62
Query: 69  GDDYSFEKGE--RFYNLLL--------EYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              +S +     R Y ++L        E A  GSL DR++K + G      + RY   + 
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVA 121
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YM 177
           +G+ ++ SK F+H D+  +N+L+   D  KI DFGL +    + +     E R  P  + 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PES+    +    D W  G  + EM + G+  W     S +   + +   G+ LP  P 
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--EGERLPR-PE 238
Query: 237 DLSEQGKDFLIKCFLKDPKRRWT 259
           D  +   + +++C+   P+ R T
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 29/263 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G GSFG V      +   + PS   V     C    V   ++ EA+D        +R  
Sbjct: 20  LGDGSFGVVR-----RGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDF------IREV 66
Query: 69  GDDYSFEKGE--RFYNLLL--------EYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              +S +     R Y ++L        E A  GSL DR++K + G      + RY   + 
Sbjct: 67  NAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVA 125
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YM 177
           +G+ ++ SK F+H D+  +N+L+   D  KI DFGL +    + +     E R  P  + 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PES+    +    D W  G  + EM + G+  W     S +   + +   G+ LP  P 
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--EGERLPR-PE 242
Query: 237 DLSEQGKDFLIKCFLKDPKRRWT 259
           D  +   + +++C+   P+ R T
Sbjct: 243 DCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 29/263 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G GSFG V      +   + PS   V     C    V   ++ EA+D        +R  
Sbjct: 26  LGDGSFGVVR-----RGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDF------IREV 72
Query: 69  GDDYSFEKGE--RFYNLLL--------EYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              +S +     R Y ++L        E A  GSL DR++K + G      + RY   + 
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVA 131
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YM 177
           +G+ ++ SK F+H D+  +N+L+   D  KI DFGL +    + +     E R  P  + 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PES+    +    D W  G  + EM + G+  W     S +   + +   G+ LP  P 
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--EGERLPR-PE 248
Query: 237 DLSEQGKDFLIKCFLKDPKRRWT 259
           D  +   + +++C+   P+ R T
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 31/274 (11%)
Query: 14  FGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTL---KNEKEALDQIGI-CPQIVRCFG 69
            GS   +K  +V +E   + A+K        + TL   +NE   L+++     +I+R   
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL-- 93
Query: 70  DDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGF 129
             Y +E  +++  +++E      L   +KK+ +  +   + K Y ++ML+ +  IH  G 
Sbjct: 94  --YDYEITDQYIYMVME-CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 130 VHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE----- 184
           VH D+K  N L+ D    K+ DFG+A +   D          GT  YM PE++ +     
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 185 ------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD---ELPNIP 235
                 ++     D+W+LGC +  M  GK  +  +Q  N  S L  I   +   E P+IP
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
               +  +D L  C  +DPK+R +   LL HP+V
Sbjct: 266 ---EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 31/274 (11%)
Query: 14  FGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTL---KNEKEALDQIGI-CPQIVRCFG 69
            GS   +K  +V +E   + A+K        + TL   +NE   L+++     +I+R   
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL-- 93
Query: 70  DDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGF 129
             Y +E  +++  +++E      L   +KK+ +  +   + K Y ++ML+ +  IH  G 
Sbjct: 94  --YDYEITDQYIYMVME-CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 130 VHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE----- 184
           VH D+K  N L+ D    K+ DFG+A +   D          GT  YM PE++ +     
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 185 ------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI---GVGDELPNIP 235
                 ++     D+W+LGC +  M  GK  +  +Q  N  S L  I       E P+IP
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
               +  +D L  C  +DPK+R +   LL HP+V
Sbjct: 266 ---EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 29/263 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G GSFG V      +   + PS   V     C    V   ++ EA+D        +R  
Sbjct: 20  LGDGSFGVVR-----RGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDF------IREV 66
Query: 69  GDDYSFEKGE--RFYNLLL--------EYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              +S +     R Y ++L        E A  GSL DR++K + G      + RY   + 
Sbjct: 67  NAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVA 125
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YM 177
           +G+ ++ SK F+H D+  +N+L+   D  KI DFGL +    + +     E R  P  + 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PES+    +    D W  G  + EM + G+  W     S +   + +   G+ LP  P 
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--EGERLPR-PE 242
Query: 237 DLSEQGKDFLIKCFLKDPKRRWT 259
           D  +   + +++C+   P+ R T
Sbjct: 243 DCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 31/274 (11%)
Query: 14  FGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTL---KNEKEALDQIGI-CPQIVRCFG 69
            GS   +K  +V +E   + A+K        + TL   +NE   L+++     +I+R   
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL-- 121
Query: 70  DDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGF 129
             Y +E  +++  +++E      L   +KK+ +  +   + K Y ++ML+ +  IH  G 
Sbjct: 122 --YDYEITDQYIYMVME-CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 130 VHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE----- 184
           VH D+K  N L+ D    K+ DFG+A +   D          GT  YM PE++ +     
Sbjct: 177 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 235
Query: 185 ------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD---ELPNIP 235
                 ++     D+W+LGC +  M  GK  +  +Q  N  S L  I   +   E P+IP
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
               +  +D L  C  +DPK+R +   LL HP+V
Sbjct: 294 ---EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 125/268 (46%), Gaps = 30/268 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQIVRC 67
           IG G+FG   L +  K++ E  ++  ++  A     ++    ++E ++   +  P IVR 
Sbjct: 28  IGSGNFGVARLMR-DKLTKELVAVKYIERGA-----AIDENVQREIINHRSLRHPNIVR- 80
Query: 68  FGDDYSFEK---GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
                 F++         +++EYAS G L +R+   N GR  E + + + + +L G+ + 
Sbjct: 81  ------FKEVILTPTHLAIIMEYASGGELYERIC--NAGRFSEDEARFFFQQLLSGVSYC 132
Query: 125 HSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           HS    H D+KL+N L+ D   A   KI DFG +K S      SQ     GTP Y++PE 
Sbjct: 133 HSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEV 188
Query: 182 VNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD--L 238
           +   EY+    D+W+ G  +  M  G   +   ++   +   I+  +  +  +IP D  +
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-SIPDDIRI 247
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           S +    + + F+ DP  R +   +  H
Sbjct: 248 SPECCHLISRIFVADPATRISIPEIKTH 275

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
           K Y ++ML+ +  IH  G VH D+K  N L+ D    K+ DFG+A +   D         
Sbjct: 114 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 172
Query: 171 RGTPLYMSPESVNE-----------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
            GT  YM PE++ +           ++     D+W+LGC +  M  GK  +  +Q  N  
Sbjct: 173 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQI 230
Query: 220 SLLIRIGVGD---ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S L  I   +   E P+IP    +  +D L  C  +DPK+R +   LL HP+V
Sbjct: 231 SKLHAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G+FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 100 HKNIINLLG--ACTQDGPLY--VIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMT 155
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
           K Y ++ML+ +  IH  G VH D+K  N L+ D    K+ DFG+A +   D         
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 171 RGTPLYMSPESVNE-----------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
            GT  YM PE++ +           ++     D+W+LGC +  M  GK  +  +Q  N  
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQI 274
Query: 220 SLLIRI---GVGDELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S L  I       E P+IP  DL    +D L  C  +DPK+R +   LL HP+V
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDL----QDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
           K Y ++ML+ +  IH  G VH D+K  N L+ D    K+ DFG+A +   D         
Sbjct: 110 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 168
Query: 171 RGTPLYMSPESVNE-----------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
            GT  YM PE++ +           ++     D+W+LGC +  M  GK  +  +Q  N  
Sbjct: 169 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQI 226
Query: 220 SLLIRIGVGD---ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S L  I   +   E P+IP    +  +D L  C  +DPK+R +   LL HP+V
Sbjct: 227 SKLHAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 13/190 (6%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           +++EYAS G L +R+   N GR  E + + + + ++ G+ + H+    H D+KL+N L+ 
Sbjct: 92  IVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL- 148
Query: 143 DNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAP-CDIWALGC 198
           D   A   KI  FG +K S      SQ  +  GTP Y++PE + + EY+    D+W+ G 
Sbjct: 149 DGSPAPRLKICAFGYSKSSVL---HSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGV 205
Query: 199 AVVEMASGKPAWNHKQDSNVFSLLIR--IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
            +  M  G   +   ++   F   I   + V   +P+    +S + +  + + F+ DP +
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY-VHISPECRHLISRIFVADPAK 264
Query: 257 RWTAEMLLNH 266
           R +   + NH
Sbjct: 265 RISIPEIRNH 274

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 17/254 (6%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI--GICPQIV 65
           +IG G FG V   + +     +      K             NE+  L  +  G CP IV
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
            C    Y+F   ++  + +L+  + G L   + +  +G   E+D++ Y   ++ GL H+H
Sbjct: 255 -CMS--YAFHTPDKL-SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMH 308
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
           ++  V+ D+K  N+L+ ++   +I+D GLA    CD  + +     GT  YM+PE + + 
Sbjct: 309 NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 364
Query: 186 -EYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
             Y++  D ++LGC + ++  G  P   HK         + + +  ELP+     S + +
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD---SFSPELR 421
Query: 244 DFLIKCFLKDPKRR 257
             L     +D  RR
Sbjct: 422 SLLEGLLQRDVNRR 435

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
           K Y ++ML+ +  IH  G VH D+K  N L+ D    K+ DFG+A +   D         
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 171 RGTPLYMSPESVNE-----------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
            GT  YM PE++ +           ++     D+W+LGC +  M  GK  +  +Q  N  
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQI 227
Query: 220 SLLIRI---GVGDELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S L  I       E P+IP  DL    +D L  C  +DPK+R +   LL HP+V
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDL----QDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 113/265 (42%), Gaps = 17/265 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G+++G G    V+LA+  +   +    +     A  P  S  L+  +EA +   +  P I
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP--SFYLRFRREAQNAAALNHPAI 74
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V  +    +         +++EY    +L D V  +  G +             + L   
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFS 132
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER-SQSFECRGTPLYMSPESVN 183
           H  G +H D+K  N+L+   +  K+ DFG+A+  +  G    Q+    GT  Y+SPE   
Sbjct: 133 HQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR 192
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG----DLS 239
            +  +A  D+++LGC + E+ +G+P +      +V    +R     E P  P      LS
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-----EDPIPPSARHEGLS 247
Query: 240 EQGKDFLIKCFLKDPKRRW--TAEM 262
                 ++K   K+P+ R+   AEM
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 14  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 71
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+ S   L D +       +    +K Y   +L+GL   HS  
Sbjct: 72  DVIHT----ENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 184
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 32/202 (15%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K   + +L E  ++     MLKGLR+IH+ G +H D+K  N+ V ++ E KI DFG
Sbjct: 114 TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 173
Query: 154 LAKKSSCDGERSQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNH 212
           LA+++  D E       R    Y +PE + N   Y    DIW++GC + EM +GK  +  
Sbjct: 174 LARQA--DSEMXGXVVTR---WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228
Query: 213 KQDSNVFSLLIRIG-----------VGDELPNIPGDLSE-QGKDF--------------L 246
               +    ++++              DE  N    L E + KDF              L
Sbjct: 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 288
Query: 247 IKCFLKDPKRRWTAEMLLNHPF 268
            K  + D ++R TA   L HP+
Sbjct: 289 EKMLVLDAEQRVTAGEALAHPY 310

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 13  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 70
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+ S   L D +       +    +K Y   +L+GL   HS  
Sbjct: 71  DVIHT----ENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 183
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 243
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 17/254 (6%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI--GICPQIV 65
           +IG G FG V   + +     +      K             NE+  L  +  G CP IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
            C    Y+F   ++  + +L+  + G L   + +  +G   E+D++ Y   ++ GL H+H
Sbjct: 256 -CMS--YAFHTPDKL-SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMH 309
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
           ++  V+ D+K  N+L+ ++   +I+D GLA    CD  + +     GT  YM+PE + + 
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 186 -EYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
             Y++  D ++LGC + ++  G  P   HK         + + +  ELP+     S + +
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD---SFSPELR 422
Query: 244 DFLIKCFLKDPKRR 257
             L     +D  RR
Sbjct: 423 SLLEGLLQRDVNRR 436

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 18/272 (6%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG G+FG V L +  K S +  ++  +        S      E+  +      P +V+ 
Sbjct: 82  VIGRGAFGEVQLVR-HKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 140
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
           F    +F+  +  Y +++EY   G L   V   +N  + E   K YT  ++  L  IHS 
Sbjct: 141 FC---AFQDDKYLY-MVMEYMPGGDL---VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 193
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV----N 183
           G +H D+K  N+L+  +   K+ADFG   K    G         GTP Y+SPE +     
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVHCDTAVGTPDYISPEVLKSQGG 252
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
           +  Y   CD W++G  + EM  G   +        +S ++        P    ++S+  K
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPE-DAEISKHAK 311
Query: 244 DFLIKCFLKDPKRRW---TAEMLLNHPFVCAD 272
           + LI  FL D + R      E +  HPF   D
Sbjct: 312 N-LICAFLTDREVRLGRNGVEEIKQHPFFKND 342

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 114/265 (43%), Gaps = 17/265 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G+++G G    V+LA+  +   +    +     A  P  S  L+  +EA +   +  P I
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP--SFYLRFRREAQNAAALNHPAI 74
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V  +    +         +++EY    +L D V  +  G +             + L   
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFS 132
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER-SQSFECRGTPLYMSPESVN 183
           H  G +H D+K  N+++   +  K+ DFG+A+  +  G   +Q+    GT  Y+SPE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG----DLS 239
            +  +A  D+++LGC + E+ +G+P +      +V    +R     E P  P      LS
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVR-----EDPIPPSARHEGLS 247
Query: 240 EQGKDFLIKCFLKDPKRRW--TAEM 262
                 ++K   K+P+ R+   AEM
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 17/254 (6%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI--GICPQIV 65
           +IG G FG V   + +     +      K             NE+  L  +  G CP IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
            C    Y+F   ++  + +L+  + G L   + +  +G   E+D++ Y   ++ GL H+H
Sbjct: 256 -CMS--YAFHTPDKL-SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMH 309
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
           ++  V+ D+K  N+L+ ++   +I+D GLA    CD  + +     GT  YM+PE + + 
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 186 -EYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
             Y++  D ++LGC + ++  G  P   HK         + + +  ELP+     S + +
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD---SFSPELR 422
Query: 244 DFLIKCFLKDPKRR 257
             L     +D  RR
Sbjct: 423 SLLEGLLQRDVNRR 436

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 17/254 (6%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI--GICPQIV 65
           +IG G FG V   + +     +      K             NE+  L  +  G CP IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
            C    Y+F   ++  + +L+  + G L   + +  +G   E+D++ Y   ++ GL H+H
Sbjct: 256 -CMS--YAFHTPDKL-SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMH 309
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
           ++  V+ D+K  N+L+ ++   +I+D GLA    CD  + +     GT  YM+PE + + 
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 186 -EYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
             Y++  D ++LGC + ++  G  P   HK         + + +  ELP+     S + +
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD---SFSPELR 422
Query: 244 DFLIKCFLKDPKRR 257
             L     +D  RR
Sbjct: 423 SLLEGLLQRDVNRR 436

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 40/270 (14%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
            V+G G  G V      +   +F    A+K   DCP +    + E E   +   CP IVR
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCPKA----RREVELHWRASQCPHIVR 75
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                 +   G +   +++E    G L  R++ + +    E +     +S+ + ++++HS
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 127 KGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
               H D+K +N+L      N   K+ DFG AK+++  GE+                   
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--GEK------------------- 174
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRIGVGD-ELPNIP-GDLSE 240
              Y+  CD+W+LG  +  +  G P +       +   +  RI +G  E PN    ++SE
Sbjct: 175 ---YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231
Query: 241 QGKDFLIKCFLK-DPKRRWTAEMLLNHPFV 269
           + K  LI+  LK +P +R T    +NHP++
Sbjct: 232 EVK-MLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G+FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 100 HKNIINLLG--ACTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 123/266 (46%), Gaps = 32/266 (12%)
Query: 5   RGDVIGHGSFGSV--NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           R  VIG G FG V   + K S    E P  +A+K+      +  T K   + L + GI  
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVP--VAIKTLK----AGYTEKQRVDFLGEAGIMG 101
Query: 63  Q-----IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           Q     I+R  G    ++       ++ EY   G+L D+  ++ +G      +    R +
Sbjct: 102 QFSHHNIIRLEGVISKYKP----MMIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGI 156
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-Y 176
             G++++ +  +VH D+  +N+LV  N   K++DFGL++    D E + +      P+ +
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 177 MSPESVNENEYEAPCDIWALGCAVVE-MASG-KPAW---NHKQDSNVFSLLIRIGVGDEL 231
            +PE+++  ++ +  D+W+ G  + E M  G +P W   NH+       ++  I  G  L
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRL 269
Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRR 257
           P  P D        +++C+ ++  RR
Sbjct: 270 PT-PMDCPSAIYQLMMQCWQQERARR 294

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 102/199 (51%), Gaps = 7/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G FG V+L      +     ++AVK+  ADC P   +   ++  + +      I++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G     ++GE+   L++EY   GSL D + + + G  Q   +  + + + +G+ ++HS+
Sbjct: 82  KGC--CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ---LLLFAQQICEGMAYLHSQ 136
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H ++  +NVL+ ++   KI DFGLAK      E  +  E   +P++  +PE + E +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 82  NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV 141
           +L+LE  + G L DR+ ++  G   E D     + +L+ + ++H  G VH D+K +N+L 
Sbjct: 124 SLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLY 181
Query: 142 FD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGC 198
                +   KIADFGL+K    + +      C GTP Y +PE +    Y    D+W++G 
Sbjct: 182 ATPAPDAPLKIADFGLSK--IVEHQVLMKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGI 238
Query: 199 AVVEMASG-KPAWNHKQDSNVFSLLIRIGVGDELPNIP---GDLSEQGKDFLIKCFLKDP 254
               +  G +P ++ + D  +F  ++      E   I     ++S   KD + K  + DP
Sbjct: 239 ITYILLCGFEPFYDERGDQFMFRRILNC----EYYFISPWWDEVSLNAKDLVRKLIVLDP 294
Query: 255 KRRWTAEMLLNHPFVC 270
           K+R T    L HP+V 
Sbjct: 295 KKRLTTFQALQHPWVT 310

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 114/265 (43%), Gaps = 17/265 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CPQI 64
           G+++G G    V+LA+  +   +    +     A  P  S  L+  +EA +   +  P I
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP--SFYLRFRREAQNAAALNHPAI 74
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V  +    +         +++EY    +L D V  +  G +             + L   
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFS 132
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER-SQSFECRGTPLYMSPESVN 183
           H  G +H D+K  N+++   +  K+ DFG+A+  +  G   +Q+    GT  Y+SPE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG----DLS 239
            +  +A  D+++LGC + E+ +G+P +      +V    +R     E P  P      LS
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-----EDPIPPSARHEGLS 247
Query: 240 EQGKDFLIKCFLKDPKRRW--TAEM 262
                 ++K   K+P+ R+   AEM
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 27  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----GKAFKNRELQIMRKLDHC-NIVR 77
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S+ C  +  Y +PE 
Sbjct: 138 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSYIC--SRYYRAPEL 193
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 13/190 (6%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           +++EYAS G L +R+   N GR  E + + + + ++ G+ + H+    H D+KL+N L+ 
Sbjct: 92  IVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL- 148
Query: 143 DNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAP-CDIWALGC 198
           D   A   KI  FG +K S      SQ     GTP Y++PE + + EY+    D+W+ G 
Sbjct: 149 DGSPAPRLKICAFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGV 205
Query: 199 AVVEMASGKPAWNHKQDSNVFSLLIR--IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
            +  M  G   +   ++   F   I   + V   +P+    +S + +  + + F+ DP +
Sbjct: 206 TLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDY-VHISPECRHLISRIFVADPAK 264
Query: 257 RWTAEMLLNH 266
           R +   + NH
Sbjct: 265 RISIPEIRNH 274

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 27  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----GKAFKNRELQIMRKLDHC-NIVR 77
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S+ C  +  Y +PE 
Sbjct: 138 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSYIC--SRYYRAPEL 193
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 122/261 (46%), Gaps = 26/261 (9%)
Query: 9   IGHGSFGSV-----NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +G G FG V     N +    V +  P  M+V++  +      TL+++K           
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDK----------- 69
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +VR     Y+    E    ++ EY ++GSL D +K    G++    +  ++  + +G+ +
Sbjct: 70  LVRL----YAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 125
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           I  K ++H D++  NVLV ++   KIADFGLA+    D E +     +    + +PE++N
Sbjct: 126 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAIN 184
Query: 184 ENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              +    D+W+ G  + E+ + GK  +  + +++V + L +      + N P +L    
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELY--- 241
Query: 243 KDFLIKCFLKDPKRRWTAEML 263
            D +  C+ +  + R T + L
Sbjct: 242 -DIMKMCWKEKAEERPTFDYL 261

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 82/190 (43%), Gaps = 30/190 (15%)
Query: 109 DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
           +VK +   +L+GL + H +  +H D+K QN+L+ +  E K+ADFGLA+  S     ++++
Sbjct: 101 NVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTY 157
Query: 169 ECRGTPLYMSPESV--NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG 226
           +     L+  P  +     +Y    D+W +GC   EMA+G+P +           + RI 
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217
Query: 227 VGDELPNIPGDLSEQ-------------------------GKDFLIKCFLKDPKRRWTAE 261
                   PG LS +                         G D L K    + + R +AE
Sbjct: 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAE 277
Query: 262 MLLNHPFVCA 271
             + HPF  +
Sbjct: 278 DAMKHPFFLS 287

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G+FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 100 HKNIIHLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 18/276 (6%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           +VIG G F  V      +   +F   ++ V      P  S      + ++  +   P IV
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLA-DRVKKQNNGRL-QESDVKRYTRSMLKGLRH 123
               + YS    +    ++ E+     L  + VK+ + G +  E+    Y R +L+ LR+
Sbjct: 90  ELL-ETYS---SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECR-GTPLYMSP 179
            H    +H D+K   VL+   + +   K+  FG+A +    GE       R GTP +M+P
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL---GESGLVAGGRVGTPHFMAP 202
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASG-KPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E V    Y  P D+W  G  +  + SG  P +  K+   +F  +I+ G     P     +
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIK-GKYKMNPRQWSHI 259
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
           SE  KD + +  + DP  R T    LNHP++   D+
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G+FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 100 HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 18/276 (6%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           +VIG G F  V      +   +F   ++ V      P  S      + ++  +   P IV
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLA-DRVKKQNNGRL-QESDVKRYTRSMLKGLRH 123
               + YS    +    ++ E+     L  + VK+ + G +  E+    Y R +L+ LR+
Sbjct: 92  ELL-ETYS---SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECR-GTPLYMSP 179
            H    +H D+K   VL+   + +   K+  FG+A +    GE       R GTP +M+P
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL---GESGLVAGGRVGTPHFMAP 204
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASG-KPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E V    Y  P D+W  G  +  + SG  P +  K+   +F  +I+ G     P     +
Sbjct: 205 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIK-GKYKMNPRQWSHI 261
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
           SE  KD + +  + DP  R T    LNHP++   D+
Sbjct: 262 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 297

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 27  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 77
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S+ C  +  Y +PE 
Sbjct: 138 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSYIC--SRYYRAPEL 193
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 18  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 75
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 76  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES-VNENEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE  +    Y
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGXKYY 188
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 248
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 249 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 293

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G+FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 100 HKNIITLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 10/170 (5%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L E   + Y + ++KG+ ++H +  +H DIK  N+LV ++   KIADFG++  +   G  
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--NEFKGSD 191
Query: 165 SQSFECRGTPLYMSPESVNENE---YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSL 221
           +      GTP +M+PES++E          D+WA+G  +     G+  +    D  +  L
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF---MDERIMCL 248
Query: 222 LIRI-GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
             +I     E P+ P D++E  KD + +   K+P+ R     +  HP+V 
Sbjct: 249 HSKIKSQALEFPDQP-DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 114/269 (42%), Gaps = 30/269 (11%)
Query: 7   DVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVT----LKNEKEALDQIGI 60
           + IG GS+G V +A  K +++          ++    P   V      K E E +  +  
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIR---------RAAKKIPKYFVEDVDRFKQEIEIMKSLD- 64
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I+R +    +FE     Y L++E  + G L +RV  +   R  ESD  R  + +L  
Sbjct: 65  HPNIIRLYE---TFEDNTDIY-LVMELCTGGELFERVVHKRVFR--ESDAARIMKDVLSA 118
Query: 121 LRHIHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + + H     H D+K +N L      +   K+ DFGLA +              GTP Y+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYV 175
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           SP+ V E  Y   CD W+ G  +  +  G P ++   D  V  L IR G          +
Sbjct: 176 SPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM-LKIREGTFTFPEKDWLN 233
Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           +S Q +  + +   K PK+R T+   L H
Sbjct: 234 VSPQAESLIRRLLTKSPKQRITSLQALEH 262

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 130/311 (41%), Gaps = 64/311 (20%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-----ALDQIGICP- 62
           IG G+FG V  A+  K   +    +A+K         V ++NEKE     AL +I I   
Sbjct: 26  IGQGTFGEVFKARHRKTGQK----VALKK--------VLMENEKEGFPITALREIKILQL 73
Query: 63  ----------QIVRCFGDDYSFEKGERFYNL-LLEYASRGSLADRVKKQNNGRLQESDVK 111
                     +I R     Y+  KG  +      E+   G L++ + K        S++K
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIK 128
Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFEC 170
           R  + +L GL +IH    +H D+K  NVL+  +   K+ADFGLA+  S     +   +  
Sbjct: 129 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 171 RGTPLYMSPES--VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI--G 226
           R   L+  P    + E +Y  P D+W  GC + EM +  P      + +  +L+ ++   
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 248
Query: 227 VGDEL-PNIPG-DLSEQ-----------------------GKDFLIKCFLKDPKRRWTAE 261
           +  E+ PN+   +L E+                         D + K  + DP +R  ++
Sbjct: 249 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 308
Query: 262 MLLNHPFVCAD 272
             LNH F  +D
Sbjct: 309 DALNHDFFWSD 319

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 11  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 69  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES-VNENEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE  +    Y
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGXKYY 181
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G+FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 100 HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +       
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 130/311 (41%), Gaps = 64/311 (20%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-----ALDQIGICP- 62
           IG G+FG V  A+  K   +    +A+K         V ++NEKE     AL +I I   
Sbjct: 26  IGQGTFGEVFKARHRKTGQK----VALKK--------VLMENEKEGFPITALREIKILQL 73
Query: 63  ----------QIVRCFGDDYSFEKGERFYNL-LLEYASRGSLADRVKKQNNGRLQESDVK 111
                     +I R     Y+  KG  +      E+   G L++ + K        S++K
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIK 128
Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFEC 170
           R  + +L GL +IH    +H D+K  NVL+  +   K+ADFGLA+  S     +   +  
Sbjct: 129 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 171 RGTPLYMSPES--VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI--G 226
           R   L+  P    + E +Y  P D+W  GC + EM +  P      + +  +L+ ++   
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 248
Query: 227 VGDEL-PNIPG-DLSEQ-----------------------GKDFLIKCFLKDPKRRWTAE 261
           +  E+ PN+   +L E+                         D + K  + DP +R  ++
Sbjct: 249 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 308
Query: 262 MLLNHPFVCAD 272
             LNH F  +D
Sbjct: 309 DALNHDFFWSD 319

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 114/269 (42%), Gaps = 30/269 (11%)
Query: 7   DVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVT----LKNEKEALDQIGI 60
           + IG GS+G V +A  K +++          ++    P   V      K E E +  +  
Sbjct: 32  NTIGRGSWGEVKIAVQKGTRIR---------RAAKKIPKYFVEDVDRFKQEIEIMKSLD- 81
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I+R +    +FE     Y L++E  + G L +RV  +   R  ESD  R  + +L  
Sbjct: 82  HPNIIRLYE---TFEDNTDIY-LVMELCTGGELFERVVHKRVFR--ESDAARIMKDVLSA 135
Query: 121 LRHIHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + + H     H D+K +N L      +   K+ DFGLA +              GTP Y+
Sbjct: 136 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYV 192
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           SP+ V E  Y   CD W+ G  +  +  G P ++   D  V  L IR G          +
Sbjct: 193 SPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM-LKIREGTFTFPEKDWLN 250
Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           +S Q +  + +   K PK+R T+   L H
Sbjct: 251 VSPQAESLIRRLLTKSPKQRITSLQALEH 279

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 102/199 (51%), Gaps = 7/199 (3%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G FG V+L      +     ++AVK+  ADC P   +   ++  + +      I++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G     ++GE+   L++EY   GSL D + + + G  Q   +  + + + +G+ ++H++
Sbjct: 82  KGC--CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ---LLLFAQQICEGMAYLHAQ 136
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNENE 186
            ++H ++  +NVL+ ++   KI DFGLAK      E  +  E   +P++  +PE + E +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 187 YEAPCDIWALGCAVVEMAS 205
           +    D+W+ G  + E+ +
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 130/311 (41%), Gaps = 64/311 (20%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-----ALDQIGICP- 62
           IG G+FG V  A+  K   +    +A+K         V ++NEKE     AL +I I   
Sbjct: 25  IGQGTFGEVFKARHRKTGQK----VALKK--------VLMENEKEGFPITALREIKILQL 72
Query: 63  ----------QIVRCFGDDYSFEKGERFYNL-LLEYASRGSLADRVKKQNNGRLQESDVK 111
                     +I R     Y+  KG  +      E+   G L++ + K        S++K
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIK 127
Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFEC 170
           R  + +L GL +IH    +H D+K  NVL+  +   K+ADFGLA+  S     +   +  
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 171 RGTPLYMSPES--VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI--G 226
           R   L+  P    + E +Y  P D+W  GC + EM +  P      + +  +L+ ++   
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247
Query: 227 VGDEL-PNIPG-DLSEQ-----------------------GKDFLIKCFLKDPKRRWTAE 261
           +  E+ PN+   +L E+                         D + K  + DP +R  ++
Sbjct: 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 307
Query: 262 MLLNHPFVCAD 272
             LNH F  +D
Sbjct: 308 DALNHDFFWSD 318

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
           AD  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 130 ADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFG 189
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 190 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 249
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 250 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 309
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 310 LDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 40  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 90
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S+ C  +  Y +PE 
Sbjct: 151 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSYIC--SRYYRAPEL 206
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 207 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 114/269 (42%), Gaps = 41/269 (15%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 29  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 64
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLADRVK-----------KQNNGRLQESDVKR 112
           + F ++    +  R  N+LL   Y+++  LA   +             +  + +   +  
Sbjct: 65  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLID 124
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
             R   +G+ ++H+K  +H D+K  N+ + +++  KI DFGLA + S      Q  +  G
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 173 TPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVG 228
           + L+M+PE +   + N Y    D++A G  + E+ +G+ P  N      +  ++ R  + 
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +L  +  +  ++ K  + +C  K    R
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDER 273

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 127/279 (45%), Gaps = 28/279 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 87  HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 142
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 143 FKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
           +   R    +M+PE++ +  Y    D+W+ G  + E+ + G   +       +F LL   
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 262
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
              D+  N   +L    +D    C+   P +R T + L+
Sbjct: 263 HRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLV 297

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSS----VTLKNEKEALDQIGICPQI 64
           +G G FG V L +           +AVKS    P S       LK E E L  +     I
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEILRNL-YHENI 85
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V+  G     E G     L++E+   GSL + + K  N ++      +Y   + KG+ ++
Sbjct: 86  VKYKG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYL 142
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVN 183
            S+ +VH D+  +NVLV    + KI DFGL K    D E     + R +P++  +PE + 
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 184 ENEYEAPCDIWALGCAVVEMAS 205
           ++++    D+W+ G  + E+ +
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSS----VTLKNEKEALDQIGICPQI 64
           +G G FG V L +           +AVKS    P S       LK E E L  +     I
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEILRNL-YHENI 73
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V+  G     E G     L++E+   GSL + + K  N ++      +Y   + KG+ ++
Sbjct: 74  VKYKG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYL 130
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVN 183
            S+ +VH D+  +NVLV    + KI DFGL K    D E     + R +P++  +PE + 
Sbjct: 131 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 184 ENEYEAPCDIWALGCAVVEMAS 205
           ++++    D+W+ G  + E+ +
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 81/174 (46%), Gaps = 22/174 (12%)
Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
           K Y ++ML+ +  IH  G VH D+K  N L+ D    K+ DFG+A +   D         
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 171 RGTPLYMSPESVNE-----------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
            G   YM PE++ +           ++     D+W+LGC +  M  GK  +  +Q  N  
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQI 274
Query: 220 SLLIRI---GVGDELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S L  I       E P+IP  DL    +D L  C  +DPK+R +   LL HP+V
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDL----QDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G+FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 100 HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  +IADFGLA+  +      +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 32/225 (14%)
Query: 75  EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDI 134
           +K +R+Y L+ E+    ++ D ++   NG L    V++Y   ++ G+   HS   +H DI
Sbjct: 94  KKKKRWY-LVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150
Query: 135 KLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-SVNENEYEAPCDI 193
           K +N+LV  +   K+ DFG A+  +  GE     +   T  Y +PE  V + +Y    D+
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYD--DEVATRWYRAPELLVGDVKYGKAVDV 208
Query: 194 WALGCAVVEMASGKPAWNHKQD-SNVFSLLIRIG----------------VGDELPNIPG 236
           WA+GC V EM  G+P +    D   ++ +++ +G                 G  LP I  
Sbjct: 209 WAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKE 268
Query: 237 ---------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
                     LSE   D   KC   DP +R     LL+H F   D
Sbjct: 269 REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 32  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 82
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S+ C  +  Y +PE 
Sbjct: 143 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSYIC--SRYYRAPEL 198
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 199 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIG 59
           + +    VIG+GSFG V  AK    S E   L+A+K            KN E + + ++ 
Sbjct: 48  VSYTDTKVIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLD 99
Query: 60  ICPQIVRCFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRS 116
            C  IVR     YS   +K E + NL+L+Y         R   +    L    VK Y   
Sbjct: 100 HC-NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 158
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTP 174
           + + L +IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S+ C  + 
Sbjct: 159 LFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSYIC--SR 214
Query: 175 LYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAW 210
            Y +PE +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 215 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV-- 65
           VIG+GSFG V  AK  + S E    +A+K            KN +  + +I   P +V  
Sbjct: 47  VIGNGSFGVVFQAKLVE-SDE----VAIKKVLQ----DKRFKNRELQIMRIVKHPNVVDL 97
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           + F      +K E F NL+LEY       A R   +    +    +K Y   +L+ L +I
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 125 HSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV- 182
           HS G  H DIK QN+L+   +   K+ DFG A K    GE + S  C  +  Y +PE + 
Sbjct: 158 HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA-KILIAGEPNVSXIC--SRYYRAPELIF 214
Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAW 210
               Y    DIW+ GC + E+  G+P +
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQPLF 242

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIG 59
           + +    VIG+GSFG V  AK    S E   L+A+K            KN E + + ++ 
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLD 105
Query: 60  ICPQIVRCFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRS 116
            C  IVR     YS   +K E + NL+L+Y         R   +    L    VK Y   
Sbjct: 106 HC-NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTP 174
           + + L +IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S+ C  + 
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSYIC--SR 220
Query: 175 LYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAW 210
            Y +PE +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 127/279 (45%), Gaps = 28/279 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 89  HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 144
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 145 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
           +   R    +M+PE++ +  Y    D+W+ G  + E+ + G   +       +F LL   
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 264
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
              D+  N   +L    +D    C+   P +R T + L+
Sbjct: 265 HRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLV 299

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 127/279 (45%), Gaps = 28/279 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 92  HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 147
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 148 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
           +   R    +M+PE++ +  Y    D+W+ G  + E+ + G   +       +F LL   
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 267
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
              D+  N   +L    +D    C+   P +R T + L+
Sbjct: 268 HRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLV 302

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 11  IGEGTYGVVYKAR-NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 69  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE +     Y
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 181
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 10  IGEGTYGVVYKAR-NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 67
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 68  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE +     Y
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 180
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 113/269 (42%), Gaps = 41/269 (15%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 17  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 52
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLADRVK-----------KQNNGRLQESDVKR 112
           + F ++    +  R  N+LL   Y+++  LA   +             +  + +   +  
Sbjct: 53  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLID 112
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
             R   +G+ ++H+K  +H D+K  N+ + +++  KI DFGLA   S      Q  +  G
Sbjct: 113 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSG 172
Query: 173 TPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVG 228
           + L+M+PE +   + N Y    D++A G  + E+ +G+ P  N      +  ++ R  + 
Sbjct: 173 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 232
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +L  +  +  ++ K  + +C  K    R
Sbjct: 233 PDLSKVRSNCPKRMKRLMAECLKKKRDER 261

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 123/261 (47%), Gaps = 26/261 (9%)
Query: 9   IGHGSFGSV-----NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +G G FG V     N +    V +  P  M+V++  +      TL+++K           
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDK----------- 68
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +VR +       K E  Y ++ E+ ++GSL D +K    G++    +  ++  + +G+ +
Sbjct: 69  LVRLYA---VVTKEEPIY-IITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 124
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           I  K ++H D++  NVLV ++   KIADFGLA+    D E +     +    + +PE++N
Sbjct: 125 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 184 ENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              +    ++W+ G  + E+ + GK  +  + +++V S L +      + N P +L    
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELY--- 240
Query: 243 KDFLIKCFLKDPKRRWTAEML 263
            D +  C+ +  + R T + L
Sbjct: 241 -DIMKMCWKEKAEERPTFDYL 260

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKXQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 106 VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 156
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S+ C  +  Y +PE 
Sbjct: 217 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSYIC--SRYYRAPEL 272
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 273 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIG 59
           + +    VIG+GSFG V  AK    S E   L+A+K            KN E + + ++ 
Sbjct: 56  VSYTDTKVIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLD 107
Query: 60  ICPQIVRCFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRS 116
            C  IVR     YS   +K E + NL+L+Y         R   +    L    VK Y   
Sbjct: 108 HC-NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 166
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTP 174
           + + L +IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S+ C  + 
Sbjct: 167 LFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSYIC--SR 222
Query: 175 LYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAW 210
            Y +PE +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 223 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 28/205 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFG 171
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 172 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 231
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 232 GKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 291
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFVC 270
           L K    +P +R   E  L HP++ 
Sbjct: 292 LDKMLTFNPHKRIEVEQALAHPYLA 316

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 121/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y +++EY S+GSL D +K +    L+   +      +  G
Sbjct: 72  HEKLVQL----YAVVSEEPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPE 185
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 241
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ KDP+ R T E L
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 11  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L D +       +    +K Y   +L+GL   HS  
Sbjct: 69  DVIHT----ENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K +N+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 181
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIG 59
           + +    VIG+GSFG V  AK    S E   L+A+K            KN E + + ++ 
Sbjct: 58  VSYTDTKVIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLD 109
Query: 60  ICPQIVRCFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRS 116
            C  IVR     YS   +K E + NL+L+Y         R   +    L    VK Y   
Sbjct: 110 HC-NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 168
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTP 174
           + + L +IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S+ C  + 
Sbjct: 169 LFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSYIC--SR 224
Query: 175 LYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAW 210
            Y +PE +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 225 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 11  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 69  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR 123
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE +     Y
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 181
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++EYAS+G+L + ++ +    ++ S D+ R       
Sbjct: 146 HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 121/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y +++EY S+GSL D +K +    L+   +      +  G
Sbjct: 72  HEKLVQL----YAVVSEEPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 241
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ KDP+ R T E L
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 11  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 69  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE +     Y
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 181
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 27  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----GKAFKNRELQIMRKLDHC-NIVR 77
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDV---KRYTRSMLKGL 121
                YS   +K E + NL+L+Y    +   RV +  +   Q   V   K Y   + + L
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP--ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            +IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S  C  +  Y +P
Sbjct: 136 AYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSXIC--SRYYRAP 191
Query: 180 ESV-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           E +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 10  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 67
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 68  DVIHT----ENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE +     Y
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 180
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 18  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 75
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 76  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE +     Y
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 188
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 248
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 249 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 12  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 69
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 70  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE +     Y
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 182
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 10  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 67
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 68  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE +     Y
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 180
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFG 169
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 170 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 229
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 230 GKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 289
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 290 LDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 120/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + +I  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKIR- 71
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 72  HEKLVQL----YAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 241
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ KDP+ R T E L
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 11  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 69  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE +     Y
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 181
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 10  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 67
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 68  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE +     Y
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 180
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 40/210 (19%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA-KIADF 152
            D       G L E   + +   +L+GL++IHS   +H D+K  N+ +   D   KI DF
Sbjct: 106 TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165
Query: 153 GLAK----KSSCDGERSQSFEC---RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
           GLA+      S  G  S+       R   L +SP     N Y    D+WA GC   EM +
Sbjct: 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-----NNYTKAIDMWAAGCIFAEMLT 220
Query: 206 GKPAWN------------------HKQDSNVFSLLIRIGVGDELPN--------IPGDLS 239
           GK  +                   H++D      +I + + +++          +PG +S
Sbjct: 221 GKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-IS 279
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            +  DFL +     P  R TAE  L+HP++
Sbjct: 280 REAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 113/269 (42%), Gaps = 41/269 (15%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 29  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 64
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLADRVK-----------KQNNGRLQESDVKR 112
           + F ++    +  R  N+LL   Y++   LA   +             +  + +   +  
Sbjct: 65  QAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLID 124
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
             R   +G+ ++H+K  +H D+K  N+ + +++  KI DFGLA + S      Q  +  G
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 173 TPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVG 228
           + L+M+PE +   + N Y    D++A G  + E+ +G+ P  N      +  ++ R  + 
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +L  +  +  ++ K  + +C  K    R
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDER 273

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 28  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 78
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S  C  +  Y +PE 
Sbjct: 139 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSXIC--SRYYRAPEL 194
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 195 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 15  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 72
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 73  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+ + E   T  Y +PE +     Y
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAPEILLGCKYY 185
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 245
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 246 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 27  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 77
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S  C  +  Y +PE 
Sbjct: 138 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSXIC--SRYYRAPEL 193
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFG 173
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 234 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 293
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 294 LDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFG 173
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 234 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 293
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 294 LDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           DVIG G+FG V  A+  K      + +                 E E L ++G  P I+ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQ--------------NNGRLQESDVKR 112
             G   + E     Y L +EYA  G+L D ++K                   L    +  
Sbjct: 81  LLG---ACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
           +   + +G+ ++  K F+H D+  +N+LV +N  AKIADFGL++      +++     R 
Sbjct: 137 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG---RL 193
Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKP 208
              +M+ ES+N + Y    D+W+ G  + E+ S  G P
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 231

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFG 169
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 170 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 229
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 230 GKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 289
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 290 LDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFG 169
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 170 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 229
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 230 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 289
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 290 LDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           IG G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 90
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 91  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 141
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT--DDEMTGYVATRW---YRAP 196
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 255
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 287

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 27  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 77
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S  C  +  Y +PE 
Sbjct: 138 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSXIC--SRYYRAPEL 193
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 110/278 (39%), Gaps = 22/278 (7%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEAL---DQIGICPQI 64
           VIG G+F  V + K  +    +   +  K            + E++ L   D+  I  Q+
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT-QL 126
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
              F D       E +  L++EY   G L   + K    R+     + Y   ++  +  +
Sbjct: 127 HFAFQD-------ENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSV 178
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           H  G+VH DIK  N+L+      ++ADFG   K   DG   +S    GTP Y+SPE +  
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQA 237
Query: 185 -------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
                    Y   CD WALG    EM  G+  +     +  +  ++       LP +   
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297
Query: 238 LSEQGKDFLIKCFLKDPKR--RWTAEMLLNHPFVCADD 273
           + E+ +DF+ +       R  R  A     HPF    D
Sbjct: 298 VPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLD 335

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           DVIG G+FG V  A+  K      + +                 E E L ++G  P I+ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQ--------------NNGRLQESDVKR 112
             G   + E     Y L +EYA  G+L D ++K                   L    +  
Sbjct: 91  LLG---ACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
           +   + +G+ ++  K F+H D+  +N+LV +N  AKIADFGL++      +++     R 
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG---RL 203
Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKP 208
              +M+ ES+N + Y    D+W+ G  + E+ S  G P
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G+FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++ YAS+G+L + ++ +    ++ S D+ R       
Sbjct: 100 HKNIINLLGA--CTQDGPLY--VIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 120/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 62
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 63  HEKLVQL----YAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 117
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 118 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 176
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 232
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ KDP+ R T E L
Sbjct: 233 ESLHDLMCQCWRKDPEERPTFEYL 256

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 31  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 81
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S  C  +  Y +PE 
Sbjct: 142 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSXIC--SRYYRAPEL 197
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 198 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 129/311 (41%), Gaps = 64/311 (20%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-----ALDQIGICP- 62
           IG G+FG V  A+  K   +    +A+K         V ++NEKE     AL +I I   
Sbjct: 26  IGQGTFGEVFKARHRKTGQK----VALKK--------VLMENEKEGFPITALREIKILQL 73
Query: 63  ----------QIVRCFGDDYSFEKGERFYNL-LLEYASRGSLADRVKKQNNGRLQESDVK 111
                     +I R     Y+  K   +      E+   G L++ + K        S++K
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIK 128
Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFEC 170
           R  + +L GL +IH    +H D+K  NVL+  +   K+ADFGLA+  S     +   +  
Sbjct: 129 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 171 RGTPLYMSPES--VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI--G 226
           R   L+  P    + E +Y  P D+W  GC + EM +  P      + +  +L+ ++   
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 248
Query: 227 VGDEL-PNIPG-DLSEQ-----------------------GKDFLIKCFLKDPKRRWTAE 261
           +  E+ PN+   +L E+                         D + K  + DP +R  ++
Sbjct: 249 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 308
Query: 262 MLLNHPFVCAD 272
             LNH F  +D
Sbjct: 309 DALNHDFFWSD 319

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 120/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 60
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 61  HEKLVQL----YAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 115
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 116 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 174
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 230
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ KDP+ R T E L
Sbjct: 231 ESLHDLMCQCWRKDPEERPTFEYL 254

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 12  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 69
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 70  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 182
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 11  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 69  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 181
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 39  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 89
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S  C  +  Y +PE 
Sbjct: 150 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSXIC--SRYYRAPEL 205
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 14  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 71
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 72  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 184
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 13  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 70
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 71  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 183
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 243
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 14  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 71
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 72  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 184
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 14  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 71
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 72  DVIHT----ENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 184
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 35  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 85
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S  C  +  Y +PE 
Sbjct: 146 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSXIC--SRYYRAPEL 201
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 202 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 87
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 88  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 138
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHT--DDEMTGYVATRW---YRAP 193
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 252
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 284

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 11  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 69  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 181
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 10  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 67
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 68  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 180
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 113/260 (43%), Gaps = 33/260 (12%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV               K+S  F SL+  +           LK+E    + IG
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE----NVIG 91
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E     Y  L+       L + VK Q    L +  V+     +L+
Sbjct: 92  L----LDVFTPATSIEDFSEVY--LVTTLMGADLNNIVKSQA---LSDEHVQFLVYQLLR 142
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS G +H D+K  NV V ++ E +I DFGLA+++  D E +     R    Y +P
Sbjct: 143 GLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQA--DEEMTGYVATR---WYRAP 197
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG--VGDELPNIPG 236
           E  +N   Y    DIW++GC + E+  GK  +     S+    L RI   VG   P +  
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLQGKALF---PGSDYIDQLKRIMEVVGTPSPEVLA 254
Query: 237 DLSEQGKDFLIKCFLKDPKR 256
            +S +     I+     P++
Sbjct: 255 KISSEHARTYIQSLPPMPQK 274

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 11  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 69  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 181
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 91
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 92  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 142
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHT--DDEMTGYVATRW---YRAP 197
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 256
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 11  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 69  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 181
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 14  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 71
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 72  DVIHT----ENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 184
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 13  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 70
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 71  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 183
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 243
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 10  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 67
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 68  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 180
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 46  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 96
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S  C  +  Y +PE 
Sbjct: 157 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSXIC--SRYYRAPEL 212
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 213 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 15  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 72
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 73  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 185
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 245
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 246 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 12  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 69
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 70  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K QN+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 182
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 39  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 89
Query: 67  CFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
                YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S  C  +  Y +PE 
Sbjct: 150 IHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSXIC--SRYYRAPEL 205
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 27/191 (14%)
Query: 103 GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG 162
           G L+    K +   +L G+ + H +  +H D+K QN+L+    E KIADFGLA+      
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153
Query: 163 ERSQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSL 221
            R  + E   T  Y +P+ +    +Y    DIW++GC   EM +G P +    +++    
Sbjct: 154 VRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 222 LIRI-GVGD--------ELPN----------IPGD-----LSEQGKDFLIKCFLKDPKRR 257
           + RI G  +        ELP           +P +     L E G D L K    DP +R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 258 WTAEMLLNHPF 268
            TA+  L H +
Sbjct: 273 ITAKQALEHAY 283

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 27/191 (14%)
Query: 103 GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG 162
           G L+    K +   +L G+ + H +  +H D+K QN+L+    E KIADFGLA+      
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153
Query: 163 ERSQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSL 221
            R  + E   T  Y +P+ +    +Y    DIW++GC   EM +G P +    +++    
Sbjct: 154 VRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMR 212
Query: 222 LIRI-GVGD--------ELPN----------IPGD-----LSEQGKDFLIKCFLKDPKRR 257
           + RI G  +        ELP           +P +     L E G D L K    DP +R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 258 WTAEMLLNHPF 268
            TA+  L H +
Sbjct: 273 ITAKQALEHAY 283

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVKSCAD--CPPSSVTLKNEKEALDQIGI 60
           G  +G G+FG V +A+A  +  + P     +AVK   D         L +E E +  IG 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES-DVKRY------ 113
              I+   G     + G  +  +++ YAS+G+L + ++ +    ++ S D+ R       
Sbjct: 100 HKNIINLLGA--CTQDGPLY--VIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 114 -------TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
                  T  + +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +      +
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKXQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 120/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 72  HEKLVQL----YAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 241
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ KDP+ R T E L
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 90
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 91  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 141
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT--DDEMTGYVATRW---YRAP 196
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 255
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 287

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 27/191 (14%)
Query: 103 GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG 162
           G L+    K +   +L G+ + H +  +H D+K QN+L+    E KIADFGLA+      
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153
Query: 163 ERSQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSL 221
            R  + E   T  Y +P+ +    +Y    DIW++GC   EM +G P +    +++    
Sbjct: 154 VRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 222 LIRI-GVGD--------ELPN----------IPGD-----LSEQGKDFLIKCFLKDPKRR 257
           + RI G  +        ELP           +P +     L E G D L K    DP +R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 258 WTAEMLLNHPF 268
            TA+  L H +
Sbjct: 273 ITAKQALEHAY 283

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 24/271 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G G FG V   +       +      K             NEK+ L+++    + V  
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--SRFVVS 248
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y++E  +    L+L   + G L   +         E+    Y   +  GL  +H +
Sbjct: 249 LA--YAYETKDAL-CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR-GTPLYMSPESVNENE 186
             V+ D+K +N+L+ D+   +I+D GLA          Q+ + R GT  YM+PE V    
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVP----EGQTIKGRVGTVGYMAPEVVKNER 361
Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE----QG 242
           Y    D WALGC + EM +G+  +  ++       + R  V   +  +P + SE    Q 
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKK-----IKREEVERLVKEVPEEYSERFSPQA 416
Query: 243 KDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
           +    +   KDP  R      +A  +  HP 
Sbjct: 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 96
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 97  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 147
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHT--DDEMTGYVATRW---YRAP 202
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 261
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 293

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K   + +L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 130 TDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFG 189
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  + + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 190 LARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 249
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPGDLS-----------EQGKDF 245
            K    Q +++  +L           I +   + L ++P                +  D 
Sbjct: 250 GKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDL 309
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L +    +P +R T E  L HP++
Sbjct: 310 LDRMLTFNPNKRITVEEALAHPYL 333

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 12  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 69
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+ S   L   +       +    +K Y   +L+GL   HS  
Sbjct: 70  DVIHT----ENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K +N+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 182
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 169
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 170 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 229
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 230 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 289
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 290 LDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 14  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 71
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+ S   L   +       +    +K Y   +L+GL   HS  
Sbjct: 72  DVIHT----ENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K +N+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 184
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 120/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 72  HEKLVQL----YAVVSEEPIY-IVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 241
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ KDP+ R T E L
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 130 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 189
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 190 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 249
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 250 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 309
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 310 LDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 108 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 167
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 168 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 227
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 228 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 287
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 288 LDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 115 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 174
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 175 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 234
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 235 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 294
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 295 LDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 116 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 175
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 176 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 235
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 236 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 295
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 296 LDKMLTFNPHKRIEVEQALAHPYL 319

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 107 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 166
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 167 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 226
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 227 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 286
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 287 LDKMLTFNPHKRIEVEQALAHPYL 310

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 234 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 293
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 294 LDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 118 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 177
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 178 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 237
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 238 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 297
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 298 LDKMLTFNPHKRIEVEQALAHPYL 321

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 169
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 170 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 229
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 230 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 289
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 290 LDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 28/205 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 171
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 172 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 231
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 232 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 291
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFVC 270
           L K    +P +R   E  L HP++ 
Sbjct: 292 LDKMLTFNPHKRIEVEQALAHPYLA 316

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 171
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 172 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 231
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 232 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 291
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 292 LDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 108 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 167
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 168 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 227
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 228 GKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 287
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 288 LDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 234 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 293
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 294 LDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 64
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 65  HEKLVQL----YAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 119
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 120 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 178
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 234
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ K+P+ R T E L
Sbjct: 235 ESLHDLMCQCWRKEPEERPTFEYL 258

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 174 LARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 234 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 293
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 294 LDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 94  ADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG 153
            D  K      L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFG
Sbjct: 115 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 174
Query: 154 LAKKSSCDGERSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           LA+ +  D + +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P + 
Sbjct: 175 LARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 234
Query: 212 HK----QDSNVFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDF 245
            K    Q +++  +L           I +   + L ++P            +   +  D 
Sbjct: 235 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 294
Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    +P +R   E  L HP++
Sbjct: 295 LDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKSQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGL + +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 24/271 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G G FG V   +       +      K             NEK+ L+++    + V  
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--SRFVVS 248
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
               Y++E  +    L+L   + G L   +         E+    Y   +  GL  +H +
Sbjct: 249 LA--YAYETKDAL-CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR-GTPLYMSPESVNENE 186
             V+ D+K +N+L+ D+   +I+D GLA          Q+ + R GT  YM+PE V    
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVP----EGQTIKGRVGTVGYMAPEVVKNER 361
Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE----QG 242
           Y    D WALGC + EM +G+  +  ++       + R  V   +  +P + SE    Q 
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKK-----IKREEVERLVKEVPEEYSERFSPQA 416
Query: 243 KDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
           +    +   KDP  R      +A  +  HP 
Sbjct: 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIG 59
           + +    VIG+GSFG V  AK    S E   L+A+K            KN E + + ++ 
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLD 105
Query: 60  ICPQIVRCFGDDYSF--EKGERFYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRS 116
            C  IVR     YS   +K E + NL+L+Y         R   +    L    VK Y   
Sbjct: 106 HC-NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTP 174
           + + L +IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S  C  + 
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSXIC--SR 220
Query: 175 LYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAW 210
            Y +PE +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y +++EY S+G L D +K +    L+   +      +  G
Sbjct: 72  HEKLVQL----YAVVSEEPIY-IVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 241
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ KDP+ R T E L
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGXVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 106/242 (43%), Gaps = 28/242 (11%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSV--TLKNEKEALDQIGICP 62
           G V+G G+FG V  A A  +S    S+ +AVK   +   SS    L +E + + Q+G   
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 63  QIVR------------------CFGD--DYSFEKGERFYNLLLEYASRGSLADRVKKQNN 102
            IV                   C+GD  +Y   K E+F    +EY ++  L +   +++ 
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE---EEDL 166
Query: 103 GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDG 162
             L   D+  +   + KG+  +  K  VH D+  +NVLV      KI DFGLA+    D 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFS 220
                   R    +M+PES+ E  Y    D+W+ G  + E+ S    P      D+N + 
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 286
Query: 221 LL 222
           L+
Sbjct: 287 LI 288

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 83
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 84  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 134
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 135 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 189
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 248
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 249 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 280

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 81
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 82  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 132
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 187
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 246
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 278

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           DVIG G+FG V  A+  K      + +                 E E L ++G  P I+ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESD----VKRYTRSML---- 118
             G   + E     Y L +EYA  G+L D ++K    R+ E+D    +   T S L    
Sbjct: 88  LLG---ACEHRGYLY-LAIEYAPHGNLLDFLRK---SRVLETDPAFAIANSTASTLSSQQ 140
Query: 119 ---------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
                    +G+ ++  K F+H ++  +N+LV +N  AKIADFGL++      +++    
Sbjct: 141 LLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG-- 198
Query: 170 CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKP 208
            R    +M+ ES+N + Y    D+W+ G  + E+ S  G P
Sbjct: 199 -RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 238

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 82
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 83  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 133
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 188
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 247
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 279

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 82
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 83  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 133
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 188
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 247
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 279

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L +  V+     +L+GL++IHS G +H D+K  NV V ++ E +I DFGLA+++  D E 
Sbjct: 128 LSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQA--DEEM 185
Query: 165 SQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI 223
           +     R    Y +PE  +N   Y    DIW++GC + E+  GK  +     S+    L 
Sbjct: 186 TGYVATR---WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF---PGSDYIDQLK 239
Query: 224 RIG--VGDELPNIPGDLSEQGKDFLIKCFLKDPKR 256
           RI   VG   P +   +S +     I+     P++
Sbjct: 240 RIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQK 274

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 72  HEKLVQL----YAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D+   N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 127 MAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 241
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ KDP+ R T E L
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 237
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 238 HEKLVQL----YAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 351
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 407
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ K+P+ R T E L
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYL 431

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 105
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 106 L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 156
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 211
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 270
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 271 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 302

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 90
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 91  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 141
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 196
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 255
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 287

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 81
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 82  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 132
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 187
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 246
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAV 278

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 104
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 105 L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 155
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 210
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 269
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 270 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 301

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 87/182 (47%), Gaps = 6/182 (3%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ EY S+GSL D +K +    L+   +      +  G+ ++    +VH D++  N+LV 
Sbjct: 79  IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 138
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVE 202
           +N   K+ADFGLA+    D E +     +    + +PE+     +    D+W+ G  + E
Sbjct: 139 ENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 197
Query: 203 MAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAE 261
           + + G+  +    +  V   + R   G  +P  P +  E   D + +C+ K+P+ R T E
Sbjct: 198 LTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECPESLHDLMCQCWRKEPEERPTFE 253
Query: 262 ML 263
            L
Sbjct: 254 YL 255

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 237
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 238 HEKLVQL----YAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 351
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 407
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ K+P+ R T E L
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYL 431

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 87
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 88  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 138
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 193
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 252
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 284

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 90
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 91  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 141
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 196
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 255
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 287

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY----RELRLLKHMKHENVIG 97
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 98  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 148
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 203
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 262
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 294

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 87
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 88  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 138
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 193
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 252
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 284

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 84
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 85  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 135
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 136 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 190
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 249
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 250 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 281

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 96
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 97  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 147
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 202
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 261
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 293

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 108
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 109 L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 159
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 214
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 273
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 305

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 13  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 70
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 71  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K +N+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 183
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 243
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 87
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 88  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 138
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 193
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 252
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 284

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 92
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 93  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 143
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 198
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 257
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+  
Sbjct: 12  IGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLL 69
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              ++    E    L+ E+  +  L   +       +    +K Y   +L+GL   HS  
Sbjct: 70  DVIHT----ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEY 187
            +H D+K +N+L+      K+ADFGLA+       R+   E   T  Y +PE +     Y
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVV-TLWYRAPEILLGCKYY 182
Query: 188 EAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDEL------------PNI 234
               DIW+LGC   EM + +  +    +   +F +   +G  DE+            P+ 
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 235 PG-----------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           P             L E G+  L +    DP +R +A+  L HPF
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 104
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 105 L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 155
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 210
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 269
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 270 SSESARNYIQSLAQMPKMNFANVFIGANPLAV 301

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGICPQIVR 66
           VIG+GSFG V  AK    S E   L+A+K            KN E + + ++  C  IVR
Sbjct: 27  VIGNGSFGVVYQAKLCD-SGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHC-NIVR 77
Query: 67  CFGDDYSFEKGER----FYNLLLEYASRGSL-ADRVKKQNNGRLQESDVKRYTRSMLKGL 121
                + +  GE+    + NL+L+Y         R   +    L    VK Y   + + L
Sbjct: 78  L--RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            +IHS G  H DIK QN+L+ D D A  K+ DFG AK+    GE + S  C  +  Y +P
Sbjct: 136 AYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQ-LVRGEPNVSXIC--SRYYRAP 191
Query: 180 ESV-NENEYEAPCDIWALGCAVVEMASGKPAW 210
           E +    +Y +  D+W+ GC + E+  G+P +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 97
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 98  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 148
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 203
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 262
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 294

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP---SLMAVKSC-ADCPPSSVT-LKNEKEALDQIGI 60
           G  +G G+FG V LA+A  +  + P   + +AVK   +D     ++ L +E E +  IG 
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN--------------NGRLQ 106
              I+   G     + G  +  +++EYAS+G+L + ++ +                 +L 
Sbjct: 93  HKNIINLLG--ACTQDGPLY--VIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLS 148
Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 97
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 98  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 148
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 203
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 262
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 294

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 121/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 68
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY ++GSL D +K +    L+   +   +  +  G
Sbjct: 69  HEKLVQL----YAVVSEEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 124 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 182
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 238
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ K+P+ R T E L
Sbjct: 239 ESLHDLMCQCWRKEPEERPTFEYL 262

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 105
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 106 L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 156
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 211
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 270
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAV 302

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 95
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 96  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 146
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 147 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 201
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 260
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 261 SSESARNYIQSLAQMPKMNFANVFIGANPLAV 292

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 28/194 (14%)
Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE 163
            L    +  +   +L+GL++IHS   +H D+K  N+L+    + KI DFGLA+ +  D +
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 164 RSQSF-ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHK----QDSN 217
            +    E   T  Y +PE  +N   Y    DIW++GC + EM S +P +  K    Q ++
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 243
Query: 218 VFSLL-----------IRIGVGDELPNIPG-----------DLSEQGKDFLIKCFLKDPK 255
           +  +L           I +   + L ++P            +   +  D L K    +P 
Sbjct: 244 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 303
Query: 256 RRWTAEMLLNHPFV 269
           +R   E  L HP++
Sbjct: 304 KRIEVEQALAHPYL 317

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 91
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 92  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 142
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 197
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 256
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 288

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAV 282

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 115/257 (44%), Gaps = 29/257 (11%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 91
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 92  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 142
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 197
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 256
Query: 239 SEQGKDFLIKCFLKDPK 255
           S +     I+   + PK
Sbjct: 257 SSESARNYIQSLTQMPK 273

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 125/296 (42%), Gaps = 54/296 (18%)
Query: 9   IGHGSFGSV--------NLAKA-SKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         L  A  K+S  F S++  K         + L    +  + IG
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 114
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 115 L----LDVFTPATSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 165
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 166 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 220
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI------------- 225
           E  +N   Y    DIW++GC + E+ +G+  +      N    ++R+             
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMP 280
Query: 226 -----GVGDELPNIP----GDL----SEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                   + LP +P     D+    +    D L K  + D  +R TA   L HP+
Sbjct: 281 SHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPY 336

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 128/279 (45%), Gaps = 28/279 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP---SLMAVKSC-ADCPPSSVT-LKNEKEALDQIGI 60
           G  +G G+FG V LA+A  +  + P   + +AVK   +D     ++ L +E E +  IG 
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN--------------NGRLQ 106
              I+   G     + G  +  +++EYAS+G+L + ++ +                 +L 
Sbjct: 93  HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 148
Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
           +   R    +M+PE++ +  Y    D+W+ G  + E+ + G   +       +F LL   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 268
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
              D+  N   +L    +D    C+   P +R T + L+
Sbjct: 269 HRMDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLV 303

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 84/194 (43%), Gaps = 30/194 (15%)
Query: 102 NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD 161
           NG L    VK +   +LKGL   HS+  +H D+K QN+L+  N E K+A+FGLA+     
Sbjct: 95  NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF--- 151
Query: 162 GERSQSFECRGTPLYMSPESV--NENEYEAPCDIWALGCAVVEMA-SGKPAW-NHKQDSN 217
           G   + +      L+  P  V      Y    D+W+ GC   E+A +G+P +  +  D  
Sbjct: 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211
Query: 218 VFSLLIRIGVGDE-----------------------LPNIPGDLSEQGKDFLIKCFLKDP 254
           +  +   +G   E                       L N+   L+  G+D L      +P
Sbjct: 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271
Query: 255 KRRWTAEMLLNHPF 268
            +R +AE  L HP+
Sbjct: 272 VQRISAEEALQHPY 285

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 86/190 (45%), Gaps = 29/190 (15%)
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF- 168
           V+ +   +L+GL+++HS   +H D+K  N+LV +N E KI DFG+A+         Q F 
Sbjct: 161 VRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 220
Query: 169 -ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI- 225
            E   T  Y +PE  ++ +EY    D+W++GC   EM + +  +  K   +   L++ + 
Sbjct: 221 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 280
Query: 226 ---------GVGDE--------LP---NIPGDLSEQGKD-----FLIKCFLKDPKRRWTA 260
                     VG E        LP    +P +    G D      L +    +P  R +A
Sbjct: 281 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA 340
Query: 261 EMLLNHPFVC 270
              L HPF+ 
Sbjct: 341 AAALRHPFLA 350

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 29/195 (14%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L    V+ +   +L+GL+++HS   +H D+K  N+LV +N E KI DFG+A+        
Sbjct: 155 LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE 214
Query: 165 SQSF--ECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSL 221
            Q F  E   T  Y +PE  ++ +EY    D+W++GC   EM + +  +  K   +   L
Sbjct: 215 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL 274
Query: 222 LIRI----------GVGDE--------LP---NIPGDLSEQGKD-----FLIKCFLKDPK 255
           ++ +           VG E        LP    +P +    G D      L +    +P 
Sbjct: 275 IMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS 334
Query: 256 RRWTAEMLLNHPFVC 270
            R +A   L HPF+ 
Sbjct: 335 ARISAAAALRHPFLA 349

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 81
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 82  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 132
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMAGFVATRW---YRAP 187
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 246
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAV 278

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 22/269 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LD 56
           ++  G ++G G FGSV  A+  +    F  +      AD   SS   +  +EA      D
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 57  QIGICPQIVRCFGDDYSFEKGERFY--NLLLEYASRGSL-----ADRVKKQNNGRLQESD 109
                P + +  G         R     ++L +   G L     A R+  +N   L    
Sbjct: 84  H----PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLPLQT 138
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + R+   +  G+ ++ S+ F+H D+  +N ++ ++    +ADFGL++K        Q   
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 170 CRGTPLYMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVG 228
            +    +++ ES+ +N Y    D+WA G  + E M  G+  +   +++ +++ LI    G
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG---G 255
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           + L   P +  E+  D + +C+  DPK+R
Sbjct: 256 NRLKQ-PPECMEEVYDLMYQCWSADPKQR 283

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 115/257 (44%), Gaps = 29/257 (11%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 91
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 92  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 142
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 197
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 256
Query: 239 SEQGKDFLIKCFLKDPK 255
           S +     I+   + PK
Sbjct: 257 SSESARNYIQSLAQMPK 273

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 128/279 (45%), Gaps = 28/279 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP---SLMAVKSC-ADCPPSSVT-LKNEKEALDQIGI 60
           G  +G G+FG V LA+A  +  + P   + +AVK   +D     ++ L +E E +  IG 
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN--------------NGRLQ 106
              I+   G     + G  +  +++EYAS+G+L + ++ +                 +L 
Sbjct: 78  HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 133
Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
           +   R    +M+PE++ +  Y    D+W+ G  + E+ + G   +       +F LL   
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
              D+  N   +L    +D    C+   P +R T + L+
Sbjct: 254 HRMDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLV 288

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 121/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 68
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY ++GSL D +K +    L+   +   +  +  G
Sbjct: 69  HEKLVQL----YAVVSEEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 124 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEWTARQGAKFPIKWTAPE 182
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 238
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ K+P+ R T E L
Sbjct: 239 ESLHDLMCQCWRKEPEERPTFEYL 262

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMAGFVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 28/279 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP---SLMAVKSC-ADCPPSSVT-LKNEKEALDQIGI 60
           G  +G G+FG V LA+A  +  + P   + +AVK   +D     ++ L +E E +  IG 
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES------------ 108
              I+   G     + G  +  +++EYAS+G+L + ++ +    L+ S            
Sbjct: 85  HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 140
Query: 109 --DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 141 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
           +   R    +M+PE++ +  Y    D+W+ G  + E+ + G   +       +F LL   
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 260
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
              D+  N   +L    +D    C+   P +R T + L+
Sbjct: 261 HRMDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLV 295

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 28/279 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP---SLMAVKSC-ADCPPSSVT-LKNEKEALDQIGI 60
           G  +G G+FG V LA+A  +  + P   + +AVK   +D     ++ L +E E +  IG 
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES------------ 108
              I+   G     + G  +  +++EYAS+G+L + ++ +    L+ S            
Sbjct: 82  HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 137
Query: 109 --DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 138 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
           +   R    +M+PE++ +  Y    D+W+ G  + E+ + G   +       +F LL   
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 257
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
              D+  N   +L    +D    C+   P +R T + L+
Sbjct: 258 HRMDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLV 292

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 119/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+G L D +K +    L+   +      +  G
Sbjct: 72  HEKLVQL----YAVVSEEPIY-IVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 127 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 185
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 241
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ KDP+ R T E L
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 320
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 321 HEKLVQL----YAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 434
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 490
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ K+P+ R T E L
Sbjct: 491 ESLHDLMCQCWRKEPEERPTFEYL 514

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 105
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 106 L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 156
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E       R    Y +P
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMXGXVATRW---YRAP 211
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 270
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAV 302

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP---SLMAVKSC-ADCPPSSVT-LKNEKEALDQIGI 60
           G  +G G+FG V LA+A  +  + P   + +AVK   +D     ++ L +E E +  IG 
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES------------ 108
              I+   G     + G  +  +++EYAS+G+L + ++ +    L+ S            
Sbjct: 93  HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 148
Query: 109 --DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP---SLMAVKSC-ADCPPSSVT-LKNEKEALDQIGI 60
           G  +G G+FG V LA+A  +  + P   + +AVK   +D     ++ L +E E +  IG 
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES------------ 108
              I+   G     + G  +  +++EYAS+G+L + ++ +    L+ S            
Sbjct: 93  HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLS 148
Query: 109 --DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 149 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 28/279 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP---SLMAVKSC-ADCPPSSVT-LKNEKEALDQIGI 60
           G  +G G+FG V LA+A  +  + P   + +AVK   +D     ++ L +E E +  IG 
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES------------ 108
              I+   G     + G  +  +++EYAS+G+L + ++ +    L+ S            
Sbjct: 86  HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 141
Query: 109 --DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 142 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
           +   R    +M+PE++ +  Y    D+W+ G  + E+ + G   +       +F LL   
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 261
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
              D+  N   +L    +D    C+   P +R T + L+
Sbjct: 262 HRMDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLV 296

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR- 237
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 238 HEKLVQL----YAVVSEEPIY-IVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 351
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 407
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ K+P+ R T E L
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYL 431

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMAGFVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAV 282

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 121/261 (46%), Gaps = 27/261 (10%)
Query: 9   IGHGSFGSVNLAKASK-----VSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +G G FG V +A  +K     V +  P  M+V++         TL+++K           
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDK----------- 71
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+     ++    E  Y ++ E+ ++GSL D +K     +     +  ++  + +G+  
Sbjct: 72  LVKL----HAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 126
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           I  + ++H D++  N+LV  +   KIADFGLA+    D E +     +    + +PE++N
Sbjct: 127 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAIN 185
Query: 184 ENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              +    D+W+ G  ++E+ + G+  +    +  V   L R   G  +P  P +  E+ 
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---GYRMPR-PENCPEEL 241
Query: 243 KDFLIKCFLKDPKRRWTAEML 263
            + +++C+   P+ R T E +
Sbjct: 242 YNIMMRCWKNRPEERPTFEYI 262

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA--LDQIGICPQ 63
           G+ IG G+FG V   +    ++    L+AVKSC +  P  +  K  +EA  L Q    P 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNT----LVAVKSCRETLPPDLKAKFLQEARILKQYS-HPN 173
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR  G      + +  Y +++E    G     ++ +   RL+   + +       G+ +
Sbjct: 174 IVRLIG---VCTQKQPIY-IVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEY 228
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESV 182
           + SK  +H D+  +N LV + +  KI+DFG++++ + DG  + S   R  P+ + +PE++
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEAL 287
Query: 183 NENEYEAPCDIWALGCAVVEMAS 205
           N   Y +  D+W+ G  + E  S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 30/194 (15%)
Query: 102 NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD 161
           NG L    VK +   +LKGL   HS+  +H D+K QN+L+  N E K+ADFGLA+     
Sbjct: 95  NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAF--- 151
Query: 162 GERSQSFECRGTPLYMSPESV--NENEYEAPCDIWALGCAVVEMA-SGKPAW-NHKQDSN 217
           G   + +      L+  P  V      Y    D+W+ GC   E+A + +P +  +  D  
Sbjct: 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQ 211
Query: 218 VFSLLIRIGVGDE-----------------------LPNIPGDLSEQGKDFLIKCFLKDP 254
           +  +   +G   E                       L N+   L+  G+D L      +P
Sbjct: 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271
Query: 255 KRRWTAEMLLNHPF 268
            +R +AE  L HP+
Sbjct: 272 VQRISAEEALQHPY 285

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP---SLMAVKSC-ADCPPSSVT-LKNEKEALDQIGI 60
           G  +G G+FG V LA+A  +  + P   + +AVK   +D     ++ L +E E +  IG 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQES------------ 108
              I+   G     + G  +  +++EYAS+G+L + ++ +    L+ S            
Sbjct: 134 HKNIINLLGA--CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 109 --DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
           +   R    +M+PE++ +  Y    D+W+ G  + E+
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 108
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 109 L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 159
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E       R    Y +P
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMXGYVATRW---YRAP 214
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 273
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 305

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA--LDQIGICPQ 63
           G+ IG G+FG V   +    ++    L+AVKSC +  P  +  K  +EA  L Q    P 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNT----LVAVKSCRETLPPDLKAKFLQEARILKQYS-HPN 173
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR  G      + +  Y +++E    G     ++ +   RL+   + +       G+ +
Sbjct: 174 IVRLIG---VCTQKQPIY-IVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEY 228
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESV 182
           + SK  +H D+  +N LV + +  KI+DFG++++ + DG  + S   R  P+ + +PE++
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVXAASGGLRQVPVKWTAPEAL 287
Query: 183 NENEYEAPCDIWALGCAVVEMAS 205
           N   Y +  D+W+ G  + E  S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 119/264 (45%), Gaps = 18/264 (6%)
Query: 2   EWLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           E LR +V +G G FG V +   +  +      +A+K+      S      E + + ++  
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGNMSPEAFLQEAQVMKKLR- 238
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
             ++V+     Y+    E  Y ++ EY S+GSL D +K +    L+   +      +  G
Sbjct: 239 HEKLVQL----YAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 293
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           + ++    +VH D++  N+LV +N   K+ADFGL +    D E +     +    + +PE
Sbjct: 294 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIE-DNEYTARQGAKFPIKWTAPE 352
Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +     +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECP 408
Query: 240 EQGKDFLIKCFLKDPKRRWTAEML 263
           E   D + +C+ KDP+ R T E L
Sbjct: 409 ESLHDLMCQCWRKDPEERPTFEYL 432

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 121/261 (46%), Gaps = 27/261 (10%)
Query: 9   IGHGSFGSVNLAKASK-----VSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +G G FG V +A  +K     V +  P  M+V++         TL+++K           
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDK----------- 244
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+     ++    E  Y ++ E+ ++GSL D +K     +     +  ++  + +G+  
Sbjct: 245 LVKL----HAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           I  + ++H D++  N+LV  +   KIADFGLA+    D E +     +    + +PE++N
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAIN 358
Query: 184 ENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              +    D+W+ G  ++E+ + G+  +    +  V   L R   G  +P  P +  E+ 
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---GYRMPR-PENCPEEL 414
Query: 243 KDFLIKCFLKDPKRRWTAEML 263
            + +++C+   P+ R T E +
Sbjct: 415 YNIMMRCWKNRPEERPTFEYI 435

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI D+GLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 117/258 (45%), Gaps = 28/258 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----PQ 63
           IG GSFG+V+ A+          LM     A+            E L ++ I      P 
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE---------RVNEFLREVAIMKRLRHPN 95
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS--MLKGL 121
           IV   G            +++ EY SRGSL  R+  ++  R Q  + +R + +  + KG+
Sbjct: 96  IVLFMGAVTQPPN----LSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 122 RHIHSKG--FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            ++H++    VH ++K  N+LV      K+ DFGL++  +     S+S    GTP +M+P
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAP 208
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +       D+++ G  + E+A+ +  W +   + V +    +G   +   IP +L+
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA---AVGFKCKRLEIPRNLN 265
Query: 240 EQGKDFLIKCFLKDPKRR 257
            Q    +  C+  +P +R
Sbjct: 266 PQVAAIIEGCWTNEPWKR 283

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 124/270 (45%), Gaps = 15/270 (5%)
Query: 3   WLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           +L+ D+ IG GSF +V     ++ + E  +   ++            K E E L  +   
Sbjct: 27  FLKFDIEIGRGSFKTVYKGLDTETTVEV-AWCELQDRKLTKSERQRFKEEAEXLKGLQ-H 84
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IVR +    S  KG++   L+ E  + G+L   +K+    +++   ++ + R +LKGL
Sbjct: 85  PNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV--LRSWCRQILKGL 142
Query: 122 RHIHSKG--FVHCDIKLQNVLVFD-NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
           + +H++    +H D+K  N+ +       KI D GLA        ++      GTP + +
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFXA 198
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           PE   E +Y+   D++A G   +E A+ +  ++  Q  N   +  R+  G +  +     
Sbjct: 199 PEXY-EEKYDESVDVYAFGXCXLEXATSEYPYSECQ--NAAQIYRRVTSGVKPASFDKVA 255
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
             + K+ +  C  ++   R++ + LLNH F
Sbjct: 256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/266 (22%), Positives = 113/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 52  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ EY   GSL D   ++++ +     +    R +  G++
Sbjct: 107 NIIRLEG----VVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +N+L+  N   K++DFGLA+    D E + +      P+ + SPE+
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 276
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 113/260 (43%), Gaps = 33/260 (12%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV               K+S  F SL+  +           LK+E    + IG
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE----NVIG 83
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E     Y  L+       L + VK Q    L +  V+     +L+
Sbjct: 84  L----LDVFTPATSIEDFSEVY--LVTTLMGADLNNIVKCQA---LSDEHVQFLVYQLLR 134
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS G +H D+K  NV V ++ E +I DFGLA+++  D E +     R    Y +P
Sbjct: 135 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA--DEEMTGYVATRW---YRAP 189
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG--VGDELPNIPG 236
           E  +N   Y    DIW++GC + E+  GK  +     S+    L RI   VG   P +  
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLQGKALF---PGSDYIDQLKRIMEVVGTPSPEVLA 246
Query: 237 DLSEQGKDFLIKCFLKDPKR 256
            +S +     I+     P++
Sbjct: 247 KISSEHARTYIQSLPPMPQK 266

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 122/288 (42%), Gaps = 29/288 (10%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +  +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL    
Sbjct: 33  ITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 60  ICPQ-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRY 113
           +  Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+   
Sbjct: 91  LNHQNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE- 169
            R +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +  
Sbjct: 147 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 202
Query: 170 --CRGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
             C   P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   
Sbjct: 203 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           G  D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 263 GRMDPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 81
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK     +L +  V+     +L+
Sbjct: 82  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVK---CAKLTDDHVQFLIYQILR 132
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ +  D E +     R    Y +P
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRW---YRAP 187
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 246
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAV 278

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/266 (22%), Positives = 113/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 52  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ EY   GSL D   ++++ +     +    R +  G++
Sbjct: 107 NIIRLEG----VVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   GFVH D+  +N+L+  N   K++DFGL++    D E + +      P+ + SPE+
Sbjct: 162 YLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 276
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 92
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 93  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 143
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ ++      +      T  Y +P
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-----DEMTGYVATRWYRAP 198
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 257
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 289

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 92
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 93  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 143
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ ++      +      T  Y +P
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-----DEMTGYVATRWYRAP 198
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 257
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 289

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 4/152 (2%)
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           ++ +   +L GL  +H  G VH D+   N+L+ DN++  I DF LA++ + D  ++    
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 170 CRGTPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG 228
            R    Y +PE V + + +    D+W+ GC + EM + K  +      N  + ++ +   
Sbjct: 196 HRW---YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTA 260
            ++ ++    S   +D+L       P R WTA
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTA 284

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 116/258 (44%), Gaps = 28/258 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----PQ 63
           IG GSFG+V+ A+          LM     A+            E L ++ I      P 
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE---------RVNEFLREVAIMKRLRHPN 95
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS--MLKGL 121
           IV   G            +++ EY SRGSL  R+  ++  R Q  + +R + +  + KG+
Sbjct: 96  IVLFMGAVTQPPN----LSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 122 RHIHSKG--FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            ++H++    VH D+K  N+LV      K+ DFGL++  +     S+     GTP +M+P
Sbjct: 151 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKX--AAGTPEWMAP 208
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + +       D+++ G  + E+A+ +  W +   + V +    +G   +   IP +L+
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA---AVGFKCKRLEIPRNLN 265
Query: 240 EQGKDFLIKCFLKDPKRR 257
            Q    +  C+  +P +R
Sbjct: 266 PQVAAIIEGCWTNEPWKR 283

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 122/288 (42%), Gaps = 29/288 (10%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +  +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL    
Sbjct: 47  ITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 60  ICPQ-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRY 113
           +  Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+   
Sbjct: 105 LNHQNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE- 169
            R +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +  
Sbjct: 161 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 216
Query: 170 --CRGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
             C   P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   
Sbjct: 217 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 276
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           G  D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 277 GRMDPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI------CP 62
           +G G++G V   K   V S    + AVK       ++V  + +K  L  + I      CP
Sbjct: 42  LGRGAYGVVE--KXRHVPSG--QIXAVKRIR----ATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
             V  +G    F +G+ +    L   S      +V  +    + E  + +   S++K L 
Sbjct: 94  FTVTFYG--ALFREGDVWICXELXDTSLDKFYKQVIDKGQ-TIPEDILGKIAVSIVKALE 150
Query: 123 HIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           H+HSK   +H D+K  NVL+    + K  DFG++     D  +     C+    Y +PE 
Sbjct: 151 HLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKP---YXAPER 207
Query: 182 VN----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           +N    +  Y    DIW+LG   +E+A  +  + +      F  L ++ V +  P +P D
Sbjct: 208 INPELNQKGYSVKSDIWSLGITXIELAILR--FPYDSWGTPFQQLKQV-VEEPSPQLPAD 264
Query: 238 -LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
             S +  DF  +C  K+ K R T   L  HPF
Sbjct: 265 KFSAEFVDFTSQCLKKNSKERPTYPELXQHPF 296

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 4/152 (2%)
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           ++ +   +L GL  +H  G VH D+   N+L+ DN++  I DF LA++ + D  ++    
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 170 CRGTPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG 228
            R    Y +PE V + + +    D+W+ GC + EM + K  +      N  + ++ +   
Sbjct: 196 HRW---YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTA 260
            ++ ++    S   +D+L       P R WTA
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTA 284

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 92
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 93  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 143
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DFGLA+ ++      +      T  Y +P
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-----DEMTGYVATRWYRAP 198
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 257
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 289

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 32/227 (14%)
Query: 78  ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQ 137
           +RFY L+ E    GS+   + K+ +    E +     + +   L  +H+KG  H D+K +
Sbjct: 84  DRFY-LVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140
Query: 138 NVLVFDNDEA---KIADFGLAKKSSCDGERS-----QSFECRGTPLYMSPESVNE----- 184
           N+L    ++    KI DFGL      +G+ S     +     G+  YM+PE V       
Sbjct: 141 NILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 185 NEYEAPCDIWALGCAVVEMASGKP----------AWNHKQDSNVFSLLIRIGVGDELPNI 234
           + Y+  CD+W+LG  +  + SG P           W+  +       ++   + +     
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEF 260
Query: 235 P----GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV--CADDQT 275
           P      +S   KD + K  ++D K+R +A  +L HP+V  CA + T
Sbjct: 261 PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 73
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 74  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 189 IKSDVWSFGILLTEIVT 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 23  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 75
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 76  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 131
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 132 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEAINYGTFT 190
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 191 IKSDVWSFGILLTEIVT 207

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           + + G+V+G G FG     +A KV+  E   +M +K            + ++  L ++ +
Sbjct: 11  DLIHGEVLGKGCFG-----QAIKVTHRETGEVMVMKELI-----RFDEETQRTFLKEVKV 60
Query: 61  C-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                 P +++  G  Y     ++  N + EY   G+L   +K  ++       V  + +
Sbjct: 61  MRCLEHPNVLKFIGVLYK----DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVS-FAK 115
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK-----KSSCDGERS----- 165
            +  G+ ++HS   +H D+   N LV +N    +ADFGLA+     K+  +G RS     
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 166 --QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
             + +   G P +M+PE +N   Y+   D+++ G  + E+
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 30  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 82
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 83  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 138
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 139 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 198 IKSDVWSFGILLTEIVT 214

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 29/285 (10%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL       
Sbjct: 50  IRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNH 107
Query: 63  Q-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTRS 116
           Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+    R 
Sbjct: 108 QNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE---C 170
           +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +    C
Sbjct: 164 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGC 219
Query: 171 RGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVG 228
              P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   G  
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 279
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 280 DPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 117/282 (41%), Gaps = 35/282 (12%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV-- 65
           V+G G+FG V  A+ +  S  +    A+K          T+ +E   L  +    Q V  
Sbjct: 13  VLGQGAFGQVVKARNALDSRYY----AIKKIRHTEEKLSTILSEVMLLASLN--HQYVVR 66
Query: 66  --------RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
                   R F    +  K +    + +EY   G+L D +  +N  + Q  +  R  R +
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ-QRDEYWRLFRQI 125
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK------------SSCDGERS 165
           L+ L +IHS+G +H D+K  N+ + ++   KI DFGLAK              +  G   
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 166 QSFECRGTPLYMSPESVN-ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR 224
                 GT +Y++ E ++    Y    D+++LG    EM    P     +  N+   L  
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRS 243
Query: 225 IGVGDELPNIPGDLSEQGKDFLIKCFL-KDPKRRWTAEMLLN 265
           + +  E P    D   + +  +I+  +  DP +R  A  LLN
Sbjct: 244 VSI--EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 22  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 74
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 75  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 130
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 131 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEAINYGTFT 189
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 190 IKSDVWSFGILLTEIVT 206

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G FG V+L      +     ++AVK+  AD  P   +    K+ +D       I+R 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS--GWKQEID-------ILRT 89
Query: 68  FGDDYSF-------EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              ++         + G     L++EY   GSL D + + + G  Q   +  + + + +G
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ---LLLFAQQICEG 146
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSP 179
           + ++H++ ++H D+  +NVL+ ++   KI DFGLAK      E  +  E   +P++  +P
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAP 206
Query: 180 ESVNENEYEAPCDIWALGCAVVEMAS 205
           E + E ++    D+W+ G  + E+ +
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 73
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 74  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 189 IKSDVWSFGILLTEIVT 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 73
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 74  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 189 IKSDVWSFGILLTEIVT 205

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 79
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 80  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 195 IKSDVWSFGILLTEIVT 211

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +  +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL    
Sbjct: 33  ITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 60  ICPQ-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRY 113
              Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+   
Sbjct: 91  FNHQNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE- 169
            R +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +  
Sbjct: 147 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 202
Query: 170 --CRGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
             C   P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   
Sbjct: 203 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           G  D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 263 GRMDPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 40/192 (20%)
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +S +   +     R    Y
Sbjct: 133 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTR---YY 189
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPA---------WNHKQD-----SNVFSLL 222
            +PE +    Y+   DIW++GC + E+  G            WN   +     S  F   
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAA 249
Query: 223 IRIGVGDEL---PNIPGDLSE--------------------QGKDFLIKCFLKDPKRRWT 259
           ++  V + +   P  PG   E                    Q +D L K  + DP +R +
Sbjct: 250 LQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRIS 309
Query: 260 AEMLLNHPFVCA 271
            +  L HP++  
Sbjct: 310 VDEALRHPYITV 321

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 29/285 (10%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL       
Sbjct: 42  IRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 99
Query: 63  Q-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTRS 116
           Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+    R 
Sbjct: 100 QNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 155
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE---C 170
           +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +    C
Sbjct: 156 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGC 211
Query: 171 RGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVG 228
              P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   G  
Sbjct: 212 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 271
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 272 DPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 312

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/268 (22%), Positives = 115/268 (42%), Gaps = 12/268 (4%)
Query: 2   EWLRGDVIGHGSFGSVN-LAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           ++L GD++G GS+G V  +  +  +      ++  K     P     +K E + L ++  
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64
Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              +++     Y+ EK + +  +++EY   G + + +      R        Y   ++ G
Sbjct: 65  HKNVIQLVDVLYNEEKQKMY--MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L ++HS+G VH DIK  N+L+      KI+  G+A+              +G+P +  PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 181 SVNENEYEA--PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
             N  +  +    DIW+ G  +  + +G   +   +  N++ L   IG G     IPGD 
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPF---EGDNIYKLFENIGKGSY--AIPGDC 236
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
                D L      +P +R++   +  H
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 29  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 81
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 82  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 137
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 138 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 197 IKSDVWSFGILLTEIVT 213

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 115/272 (42%), Gaps = 47/272 (17%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 33  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 68
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLAD--------------RVKKQNNGRLQESD 109
           + F ++    +  R  N+LL   Y+++  LA                + +     ++  D
Sbjct: 69  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 128
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + R T    +G+ ++H+K  +H D+K  N+ + ++   KI DFGLA + S      Q  +
Sbjct: 129 IARQTA---QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 185
Query: 170 CRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRI 225
             G+ L+M+PE +   ++N Y    D++A G  + E+ +G+ P  N      +  ++ R 
Sbjct: 186 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 245
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +  +L  +  +  +  K  + +C  K    R
Sbjct: 246 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 277

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 79
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 80  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 195 IKSDVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 26  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 78
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 79  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 134
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 135 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 194 IKSDVWSFGILLTEIVT 210

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +  +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL    
Sbjct: 24  ITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 60  ICPQ-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRY 113
              Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+   
Sbjct: 82  FNHQNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 137
Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE- 169
            R +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +  
Sbjct: 138 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 193
Query: 170 --CRGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
             C   P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   
Sbjct: 194 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 253
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           G  D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 254 GRMDPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 297

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 29/285 (10%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL       
Sbjct: 62  IRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 119
Query: 63  Q-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTRS 116
           Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+    R 
Sbjct: 120 QNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 175
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE---C 170
           +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +    C
Sbjct: 176 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGC 231
Query: 171 RGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVG 228
              P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   G  
Sbjct: 232 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 291
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 292 DPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 332

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 29/285 (10%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL       
Sbjct: 52  IRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 109
Query: 63  Q-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTRS 116
           Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+    R 
Sbjct: 110 QNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 165
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE---C 170
           +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +    C
Sbjct: 166 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGC 221
Query: 171 RGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVG 228
              P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   G  
Sbjct: 222 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 281
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 282 DPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 322

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 31  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 83
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 84  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 139
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 140 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 199 IKSDVWSFGILLTEIVT 215

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 29/285 (10%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL       
Sbjct: 35  IRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 63  Q-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTRS 116
           Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+    R 
Sbjct: 93  QNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE---C 170
           +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +    C
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGC 204
Query: 171 RGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVG 228
              P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   G  
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 265 DPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 115/272 (42%), Gaps = 47/272 (17%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 41  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 76
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLAD--------------RVKKQNNGRLQESD 109
           + F ++    +  R  N+LL   Y+++  LA                + +     ++  D
Sbjct: 77  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 136
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + R T    +G+ ++H+K  +H D+K  N+ + ++   KI DFGLA + S      Q  +
Sbjct: 137 IARQT---AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 193
Query: 170 CRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRI 225
             G+ L+M+PE +   ++N Y    D++A G  + E+ +G+ P  N      +  ++ R 
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 253
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +  +L  +  +  +  K  + +C  K    R
Sbjct: 254 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 285

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +  +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL    
Sbjct: 33  ITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 60  ICPQ-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRY 113
              Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+   
Sbjct: 91  FNHQNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE- 169
            R +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +  
Sbjct: 147 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYYRK 202
Query: 170 --CRGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
             C   P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   
Sbjct: 203 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           G  D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 263 GRMDPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 119/285 (41%), Gaps = 23/285 (8%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +  +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL    
Sbjct: 50  ITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 60  ICPQ-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRY 113
              Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+   
Sbjct: 108 FNHQNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 163
Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFEC 170
            R +  G +++    F+H DI  +N L+        AKI DFG+A+     G   +   C
Sbjct: 164 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG-GC 222
Query: 171 RGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVG 228
              P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   G  
Sbjct: 223 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 282
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 283 DPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 323

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 115/272 (42%), Gaps = 47/272 (17%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 13  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 48
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLAD--------------RVKKQNNGRLQESD 109
           + F ++    +  R  N+LL   Y+++  LA                + +     ++  D
Sbjct: 49  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 108
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + R T    +G+ ++H+K  +H D+K  N+ + ++   KI DFGLA + S      Q  +
Sbjct: 109 IARQTA---QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 165
Query: 170 CRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRI 225
             G+ L+M+PE +   ++N Y    D++A G  + E+ +G+ P  N      +  ++ R 
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 225
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +  +L  +  +  +  K  + +C  K    R
Sbjct: 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 23  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ EY   GSL D   ++++ +     +    R +  G++
Sbjct: 78  NIIRLEG----VVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 132
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +N+L+  N   K++DFGL++    D E + +      P+ + SPE+
Sbjct: 133 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 192
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 247
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 248 AALYQLMLDCWQKDRNNRPKFEQIVS 273

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 23/282 (8%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL       
Sbjct: 76  IRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 63  Q-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTRS 116
           Q IVRC G   S +   RF  +LLE  + G L       R +      L   D+    R 
Sbjct: 134 QNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
           +  G +++    F+H DI  +N L+        AKI DFG+A+     G   +   C   
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG-GCAML 248
Query: 174 PL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL 231
           P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   G  D  
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 308
Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
            N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 309 KNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 16  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 68
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 69  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 124
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 184 IKSDVWSFGILLTEIVT 200

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 40  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ EY   GSL D   ++++ +     +    R +  G++
Sbjct: 95  NIIRLEG----VVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 149
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +N+L+  N   K++DFGL++    D E + +      P+ + SPE+
Sbjct: 150 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 209
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 210 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 264
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 265 AALYQLMLDCWQKDRNNRPKFEQIVS 290

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 52  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ EY   GSL D   ++++ +     +    R +  G++
Sbjct: 107 NIIRLEG----VVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +N+L+  N   K++DFGL++    D E + +      P+ + SPE+
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 276
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 50  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ EY   GSL D   ++++ +     +    R +  G++
Sbjct: 105 NIIRLEG----VVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 159
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +N+L+  N   K++DFGL++    D E + +      P+ + SPE+
Sbjct: 160 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 219
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 220 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 274
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 275 AALYQLMLDCWQKDRNNRPKFEQIVS 300

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 52  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ EY   GSL D   ++++ +     +    R +  G++
Sbjct: 107 NIIRLEG----VVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +N+L+  N   K++DFGL++    D E + +      P+ + SPE+
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 276
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 8   VIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
            IG G FG V L   + +KV+ +     A         S +T       +  +G+  +  
Sbjct: 28  TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-- 85
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
                    EKG  +  ++ EY ++GSL D ++ +    L    + +++  + + + ++ 
Sbjct: 86  ---------EKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNE 184
              FVH D+  +NVLV +++ AK++DFGL K++S   +  +       P+ + +PE++ E
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPVKWTAPEALRE 188
Query: 185 NEYEAPCDIWALGCAVVEMAS 205
            ++    D+W+ G  + E+ S
Sbjct: 189 KKFSTKSDVWSFGILLWEIYS 209

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 52  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ EY   GSL D   ++++ +     +    R +  G++
Sbjct: 107 NIIRLEG----VVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +N+L+  N   K++DFGL++    D E + +      P+ + SPE+
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 276
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 52  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ EY   GSL D   ++++ +     +    R +  G++
Sbjct: 107 NIIRLEG----VVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +N+L+  N   K++DFGL++    D E + +      P+ + SPE+
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 276
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI  FGLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 107/249 (42%), Gaps = 14/249 (5%)
Query: 8   VIGHGSFGSV--NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           V+G G+FG+V   +      + + P  + V      P ++  + +E   +  +G  P + 
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG-SPYVS 82
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           R  G         +    L+ Y   G L D V+ +N GRL   D+  +   + KG+ ++ 
Sbjct: 83  RLLG--ICLTSTVQLVTQLMPY---GCLLDHVR-ENRGRLGSQDLLNWCMQIAKGMSYLE 136
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
               VH D+  +NVLV   +  KI DFGLA+    D     +   +    +M+ ES+   
Sbjct: 137 DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 186 EYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
            +    D+W+ G  V E M  G   ++      +  LL +   G+ LP  P   +     
Sbjct: 197 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK---GERLPQ-PPICTIDVYM 252
Query: 245 FLIKCFLKD 253
            ++KC++ D
Sbjct: 253 IMVKCWMID 261

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 118/257 (45%), Gaps = 24/257 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCA-DCPPSSVTLKNEKEALDQIGIC----- 61
           ++G G FG V     +    E  ++ AVK+C  DC     TL N+++ + +  I      
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINV-AVKTCKKDC-----TLDNKEKFMSEAVIMKNLDH 68
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV+  G     E+   +  +++E    G L   +++  N  L+   +  Y+  + K +
Sbjct: 69  PHIVKLIG---IIEEEPTW--IIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAM 122
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++ S   VH DI ++N+LV   +  K+ DFGL++    D +  ++   R    +MSPES
Sbjct: 123 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPES 181
Query: 182 VNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
           +N   +    D+W     + E+ S GK  +   ++ +V  +L +   GD LP  P     
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLPK-PDLCPP 237
Query: 241 QGKDFLIKCFLKDPKRR 257
                + +C+  DP  R
Sbjct: 238 VLYTLMTRCWDYDPSDR 254

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 9   IGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           IG G FG V L   + +KV+ +     A         S +T       +  +G+  +   
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE--- 70
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                   EKG  +  ++ EY ++GSL D ++ +    L    + +++  + + + ++  
Sbjct: 71  --------EKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNEN 185
             FVH D+  +NVLV +++ AK++DFGL K++S   +  +       P+ + +PE++ E 
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPVKWTAPEALREK 174
Query: 186 EYEAPCDIWALGCAVVEMAS 205
           ++    D+W+ G  + E+ S
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 29/285 (10%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL       
Sbjct: 50  IRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 107
Query: 63  Q-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTRS 116
           Q IVRC G   S +   RF  +L+E  + G L       R +      L   D+    R 
Sbjct: 108 QNIVRCIG--VSLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE---C 170
           +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +    C
Sbjct: 164 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGC 219
Query: 171 RGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVG 228
              P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   G  
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 279
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 280 DPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 112/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 52  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ EY   GSL D   ++++ +     +    R +  G++
Sbjct: 107 NIIRLEG----VVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +N+L+  N   K++DFGL +    D E + +      P+ + SPE+
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 276
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 118/257 (45%), Gaps = 24/257 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCA-DCPPSSVTLKNEKEALDQIGIC----- 61
           ++G G FG V     +    E  ++ AVK+C  DC     TL N+++ + +  I      
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINV-AVKTCKKDC-----TLDNKEKFMSEAVIMKNLDH 84
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV+  G     E+   +  +++E    G L   +++  N  L+   +  Y+  + K +
Sbjct: 85  PHIVKLIG---IIEEEPTW--IIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAM 138
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++ S   VH DI ++N+LV   +  K+ DFGL++    D +  ++   R    +MSPES
Sbjct: 139 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPES 197
Query: 182 VNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
           +N   +    D+W     + E+ S GK  +   ++ +V  +L +   GD LP  P     
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLPK-PDLCPP 253
Query: 241 QGKDFLIKCFLKDPKRR 257
                + +C+  DP  R
Sbjct: 254 VLYTLMTRCWDYDPSDR 270

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 125/278 (44%), Gaps = 39/278 (14%)
Query: 9   IGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CP 62
           +G GSFG V    A  +   E  + +AVK+  +    S +L+   E L++  +     C 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 80
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------KQNNGR----LQESDVKR 112
            +VR  G      KG+    +++E  + G L   ++      + N GR    LQE  + +
Sbjct: 81  HVVRLLG---VVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 134
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
               +  G+ ++++K FVH D+  +N +V  +   KI DFG+ +    D   +  +   G
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGG 190
Query: 173 TPL----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
             L    +M+PES+ +  +    D+W+ G  + E+ S  +  +    +  V   ++  G 
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 250
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
            D+  N P    E+  D +  C+  +PK R T   ++N
Sbjct: 251 LDQPDNCP----ERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 29/285 (10%)
Query: 4   LRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           +RG  +GHG+FG V   + S + ++  P  +AVK+  +       L    EAL       
Sbjct: 35  IRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 63  Q-IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTRS 116
           Q IVRC G   S +   RF  +L+E  + G L       R +      L   D+    R 
Sbjct: 93  QNIVRCIG--VSLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAKKSSCDGERSQSFE---C 170
           +  G +++    F+H DI  +N L+        AKI DFG+A+    D  R+  +    C
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGC 204
Query: 171 RGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVG 228
              P+ +M PE+  E  + +  D W+ G  + E+ S G   +  K +  V   +   G  
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
           D   N PG +       + +C+   P+ R    ++L     C  D
Sbjct: 265 DPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 125/278 (44%), Gaps = 39/278 (14%)
Query: 9   IGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CP 62
           +G GSFG V    A  +   E  + +AVK+  +    S +L+   E L++  +     C 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 80
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------KQNNGR----LQESDVKR 112
            +VR  G      KG+    +++E  + G L   ++      + N GR    LQE  + +
Sbjct: 81  HVVRLLG---VVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 134
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
               +  G+ ++++K FVH D+  +N +V  +   KI DFG+ +    D   +  +   G
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETAYYRKGG 190
Query: 173 TPL----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
             L    +M+PES+ +  +    D+W+ G  + E+ S  +  +    +  V   ++  G 
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 250
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
            D+  N P    E+  D +  C+  +PK R T   ++N
Sbjct: 251 LDQPDNCP----ERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 118/257 (45%), Gaps = 24/257 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCA-DCPPSSVTLKNEKEALDQIGIC----- 61
           ++G G FG V     +    E  ++ AVK+C  DC     TL N+++ + +  I      
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINV-AVKTCKKDC-----TLDNKEKFMSEAVIMKNLDH 72
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV+  G     E+   +  +++E    G L   +++  N  L+   +  Y+  + K +
Sbjct: 73  PHIVKLIG---IIEEEPTW--IIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAM 126
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++ S   VH DI ++N+LV   +  K+ DFGL++    D +  ++   R    +MSPES
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPES 185
Query: 182 VNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
           +N   +    D+W     + E+ S GK  +   ++ +V  +L +   GD LP  P     
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLPK-PDLCPP 241
Query: 241 QGKDFLIKCFLKDPKRR 257
                + +C+  DP  R
Sbjct: 242 VLYTLMTRCWDYDPSDR 258

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 114/272 (41%), Gaps = 47/272 (17%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 40  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 75
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLAD--------------RVKKQNNGRLQESD 109
           + F ++    +  R  N+LL   Y+++  LA                + +     ++  D
Sbjct: 76  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 135
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + R T    +G+ ++H+K  +H D+K  N+ + ++   KI DFGLA   S      Q  +
Sbjct: 136 IARQT---AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 192
Query: 170 CRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRI 225
             G+ L+M+PE +   ++N Y    D++A G  + E+ +G+ P  N      +  ++ R 
Sbjct: 193 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 252
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +  +L  +  +  +  K  + +C  K    R
Sbjct: 253 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 284

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 8   VIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
            IG G FG V L   + +KV+ +     A         S +T       +  +G+  +  
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-- 257
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
                    EKG  +  ++ EY ++GSL D ++ +    L    + +++  + + + ++ 
Sbjct: 258 ---------EKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNE 184
              FVH D+  +NVLV +++ AK++DFGL K++S   +  +       P+ + +PE++ E
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPVKWTAPEALRE 360
Query: 185 NEYEAPCDIWALGCAVVEMAS 205
            ++    D+W+ G  + E+ S
Sbjct: 361 KKFSTKSDVWSFGILLWEIYS 381

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 114/272 (41%), Gaps = 47/272 (17%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 41  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 76
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLAD--------------RVKKQNNGRLQESD 109
           + F ++    +  R  N+LL   Y+++  LA                + +     ++  D
Sbjct: 77  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 136
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + R T    +G+ ++H+K  +H D+K  N+ + ++   KI DFGLA   S      Q  +
Sbjct: 137 IARQT---AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 193
Query: 170 CRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRI 225
             G+ L+M+PE +   ++N Y    D++A G  + E+ +G+ P  N      +  ++ R 
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 253
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +  +L  +  +  +  K  + +C  K    R
Sbjct: 254 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 285

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 114/272 (41%), Gaps = 47/272 (17%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 18  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 53
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLAD--------------RVKKQNNGRLQESD 109
           + F ++    +  R  N+LL   Y+++  LA                + +     ++  D
Sbjct: 54  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 113
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + R T    +G+ ++H+K  +H D+K  N+ + ++   KI DFGLA   S      Q  +
Sbjct: 114 IARQTA---QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 170 CRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRI 225
             G+ L+M+PE +   ++N Y    D++A G  + E+ +G+ P  N      +  ++ R 
Sbjct: 171 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 230
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +  +L  +  +  +  K  + +C  K    R
Sbjct: 231 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 262

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 114/272 (41%), Gaps = 47/272 (17%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 15  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 50
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLAD--------------RVKKQNNGRLQESD 109
           + F ++    +  R  N+LL   Y+++  LA                + +     ++  D
Sbjct: 51  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 110
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + R T    +G+ ++H+K  +H D+K  N+ + ++   KI DFGLA   S      Q  +
Sbjct: 111 IARQTA---QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 167
Query: 170 CRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRI 225
             G+ L+M+PE +   ++N Y    D++A G  + E+ +G+ P  N      +  ++ R 
Sbjct: 168 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 227
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +  +L  +  +  +  K  + +C  K    R
Sbjct: 228 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 259

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 114/272 (41%), Gaps = 47/272 (17%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 18  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 53
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLAD--------------RVKKQNNGRLQESD 109
           + F ++    +  R  N+LL   Y+++  LA                + +     ++  D
Sbjct: 54  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 113
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + R T    +G+ ++H+K  +H D+K  N+ + ++   KI DFGLA   S      Q  +
Sbjct: 114 IARQTA---QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 170 CRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRI 225
             G+ L+M+PE +   ++N Y    D++A G  + E+ +G+ P  N      +  ++ R 
Sbjct: 171 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 230
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +  +L  +  +  +  K  + +C  K    R
Sbjct: 231 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 262

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 114/272 (41%), Gaps = 47/272 (17%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 13  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 48
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLAD--------------RVKKQNNGRLQESD 109
           + F ++    +  R  N+LL   Y+++  LA                + +     ++  D
Sbjct: 49  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 108
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + R T    +G+ ++H+K  +H D+K  N+ + ++   KI DFGLA   S      Q  +
Sbjct: 109 IARQTA---QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 170 CRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRI 225
             G+ L+M+PE +   ++N Y    D++A G  + E+ +G+ P  N      +  ++ R 
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 225
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +  +L  +  +  +  K  + +C  K    R
Sbjct: 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI D GLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 9   IGHGSFGSVNLAKASK-----VSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +G G FG V +A  +K     V +  P  M+V++         TL+++K           
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDK----------- 238
Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +V+     ++    E  Y ++ E+ ++GSL D +K     +     +  ++  + +G+  
Sbjct: 239 LVKL----HAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 293
Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           I  + ++H D++  N+LV  +   KIADFGLA+  +        F  + T    +PE++N
Sbjct: 294 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVGA-------KFPIKWT----APEAIN 342
Query: 184 ENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              +    D+W+ G  ++E+ + G+  +    +  V   L R   G  +P  P +  E+ 
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---GYRMPR-PENCPEEL 398
Query: 243 KDFLIKCFLKDPKRRWTAEML 263
            + +++C+   P+ R T E +
Sbjct: 399 YNIMMRCWKNRPEERPTFEYI 419

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 114/257 (44%), Gaps = 29/257 (11%)
Query: 9   IGHGSFGSV---------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV         +     K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI DF LA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPK 255
           S +     I+   + PK
Sbjct: 251 SSESARNYIQSLTQMPK 267

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 9   IGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CP 62
           +G GSFG V    A  +   E  + +AVK+  +    S +L+   E L++  +     C 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 77
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------KQNNGR----LQESDVKR 112
            +VR  G      KG+    +++E  + G L   ++      + N GR    LQE  + +
Sbjct: 78  HVVRLLG---VVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 131
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
               +  G+ ++++K FVH D+  +N +V  +   KI DFG+ +         +  +   
Sbjct: 132 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 191
Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL 231
              +M+PES+ +  +    D+W+ G  + E+ S  +  +    +  V   ++  G  D+ 
Sbjct: 192 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 251
Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
            N P    E+  D +  C+  +PK R T   ++N
Sbjct: 252 DNCP----ERVTDLMRMCWQFNPKMRPTFLEIVN 281

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 9   IGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CP 62
           +G GSFG V    A  +   E  + +AVK+  +    S +L+   E L++  +     C 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 80
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------KQNNGR----LQESDVKR 112
            +VR  G      KG+    +++E  + G L   ++      + N GR    LQE  + +
Sbjct: 81  HVVRLLG---VVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 134
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
               +  G+ ++++K FVH D+  +N +V  +   KI DFG+ +         +  +   
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 194
Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL 231
              +M+PES+ +  +    D+W+ G  + E+ S  +  +    +  V   ++  G  D+ 
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
            N P    E+  D +  C+  +PK R T   ++N
Sbjct: 255 DNCP----ERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD-CPPSSVT-LKNEKEALDQIGICPQIVR 66
           +G G FG V+L      +     ++AVK+  + C P   +  + E E L  +     IV+
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL-YHEHIVK 74
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
             G     ++GE+   L++EY   GSL D + +   G  Q   +  + + + +G+ ++H+
Sbjct: 75  YKGC--CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQ---LLLFAQQICEGMAYLHA 129
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNEN 185
           + ++H  +  +NVL+ ++   KI DFGLAK      E  +  E   +P++  +PE + E 
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 186 EYEAPCDIWALGCAVVEMAS 205
           ++    D+W+ G  + E+ +
Sbjct: 190 KFYYASDVWSFGVTLYELLT 209

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 82/193 (42%), Gaps = 40/193 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA +++C       +    T  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTACTNFMMTPYVV--TRY 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASG---------KPAWNHKQD-----SNVFSL 221
           Y +PE +    Y A  DIW++GC + E+  G            WN   +     S  F  
Sbjct: 191 YRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMA 250
Query: 222 LIRIGVGDEL---PNIPGDLSE--------------------QGKDFLIKCFLKDPKRRW 258
            ++  V + +   P  PG   E                    Q +D L K  + DP +R 
Sbjct: 251 ALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRI 310
Query: 259 TAEMLLNHPFVCA 271
           + +  L HP++  
Sbjct: 311 SVDEALRHPYITV 323

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI D GLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 116/258 (44%), Gaps = 23/258 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           +IG G  G V   +  +V  +    +A+K+      +  T +  ++ L +  I      P
Sbjct: 56  IIGSGDSGEVCYGRL-RVPGQRDVPVAIKALK----AGYTERQRRDFLSEASIMGQFDHP 110
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G      +G R   ++ EY   GSL D   + ++G+     +    R +  G+R
Sbjct: 111 NIIRLEG---VVTRG-RLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +NVLV  N   K++DFGL++    D + + +      P+ + +PE+
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 182 VNENEYEAPCDIWALGCAVVE-MASG-KPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +    + +  D+W+ G  + E +A G +P WN      + S    +  G  LP  P    
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----VEEGYRLPA-PMGCP 280
Query: 240 EQGKDFLIKCFLKDPKRR 257
                 ++ C+ KD  +R
Sbjct: 281 HALHQLMLDCWHKDRAQR 298

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD-CPPSSVT-LKNEKEALDQIGICPQIVR 66
           +G G FG V+L      +     ++AVK+  + C P   +  + E E L  +     IV+
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL-YHEHIVK 75
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
             G     ++GE+   L++EY   GSL D + +   G  Q   +  + + + +G+ ++H+
Sbjct: 76  YKGC--CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQ---LLLFAQQICEGMAYLHA 130
Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY-MSPESVNEN 185
           + ++H  +  +NVL+ ++   KI DFGLAK      E  +  E   +P++  +PE + E 
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 186 EYEAPCDIWALGCAVVEMAS 205
           ++    D+W+ G  + E+ +
Sbjct: 191 KFYYASDVWSFGVTLYELLT 210

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 116/258 (44%), Gaps = 23/258 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           +IG G  G V   +  +V  +    +A+K+      +  T +  ++ L +  I      P
Sbjct: 56  IIGSGDSGEVCYGRL-RVPGQRDVPVAIKALK----AGYTERQRRDFLSEASIMGQFDHP 110
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G      +G R   ++ EY   GSL D   + ++G+     +    R +  G+R
Sbjct: 111 NIIRLEG---VVTRG-RLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +NVLV  N   K++DFGL++    D + + +      P+ + +PE+
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 182 VNENEYEAPCDIWALGCAVVE-MASG-KPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +    + +  D+W+ G  + E +A G +P WN      + S    +  G  LP  P    
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----VEEGYRLPA-PMGCP 280
Query: 240 EQGKDFLIKCFLKDPKRR 257
                 ++ C+ KD  +R
Sbjct: 281 HALHQLMLDCWHKDRAQR 298

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 125/278 (44%), Gaps = 39/278 (14%)
Query: 9   IGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CP 62
           +G GSFG V    A  +   E  + +AVK+  +    S +L+   E L++  +     C 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 79
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------KQNNGR----LQESDVKR 112
            +VR  G      KG+    +++E  + G L   ++      + N GR    LQE  + +
Sbjct: 80  HVVRLLG---VVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 133
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
               +  G+ ++++K FVH D+  +N +V  +   KI DFG+ +    D   +  +   G
Sbjct: 134 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGG 189
Query: 173 TPL----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
             L    +M+PES+ +  +    D+W+ G  + E+ S  +  +    +  V   ++  G 
Sbjct: 190 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 249
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
            D+  N P    E+  D +  C+  +PK R T   ++N
Sbjct: 250 LDQPDNCP----ERVTDLMRMCWQFNPKMRPTFLEIVN 283

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 115/256 (44%), Gaps = 43/256 (16%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEK----EALDQIGICPQ 63
           VIG GSFG V  A   KV       +A+K           ++NEK    +A ++I I   
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQH----VALK----------MVRNEKRFHRQAAEEIRILEH 149
Query: 64  IVRCFGDD----YSFEKGERFYN---LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
           + +   D+        +   F N   +  E  S  +L + +KK          V+++  S
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTP 174
           +L+ L  +H    +HCD+K +N+L+     +  K+ DFG    SSC  E  + +    + 
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG----SSCY-EHQRVYTXIQSR 263
Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
            Y +PE +    Y  P D+W+LGC + E+ +G P    + + +  + +I      EL  +
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI------ELLGM 317
Query: 235 PG----DLSEQGKDFL 246
           P     D S++ K+F+
Sbjct: 318 PSQKLLDASKRAKNFV 333

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 115/256 (44%), Gaps = 43/256 (16%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEK----EALDQIGICPQ 63
           VIG GSFG V  A   KV       +A+K           ++NEK    +A ++I I   
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQH----VALK----------MVRNEKRFHRQAAEEIRILEH 149
Query: 64  IVRCFGDD----YSFEKGERFYN---LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
           + +   D+        +   F N   +  E  S  +L + +KK          V+++  S
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTP 174
           +L+ L  +H    +HCD+K +N+L+     +  K+ DFG    SSC  E  + +    + 
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG----SSCY-EHQRVYTXIQSR 263
Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
            Y +PE +    Y  P D+W+LGC + E+ +G P    + + +  + +I      EL  +
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI------ELLGM 317
Query: 235 PG----DLSEQGKDFL 246
           P     D S++ K+F+
Sbjct: 318 PSQKLLDASKRAKNFV 333

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 9   IGHGSFGSVNLA---------KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           +G G++GSV  A            K+S  F S++  K         + L    +  + IG
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 85
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           +    +  F    S E+    Y  L+ +     L + VK Q   +L +  V+     +L+
Sbjct: 86  L----LDVFTPARSLEEFNDVY--LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 136
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL++IHS   +H D+K  N+ V ++ E KI D GLA+ +  D E +     R    Y +P
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHT--DDEMTGYVATRW---YRAP 191
Query: 180 E-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E  +N   Y    DIW++GC + E+ +G+  +      +   L++R+ VG     +   +
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKI 250
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           S +     I+   + PK  +    +  +P   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAV 282

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 118/265 (44%), Gaps = 29/265 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 82
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L       R + +NN  L    + +  +    +
Sbjct: 83  RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 138
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
             G+ ++++  FVH D+  +N +V ++   KI DFG+ +    D   +  +   G  L  
Sbjct: 139 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 194
Query: 176 --YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP 232
             +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  
Sbjct: 195 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 254
Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
           N P  L E     +  C+  +PK R
Sbjct: 255 NCPDMLFE----LMRMCWQYNPKMR 275

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 118/265 (44%), Gaps = 29/265 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 78
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L       R + +NN  L    + +  +    +
Sbjct: 79  RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
             G+ ++++  FVH D+  +N +V ++   KI DFG+ +    D   +  +   G  L  
Sbjct: 135 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 190
Query: 176 --YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP 232
             +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 250
Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
           N P  L E     +  C+  +PK R
Sbjct: 251 NCPDMLFE----LMRMCWQYNPKMR 271

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 118/265 (44%), Gaps = 29/265 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 85
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L       R + +NN  L    + +  +    +
Sbjct: 86  RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
             G+ ++++  FVH D+  +N +V ++   KI DFG+ +    D   +  +   G  L  
Sbjct: 142 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 197
Query: 176 --YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP 232
             +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 257
Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
           N P  L E     +  C+  +PK R
Sbjct: 258 NCPDMLFE----LMRMCWQYNPKMR 278

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 8   VIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
            IG G FG V L   + +KV+ +     A         S +T       +  +G+  +  
Sbjct: 19  TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-- 76
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
                    EKG  +  ++ EY ++GSL D ++ +    L    + +++  + + + ++ 
Sbjct: 77  ---------EKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 125
Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNE 184
              FVH D+  +NVLV +++ AK++DFGL K++S   +  +       P+ + +PE++ E
Sbjct: 126 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPVKWTAPEALRE 179
Query: 185 NEYEAPCDIWALGCAVVEMAS 205
             +    D+W+ G  + E+ S
Sbjct: 180 AAFSTKSDVWSFGILLWEIYS 200

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 118/265 (44%), Gaps = 29/265 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 84
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L       R + +NN  L    + +  +    +
Sbjct: 85  RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
             G+ ++++  FVH D+  +N +V ++   KI DFG+ +    D   +  +   G  L  
Sbjct: 141 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 196
Query: 176 --YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP 232
             +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 256
Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
           N P  L E     +  C+  +PK R
Sbjct: 257 NCPDMLFE----LMRMCWQYNPKMR 277

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 127 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR---Y 183
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 304 SVDDALQHPYI 314

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR---Y 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 250
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 311 SVDDALQHPYI 321

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 7/170 (4%)
Query: 106 QESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND--EAKIADFGLAKK--SSCD 161
           +E  +    R +   L ++H++G  H DIK +N L   N   E K+ DFGL+K+     +
Sbjct: 166 REKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
Query: 162 GERSQSFECRGTPLYMSPESVN-ENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVF 219
           GE        GTP +++PE +N  NE   P CD W+ G  +  +  G   +    D++  
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285
Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S ++   +  E PN    LS   +D L     ++   R+ A   L HP++
Sbjct: 286 SQVLNKKLCFENPNY-NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 118/265 (44%), Gaps = 29/265 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 91
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L       R + +NN  L    + +  +    +
Sbjct: 92  RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 147
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
             G+ ++++  FVH D+  +N +V ++   KI DFG+ +    D   +  +   G  L  
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 203
Query: 176 --YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP 232
             +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 263
Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
           N P  L E     +  C+  +PK R
Sbjct: 264 NCPDMLFE----LMRMCWQYNPKMR 284

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR---Y 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 250
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 311 SVDDALQHPYI 321

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 118/265 (44%), Gaps = 29/265 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 84
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L       R + +NN  L    + +  +    +
Sbjct: 85  RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
             G+ ++++  FVH D+  +N +V ++   KI DFG+ +    D   +  +   G  L  
Sbjct: 141 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 196
Query: 176 --YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP 232
             +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 256
Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
           N P  L E     +  C+  +PK R
Sbjct: 257 NCPDMLFE----LMRMCWQYNPKMR 277

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 115/256 (44%), Gaps = 17/256 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G+G FG V +   +  +      +A+K+      S  +   E + + ++    ++V+  
Sbjct: 17  LGNGQFGEVWMGTWNGNTK-----VAIKTLKPGTMSPESFLEEAQIMKKLK-HDKLVQL- 69
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY ++GSL D +K      L+  ++      +  G+ +I    
Sbjct: 70  ---YAVVSEEPIY-IVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 125
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H D++  N+LV +    KIADFGLA+    D E +     +    + +PE+     + 
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIE-DNEXTARQGAKFPIKWTAPEAALYGRFT 184
Query: 189 APCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
              D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P D      + +I
Sbjct: 185 IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER---GYRMP-CPQDCPISLHELMI 240
Query: 248 KCFLKDPKRRWTAEML 263
            C+ KDP+ R T E L
Sbjct: 241 HCWKKDPEERPTFEYL 256

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 40/190 (21%)
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    Y
Sbjct: 135 MLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR---YY 191
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL---------- 222
            +PE +    Y+   DIW++GC + EM  G    P  +H  Q + V   L          
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 223 ----IRIGVGDE-----------LPNI--PGD------LSEQGKDFLIKCFLKDPKRRWT 259
               +R  V +             P++  P D       + Q +D L K  + D  +R +
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 312 VDEALQHPYI 321

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 118/265 (44%), Gaps = 29/265 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 113
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L       R + +NN  L    + +  +    +
Sbjct: 114 RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 169
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
             G+ ++++  FVH D+  +N +V ++   KI DFG+ +    D   +  +   G  L  
Sbjct: 170 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 225
Query: 176 --YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP 232
             +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  
Sbjct: 226 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 285
Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
           N P  L E     +  C+  +PK R
Sbjct: 286 NCPDMLFE----LMRMCWQYNPKMR 306

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/261 (22%), Positives = 115/261 (44%), Gaps = 21/261 (8%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 76
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L       R + +NN  L    + +  +    +
Sbjct: 77  RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 132
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
             G+ ++++  FVH D+  +N +V ++   KI DFG+ +         +  +      +M
Sbjct: 133 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 192
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           SPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  N P 
Sbjct: 193 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD 252
Query: 237 DLSEQGKDFLIKCFLKDPKRR 257
            L E     +  C+  +PK R
Sbjct: 253 MLLE----LMRMCWQYNPKMR 269

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 2/134 (1%)
Query: 72  YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH 131
           Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + ++H
Sbjct: 74  YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPC 191
            D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   +    
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 192 DIWALGCAVVEMAS 205
           D+W+ G  + E+ +
Sbjct: 192 DVWSFGILLTEIVT 205

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V +   +  +      +AVKS      S      E   + Q+    ++VR  
Sbjct: 17  LGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL- 69
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y+    E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I  + 
Sbjct: 70  ---YAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 125
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           ++H +++  N+LV D    KIADFGLA+    D E +     +    + +PE++N   + 
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFT 184
Query: 189 APCDIWALGCAVVEMAS 205
              D+W+ G  + E+ +
Sbjct: 185 IKSDVWSFGILLTEIVT 201

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 90/186 (48%), Gaps = 9/186 (4%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ EY   GSL D   K+N+G+     +    R +  G++++   G+VH D+  +N+L+ 
Sbjct: 100 IVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILIN 158
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENEYEAPCDIWALGCAVV 201
            N   K++DFGL++    D E + +      P+ + +PE++   ++ +  D+W+ G  + 
Sbjct: 159 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMW 218
Query: 202 EMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT 259
           E+ S   +P W       + +    +  G  LP+ P D        ++ C+ K+   R  
Sbjct: 219 EVVSYGERPYWEMTNQDVIKA----VEEGYRLPS-PMDCPAALYQLMLDCWQKERNSRPK 273
Query: 260 AEMLLN 265
            + ++N
Sbjct: 274 FDEIVN 279

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/261 (22%), Positives = 115/261 (44%), Gaps = 21/261 (8%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 85
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L       R + +NN  L    + +  +    +
Sbjct: 86  RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
             G+ ++++  FVH D+  +N +V ++   KI DFG+ +         +  +      +M
Sbjct: 142 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 201
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           SPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  N P 
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD 261
Query: 237 DLSEQGKDFLIKCFLKDPKRR 257
            L E     +  C+  +PK R
Sbjct: 262 MLFE----LMRMCWQYNPKMR 278

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 78  ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQ 137
           +RFY L+ E    GS+   + K+ +    E +     + +   L  +H+KG  H D+K +
Sbjct: 84  DRFY-LVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140
Query: 138 NVLVFDNDEA---KIADFGLAKKSSCDGERS-----QSFECRGTPLYMSPESVNE----- 184
           N+L    ++    KI DF L      +G+ S     +     G+  YM+PE V       
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 185 NEYEAPCDIWALGCAVVEMASGKP----------AWNHKQDSNVFSLLIRIGVGDELPNI 234
           + Y+  CD+W+LG  +  + SG P           W+  +       ++   + +     
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEF 260
Query: 235 P----GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV--CADDQT 275
           P      +S   KD + K  ++D K+R +A  +L HP+V  CA + T
Sbjct: 261 PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 113/272 (41%), Gaps = 47/272 (17%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG+V   K       +   +AVK      P+                 PQ +
Sbjct: 13  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPT-----------------PQQL 48
Query: 66  RCFGDDYSFEKGERFYNLLL--EYASRGSLAD--------------RVKKQNNGRLQESD 109
           + F ++    +  R  N+LL   Y++   LA                + +     ++  D
Sbjct: 49  QAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 108
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + R T    +G+ ++H+K  +H D+K  N+ + ++   KI DFGLA   S      Q  +
Sbjct: 109 IARQTA---QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 170 CRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRI 225
             G+ L+M+PE +   ++N Y    D++A G  + E+ +G+ P  N      +  ++ R 
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 225
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            +  +L  +  +  +  K  + +C  K    R
Sbjct: 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 19  LGGGQYGEVY----EGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 73
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY +++E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 74  G---VCTREPPFY-IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 129
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT----APESLAYN 185
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P+IV  +G   +  +G  + N+ +E    GSL   VK+Q  G L E     Y    L+GL
Sbjct: 145 PRIVPLYG---AVREGP-WVNIFMELLEGGSLGQLVKEQ--GCLPEDRALYYLGQALEGL 198
Query: 122 RHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFE---CRGTPLYM 177
            ++HS+  +H D+K  NVL+  D   A + DFG A     DG            GT  +M
Sbjct: 199 EYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHM 258
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           +PE V     +A  D+W+  C ++ M +G   W 
Sbjct: 259 APEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWT 292

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 35/282 (12%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV-- 65
           V+G G+FG V  A+ +  S  +    A+K          T+ +E   L  +    Q V  
Sbjct: 13  VLGQGAFGQVVKARNALDSRYY----AIKKIRHTEEKLSTILSEVMLLASLN--HQYVVR 66
Query: 66  --------RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
                   R F    +  K +    + +EY    +L D +  +N  + Q  +  R  R +
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQ-QRDEYWRLFRQI 125
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK------------SSCDGERS 165
           L+ L +IHS+G +H D+K  N+ + ++   KI DFGLAK              +  G   
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 166 QSFECRGTPLYMSPESVN-ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR 224
                 GT +Y++ E ++    Y    D+++LG    EM    P     +  N+   L  
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRS 243
Query: 225 IGVGDELPNIPGDLSEQGKDFLIKCFL-KDPKRRWTAEMLLN 265
           + +  E P    D   + +  +I+  +  DP +R  A  LLN
Sbjct: 244 VSI--EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P+IV  +G   +  +G  + N+ +E    GSL   VK+Q  G L E     Y    L+GL
Sbjct: 126 PRIVPLYG---AVREGP-WVNIFMELLEGGSLGQLVKEQ--GCLPEDRALYYLGQALEGL 179
Query: 122 RHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFE---CRGTPLYM 177
            ++HS+  +H D+K  NVL+  D   A + DFG A     DG            GT  +M
Sbjct: 180 EYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHM 239
Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWN 211
           +PE V     +A  D+W+  C ++ M +G   W 
Sbjct: 240 APEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWT 273

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 26  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 80
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY +++E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 81  G---VCTREPPFY-IIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 192
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 19  LGGGQFGEVY----EGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 73
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 74  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 129
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT----APESLAYN 185
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL 223

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 117/265 (44%), Gaps = 29/265 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 78
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L       R + +NN  L    + +  +    +
Sbjct: 79  RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
             G+ ++++  FVH D+  +N  V ++   KI DFG+ +    D   +  +   G  L  
Sbjct: 135 ADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 190
Query: 176 --YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP 232
             +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 250
Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
           N P  L E     +  C+  +PK R
Sbjct: 251 NCPDMLLE----LMRMCWQYNPKMR 271

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 117/265 (44%), Gaps = 29/265 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 91
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKK-----QNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L   ++       NN  L    + +  +    +
Sbjct: 92  RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
             G+ ++++  FVH D+  +N +V ++   KI DFG+ +    D   +  +   G  L  
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 203
Query: 176 --YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP 232
             +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 263
Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
           N P  L E     +  C+  +PK R
Sbjct: 264 NCPDMLFE----LMRMCWQYNPKMR 284

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 117/265 (44%), Gaps = 29/265 (10%)
Query: 9   IGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIV 65
           +G GSFG V    A  V  + P + +A+K+  +       +   NE   + +   C  +V
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVV 81
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKK-----QNNGRLQESDVKRYTR---SM 117
           R  G      +G+    +++E  +RG L   ++       NN  L    + +  +    +
Sbjct: 82  RLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 137
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-- 175
             G+ ++++  FVH D+  +N +V ++   KI DFG+ +    D   +  +   G  L  
Sbjct: 138 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 193
Query: 176 --YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP 232
             +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++  G+ D+  
Sbjct: 194 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 253
Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
           N P  L E     +  C+  +PK R
Sbjct: 254 NCPDMLFE----LMRMCWQYNPKMR 274

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 40/190 (21%)
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR---YY 191
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL---------- 222
            +PE +    Y+   DIW++GC + EM  G    P  +H  Q + V   L          
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 223 ----IRIGVGDE-----------LPNI--PGD------LSEQGKDFLIKCFLKDPKRRWT 259
               +R  V +             P++  P D       + Q +D L K  + D  +R +
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 312 VDEALQHPYI 321

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 121/274 (44%), Gaps = 31/274 (11%)
Query: 9   IGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CP 62
           +G GSFG V    A  +   E  + +AVK+  +    S +L+   E L++  +     C 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 80
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------KQNNGR----LQESDVKR 112
            +VR  G      KG+    +++E  + G L   ++      + N GR    LQE  + +
Sbjct: 81  HVVRLLG---VVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 134
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
               +  G+ ++++K FVH D+  +N +V  +   KI DFG+ +         +  +   
Sbjct: 135 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 194
Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL 231
              +M+PES+ +  +    D+W+ G  + E+ S  +  +    +  V   ++  G  D+ 
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
            N P    E+  D +  C+  +P  R T   ++N
Sbjct: 255 DNCP----ERVTDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 22  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 76
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY +++E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 77  G---VCTREPPFY-IIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 132
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT----APESLAYN 188
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 189 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 226

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 40/190 (21%)
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR---YY 191
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL---------- 222
            +PE +    Y+   DIW++GC + EM  G    P  +H  Q + V   L          
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 223 ----IRIGVGDE-----------LPNI--PGD------LSEQGKDFLIKCFLKDPKRRWT 259
               +R  V +             P++  P D       + Q +D L K  + D  +R +
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 312 VDEALQHPYI 321

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 15/252 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAV-KSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G+FG+V               + + K+ A+ P     L  E   + Q+   P IVR 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRM 77
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G      + E +  L++E A  G L   +  Q N  +++ ++      +  G++++   
Sbjct: 78  IG----ICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES 130
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENE 186
            FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ + +PE +N  +
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK 190
Query: 187 YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           + +  D+W+ G  + E  S G+  +   + S V ++L +     E    P     +  D 
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPREMYDL 246
Query: 246 LIKCFLKDPKRR 257
           +  C+  D + R
Sbjct: 247 MNLCWTYDVENR 258

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 15/252 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAV-KSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G+FG+V               + + K+ A+ P     L  E   + Q+   P IVR 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRM 77
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G      + E +  L++E A  G L   +  Q N  +++ ++      +  G++++   
Sbjct: 78  IG----ICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES 130
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENE 186
            FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ + +PE +N  +
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 187 YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           + +  D+W+ G  + E  S G+  +   + S V ++L +     E    P     +  D 
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPREMYDL 246
Query: 246 LIKCFLKDPKRR 257
           +  C+  D + R
Sbjct: 247 MNLCWTYDVENR 258

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 92  SLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--KI 149
           +L + +KK          V+++  S+L+ L  +H    +HCD+K +N+L+     +  K+
Sbjct: 184 NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKV 243
Query: 150 ADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPA 209
            DFG    SSC  E  + +    +  Y +PE +    Y  P D+W+LGC + E+ +G P 
Sbjct: 244 IDFG----SSCY-EHQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298
Query: 210 WNHKQDSNVFSLLIRIGVGDELPNIPG----DLSEQGKDFL 246
              + + +  + +I      EL  +P     D S++ K+F+
Sbjct: 299 LPGEDEGDQLACMI------ELLGMPXQKLLDASKRAKNFV 333

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 15/252 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAV-KSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G+FG+V               + + K+ A+ P     L  E   + Q+   P IVR 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRM 93
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G      + E +  L++E A  G L   +  Q N  +++ ++      +  G++++   
Sbjct: 94  IG----ICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENE 186
            FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ + +PE +N  +
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 187 YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           + +  D+W+ G  + E  S G+  +   + S V ++L +     E    P     +  D 
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPREMYDL 262
Query: 246 LIKCFLKDPKRR 257
           +  C+  D + R
Sbjct: 263 MNLCWTYDVENR 274

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 15/252 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAV-KSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G+FG+V               + + K+ A+ P     L  E   + Q+   P IVR 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRM 93
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G      + E +  L++E A  G L   +  Q N  +++ ++      +  G++++   
Sbjct: 94  IG----ICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENE 186
            FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ + +PE +N  +
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 187 YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           + +  D+W+ G  + E  S G+  +   + S V ++L +     E    P     +  D 
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPREMYDL 262
Query: 246 LIKCFLKDPKRR 257
           +  C+  D + R
Sbjct: 263 MNLCWTYDVENR 274

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR---Y 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 250
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 311 SVDDALQHPYI 321

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 15/252 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAV-KSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G+FG+V               + + K+ A+ P     L  E   + Q+   P IVR 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRM 73
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G      + E +  L++E A  G L   +  Q N  +++ ++      +  G++++   
Sbjct: 74  IG----ICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENE 186
            FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ + +PE +N  +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 187 YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           + +  D+W+ G  + E  S G+  +   + S V ++L +     E    P     +  D 
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPREMYDL 242
Query: 246 LIKCFLKDPKRR 257
           +  C+  D + R
Sbjct: 243 MNLCWTYDVENR 254

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR---Y 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 250
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 311 SVDDALQHPYI 321

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 34/197 (17%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L+ + VK +   +L+GL   H    +H D+K QN+L+    + K+ DFGLA+     G  
Sbjct: 105 LELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR---AFGIP 161
Query: 165 SQSFECRGTPL-YMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLL 222
             +F      L Y +P+ +     Y    DIW+ GC + EM +GKP +    D     L+
Sbjct: 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221
Query: 223 IRI-GVGDEL------------PNI----PGDLSEQGK------------DFLIKCFLKD 253
             I G  +E             PNI    P DL +  +            DFL      +
Sbjct: 222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281
Query: 254 PKRRWTAEMLLNHPFVC 270
           P  R +A+  L+HP+  
Sbjct: 282 PDMRLSAKQALHHPWFA 298

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 13/210 (6%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPS--SVTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +  E   L +AVK       +     L +E + +  +G   
Sbjct: 43  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 102
Query: 63  QIVRCFGDDYSFEKGERF-------YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
            IV   G       G          Y  LL +  R + AD + K++   L+  D+  ++ 
Sbjct: 103 NIVNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKAEAD-LDKEDGRPLELRDLLHFSS 159
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            + +G+  + SK  +H D+  +NVL+ +   AKI DFGLA+    D         R    
Sbjct: 160 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMAS 205
           +M+PES+ +  Y    D+W+ G  + E+ S
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEAL-------DQ 57
           G  +G G+FG V  A A  +  E   L +AVK        S    +EKEAL         
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-----KSTAHADEKEALMSELKIMSH 105
Query: 58  IGICPQIVRCFGDDYSFEKGERF-------YNLLLEYASRGSLADRVKKQNNGRLQESDV 110
           +G    IV   G       G          Y  LL +  R + AD + K++   L+  D+
Sbjct: 106 LGQHENIVNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKAEAD-LDKEDGRPLELRDL 162
Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
             ++  + +G+  + SK  +H D+  +NVL+ +   AKI DFGLA+    D         
Sbjct: 163 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
           R    +M+PES+ +  Y    D+W+ G  + E+ S
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 15/252 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAV-KSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G+FG+V               + + K+ A+ P     L  E   + Q+   P IVR 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRM 91
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G      + E +  L++E A  G L   +  Q N  +++ ++      +  G++++   
Sbjct: 92  IG----ICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES 144
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENE 186
            FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ + +PE +N  +
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 187 YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           + +  D+W+ G  + E  S G+  +   + S V ++L +     E    P     +  D 
Sbjct: 205 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPREMYDL 260
Query: 246 LIKCFLKDPKRR 257
           +  C+  D + R
Sbjct: 261 MNLCWTYDVENR 272

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 15/252 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAV-KSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G+FG+V               + + K+ A+ P     L  E   + Q+   P IVR 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRM 71
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G      + E +  L++E A  G L   +  Q N  +++ ++      +  G++++   
Sbjct: 72  IG----ICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES 124
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENE 186
            FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ + +PE +N  +
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 187 YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           + +  D+W+ G  + E  S G+  +   + S V ++L +     E    P     +  D 
Sbjct: 185 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPREMYDL 240
Query: 246 LIKCFLKDPKRR 257
           +  C+  D + R
Sbjct: 241 MNLCWTYDVENR 252

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 15/252 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAV-KSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G+FG+V               + + K+ A+ P     L  E   + Q+   P IVR 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRM 83
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G      + E +  L++E A  G L   +  Q N  +++ ++      +  G++++   
Sbjct: 84  IG----ICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENE 186
            FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ + +PE +N  +
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 187 YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           + +  D+W+ G  + E  S G+  +   + S V ++L +     E    P     +  D 
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPREMYDL 252
Query: 246 LIKCFLKDPKRR 257
           +  C+  D + R
Sbjct: 253 MNLCWTYDVENR 264

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC----- 61
           +VIG G FG V   +  K   +  S +A+K+         T +  +E L +  I      
Sbjct: 20  EVIGAGEFGEVCRGRL-KAPGKKESCVAIKTLK----GGYTERQRREFLSEASIMGQFEH 74
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P I+R  G             +L E+   G+L D   + N+G+     +    R +  G+
Sbjct: 75  PNIIRLEG----VVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIASGM 129
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK---KSSCDGERSQSFECRGTPLYMS 178
           R++    +VH D+  +N+LV  N   K++DFGL++   ++S D   + S   +    + +
Sbjct: 130 RYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTA 189
Query: 179 PESVNENEYEAPCDIWALGCAVVEMAS--GKPAWN 211
           PE++   ++ +  D W+ G  + E+ S   +P W+
Sbjct: 190 PEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD 224

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 21  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY +++E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 76  G---VCTREPPFY-IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 21  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY +++E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 76  G---VCTREPPFY-IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 121/275 (44%), Gaps = 20/275 (7%)
Query: 6   GDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +  +     +AVK   +    S    L +E + L  IG   
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKR---------- 112
            +V   G   +  K      +++E+   G+L+  ++ + N  +   D+ +          
Sbjct: 92  NVVNLLG---ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
           Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  + R 
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL 231
              +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G     
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRA 268
Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 269 PDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 72
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+++    G L D V++  +  +    +  +   
Sbjct: 73  ASVDNPHVCRLLGICLT-----STVQLIMQLMPFGXLLDYVREHKDN-IGSQYLLNWCVQ 126
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 127 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 185
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 241
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 242 PPICTIDVYMIMVKCWMIDADSR 264

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 23  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ E    GSL D   ++++ +     +    R +  G++
Sbjct: 78  NIIRLEG----VVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 132
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +N+L+  N   K++DFGL++    D E + +      P+ + SPE+
Sbjct: 133 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 192
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 247
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 248 AALYQLMLDCWQKDRNNRPKFEQIVS 273

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/242 (22%), Positives = 107/242 (44%), Gaps = 42/242 (17%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           IG GSFG+V   K       +   +AVK      P+                 P+  + F
Sbjct: 44  IGSGSFGTVYKGK-------WHGDVAVKILKVVDPT-----------------PEQFQAF 79
Query: 69  GDDYSFEKGERFYNLLL--EYASRGSLADRVK------KQNNGRLQESDVKRY-----TR 115
            ++ +  +  R  N+LL   Y ++ +LA   +         +  +QE+  + +      R
Sbjct: 80  RNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIAR 139
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
              +G+ ++H+K  +H D+K  N+ + +    KI DFGLA   S      Q  +  G+ L
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 176 YMSPESV---NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
           +M+PE +   + N +    D+++ G  + E+ +G+  ++H  + +   ++  +G G   P
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QIIFMVGRGYASP 257
Query: 233 NI 234
           ++
Sbjct: 258 DL 259

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC----- 61
           +VIG G FG V   +  K   +  S +A+K+         T +  +E L +  I      
Sbjct: 22  EVIGAGEFGEVCRGRL-KAPGKKESCVAIKTLK----GGYTERQRREFLSEASIMGQFEH 76
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P I+R  G             +L E+   G+L D   + N+G+     +    R +  G+
Sbjct: 77  PNIIRLEG----VVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIASGM 131
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK---KSSCDGERSQSFECRGTPLYMS 178
           R++    +VH D+  +N+LV  N   K++DFGL++   ++S D   + S   +    + +
Sbjct: 132 RYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTA 191
Query: 179 PESVNENEYEAPCDIWALGCAVVEMAS--GKPAWN 211
           PE++   ++ +  D W+ G  + E+ S   +P W+
Sbjct: 192 PEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD 226

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 71
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+++    G L D V++  +  +    +  +   
Sbjct: 72  ASVDNPHVCRLLGICLT-----STVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 125
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 184
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 240
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSR 263

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 52  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ E    GSL D   ++++ +     +    R +  G++
Sbjct: 107 NIIRLEG----VVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G+VH D+  +N+L+  N   K++DFGL++    D E + +      P+ + SPE+
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 276
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 75
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+++    G L D V++  +  +    +  +   
Sbjct: 76  ASVDNPHVCRLLGICLT-----STVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 129
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 130 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 188
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 244
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 245 PPICTIDVYMIMVKCWMIDADSR 267

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 74
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+++    G L D V++  +  +    +  +   
Sbjct: 75  ASVDNPHVCRLLGICLT-----STVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 128
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 187
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 243
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSR 266

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 73
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+++    G L D V++  +  +    +  +   
Sbjct: 74  ASVDNPHVCRLLGICLT-----STVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 127
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 186
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 242
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSR 265

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           VIG G FG V   +  KV  +    +A+K+      +  T K  ++ L +  I      P
Sbjct: 15  VIGVGEFGEVCSGRL-KVPGKREICVAIKTLK----AGYTDKQRRDFLSEASIMGQFDHP 69
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+   G         +   ++ EY   GSL D   ++N+GR     +    R +  G++
Sbjct: 70  NIIHLEG----VVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 124
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++    +VH D+  +N+LV  N   K++DFG+++    D E + +      P+ + +PE+
Sbjct: 125 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWN 211
           +   ++ +  D+W+ G  + E+ S   +P W+
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 72
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+++    G L D V++  +  +    +  +   
Sbjct: 73  ASVDNPHVCRLLGICLT-----STVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 126
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 127 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 185
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 241
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 242 PPICTIDVYMIMVKCWMIDADSR 264

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 26  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 80
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 81  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT----APESLAYN 192
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           WL  D++G G+  +V   +  K    F ++    + +   P  V ++ E E L ++    
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLF-AIKVFNNISFLRPVDVQMR-EFEVLKKLN-HK 67
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR-LQESDVKRYTRSMLKGL 121
            IV+ F  +   E   R   L++E+   GSL   +++ +N   L ES+     R ++ G+
Sbjct: 68  NIVKLFAIEE--ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEA----KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
            H+   G VH +IK  N++    ++     K+ DFG A++   D    Q     GT  Y+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVXLYGTEEYL 182
Query: 178 SPESV--------NENEYEAPCDIWALGCAVVEMASG 206
            P+          ++ +Y A  D+W++G      A+G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           WL  D++G G+  +V   +  K    F ++    + +   P  V ++ E E L ++    
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLF-AIKVFNNISFLRPVDVQMR-EFEVLKKLN-HK 67
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR-LQESDVKRYTRSMLKGL 121
            IV+ F  +   E   R   L++E+   GSL   +++ +N   L ES+     R ++ G+
Sbjct: 68  NIVKLFAIEE--ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEA----KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
            H+   G VH +IK  N++    ++     K+ DFG A++   D    Q     GT  Y+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYL 182
Query: 178 SPESV--------NENEYEAPCDIWALGCAVVEMASG 206
            P+          ++ +Y A  D+W++G      A+G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           VIG G FG V   +  KV  +    +A+K+      +  T K  ++ L +  I      P
Sbjct: 21  VIGVGEFGEVCSGRL-KVPGKREICVAIKTLK----AGYTDKQRRDFLSEASIMGQFDHP 75
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+   G         +   ++ EY   GSL D   ++N+GR     +    R +  G++
Sbjct: 76  NIIHLEG----VVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 130
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++    +VH D+  +N+LV  N   K++DFG+++    D E + +      P+ + +PE+
Sbjct: 131 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWN 211
           +   ++ +  D+W+ G  + E+ S   +P W+
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 222

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 121/275 (44%), Gaps = 20/275 (7%)
Query: 6   GDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +  +     +AVK   +    S    L +E + L  IG   
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKR---------- 112
            +V   G   +  K      +++E+   G+L+  ++ + N  +   D+ +          
Sbjct: 92  NVVNLLG---ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
           Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  + R 
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL 231
              +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G     
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 268
Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 269 PDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 21  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 76  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 131
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTR---Y 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL--------- 222
           Y +PE +    Y+   DIW++GC + EM  G    P  +H  Q + V   L         
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250
Query: 223 -----IRIGVGDE-----------LPNI--PGD------LSEQGKDFLIKCFLKDPKRRW 258
                +R  V +             P++  P D       + Q +D L K  + D  +R 
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRI 310
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 311 SVDEALQHPYI 321

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 120/281 (42%), Gaps = 38/281 (13%)
Query: 2   EWLRGDVIGHGSFGSV--------NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE 53
           E+  G ++G G FG+V         L  A KV      ++     +D    SVT   E  
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRN-RVLGWSPLSD----SVTCPLEVA 86
Query: 54  ALDQIGIC---PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDV 110
            L ++G     P ++R    D+ FE  E F  +L        L D + ++  G L E   
Sbjct: 87  LLWKVGAGGGHPGVIRLL--DW-FETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPS 141
Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFE 169
           + +   ++  ++H HS+G VH DIK +N+L+      AK+ DFG    +    E    F+
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG--SGALLHDEPYTDFD 199
Query: 170 CRGTPLYMSPESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG 228
             GT +Y  PE ++ ++Y A P  +W+LG  + +M  G   +   Q+     L       
Sbjct: 200 --GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL------- 250
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
               + P  +S      + +C    P  R + E +L  P++
Sbjct: 251 ----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPS--SVTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +  E   L +AVK       +     L +E + +  +G   
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN------------NGRLQESDV 110
            IV   G       G     ++ EY   G L + +++++            N  L   D+
Sbjct: 111 NIVNLLGA--CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
             ++  + +G+  + SK  +H D+  +NVL+ +   AKI DFGLA+    D         
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
           R    +M+PES+ +  Y    D+W+ G  + E+ S
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 38/272 (13%)
Query: 9   IGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPPSSVTLKN---EKEALDQIGICPQI 64
           +G G+FG V LA+   +S ++   L+AVK+  D  P+    K+   E E L  +     I
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQ-HEHI 79
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSL--------------ADRVKKQNNGRLQESDV 110
           V+ +G       G+    ++ EY   G L               D   +Q  G L  S +
Sbjct: 80  VKFYG---VCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
                 +  G+ ++ S+ FVH D+  +N LV  N   KI DFG+++    D   +  +  
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV 191
Query: 171 RGTPL----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
            G  +    +M PES+   ++    D+W+ G  + E+ + GK  W    ++ V   + + 
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ- 250
Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           G   E P +     ++  D ++ C+ ++P++R
Sbjct: 251 GRVLERPRV---CPKEVYDVMLGCWQREPQQR 279

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 25  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 79
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 80  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 135
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 191
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 32/226 (14%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEAL--------- 55
           G  +G G+FG V  A A  +  E   L +AVK        S    +EKEAL         
Sbjct: 36  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-----KSTAHADEKEALMSELKIMSH 90
Query: 56  --------DQIGIC----PQIVR----CFGDDYSFEKGERFYNLLLEYASRGSLADRVKK 99
                   + +G C    P +V     C+GD  +F +  +   +L    + G   + + K
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKAEAMLGPSLAPGQDPEGLDK 149
Query: 100 QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS 159
           ++   L+  D+  ++  + +G+  + SK  +H D+  +NVL+ +   AKI DFGLA+   
Sbjct: 150 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
            D         R    +M+PES+ +  Y    D+W+ G  + E+ S
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 26  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 80
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 81  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 192
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V +     V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 40  LGGGQYGEVYVG----VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 94
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G        E  + ++ EY   G+L D +++ N   +    +      +   + ++  K 
Sbjct: 95  G----VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN 150
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 151 FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 206
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
            +    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 207 TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLL 244

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 39/278 (14%)
Query: 9   IGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CP 62
           +G GSFG V    A  +   E  + +AVK+  +    S +L+   E L++  +     C 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 80
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------KQNNGR----LQESDVKR 112
            +VR  G      KG+    +++E  + G L   ++      + N GR    LQE  + +
Sbjct: 81  HVVRLLG---VVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 134
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
               +  G+ ++++K FVH ++  +N +V  +   KI DFG+ +    D   +  +   G
Sbjct: 135 MAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGG 190
Query: 173 TPL----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
             L    +M+PES+ +  +    D+W+ G  + E+ S  +  +    +  V   ++  G 
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 250
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
            D+  N P    E+  D +  C+  +P  R T   ++N
Sbjct: 251 LDQPDNCP----ERVTDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK--NEKEALDQIGIC-PQIV 65
           +G GSFG V+  K  +   +            C    V L+    +E +   G+  P+IV
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQ------------CAVKKVRLEVFRVEELVACAGLSSPRIV 113
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
             +G   +  +G  + N+ +E    GSL   +K+   G L E     Y    L+GL ++H
Sbjct: 114 PLYG---AVREGP-WVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLH 167
Query: 126 SKGFVHCDIKLQNVLVF-DNDEAKIADFGLAKKSSCDGERSQSFE---CRGTPLYMSPES 181
           ++  +H D+K  NVL+  D   A + DFG A     DG            GT  +M+PE 
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNH 212
           V     +A  DIW+  C ++ M +G   W  
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 40/190 (21%)
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YY 191
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL---------- 222
            +PE +    Y+   DIW++GC + EM  G    P  +H  Q + V   L          
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 223 ----IRIGVGDE-----------LPNI--PGD------LSEQGKDFLIKCFLKDPKRRWT 259
               +R  V +             P++  P D       + Q +D L K  + D  +R +
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 312 VDEALQHPYI 321

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 9   GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 122
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 123 VRHCHNXGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 178
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 227
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 228 SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 40/190 (21%)
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    Y
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YY 229
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV-------- 227
            +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G         
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 228 ----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRWT 259
                           G   P +      P D       + Q +D L K  + DP +R +
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 350 VDDALQHPYI 359

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 21  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 76  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 131
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK--NEKEALDQIGIC-PQIV 65
           +G GSFG V+  K  +   +            C    V L+    +E +   G+  P+IV
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQ------------CAVKKVRLEVFRVEELVACAGLSSPRIV 129
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
             +G   +  +G  + N+ +E    GSL   +K+   G L E     Y    L+GL ++H
Sbjct: 130 PLYG---AVREGP-WVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLH 183
Query: 126 SKGFVHCDIKLQNVLVF-DNDEAKIADFGLAKKSSCDGERSQSFE---CRGTPLYMSPES 181
           ++  +H D+K  NVL+  D   A + DFG A     DG            GT  +M+PE 
Sbjct: 184 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 243
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNH 212
           V     +A  DIW+  C ++ M +G   W  
Sbjct: 244 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 274

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 11/217 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAV-KSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G+FG+V               + + K+ A+ P     L  E   + Q+   P IVR 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRM 435
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G      + E +  L++E A  G L   +  Q N  +++ ++      +  G++++   
Sbjct: 436 IG----ICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES 488
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENE 186
            FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ + +PE +N  +
Sbjct: 489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 187 YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           + +  D+W+ G  + E  S G+  +   + S V ++L
Sbjct: 549 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 585

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 34  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 88
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 89  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 144
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 200
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 201 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 238

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 39/278 (14%)
Query: 9   IGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CP 62
           +G GSFG V    A  +   E  + +AVK+  +    S +L+   E L++  +     C 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE----SASLRERIEFLNEASVMKGFTCH 81
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------KQNNGR----LQESDVKR 112
            +VR  G      KG+    +++E  + G L   ++      + N GR    LQE  + +
Sbjct: 82  HVVRLLG---VVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE--MIQ 135
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
               +  G+ ++++K FVH ++  +N +V  +   KI DFG+ +    D   +  +   G
Sbjct: 136 MAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGG 191
Query: 173 TPL----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
             L    +M+PES+ +  +    D+W+ G  + E+ S  +  +    +  V   ++  G 
Sbjct: 192 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 251
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
            D+  N P    E+  D +  C+  +P  R T   ++N
Sbjct: 252 LDQPDNCP----ERVTDLMRMCWQFNPNMRPTFLEIVN 285

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 36/234 (15%)
Query: 10  GHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGIC--PQIVR 66
           G G+FG+V L K           +A+K     P      +N E + +  + +   P IV+
Sbjct: 32  GQGTFGTVQLGKEKSTGMS----VAIKKVIQDP----RFRNRELQIMQDLAVLHHPNIVQ 83
Query: 67  CFGDDYSFEKGER-----FYNLLLEYASRGSLADRVKK--QNNGRLQESD----VKRYTR 115
                Y +  GER     + N+++EY     + D + +  +N  R Q +     +K +  
Sbjct: 84  L--QSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 116 SMLK--GLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCDGERSQSFECRG 172
            +++  G  H+ S    H DIK  NVLV + D   K+ DFG AKK S   E + ++ C  
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYIC-- 193
Query: 173 TPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI 225
           +  Y +PE +  N+ Y    DIW++GC   EM  G+P +     +     ++R+
Sbjct: 194 SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 40/190 (21%)
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YY 191
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL---------- 222
            +PE +    Y+   DIW++GC + EM  G    P  +H  Q + V   L          
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 223 ----IRIGVGDE-----------LPNI--PGD------LSEQGKDFLIKCFLKDPKRRWT 259
               +R  V +             P++  P D       + Q +D L K  + D  +R +
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 312 VDEALQHPYI 321

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 38/202 (18%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK---KSSCD 161
           L +  ++ +    L+ ++ +H    +H D+K  N+L+  N + K+ DFGLA+   +S+ D
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 162 -----GERSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                G++S   E   T  Y +PE  +   +Y    D+W+ GC + E+   +P +  +  
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 216 SNVFSLLIRIGVGD--------------------ELPNIPGD--------LSEQGKDFLI 247
            +   L+  I +G                      LP  P          ++ +G D L 
Sbjct: 229 RHQLLLIFGI-IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 248 KCFLKDPKRRWTAEMLLNHPFV 269
           +  + DP +R TA+  L HP++
Sbjct: 288 RMLVFDPAKRITAKEALEHPYL 309

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL--------- 222
           Y +PE +    Y+   DIW++GC + EM  G    P  +H  Q + V   L         
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250
Query: 223 -----IRIGVGDE-----------LPNI--PGD------LSEQGKDFLIKCFLKDPKRRW 258
                +R  V +             P++  P D       + Q +D L K  + D  +R 
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 311 SVDEALQHPYI 321

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 89/186 (47%), Gaps = 9/186 (4%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           +++E+   G+L D   ++++G+     +    R +  G+R++   G+VH D+  +N+LV 
Sbjct: 121 IVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVN 179
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENEYEAPCDIWALGCAVV 201
            N   K++DFGL++    D E   +      P+ + +PE++   ++ +  D+W+ G  + 
Sbjct: 180 SNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMW 239
Query: 202 EMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT 259
           E+ S   +P W+      + +    I  G  LP  P D        ++ C+ K+   R  
Sbjct: 240 EVMSYGERPYWDMSNQDVIKA----IEEGYRLPA-PMDCPAGLHQLMLDCWQKERAERPK 294
Query: 260 AEMLLN 265
            E ++ 
Sbjct: 295 FEQIVG 300

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 191
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 251
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 252 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 311
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 312 SVDDALQHPYI 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 250
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 311 SVDDALQHPYI 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 133 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 189
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 249
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 250 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 309
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 310 SVDDALQHPYI 320

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 23  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 77
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 78  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 133
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 189
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 190 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 191
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL--------- 222
           Y +PE +    Y+   DIW++GC + EM  G    P  +H  Q + V   L         
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 223 -----IRIGVGDE-----------LPNI--PGD------LSEQGKDFLIKCFLKDPKRRW 258
                +R  V +             P++  P D       + Q +D L K  + D  +R 
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 312 SVDEALQHPYI 322

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 191
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 251
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 252 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 311
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 312 SVDDALQHPYI 322

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 184
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 244
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 245 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 304
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 305 SVDDALQHPYI 315

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 250
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 251 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 310
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 311 SVDDALQHPYI 321

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +   G          T  
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRY 192
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL--------- 222
           Y +PE +    Y+   DIW++GC + EM  G    P  +H  Q + V   L         
Sbjct: 193 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 252
Query: 223 -----IRIGVGDE-----------LPNI--PGD------LSEQGKDFLIKCFLKDPKRRW 258
                +R  V +             P++  P D       + Q +D L K  + D  +R 
Sbjct: 253 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 312
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 313 SVDEALQHPYI 323

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 26  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 80
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 81  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 192
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 40/190 (21%)
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    Y
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YY 229
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV-------- 227
            +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G         
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 228 ----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRWT 259
                           G   P +      P D       + Q +D L K  + DP +R +
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 350 VDDALQHPYI 359

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 11/217 (5%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAV-KSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +G G+FG+V               + + K+ A+ P     L  E   + Q+   P IVR 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRM 436
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK 127
            G      + E +  L++E A  G L   +  Q N  +++ ++      +  G++++   
Sbjct: 437 IG----ICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES 489
Query: 128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENE 186
            FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ + +PE +N  +
Sbjct: 490 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 549
Query: 187 YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           + +  D+W+ G  + E  S G+  +   + S V ++L
Sbjct: 550 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 586

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 183
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 304 SVDDALQHPYI 314

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/258 (21%), Positives = 116/258 (44%), Gaps = 17/258 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G GSFG V LA  +    +    +  K           ++ E   L  +   P I++  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKL- 73
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y   K +    +++EYA    L D + +++  ++ E + +R+ + ++  + + H   
Sbjct: 74  ---YDVIKSKDEIIMVIEYAG-NELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK 127
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
            VH D+K +N+L+ ++   KIADFGL+   + DG   ++  C G+P Y +PE ++   Y 
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKT-SC-GSPNYAAPEVISGKLYA 184
Query: 189 AP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
            P  D+W+ G  +  M   +  ++ +    +F       + + +  +P  LS      + 
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK-----NISNGVYTLPKFLSPGAAGLIK 239
Query: 248 KCFLKDPKRRWTAEMLLN 265
           +  + +P  R +   ++ 
Sbjct: 240 RMLIVNPLNRISIHEIMQ 257

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK--NEKEALDQIGIC-PQIV 65
           +G GSFG V+  K  +   +            C    V L+    +E +   G+  P+IV
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQ------------CAVKKVRLEVFRVEELVACAGLSSPRIV 127
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
             +G   +  +G  + N+ +E    GSL   +K+   G L E     Y    L+GL ++H
Sbjct: 128 PLYG---AVREGP-WVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLH 181
Query: 126 SKGFVHCDIKLQNVLVF-DNDEAKIADFGLAKKSSCDGERSQSFE---CRGTPLYMSPES 181
           ++  +H D+K  NVL+  D   A + DFG A     DG            GT  +M+PE 
Sbjct: 182 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 241
Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNH 212
           V     +A  DIW+  C ++ M +G   W  
Sbjct: 242 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 21  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 76  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 184
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-RIGV------- 227
           Y +PE +    Y+   DIW++GC + EM   K  +  +   + ++ +I ++G        
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 244
Query: 228 -----------------GDELPNI------PGD------LSEQGKDFLIKCFLKDPKRRW 258
                            G   P +      P D       + Q +D L K  + DP +R 
Sbjct: 245 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 304
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 305 SVDDALQHPYI 315

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 23  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 77
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 78  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 133
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 189
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 190 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 30/272 (11%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 13  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITER--GALQEELARSFFWQVLEA 126
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 127 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 182
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V  E  +     
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH----- 237
Query: 239 SEQGKDFLIK-CFLKDPKRRWTAEMLLNHPFV 269
                  LI+ C    P  R T E + NHP++
Sbjct: 238 -------LIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 40/190 (21%)
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    Y
Sbjct: 135 MLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR---YY 191
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL---------- 222
            +PE +    Y+   DIW++G  + EM  G    P  +H  Q + V   L          
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 223 ----IRIGVGDE-----------LPNI--PGD------LSEQGKDFLIKCFLKDPKRRWT 259
               +R  V +             P++  P D       + Q +D L K  + D  +R +
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 312 VDEALQHPYI 321

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 26  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 80
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 81  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 136
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 192
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 38/202 (18%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK---KSSCD 161
           L +  ++ +    L+ ++ +H    +H D+K  N+L+  N + K+ DFGLA+   +S+ D
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 162 -----GERSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                G++S   E   T  Y +PE  +   +Y    D+W+ GC + E+   +P +  +  
Sbjct: 169 NSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 216 SNVFSLLIRIGVGD--------------------ELPNIPGD--------LSEQGKDFLI 247
            +   L+  I +G                      LP  P          ++ +G D L 
Sbjct: 229 RHQLLLIFGI-IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 248 KCFLKDPKRRWTAEMLLNHPFV 269
           +  + DP +R TA+  L HP++
Sbjct: 288 RMLVFDPAKRITAKEALEHPYL 309

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 116/267 (43%), Gaps = 31/267 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPS-LMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVR 66
           +G G+FG V LA+   +  E    L+AVK+  D   ++      E E L  +     IV+
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVK 79
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNN-----------GRLQESDVKRYTR 115
            +G      +G+    ++ EY   G L   ++                 L +S +    +
Sbjct: 80  FYG---VCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            +  G+ ++ S+ FVH D+  +N LV +N   KI DFG+++    D   +  +   G  +
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTM 191
Query: 176 ----YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDE 230
               +M PES+   ++    D+W+LG  + E+ + GK  W    ++ V   + +  V   
Sbjct: 192 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR 251
Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRR 257
               P ++ E     ++ C+ ++P  R
Sbjct: 252 PRTCPQEVYE----LMLGCWQREPHMR 274

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 21  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 76  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 71
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 72  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGXLLDYVREHKDN-IGSQYLLNWCVQ 125
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 184
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 240
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSR 263

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 38/202 (18%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK---KSSCD 161
           L +  ++ +    L+ ++ +H    +H D+K  N+L+  N + K+ DFGLA+   +S+ D
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 162 -----GERSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                G++S   E   T  Y +PE  +   +Y    D+W+ GC + E+   +P +  +  
Sbjct: 169 NSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 216 SNVFSLLIRIGVGD--------------------ELPNIPGD--------LSEQGKDFLI 247
            +   L+  I +G                      LP  P          ++ +G D L 
Sbjct: 229 RHQLLLIFGI-IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 248 KCFLKDPKRRWTAEMLLNHPFV 269
           +  + DP +R TA+  L HP++
Sbjct: 288 RMLVFDPAKRITAKEALEHPYL 309

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 40/190 (21%)
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    Y
Sbjct: 135 MLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR---YY 191
Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGK---PAWNH-KQDSNVFSLL---------- 222
            +PE +    Y+   DIW++G  + EM  G    P  +H  Q + V   L          
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 223 ----IRIGVGDE-----------LPNI--PGD------LSEQGKDFLIKCFLKDPKRRWT 259
               +R  V +             P++  P D       + Q +D L K  + D  +R +
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 312 VDEALQHPYI 321

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 19  LGGGQYGEVY----EGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 73
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 74  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 129
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWT----APESLAYN 185
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL 223

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/258 (21%), Positives = 116/258 (44%), Gaps = 17/258 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G GSFG V LA  +    +    +  K           ++ E   L  +   P I++  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKL- 69
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y   K +    +++EYA    L D + +++  ++ E + +R+ + ++  + + H   
Sbjct: 70  ---YDVIKSKDEIIMVIEYAG-NELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK 123
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
            VH D+K +N+L+ ++   KIADFGL+   + DG   ++  C G+P Y +PE ++   Y 
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKT-SC-GSPNYAAPEVISGKLYA 180
Query: 189 AP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
            P  D+W+ G  +  M   +  ++ +    +F       + + +  +P  LS      + 
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK-----NISNGVYTLPKFLSPGAAGLIK 235
Query: 248 KCFLKDPKRRWTAEMLLN 265
           +  + +P  R +   ++ 
Sbjct: 236 RMLIVNPLNRISIHEIMQ 253

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 65
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 66  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 119
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 178
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 234
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSR 257

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/257 (21%), Positives = 116/257 (45%), Gaps = 17/257 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G GSFG V LA  +    +    +  K           ++ E   L  +   P I++  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKL- 78
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y   K +    +++EYA    L D + +++  ++ E + +R+ + ++  + + H   
Sbjct: 79  ---YDVIKSKDEIIMVIEYAG-NELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK 132
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
            VH D+K +N+L+ ++   KIADFGL+   + DG   ++  C G+P Y +PE ++   Y 
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKT-SC-GSPNYAAPEVISGKLYA 189
Query: 189 AP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
            P  D+W+ G  +  M   +  ++ +    +F       + + +  +P  LS      + 
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK-----NISNGVYTLPKFLSPGAAGLIK 244
Query: 248 KCFLKDPKRRWTAEMLL 264
           +  + +P  R +   ++
Sbjct: 245 RMLIVNPLNRISIHEIM 261

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 73
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 74  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 127
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 186
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 242
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSR 265

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 71
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 72  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 125
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 184
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 240
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSR 263

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 74
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 75  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 128
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 187
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 243
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSR 266

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 96
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 97  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 150
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 151 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 209
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 265
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 266 PPICTIDVYMIMVKCWMIDADSR 288

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 74
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 75  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 128
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 187
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 243
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSR 266

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 22  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 76
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 77  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 132
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT----APESLAYN 188
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 189 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 226

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 30/272 (11%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 12  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 125
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 126 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 181
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V  E  +     
Sbjct: 182 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH----- 236
Query: 239 SEQGKDFLIK-CFLKDPKRRWTAEMLLNHPFV 269
                  LI+ C    P  R T E + NHP++
Sbjct: 237 -------LIRWCLALRPSDRPTFEEIQNHPWM 261

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 78
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 79  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 132
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 191
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 247
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSR 270

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 77
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 78  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 131
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 132 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 246
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 247 PPICTIDVYMIMVKCWMIDADSR 269

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/257 (21%), Positives = 116/257 (45%), Gaps = 17/257 (6%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G GSFG V LA  +    +    +  K           ++ E   L  +   P I++  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKL- 79
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
              Y   K +    +++EYA    L D + +++  ++ E + +R+ + ++  + + H   
Sbjct: 80  ---YDVIKSKDEIIMVIEYAG-NELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK 133
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
            VH D+K +N+L+ ++   KIADFGL+   + DG   ++  C G+P Y +PE ++   Y 
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKT-SC-GSPNYAAPEVISGKLYA 190
Query: 189 AP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLI 247
            P  D+W+ G  +  M   +  ++ +    +F       + + +  +P  LS      + 
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK-----NISNGVYTLPKFLSPGAAGLIK 245
Query: 248 KCFLKDPKRRWTAEMLL 264
           +  + +P  R +   ++
Sbjct: 246 RMLIVNPLNRISIHEIM 262

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 118/298 (39%), Gaps = 66/298 (22%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN---EKEALDQIGICPQIV 65
           IG G FGSV       V      + A+K        SV  +N   E  A   +G    +V
Sbjct: 15  IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 70
Query: 66  RCFG----DDYSFEKGERFYNLLLEYASRGSLADRVKKQNN--GRLQESDVKRYTRSMLK 119
           R F     DD+   + E        Y + GSLAD + +        +E+++K     + +
Sbjct: 71  RYFSAWAEDDHMLIQNE--------YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 120 GLRHIHSKGFVHCDIKLQNVLVF------------DNDE-------AKIADFGLAKKSSC 160
           GLR+IHS   VH DIK  N+ +             D D+        KI D G   + S 
Sbjct: 123 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 181
Query: 161 DGERSQSFECRGTPLYMSPESVNENEYEAP-CDIWALGCAVVEMASGKP------AWNHK 213
               S   E  G   +++ E + EN    P  DI+AL   VV  A  +P       W+  
Sbjct: 182 ----SPQVE-EGDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPRNGDQWHE- 235
Query: 214 QDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA 271
                    IR G    LP IP  LS++  + L      DP+RR +A  L+ H  + +
Sbjct: 236 ---------IRQG---RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 281

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 30/272 (11%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 9   GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 122
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 178
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V  E  +     
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH----- 233
Query: 239 SEQGKDFLIK-CFLKDPKRRWTAEMLLNHPFV 269
                  LI+ C    P  R T E + NHP++
Sbjct: 234 -------LIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 118/260 (45%), Gaps = 21/260 (8%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G FG V L K           +AVK   +   S      E + + ++   P++V+ +
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-----VAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLVKFY 69
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G        E    ++ EY S G L + ++    G L+ S +      + +G+  + S  
Sbjct: 70  G----VCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
           F+H D+  +N LV  +   K++DFG+  +   D +   S   +    + +PE  +  +Y 
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMT-RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 189 APCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL--PNIPGDLSEQGKDF 245
           +  D+WA G  + E+ S GK  ++   +S V   ++++  G  L  P++  D   Q    
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEV---VLKVSQGHRLYRPHLASDTIYQ---I 237
Query: 246 LIKCFLKDPKRRWTAEMLLN 265
           +  C+ + P++R T + LL+
Sbjct: 238 MYSCWHELPEKRPTFQQLLS 257

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 29  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 142
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 198
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 247
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 248 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 23  LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 77
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 78  G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 133
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H D+  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT----APESLAYN 189
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 190 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 30/272 (11%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 14  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 127
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 183
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V  E  +     
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH----- 238
Query: 239 SEQGKDFLIK-CFLKDPKRRWTAEMLLNHPFV 269
                  LI+ C    P  R T E + NHP++
Sbjct: 239 -------LIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 29  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 142
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 198
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 247
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 248 SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 9   GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 122
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 178
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRV----------- 227
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 29  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 142
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 198
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 247
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 248 SXECQHLIRWCLALRPXDRPTFEEIQNHPWM 278

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 30/272 (11%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 13  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 126
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 127 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 182
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V  E  +     
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH----- 237
Query: 239 SEQGKDFLIK-CFLKDPKRRWTAEMLLNHPFV 269
                  LI+ C    P  R T E + NHP++
Sbjct: 238 -------LIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 28  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 141
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 142 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 197
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 246
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 247 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 30/272 (11%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 14  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 127
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 183
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V  E  +     
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH----- 238
Query: 239 SEQGKDFLIK-CFLKDPKRRWTAEMLLNHPFV 269
                  LI+ C    P  R T E + NHP++
Sbjct: 239 -------LIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 28  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 141
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 142 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 197
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 246
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 247 SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 48  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 161
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 217
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 266
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 41  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 154
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 210
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 259
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 260 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 30/272 (11%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 14  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 127
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 183
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V  E  +     
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH----- 238
Query: 239 SEQGKDFLIK-CFLKDPKRRWTAEMLLNHPFV 269
                  LI+ C    P  R T E + NHP++
Sbjct: 239 -------LIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ EY + G L + +++  + R Q   +    + + + + ++ SK F+H D+  +N LV 
Sbjct: 96  IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 154
Query: 143 DNDEAKIADFGLAKKSSCDGERS---QSFECRGTPLYMSPESVNENEYEAPCDIWALGCA 199
           D    K++DFGL++    D E S     F  R +P    PE +  +++ +  DIWA G  
Sbjct: 155 DQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSP----PEVLMYSKFSSKSDIWAFGVL 210
Query: 200 VVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRW 258
           + E+ S GK  +    +S        I  G  L   P   SE+    +  C+ +    R 
Sbjct: 211 MWEIYSLGKMPYERFTNSETAE---HIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERP 266
Query: 259 TAEMLLNHPFVCADDQT 275
           T ++LL++     D+++
Sbjct: 267 TFKILLSNILDVMDEES 283

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 56  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 169
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 170 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 225
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 274
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 275 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 111/266 (41%), Gaps = 23/266 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           V+G G FG V   +      + PS   +           T K  ++ L +  I      P
Sbjct: 52  VVGAGEFGEVCSGRL-----KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G         +   ++ E    GSL D   ++++ +     +    R +  G++
Sbjct: 107 NIIRLEG----VVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++   G VH D+  +N+L+  N   K++DFGL++    D E + +      P+ + SPE+
Sbjct: 162 YLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           +   ++ +  D+W+ G  + E+ S   +P W          ++  +  G  LP  P D  
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPP-PMDCP 276
Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLN 265
                 ++ C+ KD   R   E +++
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           VIG G FG V   +  KV  +    +A+K+      +  T K  ++ L +  I      P
Sbjct: 36  VIGVGEFGEVCSGRL-KVPGKREICVAIKTLK----AGYTDKQRRDFLSEASIMGQFDHP 90
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+   G     +       ++ EY   GSL D   ++N+GR     +    R +  G++
Sbjct: 91  NIIHLEGVVTKCKP----VMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 145
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPES 181
           ++     VH D+  +N+LV  N   K++DFG+++    D E + +      P+ + +PE+
Sbjct: 146 YLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWN 211
           +   ++ +  D+W+ G  + E+ S   +P W+
Sbjct: 206 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 237

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 36  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 149
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 150 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 205
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 206 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 254
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 255 SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 41  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 154
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 210
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRV----------- 259
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 260 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 61  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 174
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 175 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 230
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 231 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 279
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 280 SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 42  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 155
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 211
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRV----------- 260
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 261 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           VIG G FG V  +   K+  +    +A+K+      S  T K  ++ L +  I      P
Sbjct: 40  VIGAGEFGEV-CSGHLKLPGKREIFVAIKTLK----SGYTEKQRRDFLSEASIMGQFDHP 94
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            ++   G             ++ E+   GSL D   +QN+G+     +    R +  G++
Sbjct: 95  NVIHLEG----VVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMK 149
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK---KSSCDGERSQSFECRGTPLYMSP 179
           ++    +VH D+  +N+LV  N   K++DFGL++     + D   + +   +    + +P
Sbjct: 150 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209
Query: 180 ESVNENEYEAPCDIWALGCAVVEMAS--GKPAWN 211
           E++   ++ +  D+W+ G  + E+ S   +P W+
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 243

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 42  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 155
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 211
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRV----------- 260
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 261 SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 56  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 169
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 170 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 225
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----------- 274
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 275 SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 41  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 154
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 210
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRV----------- 259
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 260 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 64/124 (51%), Gaps = 1/124 (0%)
Query: 82  NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV 141
            L+ +Y   GSL D V+ Q+ G L    +  +   + KG+ ++   G VH ++  +NVL+
Sbjct: 90  QLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 148
Query: 142 FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVV 201
               + ++ADFG+A     D ++    E +    +M+ ES++  +Y    D+W+ G  V 
Sbjct: 149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVW 208
Query: 202 EMAS 205
           E+ +
Sbjct: 209 ELMT 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 64/124 (51%), Gaps = 1/124 (0%)
Query: 82  NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV 141
            L+ +Y   GSL D V+ Q+ G L    +  +   + KG+ ++   G VH ++  +NVL+
Sbjct: 108 QLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 166
Query: 142 FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVV 201
               + ++ADFG+A     D ++    E +    +M+ ES++  +Y    D+W+ G  V 
Sbjct: 167 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVW 226
Query: 202 EMAS 205
           E+ +
Sbjct: 227 ELMT 230

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 41  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 154
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 210
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRV----------- 259
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 260 SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 125/278 (44%), Gaps = 35/278 (12%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCAD-CPPSSVT-LKNEKEALDQIGICP 62
           G  +G G FG V  A A  +      + +AVK   +   PS +  L +E   L Q+   P
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HP 86
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQ---------------------- 100
            +++ +G     + G     L++EYA  GSL   +++                       
Sbjct: 87  HVIKLYGA--CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 101 NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC 160
           +   L   D+  +   + +G++++     VH D+  +N+LV +  + KI+DFGL++    
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVF 219
           +    +  + R    +M+ ES+ ++ Y    D+W+ G  + E+ + G   +       +F
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           +LL + G   E P+   + SE+    +++C+ ++P +R
Sbjct: 263 NLL-KTGHRMERPD---NCSEEMYRLMLQCWKQEPDKR 296

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 42  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 155
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 211
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRV----------- 260
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 261 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
           G ++G G FGSV      +VS   P  +A+K    D       L N      ++ +  ++
Sbjct: 42  GPLLGSGGFGSV--YSGIRVSDNLP--VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 65  VRCFGDDYS----FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              F         FE+ + F  +L        L D + ++  G LQE   + +   +L+ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 155
Query: 121 LRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +RH H+ G +H DIK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  P
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPP 211
Query: 180 ESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +  + Y      +W+LG  + +M  G   + H ++     +  R  V           
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRV----------- 260
Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S + +  +  C    P  R T E + NHP++
Sbjct: 261 SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEAL--------- 55
           G  +G G+FG V  A A  +  E   L +AVK        S    +EKEAL         
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-----KSTAHADEKEALMSELKIMSH 105
Query: 56  --------DQIGIC----PQIVR----CFGDDYSFEKGERFYNLLLEYASRGSLADRVKK 99
                   + +G C    P +V     C+GD  +F + +R   L  EY+   S       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGL--EYSYNPS------H 157
Query: 100 QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS 159
               +L   D+  ++  + +G+  + SK  +H D+  +NVL+ +   AKI DFGLA+   
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 217
Query: 160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
            D         R    +M+PES+ +  Y    D+W+ G  + E+ S
Sbjct: 218 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 114/267 (42%), Gaps = 30/267 (11%)
Query: 2   EWLRGDVIGHGSFGSVN----LAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ 57
           E+ +  V+G G+FG+V     + +  KV  + P  +     A  P      K  KE LD+
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKV--KIPVAIMELREATSP------KANKEILDE 101
Query: 58  IGIC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKR 112
             +      P + R  G   +         L+ +    G L D V++  +  +    +  
Sbjct: 102 AYVMASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 155
Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
           +   + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E   
Sbjct: 156 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGK 214
Query: 173 TPL-YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDE 230
            P+ +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ 
Sbjct: 215 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GER 271
Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           LP  P   +      ++KC++ D   R
Sbjct: 272 LPQ-PPICTIDVYMIMVKCWMIDADSR 297

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 20/221 (9%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ----IGIC 61
           G+ +G G FG V     +  +      +AVK  A      +T +  K+  DQ    +  C
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTT------VAVKKLA--AMVDITTEELKQQFDQEIKVMAKC 81
Query: 62  PQ--IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVK-RYTRSML 118
               +V   G    F        L+  Y   GSL DR+   +        ++ +  +   
Sbjct: 82  QHENLVELLG----FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 137
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            G+  +H    +H DIK  N+L+ +   AKI+DFGLA+ S    +        GT  YM+
Sbjct: 138 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
           PE++   E     DI++ G  ++E+ +G PA +  ++  + 
Sbjct: 198 PEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 237

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 20/221 (9%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ----IGIC 61
           G+ +G G FG V     +  +      +AVK  A      +T +  K+  DQ    +  C
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTT------VAVKKLA--AMVDITTEELKQQFDQEIKVMAKC 87
Query: 62  PQ--IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVK-RYTRSML 118
               +V   G    F        L+  Y   GSL DR+   +        ++ +  +   
Sbjct: 88  QHENLVELLG----FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            G+  +H    +H DIK  N+L+ +   AKI+DFGLA+ S    +        GT  YM+
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
           PE++   E     DI++ G  ++E+ +G PA +  ++  + 
Sbjct: 204 PEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 29/220 (13%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSVTLKNEKEAL-------DQ 57
           G  +G G+FG V  A A  +  E   L +AVK        S    +EKEAL         
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-----KSTAHADEKEALMSELKIMSH 105
Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN------------NGRL 105
           +G    IV   G       G     ++ EY   G L + +++++            N   
Sbjct: 106 LGQHENIVNLLGA--CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 106 QESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERS 165
              D+  ++  + +G+  + SK  +H D+  +NVL+ +   AKI DFGLA+    D    
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 166 QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS 205
                R    +M+PES+ +  Y    D+W+ G  + E+ S
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 75
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+++    G L D V++  +  +    +  +   
Sbjct: 76  ASVDNPHVCRLLGICLT-----STVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 129
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFG AK    + E+    E    P+ 
Sbjct: 130 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-EKEYHAEGGKVPIK 188
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 244
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 245 PPICTIDVYMIMVKCWMIDADSR 267

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 9/216 (4%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G+FGSV          +    + V         +  +  E + + Q+   P IVR  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLI 76
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      + E    L++E A  G L   +  +    +  S+V      +  G++++  K 
Sbjct: 77  G----VCQAEALM-LVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENEY 187
           FVH D+  +NVL+ +   AKI+DFGL+K    D     +      PL + +PE +N  ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 188 EAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLL 222
            +  D+W+ G  + E ++ G+  +   +   V + +
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 21/241 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 74
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 75  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 128
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 187
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQP 244
Query: 235 P 235
           P
Sbjct: 245 P 245

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+  G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 78
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+++    G L D V++  +  +    +  +   
Sbjct: 79  ASVDNPHVCRLLGICLT-----STVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 132
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 191
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 247
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSR 270

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 21/241 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 81
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 82  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 135
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 136 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 194
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQP 251
Query: 235 P 235
           P
Sbjct: 252 P 252

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 73
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+++    G L D V++  +  +    +  +   
Sbjct: 74  ASVDNPHVCRLLGICLT-----STVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 127
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFG AK    + E+    E    P+ 
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-EKEYHAEGGKVPIK 186
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 242
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSR 265

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 22/277 (7%)
Query: 6   GDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +  +     +AVK   +    S    L +E + L  IG   
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNN------------GRLQESDV 110
            +V   G   +  K      +++E+   G+L+  ++ + N              L    +
Sbjct: 94  NVVNLLG---ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHL 150
Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
             Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  + 
Sbjct: 151 IXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD 229
           R    +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G   
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270
Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
             P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 271 RAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 68
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 69  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 122
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + +G+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 123 IAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 181
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 237
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 238 PPICTIDVYMIMVKCWMIDADSR 260

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 125/278 (44%), Gaps = 35/278 (12%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCAD-CPPSSVT-LKNEKEALDQIGICP 62
           G  +G G FG V  A A  +      + +AVK   +   PS +  L +E   L Q+   P
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HP 86
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQ---------------------- 100
            +++ +G     + G     L++EYA  GSL   +++                       
Sbjct: 87  HVIKLYGA--CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 101 NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC 160
           +   L   D+  +   + +G++++     VH D+  +N+LV +  + KI+DFGL++    
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVF 219
           +    +  + R    +M+ ES+ ++ Y    D+W+ G  + E+ + G   +       +F
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           +LL + G   E P+   + SE+    +++C+ ++P +R
Sbjct: 263 NLL-KTGHRMERPD---NCSEEMYRLMLQCWKQEPDKR 296

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 21/241 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 71
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 72  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 125
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 184
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQP 241
Query: 235 P 235
           P
Sbjct: 242 P 242

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 125/278 (44%), Gaps = 35/278 (12%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCAD-CPPSSVT-LKNEKEALDQIGICP 62
           G  +G G FG V  A A  +      + +AVK   +   PS +  L +E   L Q+   P
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HP 86
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQ---------------------- 100
            +++ +G     + G     L++EYA  GSL   +++                       
Sbjct: 87  HVIKLYGA--CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 101 NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC 160
           +   L   D+  +   + +G++++     VH D+  +N+LV +  + KI+DFGL++    
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVF 219
           +    +  + R    +M+ ES+ ++ Y    D+W+ G  + E+ + G   +       +F
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           +LL + G   E P+   + SE+    +++C+ ++P +R
Sbjct: 263 NLL-KTGHRMERPD---NCSEEMYRLMLQCWKQEPDKR 296

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 1/100 (1%)
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+  +H    +H DIK  N+L+ +   AKI+DFGLA+ S    +        GT  YM+P
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
           E++   E     DI++ G  ++E+ +G PA +  ++  + 
Sbjct: 205 EAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 118/298 (39%), Gaps = 66/298 (22%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN---EKEALDQIGICPQIV 65
           IG G FGSV       V      + A+K        SV  +N   E  A   +G    +V
Sbjct: 17  IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 72
Query: 66  RCFG----DDYSFEKGERFYNLLLEYASRGSLADRVKKQNN--GRLQESDVKRYTRSMLK 119
           R F     DD+   + E        Y + GSLAD + +        +E+++K     + +
Sbjct: 73  RYFSAWAEDDHMLIQNE--------YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 120 GLRHIHSKGFVHCDIKLQNVLVF------------DNDE-------AKIADFGLAKKSSC 160
           GLR+IHS   VH DIK  N+ +             D D+        KI D G   + S 
Sbjct: 125 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 183
Query: 161 DGERSQSFECRGTPLYMSPESVNENEYEAP-CDIWALGCAVVEMASGKP------AWNHK 213
               S   E  G   +++ E + EN    P  DI+AL   VV  A  +P       W+  
Sbjct: 184 ----SPQVE-EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE- 237
Query: 214 QDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA 271
                    IR G    LP IP  LS++  + L      DP+RR +A  L+ H  + +
Sbjct: 238 ---------IRQG---RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 283

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 79/191 (41%), Gaps = 40/191 (20%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +            R    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTR---Y 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGK-----------------------PAWNH 212
           Y +PE +    Y+   DIW++GC + EM   K                       PA+  
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMK 250
Query: 213 KQDSNVFSLLIR----IGVGDE--LPNI--PGD------LSEQGKDFLIKCFLKDPKRRW 258
           K    V + +       G   E   P++  P D       + Q +D L K  + D  +R 
Sbjct: 251 KLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 259 TAEMLLNHPFV 269
           + +  L HP++
Sbjct: 311 SVDEALQHPYI 321

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQI-GICPQI 64
           +G G FG V   K          ++   S ++      + V +    E L Q+ G+C + 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK- 74
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
                        +R   ++ EY + G L + +++  + R Q   +    + + + + ++
Sbjct: 75  -------------QRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYL 120
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
            SK F+H D+  +N LV D    K++DFGL+ +   D E + S   +    +  PE +  
Sbjct: 121 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 185 NEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
           +++ +  DIWA G  + E+ S GK  +    +S        I  G  L   P   SE+  
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---HIAQGLRLYR-PHLASEKVY 235
Query: 244 DFLIKCFLKDPKRRWTAEMLLNHPFVCADDQT 275
             +  C+ +    R T ++LL++     D+++
Sbjct: 236 TIMYSCWHEKADERPTFKILLSNILDVMDEES 267

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HSKG +H D+K  NV++     + ++ D+GLA+ 
Sbjct: 128 KQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEF 187
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                  +Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   +  + H QD
Sbjct: 188 YHP----AQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQD 243
Query: 216 SNVFSLLIRIG 226
           +  +  L+RI 
Sbjct: 244 N--YDQLVRIA 252

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 118/298 (39%), Gaps = 66/298 (22%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN---EKEALDQIGICPQIV 65
           IG G FGSV       V      + A+K        SV  +N   E  A   +G    +V
Sbjct: 17  IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 72
Query: 66  RCFG----DDYSFEKGERFYNLLLEYASRGSLADRVKKQNN--GRLQESDVKRYTRSMLK 119
           R F     DD+   + E        Y + GSLAD + +        +E+++K     + +
Sbjct: 73  RYFSAWAEDDHMLIQNE--------YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 120 GLRHIHSKGFVHCDIKLQNVLVF------------DNDE-------AKIADFGLAKKSSC 160
           GLR+IHS   VH DIK  N+ +             D D+        KI D G   + S 
Sbjct: 125 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 183
Query: 161 DGERSQSFECRGTPLYMSPESVNENEYEAP-CDIWALGCAVVEMASGKP------AWNHK 213
               S   E  G   +++ E + EN    P  DI+AL   VV  A  +P       W+  
Sbjct: 184 ----SPQVE-EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE- 237
Query: 214 QDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA 271
                    IR G    LP IP  LS++  + L      DP+RR +A  L+ H  + +
Sbjct: 238 ---------IRQG---RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 283

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HSKG +H D+K  NV++     + ++ D+GLA+ 
Sbjct: 123 KQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEF 182
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                  +Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   +  + H QD
Sbjct: 183 YHP----AQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQD 238
Query: 216 SNVFSLLIRIG 226
           +  +  L+RI 
Sbjct: 239 N--YDQLVRIA 247

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQI-GICPQI 64
           +G G FG V   K          ++   S ++      + V +    E L Q+ G+C + 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK- 81
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
                        +R   ++ EY + G L + +++  + R Q   +    + + + + ++
Sbjct: 82  -------------QRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYL 127
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
            SK F+H D+  +N LV D    K++DFGL+ +   D E + S   +    +  PE +  
Sbjct: 128 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMY 186
Query: 185 NEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
           +++ +  DIWA G  + E+ S GK  +    +S        I  G  L   P   SE+  
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---HIAQGLRLYR-PHLASEKVY 242
Query: 244 DFLIKCFLKDPKRRWTAEMLLNHPFVCADDQT 275
             +  C+ +    R T ++LL++     D+++
Sbjct: 243 TIMYSCWHEKADERPTFKILLSNILDVMDEES 274

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 118/298 (39%), Gaps = 66/298 (22%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN---EKEALDQIGICPQIV 65
           IG G FGSV       V      + A+K        SV  +N   E  A   +G    +V
Sbjct: 19  IGSGEFGSV----FKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 66  RCFG----DDYSFEKGERFYNLLLEYASRGSLADRVKKQNN--GRLQESDVKRYTRSMLK 119
           R F     DD+   + E        Y + GSLAD + +        +E+++K     + +
Sbjct: 75  RYFSAWAEDDHMLIQNE--------YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 120 GLRHIHSKGFVHCDIKLQNVLVF------------DNDE-------AKIADFGLAKKSSC 160
           GLR+IHS   VH DIK  N+ +             D D+        KI D G   + S 
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 185
Query: 161 DGERSQSFECRGTPLYMSPESVNENEYEAP-CDIWALGCAVVEMASGKP------AWNHK 213
               S   E  G   +++ E + EN    P  DI+AL   VV  A  +P       W+  
Sbjct: 186 ----SPQVE-EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE- 239
Query: 214 QDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA 271
                    IR G    LP IP  LS++  + L      DP+RR +A  L+ H  + +
Sbjct: 240 ---------IRQG---RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC----- 61
           D +G G F +V  A+    +     ++A+K       S       + AL +I +      
Sbjct: 16  DFLGEGQFATVYKARDKNTNQ----IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P I+    D +  +      N+ L +    +  + + K N+  L  S +K Y    L+GL
Sbjct: 72  PNIIGLL-DAFGHKS-----NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++H    +H D+K  N+L+ +N   K+ADFGLA KS     R+   +   T  Y +PE 
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-KSFGSPNRAYXHQVV-TRWYRAPEL 183
Query: 182 V-NENEYEAPCDIWALGCAVVEMASGKP 208
           +     Y    D+WA+GC + E+    P
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 8   VIGHGSFGSVN---LAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--P 62
           +IGHG FG V    L   +KV+ +             P SS  ++  +  ++ +  C  P
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALK----------RRTPESSQGIEEFETEIETLSFCRHP 95
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM--LKG 120
            +V   G  +  E+ E    L+ +Y   G+L   +   +   +  S  +R    +   +G
Sbjct: 96  HLVSLIG--FCDERNEMI--LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L ++H++  +H D+K  N+L+ +N   KI DFG++KK +  G+       +GT  Y+ PE
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPE 211
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPA 209
              +       D+++ G  + E+   + A
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ EY + G L + +++  + R Q   +    + + + + ++ SK F+H D+  +N LV 
Sbjct: 96  IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 154
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVE 202
           D    K++DFGL+ +   D E + S   +    +  PE +  +++ +  DIWA G  + E
Sbjct: 155 DQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE 213
Query: 203 MAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAE 261
           + S GK  +    +S        I  G  L   P   SE+    +  C+ +    R T +
Sbjct: 214 IYSLGKMPYERFTNSETAE---HIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFK 269
Query: 262 MLLNHPFVCADDQT 275
           +LL++     D+++
Sbjct: 270 ILLSNILDVMDEES 283

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 139 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 195
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGK 207
           Y +PE +    Y+   D+W++GC + EM   K
Sbjct: 196 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 31/275 (11%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           DV+GHG+ G++ + +    + +      +  C       V L  E +        P ++R
Sbjct: 30  DVLGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE------HPNVIR 82
Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            F      EK  +F  + +E  +  +L + V++++   L    +    ++   GL H+HS
Sbjct: 83  YFCT----EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTT-SGLAHLHS 136
Query: 127 KGFVHCDIKLQNVLV-----FDNDEAKIADFGLAKKSSCDGERSQSFECR----GTPLYM 177
              VH D+K  N+L+         +A I+DFGL KK +       SF  R    GT  ++
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG---RHSFSRRSGVPGTEGWI 193
Query: 178 SPESVNENEYEAP---CDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPN 233
           +PE ++E+  E P    DI++ GC    + S G   +          LL    +    P 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
              D+    ++ + K    DP++R +A+ +L HPF
Sbjct: 254 KHEDVI--ARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +     R    
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 184
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGK 207
           Y +PE +    Y+   D+W++GC + EM   K
Sbjct: 185 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 114/272 (41%), Gaps = 31/272 (11%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQI-GICPQI 64
           +G G FG V   K          ++   S ++      + V +    E L Q+ G+C + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK- 75
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
                        +R   ++ EY + G L + +++  + R Q   +    + + + + ++
Sbjct: 76  -------------QRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYL 121
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD---GERSQSFECRGTPLYMSPES 181
            SK F+H D+  +N LV D    K++DFGL++    D     R   F  R +P    PE 
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSP----PEV 177
Query: 182 VNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
           +  +++ +  DIWA G  + E+ S GK  +    +S        I  G  L   P   SE
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---HIAQGLRLYR-PHLASE 233
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
           +    +  C+ +    R T ++LL++     D
Sbjct: 234 KVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 76/151 (50%), Gaps = 6/151 (3%)
Query: 109 DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
           D+  Y+  + +G+  + S+  +H D+  +N+L+ +N+  KI DFGLA+    + +  +  
Sbjct: 200 DLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKG 259
Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIG 226
           + R    +M+PES+ +  Y    D+W+ G  + E+ S  G P    + D +  S L R G
Sbjct: 260 DTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRL-REG 318
Query: 227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           +    P      + +    ++ C+ +DPK R
Sbjct: 319 MRMRAPEYS---TPEIYQIMLDCWHRDPKER 346

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 79  RFYNLLLEYASRGSLADRVKK-QNNGR-LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKL 136
           ++ N+++EY    +L   +K    +GR +  + +  Y   + + +  IHS G  H DIK 
Sbjct: 111 KYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKP 169
Query: 137 QNVLVFDNDEA-KIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-SVNENEYEAPCDIW 194
           QN+LV   D   K+ DFG AKK     E S +  C  +  Y +PE  +   EY    D+W
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKL-IPSEPSVAXIC--SRFYRAPELMLGATEYTPSIDLW 226
Query: 195 ALGCAVVEMASGKPAWNHKQDSNVFSLLIRI 225
           ++GC   E+  GKP ++ +   +    +I+I
Sbjct: 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQI 257

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++ EY + G L + +++  + R Q   +    + + + + ++ SK F+H D+  +N LV 
Sbjct: 76  IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 134
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVE 202
           D    K++DFGL+ +   D E + S   +    +  PE +  +++ +  DIWA G  + E
Sbjct: 135 DQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE 193
Query: 203 MAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAE 261
           + S GK  +    +S        I  G  L   P   SE+    +  C+ +    R T +
Sbjct: 194 IYSLGKMPYERFTNSETAE---HIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFK 249
Query: 262 MLLNHPFVCADDQT 275
           +LL++     D+++
Sbjct: 250 ILLSNILDVMDEES 263

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 110/235 (46%), Gaps = 39/235 (16%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +IG GSFG V +    +V  E+   +A+K           +KN+K  L+Q  I  +++  
Sbjct: 61  LIGKGSFGQV-VKAYDRVEQEW---VAIK----------IIKNKKAFLNQAQIEVRLLEL 106
Query: 68  FGDD-----YSFEKGERFYN------LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                    Y     +R +       L+ E  S  +L D ++  N   +  +  +++ + 
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 117 MLKGLRHIHSK--GFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCD-GER-SQSFEC 170
           M   L  + +     +HCD+K +N+L+ +   +  KI DFG    SSC  G+R  Q  + 
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQXIQS 221
Query: 171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI 225
           R    Y SPE +    Y+   D+W+LGC +VEM +G+P ++   + +  + ++ +
Sbjct: 222 R---FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+  G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 71
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 72  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 125
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 184
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 240
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSR 263

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 21/241 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 73
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+++    G L D V++  +  +    +  +   
Sbjct: 74  ASVDNPHVCRLLGICLT-----STVQLIMQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 127
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFG AK    + E+    E    P+ 
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-EKEYHAEGGKVPIK 186
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQP 243
Query: 235 P 235
           P
Sbjct: 244 P 244

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 110/235 (46%), Gaps = 39/235 (16%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +IG GSFG V +    +V  E+   +A+K           +KN+K  L+Q  I  +++  
Sbjct: 42  LIGKGSFGQV-VKAYDRVEQEW---VAIK----------IIKNKKAFLNQAQIEVRLLEL 87
Query: 68  FGDD-----YSFEKGERFYN------LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                    Y     +R +       L+ E  S  +L D ++  N   +  +  +++ + 
Sbjct: 88  MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQ 146
Query: 117 MLKGLRHIHSK--GFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCD-GER-SQSFEC 170
           M   L  + +     +HCD+K +N+L+ +   +  KI DFG    SSC  G+R  Q  + 
Sbjct: 147 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQXIQS 202
Query: 171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI 225
           R    Y SPE +    Y+   D+W+LGC +VEM +G+P ++   + +  + ++ +
Sbjct: 203 R---FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 254

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 74  FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCD 133
           FE+ + F  +L        L D + ++  G LQE   + +   +L+ +RH H+ G +H D
Sbjct: 125 FERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRD 182
Query: 134 IKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEA-PC 191
           IK +N+L+  +  E K+ DFG    S    + +   +  GT +Y  PE +  + Y     
Sbjct: 183 IKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 238
Query: 192 DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFL 251
            +W+LG  + +M  G   + H ++     +  R  V           S + +  +  C  
Sbjct: 239 AVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV-----------SSECQHLIRWCLA 287
Query: 252 KDPKRRWTAEMLLNHPFV 269
             P  R T E + NHP++
Sbjct: 288 LRPSDRPTFEEIQNHPWM 305

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+  G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 78
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 79  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 132
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + E+    E    P+ 
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 191
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 247
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSR 270

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NVL+  ++ + ++ D+GLA+ 
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEF 181
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 182 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 238 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 228 LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 282
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 283 G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H ++  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 394
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 71
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 72  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 125
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFG AK    + E+    E    P+ 
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-EKEYHAEGGKVPIK 184
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 240
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSR 263

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 22/263 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 78
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 79  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 132
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFG AK    + E+    E    P+ 
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-EKEYHAEGGKVPIK 191
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ- 247
Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P   +      ++KC++ D   R
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSR 270

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 122 KQLRQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 182 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 238 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +            R    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTR---Y 190
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGK 207
           Y +PE +    Y+   D+W++GC + EM   K
Sbjct: 191 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 109/235 (46%), Gaps = 39/235 (16%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           +IG GSFG V +    +V  E+   +A+K           +KN+K  L+Q  I  +++  
Sbjct: 61  LIGKGSFGQV-VKAYDRVEQEW---VAIK----------IIKNKKAFLNQAQIEVRLLEL 106
Query: 68  FGDD-----YSFEKGERFYN------LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                    Y     +R +       L+ E  S  +L D ++  N   +  +  +++ + 
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 117 MLKGLRHIHSK--GFVHCDIKLQNVLVFD--NDEAKIADFGLAKKSSCD-GER-SQSFEC 170
           M   L  + +     +HCD+K +N+L+ +      KI DFG    SSC  G+R  Q  + 
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFG----SSCQLGQRIYQXIQS 221
Query: 171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI 225
           R    Y SPE +    Y+   D+W+LGC +VEM +G+P ++   + +  + ++ +
Sbjct: 222 R---FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G +G V       V  ++   +AVK+  +          E   + +I   P +V+  
Sbjct: 267 LGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLL 321
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++  K 
Sbjct: 322 G---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 377
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---FECRGTPLYMSPESVNEN 185
           F+H ++  +N LV +N   K+ADFGL++  + D   + +   F  + T    +PES+  N
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 433
Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLL 222
           ++    D+WA G  + E+A+ G   +     S V+ LL
Sbjct: 434 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 471

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 25/270 (9%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQI-GICPQI 64
           +G G FG V   K          ++   S ++      + V +    E L Q+ G+C + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK- 75
Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
                        +R   ++ EY + G L + +++  + R Q   +    + + + + ++
Sbjct: 76  -------------QRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYL 121
Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
            SK F+H D+  +N LV D    K++DFGL+ +   D E + S   +    +  PE +  
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMY 180
Query: 185 NEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
           +++ +  DIWA G  + E+ S GK  +    +S        I  G  L   P   SE+  
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---HIAQGLRLYR-PHLASEKVY 236
Query: 244 DFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
             +  C+ +    R T ++LL++     D+
Sbjct: 237 TIMYSCWHEKADERPTFKILLSNILDVMDE 266

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 182 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 238 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 121 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 181 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 237 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 294
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 182 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 238 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 182 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 238 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 121 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 181 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 237 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 294
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 182 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 238 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 10/95 (10%)
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR------- 171
           + +  +HSKG +H D+K  N+    +D  K+ DFGL      D E               
Sbjct: 175 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHX 234
Query: 172 ---GTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
              GT LYMSPE ++ N Y    DI++LG  + E+
Sbjct: 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 182 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 238 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 182 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 238 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 182 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 238 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 120 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 180 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 236 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 293
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 294 EALDFLDKLLRYDHQSRLTAREAMEHPY 321

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 182 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 238 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 122/279 (43%), Gaps = 24/279 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +  +     +AVK   +    S    L +E + L  IG   
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNG----RLQESDVKR------ 112
            +V   G   +  K      +++E+   G+L+  ++ + N     ++   D+ +      
Sbjct: 92  NVVNLLG---ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 113 ----YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
               Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
           + R    +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 269 RMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 127 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 186
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 187 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 242
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 243 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 300
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 301 EALDFLDKLLRYDHQSRLTAREAMEHPY 328

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 44/208 (21%)
Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKK 157
           KQ    L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+ 
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 158 SSCDGERSQSFECRGTPLYMS-PE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
                   Q +  R    Y   PE  V+   Y+   D+W+LGC +  M   K  + H  D
Sbjct: 182 YHP----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 216 SNVFSLLIRIG--VGDE-------LPNIPGD--------------------------LSE 240
           +  +  L+RI   +G E         NI  D                          +S 
Sbjct: 238 N--YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 295
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  DFL K    D + R TA   + HP+
Sbjct: 296 EALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 10/95 (10%)
Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR------- 171
           + +  +HSKG +H D+K  N+    +D  K+ DFGL      D E               
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 172 ---GTPLYMSPESVNENEYEAPCDIWALGCAVVEM 203
              GT LYMSPE ++ N Y    DI++LG  + E+
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 121/279 (43%), Gaps = 24/279 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +        +AVK   +    S    L +E + L  IG   
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNG----RLQESDVKR------ 112
            +V   G   +  K      +++E+   G+L+  ++ + N     ++   D+ +      
Sbjct: 92  NVVNLLG---ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 113 ----YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
               Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
           + R    +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 269 RMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 95/216 (43%), Gaps = 9/216 (4%)
Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCF 68
           +G G+FGSV          +    + V         +  +  E + + Q+   P IVR  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLI 402
Query: 69  GDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG 128
           G      + E    L++E A  G L   +  +    +  S+V      +  G++++  K 
Sbjct: 403 G----VCQAEALM-LVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVNENEY 187
           FVH ++  +NVL+ +   AKI+DFGL+K    D     +      PL + +PE +N  ++
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 188 EAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLL 222
            +  D+W+ G  + E ++ G+  +   +   V + +
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 121/279 (43%), Gaps = 24/279 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +        +AVK   +    S    L +E + L  IG   
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNG----RLQESDVKR------ 112
            +V   G   +  K      +++E+   G+L+  ++ + N     ++   D+ +      
Sbjct: 92  NVVNLLG---ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 113 ----YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
               Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
           + R    +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 269 RMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 121/279 (43%), Gaps = 24/279 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +        +AVK   +    S    L +E + L  IG   
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNG----RLQESDVKR------ 112
            +V   G   +  K      +++E+   G+L+  ++ + N     ++   D+ +      
Sbjct: 83  NVVNLLG---ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 113 ----YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
               Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
           + R    +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 260 RMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 125/292 (42%), Gaps = 46/292 (15%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G+GS G+V    + +        M +  C D     + L  E +        P ++R 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-DIALMEIKLLTESDD------HPNVIRY 74
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN----NGRLQ-ESDVKRYTRSMLKGLR 122
               Y  E  +RF  + LE  +  +L D V+ +N    N +LQ E +     R +  G+ 
Sbjct: 75  ----YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 123 HIHSKGFVHCDIKLQNVLV-----FDNDEAK--------IADFGLAKK--SSCDGERSQS 167
           H+HS   +H D+K QN+LV     F  D+          I+DFGL KK  S     R+  
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 168 FECRGTPLYMSPESVNEN-------EYEAPCDIWALGCAVVEMAS-GKPAWNHK--QDSN 217
               GT  + +PE + E+             DI+++GC    + S GK  +  K  ++SN
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 218 VFSLLIRIGVGDELPNIPG-DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +   +  +   DE+  +    L  +  D + +    DP +R TA  +L HP 
Sbjct: 250 IIRGIFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/260 (21%), Positives = 110/260 (42%), Gaps = 25/260 (9%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-----P 62
           VIG G FG V  +   K+  +    +A+K+      S  T K  ++ L +  I      P
Sbjct: 14  VIGAGEFGEV-CSGHLKLPGKREIFVAIKTLK----SGYTEKQRRDFLSEASIMGQFDHP 68
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            ++   G             ++ E+   GSL D   +QN+G+     +    R +  G++
Sbjct: 69  NVIHLEG----VVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK---KSSCDGERSQSFECRGTPLYMSP 179
           ++    +VH  +  +N+LV  N   K++DFGL++     + D   + +   +    + +P
Sbjct: 124 YLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 180 ESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           E++   ++ +  D+W+ G  + E+ S   +P W+      + +    I     LP  P D
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA----IEQDYRLPP-PMD 238
Query: 238 LSEQGKDFLIKCFLKDPKRR 257
                   ++ C+ KD   R
Sbjct: 239 CPSALHQLMLDCWQKDRNHR 258

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 124/288 (43%), Gaps = 42/288 (14%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G+GS G+V    + +        M +  C D     + L  E +        P ++R 
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-DIALMEIKLLTESDD------HPNVIRY 92
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN----NGRLQ-ESDVKRYTRSMLKGLR 122
               Y  E  +RF  + LE  +  +L D V+ +N    N +LQ E +     R +  G+ 
Sbjct: 93  ----YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 123 HIHSKGFVHCDIKLQNVLV-----FDNDEAK--------IADFGLAKK--SSCDGERSQS 167
           H+HS   +H D+K QN+LV     F  D+          I+DFGL KK  S     R   
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 168 FECRGTPLYMSPESVNEN---EYEAPCDIWALGCAVVEMAS-GKPAWNHK--QDSNVFSL 221
               GT  + +PE + E+         DI+++GC    + S GK  +  K  ++SN+   
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 267
Query: 222 LIRIGVGDELPNIPG-DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  +   DE+  +    L  +  D + +    DP +R TA  +L HP 
Sbjct: 268 IFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 124/288 (43%), Gaps = 42/288 (14%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G+GS G+V    + +        M +  C D     + L  E +        P ++R 
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-DIALMEIKLLTESDD------HPNVIRY 92
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN----NGRLQ-ESDVKRYTRSMLKGLR 122
               Y  E  +RF  + LE  +  +L D V+ +N    N +LQ E +     R +  G+ 
Sbjct: 93  ----YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 123 HIHSKGFVHCDIKLQNVLV-----FDNDEAK--------IADFGLAKK--SSCDGERSQS 167
           H+HS   +H D+K QN+LV     F  D+          I+DFGL KK  S     R   
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 168 FECRGTPLYMSPESVNEN---EYEAPCDIWALGCAVVEMAS-GKPAWNHK--QDSNVFSL 221
               GT  + +PE + E+         DI+++GC    + S GK  +  K  ++SN+   
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 267
Query: 222 LIRIGVGDELPNIPG-DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +  +   DE+  +    L  +  D + +    DP +R TA  +L HP 
Sbjct: 268 IFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 21/241 (8%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
           E+ +  V+G G+FG+V          +    +A+K   +    + + K  KE LD+  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVM 73
Query: 62  -----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P + R  G   +         L+ +    G L D V++  +  +    +  +   
Sbjct: 74  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 127
Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           + KG+ ++  +  VH D+  +NVLV      KI DFG AK    + E+    E    P+ 
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE-EKEYHAEGGKVPIK 186
Query: 176 YMSPESVNENEYEAPCDIWALGCAVVE-MASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +M+ ES+    Y    D+W+ G  V E M  G   ++    S + S+L +   G+ LP  
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQP 243
Query: 235 P 235
           P
Sbjct: 244 P 244

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 113/265 (42%), Gaps = 25/265 (9%)
Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNE-KEALDQIG 59
           E LR   IG GSFG V + + +     +    M  + C +        +NE +    ++ 
Sbjct: 18  EILRA--IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE--------RNEVRNVFKELQ 67
Query: 60  ICPQIVRCFGDD--YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           I   +   F  +  YSF+  E  + ++++    G L  R   Q N   +E  VK +   +
Sbjct: 68  IMQGLEHPFLVNLWYSFQDEEDMF-MVVDLLLGGDL--RYHLQQNVHFKEETVKLFICEL 124
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           +  L ++ ++  +H D+K  N+L+ ++    I DF +A   +     +Q     GT  YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA---AMLPRETQITTMAGTKPYM 181
Query: 178 SPESVNENE---YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +PE  +  +   Y    D W+LG    E+  G+  ++ +  S+  S  I       +   
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR--SSTSSKEIVHTFETTVVTY 239
Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWT 259
           P   S++    L K    +P +R++
Sbjct: 240 PSAWSQEMVSLLKKLLEPNPDQRFS 264

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/271 (21%), Positives = 120/271 (44%), Gaps = 23/271 (8%)
Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-LDQIGICPQIV 65
           +++G G FG V   + +       +L+AVK   +       L+ + E  +  + +   ++
Sbjct: 44  NILGRGGFGKVYKGRLAD-----GTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLL 98
Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLAD--RVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           R  G  +     ER   L+  Y + GS+A   R + ++   L     +R      +GL +
Sbjct: 99  RLRG--FCMTPTERL--LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 154
Query: 124 IHSK---GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +H       +H D+K  N+L+ +  EA + DFGLAK      +       RGT  +++PE
Sbjct: 155 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DXHVXXAVRGTIGHIAPE 213
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            ++  +     D++  G  ++E+ +G+ A++  + +N   +++       L  + G L E
Sbjct: 214 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML-------LDWVKGLLKE 266
Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA 271
           +  + L+   L+   +    E L+    +C 
Sbjct: 267 KKLEALVDVDLQGNYKDEEVEQLIQVALLCT 297

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 121/279 (43%), Gaps = 24/279 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +        +AVK   +    S    L +E + L  IG   
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNG----RLQESDVKR------ 112
            +V   G   +  K      +++E+   G+L+  ++ + N     ++   D+ +      
Sbjct: 129 NVVNLLG---ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 185
Query: 113 ----YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
               Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  
Sbjct: 186 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
           + R    +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G 
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 305
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 306 RMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 108/243 (44%), Gaps = 28/243 (11%)
Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSSVTLKNEKEA----- 54
           +E++R   IG G+FG V  A+A  +    P +++AVK   +   + +    ++EA     
Sbjct: 49  IEYVRD--IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 55  ------LDQIGIC----PQIV----RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQ 100
                 +  +G+C    P  +      +GD   F +    + +     S  S   RV   
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 101 NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SS 159
               L  ++     R +  G+ ++  + FVH D+  +N LV +N   KIADFGL++   S
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 160 CDGERSQSFECRGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMASG--KPAWNHKQDS 216
            D  ++   +    P+ +M PES+  N Y    D+WA G  + E+ S   +P +    + 
Sbjct: 227 ADYYKADGND--AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 217 NVF 219
            ++
Sbjct: 285 VIY 287

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++L Y   G L + ++ + +    + D+  +   + KG++++ SK FVH D+  +N ++ 
Sbjct: 108 VVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 166
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESVNENEYEAPCDIWALGCA 199
           +    K+ADFGLA +   D E        G  L   +M+ ES+   ++    D+W+ G  
Sbjct: 167 EKFTVKVADFGLA-RDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 225
Query: 200 VVE-MASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + E M  G P +    D N F + + +  G  L
Sbjct: 226 LWELMTRGAPPY---PDVNTFDITVYLLQGRRL 255

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/279 (21%), Positives = 118/279 (42%), Gaps = 24/279 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +        +AVK   +    S    L +E + L  IG   
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKR---------- 112
            +V   G   +  K      +++E+   G+L+  ++ + N  +   +             
Sbjct: 94  NVVNLLG---ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLE 150
Query: 113 ----YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
               Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  
Sbjct: 151 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
           + R    +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G 
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 270
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 271 RMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++L Y   G L + ++ + +    + D+  +   + KG++++ SK FVH D+  +N ++ 
Sbjct: 109 VVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 167
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESVNENEYEAPCDIWALGCA 199
           +    K+ADFGLA +   D E        G  L   +M+ ES+   ++    D+W+ G  
Sbjct: 168 EKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 226
Query: 200 VVE-MASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + E M  G P +    D N F + + +  G  L
Sbjct: 227 LWELMTRGAPPY---PDVNTFDITVYLLQGRRL 256

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++L Y   G L + ++ + +    + D+  +   + KG++++ SK FVH D+  +N ++ 
Sbjct: 101 VVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 159
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESVNENEYEAPCDIWALGCA 199
           +    K+ADFGLA +   D E        G  L   +M+ ES+   ++    D+W+ G  
Sbjct: 160 EKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 218
Query: 200 VVE-MASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + E M  G P +    D N F + + +  G  L
Sbjct: 219 LWELMTRGAPPY---PDVNTFDITVYLLQGRRL 248

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 120/279 (43%), Gaps = 24/279 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +        +AVK   +    S    L +E + L  IG   
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNG----RLQESDVKR------ 112
            +V   G   +  K      ++ E+   G+L+  ++ + N     ++   D+ +      
Sbjct: 83  NVVNLLG---ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 113 ----YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
               Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
           + R    +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 260 RMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++L Y   G L + ++ + +    + D+  +   + KG++++ SK FVH D+  +N ++ 
Sbjct: 127 VVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 185
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESVNENEYEAPCDIWALGCA 199
           +    K+ADFGLA +   D E        G  L   +M+ ES+   ++    D+W+ G  
Sbjct: 186 EKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 244
Query: 200 VVE-MASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + E M  G P +    D N F + + +  G  L
Sbjct: 245 LWELMTRGAPPY---PDVNTFDITVYLLQGRRL 274

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++L Y   G L + ++ + +    + D+  +   + KG++++ SK FVH D+  +N ++ 
Sbjct: 104 VVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 162
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESVNENEYEAPCDIWALGCA 199
           +    K+ADFGLA +   D E        G  L   +M+ ES+   ++    D+W+ G  
Sbjct: 163 EKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221
Query: 200 VVE-MASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + E M  G P +    D N F + + +  G  L
Sbjct: 222 LWELMTRGAPPY---PDVNTFDITVYLLQGRRL 251

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++L Y   G L + ++ + +    + D+  +   + KG++++ SK FVH D+  +N ++ 
Sbjct: 106 VVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 164
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESVNENEYEAPCDIWALGCA 199
           +    K+ADFGLA +   D E        G  L   +M+ ES+   ++    D+W+ G  
Sbjct: 165 EKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 223
Query: 200 VVE-MASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + E M  G P +    D N F + + +  G  L
Sbjct: 224 LWELMTRGAPPY---PDVNTFDITVYLLQGRRL 253

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/278 (21%), Positives = 119/278 (42%), Gaps = 23/278 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +  +     +AVK   +    S    L +E + L  IG   
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNN-------------GRLQESD 109
            +V   G   +  K      +++E+   G+L+  ++ + N               L    
Sbjct: 93  NVVNLLG---ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEH 149
Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           +  Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  +
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 170 CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVG 228
            R    +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G  
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
              P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 270 MRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++L Y   G L + ++ + +    + D+  +   + KG++++ SK FVH D+  +N ++ 
Sbjct: 128 VVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 186
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESVNENEYEAPCDIWALGCA 199
           +    K+ADFGLA +   D E        G  L   +M+ ES+   ++    D+W+ G  
Sbjct: 187 EKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 245
Query: 200 VVE-MASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + E M  G P +    D N F + + +  G  L
Sbjct: 246 LWELMTRGAPPY---PDVNTFDITVYLLQGRRL 275

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++L Y   G L + ++ + +    + D+  +   + KG++++ SK FVH D+  +N ++ 
Sbjct: 107 VVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 165
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESVNENEYEAPCDIWALGCA 199
           +    K+ADFGLA +   D E        G  L   +M+ ES+   ++    D+W+ G  
Sbjct: 166 EKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 224
Query: 200 VVE-MASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + E M  G P +    D N F + + +  G  L
Sbjct: 225 LWELMTRGAPPY---PDVNTFDITVYLLQGRRL 254

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++L Y   G L + ++ + +    + D+  +   + KG++++ SK FVH D+  +N ++ 
Sbjct: 108 VVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 166
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESVNENEYEAPCDIWALGCA 199
           +    K+ADFGLA +   D E        G  L   +M+ ES+   ++    D+W+ G  
Sbjct: 167 EKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 225
Query: 200 VVE-MASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + E M  G P +    D N F + + +  G  L
Sbjct: 226 LWELMTRGAPPY---PDVNTFDITVYLLQGRRL 255

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/261 (22%), Positives = 116/261 (44%), Gaps = 18/261 (6%)
Query: 2   EWLRGDVIGHGSFGSV--NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           E  R  V+G G+FG+V   +      + + P  + + +    P ++V   +E   +  + 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P +VR  G   S         L+ +    G L + V +  +  +    +  +   + K
Sbjct: 76  -HPHLVRLLGVCLS-----PTIQLVTQLMPHGCLLEYVHEHKDN-IGSQLLLNWCVQIAK 128
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMS 178
           G+ ++  +  VH D+  +NVLV   +  KI DFGLA+    D E+  + +    P+ +M+
Sbjct: 129 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMA 187
Query: 179 PESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
            E ++  ++    D+W+ G  + E+ +  GKP ++      +  LL +   G+ LP  P 
Sbjct: 188 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKP-YDGIPTREIPDLLEK---GERLPQ-PP 242
Query: 237 DLSEQGKDFLIKCFLKDPKRR 257
             +      ++KC++ D   R
Sbjct: 243 ICTIDVYMVMVKCWMIDADSR 263

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           ++L Y   G L + ++ + +    + D+  +   + KG++++ SK FVH D+  +N ++ 
Sbjct: 109 VVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 167
Query: 143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESVNENEYEAPCDIWALGCA 199
           +    K+ADFGLA +   D E        G  L   +M+ ES+   ++    D+W+ G  
Sbjct: 168 EKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 226
Query: 200 VVE-MASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + E M  G P +    D N F + + +  G  L
Sbjct: 227 LWELMTRGAPPY---PDVNTFDITVYLLQGRRL 256

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 64/138 (46%), Gaps = 2/138 (1%)
Query: 83  LLLEYASRGSLADRVK-KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV 141
           L+  Y   GSL DR+        L      +  +    G+  +H    +H DIK  N+L+
Sbjct: 98  LVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHRDIKSANILL 157
Query: 142 FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVV 201
            +   AKI+DFGLA+ S    +        GT  Y +PE++   E     DI++ G  ++
Sbjct: 158 DEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLL 216
Query: 202 EMASGKPAWNHKQDSNVF 219
           E+ +G PA +  ++  + 
Sbjct: 217 EIITGLPAVDEHREPQLL 234

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 121/279 (43%), Gaps = 24/279 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +  +     +AVK   +    S    L +E + L  IG   
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNG----RLQESDVKR------ 112
            +V   G   +  K      ++ E+   G+L+  ++ + N     ++   D+ +      
Sbjct: 83  NVVNLLG---ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 113 ----YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
               Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
           + R    +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 260 RMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/261 (22%), Positives = 116/261 (44%), Gaps = 18/261 (6%)
Query: 2   EWLRGDVIGHGSFGSV--NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           E  R  V+G G+FG+V   +      + + P  + + +    P ++V   +E   +  + 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P +VR  G   S         L+ +    G L + V +  +  +    +  +   + K
Sbjct: 99  -HPHLVRLLGVCLS-----PTIQLVTQLMPHGCLLEYVHEHKDN-IGSQLLLNWCVQIAK 151
Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMS 178
           G+ ++  +  VH D+  +NVLV   +  KI DFGLA+    D E+  + +    P+ +M+
Sbjct: 152 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMA 210
Query: 179 PESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
            E ++  ++    D+W+ G  + E+ +  GKP ++      +  LL +   G+ LP  P 
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKP-YDGIPTREIPDLLEK---GERLPQ-PP 265
Query: 237 DLSEQGKDFLIKCFLKDPKRR 257
             +      ++KC++ D   R
Sbjct: 266 ICTIDVYMVMVKCWMIDADSR 286

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 8   VIGHGSFGSVN---LAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--P 62
           +IGHG FG V    L   +KV+ +             P SS  ++  +  ++ +  C  P
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALK----------RRTPESSQGIEEFETEIETLSFCRHP 95
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM--LKG 120
            +V   G  +  E+ E    L+ +Y   G+L   +   +   +  S  +R    +   +G
Sbjct: 96  HLVSLIG--FCDERNEMI--LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L ++H++  +H D+K  N+L+ +N   KI DFG++KK +   +       +GT  Y+ PE
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPE 211
Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPA 209
              +       D+++ G  + E+   + A
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 120/279 (43%), Gaps = 24/279 (8%)
Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +        +AVK   +    S    L +E + L  IG   
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNG----RLQESDVKR------ 112
            +V   G   +  K      ++ E+   G+L+  ++ + N     ++   D+ +      
Sbjct: 83  NVVNLLG---ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 113 ----YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
               Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV 227
           + R    +M+PE++ +  Y    D+W+ G  + E+ S G   +   +    F   ++ G 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               P+     + +    ++ C+  +P +R T   L+ H
Sbjct: 260 RMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 113/282 (40%), Gaps = 35/282 (12%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V+G G+FG V  A+ +  S  +    A+K          T+ +E   L  +     +VR 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYY----AIKKIRHTEEKLSTILSEVXLLASLN-HQYVVRY 67
Query: 68  FGD----------DYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           +              + +K    + +  EY    +L D +  +N  + Q  +  R  R +
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLF-IQXEYCENRTLYDLIHSENLNQ-QRDEYWRLFRQI 125
Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK------------SSCDGERS 165
           L+ L +IHS+G +H ++K  N+ + ++   KI DFGLAK              +  G   
Sbjct: 126 LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 166 QSFECRGTPLYMSPESVN-ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR 224
                 GT  Y++ E ++    Y    D ++LG    E     P     +  N+   L  
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY--PFSTGXERVNILKKLRS 243
Query: 225 IGVGDELPNIPGDLSEQGKDFLIKCFL-KDPKRRWTAEMLLN 265
           + +  E P    D   + +  +I+  +  DP +R  A  LLN
Sbjct: 244 VSI--EFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 46/292 (15%)
Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           ++G+GS G+V    + +        M +  C D     + L  E +        P ++R 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-DIALMEIKLLTESDD------HPNVIRY 74
Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN----NGRLQ-ESDVKRYTRSMLKGLR 122
               Y  E  +RF  + LE  +  +L D V+ +N    N +LQ E +     R +  G+ 
Sbjct: 75  ----YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 123 HIHSKGFVHCDIKLQNVLV-----FDNDEAK--------IADFGLAKK--SSCDGERSQS 167
           H+HS   +H D+K QN+LV     F  D+          I+DFGL KK  S     R   
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 168 FECRGTPLYMSPESVNEN-------EYEAPCDIWALGCAVVEMAS-GKPAWNHK--QDSN 217
               GT  + +PE + E+             DI+++GC    + S GK  +  K  ++SN
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 218 VFSLLIRIGVGDELPNIPG-DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           +   +  +   DE+  +    L  +  D + +    DP +R TA  +L HP 
Sbjct: 250 IIRGIFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 38/199 (19%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGE 163
           L + D++ Y   +LK L + HS+G +H D+K  NV++  +  + ++ D+GLA+      E
Sbjct: 124 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 183
Query: 164 RSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------ 216
            +     R    +  PE  V+  +Y+   D+W+LGC    M   K  + +  D+      
Sbjct: 184 YNVRVASR---YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 240
Query: 217 ----------NVFSLLIRIGVGDELPNIPGD-----------------LSEQGKDFLIKC 249
                     NV+    RI +  +L  + G                  +S +  DFL K 
Sbjct: 241 IAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKL 300
Query: 250 FLKDPKRRWTAEMLLNHPF 268
              D + R TA   + HP+
Sbjct: 301 LRYDHQERLTALEAMTHPY 319

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 38/199 (19%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGE 163
           L + D++ Y   +LK L + HS+G +H D+K  NV++  +  + ++ D+GLA+      E
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 181
Query: 164 RSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------ 216
            +     R    +  PE  V+  +Y+   D+W+LGC    M   K  + +  D+      
Sbjct: 182 YNVRVASR---YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 238
Query: 217 ----------NVFSLLIRIGVGDELPNIPGD-----------------LSEQGKDFLIKC 249
                     NV+    RI +  +L  + G                  +S +  DFL K 
Sbjct: 239 IAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKL 298
Query: 250 FLKDPKRRWTAEMLLNHPF 268
              D + R TA   + HP+
Sbjct: 299 LRYDHQERLTALEAMTHPY 317

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 38/199 (19%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGE 163
           L + D++ Y   +LK L + HS+G +H D+K  NV++  +  + ++ D+GLA+      E
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 181
Query: 164 RSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------ 216
            +     R    +  PE  V+  +Y+   D+W+LGC    M   K  + +  D+      
Sbjct: 182 YNVRVASR---YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 238
Query: 217 ----------NVFSLLIRIGVGDELPNIPGD-----------------LSEQGKDFLIKC 249
                     NV+    RI +  +L  + G                  +S +  DFL K 
Sbjct: 239 IAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKL 298
Query: 250 FLKDPKRRWTAEMLLNHPF 268
              D + R TA   + HP+
Sbjct: 299 LRYDHQERLTALEAMTHPY 317

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 38/199 (19%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGE 163
           L + D++ Y   +LK L + HS+G +H D+K  NV++  +  + ++ D+GLA+      E
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 182
Query: 164 RSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------ 216
            +     R    +  PE  V+  +Y+   D+W+LGC    M   K  + +  D+      
Sbjct: 183 YNVRVASR---YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 239
Query: 217 ----------NVFSLLIRIGVGDELPNIPGD-----------------LSEQGKDFLIKC 249
                     NV+    RI +  +L  + G                  +S +  DFL K 
Sbjct: 240 IAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKL 299
Query: 250 FLKDPKRRWTAEMLLNHPF 268
              D + R TA   + HP+
Sbjct: 300 LRYDHQERLTALEAMTHPY 318

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 38/199 (19%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGE 163
           L + D++ Y   +LK L + HS+G +H D+K  NV++  +  + ++ D+GLA+      E
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 181
Query: 164 RSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------ 216
            +     R    +  PE  V+  +Y+   D+W+LGC    M   K  + +  D+      
Sbjct: 182 YNVRVASR---YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 238
Query: 217 ----------NVFSLLIRIGVGDELPNIPGD-----------------LSEQGKDFLIKC 249
                     NV+    RI +  +L  + G                  +S +  DFL K 
Sbjct: 239 IAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKL 298
Query: 250 FLKDPKRRWTAEMLLNHPF 268
              D + R TA   + HP+
Sbjct: 299 LRYDHQERLTALEAMTHPY 317

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 38/199 (19%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGE 163
           L + D++ Y   +LK L + HS+G +H D+K  NV++  +  + ++ D+GLA+      E
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 182
Query: 164 RSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------ 216
            +     R    +  PE  V+  +Y+   D+W+LGC    M   K  + +  D+      
Sbjct: 183 YNVRVASR---YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 239
Query: 217 ----------NVFSLLIRIGVGDELPNIPGD-----------------LSEQGKDFLIKC 249
                     NV+    RI +  +L  + G                  +S +  DFL K 
Sbjct: 240 IAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKL 299
Query: 250 FLKDPKRRWTAEMLLNHPF 268
              D + R TA   + HP+
Sbjct: 300 LRYDHQERLTALEAMTHPY 318

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 109/252 (43%), Gaps = 28/252 (11%)
Query: 2   EWLRGDVIGHGSFGSVNLA-KASKVSSEFPSLMAVKSCADCPPSS-------VTLKN--- 50
           +W+ G  IG G FG + LA   +K   +   ++ V+   + P  S       V  K+   
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 51  ---EKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQE 107
              E++ LD +GI P     +G   +  KG  +  +++E    G    ++  QN G  ++
Sbjct: 98  KWIERKQLDYLGI-PLF---YGSGLTEFKGRSYRFMVME--RLGIDLQKISGQN-GTFKK 150
Query: 108 SDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDN-DEAKIADFGLAKKSSCDGERS 165
           S V +    ML  L +IH   +VH DIK  N+L+ + N D+  +AD+GL+ +   +G   
Sbjct: 151 STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 166 QSFE-----CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFS 220
           Q  E       GT  + S ++          D+  LG  ++    GK  W       V  
Sbjct: 211 QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270
Query: 221 LLIRIGVGDELP 232
              +  + DELP
Sbjct: 271 QTAKTNLLDELP 282

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 38/199 (19%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGE 163
           L + D++ Y   +LK L + HS+G +H D+K  NV++  +  + ++ D+GLA+      E
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 181
Query: 164 RSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------ 216
            +     R    +  PE  V+  +Y+   D+W+LGC    M   K  + +  D+      
Sbjct: 182 YNVRVASR---YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 238
Query: 217 ----------NVFSLLIRIGVGDELPNIPGD-----------------LSEQGKDFLIKC 249
                     NV+    RI +  +L  + G                  +S +  DFL K 
Sbjct: 239 IAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKL 298
Query: 250 FLKDPKRRWTAEMLLNHPF 268
              D + R TA   + HP+
Sbjct: 299 LRYDHQERLTALEAMTHPY 317

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 38/199 (19%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGE 163
           L + D++ Y   +LK L + HS+G +H D+K  NV++  +  + ++ D+GLA+      E
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 181
Query: 164 RSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------ 216
            +     R    +  PE  V+  +Y+   D+W+LGC    M   K  + +  D+      
Sbjct: 182 YNVRVASR---YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 238
Query: 217 ----------NVFSLLIRIGVGDELPNIPGD-----------------LSEQGKDFLIKC 249
                     NV+    RI +  +L  + G                  +S +  DFL K 
Sbjct: 239 IAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKL 298
Query: 250 FLKDPKRRWTAEMLLNHPF 268
              D + R TA   + HP+
Sbjct: 299 LRYDHQERLTALEAMTHPY 317

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 38/199 (19%)
Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGE 163
           L + D++ Y   +LK L + HS+G +H D+K  NV++  +  + ++ D+GLA+      E
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 181
Query: 164 RSQSFECRGTPLYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------ 216
            +     R    +  PE  V+  +Y+   D+W+LGC    M   K  + +  D+      
Sbjct: 182 YNVRVASR---YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 238
Query: 217 ----------NVFSLLIRIGVGDELPNIPGD-----------------LSEQGKDFLIKC 249
                     NV+    RI +  +L  + G                  +S +  DFL K 
Sbjct: 239 IAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKL 298
Query: 250 FLKDPKRRWTAEMLLNHPF 268
              D + R TA   + HP+
Sbjct: 299 LRYDHQERLTALEAMTHPY 317
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	366
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-80
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-70
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-70
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-69
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-69
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-68
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-68
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-66
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-65
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-64
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-58
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-57
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-55
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-52
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-51
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-51
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-51
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-50
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-49
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-49
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-48
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-48
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-48
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-48
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-48
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-48
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-48
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-47
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-47
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-47
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-47
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-46
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-46
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-46
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-45
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-45
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-45
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-45
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-45
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-45
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-44
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-44
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-44
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-44
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-44
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-43
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-43
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-43
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-43
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-43
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-43
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-42
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-42
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-42
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-42
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-42
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-42
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-42
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-42
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-42
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-42
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-41
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-41
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-41
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-41
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-41
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-40
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-40
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-40
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-40
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-40
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-39
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-39
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-39
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-38
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-38
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-38
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-37
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-37
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-37
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-37
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-37
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-37
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-37
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-37
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-37
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-36
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-36
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-36
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-35
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-35
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-35
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-35
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-35
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-35
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-34
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-34
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-34
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-33
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-33
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-33
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-31
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-30
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-30
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-30
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-30
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-29
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-29
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-29
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-29
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-29
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-28
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-28
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-28
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-28
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-28
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-27
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-26
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-26
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-26
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-25
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-25
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-25
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-25
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-25
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-24
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-24
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-24
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-24
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-23
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-23
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-23
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-23
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-23
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-23
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-22
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-22
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-22
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-22
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-22
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-21
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-21
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-21
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-21
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-21
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-21
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-21
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-21
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-04
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-19
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-19
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-16
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-13
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-10
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-10
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-04

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  247 bits (633), Expect = 1e-80
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 20/274 (7%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGI 60
           E     V+G G++G V               +A+K   +        L  E      +  
Sbjct: 23  ENGDRVVLGKGTYGIVYAG----RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK- 77

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQ--ESDVKRYTRSML 118
              IV+  G          F  + +E    GSL+  ++ +  G L+  E  +  YT+ +L
Sbjct: 78  HKNIVQYLG----SFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQIL 132

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           +GL+++H    VH DIK  NVL+       KI+DFG +K+ +     +++F   GT  YM
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYM 190

Query: 178 SPESVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           +PE +++    Y    DIW+LGC ++EMA+GKP +         + + ++G+    P IP
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL--GEPQAAMFKVGMFKVHPEIP 248

Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             +S + K F++KCF  DP +R  A  LL   F+
Sbjct: 249 ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  223 bits (569), Expect = 2e-70
 Identities = 69/278 (24%), Positives = 110/278 (39%), Gaps = 35/278 (12%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC- 61
                 +G GSFG V+  K  K +       AVK         V L+  +   +++  C 
Sbjct: 60  MTHQPRVGRGSFGEVHRMK-DKQTGF---QCAVKK--------VRLEVFRV--EELVACA 105

Query: 62  ----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P+IV  +G      +   + N+ +E    GSL   +K+   G L E     Y    
Sbjct: 106 GLSSPRIVPLYG----AVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQA 159

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDND--EAKIADFGLAKKSSCDGERSQSFEC---RG 172
           L+GL ++H++  +H D+K  NVL+  +D   A + DFG A     DG            G
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLL-SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-EL 231
           T  +M+PE V     +A  DIW+  C ++ M +G   W          L ++I      +
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT---QYFRGPLCLKIASEPPPI 275

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             IP   +      + +   K+P  R +A  L      
Sbjct: 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  220 bits (562), Expect = 4e-70
 Identities = 75/294 (25%), Positives = 118/294 (40%), Gaps = 46/294 (15%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK---NEKEALDQI 58
           E+   + IG G FGSV      ++      + A+K        SV  +    E  A   +
Sbjct: 12  EFHELEKIGSGEFGSVFKCV-KRLDGC---IYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 59  GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN--NGRLQESDVKRYTRS 116
           G    +VR F    ++ + +    +  EY + GSLAD + +        +E+++K     
Sbjct: 68  GQHSHVVRYFS---AWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDE-------------------AKIADFGLAKK 157
           + +GLR+IHS   VH DIK  N+ +                         KI D G   +
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 158 SSCDGERSQSFECRGTPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDS 216
            S      Q  E  G   +++ E + EN  +    DI+AL   VV  A  +P   +    
Sbjct: 184 IS----SPQVEE--GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237

Query: 217 NVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           +     IR G    LP IP  LS++  + L      DP+RR +A  L+ H  + 
Sbjct: 238 HE----IRQG---RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  219 bits (561), Expect = 1e-69
 Identities = 75/274 (27%), Positives = 112/274 (40%), Gaps = 29/274 (10%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI- 60
            + R   +GHGS+G V   + SK       L AVK            K+    L ++G  
Sbjct: 58  SFQRLSRLGHGSYGEVFKVR-SKEDGR---LYAVKRS---MSPFRGPKDRARKLAEVGSH 110

Query: 61  -----CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                 P  VR      ++E+G   Y L  E     SL    +      L E+ V  Y R
Sbjct: 111 EKVGQHPCCVRLEQ---AWEEGGILY-LQTELCG-PSLQQHCEAWG-ASLPEAQVWGYLR 164

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
             L  L H+HS+G VH D+K  N+ +      K+ DFGL  +        +  E  G P 
Sbjct: 165 DTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQE--GDPR 221

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           YM+PE + +  Y    D+++LG  ++E+A      +  +         ++  G   P   
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQ------QLRQGYLPPEFT 274

Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             LS + +  L+     DPK R TAE LL  P +
Sbjct: 275 AGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  219 bits (559), Expect = 5e-69
 Identities = 74/339 (21%), Positives = 128/339 (37%), Gaps = 31/339 (9%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVT-LKNEKEALDQI 58
            +     IG G    V      K       + A+K  +  +    ++   +NE   L+++
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 64

Query: 59  -GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
                +I+R +     +E  +++  +++E  +   L   +KK     +   + K Y ++M
Sbjct: 65  QQHSDKIIRLYD----YEITDQYIYMVMECGN-IDLNSWLKK--KKSIDPWERKSYWKNM 117

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           L+ +  IH  G VH D+K  N L   +   K+ DFG+A +   D          GT  YM
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 178 SPESVNENEYE-----------APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG 226
            PE++ +                  D+W+LGC +  M  GK  +      N  S L  I 
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAII 234

Query: 227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSS 286
             +     P    +  +D L  C  +DPK+R +   LL HP+V       +         
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE 294

Query: 287 SSPSLKGIKDEKFSQSP-RSPFGFPEWVSVQSSSSVTSS 324
               L  +       S  ++     E  S   S + +SS
Sbjct: 295 MKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSS 333

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  217 bits (554), Expect = 1e-68
 Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 30/283 (10%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVT-LKNEKEALDQI 58
            +     IG G    V      K       + A+K  +  +    ++   +NE   L+++
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 83

Query: 59  -GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
                +I+R +     +E  +++  +++E  +   L   +KK     +   + K Y ++M
Sbjct: 84  QQHSDKIIRLYD----YEITDQYIYMVMECGN-IDLNSWLKK--KKSIDPWERKSYWKNM 136

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           L+ +  IH  G VH D+K  N L   +   K+ DFG+A +   D          GT  YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195

Query: 178 SPESVNENEYE-----------APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG 226
            PE++ +                  D+W+LGC +  M  GK  +    +    S L  I 
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAII 253

Query: 227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             +     P    +  +D L  C  +DPK+R +   LL HP+V
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  218 bits (557), Expect = 4e-68
 Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 30/283 (10%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVT-LKNEKEALDQI 58
            +     IG G    V      K       + A+K  +  +    ++   +NE   L+++
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 111

Query: 59  -GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
                +I+R +     +E  +++  +++E  +   L   +KK     +   + K Y ++M
Sbjct: 112 QQHSDKIIRLYD----YEITDQYIYMVMECGN-IDLNSWLKK--KKSIDPWERKSYWKNM 164

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           L+ +  IH  G VH D+K  N L   +   K+ DFG+A +   D          G   YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223

Query: 178 SPESVNENEYE-----------APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG 226
            PE++ +                  D+W+LGC +  M  GK  +    +    S L  I 
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAII 281

Query: 227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             +     P    +  +D L  C  +DPK+R +   LL HP+V
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  211 bits (538), Expect = 3e-66
 Identities = 74/275 (26%), Positives = 121/275 (44%), Gaps = 20/275 (7%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSS--VTLKNEKEALDQ 57
            +     IG G F  V  A    +       +A+K     D   +        E + L Q
Sbjct: 33  NFRIEKKIGRGQFSEVYRAA-CLLDGV---PVALKKVQIFDLMDAKARADCIKEIDLLKQ 88

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK--KQNNGRLQESDVKRYTR 115
           +   P +++ +    SF +      ++LE A  G L+  +K  K+    + E  V +Y  
Sbjct: 89  LN-HPNVIKYYA---SFIEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            +   L H+HS+  +H DIK  NV +      K+ D GL +  S     + S    GTP 
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPY 201

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           YMSPE ++EN Y    DIW+LGC + EMA+ +  + +    N++SL  +I    + P +P
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKI-EQCDYPPLP 259

Query: 236 GD-LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            D  SE+ +  +  C   DP++R     + +    
Sbjct: 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  207 bits (530), Expect = 3e-65
 Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 20/276 (7%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVT-LKNEKEALDQIG 59
                 IG GSF +V     ++ + E     A           S     K E E L  + 
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEV----AWCELQDRKLTKSERQRFKEEAEMLKGLQ 83

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P IVR +    S  KG++   L+ E  + G+L   +K+     ++   ++ + R +LK
Sbjct: 84  -HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILK 140

Query: 120 GLRHIHSKG--FVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           GL+ +H++    +H D+K  N+ +       KI D GLA        ++      GTP +
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEF 196

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           M+PE + E +Y+   D++A G  ++EMA+ +  ++  Q  N   +  R+  G +  +   
Sbjct: 197 MAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKPASFDK 253

Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
               + K+ +  C  ++   R++ + LLNH F   +
Sbjct: 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  208 bits (531), Expect = 1e-64
 Identities = 69/270 (25%), Positives = 126/270 (46%), Gaps = 22/270 (8%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI---- 60
           R   IG GSFG   L K S           +K   +   S ++ K  +E+  ++ +    
Sbjct: 28  RLQKIGEGSFGKAILVK-STEDGR---QYVIK---EINISRMSSKEREESRREVAVLANM 80

Query: 61  -CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P IV+      SFE+    Y ++++Y   G L  R+  Q     QE  +  +   +  
Sbjct: 81  KHPNIVQYRE---SFEENGSLY-IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            L+H+H +  +H DIK QN+ +  +   ++ DFG+A+  +   E +++    GTP Y+SP
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC--IGTPYYLSP 194

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E      Y    DIWALGC + E+ + K A+   +  ++ +L+++I +    P +    S
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAF---EAGSMKNLVLKI-ISGSFPPVSLHYS 250

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
              +  + + F ++P+ R +   +L   F+
Sbjct: 251 YDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  189 bits (483), Expect = 2e-58
 Identities = 67/282 (23%), Positives = 117/282 (41%), Gaps = 42/282 (14%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI---- 60
             ++IG G FG V  AK  ++  +      +K         V   NEK A  ++      
Sbjct: 15  EIELIGSGGFGQVFKAK-HRIDGK---TYVIKR--------VKYNNEK-AEREVKALAKL 61

Query: 61  -CPQIVR---CFGDDYSFEKGERFYN---------LLLEYASRGSLADRVKKQNNGRLQE 107
               IV    C+       +     +         + +E+  +G+L   ++K+   +L +
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121

Query: 108 SDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS 167
                    + KG+ +IHSK  ++ D+K  N+ + D  + KI DFGL      DG+R++S
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181

Query: 168 FECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV 227
              +GT  YMSPE ++  +Y    D++ALG  + E+           +++ F   +R G+
Sbjct: 182 ---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD---TAFETSKFFTDLRDGI 235

Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
                 I     ++ K  L K   K P+ R     +L    V
Sbjct: 236 ------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  187 bits (477), Expect = 2e-57
 Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 27/277 (9%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI---- 60
               IG GS+G     +  K   +   ++  K   +    S+T   ++  + ++ +    
Sbjct: 10  VLYTIGTGSYGRCQKIR-RKSDGK---ILVWK---ELDYGSMTEAEKQMLVSEVNLLREL 62

Query: 61  -CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK--KQNNGRLQESDVKRYTRSM 117
             P IVR +  D   ++      +++EY   G LA  +    +    L E  V R    +
Sbjct: 63  KHPNIVRYY--DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 118 LKGLRHIHSKGF-----VHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
              L+  H +       +H D+K  NV +      K+ DFGLA+  + D   +++F   G
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF--VG 178

Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
           TP YMSPE +N   Y    DIW+LGC + E+ +  P +      +   L  +I  G +  
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF---TAFSQKELAGKIREG-KFR 234

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            IP   S++  + + +        R + E +L +P +
Sbjct: 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  186 bits (474), Expect = 2e-55
 Identities = 63/281 (22%), Positives = 116/281 (41%), Gaps = 29/281 (10%)

Query: 1   MEWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIG 59
           + +   DV+GHG+ G++         +     +AVK      P   +    E + L +  
Sbjct: 24  ISFCPKDVLGHGAEGTI--VYRGMFDNR---DVAVKRI---LPECFSFADREVQLLRESD 75

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P ++R F      EK  +F  + +E  +  +L + V++  +      +     +    
Sbjct: 76  EHPNVIRYFC----TEKDRQFQYIAIELCA-ATLQEYVEQ-KDFAHLGLEPITLLQQTTS 129

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDE-----AKIADFGLAKK-SSCDGERSQSFECRGT 173
           GL H+HS   VH D+K  N+L+   +      A I+DFGL KK +      S+     GT
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

Query: 174 PLYMSPESVNENE---YEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD 229
             +++PE ++E+         DI++ GC    + S G   +            I +G   
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---ILLGACS 246

Query: 230 -ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            +  +         ++ + K    DP++R +A+ +L HPF 
Sbjct: 247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  175 bits (446), Expect = 1e-52
 Identities = 60/286 (20%), Positives = 104/286 (36%), Gaps = 32/286 (11%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICP 62
               +G G FG V  AK +KV        A+K     +   +   +  E +AL ++   P
Sbjct: 9   PIQCLGRGGFGVVFEAK-NKVDDC---NYAIKRIRLPNRELAREKVMREVKALAKLE-HP 63

Query: 63  QIVR---CFGDDYSFEKGERFYN-----LLLEYASRGSLADRVKKQNNGRLQE-SDVKRY 113
            IVR    + +  + EK +         + ++   + +L D +  +     +E S     
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR-- 171
              + + +  +HSKG +H D+K  N+    +D  K+ DFGL      D E          
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 172 --------GTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI 223
                   GT LYMSPE ++ N Y    DI++LG  + E+      +           L 
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLT 238

Query: 224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            +    + P +           +       P  R  A  ++ +   
Sbjct: 239 DVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  173 bits (440), Expect = 1e-51
 Identities = 65/287 (22%), Positives = 116/287 (40%), Gaps = 33/287 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
             V+G G+FG V  A+ + + S      A+K          T+ +E   L  +     +V
Sbjct: 11  IAVLGQGAFGQVVKAR-NALDSR---YYAIKKIRHTEEKLSTILSEVMLLASLN-HQYVV 65

Query: 66  RCFG----------DDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
           R +              + +K    + + +EY   G+L D +  +N    Q  +  R  R
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLF-IQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFR 123

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR---- 171
            +L+ L +IHS+G +H D+K  N+ + ++   KI DFGLAK      +  +         
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 172 --------GTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLL 222
                   GT +Y++ E ++    Y    D+++LG    EM    P     +  N+    
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILK-K 240

Query: 223 IRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           +R    +  P+   +  +  K  +      DP +R  A  LLN  ++
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  171 bits (436), Expect = 4e-51
 Identities = 74/267 (27%), Positives = 123/267 (46%), Gaps = 27/267 (10%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGI-----CP 62
           IG G+ G+V  A     + +    +A++        ++  + +KE +   I +      P
Sbjct: 28  IGQGASGTVYTAM-DVATGQ---EVAIRQM------NLQQQPKKELIINEILVMRENKNP 77

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            IV       S+  G+  + +++EY + GSL D V       + E  +    R  L+ L 
Sbjct: 78  NIVNYLD---SYLVGDELW-VVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALE 130

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV 182
            +HS   +H DIK  N+L+  +   K+ DFG   + + +  +  +    GTP +M+PE V
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVV 188

Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               Y    DIW+LG   +EM  G+P + ++        LI      EL N P  LS   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTPELQN-PEKLSAIF 246

Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           +DFL +C   D ++R +A+ LL H F+
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQHQFL 273

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  171 bits (436), Expect = 6e-51
 Identities = 79/267 (29%), Positives = 131/267 (49%), Gaps = 27/267 (10%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGI-----CP 62
           IG GS G V LA+  K S      +AVK         +  +  +E L   + I       
Sbjct: 53  IGEGSTGIVCLAR-EKHSGR---QVAVKMM------DLRKQQRRELLFNEVVIMRDYQHF 102

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            +V  +    S+  GE  + +L+E+   G+L D V      RL E  +     ++L+ L 
Sbjct: 103 NVVEMYK---SYLVGEELW-VLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALA 155

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV 182
           ++H++G +H DIK  ++L+  +   K++DFG   + S D  + +S    GTP +M+PE +
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVI 213

Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
           + + Y    DIW+LG  V+EM  G+P +            +R     +L N    +S   
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRDSPPPKLKN-SHKVSPVL 271

Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           +DFL +  ++DP+ R TA+ LL+HPF+
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFL 298

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  168 bits (428), Expect = 7e-50
 Identities = 79/269 (29%), Positives = 140/269 (52%), Gaps = 20/269 (7%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC--ADCPPSSVTLKNEKEALDQIGI 60
           + + + IG GSFG V        + +   ++A+K     +       ++ E   L Q   
Sbjct: 24  FTKLEKIGKGSFGEVFKGI-DNRTQK---VVAIKIIDLEEAEDEIEDIQQEITVLSQCD- 78

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P + + +G   S+ K  + + +++EY   GS  D ++    G L E+ +    R +LKG
Sbjct: 79  SPYVTKYYG---SYLKDTKLW-IIMEYLGGGSALDLLE---PGPLDETQIATILREILKG 131

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L ++HS+  +H DIK  NVL+ ++ E K+ADFG+A + +    +  +F   GTP +M+PE
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPE 189

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            + ++ Y++  DIW+LG   +E+A G+P  +      V  L+ +    +  P + G+ S+
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK----NNPPTLEGNYSK 245

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             K+F+  C  K+P  R TA+ LL H F+
Sbjct: 246 PLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  167 bits (426), Expect = 2e-49
 Identities = 59/278 (21%), Positives = 104/278 (37%), Gaps = 26/278 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICPQ 63
              +G G F  V+L +       +    A+K   C +        + E +        P 
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFY----ALKRILCHE-QQDREEAQREADMHRLFN-HPN 87

Query: 64  IVRCFGDDYSFEKGERFYN--LLLEYASRGSLADRVK--KQNNGRLQESDVKRYTRSMLK 119
           I+R     Y   +    +   LLL +  RG+L + ++  K     L E  +      + +
Sbjct: 88  ILRLV--AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF-------ECRG 172
           GL  IH+KG+ H D+K  N+L+ D  +  + D G   ++    E S+           R 
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 173 TPLYMSPESVNENEYEA---PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
           T  Y +PE  +   +       D+W+LGC +  M  G+  ++        S+ + +    
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM-VFQKGDSVALAVQNQL 264

Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHP 267
            +P      S      L      DP +R    +LL+  
Sbjct: 265 SIP-QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  166 bits (423), Expect = 2e-49
 Identities = 71/295 (24%), Positives = 117/295 (39%), Gaps = 51/295 (17%)

Query: 7   DVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI----GI 60
             +G G++G V       S        +MAVK         +      +   ++     I
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQ------IMAVKR--------IRATVNSQEQKRLLMDLDI 58

Query: 61  ------CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKK--QNNGRLQESDVKR 112
                 CP  V  +G   +  +    + + +E     SL    K+       + E  + +
Sbjct: 59  SMRTVDCPFTVTFYG---ALFREGDVW-ICMELMD-TSLDKFYKQVIDKGQTIPEDILGK 113

Query: 113 YTRSMLKGLRHIHSKG-FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR 171
              S++K L H+HSK   +H D+K  NVL+    + K+ DFG++      G         
Sbjct: 114 IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS------GYLVDDVAKD 167

Query: 172 ---GTPLYMSPE----SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR 224
              G   YM+PE     +N+  Y    DIW+LG  ++E+A  +    +      F  L +
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQ 225

Query: 225 IGVGDELPNIPGDL-SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDD 278
           + V +  P +P D  S +  DF  +C  K+ K R T   L+ HPF    +  G D
Sbjct: 226 V-VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTD 279

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  165 bits (420), Expect = 1e-48
 Identities = 57/309 (18%), Positives = 112/309 (36%), Gaps = 57/309 (18%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGI 60
            WL  D++G G+  +V   +  K + +   L A+K       ++++     +   +   +
Sbjct: 10  LWLLSDILGQGATANVFRGR-HKKTGD---LFAIKVF-----NNISFLRPVDVQMREFEV 60

Query: 61  C-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADR-VKKQNNGRLQESDVKRYT 114
                   IV+ F              L++E+   GSL     +  N   L ES+     
Sbjct: 61  LKKLNHKNIVKLF-AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA----KIADFGLAKKSSCDGERSQSFEC 170
           R ++ G+ H+   G VH +IK  N++    ++     K+ DFG A++   D E+  S   
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSL-Y 176

Query: 171 RGTPLYMSPE--------SVNENEYEAPCDIWALGCAVVEMASGKPAWN-HKQDSNVFSL 221
            GT  Y+ P+          ++ +Y A  D+W++G      A+G   +   +       +
Sbjct: 177 -GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

Query: 222 LIRIGVG--------------------DELP---NIPGDLSEQGKDFLIKCFLKDPKRRW 258
           + +I  G                     ++P   ++   L       L      D ++ W
Sbjct: 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295

Query: 259 TAEMLLNHP 267
             +      
Sbjct: 296 GFDQFFAET 304

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  165 bits (419), Expect = 3e-48
 Identities = 81/308 (26%), Positives = 133/308 (43%), Gaps = 29/308 (9%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGIC-- 61
           RG  +G G F        +     F    A K     P S +   +++E +   I I   
Sbjct: 45  RGRFLGKGGFAKCFEISDADTKEVF----AGKIV---PKSLLLKPHQREKMSMEISIHRS 97

Query: 62  ---PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
                +V   G    FE  +  + ++LE   R SL +  K++    L E + + Y R ++
Sbjct: 98  LAHQHVVGFHG---FFEDNDFVF-VVLELCRRRSLLELHKRR--KALTEPEARYYLRQIV 151

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            G +++H    +H D+KL N+ + ++ E KI DFGLA K   DGER +   C GTP Y++
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-C-GTPNYIA 209

Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           PE +++  +    D+W++GC +  +  GKP +   + S +    +RI   +   +IP  +
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNE--YSIPKHI 264

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEK 298
           +      + K    DP  R T   LLN  F  +         + I   + P    I    
Sbjct: 265 NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG---YIPARLPITCLTIPPRFSIAPSS 321

Query: 299 FSQSPRSP 306
              S R P
Sbjct: 322 LDPSNRKP 329

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  164 bits (418), Expect = 4e-48
 Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 45/294 (15%)

Query: 7   DVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI---- 60
             IG G++GSVN    K S        +MAVK       S+V  K +K+ L  + +    
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQ------IMAVKRI----RSTVDEKEQKQLLMDLDVVMRS 77

Query: 61  --CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD---RVKKQNNGRLQESDVKRYTR 115
             CP IV+ +G   +  +    + + +E  S  S       V    +  + E  + + T 
Sbjct: 78  SDCPYIVQFYG---ALFREGDCW-ICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITL 132

Query: 116 SMLKGLRHIHSKGFV-HCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR--- 171
           + +K L H+     + H DIK  N+L+  +   K+ DFG++      G+   S       
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS------GQLVDSIAKTRDA 186

Query: 172 GTPLYMSPE----SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV 227
           G   YM+PE    S +   Y+   D+W+LG  + E+A+G+    + + ++VF  L ++  
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP--YPKWNSVFDQLTQVVK 244

Query: 228 GD--ELPNIPGDL-SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDD 278
           GD  +L N      S    +F+  C  KD  +R   + LL HPF+   ++   +
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVE 298

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  162 bits (412), Expect = 7e-48
 Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 40/276 (14%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-------I 58
           G  +G G FG+V LA+  K S      +A+K         V  K + E           +
Sbjct: 14  GRPLGKGKFGNVYLAR-EKQSKFI---LALK---------VLFKAQLEKAGVEHQLRREV 60

Query: 59  GIC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
            I      P I+R +G    F    R Y L+LEYA  G++   ++K    +  E     Y
Sbjct: 61  EIQSHLRHPNILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKL--SKFDEQRTATY 114

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
              +   L + HSK  +H DIK +N+L+    E KIADFG +  +     R     C GT
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDL-C-GT 170

Query: 174 PLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN 233
             Y+ PE +    ++   D+W+LG    E   GKP +   + +       RI   +    
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQETYKRISRVE--FT 225

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            P  ++E  +D + +    +P +R     +L HP++
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  163 bits (415), Expect = 7e-48
 Identities = 70/293 (23%), Positives = 131/293 (44%), Gaps = 48/293 (16%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI-------- 58
             +G G+ G V   +  + +     ++AVK         +     KE   +I        
Sbjct: 31  GEMGSGTCGQVWKMR-FRKTGH---VIAVKQ--------MRRSGNKEENKRILMDLDVVL 78

Query: 59  --GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
               CP IV+CFG   +F      + + +E     +  +++KK+  G + E  + + T +
Sbjct: 79  KSHDCPYIVQCFG---TFITNTDVF-IAMELMGTCA--EKLKKRMQGPIPERILGKMTVA 132

Query: 117 MLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR---G 172
           ++K L ++  K G +H D+K  N+L+ +  + K+ DFG++      G            G
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS------GRLVDDKAKDRSAG 186

Query: 173 TPLYMSPE-----SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV 227
              YM+PE        + +Y+   D+W+LG ++VE+A+G+    +K     F +L ++ +
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP--YKNCKTDFEVLTKV-L 243

Query: 228 GDELPNIPGDL--SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDD 278
            +E P +PG +  S   + F+  C  KD ++R     LL H F+   +    D
Sbjct: 244 QEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  163 bits (414), Expect = 8e-48
 Identities = 80/281 (28%), Positives = 134/281 (47%), Gaps = 34/281 (12%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGI- 60
           W     +G G+FG V  AK +K +     L A K            + E E     I I 
Sbjct: 21  WEIVGELGDGAFGKVYKAK-NKETGA---LAAAKVI------ETKSEEELEDYIVEIEIL 70

Query: 61  ----CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
                P IV+  G   ++    + + +++E+   G++   +  + +  L E  ++   R 
Sbjct: 71  ATCDHPYIVKLLG---AYYHDGKLW-IMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQ 125

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML+ L  +HSK  +H D+K  NVL+    + ++ADFG++ K+    ++  SF   GTP +
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF--IGTPYW 183

Query: 177 MSPE-----SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-- 229
           M+PE     ++ +  Y+   DIW+LG  ++EMA  +P  +   + N   +L++I   D  
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAKSDPP 240

Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            L   P   S + +DFL     K+P+ R +A  LL HPFV 
Sbjct: 241 TLLT-PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  163 bits (414), Expect = 1e-47
 Identities = 82/271 (30%), Positives = 137/271 (50%), Gaps = 31/271 (11%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGI----- 60
           + +G GS+GSV  A   K + +   ++A+K         V ++++ + + + I I     
Sbjct: 35  EKLGEGSYGSVYKAI-HKETGQ---IVAIKQ--------VPVESDLQEIIKEISIMQQCD 82

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +V+ +G   S+ K    + +++EY   GS++D + +  N  L E ++    +S LKG
Sbjct: 83  SPHVVKYYG---SYFKNTDLW-IVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKG 137

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L ++H    +H DIK  N+L+     AK+ADFG+A + +    +  +    GTP +M+PE
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI--GTPFWMAPE 195

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD--ELPNIPGDL 238
            + E  Y    DIW+LG   +EMA GKP +    D +    +  I           P   
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFMIPTNPPPTFRK-PELW 251

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S+   DF+ +C +K P++R TA  LL HPFV
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  162 bits (412), Expect = 1e-47
 Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 26/274 (9%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGI--- 60
           RG  +G G F        +     F    A K     P S +   +++E +   I I   
Sbjct: 19  RGRFLGKGGFAKCFEISDADTKEVF----AGKIV---PKSLLLKPHQREKMSMEISIHRS 71

Query: 61  --CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
                +V   G    FE  +  + ++LE   R SL +  K+     L E + + Y R ++
Sbjct: 72  LAHQHVVGFHG---FFEDNDFVF-VVLELCRRRSLLELHKR--RKALTEPEARYYLRQIV 125

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            G +++H    +H D+KL N+ + ++ E KI DFGLA K   DGER +   C GTP Y++
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-C-GTPNYIA 183

Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           PE +++  +    D+W++GC +  +  GKP +   + S +    +RI   +   +IP  +
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNE--YSIPKHI 238

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
           +      + K    DP  R T   LLN  F  + 
Sbjct: 239 NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  162 bits (412), Expect = 3e-47
 Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 24/278 (8%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           +   +++G+G++G V   +    + +   L A+K           +K E   L +     
Sbjct: 26  FELVELVGNGTYGQVYKGR-HVKTGQ---LAAIKVMDVTGDEEEEIKQEINMLKKYSHHR 81

Query: 63  QIVRCFGDDYSFEKGERFYN-----LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
            I   +G   +F K           L++E+   GS+ D +K      L+E  +    R +
Sbjct: 82  NIATYYG---AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           L+GL H+H    +H DIK QNVL+ +N E K+ DFG++ +      R  +F   GTP +M
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWM 196

Query: 178 SPE-----SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
           +PE        +  Y+   D+W+LG   +EMA G P      D +    L  I   +  P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL---CDMHPMRALFLI-PRNPAP 252

Query: 233 NI-PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            +     S++ + F+  C +K+  +R   E L+ HPF+
Sbjct: 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  159 bits (405), Expect = 8e-47
 Identities = 71/279 (25%), Positives = 125/279 (44%), Gaps = 37/279 (13%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ----- 57
           +  G+++G GSF  V  A+ S  +      +A+K         +  K             
Sbjct: 13  FKVGNLLGKGSFAGVYRAE-SIHTGL---EVAIK---------MIDKKAMYKAGMVQRVQ 59

Query: 58  --IGIC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDV 110
             + I      P I+  +     FE     Y L+LE    G +   +K +      E++ 
Sbjct: 60  NEVKIHCQLKHPSILELYN---YFEDSNYVY-LVLEMCHNGEMNRYLKNRV-KPFSENEA 114

Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
           + +   ++ G+ ++HS G +H D+ L N+L+  N   KIADFGLA +     E+  +  C
Sbjct: 115 RHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-C 173

Query: 171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE 230
            GTP Y+SPE    + +    D+W+LGC    +  G+P +       V + L ++ + D 
Sbjct: 174 -GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF---DTDTVKNTLNKVVLADY 229

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
              +P  LS + KD + +   ++P  R +   +L+HPF+
Sbjct: 230 --EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  160 bits (408), Expect = 1e-46
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 23/283 (8%)

Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           L+   +G GSF         K +  F    AVK  +    ++   + E  AL      P 
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAF----AVKIISKRMEANT--QKEITALKLCEGHPN 67

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+       F      + L++E  + G L +R+KK+      E++     R ++  + H
Sbjct: 68  IVKLHE---VFHDQLHTF-LVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSH 121

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +H  G VH D+K +N+L  D ++    KI DFG A+    D +  ++  C  T  Y +PE
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-C-FTLHYAAPE 179

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFS---LLIRIGVGD-ELPNIP 235
            +N+N Y+  CD+W+LG  +  M SG+    +H +     S   ++ +I  GD       
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239

Query: 236 -GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGD 277
             ++S++ KD +      DP +R     L  + ++    Q   
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS 282

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  160 bits (407), Expect = 3e-46
 Identities = 79/322 (24%), Positives = 127/322 (39%), Gaps = 73/322 (22%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI-------- 58
             +G G+ G V      K S     +MA K         + L+ +    +QI        
Sbjct: 39  SELGAGNGGVVFKVS-HKPSGL---VMARKL--------IHLEIKPAIRNQIIRELQVLH 86

Query: 59  -GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P IV  +G   +F        + +E+   GSL   +KK   GR+ E  + + + ++
Sbjct: 87  ECNSPYIVGFYG---AFYSDGEIS-ICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAV 140

Query: 118 LKGLRHIHSKGFV-HCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           +KGL ++  K  + H D+K  N+LV    E K+ DFG++ +       S +    GT  Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSY 196

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN------------------- 217
           MSPE +    Y    DIW++G ++VEMA G+                             
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256

Query: 218 --------------------VFSLLIRIGVGDELPNIPGDL-SEQGKDFLIKCFLKDPKR 256
                               +F LL  I V +  P +P  + S + +DF+ KC +K+P  
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYI-VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315

Query: 257 RWTAEMLLNHPFVCADDQTGDD 278
           R   + L+ H F+   D    D
Sbjct: 316 RADLKQLMVHAFIKRSDAEEVD 337

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  159 bits (405), Expect = 5e-46
 Identities = 79/295 (26%), Positives = 129/295 (43%), Gaps = 28/295 (9%)

Query: 6   GDVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
            + IG GS+        KA+ +  EF    AVK       S      E E L + G  P 
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNM--EF----AVKIIDK---SKRDPTEEIEILLRYGQHPN 77

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           I+        ++ G+  Y ++ E    G L D++ +Q      E +      ++ K + +
Sbjct: 78  IITLKD---VYDDGKYVY-VVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEY 131

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA----KIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           +H++G VH D+K  N+L  D        +I DFG AK+   +     +  C  T  +++P
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-C-YTANFVAP 189

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-ELPNIP-GD 237
           E +    Y+A CDIW+LG  +  M +G   + +  D     +L RIG G   L       
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249

Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLK 292
           +S+  KD + K    DP +R TA ++L HP++   DQ        ++   +P L 
Sbjct: 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQY---QLNRQDAPHLV 301

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  156 bits (397), Expect = 1e-45
 Identities = 75/268 (27%), Positives = 117/268 (43%), Gaps = 24/268 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVT--LKNEKEALDQIGIC 61
           G  +G G FG+V LA+  K +      MA+K    +      V   L+ E E    +   
Sbjct: 19  GRPLGKGKFGNVYLAR-EKQNKFI---MALKVLFKSQLEKEGVEHQLRREIEIQSHL-RH 73

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P I+R +     F   +R Y L+LE+A RG L   ++K  +GR  E     +   +   L
Sbjct: 74  PNILRMYN---YFHDRKRIY-LMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADAL 127

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            + H +  +H DIK +N+L+    E KIADFG +  +     R ++  C GT  Y+ PE 
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA--PSLRRRTM-C-GTLDYLPPEM 183

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           +    ++   D+W  G    E   G P +      +      RI   D     P  LS+ 
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPF---DSPSHTETHRRIVNVD--LKFPPFLSDG 238

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            KD + K     P +R   + ++ HP+V
Sbjct: 239 SKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  160 bits (405), Expect = 1e-45
 Identities = 60/304 (19%), Positives = 110/304 (36%), Gaps = 49/304 (16%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC--ADCPPSSVTLKNEKEALDQIG 59
            WL  D++G G+  +V   +  K + +   L A+K                E E L ++ 
Sbjct: 10  LWLLSDILGQGATANVFRGR-HKKTGD---LFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADR-VKKQNNGRLQESDVKRYTRSML 118
               IV+ F              L++E+   GSL     +  N   L ES+     R ++
Sbjct: 66  -HKNIVKLF-AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEA----KIADFGLAKKSSCDGERSQSFECRGTP 174
            G+ H+   G VH +IK  N++    ++     K+ DFG A++   D E+  S    GT 
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSL-Y-GTE 179

Query: 175 LYMSPE--------SVNENEYEAPCDIWALGCAVVEMASGKPAWN-HKQDSNVFSLLIRI 225
            Y+ P+          ++ +Y A  D+W++G      A+G   +   +       ++ +I
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

Query: 226 GVG--------------------DELP---NIPGDLSEQGKDFLIKCFLKDPKRRWTAEM 262
             G                     ++P   ++   L       L      D ++ W  + 
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299

Query: 263 LLNH 266
               
Sbjct: 300 FFAE 303

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  161 bits (409), Expect = 2e-45
 Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 35/300 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGIC--- 61
             V+G GSFG V L K      E     AVK         V  K +KE+L + + +    
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQEC----AVKVI---SKRQVKQKTDKESLLREVQLLKQL 83

Query: 62  --PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P I++ +     FE    FY L+ E  + G L D +  +   R  E D  R  R +L 
Sbjct: 84  DHPNIMKLYE---FFEDKGYFY-LVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLS 137

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLY 176
           G+ ++H    VH D+K +N+L+    +    +I DFGL+       +        GT  Y
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYY 194

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELP 232
           ++PE V    Y+  CD+W+ G  +  + SG P +N   + ++    +  G       +  
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK-KVEKGKYTFELPQWK 252

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLK 292
            +    SE  KD + K     P  R +A   L+H ++    +      +    ++  +++
Sbjct: 253 KV----SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIR 308

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  160 bits (407), Expect = 5e-45
 Identities = 69/307 (22%), Positives = 128/307 (41%), Gaps = 39/307 (12%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKS--------CADCPPSSVTLKNEKEALDQ 57
              +G G++G V L K     SE     A+K               +    K  +E  ++
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEK----AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 58  IGIC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKR 112
           I +      P I++ F     FE  + FY L+ E+   G L +++  +   +  E D   
Sbjct: 97  ISLLKSLDHPNIIKLFD---VFEDKKYFY-LVTEFYEGGELFEQIINR--HKFDECDAAN 150

Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFE 169
             + +L G+ ++H    VH DIK +N+L+ + +     KI DFGL+   S    + +   
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKLRDRL 209

Query: 170 CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV-- 227
             GT  Y++PE V + +Y   CD+W+ G  +  +  G P +  + D ++    +  G   
Sbjct: 210 --GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK-KVEKGKYY 265

Query: 228 --GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHS 285
              ++  NI    S++ K+ +      D  +R TAE  LN  ++       +        
Sbjct: 266 FDFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLC 321

Query: 286 SSSPSLK 292
            +  +++
Sbjct: 322 GALSNMR 328

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  157 bits (398), Expect = 6e-45
 Identities = 69/291 (23%), Positives = 110/291 (37%), Gaps = 38/291 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKS-----CADCPPSSVT-LKNEKEALDQIG 59
            +VIG G F  V      +   +F    AVK          P  S   LK E        
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQF----AVKIVDVAKFTSSPGLSTEDLKRE------AS 78

Query: 60  IC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRV--KKQNNGRLQESDVKR 112
           IC     P IV       ++   +    ++ E+     L   +  +        E+    
Sbjct: 79  ICHMLKHPHIVELLE---TYS-SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134

Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFE 169
           Y R +L+ LR+ H    +H D+K   VL+   + +   K+  FG+A +    G  +    
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR- 193

Query: 170 CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
             GTP +M+PE V    Y  P D+W  G  +  + SG   +   ++     L   I  G 
Sbjct: 194 V-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFEGIIKGK 248

Query: 230 -ELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDD 278
            ++       +SE  KD + +  + DP  R T    LNHP++   D+    
Sbjct: 249 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYK 299

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  160 bits (406), Expect = 6e-45
 Identities = 67/300 (22%), Positives = 135/300 (45%), Gaps = 35/300 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
              +G G++G V L +      E     A+K       +SV+  +  + L+++ +     
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVER----AIKII---RKTSVSTSSNSKLLEEVAVLKLLD 94

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I++ +     FE    +Y L++E    G L D +  +   +  E D     + +L G
Sbjct: 95  HPNIMKLYD---FFEDKRNYY-LVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSG 148

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + ++H    VH D+K +N+L+   ++    KI DFGL+     + ++ +     GT  Y+
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERL--GTAYYI 205

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELPN 233
           +PE V   +Y+  CD+W++G  +  + +G P +  + D  +    +  G       E  N
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR-KVEKGKYTFDSPEWKN 263

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGG-IHIHSSSSPSLK 292
           +    SE  KD + +    D +RR +A+  L HP++       + G  +   +++  +++
Sbjct: 264 V----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMR 319

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  154 bits (392), Expect = 1e-44
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 28/281 (9%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC--ADCPPSSVTLKNEKEALDQIGICPQI 64
           +VIG G+   V  A       E    +A+K      C  S   L  E +A+ Q    P I
Sbjct: 21  EVIGSGATAVVQAAY-CAPKKE---KVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNI 75

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVK------KQNNGRLQESDVKRYTRSML 118
           V  +    SF   +  + L+++  S GS+ D +K      +  +G L ES +    R +L
Sbjct: 76  VSYYT---SFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR----GTP 174
           +GL ++H  G +H D+K  N+L+ ++   +IADFG++   +  G+ +++   R    GTP
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV-RKTFVGTP 190

Query: 175 LYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI-----RIGVG 228
            +M+PE + +   Y+   DIW+ G   +E+A+G   ++      V  L +      +  G
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250

Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            +   +     +  +  +  C  KDP++R TA  LL H F 
Sbjct: 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  153 bits (389), Expect = 4e-44
 Identities = 75/299 (25%), Positives = 125/299 (41%), Gaps = 40/299 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
            +V+G G+F  V L K       F    A+K              +    ++I +     
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLF----ALKCI-----KKSPAFRDSSLENEIAVLKKIK 64

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              IV        +E    +Y L+++  S G L DR+ ++  G   E D     + +L  
Sbjct: 65  HENIVTLED---IYESTTHYY-LVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSA 118

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           ++++H  G VH D+K +N+L    +E     I DFGL+K      +        GTP Y+
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYV 174

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELPN 233
           +PE + +  Y    D W++G     +  G P +  + +S +F   I+ G          +
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE-KIKEGYYEFESPFWDD 233

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLK 292
           I    SE  KDF+     KDP  R+T E  L+HP++  +     D    I+ S S  ++
Sbjct: 234 I----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRD----IYPSVSLQIQ 284

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  156 bits (397), Expect = 4e-44
 Identities = 67/296 (22%), Positives = 110/296 (37%), Gaps = 50/296 (16%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK----SCADCPPSSVTLKNEKEALDQIGIC 61
             ++G+GS G+V               +AVK       D          E + L +    
Sbjct: 20  EKILGYGSSGTVVFQG--SFQGR---PVAVKRMLIDFCD------IALMEIKLLTESDDH 68

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKK-----QNNGRLQESDVKRYTRS 116
           P ++R +      E  +RF  + LE  +  +L D V+      +N    +E +     R 
Sbjct: 69  PNVIRYYC----SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLV-------------FDNDEAKIADFGLAKKSSCDGE 163
           +  G+ H+HS   +H D+K QN+LV              +N    I+DFGL KK    G+
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD-SGQ 182

Query: 164 RSQSFECR---GTPLYMSPE-------SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNH 212
            S         GT  + +PE          +       DI+++GC    + S GK  +  
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

Query: 213 KQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           K       +     + +        L  +  D + +    DP +R TA  +L HP 
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  154 bits (390), Expect = 5e-44
 Identities = 66/280 (23%), Positives = 116/280 (41%), Gaps = 18/280 (6%)

Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           L   V+G G  G V      +   +     A+K   D P      + E +   Q    P 
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKC----ALKLLYDSP----KARQEVDHHWQASGGPH 83

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV       +   G+R   +++E    G L  R++++ +    E +     R +   ++ 
Sbjct: 84  IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L    ++    K+ DFG AK+        Q+  C  TP Y++PE
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTP-C-YTPYYVAPE 199

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P  +++   +    +  RI +G    PN    +
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259

Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGD 277
           +SE  K  +      DP  R T    +NHP++        
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  153 bits (388), Expect = 8e-44
 Identities = 47/272 (17%), Positives = 86/272 (31%), Gaps = 21/272 (7%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           V    ++      K  +   E              PS +   + K            V  
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 68  FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESD-VKRYTRSMLKGLRHIHS 126
                        Y + ++   + +L D + ++ +   +E          + + +  +HS
Sbjct: 127 L---QPSSPKVYLY-IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR----------GTPLY 176
           KG +H D+K  N+    +D  K+ DFGL      D E                  GT LY
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           MSPE ++ N Y    DI++LG  + E+                 ++  +    + P +  
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-----QMERVRIITDVRNL-KFPLLFT 296

Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
               Q    +       P  R  A  ++ +  
Sbjct: 297 QKYPQEHMMVQDMLSPSPTERPEATDIIENAI 328

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  152 bits (386), Expect = 2e-43
 Identities = 81/276 (29%), Positives = 133/276 (48%), Gaps = 39/276 (14%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ----IGI-- 60
             IGHGSFG+V  A+    +SE   ++A+K        S + K   E        +    
Sbjct: 60  REIGHGSFGAVYFAR-DVRNSE---VVAIKKM------SYSGKQSNEKWQDIIKEVRFLQ 109

Query: 61  ---CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P  ++  G    + +    + L++EY   GS +D + + +   LQE ++   T   
Sbjct: 110 KLRHPNTIQYRG---CYLREHTAW-LVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGA 163

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           L+GL ++HS   +H D+K  N+L+ +    K+ DFG A   +     + SF   GTP +M
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANSFV--GTPYWM 217

Query: 178 SPE---SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           +PE   +++E +Y+   D+W+LG   +E+A  KP      + N  S L  I   +  P +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNES-PAL 273

Query: 235 -PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             G  SE  ++F+  C  K P+ R T+E+LL H FV
Sbjct: 274 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  155 bits (394), Expect = 2e-43
 Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 35/300 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
             ++G GSFG V   K      E+    AVK       +S   K+    L ++ +     
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEY----AVKVI---NKASAKNKDTSTILREVELLKKLD 79

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I++ F      E    FY ++ E  + G L D + K+   R  E D  R  + +  G
Sbjct: 80  HPNIMKLFE---ILEDSSSFY-IVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSG 133

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + ++H    VH D+K +N+L+   ++    KI DFGL+        + +     GT  Y+
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI--GTAYYI 190

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELPN 233
           +PE V    Y+  CD+W+ G  +  + SG P +  K + ++    +  G       +   
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK-RVETGKYAFDLPQWRT 248

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ-TGDDGGIHIHSSSSPSLK 292
           I    S+  KD + K     P  R TA   L HP++      T     +    S+  +++
Sbjct: 249 I----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIR 304

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  152 bits (385), Expect = 3e-43
 Identities = 66/296 (22%), Positives = 122/296 (41%), Gaps = 30/296 (10%)

Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCA---DCPPSSVTLKNEKEALDQIGI 60
           L    +G G F  V    +     E+    A K              + +E   L+    
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEY----AAKFLKKRRRGQDCRAEILHEIAVLELAKS 87

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
           CP+++        +E       L+LEYA+ G +      +    + E+DV R  + +L+G
Sbjct: 88  CPRVINLHE---VYENTSEII-LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + ++H    VH D+K QN+L+         KI DFG+++K     E  +     GTP Y+
Sbjct: 144 VYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---GTPEYL 200

Query: 178 SPESVNENEYEAPCDIWALGCAVVE--MASGKPAWNHKQDSNVFSLLIRIGV----GDEL 231
           +PE +N +      D+W +G  ++   + +    +  + +   +   I         +  
Sbjct: 201 APEILNYDPITTATDMWNIG--IIAYMLLTHTSPFVGEDNQETYL-NISQVNVDYSEETF 257

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSS 287
            ++    S+   DF+    +K+P++R TAE+ L+H ++   D           SSS
Sbjct: 258 SSV----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  153 bits (387), Expect = 3e-43
 Identities = 37/304 (12%), Positives = 82/304 (26%), Gaps = 52/304 (17%)

Query: 2   EWLRGDVIGHGSFGSVNLAK--------ASKV-----SSEFPSLMAVKSCADCPPSSVTL 48
             +RG V+G     +   A            V          ++  +K           +
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 49  KNEKEALDQIGI-----------CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRV 97
           KN+K+A   +               +++R   D+       RF+      ++  +  + +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 98  --KKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA 155
                 +  L      + T  +++ L  +H  G VH  ++  ++++       +  F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 156 KKSSCDGERSQSFECRGTPLYMSPESV-----------NENEYEAPCDIWALGCAVVEMA 204
            +   DG R        +  +  PE                      D WALG  +  + 
Sbjct: 254 VR---DGARV---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 205 SGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
                            + R            ++ +  +  L        + R      +
Sbjct: 308 CADLPITKDAALGGSEWIFR---------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358

Query: 265 NHPF 268
             P 
Sbjct: 359 ETPE 362

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  150 bits (380), Expect = 5e-43
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 30/276 (10%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGIC--- 61
              +G G+FG V+L +  + S        +K+      +    +   E ++  I +    
Sbjct: 27  KRKLGSGAFGDVHLVE-ERSSGLER---VIKTI-----NKDRSQVPMEQIEAEIEVLKSL 77

Query: 62  --PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRV--KKQNNGRLQESDVKRYTRSM 117
             P I++ F     FE     Y +++E    G L +R+   +     L E  V    + M
Sbjct: 78  DHPNIIKIFE---VFEDYHNMY-IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTP 174
           +  L + HS+  VH D+K +N+L  D       KI DFGLA+      E S +    GT 
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNA-A-GTA 190

Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           LYM+PE V + +    CDIW+ G  +  + +G   +       V          +     
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ-KATYKEPN-YAVE 247

Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
              L+ Q  D L +   KDP+RR +A  +L+H +  
Sbjct: 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  149 bits (379), Expect = 6e-43
 Identities = 70/293 (23%), Positives = 127/293 (43%), Gaps = 35/293 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
            + +G G+F  V          EF    A K         ++ ++ ++   +  IC    
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEF----AAKII---NTKKLSARDFQKLEREARICRKLQ 63

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IVR      S ++    Y L+ +  + G L + +  +      E+D     + +L+ 
Sbjct: 64  HPNIVRLHD---SIQEESFHY-LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILES 117

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + + HS G VH ++K +N+L+    +    K+ADFGLA + + D E    F   GTP Y+
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGF-A-GTPGYL 174

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELPN 233
           SPE + ++ Y  P DIWA G  +  +  G P +  +    +++  I+ G       E   
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA-QIKAGAYDYPSPEWDT 233

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSS 286
           +    + + K  +      +PK+R TA+  L  P++C  ++      IH   +
Sbjct: 234 V----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA--IHRQDT 280

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  148 bits (377), Expect = 1e-42
 Identities = 72/284 (25%), Positives = 116/284 (40%), Gaps = 36/284 (12%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
            + IG GS+G V +A             A K           +++      +I I     
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRR----AAKKI-----PKYFVEDVDRFKQEIEIMKSLD 64

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I+R +    +FE     Y L++E  + G L +RV  +     +ESD  R  + +L  
Sbjct: 65  HPNIIRLYE---TFEDNTDIY-LVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSA 118

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + + H     H D+K +N L   +      K+ DFGLA +    G+  ++    GTP Y+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTK-V-GTPYYV 175

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELPN 233
           SP+ V E  Y   CD W+ G  +  +  G P ++   DS V    IR G       +  N
Sbjct: 176 SPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML-KIREGTFTFPEKDWLN 233

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGD 277
           +    S Q +  + +   K PK+R T+   L H +      +  
Sbjct: 234 V----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSP 273

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  151 bits (384), Expect = 1e-42
 Identities = 63/316 (19%), Positives = 108/316 (34%), Gaps = 62/316 (19%)

Query: 7   DVIGHG--SFGSVNLAKASKVSSEFPSLMAVKSC--ADCPPSSVT-LKNEKEALDQIGIC 61
            VIG G     +VNLA+  K + E    + V+      C    VT L+ E          
Sbjct: 31  TVIGKGFEDLMTVNLAR-YKPTGE---YVTVRRINLEACSNEMVTFLQGELHVSKLFN-H 85

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV       +F      + ++  + + GS  D +       + E  +    + +LK L
Sbjct: 86  PNIVPYRA---TFIADNELW-VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR-----GTPLY 176
            +IH  G+VH  +K  ++L+  + +  ++           G+R +              +
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 177 MSPESVNEN--EYEAPCDIWALGCAVVEMASGKP-------------------------- 208
           +SPE + +N   Y+A  DI+++G    E+A+G                            
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261

Query: 209 ---------------AWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKD 253
                          A +   DS   S                  S     F+ +C  ++
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321

Query: 254 PKRRWTAEMLLNHPFV 269
           P  R +A  LLNH F 
Sbjct: 322 PDARPSASTLLNHSFF 337

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  149 bits (378), Expect = 1e-42
 Identities = 65/286 (22%), Positives = 124/286 (43%), Gaps = 34/286 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKS----------CADCPPSSVTLKNEKEAL 55
            +++G G    V          E+    AVK             +          E + L
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEY----AVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77

Query: 56  DQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
            ++   P I++      ++E    F+ L+ +   +G L D + ++    L E + ++  R
Sbjct: 78  RKVSGHPNIIQLKD---TYETNTFFF-LVFDLMKKGELFDYLTEK--VTLSEKETRKIMR 131

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
           ++L+ +  +H    VH D+K +N+L+ D+   K+ DFG + +    GE+ +   C GTP 
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREV-C-GTPS 188

Query: 176 YMSPE------SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
           Y++PE      + N   Y    D+W+ G  +  + +G P + H++   +      I  G+
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR---MIMSGN 245

Query: 230 -ELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD 273
            +  +    D S+  KD + +  +  P++R+TAE  L HPF     
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  149 bits (379), Expect = 2e-42
 Identities = 61/323 (18%), Positives = 114/323 (35%), Gaps = 68/323 (21%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
              IG GS+G V +A  ++  +      A+K         +  K+ +    ++ +     
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIR----AIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNN------------------ 102
            P I R +     +E  +    L++E    G L D++    +                  
Sbjct: 87  HPNIARLYE---VYEDEQYIC-LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 103 --------------------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
                                  +E  +    R +   L ++H++G  H DIK +N L F
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL-F 201

Query: 143 DNDEA---KIADFGLAKK--SSCDGERSQSFECRGTPLYMSPESVNENE--YEAPCDIWA 195
             +++   K+ DFGL+K+     +GE        GTP +++PE +N     Y   CD W+
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 196 LGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELPNIPGDLSEQGKDFLIKCFL 251
            G  +  +  G   +    D++  S  +              +    S   +D L     
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTIS-QVLNKKLCFENPNYNVL----SPLARDLLSNLLN 316

Query: 252 KDPKRRWTAEMLLNHPFVCADDQ 274
           ++   R+ A   L HP++     
Sbjct: 317 RNVDERFDAMRALQHPWISQFSD 339

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  155 bits (393), Expect = 2e-42
 Identities = 64/327 (19%), Positives = 113/327 (34%), Gaps = 41/327 (12%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI- 60
            W   + +G G FG V      + + E    +A+K C       ++ KN +    +I I 
Sbjct: 15  PWEMKERLGTGGFGYVLRWI-HQDTGE---QVAIKQC----RQELSPKNRERWCLEIQIM 66

Query: 61  ----CPQIVRCF--GDDYSFEKGERFYNLLLEYASRGSLADR-VKKQNNGRLQESDVKRY 113
                P +V      D            L +EY   G L     + +N   L+E  ++  
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFEC 170
              +   LR++H    +H D+K +N+++    +    KI D G AK+    GE    F  
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF-V 184

Query: 171 RGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE 230
            GT  Y++PE + + +Y    D W+ G    E  +G   +        +   +R    + 
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243

Query: 231 LP---------------NIPGDLSEQGKDF---LIKCFLK-DPKRRWTAEMLLNHPFVCA 271
           +                  P  LS          ++C L    ++R T     N     A
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303

Query: 272 DDQTGDDGGIHIHSSSSPSLKGIKDEK 298
            D       + + +  S  +      +
Sbjct: 304 LDSILSLKLLSVMNMVSGRVHTYPVTE 330

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  148 bits (377), Expect = 3e-42
 Identities = 66/309 (21%), Positives = 122/309 (39%), Gaps = 38/309 (12%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGIC--- 61
           G+ +G G F  V   +      E+    A K        +      +E +++ + I    
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEY----AAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 62  --PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               ++        +E       L+LE  S G L D + ++    L E +   + + +L 
Sbjct: 73  LHHNVITLHD---VYENRTDVV-LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILD 126

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEA----KIADFGLAKKSSCDGERSQSFECRGTPL 175
           G+ ++H+K   H D+K +N+++ D +      K+ DFGLA +     E    F   GTP 
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPE 183

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDEL 231
           +++PE VN        D+W++G     + SG   +         +  I         +  
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-NITSVSYDFDEEFF 242

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSL 291
            +     SE  KDF+ K  +K+ ++R T +  L HP++   D         +   S  +L
Sbjct: 243 SHT----SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAM----VRRESVVNL 294

Query: 292 KGIKDEKFS 300
           +  +  K  
Sbjct: 295 ENFR--KQY 301

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  148 bits (375), Expect = 5e-42
 Identities = 57/278 (20%), Positives = 104/278 (37%), Gaps = 24/278 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
            + +G G FG V+    +     +      K         V +K E   L+       I+
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTY----MAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
                  SFE  E    ++ E+ S   + +R+       L E ++  Y   + + L+ +H
Sbjct: 65  HLHE---SFESMEELV-MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH 119

Query: 126 SKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           S    H DI+ +N++      +  KI +FG A++       +        P Y +PE   
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAPEVHQ 176

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELPNIPGDLS 239
            +      D+W+LG  V  + SG   +  + +  +    I         +    I    S
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE-NIMNAEYTFDEEAFKEI----S 231

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGD 277
            +  DF+ +  +K+ K R TA   L HP++    +   
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  149 bits (379), Expect = 6e-42
 Identities = 73/311 (23%), Positives = 128/311 (41%), Gaps = 36/311 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
            + +G G+FG V+          F      K       ++    ++    ++I I     
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVF----VAKFI-----NTPYPLDKYTVKNEISIMNQLH 106

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P+++       +FE       L+LE+ S G L DR+  ++  ++ E++V  Y R   +G
Sbjct: 107 HPKLINLHD---AFEDKYEMV-LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEG 161

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
           L+H+H    VH DIK +N++      +  KI DFGLA K + D     +     T  + +
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAA 218

Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELPNI 234
           PE V+        D+WA+G     + SG   +  + D       ++        D   ++
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ-NVKRCDWEFDEDAFSSV 277

Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGI 294
               S + KDF+     K+P++R T    L HP++  D          I SS    ++  
Sbjct: 278 ----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS---RIPSSRYNKIRQK 330

Query: 295 KDEKFSQSPRS 305
             EK++  P  
Sbjct: 331 IKEKYADWPAP 341

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  150 bits (382), Expect = 7e-42
 Identities = 67/286 (23%), Positives = 118/286 (41%), Gaps = 34/286 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGIC--- 61
            + +G G+F  V          E+    A         +      + + L++   IC   
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEY----AAM----IINTKKLSARDHQKLEREARICRLL 67

Query: 62  --PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P IVR      S  +    Y L+ +  + G L + +  +      E+D     + +L+
Sbjct: 68  KHPNIVRLHD---SISEEGHHY-LIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILE 121

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLY 176
            + H H  G VH ++K +N+L+    +    K+ADFGLA +   +GE+   F   GTP Y
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGY 179

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELP 232
           +SPE + ++ Y  P D+WA G  +  +  G P +  +    ++   I+ G       E  
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ-IKAGAYDFPSPEWD 238

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDD 278
            +    + + KD + K    +P +R TA   L HP++         
Sbjct: 239 TV----TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASC 280

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  146 bits (372), Expect = 8e-42
 Identities = 71/277 (25%), Positives = 117/277 (42%), Gaps = 34/277 (12%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
             ++G GSFG V   K      E+    AVK       +S   K+    L ++ +     
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEY----AVKVI---NKASAKNKDTSTILREVELLKKLD 79

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I++ F      E    FY ++ E  + G L D + K+   R  E D  R  + +  G
Sbjct: 80  HPNIMKLFE---ILEDSSSFY-IVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSG 133

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + ++H    VH D+K +N+L+   ++    KI DFGL+        + +     GT  Y+
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR-I-GTAYYI 190

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELPN 233
           +PE V    Y+  CD+W+ G  +  + SG P +  K + ++    +  G       +   
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK-RVETGKYAFDLPQWRT 248

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
           I    S+  KD + K     P  R TA   L HP++ 
Sbjct: 249 I----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  147 bits (373), Expect = 2e-41
 Identities = 75/357 (21%), Positives = 135/357 (37%), Gaps = 40/357 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGIC--- 61
           G+ +G G F  V   +      E+    A K        +      +E +++ + I    
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEY----AAKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 62  --PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P I+        +E       L+LE  S G L D + ++    L E +   + + +L 
Sbjct: 73  LHPNIITLHD---VYENRTDVV-LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILD 126

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEA----KIADFGLAKKSSCDGERSQSFECRGTPL 175
           G+ ++H+K   H D+K +N+++ D +      K+ DFGLA +     E    F   GTP 
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPE 183

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDEL 231
           +++PE VN        D+W++G     + SG   +         +  I         +  
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-NITAVSYDFDEEFF 242

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSL 291
                  SE  KDF+ K  +K+ ++R T +  L HP++   D         +   S  +L
Sbjct: 243 SQT----SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAM----VRRESVVNL 294

Query: 292 KGIKDEKFSQSPRSPFGFPEWVSVQSSSSVTSSINSPSFDSFLSSRDCLLDRIRVLA 348
           +  K  K     R  +     +    +    S +      +    R+C  D    +A
Sbjct: 295 ENFK--KQYV--RRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIA 347

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  147 bits (373), Expect = 2e-41
 Identities = 69/285 (24%), Positives = 125/285 (43%), Gaps = 33/285 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
            + +G G+F  V          EF    A K         ++ ++ ++   +  IC    
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEF----AAKII---NTKKLSARDFQKLEREARICRKLQ 86

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IVR      S +  E F+ L+ +  + G L + +  +      E+D     + +L+ 
Sbjct: 87  HPNIVRLHD---SIQ-EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILES 140

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + + HS G VH ++K +N+L+    +    K+ADFGLA + + D E    F   GTP Y+
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGF-A-GTPGYL 197

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELPN 233
           SPE + ++ Y  P DIWA G  +  +  G P +  +    +++  I+ G       E   
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ-IKAGAYDYPSPEWDT 256

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDD 278
           +    + + K  +      +PK+R TA+  L  P++C  ++    
Sbjct: 257 V----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 297

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  148 bits (375), Expect = 3e-41
 Identities = 67/277 (24%), Positives = 124/277 (44%), Gaps = 17/277 (6%)

Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP      + E E   +   CP 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCP----KARREVELHWRASQCPH 116

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L          K+ DFG AK+++       +  C  TP Y++PE
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTP-C-YTPYYVAPE 233

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGD-ELPNIP-GD 237
            +   +Y+  CD+W+LG  +  +  G P  +++   +    +  RI +G  E PN    +
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293

Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
           +SE+ K  +      +P +R T    +NHP++    +
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  148 bits (375), Expect = 4e-41
 Identities = 79/287 (27%), Positives = 128/287 (44%), Gaps = 30/287 (10%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCA--DCPPSSVTLKNEKEALDQ-IGIC- 61
              +G G+ G V LA   K   +     A++  +       S    +    ++  I I  
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKV----AIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 62  ----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P I++       F+     Y ++LE    G L D+V    N RL+E+  K Y   M
Sbjct: 196 KLNHPCIIKIKN---FFD--AEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQM 248

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTP 174
           L  ++++H  G +H D+K +NVL+   +E    KI DFG +K    +    ++  C GTP
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTL-C-GTP 305

Query: 175 LYMSPE---SVNENEYEAPCDIWALGCAVVEMASG-KPAWNHKQDSNVFSLLIRIGVGDE 230
            Y++PE   SV    Y    D W+LG  +    SG  P   H+   ++    I  G  + 
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD-QITSGKYNF 364

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGD 277
           +P +  ++SE+  D + K  + DPK R+T E  L HP++  +D    
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 411

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (369), Expect = 4e-41
 Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 32/283 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGIC--- 61
           G+ +G G F  V   +      ++    A K        S      +E +++ + I    
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQY----AAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 62  --PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P ++        +E       L+LE  + G L D + ++    L E +   + + +L 
Sbjct: 72  QHPNVITLHE---VYENKTDVI-LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILN 125

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEA----KIADFGLAKKSSCDGERSQSFECRGTPL 175
           G+ ++HS    H D+K +N+++ D +      KI DFGLA K     E    F   GTP 
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPE 182

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDEL 231
           +++PE VN        D+W++G     + SG   +         +  +         +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-NVSAVNYEFEDEYF 241

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
            N     S   KDF+ +  +KDPK+R T +  L HP++   D 
Sbjct: 242 SNT----SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  144 bits (366), Expect = 1e-40
 Identities = 76/294 (25%), Positives = 121/294 (41%), Gaps = 38/294 (12%)

Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSV-TLKNEKEALDQIGICP 62
           L+ DV+G G+   V        S E+    AVK     P      +  E E L Q     
Sbjct: 16  LQEDVLGEGAHARVQTCINLITSQEY----AVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            ++        FE+ +RFY L+ E    GS+   + K+      E +     + +   L 
Sbjct: 72  NVLELIE---FFEEEDRFY-LVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALD 125

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECR-----GTP 174
            +H+KG  H D+K +N+L    ++    KI DF L      +G+ S           G+ 
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 175 LYMSPE-----SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFS--------- 220
            YM+PE     S   + Y+  CD+W+LG  +  + SG P +  +  S+            
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 221 ---LLIRIGVGD-ELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
              L   I  G  E P+     +S   KD + K  ++D K+R +A  +L HP+V
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  144 bits (366), Expect = 1e-40
 Identities = 73/281 (25%), Positives = 126/281 (44%), Gaps = 42/281 (14%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC----------ADCPPSSVTLKNEKEAL 55
           G ++G GSF +V LA+    +S      A+K                     +  E++ +
Sbjct: 35  GKILGEGSFSTVVLAR-ELATSRE---YAIKILEKRHIIKENKVPY------VTRERDVM 84

Query: 56  DQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
            ++   P  V+ +   ++F+  E+ Y   L YA  G L   ++K   G   E+  + YT 
Sbjct: 85  SRLD-HPFFVKLY---FTFQDDEKLY-FGLSYAKNGELLKYIRKI--GSFDETCTRFYTA 137

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK--SSCDGERSQSFECRGT 173
            ++  L ++H KG +H D+K +N+L+ ++   +I DFG AK         R+ SF   GT
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF-V-GT 195

Query: 174 PLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN 233
             Y+SPE + E       D+WALGC + ++ +G P +      N + +  +I +  E  +
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR---AGNEYLIFQKI-IKLEY-D 250

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEM------LLNHPF 268
            P     + +D + K  + D  +R   E       L  HPF
Sbjct: 251 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  144 bits (365), Expect = 2e-40
 Identities = 82/315 (26%), Positives = 133/315 (42%), Gaps = 35/315 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCA--DCPPSSVTLKNEKEALDQ-IGIC- 61
              +G G+ G V LA   K   +     A+K  +       S    +    ++  I I  
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKV----AIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 62  ----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P I++       F+     Y ++LE    G L D+V    N RL+E+  K Y   M
Sbjct: 71  KLNHPCIIKIKN---FFD--AEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQM 123

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTP 174
           L  ++++H  G +H D+K +NVL+   +E    KI DFG +K    +    ++  C GTP
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTL-C-GTP 180

Query: 175 LYMSPE---SVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGDE 230
            Y++PE   SV    Y    D W+LG  +    SG P    H+   ++    I  G  + 
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD-QITSGKYNF 239

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPS 290
           +P +  ++SE+  D + K  + DPK R+T E  L HP++       +D         S  
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL-----QDEDMKRKFQDLLSEE 294

Query: 291 LKGIKDEKFSQSPRS 305
            +     +    P +
Sbjct: 295 NESTALPQVLAQPST 309

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  142 bits (361), Expect = 2e-40
 Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 32/286 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-IGIC--- 61
           G+ +G G F  V   +      E+    A K       SS      +E +++ + I    
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEY----AAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 62  --PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P I+        FE       L+LE  S G L D + ++    L E +  ++ + +L 
Sbjct: 66  RHPNIITLHD---IFENKTDVV-LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILD 119

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEA----KIADFGLAKKSSCDGERSQSFECRGTPL 175
           G+ ++HSK   H D+K +N+++ D +      K+ DFG+A K     E    F   GTP 
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPE 176

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDEL 231
           +++PE VN        D+W++G     + SG   +  +      +  I         +  
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT-NISAVNYDFDEEYF 235

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGD 277
            N     SE  KDF+ +  +KDPKRR T    L H ++ A  +   
Sbjct: 236 SNT----SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  143 bits (362), Expect = 9e-40
 Identities = 68/280 (24%), Positives = 111/280 (39%), Gaps = 38/280 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
              +G G+   V   K       +    A+K             ++K    +IG+     
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPY----ALKVLK-------KTVDKKIVRTEIGVLLRLS 106

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I++       FE       L+LE  + G L DR+ ++  G   E D     + +L+ 
Sbjct: 107 HPNIIKLKE---IFETPTEIS-LVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEA 160

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + ++H  G VH D+K +N+L          KIADFGL+K         ++  C GTP Y 
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTV-C-GTPGYC 217

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIG----VGDELP 232
           +PE +    Y    D+W++G     +  G    ++ + D  +F   I       +     
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR-RILNCEYYFISPWWD 276

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            +    S   KD + K  + DPK+R T    L HP+V   
Sbjct: 277 EV----SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  143 bits (361), Expect = 2e-39
 Identities = 39/297 (13%), Positives = 80/297 (26%), Gaps = 38/297 (12%)

Query: 5   RGDVIGHGSFGSVNLAK--------ASKV--SSEFPSLMAVKSC--ADCPPSSVTLKNEK 52
             + +  G    V L +        A KV       S   ++    A    + +  ++ +
Sbjct: 66  LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125

Query: 53  EALDQIGI-----------CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKK-- 99
           EA D+  +            P   +       +        +         L   +    
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185

Query: 100 QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS 159
              G      +   T  +++   ++ SKG VH      N+ +  +    + D     K  
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK-- 243

Query: 160 CDGERSQSFECRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGKP----AWNH 212
             G R  +      P+  +P      +   +    + W LG ++  +             
Sbjct: 244 -VGTRGPAS---SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 213 KQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            + S     L   G           L +  K  + +    D +RR      +  P  
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  142 bits (361), Expect = 2e-39
 Identities = 69/279 (24%), Positives = 132/279 (47%), Gaps = 37/279 (13%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--- 61
           + +++G G FG V+  + +    +     A K        +  +K+++E  ++I +    
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKL----AAKII-----KTRGMKDKEEVKNEISVMNQL 143

Query: 62  --PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +++ +    +FE       L++EY   G L DR+  ++   L E D   + + + +
Sbjct: 144 DHANLIQLYD---AFESKNDIV-LVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICE 198

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           G+RH+H    +H D+K +N+L  + D    KI DFGLA++     +   +F   GTP ++
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFL 255

Query: 178 SPESVNENEYEAPCDIWALGCAVVE--MASGKPAWNHKQDSNVFSLLIRIGV----GDEL 231
           +PE VN +    P D+W++G  V+   + SG   +    D+   +  I         +E 
Sbjct: 256 APEVVNYDFVSFPTDMWSVG--VIAYMLLSGLSPFLGDNDAETLN-NILACRWDLEDEEF 312

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC 270
            +I    SE+ K+F+ K  +K+   R +A   L HP++ 
Sbjct: 313 QDI----SEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  144 bits (366), Expect = 7e-39
 Identities = 65/289 (22%), Positives = 110/289 (38%), Gaps = 33/289 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC---- 61
            + +G G+FG V+        + F    A K        +    +++    +I       
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNF----AAKFV-----MTPHESDKETVRKEIQTMSVLR 212

Query: 62  -PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +V       +FE       ++ E+ S G L ++V  ++  ++ E +   Y R + KG
Sbjct: 213 HPTLVNLHD---AFEDDNEMV-MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKG 267

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
           L H+H   +VH D+K +N++         K+ DFGL            +    GT  + +
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAA 324

Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----GDELPNI 234
           PE           D+W++G     + SG   +  + D       ++             I
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-NVKSCDWNMDDSAFSGI 383

Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHI 283
               SE GKDF+ K  L DP  R T    L HP++   +  G D  I  
Sbjct: 384 ----SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS 428

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  140 bits (354), Expect = 1e-38
 Identities = 72/281 (25%), Positives = 116/281 (41%), Gaps = 33/281 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKS---------CADCPPSSVTLKNEKEALD 56
            DVIG G    V          EF    AVK                     + E   L 
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEF----AVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 57  QIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRS 116
           Q+   P I+       S+E     + L+ +   +G L D + ++    L E + +   RS
Sbjct: 155 QVAGHPHIITLID---SYESSSFMF-LVFDLMRKGELFDYLTEK--VALSEKETRSIMRS 208

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           +L+ +  +H+   VH D+K +N+L+ DN + +++DFG +      GE+ +   C GTP Y
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLREL-C-GTPGY 265

Query: 177 MSPE------SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD- 229
           ++PE            Y    D+WA G  +  + +G P + H++   +      I  G  
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR---MIMEGQY 322

Query: 230 ELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           +  +    D S   KD + +    DP+ R TAE  L HPF 
Sbjct: 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  139 bits (352), Expect = 2e-38
 Identities = 61/323 (18%), Positives = 115/323 (35%), Gaps = 44/323 (13%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICPQIV 65
           V+  G F  V  A+      E+    A+K     +    +  +  E   + ++   P IV
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREY----ALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 66  RCFGDDYSFEKGERFYN-----LLLEYASRGSLAD-RVKKQNNGRLQESDVKRYTRSMLK 119
           +      +    E         LLL    +G L +   K ++ G L    V +      +
Sbjct: 90  QFC--SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147

Query: 120 GLRHIHSKG--FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQS---------- 167
            ++H+H +    +H D+K++N+L+ +    K+ DFG A   S   + S S          
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 168 FECRGTPLYMSPESVN---ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR 224
                TP+Y +PE ++           DIWALGC +  +   +  +   +D        R
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF---EDGAKL----R 260

Query: 225 IGVGD-ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHI 283
           I  G   +P             +      +P+ R +   +++     A  +      ++ 
Sbjct: 261 IVNGKYSIPPHDT-QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR-----NVNP 314

Query: 284 HSSSSPSLKGIKDEKFSQSPRSP 306
            S  +  L+       +   R P
Sbjct: 315 KSPITELLEQNGGYGSATLSRGP 337

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  138 bits (350), Expect = 4e-38
 Identities = 71/274 (25%), Positives = 123/274 (44%), Gaps = 24/274 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVR 66
           VIG GS+  V L +  K +    ++  VK         +  ++ EK   +Q    P +V 
Sbjct: 16  VIGRGSYAKVLLVR-LKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                  F+   R +  ++EY + G L   +++Q   +L E   + Y+  +   L ++H 
Sbjct: 75  LH---SCFQTESRLF-FVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE 128

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           +G ++ D+KL NVL+      K+ D+G+ K+    G+ + +F C GTP Y++PE +   +
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-C-GTPNYIAPEILRGED 186

Query: 187 YEAPCDIWALGCAVVEMASGKP------AWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
           Y    D WALG  + EM +G+       + ++   +    L   I +  ++  IP  LS 
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIR-IPRSLSV 244

Query: 241 QGKDFLIKCFLKDPKRR------WTAEMLLNHPF 268
           +    L     KDPK R           +  HPF
Sbjct: 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  137 bits (347), Expect = 1e-37
 Identities = 78/277 (28%), Positives = 124/277 (44%), Gaps = 39/277 (14%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSC----------ADCPPSSVTLKNEKEALDQ 57
           V+G GSFG V LA+  K + +   L AVK             +C         EK  L  
Sbjct: 30  VLGKGSFGKVMLAR-VKETGD---LYAVKVLKKDVILQDDDVEC------TMTEKRILSL 79

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P + + F     F+  +R +  ++E+ + G L   ++K    R  E+  + Y   +
Sbjct: 80  ARNHPFLTQLF---CCFQTPDRLF-FVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEI 133

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           +  L  +H KG ++ D+KL NVL+      K+ADFG+ K+  C+G  + +F C GTP Y+
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF-C-GTPDYI 191

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           +PE + E  Y    D WA+G  + EM  G   +  + + ++F  ++     DE+   P  
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN----DEVV-YPTW 246

Query: 238 LSEQGKDFLIKCFLKDPKRR------WTAEMLLNHPF 268
           L E     L     K+P  R           +L HPF
Sbjct: 247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  138 bits (349), Expect = 1e-37
 Identities = 46/298 (15%), Positives = 90/298 (30%), Gaps = 47/298 (15%)

Query: 5   RGDVIGHGSFGSVNLAK--------ASKV--SSEFPSLMAVKSCADCPPSSVTL---KNE 51
           RG V+G     +   A            V   +E P   A+K   +       L   KN+
Sbjct: 82  RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 141

Query: 52  KEALDQIGIC-----------PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRV--K 98
           K+A   +               +++R   D+       RF+      ++  +  + +   
Sbjct: 142 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 201

Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS 158
              +  L      + T  +++ L  +H  G VH  ++  ++++       +  F    + 
Sbjct: 202 SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 260

Query: 159 SCDGERSQSFECR--GTPLYMSPESV-----NENEYEAPCDIWALGCAVVEMASGKPAWN 211
             DG  + S   R    P   +   +     +        D W LG A+  +        
Sbjct: 261 --DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318

Query: 212 HKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFL-KDPKRRWTAEMLLNHPF 268
                     + R        NIP  +       L++ FL    + R      +  P 
Sbjct: 319 DDAALGGSEWIFR-----SCKNIPQPVRA-----LLEGFLRYPKEDRLLPLQAMETPE 366

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  136 bits (346), Expect = 2e-37
 Identities = 72/272 (26%), Positives = 128/272 (47%), Gaps = 34/272 (12%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSC----------ADCPPSSVTLKNEKEALDQ 57
           ++G GSFG V LA+  K +++     A+K+            +C         EK  L  
Sbjct: 24  MLGKGSFGKVFLAE-FKKTNQ---FFAIKALKKDVVLMDDDVEC------TMVEKRVLSL 73

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P +   F    +F+  E  +  ++EY + G L   ++     +   S    Y   +
Sbjct: 74  AWEHPFLTHMF---CTFQTKENLF-FVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEI 127

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           + GL+ +HSKG V+ D+KL N+L+  +   KIADFG+ K++     ++ +F C GTP Y+
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-C-GTPDYI 185

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           +PE +   +Y    D W+ G  + EM  G+  ++ + +  +F  +      D     P  
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----DNPF-YPRW 240

Query: 238 LSEQGKDFLIKCFLKDPKRRWTA-EMLLNHPF 268
           L ++ KD L+K F+++P++R      +  HP 
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  136 bits (344), Expect = 3e-37
 Identities = 73/276 (26%), Positives = 124/276 (44%), Gaps = 39/276 (14%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSC----------ADCPPSSVTLKNEKEALDQ 57
           ++G G+FG V L +  K +       A+K                        E   L  
Sbjct: 12  LLGKGTFGKVILVR-EKATGR---YYAMKILRKEVIIAKDEVAH------TVTESRVLQN 61

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P +       Y+F+  +R    ++EYA+ G L   + ++      E   + Y   +
Sbjct: 62  TR-HPFLTALK---YAFQTHDRLC-FVMEYANGGELFFHLSRE--RVFTEERARFYGAEI 114

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
           +  L ++HS+  V+ DIKL+N+++  +   KI DFGL K+   DG   ++F C GTP Y+
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-C-GTPEYL 172

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           +PE + +N+Y    D W LG  + EM  G+  + ++    +F L++     +E+   P  
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIR-FPRT 227

Query: 238 LSEQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
           LS + K  L     KDPK+R       A+ ++ H F
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  136 bits (343), Expect = 4e-37
 Identities = 61/302 (20%), Positives = 108/302 (35%), Gaps = 49/302 (16%)

Query: 6   GDVIGHGSFGSVNLAK------ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ-I 58
              +  G F  + L +      A K   +   L   +         +++K++ +     +
Sbjct: 36  IRTLNQGKFNKIILCEKDNKFYALKKYEK-SLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 59  GIC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD------RVKKQNNGRLQE 107
            I         + C G        +  Y ++ EY    S+         + K     +  
Sbjct: 95  QIITDIKNEYCLTCEG---IITNYDEVY-IIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150

Query: 108 SDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             +K   +S+L    +IH+ K   H D+K  N+L+  N   K++DFG ++    D +   
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKIKG 209

Query: 167 SFECRGTPLYMSPESVN--ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR 224
           S    GT  +M PE  +   +   A  DIW+LG  +  M      ++     ++  L   
Sbjct: 210 S--R-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL--KISLVELFNN 264

Query: 225 IGVGD-ELPNIPGD----------------LSEQGKDFLIKCFLKDPKRRWTAEMLLNHP 267
           I   + E P                     LS +  DFL     K+P  R T+E  L H 
Sbjct: 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324

Query: 268 FV 269
           ++
Sbjct: 325 WL 326

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  135 bits (342), Expect = 5e-37
 Identities = 70/274 (25%), Positives = 128/274 (46%), Gaps = 31/274 (11%)

Query: 8   VIGHGSFGSVNLAK--ASKVSSEFPSLMAVK-----SCADCPPSSVTLKNEKEALDQIGI 60
           V+G G +G V   +      + +   + A+K             +   K E+  L+++  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGK---IFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK- 79

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV      Y+F+ G + Y L+LEY S G L  +++++  G   E     Y   +   
Sbjct: 80  HPFIVDLI---YAFQTGGKLY-LILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMA 133

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           L H+H KG ++ D+K +N+++ ++    K+ DFGL K+S  DG  + +F C GT  YM+P
Sbjct: 134 LGHLHQKGIIYRDLKPENIML-NHQGHVKLTDFGLCKESIHDGTVTHTF-C-GTIEYMAP 190

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E +  + +    D W+LG  + +M +G P +  +        +++     +L  +P  L+
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK----CKLN-LPPYLT 245

Query: 240 EQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
           ++ +D L K   ++   R       A  +  HPF
Sbjct: 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  137 bits (346), Expect = 6e-37
 Identities = 71/280 (25%), Positives = 111/280 (39%), Gaps = 36/280 (12%)

Query: 8   VIGHGSFGSVNLAK--------ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           VIG G+F  V + K        A K+ ++    M  +    C       + E++ L    
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNK--WDMLKRGEVSC------FREERDVLVNGD 119

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               I +     ++F+     Y L++EY   G L   + K    R+     + Y   ++ 
Sbjct: 120 -RRWITQLH---FAFQDENYLY-LVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVM 173

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE-RSQSFECRGTPLYMS 178
            +  +H  G+VH DIK  N+L+      ++ADFG   K   DG  RS      GTP Y+S
Sbjct: 174 AIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA-V-GTPDYLS 231

Query: 179 PE-------SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           PE             Y   CD WALG    EM  G+  +     +  +  ++       L
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWT---AEMLLNHPF 268
           P +   + E+ +D  I+  L  P+ R     A     HPF
Sbjct: 292 PLVDEGVPEEARD-FIQRLLCPPETRLGRGGAGDFRTHPF 330

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  136 bits (344), Expect = 7e-37
 Identities = 71/274 (25%), Positives = 123/274 (44%), Gaps = 24/274 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVR 66
           VIG GS+  V L +  K +    ++  VK         +  ++ EK   +Q    P +V 
Sbjct: 59  VIGRGSYAKVLLVR-LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                  F+   R +  ++EY + G L   +++Q   +L E   + Y+  +   L ++H 
Sbjct: 118 LH---SCFQTESRLF-FVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE 171

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           +G ++ D+KL NVL+      K+ D+G+ K+    G+ + +F C GTP Y++PE +   +
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-C-GTPNYIAPEILRGED 229

Query: 187 YEAPCDIWALGCAVVEMASGKP------AWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
           Y    D WALG  + EM +G+       + ++   +    L   I +  ++  IP  LS 
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIR-IPRSLSV 287

Query: 241 QGKDFLIKCFLKDPKRR------WTAEMLLNHPF 268
           +    L     KDPK R           +  HPF
Sbjct: 288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  134 bits (340), Expect = 9e-37
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 49/282 (17%)

Query: 8   VIGHGSFGSVNLAK--ASKVSSEFPSLMAVKSCADCPPSSVTLK-------------NEK 52
           V+G GSFG V L K  +   + +   L A+K           LK              E+
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQ---LYAMK----------VLKKATLKVRDRVRTKMER 77

Query: 53  EALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKR 112
           + L ++   P IV+     Y+F+   + Y L+L++   G L  R+ K+      E DVK 
Sbjct: 78  DILVEVN-HPFIVKLH---YAFQTEGKLY-LILDFLRGGDLFTRLSKE--VMFTEEDVKF 130

Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCDGERSQSFECR 171
           Y   +   L H+HS G ++ D+K +N+L+ D +   K+ DFGL+K+S    +++ SF C 
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILL-DEEGHIKLTDFGLSKESIDHEKKAYSF-C- 187

Query: 172 GTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           GT  YM+PE VN   +    D W+ G  + EM +G   +  K      +++++     +L
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK----AKL 243

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
             +P  LS + +  L   F ++P  R        E +  H F
Sbjct: 244 G-MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  135 bits (341), Expect = 1e-36
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 40/277 (14%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSC----------ADCPPSSVTLKNEKEALDQ 57
           V+G GSFG V L++  K + E   L AVK             +C         EK  L  
Sbjct: 27  VLGKGSFGKVMLSE-RKGTDE---LYAVKILKKDVVIQDDDVEC------TMVEKRVLAL 76

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
            G  P + +       F+  +R Y  ++EY + G L   +++   GR +E     Y   +
Sbjct: 77  PGKPPFLTQLH---SCFQTMDRLY-FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEI 130

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDE-AKIADFGLAKKSSCDGERSQSFECRGTPLY 176
             GL  + SKG ++ D+KL NV+  D++   KIADFG+ K++  DG  +++F C GTP Y
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVM-LDSEGHIKIADFGMCKENIWDGVTTKTF-C-GTPDY 187

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           ++PE +    Y    D WA G  + EM +G+  +  + +  +F  ++       +   P 
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----HNVA-YPK 242

Query: 237 DLSEQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
            +S++          K P +R          +  H F
Sbjct: 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  134 bits (340), Expect = 2e-36
 Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 45/279 (16%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK--------------NEKE 53
           VIG GSFG V LA+  K         AVK           L+              +E+ 
Sbjct: 45  VIGKGSFGKVLLAR-HKAEEV---FYAVK----------VLQKKAILKKKEEKHIMSERN 90

Query: 54  ALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
            L +    P +V      +SF+  ++ Y  +L+Y + G L   ++++      E   + Y
Sbjct: 91  VLLKNVKHPFLVGLH---FSFQTADKLY-FVLDYINGGELFYHLQRE--RCFLEPRARFY 144

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
              +   L ++HS   V+ D+K +N+L+       + DFGL K++      + +F C GT
Sbjct: 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF-C-GT 202

Query: 174 PLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN 233
           P Y++PE +++  Y+   D W LG  + EM  G P +  +  + ++  ++       L  
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----KPL-Q 257

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRR----WTAEMLLNHPF 268
           +  +++   +  L     KD  +R         + +H F
Sbjct: 258 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  136 bits (343), Expect = 9e-36
 Identities = 63/276 (22%), Positives = 108/276 (39%), Gaps = 34/276 (12%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVK----------SCADCPPSSVTLKNEKEALDQ 57
           V+G G FG V   +  + + +   + A K                       NEK+ L++
Sbjct: 191 VLGKGGFGEVCACQ-VRATGK---MYACKKLEKKRIKKRKGEAM------ALNEKQILEK 240

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
           +     +V      Y++E  +    L+L   + G L   +         E+    Y   +
Sbjct: 241 VN-SRFVVSLA---YAYETKDALC-LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEI 295

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
             GL  +H +  V+ D+K +N+L+ D+   +I+D GLA     +G+  +     GT  YM
Sbjct: 296 CCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGR-V-GTVGYM 352

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD 237
           +PE V    Y    D WALGC + EM +G+  +  ++       + R+            
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE-YSER 411

Query: 238 LSEQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
            S Q +    +   KDP  R      +A  +  HP 
Sbjct: 412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  130 bits (329), Expect = 2e-35
 Identities = 62/280 (22%), Positives = 112/280 (40%), Gaps = 38/280 (13%)

Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP      + E E   +   CP 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCP----KARREVELHWRASQCPH 72

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEA---KIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +HS    H D+K +N+L          K+ DFG A                        E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-----------------------KE 169

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPA-WNHKQDSNVFSLLIRIGVGD-ELPNIP-GD 237
           +  E  Y+  CD+W+LG  +  +  G P  +++   +    +  RI +G  E PN    +
Sbjct: 170 TTGEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 228

Query: 238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGD 277
           +SE+ K  +      +P +R T    +NHP++    +   
Sbjct: 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  135 bits (340), Expect = 4e-35
 Identities = 71/267 (26%), Positives = 120/267 (44%), Gaps = 20/267 (7%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVR 66
           V+G GSFG V L++  K + E  ++  +K         V     EK  L   G  P + +
Sbjct: 348 VLGKGSFGKVMLSE-RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                  F+  +R Y  ++EY + G L   +++   GR +E     Y   +  GL  + S
Sbjct: 407 LH---SCFQTMDRLY-FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS 460

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           KG ++ D+KL NV++      KIADFG+ K++  DG  +++F C GTP Y++PE +    
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-C-GTPDYIAPEIIAYQP 518

Query: 187 YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFL 246
           Y    D WA G  + EM +G+  +  + +  +F  ++       +   P  +S++     
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----HNVA-YPKSMSKEAVAIC 573

Query: 247 IKCFLKDPKRR-----WTAEMLLNHPF 268
                K P +R          +  H F
Sbjct: 574 KGLMTKHPGKRLGCGPEGERDIKEHAF 600

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  132 bits (334), Expect = 4e-35
 Identities = 74/268 (27%), Positives = 124/268 (46%), Gaps = 22/268 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVT-LKNEKEALDQIGICPQIVR 66
           ++G G+FG V L K  K +  + ++  +K         V     E   L      P +  
Sbjct: 155 LLGKGTFGKVILVK-EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTA 212

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                YSF+  +R    ++EYA+ G L   + ++      E   + Y   ++  L ++HS
Sbjct: 213 LK---YSFQTHDRLC-FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS 266

Query: 127 -KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            K  V+ D+KL+N+++  +   KI DFGL K+   DG   ++F C GTP Y++PE + +N
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-C-GTPEYLAPEVLEDN 324

Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           +Y    D W LG  + EM  G+  + ++    +F L++      E    P  L  + K  
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFPRTLGPEAKSL 379

Query: 246 LIKCFLKDPKRR-----WTAEMLLNHPF 268
           L     KDPK+R       A+ ++ H F
Sbjct: 380 LSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  128 bits (325), Expect = 7e-35
 Identities = 69/293 (23%), Positives = 123/293 (41%), Gaps = 37/293 (12%)

Query: 3   WLRGDVIGHGSFGSVNLAK--------ASKVSS-----EFPSLMAVKSCADCPPSSVTLK 49
           +   D IG GS+G V LA         A KV S                    P+     
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 50  NEKEALDQIG--IC-------PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQ 100
             +  ++Q+   I        P +V+   +       +  Y ++ E  ++G + +     
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLY-MVFELVNQGPVMEVPTL- 131

Query: 101 NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC 160
               L E   + Y + ++KG+ ++H +  +H DIK  N+LV ++   KIADFG++ +   
Sbjct: 132 --KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 161 DGERSQSFECRGTPLYMSPESVNEN--EYE-APCDIWALGCAVVEMASGKPAWNHKQDSN 217
                 +    GTP +M+PES++E    +     D+WA+G  +     G+  +    D  
Sbjct: 190 SDALLSNT-V-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM---DER 244

Query: 218 VFSLLIRIGVGD-ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           +  L  +I     E P+ P D++E  KD + +   K+P+ R     +  HP+V
Sbjct: 245 IMCLHSKIKSQALEFPDQP-DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  129 bits (326), Expect = 7e-35
 Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 47/285 (16%)

Query: 6   GDVIGHGSFGSVNLAK----ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC 61
              IG G+F  V LA+      +V        A+K         +  K +        + 
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREV--------AIK---------IIDKTQLNPTSLQKLF 62

Query: 62  -----------PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDV 110
                      P IV+ F      E  +  Y L++EYAS G + D +    +GR++E + 
Sbjct: 63  REVRIMKILNHPNIVKLF---EVIETEKTLY-LIMEYASGGEVFDYLVA--HGRMKEKEA 116

Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC 170
           +   R ++  +++ H K  VH D+K +N+L+  +   KIADFG + + +  G +  +F C
Sbjct: 117 RSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAF-C 174

Query: 171 RGTPLYMSPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD 229
            G P Y +PE     +Y+ P  D+W+LG  +  + SG   +      N+  L  R+  G 
Sbjct: 175 -GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF---DGQNLKELRERVLRGK 230

Query: 230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ 274
               IP  +S   ++ L +  + +P +R T E ++   ++ A  +
Sbjct: 231 --YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  131 bits (331), Expect = 9e-35
 Identities = 75/278 (26%), Positives = 116/278 (41%), Gaps = 34/278 (12%)

Query: 8   VIGHGSFGSVNLAK--------ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
           VIG G+FG V + K        A K+ ++    M  ++   C       + E++ L    
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNK--WEMLKRAETAC------FREERDVLVNGD 132

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               I       Y+F+     Y L+++Y   G L   + K    RL E   + Y   M+ 
Sbjct: 133 -SKWITTLH---YAFQDDNNLY-LVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVI 186

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE-RSQSFECRGTPLYMS 178
            +  +H   +VH DIK  N+L+  N   ++ADFG   K   DG  +S      GTP Y+S
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA-V-GTPDYIS 244

Query: 179 PESVNENE-----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN 233
           PE +   E     Y   CD W+LG  + EM  G+  +  +     +  ++      + P 
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWT---AEMLLNHPF 268
              D+SE  KD LI+  +   + R      E    HPF
Sbjct: 305 QVTDVSENAKD-LIRRLICSREHRLGQNGIEDFKKHPF 341

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  132 bits (333), Expect = 2e-34
 Identities = 68/279 (24%), Positives = 117/279 (41%), Gaps = 37/279 (13%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVK----------SCADCPPSSVTLKNEKEALDQ 57
           V+G G FG V   +  K + +   L A K                        EK+ L +
Sbjct: 192 VLGRGGFGEVFACQ-MKATGK---LYACKKLNKKRLKKRKGYQG------AMVEKKILAK 241

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTR 115
           +     IV      Y+FE       L++   + G +   +    ++N   QE     YT 
Sbjct: 242 VH-SRFIVSLA---YAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ++ GL H+H +  ++ D+K +NVL+ D+   +I+D GLA +      +++ +   GTP 
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-A-GTPG 354

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDELPNI 234
           +M+PE +   EY+   D +ALG  + EM + +  +    +      L  R+ +   +   
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVT-Y 412

Query: 235 PGDLSEQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
           P   S   KDF      KDP++R      + + L  HP 
Sbjct: 413 PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  128 bits (324), Expect = 2e-34
 Identities = 76/288 (26%), Positives = 136/288 (47%), Gaps = 51/288 (17%)

Query: 8   VIGHGSFGSVNLAK--ASKVSSEFPSLMAVKSCADCPPSSVTLK---------------N 50
           V+G G++G V L +  +   + +   L A+K           LK                
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGK---LYAMK----------VLKKATIVQKAKTTEHTRT 107

Query: 51  EKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDV 110
           E++ L+ I   P +V      Y+F+   + + L+L+Y + G L   + ++   R  E +V
Sbjct: 108 ERQVLEHIRQSPFLVTLH---YAFQTETKLH-LILDYINGGELFTHLSQR--ERFTEHEV 161

Query: 111 KRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCD-GERSQSF 168
           + Y   ++  L H+H  G ++ DIKL+N+L+ D++    + DFGL+K+   D  ER+  F
Sbjct: 162 QIYVGEIVLALEHLHKLGIIYRDIKLENILL-DSNGHVVLTDFGLSKEFVADETERAYDF 220

Query: 169 ECRGTPLYMSPESVNENE--YEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRI 225
            C GT  YM+P+ V   +  ++   D W+LG  + E+ +G  P     + ++   +  RI
Sbjct: 221 -C-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278

Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
              +  P  P ++S   KD + +  +KDPK+R       A+ +  H F
Sbjct: 279 LKSE--PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  128 bits (324), Expect = 4e-34
 Identities = 57/271 (21%), Positives = 114/271 (42%), Gaps = 28/271 (10%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVK-----SCADCPPSSVT-LKNEKEALDQIGIC 61
            IG GSFG V + +    + +   + A+K      C +   + V  +  E + +  +   
Sbjct: 22  AIGKGSFGKVCIVQ-KNDTKK---MYAMKYMNKQKCVE--RNEVRNVFKELQIMQGLE-H 74

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P +V  +   YSF+  E  + ++++    G L  R   Q N   +E  VK +   ++  L
Sbjct: 75  PFLVNLW---YSFQDEEDMF-MVVDLLLGGDL--RYHLQQNVHFKEETVKLFICELVMAL 128

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++ ++  +H D+K  N+L+ ++    I DF +A        +  +    GT  YM+PE 
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITTM-A-GTKPYMAPEM 185

Query: 182 VNENE---YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
            +  +   Y    D W+LG    E+  G+  ++ +  ++   ++            P   
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAW 243

Query: 239 SEQGKDFLIKCFLKDPKRRW-TAEMLLNHPF 268
           S++    L K    +P +R+     + N P+
Sbjct: 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  129 bits (325), Expect = 5e-34
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 38/278 (13%)

Query: 8   VIGHGSFGSVNLAKASKVSSEF-------PSLMAVKSCADCPPSSVTLKNEKEALDQIGI 60
           VIG G+FG V L +  K + +           M  +S +           E++ +     
Sbjct: 76  VIGRGAFGEVQLVR-HKSTRKVYAMKLLSKFEMIKRSDSAF------FWEERDIMAFAN- 127

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +V+ F   Y+F+     Y +++EY   G L   V   +N  + E   + YT  ++  
Sbjct: 128 SPWVVQLF---YAFQDDRYLY-MVMEYMPGGDL---VNLMSNYDVPEKWARFYTAEVVLA 180

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE-RSQSFECRGTPLYMSP 179
           L  IHS GF+H D+K  N+L+  +   K+ADFG   K + +G  R  +    GTP Y+SP
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-V-GTPDYISP 238

Query: 180 ESV----NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           E +     +  Y   CD W++G  + EM  G   +      ++     +I         P
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY---ADSLVGTYSKIMNHKNSLTFP 295

Query: 236 G--DLSEQGKDFLIKCFLKDPKRRWT---AEMLLNHPF 268
              D+S++ K+ LI  FL D + R      E +  H F
Sbjct: 296 DDNDISKEAKN-LICAFLTDREVRLGRNGVEEIKRHLF 332

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  126 bits (317), Expect = 2e-33
 Identities = 41/291 (14%), Positives = 94/291 (32%), Gaps = 33/291 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS-LMAVKSCADCPPSSVTLKNEKEALDQIG--ICP 62
             ++G G+F  V  A    ++         +K     P +        + ++++   +  
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK--VQKPANPWEFYIGTQLMERLKPSMQH 127

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRV---KKQNNGRLQESDVKRYTRSMLK 119
             ++ +    +         L+ E  S G+L + +   K      + +  V  +   ML 
Sbjct: 128 MFMKFY---SAHLFQNGSV-LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEA-----------KIADFGLAKKSSCDGERSQSF 168
            +  +H    +H DIK  N ++ +                + D G +       + +   
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243

Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKP-----AWNHKQDSNVFSLLI 223
               T  +   E ++   +    D + +   V  M  G            +   +F  L 
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303

Query: 224 RIGVGDELP----NIPGDLSEQGKDFLIKCFLKDPKRRWTAEML-LNHPFV 269
            + + +E      NIP        D L +   K  ++ +T ++  L +  +
Sbjct: 304 HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLI 354

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  129 bits (325), Expect = 5e-33
 Identities = 61/283 (21%), Positives = 118/283 (41%), Gaps = 48/283 (16%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK--------------NEKE 53
           +IG G FG V   +    + +   + A+K           L               NE+ 
Sbjct: 196 IIGRGGFGEVYGCR-KADTGK---MYAMK----------CLDKKRIKMKQGETLALNERI 241

Query: 54  ALDQI--GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVK 111
            L  +  G CP IV      Y+F   ++    +L+  + G L   +    +G   E+D++
Sbjct: 242 MLSLVSTGDCPFIVCMS---YAFHTPDKLS-FILDLMNGGDLHYHL--SQHGVFSEADMR 295

Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR 171
            Y   ++ GL H+H++  V+ D+K  N+L+ ++   +I+D GLA       ++  +    
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHAS-V- 351

Query: 172 GTPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE 230
           GT  YM+PE + +   Y++  D ++LGC + ++  G   +   +  +   +     +   
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMA 410

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRR-----WTAEMLLNHPF 268
           +  +P   S + +  L     +D  RR       A+ +   PF
Sbjct: 411 VE-LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  123 bits (312), Expect = 8e-33
 Identities = 71/280 (25%), Positives = 121/280 (43%), Gaps = 50/280 (17%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK--------------NEKE 53
            +G GSFG V+L + S+ +  +    A+K           LK              +E+ 
Sbjct: 13  TLGTGSFGRVHLIR-SRHNGRY---YAMK----------VLKKEIVVRLKQVEHTNDERL 58

Query: 54  ALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
            L  +   P I+R +    +F+  ++ + ++++Y   G L   ++K    R      K Y
Sbjct: 59  MLSIVT-HPFIIRMW---GTFQDAQQIF-MIMDYIEGGELFSLLRKS--QRFPNPVAKFY 111

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
              +   L ++HSK  ++ D+K +N+L+  N   KI DFG AK      + + +  C GT
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY---VPDVTYTL-C-GT 166

Query: 174 PLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN 233
           P Y++PE V+   Y    D W+ G  + EM +G   +    DSN      +I   +    
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF---YDSNTMKTYEKILNAE--LR 221

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
            P   +E  KD L +   +D  +R        E + NHP+
Sbjct: 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  120 bits (302), Expect = 3e-31
 Identities = 69/280 (24%), Positives = 112/280 (40%), Gaps = 50/280 (17%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK--------------NEKE 53
            +G GSFG V L K  K S       A+K           L               NEK 
Sbjct: 48  TLGTGSFGRVMLVK-HKESGNH---YAMK----------ILDKQKVVKLKQIEHTLNEKR 93

Query: 54  ALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
            L  +   P +V+     +SF+     Y +++EY + G +   +++   GR  E   + Y
Sbjct: 94  ILQAVN-FPFLVKLE---FSFKDNSNLY-MVMEYVAGGEMFSHLRRI--GRFSEPHARFY 146

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
              ++    ++HS   ++ D+K +N+L+      ++ DFG AK+      R+ +  C GT
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTL-C-GT 201

Query: 174 PLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN 233
           P  ++PE +    Y    D WALG  + EMA+G P +          +  +I  G     
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF---ADQPIQIYEKIVSGK--VR 256

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
            P   S   KD L      D  +R+         + NH +
Sbjct: 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  116 bits (294), Expect = 1e-30
 Identities = 71/276 (25%), Positives = 120/276 (43%), Gaps = 30/276 (10%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG--I 60
           W     +G G++G V LA  ++V+ E    +AVK         V +K   +  + I   I
Sbjct: 9   WDLVQTLGEGAYGEVQLAV-NRVTEE---AVAVKI--------VDMKRAVDCPENIKKEI 56

Query: 61  C-------PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
           C         +V+ +G      +G   Y L LEY S G L DR++   +  + E D +R+
Sbjct: 57  CINKMLNHENVVKFYG---HRREGNIQY-LFLEYCSGGELFDRIEP--DIGMPEPDAQRF 110

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
              ++ G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 174 PLYMSPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
             Y++PE +   E+ A   D+W+ G  +  M +G+  W+  Q S+               
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKKTYL 228

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           N    +       L K  +++P  R T   +    +
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  117 bits (296), Expect = 1e-30
 Identities = 74/311 (23%), Positives = 119/311 (38%), Gaps = 62/311 (19%)

Query: 6   GDVIGHGSFGSVNLAK----ASKVSSEFPSLMAVK-------SCADCPPSSVTLKNEKEA 54
           G ++G G FGSV           V        A+K       S     P+   +  E   
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPV--------AIKHVEKDRISDWGELPNGTRVPMEVVL 99

Query: 55  LDQIG-ICPQIVRCFGDDYSFEKGERFYNLLLEYAS-RGSLADRVKKQNNGRLQESDVKR 112
           L ++      ++R    D+ FE+ + F  L+LE       L D + +   G LQE   + 
Sbjct: 100 LKKVSSGFSGVIRLL--DW-FERPDSFV-LILERPEPVQDLFDFITE--RGALQEELARS 153

Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAK-------KSSCDGER 164
           +   +L+ +RH H+ G +H DIK +N+L+  N  E K+ DFG                  
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---- 209

Query: 165 SQSFECRGTPLYMSPESVNENEYEAP-CDIWALGCAVV--EMASGKPAWNHKQDSNVFSL 221
                  GT +Y  PE +  + Y      +W+LG  ++  +M  G   + H +       
Sbjct: 210 -------GTRVYSPPEWIRYHRYHGRSAAVWSLG--ILLYDMVCGDIPFEHDE------- 253

Query: 222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGI 281
              I  G         +S + +  +  C    P  R T E + NHP++       +   I
Sbjct: 254 --EIIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 309

Query: 282 HIHSSSSPSLK 292
           H+HS S    K
Sbjct: 310 HLHSLSPGPSK 320

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  116 bits (292), Expect = 5e-30
 Identities = 67/279 (24%), Positives = 116/279 (41%), Gaps = 30/279 (10%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVK-----SCADCPPSSVTLKNEKEALDQ 57
           +L GD++G GS+G V     S+         AVK          P     +K E + L +
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRR----AVKILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGS--LADRVKKQNNGRLQESDVKRYTR 115
           +     +++   D    E+ ++ Y +++EY   G   + D V +    R        Y  
Sbjct: 63  L-RHKNVIQLV-DVLYNEEKQKMY-MVMEYCVCGMQEMLDSVPE---KRFPVCQAHGYFC 116

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA--KKSSCDGERSQSFECRGT 173
            ++ GL ++HS+G VH DIK  N+L+      KI+  G+A         +  ++    G+
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-Q-GS 174

Query: 174 PLYMSPESVNENE-YEAP-CDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDE 230
           P +  PE  N  + +     DIW+ G  +  + +G  P     +  N++ L   IG G  
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF----EGDNIYKLFENIGKGS- 229

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
              IPGD      D L      +P +R++   +  H + 
Sbjct: 230 -YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  115 bits (291), Expect = 6e-30
 Identities = 51/204 (25%), Positives = 75/204 (36%), Gaps = 43/204 (21%)

Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS 158
            +    + E  VK  T   L+ +   H    +H D+K +N+L+  +   K+ DFG A   
Sbjct: 93  DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA--- 149

Query: 159 SCDGERSQSFECRG------TPLYMSPES-VNENEYEAPCDIWALGCAVVEMASGKPAWN 211
                R  +           T  Y SPE  V + +Y  P D+WA+GC   E+ SG P W 
Sbjct: 150 -----RLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204

Query: 212 HKQDSN----VFSLL------IRIGVGDELPNIPG-----------------DLSEQGKD 244
            K D +    +   L       +           G                 ++S     
Sbjct: 205 GKSDVDQLYLIRKTLGDLIPRHQQVF-STNQYFSGVKIPDPEDMEPLELKFPNISYPALG 263

Query: 245 FLIKCFLKDPKRRWTAEMLLNHPF 268
            L  C   DP  R T E LL+HP+
Sbjct: 264 LLKGCLHMDPTERLTCEQLLHHPY 287

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  114 bits (288), Expect = 2e-29
 Identities = 63/276 (22%), Positives = 111/276 (40%), Gaps = 38/276 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK---------SCADCPPSSVTLKNEKEALD 56
              +G G+FG V  A   + + E    + VK          C    P    +  E   L 
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKE----VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 57  QIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGS-LADRVKKQNNGRLQESDVKRYTR 115
           ++     I++         + + F+ L++E    G  L   + +  + RL E       R
Sbjct: 85  RV-EHANIIKV----LDIFENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFR 137

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            ++  + ++  K  +H DIK +N+++ ++   K+ DFG A      G+   +F C GT  
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTF-C-GTIE 194

Query: 176 YMSPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
           Y +PE +  N Y  P  ++W+LG  +  +             N F  L          + 
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE---------ENPFCELEETVEAA--IHP 243

Query: 235 PGDLSEQGKDFLIKCFL-KDPKRRWTAEMLLNHPFV 269
           P  +S++    L+   L   P+RR T E L+  P+V
Sbjct: 244 PYLVSKELMS-LVSGLLQPVPERRTTLEKLVTDPWV 278

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  113 bits (284), Expect = 3e-29
 Identities = 79/277 (28%), Positives = 126/277 (45%), Gaps = 40/277 (14%)

Query: 6   GDVIGHGSFGSVNLAK----ASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIG 59
           GD +G G+FG V + +      KV        AVK  +        V  K ++E    I 
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKV--------AVKILNRQKIRSLDVVGKIKRE----IQ 63

Query: 60  IC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYT 114
                  P I++ +           F+ +++EY S G L D + K  +GR++E + +R  
Sbjct: 64  NLKLFRHPHIIKLYQ---VISTPTDFF-MVMEYVSGGELFDYICK--HGRVEEMEARRLF 117

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
           + +L  + + H    VH D+K +NVL+  +  AKIADFGL+   S DGE  ++  C G+P
Sbjct: 118 QQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS-C-GSP 174

Query: 175 LYMSPESVNENEYEAP-CDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELP 232
            Y +PE ++   Y  P  DIW+ G  +  +  G  P      D +V +L  +I  G    
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF----DDEHVPTLFKKIRGGV--F 228

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            IP  L+      L+     DP +R T + +  H + 
Sbjct: 229 YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  113 bits (286), Expect = 3e-29
 Identities = 71/276 (25%), Positives = 120/276 (43%), Gaps = 30/276 (10%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG--I 60
           W     +G G++G V LA  ++V+ E    +AVK         V +K   +  + I   I
Sbjct: 9   WDLVQTLGEGAYGEVQLAV-NRVTEE---AVAVKI--------VDMKRAVDCPENIKKEI 56

Query: 61  C-------PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
           C         +V+ +G      +G   Y L LEY S G L DR++   +  + E D +R+
Sbjct: 57  CINKMLNHENVVKFYG---HRREGNIQY-LFLEYCSGGELFDRIEP--DIGMPEPDAQRF 110

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
              ++ G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 174 PLYMSPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP 232
             Y++PE +   E+ A   D+W+ G  +  M +G+  W+  Q S+               
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKKTYL 228

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           N    +       L K  +++P  R T   +    +
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  113 bits (286), Expect = 4e-29
 Identities = 77/309 (24%), Positives = 126/309 (40%), Gaps = 77/309 (24%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-----ALDQIGIC-- 61
           IG G++G V  A+  K        +A+K         V ++  +E      + ++ +   
Sbjct: 19  IGEGAYGKVFKARDLKNGGR---FVALKR--------VRVQTGEEGMPLSTIREVAVLRH 67

Query: 62  ------PQIVR----CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVK 111
                 P +VR    C       E   +   L+ E+  +  L   + K     +    +K
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRET--KLT-LVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123

Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR 171
                +L+GL  +HS   VH D+K QN+LV  + + K+ADFGLA        R  SF+  
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA--------RIYSFQMA 175

Query: 172 GTPL-----YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI- 225
            T +     Y +PE + ++ Y  P D+W++GC   EM   KP +   + S+    L +I 
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF---RGSSDVDQLGKIL 232

Query: 226 ------------GVGDELPN--------------IPGDLSEQGKDFLIKCFLKDPKRRWT 259
                            LP               +  D+ E GKD L+KC   +P +R +
Sbjct: 233 DVIGLPGEEDWPRD-VALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRIS 290

Query: 260 AEMLLNHPF 268
           A   L+HP+
Sbjct: 291 AYSALSHPY 299

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  113 bits (285), Expect = 7e-29
 Identities = 54/203 (26%), Positives = 79/203 (38%), Gaps = 41/203 (20%)

Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS 158
           +     L    V++Y   ++ G+   HS   +H DIK +N+LV  +   K+ DFG A   
Sbjct: 115 ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA--- 171

Query: 159 SCDGERSQSFECRG------TPLYMSPES-VNENEYEAPCDIWALGCAVVEMASGKPAWN 211
                R+ +           T  Y +PE  V + +Y    D+WA+GC V EM  G+P + 
Sbjct: 172 -----RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226

Query: 212 HKQDSN----VFSLL------IRIGV-------GDELPNIPG---------DLSEQGKDF 245
              D +    +   L       +          G  LP I            LSE   D 
Sbjct: 227 GDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDL 286

Query: 246 LIKCFLKDPKRRWTAEMLLNHPF 268
             KC   DP +R     LL+H F
Sbjct: 287 AKKCLHIDPDKRPFCAELLHHDF 309

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  112 bits (282), Expect = 1e-28
 Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 56/284 (19%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK-------SCADCPPSSVTLKNEKEALDQI 58
           G ++G G FG+V      +++      +A+K               SVT   E   L ++
Sbjct: 36  GPLLGKGGFGTVFAGH--RLTDRLQ--VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 59  ---GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGS-LADRVKKQNNGRLQESDVKRYT 114
              G  P ++R    D+ FE  E F  L+LE       L D + +   G L E   + + 
Sbjct: 92  GAGGGHPGVIRLL--DW-FETQEGFM-LVLERPLPAQDLFDYITE--KGPLGEGPSRCFF 145

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAK-------KSSCDGERSQ 166
             ++  ++H HS+G VH DIK +N+L+      AK+ DFG                    
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD------ 199

Query: 167 SFECRGTPLYMSPESVNENEYEAP-CDIWALGCAVV--EMASGKPAWNHKQDSNVFSLLI 223
                GT +Y  PE ++ ++Y A    +W+LG  ++  +M  G   +   Q         
Sbjct: 200 -----GTRVYSPPEWISRHQYHALPATVWSLG--ILLYDMVCGDIPFERDQ--------- 243

Query: 224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHP 267
            I   +   + P  +S      + +C    P  R + E +L  P
Sbjct: 244 EILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  111 bits (281), Expect = 2e-28
 Identities = 73/316 (23%), Positives = 118/316 (37%), Gaps = 81/316 (25%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--- 61
               IG G++G+V  A+    S      +A+KS        V + N       + I    
Sbjct: 13  PVAEIGVGAYGTVYKAR-DPHSGH---FVALKS--------VRVPNGGGGGGGLPISTVR 60

Query: 62  -------------PQIVR----CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR 104
                        P +VR    C       E   +   L+ E+  +  L   + K     
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREI--KVT-LVFEHVDQ-DLRTYLDKAPPPG 116

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER 164
           L    +K   R  L+GL  +H+   VH D+K +N+LV      K+ADFGLA        R
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA--------R 168

Query: 165 SQSFECRGTPL-----YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF 219
             S++   TP+     Y +PE + ++ Y  P D+W++GC   EM   KP +     ++  
Sbjct: 169 IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF---CGNSEA 225

Query: 220 SLLIRI-------------GVGDELPN--------------IPGDLSEQGKDFLIKCFLK 252
             L +I                  LP               +P ++ E G   L++    
Sbjct: 226 DQLGKIFDLIGLPPEDDWPRD-VSLPRGAFPPRGPRPVQSVVP-EMEESGAQLLLEMLTF 283

Query: 253 DPKRRWTAEMLLNHPF 268
           +P +R +A   L H +
Sbjct: 284 NPHKRISAFRALQHSY 299

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  114 bits (287), Expect = 2e-28
 Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 38/279 (13%)

Query: 6   GDVIGHGSFGSVNLAK----ASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIG 59
           GD +G G+FG V + K      KV        AVK  +        V  K  +E    I 
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKV--------AVKILNRQKIRSLDVVGKIRRE----IQ 68

Query: 60  IC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYT 114
                  P I++ +            + +++EY S G L D + K  NGRL E + +R  
Sbjct: 69  NLKLFRHPHIIKLYQ---VISTPSDIF-MVMEYVSGGELFDYICK--NGRLDEKESRRLF 122

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
           + +L G+ + H    VH D+K +NVL+  +  AKIADFGL+   S DGE  ++  C G+P
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS-C-GSP 179

Query: 175 LYMSPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN 233
            Y +PE ++   Y  P  DIW+ G  +  +  G   +    D +V +L  +I  G     
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTLFKKICDGI--FY 234

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            P  L+      L      DP +R T + +  H +   D
Sbjct: 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  111 bits (281), Expect = 3e-28
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 39/279 (13%)

Query: 3   WLRGDVIGHGSFGSVNLAK----ASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALD 56
           ++  + +G GSFG V LA       KV        A+K  S      S + ++ E+E   
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKV--------ALKFISRQLLKKSDMHMRVERE--- 59

Query: 57  QIGIC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVK 111
            I        P I++ +              +++EYA  G L D + +    R+ E + +
Sbjct: 60  -ISYLKLLRHPHIIKLYD---VITTPTDIV-MVIEYAG-GELFDYIVE--KKRMTEDEGR 111

Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR 171
           R+ + ++  + + H    VH D+K +N+L+ DN   KIADFGL+   + DG   ++  C 
Sbjct: 112 RFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTS-C- 168

Query: 172 GTPLYMSPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE 230
           G+P Y +PE +N   Y  P  D+W+ G  +  M  G+  +    D  + +L  ++     
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF---DDEFIPNLFKKVNSCV- 224

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
              +P  LS   +  + +  + DP +R T + +   P+ 
Sbjct: 225 -YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  109 bits (275), Expect = 9e-28
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
             IV     D   E    +  L++EY    +L++ ++   +G L       +T  +L G+
Sbjct: 71  QNIVSMI--DVDEEDDCYY--LVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGI 124

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           +H H    VH DIK QN+L+  N   KI DFG+AK  S +   +Q+    GT  Y SPE 
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQ 183

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE- 240
                 +   DI+++G  + EM  G+P      ++ V S+ I+  + D +PN+  D+ + 
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP--FNGETAV-SIAIK-HIQDSVPNVTTDVRKD 239

Query: 241 --QGKDFLI-KCFLKDPKRRW--TAEML 263
             Q    +I +   KD   R+    EM 
Sbjct: 240 IPQSLSNVILRATEKDKANRYKTIQEMK 267

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  110 bits (278), Expect = 1e-27
 Identities = 64/276 (23%), Positives = 120/276 (43%), Gaps = 26/276 (9%)

Query: 83  LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF 142
           +++EYAS G L +R+   N GR  E + + + + +L G+ + HS    H D+KL+N L+ 
Sbjct: 93  IIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD 150

Query: 143 DNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAP-CDIWALGCA 199
            +     KI DFG + KSS    + +S    GTP Y++PE +   EY+    D+W+ G  
Sbjct: 151 GSPAPRLKICDFGYS-KSSVLHSQPKST-V-GTPAYIAPEVLLRQEYDGKIADVWSCGVT 207

Query: 200 VVEMASGKPAWNHKQDSNVF-SLLIRIGVGDELPNIPGD--LSEQGKDFLIKCFLKDPKR 256
           +  M  G   +   ++   +   + RI       +IP D  +S +    + + F+ DP  
Sbjct: 208 LYVMLVGAYPFEDPEEPRDYRKTIQRILSVK--YSIPDDIRISPECCHLISRIFVADPAT 265

Query: 257 RWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKFSQSPRSPFGFPEWVSVQ 316
           R +   +  H +   +          + + S+   +  + E+  QS  +           
Sbjct: 266 RISIPEIKTHSWFLKNLPA------DLMNESNTGSQFQEPEQPMQSLDTIMQI------- 312

Query: 317 SSSSVTSSINSPSFDSFLSSRDCLLDRIRVLAGDDE 352
            S +   ++ +   D F++    L D +     + E
Sbjct: 313 ISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESE 348

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  108 bits (273), Expect = 4e-27
 Identities = 71/316 (22%), Positives = 114/316 (36%), Gaps = 82/316 (25%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-----ALDQIGI--- 60
           IG G+FG V  A+  + + +    +A+K         V ++NEKE     AL +I I   
Sbjct: 25  IGQGTFGEVFKAR-HRKTGQ---KVALKK--------VLMENEKEGFPITALREIKILQL 72

Query: 61  --CPQIVR----CFGDDYSFEKGERFYNLLLEYASR--GSLADRVKKQNNGRLQESDVKR 112
                +V     C      + + +    L+ ++       L   V      +   S++KR
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKR 128

Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
             + +L GL +IH    +H D+K  NVL+  +   K+ADFGLA        R+ S     
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA--------RAFSLAKNS 180

Query: 173 TPLYMSPESV-----------NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN---- 217
            P   +   V            E +Y  P D+W  GC + EM +  P      + +    
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240

Query: 218 VFSLL-------------------------IRIGVGDELPNIPGDLSEQGKDFLIKCFLK 252
           +  L                           +  V D L            D + K  + 
Sbjct: 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV--RDPYALDLIDKLLVL 298

Query: 253 DPKRRWTAEMLLNHPF 268
           DP +R  ++  LNH F
Sbjct: 299 DPAQRIDSDDALNHDF 314

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  107 bits (270), Expect = 7e-27
 Identities = 52/230 (22%), Positives = 83/230 (36%), Gaps = 55/230 (23%)

Query: 82  NLLLEYAS---RGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQN 138
            L+ E+     +  +  R        L+ + VK +   +L+GL   H    +H D+K QN
Sbjct: 79  TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQN 138

Query: 139 VLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG-TPL-----YMSPES-VNENEYEAPC 191
           +L+    + K+ DFGLA        R+        +       Y +P+  +    Y    
Sbjct: 139 LLINKRGQLKLGDFGLA--------RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI 190

Query: 192 DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI-------------GVGDELPN----- 233
           DIW+ GC + EM +GKP +     +N    L  I              V  +LP      
Sbjct: 191 DIWSCGCILAEMITGKPLF---PGTNDEEQLKLIFDIMGTPNESLWPSV-TKLPKYNPNI 246

Query: 234 ---------------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                              L     DFL      +P  R +A+  L+HP+
Sbjct: 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  106 bits (267), Expect = 1e-26
 Identities = 56/206 (27%), Positives = 81/206 (39%), Gaps = 49/206 (23%)

Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS 158
               G L+    K +   +L G+ + H +  +H D+K QN+L+    E KIADFGLA   
Sbjct: 91  DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA--- 147

Query: 159 SCDGERSQSFECRG-TPL-----YMSPES-VNENEYEAPCDIWALGCAVVEMASGKPAWN 211
                R+     R  T       Y +P+  +   +Y    DIW++GC   EM +G P + 
Sbjct: 148 -----RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF- 201

Query: 212 HKQDSNVFSLLIRI-------------GVGDELPN----------------IPGDLSEQG 242
                +    L+RI              V  ELP                 +   L E G
Sbjct: 202 --PGVSEADQLMRIFRILGTPNSKNWPNV-TELPKYDPNFTVYEPLPWESFLK-GLDESG 257

Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPF 268
            D L K    DP +R TA+  L H +
Sbjct: 258 IDLLSKMLKLDPNQRITAKQALEHAY 283

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  107 bits (269), Expect = 1e-26
 Identities = 50/209 (23%), Positives = 78/209 (37%), Gaps = 53/209 (25%)

Query: 101 NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA-----KIADFGLA 155
            N  +    +K +   ++ G+   HS+  +H D+K QN+L+  +D +     KI DFGLA
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184

Query: 156 KKSSCDGERSQSFECRG-TPL-----YMSPES-VNENEYEAPCDIWALGCAVVEMASGKP 208
                   R+     R  T       Y  PE  +    Y    DIW++ C   EM    P
Sbjct: 185 --------RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236

Query: 209 AWNHKQDSNVFSLLIRI-------------GVGDELPN----------------IPGDLS 239
            +      +    L +I             GV   LP+                +   L 
Sbjct: 237 LF---PGDSEIDQLFKIFEVLGLPDDTTWPGV-TALPDWKQSFPKFRGKTLKRVLGALLD 292

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           ++G D L      DP +R +A+  L HP+
Sbjct: 293 DEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  106 bits (268), Expect = 1e-26
 Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 50/207 (24%)

Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS 158
            +N   LQ+S +K Y   +L+G+ H H    +H D+K QN+L+  +   K+ADFGLA   
Sbjct: 110 DENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA--- 166

Query: 159 SCDGERSQSFECRG-TPL-----YMSPES-VNENEYEAPCDIWALGCAVVEMASGKPAWN 211
                R+     R  T       Y +P+  +   +Y    DIW++GC   EM +GKP + 
Sbjct: 167 -----RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF- 220

Query: 212 HKQDSNVFSLLIRI-------------GVGDELPN-----------------IPGDLSEQ 241
                     L +I              V  ELP                  IP    ++
Sbjct: 221 --PGVTDDDQLPKIFSILGTPNPREWPQV-QELPLWKQRTFQVFEKKPWSSIIP-GFCQE 276

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           G D L      DP +R +A   +NHP+
Sbjct: 277 GIDLLSNMLCFDPNKRISARDAMNHPY 303

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  108 bits (271), Expect = 1e-26
 Identities = 78/302 (25%), Positives = 122/302 (40%), Gaps = 63/302 (20%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC----- 61
            VIG+GSFG V  AK    S E     A+K           L++++    ++ I      
Sbjct: 46  KVIGNGSFGVVFQAK-LVESDEV----AIKK---------VLQDKRFKNRELQIMRIVKH 91

Query: 62  PQIVR---CFGDDYSFEKGERFYNLLLEYASRGSLADRVKK------QNNGRLQESDVKR 112
           P +V     F  +   +K E F NL+LEY     + + V +      +    +    +K 
Sbjct: 92  PNVVDLKAFFYSNGD-KKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKL 145

Query: 113 YTRSMLKGLRHIHSKGFVHCDIKLQNVLVF-DNDEAKIADFGLAKKSSCDGERSQSFECR 171
           Y   +L+ L +IHS G  H DIK QN+L+   +   K+ DFG AK     GE + S+ C 
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPNVSYIC- 203

Query: 172 GTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI-G--- 226
            +  Y +PE +     Y    DIW+ GC + E+  G+P +  +   +    +I++ G   
Sbjct: 204 -SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262

Query: 227 -----------VGDELPNIPG---------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
                      +  + P I                  D + +     P  R TA   L H
Sbjct: 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322

Query: 267 PF 268
           PF
Sbjct: 323 PF 324

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  108 bits (272), Expect = 1e-26
 Identities = 76/300 (25%), Positives = 117/300 (39%), Gaps = 58/300 (19%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC----- 61
            VIG+GSFG V  AK    S E   L+A+K           L++++    ++ I      
Sbjct: 60  KVIGNGSFGVVYQAK-LCDSGE---LVAIKK---------VLQDKRFKNRELQIMRKLDH 106

Query: 62  PQIVRCFGDDYSF--EKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYT 114
             IVR     YS   +K E + NL+L+Y             R   +    L    VK Y 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYM 162

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVF-DNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
             + + L +IHS G  H DIK QN+L+  D    K+ DFG AK+    GE + S+ C  +
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYIC--S 219

Query: 174 PLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI-G----- 226
             Y +PE +    +Y +  D+W+ GC + E+  G+P +      +    +I++ G     
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279

Query: 227 ---------VGDELPNIPG---------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                       + P I               +      +     P  R T      H F
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  105 bits (264), Expect = 3e-26
 Identities = 67/293 (22%), Positives = 105/293 (35%), Gaps = 51/293 (17%)

Query: 6   GDVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-P 62
            + +G G +G V     +   V        AVK          +   E E  + + +   
Sbjct: 13  LECVGKGRYGEVWRGSWQGENV--------AVK--IFSSRDEKSWFRETELYNTVMLRHE 62

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+     D +         L+  Y   GSL D ++      L      R   S+  GL 
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLA 119

Query: 123 HIHSKGF--------VHCDIKLQNVLVFDNDEAKIADFGLAKK---SSCDGERSQSFECR 171
           H+H + F         H D+K +N+LV  N +  IAD GLA     S+   +   +    
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV- 178

Query: 172 GTPLYMSPE------SVNENEYEAPCDIWALGCAVVEMASG----------KPAWNHKQD 215
           GT  YM+PE       V+  +     DIWA G  + E+A            KP +     
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238

Query: 216 SNVFSLLIRIGVGDE--LPNIPGDLSEQG-----KDFLIKCFLKDPKRRWTAE 261
           ++     +R  V  +   PNIP               + +C+ ++P  R TA 
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  105 bits (263), Expect = 4e-26
 Identities = 57/273 (20%), Positives = 105/273 (38%), Gaps = 41/273 (15%)

Query: 6   GDVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEA-----LDQ 57
           G+V+G G FG       + +         M +K          T +   KE      L+ 
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEV------MVMKELIR--FDEETQRTFLKEVKVMRCLEH 66

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P +++  G      K +R    + EY   G+L   +K  +  +   S    + + +
Sbjct: 67  ----PNVLKFIG---VLYKDKRLN-FITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDI 117

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE------------RS 165
             G+ ++HS   +H D+   N LV +N    +ADFGLA+    +              R 
Sbjct: 118 ASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177

Query: 166 QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV-FSLLIR 224
           + +   G P +M+PE +N   Y+   D+++ G  + E+     A        + F L +R
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237

Query: 225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
             +  +    P +         ++C   DP++R
Sbjct: 238 GFL--DRY-CPPNCPPSFFPITVRCCDLDPEKR 267

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  104 bits (261), Expect = 1e-25
 Identities = 67/264 (25%), Positives = 114/264 (43%), Gaps = 34/264 (12%)

Query: 6   GDVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-- 61
            + IG GSFG+V+ A    S V        AVK            +   E L ++ I   
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDV--------AVKIL---MEQDFHAERVNEFLREVAIMKR 90

Query: 62  ---PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR-LQESDVKRYTRSM 117
              P IV   G   +  +      ++ EY SRGSL   + K      L E         +
Sbjct: 91  LRHPNIVLFMG---AVTQPPNLS-IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146

Query: 118 LKGLRHIHSKG--FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            KG+ ++H++    VH ++K  N+LV      K+ DFGL++  +     S+S    GTP 
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPE 204

Query: 176 YMSPESVNENEYEAPCDIWALGCAVV--EMASGKPAWNHKQDSNVFSLLIRIGVGDELPN 233
           +M+PE + +       D+++ G  V+  E+A+ +  W +    N   ++  +G   +   
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFG--VILWELATLQQPWGNL---NPAQVVAAVGFKCKRLE 259

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRR 257
           IP +L+ Q    +  C+  +P +R
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKR 283

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  103 bits (260), Expect = 1e-25
 Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 50/207 (24%)

Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS 158
              NG L    VK +   +LKGL   HS+  +H D+K QN+L+  N E K+A+FGLA   
Sbjct: 92  DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA--- 148

Query: 159 SCDGERSQSFECRG-TPL-----YMSPES-VNENEYEAPCDIWALGCAVVEMAS-GKPAW 210
                R+     R  +       Y  P+       Y    D+W+ GC   E+A+ G+P +
Sbjct: 149 -----RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203

Query: 211 NHKQDSNVFSLLIRI-------------GVGDELPN----------------IPGDLSEQ 241
                ++V   L RI              +  +LP+                +P  L+  
Sbjct: 204 ---PGNDVDDQLKRIFRLLGTPTEEQWPSM-TKLPDYKPYPMYPATTSLVNVVP-KLNAT 258

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           G+D L      +P +R +AE  L HP+
Sbjct: 259 GRDLLQNLLKCNPVQRISAEEALQHPY 285

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  103 bits (260), Expect = 1e-25
 Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 30/217 (13%)

Query: 62  PQIVRCFGDDYSFEKGE--RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           P IV  +  D    +        +++EY    +L D V     G +             +
Sbjct: 72  PAIVAVY--DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQ 127

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER-SQSFECRGTPLYMS 178
            L   H  G +H D+K  N+++   +  K+ DFG+A+  +  G   +Q+    GT  Y+S
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKP----------AWNHKQDSNVFSLLIRIGVG 228
           PE    +  +A  D+++LGC + E+ +G+P          A+ H ++  +          
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-------PS 240

Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWT--AEML 263
                +  DL       ++K   K+P+ R+   AEM 
Sbjct: 241 ARHEGLSADLDA----VVLKALAKNPENRYQTAAEMR 273

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  104 bits (261), Expect = 1e-25
 Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 50/207 (24%)

Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS 158
                 +   +VK +   +L+GL + H +  +H D+K QN+L+ +  E K+ADFGLA   
Sbjct: 91  DDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA--- 147

Query: 159 SCDGERSQSFECRG-TPL-----YMSPES-VNENEYEAPCDIWALGCAVVEMASGKPAWN 211
                R++S   +          Y  P+  +   +Y    D+W +GC   EMA+G+P + 
Sbjct: 148 -----RAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF- 201

Query: 212 HKQDSNVFSLLIRI-------------GVGDELPN-----------------IPGDLSEQ 241
               S V   L  I             G+                        P  L   
Sbjct: 202 --PGSTVEEQLHFIFRILGTPTEETWPGI-LSNEEFKTYNYPKYRAEALLSHAP-RLDSD 257

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPF 268
           G D L K    + + R +AE  + HPF
Sbjct: 258 GADLLTKLLQFEGRNRISAEDAMKHPF 284

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  103 bits (260), Expect = 1e-25
 Identities = 57/260 (21%), Positives = 106/260 (40%), Gaps = 32/260 (12%)

Query: 6   GDVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
            +V+G G+FG V  A  +A  V        A+K   +          E   L ++   P 
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDV--------AIKQ-IESESERKAFIVELRQLSRV-NHPN 62

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRV-KKQNNGRLQESDVKRYTRSMLKGLR 122
           IV+ +G             L++EYA  GSL + +   +       +    +     +G+ 
Sbjct: 63  IVKLYG--ACLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116

Query: 123 HIHS---KGFVHCDIKLQNVLVFDNDE-AKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
           ++HS   K  +H D+K  N+L+       KI DFG A         +     +G+  +M+
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-----THMTNNKGSAAWMA 171

Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL-PNIPGD 237
           PE    + Y   CD+++ G  + E+ + +  ++           I   V +   P +  +
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWAVHNGTRPPLIKN 228

Query: 238 LSEQGKDFLIKCFLKDPKRR 257
           L +  +  + +C+ KDP +R
Sbjct: 229 LPKPIESLMTRCWSKDPSQR 248

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  102 bits (257), Expect = 2e-25
 Identities = 39/178 (21%), Positives = 83/178 (46%), Gaps = 9/178 (5%)

Query: 86  EYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND 145
           ++    SL   +      + +   +    R   +G+ ++H+K  +H D+K  N+ + +++
Sbjct: 99  QWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN 157

Query: 146 EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE---SVNENEYEAPCDIWALGCAVVE 202
             KI DFGLA + S      Q  +  G+ L+M+PE     + N Y    D++A G  + E
Sbjct: 158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217

Query: 203 MASGKPAWNHKQDSNVFSLLIRIGVGD---ELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           + +G+  +++   +N   ++  +G G    +L  +  +  ++ K  + +C  K    R
Sbjct: 218 LMTGQLPYSNI--NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  101 bits (253), Expect = 8e-25
 Identities = 56/270 (20%), Positives = 110/270 (40%), Gaps = 37/270 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC--ADCPPSSVTLKNEKEALDQIGI--- 60
              IG G FG V+  +  K  S     +A+KS    D    +  ++  +E   ++ I   
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSV----VAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79

Query: 61  --CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              P IV+ +G             +++E+   G L  R+  + +  ++ S   R    + 
Sbjct: 80  LNHPNIVKLYG--LMHNP----PRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIA 132

Query: 119 KGLRHIHSKG--FVHCDIKLQNVLVFDNDE-----AKIADFGLAKKSSCDGERSQSFECR 171
            G+ ++ ++    VH D++  N+ +   DE     AK+ADFGL+++              
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLL 187

Query: 172 GTPLYMSPE--SVNENEYEAPCDIWALGCAVV--EMASGKPAWNHKQDSNVFSLLIRIGV 227
           G   +M+PE     E  Y    D ++    ++   + +G+  ++      +   +  I  
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFA--MILYTILTGEGPFDEYSYGKI-KFINMIRE 244

Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
               P IP D   + ++ +  C+  DPK+R
Sbjct: 245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  101 bits (252), Expect = 2e-24
 Identities = 55/230 (23%), Positives = 88/230 (38%), Gaps = 34/230 (14%)

Query: 6   GDVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CP 62
            + IG G FG V     +  +V        AVK  +     S     E E    + +   
Sbjct: 47  QESIGKGRFGEVWRGKWRGEEV--------AVKIFSSREERSW--FREAEIYQTVMLRHE 96

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+     D           L+ +Y   GSL D + +     +    + +   S   GL 
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLA 153

Query: 123 HIHSK--------GFVHCDIKLQNVLVFDNDEAKIADFGLAKK---SSCDGERSQSFECR 171
           H+H +           H D+K +N+LV  N    IAD GLA +   ++   + + +    
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV- 212

Query: 172 GTPLYMSPE----SVNENEYEA--PCDIWALGCAVVEMASGKPAWNHKQD 215
           GT  YM+PE    S+N   +E+    DI+A+G    E+A         +D
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  101 bits (253), Expect = 3e-24
 Identities = 52/210 (24%), Positives = 76/210 (36%), Gaps = 58/210 (27%)

Query: 99  KQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS 158
           K N+  L  S +K Y    L+GL ++H    +H D+K  N+L+ +N   K+ADFGLAK  
Sbjct: 103 KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-- 160

Query: 159 SCDGERSQSFECRGTPL-----------YMSPES-VNENEYEAPCDIWALGCAVVEMASG 206
                   SF   G+P            Y +PE       Y    D+WA+GC + E+   
Sbjct: 161 --------SF---GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

Query: 207 KPAWNHKQDSNVFSLLIRI-------------GVGDELPN---------------IPGDL 238
            P        +    L RI              +   LP+                    
Sbjct: 210 VPFL---PGDSDLDQLTRIFETLGTPTEEQWPDM-CSLPDYVTFKSFPGIPLHHIFS-AA 264

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
            +   D +   FL +P  R TA   L   +
Sbjct: 265 GDDLLDLIQGLFLFNPCARITATQALKMKY 294

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  103 bits (258), Expect = 3e-24
 Identities = 42/206 (20%), Positives = 78/206 (37%), Gaps = 28/206 (13%)

Query: 62  PQIVRC--FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
           P IV+   F +          Y +++EY    SL          +L  ++   Y   +L 
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGY-IVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILP 193

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            L ++HS G V+ D+K +N+++   ++ K+ D G   +       +      GTP + +P
Sbjct: 194 ALSYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSR------INSFGYLYGTPGFQAP 246

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E V         DI+ +G  +  +    P  N +        +  +   D +        
Sbjct: 247 EIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGR-------YVDGLPEDDPVLKTYDSYG 298

Query: 240 EQGKDFLIKCFLKDPKRRWT--AEML 263
                 L +    DP++R+T   EM 
Sbjct: 299 R----LLRRAIDPDPRQRFTTAEEMS 320

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  101 bits (253), Expect = 3e-24
 Identities = 53/232 (22%), Positives = 90/232 (38%), Gaps = 65/232 (28%)

Query: 92  SLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEA--- 147
           +L   +KK  +  +    VK+ ++ +L GL ++H + G +H DIK +NVL+   D     
Sbjct: 115 NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174

Query: 148 ---KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMA 204
              KIAD G    ++C  +   +   + T  Y SPE +    +    DIW+  C + E+ 
Sbjct: 175 IQIKIADLG----NACWYDEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELI 229

Query: 205 SGKP------AWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK--------------- 243
           +G          ++ +D +  + +I +     L  +P  L   GK               
Sbjct: 230 TGDFLFEPDEGHSYTKDDDHIAQIIEL-----LGELPSYLLRNGKYTRTFFNSRGLLRNI 284

Query: 244 ---------------------------DFLIKCFLKDPKRRWTAEMLLNHPF 268
                                      DFL      DP++R  A  L+NHP+
Sbjct: 285 SKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 336

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 99.2 bits (248), Expect = 7e-24
 Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 31/214 (14%)

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P +V     D+  E   + Y + +   +   LA  +++Q  G L         R +   L
Sbjct: 94  PHVVPIH--DFG-EIDGQLY-VDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSAL 147

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
              H+ G  H D+K +N+LV  +D A + DFG+A  ++ D + +Q     GT  YM+PE 
Sbjct: 148 DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPER 206

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKP---------AWNHKQDSNVFSLLIRIGVGDELP 232
            +E+      DI+AL C + E  +G P            H   +               P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIP-------RPSTVRP 259

Query: 233 NIPGDLSEQGKDFLI-KCFLKDPKRRW--TAEML 263
            IP        D +I +   K+P+ R+    ++ 
Sbjct: 260 GIPVAF-----DAVIARGMAKNPEDRYVTCGDLS 288

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 99.4 bits (248), Expect = 7e-24
 Identities = 66/295 (22%), Positives = 106/295 (35%), Gaps = 55/295 (18%)

Query: 6   GDVIGHGSFGSVNLAK--ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CP 62
              IG G +G V + K    KV        AVK       +S     E E    + +   
Sbjct: 42  VKQIGKGRYGEVWMGKWRGEKV--------AVKVFFTTEEAS--WFRETEIYQTVLMRHE 91

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+     D           L+ +Y   GSL D +K      L    + +   S + GL 
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLC 148

Query: 123 HIHSKGF--------VHCDIKLQNVLVFDNDEAKIADFGLAKK---SSCDGERSQSFECR 171
           H+H++ F         H D+K +N+LV  N    IAD GLA K    + + +   +    
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV- 207

Query: 172 GTPLYMSPE------SVNENEYEAPCDIWALGCAVV--EMASG----------KPAWNHK 213
           GT  YM PE      + N  +     D+++ G  ++  E+A            +  ++  
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFG--LILWEVARRCVSGGIVEEYQLPYHDL 265

Query: 214 QDSNVFSLLIRIGVGDEL--PNIPGDLSEQGKDFLIK-----CFLKDPKRRWTAE 261
             S+     +R  V  +   P+ P   S       +      C+  +P  R TA 
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 98.1 bits (245), Expect = 9e-24
 Identities = 34/266 (12%), Positives = 94/266 (35%), Gaps = 39/266 (14%)

Query: 6   GDVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-- 61
              +     G +     + + +         VK          + +  ++  ++      
Sbjct: 15  LTKLNENHSGELWKGRWQGNDI--------VVKVLK---VRDWSTRKSRDFNEECPRLRI 63

Query: 62  ---PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              P ++   G             L+  +   GSL + + +  N  + +S   ++   M 
Sbjct: 64  FSHPNVLPVLG--ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121

Query: 119 KGLRHIHSKGF--VHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           +G+  +H+         +  ++V++ ++  A+I+   +       G           P +
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAW 174

Query: 177 MSPESVNENEYEAP---CDIWALGCAVV--EMASGKPAWNHKQDSNVFSLLIRIGVGDEL 231
           ++PE++ +   +      D+W+    V+  E+ + +  +    D +   + +++ +    
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFA--VLLWELVTREVPF---ADLSNMEIGMKVALEGLR 229

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRR 257
           P IP  +S      +  C  +DP +R
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKR 255

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 61/321 (19%), Positives = 107/321 (33%), Gaps = 66/321 (20%)

Query: 7   DVIGHGSFGSVNLAKAS---------KVSSEFP------SLM---------AVKSC--AD 40
             +G GSFG V               KV  +         +M          +       
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTT 72

Query: 41  CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD----- 95
                   +   +     G    +              ++ N+++EY             
Sbjct: 73  GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP----DTLHKVL 128

Query: 96  RVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF-DNDEAKIADFGL 154
           +   ++   +  + +  Y   + + +  IHS G  H DIK QN+LV   ++  K+ DFG 
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188

Query: 155 AKKSSCDGERSQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHK 213
           AKK     E S ++ C  +  Y +PE +    EY    D+W++GC   E+  GKP ++ +
Sbjct: 189 AKKLI-PSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE 245

Query: 214 QDSNVFSLLIRIGVG----------------DELPNIPG-DLSE--------QGKDFLIK 248
              +    +I+I +G                   P +   D  +           D L +
Sbjct: 246 TSIDQLVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304

Query: 249 CFLKDPKRRWTAEMLLNHPFV 269
               +P  R      + HPF 
Sbjct: 305 ILRYEPDLRINPYEAMAHPFF 325

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 53/271 (19%), Positives = 109/271 (40%), Gaps = 40/271 (14%)

Query: 6   GDVIGHGSFGSVNLAK-ASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEA-----LDQI 58
           G++IG G FG V   +   +V        A++       +   LK  ++E          
Sbjct: 38  GELIGKGRFGQVYHGRWHGEV--------AIRLIDIERDNEDQLKAFKREVMAYRQTRH- 88

Query: 59  GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
                +V   G   +         ++       +L   V+      L  +  ++  + ++
Sbjct: 89  ---ENVVLFMG---ACMSPPHLA-IITSLCKGRTLYSVVRDAKI-VLDVNKTRQIAQEIV 140

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR---GTPL 175
           KG+ ++H+KG +H D+K +NV   DN +  I DFGL   S       +  + R   G   
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 176 YMSPE-----SVNENEYEAP----CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG 226
           +++PE     S +  E + P     D++ALG    E+ + +  +   +     +++ ++G
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF---KTQPAEAIIWQMG 256

Query: 227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            G +       + ++  D L+ C+  + + R
Sbjct: 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEER 287

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 6/202 (2%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
              +G G+FGSV + +   +      ++AVK             + E E L  +     I
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNI 104

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V+  G    +  G R   L++EY   GSL D ++K +  R+    + +YT  + KG+ ++
Sbjct: 105 VKYKG--VCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL 161

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVN 183
            +K ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P+ + +PES+ 
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221

Query: 184 ENEYEAPCDIWALGCAVVEMAS 205
           E+++    D+W+ G  + E+ +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 6/202 (2%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
              +G G+FGSV + +   +      ++AVK             + E E L  +     I
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNI 73

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V+  G    +  G R   L++EY   GSL D ++K +  R+    + +YT  + KG+ ++
Sbjct: 74  VKYKG--VCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL 130

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVN 183
            +K ++H D+  +N+LV + +  KI DFGL K    D E  +  E   +P+ + +PES+ 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190

Query: 184 ENEYEAPCDIWALGCAVVEMAS 205
           E+++    D+W+ G  + E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 97.5 bits (243), Expect = 4e-23
 Identities = 57/231 (24%), Positives = 93/231 (40%), Gaps = 31/231 (13%)

Query: 6   GDVIGHGSFGSVNLAKA--SKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CP 62
            +V   G FG V  A+     V        AVK          + +NE E     G+   
Sbjct: 29  LEVKARGRFGCVWKAQLLNEYV--------AVKIFP--IQDKQSWQNEYEVYSLPGMKHE 78

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I++  G +      +    L+  +  +GSL+D +K      +  +++     +M +GL 
Sbjct: 79  NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLA 135

Query: 123 HIHSKGF----------VHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
           ++H               H DIK +NVL+ +N  A IADFGLA K         +    G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195

Query: 173 TPLYMSPE-----SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV 218
           T  YM+PE        + +     D++A+G  + E+AS   A +   D  +
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 96.2 bits (240), Expect = 4e-23
 Identities = 55/270 (20%), Positives = 105/270 (38%), Gaps = 41/270 (15%)

Query: 6   GDVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-- 61
            ++IG G FG V  A     +V        AVK+ A   P     +  +    +  +   
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEV--------AVKA-ARHDPDEDISQTIENVRQEAKLFAM 62

Query: 62  ---PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              P I+   G      K      L++E+A  G L   +  +   R+    +  +   + 
Sbjct: 63  LKHPNIIALRG---VCLKEPNLC-LVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIA 115

Query: 119 KGLRHIHSKG---FVHCDIKLQNVLV--------FDNDEAKIADFGLAKKSSCDGERSQS 167
           +G+ ++H +     +H D+K  N+L+          N   KI DFGLA++     + S  
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA- 174

Query: 168 FECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV 227
               G   +M+PE +  + +    D+W+ G  + E+ +G+  +   +  +  ++   + +
Sbjct: 175 ---AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF---RGIDGLAVAYGVAM 228

Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
                 IP    E     +  C+  DP  R
Sbjct: 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 98.7 bits (246), Expect = 5e-23
 Identities = 57/255 (22%), Positives = 112/255 (43%), Gaps = 17/255 (6%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              +G G FG V +   +       + +A+K+      S      E + + ++    ++V
Sbjct: 189 EVKLGQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLV 242

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +         E  Y ++ EY S+GSL D +K +    L+   +      +  G+ ++ 
Sbjct: 243 QLYA----VVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
              +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE+    
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 356

Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
            +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  E   D
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECPESLHD 412

Query: 245 FLIKCFLKDPKRRWT 259
            + +C+ K+P+ R T
Sbjct: 413 LMCQCWRKEPEERPT 427

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 96.6 bits (241), Expect = 7e-23
 Identities = 66/269 (24%), Positives = 118/269 (43%), Gaps = 25/269 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
              +G G+FGSV L +   +     +L+AVK      P      + E + L  +     I
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH-SDFI 86

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V+  G   S+  G +   L++EY   G L D +++ +  RL  S +  Y+  + KG+ ++
Sbjct: 87  VKYRG--VSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL 143

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESVN 183
            S+  VH D+  +N+LV      KIADFGLAK    D +     E   +P+ + +PES++
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203

Query: 184 ENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           +N +    D+W+ G  + E+ +   K      +   +      +     L     +L E+
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL----ELLEE 259

Query: 242 GK-------------DFLIKCFLKDPKRR 257
           G+             + +  C+   P+ R
Sbjct: 260 GQRLPAPPACPAEVHELMKLCWAPSPQDR 288

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 43/202 (21%), Positives = 81/202 (40%), Gaps = 31/202 (15%)

Query: 96  RVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA 155
           +V       +    ++ +   +L GL  +H  G VH D+   N+L+ DN++  I DF LA
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181

Query: 156 KKSSCDGERSQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAW---- 210
           ++ + D  ++          Y +PE V     +    D+W+ GC + EM + K  +    
Sbjct: 182 REDTADANKT---HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238

Query: 211 NHKQDSNVFSLL--------IRIG-------VGDELPNIPG--------DLSEQGKDFLI 247
            + Q + +  ++        +          + + L N+P                D + 
Sbjct: 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298

Query: 248 KCFLKDPKRRWTAEMLLNHPFV 269
           K    +P+RR + E  L HP+ 
Sbjct: 299 KMLEFNPQRRISTEQALRHPYF 320

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 60/327 (18%), Positives = 106/327 (32%), Gaps = 80/327 (24%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE-----ALDQIGI 60
           G  +G G++G V   KA +   +     A+K            + E       A  +I +
Sbjct: 26  GCKVGRGTYGHV--YKAKRKDGKDDKDYALK------------QIEGTGISMSACREIAL 71

Query: 61  C-----PQIVRCFGDDYSFEKGERFYNLLLEYASR------GSLADRVKKQNNGRLQESD 109
                 P ++            +R   LL +YA                 +   +L    
Sbjct: 72  LRELKHPNVISLQ--KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129

Query: 110 VKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA----KIADFGLAKKSSCDGERS 165
           VK     +L G+ ++H+   +H D+K  N+LV          KIAD G A+  +   +  
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189

Query: 166 QSFECR-GTPLYMSPES-VNENEYEAPCDIWALGCAVVEMASGKP-------------AW 210
              +    T  Y +PE  +    Y    DIWA+GC   E+ + +P              +
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249

Query: 211 NHKQDSNVFSLL-----------------------------IRIGVGDELPNIPGDLSEQ 241
           +H Q   +F+++                                 +   +         +
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPF 268
               L K    DP +R T+E  +  P+
Sbjct: 310 AFHLLQKLLTMDPIKRITSEQAMQDPY 336

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 57/255 (22%), Positives = 112/255 (43%), Gaps = 17/255 (6%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              +G G FG V +   +       + +A+K+      S      E + + ++    ++V
Sbjct: 272 EVKLGQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLV 325

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +         E  Y ++ EY S+GSL D +K +    L+   +      +  G+ ++ 
Sbjct: 326 QLYA----VVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
              +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE+    
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 439

Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
            +    D+W+ G  + E+ + G+  +    +  V   + R   G  +P  P +  E   D
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMP-CPPECPESLHD 495

Query: 245 FLIKCFLKDPKRRWT 259
            + +C+ K+P+ R T
Sbjct: 496 LMCQCWRKEPEERPT 510

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 65/351 (18%), Positives = 104/351 (29%), Gaps = 126/351 (35%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE----ALDQIGI-- 60
           D +G G+FG V      K        +AVK           +KN       A  +I +  
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRH---VAVK----------IVKNVDRYCEAARSEIQVLE 66

Query: 61  ------------CPQIVRCFGDDY------SFEKGERFYNLLLEYASRGSLADRVKKQNN 102
                       C Q++  F  ++       FE        LL      S  D +K+   
Sbjct: 67  HLNTTDPNSTFRCVQMLEWF--EHHGHICIVFE--------LLGL----STYDFIKENGF 112

Query: 103 GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--------------- 147
              +   +++    + K +  +HS    H D+K +N+L   +D                 
Sbjct: 113 LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172

Query: 148 ----KIADFGLAKKSSC-DGERS----QS-FECRGTPLYMSPESVNENEYEAPCDIWALG 197
               K+ DFG    S+  D E       +         Y +PE +    +  PCD+W++G
Sbjct: 173 NPDIKVVDFG----SATYDDEHHSTLVSTRH-------YRAPEVILALGWSQPCDVWSIG 221

Query: 198 CAVVEMASGKP----------------------------AWNHKQ-DSNVFSLLIRIGVG 228
           C ++E   G                                  K    +          G
Sbjct: 222 CILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAG 281

Query: 229 DELPNIPGDLSE----------QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             +      L E          +  D + K    DP +R T    L HPF 
Sbjct: 282 RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 7/203 (3%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVT-LKNEKEALDQIGICPQ 63
              +G G FG V L +           +AVKS   +   + +  LK E E L  +     
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HEN 84

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G     + G     L++E+   GSL + + K N  ++      +Y   + KG+ +
Sbjct: 85  IVKYKGICTE-DGGNGIK-LIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDY 141

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESV 182
           + S+ +VH D+  +NVLV    + KI DFGL K    D E     + R +P+ + +PE +
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201

Query: 183 NENEYEAPCDIWALGCAVVEMAS 205
            ++++    D+W+ G  + E+ +
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 28/181 (15%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCDGERSQSF-ECRGTP 174
           +L+GL++IHS   +H D+K  N+ +   D   KI DFGLA+             E   T 
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 175 LYMSPE-SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR-IGVGDE-- 230
            Y SP   ++ N Y    D+WA GC   EM +GK  +    +     L++  I V  E  
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248

Query: 231 --------------LPNIPG--------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                             P          +S +  DFL +     P  R TAE  L+HP+
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308

Query: 269 V 269
           +
Sbjct: 309 M 309

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 40/189 (21%), Positives = 77/189 (40%), Gaps = 36/189 (19%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
            L+ ++ +H    +H D+K  N+L+  N + K+ DFGLA+        +     + + + 
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 176 -------YMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI-- 225
                  Y +PE +    +Y    D+W+ GC + E+   +P +  +   +   L+  I  
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240

Query: 226 ---------GVGDE--------LPNIPG--------DLSEQGKDFLIKCFLKDPKRRWTA 260
                     +           LP  P          ++ +G D L +  + DP +R TA
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300

Query: 261 EMLLNHPFV 269
           +  L HP++
Sbjct: 301 KEALEHPYL 309

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 59/204 (28%), Positives = 86/204 (42%), Gaps = 41/204 (20%)

Query: 96  RVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA 155
           ++         E  ++     MLKGL++IHS G VH D+K  N+ V ++ E KI DFGLA
Sbjct: 117 KIMGLK---FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173

Query: 156 KKSSCDGERSQSFECRG---TPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWN 211
                   R    E  G   T  Y +PE + +   Y    DIW++GC + EM +GK  + 
Sbjct: 174 --------RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225

Query: 212 HKQDSNVFSLLIRI----------GVGDE--------LPNIPG--------DLSEQGKDF 245
            K   +  + ++++           + D+        LP  P           S Q  D 
Sbjct: 226 GKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADL 285

Query: 246 LIKCFLKDPKRRWTAEMLLNHPFV 269
           L K    D  +R TA   L HPF 
Sbjct: 286 LEKMLELDVDKRLTAAQALTHPFF 309

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 94.3 bits (235), Expect = 6e-22
 Identities = 62/358 (17%), Positives = 97/358 (27%), Gaps = 134/358 (37%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE----ALDQIGI-- 60
             +G G+FG V L +            AVK           ++N K+    A  +  I  
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKK----YYAVK----------VVRNIKKYTRSAKIEADILK 86

Query: 61  -----------CPQIVRCFGDDY------SFEKGERFYNLLLEYASRGSLADRVKKQNNG 103
                        +    F   Y       FE         L      SL + + + N  
Sbjct: 87  KIQNDDINNNNIVKYHGKF--MYYDHMCLIFE--------PLGP----SLYEIITRNNYN 132

Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA---------------- 147
                D+K Y   +LK L ++      H D+K +N+L+ D                    
Sbjct: 133 GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192

Query: 148 ---------KIADFGLAKKSSC-DGERS----QS-FECRGTPLYMSPESVNENEYEAPCD 192
                    K+ DFG     +    +       +         Y +PE +    ++   D
Sbjct: 193 IYRTKSTGIKLIDFG----CATFKSDYHGSIINTRQ-------YRAPEVILNLGWDVSSD 241

Query: 193 IWALGCAVVEMASGKP-----------------------------------------AWN 211
           +W+ GC + E+ +G                                              
Sbjct: 242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELK 301

Query: 212 HKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
                N  S+     V   LP       E   DFL      DP  R +   LL H F+
Sbjct: 302 LAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 54/256 (21%), Positives = 107/256 (41%), Gaps = 17/256 (6%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              +G G +G V      K S      +AVK+  +          E   + +I   P +V
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLT----VAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 279

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           +  G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++ 
Sbjct: 280 QLLG---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            K F+H ++  +N LV +N   K+ADFGL++  +     +     +    + +PES+  N
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYN 394

Query: 186 EYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
           ++    D+WA G  + E+A+    P       S V+ LL +      +   P    E+  
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEK---DYRME-RPEGCPEKVY 449

Query: 244 DFLIKCFLKDPKRRWT 259
           + +  C+  +P  R +
Sbjct: 450 ELMRACWQWNPSDRPS 465

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 65/305 (21%), Positives = 110/305 (36%), Gaps = 57/305 (18%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKN-EKEALDQIGIC--PQ 63
            + G G+FG+V L K  K +      +A+K     P      +N E + +  + +   P 
Sbjct: 29  RMAGQGTFGTVQLGK-EKSTGM---SVAIKKVIQDP----RFRNRELQIMQDLAVLHHPN 80

Query: 64  IVR---CFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTR 115
           IV+    F      ++ + + N+++EY             R   +         +K +  
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLF 136

Query: 116 SMLKGLRHIH--SKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCDGERSQSFECRG 172
            +++ +  +H  S    H DIK  NVLV + D   K+ DFG AKK S   E + ++ C  
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYIC-- 193

Query: 173 TPLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKP----------------------- 208
           +  Y +PE +     Y    DIW++GC   EM  G+P                       
Sbjct: 194 SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253

Query: 209 ----AWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
                 N             I   +   +     +++  D L       P+ R      L
Sbjct: 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313

Query: 265 NHPFV 269
            HP+ 
Sbjct: 314 CHPYF 318

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 28/181 (15%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF-ECRGTPL 175
           +L+GL++IHS   +H D+K  N+L+    + KI DFGLA+ +  D + +    E   T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 176 YMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI--------- 225
           Y +PE + N   Y    DIW++GC + EM S +P +  K   +  + ++ I         
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256

Query: 226 -GVGDE--------LPNIPG--------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
             + +         LP+           +   +  D L K    +P +R   E  L HP+
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

Query: 269 V 269
           +
Sbjct: 317 L 317

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 38/183 (20%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG---T 173
           +L+GL++IHS   +H D+K  N+ V ++ E KI DFGLA        R  + E  G   T
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------RHTADEMTGYVAT 192

Query: 174 PLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI------- 225
             Y +PE + N   Y    DIW++GC + E+ +G+  +      +   L++R+       
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252

Query: 226 ---GVGDE--------LPNIPG--------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               +  E        L  +P           +    D L K  + D  +R TA   L H
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312

Query: 267 PFV 269
            + 
Sbjct: 313 AYF 315

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 52/183 (28%), Positives = 80/183 (43%), Gaps = 38/183 (20%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG---T 173
           MLKGLR+IH+ G +H D+K  N+ V ++ E KI DFGLA        R    E  G   T
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--------RQADSEMTGYVVT 188

Query: 174 PLYMSPESV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI------- 225
             Y +PE + N   Y    DIW++GC + EM +GK  +      +    ++++       
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248

Query: 226 ---GVGDE--------LPNIPG--------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               +  +        LP +          + S    + L K  + D ++R TA   L H
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308

Query: 267 PFV 269
           P+ 
Sbjct: 309 PYF 311

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 92.6 bits (230), Expect = 2e-21
 Identities = 51/230 (22%), Positives = 83/230 (36%), Gaps = 43/230 (18%)

Query: 6   GDVIGHGSFGSVNLAK--ASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-CP 62
            ++IG G +G+V         V        AVK  +     +    NEK       +   
Sbjct: 18  LELIGRGRYGAVYKGSLDERPV--------AVKVFSFANRQN--FINEKNIYRVPLMEHD 67

Query: 63  QIVRCFG-DDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
            I R    D+     G   Y L++EY   GSL   +              R   S+ +GL
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGL 124

Query: 122 RHIHS---------KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR- 171
            ++H+             H D+  +NVLV ++    I+DFGL+ + + +       E   
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 172 -----GTPLYMSPE-------SVNENEYEAPCDIWALGCAVV--EMASGK 207
                GT  YM+PE         +        D++ALG  ++  E+    
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG--LIYWEIFMRC 232

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 59/269 (21%), Positives = 104/269 (38%), Gaps = 42/269 (15%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LD---- 56
             V+G G+FG+V          +    +A+K   +        +   EA     +D    
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 57  --QIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYT 114
              +GIC                     L+ +    G L D V++ +   +    +  + 
Sbjct: 80  CRLLGICLT--------------STVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWC 123

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
             + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + +   +   +  P
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-VP 182

Query: 175 L-YMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + +M+ ES+    Y    D+W+ G  V E+ +   KP       S + S+L +   G+ L
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEK---GERL 238

Query: 232 P---NIPGDLSEQGKDFLIKCFLKDPKRR 257
           P       D+       + KC++ D   R
Sbjct: 239 PQPPICTIDVYM----IMRKCWMIDADSR 263

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 45/190 (23%), Positives = 76/190 (40%), Gaps = 40/190 (21%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +       T  Y
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---PYVVTRYY 192

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR-IGVGDE----- 230
            +PE +    Y+   DIW++GC + EM  G   +      + ++ +I  +G         
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

Query: 231 -----------LPNIPG--------------------DLSEQGKDFLIKCFLKDPKRRWT 259
                       P   G                      + Q +D L K  + D  +R +
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312

Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 313 VDEALQHPYI 322

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 46/216 (21%), Positives = 92/216 (42%), Gaps = 21/216 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGI 60
             VIG G FG V        S +    +A+K+          +    EA           
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS---- 104

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
              I+R  G      K +    ++ EY   G+L   +++  +G      +    R +  G
Sbjct: 105 HHNIIRLEG---VISKYKPMM-IITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAG 159

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YM 177
           ++++ +  +VH D+  +N+LV  N   K++DFGL++    D E   ++   G  +   + 
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--ATYTTSGGKIPIRWT 217

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWN 211
           +PE+++  ++ +  D+W+ G  + E+ +   +P W 
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 57/352 (16%), Positives = 101/352 (28%), Gaps = 128/352 (36%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE----ALDQIGI-- 60
             +G G+FG V               +A+K           ++N  +    A  +I +  
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQ---VALK----------IIRNVGKYREAARLEINVLK 71

Query: 61  ------------CPQIVRCFGDDY------SFEKGERFYNLLLEYASRGSLADRVKKQNN 102
                       C  +   F  ++      +FE        LL      +  + +K+ N 
Sbjct: 72  KIKEKDKENKFLCVLMSDWF--NFHGHMCIAFE--------LLGK----NTFEFLKENNF 117

Query: 103 GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--------------- 147
                  V+     +   LR +H     H D+K +N+L  +++                 
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177

Query: 148 ----KIADFGLAKKSSC-DGERS----QS-FECRGTPLYMSPESVNENEYEAPCDIWALG 197
               ++ADFG    S+  D E       +         Y  PE + E  +  PCD+W++G
Sbjct: 178 NTSIRVADFG----SATFDHEHHTTIVATRH-------YRPPEVILELGWAQPCDVWSIG 226

Query: 198 CAVVEMASG----------------------------------------KPAWNHKQDSN 217
           C + E   G                                           W+      
Sbjct: 227 CILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG 286

Query: 218 VFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            +       +   +     +   Q  D + +    DP +R T    L HPF 
Sbjct: 287 RYVKENCKPLKSYMLQDSLEH-VQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 92.5 bits (230), Expect = 6e-21
 Identities = 60/234 (25%), Positives = 92/234 (39%), Gaps = 71/234 (30%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ----IGI-- 60
            VIG GSFG V   KA          +A+K           ++NEK    Q    I I  
Sbjct: 103 KVIGKGSFGQV--VKAYDHKVH--QHVALK----------MVRNEKRFHRQAAEEIRILE 148

Query: 61  ------------CPQIVRCFGDDY------SFEKGERFYNLLLEYASRGSLADRVKKQNN 102
                          ++  F   +      +FE        LL      +L + +KK   
Sbjct: 149 HLRKQDKDNTMNVIHMLENF--TFRNHICMTFE--------LLSM----NLYELIKKNKF 194

Query: 103 GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSC 160
                  V+++  S+L+ L  +H    +HCD+K +N+L+     +  K+ DFG    SSC
Sbjct: 195 QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG----SSC 250

Query: 161 DGERS-----QS-FECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKP 208
              +      QS F       Y +PE +    Y  P D+W+LGC + E+ +G P
Sbjct: 251 YEHQRVYTYIQSRF-------YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 11/27 (40%), Positives = 14/27 (51%)

Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFV 269
            DFL +C   DP  R T    L HP++
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWL 412

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 90.9 bits (226), Expect = 8e-21
 Identities = 50/203 (24%), Positives = 98/203 (48%), Gaps = 9/203 (4%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVT-LKNEKEALDQIGICPQ 63
              +G G FG V+L      +     ++AVK+  AD  P   +  K E + L  +     
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEH 94

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           I++  G     + G     L++EY   GSL D + +     +  + +  + + + +G+ +
Sbjct: 95  IIKYKG--CCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAY 149

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESV 182
           +H++ ++H D+  +NVL+ ++   KI DFGLAK      E  +  E   +P+ + +PE +
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 183 NENEYEAPCDIWALGCAVVEMAS 205
            E ++    D+W+ G  + E+ +
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT 232

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 93.0 bits (231), Expect = 9e-21
 Identities = 71/262 (27%), Positives = 110/262 (41%), Gaps = 30/262 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGI 60
           G  IG G FG V+              +A+K+C +C   SV  K  +EA      D    
Sbjct: 395 GRCIGEGQFGDVHQGIY-MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD---- 449

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV+  G           + +++E  + G L   ++      L  + +  Y   +   
Sbjct: 450 HPHIVKLIG----VITENPVW-IIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTA 503

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YM 177
           L ++ SK FVH DI  +NVLV  ND  K+ DFGL++      E S  ++     L   +M
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR----YMEDSTYYKASKGKLPIKWM 559

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           +PES+N   + +  D+W  G  + E+     KP    K +++V   +         PN P
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPPNCP 618

Query: 236 GDLSEQGKDFLIKCFLKDPKRR 257
             L       + KC+  DP RR
Sbjct: 619 PTLYS----LMTKCWAYDPSRR 636

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 62/273 (22%), Positives = 113/273 (41%), Gaps = 39/273 (14%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSSVTLKNEKEA--LDQIGICP 62
              +G GSFG V    A  V  + P    A+K+  +       ++   EA  + +   C 
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CH 88

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTRSM 117
            +VR  G      +G+    +++E  +RG L       R    NN  L    + +  +  
Sbjct: 89  HVVRLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 118 L---KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFECRGT 173
                G+ ++++  FVH D+  +N +V ++   KI DFG+ +     D  R         
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG----KG 200

Query: 174 PL---YMSPESVNENEYEAPCDIWALGCAVV--EMAS-GK---PAWNHKQDSNVFSLLIR 224
            L   +MSPES+ +  +    D+W+ G  VV  E+A+  +      +++Q   V   ++ 
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFG--VVLWEIATLAEQPYQGLSNEQ---VLRFVME 255

Query: 225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
              G  L   P +  +   + +  C+  +PK R
Sbjct: 256 ---GGLLD-KPDNCPDMLFELMRMCWQYNPKMR 284

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 63/270 (23%), Positives = 119/270 (44%), Gaps = 31/270 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGI 60
           G+ IG G+FG V   +    ++     +AVKSC +  P  +  K  +EA           
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTL----VAVKSCRETLPPDLKAKFLQEARILKQYS---- 170

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IVR  G      + +  Y +++E    G     ++     RL+   + +       G
Sbjct: 171 HPNIVRLIG---VCTQKQPIY-IVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAG 225

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSP 179
           + ++ SK  +H D+  +N LV + +  KI+DFG++++ + DG  + S   R  P+ + +P
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAP 284

Query: 180 ESVNENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           E++N   Y +  D+W+ G  + E  S G    P  +++Q       + +   G  LP  P
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFVEK---GGRLP-CP 337

Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
               +     + +C+  +P +R +   +  
Sbjct: 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 59/267 (22%), Positives = 106/267 (39%), Gaps = 36/267 (13%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LD--- 56
           +  V+G G+FG+V          +    +A+K   +        +   EA     +D   
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 57  ---QIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
               +GIC                     L+ +    G L D V++ +   +    +  +
Sbjct: 79  VCRLLGICLT--------------STVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNW 122

Query: 114 TRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
              + KG+ ++  +  VH D+  +NVLV      KI DFGLAK    + +   +   +  
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-V 181

Query: 174 PL-YMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDE 230
           P+ +M+ ES+    Y    D+W+ G  V E+ +   KP       S + S+L +   G+ 
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEK---GER 237

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           LP  P   +      ++KC++ D   R
Sbjct: 238 LPQ-PPICTIDVYMIMVKCWMIDADSR 263

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 59/266 (22%), Positives = 108/266 (40%), Gaps = 36/266 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LD---- 56
             V+G G FG+V+              + +K   D                   LD    
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 57  --QIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYT 114
              +G+CP                    L+ +Y   GSL D V++ + G L    +  + 
Sbjct: 78  VRLLGLCPG--------------SSLQ-LVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWG 121

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
             + KG+ ++   G VH ++  +NVL+    + ++ADFG+A     D ++    E + TP
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK-TP 180

Query: 175 L-YMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDEL 231
           + +M+ ES++  +Y    D+W+ G  V E+ +   +P    +  + V  LL +   G+ L
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEK---GERL 236

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRR 257
              P   +      ++KC++ D   R
Sbjct: 237 AQ-PQICTIDVYMVMVKCWMIDENIR 261

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 87.3 bits (217), Expect = 7e-20
 Identities = 71/262 (27%), Positives = 113/262 (43%), Gaps = 30/262 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGI 60
           G  IG G FG V+              +A+K+C +C   SV  K  +EA      D    
Sbjct: 20  GRCIGEGQFGDVHQGIY-MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD---- 74

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV+  G           + +++E  + G L   ++      L  + +  Y   +   
Sbjct: 75  HPHIVKLIG----VITENPVW-IIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTA 128

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YM 177
           L ++ SK FVH DI  +NVLV  ND  K+ DFGL++      E S  ++     L   +M
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR----YMEDSTYYKASKGKLPIKWM 184

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
           +PES+N   + +  D+W  G  + E+     KP    K +++V   +     G+ LP +P
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIEN---GERLP-MP 239

Query: 236 GDLSEQGKDFLIKCFLKDPKRR 257
            +        + KC+  DP RR
Sbjct: 240 PNCPPTLYSLMTKCWAYDPSRR 261

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 26/218 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGI 60
             +IG G  G V   +  +V  +    +A+K+               EA      D    
Sbjct: 54  EKIIGSGDSGEVCYGRL-RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD---- 108

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I+R  G      +G     ++ EY   GSL   ++  ++G+     +    R +  G
Sbjct: 109 HPNIIRLEG---VVTRGRLAM-IVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAG 163

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK--KSSCDGERSQSFECRGTPL--- 175
           +R++   G+VH D+  +NVLV  N   K++DFGL++  +   D   + +    G  +   
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT----GGKIPIR 219

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWN 211
           + +PE++    + +  D+W+ G  + E+ +   +P WN
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 60/274 (21%), Positives = 105/274 (38%), Gaps = 32/274 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSSVT--LKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +         AVK   +    S    L +E + L  IG   
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRY-TRS 116
            +V   G     + G     +++E+   G+L+      R +        E   K + T  
Sbjct: 92  NVVNLLG--ACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 117 ML--------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
            L        KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK- 207

Query: 169 ECRGTPL---YMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLI 223
                 L   +M+PE++ +  Y    D+W+ G  + E+ S    P    K D      L 
Sbjct: 208 --GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265

Query: 224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
                        ++       ++ C+  +P +R
Sbjct: 266 EGTRMRAPDYTTPEMY----QTMLDCWHGEPSQR 295

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 23/262 (8%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNE--KEA-----LDQ 57
             + +G GSFG V   +     S     +AVK       S     ++  +E      LD 
Sbjct: 22  LLEKLGDGSFGVVRRGEW-DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
                 ++R +G             ++ E A  GSL DR++K + G      + RY   +
Sbjct: 81  ----RNLIRLYG----VVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQV 130

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-Y 176
            +G+ ++ SK F+H D+  +N+L+   D  KI DFGL +    + +     E R  P  +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
            +PES+    +    D W  G  + EM + G+  W     S +   + +   G+ LP  P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--EGERLPR-P 247

Query: 236 GDLSEQGKDFLIKCFLKDPKRR 257
            D  +   + +++C+   P+ R
Sbjct: 248 EDCPQDIYNVMVQCWAHKPEDR 269

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 54/263 (20%), Positives = 102/263 (38%), Gaps = 27/263 (10%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI----- 60
            +VIG G FG V        +       AVKS          +    + L +  I     
Sbjct: 30  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSL----NRITDIGEVSQFLTEGIIMKDFS 84

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P ++   G             ++L Y   G L + ++          D+  +   + KG
Sbjct: 85  HPNVLSLLG--ICLRSEGSPL-VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKG 140

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFECRGTPL-YMS 178
           ++++ SK FVH D+  +N ++ +    K+ADFGLA+     +     +      P+ +M+
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200

Query: 179 PESVNENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGVGDELPNI 234
            ES+   ++    D+W+ G  + E+ + G    P  N      +   L++   G  L   
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQ---GRRLLQ- 253

Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P    +   + ++KC+    + R
Sbjct: 254 PEYCPDPLYEVMLKCWHPKAEMR 276

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 40/201 (19%)

Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDG 162
            L + D++ Y   +LK L + HS G +H D+K  NV++  ++ + ++ D+GLA+      
Sbjct: 126 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF----Y 181

Query: 163 ERSQSFECR-GTPLYMSPES-VNENEYEAPCDIWALGCAVVEMASGKPAW-----NHKQD 215
              Q +  R  +  +  PE  V+   Y+   D+W+LGC +  M   K  +     N+ Q 
Sbjct: 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241

Query: 216 SNVFSLL-----------IRIGVGDE----LPNIPG-------------DLSEQGKDFLI 247
             +  +L             I +       L                   +S +  DFL 
Sbjct: 242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 301

Query: 248 KCFLKDPKRRWTAEMLLNHPF 268
           K    D + R TA   + HP+
Sbjct: 302 KLLRYDHQSRLTAREAMEHPY 322

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 18/214 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGI 60
             V+G G FG V   +  K+ S+    +A+K+               EA      D    
Sbjct: 50  DKVVGAGEFGEVCSGRL-KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD---- 104

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P I+R  G      K +    ++ EY   GSL   ++K ++ +     +    R +  G
Sbjct: 105 HPNIIRLEG---VVTKSKPVM-IVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASG 159

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSP 179
           ++++   G+VH D+  +N+L+  N   K++DFGL +    D E + +      P+ + SP
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 180 ESVNENEYEAPCDIWALGCAVVEMAS--GKPAWN 211
           E++   ++ +  D+W+ G  + E+ S   +P W 
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 46/190 (24%), Positives = 73/190 (38%), Gaps = 40/190 (21%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           ML G++H+HS G +H D+K  N++V  +   KI DFGLA+ +      +       T  Y
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYY 229

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKP---------------------------- 208
            +PE +    Y+   DIW++GC + EM   K                             
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289

Query: 209 ----AWNH-----KQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWT 259
                 N+     K     F  L    +           + Q +D L K  + DP +R +
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349

Query: 260 AEMLLNHPFV 269
            +  L HP++
Sbjct: 350 VDDALQHPYI 359

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 86.1 bits (214), Expect = 2e-19
 Identities = 58/263 (22%), Positives = 110/263 (41%), Gaps = 35/263 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              +G G +G V      K S      +AVK+  +          E   + +I   P +V
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLT----VAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 72

Query: 66  R----CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           +    C        +   FY ++ E+ + G+L D +++ N   +    +      +   +
Sbjct: 73  QLLGVCT-------REPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMS 178
            ++  K F+H D+  +N LV +N   K+ADFGL++  + D   + +    G      + +
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA----GAKFPIKWTA 180

Query: 179 PESVNENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGVGDELPNI 234
           PES+  N++    D+WA G  + E+A+ G    P  +  Q   V+ LL +      +   
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEK---DYRMER- 233

Query: 235 PGDLSEQGKDFLIKCFLKDPKRR 257
           P    E+  + +  C+  +P  R
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDR 256

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 20/218 (9%)

Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQI 58
           +    +G G+FGSV          +    +A+K        + T +  +EA     LD  
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQID--VAIKVLKQGTEKADTEEMMREAQIMHQLDN- 395

Query: 59  GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              P IVR  G      + E    L++E A  G L   +       +  S+V      + 
Sbjct: 396 ---PYIVRLIG----VCQAEALM-LVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVS 446

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YM 177
            G++++  K FVH ++  +NVL+ +   AKI+DFGL+K    D     +      PL + 
Sbjct: 447 MGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 506

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHK 213
           +PE +N  ++ +  D+W+ G  + E  S   KP    K
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 56/279 (20%), Positives = 113/279 (40%), Gaps = 32/279 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK---NEKEALDQIGICP 62
           G ++G G FGSV  A+  K        +AVK       +S  ++    E   + +    P
Sbjct: 28  GRMLGKGEFGSVREAQL-KQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HP 85

Query: 63  QIVRCFG---DDYSFEKGERFYNLLLEYASRGSLAD----RVKKQNNGRLQESDVKRYTR 115
            + +  G      +  +      ++L +   G L          +N   L    + R+  
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPM-VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            +  G+ ++ S+ F+H D+  +N ++ ++    +ADFGL++           +       
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCASK 200

Query: 176 Y----MSPESVNENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGV 227
                ++ ES+ +N Y    D+WA G  + E+ + G+       + +   +++ LI    
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNYLIG--- 254

Query: 228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           G+ L   P +  E+  D + +C+  DPK+R +   L   
Sbjct: 255 GNRLK-QPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 85.3 bits (212), Expect = 4e-19
 Identities = 64/265 (24%), Positives = 114/265 (43%), Gaps = 36/265 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI----- 60
             ++G G FG V               +AVK+C        TL N+++ + +  I     
Sbjct: 17  NRILGEGFFGEVYEGVY-TNHKGEKINVAVKTC----KKDCTLDNKEKFMSEAVIMKNLD 71

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P IV+  G      + E  + +++E    G L   +++ N   L+   +  Y+  + K 
Sbjct: 72  HPHIVKLIG----IIEEEPTW-IIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKA 125

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YM 177
           + ++ S   VH DI ++N+LV   +  K+ DFGL++      E    ++   T L   +M
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR----YIEDEDYYKASVTRLPIKWM 181

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELP--- 232
           SPES+N   +    D+W     + E+ S   +P +  + + +V  +L +   GD LP   
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-NKDVIGVLEK---GDRLPKPD 237

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
             P  L       + +C+  DP  R
Sbjct: 238 LCPPVLYT----LMTRCWDYDPSDR 258

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 61/271 (22%), Positives = 111/271 (40%), Gaps = 53/271 (19%)

Query: 6   GDVIGHGSFGSVNLA--KASKVSSEFPSLMAVKSCADCPPSSVTLKN---EKEALDQIGI 60
              IG G FG V L   + +KV        AVK           +KN    +  L +  +
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKV--------AVK----------CIKNDATAQAFLAEASV 239

Query: 61  -----CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                   +V+  G     E+    Y ++ EY ++GSL D ++ +    L    + +++ 
Sbjct: 240 MTQLRHSNLVQLLG--VIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 296

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            + + + ++    FVH D+  +NVLV +++ AK++DFGL         +  S       L
Sbjct: 297 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT--------KEASSTQDTGKL 348

Query: 176 ---YMSPESVNENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGVG 228
              + +PE++ E ++    D+W+ G  + E+ S G+   P    K    V   + +   G
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK---G 402

Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWT 259
            ++   P        D +  C+  D   R T
Sbjct: 403 YKMD-APDGCPPAVYDVMKNCWHLDAATRPT 432

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 85.1 bits (211), Expect = 7e-19
 Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 41/283 (14%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSSVTLKNEKEALDQIGI---- 60
              +GHG+FG V   + S + ++   L  AVK+     P   + ++E + L +  I    
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL----PEVCSEQDELDFLMEALIISKF 90

Query: 61  -CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYT 114
               IVRC G   S +   RF  +L+E  + G L       R +      L   D+    
Sbjct: 91  NHQNIVRCIG--VSLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKK-SSCDGERSQSFEC 170
           R +  G +++    F+H DI  +N L+        AKI DFG+A+        R      
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG--- 203

Query: 171 RGTPL---YMSPESVNENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLI 223
               L   +M PE+  E  + +  D W+ G  + E+ S G    P+ ++++   V   + 
Sbjct: 204 -CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVT 259

Query: 224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
             G  D   N PG +       + +C+   P+ R    ++L  
Sbjct: 260 SGGRMDPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILER 298

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 45/215 (20%), Positives = 75/215 (34%), Gaps = 62/215 (28%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           ++K ++++HS G +H D+K  N+L+      K+ADFGL++        + +         
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 176 ------------------YMSPES-VNENEYEAPCDIWALGCAVVEMASGKP-------- 208
                             Y +PE  +   +Y    D+W+LGC + E+  GKP        
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237

Query: 209 -------------------------AWN---------HKQDSNVFSLLIRIGVGDELPNI 234
                                    A             + SN   +  +        N 
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297

Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             D +E+  D L K    +P +R +A   L HPFV
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 66/278 (23%), Positives = 118/278 (42%), Gaps = 40/278 (14%)

Query: 6   GDVIGHGSFGSVNLAKA---SKVSSEFPSLMAVKSCADCPPSSVT--LKNEKEALDQIGI 60
           G  +G G FG V +A+A    K   +    +AVK   D         L +E E +  IG 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD------RVKKQNNGRLQESDVKRYT 114
              I+   G   +  +    Y +++EYAS+G+L +          + +  +     ++ T
Sbjct: 146 HKNIINLLG---ACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 115 RSML--------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE-RS 165
              L        +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +     + 
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 166 QSFECRGTPL---YMSPESVNENEYEAPCDIWALGCAVV--EMAS-GKPAWNHKQDSNVF 219
            +       L   +M+PE++ +  Y    D+W+ G  V+  E+ + G   +       +F
Sbjct: 262 TT----NGRLPVKWMAPEALFDRVYTHQSDVWSFG--VLMWEIFTLGGSPYPGIPVEELF 315

Query: 220 SLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            LL      D+  N   +L       +  C+   P +R
Sbjct: 316 KLLKEGHRMDKPANCTNELY----MMMRDCWHAVPSQR 349

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 63/274 (22%), Positives = 104/274 (37%), Gaps = 31/274 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +     ++  AVK        +    L +E + L  +G   
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSL--------ADRVKKQNNGRLQESDVKRYT 114
            IV   G   +   G     ++ EY   G L           +  + +  + E D     
Sbjct: 88  NIVNLLG---ACTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 115 RSML--------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
              L        KG+  + SK  +H D+  +N+L+      KI DFGLA+    D     
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 167 SFECRGTPL-YMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLI 223
               R  P+ +M+PES+    Y    D+W+ G  + E+ S    P      DS  + ++ 
Sbjct: 204 KGNAR-LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

Query: 224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
                    + P ++     D +  C+  DP +R
Sbjct: 263 EGFRMLSPEHAPAEMY----DIMKTCWDADPLKR 292

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 51/264 (19%), Positives = 102/264 (38%), Gaps = 29/264 (10%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGI 60
             VIG G FG V   +     ++     A+KS +            +E      L+    
Sbjct: 26  DRVIGKGHFGVVYHGEY-IDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN---- 80

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P ++   G           + +LL Y   G L   ++          D+  +   + +G
Sbjct: 81  HPNVLALIG--IMLPPEGLPH-VLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARG 136

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT-----PL 175
           + ++  + FVH D+  +N ++ ++   K+ADFGLA+    D    + +  +       P+
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLAR----DILDREYYSVQQHRHARLPV 192

Query: 176 -YMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPN 233
            + + ES+    +    D+W+ G  + E+ + G P + H    ++   L +     +   
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY 252

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRR 257
            P  L +     + +C+  DP  R
Sbjct: 253 CPDSLYQ----VMQQCWEADPAVR 272

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 53/265 (20%), Positives = 101/265 (38%), Gaps = 31/265 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI----- 60
            +VIG G FG V        +       AVKS          +    + L +  I     
Sbjct: 94  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSL----NRITDIGEVSQFLTEGIIMKDFS 148

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P ++   G             ++L Y   G L + ++          D+  +   + KG
Sbjct: 149 HPNVLSLLG--ICLRSEGSPL-VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKG 204

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGT-----PL 175
           ++ + SK FVH D+  +N ++ +    K+ADFGLA+    D    +            P+
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPV 260

Query: 176 -YMSPESVNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELP 232
            +M+ ES+   ++    D+W+ G  + E+ +    P  +     ++   L++   G  L 
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQ---GRRLL 316

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRR 257
             P    +   + ++KC+    + R
Sbjct: 317 Q-PEYCPDPLYEVMLKCWHPKAEMR 340

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 20/209 (9%)

Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEA-----LDQ 57
           L    +G G+FG+V               +AVK    +    ++  +   EA     LD 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKT--VAVKILKNEANDPALKDELLAEANVMQQLDN 77

Query: 58  IGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
               P IVR  G      + E +  L++E A  G L   +++  N  +++ ++      +
Sbjct: 78  ----PYIVRMIG----ICEAESWM-LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQV 126

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-Y 176
             G++++    FVH D+  +NVL+     AKI+DFGL+K    D    ++      P+ +
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMAS 205
            +PE +N  ++ +  D+W+ G  + E  S
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 60/286 (20%), Positives = 110/286 (38%), Gaps = 43/286 (15%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSSVT-LKNEKEALDQIGICPQ 63
              +G G+FG V LA+   +  E   ++ AVK+  +   S+    + E E L  +     
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQH 104

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYTRSML 118
           IVR FG      +G     ++ EY   G L           +     ++          L
Sbjct: 105 IVRFFG---VCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 119 --------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFE 169
                    G+ ++    FVH D+  +N LV      KI DFG+++   S D  R     
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG-- 218

Query: 170 CRGTPL---YMSPESVNENEYEAPCDIWALGCAVV--EMAS-GK---PAWNHKQDSNVFS 220
              T L   +M PES+   ++    D+W+ G  VV  E+ + GK      ++ +      
Sbjct: 219 --RTMLPIRWMPPESILYRKFTTESDVWSFG--VVLWEIFTYGKQPWYQLSNTE---AID 271

Query: 221 LLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
            + +    +     P ++       +  C+ ++P++R + + +   
Sbjct: 272 CITQGRELERPRACPPEVYA----IMRGCWQREPQQRHSIKDVHAR 313

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 18/203 (8%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA-----LDQIGICPQ 63
           +G G+FGSV          +    +A+K        + T +  +EA     LD     P 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQID--VAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 71

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR  G      + E    L++E A  G L   +       +  S+V      +  G+++
Sbjct: 72  IVRLIG----VCQAEALM-LVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKY 125

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL-YMSPESV 182
           +  K FVH D+  +NVL+ +   AKI+DFGL+K    D     +      PL + +PE +
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185

Query: 183 NENEYEAPCDIWALGCAVVEMAS 205
           N  ++ +  D+W+ G  + E  S
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 45/285 (15%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSSVTLKNEKEALDQIGI---- 60
              +GHG+FG V   + S + ++   L  AVK+     P   + ++E + L +  I    
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL----PEVCSEQDELDFLMEALIISKF 131

Query: 61  -CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD-----RVKKQNNGRLQESDVKRYT 114
               IVRC G   S +   RF  +LLE  + G L       R +      L   D+    
Sbjct: 132 NHQNIVRCIG--VSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKK-SSCDGERSQSFEC 170
           R +  G +++    F+H DI  +N L+        AKI DFG+A+        R      
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG--- 244

Query: 171 RGTPL---YMSPESVNENEYEAPCDIWALGCAVV--EMAS-GK---PAWNHKQDSNVFSL 221
               L   +M PE+  E  + +  D W+ G  V+  E+ S G    P+ ++++   V   
Sbjct: 245 -CAMLPVKWMPPEAFMEGIFTSKTDTWSFG--VLLWEIFSLGYMPYPSKSNQE---VLEF 298

Query: 222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           +   G  D   N PG +       + +C+   P+ R    ++L  
Sbjct: 299 VTSGGRMDPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILER 339

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 61/230 (26%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKE----ALDQIGI-- 60
            +IG GSFG V   KA     +    +A+K           +KN+K     A  ++ +  
Sbjct: 60  SLIGKGSFGQV--VKAYDRVEQ--EWVAIK----------IIKNKKAFLNQAQIEVRLLE 105

Query: 61  ------------CPQIVRCFGDDY------SFEKGERFYNLLLEYASRGSLADRVKKQNN 102
                          + R F   +       FE        +L Y    +L D ++  N 
Sbjct: 106 LMNKHDTEMKYYIVHLKRHF--MFRNHLCLVFE--------MLSY----NLYDLLRNTNF 151

Query: 103 GRLQESDVKRYTRSMLKGLRHIHSK--GFVHCDIKLQNVLVFDNDEA--KIADFGLAKKS 158
             +  +  +++ + M   L  + +     +HCD+K +N+L+ +   +  KI DFG    S
Sbjct: 152 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----S 207

Query: 159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKP 208
           SC     + ++   +  Y SPE +    Y+   D+W+LGC +VEM +G+P
Sbjct: 208 SCQ-LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 9/27 (33%), Positives = 12/27 (44%)

Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           KD +++    DPK R      L H F 
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFF 376

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 83.4 bits (206), Expect = 5e-18
 Identities = 67/363 (18%), Positives = 113/363 (31%), Gaps = 116/363 (31%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI---------- 58
           +G G F +V L+   +        +A+K        + T  +E   L  +          
Sbjct: 45  LGWGHFSTVWLSWDIQGKK----FVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100

Query: 59  GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
            +  Q++  F    S   G     ++ E      L   + K N   L    VK+  + +L
Sbjct: 101 EMVVQLLDDF--KISGVNGTHIC-MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 119 KGLRHIHSK-GFVHCDIKLQNVLVFDND-------------------------------- 145
           +GL ++H+K   +H DIK +N+L+  N+                                
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 146 -----------------EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE 188
                            + KIAD G A    C   +  + E   T  Y S E +  + Y 
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNA----CWVHKHFT-EDIQTRQYRSLEVLIGSGYN 271

Query: 189 APCDIWALGCAVVEMASGKP---AWNHKQDSNVFSLLIRI-------------------- 225
            P DIW+  C   E+A+G       + ++ +     +  I                    
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331

Query: 226 --------------------GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
                                V  E      + +    DFL+      P++R TA   L 
Sbjct: 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

Query: 266 HPF 268
           HP+
Sbjct: 392 HPW 394

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 81.9 bits (203), Expect = 5e-18
 Identities = 58/259 (22%), Positives = 108/259 (41%), Gaps = 29/259 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              +G G FG V L K           +AVK   +   S      E + + ++   P++V
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-----VAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLV 66

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +G      K    Y ++ EY S G L + ++  +   L+ S +      + +G+  + 
Sbjct: 67  KFYG---VCSKEYPIY-IVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESV 182
           S  F+H D+  +N LV  +   K++DFG+ +         Q     GT     + +PE  
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTR----YVLDDQYVSSVGTKFPVKWSAPEVF 177

Query: 183 NENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           +  +Y +  D+WA G  + E+ S GK     + + +   V   + +   G  L   P   
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VVLKVSQ---GHRLYR-PHLA 230

Query: 239 SEQGKDFLIKCFLKDPKRR 257
           S+     +  C+ + P++R
Sbjct: 231 SDTIYQIMYSCWHELPEKR 249

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 63/284 (22%), Positives = 110/284 (38%), Gaps = 37/284 (13%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +  E   L  AVK       +     L +E + +  +G   
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSL-----ADRVKKQNNGRLQESDVKRYTRSM 117
            IV   G   +   G     ++ EY   G L           + +     ++    TR +
Sbjct: 111 NIVNLLG---ACTHGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 118 L-------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE-RSQSFE 169
           L       +G+  + SK  +H D+  +NVL+ +   AKI DFGLA+    D     +   
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG-- 224

Query: 170 CRGTPL---YMSPESVNENEYEAPCDIWALGCAVV--EMAS--GKPAWNHKQDSNVFSLL 222
                L   +M+PES+ +  Y    D+W+ G  ++  E+ S    P      +S  + L+
Sbjct: 225 --NARLPVKWMAPESIFDCVYTVQSDVWSYG--ILLWEIFSLGLNPYPGILVNSKFYKLV 280

Query: 223 IRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
                  +    P ++       +  C+  +P  R T + + + 
Sbjct: 281 KDGYQMAQPAFAPKNIY----SIMQACWALEPTHRPTFQQICSF 320

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 81.5 bits (202), Expect = 7e-18
 Identities = 55/259 (21%), Positives = 104/259 (40%), Gaps = 29/259 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              IG G FG V+L             +A+K+  +   S      E E + ++   P++V
Sbjct: 13  VQEIGSGQFGLVHLGYWLN-----KDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLV 66

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +G      +      L+ E+   G L+D ++    G      +      + +G+ ++ 
Sbjct: 67  QLYG---VCLEQAPIC-LVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLE 121

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESV 182
               +H D+  +N LV +N   K++DFG+ +    D   S +    GT     + SPE  
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVF 177

Query: 183 NENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           + + Y +  D+W+ G  + E+ S GK      ++ +   V   +     G  L   P   
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIST---GFRLYK-PRLA 230

Query: 239 SEQGKDFLIKCFLKDPKRR 257
           S      +  C+ + P+ R
Sbjct: 231 STHVYQIMNHCWRERPEDR 249

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 83.2 bits (206), Expect = 8e-18
 Identities = 56/259 (21%), Positives = 115/259 (44%), Gaps = 29/259 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              +G G FG V +A  +K      + +AVK+      S      E   +  +    ++V
Sbjct: 193 EKKLGAGQFGEVWMATYNK-----HTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLV 246

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           +           E  Y ++ E+ ++GSL D +K     +     +  ++  + +G+  I 
Sbjct: 247 KLHA----VVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESV 182
            + ++H D++  N+LV  +   KIADFGLA+    +   ++     G      + +PE++
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAI 357

Query: 183 NENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           N   +    D+W+ G  ++E+ + G+   P  ++ +   V   L R   G  +P  P + 
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALER---GYRMP-RPENC 410

Query: 239 SEQGKDFLIKCFLKDPKRR 257
            E+  + +++C+   P+ R
Sbjct: 411 PEELYNIMMRCWKNRPEER 429

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 31/215 (14%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM---AVKSCADCPPSS--VTLKNEKEALDQIGI 60
           G  +G G+FG V LA+A  +  + P+ +   AVK             L +E E +  IG 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD----RVKKQNNGRLQESDVKRYTRS 116
              I+   G   +  +    Y +++EYAS+G+L +    R           S       S
Sbjct: 134 HKNIINLLG---ACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 117 ML----------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE-RS 165
                       +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+        + 
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249

Query: 166 QSFECRGTPL---YMSPESVNENEYEAPCDIWALG 197
            +       L   +M+PE++ +  Y    D+W+ G
Sbjct: 250 TT----NGRLPVKWMAPEALFDRIYTHQSDVWSFG 280

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 72/281 (25%), Positives = 111/281 (39%), Gaps = 40/281 (14%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSSVT--LKNEKEALDQIGICP 62
           G V+G G+FG V  A A  +S    S+  AVK   +   SS    L +E + + Q+G   
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSL-------------ADRVKKQNNGRLQESD 109
            IV   G       G  +  L+ EY   G L              +   +      +E D
Sbjct: 110 NIVNLLG--ACTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 110 VKRYTRSML--------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD 161
           +   T   L        KG+  +  K  VH D+  +NVLV      KI DFGLA+    D
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 162 GERSQSFECRGTPL-YMSPESVNENEYEAPCDIWALGCAVV--EMAS--GKPAWNHKQDS 216
                    R  P+ +M+PES+ E  Y    D+W+ G  ++  E+ S    P      D+
Sbjct: 226 SNYVVRGNAR-LPVKWMAPESLFEGIYTIKSDVWSYG--ILLWEIFSLGVNPYPGIPVDA 282

Query: 217 NVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
           N + L+      D+      ++       +  C+  D ++R
Sbjct: 283 NFYKLIQNGFKMDQPFYATEEIY----IIMQSCWAFDSRKR 319

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 38/221 (17%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSS--VTLKNEKEALDQIGICP 62
           G  +G G FG V  A A  +         AVK   +    S    L +E   L Q+   P
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HP 86

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSL--------------ADRVKKQNNGRLQES 108
            +++ +G   +  +      L++EYA  GSL                    +N+  L   
Sbjct: 87  HVIKLYG---ACSQDGPLL-LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 109 DVKRYTRSML--------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC 160
           D +  T   L        +G++++     VH D+  +N+LV +  + KI+DFGL++    
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 161 DGE-RSQSFECRGTPL---YMSPESVNENEYEAPCDIWALG 197
           +     +S       +   +M+ ES+ ++ Y    D+W+ G
Sbjct: 203 EDSYVKRS----QGRIPVKWMAIESLFDHIYTTQSDVWSFG 239

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 6   GDVIGHGSFGSVNLAKA---SKVSSEFPSLMAVKSCADCPPSS--VTLKNEKEALDQIGI 60
           G  +G G+FG V +A+A    K   +    +AVK   D         L +E E +  IG 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD------RVKKQNNGRLQESDVKRYT 114
              I+   G   +  +    Y +++EYAS+G+L +          + +  +     ++ T
Sbjct: 100 HKNIINLLG---ACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 115 RSML--------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE-RS 165
              L        +G+ ++ S+  +H D+  +NVLV +N+  KIADFGLA+  +     + 
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215

Query: 166 QSFECRGTPL---YMSPESVNENEYEAPCDIWALG 197
            +       L   +M+PE++ +  Y    D+W+ G
Sbjct: 216 TT----NGRLPVKWMAPEALFDRVYTHQSDVWSFG 246

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 80.3 bits (199), Expect = 2e-17
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 53/269 (19%)

Query: 6   GDVIGHGSFGSVNLAKA--SKVSSEFPSLMAVKSCADCPPSSVTLKN---EKEALDQIGI 60
              IG G FG V L     +KV        AVK           +KN    +  L +  +
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNKV--------AVK----------CIKNDATAQAFLAEASV 67

Query: 61  -----CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                   +V+  G     E+    Y ++ EY ++GSL D ++ +    L    + +++ 
Sbjct: 68  MTQLRHSNLVQLLG--VIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124

Query: 116 SMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL 175
            + + + ++    FVH D+  +NVLV +++ AK++DFGL K    +   +Q        L
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQD----TGKL 176

Query: 176 ---YMSPESVNENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGVG 228
              + +PE++ E ++    D+W+ G  + E+ S G+   P    K    V   + +   G
Sbjct: 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK---G 230

Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            ++   P        + +  C+  D   R
Sbjct: 231 YKMDA-PDGCPPAVYEVMKNCWHLDAAMR 258

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 79.9 bits (198), Expect = 3e-17
 Identities = 56/282 (19%), Positives = 107/282 (37%), Gaps = 51/282 (18%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSSVTLKNEKEA-----LDQIG 59
            + +G   FG V        +    +   A+K+  D     +  +   EA     L    
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ--- 70

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD--RVKKQNNGRLQESDVKRYTR-- 115
             P +V   G      K +    ++  Y S G L +   ++  ++      D +      
Sbjct: 71  -HPNVVCLLG---VVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 116 ------SML----KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERS 165
                  ++     G+ ++ S   VH D+  +NVLV+D    KI+D GL +    +   +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAA 181

Query: 166 QSFECRGTPLY----MSPESVNENEYEAPCDIWALGCAVV--EMAS-GK---PAWNHKQD 215
             ++  G  L     M+PE++   ++    DIW+ G  VV  E+ S G      ++++  
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG--VVLWEVFSYGLQPYCGYSNQD- 238

Query: 216 SNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
             V  ++    V     + P  +       +I+C+ + P RR
Sbjct: 239 --VVEMIRNRQVLPCPDDCPAWVYA----LMIECWNEFPSRR 274

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 79.6 bits (197), Expect = 5e-17
 Identities = 58/281 (20%), Positives = 111/281 (39%), Gaps = 56/281 (19%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSSVTLKNE--KEA-----LDQIGI 60
           +G G+FG V LA+   +S     ++ AVK+       ++  + +  +EA     L     
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQ---- 75

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLAD------RVKKQNNGRLQESDVKRYT 114
              IV+ +G       G+    ++ EY   G L                           
Sbjct: 76  HEHIVKFYG---VCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 115 RSML--------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
            S +         G+ ++ S+ FVH D+  +N LV  N   KI DFG+++    D   + 
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTD 187

Query: 167 SFECRGTPLY----MSPESVNENEYEAPCDIWALGCAVV--EMAS-GK---PAWNHKQDS 216
            +   G  +     M PES+   ++    D+W+ G  V+  E+ + GK      ++ +  
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG--VILWEIFTYGKQPWFQLSNTE-- 243

Query: 217 NVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR 257
            V   + +  V +     P ++     D ++ C+ ++P++R
Sbjct: 244 -VIECITQGRVLERPRVCPKEVY----DVMLGCWQREPQQR 279

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 79.2 bits (196), Expect = 5e-17
 Identities = 60/259 (23%), Positives = 110/259 (42%), Gaps = 29/259 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
            + +G G FG V +   +       + +AVKS      S      E   + Q+    ++V
Sbjct: 18  VERLGAGQFGEVWMGYYNG-----HTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLV 71

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           R +         E  Y ++ EY   GSL D +K  +  +L  + +      + +G+  I 
Sbjct: 72  RLYA----VVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESV 182
            + ++H D++  N+LV D    KIADFGLA+      E ++     G      + +PE++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTAPEAI 182

Query: 183 NENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           N   +    D+W+ G  + E+ + G+   P   + +   V   L R   G  +   P + 
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLER---GYRMVR-PDNC 235

Query: 239 SEQGKDFLIKCFLKDPKRR 257
            E+    +  C+ + P+ R
Sbjct: 236 PEELYQLMRLCWKERPEDR 254

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 59/231 (25%), Positives = 91/231 (39%), Gaps = 42/231 (18%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSSVTLKNEKEA--LDQIGICP 62
              IG G+FG V  A+A  +    P  M AVK   +   + +    ++EA  + +    P
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NP 110

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSL--------------ADRVKKQNNGRLQES 108
            IV+  G       G+    LL EY + G L                        R+   
Sbjct: 111 NIVKLLG---VCAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 109 DVKRYTRSML--------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS-S 159
                + +           G+ ++  + FVH D+  +N LV +N   KIADFGL++   S
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 160 CDGERSQSFECRGTPL---YMSPESVNENEYEAPCDIWALGCAVV--EMAS 205
            D  ++         +   +M PES+  N Y    D+WA G  VV  E+ S
Sbjct: 227 ADYYKADG----NDAIPIRWMPPESIFYNRYTTESDVWAYG--VVLWEIFS 271

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 35/213 (16%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSS--VTLKNEKEALDQIGICPQ 63
            DVIG G+FG V  A+  K         A+K   +            E E L ++G  P 
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMD--AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLAD------RVKKQNNGRLQESDVKRYTRSM 117
           I+   G   + E     Y L +EYA  G+L D       ++      +  S     +   
Sbjct: 88  IINLLG---ACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 118 L--------KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE 169
           L        +G+ ++  K F+H D+  +N+LV +N  AKIADFGL+        R Q   
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVY 195

Query: 170 CRGT----PL-YMSPESVNENEYEAPCDIWALG 197
            + T    P+ +M+ ES+N + Y    D+W+ G
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 228

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 43/207 (20%), Positives = 87/207 (42%), Gaps = 24/207 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI----- 60
           G ++G G FGSV      K        +AVK+       + + +  +E L +        
Sbjct: 39  GKILGEGEFGSVMEGNL-KQEDGTSLKVAVKTM---KLDNSSQREIEEFLSEAACMKDFS 94

Query: 61  CPQIVRCFG--DDYSFEKGERFYNLLLEYASRGSLAD----RVKKQNNGRLQESDVKRYT 114
            P ++R  G   + S +   +   ++L +   G L         +     +    + ++ 
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPM-VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFECRGT 173
             +  G+ ++ ++ F+H D+  +N ++ D+    +ADFGL+KK  S D  R         
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR----IA 209

Query: 174 PL---YMSPESVNENEYEAPCDIWALG 197
            +   +++ ES+ +  Y +  D+WA G
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFG 236

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 52/259 (20%), Positives = 104/259 (40%), Gaps = 29/259 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              +G G FG V   K           +A+K   +   S      E + +  +    ++V
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-----VAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 82

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +G      K    + ++ EY + G L + +++    R Q   +    + + + + ++ 
Sbjct: 83  QLYG---VCTKQRPIF-IITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL---YMSPESV 182
           SK F+H D+  +N LV D    K++DFGL++         +     G+     +  PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR----YVLDDEYTSSVGSKFPVRWSPPEVL 193

Query: 183 NENEYEAPCDIWALGCAVVEMAS-GK---PAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
             +++ +  DIWA G  + E+ S GK     + + +       + +   G  L   P   
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQ---GLRLYR-PHLA 246

Query: 239 SEQGKDFLIKCFLKDPKRR 257
           SE+    +  C+ +    R
Sbjct: 247 SEKVYTIMYSCWHEKADER 265

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 45/263 (17%), Positives = 80/263 (30%), Gaps = 98/263 (37%)

Query: 105 LQESDVKRYTRS---------------MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKI 149
           + +SD K+  R+               +L G++++HS G +H D+K  N LV  +   K+
Sbjct: 138 IADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKV 197

Query: 150 ADFGLAKKSSCDGERSQSFECRGTPL-------------------------YMSPE-SVN 183
            DFGLA+        +                                   Y +PE  + 
Sbjct: 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL 257

Query: 184 ENEYEAPCDIWALGCAVVEM-----------ASGKP--------------------AWNH 212
           +  Y    D+W++GC   E+           A   P                     ++ 
Sbjct: 258 QENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHT 317

Query: 213 KQDSNVFSLLIRI----------GVGDE--------LPNIPG--------DLSEQGKDFL 246
           + + +  +++  I           +  E         P   G          S      L
Sbjct: 318 RGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLL 377

Query: 247 IKCFLKDPKRRWTAEMLLNHPFV 269
            +  + +P +R T    L HPF 
Sbjct: 378 KRMLVFNPNKRITINECLAHPFF 400

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 39/228 (17%), Positives = 70/228 (30%), Gaps = 75/228 (32%)

Query: 117 MLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPL- 175
           +L G   IH  G +H D+K  N L+  +   K+ DFGLA+  + + + +   +       
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 176 -------------------YMSPE-SVNENEYEAPCDIWALGCAVVEMASG--------- 206
                              Y +PE  + +  Y    DIW+ GC   E+ +          
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 207 --KP--------------AWNHKQDSNVFSLLIRI-------------GVGDE------- 230
              P                    + +    L  I              +          
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317

Query: 231 -LPNIPG--------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             P+            +S+ G + L      +P +R T +  L+HP++
Sbjct: 318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 72.9 bits (179), Expect = 8e-15
 Identities = 26/208 (12%), Positives = 50/208 (24%), Gaps = 47/208 (22%)

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P + R    D           ++ E+   GSL +                R  +S+    
Sbjct: 91  PGVARVL--DVV-HTRAGGL-VVAEWIRGGSLQEVAD----TSPSPVGAIRAMQSLAAAA 142

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
              H  G          V V  + +  +A                          M   +
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDAN 180

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL------PNIP 235
                     DI  +G ++  +   +         +  +   R   G  +       +IP
Sbjct: 181 -------PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233

Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEML 263
             +S        +    D   R  + +L
Sbjct: 234 FQISA----VAARSVQGDGGIRSASTLL 257

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 61/279 (21%), Positives = 111/279 (39%), Gaps = 53/279 (18%)

Query: 8   VIGHGSFGSV---NLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQI 64
           +IGHG FG V    L   +KV        A+K       +  + +  +E   +I      
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKV--------ALKRR-----TPESSQGIEEFETEIETLSFC 92

Query: 65  -----VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
                V   G  +  E+ E    L+ +Y   G+L   +   +   +  S  +R     L+
Sbjct: 93  RHPHLVSLIG--FCDERNEMI--LIYKYMENGNLKRHLYGSDLPTMSMSWEQR-----LE 143

Query: 120 -------GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRG 172
                  GL ++H++  +H D+K  N+L+ +N   KI DFG++KK +   +   S   +G
Sbjct: 144 ICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203

Query: 173 TPLYMSPESVNENEYEAPCDIWALGCAVV--EMASGKPAWNHKQDSNVFSL------LIR 224
           T  Y+ PE   +       D+++ G  VV  E+   + A        + +L         
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFG--VVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261

Query: 225 IGVGDEL--PNIPGDLSEQG-KDFL---IKCFLKDPKRR 257
            G  +++  PN+   +  +  + F    +KC     + R
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 70.1 bits (172), Expect = 8e-14
 Identities = 52/234 (22%), Positives = 85/234 (36%), Gaps = 29/234 (12%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQI- 64
           G  IG GSFG + L      + E  ++         P     L  E +    +     I 
Sbjct: 14  GRKIGSGSFGDIYLGT-DIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIP 68

Query: 65  -VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
            +R  G +        +  +++E     SL D +    + +     V      M+  + +
Sbjct: 69  TIRWCGAE------GDYNVMVMELLGP-SLED-LFNFCSRKFSLKTVLLLADQMISRIEY 120

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAK---IADFGLAKK--SSCDGERSQSFECR---GTPL 175
           IHSK F+H D+K  N L+    +     I DFGLAKK   +   +     E +   GT  
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180

Query: 176 YMSPESVNENEYEAPC---DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG 226
           Y    S+N +         D+ +LG  ++    G   W   + +       RI 
Sbjct: 181 YA---SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 49/201 (24%), Positives = 78/201 (38%), Gaps = 34/201 (16%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVK-SCADCPP--------------SSV 46
           +W+ G  IG G FG + LA       E  +   VK    +  P                +
Sbjct: 38  QWVLGKKIGSGGFGLIYLAF-PTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 47  TLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL-LEYASRGSLADRVKKQNNGRL 105
               E++ LD +GI P      G     E   R Y  + +E      L     +  NG  
Sbjct: 97  KKWIERKQLDYLGI-PL-FYGSG---LTEFKGRSYRFMVMERLGI-DLQKISGQ--NGTF 148

Query: 106 QESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKI--ADFGLAKKSSCDGE 163
           ++S V +    ML  L +IH   +VH DIK  N+L+   +  ++  AD+GL+ +  C   
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR-YCPNG 207

Query: 164 RSQSFECR------GTPLYMS 178
             + ++        GT  + S
Sbjct: 208 NHKQYQENPRKGHNGTIEFTS 228

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 59/318 (18%), Positives = 104/318 (32%), Gaps = 70/318 (22%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLM-AVKSCADCPPSSVT--LKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +         AVK   +    S    L +E + L  IG   
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 63  QIVR-------------------CFGDDYSF--EKGERFYNLLLEYASRGSLADRVKKQN 101
            +V                     FG+  ++   K   F     + A      D V    
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 102 NGRLQESDVKRYTRSML----------------------------------------KGL 121
               +  D    ++S                                          KG+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
             + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  + R    +M+PE+
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266

Query: 182 VNENEYEAPCDIWALGCAVVEMAS--GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           + +  Y    D+W+ G  + E+ S    P    K D      L              ++ 
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 326

Query: 240 EQGKDFLIKCFLKDPKRR 257
           +     ++ C+  +P +R
Sbjct: 327 Q----TMLDCWHGEPSQR 340

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 31/204 (15%), Positives = 66/204 (32%), Gaps = 37/204 (18%)

Query: 2   EWLRGDVIGHGSFGSVNLAK----------------ASKVSSEFPSLMAVKSC--ADCPP 43
           +W         + G +  A                 + K+ ++   L   ++       P
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102

Query: 44  SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNG 103
             V    +  +   + I P  +            +++  L+L    R SL   +      
Sbjct: 103 LQVNKWKKLYSTPLLAI-PTCM------GFGVHQDKYRFLVLPSLGR-SLQSALDVSPKH 154

Query: 104 RLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKI--ADFGLAKKSSCD 161
            L E  V +    +L  L  +H   +VH ++  +N+ V   D++++  A +G A +    
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214

Query: 162 GE-------RSQSFECRGTPLYMS 178
           G+               G   ++S
Sbjct: 215 GKHVAYVEGSRSPH--EGDLEFIS 236

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 30/219 (13%), Positives = 71/219 (32%), Gaps = 37/219 (16%)

Query: 6   GDVIGHGSFGSVNLAKA---SKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-- 60
            + +G G+F  +                + + +K       +       +   +   +  
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN-----YSESFFEAASMMS 67

Query: 61  ---CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
                 +V  +G       G+    L+ E+   GSL   +KK N   +         + +
Sbjct: 68  KLSHKHLVLNYG---VCVCGDENI-LVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQL 122

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVF--------DNDEAKIADFGLAKK-SSCDGERSQSF 168
              +  +     +H ++  +N+L+         +    K++D G++      D  +    
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE--- 179

Query: 169 ECRGTPL-YMSPESV-NENEYEAPCDIWALGCAVVEMAS 205
                 + ++ PE + N        D W+ G  + E+ S
Sbjct: 180 -----RIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 67.0 bits (164), Expect = 9e-13
 Identities = 51/238 (21%), Positives = 86/238 (36%), Gaps = 35/238 (14%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQI- 64
           G  IG GSFG +     + ++++  ++      +D P     L++E      +  C  I 
Sbjct: 15  GRRIGEGSFGVIFEGT-NLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIP 69

Query: 65  -VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
            V  FG +           L+++     SL D +      +     V    + ML  ++ 
Sbjct: 70  NVYYFGQE------GLHNVLVIDLLGP-SLED-LLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAK-----IADFGLAKK--SSCDGER-----SQSFECR 171
           IH K  V+ DIK  N L+   +        + DFG+ K        +       ++    
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL--S 179

Query: 172 GTPLYMSPESVNENEYEAPC---DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG 226
           GT  YM   S+N +         D+ ALG   +    G   W   + +       RIG
Sbjct: 180 GTARYM---SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 50/244 (20%), Positives = 92/244 (37%), Gaps = 39/244 (15%)

Query: 2   EWLRGDVIGHGSFGSVNLA---KASKVSSEFPSLMAVKSCAD-------------CPPSS 45
            W  G  IG G FG + LA    +  V S+ P ++ V+   +               P  
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 46  VTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLL-LEYASRGSLADRVKKQNNGR 104
           +        L  +G+ P+     G     +K  + Y  + ++      L   + + N  R
Sbjct: 96  IQKWIRTRKLKYLGV-PK-YWGSG---LHDKNGKSYRFMIMDRFGS-DLQK-IYEANAKR 148

Query: 105 LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKI--ADFGLAKKSSCDG 162
                V + +  +L  L +IH   +VH DIK  N+L+   +  ++   D+GLA +  C  
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR-YCPE 207

Query: 163 ERSQSFECR------GTPLYMSPESVNENEYEAPC---DIWALGCAVVEMASGKPAWNHK 213
              +++         GT  +    S++ +   AP    D+  LG  +++  +G   W   
Sbjct: 208 GVHKAYAADPKRCHDGTIEFT---SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264

Query: 214 QDSN 217
               
Sbjct: 265 LKDP 268

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 48/183 (26%), Positives = 72/183 (39%), Gaps = 23/183 (12%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQI- 64
           G  IG GSFG + L   +  ++E  ++         P     L  E +    +     I 
Sbjct: 12  GRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIP 66

Query: 65  -VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
            VR FG +        +  L+++     SL D +    + +L    V      M+  +  
Sbjct: 67  NVRWFGVE------GDYNVLVMDLLGP-SLED-LFNFCSRKLSLKTVLMLADQMINRVEF 118

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAK---IADFGLAKK--SSCDGERSQSFECR---GTPL 175
           +HSK F+H DIK  N L+     A    I DFGLAKK   +   +     E +   GT  
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178

Query: 176 YMS 178
           Y S
Sbjct: 179 YAS 181

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 52/239 (21%), Positives = 84/239 (35%), Gaps = 37/239 (15%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK-SCADCPPSSVTLKNEKEALDQIGICPQI 64
           G  IG G+FG + L K    +       A+K            L  E     Q+G    I
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYV----AIKLEPMKSRAPQ--LHLEYRFYKQLGSGDGI 67

Query: 65  --VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
             V  FG         ++  ++LE     SL D +    +       V      ++  + 
Sbjct: 68  PQVYYFGPC------GKYNAMVLELLGP-SLED-LFDLCDRTFSLKTVLMIAIQLISRME 119

Query: 123 HIHSKGFVHCDIKLQNVLV-----FDNDEAKIADFGLAKK--SSCDGER-----SQSFEC 170
           ++HSK  ++ D+K +N L+            I DF LAK+       +       +S   
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL-- 177

Query: 171 RGTPLYMSPESVNENEYEAPC---DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG 226
            GT  YM   S+N +  +      D+ ALG   +    G   W   +   +     +IG
Sbjct: 178 TGTARYM---SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 58.7 bits (143), Expect = 7e-10
 Identities = 40/159 (25%), Positives = 67/159 (42%), Gaps = 32/159 (20%)

Query: 72  YSFEKGERFYNLLL--EYASRGSLADRVKKQNNGRLQESDVKRYTRSML----------- 118
           +S +  +      L   Y   GSL DR+   +                L           
Sbjct: 98  FSSDGDDL----CLVYVYMPNGSLLDRLSCLDG------------TPPLSWHMRCKIAQG 141

Query: 119 --KGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
              G+  +H    +H DIK  N+L+ +   AKI+DFGLA+ S    +   +    GT  Y
Sbjct: 142 AANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAY 201

Query: 177 MSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD 215
           M+PE++   E     DI++ G  ++E+ +G PA +  ++
Sbjct: 202 MAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 58.4 bits (142), Expect = 8e-10
 Identities = 51/232 (21%), Positives = 99/232 (42%), Gaps = 48/232 (20%)

Query: 8   VIGHGSFGSV---NLAKASKVSSEFPSLMAVKSCADCPPSSVTLK------NEKEALDQI 58
           ++G G FG V    LA  + V        AVK           LK       E +   ++
Sbjct: 37  ILGRGGFGKVYKGRLADGTLV--------AVKR----------LKEERTQGGELQFQTEV 78

Query: 59  GIC-----PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRY 113
            +        ++R  G  +     ER   L+  Y + GS+A  ++++   +     +   
Sbjct: 79  EMISMAVHRNLLRLRG--FCMTPTERL--LVYPYMANGSVASCLRERPESQPP---LDWP 131

Query: 114 TRSML-----KGLRHIHSKG---FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERS 165
            R  +     +GL ++H       +H D+K  N+L+ +  EA + DFGLAK      +  
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTH 190

Query: 166 QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN 217
            +   RGT  +++PE ++  +     D++  G  ++E+ +G+ A++  + +N
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 9e-07
 Identities = 49/324 (15%), Positives = 81/324 (25%), Gaps = 85/324 (26%)

Query: 40  DCPPSSVTLKN--EKEALDQIGICP----QIVRCFG--DDYSFEKGERFYNLLLE--YAS 89
           DC       K+   KE +D I +        +R F        E  ++F   +L   Y  
Sbjct: 34  DCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY-- 91

Query: 90  RGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFV---HCDIKLQNVLVFDNDE 146
              L   +K +       + +    R  L     + +K  V      +KL+  L+     
Sbjct: 92  -KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPA 150

Query: 147 AKIADFGLA--KKSSCDGE--RSQSFECRGTPLYMSPESVNENEYEAPCDI-WA-LGCAV 200
             +   G+    K+    +   S   +C+                     I W  L    
Sbjct: 151 KNVLIDGVLGSGKTWVALDVCLSYKVQCK-----------------MDFKIFWLNLKNCN 193

Query: 201 VEMASGKPAWN--HKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRR- 257
                 +      ++ D N  S        D   NI   +    +  L +     P    
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSR------SDHSSNIKLRI-HSIQAELRRLLKSKPYENC 246

Query: 258 -------WTAEML--LNHPFVC------ADDQTGD--DGGIHIHSSSSPSLKGI-KDE-- 297
                    A+     N    C         Q  D        H S       +  DE  
Sbjct: 247 LLVLLNVQNAKAWNAFN--LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK 304

Query: 298 ---------KFSQSPR-----SPF 307
                    +    PR     +P 
Sbjct: 305 SLLLKYLDCRPQDLPREVLTTNPR 328

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 7e-05
 Identities = 39/266 (14%), Positives = 76/266 (28%), Gaps = 79/266 (29%)

Query: 4   LR--GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEA--LDQIG 59
           LR   +V+  G  GS    K         + +A+  C       V  K + +   L+ + 
Sbjct: 147 LRPAKNVLIDGVLGS---GK---------TWVALDVCLS---YKVQCKMDFKIFWLN-LK 190

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
                  C   +   E  ++    +       +   R    +N +L+   ++   R    
Sbjct: 191 ------NCNSPETVLEMLQKLLYQI-----DPNWTSRSDHSSNIKLRIHSIQAELR---- 235

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDN--DEAKIADFGLAKKSSCDGERSQSFECRGTPLYM 177
             R + SK + +C      +LV  N  +      F                 C+   L  
Sbjct: 236 --RLLKSKPYENC------LLVLLNVQNAKAWNAFN--------------LSCK-ILLTT 272

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN---- 233
             + V +        + A     + +          +  ++    +     D LP     
Sbjct: 273 RFKQVTD-------FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD-LPREVLT 324

Query: 234 -IPGDLSEQGKDFLIKCFLKDPKRRW 258
             P  LS      +I   ++D    W
Sbjct: 325 TNPRRLS------IIAESIRDGLATW 344

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 42.2 bits (98), Expect = 1e-04
 Identities = 31/188 (16%), Positives = 54/188 (28%), Gaps = 41/188 (21%)

Query: 9   IGHGSFGSVNLAK------ASKV----SSEFPSLMAVKSCADCPPSSVTLKNE------- 51
           IG G FG V          A K+      +  +    K+  +  P  +  K         
Sbjct: 28  IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87

Query: 52  ----------KEALDQIGICPQIVRCFGDDYSFEKGERFYN----------LLLEYASRG 91
                            G  P ++    D Y+  KG               ++LE+   G
Sbjct: 88  CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147

Query: 92  SLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIA 150
              ++++ +       +  K     +   L    +   F H D+   NVL+      K+ 
Sbjct: 148 IDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204

Query: 151 DFGLAKKS 158
                K S
Sbjct: 205 YTLNGKSS 212

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	366
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.83
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.64
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.32
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.23
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.22
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.19
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.18
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.09
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.92
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.64
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.62
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.55
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.46
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.42
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.41
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.34
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.25
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.22
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.15
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.85
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.58
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.12
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.76

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.8e-67  Score=485.17  Aligned_cols=256  Identities=27%  Similarity=0.495  Sum_probs=222.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||+||+|+++.+++    .+|+|.+..    .......+.+|+++|++++ |||||++++.   +++ 
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~---~~~-  103 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSR----EYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFT---FQD-  103 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEE---EEC-
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCC----EEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEE---EEe-
Confidence            59999999999999999999998876    677776653    3345677999999999998 9999999984   333 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +..+|||||||+||+|.+++.+.  +.++|.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus       104 ~~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          104 DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            44577999999999999999874  5799999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      +..........+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+....+.+..     +.+|..
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-----~~~p~~  256 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-----YDFPEK  256 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----CCCCTT
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----CCCCcc
Confidence            765444444556789999999999999999999999999999999999999999887766666655432     345678


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHH------HHcCCCcccCC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEM------LLNHPFVCADD  273 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~------ll~hp~~~~~~  273 (366)
                      +++++++||.+||++||++|||++|      |++||||+.-+
T Consensus       257 ~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          257 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             cCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            9999999999999999999999987      68999996543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.1e-65  Score=480.91  Aligned_cols=254  Identities=26%  Similarity=0.391  Sum_probs=217.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC-CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD-CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~-~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      .|.+++.||+|+||+||+|+++.+++    .||+|++.. .......+.+|+.+|++++ |||||++++.+.   . +..
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~---~-~~~  145 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGK----LVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYL---V-GDE  145 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEGGGCSSGGGGHHHHHHHHHCC-CTTBCCEEEEEE---E-TTE
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCC----EEEEEEEecCchhHHHHHHHHHHHHHhCC-CCCCCcEEEEEE---E-CCE
Confidence            48899999999999999999998875    788887754 2345567899999999998 999999998533   2 345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +|||||||+||+|.+++.+   +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus       146 ~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            6799999999999999975   4699999999999999999999999999999999999999999999999999998753


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ..  ....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+....+.... . .....+..+|+
T Consensus       223 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~-~~~~~~~~~s~  298 (346)
T 4fih_A          223 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-P-PRLKNLHKVSP  298 (346)
T ss_dssp             SS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-C-CCCSCGGGSCH
T ss_pred             CC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-C-CCCCccccCCH
Confidence            32  22345689999999999999999999999999999999999999998877666555554321 1 11223456899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ++++||.+||++||++|||++|+++||||..
T Consensus       299 ~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          299 SLKGFLDRLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence            9999999999999999999999999999964

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.4e-66  Score=487.01  Aligned_cols=255  Identities=25%  Similarity=0.449  Sum_probs=214.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|+++.+++    .||+|.+.....   ....+.+|+++|++|+ |||||++++.+   ++ +
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~---~~-~   95 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGR----QYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESF---EE-N   95 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCC----EEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE---EE-T
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCC----EEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEE---EE-C
Confidence            69999999999999999999988775    788888765322   3457889999999998 99999999843   33 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+|||||||+||+|.++|.++.+..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..
T Consensus        96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence            45679999999999999998766667899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ...  .......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+....+...    ..|.++..+
T Consensus       176 ~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----~~~~~~~~~  249 (350)
T 4b9d_A          176 NST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG----SFPPVSLHY  249 (350)
T ss_dssp             CHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----CCCCCCTTS
T ss_pred             cCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC----CCCCCCccC
Confidence            321  11223468999999999999999999999999999999999999999887766555554442    335567789


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      |+++++||.+||++||++|||++|+++||||..
T Consensus       250 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          250 SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999999964

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2e-64  Score=464.83  Aligned_cols=254  Identities=26%  Similarity=0.412  Sum_probs=212.5

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +..+.||+|+||+||+|+++.++.    .||+|.+....   .....+.+|+++|++|+ |||||++++++.+...++..
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTV----EVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCe----EEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcE
Confidence            566789999999999999988765    78888775422   23456889999999998 99999999976655566777


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEecc-CCceEEEecCCccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG--FVHCDIKLQNVLVFD-NDEAKIADFGLAKK  157 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~-~~~vkl~DFG~a~~  157 (366)
                      ++||||||+||+|.+++.+.  +.+++..+..|+.||+.||+|||++|  ||||||||+||||+. +|.+||+|||+|+.
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            88999999999999999874  57999999999999999999999998  999999999999974 78999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ..    .....+.+||+.|||||++.+ .|+.++|||||||++|||+||++||.+......  ....+......+.++..
T Consensus       182 ~~----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i~~~~~~~~~~~~  254 (290)
T 3fpq_A          182 KR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKV  254 (290)
T ss_dssp             CC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTCCCGGGGGC
T ss_pred             CC----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHHHcCCCCCCCCcc
Confidence            43    122345689999999999865 699999999999999999999999976654332  22233333334455667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +++++++||.+||.+||++|||++|+++||||+.
T Consensus       255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            8999999999999999999999999999999953

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.8e-65  Score=463.52  Aligned_cols=250  Identities=20%  Similarity=0.361  Sum_probs=201.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|+++.+++    .||+|.+..    .......+.+|+++|++++ |||||++++.+   + .
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~---~-~   84 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQ----KVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVI---K-S   84 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCC----EEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEE---E-C
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEE---E-E
Confidence            69999999999999999999988776    677777654    2234567899999999998 99999999843   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +..+++||||| +|+|.+++.++  +.+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.
T Consensus        85 ~~~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           85 KDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             SSEEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             CCEEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence            45577999999 67999999763  5799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCC-CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEY-EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ....   ....+.+||+.|||||++.+..| +.++|||||||++|+|+||++||.+.+.......+...     .+.+|.
T Consensus       162 ~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~-----~~~~p~  233 (275)
T 3hyh_A          162 MTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG-----VYTLPK  233 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----CCCCCT
T ss_pred             cCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-----CCCCCC
Confidence            6422   22335689999999999999887 47999999999999999999999887665555544432     235667


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+|+++++||.+||++||++|||++|+++||||+.
T Consensus       234 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          234 FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            89999999999999999999999999999999964

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.3e-64  Score=483.17  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=218.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      .|.+++.||+|+||+||+|+++.+++    .||+|++... ......+.+|+.+|+.++ |||||++++.+.   . +..
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~---~-~~~  222 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGK----LVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYL---V-GDE  222 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEESTTCSSGGGHHHHHHHHHHCC-CTTBCCEEEEEE---E-TTE
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCC----EEEEEEEeccchhHHHHHHHHHHHHHhCC-CCCCCceEEEEE---E-CCE
Confidence            48899999999999999999998875    7888887653 345567899999999998 999999998543   2 345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +|||||||+||+|.+++..   +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus       223 ~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            6799999999999999965   4699999999999999999999999999999999999999999999999999998753


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ..  ....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+....+.+..+.....  .....+..+|+
T Consensus       300 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--~~~~~~~~~s~  375 (423)
T 4fie_A          300 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--PRLKNLHKVSP  375 (423)
T ss_dssp             SC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCSCTTSSCH
T ss_pred             CC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC--CCCcccccCCH
Confidence            32  233456899999999999999999999999999999999999999988776666555543221  12233457899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ++++||.+||.+||++|||++|||+||||..
T Consensus       376 ~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          376 SLKGFLDRLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence            9999999999999999999999999999964

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-64  Score=468.37  Aligned_cols=255  Identities=29%  Similarity=0.447  Sum_probs=209.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++..+. .....+|+|.+...   ......+.+|+++|++++ |||||++++.+   +. +
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~---~~-~   98 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGS-DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAF---QT-E   98 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSST-TTTCEEEEEEEESEEEEEEECC------CCCCCCC-CTTEECEEEEE---EE-T
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCC-CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC-CCCCCeEEEEE---EE-C
Confidence            5999999999999999999985432 23457888877542   123446788999999998 99999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+|+|||||+||+|.+++.+.  +.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+..
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             CEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            4567999999999999999874  57999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ....  ....+.+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+....+.+.     .+.+|..+
T Consensus       177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-----~~~~p~~~  249 (304)
T 3ubd_A          177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-----KLGMPQFL  249 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----CCCCCTTS
T ss_pred             cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-----CCCCCCcC
Confidence            4322  2234568999999999999999999999999999999999999999988776666555542     23557789


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCccc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCA  271 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~  271 (366)
                      |+++++||.+||++||++|||     ++|+++||||+.
T Consensus       250 s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            999999999999999999998     589999999964

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.6e-63  Score=463.65  Aligned_cols=252  Identities=27%  Similarity=0.370  Sum_probs=210.4

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      |.++++||+|+||+||+|+++.+++    .||+|.+...    ....+|+.+|++++ |||||++++.+   .+ +..+|
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~----~vAiK~i~~~----~~~~~E~~il~~l~-HpnIV~l~~~~---~~-~~~~~  126 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGF----QCAVKKVRLE----VFRVEELVACAGLS-SPRIVPLYGAV---RE-GPWVN  126 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETT----TCCTHHHHTTTTCC-CTTBCCEEEEE---EE-TTEEE
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCC----EEEEEEECHH----HhHHHHHHHHHhCC-CCCCCcEEEEE---EE-CCEEE
Confidence            6678899999999999999988765    7889987653    22357999999998 99999999843   22 34567


Q ss_pred             EEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-ceEEEecCCccccCCC
Q 017746           83 LLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCD  161 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~~  161 (366)
                      ||||||+||+|.++|++.  +.+++.++..|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+..+
T Consensus       127 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            999999999999999874  5799999999999999999999999999999999999999988 6999999999986543


Q ss_pred             CCCc---ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          162 GERS---QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       162 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ....   .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.........+....  ...+.++..+
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~  282 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PPIREIPPSC  282 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CGGGGSCTTS
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CCchhcCccC
Confidence            2221   2234579999999999999999999999999999999999999998877766665555432  1223567789


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHH-------------HcCCCccc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEML-------------LNHPFVCA  271 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~l-------------l~hp~~~~  271 (366)
                      ++++++||.+||++||++|||+.||             ++|||+..
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~  328 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE  328 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence            9999999999999999999999998             46888844

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-60  Score=443.05  Aligned_cols=250  Identities=23%  Similarity=0.352  Sum_probs=200.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      ++.+++.||+|+||+||+|+++.       .+|||.+.....   ....+.+|+.+|++++ |||||+++|++   .+ +
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~~-------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~---~~-~  104 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWHG-------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTR-HVNILLFMGYM---TK-D  104 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESSS-------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE---CS-S
T ss_pred             HeEEeeEEeeCCCcEEEEEEECC-------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE---EC-C
Confidence            35678899999999999998653       478887754322   3457889999999998 99999999842   22 2


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                       .++||||||+||+|.++|.. ..+++++.++..|+.||+.||+|||++|||||||||+||||++++++||+|||+|+..
T Consensus       105 -~~~iVmEy~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          105 -NLAIVTQWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             -SCEEEEECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             -eEEEEEEcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence             25699999999999999976 4467999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC---cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc-CCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE---NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV-GDELPNI  234 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~  234 (366)
                      ............+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.........+...+. ....+.+
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~  262 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL  262 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence            54333333445689999999999964   4589999999999999999999999987765544444443332 2233456


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +..+++++.+|+.+||++||++|||+.||++
T Consensus       263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          263 YKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            6789999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.3e-61  Score=443.02  Aligned_cols=257  Identities=22%  Similarity=0.382  Sum_probs=211.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|++... ....+..||||.+.... .....+.+|+++|++++ |||||+++|++.    ...
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~----~~~   88 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVCV----EGD   88 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC----SSS
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCC-CCCCccEEEEEe----eCC
Confidence            477889999999999999997643 22235689999987532 23467899999999998 999999999432    233


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceE
Q 017746           80 FYNLLLEYASRGSLADRVKKQN-----------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAK  148 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vk  148 (366)
                      .++||||||++|+|.++|.+..           ...+++.++..|+.||++||+|||+++||||||||+||||++++.+|
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence            4679999999999999997631           24699999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhc
Q 017746          149 IADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGV  227 (366)
Q Consensus       149 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~  227 (366)
                      |+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+....+..   
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~---  245 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ---  245 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH---
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---
Confidence            999999987644333333344579999999999999999999999999999999998 9999998876665555443   


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                       ...+..|..+++++.+|+.+||++||++|||+++|+  +++
T Consensus       246 -~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L  284 (299)
T 4asz_A          246 -GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLL  284 (299)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHH
T ss_pred             -CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHH
Confidence             233456778999999999999999999999999994  454

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-60  Score=441.41  Aligned_cols=259  Identities=22%  Similarity=0.293  Sum_probs=197.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccC---
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK---   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~---   76 (366)
                      +|.+++.||+|+||+||+|+++.+++    .||+|.+.....  ....+.+|+.+|++|+ |||||++++.+.....   
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~   80 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDC----NYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEK   80 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCC----EEEEEEEEECSSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC----
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCC----EEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCcccc
Confidence            58899999999999999999988765    788887764322  3356889999999998 9999999996543221   


Q ss_pred             -----CeeEEEEEeecCCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEE
Q 017746           77 -----GERFYNLLLEYASRGSLADRVKKQNN-GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIA  150 (366)
Q Consensus        77 -----~~~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~  150 (366)
                           ...++|+|||||+||+|.+++.++.. ...++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+
T Consensus        81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence                 23457899999999999999976321 124567789999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCCCCc----------ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHH
Q 017746          151 DFGLAKKSSCDGERS----------QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFS  220 (366)
Q Consensus       151 DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~  220 (366)
                      |||+|+.........          ...+.+||+.|||||++.+..|+.++|||||||++|||++   ||...  .+...
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~  235 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVR  235 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHH
Confidence            999998765332211          1234579999999999999999999999999999999996   77543  22233


Q ss_pred             HHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          221 LLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+..... ...|..+...++.+.+||.+||++||++|||+.|+++||||+.
T Consensus       236 ~~~~~~~-~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          236 TLTDVRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HHHHHHT-TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HHHHHhc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            3333322 2333333445778899999999999999999999999999954

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-59  Score=451.40  Aligned_cols=262  Identities=23%  Similarity=0.333  Sum_probs=214.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeec--cC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSF--EK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~--~~   76 (366)
                      +|.+++.||+|+||+||+|+++.+++    .||+|++.....   ....+.+|+++|+.|+ |||||++++++...  ..
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQ----QVAIKKIPNAFDVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCTT
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCC----EEEEEEECccccchHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccccc
Confidence            58999999999999999999988775    789998865333   2345778999999998 99999999865422  12


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+|||||||+ |+|.+++.+  .+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence            3345679999996 589999965  3579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC--CcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC---
Q 017746          157 KSSCDGE--RSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE---  230 (366)
Q Consensus       157 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~---  230 (366)
                      .+.....  .....+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+....+........   
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            7643221  2223456899999999998875 568999999999999999999999998887777766655332111   


Q ss_pred             ---------------CCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          231 ---------------LPN--------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       231 ---------------~~~--------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                     .|.        +...++++++|||.+||.+||++|||++|+|+||||..
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  350 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK  350 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence                           000        11246899999999999999999999999999999954

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.9e-60  Score=443.34  Aligned_cols=256  Identities=21%  Similarity=0.340  Sum_probs=203.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      ++.+.+.||+|+||+||+|++... .......||||.+..... ....+.+|+++|.+++ |||||+++|++.    ...
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~----~~~  116 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCT----EGR  116 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC----SSS
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE----ECC
Confidence            356778999999999999997642 223356899999875322 3467899999999998 999999999432    234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc
Q 017746           80 FYNLLLEYASRGSLADRVKKQN-------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE  146 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~-------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~  146 (366)
                      .++||||||++|+|.+++.+..             .+++++.++..|+.||++||+|||+++||||||||+||||++++.
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence            4679999999999999997532             246999999999999999999999999999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHh
Q 017746          147 AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI  225 (366)
Q Consensus       147 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~  225 (366)
                      +||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+....+.+.
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g  276 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG  276 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999997654433333445679999999999999999999999999999999999 99999987766655544432


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       226 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                          ..+..|..+++++.+|+.+||++||++|||++||+.+
T Consensus       277 ----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          277 ----RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             ----CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                2345677899999999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-59  Score=437.28  Aligned_cols=255  Identities=20%  Similarity=0.310  Sum_probs=209.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +++.+.||+|+||+||+|+.... .......||||.+....  .....+.+|+.++.+++ |||||+++|++.    ...
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~----~~~  102 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVT----KDQ  102 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC-CTTBCCEEEEEC----SSS
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC-CCCCCCcceEEE----ECC
Confidence            56678999999999999997532 12234579999986532  34567999999999998 999999999432    233


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC
Q 017746           80 FYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND  145 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~  145 (366)
                      .++||||||++|+|.++|..+.              ...+++.++..|+.||++||+|||+++||||||||+||||++++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence            4569999999999999996532              24589999999999999999999999999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 017746          146 EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       146 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~  224 (366)
                      ++||+|||+|+..............+||+.|||||++.++.|+.++|||||||++|||+| |..||.+.+..+....+..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~  262 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN  262 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999987644333333445679999999999999999999999999999999998 8999998876655544432


Q ss_pred             hhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       225 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                          ...+..|..+++++.+|+.+||+.||++|||+.||+++
T Consensus       263 ----~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          263 ----RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                23345677899999999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-59  Score=444.60  Aligned_cols=259  Identities=23%  Similarity=0.358  Sum_probs=216.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCC-ceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFP-SLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~-~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++...++... ..||||.+.....  ....+.+|+++|.++.+|||||+++|.+.   ...
T Consensus        65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~---~~~  141 (353)
T 4ase_A           65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---KPG  141 (353)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---CTT
T ss_pred             HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE---ecC
Confidence            47889999999999999999877654443 4689998875433  34568899999999997799999999432   223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN  144 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~  144 (366)
                      ..++||||||++|+|.++|++..              ...+++..+..|+.||++||+|||+++||||||||+||||+++
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  221 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence            34569999999999999997632              2358999999999999999999999999999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 017746          145 DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLI  223 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~  223 (366)
                      +.+||+|||+|+....+.........+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....+......
T Consensus       222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i  301 (353)
T 4ase_A          222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  301 (353)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred             CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999998755444444455679999999999999999999999999999999998 999998876555444444


Q ss_pred             HhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+   ..+..|..+++++.+||.+||+.||++|||+.+|++|
T Consensus       302 ~~g---~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          302 KEG---TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HcC---CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            333   2345677899999999999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.9e-59  Score=442.33  Aligned_cols=259  Identities=25%  Similarity=0.349  Sum_probs=203.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|+++.+. .....||+|.+... .....+.+|+++|+.+.+||||+++++.+   .. ...+
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~-~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~---~~-~~~~   95 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQV-GPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCF---RK-NDHV   95 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTT-SCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEE---EE-TTEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccC-CCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEE---EE-CCEE
Confidence            5999999999999999999875321 12458999987653 44567889999999997799999999743   33 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC-CceEEEecCCccccCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN-DEAKIADFGLAKKSSC  160 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~~~~~  160 (366)
                      ++|||||+||+|.+++.     .+++.+++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+....
T Consensus        96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            79999999999999983     48999999999999999999999999999999999999876 7999999999986542


Q ss_pred             CCCC--------------------------cccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCC
Q 017746          161 DGER--------------------------SQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHK  213 (366)
Q Consensus       161 ~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~  213 (366)
                      ....                          ......+||+.|||||++.+. .|+.++||||+||++|||++|++||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            2110                          112345799999999999775 5899999999999999999999999655


Q ss_pred             Ccc-hHHHHHHHhh------------------------------------cCCCCC-------------CCCCCCCHHHH
Q 017746          214 QDS-NVFSLLIRIG------------------------------------VGDELP-------------NIPGDLSEQGK  243 (366)
Q Consensus       214 ~~~-~~~~~~~~~~------------------------------------~~~~~~-------------~~~~~~s~~~~  243 (366)
                      .+. +....+....                                    .....|             .....+|++++
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence            432 2222222110                                    000000             11235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          244 DFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       244 ~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      |||.+||+.||++|+|++|+|+||||+.
T Consensus       331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          331 DLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999999953

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.9e-59  Score=465.51  Aligned_cols=255  Identities=24%  Similarity=0.400  Sum_probs=209.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHH---HHcCCCCceeEeecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEAL---DQIGICPQIVRCFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l---~~l~~~p~Iv~~~g~~~~~   74 (366)
                      +|.++++||+|+||+||+|+++.+++    .||+|.+.+    .........+|..++   ..++ |||||++++.   +
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~----~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~---f  261 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYA---F  261 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEE---E
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCC----EEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEE---E
Confidence            68999999999999999999998876    667776643    223344455554444   4445 9999999984   3


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCC
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                      +. ...+|||||||+||+|.++|.+.  +.+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+
T Consensus       262 ~~-~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          262 HT-PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             EC-SSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EE-CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccce
Confidence            33 44567999999999999999874  5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccC-CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVN-ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      |+.....    ...+.+||+.|||||++. +..|+.++|||||||++|||++|++||.+............+..  ..+.
T Consensus       339 A~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~  412 (689)
T 3v5w_A          339 ACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVE  412 (689)
T ss_dssp             CEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCC
T ss_pred             eeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCC
Confidence            9886432    234568999999999996 46899999999999999999999999987655444433333222  2245


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCcccCC
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCADD  273 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~~  273 (366)
                      +|..+|+++++||.+||++||++|++     ++||++||||+.-+
T Consensus       413 ~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            67789999999999999999999998     79999999996543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.7e-58  Score=462.50  Aligned_cols=259  Identities=24%  Similarity=0.403  Sum_probs=219.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+.... .....+.+|+.+|+.|+ |||||++++.+   . ....
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~----~~AiK~i~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~---~-~~~~  228 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGN----NFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAF---E-DDNE  228 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEE---E-CSSE
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCC----EEEEEEEeccchhhHHHHHHHHHHHHhCC-CCCCCeEEEEE---E-ECCE
Confidence            58999999999999999999998876    67888775532 23466889999999998 99999999843   3 3456


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC--CceEEEecCCcccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN--DEAKIADFGLAKKS  158 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~--~~vkl~DFG~a~~~  158 (366)
                      ++||||||+||+|.++|.+ ..+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+.+
T Consensus       229 ~~iv~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEEEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            7799999999999999975 34579999999999999999999999999999999999999854  89999999999987


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ...   ......+||+.|||||++.+..|+.++|||||||++|+|++|++||.+....+.+..+....... .+..+..+
T Consensus       308 ~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~  383 (573)
T 3uto_A          308 DPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-DDSAFSGI  383 (573)
T ss_dssp             CTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC-CSGGGTTS
T ss_pred             cCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC-CcccccCC
Confidence            432   22345689999999999999999999999999999999999999999887766666555433221 22334568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCCC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQ  274 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~~  274 (366)
                      |+++++||.+||++||++|||++|+|+||||+....
T Consensus       384 s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            999999999999999999999999999999976443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.2e-56  Score=413.48  Aligned_cols=255  Identities=24%  Similarity=0.268  Sum_probs=192.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||+||+|++.+      ..||||.+..........+.|+..+.+++ |||||+++|++..-......+
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~g------~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWRG------EEVAVKIFSSREERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETT------EEEEEEEECGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECC------EEEEEEEECccchhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCceEE
Confidence            57889999999999999998742      47999998763322233344555556777 999999999655433333467


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCCCCcEEeccCCceEEEecC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK--------GFVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                      +||||||+||+|.+++.+   ..++++.+..++.|++.||+|||++        +||||||||+||||+.++++||+|||
T Consensus        77 ~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            899999999999999976   3589999999999999999999987        99999999999999999999999999


Q ss_pred             CccccCCCCCC--cccccccCCCCCCCccccCCc------CCCCccchhhhHHHHHHHHhCCCCCCCCCcc---------
Q 017746          154 LAKKSSCDGER--SQSFECRGTPLYMSPESVNEN------EYEAPCDIWALGCAVVEMASGKPAWNHKQDS---------  216 (366)
Q Consensus       154 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~emltg~~pf~~~~~~---------  216 (366)
                      +|+........  ......+||+.|||||++.+.      .|+.++|||||||++|||+||.+||......         
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876433221  122345799999999999764      4778999999999999999998776432110         


Q ss_pred             --hHHHHHHH-hhcCCCCCCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          217 --NVFSLLIR-IGVGDELPNIPGD-----LSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       217 --~~~~~~~~-~~~~~~~~~~~~~-----~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                        .....+.+ .......|.+|..     .+..+.+|+.+||+.||++|||+.||++.
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              01112222 2222333444432     23568899999999999999999999863

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.8e-53  Score=400.42  Aligned_cols=252  Identities=26%  Similarity=0.426  Sum_probs=215.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+....   .....+.+|+++++.++ ||||+++++.+    ...
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~----~~~   86 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGR----EVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVI----ETE   86 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE----ECS
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE----EEC
Confidence            68999999999999999999987765    78888875422   23456789999999998 99999999843    234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||++||+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             CEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            4577999999999999999774  46999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCC-CccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYE-APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....   .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+....+....+....     ..+|..
T Consensus       165 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~p~~  236 (328)
T 3fe3_A          165 TVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK-----YRIPFY  236 (328)
T ss_dssp             SSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----CCCCTT
T ss_pred             CCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----CCCCCC
Confidence            4322   23455799999999999988876 68999999999999999999998877665555544322     245667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +++++.+||.+||..||++|||++|+++||||...
T Consensus       237 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence            89999999999999999999999999999999643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.2e-54  Score=409.39  Aligned_cols=254  Identities=28%  Similarity=0.456  Sum_probs=213.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||+||+|+++.+++    .+|+|.+..    .......+.+|..++..+..||||+++++.+   .. 
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~----~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~---~~-   95 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGD----LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF---QT-   95 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE---EC-
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCC----EEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE---Ee-
Confidence            68999999999999999999988765    677776653    2234566788999999997799999999843   33 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||+||+|.+++.+.  +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            34567999999999999999874  4699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....  ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+....     ..+|..
T Consensus       174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-----~~~p~~  246 (353)
T 3txo_A          174 GICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-----VVYPTW  246 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----CCCCTT
T ss_pred             cccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----CCCCCC
Confidence            43222  22345589999999999999999999999999999999999999999887766666655432     345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH------HHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTA------EMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~------~~ll~hp~~~~~  272 (366)
                      +++++.+||.+||.+||++||++      +++++||||...
T Consensus       247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            89999999999999999999998      999999999653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2e-53  Score=401.43  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=215.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+..    .......+.+|+.+++.++ ||||+++++.+   .. 
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~---~~-   76 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGR----YYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAF---QT-   76 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEE---EC-
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEE---Ee-
Confidence            68999999999999999999987765    677777643    2345667889999999998 99999999843   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        77 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           77 HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            34567999999999999999764  4699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+...     ...+|..
T Consensus       155 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----~~~~p~~  227 (337)
T 1o6l_A          155 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----EIRFPRT  227 (337)
T ss_dssp             SCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----CCCCCTT
T ss_pred             cccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCC
Confidence            43222  2234557999999999999999999999999999999999999999887665555554432     2345677


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~  272 (366)
                      +++++++||.+||.+||++||     +++++++||||...
T Consensus       228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            999999999999999999999     89999999999653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.5e-53  Score=390.97  Aligned_cols=255  Identities=27%  Similarity=0.436  Sum_probs=215.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC-CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD-CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~-~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||+||+|.+..+++    .+|+|.+.. .......+.+|+.++++++ ||||+++++.+.   . ...
T Consensus        21 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~---~-~~~   91 (297)
T 3fxz_A           21 KYTRFEKIGQGASGTVYTAMDVATGQ----EVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYL---V-GDE   91 (297)
T ss_dssp             TBCCCEEEEEETTEEEEEEEBTTTCC----EEEEEEEEGGGCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEE---E-TTE
T ss_pred             ceeeeeeeccCCCeEEEEEEECCCCc----EEEEEEeecccccHHHHHHHHHHHHhcCC-CCCCCeEeEEEE---E-CCE
Confidence            69999999999999999999887765    788887754 2345567889999999998 999999998433   2 234


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||++||+|.+++.+.   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            67999999999999999762   599999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ...  ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+.....  .....+..++.
T Consensus       169 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  244 (297)
T 3fxz_A          169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT--PELQNPEKLSA  244 (297)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS--CCCSCGGGSCH
T ss_pred             ccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCccccCH
Confidence            322  23345799999999999999999999999999999999999999987765554444433322  22334567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .+.+||.+||..||++|||++++++||||+..
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999999999643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.3e-53  Score=406.97  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=208.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||+||+|+++.+++    .+|+|.+..    .......+.+|..++.++..||||+++++.+   .. 
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~----~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~---~~-  124 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDR----IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF---QT-  124 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE---EC-
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE---EE-
Confidence            58899999999999999999988765    566666543    2334456889999999986699999999843   33 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||+||+|.+++.+.  +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            44567999999999999999874  4699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc---------hHHHHHHHhhcC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS---------NVFSLLIRIGVG  228 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~---------~~~~~~~~~~~~  228 (366)
                      ....  .......+||+.|+|||++.+..|+.++|||||||++|||++|++||......         .....+..    
T Consensus       203 ~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~----  276 (396)
T 4dc2_A          203 GLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----  276 (396)
T ss_dssp             CCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH----
T ss_pred             cccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc----
Confidence            4322  22234568999999999999999999999999999999999999999643211         11222221    


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCCCcccC
Q 017746          229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTA------EMLLNHPFVCAD  272 (366)
Q Consensus       229 ~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~------~~ll~hp~~~~~  272 (366)
                       ..+.+|..++.++++||.+||++||++||++      +++++||||...
T Consensus       277 -~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          277 -KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             -cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence             2235677899999999999999999999985      899999999653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7e-53  Score=401.28  Aligned_cols=255  Identities=24%  Similarity=0.382  Sum_probs=214.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-------chhhHHHHHHHHHHcCCCCceeEeecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-------SSVTLKNEKEALDQIGICPQIVRCFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~   74 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+.....       ....+.+|+.+++++. ||||+++++.+   
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~---   84 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGL----EYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVY---   84 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEE---
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCC----EEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEE---
Confidence            58999999999999999999988765    677776654221       2467899999999998 99999999843   


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC----ceEEE
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND----EAKIA  150 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~  150 (366)
                       .....+++||||++||+|.+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+
T Consensus        85 -~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           85 -ENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             -EeCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence             234567799999999999999965  35799999999999999999999999999999999999998776    79999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      |||+++......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+....+....+...... .
T Consensus       162 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~  237 (361)
T 2yab_A          162 DFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD-F  237 (361)
T ss_dssp             CCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-C
T ss_pred             ecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-C
Confidence            999998764322   223457999999999999999999999999999999999999999887766655555443221 1


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+..+..+++++++||.+||.+||++|||++|+++||||..
T Consensus       238 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            12223568999999999999999999999999999999964

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.4e-53  Score=411.95  Aligned_cols=263  Identities=26%  Similarity=0.398  Sum_probs=220.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||+||+|+++.+++    .+|+|.+..    .......+.+|..++..++ ||||+++++.+   .. 
T Consensus        75 ~y~~~~~LG~G~fG~V~~~~~~~~~~----~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~---~~-  145 (437)
T 4aw2_A           75 DFEILKVIGRGAFGEVAVVKLKNADK----VFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAF---QD-  145 (437)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEE---EC-
T ss_pred             heEEEEEEEeCCCEEEEEEEEcCCCc----EEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE---ee-
Confidence            58899999999999999999987765    677777643    2234455889999999997 99999999843   33 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||+||+|.+++.+ .++.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            4456799999999999999976 346799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      ...... ......+||+.|+|||++.     ...|+.++|||||||++|||++|++||.+.+..+....+.........|
T Consensus       225 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p  303 (437)
T 4aw2_A          225 LMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP  303 (437)
T ss_dssp             CCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             cccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence            643322 2223457999999999987     5679999999999999999999999999887777776666544334455


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCCcccCCCC
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKR--RWTAEMLLNHPFVCADDQT  275 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~--R~t~~~ll~hp~~~~~~~~  275 (366)
                      .....+++++++||.+||..+|++  |++++|+++||||....+.
T Consensus       304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~  348 (437)
T 4aw2_A          304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD  348 (437)
T ss_dssp             SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred             cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence            555668999999999999998888  9999999999999765443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.1e-53  Score=401.36  Aligned_cols=254  Identities=26%  Similarity=0.452  Sum_probs=216.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||.||+|+++.+++    .+|+|.+...    ......+..|..++..+..||||+++++.+   .. 
T Consensus        18 ~y~~~~~lG~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~---~~-   89 (345)
T 1xjd_A           18 DFILHKMLGKGSFGKVFLAEFKKTNQ----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF---QT-   89 (345)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTE----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE---EC-
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE---Ee-
Confidence            68999999999999999999987765    6778876542    345567888999999885699999999843   33 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            34567999999999999999864  4699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....  ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+...     .+.++..
T Consensus       168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----~~~~p~~  240 (345)
T 1xjd_A          168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-----NPFYPRW  240 (345)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----CCCCCTT
T ss_pred             cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----CCCCCcc
Confidence            43222  2234568999999999999999999999999999999999999999887666555554432     2455677


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHH-HHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAE-MLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~-~ll~hp~~~~~  272 (366)
                      +++++++||.+||.+||++||++. ++++||||...
T Consensus       241 ~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            999999999999999999999998 99999999653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1e-52  Score=393.56  Aligned_cols=249  Identities=25%  Similarity=0.422  Sum_probs=214.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|+++.+++    .+|+|.+..    .......+.+|..+++.++ ||||+++++.+   . .
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~---~-~   77 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGR----YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTF---Q-D   77 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEE---E-C
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEE---E-e
Confidence            68999999999999999999988765    677776643    2245567888999999998 99999999843   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        78 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           78 AQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCccee
Confidence            44567999999999999999763  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...     .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+....     ..+|..
T Consensus       156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~p~~  225 (318)
T 1fot_A          156 VPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----LRFPPF  225 (318)
T ss_dssp             CSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----CCCCTT
T ss_pred             cCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----CCCCCC
Confidence            532     1234579999999999999999999999999999999999999998876655555554422     345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      +++++.++|.+||.+||++||     +++++++||||..
T Consensus       226 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            899999999999999999999     9999999999964

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.7e-53  Score=400.28  Aligned_cols=254  Identities=26%  Similarity=0.402  Sum_probs=216.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||.||+|+++.+++    .+|+|.+..    .......+..|..++..+..||+|+++++.+   .. 
T Consensus        21 ~y~~~~~lG~G~fg~V~~~~~~~~~~----~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~---~~-   92 (353)
T 2i0e_A           21 DFNFLMVLGKGSFGKVMLSERKGTDE----LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF---QT-   92 (353)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTEEE----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE---EC-
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE---Ec-
Confidence            68999999999999999999987654    677777654    2345567888999999987799999999843   33 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            34567999999999999999864  4699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....  ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+....+....+....     +.+|..
T Consensus       171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-----~~~p~~  243 (353)
T 2i0e_A          171 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----VAYPKS  243 (353)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----CCCCTT
T ss_pred             cccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-----CCCCCC
Confidence            43222  22345689999999999999999999999999999999999999998877666655555422     345677


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~  272 (366)
                      ++.++++||.+||.+||++||+     ++++++||||...
T Consensus       244 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            9999999999999999999994     6999999999653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-53  Score=398.91  Aligned_cols=257  Identities=20%  Similarity=0.307  Sum_probs=217.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|+++.+++    .+++|.+.........+.+|+.+++.++ ||||+++++.+.   . ...+
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~---~-~~~~   76 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKK----TYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHESFE---S-MEEL   76 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECCCTHHHHHHHHHHHHHHHSC-CTTBCCEEEEEE---E-TTEE
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCc----EEEEEEEecCcccHHHHHHHHHHHHhCC-CCCCCeEeEEEe---c-CCEE
Confidence            68999999999999999999987654    7888887765555667889999999998 999999998432   2 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc--CCceEEEecCCccccC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD--NDEAKIADFGLAKKSS  159 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~~~vkl~DFG~a~~~~  159 (366)
                      ++|||||+||+|.+++.. .+..+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++...
T Consensus        77 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            799999999999999975 3457999999999999999999999999999999999999987  7899999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      ..   .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+........ +.....++
T Consensus       156 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s  231 (321)
T 1tki_A          156 PG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-EEAFKEIS  231 (321)
T ss_dssp             TT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-HHHHTTSC
T ss_pred             CC---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC-hhhhccCC
Confidence            32   222345799999999999999999999999999999999999999988776665555554332211 11123589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .++.+||.+||..||++|||+.|+++||||...
T Consensus       232 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            999999999999999999999999999999653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-52  Score=404.58  Aligned_cols=262  Identities=26%  Similarity=0.416  Sum_probs=216.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||+||+|+++.+++    .+|+|.+..    .......+.+|..++..++ ||||+++++.+   .. 
T Consensus        62 ~f~~~~~lG~G~fG~V~~~~~~~~~~----~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~---~~-  132 (412)
T 2vd5_A           62 DFEILKVIGRGAFSEVAVVKMKQTGQ----VYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAF---QD-  132 (412)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEE---EC-
T ss_pred             hEEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEE---ee-
Confidence            58899999999999999999987765    677777653    1123456888999999998 99999999843   33 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+. +..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence            44577999999999999999874 34799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccC-------CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVN-------ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      ...... ......+||+.|+|||++.       ...|+.++|||||||++|||++|++||.+.+..+....+........
T Consensus       212 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  290 (412)
T 2vd5_A          212 LRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS  290 (412)
T ss_dssp             CCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             ccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence            643322 1223458999999999997       46799999999999999999999999998877776666665433334


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHHcCCCcccCCCC
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRR---WTAEMLLNHPFVCADDQT  275 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R---~t~~~ll~hp~~~~~~~~  275 (366)
                      .|..+..+++++++||.+||. +|++|   ++++++++||||....+.
T Consensus       291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~  337 (412)
T 2vd5_A          291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD  337 (412)
T ss_dssp             CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred             CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            455556799999999999999 99998   599999999999765443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-52  Score=405.69  Aligned_cols=259  Identities=26%  Similarity=0.435  Sum_probs=216.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||+||+|+++.+++    .+|+|.+..    .......+.+|+.++..++ ||||+++++.+   . .
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~----~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~---~-~  140 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRK----VYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAF---Q-D  140 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEE---E-C
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCc----EEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEE---E-E
Confidence            58899999999999999999988765    677776543    2234556889999999998 99999999843   3 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||+||+|.+++.+   ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            4457799999999999999975   3699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcC----CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENE----YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      ...... ......+||+.|+|||++.+..    |+.++|||||||++|||++|++||.+.+.......+.........|.
T Consensus       218 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  296 (410)
T 3v8s_A          218 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD  296 (410)
T ss_dssp             CCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred             eccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence            643221 1233568999999999998765    88999999999999999999999998877766666655432223332


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCCCcccCCC
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKR--RWTAEMLLNHPFVCADDQ  274 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~--R~t~~~ll~hp~~~~~~~  274 (366)
                       ...++.++++||.+||..+|.+  |++++||++||||+...+
T Consensus       297 -~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          297 -DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             -TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             -cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence             2358999999999999999988  999999999999976543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.7e-52  Score=396.35  Aligned_cols=254  Identities=26%  Similarity=0.434  Sum_probs=209.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|+++.+++    .+|+|.+....    .....+.+|..++.++..||||+++++.+   .. 
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~---~~-   81 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDR----IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF---QT-   81 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE---EC-
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE---Ee-
Confidence            58999999999999999999987765    67777765421    23455788999999986699999999843   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.
T Consensus        82 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           82 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence            34567999999999999999864  4699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCc---------chHHHHHHHhhcC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD---------SNVFSLLIRIGVG  228 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~---------~~~~~~~~~~~~~  228 (366)
                      .....  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....         ......+..    
T Consensus       160 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~----  233 (345)
T 3a8x_A          160 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----  233 (345)
T ss_dssp             SCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH----
T ss_pred             ccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc----
Confidence            43222  223455899999999999999999999999999999999999999965211         111222221    


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCCCcccC
Q 017746          229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTA------EMLLNHPFVCAD  272 (366)
Q Consensus       229 ~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~------~~ll~hp~~~~~  272 (366)
                       ....+|..++.++++||.+||.+||++||++      +++++||||...
T Consensus       234 -~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          234 -KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             -CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence             1234567799999999999999999999995      899999999653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.2e-52  Score=401.40  Aligned_cols=258  Identities=22%  Similarity=0.366  Sum_probs=206.4

Q ss_pred             Ccccc-CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRG-DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+. ++||+|+||+||+|.++.+++    .+|+|.+..    .....+|+.++.++..||||+++++.+.....+...
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~----~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQE----KFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCC----EEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            35554 789999999999999987765    788888753    346788999987777799999999976555556777


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc---CCceEEEecCCccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKK  157 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~~  157 (366)
                      +++|||||+||+|.+++.+.....+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            889999999999999998644456999999999999999999999999999999999999987   78899999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcch----HHHHHHHhhcCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN----VFSLLIRIGVGDELPN  233 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~  233 (366)
                      ....   ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.....    ....+......... .
T Consensus       214 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~-~  289 (400)
T 1nxk_A          214 TTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN-P  289 (400)
T ss_dssp             CC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT-T
T ss_pred             cCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC-c
Confidence            6422   22234579999999999999999999999999999999999999997654322    23333332222111 2


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ....++.++++||.+||..||++|||++++++||||..
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            23468999999999999999999999999999999964

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-51  Score=382.62  Aligned_cols=263  Identities=24%  Similarity=0.381  Sum_probs=213.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC------CchhhHHHHHHHHHHcC--CCCceeEeecceee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP------PSSVTLKNEKEALDQIG--ICPQIVRCFGDDYS   73 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~------~~~~~~~~E~~~l~~l~--~~p~Iv~~~g~~~~   73 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+....      .......+|+.+++++.  .||||+++++.+..
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGH----FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCC----EEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCc----EEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            69999999999999999999887765    67888765321      22356778888888876  39999999996554


Q ss_pred             cc-CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEec
Q 017746           74 FE-KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADF  152 (366)
Q Consensus        74 ~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF  152 (366)
                      .. .....+++||||+.+ +|.+++.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            33 234467899999975 9999998754455999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          153 GLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       153 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      |+++.....   ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+....+....+..........
T Consensus       165 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          165 GLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             SCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            999876422   22334579999999999999999999999999999999999999999887766665555432111111


Q ss_pred             C----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          233 N----------------------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       233 ~----------------------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .                      ....+++++.+||.+||+.||++|||+.|+++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            1                      113578999999999999999999999999999999653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.7e-52  Score=405.20  Aligned_cols=256  Identities=24%  Similarity=0.381  Sum_probs=213.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|.++.+++    .+|+|.+.....   ....+.+|+.+++.++ ||||+++++.+    ...
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~----~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~----~~~   82 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQ----EYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSI----SEE   82 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTE----EEEEEEEESCSCHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEE----ECS
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCc----EEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEE----EEC
Confidence            58999999999999999999988765    677777665322   3456889999999998 99999999832    234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec---cCCceEEEecCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLA  155 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~~~vkl~DFG~a  155 (366)
                      ..+++|||||+||+|.+++...  +.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             CEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            5667999999999999999763  5699999999999999999999999999999999999998   4578999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      .......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+....+....+.........+ ..
T Consensus       161 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~  237 (444)
T 3soa_A          161 IEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP-EW  237 (444)
T ss_dssp             BCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT-TT
T ss_pred             EEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc-cc
Confidence            8764322  22334579999999999999999999999999999999999999998887666666655544332222 23


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..+++++++||.+||..||++|||+.|+++||||..
T Consensus       238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            468999999999999999999999999999999954

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.8e-52  Score=391.33  Aligned_cols=258  Identities=25%  Similarity=0.400  Sum_probs=210.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+....  .....+.+|+.+++.++ ||||+++++.+    ....
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~----~~~~   78 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHR----REGN   78 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECC-------CHHHHHHHHHHCC-CTTBCCEEEEE----ECSS
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCc----EEEEEEEEcccccchHHHHHHHHHHHHhCC-CCCCCeEEEEE----ecCC
Confidence            69999999999999999999987765    78888775422  23467899999999998 99999999842    2344


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++|||||+||+|.+++..  .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             eEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            56799999999999999965  3469999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCC-CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEY-EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ...........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||................  .........+
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~  234 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKI  234 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT--CTTSTTGGGS
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc--cccCCccccC
Confidence            3332233335679999999999988776 678999999999999999999998765543322222211  1222223568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +.++.+||.+||..||++|||++|+++||||...
T Consensus       235 ~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence            9999999999999999999999999999999653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-51  Score=383.85  Aligned_cols=256  Identities=27%  Similarity=0.445  Sum_probs=209.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++.. +    ..+|+|.+.....   ....+.+|++++++++ ||||+++++.+    ...
T Consensus        22 ~y~~~~~lG~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~----~~~   91 (311)
T 3niz_A           22 KYQKLEKVGEGTYGVVYKAKDSQ-G----RIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLIDVI----HSE   91 (311)
T ss_dssp             EEEEEEEEEECSSCEEEEEEETT-S----CEEEEEEEC------CHHHHHHHHHHHHHHCC-CTTBCCEEEEE----CCS
T ss_pred             hhHhhhhccCCCCeEEEEEEECC-C----CEEEEEEEecccccchhhHHHHHHHHHHHHcC-CCCEeeeeeEE----ccC
Confidence            68999999999999999999853 3    4788888764322   2356889999999998 99999999843    234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           92 RCLTLVFEFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             SCEEEEEECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             CEEEEEEcCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence            456799999986 99999876 4456999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC----
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN----  233 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----  233 (366)
                      .....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+...........    
T Consensus       170 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          170 GIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             TSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             CCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            43222  2233479999999999876 5689999999999999999999999998877777666655332211111    


Q ss_pred             ---------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          234 ---------------------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       234 ---------------------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                           +...+++++.+||.+||..||++|||++|+++||||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  306 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD  306 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence                                 11346789999999999999999999999999999964

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.9e-52  Score=394.65  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=215.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|+++.+++    .+|+|.+..    .......+.+|+.+++.++ ||||+++++.+   .. 
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~---~~-  112 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGN----HYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSF---KD-  112 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEE---EC-
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCC----EEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE---Ec-
Confidence            68899999999999999999987765    677777643    2244567888999999997 99999998743   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus       113 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~  190 (350)
T 1rdq_E          113 NSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccccccee
Confidence            44567999999999999999874  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....     ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+....+....+...     ...+|..
T Consensus       191 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----~~~~p~~  260 (350)
T 1rdq_E          191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-----KVRFPSH  260 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----CCCCCTT
T ss_pred             ccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-----CCCCCCC
Confidence            6321     23457999999999999999999999999999999999999999887666555555442     2345677


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~  272 (366)
                      ++.++.+||.+||..||++||+     +++|++||||...
T Consensus       261 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            8999999999999999999998     9999999999653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=387.70  Aligned_cols=255  Identities=24%  Similarity=0.394  Sum_probs=212.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-------chhhHHHHHHHHHHcCCCCceeEeecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-------SSVTLKNEKEALDQIGICPQIVRCFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~   74 (366)
                      +|.+++.||+|+||.||+|+++.+++    .+|+|.+.....       ....+.+|+.++++++ ||||+++++.+   
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~---   83 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGL----QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY---   83 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCC----EEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE---
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCc----EEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEE---
Confidence            48899999999999999999987765    677776654221       3467899999999998 99999999843   


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC----ceEEE
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND----EAKIA  150 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~  150 (366)
                       .....+++||||+++|+|.+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+
T Consensus        84 -~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           84 -ENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             -EeCCEEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence             234456799999999999999965  35799999999999999999999999999999999999998887    79999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      |||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+...... .
T Consensus       161 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~  236 (326)
T 2y0a_A          161 DFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE-F  236 (326)
T ss_dssp             CCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC-C
T ss_pred             ECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC-c
Confidence            999998764322   223457999999999999999999999999999999999999999887665555554443221 1


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+..+..++..+.+||.+||..||++|||++++++||||..
T Consensus       237 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence            11222467999999999999999999999999999999954

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.9e-52  Score=396.78  Aligned_cols=255  Identities=20%  Similarity=0.344  Sum_probs=213.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|.++.+++    .+|+|.+..    .......+.+|+.+|+.++ ||||+++++.+   .. 
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~----~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~---~~-   86 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKK----MYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSF---QD-   86 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEE---EC-
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE---Ee-
Confidence            58999999999999999999988765    677776643    2345567889999999998 99999999843   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+.||+|.+++.+  ++.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence            3456799999999999999975  35799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC---cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE---NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ....   ......+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||...........+.....  ....+
T Consensus       165 ~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~  239 (384)
T 4fr4_A          165 LPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTY  239 (384)
T ss_dssp             CCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCC
T ss_pred             ccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCC
Confidence            6422   22345679999999999964   4589999999999999999999999986655444443333322  22455


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCC-HHHHHcCCCcccC
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWT-AEMLLNHPFVCAD  272 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t-~~~ll~hp~~~~~  272 (366)
                      |..++.++.+||.+||..||++||+ ++++++||||...
T Consensus       240 p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          240 PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            6778999999999999999999998 9999999999653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.3e-51  Score=392.62  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=202.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+.........+.+|+.+++.++ ||||+++++.+.    ....+
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~----~~~~~   91 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKE----LVAVKYIERGAAIDENVQREIINHRSLR-HPNIVRFKEVIL----TPTHL   91 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCC----EEEEEEEESSTTSCHHHHHHHHHHHHCC-CTTBCCEEEEEE----CSSEE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCc----EEEEEEEecCccccHHHHHHHHHHHhCC-CCCCCcEEEEEe----eCCEE
Confidence            69999999999999999999987765    7899988776566678999999999998 999999998432    24456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc--eEEEecCCccccC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE--AKIADFGLAKKSS  159 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~--vkl~DFG~a~~~~  159 (366)
                      ++||||+++|+|.+++...  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        92 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            7999999999999999764  46999999999999999999999999999999999999987765  9999999998542


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCc-cchhhhHHHHHHHHhCCCCCCCCCcchHHHH-HHHhhcCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSL-LIRIGVGDELPNIPGD  237 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~emltg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (366)
                      .   .......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......... +...............
T Consensus       170 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (361)
T 3uc3_A          170 L---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR  246 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred             c---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence            2   222234579999999999988888765 8999999999999999999987654333322 2222222111112235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +++++.+||.+||..||++|||+.++++||||...
T Consensus       247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            79999999999999999999999999999999543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.7e-51  Score=392.01  Aligned_cols=255  Identities=24%  Similarity=0.389  Sum_probs=212.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|.++.+++    .+|+|.+.....   ....+.+|+.++++++ ||||+++++.+    ...
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~----~~~  100 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGL----EFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSI----QEE  100 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE----ECS
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCC----EEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE----EeC
Confidence            48899999999999999999987765    788888765322   3356889999999998 99999999843    234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC---ceEEEecCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND---EAKIADFGLA  155 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~DFG~a  155 (366)
                      ..+++||||++||+|.+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             CEEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            456799999999999999965  35699999999999999999999999999999999999998654   5999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      .......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.........+........ ....
T Consensus       179 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~  254 (362)
T 2bdw_A          179 IEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-SPEW  254 (362)
T ss_dssp             BCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-TTGG
T ss_pred             eEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-cccc
Confidence            8764222   22345799999999999999999999999999999999999999988766555555544332221 1222


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..+++++++||.+||..||++||++.++++||||+.
T Consensus       255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            458999999999999999999999999999999964

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.3e-51  Score=377.96  Aligned_cols=257  Identities=26%  Similarity=0.379  Sum_probs=206.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+.....   ....+.+|+.++++++ ||||+++++.+.   . .
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~---~-~   73 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHE----IVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH---S-D   73 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEE---E-T
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCc----eEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEE---e-C
Confidence            69999999999999999999987765    788887764322   3366789999999998 999999998432   2 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+++ +|.+++.. .++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        74 ~~~~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           74 KKLTLVFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             TEEEEEEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CEEEEEEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            456799999986 77777765 3567999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcC-CCCccchhhhHHHHHHHHhCCCCC-CCCCcchHHHHHHHhhcCC-------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGD-------  229 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~emltg~~pf-~~~~~~~~~~~~~~~~~~~-------  229 (366)
                      .....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..|| .+....+....+.+.....       
T Consensus       152 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             CCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence            43222  223447999999999998766 899999999999999999988775 4444444444433321110       


Q ss_pred             -----------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 -----------------ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 -----------------~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                       ........+++++++||.+||+.||++|||++|+++||||..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  288 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence                             011122357899999999999999999999999999999954

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.6e-51  Score=382.62  Aligned_cols=260  Identities=23%  Similarity=0.362  Sum_probs=199.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|.++.+++    .+|+|.+...  ......+.+|+.++++++ ||||+++++.+   . .+.
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~---~-~~~   76 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGV----YVALKEVKLDSEEGTPSTAIREISLMKELK-HENIVRLYDVI---H-TEN   76 (317)
T ss_dssp             -------------CEEEEEECSSSCC----EEEEEEEECCSTTCSCHHHHHHHHHHTTCC-BTTBCCEEEEE---C-CTT
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCc----EEEEEEeecccccccHHHHHHHHHHHHhcC-CCCcceEEEEE---E-ECC
Confidence            68999999999999999999887664    7888877542  234467889999999998 99999999843   2 234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           80 FYNLLLEYASRGSLADRVKKQN----NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      .+++||||+++ +|.+++....    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           77 KLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            56799999985 9999997642    135899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC----
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE----  230 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~----  230 (366)
                      +.......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+........    
T Consensus       156 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          156 RAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW  233 (317)
T ss_dssp             EETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred             eecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence            87643222  2234479999999999976 4689999999999999999999999998877666655544321100    


Q ss_pred             -------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          231 -------------------------LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       231 -------------------------~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                                               .+..+..++.++.+||.+||..||++|||++|+++||||....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                                     0011235788999999999999999999999999999996543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.1e-52  Score=393.10  Aligned_cols=250  Identities=25%  Similarity=0.416  Sum_probs=209.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+|+|.+..    .......+.+|+.+++.++ ||||+++++.+.    .
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~----~   80 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQ----KVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVIT----T   80 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEE----C
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEE----e
Confidence            69999999999999999999987765    778887643    2234467899999999998 999999998432    2


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+ +|+|.+++.+.  +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~  157 (336)
T 3h4j_B           81 PTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI  157 (336)
T ss_dssp             SSEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred             CCEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence            34567999999 67999999764  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCC-CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEY-EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ....   ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........     .......+|.
T Consensus       158 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-----i~~~~~~~p~  229 (336)
T 3h4j_B          158 MTDG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-----VNSCVYVMPD  229 (336)
T ss_dssp             TTTS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----CCSSCCCCCT
T ss_pred             ccCC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----HHcCCCCCcc
Confidence            6432   22334579999999999998887 6799999999999999999999987654332211     1122335567


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+++++.+||.+||..||.+|||++|+++||||..
T Consensus       230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          230 FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            78999999999999999999999999999999964

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.3e-51  Score=378.45  Aligned_cols=256  Identities=25%  Similarity=0.370  Sum_probs=205.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++. ++    ..+|+|.+....   .....+.+|+.++++++ ||||+++++.+.    ..
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~-~~----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~----~~   72 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNN-YG----ETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIH----TK   72 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TS----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEE----CS
T ss_pred             cchhhhhcccCCCEEEEEEEcC-CC----CEEEEEEEeccccccccchhHHHHHHHHHhcC-CCCEeeeeeEEc----cC
Confidence            6999999999999999999983 33    378888876432   23356789999999998 999999998432    23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+++ +|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        73 ~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           73 KRLVLVFEHLDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             SCEEEEEECCSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             CeEEEEEEecCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            456799999986 99999976 4467999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL------  231 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~------  231 (366)
                      ....  .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+....+....+.+.......      
T Consensus       151 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          151 GIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             Cccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhh
Confidence            4221  122334689999999999764 5899999999999999999999999887665555554442111100      


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          232 ------------------PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       232 ------------------~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                        ......+++++.+||.+||..||++|||++|+++||||+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                              0112357899999999999999999999999999999954

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.9e-52  Score=395.29  Aligned_cols=253  Identities=23%  Similarity=0.384  Sum_probs=203.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHH-HHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEAL-DQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l-~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.++++||+|+||.||+|+++.+++    .+|+|.+..    .......+.+|..++ +.++ ||||+++++.+   ..
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~----~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~---~~  110 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEV----FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSF---QT  110 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCC----EEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEE---EC
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCC----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEE---Ee
Confidence            58899999999999999999988765    567776643    223344566677764 4555 99999999743   33


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                       ...+++||||++||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++
T Consensus       111 -~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          111 -ADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence             34567999999999999999874  469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ......  ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+....+....+....     ..++.
T Consensus       188 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-----~~~~~  260 (373)
T 2r5t_A          188 ENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-----LQLKP  260 (373)
T ss_dssp             GGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-----CCCCS
T ss_pred             ccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----cCCCC
Confidence            643222  22345689999999999999999999999999999999999999998877666655554422     24566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCH----HHHHcCCCcccC
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTA----EMLLNHPFVCAD  272 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~----~~ll~hp~~~~~  272 (366)
                      .++.++++||.+||.+||++||++    +++++||||...
T Consensus       261 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          261 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            789999999999999999999986    699999999653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-51  Score=390.08  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=208.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|.++.+++    .+|+|.+....   ....+|++++.++..||||+++++.+    .+...+
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~---~~~~~E~~~l~~~~~hp~iv~~~~~~----~~~~~~   91 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNM----EFAVKIIDKSK---RDPTEEIEILLRYGQHPNIITLKDVY----DDGKYV   91 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEETTT---CCCHHHHHHHHHHTTSTTBCCEEEEE----ECSSEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEccc---CChHHHHHHHHHhcCCCCcCeEEEEE----EcCCEE
Confidence            48899999999999999999987764    78888876532   34578999999997799999999843    234567


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC----CceEEEecCCccc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN----DEAKIADFGLAKK  157 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~----~~vkl~DFG~a~~  157 (366)
                      ++|||||+||+|.+++.+  .+.+++..+..++.||+.||+|||++||+||||||+|||+..+    +.+||+|||+++.
T Consensus        92 ~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            799999999999999975  3579999999999999999999999999999999999998543    3599999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC--CCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD--ELPNIP  235 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~  235 (366)
                      ......  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+..+....  .....+
T Consensus       170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  247 (342)
T 2qr7_A          170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW  247 (342)
T ss_dssp             CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred             CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence            643222  2334579999999999998889999999999999999999999998654333333333332222  122234


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..+++++++||.+||..||++||++.++++||||..
T Consensus       248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            568999999999999999999999999999999954

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.3e-51  Score=383.90  Aligned_cols=255  Identities=25%  Similarity=0.419  Sum_probs=204.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|++... ...+..+|+|.+...     ......+.+|+.+++.++ ||||+++++.+   ..
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~---~~   92 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTG-ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAF---QT   92 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSS-TTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEE---EC
T ss_pred             HeEEEEEEEeCCCEEEEEEEEecc-CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEE---Ec
Confidence            589999999999999999998531 122457888887653     123456788999999998 99999999843   22


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                       ...+++||||++||+|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        93 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           93 -GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             -SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence             34567999999999999999764  469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      .......  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....     ..++.
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-----~~~p~  242 (327)
T 3a62_A          170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-----LNLPP  242 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----CCCCT
T ss_pred             ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----CCCCC
Confidence            6432222  2234579999999999999999999999999999999999999998876655555544422     34566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      .++.++.+||.+||..||++||     +++++++||||..
T Consensus       243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            7899999999999999999999     8899999999964

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9e-52  Score=397.28  Aligned_cols=260  Identities=24%  Similarity=0.344  Sum_probs=202.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+|+|++....   .......+|+.+++.+..||||+++++.+.  ..+.
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~--~~~~   83 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGE----VVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR--ADND   83 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCC----EEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CTTS
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCC----EEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe--cCCC
Confidence            69999999999999999999988765    78888775422   234567789999999988999999998543  2334


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++|||||++ +|.+++..   +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        84 ~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           84 RDVYLVFDYMET-DLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             SCEEEEEECCSE-EHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             CEEEEEecccCc-CHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            456799999985 99999976   36999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCC-------------------CCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchH
Q 017746          159 SCDG-------------------ERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV  218 (366)
Q Consensus       159 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~  218 (366)
                      ....                   ........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            3211                   0111234579999999999977 6799999999999999999999999998876666


Q ss_pred             HHHHHHhhcCCC-----------------------------CC-------------CCCCCCCHHHHHHHHHhcccCCCC
Q 017746          219 FSLLIRIGVGDE-----------------------------LP-------------NIPGDLSEQGKDFLIKCFLKDPKR  256 (366)
Q Consensus       219 ~~~~~~~~~~~~-----------------------------~~-------------~~~~~~s~~~~~ll~~cL~~dp~~  256 (366)
                      ...+........                             ..             ..+..+++++.+||.+||..||++
T Consensus       240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            555543211000                             00             011257899999999999999999


Q ss_pred             CCCHHHHHcCCCccc
Q 017746          257 RWTAEMLLNHPFVCA  271 (366)
Q Consensus       257 R~t~~~ll~hp~~~~  271 (366)
                      |||++|+++||||..
T Consensus       320 R~t~~e~l~Hp~~~~  334 (388)
T 3oz6_A          320 RISANDALKHPFVSI  334 (388)
T ss_dssp             SCCHHHHTTSTTTTT
T ss_pred             CCCHHHHhCCHHHHH
Confidence            999999999999954

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-51  Score=393.57  Aligned_cols=257  Identities=26%  Similarity=0.392  Sum_probs=214.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||.||+|.++.+++    .+|+|.+.... .....+.+|+.++++++ ||||+++++.+   . ....
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~---~-~~~~  122 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGR----VFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAF---E-DKYE  122 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCSHHHHHHHHHHHHHHTTCC-STTBCCEEEEE---E-CSSE
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCC----EEEEEEecccchhhHHHHHHHHHHHHhCC-CcCCCeEEEEE---E-eCCE
Confidence            58899999999999999999987765    67888776432 23456889999999998 99999999843   2 3445


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc--CCceEEEecCCcccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD--NDEAKIADFGLAKKS  158 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~~~vkl~DFG~a~~~  158 (366)
                      +++||||++||+|.+++.. .+..+++..+..++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++..
T Consensus       123 ~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence            6799999999999999975 3457999999999999999999999999999999999999974  467999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ....   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+...... ..+.....+
T Consensus       202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~  277 (387)
T 1kob_A          202 NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-FDEDAFSSV  277 (387)
T ss_dssp             CTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-CCSSTTTTS
T ss_pred             CCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCccccccC
Confidence            4322   223347999999999999999999999999999999999999999887665555555443322 222334568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ++++.+||.+||..||++|||+.++++||||...
T Consensus       278 s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence            9999999999999999999999999999999653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.1e-51  Score=388.60  Aligned_cols=257  Identities=25%  Similarity=0.380  Sum_probs=209.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC------CCCchhhHHHHHHHHHHcCCCCceeEeecceeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD------CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~------~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~   75 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+..      .......+.+|+.+++.++ ||||+++++.+.   
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~---   96 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQ----QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYS---   96 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEE---
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCC----EEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEE---
Confidence            48899999999999999999988765    778887643      1124567899999999998 999999998432   


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc---eEEE
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIA  150 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~---vkl~  150 (366)
                      . ...+++|||||+||+|.+++.+.  .+..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+
T Consensus        97 ~-~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A           97 S-DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             E-TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             e-CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence            2 34567999999999999888653  2345899999999999999999999999999999999999987654   9999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      |||++........  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.. ......+..... ..
T Consensus       176 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~-~~  251 (351)
T 3c0i_A          176 GFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKY-KM  251 (351)
T ss_dssp             CCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCC-CC
T ss_pred             cCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCC-CC
Confidence            9999987653222  2234579999999999999999999999999999999999999998753 233333333221 11


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+.....+++++++||.+||..||++|||+.++++||||..
T Consensus       252 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            11122468999999999999999999999999999999964

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-51  Score=378.50  Aligned_cols=254  Identities=25%  Similarity=0.393  Sum_probs=204.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---------------------------chhhHHHHHHH
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---------------------------SSVTLKNEKEA   54 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---------------------------~~~~~~~E~~~   54 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+.....                           ....+.+|+++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNT----YYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTE----EEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCc----EEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            68999999999999999999987764    678887654221                           13568899999


Q ss_pred             HHHcCCCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 017746           55 LDQIGICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDI  134 (366)
Q Consensus        55 l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDl  134 (366)
                      +++++ ||||+++++.+.  ......+++||||+++++|.+++.   .+.+++..+..++.||+.||+|||++||+||||
T Consensus        90 l~~l~-h~~iv~~~~~~~--~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  163 (298)
T 2zv2_A           90 LKKLD-HPNVVKLVEVLD--DPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI  163 (298)
T ss_dssp             HHTCC-CTTBCCEEEEEE--CSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             HHhCC-CCCCCeEEEEEE--cCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence            99998 999999998432  223456779999999999988753   357999999999999999999999999999999


Q ss_pred             CCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcC---CCCccchhhhHHHHHHHHhCCCCCC
Q 017746          135 KLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE---YEAPCDIWALGCAVVEMASGKPAWN  211 (366)
Q Consensus       135 kp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~emltg~~pf~  211 (366)
                      ||+|||++.++.+||+|||+++.......  ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            99999999999999999999987643221  223457999999999998765   4778999999999999999999998


Q ss_pred             CCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          212 HKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      ..........+....  ...+ ....+++++.+||.+||..||++|||+.|+++||||.
T Consensus       242 ~~~~~~~~~~~~~~~--~~~~-~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          242 DERIMCLHSKIKSQA--LEFP-DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             CSSHHHHHHHHHHCC--CCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             CccHHHHHHHHhccc--CCCC-CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            765544433333321  1122 2346899999999999999999999999999999984

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.4e-51  Score=418.10  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=217.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||.||+|+++.+++    .+|+|.+..    .......+..|..++..+..||+|+++++.   ++. 
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~----~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~---~~~-  413 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDE----LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC---FQT-  413 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCC----EEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE---CBC-
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCc----EEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE---EEe-
Confidence            58899999999999999999988765    677776653    234556788899999999879999999873   333 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...++|||||++||+|.+++.+.  +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            44567999999999999999874  4699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ......  .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+...     ...+|..
T Consensus       492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-----~~~~p~~  564 (674)
T 3pfq_A          492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----NVAYPKS  564 (674)
T ss_dssp             CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----CCCCCTT
T ss_pred             cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----CCCCCcc
Confidence            432222  234568999999999999999999999999999999999999999988766665555432     2356678


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH-----HHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTA-----EMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~-----~~ll~hp~~~~~  272 (366)
                      +++++++||.+||++||++||++     ++|++||||...
T Consensus       565 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            99999999999999999999997     999999999654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.9e-51  Score=410.71  Aligned_cols=258  Identities=24%  Similarity=0.342  Sum_probs=213.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||.||+|+++.+++    .+|+|.+..    .......+.+|+.+|+.++ ||||+++++.+   .. 
T Consensus       185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~---~~-  255 (576)
T 2acx_A          185 TFRQYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAY---ET-  255 (576)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEE---EC-
T ss_pred             ceEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEE---ee-
Confidence            48899999999999999999988765    677777643    2344566889999999998 99999998743   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.......+++..+..|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus       256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence            34577999999999999999764444599999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....   .....+||+.|+|||++.+..|+.++|||||||++|||++|++||...........+..... .....++..
T Consensus       336 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~p~~  411 (576)
T 2acx_A          336 VPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVPEEYSER  411 (576)
T ss_dssp             CCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-HCCCCCCTT
T ss_pred             cccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-cccccCCcc
Confidence            64322   22345799999999999999999999999999999999999999987643221122221111 112345677


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~  272 (366)
                      +++++++||.+||.+||++||     +++|+++||||...
T Consensus       412 ~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            999999999999999999999     79999999999653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.5e-51  Score=385.35  Aligned_cols=254  Identities=25%  Similarity=0.357  Sum_probs=195.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+|+|.+... .....+.+|+.++++++ ||||+++++.+   . ....+
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~---~-~~~~~  123 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQK----PYALKVLKKT-VDKKIVRTEIGVLLRLS-HPNIIKLKEIF---E-TPTEI  123 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEC-----------CHHHHHCC-CTTBCCEEEEE---E-CSSEE
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCc----EEEEEEeccc-hhHHHHHHHHHHHHhCC-CCCCcceeeeE---e-cCCeE
Confidence            48889999999999999999987654    7888887653 24456889999999998 99999999843   2 23456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc---CCceEEEecCCcccc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKS  158 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~~~  158 (366)
                      ++||||+++|+|.+++..  .+.+++.++..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       124 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            799999999999999965  356999999999999999999999999999999999999975   789999999999875


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcch-HHHHHHHhhcCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN-VFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...   ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+..... ...+.....
T Consensus       202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~-~~~~~~~~~  277 (349)
T 2w4o_A          202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY-YFISPWWDE  277 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-CCCTTTTTT
T ss_pred             Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-ccCCchhhh
Confidence            322   12234579999999999999999999999999999999999999998765543 2223322221 222233456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ++.++.+||.+||..||++|||+.++++||||..
T Consensus       278 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  311 (349)
T 2w4o_A          278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG  311 (349)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            8999999999999999999999999999999954

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.9e-51  Score=383.94  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=187.9

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEe
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      ++.||+|+||.||+|+++.+++    .+|+|.+..  .......+|+.+++.+..||||+++++.+    .....+++||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~--~~~~~~~~e~~~l~~l~~h~niv~~~~~~----~~~~~~~lv~   85 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQ----AFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHEVF----HDQLHTFLVM   85 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCC----EEEEEEEEG--GGHHHHHHHHHHHHHTTTCTTBCCEEEEE----ECSSEEEEEE
T ss_pred             CCccccCCCeEEEEEEECCCCC----EEEEEEECh--hhhhhHHHHHHHHHHhcCCCCeeEEEEEE----EcCCEEEEEE
Confidence            5889999999999999987765    788888765  45567889999999998899999999843    2344567999


Q ss_pred             ecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC---ceEEEecCCccccCCCC
Q 017746           86 EYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND---EAKIADFGLAKKSSCDG  162 (366)
Q Consensus        86 E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~DFG~a~~~~~~~  162 (366)
                      ||++||+|.+++.+.  +.+++.++..++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++......
T Consensus        86 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           86 ELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             CCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             EccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            999999999999763  5799999999999999999999999999999999999998765   79999999998764322


Q ss_pred             CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc----hHHHHHHHhhcCCCCC--CCCC
Q 017746          163 ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS----NVFSLLIRIGVGDELP--NIPG  236 (366)
Q Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~----~~~~~~~~~~~~~~~~--~~~~  236 (366)
                      .  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||......    .....+..........  ....
T Consensus       164 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (325)
T 3kn6_A          164 Q--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK  241 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred             C--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence            2  223457899999999999999999999999999999999999999765331    1223333332222111  1113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+++++++||.+||..||++|||++++++||||..
T Consensus       242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~  276 (325)
T 3kn6_A          242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD  276 (325)
T ss_dssp             TSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred             CCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence            57999999999999999999999999999999954

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.5e-51  Score=384.36  Aligned_cols=258  Identities=23%  Similarity=0.379  Sum_probs=212.1

Q ss_pred             cccc-CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            3 WLRG-DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         3 y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      |.+. +.||+|+||.||+|+++.+++    .+|+|.+...   ......+.+|+.++..+..||||+++++.+    ...
T Consensus        30 y~~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~----~~~  101 (327)
T 3lm5_A           30 YILTSKELGRGKFAVVRQCISKSTGQ----EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY----ENT  101 (327)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE----ECS
T ss_pred             EeeccceeCCCCCeEEEEEEECCCCC----EEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE----EeC
Confidence            5565 899999999999999987765    6777766542   223567889999999998789999999843    234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc---CCceEEEecCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLA  155 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a  155 (366)
                      ..+++||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            45679999999999999986544567999999999999999999999999999999999999987   789999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      +......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+...... ..+...
T Consensus       182 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~  257 (327)
T 3lm5_A          182 RKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD-YSEETF  257 (327)
T ss_dssp             EEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CCTTTT
T ss_pred             cccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc-cCchhh
Confidence            8764222   223457999999999999999999999999999999999999999887766655555544332 223344


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ..+++.+.+||.+||..||++|||++++++||||+..
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            5689999999999999999999999999999999654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.7e-51  Score=391.24  Aligned_cols=263  Identities=20%  Similarity=0.268  Sum_probs=208.9

Q ss_pred             CccccCeeeec--CCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHG--SFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G--~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|  +||.||+|+++.+++    .||+|.+....   .....+.+|+.+++.++ ||||+++++.+.   .
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~---~   97 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGE----YVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFI---A   97 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCC----EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE---E
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCC----EEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEE---E
Confidence            69999999999  999999999987765    78888876432   23456788999999998 999999998543   2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                       ...+++|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B           98 -DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             -TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             -CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence             3356799999999999999987655679999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCCC-----CcccccccCCCCCCCccccCC--cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC-
Q 017746          157 KSSCDGE-----RSQSFECRGTPLYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG-  228 (366)
Q Consensus       157 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~-  228 (366)
                      .......     .......+||+.|+|||++.+  ..|+.++|||||||++|+|++|+.||.+.........+...... 
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            5422211     111223479999999999987  67999999999999999999999999876555443322211000 


Q ss_pred             ----------------------------------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          229 ----------------------------------------DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       229 ----------------------------------------~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                                                              ......+..+++++.+||.+||+.||++|||++|+++|||
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence                                                    0001134457899999999999999999999999999999


Q ss_pred             cccCC
Q 017746          269 VCADD  273 (366)
Q Consensus       269 ~~~~~  273 (366)
                      |....
T Consensus       337 f~~~~  341 (389)
T 3gni_B          337 FKQIK  341 (389)
T ss_dssp             GGGC-
T ss_pred             HHHHh
Confidence            96543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.5e-51  Score=387.51  Aligned_cols=255  Identities=25%  Similarity=0.326  Sum_probs=209.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcC----CCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG----ICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~----~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+............|+.+++.+.    .||||+++++.+..    
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~----  107 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKK----YYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY----  107 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE----
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCe----EEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE----
Confidence            68999999999999999999987654    7899988754445567788999999997    48999999985432    


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc--------------
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD--------------  143 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--------------  143 (366)
                      ...+++||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.              
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            23567999999 889999998755556999999999999999999999999999999999999975              


Q ss_pred             -----------CCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCC
Q 017746          144 -----------NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNH  212 (366)
Q Consensus       144 -----------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~  212 (366)
                                 ++.+||+|||+|+.....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                       788999999999875321     2244799999999999999999999999999999999999999988


Q ss_pred             CCcchHHHHHHHhhcCCC-----------------------------------------CCCCCCCCCHHHHHHHHHhcc
Q 017746          213 KQDSNVFSLLIRIGVGDE-----------------------------------------LPNIPGDLSEQGKDFLIKCFL  251 (366)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~s~~~~~ll~~cL~  251 (366)
                      ....+....+........                                         .+..+...++.+.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            766655555443221000                                         000011124778899999999


Q ss_pred             cCCCCCCCHHHHHcCCCcc
Q 017746          252 KDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       252 ~dp~~R~t~~~ll~hp~~~  270 (366)
                      .||++|||++|+++||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence            9999999999999999984

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.2e-51  Score=382.15  Aligned_cols=259  Identities=25%  Similarity=0.383  Sum_probs=206.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+.....  ....+.+|+.++++++ ||||+++++.+.    ...
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~----~~~   73 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDN----LVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIH----TEK   73 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECC------CCCCCCCHHHHSCCC-CTTBCCEEEEEE----CSS
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCc----EEEEEEEecccccccchhHHHHHHHHHhcC-CCCCCeeeeEEe----eCC
Confidence            69999999999999999999987664    788887764222  2235568999999998 999999998432    234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++ +|.+++.. .+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        74 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           74 SLTLVFEYLDK-DLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             CEEEEEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEEEEeccccc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            56799999985 99999987 45579999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC----
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI----  234 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  234 (366)
                      ....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.+.........+    
T Consensus       152 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          152 IPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             CCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence            2221  2233468999999999876 56899999999999999999999999988776666665553322111111    


Q ss_pred             ---------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          235 ---------------------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       235 ---------------------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                                           ...+++++.+||.+||..||++|||++|+++||||....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                                 124688999999999999999999999999999996543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-51  Score=402.27  Aligned_cols=252  Identities=27%  Similarity=0.443  Sum_probs=204.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|+++.+++    .+|+|.+..    .......+.+|+.+++.++ ||||+++++.+.   . 
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~---~-  219 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGR----YYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQ---T-  219 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEE---E-
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCC----EEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEe---e-
Confidence            58899999999999999999988765    677777653    2234456778999999998 999999998432   2 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ...+++||||+++|+|.+++.+.  +.+++..+..++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|+
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            33467999999999999999764  469999999999999999999998 999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+....     ..+|.
T Consensus       298 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-----~~~p~  370 (446)
T 4ejn_A          298 EGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-----IRFPR  370 (446)
T ss_dssp             TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----CCCCT
T ss_pred             eccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-----CCCCc
Confidence            643222  22334679999999999999999999999999999999999999998876665555554422     24566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      .+++++.+||.+||.+||++||     +++++++||||..
T Consensus       371 ~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            7899999999999999999999     9999999999964

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.5e-51  Score=401.30  Aligned_cols=257  Identities=23%  Similarity=0.339  Sum_probs=202.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+++.||+|+||+||+|.+..+++    .+|+|++...   ......+.+|+.+++.++ ||||+++++.+....  .
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAVLDR----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTE----EEEEEEEESGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCC----EEEEEEECccccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCccc
Confidence            58899999999999999999988764    7888887642   123456789999999998 999999998653221  2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||+++ +|.+.+..    .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+
T Consensus       138 ~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          138 EFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             cCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            23456799999987 67777743    48999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC-------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-------  229 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~-------  229 (366)
                      .....   ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+....+.+.....       
T Consensus       213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          213 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             ----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            76422   22334579999999999999999999999999999999999999999887666555554321100       


Q ss_pred             ----------CCCCC---------CCC-----------CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 ----------ELPNI---------PGD-----------LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 ----------~~~~~---------~~~-----------~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                ..+..         +..           .++++++||.+||..||++|||++|+++||||..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                      00110         000           1567999999999999999999999999999964

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.9e-51  Score=405.31  Aligned_cols=259  Identities=25%  Similarity=0.347  Sum_probs=212.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.++||+|+||.||+|+++.+++    .+|+|.+..    .......+.+|+.++++++ ||||+++++.+   .. 
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~---~~-  256 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGK----LYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAF---ET-  256 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEE---EC-
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCc----EEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEE---ee-
Confidence            57888999999999999999988765    677777643    2234567889999999998 99999998743   33 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQN--NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      ...+++||||++||+|.+++....  ...+++..+..|+.||+.||+|||++||+||||||+||||+.+|.+||+|||++
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence            345679999999999999997632  346999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      +.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|++||...........+...... ....+|
T Consensus       337 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~~~~p  413 (543)
T 3c4z_A          337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAVTYP  413 (543)
T ss_dssp             EECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CCCCCC
T ss_pred             eeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-cccCCC
Confidence            87643322  223458999999999999999999999999999999999999999876432111112211111 223456


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCcccC
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCAD  272 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~  272 (366)
                      ..++.++++||.+||.+||++||+     +++|++||||...
T Consensus       414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            789999999999999999999996     5899999999653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.1e-50  Score=377.08  Aligned_cols=253  Identities=28%  Similarity=0.407  Sum_probs=211.2

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      |...+.||+|+||.||+|+++.+++    .+|+|.+.... .....+.+|+.++++++ ||||+++++.+..    ...+
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~----~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~----~~~~  117 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGR----QVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLV----GEEL  117 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETTTCCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEE----TTEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCc----EEEEEEEeccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEE----CCEE
Confidence            5667899999999999999987664    78899876533 34567889999999998 9999999984332    2346


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++.+   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       118 ~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  194 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  194 (321)
T ss_dssp             EEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence            699999999999999854   46999999999999999999999999999999999999999999999999999876533


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      ..  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....  .....+..++++
T Consensus       195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  270 (321)
T 2c30_A          195 VP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP--PKLKNSHKVSPV  270 (321)
T ss_dssp             SC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC--CCCTTGGGSCHH
T ss_pred             cc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCcCccccCCHH
Confidence            22  22345799999999999999999999999999999999999999987765554444433211  111223457999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +.+||.+||..||++|||++++++||||..
T Consensus       271 l~~li~~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          271 LRDFLERMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence            999999999999999999999999999954

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.3e-50  Score=369.27  Aligned_cols=257  Identities=23%  Similarity=0.393  Sum_probs=214.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|.++.+++    .+++|.+.....   ....+.+|+.++++++ ||||+++++.+    ...
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~   77 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGL----EFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSI----QEE   77 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE----ECS
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCc----eEEEEEeecccCCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEE----EcC
Confidence            68999999999999999999987765    688887754222   3356788999999998 99999999843    234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc---eEEEecCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLA  155 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~---vkl~DFG~a  155 (366)
                      ...++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.   +||+|||++
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~  155 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA  155 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence            4567999999999999999764  46999999999999999999999999999999999999987655   999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ......   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+........ ....
T Consensus       156 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  231 (284)
T 3kk8_A          156 IEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-SPEW  231 (284)
T ss_dssp             EECCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-TTTT
T ss_pred             EEcccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC-chhh
Confidence            876432   222345799999999999999999999999999999999999999988766655555544333222 2233


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                      ..+++++.+||.+||..||++|||++|+++||||....
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          232 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            46899999999999999999999999999999996543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.8e-51  Score=390.42  Aligned_cols=253  Identities=26%  Similarity=0.429  Sum_probs=205.8

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      ..+.||+|+||.||+|++..++.    .+|+|.+.... .....+.+|+.++++++ ||||+++++.+   . ....+++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~----~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~---~-~~~~~~l  163 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGL----KLAAKIIKTRGMKDKEEVKNEISVMNQLD-HANLIQLYDAF---E-SKNDIVL  163 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCC----EEEEEEEECCSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE---E-CSSEEEE
T ss_pred             cceEEecCcCEEEEEEEEcCCCc----EEEEEEEcccccccHHHHHHHHHHHHhCC-CCCCCeEEEEE---E-ECCEEEE
Confidence            36789999999999999987764    78888876532 24567889999999998 99999999843   2 2345679


Q ss_pred             EeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe--ccCCceEEEecCCccccCCC
Q 017746           84 LLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV--FDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl--~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ||||+++|+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||+  +.++.+||+|||+++.....
T Consensus       164 v~E~~~~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          164 VMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EEECCTTCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             EEeCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            9999999999999976 34569999999999999999999999999999999999999  56678999999999876432


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .   .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+....... .+.....++++
T Consensus       243 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~  318 (373)
T 2x4f_A          243 E---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL-EDEEFQDISEE  318 (373)
T ss_dssp             C---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS-CSGGGTTSCHH
T ss_pred             c---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-ChhhhccCCHH
Confidence            2   2234469999999999999999999999999999999999999999887666555555433221 11223468999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +++||.+||..||++|||++++++||||..
T Consensus       319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          319 AKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            999999999999999999999999999954

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.8e-51  Score=399.97  Aligned_cols=252  Identities=27%  Similarity=0.401  Sum_probs=214.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+...    ......+.+|+.+++.++ ||||+++++.+    ..
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~----~~   87 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGH----KVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVI----ST   87 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCC----EEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEE----EC
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE----EE
Confidence            68999999999999999999987765    7888877541    234467889999999998 99999999843    22


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+  ++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence            3456799999999999999965  35799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCC-CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEY-EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      .....   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+...     ....|.
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-----~~~~p~  237 (476)
T 2y94_A          166 MSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG-----IFYTPQ  237 (476)
T ss_dssp             CCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT-----CCCCCT
T ss_pred             ccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----CcCCCc
Confidence            64322   2234579999999999998876 67999999999999999999999887665555444332     224466


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .+++++.+||.+||..||++|||++++++||||...
T Consensus       238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            789999999999999999999999999999999653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.8e-50  Score=377.04  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=212.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-------chhhHHHHHHHHHHcCCCCceeEeecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-------SSVTLKNEKEALDQIGICPQIVRCFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~   74 (366)
                      +|.+++.||+|+||.||+|+++.+++    .+++|.+.....       ....+.+|+.+++++. ||||+++++.+   
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---   84 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGL----EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVY---   84 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE---
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCe----EEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEE---
Confidence            48899999999999999999987765    677777654221       2466899999999998 99999999843   


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC----ceEEE
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND----EAKIA  150 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~  150 (366)
                       .....+++||||+++++|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+
T Consensus        85 -~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           85 -ENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             -ecCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence             234456799999999999999975  35799999999999999999999999999999999999999887    79999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      |||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+..... ..
T Consensus       162 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~  237 (321)
T 2a2a_A          162 DFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY-DF  237 (321)
T ss_dssp             CCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-CC
T ss_pred             cCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-cc
Confidence            999998764322   22344699999999999999999999999999999999999999988766555544443221 11


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+..+..+++.+.+||.+||..||++|||++++++||||..
T Consensus       238 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          238 DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            11223467899999999999999999999999999999954

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.7e-50  Score=368.74  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=204.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|.+..++.    .+++|.+...  ......+.+|++++++++ ||||+++++.+    ....
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~----~~~~   93 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGL----ERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVF----EDYH   93 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEGGGCCSCHHHHHHHHHHHHTCC-CTTBCCEEEEE----ECSS
T ss_pred             heeecceeccCCCeEEEEEEEccCCc----eEEEEEeeccccchhHHHHHHHHHHHHhCC-CchHHhHHHhe----ecCC
Confidence            48899999999999999999987654    6777776542  234578899999999998 99999999843    2344


Q ss_pred             EEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe---ccCCceEEEecCC
Q 017746           80 FYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV---FDNDEAKIADFGL  154 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~  154 (366)
                      .+++||||+++|+|.+++...  .+..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            567999999999999999653  24579999999999999999999999999999999999999   4457899999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      +......   .......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+..........  ..+..
T Consensus       174 a~~~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~  247 (285)
T 3is5_A          174 AELFKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--NYAVE  247 (285)
T ss_dssp             CCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCC-
T ss_pred             ceecCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc--ccccc
Confidence            9875432   2223457999999999986 5688999999999999999999999988765544433332221  11222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ...+++++.+||.+||..||++|||+.|+++||||+.
T Consensus       248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             -CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            2347899999999999999999999999999999953

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.8e-50  Score=378.41  Aligned_cols=264  Identities=24%  Similarity=0.340  Sum_probs=211.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeecc---
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE---   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~---   75 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+....   .....+.+|+.+++.++ ||||+++++.+....   
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQ----KVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPY   92 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCC----EEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC----
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCC----EEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeecccccc
Confidence            68999999999999999999987765    78888775432   23456789999999998 999999998654321   


Q ss_pred             -CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCC
Q 017746           76 -KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        76 -~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                       .....+++||||+++ +|.+.+.. ....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence             114467799999986 88888876 345799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC--CcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          155 AKKSSCDGE--RSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       155 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      ++.......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+.........
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            987643222  122234579999999999876 56899999999999999999999999988776666655554322221


Q ss_pred             CCCCCC---------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          232 PNIPGD---------------------------LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       232 ~~~~~~---------------------------~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ...+..                           .++++.+||.+||..||++|||++|+++||||...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence            111110                           26789999999999999999999999999999543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=380.92  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=202.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---hhhHHHHHHHHHHcCCC-CceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---SVTLKNEKEALDQIGIC-PQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~E~~~l~~l~~~-p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|.+.. +    ..+|+|.+......   ...+.+|+.++.++..| |||+++++.+    ..
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~----~~   80 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNEK-K----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE----IT   80 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECTT-S----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE----EC
T ss_pred             EEEEEEEEecCCCeEEEEEEeCC-C----CEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE----ee
Confidence            58999999999999999998743 2    47899987653332   35678999999999843 9999999843    23


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||| +.+|+|.+++.+.  +.+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus        81 ~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           81 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             CCEEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            456779999 5577999999863  5799999999999999999999999999999999999996 67899999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC-----------cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE-----------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG  226 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~  226 (366)
                      .............+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||......  ...+....
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~  234 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAII  234 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHH
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHHh
Confidence            654333333345579999999999865           67888999999999999999999999765332  22333333


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       227 ~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .......++...+.++.+||.+||..||++|||+.++++||||...
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            3333445666778999999999999999999999999999999654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-50  Score=372.11  Aligned_cols=251  Identities=26%  Similarity=0.459  Sum_probs=210.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|.+..++.    .+++|.+..    .......+.+|+.++++++ ||||+++++.+    ..
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~   80 (279)
T 3fdn_A           10 DFEIGRPLGKGKFGNVYLAREKQSKF----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYF----HD   80 (279)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEE----EC
T ss_pred             cEEEeeEEecCCCeEEEEEEEccCCc----EEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheE----ec
Confidence            68999999999999999999987764    677777643    1233556889999999999 99999999843    23


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence            34567999999999999999874  4699999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....    ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+....     ..++..
T Consensus       159 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~  229 (279)
T 3fdn_A          159 APSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----FTFPDF  229 (279)
T ss_dssp             C------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-----CCCCTT
T ss_pred             CCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-----CCCCCc
Confidence            4321    2234479999999999999999999999999999999999999998876655555444322     245567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +++++.+||.+||..||++|||++++++||||...
T Consensus       230 ~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             CCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence            89999999999999999999999999999999654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.1e-50  Score=368.15  Aligned_cols=256  Identities=26%  Similarity=0.401  Sum_probs=211.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      .|.+.+.||+|+||.||+|.+..++.    .+++|.+...   ......+.+|+.++++++ ||||+++++.+.....+.
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~----~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTV----EVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSC
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCce----EEEEEEecchhhCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCC
Confidence            37788899999999999999987654    6777776542   223456889999999998 999999999765555566


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEec-cCCceEEEecCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG--FVHCDIKLQNVLVF-DNDEAKIADFGLA  155 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~~~vkl~DFG~a  155 (366)
                      ..+++||||+++|+|.+++.+.  +.+++..+..++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            7788999999999999999764  46999999999999999999999999  99999999999997 7889999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      .....    .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.........  ..........+..+
T Consensus       180 ~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~  252 (290)
T 1t4h_A          180 TLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTSGVKPASFD  252 (290)
T ss_dssp             GGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHTTTCCCGGGG
T ss_pred             ccccc----cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HHHHhccCCccccC
Confidence            76432    12234579999999998864 5999999999999999999999999876543332  22222233334455


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ...++++.+||.+||..||++|||++++++||||+.
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            667899999999999999999999999999999954

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.1e-50  Score=393.30  Aligned_cols=263  Identities=22%  Similarity=0.338  Sum_probs=193.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeecc-CC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~   77 (366)
                      +|.+++.||+|+||+||+|+++.+++    .||+|++.....   ....+.+|+.+|+.++ ||||+++++.+.... ..
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  128 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKR----VVAIKKILRVFEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVEK  128 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--C----EEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTT
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCc----EEEEEEechhhcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCccc
Confidence            58999999999999999999987765    788888765322   2356789999999998 999999998653322 23


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+. |+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus       129 ~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          129 FDELYVVLEIAD-SDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             CceEEEEEeccc-cchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            345779999985 599999965  35799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCC-------------------------cccccccCCCCCCCcccc-CCcCCCCccchhhhHHHHHHHHh------
Q 017746          158 SSCDGER-------------------------SQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMAS------  205 (366)
Q Consensus       158 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~emlt------  205 (366)
                      .......                         ......+||+.|+|||++ .+..|+.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            6432211                         122345799999999976 56779999999999999999999      


Q ss_pred             -----CCCCCCCCCc--------------------chHHHHHHHhhc--------------------------CCCCCCC
Q 017746          206 -----GKPAWNHKQD--------------------SNVFSLLIRIGV--------------------------GDELPNI  234 (366)
Q Consensus       206 -----g~~pf~~~~~--------------------~~~~~~~~~~~~--------------------------~~~~~~~  234 (366)
                           |+++|.+...                    .+....+.....                          .......
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 7777765431                    111111111100                          0000111


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ...+++++.+||.+||..||++|||++|+++||||...
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            23468999999999999999999999999999999654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.9e-50  Score=387.18  Aligned_cols=259  Identities=25%  Similarity=0.351  Sum_probs=209.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc--CCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--KGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~~~~   79 (366)
                      +|..++.||+|+||+||+|++..+++    .||+|++...   .....+|+++|+.++ ||||+++++.++...  .+..
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~---~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGE----LVAIKKVLQD---KRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEECC---TTSCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTTEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCc----EEEEEEeccc---chhHHHHHHHHHHcC-CCCccceeeEEeccCCCCcce
Confidence            68999999999999999999987664    7888887642   234567999999998 999999998665432  3455


Q ss_pred             EEEEEeecCCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC-CceEEEecCCcc
Q 017746           80 FYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN-DEAKIADFGLAK  156 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~DFG~a~  156 (366)
                      ++++||||+++ +|.+.+..  .....+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            67899999986 78777653  234679999999999999999999999999999999999999965 578999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc--------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV--------  227 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~--------  227 (366)
                      ......   .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+....+....+.+...        
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            764322   22345799999999998765 799999999999999999999999988766555544443210        


Q ss_pred             -------CCCCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          228 -------GDELPN---------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       228 -------~~~~~~---------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                             ....|.         ++..+++++.+||.+||..||++||++.|+++||||...
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence                   011121         234578999999999999999999999999999999654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.2e-50  Score=393.46  Aligned_cols=255  Identities=29%  Similarity=0.472  Sum_probs=199.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---------CCchhhHHHHHHHHHHcCCCCceeEeeccee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---------PPSSVTLKNEKEALDQIGICPQIVRCFGDDY   72 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---------~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~   72 (366)
                      +|.+++.||+|+||+||+|.+..+++    .+|+|.+...         ......+.+|+.+|++++ ||||+++++.+ 
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~-  209 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCK----KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF-  209 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEE-
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCc----EEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEE-
Confidence            58899999999999999999988765    6777776531         112335789999999998 99999999842 


Q ss_pred             eccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC---ceEE
Q 017746           73 SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND---EAKI  149 (366)
Q Consensus        73 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~vkl  149 (366)
                        .. +. +++||||+++|+|.+++..  .+.+++..+..++.||+.||+|||++||+||||||+|||++.++   .+||
T Consensus       210 --~~-~~-~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          210 --DA-ED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             --ES-SE-EEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             --ec-Cc-eEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEE
Confidence              22 33 5699999999999998864  35799999999999999999999999999999999999997554   5999


Q ss_pred             EecCCccccCCCCCCcccccccCCCCCCCccccCC---cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh
Q 017746          150 ADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE---NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG  226 (366)
Q Consensus       150 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~  226 (366)
                      +|||+|+....   .......+||+.|+|||++.+   ..|+.++|||||||++|+|++|++||...............+
T Consensus       284 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~  360 (419)
T 3i6u_A          284 TDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG  360 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT
T ss_pred             eecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC
Confidence            99999987642   222334579999999999864   668889999999999999999999998765443333333333


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       227 ~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .....+.....+++++.+||.+||..||++|||++++++||||..
T Consensus       361 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            222333333568999999999999999999999999999999953

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-50  Score=379.45  Aligned_cols=258  Identities=21%  Similarity=0.299  Sum_probs=204.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeecc----
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE----   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~----   75 (366)
                      +|.+++.||+|+||.||+|+++.+++    .+|+|.+...  ......+.+|+.++++++ ||||+++++.+....    
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDC----NYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCC----EEEEEEEECCSTTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCc----EEEEEEeecCCchhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccchh
Confidence            58899999999999999999987765    7888887642  234567899999999998 999999998653211    


Q ss_pred             -------------------------------------------------CCeeEEEEEeecCCCCCHHHHHHHhCC-CCC
Q 017746           76 -------------------------------------------------KGERFYNLLLEYASRGSLADRVKKQNN-GRL  105 (366)
Q Consensus        76 -------------------------------------------------~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~l  105 (366)
                                                                       ....++++|||||++|+|.+++.+... ...
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                             112347899999999999999976321 235


Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCC----------cccccccCCCC
Q 017746          106 QESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER----------SQSFECRGTPL  175 (366)
Q Consensus       106 ~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~----------~~~~~~~gt~~  175 (366)
                      ++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........          ......+||+.
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            66679999999999999999999999999999999999999999999999876543211          12234579999


Q ss_pred             CCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCC
Q 017746          176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPK  255 (366)
Q Consensus       176 y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~  255 (366)
                      |+|||++.+..++.++|||||||++|+|++|..|+..     ....+.... ....+......++++.+||.+||..||+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCC
Confidence            9999999999999999999999999999999887532     122222222 2233333345678889999999999999


Q ss_pred             CCCCHHHHHcCCCcc
Q 017746          256 RRWTAEMLLNHPFVC  270 (366)
Q Consensus       256 ~R~t~~~ll~hp~~~  270 (366)
                      +|||++++++||||+
T Consensus       316 ~Rps~~~~l~~~~f~  330 (332)
T 3qd2_B          316 ERPEATDIIENAIFE  330 (332)
T ss_dssp             GSCCHHHHHHSTTCC
T ss_pred             cCCCHHHHhhchhhh
Confidence            999999999999995

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.1e-50  Score=385.99  Aligned_cols=258  Identities=24%  Similarity=0.396  Sum_probs=209.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc------
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE------   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~------   75 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|++...   .....+|+++++.++ ||||+++++.++...      
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~~~~~---~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGK----RFALKKVLQD---PRYKNRELDIMKVLD-HVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCC----EEEEEEEECC---TTSCCHHHHHHTTCC-CTTBCCEEEEEEEC-------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCC----EEEEEEEecC---cchHHHHHHHHHHcC-CCCccchhheeeecCcccccc
Confidence            69999999999999999999987765    7888887643   234458999999998 999999998664322      


Q ss_pred             ----------------------------CCeeEEEEEeecCCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH
Q 017746           76 ----------------------------KGERFYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSMLKGLRHIH  125 (366)
Q Consensus        76 ----------------------------~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH  125 (366)
                                                  .+..++++||||+++ +|.+.+..  ..+..+++..++.++.||+.||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                        234457899999985 98888864  24567999999999999999999999


Q ss_pred             HCCcEecCCCCCcEEec-cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHH
Q 017746          126 SKGFVHCDIKLQNVLVF-DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEM  203 (366)
Q Consensus       126 ~~givHrDlkp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~em  203 (366)
                      ++||+||||||+|||++ .++.+||+|||+|+......   ......||+.|+|||++.+. .++.++|||||||++|+|
T Consensus       159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            99999999999999998 68899999999998764322   23345789999999998775 499999999999999999


Q ss_pred             HhCCCCCCCCCcchHHHHHHHhhcC---------------CCCCC---------CCCCCCHHHHHHHHHhcccCCCCCCC
Q 017746          204 ASGKPAWNHKQDSNVFSLLIRIGVG---------------DELPN---------IPGDLSEQGKDFLIKCFLKDPKRRWT  259 (366)
Q Consensus       204 ltg~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~---------~~~~~s~~~~~ll~~cL~~dp~~R~t  259 (366)
                      ++|++||.+....+....+.+....               ...|.         ++..+++++.+||.+||..||++|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            9999999988766655555432110               01111         34558899999999999999999999


Q ss_pred             HHHHHcCCCccc
Q 017746          260 AEMLLNHPFVCA  271 (366)
Q Consensus       260 ~~~ll~hp~~~~  271 (366)
                      +.|+++||||..
T Consensus       316 ~~e~l~hp~f~~  327 (383)
T 3eb0_A          316 PYEAMAHPFFDH  327 (383)
T ss_dssp             HHHHHTSGGGHH
T ss_pred             HHHHhcCHHHHH
Confidence            999999999954

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-50  Score=374.44  Aligned_cols=249  Identities=28%  Similarity=0.363  Sum_probs=199.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.......   .......|+..+..+..||||+++++.+.    ..
T Consensus        58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~----~~  129 (311)
T 3p1a_A           58 SFQRLSRLGHGSYGEVFKVRSKEDGR----LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE----EG  129 (311)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTSC----EEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE----ET
T ss_pred             heeeeheeccCCCeEEEEEEECCCCe----EEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE----eC
Confidence            48889999999999999999987664    788997754322   23345566677777756999999998432    23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+ +++|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          130 GILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             CEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            4567999999 56999999874 457999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ...   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...   .....+.   .....+.++..+
T Consensus       208 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~---~~~~~~~~~~~~  277 (311)
T 3p1a_A          208 GTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLR---QGYLPPEFTAGL  277 (311)
T ss_dssp             C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHT---TTCCCHHHHTTS
T ss_pred             ccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHh---ccCCCcccccCC
Confidence            432   22334469999999999876 7999999999999999999997776543   2222222   222233445668


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      ++++.+||.+||..||++|||++++++||||+
T Consensus       278 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (311)
T 3p1a_A          278 SSELRSVLVMMLEPDPKLRATAEALLALPVLR  309 (311)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence            99999999999999999999999999999995

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.5e-50  Score=377.41  Aligned_cols=253  Identities=26%  Similarity=0.448  Sum_probs=213.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||++++..+++    .+++|.+...    ......+.+|+.+++.++ ||||+++++.+    ..
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~----~~  112 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDADTKE----VFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFF----ED  112 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE----EC
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE----ec
Confidence            58999999999999999999987765    6777766532    123466888999999998 99999999843    23


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++++|.+++...  +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       113 ~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  190 (335)
T 2owb_A          113 NDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK  190 (335)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence            44677999999999999999764  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+....     ..++..
T Consensus       191 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~  263 (335)
T 2owb_A          191 VEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-----YSIPKH  263 (335)
T ss_dssp             CCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-----CCCCTT
T ss_pred             cccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-----CCCCcc
Confidence            6433222  234579999999999999999999999999999999999999998776555444443322     245567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ++.++.+||.+||..||++||+++++++||||...
T Consensus       264 ~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          264 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            89999999999999999999999999999999643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-50  Score=370.49  Aligned_cols=253  Identities=26%  Similarity=0.464  Sum_probs=189.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+...    ......+.+|+.++++++ ||||+++++.+    ..
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~   82 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGL----EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYF----ED   82 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEE----EC
T ss_pred             cceeeeeecCCCceEEEEEEEccCCc----eEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEE----cc
Confidence            58999999999999999999877665    6788876531    233467889999999998 99999999843    23


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           83 SNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCeEEEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            4567799999999999999976 345799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+   .  ......+..
T Consensus       162 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~--~~~~~~~~~  234 (278)
T 3cok_A          162 LKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV---V--LADYEMPSF  234 (278)
T ss_dssp             CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---C--SSCCCCCTT
T ss_pred             ccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---h--hcccCCccc
Confidence            643222  223457999999999999999999999999999999999999999876554433221   1  112245667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ++.++.+||.+||..||++||+++++++||||..
T Consensus       235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  268 (278)
T 3cok_A          235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR  268 (278)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence            8999999999999999999999999999999954

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-50  Score=378.07  Aligned_cols=258  Identities=24%  Similarity=0.331  Sum_probs=207.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC------chhhHHHHHHHHHHcCCCCceeEeecceeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP------SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~   75 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+.....      ....+.+|++++++++ ||||+++++.+   .
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---~   82 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQ----IVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAF---G   82 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCS----EEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEE---C
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCc----EEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEE---e
Confidence            68999999999999999999887654    788888764211      2346789999999998 99999999843   2


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                       ....+++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        83 -~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           83 -HKSNISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             -CTTCCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             -eCCceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence             23345699999987 99999976 4457999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC---
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL---  231 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~---  231 (366)
                      +.......  .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+.........   
T Consensus       160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            87643222  22345799999999999764 5889999999999999999999999888766665555443211110   


Q ss_pred             ---------------CCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          232 ---------------PNI-----PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       232 ---------------~~~-----~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                     +..     ...++.++++||.+||..||++|||++|+++||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                           011     14467899999999999999999999999999999543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.4e-50  Score=378.92  Aligned_cols=257  Identities=23%  Similarity=0.319  Sum_probs=200.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+.....   ....+.+|+.++++++ ||||+++++.+.   . .
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~---~-~  105 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNE----TVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIH---H-N  105 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTE----EEEEEECCCCC--------CHHHHHHGGGCC-CTTBCCEEEEEE---E-T
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCc----eEEEEEEcccccccccchhHHHHHHHHHHcC-CCCcceEEEEEe---c-C
Confidence            68999999999999999999887754    788998764322   2345778999999998 999999998432   2 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec-----cCCceEEEecC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF-----DNDEAKIADFG  153 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-----~~~~vkl~DFG  153 (366)
                      ..+++||||+++ +|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++     .++.+||+|||
T Consensus       106 ~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          106 HRLHLIFEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             CEEEEEEecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            456799999985 999999763  4699999999999999999999999999999999999994     44569999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      +++......  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+..........
T Consensus       183 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          183 LARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            998764222  222344689999999999874 58999999999999999999999998877665555544432111100


Q ss_pred             CC-------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          233 NI-------------------------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       233 ~~-------------------------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ..                         +..+++++.+||.+||..||++|||++|+++||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence            00                         01168999999999999999999999999999999654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.5e-50  Score=397.40  Aligned_cols=255  Identities=26%  Similarity=0.426  Sum_probs=211.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+..   .......+.+|+.++++++ ||||+++++.+    ...
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~----~~~   93 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQ----EYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEIL----EDS   93 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETTTCC----EEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC-CTTBCCEEEEE----ECS
T ss_pred             ceEEeEEEeecCCEEEEEEEECCCCC----EEEEEEEecccccchHHHHHHHHHHHHHhCC-CCCcCeEEEEE----EcC
Confidence            58999999999999999999987765    677777643   2345677899999999998 99999999843    234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec---cCCceEEEecCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLA  155 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~~~vkl~DFG~a  155 (366)
                      ..+++|||||.+|+|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            5677999999999999999764  4699999999999999999999999999999999999995   4567999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      +.....   ......+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+....+....+.........+. .
T Consensus       172 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~  246 (486)
T 3mwu_A          172 TCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ-W  246 (486)
T ss_dssp             TTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG-G
T ss_pred             eECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc-c
Confidence            876432   22234579999999999876 599999999999999999999999988876666555554433322222 2


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ..+++++++||.+||..||++|||+.++++||||...
T Consensus       247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            4589999999999999999999999999999999654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.9e-50  Score=365.66  Aligned_cols=255  Identities=25%  Similarity=0.356  Sum_probs=210.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+.+.||+|+||.||+|.++.++.    .+++|.+... ......+.+|++++++++ ||||+++++.+    .....
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~~a~k~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~----~~~~~   80 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRI----RRAAKKIPKYFVEDVDRFKQEIEIMKSLD-HPNIIRLYETF----EDNTD   80 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCSCHHHHHHHHHHHHTCC-CTTBCCEEEEE----ECSSE
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCc----EEEEEeehhhccchHHHHHHHHHHHHhCC-CCCEeeEEEEE----ecCCe
Confidence            58899999999999999999987654    6777776542 345678899999999997 99999999843    23445


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe---ccCCceEEEecCCccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV---FDNDEAKIADFGLAKK  157 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~  157 (366)
                      +++||||+++++|.+++...  +.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            67999999999999999764  469999999999999999999999999999999999999   7788999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....   ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+....+...... ........
T Consensus       159 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  233 (277)
T 3f3z_A          159 FKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT-FPEKDWLN  233 (277)
T ss_dssp             CCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCHHHHTT
T ss_pred             ccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-CCchhhhc
Confidence            64322   22345699999999998765 999999999999999999999999887665555444432211 11111125


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +++++.+||.+||..||++|||+.++++||||...
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          234 VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            79999999999999999999999999999999543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.9e-50  Score=368.59  Aligned_cols=253  Identities=26%  Similarity=0.446  Sum_probs=213.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+++|.....    ......+.+|+.+++.++ ||||+++++.+    ..
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~----~~   86 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKE----VFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFF----ED   86 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE----EC
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCc----eEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeee----cc
Confidence            58999999999999999999987765    6777766542    123456888999999997 99999999843    23


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++++|.+++...  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        87 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  164 (294)
T 2rku_A           87 NDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK  164 (294)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence            44567999999999999999764  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+...     ...++..
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~  237 (294)
T 2rku_A          165 VEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----EYSIPKH  237 (294)
T ss_dssp             CCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----CCCCCTT
T ss_pred             cccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-----cCCCccc
Confidence            6433222  23357999999999999999999999999999999999999999877655444333321     2345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ++..+.++|.+||..||++|||++++++||||...
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          238 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             cCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence            89999999999999999999999999999999543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.9e-50  Score=396.08  Aligned_cols=254  Identities=25%  Similarity=0.434  Sum_probs=208.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|+++.++.    .+|+|.+...   ......+.+|+.+++.++ ||||+++++.+    ...
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~----~~~  108 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHV----ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFF----EDK  108 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCC----EEEEEEEEC-----CTTHHHHHHHHHHTTCC-CTTBCCEEEEE----ECS
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCc----EEEEEEEeccccCchHHHHHHHHHHHHHhCC-CCCCCeEEEEE----EeC
Confidence            48899999999999999999987765    6677766542   234567899999999998 99999999843    234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC---CceEEEecCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN---DEAKIADFGLA  155 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a  155 (366)
                      ..+++|||||++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++..   +.+||+|||++
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            4577999999999999999764  469999999999999999999999999999999999999764   45999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ......   ......+||+.|+|||++. ..|+.++|||||||++|+|++|++||.+....+....+.........+ ..
T Consensus       187 ~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~  261 (494)
T 3lij_A          187 AVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP-EW  261 (494)
T ss_dssp             EECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG-GG
T ss_pred             eECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch-hc
Confidence            876422   2233457999999999986 569999999999999999999999999887766666655543332222 22


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..+++++++||.+||..||++|||+.++++||||..
T Consensus       262 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          262 KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             ccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            458999999999999999999999999999999954

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.1e-50  Score=397.41  Aligned_cols=256  Identities=24%  Similarity=0.424  Sum_probs=210.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--------------CchhhHHHHHHHHHHcCCCCceeEe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--------------PSSVTLKNEKEALDQIGICPQIVRC   67 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~E~~~l~~l~~~p~Iv~~   67 (366)
                      +|.+++.||+|+||+||+|+++.++.    .+|+|.+....              .....+.+|+.++++++ ||||+++
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~  111 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHS----EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKL  111 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCC----EEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBCCE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCc----EEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCCeE
Confidence            58999999999999999999988765    66777665422              23467889999999998 9999999


Q ss_pred             ecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC--
Q 017746           68 FGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND--  145 (366)
Q Consensus        68 ~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~--  145 (366)
                      ++.+    .....+++|||||+||+|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+|||++.++  
T Consensus       112 ~~~~----~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          112 FDVF----EDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             EEEE----ECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCC
T ss_pred             EEEE----EcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCC
Confidence            9843    2345677999999999999999764  4699999999999999999999999999999999999998776  


Q ss_pred             -ceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 017746          146 -EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       146 -~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~  224 (366)
                       .+||+|||+++......   .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+....+....+..
T Consensus       186 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             SSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence             69999999998764322   233457999999999987 4699999999999999999999999998877666555554


Q ss_pred             hhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       225 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                      ....... .....+++++++||.+||..||++|||++++++||||....
T Consensus       262 ~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          262 GKYYFDF-NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             CCCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CCCCCCc-cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            3221111 11245899999999999999999999999999999996543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6e-50  Score=373.33  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=201.0

Q ss_pred             Ccccc-CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRG-DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+. +.||+|+||+||+|++..+++    .+|+|.+.... .....+.+|++++.++..||||+++++.+.   . ..
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~---~-~~   84 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQ----EYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE---E-ED   84 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCC----EEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE---E-TT
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCc----EEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe---e-CC
Confidence            46774 789999999999999877665    78888876532 345678999999999766999999998432   2 34


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc---eEEEecCCcc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAK  156 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~---vkl~DFG~a~  156 (366)
                      .+++||||+++|+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.   +||+|||++.
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            567999999999999999874  46999999999999999999999999999999999999988775   9999999998


Q ss_pred             ccCCCCC-----CcccccccCCCCCCCccccCC-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCcch---------
Q 017746          157 KSSCDGE-----RSQSFECRGTPLYMSPESVNE-----NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN---------  217 (366)
Q Consensus       157 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~emltg~~pf~~~~~~~---------  217 (366)
                      .......     .......+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.....         
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            6532211     111223469999999999875     568999999999999999999999998754321         


Q ss_pred             ------HHHHHHHhhcCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          218 ------VFSLLIRIGVGDELP-NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       218 ------~~~~~~~~~~~~~~~-~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                            ....+.....  ..| .....++.++++||.+||..||++|||++|+++||||..
T Consensus       243 ~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  301 (316)
T 2ac3_A          243 PACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG  301 (316)
T ss_dssp             HHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred             hhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence                  1222222111  111 011357899999999999999999999999999999954

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=373.22  Aligned_cols=261  Identities=26%  Similarity=0.443  Sum_probs=210.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc--CCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--KGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~~~~   79 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+.........+.+|+.+++++..||||+++++.+....  ....
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           25 IFELVELVGNGTYGQVYKGRHVKTGQ----LAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCC----eEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            58899999999999999999987654    78899887666667889999999999966999999998654322  1145


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+++....+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            67799999999999999987545679999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCCCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ...  .......||+.|+|||++.     +..++.++|||||||++|+|++|..||...........+...   ......
T Consensus       181 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~  255 (326)
T 2x7f_A          181 RTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PAPRLK  255 (326)
T ss_dssp             ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCS
T ss_pred             cCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---ccccCC
Confidence            221  1223446999999999987     567899999999999999999999999876554433333322   222233


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +..++..+.+||.+||..||++||+++++++||||..
T Consensus       256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             ccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence            4568999999999999999999999999999999954

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.2e-50  Score=384.52  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=203.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCC-CCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGI-CPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~-~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|.+.. +    ..+|+|.+.....   ....+.+|+.+|+++.. ||||+++++++.    .
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~----~  127 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-K----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI----T  127 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-C----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE----C
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-C----CEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe----c
Confidence            48999999999999999998754 3    4788998765322   34568899999999984 699999998432    2


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||| +.+++|.+++.+.  ..+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus       128 ~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          128 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             SSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             CCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence            345779999 5678999999863  4789999999999999999999999999999999999995 58999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC-----------cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE-----------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG  226 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~  226 (366)
                      .............+||+.|+|||++.+           ..|+.++|||||||++|+|++|+.||......  ...+....
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~~~~  281 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAII  281 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHH
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HHHHHHHh
Confidence            653333223345579999999999865           46888999999999999999999999765432  22333333


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       227 ~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .......++...+.++.+||.+||..||++||++.++++||||...
T Consensus       282 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            3333334556678999999999999999999999999999999654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-50  Score=400.64  Aligned_cols=255  Identities=27%  Similarity=0.441  Sum_probs=213.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|+++.+++    .+|+|.+...    ......+.+|+.++++++ ||||+++++.+    ..
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~----~~   97 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQ----ECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFF----ED   97 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEE----EC
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCC----EEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEE----Ee
Confidence            58899999999999999999987765    6788876542    235677899999999998 99999999843    23


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe---ccCCceEEEecCC
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV---FDNDEAKIADFGL  154 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~  154 (366)
                      ...+++|||||.+|+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             CCEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            4567799999999999999975  3579999999999999999999999999999999999999   4678999999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ++......   .....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+....+....+.........|. 
T Consensus       176 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-  250 (484)
T 3nyv_A          176 STHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ-  250 (484)
T ss_dssp             HHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG-
T ss_pred             eEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc-
Confidence            98764322   2234579999999999876 699999999999999999999999998876666555554433322222 


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ...+++++++||.+||..||++|||++++++||||...
T Consensus       251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          251 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            24589999999999999999999999999999999653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-49  Score=378.92  Aligned_cols=257  Identities=24%  Similarity=0.364  Sum_probs=205.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|++.....   ....+.+|+.+++.++ ||||+++++.+..-.  .
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~  100 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGA----KVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLD  100 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCC----EEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTT
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCC----EEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCccc
Confidence            58899999999999999999987765    789998754322   2356789999999998 999999998543211  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||+ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          101 DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            123457999999 7799999976   469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC-------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG-------  228 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~-------  228 (366)
                      .....     ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+....+....+......       
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            76421     234579999999999877 78999999999999999999999999987765555544432110       


Q ss_pred             -------------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          229 -------------------DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       229 -------------------~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                         .....+...+++++.+||.+||..||++|||++++++||||...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                               11112334578999999999999999999999999999999643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2e-49  Score=372.01  Aligned_cols=255  Identities=22%  Similarity=0.309  Sum_probs=206.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+..  .....+.+|+.+++++..||||+++++.+.  .......
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~--~~~~~~~  108 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNE----KVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVK--DPVSRTP  108 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEE--CTTTCCE
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCc----EEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeec--cCCCCce
Confidence            58899999999999999999987764    789998765  556789999999999988999999998432  2224456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-ceEEEecCCccccCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSC  160 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~  160 (366)
                      ++||||+++++|.+++..     +++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus       109 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            799999999999999843     89999999999999999999999999999999999999776 899999999987643


Q ss_pred             CCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcch-HHHHHHHh-------------
Q 017746          161 DGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN-VFSLLIRI-------------  225 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~-~~~~~~~~-------------  225 (366)
                      ...   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+...             
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            322   234469999999999877 679999999999999999999999996543321 11111110             


Q ss_pred             hcCC-------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          226 GVGD-------------------ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       226 ~~~~-------------------~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ....                   .....+..+++++.+||.+||..||++|||++|+++||||...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            0000                   0011122379999999999999999999999999999999643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-49  Score=380.21  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=212.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC---CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS---SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~---~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|++...+   ...+..+|+|.+.....  ....+.+|+.+++++..||||+++++.+   . 
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---~-  157 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC---T-  157 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE---C-
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---c-
Confidence            5888999999999999999975432   22356799998865322  3356889999999995599999999843   2 


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF  142 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  142 (366)
                      ....+++||||+++|+|.+++....              ...+++.++..++.||+.||+|||++||+||||||+|||++
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence            2334669999999999999998642              13589999999999999999999999999999999999999


Q ss_pred             cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHH
Q 017746          143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSL  221 (366)
Q Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~  221 (366)
                      .++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++ |..||.+....+....
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~  317 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  317 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999999987654333333344568899999999999999999999999999999999 9999988776665544


Q ss_pred             HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +..    ...+..+..++.++.++|.+||..||++||++.+++++
T Consensus       318 ~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          318 LKE----GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHT----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hhc----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            432    22345667789999999999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.4e-50  Score=378.36  Aligned_cols=245  Identities=21%  Similarity=0.301  Sum_probs=206.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---------chhhHHHHHHHHHHcCCCCceeEeeccee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---------SSVTLKNEKEALDQIGICPQIVRCFGDDY   72 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~   72 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+.....         ....+.+|+.++++++ ||||+++++.+ 
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~-   98 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNK----EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIF-   98 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTE----EEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEE-
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCc----EEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEE-
Confidence            58899999999999999999987764    788887765321         3446788999999997 99999999843 


Q ss_pred             eccCCeeEEEEEeecCCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEe
Q 017746           73 SFEKGERFYNLLLEYASRG-SLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        73 ~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D  151 (366)
                         .....+++||||+.+| +|.+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        99 ---~~~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A           99 ---ENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             ---ECSSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred             ---eeCCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEee
Confidence               2345667999999777 99999975  35699999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccCCCCCCCccccCCcCC-CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          152 FGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY-EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       152 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      ||++.......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......           ...
T Consensus       174 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~~~  239 (335)
T 3dls_A          174 FGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------VEA  239 (335)
T ss_dssp             CTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------TTT
T ss_pred             cccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------Hhh
Confidence            99998764322   2234579999999999998887 77999999999999999999999753221           111


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ....+..+++++.+||.+||..||++|||++++++||||..
T Consensus       240 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          240 AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence            22345568999999999999999999999999999999954

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.3e-49  Score=367.40  Aligned_cols=258  Identities=22%  Similarity=0.381  Sum_probs=213.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|.+..++.    .+++|.+...     ......+.+|+.++++++ ||||+++++.++  ..
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~   78 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLC----RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLY--NE   78 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCC----EEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CC
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCc----EEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEE--cC
Confidence            69999999999999999999877654    7788877542     244567899999999998 999999998542  23


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||++++ |.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            445577999999985 8888877556679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcC--CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ...............||+.|+|||++.+..  ++.++|||||||++|+|++|+.||...........+...     ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-----~~~~  232 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-----SYAI  232 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----CCCC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----CCCC
Confidence            765333333334457999999999997654  477999999999999999999999887655544444332     2345


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +..+++++.+||.+||..||++|||++++++||||...
T Consensus       233 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence            66789999999999999999999999999999999654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.4e-50  Score=371.50  Aligned_cols=259  Identities=26%  Similarity=0.422  Sum_probs=206.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---hhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+......   ...+.+|+.++++++ ||||+++++.+.   . .
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~-~   74 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQ----IVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFR---R-K   74 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE---E-T
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhheee---c-C
Confidence            69999999999999999999987765    7888877654332   355778999999998 999999998532   2 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+++++|.+++..  .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           75 RRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             TEEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CeEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence            456699999999999998865  356999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC---------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG---------  228 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~---------  228 (366)
                      .....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+....+.+....         
T Consensus       153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          153 TGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             C--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence            43222  2234479999999999876 67899999999999999999999999888766555544432110         


Q ss_pred             --------CCCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          229 --------DELPNI---------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       229 --------~~~~~~---------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                              ...+..         ...++.++.+||.+||..||++|||++|+++||||....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence                    011110         134788999999999999999999999999999996543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.4e-50  Score=367.76  Aligned_cols=251  Identities=26%  Similarity=0.436  Sum_probs=212.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|++..++.    .+++|.+..    .......+.+|+.+++.++ ||||+++++.+.    .
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~   85 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKF----IMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFH----D   85 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE----C
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCc----EEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEE----c
Confidence            58899999999999999999987654    678887643    1234567889999999998 999999998432    2


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++|+|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            44567999999999999999874  4699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....    ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...     ...++..
T Consensus       164 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~  234 (284)
T 2vgo_A          164 APSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----DLKFPPF  234 (284)
T ss_dssp             CSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----CCCCCTT
T ss_pred             Cccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-----ccCCCCc
Confidence            5321    123457999999999999999999999999999999999999999877655544443322     2345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ++.++.+||.+||..||++||+++++++||||...
T Consensus       235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          235 LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            89999999999999999999999999999999653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.8e-50  Score=388.90  Aligned_cols=256  Identities=24%  Similarity=0.388  Sum_probs=210.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcC-----CCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG-----ICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~-----~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||+||+|.+..+++    .||+|.+.........+.+|+.+++.+.     .|+||+++++.+..   
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~----~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---  170 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQ----HVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---  170 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTE----EEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE---
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCc----EEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc---
Confidence            58999999999999999999987654    7999988764444567888999999984     36799999984322   


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc--eEEEecCC
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE--AKIADFGL  154 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~--vkl~DFG~  154 (366)
                       ...+++||||+. ++|.+++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.  +||+|||+
T Consensus       171 -~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          171 -RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             -TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             -CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence             345679999997 59999998755556999999999999999999999999999999999999999887  99999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC-----
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-----  229 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~-----  229 (366)
                      |.....     .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+....+....+.......     
T Consensus       249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            976532     1234579999999999999999999999999999999999999999887666555544321000     


Q ss_pred             -------------CCC------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 017746          230 -------------ELP------------------------------------NIPGDLSEQGKDFLIKCFLKDPKRRWTA  260 (366)
Q Consensus       230 -------------~~~------------------------------------~~~~~~s~~~~~ll~~cL~~dp~~R~t~  260 (366)
                                   ..|                                    .++...++++.+||.+||..||++|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                         000                                    0112347889999999999999999999


Q ss_pred             HHHHcCCCccc
Q 017746          261 EMLLNHPFVCA  271 (366)
Q Consensus       261 ~~ll~hp~~~~  271 (366)
                      +|+++||||..
T Consensus       404 ~e~L~Hpw~~~  414 (429)
T 3kvw_A          404 GQALRHPWLRR  414 (429)
T ss_dssp             HHHHTSTTTC-
T ss_pred             HHHhCChhhcc
Confidence            99999999964

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-50  Score=380.76  Aligned_cols=261  Identities=25%  Similarity=0.402  Sum_probs=207.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC------CCCchhhHHHHHHHHHHcCCCCceeEeecceeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD------CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~------~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~   75 (366)
                      +|.+++.||+|+||.||+|.+..++.    .+|+|.+..      .......+.+|+.++++++ ||||+++++.+    
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~----   97 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRA----IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY----   97 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE----
T ss_pred             heeecceeeecCCeEEEEEEECCCCc----eEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh----
Confidence            58999999999999999999987765    677776643      2345567899999999998 99999999843    


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhC--------------------------------------CCCCCHHHHHHHHHHH
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQN--------------------------------------NGRLQESDVKRYTRSM  117 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~~~~qi  117 (366)
                      .....+++|||||+||+|.+++....                                      ...+++..+..++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            23446779999999999999985210                                      1124678899999999


Q ss_pred             HHHHHHHHHCCcEecCCCCCcEEeccCC--ceEEEecCCccccCCCCCC--cccccccCCCCCCCccccCC--cCCCCcc
Q 017746          118 LKGLRHIHSKGFVHCDIKLQNVLVFDND--EAKIADFGLAKKSSCDGER--SQSFECRGTPLYMSPESVNE--NEYEAPC  191 (366)
Q Consensus       118 ~~aL~~LH~~givHrDlkp~NILl~~~~--~vkl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~  191 (366)
                      +.||+|||++||+||||||+|||++.++  .+||+|||+++........  .......||+.|+|||++.+  ..++.++
T Consensus       178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999999999999999999998776  8999999999865322211  12234579999999999975  6789999


Q ss_pred             chhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          192 DIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       192 DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      |||||||++|+|++|+.||.+....+....+.........+ ....+++++.+||.+||..||++||++.++++||||+.
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~  336 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence            99999999999999999998887666555555433222222 12347999999999999999999999999999999965


Q ss_pred             C
Q 017746          272 D  272 (366)
Q Consensus       272 ~  272 (366)
                      .
T Consensus       337 ~  337 (345)
T 3hko_A          337 F  337 (345)
T ss_dssp             T
T ss_pred             C
Confidence            3

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.9e-49  Score=378.31  Aligned_cols=255  Identities=26%  Similarity=0.406  Sum_probs=209.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---------hhhHHHHHHHHHHcCCCCceeEeeccee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---------SVTLKNEKEALDQIGICPQIVRCFGDDY   72 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---------~~~~~~E~~~l~~l~~~p~Iv~~~g~~~   72 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .||||........         ...+.+|+.+++++..||||+++++.+ 
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-  169 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGH----EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-  169 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             hcccceEEecCCCEEEEEEEECCCCc----EEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE-
Confidence            48888999999999999999987664    7888887653211         346788999999996699999999843 


Q ss_pred             eccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEec
Q 017746           73 SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADF  152 (366)
Q Consensus        73 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF  152 (366)
                        . .....++||||++|++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus       170 --~-~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          170 --E-SSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             --E-BSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             --e-eCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEec
Confidence              2 244567999999999999999764  46999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccCCCCCCCccccCC------cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh
Q 017746          153 GLAKKSSCDGERSQSFECRGTPLYMSPESVNE------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG  226 (366)
Q Consensus       153 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~  226 (366)
                      |++.......   .....+||+.|+|||++.+      ..++.++|||||||++|+|++|+.||...........+....
T Consensus       245 G~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~  321 (365)
T 2y7j_A          245 GFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ  321 (365)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             CcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            9998764322   2234579999999999853      368899999999999999999999998766554444443322


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       227 ~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      .....+ ....++.++.+||.+||..||++|||++++++||||+
T Consensus       322 ~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          322 YQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             CCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             CCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            211111 1245789999999999999999999999999999994

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.6e-49  Score=367.32  Aligned_cols=254  Identities=29%  Similarity=0.468  Sum_probs=211.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+..... ....+.+|+.++++++ ||||+++++.+    .....
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~~~   80 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGK----LFALKCIKKSPAFRDSSLENEIAVLKKIK-HENIVTLEDIY----ESTTH   80 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEECC------HHHHHHHHHHHCC-CTTBCCEEEEE----ECSSE
T ss_pred             cceeeeeccCCCCceEEEEEECCCCC----EEEEEEEecccccchHHHHHHHHHHHhCC-CCCeeehhhhc----ccCCE
Confidence            58899999999999999999987665    788888765322 3456889999999998 99999999843    23445


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe---ccCCceEEEecCCccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV---FDNDEAKIADFGLAKK  157 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~  157 (366)
                      +++||||+++++|.+++...  +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             EEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            67999999999999999764  469999999999999999999999999999999999999   6788999999999876


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...... .....+..
T Consensus       159 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~  233 (304)
T 2jam_A          159 EQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-FESPFWDD  233 (304)
T ss_dssp             CCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-CCTTTTTT
T ss_pred             cCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCcccccc
Confidence            432    1122346999999999999999999999999999999999999999887665555554443222 22234456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +++++.+||.+||..||++||+++++++||||..
T Consensus       234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          234 ISESAKDFICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence            8999999999999999999999999999999954

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.1e-50  Score=376.21  Aligned_cols=263  Identities=21%  Similarity=0.375  Sum_probs=208.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc----hhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS----SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+......    ...+.+|+.++++++ ||||+++++.+......
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHR----DVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEETT
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCc----eEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCCC
Confidence            69999999999999999999987654    7899988653222    246788999999998 99999999866554445


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ....++||||++||+|.+++...  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            55668999999999999999764  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCC-cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          158 SSCDGER-SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       158 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+............... ........
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~  244 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-IPPSARHE  244 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CCHHHHST
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-CCcccccC
Confidence            6432221 222345699999999999999999999999999999999999999987765544333332211 11111234


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .++.++.+||.+||..||++||++.+++.|+|+...
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            589999999999999999999999999999999653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.2e-49  Score=376.39  Aligned_cols=262  Identities=23%  Similarity=0.317  Sum_probs=212.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeecc-CCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~~   78 (366)
                      +|.+++.||+|+||.||+|++..++.    .+|+|.+.....  ....+.+|++++++++ ||||+++++.+.... ...
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKV----RVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTC
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCe----EEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCcccc
Confidence            69999999999999999999887654    789998764322  2356789999999998 999999998543322 223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+.+ +|.+++..   +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       103 ~~~~iv~e~~~~-~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          103 KDVYIVQDLMET-DLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             CCEEEEEECCSE-EHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ceEEEEEcccCc-CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            456799999985 99999976   36999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCc-ccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC------
Q 017746          159 SCDGERS-QSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE------  230 (366)
Q Consensus       159 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~------  230 (366)
                      ....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+....+........      
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            4332221 1234579999999998654 5589999999999999999999999998877766665543211100      


Q ss_pred             ------------C--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          231 ------------L--------PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       231 ------------~--------~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                  .        ..+...++.++.+||.+||..||++|||++|+++||||...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                        0        01123578999999999999999999999999999999653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1e-48  Score=366.44  Aligned_cols=264  Identities=27%  Similarity=0.408  Sum_probs=213.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcC--CCCceeEeecceeec-c
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIG--ICPQIVRCFGDDYSF-E   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~--~~p~Iv~~~g~~~~~-~   75 (366)
                      +|.+++.||+|+||.||+|++...+   +..+++|.+...   ......+.+|+.+++.+.  .||||+++++.+... .
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNG---GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTT---TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             ceeeeeeecccccEEEEEEEecCCC---CEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            5899999999999999999985332   236778876532   223456778999888883  499999999865421 2


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      .....+++||||+. |+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence            34667789999998 59999998755556999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC-------
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG-------  228 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~-------  228 (366)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......       
T Consensus       168 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          168 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             ccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            875321   2233457999999999999999999999999999999999999999887766555554432110       


Q ss_pred             ---------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          229 ---------------DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       229 ---------------~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                     .....+...++..+++||.+||..||++|||+.++++||||...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                           00112335689999999999999999999999999999999543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7e-50  Score=375.06  Aligned_cols=254  Identities=24%  Similarity=0.332  Sum_probs=214.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|++..++..++.++++|......  .....+.+|+.++.+++ ||||+++++.+   .  ..
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~---~--~~   87 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLC---P--GS   87 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC-CTTBCCEEEEE---C--BS
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC-CCCcCeEEEEE---c--CC
Confidence            68999999999999999999998888888899999876432  33456788999999998 99999999843   2  22


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+++.. .++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             ccEEEEEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            35699999999999999976 34579999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....+...    ..+..+..+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~  242 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG----ERLAQPQIC  242 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT----CBCCCCTTB
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC----CCCCCCCcC
Confidence            4444433445578899999999999999999999999999999999 99999987766655544432    223445567


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +.++.++|.+||..||++||++.++++|
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          243 TIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8899999999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-49  Score=374.02  Aligned_cols=254  Identities=22%  Similarity=0.342  Sum_probs=209.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||+||+|++..+++.++.++++|.+...  ......+.+|+.++++++ ||||+++++.+.   .+. 
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~---~~~-   90 (327)
T 3poz_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICL---TST-   90 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC-BTTBCCEEEEEE---SSS-
T ss_pred             HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEe---cCC-
Confidence            6899999999999999999998888888888999987542  235567899999999998 999999998543   222 


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                       .++||||+++|+|.+++.+ ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        91 -~~~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             -eEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence             4589999999999999987 45679999999999999999999999999999999999999999999999999998775


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+...    ..+..+..+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~  244 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG----ERLPQPPIC  244 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----CCCCCCTTB
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC----CCCCCCccC
Confidence            4443333344567889999999999999999999999999999999 99999987766655444332    223345668


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +.++.+++.+||..||++||++.+++++
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          245 TIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.7e-49  Score=382.43  Aligned_cols=258  Identities=27%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc--CCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--KGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~~~~   79 (366)
                      +|.+++.||+|+||+||+|++..++     .+++|++...   .....+|+++++.++ ||||+++++.++...  .+..
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~-----~~aikk~~~~---~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESD-----EVAIKKVLQD---KRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTE-----EEEEEEEECC---TTSCCHHHHHHHTCC-CTTBCCEEEEEEEESSSSSCE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCC-----eEEEEEEecC---cchHHHHHHHHHhCC-CCCcceEEEEEEecCCCCCce
Confidence            6999999999999999999987653     3677766542   233457999999998 999999998665433  3455


Q ss_pred             EEEEEeecCCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec-cCCceEEEecCCcc
Q 017746           80 FYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF-DNDEAKIADFGLAK  156 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-~~~~vkl~DFG~a~  156 (366)
                      ++++||||+++ +|.+.+..  .....+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+
T Consensus       112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            67899999987 55544432  2345799999999999999999999999999999999999999 78999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc--------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV--------  227 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~--------  227 (366)
                      ......   ......||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+....+....+.+...        
T Consensus       191 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          191 ILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             ECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            764322   22345799999999998765 599999999999999999999999998876655555444210        


Q ss_pred             -------CCCCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          228 -------GDELPN---------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       228 -------~~~~~~---------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                             ....+.         ++..+++++.+||.+||..||++|||+.++++||||...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence                   111111         223478999999999999999999999999999999654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.8e-50  Score=383.90  Aligned_cols=259  Identities=25%  Similarity=0.298  Sum_probs=207.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCC-------CCceeEeecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-------CPQIVRCFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~-------~p~Iv~~~g~~~~~   74 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+.........+.+|+.+++.+..       ||||+++++.+...
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           38 RYHVIRKLGWGHFSTVWLSWDIQGKK----FVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             eEEEEEEeeecCCeeEEEEEecCCCe----EEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            68999999999999999999887654    78999887644455678899999999962       78899999865544


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCC--------
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDND--------  145 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~--------  145 (366)
                      ......+++||||+ +++|.+++.+.....+++..+..++.||+.||.|||++ ||+||||||+||||+.++        
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            44567788999999 56888877765546799999999999999999999999 999999999999998775        


Q ss_pred             -----------------------------------------ceEEEecCCccccCCCCCCcccccccCCCCCCCccccCC
Q 017746          146 -----------------------------------------EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE  184 (366)
Q Consensus       146 -----------------------------------------~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  184 (366)
                                                               .+||+|||++......     ....+||+.|+|||++.+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHT
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcC
Confidence                                                     7999999999876422     223479999999999999


Q ss_pred             cCCCCccchhhhHHHHHHHHhCCCCCCCCCcch------HHHHHHHhhcCC-------------------CC--------
Q 017746          185 NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN------VFSLLIRIGVGD-------------------EL--------  231 (366)
Q Consensus       185 ~~~~~~~DiwslG~il~emltg~~pf~~~~~~~------~~~~~~~~~~~~-------------------~~--------  231 (366)
                      ..|+.++|||||||++|+|++|+.||.......      ....+.......                   ..        
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            999999999999999999999999997654321      112221111000                   00        


Q ss_pred             ----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          232 ----------PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       232 ----------~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                                ...+...+.++.+||.+||..||++|||++|+++||||.
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                      011223456788999999999999999999999999994

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.8e-49  Score=364.03  Aligned_cols=256  Identities=23%  Similarity=0.383  Sum_probs=212.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----------chhhHHHHHHHHHHcCCCCceeEeecce
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----------SSVTLKNEKEALDQIGICPQIVRCFGDD   71 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~   71 (366)
                      +|.+++.||+|+||.||+|.++.+++    .+++|.+.....          ....+.+|+.+++++..||||+++++.+
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           18 NYEPKEILGRGVSSVVRRCIHKPTCK----EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             ccceeeeecCCCceEEEEEEEcCcCc----eEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            68999999999999999999987654    788888765321          1345778999999997799999999843


Q ss_pred             eeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEe
Q 017746           72 YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        72 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D  151 (366)
                          .....+++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus        94 ----~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ----ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ----ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             ----ccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEec
Confidence                2345677999999999999999864  4699999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccCCCCCCCccccC------CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHh
Q 017746          152 FGLAKKSSCDGERSQSFECRGTPLYMSPESVN------ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI  225 (366)
Q Consensus       152 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~  225 (366)
                      ||++.......   ......||+.|+|||++.      ...++.++|||||||++|+|++|..||...........+...
T Consensus       168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            99998764322   223456999999999985      456889999999999999999999999887665555544443


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       226 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ...... .....++.++.+||.+||..||++|||++++++||||..
T Consensus       245 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (298)
T 1phk_A          245 NYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  289 (298)
T ss_dssp             CCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CcccCc-ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence            322221 222458999999999999999999999999999999954

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.5e-50  Score=373.28  Aligned_cols=257  Identities=23%  Similarity=0.376  Sum_probs=204.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+...  ......+.+|++++++++ ||||+++++.+.  ..+..
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~   82 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGD----LFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEE--ETTTR   82 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CTTTC
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCc----EEEEEEeccccccchHHHHHHHHHHHHhcC-CCCcceEEEEee--cCCCc
Confidence            59999999999999999999987765    7888887642  134566789999999998 999999998432  23344


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe----ccCCceEEEecCC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNN-GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV----FDNDEAKIADFGL  154 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~~~vkl~DFG~  154 (366)
                      .+++||||+++|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            56799999999999999976422 239999999999999999999999999999999999999    7778899999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccC--------CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc----hHHHHH
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVN--------ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS----NVFSLL  222 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~emltg~~pf~~~~~~----~~~~~~  222 (366)
                      ++......   ......||+.|+|||++.        +..++.++|||||||++|+|++|+.||......    +....+
T Consensus       163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             ceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            98764332   223457999999999986        578999999999999999999999999754332    222222


Q ss_pred             HHhhcCC-----------------CC---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          223 IRIGVGD-----------------EL---PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       223 ~~~~~~~-----------------~~---~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                      .......                 ..   ..++..++..+.+||.+||+.||++|||++|+++||-
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            2211000                 00   1222335668899999999999999999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.1e-49  Score=362.27  Aligned_cols=258  Identities=25%  Similarity=0.393  Sum_probs=209.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+...  ......+.+|+.+++.++ ||||+++++.+.    ...
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~   78 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRR----EGN   78 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEEGGGCTTHHHHHHHHHHHHHTCC-CTTBCCEEEEEE----ETT
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCc----EEEEEEeeeccchhhhHHHHHHHHHHHhcC-CCCceeeeeEEE----cCC
Confidence            58999999999999999999987665    7888877542  234567889999999998 999999998432    234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++++|.+++..  ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           79 IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            56699999999999999864  3469999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCC-CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEY-EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||................  .........+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~  234 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKI  234 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT--CTTSTTGGGS
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc--ccccCchhhc
Confidence            3222222334579999999999988776 678999999999999999999998765543222211111  1111223468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ++++.+||.+||..||++|||++++++||||...
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence            9999999999999999999999999999999543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.1e-49  Score=362.45  Aligned_cols=249  Identities=27%  Similarity=0.352  Sum_probs=204.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++..+++    .+++|.+...   ......+.+|+..+..+..||||+++++.+.   . .
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~---~-~   83 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGC----IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA---E-D   83 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE---E-T
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCc----eEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee---c-C
Confidence            58899999999999999999987765    7888877642   2245678889999999955999999998432   2 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC------------
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN--NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN------------  144 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~------------  144 (366)
                      ..+++||||+++|+|.+++.+..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+            
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence            35679999999999999997632  2569999999999999999999999999999999999999844            


Q ss_pred             -------CceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcc
Q 017746          145 -------DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDS  216 (366)
Q Consensus       145 -------~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~  216 (366)
                             ..+||+|||++......      ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+...   
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---  234 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---  234 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---
T ss_pred             ccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---
Confidence                   47999999999876422      123599999999999876 5668999999999999999999887543   


Q ss_pred             hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          217 NVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .....+..    ...+.++..+++++.+||.+||..||++|||+.++++||||..
T Consensus       235 ~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  285 (289)
T 1x8b_A          235 DQWHEIRQ----GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS  285 (289)
T ss_dssp             HHHHHHHT----TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred             hHHHHHHc----CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence            22223322    3445677789999999999999999999999999999999954

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.4e-49  Score=372.26  Aligned_cols=255  Identities=30%  Similarity=0.474  Sum_probs=205.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---------CchhhHHHHHHHHHHcCCCCceeEeeccee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---------PSSVTLKNEKEALDQIGICPQIVRCFGDDY   72 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---------~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~   72 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+....         .....+.+|+.++++++ ||||+++++.+ 
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-   84 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCK----KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF-   84 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEE-
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCc----EEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEE-
Confidence            58999999999999999999987654    78888775421         12346889999999998 99999999843 


Q ss_pred             eccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc---eEE
Q 017746           73 SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKI  149 (366)
Q Consensus        73 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~---vkl  149 (366)
                        ..+ . +++||||+++|+|.+++..  +..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||
T Consensus        85 --~~~-~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           85 --DAE-D-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             --ESS-S-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             --cCC-c-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEE
Confidence              222 2 5699999999999999965  357999999999999999999999999999999999999987664   999


Q ss_pred             EecCCccccCCCCCCcccccccCCCCCCCccccC---CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh
Q 017746          150 ADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN---ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG  226 (366)
Q Consensus       150 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~  226 (366)
                      +|||+++....   ........||+.|+|||++.   ...++.++|||||||++|+|++|..||...............+
T Consensus       159 ~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  235 (322)
T 2ycf_A          159 TDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG  235 (322)
T ss_dssp             CCCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred             ccCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence            99999987632   22223446999999999973   5678999999999999999999999997665443222222223


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       227 ~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .....+..+..+++++.+||.+||..||++||+++++++||||..
T Consensus       236 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            222233334568999999999999999999999999999999954

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-49  Score=377.56  Aligned_cols=261  Identities=26%  Similarity=0.455  Sum_probs=208.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|++... ...+..+|+|.+...     ......+.+|+++++.+..||||+++++.+   ..
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---~~  130 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISG-HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---QT  130 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSS-TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE---EE
T ss_pred             ceEEEEEeccCCCEEEEEEEEccc-CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE---ee
Confidence            688999999999999999998531 122457888876542     234566788999999997699999998843   22


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                       ...+++||||+++|+|.+++...  +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus       131 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          131 -ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             -TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             -CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence             33567999999999999999864  469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC--cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ...... .......+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...........+.+.... ..+.+
T Consensus       208 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~  285 (355)
T 1vzo_A          208 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPY  285 (355)
T ss_dssp             ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCCCC
T ss_pred             ecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-cCCCC
Confidence            753221 122334579999999999986  35788999999999999999999999765433322222222211 23456


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      +..++..+.+||.+||..||++||     +++++++||||..
T Consensus       286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            677899999999999999999999     9999999999954

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.6e-48  Score=380.04  Aligned_cols=264  Identities=23%  Similarity=0.339  Sum_probs=200.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeecc-CC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~   77 (366)
                      +|.+++.||+|+||.||+|+++.+++    .||+|++.....   ....+.+|+.+|+.++ ||||+++++.+.... ..
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEK----NVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTE----EEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTT
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCc----EEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCCc
Confidence            68999999999999999999987754    789998865322   2356789999999998 999999998543211 11


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+.+ +|.+++..  +..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus       102 ~~~~~lv~e~~~~-~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          102 FDELYIVLEIADS-DLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             CCCEEEEEECCSE-EHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCeEEEEEecCCc-CHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            1456799999975 99999965  35699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCC--------------------cccccccCCCCCCCcccc-CCcCCCCccchhhhHHHHHHHHhC----------
Q 017746          158 SSCDGER--------------------SQSFECRGTPLYMSPESV-NENEYEAPCDIWALGCAVVEMASG----------  206 (366)
Q Consensus       158 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~emltg----------  206 (366)
                      .......                    ......+||+.|+|||++ ....|+.++|||||||++|||++|          
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            6433211                    112456899999999986 566799999999999999999984          


Q ss_pred             -CCCCCCCCc-----------------chHHHHHHHhh---------------------cCCCCCC-----CCCCCCHHH
Q 017746          207 -KPAWNHKQD-----------------SNVFSLLIRIG---------------------VGDELPN-----IPGDLSEQG  242 (366)
Q Consensus       207 -~~pf~~~~~-----------------~~~~~~~~~~~---------------------~~~~~~~-----~~~~~s~~~  242 (366)
                       +++|.+...                 .+....+....                     .......     ....+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence             444444321                 11111111100                     0000000     113479999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          243 KDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       243 ~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                      .+||.+||..||++|||++|+++||||....
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            9999999999999999999999999996543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-49  Score=368.64  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=202.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|++..++.    .+++|.+.....    ....+.+|+.++.+++ ||||+++++.+    ..
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~----~~   82 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNI----KVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVD----EE   82 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCS----EEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEE----EC
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCC----eEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEee----ee
Confidence            69999999999999999999887654    788887644222    2356789999999998 99999999842    33


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++||+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  160 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA  160 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence            45677999999999999999874  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......................+..
T Consensus       161 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T 4eqm_A          161 LSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD  239 (294)
T ss_dssp             C--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTT
T ss_pred             cccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccC
Confidence            643221 2223457999999999999999999999999999999999999999877654433222222111111234456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +++.+.++|.+||.+||++||+..+.+.+.|.
T Consensus       240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             CCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            89999999999999999999966665655554

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.8e-49  Score=381.17  Aligned_cols=264  Identities=23%  Similarity=0.317  Sum_probs=190.5

Q ss_pred             ccc-cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            3 WLR-GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         3 y~~-~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      |.+ +++||+|+||+||+|+++...  ....+|+|.+... .....+.+|+.+|++++ ||||+++++.+..  .....+
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~--~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~~   95 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGK--DDKDYALKQIEGT-GISMSACREIALLRELK-HPNVISLQKVFLS--HADRKV   95 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSS--CCCCEEEEECSSS-SCCHHHHHHHHHHHHCC-CTTBCCCCEEEEE--TTTTEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCC--CCeEEEEEEECCC-CCCHHHHHHHHHHHhcC-CCCeeeEeeEEec--CCCCeE
Confidence            444 678999999999999976432  1347899988653 34457889999999998 9999999985432  334467


Q ss_pred             EEEeecCCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe----ccCCceEEE
Q 017746           82 NLLLEYASRGSLADRVKKQN-------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV----FDNDEAKIA  150 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~~~vkl~  150 (366)
                      ++||||+.+ +|.+++....       ...+++..++.++.||+.||+|||++||+||||||+||||    +.++.+||+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            799999975 9998886421       1249999999999999999999999999999999999999    677899999


Q ss_pred             ecCCccccCCCCCC-cccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcc---------hHH
Q 017746          151 DFGLAKKSSCDGER-SQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDS---------NVF  219 (366)
Q Consensus       151 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~---------~~~  219 (366)
                      |||+|+........ ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+....         +..
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999876432211 22234579999999999987 45899999999999999999999999765432         222


Q ss_pred             HHHHHhhcCCCCCC---------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          220 SLLIRIGVGDELPN---------------------------------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       220 ~~~~~~~~~~~~~~---------------------------------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+...........                                 .....++++.+||.+||..||++|||++|+++|
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            22222111000000                                 001126788999999999999999999999999


Q ss_pred             CCcccCC
Q 017746          267 PFVCADD  273 (366)
Q Consensus       267 p~~~~~~  273 (366)
                      |||....
T Consensus       335 p~f~~~~  341 (405)
T 3rgf_A          335 PYFLEDP  341 (405)
T ss_dssp             GGGTSSS
T ss_pred             hhhccCC
Confidence            9996543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.9e-49  Score=363.90  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=202.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeec-------
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSF-------   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~-------   74 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+.........+.+|+.++++++ ||||+++++.+...       
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSR----YYAIKKIRHTEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEEEHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCCC--
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCe----EEEEEEEeccHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchhhhh
Confidence            58899999999999999999887664    7888887654345567889999999998 99999999865321       


Q ss_pred             --cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEec
Q 017746           75 --EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADF  152 (366)
Q Consensus        75 --~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF  152 (366)
                        ......+++||||+++|+|.+++.. .+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence              1345677899999999999999986 4456889999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCC------------CcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCc-chH
Q 017746          153 GLAKKSSCDGE------------RSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQD-SNV  218 (366)
Q Consensus       153 G~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~-~~~  218 (366)
                      |++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||..... ...
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            99986542110            1112345699999999999865 68999999999999999998   5543221 122


Q ss_pred             HHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          219 FSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ...+.. ......+.++...+..+.++|.+||..||++|||++++++||||..
T Consensus       238 ~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          238 LKKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHhccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            222221 2222334455667888999999999999999999999999999954

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.3e-48  Score=370.69  Aligned_cols=262  Identities=23%  Similarity=0.358  Sum_probs=201.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc---CCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE---KGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~---~~~   78 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+...........++++.+..++ ||||+++++++....   ...
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           24 RFQVERMAGQGTFGTVQLGKEKSTGM----SVAIKKVIQDPRFRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             TEEEC----------CEEEEETTTCC----EEEEEEEECCTTCCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCTTC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEecCccccHHHHHHHHHHHhcC-CCCcccHHHhhhccccccccc
Confidence            68999999999999999999987764    7888887665555566777888888888 999999999765432   234


Q ss_pred             eEEEEEeecCCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCCCcEEecc-CCceEEEecC
Q 017746           79 RFYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSMLKGLRHIH--SKGFVHCDIKLQNVLVFD-NDEAKIADFG  153 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~~-~~~vkl~DFG  153 (366)
                      .++++||||+++ +|.+.+..  .....+++..+..++.||+.||.|||  ++||+||||||+|||++. ++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg  177 (360)
T 3e3p_A           99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG  177 (360)
T ss_dssp             EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred             eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence            457799999987 66655543  23457999999999999999999999  999999999999999996 8999999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCCcC-CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC---
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD---  229 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~---  229 (366)
                      +++......   ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+.+.....   
T Consensus       178 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          178 SAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             TCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            998764322   223457999999999986654 8999999999999999999999999877666555554321100   


Q ss_pred             ------------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          230 ------------------------ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       230 ------------------------~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                              ..+..+...++++.+||.+||+.||++|||+.|+++||||...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence                                    0112223357899999999999999999999999999999654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.6e-49  Score=372.70  Aligned_cols=250  Identities=29%  Similarity=0.460  Sum_probs=207.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|..++.||+|+||+||+|++..+++    .+|+|.+.....    ....+.+|++++++++ ||||+++++.+.   . 
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~---~-  125 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYL---R-  125 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE---E-
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCe----EEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE---E-
Confidence            37888999999999999999877654    788998765322    2246789999999998 999999998433   2 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ....++||||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       126 ~~~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          126 EHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             CCeEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            335679999998 5899988763 45799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccC---CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVN---ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ...      ....+||+.|+|||++.   +..++.++|||||||++|+|++|+.||.+.........+..   .......
T Consensus       204 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~---~~~~~~~  274 (348)
T 1u5q_A          204 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NESPALQ  274 (348)
T ss_dssp             SSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCC
T ss_pred             cCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---cCCCCCC
Confidence            532      12347999999999984   57799999999999999999999999987755444333332   2222333


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +..+++.+.+||.+||..||++|||++++++||||..
T Consensus       275 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence            4568999999999999999999999999999999954

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.6e-49  Score=362.17  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=209.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-------chhhHHHHHHHHHHcCCCCceeEeecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-------SSVTLKNEKEALDQIGICPQIVRCFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~   74 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+.....       ....+.+|+.++++++ ||||+++++.+.  
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--   78 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGK----EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFE--   78 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCC----eeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheec--
Confidence            58999999999999999999987765    677776654211       3567899999999998 999999998432  


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC----ceEEE
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND----EAKIA  150 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~  150 (366)
                        ....+++||||+++++|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+||+++.++    .+||+
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           79 --NKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             --CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             --CCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEE
Confidence              244567999999999999999764  4699999999999999999999999999999999999998877    79999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      |||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... .
T Consensus       155 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~  230 (283)
T 3bhy_A          155 DFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD-F  230 (283)
T ss_dssp             CCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC-C
T ss_pred             ecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC-C
Confidence            999998764322   223346999999999999999999999999999999999999999887655544443332211 1


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .+..+..+++.+.+||.+||..||++||++.++++||||...
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          231 DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            112224578999999999999999999999999999999653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8e-49  Score=368.45  Aligned_cols=253  Identities=22%  Similarity=0.335  Sum_probs=208.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC--CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~--~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|.+..+++.++.++++|....  .......+.+|+.++++++ ||||+++++.+.   .+. 
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~---~~~-   90 (327)
T 3lzb_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICL---TST-   90 (327)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEE---SSS-
T ss_pred             HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEe---cCC-
Confidence            689999999999999999999988888888999998764  2345678899999999998 999999998543   222 


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                       .++||||+.+|+|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        91 -~~~v~~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             -ceEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence             5589999999999999987 44679999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+...    ..+..+..+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~  244 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG----ERLPQPPIC  244 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----CCCCCCTTB
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC----CCCCCCccC
Confidence            4333333344567889999999999999999999999999999999 99999988776655544332    223445678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +.++.++|.+||..||++||++.++++
T Consensus       245 ~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          245 TIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999996

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.9e-49  Score=376.40  Aligned_cols=259  Identities=23%  Similarity=0.362  Sum_probs=212.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++...+ ......+|+|.+.....  ....+.+|++++.++..||||+++++.+   ....
T Consensus        23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~---~~~~   99 (359)
T 3vhe_A           23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC---TKPG   99 (359)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---CSTT
T ss_pred             ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee---ecCC
Confidence            5889999999999999999964321 22345899999876433  2346889999999997799999999843   2333


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC--------------------------------------------------------
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN--------------------------------------------------------  102 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~--------------------------------------------------------  102 (366)
                      ..+++|||||++|+|.+++.....                                                        
T Consensus       100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence            446699999999999999976421                                                        


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCC
Q 017746          103 --------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP  174 (366)
Q Consensus       103 --------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~  174 (366)
                              ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............||+
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~  259 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  259 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence                    128999999999999999999999999999999999999999999999999998765444333344557899


Q ss_pred             CCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccC
Q 017746          175 LYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKD  253 (366)
Q Consensus       175 ~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~d  253 (366)
                      .|+|||++.+..++.++|||||||++|+|++ |+.||.+...............   .+..+..+++++.++|.+||..|
T Consensus       260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~d  336 (359)
T 3vhe_A          260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGE  336 (359)
T ss_dssp             GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC---CCCCCCCCCHHHHHHHHHHccCC
Confidence            9999999999999999999999999999998 9999988765554444443332   33456678999999999999999


Q ss_pred             CCCCCCHHHHHcC
Q 017746          254 PKRRWTAEMLLNH  266 (366)
Q Consensus       254 p~~R~t~~~ll~h  266 (366)
                      |++|||+.++++|
T Consensus       337 P~~Rps~~ell~~  349 (359)
T 3vhe_A          337 PSQRPTFSELVEH  349 (359)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCCCHHHHHHH
Confidence            9999999999976

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.1e-49  Score=361.32  Aligned_cols=251  Identities=26%  Similarity=0.404  Sum_probs=203.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+..    .......+.+|+.+++.++ ||||+++++.+    ..
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~   82 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGH----KVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVI----ST   82 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEE----EC
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCc----eEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEE----ec
Confidence            68999999999999999999987665    788887653    1234567889999999998 99999999843    22


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++++|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence            44567999999999999999764  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCC-CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEY-EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      .....   ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+...     ...++.
T Consensus       161 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~  232 (276)
T 2h6d_A          161 MSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG-----VFYIPE  232 (276)
T ss_dssp             CCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----CCCCCT
T ss_pred             cCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-----cccCch
Confidence            64322   1223469999999999988776 57999999999999999999999876555444443321     234566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .++.++.++|.+||..||++|||++++++||||..
T Consensus       233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          233 YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence            78999999999999999999999999999999954

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.5e-49  Score=372.28  Aligned_cols=258  Identities=23%  Similarity=0.375  Sum_probs=184.4

Q ss_pred             Ccccc-CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRG-DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+. ++||+|+||+||+|+++.+++    .+|+|.+...    ....+|+..+.++..||||+++++.+.....+...
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQ----KCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCC----EEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            57774 469999999999999987765    7888887542    23444555544454599999999976665566777


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC---CceEEEecCCccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN---DEAKIADFGLAKK  157 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a~~  157 (366)
                      +++||||++||+|.+++.+..+..+++.++..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+++.
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            8899999999999999987544579999999999999999999999999999999999999764   4599999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHH---hhcCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR---IGVGDELPNI  234 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~  234 (366)
                      ....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............   ..........
T Consensus       181 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (336)
T 3fhr_A          181 TTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE  256 (336)
T ss_dssp             C--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred             cccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence            5422    12344689999999999999999999999999999999999999976654433211111   1111111222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ...+++++.+||.+||..||++|||++++++||||..
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            3468999999999999999999999999999999954

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3e-49  Score=361.99  Aligned_cols=259  Identities=24%  Similarity=0.394  Sum_probs=213.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|+++.+++    .+++|.+.....   ....+.+|+.++++++ ||||+++++.+.  ....
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~   79 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGK----ILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRII--DRTN   79 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--EGGG
T ss_pred             heeeehhccCCCCcEEEEEEECCCCc----EEEEEEEEcccCCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEe--cCCC
Confidence            68999999999999999999987664    788888765322   3456889999999998 999999998543  2334


Q ss_pred             eEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCCCcEEeccCCceEEEe
Q 017746           79 RFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKG-----FVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NILl~~~~~vkl~D  151 (366)
                      ..+++||||+++|+|.+++...  .+..+++..+..++.||+.||+|||++|     |+||||||+|||++.++.+||+|
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d  159 (279)
T 2w5a_A           80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  159 (279)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence            4577999999999999999763  2345999999999999999999999999     99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          152 FGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       152 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      ||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...    ..
T Consensus       160 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----~~  233 (279)
T 2w5a_A          160 FGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----KF  233 (279)
T ss_dssp             CCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----CC
T ss_pred             Cchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc----cc
Confidence            99998764221  1122346999999999999999999999999999999999999999887655444444332    23


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccCC
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADD  273 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~~  273 (366)
                      +.++..++.++.++|.+||..||++||++++|++|+|+....
T Consensus       234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          234 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            456677899999999999999999999999999999996543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.4e-48  Score=362.18  Aligned_cols=252  Identities=31%  Similarity=0.527  Sum_probs=213.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+...  ......+.+|+.+++.++ ||||+++++.+.   . ..
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~-~~   93 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQK----VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYL---K-DT   93 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEETTTCSTTHHHHHHHHHHHHHCC-CTTBCCEEEEEE---E-TT
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCc----EEEEEEecccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEe---c-CC
Confidence            48899999999999999999887654    7888887653  234577899999999998 999999998433   2 33


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++++|.+++..   +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        94 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A           94 KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             EEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred             eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence            56799999999999999954   479999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..    ...+.++..++
T Consensus       171 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~  244 (303)
T 3a7i_A          171 DTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK----NNPPTLEGNYS  244 (303)
T ss_dssp             TTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCCSSCC
T ss_pred             ccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc----CCCCCCccccC
Confidence            322  122345799999999999999999999999999999999999999987655444333322    23345667789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..+.+||.+||..||++|||++++++||||..
T Consensus       245 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence            99999999999999999999999999999954

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=364.47  Aligned_cols=256  Identities=30%  Similarity=0.484  Sum_probs=209.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+++|.+... .....+.+|+.++++++ ||||+++++.+..    ...+
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----~~~~   99 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHKETGQ----IVAIKQVPVE-SDLQEIIKEISIMQQCD-SPHVVKYYGSYFK----NTDL   99 (314)
T ss_dssp             CEEEEEECC----CEEEEEEETTTCC----EEEEEEEETT-SCCHHHHHHHHHHHTCC-CTTBCCEEEEEEE----TTEE
T ss_pred             hhhhheeeccCCCeEEEEEEECCCCC----EEEEEecCch-HHHHHHHHHHHHHHhCC-CCCCccEEEEEEe----CCEE
Confidence            58899999999999999999987664    7888887653 34567899999999998 9999999985432    3356


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++++|.+++.. .+..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus       100 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            799999999999999975 3457999999999999999999999999999999999999999999999999999876422


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...  .......+..++.+
T Consensus       179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  254 (314)
T 3com_A          179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN--PPPTFRKPELWSDN  254 (314)
T ss_dssp             B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCCCSSGGGSCHH
T ss_pred             c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CCcccCCcccCCHH
Confidence            1  1223447999999999999999999999999999999999999999876544333322221  11112234567999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +.+||.+||..||++|||+.++++||||...
T Consensus       255 l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            9999999999999999999999999999653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=374.85  Aligned_cols=257  Identities=25%  Similarity=0.389  Sum_probs=212.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC---CCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS---EFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~---~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|++...++   .....+|+|.+.....  ....+.+|+++++++..||||+++++.+   . 
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---~-  145 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC---T-  145 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---C-
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee---c-
Confidence            57889999999999999999765432   2345799998875433  2356889999999996699999999843   2 


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF  142 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  142 (366)
                      ....+++||||+++|+|.+++....              ...+++.++..++.||+.||.|||++||+||||||+||||+
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence            2334569999999999999998743              13599999999999999999999999999999999999999


Q ss_pred             cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHH
Q 017746          143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSL  221 (366)
Q Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~  221 (366)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~  305 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  305 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999987654333333444568899999999999999999999999999999999 9999987765554443


Q ss_pred             HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +..    ...+..+..+++++.+||.+||..||++|||+.+++++
T Consensus       306 ~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          306 LKE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHT----TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHc----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            332    22345567789999999999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.2e-49  Score=373.63  Aligned_cols=260  Identities=22%  Similarity=0.350  Sum_probs=203.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc------------hhhHHHHHHHHHHcCCCCceeEeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS------------SVTLKNEKEALDQIGICPQIVRCFG   69 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~------------~~~~~~E~~~l~~l~~~p~Iv~~~g   69 (366)
                      +|.+++.||+|+||.||+|.+.. +    ..+|+|.+......            ...+.+|+.++++++ ||||+++++
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~   96 (362)
T 3pg1_A           23 PYTVQRFISSGSYGAVCAGVDSE-G----IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRD   96 (362)
T ss_dssp             SCEEEEEEEEETTEEEEEEECTT-S----CEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSE
T ss_pred             ceEEeEEeccCCCEEEEEEECCC-C----CeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccceee
Confidence            68999999999999999998754 3    47888877542221            256889999999998 999999999


Q ss_pred             ceeecc-CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceE
Q 017746           70 DDYSFE-KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAK  148 (366)
Q Consensus        70 ~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vk  148 (366)
                      .+.... .....+++||||+. |+|.+++.. .+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence            665443 34456789999998 599999876 445799999999999999999999999999999999999999999999


Q ss_pred             EEecCCccccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc
Q 017746          149 IADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV  227 (366)
Q Consensus       149 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~  227 (366)
                      |+|||+++.....   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus       175 l~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (362)
T 3pg1_A          175 ICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG  251 (362)
T ss_dssp             ECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            9999999865322   22234579999999999877 6799999999999999999999999988766555554433211


Q ss_pred             C-------------------CCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          228 G-------------------DELP--------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       228 ~-------------------~~~~--------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .                   ....        ..+..+++.+.+||.+||..||++|||++++++||||...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence            1                   0001        1123468899999999999999999999999999999543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.5e-49  Score=374.47  Aligned_cols=256  Identities=27%  Similarity=0.375  Sum_probs=207.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|.+..++.    .+++|.+.....  ....+.+|+.++++++ ||||+++++.+.   . ..
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~va~K~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~---~-~~  104 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKPSGL----VMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFY---S-DG  104 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEECCCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEE---E-TT
T ss_pred             cceeeeeecCCCCeEEEEEEECCCCc----EEEEEEeccccCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEE---E-CC
Confidence            58999999999999999999987664    788887765322  3456889999999998 999999998433   2 33


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      .+++||||+++|+|.+++.+.  +.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            567999999999999999874  4699999999999999999999996 9999999999999999999999999999764


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHH-----------------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSL-----------------  221 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~-----------------  221 (366)
                      ...    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....                 
T Consensus       183 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          183 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             ccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            211    12234799999999999999999999999999999999999999987654332111                 


Q ss_pred             ----------------------HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          222 ----------------------LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       222 ----------------------~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                            +...............++.++.+||.+||..||++|||++++++||||...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                                  111111111112223579999999999999999999999999999999653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.4e-49  Score=374.06  Aligned_cols=261  Identities=23%  Similarity=0.300  Sum_probs=207.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCC----------CCceeEeecce
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI----------CPQIVRCFGDD   71 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~----------~p~Iv~~~g~~   71 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+.........+.+|+.+++++..          ||||+++++.+
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNT----HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCc----EEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            68999999999999999999887654    78999887544455678899999998862          68999999966


Q ss_pred             eeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEecc------C
Q 017746           72 YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFD------N  144 (366)
Q Consensus        72 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~------~  144 (366)
                      .....+...+++||||+ +++|.+++.+.....+++..+..++.||+.||+|||++ ||+||||||+|||++.      .
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence            55444556788999999 88999999876556799999999999999999999998 9999999999999953      3


Q ss_pred             CceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc------hH
Q 017746          145 DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------NV  218 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~------~~  218 (366)
                      +.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ..
T Consensus       175 ~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          175 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence            47999999999876422     22346999999999999999999999999999999999999999765421      11


Q ss_pred             HHHHHHhhcC-------------------------------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 017746          219 FSLLIRIGVG-------------------------------------DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAE  261 (366)
Q Consensus       219 ~~~~~~~~~~-------------------------------------~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~  261 (366)
                      ...+......                                     .....++..++.++.+||.+||..||++|||++
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            1122111000                                     000122334567889999999999999999999


Q ss_pred             HHHcCCCcccC
Q 017746          262 MLLNHPFVCAD  272 (366)
Q Consensus       262 ~ll~hp~~~~~  272 (366)
                      |+++||||...
T Consensus       330 ell~hp~f~~~  340 (373)
T 1q8y_A          330 GLVNHPWLKDT  340 (373)
T ss_dssp             HHHTCGGGTTC
T ss_pred             HHhhChhhhcc
Confidence            99999999653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.1e-49  Score=367.79  Aligned_cols=265  Identities=21%  Similarity=0.354  Sum_probs=197.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC-
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG-   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~-   77 (366)
                      +|.+++.||+|+||+||+|++..+++ ....+|+|.+...   ......+.+|+.++++++ ||||+++++.+...... 
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDG-SFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC--------CEEEEEEC------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC----
T ss_pred             HeEEeceecccCCeEEEEEEEcccCC-cceeEEEEEecccccCHHHHHHHHHHHHHHHHCC-CCceehhhceeecccccc
Confidence            58999999999999999999876543 2247889987652   234567889999999997 99999999854432211 


Q ss_pred             -eeEEEEEeecCCCCCHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEec
Q 017746           78 -ERFYNLLLEYASRGSLADRVKKQNN----GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADF  152 (366)
Q Consensus        78 -~~~~~lv~E~~~~g~L~~~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DF  152 (366)
                       ....++||||+++|+|.+++.....    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence             1123699999999999999975321    25999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          153 GLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       153 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      |+++...............||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....+...    ..
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~----~~  257 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG----NR  257 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----CC
T ss_pred             cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC----CC
Confidence            99987654333333334467889999999999999999999999999999999 99999988777665554432    23


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHHcCCCcccC
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRRWT-------AEMLLNHPFVCAD  272 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R~t-------~~~ll~hp~~~~~  272 (366)
                      +..+..+++++.+||.+||..||++|||       ++++++|||+...
T Consensus       258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            3455678999999999999999999999       7778889999553

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-48  Score=373.69  Aligned_cols=257  Identities=22%  Similarity=0.314  Sum_probs=197.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+|+|.+.....   ....+.+|+.+++.++ ||||+++++.+....  .
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILER----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEECTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCSTT
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCc----eEEEEEeccccCChHHHHHHHHHHHHHHhcC-CCCccceEEeeccccccc
Confidence            68999999999999999999987654    788888765322   2356788999999998 999999998543211  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||+.+ +|.+++..    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       101 ~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          101 EFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             cccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            22357799999986 89988853    48999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC-------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-------  229 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~-------  229 (366)
                      .....   ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......       
T Consensus       176 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          176 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             ccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            75322   12234579999999999999999999999999999999999999998876555444433211000       


Q ss_pred             ----------CCCCCC--------------C------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 ----------ELPNIP--------------G------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 ----------~~~~~~--------------~------~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                ..+...              .      ..+.++++||.+||..||++|||++|+++||||..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                      001100              0      01567899999999999999999999999999954

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.2e-49  Score=374.90  Aligned_cols=259  Identities=20%  Similarity=0.266  Sum_probs=203.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCC-CCceeEEeeecCCCCchhhHHHHHHHHHHcCC--------------CCceeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPPSSVTLKNEKEALDQIGI--------------CPQIVR   66 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~-~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~--------------~p~Iv~   66 (366)
                      +|.+++.||+|+||.||+|.+..++.. ....+|+|.....   ...+.+|+++++++..              ||||++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD---NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETT---CHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeecc---chhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            589999999999999999998765322 2457899987653   2345556665555543              899999


Q ss_pred             eecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec--cC
Q 017746           67 CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF--DN  144 (366)
Q Consensus        67 ~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~--~~  144 (366)
                      +++.+.....+..+.++||||+ |++|.+++.. .++.+++..+..++.||+.||+|||++||+||||||+||||+  .+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            9997765555567788999999 9999999987 456799999999999999999999999999999999999999  88


Q ss_pred             CceEEEecCCccccCCCCCCc-----ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHH
Q 017746          145 DEAKIADFGLAKKSSCDGERS-----QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF  219 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~  219 (366)
                      +.+||+|||+++.........     .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            999999999998764332211     113346999999999999999999999999999999999999999865443332


Q ss_pred             HHHHHhhcCCCCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          220 SLLIRIGVGDELPN------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       220 ~~~~~~~~~~~~~~------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ............+.      ....++.++.+|+..||..||++||++.+|++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            22222111111110      01457899999999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.7e-49  Score=371.85  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=204.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---hhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+......   ...+.+|+.++++++ ||||+++++.+.    ..
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~----~~   96 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGR----IVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVCK----KK   96 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCC----EEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE----ET
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCc----eEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEEee----cC
Confidence            68999999999999999999987765    7888877553332   344678999999998 999999998432    23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+++++|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             CEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            456799999999888888754  356999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc----------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV----------  227 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~----------  227 (366)
                      .....  ......||+.|+|||++.+. .++.++|||||||++|+|++|++||......+....+.....          
T Consensus       175 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          175 AAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence            43222  22344699999999999876 789999999999999999999999988766555444332110          


Q ss_pred             -------CCCCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          228 -------GDELPNI---------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       228 -------~~~~~~~---------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                             ....+.+         ...+++++.+||.+||..||++|||++|+++||||+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence                   1111111         1247899999999999999999999999999999954

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.7e-48  Score=363.35  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=197.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---hhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++.+      ..+|+|.+......   ...+.+|++++++++ ||||+++++.+   .. .
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~---~~-~  106 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEWHG------SDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAV---TQ-P  106 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT------EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE---CS-T
T ss_pred             HceeeeEeecCCCeEEEEEEECC------CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE---EE-C
Confidence            58899999999999999998742      36888987654332   346788999999998 99999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEeccCCceEEEecCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN-GRLQESDVKRYTRSMLKGLRHIHSKG--FVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      ..+++||||+++|+|.+++.+... ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            345699999999999999975211 13899999999999999999999999  999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      +.....  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+   ........++
T Consensus       187 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~~~~~  261 (309)
T 3p86_A          187 RLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GFKCKRLEIP  261 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH---HHSCCCCCCC
T ss_pred             cccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCCCCC
Confidence            865322  12223457999999999999999999999999999999999999999877655443333   2233445667


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ..+++++.+||.+||..||++|||++++++
T Consensus       262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            789999999999999999999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.1e-49  Score=363.57  Aligned_cols=256  Identities=29%  Similarity=0.445  Sum_probs=206.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|..... ......+.+|+.++..++ ||||+++++.+.    ....
T Consensus        20 ~y~i~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~   90 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKAKNKETGA----LAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLLGAYY----HDGK   90 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEEEETTTCC----EEEEEEEC----CCHHHHHHHHHHHHHCC-CTTBCCEEEEEE----CC-C
T ss_pred             ceeecceeccCCCeEEEEEEEcCCCc----EEEEEEecCCCHHHHHHHHHHHHHHhcCC-CCCEeeeeeeee----eCCe
Confidence            58899999999999999999987654    7788877643 235577889999999998 999999998432    2345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|.+++.+. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            67999999999999999763 45699999999999999999999999999999999999999999999999998754211


Q ss_pred             CCCCcccccccCCCCCCCcccc-----CCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          161 DGERSQSFECRGTPLYMSPESV-----NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      .  ........||+.|+|||++     .+..++.++|||||||++|+|++|..||...........+....  ......+
T Consensus       170 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~  245 (302)
T 2j7t_A          170 T--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPTLLTP  245 (302)
T ss_dssp             H--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCCCSSG
T ss_pred             c--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--CcccCCc
Confidence            1  0111234699999999998     46778999999999999999999999998776544433333221  1112234


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..++.++.++|.+||..||++|||++++++||||..
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  281 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS  281 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence            568999999999999999999999999999999954

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.9e-49  Score=368.17  Aligned_cols=253  Identities=21%  Similarity=0.334  Sum_probs=207.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|.+..+++ ....+|+|.+.....  ....+.+|+.++++++ ||||+++++.+    ....
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~----~~~~  123 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQ-RDVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVV----TRGR  123 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTS-CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE----CGGG
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCC-CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE----EeCC
Confidence            58899999999999999999976654 345689998875322  3456889999999998 99999999843    2244


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             ccEEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            56699999999999999976 44579999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          160 CDGERS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       160 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..   . ..+..+..
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---~-~~~~~~~~  278 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE---G-YRLPAPMG  278 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT---T-CCCCCCTT
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc---C-CCCCCCCC
Confidence            432221 2223356888999999999999999999999999999999 9999988766554444332   2 22345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +++++.+||.+||..||++||++.++++
T Consensus       279 ~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          279 CPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            8999999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.2e-49  Score=370.16  Aligned_cols=254  Identities=24%  Similarity=0.242  Sum_probs=203.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.++++||+|+||+||+|++.+      ..+|+|.+...........+|+.++++++ ||||+++++.+..-......+
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           25 PLQLLEVKARGRFGCVWKAQLLN------EYVAVKIFPIQDKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             EEEEEEEEECSTTCEEEEEEETT------EEEEEEEECGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEE
T ss_pred             hchhhheecccCceEEEEEEECC------CEEEEEEeecCchHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCceE
Confidence            68999999999999999998762      47999998765445556677888899998 999999999655433335567


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcEecCCCCCcEEeccCCceEEEe
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK----------GFVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----------givHrDlkp~NILl~~~~~vkl~D  151 (366)
                      ++|||||++|+|.+++..   ..+++..+..++.||+.||.|||++          ||+||||||+|||++.++.+||+|
T Consensus        98 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            899999999999999976   3599999999999999999999999          999999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccCCCCCCCccccCC-----cCCCCccchhhhHHHHHHHHhCCCCCCCCCcch---------
Q 017746          152 FGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-----NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN---------  217 (366)
Q Consensus       152 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~emltg~~pf~~~~~~~---------  217 (366)
                      ||+++...............||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+..+..         
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            999987654443333444679999999999987     456778999999999999999999997643211         


Q ss_pred             ----HHHHHHHhhcCCCCCCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          218 ----VFSLLIRIGVGDELPNIPGD-----LSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       218 ----~~~~~~~~~~~~~~~~~~~~-----~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                          ..............|.++..     .++++.+||.+||..||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                11111111222223333321     2455899999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.3e-49  Score=358.33  Aligned_cols=249  Identities=22%  Similarity=0.329  Sum_probs=209.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|++...     ..+++|.+.........+.+|++++++++ ||||+++++.+    .....+
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~----~~~~~~   80 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWLNK-----DKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVC----LEQAPI   80 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTT-----EEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEE----CSSSSE
T ss_pred             hceeeheecCCCccEEEEEEecCC-----CeEEEEEecccccCHHHHHHHHHHHHhCC-CCCEeeEEEEE----ecCCce
Confidence            588999999999999999998642     36899998876666778999999999998 99999999843    223446


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++.. ..+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EEEEEeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            799999999999999976 3457999999999999999999999999999999999999999999999999999865322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+..    ...+..+..+++
T Consensus       160 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  234 (269)
T 4hcu_A          160 Q-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYKPRLAST  234 (269)
T ss_dssp             H-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----TCCCCCCTTSCH
T ss_pred             c-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc----CccCCCCCcCCH
Confidence            1 112233457888999999999999999999999999999999 9999988766554444332    223345566899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++.+++.+||..||++||++.++++|
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          235 HVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.1e-50  Score=385.46  Aligned_cols=259  Identities=15%  Similarity=0.067  Sum_probs=189.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcC-CCCceeEeeccee----
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIG-ICPQIVRCFGDDY----   72 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~-~~p~Iv~~~g~~~----   72 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+.....    ....+.+|+.+++.|. .||||++++..++    
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLE----DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCc----eeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence            38899999999999999999987754    788888876432    2345677765555554 4999988664332    


Q ss_pred             ecc-CC---------------eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHH------HHHHHHHHHHHHHHHHCCcE
Q 017746           73 SFE-KG---------------ERFYNLLLEYASRGSLADRVKKQNNGRLQESDV------KRYTRSMLKGLRHIHSKGFV  130 (366)
Q Consensus        73 ~~~-~~---------------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~------~~~~~qi~~aL~~LH~~giv  130 (366)
                      .+. .+               ...+++|||||+ |+|.+++... +..+.+...      ..++.||+.||+|||++||+
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv  216 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV  216 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence            111 11               145789999999 7999999874 234555555      67779999999999999999


Q ss_pred             ecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCC--cCCCCccchhhhHHHHHHHHhCCC
Q 017746          131 HCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKP  208 (366)
Q Consensus       131 HrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~emltg~~  208 (366)
                      ||||||+||||+.++.+||+|||+|+....   .  .....||+.|+|||++.+  ..|+.++|||||||++|+|++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT---R--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC---E--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC---C--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999987631   1  113457899999999987  789999999999999999999999


Q ss_pred             CCCCCCcchHH--HHH--HHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          209 AWNHKQDSNVF--SLL--IRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       209 pf~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ||.........  ...  ............+..+++++.+||.+||..||++|||++++++||||..
T Consensus       292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            99876432110  000  0000001111122468999999999999999999999999999999954

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.2e-49  Score=376.19  Aligned_cols=256  Identities=24%  Similarity=0.340  Sum_probs=192.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+|+|++.....   ....+.+|+.+++.++ ||||+++++.+....  .
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTKTGL----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETTTTE----EEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGG
T ss_pred             ceEEeeEEeecCCeEEEEEEECCCCC----EEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCccc
Confidence            68999999999999999999887654    789998765322   2356778999999998 999999998543211  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||+ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             GCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             cCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            123466999999 6799999865   469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD------  229 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~------  229 (366)
                      .....     ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+....+....+.+.....      
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            75321     234579999999999887 679999999999999999999999998877665555554321100      


Q ss_pred             ------------CCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 ------------ELPN--------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 ------------~~~~--------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                  ..+.        ....+++++.+||.+||..||++|||++++++||||..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~  317 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  317 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence                        0011        11246889999999999999999999999999999954

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-48  Score=360.23  Aligned_cols=253  Identities=19%  Similarity=0.191  Sum_probs=206.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+... .....+.+|+.+++.+..|+|++++++.+    .....+
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~----~~~~~~   81 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQ----QVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFG----QEGLHN   81 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTE----EEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEE----EETTEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCc----EEEEEEeccC-CccHHHHHHHHHHHHHhcCCCCCeEEeec----CCCcee
Confidence            58999999999999999999877654    7888877543 34567899999999997799999998732    234456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc-----eEEEecCCcc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE-----AKIADFGLAK  156 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~-----vkl~DFG~a~  156 (366)
                      ++||||+ +++|.+++.. .+..+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++
T Consensus        82 ~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEEEec-CCCHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            7999999 8899999987 3456999999999999999999999999999999999999987765     9999999998


Q ss_pred             ccCCCCCC-----cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHH---HhhcC
Q 017746          157 KSSCDGER-----SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI---RIGVG  228 (366)
Q Consensus       157 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~---~~~~~  228 (366)
                      ........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.   .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            76433221     12234579999999999999999999999999999999999999998754433333222   22222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       229 ~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ...+.....+++++.+++.+||..||++||++++|++
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            2223334568999999999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3e-48  Score=357.91  Aligned_cols=257  Identities=29%  Similarity=0.497  Sum_probs=205.5

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      |....+||+|+||.||+|.+..++.    .+++|.+.... .....+.+|+.+++.++ ||||+++++.+.   . ...+
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~---~-~~~~   94 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQV----RIAIKEIPERDSRYSQPLHEEIALHKHLK-HKNIVQYLGSFS---E-NGFI   94 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCC----EEEEEEEECCCC---HHHHHHHHHHHTCC-CTTBCCEEEEEE---E-TTEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCe----EEEEEEccCCchHHHHHHHHHHHHHHhCC-CCCEeeEeeEEE---e-CCcE
Confidence            3344599999999999999987654    78888876532 34567889999999998 999999998432   2 3356


Q ss_pred             EEEeecCCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-CCceEEEecCCccccC
Q 017746           82 NLLLEYASRGSLADRVKKQNN-GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-NDEAKIADFGLAKKSS  159 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~~~vkl~DFG~a~~~~  159 (366)
                      ++||||+++++|.+++....+ ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            799999999999999987422 34679999999999999999999999999999999999987 8999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcC--CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...  .......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||........  .+.........+.++..
T Consensus       175 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~  250 (295)
T 2clq_A          175 GIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFKVGMFKVHPEIPES  250 (295)
T ss_dssp             C-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHHHHHHHCCCCCCCTT
T ss_pred             CCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHHhhcccccccccccc
Confidence            322  1223457999999999997654  88899999999999999999999976543322  22222222344566778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ++.++.+||.+||..||++||+++++++||||...
T Consensus       251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             SCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            99999999999999999999999999999999643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-48  Score=366.66  Aligned_cols=257  Identities=22%  Similarity=0.319  Sum_probs=206.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCC-----CCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----CPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~-----~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|.+...+   ...+|+|.+.........+.+|+.+++.++.     +++++++++.+   ..
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~---~~   88 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAG---GRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF---EH   88 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTT---TEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE---EE
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCC---CcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc---cc
Confidence            6999999999999999999984322   2478999887644445678899999999862     23588888733   22


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-------------
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-------------  143 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-------------  143 (366)
                       ...+++||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.             
T Consensus        89 -~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           89 -HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             -TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             -CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence             34567999999 789999998754457999999999999999999999999999999999999987             


Q ss_pred             ------CCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcch
Q 017746          144 ------NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN  217 (366)
Q Consensus       144 ------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~  217 (366)
                            ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  668999999999875321     223479999999999999999999999999999999999999998876655


Q ss_pred             HHHHHHHhhcCCC---------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 017746          218 VFSLLIRIGVGDE---------------------------------------LPNIPGDLSEQGKDFLIKCFLKDPKRRW  258 (366)
Q Consensus       218 ~~~~~~~~~~~~~---------------------------------------~~~~~~~~s~~~~~ll~~cL~~dp~~R~  258 (366)
                      ....+.+......                                       ....+...++++.+||.+||..||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            5444433221000                                       0001122357789999999999999999


Q ss_pred             CHHHHHcCCCccc
Q 017746          259 TAEMLLNHPFVCA  271 (366)
Q Consensus       259 t~~~ll~hp~~~~  271 (366)
                      |++|+++||||..
T Consensus       322 t~~ell~hp~f~~  334 (339)
T 1z57_A          322 TLREALKHPFFDL  334 (339)
T ss_dssp             CHHHHTTSGGGGG
T ss_pred             CHHHHhcCHHHHH
Confidence            9999999999964

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.1e-48  Score=354.52  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=209.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|.++..     ..+|+|.+.........+.+|+.++++++ ||||+++++.+    .....+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~----~~~~~~   78 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWKGQ-----YDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLVKFYGVC----SKEYPI   78 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTT-----EEEEEEEECBTTBCHHHHHHHHHHHHHCC-CTTBCCEEEEE----CSSSSE
T ss_pred             heeeeeeeccCCCceEEEEEecCc-----eeEEEEEeccCCCcHHHHHHHHHHHHhCC-CCCEeeEEEEE----ccCCce
Confidence            689999999999999999987642     36899998876666778999999999998 99999999843    234456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++++|.+++... +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            7999999999999999874 346999999999999999999999999999999999999999999999999999876433


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+..    ...+..+...++
T Consensus       158 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  232 (268)
T 3sxs_A          158 QY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ----GHRLYRPHLASD  232 (268)
T ss_dssp             CE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT----TCCCCCCTTSCH
T ss_pred             hh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc----CCCCCCCCcChH
Confidence            21 12233457788999999999999999999999999999999 9999987765544433332    222344566899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++.++|.+||..||++|||+.++++|
T Consensus       233 ~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          233 TIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999975

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=379.16  Aligned_cols=261  Identities=22%  Similarity=0.328  Sum_probs=210.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|+.... .......+|+|.+....  .....+.+|+.++.+++ ||||+++++.+   .. .
T Consensus        72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~---~~-~  146 (367)
T 3l9p_A           72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVS---LQ-S  146 (367)
T ss_dssp             GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE---CS-S
T ss_pred             HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC-CCCCCeEEEEE---ec-C
Confidence            588899999999999999996543 22345689999886432  23446788999999998 99999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC---ceEEE
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN-----GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND---EAKIA  150 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~---~vkl~  150 (366)
                      ...++|||||+||+|.+++.....     ..+++.++..++.||+.||+|||++||+||||||+|||++.+|   .+||+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            344699999999999999987432     3589999999999999999999999999999999999999655   59999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+...    
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~----  302 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG----  302 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT----
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----
Confidence            9999986432222233334568999999999999999999999999999999998 99999887665544444332    


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..+..+..++.++.+||.+||..||++||++.+|++|.++..
T Consensus       303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            233446678999999999999999999999999999987643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.9e-50  Score=384.57  Aligned_cols=248  Identities=11%  Similarity=0.051  Sum_probs=193.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcC--CCCceeEeecceee--
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIG--ICPQIVRCFGDDYS--   73 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~--~~p~Iv~~~g~~~~--   73 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+..    .......+.+|+.+++.+.  .||||+++++.+..  
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGE----SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCC----EEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCc----EEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            47889999999999999999877665    788887753    2234567889996666554  49999999854321  


Q ss_pred             --ccCC------------ee----EEEEEeecCCCCCHHHHHHHhCCCCCCH-------HHHHHHHHHHHHHHHHHHHCC
Q 017746           74 --FEKG------------ER----FYNLLLEYASRGSLADRVKKQNNGRLQE-------SDVKRYTRSMLKGLRHIHSKG  128 (366)
Q Consensus        74 --~~~~------------~~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~-------~~~~~~~~qi~~aL~~LH~~g  128 (366)
                        ++..            ..    ..++||||+ +|+|.+++.+.  +.+++       ..+..++.||+.||+|||++|
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence              1111            11    257999999 57999999864  23444       888889999999999999999


Q ss_pred             cEecCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCc-----------CCCCccchhhhH
Q 017746          129 FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN-----------EYEAPCDIWALG  197 (366)
Q Consensus       129 ivHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG  197 (366)
                      |+||||||+||||+.++.+||+|||+|+...   .  .....+| +.|+|||++.+.           .|+.++||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---A--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETT---C--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecC---C--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            9999999999999999999999999998642   1  2234468 999999999888           899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          198 CAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       198 ~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      |++|+|++|+.||...........+         ......+++++.+||.+||..||++|||+.++++||||..
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGSEWI---------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHHHHSSCCC------CCSGGG---------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHHHHCCCCCcccccccchhhh---------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            9999999999999765433221111         1122467999999999999999999999999999999954

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.2e-49  Score=366.35  Aligned_cols=247  Identities=21%  Similarity=0.397  Sum_probs=202.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||+||+|.+..+++    .+++|.+... ......+.+|++++++++ ||||+++++.+.   . ...
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~----~va~K~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~---~-~~~   81 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGE----VMVMKELIRFDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLY---K-DKR   81 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCC----EEEEEEESCCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE---E-TTE
T ss_pred             HeeccceecCCCCEEEEEEEECCCCc----EEEEEEeccCCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEe---c-CCe
Confidence            68899999999999999999987764    7888876542 234567889999999998 999999998543   2 344


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++|+|.+++.. ....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            6699999999999999987 456799999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCc------------ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchH-----HHHHH
Q 017746          161 DGERS------------QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNV-----FSLLI  223 (366)
Q Consensus       161 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~-----~~~~~  223 (366)
                      .....            .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........     .....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  240 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL  240 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence            32211            11245799999999999999999999999999999999999999975432211     11111


Q ss_pred             HhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .       ...+..+++++.++|.+||..||++|||+.++++
T Consensus       241 ~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          241 D-------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             H-------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c-------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1       1234567889999999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.8e-49  Score=363.39  Aligned_cols=261  Identities=27%  Similarity=0.416  Sum_probs=191.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+++|.+...  ......+.+|+.++++++ ||||+++++.+.   . ..
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~-~~   86 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKE----KVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTSFV---V-KD   86 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----C----EEEEECCC----------------CCCCCC-CTTBCCEEEEEE---S-SS
T ss_pred             hhhhhheeccccceEEEEEEECCCCc----EEEEEEEEhhhcchhHHHHHHHHHHHhhcC-CCCEeeEEEEEe---e-cC
Confidence            68999999999999999999876654    7899987643  234566788999999998 999999998432   2 23


Q ss_pred             EEEEEeecCCCCCHHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecC
Q 017746           80 FYNLLLEYASRGSLADRVKKQ------NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                      .+++||||+++++|.+++...      ..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            466999999999999999742      23569999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCC---cccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC
Q 017746          154 LAKKSSCDGER---SQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       154 ~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      ++.........   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...................
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS  246 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence            99876432211   11233469999999999876 568999999999999999999999998876655443332221110


Q ss_pred             -----CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 -----ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 -----~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                           ..+.....++.++.++|.+||..||++||++.++++||||..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  293 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK  293 (303)
T ss_dssp             TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence                 112233567899999999999999999999999999999954

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-48  Score=373.82  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=205.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCc-----eeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ-----IVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~-----Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+...........+|+.+++.+..|++     |+++++.+.   .
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~---~  127 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQE----WVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM---F  127 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTE----EEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE---E
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCc----EEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec---c
Confidence            58899999999999999999987654    78999887543445667889999999975664     888877432   2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCCCcEEec--cCCceEEEec
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH--SKGFVHCDIKLQNVLVF--DNDEAKIADF  152 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~--~~~~vkl~DF  152 (366)
                       ...+++||||+.+ +|.+++.......+++..+..++.||+.||.|||  +.||+||||||+||||+  .++.+||+||
T Consensus       128 -~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          128 -RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             -TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             -CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence             3456799999975 9999998754456999999999999999999999  57999999999999995  4678999999


Q ss_pred             CCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC--
Q 017746          153 GLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE--  230 (366)
Q Consensus       153 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~--  230 (366)
                      |+++.....     .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+....+....+........  
T Consensus       206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999876321     2345799999999999999999999999999999999999999998876666555544211000  


Q ss_pred             --------------CCC--------------C--C--CC-------------------------CCHHHHHHHHHhcccC
Q 017746          231 --------------LPN--------------I--P--GD-------------------------LSEQGKDFLIKCFLKD  253 (366)
Q Consensus       231 --------------~~~--------------~--~--~~-------------------------~s~~~~~ll~~cL~~d  253 (366)
                                    .+.              .  +  ..                         .++++++||.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence                          000              0  0  00                         0147899999999999


Q ss_pred             CCCCCCHHHHHcCCCccc
Q 017746          254 PKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       254 p~~R~t~~~ll~hp~~~~  271 (366)
                      |++|||++|+++||||..
T Consensus       361 P~~Rpta~e~L~hp~f~~  378 (382)
T 2vx3_A          361 PKTRIQPYYALQHSFFKK  378 (382)
T ss_dssp             TTTSCCHHHHTTSGGGCC
T ss_pred             hhhCCCHHHHhcCccccc
Confidence            999999999999999964

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.8e-48  Score=362.65  Aligned_cols=256  Identities=23%  Similarity=0.386  Sum_probs=211.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|.+.... ......+++|.+.....  ....+.+|+.++++++ ||||+++++.+   .. .
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~---~~-~   98 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGAC---SQ-D   98 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE---CS-S
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCceeeEEEEE---ec-C
Confidence            5889999999999999999985432 22346799998875322  3356889999999998 99999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN----------------------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKL  136 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp  136 (366)
                      ..+++||||+++|+|.+++.....                      ..+++.++..++.||+.||.|||++||+||||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp  178 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA  178 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence            346699999999999999986422                      2389999999999999999999999999999999


Q ss_pred             CcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCc
Q 017746          137 QNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQD  215 (366)
Q Consensus       137 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~  215 (366)
                      +|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654333333344568899999999999999999999999999999999 9999988877


Q ss_pred             chHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          216 SNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ......+...    ..+..+..+++++.++|.+||..||++||++.+++++
T Consensus       259 ~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          259 ERLFNLLKTG----HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GGHHHHHHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhhcC----CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6655544332    2345567789999999999999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-48  Score=367.17  Aligned_cols=252  Identities=20%  Similarity=0.222  Sum_probs=203.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|..... .....+.+|+.+++++..||||+++++.+..    ....
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----~~~~   80 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNE----YVAIKLEPMK-SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC----GKYN   80 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTE----EEEEEEEETT-CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE----TTEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCc----EEEEEEeccc-cchHHHHHHHHHHHHhhCCCCCCEEEEEEec----CCcc
Confidence            58999999999999999999877654    7889987653 3345789999999999669999999984322    3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc-----eEEEecCCcc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE-----AKIADFGLAK  156 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~-----vkl~DFG~a~  156 (366)
                      ++||||+ +++|.+++... ++.+++..+..++.||+.||+|||++||+||||||+|||++.++.     +||+|||+++
T Consensus        81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            7999999 88999999873 567999999999999999999999999999999999999998887     9999999998


Q ss_pred             ccCCCCCCc-----ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh---cC
Q 017746          157 KSSCDGERS-----QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG---VG  228 (366)
Q Consensus       157 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~---~~  228 (366)
                      .........     .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..+.   ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            754332211     1235679999999999999999999999999999999999999998865554444333321   11


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       229 ~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .........++ ++.+++.+||..||.+||++++|++
T Consensus       239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11111112244 8999999999999999999999876

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.8e-48  Score=358.52  Aligned_cols=256  Identities=25%  Similarity=0.364  Sum_probs=190.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc--hhhHHHHHH-HHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS--SVTLKNEKE-ALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~E~~-~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+......  ......|.. .++.++ ||||+++++.+.    ..
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~----~~   78 (290)
T 3fme_A            8 DLEPIMELGRGAYGVVEKMRHVPSGQ----IMAVKRIRATVNSQEQKRLLMDLDISMRTVD-CPFTVTFYGALF----RE   78 (290)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEC---CHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE----CS
T ss_pred             hhhhHHhcCCCCCeEEEEEEecCCCe----EEEEEEeecccCcHHHHHHHHHHHHHHHhCC-CCeEEEEeeeee----cc
Confidence            68999999999999999999987654    7889987653222  222333444 455555 999999998432    23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      ..+++||||+++ +|.+++...  .+..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           79 GDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             SSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             CCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence            346699999985 998887642  346799999999999999999999998 9999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCcccc----CCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESV----NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      +......   ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||.......  ..+.........
T Consensus       158 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~  232 (290)
T 3fme_A          158 GYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVEEPSP  232 (290)
T ss_dssp             ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HHHHHHHHSCCC
T ss_pred             ccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HHHHHHhccCCC
Confidence            8764322   22234699999999996    56678899999999999999999999997643322  222222222222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ...+..+++++.+||.+||..||++|||++++++||||...
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            23345689999999999999999999999999999999643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.9e-48  Score=369.26  Aligned_cols=255  Identities=25%  Similarity=0.365  Sum_probs=203.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---hhhHHHHHHHHHHcCCCCceeEeecceeeccCC-
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG-   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~-   77 (366)
                      +|.+++.||+|+||.||+|.++.+++    .+|+|.+......   ...+.+|+.+++.++ ||||+++++.+...... 
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGE----KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSST
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCC----EEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCcc
Confidence            58899999999999999999987764    7899988653222   356789999999998 99999999854322111 


Q ss_pred             -eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           78 -ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        78 -~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                       ...+++||||+.+ +|.+++.    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       118 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          118 NFYDFYLVMPFMQT-DLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             TCCCCEEEEECCCE-EHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             cceeEEEEEccccc-cHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence             1123699999984 9988873    359999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD------  229 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~------  229 (366)
                      .....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.......      
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            65321     223478999999999987 789999999999999999999999998876655554444321100      


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 --------------------ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 --------------------~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                          .....+..+++++.+||.+||+.||++|||++|+++||||..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  329 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  329 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence                                001122357899999999999999999999999999999954

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-47  Score=363.51  Aligned_cols=262  Identities=21%  Similarity=0.362  Sum_probs=207.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeec-cCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSF-EKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~-~~~~   78 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+.....  ....+.+|+.++++++ ||||+++++.+... ....
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGE----IVAIKKIEPFDKPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECCCSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCSTTC
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCc----EEEEEeecccccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccccCcc
Confidence            68999999999999999999987654    788998764322  2345778999999998 99999999854321 1223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+.+ +|.+++..   +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           87 NEVYIIQELMQT-DLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             CCEEEEECCCSE-EHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ceEEEEEeccCc-cHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            456799999985 99999976   36999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCc--------ccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC
Q 017746          159 SCDGERS--------QSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       159 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      .......        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            4322111        1223579999999998754 778999999999999999999999998876554444333321110


Q ss_pred             C-------------------CC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          230 E-------------------LP--------NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       230 ~-------------------~~--------~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .                   .+        .....+++++.+||.+||..||++|||++++++||||...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            0                   00        1123578999999999999999999999999999999653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-48  Score=366.61  Aligned_cols=260  Identities=26%  Similarity=0.327  Sum_probs=210.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++.... ......+++|.+...  ......+.+|+.++.++..||||+++++.+.   . .
T Consensus        46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---~-~  121 (344)
T 1rjb_A           46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---L-S  121 (344)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---S-S
T ss_pred             HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---e-C
Confidence            5788999999999999999974322 223457999988652  2345678999999999955999999998432   2 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN---------------------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQ  137 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~  137 (366)
                      ..+++||||+++|+|.+++.....                     ..+++..+..++.||+.||+|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            346699999999999999976322                     23799999999999999999999999999999999


Q ss_pred             cEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcc
Q 017746          138 NVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDS  216 (366)
Q Consensus       138 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~  216 (366)
                      |||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            99999999999999999987654333333344568899999999999999999999999999999998 99999887665


Q ss_pred             hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          217 NVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                      ..........   ..+..+..+++++.+||.+||..||++|||+.++++|..
T Consensus       282 ~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          282 ANFYKLIQNG---FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             HHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            5544444433   233455678999999999999999999999999998643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.7e-48  Score=358.89  Aligned_cols=260  Identities=23%  Similarity=0.368  Sum_probs=203.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||+||+|+........+..+|+|.+..... ....+.+|+.++++++ ||||+++++.+..  .+...
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~   87 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS--AGRRN   87 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECH--HHHTS
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec--CCCCc
Confidence            689999999999999999996544444456899998875322 2356889999999998 9999999985432  22334


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHH-CGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             eEEEEEeCCCCCHHHHHHh-cccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            6699999999999999987 344699999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCC-cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc------------hHHHHHHHhhc
Q 017746          161 DGER-SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS------------NVFSLLIRIGV  227 (366)
Q Consensus       161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~------------~~~~~~~~~~~  227 (366)
                      .... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......            .....+.....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  246 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence            3221 1122345788899999999999999999999999999999999998643211            01111122222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ....+..+..+++++.+||.+||..||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            23334456789999999999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=364.07  Aligned_cols=261  Identities=25%  Similarity=0.349  Sum_probs=201.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceee-------
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYS-------   73 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~-------   73 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+++|.+.... .....+.+|+.++++++ ||||+++++.+..       
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDNDCDK----RVAIKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETTTTE----EEEEEEEECCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCBCCC
T ss_pred             ceeEEEEeccCCCeEEEEEEECCCCe----EEEEEEEecCChHHHHHHHHHHHHHHhcC-CCCeeEEEEecccccccccc
Confidence            68999999999999999999987654    78888776532 23456789999999998 9999999985321       


Q ss_pred             ---ccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec-cCCceEE
Q 017746           74 ---FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF-DNDEAKI  149 (366)
Q Consensus        74 ---~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-~~~~vkl  149 (366)
                         .......+++||||++ |+|.+++.+   +.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence               1123456779999998 599999954   5799999999999999999999999999999999999997 5679999


Q ss_pred             EecCCccccCCCCCC-cccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc
Q 017746          150 ADFGLAKKSSCDGER-SQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV  227 (366)
Q Consensus       150 ~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~  227 (366)
                      +|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999876422111 12233468999999998865 6789999999999999999999999988766554444432210


Q ss_pred             C-------------------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          228 G-------------------------DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       228 ~-------------------------~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .                         ......+..++.++.+||.+||..||++|||++++++||||..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence            0                         0000122457999999999999999999999999999999964

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-48  Score=374.44  Aligned_cols=250  Identities=22%  Similarity=0.373  Sum_probs=205.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|+++.++.    .+|+|.+.....  ....+.+|++++++++ ||||+++++.+    ....
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~----~~~~  185 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNT----LVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVC----TQKQ  185 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCC----EEEEEECCTTSCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEE----CSSS
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCe----EEEEEEccccCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE----ecCC
Confidence            47889999999999999999986654    789998765322  2346788999999998 99999999843    2233


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            466999999999999999863 4469999999999999999999999999999999999999999999999999998653


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..   . ..+..+..+
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~---~-~~~~~~~~~  340 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK---G-GRLPCPELC  340 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT---T-CCCCCCTTC
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---C-CCCCCCCCC
Confidence            2211111112235778999999999999999999999999999998 9999988765544443332   1 223456678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++++.+||.+||..||++|||+++|++
T Consensus       341 ~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.4e-48  Score=355.60  Aligned_cols=254  Identities=26%  Similarity=0.426  Sum_probs=208.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+..   .......+.+|+.++++++ ||||+++++.+    ...
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~~   93 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQ----EYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEIL----EDS   93 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEE----ECS
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCc----EEEEEEecccccchHHHHHHHHHHHHHHhcc-CCCccEEEEEE----eCC
Confidence            58999999999999999999987665    677887643   2345667889999999997 99999999843    224


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC---CceEEEecCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN---DEAKIADFGLA  155 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG~a  155 (366)
                      ..+++||||+++++|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             CeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            4567999999999999999764  469999999999999999999999999999999999999754   46999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      .......   ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.........+.........+. .
T Consensus       172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~  246 (287)
T 2wei_A          172 TCFQQNT---KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ-W  246 (287)
T ss_dssp             GTBCCCS---SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG-G
T ss_pred             eeecCCC---ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchh-h
Confidence            8764322   12234589999999998764 89999999999999999999999988766555444444322222221 2


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..+++++.+||.+||..||++|||+.++++||||..
T Consensus       247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence            457999999999999999999999999999999954

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.6e-48  Score=365.46  Aligned_cols=256  Identities=21%  Similarity=0.259  Sum_probs=204.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCc------eeEeecceeecc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ------IVRCFGDDYSFE   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~------Iv~~~g~~~~~~   75 (366)
                      +|.+++.||+|+||+||+|.+..+++   ..+|+|.+.........+.+|+.+++++. |++      ++.+++.+   .
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~---~   92 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGK---SQVALKIIRNVGKYREAARLEINVLKKIK-EKDKENKFLCVLMSDWF---N   92 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTT---EEEEEEEECSCHHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCEEEEE---E
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCc---eEEEEEEEcccccchhHHHHHHHHHHHHh-hcCCCCceeEEEeeeee---e
Confidence            68999999999999999999877653   47899988754445567888999999997 444      77776532   2


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe--------------
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV--------------  141 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl--------------  141 (366)
                       ....+++||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||+              
T Consensus        93 -~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           93 -FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             -ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             -eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence             233567999999 5688888877554679999999999999999999999999999999999999              


Q ss_pred             -----ccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc
Q 017746          142 -----FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS  216 (366)
Q Consensus       142 -----~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~  216 (366)
                           +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                 56789999999999875322     22347999999999999999999999999999999999999999887665


Q ss_pred             hHHHHHHHhhcCCCC---------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCC
Q 017746          217 NVFSLLIRIGVGDEL---------------------------------------PNIPGDLSEQGKDFLIKCFLKDPKRR  257 (366)
Q Consensus       217 ~~~~~~~~~~~~~~~---------------------------------------~~~~~~~s~~~~~ll~~cL~~dp~~R  257 (366)
                      +....+.+.......                                       .......+.++.+||.+||..||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            554444433211000                                       00011124578899999999999999


Q ss_pred             CCHHHHHcCCCccc
Q 017746          258 WTAEMLLNHPFVCA  271 (366)
Q Consensus       258 ~t~~~ll~hp~~~~  271 (366)
                      ||++++++||||..
T Consensus       326 pt~~e~l~hp~f~~  339 (355)
T 2eu9_A          326 ITLAEALLHPFFAG  339 (355)
T ss_dssp             CCHHHHTTSGGGGG
T ss_pred             cCHHHHhcChhhcC
Confidence            99999999999954

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.8e-48  Score=354.32  Aligned_cols=252  Identities=24%  Similarity=0.368  Sum_probs=198.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|.+..++. ....+++|.......  ....+.+|+.++++++ ||||+++++.+   .+  .
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~---~~--~   88 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPEN-PALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVI---TE--N   88 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE---CS--S
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCC-CceEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCccceEEEEE---cc--C
Confidence            58899999999999999999876432 345789998765322  2456889999999998 99999999842   22  2


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+++.. .+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             ccEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            35699999999999999986 34579999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ..... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+...    ..+..+..+
T Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~  242 (281)
T 1mp8_A          168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG----ERLPMPPNC  242 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----CCCCCCTTC
T ss_pred             ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC----CCCCCCCCC
Confidence            32211 1223457889999999999999999999999999999997 99999887776665554432    233456778


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++++.++|.+||..||++|||+.+++++
T Consensus       243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          243 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-47  Score=354.43  Aligned_cols=260  Identities=23%  Similarity=0.336  Sum_probs=208.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|+....+...+..+|+|.+....  .....+.+|+.++++++ ||||+++++.+.  ..+..
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~   98 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICT--EDGGN   98 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--C---C
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC-CCCeeeeeeEEe--cCCCc
Confidence            48899999999999999999655444556789999887532  34567899999999998 999999998543  23334


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            567999999999999999763 4579999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCC-cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCC-----------cchHHHHHHHhhc
Q 017746          160 CDGER-SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQ-----------DSNVFSLLIRIGV  227 (366)
Q Consensus       160 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~-----------~~~~~~~~~~~~~  227 (366)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|..|+....           .......+.....
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            43321 12234568889999999999999999999999999999999999864221           1112222222222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .......+..+++++.+||.+||..||++|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            33344566779999999999999999999999999985

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-48  Score=364.13  Aligned_cols=256  Identities=23%  Similarity=0.305  Sum_probs=209.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC-CCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++..... .....+++|.+.....  ....+.+|+.++++++ ||||+++++.+   .. .
T Consensus        48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~---~~-~  122 (343)
T 1luf_A           48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVC---AV-G  122 (343)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE---CS-S
T ss_pred             HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE---cc-C
Confidence            58899999999999999999874321 2235799998875322  2456889999999997 99999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN----------------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKL  136 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp  136 (366)
                      ..+++||||+++|+|.+++....                      ...+++.++..++.||+.||.|||++||+||||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  202 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  202 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence            34669999999999999998632                      15699999999999999999999999999999999


Q ss_pred             CcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCc
Q 017746          137 QNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQD  215 (366)
Q Consensus       137 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~  215 (366)
                      +|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            999999999999999999987643322222334568999999999999999999999999999999999 9999988765


Q ss_pred             chHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          216 SNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .+....+..    ...+..+..++.++.++|.+||..||++||++.+++++
T Consensus       283 ~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          283 EEVIYYVRD----GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhC----CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            554443332    23345667889999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.9e-48  Score=355.49  Aligned_cols=249  Identities=22%  Similarity=0.323  Sum_probs=206.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|.+...     ..+++|.+.........+.+|++++++++ ||||+++++.+    .....+
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~----~~~~~~   94 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWRGQ-----YDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVC----TKQRPI   94 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEETTT-----EEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEE----CSSSSE
T ss_pred             HHHhHhhcCCCCCceEEEEEEcCC-----CeEEEEEecCCCCCHHHHHHHHHHHhcCC-CCCEeeEEEEE----ecCCCe
Confidence            588899999999999999987642     36899998876666778999999999998 99999999843    234456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             EEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            7999999999999999763 356999999999999999999999999999999999999999999999999999865322


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+...    ..+..+..+++
T Consensus       174 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~  248 (283)
T 3gen_A          174 E-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG----LRLYRPHLASE  248 (283)
T ss_dssp             H-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT----CCCCCCTTCCH
T ss_pred             c-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc----cCCCCCCcCCH
Confidence            1 112233457888999999999999999999999999999998 99999887665554444332    22344566799


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .+.++|.+||..||++|||+.++++|
T Consensus       249 ~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          249 KVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999999976

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.9e-48  Score=354.33  Aligned_cols=250  Identities=22%  Similarity=0.383  Sum_probs=193.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++..       .+++|.+.....   ....+.+|+.++++++ ||||+++++.    ....
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~~-------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~----~~~~   92 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWHG-------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGY----STAP   92 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESSS-------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEE----ECSS
T ss_pred             ceeeeeEecCCCCeEEEEEEEcC-------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCcEEEEEee----ccCC
Confidence            68999999999999999998643       478887765332   2356889999999998 9999999982    2222


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                       .+++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        93 -~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           93 -QLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             -SCEEEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             -ccEEEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence             35699999999999999976 4467999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCcccccccCCCCCCCccccC---CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHh-hcCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVN---ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI-GVGDELPNI  234 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~  234 (366)
                      .............||+.|+|||++.   +..++.++|||||||++|+|++|+.||............... .........
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV  250 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence            4322233333457999999999986   667888999999999999999999999876554443333332 333334445


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ...+++++.+||.+||..||++||++.++++
T Consensus       251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          251 RSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            5678999999999999999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-47  Score=357.24  Aligned_cols=258  Identities=24%  Similarity=0.343  Sum_probs=211.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++... .......+++|.+.....  ....+.+|+.+++++..||||+++++.+   .. .
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---~~-~   99 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---TI-G   99 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---CS-S
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE---ec-C
Confidence            588999999999999999986432 222346899998875432  3467889999999995599999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN----------------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF  142 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  142 (366)
                      ..+++||||+++|+|.+++.....                ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence            345699999999999999987432                2489999999999999999999999999999999999999


Q ss_pred             cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHH
Q 017746          143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSL  221 (366)
Q Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~  221 (366)
                      .++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  259 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence            999999999999987754433333334568889999999999999999999999999999999 9999988766555444


Q ss_pred             HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .......   +..+..++.++.++|.+||..||++|||+.+++++
T Consensus       260 ~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          260 MIKEGFR---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhccCCC---CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            4443322   33456689999999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.5e-48  Score=355.18  Aligned_cols=250  Identities=22%  Similarity=0.333  Sum_probs=213.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|.++.++    ..+++|.+.........+.+|+.++++++ ||||+++++.+    .....+
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~----~~~~~~   84 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVC----TREPPF   84 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEGGGT----EEEEEEEECSCSTHHHHHHHHHHHHHHCC-CTTBCCEEEEE----CSSSSE
T ss_pred             ceeEEeecCCCCceeEEEeEecCCC----EEEEEEecCcCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE----ccCCCE
Confidence            5888999999999999999998764    47899998876667788999999999998 99999999843    233446


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++++|.+++.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            79999999999999998755567999999999999999999999999999999999999999999999999999876432


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+...    ..+..+..+++
T Consensus       165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~  239 (288)
T 3kfa_A          165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----YRMERPEGCPE  239 (288)
T ss_dssp             S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----CCCCCCTTCCH
T ss_pred             c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc----CCCCCCCCCCH
Confidence            2 122233457889999999999999999999999999999999 99999887766655544432    22345567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.+||.+||..||++|||++++++
T Consensus       240 ~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          240 KVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhCCChhhCcCHHHHHH
Confidence            9999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7e-48  Score=362.12  Aligned_cols=258  Identities=24%  Similarity=0.343  Sum_probs=212.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCC-CCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSE-FPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|.+..+++. ....+++|.+.....  ....+.+|+.+++.+..||||+++++.+   . ..
T Consensus        47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---~-~~  122 (333)
T 2i1m_A           47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC---T-HG  122 (333)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---C-SS
T ss_pred             HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE---e-cC
Confidence            588899999999999999999876543 345789998875432  3456889999999995599999999843   2 23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE  146 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~  146 (366)
                      ..+++||||+++|+|.+++....            ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence            34669999999999999997632            346899999999999999999999999999999999999999999


Q ss_pred             eEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHh
Q 017746          147 AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI  225 (366)
Q Consensus       147 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~  225 (366)
                      +||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+...
T Consensus       203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  282 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD  282 (333)
T ss_dssp             EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred             EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence            99999999987643333323334467889999999999999999999999999999998 99999887665555544444


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       226 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ...   +..+..+++++.++|.+||..||.+|||+.+++++
T Consensus       283 ~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          283 GYQ---MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            332   23455679999999999999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.9e-47  Score=348.31  Aligned_cols=246  Identities=23%  Similarity=0.369  Sum_probs=203.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc--------hhhHHHHHHHHHHcCCCCceeEeecceee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS--------SVTLKNEKEALDQIGICPQIVRCFGDDYS   73 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~   73 (366)
                      +|.+.+.||+|+||+||+|++..+++    .+|+|.+......        ...+.+|+.++++++ ||||+++++.+  
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~--   92 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVKDKS----VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLM--   92 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETTTCC----EEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEE--
T ss_pred             cceehhccccCCceeEEEEEEcCCce----EEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheee--
Confidence            68899999999999999999987654    7889987653221        157889999999998 99999999843  


Q ss_pred             ccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEeccCCc-----
Q 017746           74 FEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG--FVHCDIKLQNVLVFDNDE-----  146 (366)
Q Consensus        74 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~-----  146 (366)
                       .. ..  ++||||+++|+|.+++.+ ....+++..+..++.||+.||+|||++|  |+||||||+|||++.++.     
T Consensus        93 -~~-~~--~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           93 -HN-PP--RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             -TT-TT--EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             -cC-CC--eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence             22 22  489999999999999976 4457999999999999999999999999  999999999999988776     


Q ss_pred             eEEEecCCccccCCCCCCcccccccCCCCCCCcccc--CCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 017746          147 AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV--NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       147 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~  224 (366)
                      +||+|||+++....     ......||+.|+|||++  ....++.++|||||||++|+|++|+.||......... ....
T Consensus       168 ~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~  241 (287)
T 4f0f_A          168 AKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINM  241 (287)
T ss_dssp             EEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHH
T ss_pred             EEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHH
Confidence            99999999985432     22345799999999998  4556788999999999999999999999876654432 2222


Q ss_pred             hhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       225 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .......+.++..+++++.++|.+||..||++|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            23334455677789999999999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.1e-47  Score=355.24  Aligned_cols=252  Identities=26%  Similarity=0.377  Sum_probs=200.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHH--cCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ--IGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~--l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|++.  +    ..+|+|.+..  ........|.+++..  ++ ||||+++++.+........
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~--~----~~vavK~~~~--~~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSWQ--G----ENVAVKIFSS--RDEKSWFRETELYNTVMLR-HENILGFIASDMTSRHSST   79 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEET--T----EEEEEEEECG--GGHHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEEETTEE
T ss_pred             cEEEEEeeccCCCcEEEEEEEC--C----EEEEEEEecc--ccchhhHHHHHHHHHhhcc-CcCeeeEEEeeccccCCCc
Confidence            6899999999999999999873  2    4799998765  345566777888777  55 9999999997665555667


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEecCCCCCcEEeccCCceEEEe
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH--------SKGFVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------~~givHrDlkp~NILl~~~~~vkl~D  151 (366)
                      .+++||||+++|+|.++++.   ..+++..+..++.||+.||+|||        ++||+||||||+|||++.++.+||+|
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             eeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence            78899999999999999954   46999999999999999999999        99999999999999999999999999


Q ss_pred             cCCccccCCCCCCc--ccccccCCCCCCCccccCCc------CCCCccchhhhHHHHHHHHhC----------CCCCCCC
Q 017746          152 FGLAKKSSCDGERS--QSFECRGTPLYMSPESVNEN------EYEAPCDIWALGCAVVEMASG----------KPAWNHK  213 (366)
Q Consensus       152 FG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~emltg----------~~pf~~~  213 (366)
                      ||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          ..||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            99997654322211  12234799999999999877      566799999999999999999          8898654


Q ss_pred             Ccch-HHHHHHH-hhcCCCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          214 QDSN-VFSLLIR-IGVGDELPNIPG-----DLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       214 ~~~~-~~~~~~~-~~~~~~~~~~~~-----~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .... ....+.. .......+.++.     .++.++.+||.+||..||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            3221 1122222 222233333332     24578999999999999999999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.2e-48  Score=358.12  Aligned_cols=259  Identities=23%  Similarity=0.362  Sum_probs=211.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++.... ......+++|.+.....  ....+.+|+.++.++..||||+++++.+   ....
T Consensus        28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---~~~~  104 (316)
T 2xir_A           28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC---TKPG  104 (316)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---CCTT
T ss_pred             heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE---ecCC
Confidence            5889999999999999999865421 22346899998876433  2346889999999997799999999843   2333


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN--------------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN  144 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~  144 (366)
                      ..+++||||+++|+|.+++.....              ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  184 (316)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence            446699999999999999976321              128999999999999999999999999999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 017746          145 DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLI  223 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~  223 (366)
                      +.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus       185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~  264 (316)
T 2xir_A          185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  264 (316)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence            9999999999987654433333344568999999999999999999999999999999998 999998776554433333


Q ss_pred             HhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+.   .+..+..+++++.++|.+||..||++|||+.++++|
T Consensus       265 ~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          265 KEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCc---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3322   234556789999999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.1e-47  Score=359.44  Aligned_cols=257  Identities=25%  Similarity=0.384  Sum_probs=209.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC---CCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS---EFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~---~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|++...++   ..+..+|+|.+.....  ....+.+|+.+++++..||||+++++.+    .
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~----~  111 (334)
T 2pvf_A           36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC----T  111 (334)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----C
T ss_pred             HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE----c
Confidence            58899999999999999999864321   2356799998875332  3456889999999996699999999843    2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNN--------------GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF  142 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  142 (366)
                      ....+++||||+++|+|.+++.....              ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence            23456699999999999999976321              2489999999999999999999999999999999999999


Q ss_pred             cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHH
Q 017746          143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSL  221 (366)
Q Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~  221 (366)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  271 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  271 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence            999999999999987654332222334467889999999999999999999999999999999 9999988765554444


Q ss_pred             HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +...    ..+..+..++.++.++|.+||..||++||++.+++++
T Consensus       272 ~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          272 LKEG----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcC----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            4332    2234566789999999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.2e-48  Score=380.82  Aligned_cols=250  Identities=22%  Similarity=0.341  Sum_probs=212.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|+++.++    ..+|+|.+.........+.+|+.+|++++ ||||+++++.+    .....+
T Consensus       221 ~~~~~~~lG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~----~~~~~~  291 (495)
T 1opk_A          221 DITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVC----TREPPF  291 (495)
T ss_dssp             GEEEEEESGGGTTSSEEEEEEGGGT----EEEEEEECCSSSSCHHHHHHHHHHHHHCC-CTTBCCEEEEE----CSSSSC
T ss_pred             HceeeeEecCCCCeEEEEEEEcCCC----eEEEEEEecCcccchHHHHHHHHHHHhcC-CCCEeeEEEEE----ecCCcE
Confidence            4778899999999999999997654    48999998876667788999999999998 99999999843    223346


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            69999999999999998755566999999999999999999999999999999999999999999999999999876422


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..    ......+..+++
T Consensus       372 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  446 (495)
T 1opk_A          372 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRMERPEGCPE  446 (495)
T ss_dssp             C-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT----TCCCCCCTTCCH
T ss_pred             c-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CCCCCCCCCCCH
Confidence            1 122233457788999999999999999999999999999999 9999998876665554433    222345667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.+||.+||..||++|||+.+|++
T Consensus       447 ~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          447 KVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCcChhHCcCHHHHHH
Confidence            9999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.4e-47  Score=357.16  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=200.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCC-CCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGI-CPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~-~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|.+.. +    ..+|+|.+.....   ....+.+|+.++.++.. ||||+++++.+    ..
T Consensus        29 ~y~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~----~~   99 (313)
T 3cek_A           29 IYSILKQIGSGGSSKVFQVLNEK-K----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE----IT   99 (313)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-C----CEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE----EC
T ss_pred             eEEEEEEecCCCCEEEEEEEcCC-C----cEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe----ec
Confidence            58999999999999999998753 3    4788888765322   34567899999999984 69999999843    23


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||| +.+++|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~  175 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  175 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence            445779999 5677999999863  4799999999999999999999999999999999999996 48999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC-----------cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE-----------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG  226 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~  226 (366)
                      ..............||+.|+|||++.+           ..++.++|||||||++|+|++|+.||......  ...+....
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~  253 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAII  253 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHH
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--HHHHHHHH
Confidence            643333222334579999999999876           46888999999999999999999999765432  22233333


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       227 ~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      .......++...+.++.+||.+||..||++||+++++++||||...
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            3333345566678999999999999999999999999999999643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3e-47  Score=351.42  Aligned_cols=253  Identities=19%  Similarity=0.207  Sum_probs=202.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|..... .....+.+|+.+++.+. |++++..++.   +......+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~e~~~l~~l~-~~~~i~~~~~---~~~~~~~~   80 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGE----EVAIKLECVK-TKHPQLHIESKIYKMMQ-GGVGIPTIRW---CGAEGDYN   80 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTE----EEEEEEEESC-SSCCHHHHHHHHHHHHT-TSTTCCCEEE---EEEETTEE
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCc----EEEEEEecCC-cchhHHHHHHHHHHHhh-cCCCCCcccc---ccCCCCce
Confidence            68999999999999999999877654    7888876653 33456899999999999 5555554442   22233456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe---ccCCceEEEecCCcccc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV---FDNDEAKIADFGLAKKS  158 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~~  158 (366)
                      ++||||+ +++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        81 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEEec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            7999999 8899999976 34579999999999999999999999999999999999999   47889999999999876


Q ss_pred             CCCCCCc-----ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCc---chHHHHHHHhhcCCC
Q 017746          159 SCDGERS-----QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD---SNVFSLLIRIGVGDE  230 (366)
Q Consensus       159 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~---~~~~~~~~~~~~~~~  230 (366)
                      .......     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ......+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            4332211     12345799999999999999999999999999999999999999986432   233333333322222


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+..+..+++++.+++.+||..||++||+++++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            22333568999999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.3e-48  Score=366.37  Aligned_cols=253  Identities=24%  Similarity=0.319  Sum_probs=206.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----ch--------------hhHHHHHHHHHHcCCCCc
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SS--------------VTLKNEKEALDQIGICPQ   63 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~--------------~~~~~E~~~l~~l~~~p~   63 (366)
                      +|.+++.||+|+||.||+|.+  ++    ..+++|.+.....    ..              ..+.+|+.++++++ |||
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~  104 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK--DN----KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEY  104 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE--TT----EEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTT
T ss_pred             ceEEEEEEcCCCCeEEEEEEc--CC----ceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCC
Confidence            689999999999999999998  33    4788887754211    11              78899999999998 999


Q ss_pred             eeEeecceeeccCCeeEEEEEeecCCCCCHHHH------HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCC
Q 017746           64 IVRCFGDDYSFEKGERFYNLLLEYASRGSLADR------VKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKL  136 (366)
Q Consensus        64 Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp  136 (366)
                      |+++++.+.   . ...+++||||+++|+|.++      +.+.....+++..+..++.||+.||.|||+ +||+||||||
T Consensus       105 i~~~~~~~~---~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p  180 (348)
T 2pml_X          105 CLTCEGIIT---N-YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP  180 (348)
T ss_dssp             BCCCSEEEE---S-SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred             cceEEEEEe---e-CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence            999998432   2 3456799999999999998      654335679999999999999999999999 9999999999


Q ss_pred             CcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCc-CCCC-ccchhhhHHHHHHHHhCCCCCCCCC
Q 017746          137 QNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN-EYEA-PCDIWALGCAVVEMASGKPAWNHKQ  214 (366)
Q Consensus       137 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~emltg~~pf~~~~  214 (366)
                      +|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|+|++|+.||....
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999875322    23345799999999999887 6776 9999999999999999999998776


Q ss_pred             c-chHHHHHHHhhcCCCCCC----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          215 D-SNVFSLLIRIGVGDELPN----------------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       215 ~-~~~~~~~~~~~~~~~~~~----------------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      . .+....+....  ...|.                ....++.++.+||.+||..||++|||++++++||||..
T Consensus       257 ~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          257 SLVELFNNIRTKN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             CSHHHHHHHTSCC--CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cHHHHHHHHhccC--cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            5 33333322211  11110                01468999999999999999999999999999999954

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.3e-48  Score=361.01  Aligned_cols=261  Identities=24%  Similarity=0.375  Sum_probs=211.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||.||+|++...+...+..+++|.+..... ....+.+|++++++++ ||||+++++.++  ..+...
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~  100 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH-SDFIVKYRGVSY--GPGRQS  100 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSSCE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcC-CCceeEEEEEEe--cCCCce
Confidence            689999999999999999997554445567899998876322 3356899999999997 999999998543  334556


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            77999999999999999873 34699999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc-----------hHHHHHHHhhcC
Q 017746          161 DGERS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS-----------NVFSLLIRIGVG  228 (366)
Q Consensus       161 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~-----------~~~~~~~~~~~~  228 (366)
                      ..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......           .....+......
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE  259 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence            32211 223346888999999999999999999999999999999999999644321           111222222222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       229 ~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ...+..+..+++++.+||.+||..||++|||+++++++
T Consensus       260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33445567789999999999999999999999999764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-47  Score=349.90  Aligned_cols=249  Identities=26%  Similarity=0.374  Sum_probs=208.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc------
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE------   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~------   75 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+...   ...+.+|++++++++ ||||+++++.+....      
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGK----TYVIKRVKYN---NEKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCC----EEEEEEEECC---SGGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC----
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCe----EEEEEEeccc---cHHHHHHHHHHHhCC-CCCEEEEeeeEeccccCcccc
Confidence            68999999999999999999987654    7888887642   357889999999998 999999998654321      


Q ss_pred             ------CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEE
Q 017746           76 ------KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKI  149 (366)
Q Consensus        76 ------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl  149 (366)
                            .....+++||||+++|+|.+++.+..+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence                  22456789999999999999998765567999999999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC
Q 017746          150 ADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       150 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      +|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...  ......+   ..  
T Consensus       164 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~---~~--  233 (284)
T 2a19_B          164 GDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL---RD--  233 (284)
T ss_dssp             CCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH---HT--
T ss_pred             Ccchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh---hc--
Confidence            99999987643322   23346999999999999999999999999999999999999998532  1111111   11  


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                        ..++..++.++.++|.+||..||++||++.++++|++.-
T Consensus       234 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          234 --GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             --TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              123456899999999999999999999999999998763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6e-47  Score=370.75  Aligned_cols=244  Identities=23%  Similarity=0.368  Sum_probs=205.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|.+.+      ..+|+|.+... .....+.+|+.+|++++ ||||+++++.+.   .....+
T Consensus       194 ~~~~~~~lG~G~fg~V~~~~~~~------~~vavK~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~---~~~~~~  262 (450)
T 1k9a_A          194 ELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKND-ATAQAFLAEASVMTQLR-HSNLVQLLGVIV---EEKGGL  262 (450)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT------EEEEEEEESSC-TTSHHHHHHHHHHHTCC-CTTBCCEEEEEE---CTTSCE
T ss_pred             HeEEEeeecCcCCeeEEEEEecC------CeEEEEEeCCc-hHHHHHHHHHHHHHhcc-CCCEEEEEEEEE---cCCCce
Confidence            47889999999999999998753      37999988764 35677899999999998 999999998432   223346


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++|||||++|+|.+++.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            69999999999999998754445899999999999999999999999999999999999999999999999999865321


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                           .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.. +   ..+..|..+++
T Consensus       343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~---~~~~~p~~~~~  413 (450)
T 1k9a_A          343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-G---YKMDAPDGCPP  413 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-T---CCCCCCTTCCH
T ss_pred             -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-C---CCCCCCCcCCH
Confidence                 112357899999999999999999999999999999998 9999988776665554432 1   23345677999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.++|.+||..||++|||+.+|++
T Consensus       414 ~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.6e-47  Score=360.54  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=204.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---hhhHHHHHHHHHHcCCCCceeEeecceeeccC--
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---SVTLKNEKEALDQIGICPQIVRCFGDDYSFEK--   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~--   76 (366)
                      +|.+.+.||+|+||.||+|+++.+++    .+|+|.+......   ...+.+|+.+++.++ ||||+++++.+.....  
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGE----KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGG
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCC----EEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccccc
Confidence            58899999999999999999987654    7899987653222   356788999999998 9999999985432111  


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||+.+ +|.+++.    ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          100 NFYDFYLVMPFMQT-DLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             GCCCCEEEEECCSE-EGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             cceeEEEEeccccC-CHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence            01234699999985 8888773    259999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc--------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV--------  227 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~--------  227 (366)
                      .....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.+...        
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            65321     223478999999999887 6789999999999999999999999988765554444433110        


Q ss_pred             ------------------CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          228 ------------------GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       228 ------------------~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                        ....+.....+++++.+||.+||..||++|||++++++||||..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  311 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  311 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                              11122334567999999999999999999999999999999954

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-47  Score=357.93  Aligned_cols=255  Identities=20%  Similarity=0.326  Sum_probs=202.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||+||+|.++.++......+++|.+.....  ....+.+|+.++++++ ||||+++++.+    ....
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~----~~~~  119 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVI----SKYK  119 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE----CSSS
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE----ecCC
Confidence            578889999999999999998876655566799999875332  3346789999999998 99999999843    2334


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+++.. .++.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CcEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            56799999999999999987 44679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          160 CDGERS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       160 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+..   . ..+..+..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~---~-~~~~~~~~  274 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---G-FRLPTPMD  274 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---T-CCCCCCTT
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC---C-CcCCCccc
Confidence            322211 1222346889999999999999999999999999999999 9999987765544443332   2 22334567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++.++.++|.+||..||++||++.+++++
T Consensus       275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          275 CPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            89999999999999999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.9e-47  Score=351.29  Aligned_cols=253  Identities=19%  Similarity=0.205  Sum_probs=200.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|..... .....+.+|+.+++.+. |++++..++.+   .......
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~e~~~l~~l~-~~~~i~~~~~~---~~~~~~~   80 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGE----EVAIKLECVK-TKHPQLHIESKIYKMMQ-GGVGIPTIRWC---GAEGDYN   80 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTE----EEEEEEEEC----CCCHHHHHHHHHHHT-TSTTCCCEEEE---EEETTEE
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCc----eEEEEeeccc-ccchHHHHHHHHHHHhc-CCCCCCeeeee---cCCCCce
Confidence            68999999999999999999877654    7888875542 33456899999999999 56655555422   2233456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe---ccCCceEEEecCCcccc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV---FDNDEAKIADFGLAKKS  158 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~~  158 (366)
                      ++||||+ +++|.+++.. .+..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEECC-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEEcc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            7999999 8899999986 34579999999999999999999999999999999999999   78899999999999876


Q ss_pred             CCCCCC-----cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc---hHHHHHHHhhcCCC
Q 017746          159 SCDGER-----SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS---NVFSLLIRIGVGDE  230 (366)
Q Consensus       159 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~---~~~~~~~~~~~~~~  230 (366)
                      ......     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....   .....+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            433221     1223457999999999999999999999999999999999999999764432   23333333222222


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+.....+++++.++|.+||..||++|||++++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            22233567999999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.6e-48  Score=362.77  Aligned_cols=245  Identities=25%  Similarity=0.377  Sum_probs=203.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-------chhhHHHHHHHHHHcC-CCCceeEeecceee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-------SSVTLKNEKEALDQIG-ICPQIVRCFGDDYS   73 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~E~~~l~~l~-~~p~Iv~~~g~~~~   73 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+.....       ....+.+|+.+++++. .||||+++++.+  
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~--  117 (320)
T 3a99_A           44 QYQVGPLLGSGGFGSVYSGIRVSDNL----PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--  117 (320)
T ss_dssp             TEEEEEECSSSSSCEEEEEEETTTTE----EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCc----EEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE--
Confidence            68999999999999999999887654    788887765221       2356788999999997 379999999843  


Q ss_pred             ccCCeeEEEEEeecCCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec-cCCceEEEe
Q 017746           74 FEKGERFYNLLLEYASR-GSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF-DNDEAKIAD  151 (366)
Q Consensus        74 ~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-~~~~vkl~D  151 (366)
                       . ....+++|||++.+ ++|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus       118 -~-~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          118 -E-RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             -E-CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             -e-cCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence             2 23456799999986 8999999864  4699999999999999999999999999999999999999 778999999


Q ss_pred             cCCccccCCCCCCcccccccCCCCCCCccccCCcCC-CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          152 FGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY-EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       152 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      ||+++.....    ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....      .+...     
T Consensus       194 fg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~-----  258 (320)
T 3a99_A          194 FGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-----  258 (320)
T ss_dssp             CTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-----
T ss_pred             Cccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc-----
Confidence            9999876422    1223469999999999987776 678999999999999999999996531      11111     


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ....+..+++++.+||.+||..||++|||++++++||||..
T Consensus       259 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~  299 (320)
T 3a99_A          259 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  299 (320)
T ss_dssp             CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence            12345678999999999999999999999999999999954

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.1e-47  Score=346.29  Aligned_cols=244  Identities=23%  Similarity=0.380  Sum_probs=194.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-----CchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+.+.||+|+||.||+|.+.+      ..+++|......     .....+.+|+++++.++ ||||+++++.+    .
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~   76 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWIG------DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVC----L   76 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETT------EEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEE----C
T ss_pred             heeeeeeeccCCCeEEEEEEEcC------CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEE----e
Confidence            68999999999999999999752      368888775422     23467889999999998 99999999843    2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCCCcEEecc--------CC
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG---FVHCDIKLQNVLVFD--------ND  145 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~--------~~  145 (366)
                      ....+++||||+++++|.+++..   ..+++..+..++.||+.||.|||++|   |+||||||+|||++.        ++
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~  153 (271)
T 3dtc_A           77 KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK  153 (271)
T ss_dssp             CC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred             cCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc
Confidence            34456799999999999999853   47999999999999999999999999   999999999999986        67


Q ss_pred             ceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHh
Q 017746          146 EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI  225 (366)
Q Consensus       146 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~  225 (366)
                      .+||+|||++.......    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+   
T Consensus       154 ~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---  226 (271)
T 3dtc_A          154 ILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV---  226 (271)
T ss_dssp             CEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH---
T ss_pred             ceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh---
Confidence            89999999998653221    22346999999999999999999999999999999999999999877554433332   


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       226 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ......+..+..+++++.++|.+||..||++|||+.++++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            23333445667889999999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-47  Score=346.48  Aligned_cols=249  Identities=22%  Similarity=0.329  Sum_probs=208.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|.+.. +    ..+++|.+.........+.+|+.++++++ ||||+++++.+.    ....+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~-~----~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~   78 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWLN-K----DKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCL----EQAPI   78 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETT-T----EEEEEEEECTTTBCHHHHHHHHHHHHTCC-CTTBCCEEEEEC----SSSSC
T ss_pred             heeeeeEecCCCceeEEEEEecC-C----CeEEEEEccccCCCHHHHHHHHHHHHhCC-CCCEeeEEEEEc----cCCCe
Confidence            58899999999999999999863 2    37899998876666778999999999998 999999998432    23346


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++++|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        79 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             EEEECCCTTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EEEEeCCCCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            699999999999999987 3457999999999999999999999999999999999999999999999999999875321


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........||+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+..    ...+..+..++.
T Consensus       158 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~----~~~~~~~~~~~~  232 (267)
T 3t9t_A          158 Q-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYKPRLAST  232 (267)
T ss_dssp             H-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----TCCCCCCTTSCH
T ss_pred             c-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc----CCcCCCCccCcH
Confidence            1 111223457889999999998999999999999999999999 9999987765544443332    122344566899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++.+++.+||..||++||++.+++++
T Consensus       233 ~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          233 HVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-47  Score=348.45  Aligned_cols=254  Identities=20%  Similarity=0.300  Sum_probs=205.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      .|..+++||+|+||+||+|.+..++. ....+++|.......  ....+.+|+.++++++ ||||+++++.+   ...+.
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---~~~~~   96 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQ-NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN-HPNVLALIGIM---LPPEG   96 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSS-CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEE---CCSSS
T ss_pred             EEccCceeccCCCceEEEEEEecCCC-ceeeeeeeeccccccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEE---ecCCC
Confidence            47778999999999999999765443 345789998775333  3356789999999998 99999999843   23334


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+.+|+|.+++.. .+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             CcEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            44699999999999999976 45679999999999999999999999999999999999999999999999999998653


Q ss_pred             CCC--CCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          160 CDG--ERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       160 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ...  .........||+.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+...    ..+..+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~----~~~~~~~  251 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG----RRLPQPE  251 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT----CCCCCCT
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC----CCCCCCc
Confidence            321  1112234468999999999999999999999999999999999 45556555554444433322    2234456


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+++++.+++.+||..||++|||+.++++
T Consensus       252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          252 YCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            78999999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.6e-47  Score=350.33  Aligned_cols=254  Identities=20%  Similarity=0.299  Sum_probs=203.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|++..++. ....+++|.......  ....+.+|+.++++++ ||||+++++.+.   ..+.
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~---~~~~  100 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICL---RSEG  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEC---CSSS
T ss_pred             ehhhcceeeecCCceEEEEEEecCCC-ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEE---cCCC
Confidence            58899999999999999999765432 244688888765322  3456889999999998 999999998432   2334


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             ceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            45699999999999999976 44578999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCC--CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          160 CDGE--RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       160 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ....  ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+...    ..+..+.
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  255 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----RRLLQPE  255 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT----CCCCCCT
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC----CCCCCCc
Confidence            3221  111233468889999999999999999999999999999999 67788776665554444332    2334456


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+++++.+++.+||..||++||++.++++
T Consensus       256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          256 YCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            78999999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.3e-47  Score=347.24  Aligned_cols=248  Identities=23%  Similarity=0.352  Sum_probs=207.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|.+..     ...+++|.+.........+.+|++++++++ ||||+++++.+   .. + .+
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~---~~-~-~~   82 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYNG-----HTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYAVV---TQ-E-PI   82 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETT-----TEEEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEE---CS-S-SC
T ss_pred             hhhheeeecCCCCeEEEEEEEcC-----CcEEEEEEecCCcccHHHHHHHHHHHHhCC-CcCcceEEEEE---cC-C-Cc
Confidence            57889999999999999999753     247899988876667788999999999998 99999999842   22 2 25


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++++|.+++....+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            69999999999999997543336999999999999999999999999999999999999999999999999999876432


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....+..    ...+..+..+++
T Consensus       163 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  237 (279)
T 1qpc_A          163 E-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPE  237 (279)
T ss_dssp             C-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----TCCCCCCTTCCH
T ss_pred             c-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc----ccCCCCcccccH
Confidence            2 112233457889999999998899999999999999999999 9999987765554443332    122345567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.+++.+||..||++|||++++++
T Consensus       238 ~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          238 ELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.3e-48  Score=360.92  Aligned_cols=256  Identities=20%  Similarity=0.267  Sum_probs=202.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+.+.||+|+||.||+|++.. +    ..+++|...... .....+.+|+.+++.++ ||||+++++.+    .....
T Consensus        40 ~y~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~----~~~~~  109 (321)
T 2qkw_B           40 NFDHKFLIGHGVFGKVYKGVLRD-G----AKVALKRRTPESSQGIEEFETEIETLSFCR-HPHLVSLIGFC----DERNE  109 (321)
T ss_dssp             CCSCCCCSCBCSSSEEEEEECTT-C----CEEEEEECCSCCSSHHHHHHHHHHGGGSCC-CTTBCCEEEEC----CCTTC
T ss_pred             ccCccceeecCCCeeEEEEEECC-C----CEEEEEEecccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEE----cCCCe
Confidence            68899999999999999999642 3    478999876532 34567899999999998 99999999843    22344


Q ss_pred             EEEEeecCCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           81 YNLLLEYASRGSLADRVKKQN--NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      +++||||+++|+|.+++....  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            669999999999999996532  235899999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHH---HhhcCCC-----
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI---RIGVGDE-----  230 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~---~~~~~~~-----  230 (366)
                      .............||+.|+|||++.+..++.++|||||||++|+|++|+.||......+......   .......     
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            43332222334569999999999999999999999999999999999999997654432211111   1110110     


Q ss_pred             ----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 017746          231 ----LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHP  267 (366)
Q Consensus       231 ----~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp  267 (366)
                          ...++...+.++.+++.+||..||++|||+.++++|.
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                1122233456789999999999999999999999764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.9e-47  Score=357.33  Aligned_cols=256  Identities=20%  Similarity=0.353  Sum_probs=208.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++... .......+++|.+.....  ....+.+|+.+++.++ ||||+++++.+   . ..
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~---~-~~  100 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVV---S-QG  100 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEE---C-SS
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEE---c-cC
Confidence            588999999999999999987631 112245799998875333  2345789999999998 99999999843   2 23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEE
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN--------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIA  150 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~  150 (366)
                      ..+++||||+++|+|.+++....        ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~  180 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  180 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence            34569999999999999997632        1357999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..    .
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~----~  256 (322)
T 1p4o_A          181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME----G  256 (322)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT----T
T ss_pred             cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc----C
Confidence            9999986543222222334467899999999999999999999999999999999 8999987765544443332    2


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+..+..++.++.++|.+||..||++|||+.++++|
T Consensus       257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3344566789999999999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.4e-47  Score=346.43  Aligned_cols=252  Identities=22%  Similarity=0.321  Sum_probs=206.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||+||+|++..... ....+++|.......  ....+.+|+.+++.++ ||||+++++.+   ..+ .
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~---~~~-~   86 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKG-EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLIGII---EEE-P   86 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTC-CEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEE---CSS-S
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCC-CcceEEEEecccccCchHHHHHHHHHHHHHhCC-CCCcceEEEEE---cCC-C
Confidence            58899999999999999999765332 244689998775322  3467889999999998 99999999842   222 2


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                       .++||||+++++|.+++.+. +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        87 -~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           87 -TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             -CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             -CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence             35999999999999999873 4569999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ..... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+....    .+..+..+
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~  239 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD----RLPKPDLC  239 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC----CCCCCTTC
T ss_pred             ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC----CCCCCCCC
Confidence            32211 1223457889999999998999999999999999999998 999998777666655544322    23345668


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++.+.++|.+||..||++||++.+++++
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          240 PPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            9999999999999999999999999864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.2e-47  Score=374.32  Aligned_cols=248  Identities=21%  Similarity=0.355  Sum_probs=207.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||+||+|.++.     ...+|+|.+.........+.+|+.+|++++ ||||+++++.+   . . ..+
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~---~-~-~~~  257 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYNK-----HTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVV---T-K-EPI  257 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETT-----TEEEEEEEECTTSBCHHHHHHHHHHHTTCC-CTTBCCEEEEE---C-S-SSC
T ss_pred             HeEEEEEcccCCceEEEEEEECC-----ccEEEEEEecCCCccHHHHHHHHHHHhhCC-CCCEeeEEEEE---e-C-Ccc
Confidence            47788999999999999999864     247899998876566788999999999998 99999999843   2 2 235


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++|||||++|+|.+++.+..+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            69999999999999997644346899999999999999999999999999999999999999999999999999876321


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........+|+.|+|||++....++.++|||||||++|||++ |+.||.+....+....+...   .. ...+..+++
T Consensus       338 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~-~~~~~~~~~  412 (454)
T 1qcf_A          338 E-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---YR-MPRPENCPE  412 (454)
T ss_dssp             H-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT---CC-CCCCTTSCH
T ss_pred             c-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CC-CCCCCCCCH
Confidence            1 111223357788999999999999999999999999999999 99999887665555444332   22 234567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.+||.+||..||++|||+++|++
T Consensus       413 ~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          413 ELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHH
Confidence            9999999999999999999999975

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.1e-47  Score=351.50  Aligned_cols=259  Identities=20%  Similarity=0.330  Sum_probs=201.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccC-C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK-G   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~-~   77 (366)
                      +|.+++.||+|+||.||+|.+...+. ....+++|.+.....   ....+.+|+.++++++ ||||+++++.+..... +
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDG-TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTS-CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC-----
T ss_pred             HeeeccceeecCCeEEEEEEEeccCC-ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeeccccC
Confidence            58899999999999999998765332 345799998775332   2356888999999998 9999999985443221 1


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecC
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQ----NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                      ....++||||+++|+|.+++...    ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg  192 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG  192 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence            22457999999999999999542    23569999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCC
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELP  232 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (366)
                      +++...............|++.|+|||++.+..++.++|||||||++|+|++ |..||...........+...    ..+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~----~~~  268 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG----HRL  268 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----CCC
T ss_pred             cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC----CCC
Confidence            9987644332233334468889999999999999999999999999999999 99999887766655544332    234


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       233 ~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+..+++++.++|.+||..||++||++.+++++
T Consensus       269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5566789999999999999999999999999874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=359.78  Aligned_cols=259  Identities=22%  Similarity=0.271  Sum_probs=196.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC------------chhhHHHHHHHHHHcCCCCceeEeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP------------SSVTLKNEKEALDQIGICPQIVRCFG   69 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~------------~~~~~~~E~~~l~~l~~~p~Iv~~~g   69 (366)
                      +|.+++.||+|+||.||+|.+..++. ....+++|.......            ....+.+|+..+..+. ||||+++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~~~  115 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPE-KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLFYG  115 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCG-GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCC-ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcceeec
Confidence            58999999999999999999976322 245788888765322            1123456677777777 999999999


Q ss_pred             ceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC--ce
Q 017746           70 DDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND--EA  147 (366)
Q Consensus        70 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~--~v  147 (366)
                      .+.....+...+++||||+ +++|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+|||++.++  .+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            7655444566788999999 99999999763  3799999999999999999999999999999999999999887  99


Q ss_pred             EEEecCCccccCCCCCC-----cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHH
Q 017746          148 KIADFGLAKKSSCDGER-----SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLL  222 (366)
Q Consensus       148 kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~  222 (366)
                      ||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            99999999876432211     1123457999999999999999999999999999999999999999654332222211


Q ss_pred             HHhhcCCCCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          223 IRIGVGDELPN------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       223 ~~~~~~~~~~~------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .........+.      -...+++++.++|.+||..||++||++++|++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            11111111111      01268899999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4e-47  Score=363.28  Aligned_cols=253  Identities=21%  Similarity=0.325  Sum_probs=194.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|+++..++ ....+|+|.+.....  ....+.+|+.++.+++ ||||+++++.+    ....
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~----~~~~  119 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSK-KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVV----TKSK  119 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTS-CBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE----CSSS
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCC-CceeEEEEEecCccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE----eeCC
Confidence            58899999999999999998764322 245789998865322  3456889999999998 99999999843    2234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+++.+ .+..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             ceEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            46699999999999999976 44579999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          160 CDGERS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       160 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+...   . .+..+..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~---~-~~~~~~~  274 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG---Y-RLPPPMD  274 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT---E-ECCCCTT
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---C-CCCCCcc
Confidence            332211 1222346788999999999999999999999999999998 99999877655444433321   1 1233456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.++.+++.+||..||++||++.++++
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            8999999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.7e-47  Score=372.49  Aligned_cols=248  Identities=22%  Similarity=0.353  Sum_probs=203.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|.+..+     ..+|+|.+.........+.+|+.+|++++ ||||+++++.+   ..  ..+
T Consensus       185 ~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~---~~--~~~  253 (452)
T 1fmk_A          185 SLRLEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVV---SE--EPI  253 (452)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTT-----EEEEEEECCTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEE---CS--SSC
T ss_pred             HceeeeeecCCCCeEEEEEEECCC-----ceEEEEEeccCCCCHHHHHHHHHHHHhCC-CCCEeeEEEEE---cC--Cce
Confidence            477889999999999999998653     36999998875556678999999999998 99999999843   22  235


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++.+..+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            69999999999999997644456999999999999999999999999999999999999999999999999999876422


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+..   . ..+..+..+++
T Consensus       334 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---~-~~~~~~~~~~~  408 (452)
T 1fmk_A          334 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---G-YRMPCPPECPE  408 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---T-CCCCCCTTSCH
T ss_pred             c-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---C-CCCCCCCCCCH
Confidence            1 112223457889999999999999999999999999999999 9999988766554444332   2 22345667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+.+||.+||..||++|||+++|++
T Consensus       409 ~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          409 SLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.1e-47  Score=358.27  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=202.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC--CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~--~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|++..++..  ..+++|.+..  .......+.+|+.+++++..||||+++++.+.    ...
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~----~~~   99 (327)
T 1fvr_A           26 DIKFQDVIGEGNFGQVLKARIKKDGLR--MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE----HRG   99 (327)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEE--EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE----ETT
T ss_pred             HccceeeeecCCCceEEEEEEccCCcc--cceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee----eCC
Confidence            588999999999999999998876542  2357777654  22345678999999999955999999998432    234


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC
Q 017746           80 FYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND  145 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~  145 (366)
                      .+++||||+++|+|.+++.+..              ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            5679999999999999997632              24699999999999999999999999999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHH
Q 017746          146 EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       146 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~  224 (366)
                      .+||+|||+++.....   .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....+. 
T Consensus       180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-  255 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-  255 (327)
T ss_dssp             CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred             eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-
Confidence            9999999999754211   11223457899999999998999999999999999999998 999998776544433322 


Q ss_pred             hhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       225 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                        . ...+..+..+++++.+||.+||..||++|||+++++++
T Consensus       256 --~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          256 --Q-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             --G-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --c-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              2 22334566789999999999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-47  Score=348.27  Aligned_cols=254  Identities=22%  Similarity=0.336  Sum_probs=207.7

Q ss_pred             CccccC-eeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGD-VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~-~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+ .||+|+||.||+|.+.....  ...+++|.+.....  ....+.+|++++++++ ||||+++++.+   .. +
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~---~~-~   82 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKK--QIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVC---QA-E   82 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---C--CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE---ES-S
T ss_pred             HhhhhhccccccCceeEEEeEeccCCC--cceEEEEecCCccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEe---cC-C
Confidence            355555 99999999999998754322  35789998876322  3466889999999997 99999999843   22 2


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                       .+++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        83 -~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           83 -ALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             -SEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -CcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence             36699999999999999975 4457999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          159 SCDGERS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       159 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+..    ...+..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~----~~~~~~~~  236 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----GKRMECPP  236 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT----TCCCCCCT
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc----CCcCCCCC
Confidence            4332211 1223457899999999998899999999999999999998 9999988766555444332    23345667


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                      .+++++.++|.+||..||++||++.++++|.+
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            89999999999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-46  Score=342.37  Aligned_cols=245  Identities=15%  Similarity=0.219  Sum_probs=204.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++.+      ..+++|.......   ....+.+|+.++++++ ||||+++++.+.  ....
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~   81 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQG------NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQ--SPPA   81 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEETT------EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS-CTTEECEEEEEC--TTTS
T ss_pred             HhHHHHHhcCCCcceEEEEEECC------eeEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCchhheEEEEc--cCCC
Confidence            68899999999999999999852      3688888775432   2356889999999998 999999998432  2223


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG--FVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ..+++||||+++|+|.+++.+..+..+++..+..++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            45679999999999999998744446999999999999999999999999  9999999999999999999999999876


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCC---ccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEA---PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      ...       .....||+.|+|||++.+..++.   ++|||||||++|+|++|+.||...........+..   ....+.
T Consensus       162 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~  231 (271)
T 3kmu_A          162 SFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL---EGLRPT  231 (271)
T ss_dssp             TTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH---SCCCCC
T ss_pred             eec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh---cCCCCC
Confidence            432       12346899999999998876665   79999999999999999999987765544333333   334456


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++..+++++.++|.+||..||++|||++++++
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            67789999999999999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-47  Score=364.78  Aligned_cols=255  Identities=20%  Similarity=0.303  Sum_probs=198.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|++..++. ....+++|......  .....+.+|+.++++++ ||||+++++.+  +. .+.
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~--~~-~~~  164 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGIC--LR-SEG  164 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTT-EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEE--CC-CSS
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCC-cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEE--Ec-CCC
Confidence            46778999999999999999764332 23468888876432  23467889999999998 99999999843  22 233


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++||||+++|+|.+++.+ .+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence            45699999999999999976 44568999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCCc--ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          160 CDGERS--QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       160 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++ |.+||......+....+...    ..+..+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~----~~~~~p~  319 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----RRLLQPE  319 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT----CCCCCCT
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC----CCCCCCC
Confidence            322111  1223457889999999999999999999999999999999 78899877666655444332    2234466


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .++.++.++|.+||..||++||++.+++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.3e-47  Score=353.10  Aligned_cols=257  Identities=21%  Similarity=0.302  Sum_probs=206.6

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      |.+++.||+|+||+||++.........+..+|+|.+.....  ....+.+|++++++++ ||||+++++.+.  ..+...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCE--DAGAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-CcchhhEEEEEe--cCCCce
Confidence            38999999999999999987655555667899999876432  2456889999999999 999999998543  233456


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++|+|.+++.+   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       110 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            7799999999999999976   2499999999999999999999999999999999999999999999999999987754


Q ss_pred             CCCC-cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc-----------hHHHHHHHhhcC
Q 017746          161 DGER-SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS-----------NVFSLLIRIGVG  228 (366)
Q Consensus       161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~-----------~~~~~~~~~~~~  228 (366)
                      .... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......           .....+......
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence            3221 1123346888999999999999999999999999999999999999654211           011112222222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       229 ~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ...+..+..++.++.+||.+||..||++|||++++++
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            3344556778999999999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-47  Score=351.22  Aligned_cols=246  Identities=25%  Similarity=0.410  Sum_probs=200.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-------chhhHHHHHHHHHHcC---CCCceeEeecce
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-------SSVTLKNEKEALDQIG---ICPQIVRCFGDD   71 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~E~~~l~~l~---~~p~Iv~~~g~~   71 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+.....       ....+.+|+.++.++.   .||||+++++.+
T Consensus        32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           32 EYRLGPLLGKGGFGTVFAGHRLTDRL----QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -CEEEEEEEEETTEEEEEEECTTTCC----EEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             ceEEeeEEEcCCCEEEEEEEEccCCe----EEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            59999999999999999999877654    789998765322       3345678999999993   399999999843


Q ss_pred             eeccCCeeEEEEEeec-CCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec-cCCceEE
Q 017746           72 YSFEKGERFYNLLLEY-ASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF-DNDEAKI  149 (366)
Q Consensus        72 ~~~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-~~~~vkl  149 (366)
                          .....+++|||| +.+++|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||
T Consensus       108 ----~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          108 ----ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             ---------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             ----ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEE
Confidence                223455699999 7899999999874  4699999999999999999999999999999999999999 7899999


Q ss_pred             EecCCccccCCCCCCcccccccCCCCCCCccccCCcCCC-CccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC
Q 017746          150 ADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYE-APCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG  228 (366)
Q Consensus       150 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~  228 (366)
                      +|||++......    ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||....      .+..    
T Consensus       182 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~----  247 (312)
T 2iwi_A          182 IDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE----  247 (312)
T ss_dssp             CCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH----
T ss_pred             EEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh----
Confidence            999999876432    12344699999999999877765 48999999999999999999996531      1111    


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       229 ~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                       ....++..++.++.+||.+||..||++||+++++++||||...
T Consensus       248 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          248 -AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             -TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             -hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence             1224556789999999999999999999999999999999643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.6e-47  Score=359.02  Aligned_cols=261  Identities=21%  Similarity=0.324  Sum_probs=204.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++... ....+..+++|.+....  .....+.+|+.++++++ ||||+++++.+.    ..
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~----~~  105 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSL----QS  105 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC----SS
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEc----CC
Confidence            689999999999999999995432 12234589999886432  23456888999999997 999999998432    23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC---CceEEE
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNN-----GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN---DEAKIA  150 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---~~vkl~  150 (366)
                      ..+++||||+++|+|.+++.....     ..+++..+..++.||+.||.|||++||+||||||+|||++.+   ..+||+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            345699999999999999987421     348999999999999999999999999999999999999844   469999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      |||++................||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+..    .
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----~  261 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS----G  261 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT----T
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc----C
Confidence            9999986533222222334568999999999999999999999999999999998 9999987765544443332    2


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..+..+..++..+.++|.+||..||++||++.++++|.++..
T Consensus       262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            234456678999999999999999999999999999988743

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.2e-47  Score=349.46  Aligned_cols=247  Identities=14%  Similarity=0.233  Sum_probs=198.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCC---CCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSE---FPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~---~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|++..+++.   ....+++|.+.... .....+.+|+.++++++ ||||+++++.+.   . 
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~---~-   83 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS-HKHLVLNYGVCV---C-   83 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC-CTTBCCEEEEEC---C-
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE---e-
Confidence            688999999999999999998776532   12468888876432 34567889999999998 999999998432   2 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc--------eEE
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE--------AKI  149 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~--------vkl  149 (366)
                      ....++||||+++|+|.+++.+ .+..+++..+..++.||+.||.|||++||+||||||+|||++.++.        +||
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCCCEEEEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence            3344699999999999999987 3345999999999999999999999999999999999999998887        999


Q ss_pred             EecCCccccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCC-CCCCCCCcchHHHHHHHhhc
Q 017746          150 ADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGV  227 (366)
Q Consensus       150 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~-~pf~~~~~~~~~~~~~~~~~  227 (366)
                      +|||++.....      .....||+.|+|||++.+ ..++.++|||||||++|+|++|. +||..... .........  
T Consensus       163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~~~~--  233 (289)
T 4fvq_A          163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYED--  233 (289)
T ss_dssp             CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHT--
T ss_pred             ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHHhhc--
Confidence            99999875421      123458999999999987 77999999999999999999955 55544333 222222221  


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                         .+..+...+.++.+||.+||..||++|||+.++++|
T Consensus       234 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          234 ---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             ---TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ---cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence               234455568889999999999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=368.15  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=199.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+....  .....+.+|++++++++ ||||+++++.+.  ..+..
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~~~~~   82 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGD----LFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEE--ETTTR   82 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CTTTC
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCc----EEEEEEeccccccchHHHHHHHHHHHHhcC-CCCCCeEEEeec--cCCCC
Confidence            59999999999999999999987765    78888876421  33466789999999998 999999998432  23334


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe----ccCCceEEEecCC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNN-GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV----FDNDEAKIADFGL  154 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~~~vkl~DFG~  154 (366)
                      .+++|||||++|+|.+++.+... ..+++..+..++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            56799999999999999976322 239999999999999999999999999999999999999    6777899999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCC--------cCCCCccchhhhHHHHHHHHhCCCCCCCCCcch-HHHHHHHh
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNE--------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN-VFSLLIRI  225 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~emltg~~pf~~~~~~~-~~~~~~~~  225 (366)
                      ++.....   .......||+.|+|||++.+        ..++.++|||||||++|+|++|+.||....... ....+.+.
T Consensus       163 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          163 ARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             CEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             ceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            9876432   22334579999999999865        568889999999999999999999997533211 12222222


Q ss_pred             hcCCC--------------------C---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          226 GVGDE--------------------L---PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       226 ~~~~~--------------------~---~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .....                    .   ..++..++..+.++|.+||..||++||+++++++
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            11110                    0   0122235567889999999999999999999854

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.8e-47  Score=355.24  Aligned_cols=258  Identities=22%  Similarity=0.290  Sum_probs=193.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHH--HcCCCCceeEeecceeec-cCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALD--QIGICPQIVRCFGDDYSF-EKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~--~l~~~p~Iv~~~g~~~~~-~~~~   78 (366)
                      +|.+++.||+|+||.||+|+..+      ..+|+|.+..  ........|.+++.  .+. ||||+++++.+... ..+.
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~--~~~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSLDE------RPVAVKVFSF--ANRQNFINEKNIYRVPLME-HDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETT------EEEEEEEEEG--GGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECTTSC
T ss_pred             HhheeeecccCCCeEEEEEEECC------eEEEEEEeec--cchhhHHHHHHHHHHHhcc-CcchhhheecccccccCCC
Confidence            68999999999999999998732      4799998765  33344445555543  466 99999999755432 3445


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEecCCCCCcEEeccCCceEE
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK---------GFVHCDIKLQNVLVFDNDEAKI  149 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---------givHrDlkp~NILl~~~~~vkl  149 (366)
                      ..+++|||||++|+|.+++...   .+++..+..++.||+.||.|||++         ||+||||||+|||++.++.+||
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             ceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            5677999999999999999762   468999999999999999999999         9999999999999999999999


Q ss_pred             EecCCccccCCCCC------CcccccccCCCCCCCccccCC-------cCCCCccchhhhHHHHHHHHhCCCCCCCCCcc
Q 017746          150 ADFGLAKKSSCDGE------RSQSFECRGTPLYMSPESVNE-------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDS  216 (366)
Q Consensus       150 ~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~emltg~~pf~~~~~~  216 (366)
                      +|||+++.......      .......+||+.|+|||++.+       ..++.++|||||||++|||++|..||......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999987643221      111224579999999999987       56778999999999999999997776432211


Q ss_pred             h---------------HHHHHHHhhcCCCCCCCCCC------CCHHHHHHHHHhcccCCCCCCCHHHHHc------CCCc
Q 017746          217 N---------------VFSLLIRIGVGDELPNIPGD------LSEQGKDFLIKCFLKDPKRRWTAEMLLN------HPFV  269 (366)
Q Consensus       217 ~---------------~~~~~~~~~~~~~~~~~~~~------~s~~~~~ll~~cL~~dp~~R~t~~~ll~------hp~~  269 (366)
                      .               ..............+.++..      +++++.+||.+||..||++|||+.++++      ++|-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            0               00011111122233344433      3457999999999999999999999954      6776


Q ss_pred             cc
Q 017746          270 CA  271 (366)
Q Consensus       270 ~~  271 (366)
                      +.
T Consensus       322 ~~  323 (336)
T 3g2f_A          322 RN  323 (336)
T ss_dssp             C-
T ss_pred             hc
Confidence            44

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.7e-47  Score=359.12  Aligned_cols=257  Identities=17%  Similarity=0.156  Sum_probs=199.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCC----CCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecce------
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSE----FPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDD------   71 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~----~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~------   71 (366)
                      +|.+++.||+|+||.||+|++..++..    ....+|+|.....    ..+.+|+++++++. ||||+++++..      
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAA-KPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHC-CHHHHHHHHHHTTCTTC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhc-ccchhhhhhhhccCCcc
Confidence            689999999999999999999864210    1357899987652    46889999999998 99999843311      


Q ss_pred             -----e-eccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC
Q 017746           72 -----Y-SFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND  145 (366)
Q Consensus        72 -----~-~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~  145 (366)
                           + ........+++||||+ +++|.+++....++.+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence                 0 1112245677999999 89999999874346799999999999999999999999999999999999999988


Q ss_pred             --ceEEEecCCccccCCCCCCc-----ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCc-ch
Q 017746          146 --EAKIADFGLAKKSSCDGERS-----QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD-SN  217 (366)
Q Consensus       146 --~vkl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~-~~  217 (366)
                        .+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  276 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE  276 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH
Confidence              89999999998754322111     11334799999999999999999999999999999999999999987642 22


Q ss_pred             HHHHHHHhhcCCCCCCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          218 VFSLLIRIGVGDELPNIP------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~------~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ......... ....+.+.      ..+++++.+||.+||..||++||++++|++
T Consensus       277 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          277 DIMKQKQKF-VDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHH-HHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhc-cCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            222221111 11111111      246899999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.2e-47  Score=367.41  Aligned_cols=255  Identities=23%  Similarity=0.343  Sum_probs=190.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|...++||+|+||+|+.... .++    ..||||.+..  .......+|+++|+++..||||+++++.+    .....+
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~-~~~----~~vAvK~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~----~~~~~~   93 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGM-FDN----RDVAVKRILP--ECFSFADREVQLLRESDEHPNVIRYFCTE----KDRQFQ   93 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEE-SSS----SEEEEEEECT--TTEEECHHHHHHHHHSCCCTTBCCEEEEE----EETTEE
T ss_pred             EEecCCeeecCcCEEEEEEEE-eCC----eEEEEEEECH--HHHHHHHHHHHHHHhccCCCCcCeEEEEE----ecCCEE
Confidence            588899999999999664333 233    4799998865  34456789999999996699999999742    234456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc---C--CceEEEecCCcc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD---N--DEAKIADFGLAK  156 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~--~~vkl~DFG~a~  156 (366)
                      ++|||||.| +|.+++.. ....+.+..+..++.||+.||.|||++||+||||||+|||++.   +  ..+||+|||+|+
T Consensus        94 ~lv~E~~~g-~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           94 YIAIELCAA-TLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EEEEECCSE-EHHHHHHS-SSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EEEEECCCC-CHHHHHHh-cCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            799999975 99999986 3445667778899999999999999999999999999999953   2  358899999998


Q ss_pred             ccCCCCCC-cccccccCCCCCCCccccC---CcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          157 KSSCDGER-SQSFECRGTPLYMSPESVN---ENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       157 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      ........ ......+||+.|+|||++.   ...++.++|||||||++|+|++ |..||........ ..+ ........
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~-~~~~~~~~  249 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NIL-LGACSLDC  249 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHH-TTCCCCTT
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHH-hccCCccc
Confidence            76432211 2233457999999999997   4667889999999999999999 9999965543322 111 11111111


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ...+...+..+.+||.+||..||++|||++++++||||..
T Consensus       250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            1112234566899999999999999999999999999954

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1e-46  Score=353.41  Aligned_cols=256  Identities=25%  Similarity=0.408  Sum_probs=181.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|.++.+++    .+|+|.+.....  ....+..|+..+.+...||||+++++.+.   . ..
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~---~-~~   94 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQ----IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF---R-EG   94 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTE----EEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE---C-SS
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCC----EEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE---e-CC
Confidence            68899999999999999999987654    788888765322  23345566664444334999999998432   2 34


Q ss_pred             EEEEEeecCCCCCHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           80 FYNLLLEYASRGSLADRVKK---QNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      .+++||||+++ +|.+++..   .....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            56799999986 88888763   1246799999999999999999999999 9999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCcccc----CCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESV----NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      +......   ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||......  ...+... .....
T Consensus       174 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~-~~~~~  247 (327)
T 3aln_A          174 GQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQV-VKGDP  247 (327)
T ss_dssp             CC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC-CCSCC
T ss_pred             eeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHH-hcCCC
Confidence            8764221   12233699999999998    5667899999999999999999999999764321  1122111 11122


Q ss_pred             CCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          232 PNIP----GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       232 ~~~~----~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      +.++    ..+++++.+||.+||..||++||++.++++||||...
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            2222    3589999999999999999999999999999999543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.9e-46  Score=346.34  Aligned_cols=237  Identities=23%  Similarity=0.403  Sum_probs=191.2

Q ss_pred             Ccccc-CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRG-DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+. ++||+|+||.||+|.+..+++    .+|+|.+..    .....+|+.++.++..||||+++++.+.....+...
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQE----KFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCc----EEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            46665 789999999999999987764    788888753    356788999997776699999999976655566778


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc---CCceEEEecCCccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKK  157 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~~  157 (366)
                      +++||||+++|+|.+++....+..+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            889999999999999998855557999999999999999999999999999999999999998   78899999999875


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC--
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--  235 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  235 (366)
                      ..                        +..++.++|||||||++|+|++|+.||...........+... ........+  
T Consensus       170 ~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~  224 (299)
T 3m2w_A          170 TT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-IRMGQYEFPNP  224 (299)
T ss_dssp             CT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS-SCTTCCSSCHH
T ss_pred             cc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH-HhhccccCCch
Confidence            42                        245788999999999999999999999765433211111110 011111122  


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 --GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 --~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                        ..+++++.+||.+||..||++|||++++++||||..
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence              457999999999999999999999999999999954

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-46  Score=344.92  Aligned_cols=244  Identities=22%  Similarity=0.352  Sum_probs=198.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|.+.+      ..+++|.+... .....+.+|+.++++++ ||||+++++.+   ......+
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---~~~~~~~   90 (278)
T 1byg_A           22 ELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKND-ATAQAFLAEASVMTQLR-HSNLVQLLGVI---VEEKGGL   90 (278)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETT------EEEEEEECCCC-C--HHHHHTHHHHTTCC-CTTBCCEEEEE---CCC--CC
T ss_pred             hceEEeEEecCCCceEEEEEEcC------CEEEEEEecch-hHHHHHHHHHHHHHhCC-CCCEeeEEEEE---EcCCCce
Confidence            58899999999999999998752      47899987653 35567899999999998 99999999843   2233456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            69999999999999998743334899999999999999999999999999999999999999999999999999865321


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                           .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+..    ...+..+..+++
T Consensus       171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  241 (278)
T 1byg_A          171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----GYKMDAPDGCPP  241 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT----TCCCCCCTTCCH
T ss_pred             -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc----CCCCCCcccCCH
Confidence                 122358899999999999999999999999999999998 9999988766555443322    223455677899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.++|.+||..||++||++.++++
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          242 AVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHHH
Confidence            9999999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=347.35  Aligned_cols=252  Identities=25%  Similarity=0.441  Sum_probs=182.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc--hhhHHHHH-HHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS--SVTLKNEK-EALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~E~-~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|.++.+++    .+++|.+......  ......|+ .+++.++ ||||+++++.+.    ..
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~----~~   96 (318)
T 2dyl_A           26 DLENLGEMGSGTCGQVWKMRFRKTGH----VIAVKQMRRSGNKEENKRILMDLDVVLKSHD-CPYIVQCFGTFI----TN   96 (318)
T ss_dssp             GEEEEEEC------CEEEEEETTTCC----EEEEEEEETTSCHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEE----CS
T ss_pred             cccccceeeecCCeeEEEEEEecCCe----EEEEEEecccccchHHHHHHHHHHHHHHhcC-CCceeeEEEEEe----cC
Confidence            58889999999999999999987665    7888887653322  22233344 4555555 999999998432    23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ..+++||||+ ++.+..+... ..+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            4567999999 5566666654 356799999999999999999999995 999999999999999999999999999976


Q ss_pred             cCCCCCCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc-hHHHHHHHhhcCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS-NVFSLLIRIGVGDEL  231 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg~~pf~~~~~~-~~~~~~~~~~~~~~~  231 (366)
                      .....   ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||...... +....+...    ..
T Consensus       175 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~  247 (318)
T 2dyl_A          175 LVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE----EP  247 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS----CC
T ss_pred             ccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc----CC
Confidence            54322   222346999999999994     567889999999999999999999999864332 222222221    12


Q ss_pred             CCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          232 PNIP--GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       232 ~~~~--~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +.++  ..++.++.+||.+||..||.+||+++++++||||..
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            2222  357999999999999999999999999999999954

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.1e-47  Score=351.95  Aligned_cols=256  Identities=22%  Similarity=0.302  Sum_probs=202.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+... ......+.+|+.+++.++ ||||+++++.+.........
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGH----FYALKRILCHEQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCC----EEEEEEEEESSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCc----EEEEEEEecCCHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCce
Confidence            58999999999999999999977664    7888876542 234567889999999998 99999999965543445667


Q ss_pred             EEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           81 YNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      +++||||+++|+|.+++...  .+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            78999999999999999763  3457999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCCc-------ccccccCCCCCCCccccCCcC---CCCccchhhhHHHHHHHHhCCCCCCCCC--cchHHHHHHHhh
Q 017746          159 SCDGERS-------QSFECRGTPLYMSPESVNENE---YEAPCDIWALGCAVVEMASGKPAWNHKQ--DSNVFSLLIRIG  226 (366)
Q Consensus       159 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~emltg~~pf~~~~--~~~~~~~~~~~~  226 (366)
                      .......       ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||....  .......+..  
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--  262 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--  262 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence            3211110       011235899999999987654   7889999999999999999999995421  1112222211  


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       227 ~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                       .... ..+..++.++.++|.+||..||++||++++++++
T Consensus       263 -~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 -QLSI-PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -C--C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -cCCC-CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence             1122 2235689999999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.5e-46  Score=346.41  Aligned_cols=252  Identities=22%  Similarity=0.322  Sum_probs=199.4

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      |..++.||+|+||.||+|...  +    ..+++|.+...     ......+.+|+.++++++ ||||+++++.+    ..
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~----~~  101 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYVN--N----TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFS----SD  101 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEESS--S----CEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEE----CS
T ss_pred             cccCCccccCCCeEEEEEEEC--C----ceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEE----ec
Confidence            556799999999999999863  2    37888877542     123467889999999998 99999999843    22


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQN-NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ...+++||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  181 (307)
T 2nru_A          102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR  181 (307)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccc
Confidence            334569999999999999997532 3469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh----------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG----------  226 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~----------  226 (366)
                      ...............||+.|+|||++.+ .++.++|||||||++|+|++|.+||...........+....          
T Consensus       182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          182 ASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             ECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             ccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence            7654333333334579999999998875 58899999999999999999999998765433222222111          


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       227 ~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .....+..+...++.+.+++.+||..||++|||+.+++++
T Consensus       261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1112223334456788999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.5e-46  Score=344.13  Aligned_cols=250  Identities=23%  Similarity=0.345  Sum_probs=202.6

Q ss_pred             CccccC-eeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGD-VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~-~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+ .||+|+||+||+|.+....  ....+++|.+.....   ....+.+|+.+++.++ ||||+++++.+    ..
T Consensus        17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~----~~   89 (291)
T 1xbb_A           17 LLTLEDKELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGIC----EA   89 (291)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSS--SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE----ES
T ss_pred             hhhhccCccccccCeeeEeeeecCCC--ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE----CC
Confidence            477777 9999999999999654322  245789998765322   2467889999999998 99999999843    22


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                       ..+++||||+++++|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        90 -~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           90 -ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             -CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence             2356999999999999999763  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          158 SSCDGERS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       158 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ........ ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+..    ...+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~  242 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCP  242 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----TCCCCCC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCCC
Confidence            64332211 1222357789999999998899999999999999999999 9999988765544443332    2334566


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ..+++++.++|.+||..||++||++.++++
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            778999999999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9e-47  Score=367.87  Aligned_cols=255  Identities=26%  Similarity=0.350  Sum_probs=187.9

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      |...+.||+|+||+||.+.. .++    ..||+|.+..  .....+.+|+.+++++..||||+++++.    ......++
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~-~~g----~~vAvK~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~----~~~~~~~~   85 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGS-FQG----RPVAVKRMLI--DFCDIALMEIKLLTESDDHPNVIRYYCS----ETTDRFLY   85 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEE-SSS----SEEEEEEEEG--GGHHHHHHHHHHHHHHTTSTTBCCEEEE----EECSSEEE
T ss_pred             eeccCeEeeCCCeEEEEEEE-ECC----eEEEEEEEcH--HHHHHHHHHHHHHHhccCCCCcCeEEEE----EecCCeEE
Confidence            56678999999999987643 333    4889998765  3345678999999988669999999873    23345677


Q ss_pred             EEeecCCCCCHHHHHHHhCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC-------------
Q 017746           83 LLLEYASRGSLADRVKKQNNGR-----LQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN-------------  144 (366)
Q Consensus        83 lv~E~~~~g~L~~~l~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-------------  144 (366)
                      +|||||. |+|.+++.......     ..+..+..++.||+.||+|||++||+||||||+|||++.+             
T Consensus        86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence            9999996 59999997632110     1233467899999999999999999999999999999754             


Q ss_pred             CceEEEecCCccccCCCCCCc--ccccccCCCCCCCccccCC-------cCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 017746          145 DEAKIADFGLAKKSSCDGERS--QSFECRGTPLYMSPESVNE-------NEYEAPCDIWALGCAVVEMAS-GKPAWNHKQ  214 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~emlt-g~~pf~~~~  214 (366)
                      +.+||+|||+++.........  .....+||+.|+|||++.+       ..++.++|||||||++|+|++ |+.||....
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            479999999999865332211  1224579999999999976       678999999999999999999 999997654


Q ss_pred             cchHHHHHHHhhcCCC-CCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          215 DSNVFSLLIRIGVGDE-LPNI-PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       215 ~~~~~~~~~~~~~~~~-~~~~-~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ...  ..+........ .+.. +..++.++.+||.+||..||++|||+.++++||||..
T Consensus       245 ~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          245 SRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             THH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            332  22222221111 1111 1234688999999999999999999999999999953

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.3e-46  Score=366.86  Aligned_cols=253  Identities=20%  Similarity=0.207  Sum_probs=203.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.++++||+|+||.||+|++..+++    .||+|..... .....+.+|+++++.+..+++|..+..+    .......
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~-~~~~~~~~E~~il~~L~~~~~i~~i~~~----~~~~~~~   78 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVK-TKHPQLLYESKIYRILQGGTGIPNVRWF----GVEGDYN   78 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCC----EEEEEEEETT-CSSCCHHHHHHHHHHTTTSTTCCCEEEE----EEETTEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCc----EEEEEEeccc-cccHHHHHHHHHHHHhcCCCCCCeEEEE----EeeCCEE
Confidence            69999999999999999999887664    7888876543 3445689999999999966666665442    2223456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEe---ccCCceEEEecCCcccc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLV---FDNDEAKIADFGLAKKS  158 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~~~vkl~DFG~a~~~  158 (366)
                      +|||||+ +++|.+++.. ....+++.++..|+.||+.||+|||++|||||||||+||||   +.++.+||+|||+++..
T Consensus        79 ~lvme~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEECC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            7999999 8899999986 34679999999999999999999999999999999999999   68899999999999876


Q ss_pred             CCCCCCc-----ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHH---hhcCCC
Q 017746          159 SCDGERS-----QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR---IGVGDE  230 (366)
Q Consensus       159 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~---~~~~~~  230 (366)
                      .......     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.+   ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            5332211     12255799999999999999999999999999999999999999987655433333322   222122


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ...+...++.++.+||.+||..||++||++++|++
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            22233567999999999999999999999998864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-46  Score=351.03  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=195.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcC-CCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG-ICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~-~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||.||+|++.      ...+|+|.+..  ........|.+++..+. .||||+++++.+.........
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~--~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           38 QIQMVKQIGKGRYGEVWMGKWR------GEKVAVKVFFT--TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             HCEEEEEEEEETTEEEEEEEET------TEEEEEEEEEG--GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             ceEEEeEeecCCCeEEEEEEEC------CceEEEEEEec--cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            5899999999999999999875      24789998765  33445566666666652 499999999865443333356


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCCCCcEEeccCCceEEEec
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK--------GFVHCDIKLQNVLVFDNDEAKIADF  152 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--------givHrDlkp~NILl~~~~~vkl~DF  152 (366)
                      +++||||+++|+|.+++..   ..+++..+..++.||+.||.|||++        ||+||||||+|||++.++.+||+||
T Consensus       110 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            7899999999999999976   3699999999999999999999999        9999999999999999999999999


Q ss_pred             CCccccCCCCCCc--ccccccCCCCCCCccccCCcCCCCc------cchhhhHHHHHHHHhC----------CCCCCCCC
Q 017746          153 GLAKKSSCDGERS--QSFECRGTPLYMSPESVNENEYEAP------CDIWALGCAVVEMASG----------KPAWNHKQ  214 (366)
Q Consensus       153 G~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~emltg----------~~pf~~~~  214 (366)
                      |+++.........  ......||+.|+|||++.+..++..      +|||||||++|||++|          +.||....
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence            9998764332221  1124579999999999988877765      9999999999999999          77775432


Q ss_pred             cch-HHHHHHH-hhcCCCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          215 DSN-VFSLLIR-IGVGDELPNIPG-----DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       215 ~~~-~~~~~~~-~~~~~~~~~~~~-----~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ... ....+.. .......+..+.     .+++++.+||.+||..||++|||+.++++|
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            211 1111111 122222333333     456779999999999999999999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.8e-46  Score=344.88  Aligned_cols=244  Identities=23%  Similarity=0.404  Sum_probs=195.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||+||+|++..      ..+++|.+... .....+.+|+.++++++ ||||+++++.+.    +.  .
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~----~~--~   74 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWRA------KDVAIKQIESE-SERKAFIVELRQLSRVN-HPNIVKLYGACL----NP--V   74 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETT------EEEEEEECSST-THHHHHHHHHHHHHHCC-CTTBCCEEEBCT----TT--T
T ss_pred             HeeeeeEeecCCCceEEEEEECC------eeEEEEEecCh-hHHHHHHHHHHHHhcCC-CCCcCeEEEEEc----CC--c
Confidence            58899999999999999998753      47899987642 45567899999999998 999999998432    22  4


Q ss_pred             EEEeecCCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCCCcEEeccCCc-eEEEecCCcc
Q 017746           82 NLLLEYASRGSLADRVKKQNN-GRLQESDVKRYTRSMLKGLRHIHS---KGFVHCDIKLQNVLVFDNDE-AKIADFGLAK  156 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~~~-vkl~DFG~a~  156 (366)
                      ++||||+++|+|.+++..... ..+++..+..++.||++||.|||+   +||+||||||+|||++.++. +||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            699999999999999975321 237899999999999999999999   89999999999999998886 7999999997


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      .....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...... .....+..+.
T Consensus       155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~  227 (307)
T 2eva_A          155 DIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMWAV-HNGTRPPLIK  227 (307)
T ss_dssp             ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHHHH-HTTCCCCCBT
T ss_pred             ccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHHHH-hcCCCCCccc
Confidence            65321     1233699999999999999999999999999999999999999986544322 222222 2233445567


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .++..+.++|.+||..||++|||+++++++
T Consensus       228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            789999999999999999999999999873

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=348.86  Aligned_cols=260  Identities=23%  Similarity=0.364  Sum_probs=205.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||.||+|+........+..+++|.+..... ....+.+|+.++++++ ||||+++++.+.  ..+...
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~  118 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCY--SAGRRN  118 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC--C----C
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEE--ecCCCc
Confidence            488999999999999999996443333456899999876433 3457889999999998 999999998433  233345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++||||+++++|.+++.+ ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       119 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHH-STTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             eEEEEECCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            6799999999999999987 445799999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCCc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCc------------chHHHHHHHhhc
Q 017746          161 DGERS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQD------------SNVFSLLIRIGV  227 (366)
Q Consensus       161 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~------------~~~~~~~~~~~~  227 (366)
                      ..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....            ......+.....
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  277 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence            32211 12234578889999999999999999999999999999999999864311            001111111111


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          228 GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       228 ~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ....+..+..+++++.++|.+||..||++|||+.++++
T Consensus       278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22233456778999999999999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5e-46  Score=346.45  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=193.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|++..+++    .+++|.+.....    ....+.+|+.++++++ ||||+++++.+.   . 
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~---~-  105 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRER----IVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGE---I-  105 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTE----EEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE---E-
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCe----EEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEe---e-
Confidence            68999999999999999999887654    788998764322    2366889999999998 999999998432   2 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+++++|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          106 DGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             TTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            34567999999999999999864  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. . ........+..
T Consensus       184 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~-~~~~~~~~~~~  260 (309)
T 2h34_A          184 TTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-Q-AIPRPSTVRPG  260 (309)
T ss_dssp             --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-S-CCCCGGGTSTT
T ss_pred             cccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-c-CCCCccccCCC
Confidence            543221 12224469999999999999999999999999999999999999998764432222221 1 11122234567


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-CHHHHHc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRW-TAEMLLN  265 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~-t~~~ll~  265 (366)
                      ++.++.++|.+||..||++|| +++++++
T Consensus       261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          261 IPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            899999999999999999999 8888875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.1e-46  Score=346.61  Aligned_cols=253  Identities=27%  Similarity=0.422  Sum_probs=193.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+.+.||+|+||.||+|.+..+++    .+++|.+....    .....+.+|+.++++++ ||||+++++.+..    
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~----  103 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGV----PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIE----  103 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCC----EEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEE----
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCc----eEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEc----
Confidence            68899999999999999999887654    78888876422    23456789999999998 9999999984432    


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      ...+++||||+++|+|.+++...  .+..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            33567999999999999999752  3456999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... ..............+..+
T Consensus       184 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  260 (310)
T 2wqm_A          184 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPPLPS  260 (310)
T ss_dssp             -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHHHTTCSCCCCT
T ss_pred             eeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHhhcccCCCCcc
Confidence            87643221  122346999999999999999999999999999999999999999765432 222223333222223333


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+++++.++|.+||..||++||++.+++++
T Consensus       261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            5689999999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=356.28  Aligned_cols=250  Identities=12%  Similarity=0.114  Sum_probs=195.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCC--CCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI--CPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~--~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|.+... .......+|+|....  .....+..|.++++.+..  |+||+++++.+.   . .
T Consensus        66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~---~-~  139 (365)
T 3e7e_A           66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL---F-Q  139 (365)
T ss_dssp             EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS--CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE---C-S
T ss_pred             EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC--CChhHHHHHHHHHHHhhhhhhhhhhhhheeee---c-C
Confidence            488899999999999999964321 122345899998875  456678889999998864  799999998432   2 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-----------C
Q 017746           79 RFYNLLLEYASRGSLADRVKKQ---NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-----------N  144 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-----------~  144 (366)
                      ...++|||||++|+|.+++...   ....+++..+..++.||+.||+|||++|||||||||+||||+.           +
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence            3456999999999999999753   2456999999999999999999999999999999999999998           8


Q ss_pred             CceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHH
Q 017746          145 DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~  224 (366)
                      +.+||+|||+|+..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||........      
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------  293 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------  293 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence            99999999999765432333334456799999999999999999999999999999999999999965433210      


Q ss_pred             hhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       225 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                       ......+..  ..++...+++..||..+|.+|++..+.+.+
T Consensus       294 -~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          294 -KPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             -EECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             -eechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence             011112222  246788999999999999999765544443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-46  Score=375.10  Aligned_cols=248  Identities=22%  Similarity=0.353  Sum_probs=207.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|++...     ..+|+|.+.........+.+|+++|++++ ||||+++++.+   ..  ..+
T Consensus       268 ~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~---~~--~~~  336 (535)
T 2h8h_A          268 SLRLEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVV---SE--EPI  336 (535)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTT-----EEEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEE---CS--SSC
T ss_pred             hhhhheecccCCCeEEEEEEECCC-----ceEEEEEeCCCCCCHHHHHHHHHHHHhCC-CCCEeeEEEEE---ee--ccc
Confidence            477889999999999999998653     36899998875556678999999999998 99999999843   22  235


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++....+..+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            69999999999999997644456999999999999999999999999999999999999999999999999999875321


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........+|..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+..   .. ....+..+++
T Consensus       417 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~---~~-~~~~~~~~~~  491 (535)
T 2h8h_A          417 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GY-RMPCPPECPE  491 (535)
T ss_dssp             H-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT---TC-CCCCCTTCCH
T ss_pred             c-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CC-CCCCCCCCCH
Confidence            1 111223357788999999999999999999999999999999 9999988766554444332   22 2344567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.+||.+||..||++|||+++|++
T Consensus       492 ~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          492 SLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=349.92  Aligned_cols=255  Identities=20%  Similarity=0.277  Sum_probs=187.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceee----ccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYS----FEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~----~~~   76 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+.... .....+.+|+.++.++..||||+++++.+..    ...
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGR----EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCC----EEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCc----EEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            68999999999999999999987765    78888764422 2345688999999999779999999986531    124


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEeccCCceEEEecC
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQ-NNGRLQESDVKRYTRSMLKGLRHIHSKG--FVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                      ....+++||||+. |+|.+++... ..+.+++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            4566789999997 5999998752 3457999999999999999999999999  9999999999999999999999999


Q ss_pred             CccccCCCCCCc----------ccccccCCCCCCCcccc---CCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHH
Q 017746          154 LAKKSSCDGERS----------QSFECRGTPLYMSPESV---NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFS  220 (366)
Q Consensus       154 ~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~  220 (366)
                      +++.........          ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||........  
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--  261 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--  261 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence            998764322211          11234699999999998   567788999999999999999999999976543221  


Q ss_pred             HHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          221 LLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                        .....   ....+...+..+.+||.+||..||++||++.++++|..
T Consensus       262 --~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          262 --VNGKY---SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ------C---CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             --hcCcc---cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence              11111   11223456788999999999999999999999998754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.2e-46  Score=350.81  Aligned_cols=256  Identities=21%  Similarity=0.308  Sum_probs=199.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.+.||+|+||.||+|++.. +    ..+|+|.+....  .....+.+|+++++.+. ||||+++++.+.    ...
T Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~----~~~  100 (326)
T 3uim_A           31 NFSNKNILGRGGFGKVYKGRLAD-G----TLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM----TPT  100 (326)
T ss_dssp             SSCSTTEEECCSSSEEEEECCSS-S----CCEEEEECCC-----CCCHHHHHHHGGGTCC-CTTBCCCCEEEC----CSS
T ss_pred             ccccceeEecCCCcEEEEEEecC-C----CEEEEEEeccccCchHHHHHHHHHHHHHhcc-CCCccceEEEEe----cCC
Confidence            68999999999999999997542 3    478899876532  23346889999999998 999999998432    233


Q ss_pred             EEEEEeecCCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCCCcEEeccCCceEEEecCC
Q 017746           80 FYNLLLEYASRGSLADRVKKQN--NGRLQESDVKRYTRSMLKGLRHIHSK---GFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                      ..++||||+++|+|.+++....  ...+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence            4569999999999999997632  23499999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCC-----CCcchHHHHHHHhhcCC
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNH-----KQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~-----~~~~~~~~~~~~~~~~~  229 (366)
                      ++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..     .........+.......
T Consensus       181 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (326)
T 3uim_A          181 AKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK  259 (326)
T ss_dssp             CEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred             ccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence            987643222 222344699999999999999999999999999999999999999952     11111222221111111


Q ss_pred             CC---------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 017746          230 EL---------PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF  268 (366)
Q Consensus       230 ~~---------~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~  268 (366)
                      ..         +..+...+.++.+++.+||..||++|||+.+|++|..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            11         1112223477899999999999999999999998754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=373.10  Aligned_cols=245  Identities=22%  Similarity=0.338  Sum_probs=199.6

Q ss_pred             eeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEe
Q 017746            8 VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         8 ~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      .||+|+||.||+|.++..+.  ...||+|.+...  ......+.+|+++|++++ ||||+++++.+.   . + .+++||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~---~-~-~~~lv~  414 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKK--QIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ---A-E-ALMLVM  414 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSC--EEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEE---S-S-SEEEEE
T ss_pred             EEecCCCcEEEEEEEecCCC--cEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEec---c-C-CeEEEE
Confidence            79999999999998764432  356899988753  235577899999999998 999999999532   2 2 366999


Q ss_pred             ecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCc
Q 017746           86 EYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERS  165 (366)
Q Consensus        86 E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  165 (366)
                      |||++|+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.........
T Consensus       415 E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          415 EMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             ECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             EeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            99999999999976 34579999999999999999999999999999999999999999999999999998764332211


Q ss_pred             -ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHH
Q 017746          166 -QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK  243 (366)
Q Consensus       166 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  243 (366)
                       ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+..    ...+..+..+++++.
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~----~~~~~~p~~~~~~l~  569 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----GKRMECPPECPPELY  569 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT----TCCCCCCTTCCHHHH
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----CCCCCCCCcCCHHHH
Confidence             1222346789999999999999999999999999999998 9999998876665544432    223455677999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHc
Q 017746          244 DFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       244 ~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++|.+||..||++||++.+|++
T Consensus       570 ~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          570 ALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999854

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.3e-46  Score=342.22  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=199.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|++..... ....+++|.+...    ......+.+|+.++++++ ||||+++++.+.   ..
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~~   93 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL---TP   93 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTS-CEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SS
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCC-ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEc---cC
Confidence            58999999999999999998754322 1346888887642    123467889999999998 999999998432   22


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                       . .++||||+++|+|.+++.+. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        94 -~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           94 -P-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             -S-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             -C-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence             2 56999999999999999874 35699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          158 SSCDGERS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       158 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ........ ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+..   ....+..+
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~  247 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK---EGERLPRP  247 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---SCCCCCCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc---cCCCCCCC
Confidence            65332221 1223457889999999999999999999999999999999 9999988765544443332   22333455


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..++.++.++|.+||..||++||++.+++++
T Consensus       248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            6789999999999999999999999999973

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.1e-45  Score=344.99  Aligned_cols=253  Identities=24%  Similarity=0.300  Sum_probs=198.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHH--cCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQ--IGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~--l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|++.      +..+|+|.+..  .....+.+|.+++..  ++ ||||+++++.+........
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~--~~~~~~~~e~~~~~~~~l~-h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKWR------GEEVAVKIFSS--REERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEET------TEEEEEEEECG--GGHHHHHHHHHHHHHSCCC-CTTBCCEEEEEECCCSSCC
T ss_pred             cEEEEeeecCCCCcEEEEEEEc------CccEEEEEeCc--hhHHHHHHHHHHHHHhhcC-CCcEEEEEeeecccCCccc
Confidence            5889999999999999999974      24789998765  445677889999988  45 9999999985433222223


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEecCCCCCcEEeccCCceEEEe
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH--------SKGFVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH--------~~givHrDlkp~NILl~~~~~vkl~D  151 (366)
                      .+++||||+++|+|.+++.+   ..+++..+..++.||+.||.|||        ++||+||||||+|||++.++.+||+|
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred             eeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence            67799999999999999976   36999999999999999999999        89999999999999999999999999


Q ss_pred             cCCccccCCCCCCc--ccccccCCCCCCCccccCCc------CCCCccchhhhHHHHHHHHhC----------CCCCCCC
Q 017746          152 FGLAKKSSCDGERS--QSFECRGTPLYMSPESVNEN------EYEAPCDIWALGCAVVEMASG----------KPAWNHK  213 (366)
Q Consensus       152 FG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~emltg----------~~pf~~~  213 (366)
                      ||++..........  ......||+.|+|||++.+.      .++.++|||||||++|+|++|          ..||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            99998764332211  12344799999999999776      344689999999999999999          7898765


Q ss_pred             Ccch--HHHHHHHhhcCCCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          214 QDSN--VFSLLIRIGVGDELPNIPG-----DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       214 ~~~~--~~~~~~~~~~~~~~~~~~~-----~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ....  ..............+.++.     .++..+.++|.+||..||++|||+.++++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            3221  1111222222223333333     234678999999999999999999999975

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.2e-45  Score=372.35  Aligned_cols=245  Identities=24%  Similarity=0.377  Sum_probs=198.3

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      +.||+|+||+||+|.+....  ....+|+|.+....   .....+.+|+++|++++ ||||+++++.+   . .+. +++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~---~-~~~-~~l  446 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGIC---E-AES-WML  446 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSS--CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEE---E-SSS-EEE
T ss_pred             CEeccCCCEEEEEEEEcCCC--cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE---e-cCC-EEE
Confidence            47999999999999764322  23578999876522   23467899999999998 99999999843   2 222 569


Q ss_pred             EeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCC
Q 017746           84 LLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE  163 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  163 (366)
                      |||||++|+|.+++..  ++.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus       447 v~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             EEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             EEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            9999999999999975  35699999999999999999999999999999999999999999999999999987643322


Q ss_pred             C-cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          164 R-SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      . .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+..    ...+..+..++++
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~----~~~~~~p~~~~~~  600 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPRE  600 (635)
T ss_dssp             ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----TCCCCCCTTCCHH
T ss_pred             ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CCCCCCCCCCCHH
Confidence            1 12223457889999999999999999999999999999998 9999988766555444433    2234556779999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +.+||.+||..||++||++++|++
T Consensus       601 l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          601 MYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.8e-45  Score=370.04  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=205.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||.||+|++..++. ....+++|.......  ....+.+|+.++++++ ||||+++++.+   .+ . 
T Consensus       391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~---~~-~-  463 (656)
T 2j0j_A          391 RIELGRCIGEGQFGDVHQGIYMSPEN-PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVI---TE-N-  463 (656)
T ss_dssp             GEEEEEEEECCSSCCEEEEEECCSSS-CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE---CS-S-
T ss_pred             cEEEeeEEeeCCCEEEEEEEEecCCC-ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE---ec-C-
Confidence            47889999999999999999876443 346789998765322  2356889999999998 99999999843   22 2 


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++||||+++|+|.+++.. .+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             ceEEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            35699999999999999986 34579999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+...    ..+..+..+
T Consensus       543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~  617 (656)
T 2j0j_A          543 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG----ERLPMPPNC  617 (656)
T ss_dssp             C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT----CCCCCCTTC
T ss_pred             CCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC----CCCCCCccc
Confidence            3221 11223457889999999999999999999999999999997 99999887665554444332    223456778


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++++.+||.+||..||++||++.+|++
T Consensus       618 ~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          618 PPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=341.16  Aligned_cols=247  Identities=20%  Similarity=0.263  Sum_probs=195.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++..       .+++|.+...   ......+.+|+.++++++ ||||+++++.+.    ..
T Consensus        34 ~~~~~~~lg~G~~g~V~~~~~~~-------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~----~~  101 (319)
T 2y4i_B           34 QLEIGELIGKGRFGQVYHGRWHG-------EVAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGACM----SP  101 (319)
T ss_dssp             CEECCCBCCCSSSSEEEEEEESS-------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEE----CS
T ss_pred             HeEEeeEeccCCceEEEEEEEcC-------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEe----cC
Confidence            58899999999999999998754       3677776542   234466889999999998 999999998432    23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||+++++|.+++.. .+..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++..
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             CceEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            346799999999999999976 345799999999999999999999999999999999999998 689999999998764


Q ss_pred             CCCCC---CcccccccCCCCCCCccccCC---------cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh
Q 017746          159 SCDGE---RSQSFECRGTPLYMSPESVNE---------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG  226 (366)
Q Consensus       159 ~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~  226 (366)
                      .....   ........||+.|+|||++.+         ..++.++|||||||++|+|++|+.||...........+.   
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---  256 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG---  256 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH---
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc---
Confidence            32111   112223469999999999875         457889999999999999999999998776554433332   


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       227 ~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ........+..++.++.++|.+||..||++|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            222222233457889999999999999999999999997

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9.1e-46  Score=373.74  Aligned_cols=262  Identities=20%  Similarity=0.284  Sum_probs=202.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeecc--CC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--KG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~~   77 (366)
                      +|.+++.||+|+||.||+|.+..+++    .+|+|.+.....  ....+.+|+.++++++ ||||+++++.+....  ..
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~----~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGE----QVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTC----CEEECCCCSCCCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCT
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCc----EEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccC
Confidence            69999999999999999999877654    789998765322  3456888999999998 999999998543211  22


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCc---eEEEecC
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQN-NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDE---AKIADFG  153 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~---vkl~DFG  153 (366)
                      ....++|||||+||+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.   +||+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            445679999999999999997632 235999999999999999999999999999999999999997765   9999999


Q ss_pred             CccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHH------HHHHHhh-
Q 017746          154 LAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF------SLLIRIG-  226 (366)
Q Consensus       154 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~------~~~~~~~-  226 (366)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........      ....... 
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            998764332   223457999999999999999999999999999999999999999754211100      0000000 


Q ss_pred             ---------cCCC---CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          227 ---------VGDE---LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       227 ---------~~~~---~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                               ....   ...+...+++.+.+||.+||..||++|||+.++++||||..
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence                     0000   11223346788999999999999999999999999999854

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-45  Score=357.18  Aligned_cols=249  Identities=12%  Similarity=0.071  Sum_probs=190.7

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCcee-------------
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIV-------------   65 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv-------------   65 (366)
                      |..+++||+|+||+||+|++..+++    .||||.....    ......+.+|+.+++.+.+.+|+.             
T Consensus        80 ~~~~~~LG~G~fG~Vy~a~~~~~g~----~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           80 LVRGTVLGQEDPYAYLEATDQETGE----SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCC----EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             EEEecccccCCCEEEEEEEecCCCC----ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            6788999999999999999988765    7888887632    123567889999999997323221             


Q ss_pred             --Eeecceee---ccCC----eeEEEEEeecCCCCCHHHHHHH-----hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 017746           66 --RCFGDDYS---FEKG----ERFYNLLLEYASRGSLADRVKK-----QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVH  131 (366)
Q Consensus        66 --~~~g~~~~---~~~~----~~~~~lv~E~~~~g~L~~~l~~-----~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH  131 (366)
                        .+.+....   ....    ...++++|+++ +++|.++++.     ..+..+++..+..++.||+.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence              11111000   0000    12255778876 5699999952     12345788899999999999999999999999


Q ss_pred             cCCCCCcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCcccc----------CCcCCCCccchhhhHHHHH
Q 017746          132 CDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV----------NENEYEAPCDIWALGCAVV  201 (366)
Q Consensus       132 rDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~il~  201 (366)
                      |||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          .+..|+.++|||||||++|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999999875322     234468 999999999          6667899999999999999


Q ss_pred             HHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          202 EMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       202 emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +|++|+.||...........+    .     .....+++++.+||.+||..||++||++.++++||||..
T Consensus       309 elltg~~Pf~~~~~~~~~~~~----~-----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGSEWI----F-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCSGGG----G-----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHCCCCCCCcchhhhHHHH----H-----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            999999999876543322211    1     112357899999999999999999999999999999954

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.6e-45  Score=344.46  Aligned_cols=247  Identities=15%  Similarity=0.112  Sum_probs=188.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---------chhhHHHHHHHHHHcC--------CCCce
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---------SSVTLKNEKEALDQIG--------ICPQI   64 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---------~~~~~~~E~~~l~~l~--------~~p~I   64 (366)
                      +|.+++.||+|+||+||+|++.  +    ..+|+|.+.....         ....+.+|+.++++++        .||||
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~--~----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           21 KLQRCEKIGEGVFGEVFQTIAD--H----TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             HHHTCEEEEEETTEEEEEEEET--T----EEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cchheeeecccCceEEEEEEeC--C----ceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            5889999999999999999983  3    4788888765321         2367899999999996        47777


Q ss_pred             eEeecceee--------------ccC------------CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHH
Q 017746           65 VRCFGDDYS--------------FEK------------GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML  118 (366)
Q Consensus        65 v~~~g~~~~--------------~~~------------~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~  118 (366)
                      +++.+....              +..            +...+++|||||++|++.+.+.+   +.+++..++.++.||+
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT  171 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence            776653221              111            14457799999999987777643   4689999999999999


Q ss_pred             HHHHHHH-HCCcEecCCCCCcEEeccCC--------------------ceEEEecCCccccCCCCCCcccccccCCCCCC
Q 017746          119 KGLRHIH-SKGFVHCDIKLQNVLVFDND--------------------EAKIADFGLAKKSSCDGERSQSFECRGTPLYM  177 (366)
Q Consensus       119 ~aL~~LH-~~givHrDlkp~NILl~~~~--------------------~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~  177 (366)
                      .||+||| ++||+||||||+||||+.++                    .+||+|||+|+....       ...+||+.|+
T Consensus       172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~  244 (336)
T 2vuw_A          172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTT
T ss_pred             HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeeccc
Confidence            9999999 99999999999999999887                    899999999987642       1347999999


Q ss_pred             CccccCCcCCCCccchhhhHHH-HHHHHhCCCCCCCCCc-chHHHHHHHhhcCCC--CCCCCCCCCHHHHHHHHHhcccC
Q 017746          178 SPESVNENEYEAPCDIWALGCA-VVEMASGKPAWNHKQD-SNVFSLLIRIGVGDE--LPNIPGDLSEQGKDFLIKCFLKD  253 (366)
Q Consensus       178 aPE~~~~~~~~~~~DiwslG~i-l~emltg~~pf~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~ll~~cL~~d  253 (366)
                      |||++.+.. +.++||||||++ .+++++|..||..... ......+........  .+..+..+++++++||.+||++|
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d  323 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS  323 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence            999998776 889999998777 7888999999953211 011112221111111  11112347889999999999987


Q ss_pred             CCCCCCHHHHH-cCCCcc
Q 017746          254 PKRRWTAEMLL-NHPFVC  270 (366)
Q Consensus       254 p~~R~t~~~ll-~hp~~~  270 (366)
                           |++|++ +||||+
T Consensus       324 -----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -----SATDLLCQHSLFK  336 (336)
T ss_dssp             -----SHHHHHHHCGGGC
T ss_pred             -----CHHHHHhcCCCcC
Confidence                 999999 999983

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-42  Score=320.21  Aligned_cols=222  Identities=15%  Similarity=0.051  Sum_probs=177.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCch----hhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSS----VTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~----~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||.||+|++..+++    .+|+|.+.......    ..+.+|+.++.+++ ||||+++++.+.   . 
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~---~-  102 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDR----QVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVH---T-  102 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTE----EEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE---E-
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCc----eEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEE---E-
Confidence            59999999999999999999987654    78999887643332    67889999999998 999999998432   2 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||++|++|.+++++   + ..+.++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|    
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred             CCcEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----
Confidence            3456799999999999999953   2 4667889999999999999999999999999999999999999998443    


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC--CCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL--PNIP  235 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~  235 (366)
                                        |++|       ++.++|||||||++|+|++|+.||.+...........+.......  ....
T Consensus       175 ------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T 3uqc_A          175 ------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID  229 (286)
T ss_dssp             ------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHC
T ss_pred             ------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcc
Confidence                              3333       788999999999999999999999876543211000000001000  1223


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+++++.+||.+||.+||++| |+.++++.
T Consensus       230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          230 RDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             cCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            5689999999999999999999 99999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-42  Score=356.23  Aligned_cols=240  Identities=21%  Similarity=0.316  Sum_probs=192.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccC-Ce
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK-GE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~-~~   78 (366)
                      +|.+++.||+|+||.||+|.+....   +..|++|.+.....  ....+.+|+.++.+++ ||||+++++++..... +.
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVN---GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGT---TEEEEEEESCSSCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEECTTSC
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCC---CcEEEEEEeCccCCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecCCCCC
Confidence            5899999999999999999987522   24789998764322  2346788999999998 9999999996543322 23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++||||++|++|.+++..    .+++.++..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             ceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            346799999999999988743    69999999999999999999999999999999999999875 8999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC--CC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI--PG  236 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  236 (366)
                      ...      ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.....             .+..  ..
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------~~~~~~~~  291 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------LPEDDPVL  291 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------CCTTCHHH
T ss_pred             ccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-------------cccccccc
Confidence            422      234699999999998765 4889999999999999999999987532110             0100  01


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      ..++.+.+||.+||.+||++||+..+.+.|+|+.
T Consensus       292 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            2467899999999999999999999999998874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.2e-35  Score=297.98  Aligned_cols=186  Identities=16%  Similarity=0.088  Sum_probs=125.2

Q ss_pred             eeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-----------CchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            9 IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-----------PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         9 lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-----------~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      .+.|++|.+..++..-.+    ..+++|.+....           .....+.+|+++|+++..|+||++++++    .++
T Consensus       242 ~~~~~~~~h~~~rr~~fg----~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~----~ed  313 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFG----EDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH----GEN  313 (569)
T ss_dssp             -C--------CCEEEEEC----SSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE----EEC
T ss_pred             cccCCccccccccccccc----ceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE----EEE
Confidence            455666666666554433    466777665421           1235689999999999889999999973    333


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +..+|||||||+|++|.++|.+  ++++++.   .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus       314 ~~~~yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          314 AQSGWLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             SSEEEEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             CCEEEEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCee
Confidence            4556799999999999999975  3567764   5899999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAW  210 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf  210 (366)
                      ...+..  ...+.+||+.|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus       389 ~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          389 TPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            653322  2345689999999999875 4677899999999998887665543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.4e-30  Score=259.87  Aligned_cols=185  Identities=15%  Similarity=0.156  Sum_probs=137.6

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---------hhhHHHHHHHHHHcCCCCceeEeecceeec
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---------SVTLKNEKEALDQIGICPQIVRCFGDDYSF   74 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---------~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~   74 (366)
                      ...+.||+|+||+||+|....      ..+++|........         ...+.+|++++++++ ||||+++..++.  
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~--  409 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLD------FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDV--  409 (540)
T ss_dssp             ---------CCEEEEEEECSS------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEE--
T ss_pred             CCCCEEeeCCCEEEEEEEECC------CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEE--
Confidence            346789999999999995432      35667665432111         234789999999998 999995544222  


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCC
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                      ..+.  .++|||||+|++|.+++.+          +..++.||++||+|||++||+||||||+|||++.  ++||+|||+
T Consensus       410 ~~~~--~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGl  475 (540)
T 3en9_A          410 DLDN--KRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGL  475 (540)
T ss_dssp             ETTT--TEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTT
T ss_pred             eCCc--cEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECcc
Confidence            2222  3699999999999999854          5689999999999999999999999999999998  999999999


Q ss_pred             ccccCCCCCCc-----ccccccCCCCCCCccccCC--cCCCCccchhhhHHHHHHHHhCCCCCC
Q 017746          155 AKKSSCDGERS-----QSFECRGTPLYMSPESVNE--NEYEAPCDIWALGCAVVEMASGKPAWN  211 (366)
Q Consensus       155 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~emltg~~pf~  211 (366)
                      |+.........     .....+||+.|||||++..  ..|+..+|+|+...-..+.+.++.+|.
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            99874321111     1134579999999999987  678889999999999888888877763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=5.6e-27  Score=215.19  Aligned_cols=155  Identities=19%  Similarity=0.174  Sum_probs=119.6

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-------------------chhhHHHHHHHHHHcCCCCc
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-------------------SSVTLKNEKEALDQIGICPQ   63 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-------------------~~~~~~~E~~~l~~l~~~p~   63 (366)
                      |.+++.||+|+||.||+|.+ .++    ..+|+|.......                   ....+.+|+.++++++ |++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g----~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~  165 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLA  165 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTT----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSS
T ss_pred             EEecCEeccCCCceEEEEEe-CCC----CEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCC
Confidence            45669999999999999998 544    4789998754211                   2345789999999998 455


Q ss_pred             eeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc
Q 017746           64 IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD  143 (366)
Q Consensus        64 Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~  143 (366)
                      +..+++        ....++||||++||+|.+ +.      .  .....++.||+.||.|||++||+||||||+|||++ 
T Consensus       166 v~~~~~--------~~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          166 VPKVYA--------WEGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             SCCEEE--------EETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-
T ss_pred             cCeEEe--------ccceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-
Confidence            554432        123469999999999987 41      1  23457999999999999999999999999999999 


Q ss_pred             CCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCC----------cCCCCccchhhh
Q 017746          144 NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE----------NEYEAPCDIWAL  196 (366)
Q Consensus       144 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diwsl  196 (366)
                      ++.+||+|||+|+.               +..++|||++..          ..|+..+|+|.+
T Consensus       228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          228 EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            99999999999864               345789998754          446666777653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=2.3e-22  Score=182.07  Aligned_cols=136  Identities=21%  Similarity=0.244  Sum_probs=103.6

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCce--eEEeeecCCCCc-------------------------hhhHHHHHHHH
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSL--MAVKSCADCPPS-------------------------SVTLKNEKEAL   55 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~--~avK~~~~~~~~-------------------------~~~~~~E~~~l   55 (366)
                      |.+++.||+|+||.||+|.+..+++    .  +|+|........                         ...+.+|..+|
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  124 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGK----PVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL  124 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTE----EEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCc----EeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence            5678899999999999999855443    5  888875432111                         12578899999


Q ss_pred             HHcCCCCce--eEeecceeeccCCeeEEEEEeecCCC-C----CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HC
Q 017746           56 DQIGICPQI--VRCFGDDYSFEKGERFYNLLLEYASR-G----SLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH-SK  127 (366)
Q Consensus        56 ~~l~~~p~I--v~~~g~~~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~  127 (366)
                      .++. |+++  ...+.    .    ...+|||||+.+ |    +|.++...     .++..+..++.||+.||.||| ++
T Consensus       125 ~~l~-~~~i~~p~~~~----~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~  190 (258)
T 1zth_A          125 ERAK-EAGVSVPQPYT----Y----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA  190 (258)
T ss_dssp             HHHH-HTTCCCCCEEE----E----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHH-hCCCCCCeEEE----c----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC
Confidence            9997 5543  33332    1    123599999942 3    78776532     346678899999999999999 99


Q ss_pred             CcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746          128 GFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus       128 givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ||+||||||+|||++.  .++|+|||+|...
T Consensus       191 givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          191 ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999999988  8999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=3.8e-19  Score=168.34  Aligned_cols=136  Identities=12%  Similarity=0.095  Sum_probs=93.8

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---------------chh--------hHHHHHHHHHHcC
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---------------SSV--------TLKNEKEALDQIG   59 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---------------~~~--------~~~~E~~~l~~l~   59 (366)
                      |.++.+||+|+||.||+|.+.. +    ..+|+|.......               ...        ...+|...|.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~-G----~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~  171 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEK-G----KQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY  171 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTT-C----CEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEECCC-C----CEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence            7889999999999999998753 3    4788887543100               000        1134555666663


Q ss_pred             CCCceeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcE
Q 017746           60 ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNV  139 (366)
Q Consensus        60 ~~p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI  139 (366)
                       +.++. +.. .+...    ..+|||||++|++|.++.        ..+.+..++.||+.+|.|||++|||||||||.||
T Consensus       172 -~~gv~-vp~-p~~~~----~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NI  236 (397)
T 4gyi_A          172 -EEGFP-VPE-PIAQS----RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNI  236 (397)
T ss_dssp             -HTTCS-CCC-EEEEE----TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred             -hcCCC-CCe-eeecc----CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence             22221 110 00111    124999999998885432        2234567889999999999999999999999999


Q ss_pred             EeccCCc----------eEEEecCCcccc
Q 017746          140 LVFDNDE----------AKIADFGLAKKS  158 (366)
Q Consensus       140 Ll~~~~~----------vkl~DFG~a~~~  158 (366)
                      |++++|.          +.|+||+-+...
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccC
Confidence            9988763          899999987653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=4e-13  Score=121.02  Aligned_cols=139  Identities=15%  Similarity=0.118  Sum_probs=103.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      .|.....++.|+++.||++...  +    ..+++|...... .....+.+|..+++.+..+..+.++++...    ....
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~--~----~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~----~~~~   84 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE--N----ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----HDGW   84 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS--S----CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE----ETTE
T ss_pred             cceeEeeccCCCCCeEEEEECC--C----CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe----cCCc
Confidence            3666677888888999999743  2    368888876421 234579999999999975666777776322    2234


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS----------------------------------  126 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~----------------------------------  126 (366)
                      .++||||++|.+|.+.+.       +......++.+++.+|..||+                                  
T Consensus        85 ~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             eEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            569999999999987631       122345788899999999998                                  


Q ss_pred             -------------------------CCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          127 -------------------------KGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       127 -------------------------~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                                               ..++|+|++|.|||++.++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                     4589999999999998765667999997643

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.21  E-value=1.6e-11  Score=109.77  Aligned_cols=129  Identities=18%  Similarity=0.096  Sum_probs=88.6

Q ss_pred             eee-ecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCc-eeEeecceeeccCCeeEEEEEe
Q 017746            8 VIG-HGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ-IVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         8 ~lG-~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~-Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      .++ .|..+.||++... ++    ..+++|.....  ....+.+|..+++.+..+.- +.++++..   .. ....++||
T Consensus        26 ~~~~gg~~~~v~~~~~~-~g----~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~---~~-~~~~~~v~   94 (264)
T 1nd4_A           26 QQTIGCSDAAVFRLSAQ-GR----PVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVV---TE-AGRDWLLL   94 (264)
T ss_dssp             ECSCTTSSCEEEEEECT-TS----CCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEE---EC-SSCEEEEE
T ss_pred             ecccCCCCceEEEEecC-CC----CeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEec---cC-CCCCEEEE
Confidence            344 5556899999643 22    35788886542  34578899999999975421 44566522   12 23356999


Q ss_pred             ecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------
Q 017746           86 EYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG-------------------------------------  128 (366)
Q Consensus        86 E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g-------------------------------------  128 (366)
                      ||++|.+|.  ..     ..+.   ..++.+++..|..||+..                                     
T Consensus        95 e~i~G~~l~--~~-----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           95 GEVPGQDLL--SS-----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             ECCSSEETT--TS-----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EecCCcccC--cC-----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            999998884  21     1222   356677777777777643                                     


Q ss_pred             ---------------------cEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          129 ---------------------FVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       129 ---------------------ivHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                                           ++|+|++|.|||++.++.+.|+|||.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                 99999999999998776677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=4.2e-11  Score=112.87  Aligned_cols=142  Identities=13%  Similarity=0.153  Sum_probs=100.3

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeec--CCC--CchhhHHHHHHHHHHcCCC-CceeEeecceeeccCCee
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCA--DCP--PSSVTLKNEKEALDQIGIC-PQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~--~~~--~~~~~~~~E~~~l~~l~~~-p~Iv~~~g~~~~~~~~~~   79 (366)
                      ..+.|+.|.++.||++...+      ..+++|...  ...  .....+.+|..+++.|... ..+.++++.+... ...+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~-~~~g  114 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE-SVIG  114 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT-TTTS
T ss_pred             eEEEcCCcccceEEEEEECC------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC-CccC
Confidence            45678999999999997642      267788765  321  2345789999999999742 3356665522111 1112


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS---------------------------------  126 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---------------------------------  126 (366)
                      ..++||||++|..+.+..    -..+++.+...++.+++++|..||+                                 
T Consensus       115 ~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          115 RAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             SCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             CeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            345999999998775421    1247888889999999999999997                                 


Q ss_pred             -------------------------CCcEecCCCCCcEEeccCCc--eEEEecCCccc
Q 017746          127 -------------------------KGFVHCDIKLQNVLVFDNDE--AKIADFGLAKK  157 (366)
Q Consensus       127 -------------------------~givHrDlkp~NILl~~~~~--vkl~DFG~a~~  157 (366)
                                               ..++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     35999999999999987753  69999999874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=2.9e-11  Score=111.37  Aligned_cols=184  Identities=18%  Similarity=0.141  Sum_probs=120.9

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCc--eeEeecceeeccCCeeEEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ--IVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~--Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      .+.++.|.+..||++.         ..+++|..... .....+.+|.++|+.+..+..  +.+++.... ....-...++
T Consensus        25 i~~~~~G~~n~v~~v~---------~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~-~~~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---------RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGM-PSETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST---------TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECC-CCSSCSCSCE
T ss_pred             eEecCCCCcceEEEEC---------CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecC-CCCCCCcceE
Confidence            5678999999999863         25778875431 234678999999999853322  233332110 1111123358


Q ss_pred             EeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 017746           84 LLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-------------------------------------  126 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-------------------------------------  126 (366)
                      |||+++|.+|.+....    .++.++...++.|++..|..||+                                     
T Consensus        94 vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ  169 (304)
T ss_dssp             EEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred             EEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence            8999999988765432    37888888999999999999986                                     


Q ss_pred             ---------------------CCcEecCCCCCcEEecc--CCceEEEecCCccccCCCCCCcccccccCCCCC---CCcc
Q 017746          127 ---------------------KGFVHCDIKLQNVLVFD--NDEAKIADFGLAKKSSCDGERSQSFECRGTPLY---MSPE  180 (366)
Q Consensus       127 ---------------------~givHrDlkp~NILl~~--~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y---~aPE  180 (366)
                                           ..++|+|++|.||+++.  .+.+.|+||+.+..-.....      ......+   ..|+
T Consensus       170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~  243 (304)
T 3sg8_A          170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGME  243 (304)
T ss_dssp             HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHH
T ss_pred             HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHH
Confidence                                 13799999999999988  45689999999875321000      0001111   2233


Q ss_pred             ccCC--cCCC------------CccchhhhHHHHHHHHhCCCCC
Q 017746          181 SVNE--NEYE------------APCDIWALGCAVVEMASGKPAW  210 (366)
Q Consensus       181 ~~~~--~~~~------------~~~DiwslG~il~emltg~~pf  210 (366)
                      ....  ..|.            ...+.|++|.++|.+.+|..+|
T Consensus       244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            2111  0111            1258999999999999999887

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.64  E-value=1.2e-07  Score=85.21  Aligned_cols=134  Identities=13%  Similarity=0.028  Sum_probs=90.1

Q ss_pred             eeeecCCe-eEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEee
Q 017746            8 VIGHGSFG-SVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLLE   86 (366)
Q Consensus         8 ~lG~G~fg-~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~E   86 (366)
                      .+..|..| .||+......+.    .+++|....  .....+.+|..+|+.|...--+.++++.+   ..+ ...++|||
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~----~~~lk~~~~--~~~~~~~~E~~~l~~l~~~vPVP~v~~~~---~~~-~~~~lvme  100 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAP----ELFLKHGKG--SVANDVTDEMVRLNWLTAFMPLPTIKHFI---RTP-DDAWLLTT  100 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCC----CEEEEEEET--HHHHHHHHHHHHHHHHTTTSCCCCEEEEE---EET-TEEEEEEE
T ss_pred             EccCCCcCCeEEEEEecCCCe----EEEEEECCC--CCHhHHHHHHHHHHHhccCCCcCeEEEEE---EEC-CeEEEEEE
Confidence            34556665 589887654432    577887553  34456889999999997543344554421   122 23459999


Q ss_pred             cCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q 017746           87 YASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK---------------------------------------  127 (366)
Q Consensus        87 ~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---------------------------------------  127 (366)
                      +++|.++.+.....      ......+..++...|.-||..                                       
T Consensus       101 ~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A          101 AIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             CCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             eeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            99999988776431      222344566666666666641                                       


Q ss_pred             -------------------CcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          128 -------------------GFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       128 -------------------givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                                         .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                               179999999999998877777999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=1.6e-07  Score=86.34  Aligned_cols=135  Identities=14%  Similarity=0.088  Sum_probs=89.7

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC-C-ceeEeecceeeccCCeeEEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-P-QIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~-p-~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      .+.++.|....||+.     +    ..+++|.... ......+.+|.++|+.|..+ + .+.+.+....  . ..+..++
T Consensus        24 v~~l~~G~~n~v~~v-----g----~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~-~~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----N----GDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R-SDGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE-----T----TTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C-TTSCEEE
T ss_pred             eeecCCCcceeEEEE-----C----CEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c-CCCceEE
Confidence            456788888899988     2    2567777432 12346789999999999853 1 2334433211  1 1223459


Q ss_pred             EeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------
Q 017746           84 LLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSK------------------------------------  127 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~------------------------------------  127 (366)
                      |||+++|.+|.+..-.    .++..+...++.++...|..||+.                                    
T Consensus        91 v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           91 GYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             EEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             EEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            9999999888764321    245555566666666666666542                                    


Q ss_pred             ------------------------CcEecCCCCCcEEecc---CCc-eEEEecCCccc
Q 017746          128 ------------------------GFVHCDIKLQNVLVFD---NDE-AKIADFGLAKK  157 (366)
Q Consensus       128 ------------------------givHrDlkp~NILl~~---~~~-vkl~DFG~a~~  157 (366)
                                              .++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                    3599999999999987   455 58999998765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.23  E-value=3.8e-06  Score=79.88  Aligned_cols=76  Identities=18%  Similarity=0.140  Sum_probs=46.7

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--------CchhhHHHHHHHHHHcCCC-Cc-eeEeecceeecc
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--------PSSVTLKNEKEALDQIGIC-PQ-IVRCFGDDYSFE   75 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~E~~~l~~l~~~-p~-Iv~~~g~~~~~~   75 (366)
                      .+.||.|.++.||++.....+    ..+++|......        ........|.++++.+... |. +.+++.    +.
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~----~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~----~d  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHD----RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY----SD  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC--------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE----EE
T ss_pred             EEECCCCceEEEEEEEECCCC----cEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE----Ec
Confidence            467899999999999764433    367888654311        1234568899999988643 33 334443    22


Q ss_pred             CCeeEEEEEeecCCCC
Q 017746           76 KGERFYNLLLEYASRG   91 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g   91 (366)
                      .+.  .++|||+++|.
T Consensus       107 ~~~--~~lvmE~l~g~  120 (397)
T 2olc_A          107 TEM--AVTVMEDLSHL  120 (397)
T ss_dssp             TTT--TEEEECCCTTS
T ss_pred             CCc--cEEEEEeCCCc
Confidence            222  24999999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.19  E-value=1.1e-05  Score=74.46  Aligned_cols=31  Identities=19%  Similarity=0.235  Sum_probs=27.7

Q ss_pred             CCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       127 ~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            5799999999999998888899999997753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.18  E-value=7.5e-07  Score=83.42  Aligned_cols=86  Identities=9%  Similarity=0.042  Sum_probs=48.9

Q ss_pred             Cee-eecCCeeEEEEEEC--CCCCCCCceeEEeeecCCC----CchhhHHHHHHHHHHcCCC--CceeEeecceeeccCC
Q 017746            7 DVI-GHGSFGSVNLAKAS--KVSSEFPSLMAVKSCADCP----PSSVTLKNEKEALDQIGIC--PQIVRCFGDDYSFEKG   77 (366)
Q Consensus         7 ~~l-G~G~fg~Vy~a~~~--~~~~~~~~~~avK~~~~~~----~~~~~~~~E~~~l~~l~~~--p~Iv~~~g~~~~~~~~   77 (366)
                      +.| +.|....+|+....  .++......+++|......    .....+.+|..+++.|..+  ..+.++++.... ...
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~-~~~  104 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT-GDV  104 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS-STT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC-CCc
Confidence            456 77888899988653  1100002367788755321    0235688999999988643  234555542111 000


Q ss_pred             eeEEEEEeecCCCCCH
Q 017746           78 ERFYNLLLEYASRGSL   93 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L   93 (366)
                      ....++||||++|.+|
T Consensus       105 ~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TSSCEEEEECCCCBCC
T ss_pred             cCCceEEEEecCCCCh
Confidence            0223489999998654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.09  E-value=1.2e-05  Score=73.47  Aligned_cols=138  Identities=12%  Similarity=0.105  Sum_probs=76.1

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      |.-.+.|+.|....+|+.          ..+++|.............+|..+++.+..+.-..++++    +..+.+  +
T Consensus        20 ~~~i~~l~gG~tN~~~~~----------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~----~~~~~~--~   83 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA----------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLH----VDPATG--V   83 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE----------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEE----ECTTTC--C
T ss_pred             ccceeEcCCcccccccee----------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEE----EECCCC--E
Confidence            555678889999999998          157888776532333345778888888753321234443    222222  3


Q ss_pred             EEeecC-CCCCHHH---------------HHHHhCC--CCCC-----HHHHHHHHHH--------------HHHHHHHHH
Q 017746           83 LLLEYA-SRGSLAD---------------RVKKQNN--GRLQ-----ESDVKRYTRS--------------MLKGLRHIH  125 (366)
Q Consensus        83 lv~E~~-~~g~L~~---------------~l~~~~~--~~l~-----~~~~~~~~~q--------------i~~aL~~LH  125 (366)
                      +++||+ +|.+|..               .+.+-+.  ..+.     ...+..+..+              +...+..+.
T Consensus        84 ~v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  163 (301)
T 3dxq_A           84 MVTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVR  163 (301)
T ss_dssp             EEEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHH
T ss_pred             EEEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHH
Confidence            899999 6644421               1111111  1111     1122222111              111111111


Q ss_pred             ----H----CCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          126 ----S----KGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       126 ----~----~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                          .    ..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus       164 ~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          164 SALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence                1    24899999999999 5667889999998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.92  E-value=8.3e-05  Score=63.98  Aligned_cols=123  Identities=14%  Similarity=0.043  Sum_probs=81.8

Q ss_pred             CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCccccCCCCCCccccc
Q 017746           91 GSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE  169 (366)
Q Consensus        91 g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~  169 (366)
                      -+|.+.|+. .+.+++|++++.+..|.+.+|.-+-. ..-..+=+.|..|+|..+|.|-+.+ +.+.             
T Consensus        33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            389999988 56799999999999999999877622 1111333456899999999887764 2110             


Q ss_pred             ccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHh
Q 017746          170 CRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKC  249 (366)
Q Consensus       170 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~c  249 (366)
                       .....+.|||... ...+.+.=|||||+++|..+--..|=                      ..+..+|+++.+||..|
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e----------------------~eE~eLS~~LE~LL~~M  153 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE----------------------NEERELSPPLEQLIDHM  153 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT----------------------TEEECCCHHHHHHHHHH
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc----------------------ccchhhCHHHHHHHHHH
Confidence             0123466888763 34456778999999999988644331                      11234788999999888


Q ss_pred             ccc
Q 017746          250 FLK  252 (366)
Q Consensus       250 L~~  252 (366)
                      ..-
T Consensus       154 t~~  156 (229)
T 2yle_A          154 ANT  156 (229)
T ss_dssp             TTC
T ss_pred             Hhc
Confidence            766

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.64  E-value=0.00021  Score=68.30  Aligned_cols=32  Identities=16%  Similarity=0.342  Sum_probs=28.1

Q ss_pred             HHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       125 H~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +...++|+|++|.|||++.++ ++|+||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            356799999999999998776 99999998875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.62  E-value=0.00014  Score=66.86  Aligned_cols=76  Identities=14%  Similarity=0.159  Sum_probs=51.9

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC--CceeEeecceeeccCCeeEEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~--p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      .+.|+.|.+..+|+....  +    ..+++|....  .....+..|.+.|+.|...  ..+.+.++..    ......++
T Consensus        41 ~~~l~gG~~n~~y~v~~~--~----~~~vlK~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~----~~~g~~~l  108 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE--V----QTVFVKINER--SYRSMFRAEADQLALLAKTNSINVPLVYGIG----NSQGHSFL  108 (312)
T ss_dssp             EEEECCSSSSEEEEEESS--S----CEEEEEEEEG--GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEE----ECSSEEEE
T ss_pred             eEEeCCccceeeeEEEEC--C----CeEEEEeCCc--ccHHHHHHHHHHHHHHHhhCCCCcceEEEEe----ecCCceEE
Confidence            456889999999998742  2    3678887654  2356788999999988532  4455555422    11234569


Q ss_pred             EeecCCCCCH
Q 017746           84 LLEYASRGSL   93 (366)
Q Consensus        84 v~E~~~~g~L   93 (366)
                      ||||++|..+
T Consensus       109 vme~l~G~~~  118 (312)
T 3jr1_A          109 LLEALNKSKN  118 (312)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeccCCCC
Confidence            9999998754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.55  E-value=0.00029  Score=66.43  Aligned_cols=144  Identities=14%  Similarity=0.144  Sum_probs=83.5

Q ss_pred             cCeeeecCCeeEEEEEECCC---CCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKV---SSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~---~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      .+.|..|-...+|++.....   .......+++|...........+.+|..+++.|..+.-..++++    ...+.    
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~----~~~~g----  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYG----VFPEG----  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEE----EETTE----
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEE----EcCCc----
Confidence            34566677788999886421   01123478888865433345667789999988864433344444    12222    


Q ss_pred             EEeecCCCCCHH--------------HHHHHhCC------CCC--CHHHHHHHHHHHHH-------------------HH
Q 017746           83 LLLEYASRGSLA--------------DRVKKQNN------GRL--QESDVKRYTRSMLK-------------------GL  121 (366)
Q Consensus        83 lv~E~~~~g~L~--------------~~l~~~~~------~~l--~~~~~~~~~~qi~~-------------------aL  121 (366)
                      +||||++|.+|.              +.+.+.+.      ...  -+.++..+..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            889999985542              22222111      112  24566666655532                   23


Q ss_pred             HHHHH--------CCcEecCCCCCcEEeccC----CceEEEecCCccc
Q 017746          122 RHIHS--------KGFVHCDIKLQNVLVFDN----DEAKIADFGLAKK  157 (366)
Q Consensus       122 ~~LH~--------~givHrDlkp~NILl~~~----~~vkl~DFG~a~~  157 (366)
                      +.|.+        ..++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33332        249999999999999876    6899999998753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.46  E-value=0.00039  Score=64.10  Aligned_cols=31  Identities=35%  Similarity=0.411  Sum_probs=27.2

Q ss_pred             CCcEecCCCCCcEEeccC----CceEEEecCCccc
Q 017746          127 KGFVHCDIKLQNVLVFDN----DEAKIADFGLAKK  157 (366)
Q Consensus       127 ~givHrDlkp~NILl~~~----~~vkl~DFG~a~~  157 (366)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999874    6799999998875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.42  E-value=0.0016  Score=63.02  Aligned_cols=76  Identities=11%  Similarity=-0.006  Sum_probs=46.4

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEEEe
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      .+.|+.|-...+|++.....    ...+++|.............+|..+++.|..+.-..++++.   + .+.    +||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~----~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~---~-~~G----~v~  180 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSK----QAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVF---F-TNG----RIE  180 (458)
T ss_dssp             EEEECC--CEEEEEEEETTT----TEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEE---E-TTE----EEE
T ss_pred             EEEcCCCeEeEEEEEEECCC----CceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEE---e-CCe----EEE
Confidence            45677788889999986541    23678887654322223347899999999854333455552   2 221    589


Q ss_pred             ecCCCCCH
Q 017746           86 EYASRGSL   93 (366)
Q Consensus        86 E~~~~g~L   93 (366)
                      ||++|.+|
T Consensus       181 e~I~G~~l  188 (458)
T 2qg7_A          181 EFMDGYAL  188 (458)
T ss_dssp             ECCCSEEC
T ss_pred             EeeCCccC
Confidence            99997443

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.41  E-value=0.00042  Score=63.44  Aligned_cols=142  Identities=13%  Similarity=0.088  Sum_probs=75.5

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCC-ceeEeecc----eeeccCCeeEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP-QIVRCFGD----DYSFEKGERFY   81 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p-~Iv~~~g~----~~~~~~~~~~~   81 (366)
                      +.|+.|....+|+....+ +     .+++|..... .....+..|..+++.|..+. .+.+++..    .+. .. .+..
T Consensus        28 ~~i~~G~~n~~~~v~~~~-g-----~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~-~~-~g~~   98 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTK-D-----PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG-EL-SGRP   98 (322)
T ss_dssp             EEECC---EEEEEEEESS-C-----CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE-EE-TTEE
T ss_pred             eccCCCcccceEEEEeCC-c-----cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEE-EE-CCEE
Confidence            456668888999987532 1     5778876642 23345677888888875321 12333321    111 11 1234


Q ss_pred             EEEeecCCCCCHH-----------HHHHH---h-CC--CC----CCHHHHHH---------------HHHHHHHHHHHHH
Q 017746           82 NLLLEYASRGSLA-----------DRVKK---Q-NN--GR----LQESDVKR---------------YTRSMLKGLRHIH  125 (366)
Q Consensus        82 ~lv~E~~~~g~L~-----------~~l~~---~-~~--~~----l~~~~~~~---------------~~~qi~~aL~~LH  125 (366)
                      +++|+|++|..+.           ..+.+   . .+  ..    ........               +...+...++.++
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            6899999985431           11111   0 00  00    11010000               0011344555555


Q ss_pred             H-------CCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          126 S-------KGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       126 ~-------~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +       .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3       3699999999999998776668999997653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.34  E-value=0.00071  Score=62.06  Aligned_cols=143  Identities=10%  Similarity=0.030  Sum_probs=77.7

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC-CceeEeecc-eeeccCCeeEEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC-PQIVRCFGD-DYSFEKGERFYNLL   84 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~-p~Iv~~~g~-~~~~~~~~~~~~lv   84 (366)
                      ..|+ |....||++...+ +    ..+++|...........+..|..+++.|..+ -.+++++.. ........+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~~-g----~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDED-R----RRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCTT-C----CCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcCC-C----CEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3466 7778899876432 2    2588888764323456778899988888532 113334331 11111112345689


Q ss_pred             eecCCCCCHH-----------HHHHH---h-CC------CCCCHHHH----------------------HHHHHHHHHHH
Q 017746           85 LEYASRGSLA-----------DRVKK---Q-NN------GRLQESDV----------------------KRYTRSMLKGL  121 (366)
Q Consensus        85 ~E~~~~g~L~-----------~~l~~---~-~~------~~l~~~~~----------------------~~~~~qi~~aL  121 (366)
                      ||+++|.++.           ..+.+   . ..      ..++....                      ...+.+++..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999985421           11111   0 00      01111110                      11112222222


Q ss_pred             HHH----HHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          122 RHI----HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       122 ~~L----H~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +-+    ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            222    224589999999999998 4 899999997754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.25  E-value=0.0022  Score=57.72  Aligned_cols=75  Identities=17%  Similarity=0.212  Sum_probs=50.1

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-chhhHHHHHHHHHHcCCCC--ceeEeecceeeccCCeeEE
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-SSVTLKNEKEALDQIGICP--QIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~E~~~l~~l~~~p--~Iv~~~g~~~~~~~~~~~~   81 (366)
                      ..+.+|.|..+.||+.+..+ +    ..+++|....... ....+..|...|+.|....  -+.++++    ...    -
T Consensus        19 ~v~~~g~G~~~~vyrv~l~D-G----~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~----~~~----~   85 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELAD-G----TPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAG----WDD----R   85 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETT-S----CEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEE----EET----T
T ss_pred             EEEecCCCCCeEEEEEEECC-C----CEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEe----ccC----c
Confidence            35678999999999998643 3    3688897654322 3345789999999996431  2334443    111    1


Q ss_pred             EEEeecCCCCC
Q 017746           82 NLLLEYASRGS   92 (366)
Q Consensus        82 ~lv~E~~~~g~   92 (366)
                      ++||||++++.
T Consensus        86 ~lv~e~l~~~~   96 (288)
T 3f7w_A           86 TLAMEWVDERP   96 (288)
T ss_dssp             EEEEECCCCCC
T ss_pred             eEEEEeecccC
Confidence            38999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.22  E-value=0.00099  Score=63.94  Aligned_cols=78  Identities=18%  Similarity=0.154  Sum_probs=47.1

Q ss_pred             cCeeeecCCeeEEEEEECCCCC---CCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSS---EFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~---~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      .+.|+.|....||++.......   .....+++|..... .....+.+|..+++.|..+.-..++++.   +. +    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~---~~-~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGI---FS-G----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEE---ET-T----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEE---eC-C----C
Confidence            4567778888999998643110   01247888887431 1215566899999988643323455542   22 2    1


Q ss_pred             EEeecCCCCC
Q 017746           83 LLLEYASRGS   92 (366)
Q Consensus        83 lv~E~~~~g~   92 (366)
                      +||||++|.+
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            7899998743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.15  E-value=0.00065  Score=63.61  Aligned_cols=79  Identities=9%  Similarity=0.024  Sum_probs=43.1

Q ss_pred             cCeeeecCCeeEEEEEECCCC----CCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVS----SEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~----~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      .+.|+.|....+|++.....+    ......+++|..............|..+++.|..+.-+.++++.   . .+    
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~---~-~~----  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNT---F-NG----  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEE---E-TT----
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEe---c-CC----
Confidence            446777888899999764310    00113678887654222222357888899888643223345431   1 11    


Q ss_pred             EEEeecCCCCC
Q 017746           82 NLLLEYASRGS   92 (366)
Q Consensus        82 ~lv~E~~~~g~   92 (366)
                      ++||||++|.+
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            37899999854

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.85  E-value=0.0068  Score=56.06  Aligned_cols=31  Identities=29%  Similarity=0.302  Sum_probs=27.7

Q ss_pred             CCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       127 ~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3699999999999999888899999988765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.12  E-value=0.015  Score=55.53  Aligned_cols=143  Identities=11%  Similarity=0.100  Sum_probs=82.7

Q ss_pred             cCeeeecCCeeEEEEEECCCCC---CCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSS---EFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~---~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      .+.|..|-...+|+........   .....++++.............+|..+++.|....-..++++.   + .+    +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~---~-~~----~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIAD---F-PE----G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEE---E-TT----E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEE---c-CC----C
Confidence            3456667777899998753211   0124788888655333334567899999888643323444431   1 11    3


Q ss_pred             EEeecCCCCCHH--------------HHHHH-----h-----C---CC-CCCHHHHHHHHHHHH----------------
Q 017746           83 LLLEYASRGSLA--------------DRVKK-----Q-----N---NG-RLQESDVKRYTRSML----------------  118 (366)
Q Consensus        83 lv~E~~~~g~L~--------------~~l~~-----~-----~---~~-~l~~~~~~~~~~qi~----------------  118 (366)
                      +||||++|.+|.              +.+.+     .     .   +. +.-+.++..+..++-                
T Consensus       147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~  226 (424)
T 3mes_A          147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS  226 (424)
T ss_dssp             EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred             EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence            789999986531              11111     0     0   10 112344445543332                


Q ss_pred             ---HHHHHHH--------------------H----CCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          119 ---KGLRHIH--------------------S----KGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       119 ---~aL~~LH--------------------~----~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                         ..+..|.                    .    ..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus       227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence               1222222                    1    24899999999999 7788999999998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.76  E-value=0.089  Score=49.64  Aligned_cols=29  Identities=24%  Similarity=0.431  Sum_probs=24.8

Q ss_pred             cEecCCCCCcEEe------ccCCceEEEecCCccc
Q 017746          129 FVHCDIKLQNVLV------FDNDEAKIADFGLAKK  157 (366)
Q Consensus       129 ivHrDlkp~NILl------~~~~~vkl~DFG~a~~  157 (366)
                      ++|+|+.+.|||+      ++++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            7899999999999      3456799999998864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	366
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-58
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-57
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-57
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-56
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-55
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-54
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-54
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-53
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-53
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-45
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-45
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-45
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-45
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-44
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-44
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-43
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-42
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-42
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-42
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-42
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-41
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-41
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-40
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-40
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-39
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-35
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-34
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-12

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 9e-58
 Identities = 68/271 (25%), Positives = 117/271 (43%), Gaps = 16/271 (5%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIG 59
           +W     +G G++G V LA  ++V+ E    +AVK             +K E      + 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAV-NRVTEE---AVAVKIVDMKRAVDCPENIKKEICINKMLN 61

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
               +V+ +G      +G   Y L LEY S G L DR++   +  + E D +R+   ++ 
Sbjct: 62  -HENVVKFYG---HRREGNIQY-LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMA 114

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++H  G  H DIK +N+L+ + D  KI+DFGLA     +       +  GT  Y++P
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

Query: 180 ESVNENEYEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E +   E+ A   D+W+ G  +  M +G+  W+  Q S+               N    +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKKTYLNPWKKI 232

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
                  L K  +++P  R T   +    + 
Sbjct: 233 DSAPLALLHKILVENPSARITIPDIKKDRWY 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-57
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 24/271 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK----SCADCPPSSVTLKNEKEALDQIGIC 61
           G  +G G FG+V LA+  K S     ++A+K    +  +       L+ E E    +   
Sbjct: 11  GRPLGKGKFGNVYLAR-EKQSKF---ILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-H 65

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P I+R +G    F    R Y L+LEYA  G++   ++K    +  E     Y   +   L
Sbjct: 66  PNILRLYG---YFHDATRVY-LILEYAPLGTVYRELQKL--SKFDEQRTATYITELANAL 119

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            + HSK  +H DIK +N+L+    E KIADFG +  +      S+     GT  Y+ PE 
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEM 175

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           +    ++   D+W+LG    E   GKP +        +  + R+         P  ++E 
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----EFTFPDFVTEG 230

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
            +D + +    +P +R     +L HP++ A+
Sbjct: 231 ARDLISRLLKHNPSQRPMLREVLEHPWITAN 261

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  188 bits (479), Expect = 2e-57
 Identities = 79/345 (22%), Positives = 145/345 (42%), Gaps = 39/345 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQI 64
            + +G G+FG V+     K +     +   K      P    T+KNE   ++Q+   P++
Sbjct: 34  LEELGSGAFGVVHRCV-EKATGR---VFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKL 88

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           +       +FE       L+LE+ S G L DR+  ++  ++ E++V  Y R   +GL+H+
Sbjct: 89  INLHD---AFEDKYEMV-LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHM 143

Query: 125 HSKGFVHCDIKLQNVLV--FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV 182
           H    VH DIK +N++         KI DFGLA K + D           T  + +PE V
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIV 200

Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
           +        D+WA+G     + SG   +  + D       ++    +   +    +S + 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ-NVKRCDWEFDEDAFSSVSPEA 259

Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKFSQS 302
           KDF+     K+P++R T    L HP++  D           HS+ +  +   +  K  Q 
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGD-----------HSNLTSRIPSSRYNKIRQK 308

Query: 303 PRSPFGFPEWVSVQSSSSVTSSINSPS---------FDSFLSSRD 338
            +    + +W + Q +    ++ +S           +DS+   ++
Sbjct: 309 IKEK--YADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-57
 Identities = 58/269 (21%), Positives = 110/269 (40%), Gaps = 11/269 (4%)

Query: 4   LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQ 63
           +   V+G G  G V      +   +F    A+K   DCP      + E E   +   CP 
Sbjct: 15  VTSQVLGLGINGKVLQIFNKRTQEKF----ALKMLQDCP----KARREVELHWRASQCPH 66

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IVR      +   G +   +++E    G L  R++ + +    E +     +S+ + +++
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS    H D+K +N+L        I        +      +       TP Y++PE + 
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLL---IRIGVGDELPNIPGDLSE 240
             +Y+  CD+W+LG  +  +  G P +       +   +   IR+G  +       ++SE
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           + K  +      +P +R T    +NHP++
Sbjct: 247 EVKMLIRNLLKTEPTQRMTITEFMNHPWI 275

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (469), Expect = 2e-56
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 27/269 (10%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVK----SCADCPPSSVTLKNEKEALDQIGICPQ 63
            IGHGSFG+V  A+  + S       A+K    S          +  E   L ++   P 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVV----AIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPN 76

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
            ++  G    + +    + L++EY    +      + +   LQE ++   T   L+GL +
Sbjct: 77  TIQYRG---CYLREHTAW-LVMEYCLGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV- 182
           +HS   +H D+K  N+L+ +    K+ DFG A         + +    GTP +M+PE + 
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAPEVIL 184

Query: 183 --NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
             +E +Y+   D+W+LG   +E+A  KP      + N  S L  I   +      G  SE
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL---FNMNAMSALYHIAQNESPALQSGHWSE 241

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             ++F+  C  K P+ R T+E+LL H FV
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-56
 Identities = 78/274 (28%), Positives = 125/274 (45%), Gaps = 22/274 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSV-TLKNEKEALDQIGICPQI 64
              +G G+FG V  A+  + S       A K         +     E + L      P I
Sbjct: 17  IGELGDGAFGKVYKAQNKETSVLA----AAKVIDTKSEEELEDYMVEIDILASCD-HPNI 71

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V+      +F      + +L+E+ + G++ D V  +    L ES ++   +  L  L ++
Sbjct: 72  VKLLD---AFYYENNLW-ILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV-- 182
           H    +H D+K  N+L   + + K+ADFG++ K++   +R  SF   GTP +M+PE V  
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWMAPEVVMC 184

Query: 183 ---NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP-NIPGDL 238
               +  Y+   D+W+LG  ++EMA  +P      + N   +L++I   +      P   
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPH---HELNPMRVLLKIAKSEPPTLAQPSRW 241

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD 272
           S   KDFL KC  K+   RWT   LL HPFV  D
Sbjct: 242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  184 bits (469), Expect = 5e-56
 Identities = 77/332 (23%), Positives = 134/332 (40%), Gaps = 22/332 (6%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSV-TLKNEKEALDQIGICPQI 64
            + +G G+FG V+        + F    A K       S   T++ E + +  +   P +
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNF----AAKFVMTPHESDKETVRKEIQTMSVLR-HPTL 85

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V       +FE       ++ E+ S G L ++V  ++  ++ E +   Y R + KGL H+
Sbjct: 86  VNLHD---AFEDDNEMV-MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHM 140

Query: 125 HSKGFVHCDIKLQNVLVF--DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV 182
           H   +VH D+K +N++     ++E K+ DFGL         +       GT  + +PE  
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEFAAPEVA 197

Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
                    D+W++G     + SG   +  + D       ++    +   +    +SE G
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN-VKSCDWNMDDSAFSGISEDG 256

Query: 243 KDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKFSQS 302
           KDF+ K  L DP  R T    L HP++   +  G D    I SS    ++     K+   
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD--SQIPSSRYTKIRDSIKTKYDAW 314

Query: 303 PRS--PFG-FPEWVSVQSSSSVTSSINSPSFD 331
           P    P G    + S++       SI    +D
Sbjct: 315 PEPLPPLGRISNYSSLRKHRPQEYSIRDAFWD 346

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 1e-55
 Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 17/271 (6%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              IG GS+G     +  K   +      +   +        L +E   L ++   P IV
Sbjct: 9   LYTIGTGSYGRCQKIR-RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIV 66

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKK--QNNGRLQESDVKRYTRSMLKGLRH 123
           R +  D   ++      +++EY   G LA  + K  +    L E  V R    +   L+ 
Sbjct: 67  RYY--DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 124 IHSKG-----FVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMS 178
            H +       +H D+K  NV +      K+ DFGLA+  + D   +++F    TP YMS
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYMS 182

Query: 179 PESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           PE +N   Y    DIW+LGC + E+ +  P +       +   +       +   IP   
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----GKFRRIPYRY 238

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S++  + + +        R + E +L +P +
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 63/326 (19%), Positives = 119/326 (36%), Gaps = 28/326 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
            + +G G FG V+    +     +      K         V +K E   L+       I+
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTY----MAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
                  SFE  E    ++ E+ S   + +R+   +   L E ++  Y   + + L+ +H
Sbjct: 65  HLHE---SFESMEELV-MIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH 119

Query: 126 SKGFVHCDIKLQNVLVFDNDEA--KIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           S    H DI+ +N++      +  KI +FG A++                P Y +PE   
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQ 176

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
            +      D+W+LG  V  + SG   +  + +  +    I             ++S +  
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE-NIMNAEYTFDEEAFKEISIEAM 235

Query: 244 DFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEKFSQSP 303
           DF+ +  +K+ K R TA   L HP++             I   S+  ++ +K  ++  + 
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQ----------KIERVSTKVIRTLKHRRYYHTL 285

Query: 304 RSPFGFPEWVSVQSSSSVTSSINSPS 329
                    V   +  S   +I S  
Sbjct: 286 IKK--DLNMVVSAARISCGGAIRSQK 309

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-54
 Identities = 68/269 (25%), Positives = 121/269 (44%), Gaps = 20/269 (7%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIGICP 62
              IG GSF +V     ++ + E     A     D           K E E L  +   P
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEV----AWCELQDRKLTKSERQRFKEEAEMLKGLQ-HP 68

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            IVR +    S  KG++   L+ E  + G+L   +K+     ++   ++ + R +LKGL+
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQ 126

Query: 123 HIHSKG--FVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            +H++    +H D+K  N+ +       KI D GLA         S +    GTP +M+P
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAP 182

Query: 180 ESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           E + E +Y+   D++A G  ++EMA+ +  ++  Q  N   +  R+  G +  +      
Sbjct: 183 E-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKPASFDKVAI 239

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
            + K+ +  C  ++   R++ + LLNH F
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAF 268

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  177 bits (450), Expect = 5e-54
 Identities = 61/275 (22%), Positives = 116/275 (42%), Gaps = 22/275 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEF------PSLMAVKSCADCPPSSVTLKNEKEALDQIG 59
            +++G G    V          E+       +     S  +          E + L ++ 
Sbjct: 8   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P I++       +E    F+ L+ +   +G L D + +     L E + ++  R++L+
Sbjct: 68  GHPNIIQLKDT---YETNTFFF-LVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLE 121

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
            +  +H    VH D+K +N+L+ D+   K+ DFG + +        +  E  GTP Y++P
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAP 178

Query: 180 E------SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN 233
           E      + N   Y    D+W+ G  +  + +G P + H++   +   +I  G       
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-MIMSGNYQFGSP 237

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
              D S+  KD + +  +  P++R+TAE  L HPF
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 5e-54
 Identities = 71/273 (26%), Positives = 129/273 (47%), Gaps = 26/273 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK----SCADCPPSSVTLKNEKEALDQIGIC 61
           G ++G GSF +V LA+    S E+    A+K               +  E++ + ++   
Sbjct: 13  GKILGEGSFSTVVLARELATSREY----AIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P  V+ +    +F+  E+ Y   L YA  G L   ++K   G   E+  + YT  ++  L
Sbjct: 68  PFFVKLYF---TFQDDEKLY-FGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSAL 121

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++H KG +H D+K +N+L+ ++   +I DFG AK  S + +++++    GT  Y+SPE 
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           + E       D+WALGC + ++ +G P +   +  N + +  +I   +   + P     +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLE--YDFPEKFFPK 236

Query: 242 GKDFLIKCFLKDPKRRWTAE------MLLNHPF 268
            +D + K  + D  +R   E       L  HPF
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 2e-53
 Identities = 58/268 (21%), Positives = 111/268 (41%), Gaps = 21/268 (7%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK---SCADCPPSSVTLKNEKEALDQIGICP 62
           G  IG GSFG+V   K       +   +AVK     A  P      KNE   L +     
Sbjct: 13  GQRIGSGSFGTVYKGK-------WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HV 64

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+   G    +    +   ++ ++    SL   +      + +   +    R   +G+ 
Sbjct: 65  NILLFMG----YSTAPQLA-IVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMD 118

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV 182
           ++H+K  +H D+K  N+ + ++   KI DFGLA   S      Q  +  G+ L+M+PE +
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 183 ---NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-ELPNIPGDL 238
              ++N Y    D++A G  + E+ +G+  +++  + +    ++  G    +L  +  + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
            +  K  + +C  K    R     +L  
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 5e-53
 Identities = 73/266 (27%), Positives = 120/266 (45%), Gaps = 17/266 (6%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC-ADCPPSSVTLKNEKEALDQIGICPQ 63
           R + IG G+ G+V  A       E     A++       P    + NE   + +    P 
Sbjct: 24  RFEKIGQGASGTVYTAMDVATGQEV----AIRQMNLQQQPKKELIINEILVMRENK-NPN 78

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV       S+  G+  + +++EY + GSL D V +     + E  +    R  L+ L  
Sbjct: 79  IVNYLD---SYLVGDELW-VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEF 131

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   +H DIK  N+L+  +   K+ DFG   + + +  +  +    GTP +M+PE V 
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVT 189

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGK 243
              Y    DIW+LG   +EM  G+P + ++       L+   G  +     P  LS   +
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE--LQNPEKLSAIFR 247

Query: 244 DFLIKCFLKDPKRRWTAEMLLNHPFV 269
           DFL +C   D ++R +A+ LL H F+
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFL 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 6e-53
 Identities = 74/305 (24%), Positives = 119/305 (39%), Gaps = 57/305 (18%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICPQI 64
             +G G+ G V      K S     +MA K       P     +  E + L +    P I
Sbjct: 12  SELGAGNGGVVFKVS-HKPSGL---VMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYI 66

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           V  +G   +F        + +E+   GSL   +KK   GR+ E  + + + +++KGL ++
Sbjct: 67  VGFYG---AFYSDGEIS-ICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYL 120

Query: 125 HSK-GFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
             K   +H D+K  N+LV    E K+ DFG++ +       S +    GT  YMSPE + 
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP-------- 235
              Y    DIW++G ++VEMA G+          +  +      GD     P        
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 236 -------------------------------GDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
                                          G  S + +DF+ KC +K+P  R   + L+
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 265 NHPFV 269
            H F+
Sbjct: 297 VHAFI 301

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (444), Expect = 7e-53
 Identities = 85/292 (29%), Positives = 139/292 (47%), Gaps = 24/292 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICPQ 63
            DV+G G+F  V LA+  K + +   L+A+K  +         +++NE   L +I   P 
Sbjct: 14  RDVLGTGAFSEVILAE-DKRTQK---LVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPN 68

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV        +E G   Y L+++  S G L DR+ +   G   E D  R    +L  +++
Sbjct: 69  IVALDD---IYESGGHLY-LIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKY 122

Query: 124 IHSKGFVHCDIKLQNVLVFDNDE---AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           +H  G VH D+K +N+L +  DE     I+DFGL+K        S      GTP Y++PE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---PGSVLSTACGTPGYVAPE 179

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE 240
            + +  Y    D W++G     +  G P +  + D+ +F  +++     + P    D+S+
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD-DISD 238

Query: 241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLK 292
             KDF+     KDP++R+T E  L HP++  D         +IH S S  +K
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK----NIHQSVSEQIK 286

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 5e-50
 Identities = 71/268 (26%), Positives = 124/268 (46%), Gaps = 22/268 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK----SCADCPPSSVTLKNEKEALDQIGIC 61
             ++G GSFG V LA+  K +  F    A+K                  EK  L      
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFF----AIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P +   F    +F+  E  +  ++EY + G L   ++     +   S    Y   ++ GL
Sbjct: 63  PFLTHMFC---TFQTKENLF-FVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGL 116

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
           + +HSKG V+ D+KL N+L+  +   KIADFG+ K++     ++ +F   GTP Y++PE 
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTPDYIAPEI 174

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           +   +Y    D W+ G  + EM  G+  ++ + +  +F  +       + P  P  L ++
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPFYPRWLEKE 229

Query: 242 GKDFLIKCFLKDPKRRWTAEM-LLNHPF 268
            KD L+K F+++P++R      +  HP 
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIRQHPL 257

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 3e-48
 Identities = 69/286 (24%), Positives = 113/286 (39%), Gaps = 32/286 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSL-MAVKSCADCPPSSV--TLKNEKEALDQIGICP 62
           G V+G G+FG V  A A  +S    S+ +AVK   +   SS    L +E + + Q+G   
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNN-------------------- 102
            IV   G   +       Y L+ EY   G L + ++ +                      
Sbjct: 102 NIVNLLG---ACTLSGPIY-LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 103 -GRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD 161
              L   D+  +   + KG+  +  K  VH D+  +NVLV      KI DFGLA+    D
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFS 220
                    R    +M+PES+ E  Y    D+W+ G  + E+ S G   +       V +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY---PGIPVDA 274

Query: 221 LLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
              ++       + P   +E+    +  C+  D ++R +   L + 
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-47
 Identities = 56/262 (21%), Positives = 111/262 (42%), Gaps = 21/262 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              IG G FG V L           + +AVK C     ++     E   + Q+     +V
Sbjct: 12  LQTIGKGEFGDVMLGDYRG------NKVAVK-CIKNDATAQAFLAEASVMTQLR-HSNLV 63

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           +  G     E+    Y ++ EY ++GSL D ++ +    L    + +++  + + + ++ 
Sbjct: 64  QLLG--VIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
              FVH D+  +NVLV +++ AK++DFGL K++S     S     +    + +PE++ E 
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREK 175

Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           ++    D+W+ G  + E+ S G+  +      +V   + +        + P        +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----GYKMDAPDGCPPAVYE 231

Query: 245 FLIKCFLKDPKRRWTAEMLLNH 266
            +  C+  D   R +   L   
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQ 253

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 2e-47
 Identities = 70/287 (24%), Positives = 113/287 (39%), Gaps = 27/287 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC--PQ 63
              IG G++G V  A+  K    F +L  V+         ++   E   L  +     P 
Sbjct: 12  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           +VR F               L+       L   + K     +    +K     +L+GL  
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS   VH D+K QN+LV  + + K+ADFGLA+  S    +        T  Y +PE + 
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLL 188

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI------------------ 225
           ++ Y  P D+W++GC   EM   KP +    D +    ++ +                  
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248

Query: 226 ----GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                    +     D+ E GKD L+KC   +P +R +A   L+HP+
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 9e-47
 Identities = 64/275 (23%), Positives = 112/275 (40%), Gaps = 26/275 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK-------SCADCPPSSVTLKNEKEALDQI 58
           G+ +G G F  V   +      ++    A K         +    S   ++ E   L +I
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQY----AAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 59  GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSML 118
              P ++        +E       L+LE  + G L D + +     L E +   + + +L
Sbjct: 71  Q-HPNVITLHE---VYENKTDVI-LILELVAGGELFDFLAE--KESLTEEEATEFLKQIL 123

Query: 119 KGLRHIHSKGFVHCDIKLQNVLVFDNDEA----KIADFGLAKKSSCDGERSQSFECRGTP 174
            G+ ++HS    H D+K +N+++ D +      KI DFGLA K     E        GTP
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 180

Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI 234
            +++PE VN        D+W++G     + SG   +         +  +     +     
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEY 239

Query: 235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             + S   KDF+ +  +KDPK+R T +  L HP++
Sbjct: 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-45
 Identities = 56/262 (21%), Positives = 111/262 (42%), Gaps = 17/262 (6%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              +G G FG V   K           +A+K   +   S      E + +  +    ++V
Sbjct: 9   LKELGTGQFGVVKYGKWRG-----QYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 62

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +G      K    + ++ EY + G L + ++ +   R Q   +    + + + + ++ 
Sbjct: 63  QLYG---VCTKQRPIF-IITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
           SK F+H D+  +N LV D    K++DFGL+ +   D E + S   +    +  PE +  +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           ++ +  DIWA G  + E+ S GK  +    +S     + +          P   SE+   
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ----GLRLYRPHLASEKVYT 232

Query: 245 FLIKCFLKDPKRRWTAEMLLNH 266
            +  C+ +    R T ++LL++
Sbjct: 233 IMYSCWHEKADERPTFKILLSN 254

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  157 bits (397), Expect = 2e-45
 Identities = 62/275 (22%), Positives = 116/275 (42%), Gaps = 28/275 (10%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK----SCADCPPSSVTLKNEKEALDQI--G 59
             +IG G FG V   + +     +    A+K                 NE+  L  +  G
Sbjct: 9   HRIIGRGGFGEVYGCRKADTGKMY----AMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
            CP IV      Y+F   ++    +L+  + G L   + +  +G   E+D++ Y   ++ 
Sbjct: 65  DCPFIVCMS---YAFHTPDKLS-FILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIIL 118

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           GL H+H++  V+ D+K  N+L+ ++   +I+D GLA    CD  + +     GT  YM+P
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAP 174

Query: 180 ESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           E + +   Y++  D ++LGC + ++  G   +   +  +   +            +P   
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSF 232

Query: 239 SEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPF 268
           S + +  L     +D  RR       A+ +   PF
Sbjct: 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 3e-45
 Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 17/267 (6%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK----SCADCPPSSVTLKNEKEALDQIGIC 61
            + +G GSFG V   +    S +    +AVK         P +      E  A+  +   
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKT-VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 70

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
             ++R +G             ++ E A  GSL DR++K + G      + RY   + +G+
Sbjct: 71  RNLIRLYG---VVLTPPMK--MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGM 124

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFE-CRGTPLYMSPE 180
            ++ SK F+H D+  +N+L+   D  KI DFGL +    + +     E  +    + +PE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 181 SVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS 239
           S+    +    D W  G  + EM + G+  W      N   +L +I    E    P D  
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQILHKIDKEGERLPRPEDCP 241

Query: 240 EQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           +   + +++C+   P+ R T   L + 
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 4e-45
 Identities = 62/274 (22%), Positives = 106/274 (38%), Gaps = 34/274 (12%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK-------SCADCPPSSVTLKNEKEALDQI 58
           G ++G G FGSV        +       A+K       S     P+   +  E   L ++
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPV----AIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 59  -GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSM 117
                 ++R       FE+ + F  +L        L D + +   G LQE   + +   +
Sbjct: 65  SSGFSGVIRLLD---WFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQV 119

Query: 118 LKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSCDGERSQSFECRGTPLY 176
           L+ +RH H+ G +H DIK +N+L+  N  E K+ DFG                  GT +Y
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVY 175

Query: 177 MSPESVNENEYEA-PCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP 235
             PE +  + Y      +W+LG  + +M  G   + H ++     +              
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF-----------R 224

Query: 236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
             +S + +  +  C    P  R T E + NHP++
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 5e-45
 Identities = 62/326 (19%), Positives = 121/326 (37%), Gaps = 26/326 (7%)

Query: 2   EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSC--ADCPPSSVTLKNEKEALDQIG 59
           E+ +  V+G G+FG+V          +    +A+K    A  P ++  + +E   +  + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 60  ICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLK 119
             P + R                L+ +    G L D V++ +   +    +  +   + K
Sbjct: 70  -NPHVCRLL---GICLTSTVQ--LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAK 122

Query: 120 GLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSP 179
           G+ ++  +  VH D+  +NVLV      KI DFGLAK    + +   +   +    +M+ 
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 180 ESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
           ES+    Y    D+W+ G  V E+ + G   ++    S + S+L +     E    P   
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----GERLPQPPIC 238

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDDGGIHIHSSSSPSLKGIKDEK 298
           +      ++KC++ D   R     L+      A D                 ++G +   
Sbjct: 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD-----------PQRYLVIQGDERMH 287

Query: 299 FSQSPRSPFGFPEWVSVQSSSSVTSS 324
                 S F +   +  +    V  +
Sbjct: 288 LPSPTDSNF-YRALMDEEDMDDVVDA 312

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 5e-45
 Identities = 64/264 (24%), Positives = 111/264 (42%), Gaps = 16/264 (6%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSV--TLKNEKEALDQIGICPQ 63
           G  IG G FG V+              +A+K+C +C   SV      E   + Q    P 
Sbjct: 12  GRCIGEGQFGDVHQGI-YMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPH 69

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           IV+  G      +   +  +++E  + G L   ++ +    L  + +  Y   +   L +
Sbjct: 70  IVKLIG---VITENPVW--IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAY 123

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           + SK FVH DI  +NVLV  ND  K+ DFGL++    D    ++ + +    +M+PES+N
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 182

Query: 184 ENEYEAPCDIWALGCAVVEM-ASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
              + +  D+W  G  + E+   G   +   ++++V   +       E   +P +     
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----GERLPMPPNCPPTL 238

Query: 243 KDFLIKCFLKDPKRRWTAEMLLNH 266
              + KC+  DP RR     L   
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQ 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 6e-45
 Identities = 58/261 (22%), Positives = 111/261 (42%), Gaps = 17/261 (6%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
            + +G G FG V +   +       + +AVKS      S      E   + Q+    ++V
Sbjct: 18  VERLGAGQFGEVWMGYYNG-----HTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLV 71

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           R +       +   +  ++ EY   GSL D +K  +  +L  + +      + +G+  I 
Sbjct: 72  RLYA---VVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            + ++H D++  N+LV D    KIADFGLA+    D E +     +    + +PE++N  
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYG 185

Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
            +    D+W+ G  + E+ + G+  +    +  V   L R          P +  E+   
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQ 241

Query: 245 FLIKCFLKDPKRRWTAEMLLN 265
            +  C+ + P+ R T + L +
Sbjct: 242 LMRLCWKERPEDRPTFDYLRS 262

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 9e-45
 Identities = 62/269 (23%), Positives = 116/269 (43%), Gaps = 22/269 (8%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVK---SCADCPPSSVTLKNEKEALDQIGICPQI 64
            +G G+FG+V          +    +AVK   + A+ P     L  E   + Q+   P I
Sbjct: 14  ELGSGNFGTVKKGYYQ--MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYI 70

Query: 65  VRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
           VR  G      + E +  L++E A  G L   +++  N  +++ ++      +  G++++
Sbjct: 71  VRMIG----ICEAESWM-LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYL 123

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD-GERSQSFECRGTPLYMSPESVN 183
               FVH D+  +NVL+     AKI+DFGL+K    D          +    + +PE +N
Sbjct: 124 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 184 ENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
             ++ +  D+W+ G  + E  S G+  +   + S V ++L +     E    P     + 
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPREM 239

Query: 243 KDFLIKCFLKDPKRRWTA---EMLLNHPF 268
            D +  C+  D + R      E+ L + +
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-44
 Identities = 52/268 (19%), Positives = 109/268 (40%), Gaps = 20/268 (7%)

Query: 9   IGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           +G G+FGSV          +    +A+K          +  +  E + + Q+   P IVR
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQID--VAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVR 73

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
             G     +       L++E A  G L   +  +    +  S+V      +  G++++  
Sbjct: 74  LIG---VCQAEALM--LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE 127

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKK-SSCDGERSQSFECRGTPLYMSPESVNEN 185
           K FVH D+  +NVL+ +   AKI+DFGL+K   + D   +     +    + +PE +N  
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187

Query: 186 EYEAPCDIWALGCAVVEM-ASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
           ++ +  D+W+ G  + E  + G+  +   +   V + + +     +    P +   +   
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----GKRMECPPECPPELYA 243

Query: 245 FLIKCFLKDPKRRWTAEML---LNHPFV 269
            +  C++   + R     +   +   + 
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  152 bits (385), Expect = 3e-44
 Identities = 57/270 (21%), Positives = 112/270 (41%), Gaps = 23/270 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI----- 60
             VIG G FG V      K+  +    +A+K       S  T K  ++ L +  I     
Sbjct: 31  EQVIGAGEFGEVCSGH-LKLPGKREIFVAIK----TLKSGYTEKQRRDFLSEASIMGQFD 85

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P ++          K      ++ E+   GSL D   +QN+G+     +    R +  G
Sbjct: 86  HPNVIHLE---GVVTKSTPVM-IITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER---SQSFECRGTPLYM 177
           ++++    +VH D+  +N+LV  N   K++DFGL++    D      + +   +    + 
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 178 SPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPG 236
           +PE++   ++ +  D+W+ G  + E+ S G+  +    + +V + + +    D     P 
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ----DYRLPPPM 256

Query: 237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
           D        ++ C+ KD   R     ++N 
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 4e-44
 Identities = 60/273 (21%), Positives = 115/273 (42%), Gaps = 20/273 (7%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              +G G FG V +   +       + +A+K+      S      E + + ++    ++V
Sbjct: 22  EVKLGQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLV 75

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +         E  Y ++ EY S+GSL D +K +    L+   +      +  G+ ++ 
Sbjct: 76  QLYA----VVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
              +VH D++  N+LV +N   K+ADFGLA+    D E +     +    + +PE+    
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 189

Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
            +    D+W+ G  + E+ + G+  +    +  V   + R          P +  E   D
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHD 245

Query: 245 FLIKCFLKDPKRRWTAEML---LNHPFVCADDQ 274
            + +C+ K+P+ R T E L   L   F   + Q
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 5e-44
 Identities = 57/262 (21%), Positives = 108/262 (41%), Gaps = 17/262 (6%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              IG G FG V+L             +A+K+  +   S      E E + ++   P++V
Sbjct: 10  VQEIGSGQFGLVHLGYWLN-----KDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLV 63

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           + +G      +      L+ E+   G L+D ++ Q         +      + +G+ ++ 
Sbjct: 64  QLYG---VCLEQAPIC-LVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE 118

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
               +H D+  +N LV +N   K++DFG+ +    D + + S   +    + SPE  + +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 186 EYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKD 244
            Y +  D+W+ G  + E+ S GK  + ++ +S V      I  G  L   P   S     
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---DISTGFRLY-KPRLASTHVYQ 233

Query: 245 FLIKCFLKDPKRRWTAEMLLNH 266
            +  C+ + P+ R     LL  
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQ 255

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 1e-43
 Identities = 64/276 (23%), Positives = 115/276 (41%), Gaps = 26/276 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
            DVIG G+FG V  A+  K      + +                 E E L ++G  P I+
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKK--------------QNNGRLQESDVK 111
              G   + E     Y L +EYA  G+L D ++K                   L    + 
Sbjct: 75  NLLG---ACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 112 RYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR 171
            +   + +G+ ++  K F+H D+  +N+LV +N  AKIADFGL++      +++     R
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GR 187

Query: 172 GTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDE 230
               +M+ ES+N + Y    D+W+ G  + E+ S G   +     + ++  L +      
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----GY 243

Query: 231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
               P +  ++  D + +C+ + P  R +   +L  
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-43
 Identities = 61/278 (21%), Positives = 109/278 (39%), Gaps = 25/278 (8%)

Query: 6   GDVIGHGSFGSVNLAKASK-VSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A   + S+    +AVK    +        L +E + L  +G   
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQ----------------NNGRLQ 106
            IV   G   +   G     ++ EY   G L + ++++                +   L 
Sbjct: 88  NIVNLLG---ACTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+  ++  + KG+  + SK  +H D+  +N+L+      KI DFGLA+    D     
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG 226
               R    +M+PES+    Y    D+W+ G  + E+ S   +       +  S   ++ 
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SKFYKMI 261

Query: 227 VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
                   P     +  D +  C+  DP +R T + ++
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  149 bits (376), Expect = 3e-43
 Identities = 59/271 (21%), Positives = 113/271 (41%), Gaps = 17/271 (6%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK----SCADCPPSSVTLKNEKEALDQIGIC 61
           G+++G G    V+LA+  ++  +     AVK      A  P   +  + E +    +   
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDV----AVKVLRADLARDPSFYLRFRREAQNAAALN-H 66

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P IV  +    +         +++EY    +L D V  +  G +             + L
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQAL 124

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGER-SQSFECRGTPLYMSPE 180
              H  G +H D+K  N+++   +  K+ DFG+A+  +  G   +Q+    GT  Y+SPE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 181 SVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELP--NIPGDL 238
               +  +A  D+++LGC + E+ +G+P +      +  S+  +    D +P       L
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPF---TGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
           S      ++K   K+P+ R+     +    V
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 1e-42
 Identities = 69/275 (25%), Positives = 132/275 (48%), Gaps = 21/275 (7%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK-----SCADCPPSSVTLKNEKEALDQIGI 60
             V+G G++G V L +      +   L A+K     +      ++   + E++ L+ I  
Sbjct: 29  LKVLGTGAYGKVFLVR-KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKG 120
            P +V      Y+F+   + + L+L+Y + G L   + ++   R  E +V+ Y   ++  
Sbjct: 88  SPFLVTLH---YAFQTETKLH-LILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLA 141

Query: 121 LRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE 180
           L H+H  G ++ DIKL+N+L+  N    + DFGL+K+     E  ++++  GT  YM+P+
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAPD 200

Query: 181 SVNENE--YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL 238
            V   +  ++   D W+LG  + E+ +G   +    + N  + + R  +    P  P ++
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-RILKSEPPYPQEM 259

Query: 239 SEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
           S   KD + +  +KDPK+R       A+ +  H F
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-42
 Identities = 62/294 (21%), Positives = 108/294 (36%), Gaps = 38/294 (12%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICPQ 63
              IG G++G V  A  +          A+K  S  +          E + L +      
Sbjct: 13  LSYIGEGAYGMVCSAYDNVNKVRV----AIKKISPFEHQTYCQRTLREIKILLRFR-HEN 67

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           I+       +    +     L+ +     L   +K Q    L    +  +   +L+GL++
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKY 124

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR-GTPLYMSPESV 182
           IHS   +H D+K  N+L+    + KI DFGLA+ +  D + +        T  Y +PE +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 183 -NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV-------------- 227
            N   Y    DIW++GC + EM S +P +  K   +  + ++ I                
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 228 ------------GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV 269
                             +  +   +  D L K    +P +R   E  L HP++
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-42
 Identities = 65/281 (23%), Positives = 122/281 (43%), Gaps = 28/281 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS---LMAVK--SCADCPPSSVTLKNEKEALDQIGI 60
           G  +G G+FG V LA+A  +  + P+    +AVK             L +E E +  IG 
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77

Query: 61  CPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQ--------------NNGRLQ 106
              I+   G      +    Y +++EYAS+G+L + ++ +                 +L 
Sbjct: 78  HKNIINLLGA---CTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 107 ESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQ 166
             D+      + +G+ ++ SK  +H D+  +NVLV +++  KIADFGLA+         +
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 167 SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRI 225
           +   R    +M+PE++ +  Y    D+W+ G  + E+ + G   +       +F LL   
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE- 252

Query: 226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
                  + P + + +    +  C+   P +R T + L+  
Sbjct: 253 ---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 3e-42
 Identities = 54/264 (20%), Positives = 112/264 (42%), Gaps = 12/264 (4%)

Query: 5   RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICP 62
           R  VIG G FG V        S +    +A+K           V    E   + Q     
Sbjct: 11  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HH 69

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I+R  G      K +    ++ EY   G+L   +++++ G      +    R +  G++
Sbjct: 70  NIIRLEG---VISKYKPMM-IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMK 124

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF-ECRGTPLYMSPES 181
           ++ +  +VH D+  +N+LV  N   K++DFGL++    D E + +    +    + +PE+
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           ++  ++ +  D+W+ G  + E+ +         + +   ++  I  G  LP  P D    
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGFRLP-TPMDCPSA 241

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLN 265
               +++C+ ++  RR     +++
Sbjct: 242 IYQLMMQCWQQERARRPKFADIVS 265

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-42
 Identities = 66/291 (22%), Positives = 109/291 (37%), Gaps = 41/291 (14%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGI-----C 61
           D +G G F +V  A+  K +++   ++A+K       S       + AL +I +      
Sbjct: 4   DFLGEGQFATVYKAR-DKNTNQ---IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 59

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P I+       +F        L+ ++         + K N+  L  S +K Y    L+GL
Sbjct: 60  PNIIGLLD---AFGHKSNIS-LVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGL 113

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++H    +H D+K  N+L+ +N   K+ADFGLAK  S             T  Y +PE 
Sbjct: 114 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPEL 171

Query: 182 VNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV------------- 227
           +     Y    D+WA+GC + E+    P      D +  + +                  
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 228 ----------GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                     G  L +I     +   D +   FL +P  R TA   L   +
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 6e-42
 Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 27/272 (9%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK----SCADCPPSSVTLKNEKEALDQIGIC 61
             ++G G+FG V L +       +    A+K                  E   L      
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYY----AMKILRKEVIIAKDEVAHTVTESRVLQNTR-H 64

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P +           +       ++EYA+ G L   + ++      E   + Y   ++  L
Sbjct: 65  PFLTAL----KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSAL 118

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++HS+  V+ DIKL+N+++  +   KI DFGL K+   DG         GTP Y++PE 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEV 176

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           + +N+Y    D W LG  + EM  G+  + ++    +F L++      E    P  LS +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFPRTLSPE 231

Query: 242 GKDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
            K  L     KDPK+R       A+ ++ H F
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 6e-42
 Identities = 52/265 (19%), Positives = 98/265 (36%), Gaps = 13/265 (4%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK--SCADCPPSSVTLKNEKEALDQIGICPQ 63
            +VIG G FG V          +     AVK  +             E   +      P 
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGK-KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 89

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           ++   G             ++L Y   G L     +         D+  +   + KG++ 
Sbjct: 90  VLSLLG--ICLRSEGSPL-VVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFEC--RGTPLYMSPES 181
           + SK FVH D+  +N ++ +    K+ADFGLA+        S   +   +    +M+ ES
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           +   ++    D+W+ G  + E+ +         D N F + + +  G  L   P    + 
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP--DVNTFDITVYLLQGRRLL-QPEYCPDP 262

Query: 242 GKDFLIKCFLKDPKRRWTAEMLLNH 266
             + ++KC+    + R +   L++ 
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELVSR 287

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 9e-42
 Identities = 74/325 (22%), Positives = 117/325 (36%), Gaps = 43/325 (13%)

Query: 8   VIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRC 67
           VIG+GSFG V  AK            A+K              E + + ++     IVR 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELV----AIKKVLQ---DKRFKNRELQIMRKLD-HCNIVRL 78

Query: 68  FGDDYSF--EKGERFYNLLLEYASRGSLAD-RVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
               YS   +K E + NL+L+Y         R   +    L    VK Y   + + L +I
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 125 HSKGFVHCDIKLQNVLVFDNDE-AKIADFGLAKKSSCDGERSQSFECRGTPLYMSP-ESV 182
           HS G  H DIK QN+L+  +    K+ DFG AK+    GE + S+ C     Y +P    
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICS--RYYRAPELIF 195

Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP------- 235
              +Y +  D+W+ GC + E+  G+P +      +    +I++        I        
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255

Query: 236 -----------------GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCADDQTGDD 278
                                 +      +     P  R T      H F    D+  D 
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF---DELRDP 312

Query: 279 GGIHIHSSSSPSLKGIKDEKFSQSP 303
                +   +P+L     ++ S +P
Sbjct: 313 NVKLPNGRDTPALFNFTTQELSSNP 337

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (365), Expect = 2e-41
 Identities = 61/284 (21%), Positives = 104/284 (36%), Gaps = 33/284 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVK--SCADCPPSSVTLKNEKEALDQIGICP 62
              IG G+FG V  A+A  +    P +++AVK              + E   + +    P
Sbjct: 18  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NP 76

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQN--------------------- 101
            IV+  G       G+    LL EY + G L + ++  +                     
Sbjct: 77  NIVKLLG---VCAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 102 -NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC 160
               L  ++     R +  G+ ++  + FVH D+  +N LV +N   KIADFGL++    
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192

Query: 161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFS 220
                          +M PES+  N Y    D+WA G  + E+ S      +        
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 252

Query: 221 LLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
             +R G    +   P +   +  + +  C+ K P  R +   + 
Sbjct: 253 YYVRDG---NILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (364), Expect = 3e-41
 Identities = 54/259 (20%), Positives = 107/259 (41%), Gaps = 13/259 (5%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              +G G +G V      K S       AVK+  +          E   + +I   P +V
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTV----AVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 76

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
           +  G      +   FY ++ E+ + G+L D +++ N   +    +      +   + ++ 
Sbjct: 77  QLLG---VCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132

Query: 126 SKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNEN 185
            K F+H D+  +N LV +N   K+ADFGL++  + D   + +   +    + +PES+  N
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYN 191

Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQGKDF 245
           ++    D+WA G  + E+A+   +     D    S +  +   D     P    E+  + 
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMERPEGCPEKVYEL 248

Query: 246 LIKCFLKDPKRRWTAEMLL 264
           +  C+  +P  R +   + 
Sbjct: 249 MRACWQWNPSDRPSFAEIH 267

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (365), Expect = 3e-41
 Identities = 62/296 (20%), Positives = 108/296 (36%), Gaps = 38/296 (12%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
             IG G+FG V  A+  + + +  +L  V    +     +T   E + L  +     +V 
Sbjct: 16  AKIGQGTFGEVFKAR-HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVN 73

Query: 67  ----CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
               C      + + +    L+ ++                +   S++KR  + +L GL 
Sbjct: 74  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL--SNVLVKFTLSEIKRVMQMLLNGLY 131

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECR--GTPLYMSPE 180
           +IH    +H D+K  NVL+  +   K+ADFGLA+  S       +       T  Y  PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 181 SV-NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD-- 237
            +  E +Y  P D+W  GC + EM +  P      + +  +L+ ++         P    
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 238 -------------------------LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                                          D + K  + DP +R  ++  LNH F
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  141 bits (356), Expect = 3e-40
 Identities = 65/287 (22%), Positives = 109/287 (37%), Gaps = 36/287 (12%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           + IG G++G V  A+      E  +L  ++   +      T   E   L ++     IV+
Sbjct: 8   EKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVK 64

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
            +         ++   L+ E+  +            G L+    K +   +L G+ + H 
Sbjct: 65  LYD----VIHTKKRLVLVFEHLDQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES-VNEN 185
           +  +H D+K QN+L+    E KIADFGLA+       +           Y +P+  +   
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMGSK 176

Query: 186 EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG--------- 236
           +Y    DIW++GC   EM +G P +    +++    + RI       N P          
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 237 ---------------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                           L E G D L K    DP +R TA+  L H +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (357), Expect = 4e-40
 Identities = 52/280 (18%), Positives = 85/280 (30%), Gaps = 25/280 (8%)

Query: 3   WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP 62
           +  G  IG GSFG + L        E     A+K           L  E +    +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEV----AIK-LECVKTKHPQLHIESKIYKMMQGGV 63

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            I       +   +G+    +++E          +    + +     V      M+  + 
Sbjct: 64  GIPTI---RWCGAEGDYNV-MVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIE 117

Query: 123 HIHSKGFVHCDIKLQNVLVFDND---EAKIADFGLAKKSSCDGERSQSFECR-----GTP 174
           +IHSK F+H D+K  N L+          I DFGLAKK                   GT 
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE---L 231
            Y S  +    E     D+ +LG  ++    G   W   + +       RI        +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

Query: 232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEML---LNHPF 268
             +      +   +L  C       +     L     + F
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 4e-40
 Identities = 53/273 (19%), Positives = 113/273 (41%), Gaps = 21/273 (7%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFP-SLMAVK--SCADCPPSSVTLKNEKEALDQIGICP 62
              +G GSFG V    A  V  + P + +A+K  + A      +   NE   + +   C 
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CH 83

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGR--------LQESDVKRYT 114
            +VR  G      +G+    +++E  +RG L   ++                 S + +  
Sbjct: 84  HVVRLLG---VVSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 115 RSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTP 174
             +  G+ ++++  FVH D+  +N +V ++   KI DFG+ +         +  +     
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 175 LYMSPESVNENEYEAPCDIWALGCAVVEMASG-KPAWNHKQDSNVFSLLIRIGVGDELPN 233
            +MSPES+ +  +    D+W+ G  + E+A+  +  +    +  V   ++       L +
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME----GGLLD 255

Query: 234 IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
            P +  +   + +  C+  +PK R +   +++ 
Sbjct: 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  142 bits (358), Expect = 5e-40
 Identities = 62/298 (20%), Positives = 113/298 (37%), Gaps = 51/298 (17%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
              +G G +  V  A  +  ++E    + VK     P     +K E + L+ +   P I+
Sbjct: 40  VRKLGRGKYSEVFEAI-NITNNE---KVVVKILK--PVKKKKIKREIKILENLRGGPNII 93

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
                D   +   R   L+ E+ +        +      L + D++ Y   +LK L + H
Sbjct: 94  TLA--DIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH 146

Query: 126 SKGFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           S G +H D+K  NV++  ++ + ++ D+GLA+      E +       +  +  PE + +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKGPELLVD 203

Query: 185 NE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE------------- 230
            + Y+   D+W+LGC +  M   K  + H  D+    + I   +G E             
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

Query: 231 --------------------LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                                      +S +  DFL K    D + R TA   + HP+
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 6e-40
 Identities = 58/278 (20%), Positives = 111/278 (39%), Gaps = 22/278 (7%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPS-LMAVK--SCADCPPSSVTLKNEKEALDQIGICP 62
           G  +G G+FG V  A A  +        +AVK             L +E + L  IG   
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNN--------------GRLQES 108
            +V   G     + G     +++E+   G+L+  ++ + N                L   
Sbjct: 78  NVVNLLG--ACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 109 DVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSF 168
            +  Y+  + KG+  + S+  +H D+  +N+L+ + +  KI DFGLA+    D +  +  
Sbjct: 135 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194

Query: 169 ECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG 228
           + R    +M+PE++ +  Y    D+W+ G  + E+ S   +        +     R    
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--GVKIDEEFCRRLKE 252

Query: 229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
                 P   + +    ++ C+  +P +R T   L+ H
Sbjct: 253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  140 bits (354), Expect = 7e-40
 Identities = 51/273 (18%), Positives = 93/273 (34%), Gaps = 24/273 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G  IG GSFG +     + ++++    +A+K        +  L++E      +  C  I 
Sbjct: 10  GRRIGEGSFGVIFEGT-NLLNNQ---QVAIK-FEPRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
             +   Y  ++G     L+++    G   + +      +     V    + ML  ++ IH
Sbjct: 65  NVY---YFGQEGLHNV-LVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 126 SKGFVHCDIKLQNVLV-----FDNDEAKIADFGLAKKSSCDGERSQSFECR-----GTPL 175
            K  V+ DIK  N L+      + +   + DFG+ K       +            GT  
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 176 YMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE---LP 232
           YMS  +    E     D+ ALG   +    G   W   + +       RIG   +   L 
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238

Query: 233 NIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN 265
            +     E+   ++              + L  
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (355), Expect = 1e-39
 Identities = 63/272 (23%), Positives = 111/272 (40%), Gaps = 30/272 (11%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVK----SCADCPPSSVTLKNEKEALDQIGIC 61
              +G GSFG V+L ++      +    A+K                 +E+  L  +   
Sbjct: 9   LRTLGTGSFGRVHLIRSRHNGRYY----AMKVLKKEIVVRLKQVEHTNDERLMLSIVT-H 63

Query: 62  PQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGL 121
           P I+R +G   +F+  ++ + ++ +Y   G L      + + R      K Y   +   L
Sbjct: 64  PFIIRMWG---TFQDAQQIFMIM-DYIEGGELFSL--LRKSQRFPNPVAKFYAAEVCLAL 117

Query: 122 RHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPES 181
            ++HSK  ++ D+K +N+L+  N   KI DFG AK          ++   GTP Y++PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEV 172

Query: 182 VNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ 241
           V+   Y    D W+ G  + EM +G   +        +  ++           P   +E 
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-----AELRFPPFFNED 227

Query: 242 GKDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
            KD L +   +D  +R        E + NHP+
Sbjct: 228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-39
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 34/287 (11%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           + IG G++G V  A+ +K++ E  +L  ++   +      T   E   L ++   P IV+
Sbjct: 8   EKIGEGTYGVVYKAR-NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVK 65

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                       + Y L+ E+  +      +       +    +K Y   +L+GL   HS
Sbjct: 66  LLD---VIHTENKLY-LVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
              +H D+K QN+L+      K+ADFGLA+                T  Y +PE +   +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEILLGCK 178

Query: 187 YEAP-CDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG------------------- 226
           Y +   DIW+LGC   EM + +  +    + +    + R                     
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 227 -----VGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                   +   +   L E G+  L +    DP +R +A+  L HPF
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 4e-38
 Identities = 67/292 (22%), Positives = 119/292 (40%), Gaps = 42/292 (14%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLK---NEKEALDQIGICPQ 63
             +G G++G+V  A   +  ++     A+K       S +  K    E   L  +     
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKV----AIKKLYRPFQSELFAKRAYRELRLLKHMR-HEN 78

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           ++         E  + F +  L     G+   ++ K  + +L E  ++     MLKGLR+
Sbjct: 79  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRY 136

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV- 182
           IH+ G +H D+K  N+ V ++ E KI DFGLA+++      S+      T  Y +PE + 
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWYRAPEVIL 191

Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV--------------- 227
           N   Y    DIW++GC + EM +GK  +      +    ++++                 
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 228 -----------GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                        +  +I  + S    + L K  + D ++R TA   L HP+
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (346), Expect = 5e-38
 Identities = 60/271 (22%), Positives = 108/271 (39%), Gaps = 30/271 (11%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVK----SCADCPPSSVTLKNEKEALDQIGICP 62
             +G GSFG V L K  +  + +    A+K                 NEK  L  +   P
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHY----AMKILDKQKVVKLKQIEHTLNEKRILQAVN-FP 101

Query: 63  QIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLR 122
            +V+                +++EY + G +   +++   GR  E   + Y   ++    
Sbjct: 102 FLVKLEFSFKDN----SNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155

Query: 123 HIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESV 182
           ++HS   ++ D+K +N+L+      ++ DFG AK+      + +++   GTP  ++PE +
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEII 210

Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQG 242
               Y    D WALG  + EMA+G P +   Q   ++  ++           P   S   
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-----GKVRFPSHFSSDL 265

Query: 243 KDFLIKCFLKDPKRRW-----TAEMLLNHPF 268
           KD L      D  +R+         + NH +
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-36
 Identities = 67/287 (23%), Positives = 106/287 (36%), Gaps = 34/287 (11%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
           + IG G++G+V  AK ++ + E  +L  V+   D      +   E   L ++     IVR
Sbjct: 8   EKIGEGTYGTVFKAK-NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVR 65

Query: 67  CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS 126
                      ++   L+ E+  +           NG L    VK +   +LKGL   HS
Sbjct: 66  LHD----VLHSDKKLTLVFEFCDQDLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENE 186
           +  +H D+K QN+L+  N E K+A+FGLA+       R  S E                 
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKL 178

Query: 187 YEAPCDIWALGCAVVEMASGK-------------------------PAWNHKQDSNVFSL 221
           Y    D+W+ GC   E+A+                             W        +  
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                    L N+   L+  G+D L      +P +R +AE  L HP+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 4e-35
 Identities = 63/292 (21%), Positives = 99/292 (33%), Gaps = 43/292 (14%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
            + IG G FG V   K           +AVK  +     S   + E      +     I+
Sbjct: 8   QESIGKGRFGEVWRGKWRG------EEVAVKIFSSREERSWFREAEIYQTVMLR-HENIL 60

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIH 125
                D           L+ +Y   GSL D + +     +    + +   S   GL H+H
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLH 117

Query: 126 S--------KGFVHCDIKLQNVLVFDNDEAKIADFGLAKK--SSCDGERSQSFECRGTPL 175
                        H D+K +N+LV  N    IAD GLA +  S+ D          GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 176 YMSPESVNEN------EYEAPCDIWALGCAVVEMASGKPAWN------------HKQDSN 217
           YM+PE ++++      E     DI+A+G    E+A                      D +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 218 VFSLLIRIGVGDELPNIPG-----DLSEQGKDFLIKCFLKDPKRRWTAEMLL 264
           V  +   +      PNIP      +        + +C+  +   R TA  + 
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 5e-35
 Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 42/292 (14%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVK---SCADCPPSSVTLKNEKEALDQIGICPQ 63
             +G G++GSV  A  +K         AVK           +     E   L  +     
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRV----AVKKLSRPFQSIIHAKRTYRELRLLKHMK-HEN 78

Query: 64  IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
           ++            E F ++ L     G+  + + K    +L +  V+     +L+GL++
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKY 136

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-SV 182
           IHS   +H D+K  N+ V ++ E KI DFGLA+ +       +      T  Y +PE  +
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIML 191

Query: 183 NENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV--------------- 227
           N   Y    DIW++GC + E+ +G+  +      +   L++R+                 
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 228 -----------GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPF 268
                           N+    +    D L K  + D  +R TA   L H +
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 8e-34
 Identities = 57/303 (18%), Positives = 105/303 (34%), Gaps = 51/303 (16%)

Query: 7   DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVR 66
             IG G+ G V  A    V     ++  +         +     E   +  +     I+ 
Sbjct: 23  KPIGSGAQGIVCAAY-DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIS 80

Query: 67  ---CFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRH 123
               F    + E+ +  Y L++E            + +        +      ML G++H
Sbjct: 81  LLNVFTPQKTLEEFQDVY-LVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIKH 134

Query: 124 IHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVN 183
           +HS G +H D+K  N++V  +   KI DFGLA+ +      +       T  Y +PE + 
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRAPEVIL 191

Query: 184 ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI------------------ 225
              Y+   DIW++GC + EM   K  +  +   + ++ +I                    
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 226 -------------------GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH 266
                               +           + Q +D L K  + DP +R + +  L H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311

Query: 267 PFV 269
           P++
Sbjct: 312 PYI 314

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (289), Expect = 5e-30
 Identities = 60/319 (18%), Positives = 112/319 (35%), Gaps = 60/319 (18%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQI------- 58
              +G G F +V LAK   V++     +A+K        +   ++E + L ++       
Sbjct: 18  VRKLGWGHFSTVWLAK-DMVNNT---HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 59  ---GICPQIVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTR 115
                   I++                ++ E      L   +KK  +  +    VK+ ++
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLL-ALIKKYEHRGIPLIYVKQISK 132

Query: 116 SMLKGLRHIHSK-GFVHCDIKLQNVLV-FDNDEAKIADFGLAKKSSCDGERSQSFECRGT 173
            +L GL ++H + G +H DIK +NVL+   +    +    +A   +             T
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 174 PLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAW----NHKQDSNVFSLLIRIGVGD 229
             Y SPE +    +    DIW+  C + E+ +G   +     H    +   +   I +  
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 230 ELPN---------------------------------------IPGDLSEQGKDFLIKCF 250
           ELP+                                          D +++  DFL    
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 251 LKDPKRRWTAEMLLNHPFV 269
             DP++R  A  L+NHP++
Sbjct: 313 QLDPRKRADAGGLVNHPWL 331

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 62.9 bits (152), Expect = 2e-12
 Identities = 30/201 (14%), Positives = 66/201 (32%), Gaps = 18/201 (8%)

Query: 6   GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIV 65
           G ++G G   +V    + K          VK       S   +K +++  D       I 
Sbjct: 5   GKLMGEGKESAVFNCYSEK-----FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 66  RCFGDDYSFEKGERFYNLLLEYASRGSLA-DRVKKQNNGRLQESDVKRYTRSMLKGLRHI 124
               +  + +K +      +      ++  + +  +   R++  +       +L+ +   
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 125 HSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNE 184
           + +G VH D+   NVLV   +   I DF  +       E  +        L     ++  
Sbjct: 120 YHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV--EVGEEGWREI------LERDVRNIIT 170

Query: 185 ---NEYEAPCDIWALGCAVVE 202
                Y    DI +    +++
Sbjct: 171 YFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	366
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.07
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.0
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.39
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.1
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.68

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-63  Score=454.02  Aligned_cols=257  Identities=25%  Similarity=0.399  Sum_probs=212.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+....  .....+.+|+++|++++ |||||++++.+.   + +.
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~---~-~~   76 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRR---E-GN   76 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECC-------CHHHHHHHHHTCC-CTTBCCEEEEEE---E-TT
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEehhhcchHHHHHHHHHHHHHhCC-CCCEeeEeeeec---c-Cc
Confidence            58999999999999999999988765    78888775432  23457899999999998 999999998432   2 34


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++|||||+||+|.+++.+  .+.+++.+++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+...
T Consensus        77 ~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          77 IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR  154 (271)
T ss_dssp             EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred             eeEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence            56799999999999999964  3579999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCC-CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEY-EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ...........+||+.|||||++.+..+ +.++|||||||++|+|++|++||................  .........+
T Consensus       155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~  232 (271)
T d1nvra_         155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKI  232 (271)
T ss_dssp             ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT--CTTSTTGGGS
T ss_pred             cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCccccC
Confidence            4433333445689999999999988886 568999999999999999999998765544333322222  2222334568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ++++++||.+||..||++|||++|+++||||+.
T Consensus       233 s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         233 DSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            999999999999999999999999999999964

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-63  Score=451.60  Aligned_cols=250  Identities=26%  Similarity=0.452  Sum_probs=215.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+..    .......+.+|++++++++ ||||+++++++   . +
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~---~-~   77 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKF----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYF---H-D   77 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEE---E-C
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCc----EEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEE---E-E
Confidence            68899999999999999999988765    677776643    2345667889999999998 99999999843   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +..+++|||||+||+|.+++.+.  +.+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus        78 ~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          78 ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             CCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeee
Confidence            44567999999999999999864  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....    .....+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+....+.+.     .+.+|..
T Consensus       156 ~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-----~~~~p~~  226 (263)
T d2j4za1         156 APSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----EFTFPDF  226 (263)
T ss_dssp             CCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----CCCCCTT
T ss_pred             cCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCcc
Confidence            6422    223457999999999999999999999999999999999999999887665555544432     2356677


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +|+++++||.+||.+||++|||++|+++||||..
T Consensus       227 ~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         227 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            9999999999999999999999999999999954

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-62  Score=452.90  Aligned_cols=254  Identities=28%  Similarity=0.437  Sum_probs=217.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+.+.||+|+||+||+|+++.+++    .||+|.+... ......+.+|+++|++++ |||||++++.+.   . ...
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~----~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~---~-~~~   91 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQ----EVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYL---V-GDE   91 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCC----EEEEEEEEGGGCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEE---E-TTE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCC----EEEEEEEecccChHHHHHHHHHHHHHhCC-CCCEeeEeEEEE---E-CCE
Confidence            59999999999999999999988765    7888877642 245567899999999998 999999998433   2 335


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCC
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSC  160 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~  160 (366)
                      +++|||||+||+|.+++.+   +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus        92 ~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            6799999999999998865   3699999999999999999999999999999999999999999999999999998753


Q ss_pred             CCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          161 DGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ..  ......+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.........+.....  .....+..+++
T Consensus       169 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~  244 (293)
T d1yhwa1         169 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT--PELQNPEKLSA  244 (293)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS--CCCSSGGGSCH
T ss_pred             cc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--CCCCCcccCCH
Confidence            32  223455799999999999999999999999999999999999999988766555444444322  22345567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ++++||.+||.+||++|||++|+++||||+.
T Consensus       245 ~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            9999999999999999999999999999954

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-62  Score=452.22  Aligned_cols=255  Identities=26%  Similarity=0.475  Sum_probs=214.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.++++||+|+||+||+|+++.+++    .||+|.+..    .......+.+|+++|++++ ||||+++++.+   .+ 
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~---~~-   79 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSR----EYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTF---QD-   79 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEE---EC-
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEE---EE-
Confidence            59999999999999999999988765    678887653    2345677899999999998 99999999843   33 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      +..+++|||||+||+|.+++...  +.+++..++.++.||+.||+|||++|||||||||+|||++++|.+||+|||+|+.
T Consensus        80 ~~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          80 DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEeccccccee
Confidence            44567999999999999999764  5799999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .............+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.+.     .+.+|..
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-----~~~~p~~  232 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-----EYDFPEK  232 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-----CCCCCTT
T ss_pred             cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-----CCCCCcc
Confidence            75444444444568999999999999999999999999999999999999999887665555544432     2356678


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHH------HHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEM------LLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~------ll~hp~~~~~  272 (366)
                      +++++++||.+||++||++|||++|      +++||||+.-
T Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         233 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            9999999999999999999999987      5889999553

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-62  Score=444.27  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=206.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+.....   ....+.+|++++++++ |||||++++.+.  ....
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~   77 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGK----ILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRII--DRTN   77 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECCTTSCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEE--C---
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCC----EEEEEEEChhhCCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEE--eCCC
Confidence            68999999999999999999988765    789998765332   2355789999999998 999999998542  2334


Q ss_pred             eEEEEEeecCCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCCCcEEeccCCceEEEe
Q 017746           79 RFYNLLLEYASRGSLADRVKKQ--NNGRLQESDVKRYTRSMLKGLRHIHSKG-----FVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDlkp~NILl~~~~~vkl~D  151 (366)
                      ..+++|||||+||+|.+++.+.  .++.+++..++.++.||+.||+|||++|     ||||||||+||||+.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            4567999999999999999652  3467999999999999999999999976     99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          152 FGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       152 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      ||+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+....+...    ..
T Consensus       158 FG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~----~~  231 (269)
T d2java1         158 FGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----KF  231 (269)
T ss_dssp             HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----CC
T ss_pred             ccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC----CC
Confidence            999998753222  223467999999999999999999999999999999999999999887665555444432    33


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCc
Q 017746          232 PNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFV  269 (366)
Q Consensus       232 ~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~  269 (366)
                      +.++..+|+++.+||.+||+.||++|||++||++|||+
T Consensus       232 ~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            45677899999999999999999999999999999996

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-61  Score=440.88  Aligned_cols=253  Identities=26%  Similarity=0.414  Sum_probs=211.3

Q ss_pred             cccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            4 LRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         4 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +..+.||+|+||+||+|+++.++.    .+|+|.+....   .....+.+|+++|++++ |||||++++.+.....+...
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~----~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTV----EVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCe----EEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCE
Confidence            566789999999999999987764    67888765422   23456889999999999 99999999976655556677


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEec-cCCceEEEecCCccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKG--FVHCDIKLQNVLVF-DNDEAKIADFGLAKK  157 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~~~vkl~DFG~a~~  157 (366)
                      +++|||||++|+|.+++.+.  +.+++.+++.++.||+.||+|||++|  |+||||||+||||+ +++.+||+|||+|+.
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            88999999999999999774  46999999999999999999999999  99999999999996 578999999999986


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...    ......+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+......  ...........+.++..
T Consensus       165 ~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i~~~~~~~~~~~~  237 (270)
T d1t4ha_         165 KRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKV  237 (270)
T ss_dssp             CCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTCCCGGGGGC
T ss_pred             ccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHHHcCCCCcccCcc
Confidence            431    22335689999999999865 599999999999999999999999986654332  22233333334455667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                      .++++++||.+||.+||++|||++|+++||||+
T Consensus       238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            899999999999999999999999999999984

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-62  Score=447.67  Aligned_cols=255  Identities=29%  Similarity=0.456  Sum_probs=215.1

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      |++++.||+|+||+||+|+++.++.    .+|+|.+... ......+.+|+++|++++ |||||++++.+.   . +..+
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~---~-~~~~   84 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSV----LAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFY---Y-ENNL   84 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECSSSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEE---E-TTEE
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCe----EEEEEEECcCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe---e-CCeE
Confidence            8899999999999999999988765    7888887653 344577899999999998 999999998533   2 3356


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++|||||+||+|.+++.+. ++.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus        85 ~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          85 WILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            7999999999999998763 457999999999999999999999999999999999999999999999999999765311


Q ss_pred             CCCcccccccCCCCCCCccccC-----CcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          162 GERSQSFECRGTPLYMSPESVN-----ENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                        .......+||+.|||||++.     +..|+.++|||||||++|+|++|++||.+.+..+....+.+...  .....+.
T Consensus       164 --~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~  239 (288)
T d2jfla1         164 --IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP--PTLAQPS  239 (288)
T ss_dssp             --HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC--CCCSSGG
T ss_pred             --cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCCccc
Confidence              11223457999999999984     55689999999999999999999999998877776655554321  2223456


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+|+++++||.+||++||++|||++|+++||||+.
T Consensus       240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            78999999999999999999999999999999953

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-61  Score=447.25  Aligned_cols=255  Identities=29%  Similarity=0.494  Sum_probs=201.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC--CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP--PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~--~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.++++||+|+||+||+|+++.+++    .+|+|.+....  .....+.+|+.+|++++ |||||++++.+   . .+.
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~---~-~~~   80 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQK----LVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDDIY---E-SGG   80 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCC----EEEEEEEEC----------CHHHHHHHTCC-CTTBCCEEEEE---E-CSS
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCC----EEEEEEEchHHhhhHHHHHHHHHHHHHhCC-CCCCCcEEEEE---E-ECC
Confidence            48999999999999999999988765    67888775422  23456789999999998 99999999843   2 344


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec---cCCceEEEecCCcc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF---DNDEAKIADFGLAK  156 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~~~vkl~DFG~a~  156 (366)
                      .+++|||||+||+|.+++.+  .+.+++.++..++.||+.||+|||++||+||||||+|||+.   +++.+||+|||+|+
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            56799999999999999975  35799999999999999999999999999999999999995   47899999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      .....   ......+||+.|||||++.+..|+.++|||||||++|+|++|++||.+....+....+.+...... +..+.
T Consensus       159 ~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~  234 (307)
T d1a06a_         159 MEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD-SPYWD  234 (307)
T ss_dssp             -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-TTTTT
T ss_pred             EccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-Ccccc
Confidence            76422   223345799999999999999999999999999999999999999988776666555554433222 23445


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+|+++++||.+||.+||++|||++|+++||||..
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            78999999999999999999999999999999954

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-61  Score=450.16  Aligned_cols=252  Identities=27%  Similarity=0.458  Sum_probs=217.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+..    .......+.+|+.+|++++ ||||+++++.   +. +
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~---~~-~   76 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGR----YYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYA---FQ-T   76 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEE---EE-C
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEee---ec-c
Confidence            59999999999999999999998876    667776543    2345677889999999998 9999999983   33 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||+||+|.+++.+.  +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus        77 ~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          77 HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             ccccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccc
Confidence            44577999999999999999874  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....  ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+....+...     .+.+|..
T Consensus       155 ~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-----~~~~p~~  227 (337)
T d1o6la_         155 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----EIRFPRT  227 (337)
T ss_dssp             SCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----CCCCCTT
T ss_pred             cccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-----CCCCCcc
Confidence            64322  2234568999999999999999999999999999999999999999988766655554432     2456778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~  271 (366)
                      +|+++++||.+||++||++|++     ++|+++||||..
T Consensus       228 ~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            9999999999999999999994     899999999964

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.8e-61  Score=451.21  Aligned_cols=257  Identities=24%  Similarity=0.405  Sum_probs=216.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+.... .....+.+|+.+|++++ |||||++++.+   .+ +..
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~---~~-~~~   97 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGN----NFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAF---ED-DNE   97 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTE----EEEEEEECCCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEE---EE-TTE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEcccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEE---EE-CCE
Confidence            59999999999999999999988765    78888876532 23456789999999998 99999999843   22 345


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc--CCceEEEecCCcccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD--NDEAKIADFGLAKKS  158 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~~~vkl~DFG~a~~~  158 (366)
                      +++|||||+||+|.+++.+ ..+.+++..+..|+.||+.||+|||++|||||||||+||||+.  ++.+||+|||+|+..
T Consensus        98 ~~ivmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            6799999999999999965 3457999999999999999999999999999999999999964  578999999999987


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ...   ......+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+...... ..+.....+
T Consensus       177 ~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~  252 (350)
T d1koaa2         177 DPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-MDDSAFSGI  252 (350)
T ss_dssp             CTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-SCCGGGGGC
T ss_pred             ccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCcccccCC
Confidence            432   2334567999999999999999999999999999999999999999988766666655543322 122333568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      |+++++||.+||.+||++|||++|+++||||...
T Consensus       253 s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999999999654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.4e-60  Score=448.14  Aligned_cols=257  Identities=26%  Similarity=0.394  Sum_probs=217.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+.... .....+.+|+.+|++++ |||||++++.+   . .+..
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~---~-~~~~  100 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGR----VFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAF---E-DKYE  100 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCSHHHHHHHHHHHHHHTTCC-STTBCCEEEEE---E-CSSE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCC----EEEEEEECCcchhHHHHHHHHHHHHHhCC-CCCCCcEEEEE---E-ECCE
Confidence            48999999999999999999988765    78888776532 23456789999999998 99999999843   3 3455


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec--cCCceEEEecCCcccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF--DNDEAKIADFGLAKKS  158 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~--~~~~vkl~DFG~a~~~  158 (366)
                      +++|||||+||+|.+++.+ .+.++++.+++.|+.||+.||+|||++|||||||||+||||+  .++.+||+|||+|+..
T Consensus       101 ~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence            6799999999999998865 445799999999999999999999999999999999999997  5689999999999987


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ...   .......||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+..+....+.+.... ..+..+..+
T Consensus       180 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~  255 (352)
T d1koba_         180 NPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-FDEDAFSSV  255 (352)
T ss_dssp             CTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-CCSSTTTTS
T ss_pred             CCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCcccccCC
Confidence            532   2234457999999999999999999999999999999999999999988776665555543322 223345678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                      ++++++||.+||++||++|||++|+++||||+..
T Consensus       256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999999999653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-60  Score=446.18  Aligned_cols=255  Identities=27%  Similarity=0.423  Sum_probs=208.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+...  ......+.+|+.+|++++ |||||++++.+.   . +.
T Consensus         7 ~y~~~~~iG~G~fg~V~~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~---~-~~   77 (322)
T d1s9ja_           7 DFEKISELGAGNGGVVFKVSHKPSGL----VMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFY---S-DG   77 (322)
T ss_dssp             GEEEEEEEECCSSCCEEEEEETTTTE----EEEEEEEECCCCTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEE---C-SS
T ss_pred             CCEEEEEEecCCCeEEEEEEECCCCc----EEEEEEEChhhCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE---E-CC
Confidence            58999999999999999999987764    7888877643  233567889999999998 999999998432   2 34


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      .+++|||||+||+|.+++.+.  +.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+..
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            567999999999999999864  469999999999999999999997 59999999999999999999999999999875


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHH---------------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLI---------------  223 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~---------------  223 (366)
                      ...    ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+......               
T Consensus       156 ~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         156 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             CCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            321    2234589999999999999999999999999999999999999998765432211100               


Q ss_pred             -----------------------HhhcCCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          224 -----------------------RIGVGDELPNIP-GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       224 -----------------------~~~~~~~~~~~~-~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                             ........|..+ ..+|.++++||.+||..||++|||++|+++||||+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                                   000111222233 236899999999999999999999999999999964

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-60  Score=434.73  Aligned_cols=255  Identities=25%  Similarity=0.396  Sum_probs=214.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-------CchhhHHHHHHHHHHcCCCCceeEeecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-------PSSVTLKNEKEALDQIGICPQIVRCFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-------~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~   74 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+....       .....+.+|+++|++++ |||||++++.+   
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~----~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~---   82 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGL----QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY---   82 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE---
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCC----EEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEE---
Confidence            58999999999999999999988776    67777664321       13467899999999998 99999999843   


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC----ceEEE
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND----EAKIA  150 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~----~vkl~  150 (366)
                      . +...+++|||||+||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+
T Consensus        83 ~-~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          83 E-NKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             E-CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             E-ECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEec
Confidence            2 345677999999999999999774  4699999999999999999999999999999999999998776    59999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      |||+|+......   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+...... .
T Consensus       160 DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~-~  235 (293)
T d1jksa_         160 DFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE-F  235 (293)
T ss_dssp             CCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC-C
T ss_pred             chhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-C
Confidence            999998874322   233457999999999999999999999999999999999999999987766655555443221 1


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .+..+..+|+++++||.+||.+||++|||++|+++||||+.
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            12233568999999999999999999999999999999964

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.4e-60  Score=438.46  Aligned_cols=250  Identities=25%  Similarity=0.414  Sum_probs=216.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+..    .......+.+|+.+|++++ |||||++++++   . .
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~---~-~   75 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGR----YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTF---Q-D   75 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEE---E-C
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCC----EEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeE---e-e
Confidence            69999999999999999999988765    678887643    2345667889999999998 99999999843   2 3


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||+||+|..++...  ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus        76 ~~~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          76 AQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             CCeeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceE
Confidence            45677999999999999999763  5689999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....     ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.+..     ..+|..
T Consensus       154 ~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-----~~~p~~  223 (316)
T d1fota_         154 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----LRFPPF  223 (316)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----CCCCTT
T ss_pred             eccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-----CCCCCC
Confidence            6422     234589999999999999999999999999999999999999998876665555544322     345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~  272 (366)
                      ++++++++|.+||.+||.+|+     |++++++||||+..
T Consensus       224 ~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            899999999999999999996     99999999999653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=440.18  Aligned_cols=258  Identities=23%  Similarity=0.391  Sum_probs=212.0

Q ss_pred             Ccccc-CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeE
Q 017746            2 EWLRG-DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERF   80 (366)
Q Consensus         2 ~y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~   80 (366)
                      +|.+. ++||+|+||+||+|+++.+++    .||+|.+..    .....+|+.++.++..|||||++++.+.+.......
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~----~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQE----KFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCC----EEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            57665 579999999999999988765    788888753    456888999988776699999999976655566778


Q ss_pred             EEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc---CCceEEEecCCccc
Q 017746           81 YNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKK  157 (366)
Q Consensus        81 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~~  157 (366)
                      +|+|||||+||+|.++|.++....+++.+++.|+.||+.||+|||++||+||||||+|||++.   ++.+||+|||+|+.
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            899999999999999998744457999999999999999999999999999999999999975   45799999999988


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC--
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP--  235 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  235 (366)
                      .....   .....+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.........+........ ..+|  
T Consensus       164 ~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~-~~~~~~  239 (335)
T d2ozaa1         164 TTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-YEFPNP  239 (335)
T ss_dssp             CCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS-SSCCTT
T ss_pred             ccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC-CCCCCc
Confidence            75332   23345799999999999999999999999999999999999999987766555444433222111 1122  


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 --GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 --~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                        ..+|+++++||.+||++||++|||++|+++||||..
T Consensus       240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence              247999999999999999999999999999999954

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.6e-59  Score=423.80  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=215.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc----------hhhHHHHHHHHHHcCCCCceeEeecce
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS----------SVTLKNEKEALDQIGICPQIVRCFGDD   71 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~----------~~~~~~E~~~l~~l~~~p~Iv~~~g~~   71 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+......          ...+.+|+.++++++.||||+++++.+
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~----~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~   79 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCK----EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   79 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCC----EEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence            69999999999999999999987764    7888887653221          235788999999998899999999843


Q ss_pred             eeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEe
Q 017746           72 YSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIAD  151 (366)
Q Consensus        72 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~D  151 (366)
                         . ++..+++|||||+||+|.++|..+  +.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        80 ---~-~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~D  153 (277)
T d1phka_          80 ---E-TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD  153 (277)
T ss_dssp             ---E-CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             ---c-cCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEcc
Confidence               3 345667999999999999999764  4799999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccCCCCCCCccccCC------cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHh
Q 017746          152 FGLAKKSSCDGERSQSFECRGTPLYMSPESVNE------NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI  225 (366)
Q Consensus       152 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~  225 (366)
                      ||+++......   .....+||+.|+|||++.+      ..++.++||||+||++|+|++|+.||.+.........+...
T Consensus       154 FG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~  230 (277)
T d1phka_         154 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  230 (277)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             chheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence            99999875322   2234579999999999853      35788999999999999999999999988766665555544


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          226 GVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       226 ~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..... ......+|+++++||.+||++||++|||++|+++||||+.
T Consensus       231 ~~~~~-~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         231 NYQFG-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CCCCC-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCCCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            33222 2233468999999999999999999999999999999953

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.4e-60  Score=436.64  Aligned_cols=249  Identities=28%  Similarity=0.427  Sum_probs=208.9

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      |..++.||+|+||+||+|+++.+++    .||+|.+.....    ....+.+|+++|++++ |||||++++.+.   . .
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~---~-~   87 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYL---R-E   87 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTE----EEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE---E-T
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCc----EEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEE---E-C
Confidence            8889999999999999999988764    788888765332    2345788999999998 999999999532   2 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++|||||.+|+|..++..  ++.+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+..
T Consensus        88 ~~~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          88 HTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             TEEEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             CEEEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccccccc
Confidence            456799999999999877654  357999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC---cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE---NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ..      ....+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+....+....+..   ....+..+
T Consensus       166 ~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~---~~~~~~~~  236 (309)
T d1u5ra_         166 AP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NESPALQS  236 (309)
T ss_dssp             SS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSC
T ss_pred             CC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---CCCCCCCC
Confidence            32      234579999999999864   4589999999999999999999999987765444433333   23333345


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ..+|+++++||.+||++||++|||++|+++||||..
T Consensus       237 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            568999999999999999999999999999999954

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-60  Score=439.59  Aligned_cols=256  Identities=20%  Similarity=0.313  Sum_probs=217.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+.........+.+|+++|++++ |||||++++.+   ++ ...+
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~----~~AiK~i~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~---~~-~~~~   76 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKK----TYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHESF---ES-MEEL   76 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECCCTHHHHHHHHHHHHHHHSC-CTTBCCEEEEE---EE-TTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCc----EEEEEEEcCCcccHHHHHHHHHHHHhCC-CCCCCeEEEEE---EE-CCEE
Confidence            69999999999999999999988764    7899988775555667889999999999 99999999843   33 3456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC--CceEEEecCCccccC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN--DEAKIADFGLAKKSS  159 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~--~~vkl~DFG~a~~~~  159 (366)
                      |+|||||+||+|.+++.+ .+..+++.+++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++...
T Consensus        77 ~lvmE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          77 VMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            799999999999999976 44579999999999999999999999999999999999999854  489999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLS  239 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  239 (366)
                      .   .......+||+.|+|||.+.+..|+.++|||||||++|+|++|++||.+.+..+....+.+...... ...+..+|
T Consensus       156 ~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s  231 (321)
T d1tkia_         156 P---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-EEAFKEIS  231 (321)
T ss_dssp             T---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-HHHHTTSC
T ss_pred             c---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-hhhccCCC
Confidence            2   2223445799999999999999999999999999999999999999998877766666655332211 11223589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          240 EQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       240 ~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      +++++||.+||.+||++|||++|+++||||+.
T Consensus       232 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            99999999999999999999999999999964

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-59  Score=438.85  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=215.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|+|.+..    .......+.+|+.+|+.++ |||||++++.+   .. 
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~----~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~---~~-  112 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGN----HYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSF---KD-  112 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEE---EC-
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCC----EEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeeccccc---cc-
Confidence            58999999999999999999988776    678887643    2345567889999999998 99999999843   22 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++||||+.||+|.+++.+.  +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus       113 ~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         113 NSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            34567999999999999999774  4799999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ....     ....+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+.......+...     .+..+..
T Consensus       191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-----~~~~p~~  260 (350)
T d1rdqe_         191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-----KVRFPSH  260 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----CCCCCTT
T ss_pred             cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC-----CCCCCcc
Confidence            6422     23457999999999999999999999999999999999999999887655554444432     2345677


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCcccC
Q 017746          238 LSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCAD  272 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~~  272 (366)
                      +++++.+||.+||.+||++|+     |+++|++||||...
T Consensus       261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            999999999999999999995     99999999999653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-59  Score=433.88  Aligned_cols=253  Identities=26%  Similarity=0.462  Sum_probs=214.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|+++.+++    .||+|.+..    .......+.+|+.++.+...|||||++++.+   .. 
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~----~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~---~~-   74 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQ----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF---QT-   74 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTE----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE---EC-
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCC----EEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE---cc-
Confidence            69999999999999999999988765    778887753    2344556777888776543399999999843   33 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+|+|||||+||+|.+++...  +.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.
T Consensus        75 ~~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~  152 (320)
T d1xjda_          75 KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  152 (320)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhh
Confidence            34567999999999999999764  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      .....  ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+...     .+.+|..
T Consensus       153 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-----~~~~p~~  225 (320)
T d1xjda_         153 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-----NPFYPRW  225 (320)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----CCCCCTT
T ss_pred             ccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----CCCCCcc
Confidence            64332  2233457999999999999999999999999999999999999999988766655554432     3466778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHH-HHHcCCCccc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAE-MLLNHPFVCA  271 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~-~ll~hp~~~~  271 (366)
                      +|+++++||.+||.+||++||++. +|++||||+.
T Consensus       226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             CCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            999999999999999999999995 8999999964

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-59  Score=423.74  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=203.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|+.+.       .+|||.+...   ......+.+|+++|.+++ |||||+++|++    .+.
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~~-------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~----~~~   76 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWHG-------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS----TAP   76 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESSS-------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEE----CSS
T ss_pred             cEEEEEEEeeCCCcEEEEEEECC-------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEE----ecc
Confidence            58899999999999999998643       4888887542   334567889999999998 99999999832    222


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                       .+++|||||+||+|.+++.. .++.+++..+..++.||++||+|||++|||||||||+||||+.++.+||+|||+|+..
T Consensus        77 -~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          77 -QLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             -SCEEEEECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             -EEEEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence             35699999999999999976 4467999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCc---CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc-CCCCCCC
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNEN---EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV-GDELPNI  234 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~  234 (366)
                      .............||+.|||||++.+.   .|+.++|||||||++|||+||+.||.+.............+. ....+.+
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~  234 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV  234 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence            543333334456799999999999653   588899999999999999999999988766554444443332 2233456


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      +..+++++.+||.+||..||++|||+++|+++
T Consensus       235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            67789999999999999999999999999976

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.2e-58  Score=436.84  Aligned_cols=254  Identities=22%  Similarity=0.383  Sum_probs=208.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC----CCCchhhHHHHH---HHHHHcCCCCceeEeecceeec
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD----CPPSSVTLKNEK---EALDQIGICPQIVRCFGDDYSF   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~----~~~~~~~~~~E~---~~l~~l~~~p~Iv~~~g~~~~~   74 (366)
                      +|.++++||+|+||.||+|+++.+++    .||+|.+..    .......+.+|.   ++++.++ |||||++++.+   
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~----~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~---   76 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAF---   76 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEE---
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCC----EEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEE---
Confidence            69999999999999999999988775    678887643    112333445554   4445555 99999999843   


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCC
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                      .. ...+++|||||+||+|.+++.+.  +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+
T Consensus        77 ~~-~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          77 HT-PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             EC-SSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             EE-CCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeece
Confidence            33 34567999999999999999874  4699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCC
Q 017746          155 AKKSSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPN  233 (366)
Q Consensus       155 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (366)
                      |+.....    .....+||+.|||||++.. ..|+.++|||||||++|||+||+.||.+.............  ....+.
T Consensus       154 a~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~--~~~~~~  227 (364)
T d1omwa3         154 ACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVE  227 (364)
T ss_dssp             CEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS--SSCCCC
T ss_pred             eeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCC
Confidence            9876432    2234579999999999864 56999999999999999999999999877655544433332  233445


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCCCcccC
Q 017746          234 IPGDLSEQGKDFLIKCFLKDPKRRWT-----AEMLLNHPFVCAD  272 (366)
Q Consensus       234 ~~~~~s~~~~~ll~~cL~~dp~~R~t-----~~~ll~hp~~~~~  272 (366)
                      ++..+|+++++||.+||.+||++|||     ++|+++||||+..
T Consensus       228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         228 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            67789999999999999999999999     7999999999653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-58  Score=422.90  Aligned_cols=254  Identities=24%  Similarity=0.320  Sum_probs=205.0

Q ss_pred             ccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC------chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            5 RGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP------SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         5 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~------~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      .+++||+|+||+||+|+++.+++    .||+|++.....      ....+.+|+.+|++++ |||||++++.+   .. +
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~---~~-~   72 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQ----IVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAF---GH-K   72 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCS----EEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEE---CC-T
T ss_pred             cceEeccCcCeEEEEEEECCCCc----EEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeee---cc-C
Confidence            56899999999999999987765    788888754221      2346889999999998 99999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++|||||.++++..++.  .++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        73 ~~~~ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~  150 (299)
T d1ua2a_          73 SNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  150 (299)
T ss_dssp             TCCEEEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             CceeehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCcccccc
Confidence            34679999999877665553  3467999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC-------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE-------  230 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~-------  230 (366)
                      ....  ......+||+.|+|||++.. ..|+.++|||||||++|||++|.+||.+..+.+....+.+......       
T Consensus       151 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         151 GSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             TSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             CCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence            5332  22334579999999999865 4689999999999999999999999998877776666554321110       


Q ss_pred             -----------CCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          231 -----------LPN-----IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       231 -----------~~~-----~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                 .+.     ....+++++++||.+||+.||++|||++|+|+||||+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence                       001     11246899999999999999999999999999999954

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-58  Score=430.16  Aligned_cols=258  Identities=26%  Similarity=0.329  Sum_probs=212.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC-CCCceeEEeeecCC--CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADC--PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~avK~~~~~--~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.++++||+|+||+||+|++...++ ....+||+|.....  ......+.+|+.++.++..|||||+++|.+.    ..
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~----~~  113 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT----LS  113 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----SS
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe----eC
Confidence            46788999999999999999876543 33456889987542  2345678899999999966999999998432    23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN---------------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQ  137 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~  137 (366)
                      ..+++|||||++|+|.++|.++.                     ...+++..+..|+.||+.||+|||++|||||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            34669999999999999997632                     135899999999999999999999999999999999


Q ss_pred             cEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcc
Q 017746          138 NVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDS  216 (366)
Q Consensus       138 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~  216 (366)
                      |||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |++||.+....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654444333445678999999999999999999999999999999998 89999887666


Q ss_pred             hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          217 NVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      .....+.+.+   ..+..|..+++++++||.+||+.||++|||++||++|
T Consensus       274 ~~~~~~~~~~---~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         274 ANFYKLIQNG---FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcC---CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5555554433   3345667899999999999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-57  Score=419.92  Aligned_cols=264  Identities=27%  Similarity=0.393  Sum_probs=214.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC---CCCchhhHHHHHHHHHHcC--CCCceeEeecceeecc-
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD---CPPSSVTLKNEKEALDQIG--ICPQIVRCFGDDYSFE-   75 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~---~~~~~~~~~~E~~~l~~l~--~~p~Iv~~~g~~~~~~-   75 (366)
                      +|.+++.||+|+||+||+|++..+++   ..||+|.+..   .........+|+.+|+.|.  .||||+++++.+.... 
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGG---RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTT---EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCC---EEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            69999999999999999999976543   3577887643   2233456778999988873  4999999998664322 


Q ss_pred             CCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCc
Q 017746           76 KGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLA  155 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a  155 (366)
                      .....++++||||.++.+...... ....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             ccCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence            445677899999998766555443 5567999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcC-------
Q 017746          156 KKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVG-------  228 (366)
Q Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~-------  228 (366)
                      +....   .......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+......       
T Consensus       164 ~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         164 RIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            86532   22334567999999999999999999999999999999999999999988776666655543111       


Q ss_pred             ---------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          229 ---------------DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       229 ---------------~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                     ...+.++..+++.+++||.+||++||++|||++|+++||||+.-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                           11112345679999999999999999999999999999999643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-57  Score=418.85  Aligned_cols=251  Identities=21%  Similarity=0.298  Sum_probs=210.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|+++.+++    .||+|.+.........+.+|+++|++++ |||||+++|.+   .. ...+
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~---~~-~~~~   88 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVC---TR-EPPF   88 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEGGGTE----EEEEEECCTTCSCHHHHHHHHHHHHHCC-CTTBCCEEEEE---CS-SSSC
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCCCe----EEEEEEECCccchHHHHHHHHHHHHhCC-CCCEecCCccE---ee-CCee
Confidence            46778999999999999999987654    7899998876667788999999999998 99999999943   22 3345


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++|||||++|+|.+++.+.....+++..+..++.||+.||+|||++||+||||||+||||++++.+||+|||+|+.....
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            69999999999999998755667999999999999999999999999999999999999999999999999999876433


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .. .......||+.|+|||++.+..|+.++|||||||++|||++|..||....+......+...   ...+..+..++++
T Consensus       169 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~---~~~~~~~~~~~~~  244 (287)
T d1opja_         169 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEK  244 (287)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT---TCCCCCCTTCCHH
T ss_pred             Cc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc---CCCCCCCccchHH
Confidence            22 2223346899999999999999999999999999999999976665544333322222222   2345667789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +++||.+||..||++|||+++|++
T Consensus       245 l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         245 VYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-57  Score=410.46  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=200.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|+++. +    ..||||.+.........+.+|++++++++ |||||+++|++.    .+..+
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~-~----~~vAvK~i~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~----~~~~~   75 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLN-K----DKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCL----EQAPI   75 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETT-T----EEEEEEECCSSSSCHHHHHHHHHHHHHCC-CTTBCCEEEEEC----SSSSC
T ss_pred             HcEEEEEEeeCCCeEEEEEEECC-C----CEEEEEEECCCcCcHHHHHHHHHHHHhcC-CCCcccccceec----cCCce
Confidence            58899999999999999999864 2    36999998876677788999999999998 999999999432    22345


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++|||||++|+|.+++.. ....+++..+..++.||+.||+|||+++|+||||||+||||++++++||+|||+|+.....
T Consensus        76 ~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             EEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EEEEEecCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence            699999999999999976 3457999999999999999999999999999999999999999999999999999876433


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......||+.|+|||++.+..|+.++|||||||++|||+| |++||......+....+.. +   ..+..|..+++
T Consensus       155 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~---~~~~~p~~~~~  229 (263)
T d1sm2a_         155 QY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-G---FRLYKPRLAST  229 (263)
T ss_dssp             -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-T---CCCCCCTTSCH
T ss_pred             Cc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-c---CCCCCccccCH
Confidence            22 22234579999999999999999999999999999999999 5666766554444443333 2   23345667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++.+|+.+||+.||++|||+++|++|
T Consensus       230 ~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         230 HVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999999976

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-57  Score=415.30  Aligned_cols=253  Identities=22%  Similarity=0.339  Sum_probs=210.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|+++. +    ..||||.+.........+.+|++++++++ |||||+++|.+   .+ +. +
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~~-~----~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~---~~-~~-~   82 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYNG-H----TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYAVV---TQ-EP-I   82 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETT-T----EEEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEE---CS-SS-C
T ss_pred             HeEEeEEEecCCCcEEEEEEECC-C----CEEEEEEEccCcCCHHHHHHHHHHHHhCC-CCCEeEEEeee---cc-CC-e
Confidence            57789999999999999999863 2    37899998876667788999999999998 99999999842   22 22 4


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++|||||++|+|.+++....+..+++..+..|+.||++||.|||++||+||||||+||||++++.+||+|||+|+.....
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            59999999999999886544456999999999999999999999999999999999999999999999999999976432


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhC-CCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASG-KPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........||+.|||||++.+..|+.++|||||||++|||+|| .+||......+....+.   . ...+..|..+++
T Consensus       163 ~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~---~-~~~~~~p~~~~~  237 (272)
T d1qpca_         163 E-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---R-GYRMVRPDNCPE  237 (272)
T ss_dssp             C-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T-TCCCCCCTTCCH
T ss_pred             c-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH---h-cCCCCCcccChH
Confidence            2 2223345799999999999999999999999999999999995 55555544433333332   2 234456778999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc--CCCcc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN--HPFVC  270 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~--hp~~~  270 (366)
                      ++.+|+.+||+.||++|||+++|++  |+||.
T Consensus       238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999999999999998  78874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=413.27  Aligned_cols=258  Identities=25%  Similarity=0.369  Sum_probs=208.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|++..+++    .||+|.+....   .....+.+|+++|++++ |||||++++.+.   . .
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~---~-~   73 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGE----VVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIH---T-E   73 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEEEE---E-T
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCC----EEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEEeccccc---c-c
Confidence            69999999999999999999988765    78888875422   23567889999999998 999999998543   2 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++|||||.+ ++.+++.....+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus        74 ~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          74 NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             cceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceec
Confidence            356799999976 6666665545667999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcCC-CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC--------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENEY-EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD--------  229 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~--------  229 (366)
                      ....  .......||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+....+.+.....        
T Consensus       153 ~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         153 GVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             CCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence            4322  23334579999999999877664 789999999999999999999998876655554444321110        


Q ss_pred             -----CCCCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 -----ELPNI-----------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 -----~~~~~-----------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                           ..+..           ...+++++++||.+||..||++|||++||++||||+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~  288 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD  288 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence                 00000           1246889999999999999999999999999999954

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=417.68  Aligned_cols=255  Identities=22%  Similarity=0.350  Sum_probs=212.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC--CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~--~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|+++++||+|+||+||+|++..+++..+.+||+|.+..  .......+.+|+.++++++ |||||+++|++.   ++ .
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~---~~-~   84 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICL---TS-T   84 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC-CTTBCCEEEEEE---SS-S
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe---cC-C
Confidence            699999999999999999999998888888999998764  2345667899999999998 999999999542   22 2


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                       .+++|||+.+|+|.+++.. ....+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus        85 -~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          85 -VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             -EEEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             -eeEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence             4588999999999999987 45679999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      ............||+.|||||++.++.|+.++|||||||++|||+| |.+||.+....+....+.+ +   ..+..|..+
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~-~---~~~~~p~~~  238 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-G---ERLPQPPIC  238 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH-T---CCCCCCTTB
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-C---CCCCCCccc
Confidence            5444444445579999999999999999999999999999999998 8999988877666555443 2   234556779


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNHP  267 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~hp  267 (366)
                      ++++.+|+.+||..||++|||+.||+.|.
T Consensus       239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         239 TIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            99999999999999999999999999873

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-57  Score=413.42  Aligned_cols=255  Identities=22%  Similarity=0.360  Sum_probs=210.0

Q ss_pred             ccccCe-eeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            3 WLRGDV-IGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         3 y~~~~~-lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      |.+.+. ||+|+||+||+|.++.++.  ...||||.+.....  ....+.+|+++|++++ |||||+++|++   .. +.
T Consensus        10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~--~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~---~~-~~   82 (285)
T d1u59a_          10 LLIADIELGCGNFGSVRQGVYRMRKK--QIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVC---QA-EA   82 (285)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---C--CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE---ES-SS
T ss_pred             eEECCcEEecccCeEEEEEEEecCCC--cEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC-CCCEeeEeeee---cc-Ce
Confidence            556664 9999999999998865543  34789998865332  3467889999999998 99999999943   22 22


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                       +++|||||++|+|.+++.. .++.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus        83 -~~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          83 -LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             -EEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             -EEEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence             5699999999999999865 34579999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCC-cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          160 CDGER-SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       160 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ..... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+....+.+    ...+..|..
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~----~~~~~~p~~  236 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----GKRMECPPE  236 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT----TCCCCCCTT
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CCCCCCCCc
Confidence            43322 22234569999999999999999999999999999999998 9999998776655544432    234566778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHH---HcCCCcc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEML---LNHPFVC  270 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~l---l~hp~~~  270 (366)
                      +++++.+||.+||..||++|||+.+|   |+|+|+.
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999999888   5688874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-57  Score=411.89  Aligned_cols=245  Identities=26%  Similarity=0.393  Sum_probs=203.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC-------CchhhHHHHHHHHHHcC-CCCceeEeecceee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP-------PSSVTLKNEKEALDQIG-ICPQIVRCFGDDYS   73 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~-------~~~~~~~~E~~~l~~l~-~~p~Iv~~~g~~~~   73 (366)
                      +|.++++||+|+||+||+|+++.+++    .+|+|.+....       .....+.+|+.+|++++ .|||||++++.+  
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~--   78 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNL----PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--   78 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCC----EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE--
Confidence            69999999999999999999988765    78888765421       12244678999999997 489999999843  


Q ss_pred             ccCCeeEEEEEeecCCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC-CceEEEe
Q 017746           74 FEKGERFYNLLLEYASR-GSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN-DEAKIAD  151 (366)
Q Consensus        74 ~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-~~vkl~D  151 (366)
                       .. ...+++||||+.+ +++.+++.+.  +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus        79 -~~-~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          79 -ER-PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             -EC-SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             -ee-CCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECc
Confidence             23 4456799999986 6888888764  469999999999999999999999999999999999999854 7999999


Q ss_pred             cCCccccCCCCCCcccccccCCCCCCCccccCCcCC-CCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC
Q 017746          152 FGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEY-EAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE  230 (366)
Q Consensus       152 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~  230 (366)
                      ||+|+.....    .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+      .+.+.     
T Consensus       155 FG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-----  219 (273)
T d1xwsa_         155 FGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-----  219 (273)
T ss_dssp             CTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-----
T ss_pred             cccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-----
Confidence            9999875321    2234579999999999988776 567999999999999999999997531      12221     


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ...++..+|+++++||.+||.+||++|||++|+++||||+.
T Consensus       220 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         220 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            12456679999999999999999999999999999999954

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-56  Score=414.32  Aligned_cols=254  Identities=20%  Similarity=0.334  Sum_probs=198.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.++||+|+||+||+|+++.+++. ...+|+|.......  ....+.+|+++|++++ |||||+++|.+   .. ..
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~---~~-~~  100 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKR-EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVV---TK-ST  100 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---C-CEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE---CS-SS
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCE-EEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCCccEEEEE---ee-CC
Confidence            467789999999999999999876543 34678888765322  3456889999999998 99999999943   22 33


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++|||||++|+|.+++.. ..+.+++.++..++.||++||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            45699999999999999976 45679999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCc---ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          160 CDGERS---QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       160 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ......   ......||+.|||||++.+..|+.++|||||||++|||+| |++||.+....+....+..   + ..+..+
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~---~-~~~~~~  255 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---D-YRLPPP  255 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---T-CCCCCC
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc---C-CCCCCC
Confidence            332221   1223468999999999999999999999999999999998 8999988766554444332   2 234456


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+++++.+|+.+||..||++|||+.||+++
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            7799999999999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-56  Score=402.53  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=213.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.++++||+|+||+||+|+++. +    ..||||.+.........+.+|++++.+++ ||||++++|.+.    .+..+
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~-~----~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~----~~~~~   74 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRG-Q----YDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCT----KQRPI   74 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETT-T----EEEEEEEEESSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEC----CSSSE
T ss_pred             HCEEeEEEecCCCeEEEEEEECC-C----CEEEEEEECcCcCCHHHHHHHHHHHHhcC-CCceeeEEEEEe----eCCce
Confidence            58899999999999999999853 2    37899998876677788999999999998 999999999432    23346


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++... ...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        75 ~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          75 FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             EEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             EEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            7999999999999998763 457999999999999999999999999999999999999999999999999999876533


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      . ........||+.|+|||++.+..|+.++|||||||++|||+| |+.||...+..+....+..    ...+..|..+++
T Consensus       154 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~----~~~~~~p~~~~~  228 (258)
T d1k2pa_         154 E-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ----GLRLYRPHLASE  228 (258)
T ss_dssp             S-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT----TCCCCCCTTCCH
T ss_pred             C-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh----CCCCCCcccccH
Confidence            2 222334579999999999999999999999999999999998 8999998876665544432    223456778899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++.+||.+||+.||++|||+++|++|
T Consensus       229 ~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         229 KVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=409.64  Aligned_cols=249  Identities=23%  Similarity=0.368  Sum_probs=203.4

Q ss_pred             CeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEE
Q 017746            7 DVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         7 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      +.||+|+||+||+|.+...+  ....||+|.+.....   ....+.+|+++|++++ |||||+++|++   .. +. +++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~---~~-~~-~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGIC---EA-ES-WML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSS--SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE---ES-SS-EEE
T ss_pred             CCcccCCCeEEEEEEEccCC--cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC-CCCCceEEEEe---cc-CC-EEE
Confidence            46999999999999875432  245789998764222   2457899999999998 99999999843   22 23 459


Q ss_pred             EeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCC
Q 017746           84 LLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE  163 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  163 (366)
                      |||||++|+|.+++.+.  ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.......
T Consensus        85 vmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            99999999999999763  5699999999999999999999999999999999999999999999999999987653332


Q ss_pred             Cc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCHH
Q 017746          164 RS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSEQ  241 (366)
Q Consensus       164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  241 (366)
                      .. ......||+.|||||++.+..|+.++|||||||++|||+| |++||.+....+....+.+    ...+..|..++++
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~----~~~~~~p~~~~~~  238 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPRE  238 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----TCCCCCCTTCCHH
T ss_pred             ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc----CCCCCCCcccCHH
Confidence            22 2234579999999999999999999999999999999998 8999988766554444332    2345667789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHH---cCCCc
Q 017746          242 GKDFLIKCFLKDPKRRWTAEMLL---NHPFV  269 (366)
Q Consensus       242 ~~~ll~~cL~~dp~~R~t~~~ll---~hp~~  269 (366)
                      +.+||.+||..||++|||+++|+   +|+|+
T Consensus       239 ~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         239 MYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            99999999999999999999984   56665

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2e-56  Score=408.63  Aligned_cols=259  Identities=22%  Similarity=0.389  Sum_probs=205.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC----chhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP----SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|.+.....    ....+.+|+++++.++ ||||+++++.+......
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHR----DVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred             eeEEeEEEeeCCCeEEEEEEECCCCC----EEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence            59999999999999999999988765    788898765322    2346889999999998 99999999976554455


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      ...+++|||||+||+|.+++...  +.+++.++..++.||+.||+|||++||+||||||+|||++.++.++|+|||.+..
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             CceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence            56778999999999999999764  5799999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCC-CcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCCCC
Q 017746          158 SSCDGE-RSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNIPG  236 (366)
Q Consensus       158 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (366)
                      ...... .......+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+..+....+.+.... .......
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~  239 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-PPSARHE  239 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-CGGGTSS
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC-CCchhcc
Confidence            543222 22334567999999999999999999999999999999999999999887665554444432211 1113345


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-CHHHHHcCCCc
Q 017746          237 DLSEQGKDFLIKCFLKDPKRRW-TAEMLLNHPFV  269 (366)
Q Consensus       237 ~~s~~~~~ll~~cL~~dp~~R~-t~~~ll~hp~~  269 (366)
                      .+|+++.+||.+||.+||++|| |++++ .|+|.
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~  272 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEM-RADLV  272 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence            6899999999999999999999 55555 45554

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-56  Score=410.26  Aligned_cols=259  Identities=22%  Similarity=0.342  Sum_probs=205.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCC-CceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEF-PSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~-~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++...+... ...||+|.+.....  ....+.+|..++.++..||||+.+++.+   ....
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~---~~~~   90 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC---TKPG   90 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---CSTT
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee---ccCC
Confidence            5888999999999999999987654333 34689998765322  3456778889999998799999998843   2333


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDN  144 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~  144 (366)
                      ..+++|||||++|+|.+++....              ...+++.++..|+.||++||.|||++|||||||||+||||+++
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence            44669999999999999997532              2358999999999999999999999999999999999999999


Q ss_pred             CceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhC-CCCCCCCCcchHHHHHH
Q 017746          145 DEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASG-KPAWNHKQDSNVFSLLI  223 (366)
Q Consensus       145 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg-~~pf~~~~~~~~~~~~~  223 (366)
                      +++||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||++| .+||.+....+......
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~  250 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  250 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999999876554444444556899999999999999999999999999999999986 56887766555444444


Q ss_pred             HhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          224 RIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       224 ~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ..+   ..+..|..+++++++||.+||..||++|||++||++|
T Consensus       251 ~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         251 KEG---TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcC---CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            433   2345677899999999999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-55  Score=411.87  Aligned_cols=260  Identities=25%  Similarity=0.340  Sum_probs=207.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeecc--CCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--KGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~~~~   79 (366)
                      +|..+++||+|+||+||+|+++.+++    .||+|++...   .....+|+++|++++ ||||+++++.++...  .+..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~---~~~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGE----LVAIKKVLQD---KRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECC---SSSCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCC----EEEEEEECcc---chHHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCce
Confidence            68899999999999999999988765    7888887653   234568999999998 999999999765432  3445


Q ss_pred             EEEEEeecCCCCCHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-ceEEEecCCccc
Q 017746           80 FYNLLLEYASRGSLADRVKK-QNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKK  157 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~  157 (366)
                      ++++|||||+++.+..+... .....+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+++.
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            67899999987543333321 2445799999999999999999999999999999999999999775 899999999987


Q ss_pred             cCCCCCCcccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhh----------
Q 017746          158 SSCDGERSQSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIG----------  226 (366)
Q Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~----------  226 (366)
                      .....   ...+.+||+.|+|||.+.+ ..|+.++|||||||++|||++|++||......+....+.+..          
T Consensus       173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            64322   2334579999999998765 578999999999999999999999998877665555444321          


Q ss_pred             -----cCCCCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          227 -----VGDELPN---------IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       227 -----~~~~~~~---------~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                           .....+.         ....+++++.+||.+||..||++|||+.|+++||||...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                 0011111         123478999999999999999999999999999999653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=403.07  Aligned_cols=254  Identities=20%  Similarity=0.290  Sum_probs=199.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.+.++||+|+||+||+|.++.++......||||.+.....  ....+.+|++++++++ |||||+++|.+.    ...
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~----~~~   82 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS----KYK   82 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC----SSS
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEe----cCC
Confidence            478899999999999999998877665667899999865333  2346789999999998 999999999432    233


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      ..++|||||.+|+|.+++.+ ..+.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             ceEEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            45699999999999999877 45679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCc-ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCC-CCCCcchHHHHHHHhhcCCCCCCCCCC
Q 017746          160 CDGERS-QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAW-NHKQDSNVFSLLIRIGVGDELPNIPGD  237 (366)
Q Consensus       160 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (366)
                      ...... ......||+.|||||++.++.|+.++|||||||++|||++|..|| ......+....+.    ....+..+..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~----~~~~~~~~~~  237 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN----DGFRLPTPMD  237 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH----TTCCCCCCTT
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh----ccCCCCCchh
Confidence            332222 223456899999999999999999999999999999999965554 4443333332222    2233456777


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          238 LSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       238 ~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ++.++.+||.+||..||++|||+.+|++
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            9999999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=401.63  Aligned_cols=252  Identities=24%  Similarity=0.374  Sum_probs=201.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.++++||+|+||+||+|++..+++ ....+|+|.......  ....+.+|+.++++++ |||||+++|.+   .+  .
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~---~~--~   80 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPEN-PALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVI---TE--N   80 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE---CS--S
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCc-eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE---ec--C
Confidence            58899999999999999999876543 345788888765323  2456889999999998 99999999943   22  2


Q ss_pred             EEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccC
Q 017746           80 FYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSS  159 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~  159 (366)
                      .+++|||||++|+|.+++.. ..+.+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             eEEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence            45699999999999999876 45679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCC
Q 017746          160 CDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDL  238 (366)
Q Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (366)
                      .... .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+....+....+..    ...+.++..+
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~----~~~~~~~~~~  234 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----GERLPMPPNC  234 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT----TCCCCCCTTC
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCCCCCC
Confidence            3222 22334568999999999999999999999999999999998 8999998877776655543    2334567789


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          239 SEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       239 s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      |+++.+||.+||..||++|||++||++|
T Consensus       235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999876

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=403.69  Aligned_cols=263  Identities=23%  Similarity=0.317  Sum_probs=207.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC---CCchhhHHHHHHHHHHcCCCCceeEeecceeec----
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC---PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSF----   74 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~---~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~----   74 (366)
                      +|.+++.||+|+||+||+|+++.+++    .||||++...   ......+.+|+.+|++++ ||||+++++.+...    
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQ----KVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPY   85 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC-----
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEehhhcchHHHHHHHHHHHHHHHhc-CCCccceEeeeecccccc
Confidence            69999999999999999999987765    7888876542   234456889999999998 99999999865431    


Q ss_pred             cCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCC
Q 017746           75 EKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGL  154 (366)
Q Consensus        75 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~  154 (366)
                      ...+..+++|||||.++.+.... . ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~-~-~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLS-N-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHT-C-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cccCceEEEEEeccCCCccchhh-h-cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence            12234577999999886655443 3 446799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC--CcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCC
Q 017746          155 AKKSSCDGE--RSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDEL  231 (366)
Q Consensus       155 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~  231 (366)
                      ++.......  .......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+..+......+.+.......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            987653222  1223345799999999998765 6899999999999999999999999988776666655554322111


Q ss_pred             CCCCC---------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          232 PNIPG---------------------------DLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       232 ~~~~~---------------------------~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      .....                           ..+++++|||.+||+.||++|||++|+++||||..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            10000                           13678899999999999999999999999999964

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=401.17  Aligned_cols=254  Identities=21%  Similarity=0.344  Sum_probs=206.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|++++.||+|+||+||+|+++.+     ..||+|.+.........+.+|+.++++++ |||||+++|.+   .+ +. +
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~-----~~vAiK~l~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~---~~-~~-~   86 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVV---SE-EP-I   86 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTT-----EEEEEEECCTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEE---CS-SS-C
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCC-----CEEEEEEECcccCCHHHHHHHHHHHHhcc-cCCEeEEEEEE---ec-CC-e
Confidence            578899999999999999998653     36899998876667788999999999999 99999999943   22 22 4


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++|||||++|+|..++.......+++.++..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.....
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            59999999999999997655567999999999999999999999999999999999999999999999999999876432


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCC-CCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      .. .......||+.|+|||++....++.++|||||||++|||++|. +||......+....+.+   . ..+..+..+++
T Consensus       167 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~---~-~~~~~~~~~~~  241 (285)
T d1fmka3         167 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---G-YRMPCPPECPE  241 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---T-CCCCCCTTSCH
T ss_pred             Cc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh---c-CCCCCCcccCH
Confidence            22 2223457999999999999999999999999999999999965 45554444333333332   2 23446778999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc--CCCccc
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLN--HPFVCA  271 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~--hp~~~~  271 (366)
                      ++++||.+||+.||++||++++|++  |+||..
T Consensus       242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            9999999999999999999999988  888843

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.1e-55  Score=400.47  Aligned_cols=255  Identities=25%  Similarity=0.355  Sum_probs=203.8

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+.+.||+|+||+||+|+++ ++    ..||+|.+....   .....+.+|+.+|++++ ||||+++++.+   .. .
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~---~~-~   72 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN-YG----ETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVI---HT-K   72 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TS----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEE---EC-S
T ss_pred             CceeccEEecCCCcEEEEEEeC-CC----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeeec---cc-C
Confidence            7999999999999999999985 33    478999886532   23567889999999998 99999999843   22 3


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..++++|||+.++.+..+..  ..+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|...
T Consensus        73 ~~~~i~~e~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          73 KRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             SCEEEEEECCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             CceeEEEEeehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence            34669999998866666654  3467999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCC-------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDE-------  230 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~-------  230 (366)
                      .....  ......||+.|+|||.+.+. .++.++|||||||++|||++|++||.+....+....+.+......       
T Consensus       151 ~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         151 GIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence            43322  22334699999999998764 568999999999999999999999988766555554443211100       


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcc
Q 017746          231 -----------------LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVC  270 (366)
Q Consensus       231 -----------------~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~  270 (366)
                                       .......+++++.|||.+||++||++|||++|+++||||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                             0112345789999999999999999999999999999995

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=409.05  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=205.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeecc-CCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE-KGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~-~~~   78 (366)
                      +|.+++.||+|+||+||+|+++.+++    .+|||.+.....  ....+.+|+.+|++++ ||||+++++.+.... ...
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKV----RVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCS----EEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTC
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCc----EEEEEEEehhcChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecccccc
Confidence            59999999999999999999988765    789998765322  2346788999999998 999999998654322 122


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..++++ +|+.+|+|.+++..   ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+..
T Consensus        84 ~~~~l~-~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          84 KDVYLV-THLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             CCEEEE-EECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ceEEEE-EeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            334454 55668899999976   36999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCc-ccccccCCCCCCCccccCC-cCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC-------
Q 017746          159 SCDGERS-QSFECRGTPLYMSPESVNE-NEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-------  229 (366)
Q Consensus       159 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~-------  229 (366)
                      ....... .....+||+.|+|||++.. ..|+.++||||+||++|+|++|++||.+.................       
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            4332221 2344579999999999855 567889999999999999999999998876554444433221000       


Q ss_pred             ---------------C----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCcccC
Q 017746          230 ---------------E----LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCAD  272 (366)
Q Consensus       230 ---------------~----~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~~  272 (366)
                                     .    .......++.++++||.+||+.||++|||++|+++||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                           0    001223578899999999999999999999999999999643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-54  Score=406.05  Aligned_cols=254  Identities=22%  Similarity=0.305  Sum_probs=205.0

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|+++++||+|+||+||+|+++.+++    .||+|++..  .....+.+|+++|+++..||||+++++.+..  .....+
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~----~vAiK~i~~--~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~--~~~~~~  107 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNE----KVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKD--PVSRTP  107 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECS--SCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--TTTCSE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCC----EEEEEEECH--HHHHHHHHHHHHHHhccCCCCCcEEEEEEEe--cCCCce
Confidence            58999999999999999999987764    789998765  4567889999999999889999999985332  233456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC-ceEEEecCCccccCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND-EAKIADFGLAKKSSC  160 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~-~vkl~DFG~a~~~~~  160 (366)
                      ++|||||.+++|..+.     ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+....
T Consensus       108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence            7999999999997653     3599999999999999999999999999999999999998655 699999999987643


Q ss_pred             CCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHH-HHHHHh-------------
Q 017746          161 DGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVF-SLLIRI-------------  225 (366)
Q Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~-~~~~~~-------------  225 (366)
                      ..   .....+||+.|+|||.+.+. .|+.++|||||||++|+|++|+.||....+.... ..+...             
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            32   23345799999999998765 5799999999999999999999999766543221 111110             


Q ss_pred             hcC------C-------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          226 GVG------D-------------ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       226 ~~~------~-------------~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                      ...      .             ........++++++|||.+||..||++|||++|+|+||||..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            000      0             000112347899999999999999999999999999999964

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=406.49  Aligned_cols=256  Identities=25%  Similarity=0.375  Sum_probs=203.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCc---hhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPS---SVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+++.||+|+||+||+|+++.+++    .||+|.+......   ...+.+|+++|++++ |||||++++++....  .
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGA----KVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCC----EEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTT
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEchhhcChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCcccc
Confidence            68899999999999999999988765    7899988753222   346788999999998 999999998654322  1


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+++||||| +.+|..+++.   +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccccee
Confidence            233567999999 5688888754   469999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCc-CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhc--------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNEN-EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGV--------  227 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~--------  227 (366)
                      .....     .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+.....        
T Consensus       170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            76422     2345799999999998764 568899999999999999999999988765554443333211        


Q ss_pred             ------------------CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          228 ------------------GDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       228 ------------------~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                        ..........+++++.+||.+||..||++|||++|+|+||||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence                              01112233457899999999999999999999999999999964

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=402.52  Aligned_cols=261  Identities=26%  Similarity=0.469  Sum_probs=214.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||+||+|++... +..+..||+|.+...     ......+.+|+++++++++||||+++++.   +..
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~---~~~  100 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISG-HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA---FQT  100 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSS-TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE---EEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECcc-CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee---ecc
Confidence            589999999999999999998543 223457888876531     23456788999999999867999999873   333


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                       ...++++|||+.+|+|.+++...  +.+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+
T Consensus       101 -~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         101 -ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             -TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             -CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence             33567999999999999999774  468899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCc--CCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCCCCCCC
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNEN--EYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGDELPNI  234 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (366)
                      ...... ........||+.|+|||.+.+.  .++.++|||||||+||+|++|+.||.+.........+.+..... .+.+
T Consensus       178 ~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-~~~~  255 (322)
T d1vzoa_         178 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPY  255 (322)
T ss_dssp             ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCCC
T ss_pred             hhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-CCCC
Confidence            764322 2223445799999999999765  46789999999999999999999998877666666665544333 3456


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCccc
Q 017746          235 PGDLSEQGKDFLIKCFLKDPKRRW-----TAEMLLNHPFVCA  271 (366)
Q Consensus       235 ~~~~s~~~~~ll~~cL~~dp~~R~-----t~~~ll~hp~~~~  271 (366)
                      +..+++++.+||.+||.+||++||     |++|+++||||+.
T Consensus       256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            677999999999999999999999     5899999999954

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=391.12  Aligned_cols=245  Identities=22%  Similarity=0.358  Sum_probs=201.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||.||+|++++      .+||||.+... ...+.+.+|++++++++ ||||++++|.+  .+ ....+
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~------~~vAvK~i~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~g~~--~~-~~~~~   76 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKND-ATAQAFLAEASVMTQLR-HSNLVQLLGVI--VE-EKGGL   76 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETT------EEEEEEECCCC-C--HHHHHTHHHHTTCC-CTTBCCEEEEE--CC-C--CC
T ss_pred             HeEEeEEEecCCCeEEEEEEECC------eEEEEEEECcH-HHHHHHHHHHHHHHhCC-CCCEeeEEEEE--Ee-cCCcE
Confidence            57889999999999999999853      37899998653 45677999999999998 99999999943  22 23345


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCD  161 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~  161 (366)
                      ++||||+++|+|.+++.++....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            79999999999999997654345899999999999999999999999999999999999999999999999999875321


Q ss_pred             CCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          162 GERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                           .....+|+.|+|||++.+..++.++|||||||++|||+| |++||......+....+..    ...+.++..+++
T Consensus       157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~----~~~~~~~~~~~~  227 (262)
T d1byga_         157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----GYKMDAPDGCPP  227 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT----TCCCCCCTTCCH
T ss_pred             -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----CCCCCCCccCCH
Confidence                 223468999999999999999999999999999999998 7999988766665554432    344567778999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++++||.+||..||++|||+.+|+++
T Consensus       228 ~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         228 AVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-54  Score=396.30  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=208.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCC---CCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSE---FPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEK   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~---~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~   76 (366)
                      +|.+++.||+|+||.||+|++..+++.   ....||||.+.....  ....+.+|...+.++..|||||++++.+.   +
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~---~   90 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT---Q   90 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---S
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc---c
Confidence            578899999999999999998665432   235789999866433  34678889999999966999999998432   2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQN--------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF  142 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  142 (366)
                       +...++|||||++|+|.++|..+.              ...+++.++..++.||+.||+|||++|||||||||+|||++
T Consensus        91 -~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          91 -DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             -SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             -CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence             344669999999999999997532              24589999999999999999999999999999999999999


Q ss_pred             cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHH
Q 017746          143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSL  221 (366)
Q Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~  221 (366)
                      .++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||.+.........
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~  249 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  249 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            999999999999998765554445556689999999999999999999999999999999998 7999987765544433


Q ss_pred             HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +.    ....+..|..+++++.+||.+||+.||++|||+.||++
T Consensus       250 i~----~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         250 LK----EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HH----TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH----cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            32    23445667889999999999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=387.92  Aligned_cols=257  Identities=26%  Similarity=0.364  Sum_probs=207.9

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCC---CchhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCP---PSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~---~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|++++.||+|+||+||+|+++.+++    .||+|.+....   .....+.+|+.+|+.++ ||||+++++.+    ...
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~----~~~   73 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHE----IVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVL----HSD   73 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEE----ECS
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCc----EEEEEEEehhhCChHHHHHHHHHHHHHHhcC-cCCEEeecccc----ccc
Confidence            79999999999999999999988765    67888875432   33567889999999998 99999998833    234


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcccc
Q 017746           79 RFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKS  158 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~  158 (366)
                      ..+++|||++.+++|..++..  .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+..
T Consensus        74 ~~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          74 KKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             SEEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cceeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcc
Confidence            456699999999998888754  467999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCcccccccCCCCCCCccccCCcC-CCCccchhhhHHHHHHHHhCCCCCCCCCc-chHHHHHHHhhcC--------
Q 017746          159 SCDGERSQSFECRGTPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQD-SNVFSLLIRIGVG--------  228 (366)
Q Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~emltg~~pf~~~~~-~~~~~~~~~~~~~--------  228 (366)
                      .....  ......+++.|+|||++.... ++.++|||||||++|||++|+.||....+ .+....+......        
T Consensus       152 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             cCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence            53332  223346889999999987765 68899999999999999999998754433 3333333322111        


Q ss_pred             ----------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          229 ----------------DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       229 ----------------~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                      .........+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence                            1112233457899999999999999999999999999999953

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-53  Score=393.87  Aligned_cols=255  Identities=23%  Similarity=0.291  Sum_probs=208.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCC-CCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVS-SEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|+.+... ......||||++.....  ....+.+|+++|++++ ||||+++++.+.   . .
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~---~-~   88 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCA---V-G   88 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC---S-S
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC-CCCcccceeeec---c-C
Confidence            4888999999999999999986532 22345799998865333  2456899999999998 999999998432   2 2


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCC
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN----------------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKL  136 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp  136 (366)
                      ...+++|||+++|+|.+++....                      ...+++..+..|+.||+.||+|||++|||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            34559999999999999997521                      12488999999999999999999999999999999


Q ss_pred             CcEEeccCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCC-CCCCCCCc
Q 017746          137 QNVLVFDNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGK-PAWNHKQD  215 (366)
Q Consensus       137 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~-~pf~~~~~  215 (366)
                      +||||+.++++||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. +||.+...
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999998765444444444567999999999999999999999999999999999985 67877766


Q ss_pred             chHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          216 SNVFSLLIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      .+....+..    ...+.+|..+++++.+||.+||+.||++|||+.||++
T Consensus       249 ~e~~~~v~~----~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         249 EEVIYYVRD----GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHc----CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            555444332    3346677889999999999999999999999999964

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-54  Score=390.53  Aligned_cols=253  Identities=24%  Similarity=0.383  Sum_probs=201.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC----CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCC
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC----PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKG   77 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~----~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~   77 (366)
                      +|++.+.||+|+||+||+|+.....+ ....||+|.+...    ......+.+|+.+|++++ ||||++++|.+.   + 
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~-~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~---~-   82 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL---T-   82 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTS-CEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC---S-
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCC-cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe---e-
Confidence            58899999999999999998765433 2346888887642    223457899999999998 999999999432   2 


Q ss_pred             eeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746           78 ERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus        78 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      . .+++|||||++|+|.+++..+ .+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             c-chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhh
Confidence            2 345999999999999998874 45799999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcc-cccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHHHHHhhcCCCCCCCC
Q 017746          158 SSCDGERSQ-SFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSLLIRIGVGDELPNIP  235 (366)
Q Consensus       158 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (366)
                      ......... .....||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..+....+.+.   ...+..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~  237 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---GERLPRP  237 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS---CCCCCCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC---CCCCCCc
Confidence            754433222 233468889999999999999999999999999999998 89999887766655544433   3344566


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          236 GDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       236 ~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ..+++++.+||.+||..||++|||+++|++
T Consensus       238 ~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            789999999999999999999999999874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-54  Score=398.28  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=204.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC--CCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCee
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD--CPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGER   79 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~--~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~   79 (366)
                      +|.++++||+|+||+||+|+++.++..  ..++||....  .......+.+|+++|.++..|||||+++|++.   . +.
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~---~-~~   84 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLR--MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE---H-RG   84 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEE--EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE---E-TT
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeE--EEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe---c-CC
Confidence            578889999999999999999876542  2467777643  22345678999999999966999999999543   2 33


Q ss_pred             EEEEEeecCCCCCHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCC
Q 017746           80 FYNLLLEYASRGSLADRVKKQ--------------NNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDND  145 (366)
Q Consensus        80 ~~~lv~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~  145 (366)
                      .+++|||||++|+|.++|.+.              ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            567999999999999999752              235799999999999999999999999999999999999999999


Q ss_pred             ceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCC-CCCCCCCcchHHHHHHH
Q 017746          146 EAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGK-PAWNHKQDSNVFSLLIR  224 (366)
Q Consensus       146 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~-~pf~~~~~~~~~~~~~~  224 (366)
                      .+||+|||+|+.....   .......||+.|+|||.+.+..|+.++|||||||++|||++|. +||.+.+..+....+  
T Consensus       165 ~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i--  239 (309)
T d1fvra_         165 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--  239 (309)
T ss_dssp             CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG--
T ss_pred             ceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH--
Confidence            9999999999865322   2223456999999999999999999999999999999999965 678766544433332  


Q ss_pred             hhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          225 IGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       225 ~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                       .. ...+..+..+++++++||.+||..||++|||+++|++|
T Consensus       240 -~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         240 -PQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -GG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -Hh-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             22 23456677899999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=393.06  Aligned_cols=257  Identities=25%  Similarity=0.341  Sum_probs=213.2

Q ss_pred             CccccCeeeecCCeeEEEEEECCC-CCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKV-SSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||.||+|++... +......+|||++.....  ....+.+|+.++.++..|||||+++|.+   . ..
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~---~-~~   99 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---T-IG   99 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---C-SS
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE---e-eC
Confidence            466799999999999999997542 334566899999875433  3446789999999997799999999943   2 23


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEec
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN----------------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVF  142 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~----------------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~  142 (366)
                      ..+++|||||++|+|.+++.+..                ...+++..+..|+.||+.||+|||++|||||||||+|||++
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence            34669999999999999997632                22589999999999999999999999999999999999999


Q ss_pred             cCCceEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHh-CCCCCCCCCcchHHHH
Q 017746          143 DNDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMAS-GKPAWNHKQDSNVFSL  221 (366)
Q Consensus       143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emlt-g~~pf~~~~~~~~~~~  221 (366)
                      .++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||+| |.+||......+....
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999998765444444455689999999999999999999999999999999998 6777777666555555


Q ss_pred             HHHhhcCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          222 LIRIGVGDELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       222 ~~~~~~~~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      +.+.+.   .+..+..+++++.+||.+||+.||++|||+++|++
T Consensus       260 ~i~~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         260 MIKEGF---RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHTC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCC---CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            554443   34556678999999999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=400.48  Aligned_cols=257  Identities=22%  Similarity=0.308  Sum_probs=197.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|++++.||+|+||+||+|+++.+++    .||||++.....   ....+.+|+.+|++++ ||||+++++.+..-.  +
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDR----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTE----EEEEEEEESTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCC----EEEEEEEChhhcCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccc
Confidence            58999999999999999999988765    789998865322   2345789999999998 999999998653221  2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      ....+|+|||||.+ +|.+.+.    ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++
T Consensus        93 ~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          93 EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence            34677899999977 5555553    358999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC-------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD-------  229 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~-------  229 (366)
                      .....   ......+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.......+.......       
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            76432   22334579999999999999999999999999999999999999998876655554443321110       


Q ss_pred             -------------CCCC-----------C------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 -------------ELPN-----------I------PGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 -------------~~~~-----------~------~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                   ....           .      +...++++++||.+||..||++|||++|||+||||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                         0000           0      0114678899999999999999999999999999965

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=398.22  Aligned_cols=256  Identities=24%  Similarity=0.345  Sum_probs=204.4

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC---chhhHHHHHHHHHHcCCCCceeEeecceeecc--C
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP---SSVTLKNEKEALDQIGICPQIVRCFGDDYSFE--K   76 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~--~   76 (366)
                      +|.+++.||+|+||+||+|+++.+++    .||+|.+.....   ....+.+|+.+|++++ |||||++++.+....  +
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGL----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTE----EEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTT
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCC----EEEEEEECchhcChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccc
Confidence            68999999999999999999987764    899998875333   2345789999999998 999999998543221  2


Q ss_pred             CeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCcc
Q 017746           77 GERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAK  156 (366)
Q Consensus        77 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~  156 (366)
                      +...+ ++|+|+.||+|.+++..   +++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|.
T Consensus        94 ~~~~~-~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          94 EFNDV-YLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             TCCCC-EEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             cCceE-EEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhc
Confidence            22333 56677889999999954   469999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCCCCcccccccCCCCCCCccccCCcC-CCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHhhcCC------
Q 017746          157 KSSCDGERSQSFECRGTPLYMSPESVNENE-YEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRIGVGD------  229 (366)
Q Consensus       157 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~~~~~------  229 (366)
                      ...     .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+.+.....      
T Consensus       170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            642     2233457999999999876654 6889999999999999999999998887666555554432111      


Q ss_pred             ---------------CCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCCCccc
Q 017746          230 ---------------ELPN-----IPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLNHPFVCA  271 (366)
Q Consensus       230 ---------------~~~~-----~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~hp~~~~  271 (366)
                                     ..+.     ....+++++++||.+||..||++|||++|+|+||||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence                           0011     11347899999999999999999999999999999964

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-52  Score=385.46  Aligned_cols=251  Identities=20%  Similarity=0.300  Sum_probs=201.4

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC--chhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP--SSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYNL   83 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~l   83 (366)
                      .++||+|+||+||+|++..++. ....+|||.+.....  ....+.+|+++|.+++ ||||++++|.+.   ..+..+++
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~---~~~~~~~l  106 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICL---RSEGSPLV  106 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEE---ETTTEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCC-EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEE---ecCCceEE
Confidence            5789999999999999876542 234688998864322  3467899999999998 999999999543   22335669


Q ss_pred             EeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEEecCCccccCCCCC
Q 017746           84 LLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIADFGLAKKSSCDGE  163 (366)
Q Consensus        84 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~DFG~a~~~~~~~~  163 (366)
                      |||||++|+|.+++.. ....+++..+..++.||+.||.|||+.||+||||||+||||++++.+||+|||+++.......
T Consensus       107 v~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999999999999976 445688999999999999999999999999999999999999999999999999987654322


Q ss_pred             Cc--ccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcc-hHHHHHHHhhcCCCCCCCCCCCCH
Q 017746          164 RS--QSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDS-NVFSLLIRIGVGDELPNIPGDLSE  240 (366)
Q Consensus       164 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~  240 (366)
                      ..  ......||+.|+|||.+.+..++.++|||||||++|||+||..||...... +....+.    ....+..|..+++
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~----~g~~~~~p~~~~~  261 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QGRRLLQPEYCPD  261 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH----TTCCCCCCTTCCH
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH----cCCCCCCcccCcH
Confidence            22  223457999999999999999999999999999999999987777654322 2222222    2234556778999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          241 QGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       241 ~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                      ++.+||.+||..||++||++.||++|
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=386.70  Aligned_cols=255  Identities=20%  Similarity=0.347  Sum_probs=209.3

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCC-CCCceeEEeeecCCCCc--hhhHHHHHHHHHHcCCCCceeEeecceeeccCCe
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSS-EFPSLMAVKSCADCPPS--SVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGE   78 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~avK~~~~~~~~--~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~   78 (366)
                      +|.+++.||+|+||+||+|.++.... .....||||++......  ...+.+|++++.+++ ||||++++|.+   .. +
T Consensus        21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~---~~-~   95 (308)
T d1p4oa_          21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVV---SQ-G   95 (308)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEE---CS-S
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcC-CCCEeeeeeEE---ec-C
Confidence            46788999999999999999864321 12357999988753332  235789999999998 99999999943   22 2


Q ss_pred             eEEEEEeecCCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEeccCCceEEE
Q 017746           79 RFYNLLLEYASRGSLADRVKKQN--------NGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFDNDEAKIA  150 (366)
Q Consensus        79 ~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~~~vkl~  150 (366)
                      ...++|||||++|+|.+++....        -..+++..+..++.||++||.|||+++|+||||||+||||++++++||+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence            34569999999999999987531        1247899999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhC-CCCCCCCCcchHHHHHHHhhcCC
Q 017746          151 DFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASG-KPAWNHKQDSNVFSLLIRIGVGD  229 (366)
Q Consensus       151 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg-~~pf~~~~~~~~~~~~~~~~~~~  229 (366)
                      |||+|+...............||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+....+....+.+    .
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~----~  251 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME----G  251 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT----T
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----C
Confidence            99999876544333334445799999999999999999999999999999999998 588887766655554432    2


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          230 ELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       230 ~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ..+..+..+++++.++|.+||+.||++|||+++|++
T Consensus       252 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            345667789999999999999999999999999997

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-51  Score=376.88  Aligned_cols=258  Identities=21%  Similarity=0.191  Sum_probs=199.1

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|++++.||+|+||+||+|++..+++    .||+|..... .....+..|+++++.+.+|++|+.+.+.   .. ....+
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~-~~~~~~~~E~~i~~~l~~~~~i~~~~~~---~~-~~~~~   78 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGE----EVAIKLECVK-TKHPQLHIESKIYKMMQGGVGIPTIRWC---GA-EGDYN   78 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTE----EEEEEEEESC-TTSCCHHHHHHHHHHSTTSTTCCCEEEE---EE-ETTEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCC----EEEEEEEchh-ccCHHHHHHHHHHHHccCCCcccEEEEE---Ee-cCCEE
Confidence            59999999999999999999987764    7888876653 3445788999999999954555555431   22 23456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc---CCceEEEecCCcccc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD---NDEAKIADFGLAKKS  158 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG~a~~~  158 (366)
                      ++||||+. ++|.+.+.. .++.+++..+..++.||+.||+|||++|||||||||+|||++.   +..+||+|||+|+..
T Consensus        79 ~ivme~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          79 VMVMELLG-PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEECCC-CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEcC-Cchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            69999995 588877765 4567999999999999999999999999999999999999853   457999999999976


Q ss_pred             CCCCCC-----cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHh---hcCCC
Q 017746          159 SCDGER-----SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI---GVGDE  230 (366)
Q Consensus       159 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~---~~~~~  230 (366)
                      ......     ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.+.   .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            533222     1233457999999999999999999999999999999999999999876544433332221   11122


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH---HHcCCCcc
Q 017746          231 LPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEM---LLNHPFVC  270 (366)
Q Consensus       231 ~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~---ll~hp~~~  270 (366)
                      .+.....+|+++.+||.+||..||++||++++   +++|+|.+
T Consensus       237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            22344568999999999999999999999875   46777653

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-50  Score=372.57  Aligned_cols=253  Identities=20%  Similarity=0.203  Sum_probs=204.5

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+++.||+|+||+||+|++..+++    .+|+|..... .....+.+|.+++..+.+++|++.+++.+   . ....+
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~---~-~~~~~   76 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQ----QVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFG---Q-EGLHN   76 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTE----EEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEE---E-ETTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEe---e-cCCcc
Confidence            69999999999999999999987764    7888876543 34456889999999999789999998733   2 23456


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc-----CCceEEEecCCcc
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD-----NDEAKIADFGLAK  156 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-----~~~vkl~DFG~a~  156 (366)
                      ++||||+ +++|.+++.. .+..+++.++..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+
T Consensus        77 ~~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence            6999999 6799999976 4567999999999999999999999999999999999999964     5689999999998


Q ss_pred             ccCCCCCC-----cccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcchHHHHHHHh---hcC
Q 017746          157 KSSCDGER-----SQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSNVFSLLIRI---GVG  228 (366)
Q Consensus       157 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~~~~~~~~~---~~~  228 (366)
                      ........     ......+||+.|||||++.+..++.++|||||||++|||++|+.||.+...........+.   ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            76432221     1233457999999999999999999999999999999999999999876554443333222   111


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 017746          229 DELPNIPGDLSEQGKDFLIKCFLKDPKRRWTAEMLLN  265 (366)
Q Consensus       229 ~~~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~~~ll~  265 (366)
                      ...+.+...+|+++.+++..|+..+|++||+++.+.+
T Consensus       235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            2222344568899999999999999999999877654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=378.03  Aligned_cols=255  Identities=23%  Similarity=0.256  Sum_probs=192.6

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      +|.+.+.||+|+||.||+|++.+      .+||||.+..........+.|+..+.+++ ||||++++|.+.........+
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~g------~~vAvK~~~~~~~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWRG------EEVAVKIFSSREERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETT------EEEEEEEECGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECC------EEEEEEEECccchhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCcceEE
Confidence            57889999999999999998742      48999988653222222334444555677 999999999766555555577


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcEecCCCCCcEEeccCCceEEEecC
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS--------KGFVHCDIKLQNVLVFDNDEAKIADFG  153 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--------~givHrDlkp~NILl~~~~~vkl~DFG  153 (366)
                      ++|||||++|+|.+++++   ..+++..+..++.|++.||.|||+        +|||||||||+||||+.++++||+|||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            899999999999999976   258999999999999999999996        599999999999999999999999999


Q ss_pred             CccccCCCCCCc--ccccccCCCCCCCccccCCcC------CCCccchhhhHHHHHHHHhCCCCCCCCCcc---------
Q 017746          154 LAKKSSCDGERS--QSFECRGTPLYMSPESVNENE------YEAPCDIWALGCAVVEMASGKPAWNHKQDS---------  216 (366)
Q Consensus       154 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~emltg~~pf~~~~~~---------  216 (366)
                      +++.........  .....+||+.|||||++.+..      ++.++|||||||++|||+||.+||......         
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            998764332211  223467999999999987653      677899999999999999999887432211         


Q ss_pred             --hHHHHHHHhh-cCCCCCCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 017746          217 --NVFSLLIRIG-VGDELPNIPGD-----LSEQGKDFLIKCFLKDPKRRWTAEMLLNH  266 (366)
Q Consensus       217 --~~~~~~~~~~-~~~~~~~~~~~-----~s~~~~~ll~~cL~~dp~~R~t~~~ll~h  266 (366)
                        .....+.... .....|.++..     ....+.+|+.+||..||++|||+.||+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              0111222221 22223344332     23458899999999999999999999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6e-48  Score=364.96  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=193.7

Q ss_pred             CccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcC----------CCCceeEeecce
Q 017746            2 EWLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIG----------ICPQIVRCFGDD   71 (366)
Q Consensus         2 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~----------~~p~Iv~~~g~~   71 (366)
                      +|.++++||+|+||+||+|+++.+++    .||||++...........+|+.+++.+.          .|+||+++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~----~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNT----HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            59999999999999999999988765    7899988764444567788999999886          258899998854


Q ss_pred             eeccCCeeEEEEEeecCCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEeccCCc---
Q 017746           72 YSFEKGERFYNLLLEYASRG-SLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-KGFVHCDIKLQNVLVFDNDE---  146 (366)
Q Consensus        72 ~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~~~---  146 (366)
                      ......  ..+++|+++..+ +............+++..++.++.||+.||+|||+ +||+||||||+||||+.++.   
T Consensus        90 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          90 NHKGPN--GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEETT--EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             eecccc--ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence            332222  333555555443 44444444455679999999999999999999998 89999999999999986653   


Q ss_pred             ---eEEEecCCccccCCCCCCcccccccCCCCCCCccccCCcCCCCccchhhhHHHHHHHHhCCCCCCCCCcch------
Q 017746          147 ---AKIADFGLAKKSSCDGERSQSFECRGTPLYMSPESVNENEYEAPCDIWALGCAVVEMASGKPAWNHKQDSN------  217 (366)
Q Consensus       147 ---vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~emltg~~pf~~~~~~~------  217 (366)
                         +||+|||.|......     ....+||+.|+|||++.+..|+.++||||+||++++|++|+.||.......      
T Consensus       168 ~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence               999999999865322     234579999999999999999999999999999999999999997543211      


Q ss_pred             HHHHHHHh-h---------------------cCCC---------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 017746          218 VFSLLIRI-G---------------------VGDE---------------LPNIPGDLSEQGKDFLIKCFLKDPKRRWTA  260 (366)
Q Consensus       218 ~~~~~~~~-~---------------------~~~~---------------~~~~~~~~s~~~~~ll~~cL~~dp~~R~t~  260 (366)
                      ........ +                     ....               ....+...+++++|||.+||..||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            11111110 0                     0000               011122346789999999999999999999


Q ss_pred             HHHHcCCCcc
Q 017746          261 EMLLNHPFVC  270 (366)
Q Consensus       261 ~~ll~hp~~~  270 (366)
                      +|+|+||||+
T Consensus       323 ~e~L~Hp~f~  332 (362)
T d1q8ya_         323 GGLVNHPWLK  332 (362)
T ss_dssp             HHHHTCGGGT
T ss_pred             HHHhcCcccC
Confidence            9999999996

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=6.4e-26  Score=194.06  Aligned_cols=163  Identities=20%  Similarity=0.215  Sum_probs=116.6

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCCCC-------------------chhhHHHHHHHHHHcCCCCc
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADCPP-------------------SSVTLKNEKEALDQIGICPQ   63 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~~~-------------------~~~~~~~E~~~l~~l~~~p~   63 (366)
                      +.+++.||+|+||+||+|++.. +    ..+|+|.......                   ......+|...+.++. +++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~-g----~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~   75 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEK-F----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLA   75 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETT-T----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSS
T ss_pred             chhCCEeeeCcceEEEEEECCC-C----CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCC
Confidence            4678999999999999998753 3    3788886542110                   0123456788888998 788


Q ss_pred             eeEeecceeeccCCeeEEEEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEecc
Q 017746           64 IVRCFGDDYSFEKGERFYNLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHSKGFVHCDIKLQNVLVFD  143 (366)
Q Consensus        64 Iv~~~g~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~  143 (366)
                      ++..++    ...    .+++|||++++.+.         .+++..+..++.||+.||.|||++||+||||||+|||+++
T Consensus        76 v~~~~~----~~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~  138 (191)
T d1zara2          76 VPKVYA----WEG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE  138 (191)
T ss_dssp             SCCEEE----EET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET
T ss_pred             cceEEE----ecC----CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC
Confidence            887765    221    14999999986542         2556667889999999999999999999999999999986


Q ss_pred             CCceEEEecCCccccCCCCCCcccccccCCCCCCCcc-----ccCCcCCCCccchhhhHHH
Q 017746          144 NDEAKIADFGLAKKSSCDGERSQSFECRGTPLYMSPE-----SVNENEYEAPCDIWALGCA  199 (366)
Q Consensus       144 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DiwslG~i  199 (366)
                      + .++|+|||+|.....+...          .|....     .+..+.|+.++|+||+.--
T Consensus       139 ~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         139 E-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             T-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             C-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            5 4899999999875322110          111110     0123678999999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=1.6e-07  Score=81.76  Aligned_cols=138  Identities=17%  Similarity=0.169  Sum_probs=82.4

Q ss_pred             ccccCeeeecCCeeEEEEEECCCCCCCCceeEEeeecCC-CCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEE
Q 017746            3 WLRGDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCADC-PPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFY   81 (366)
Q Consensus         3 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~~-~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~   81 (366)
                      |+..+..+-++.+.||+....  +    ..+++|..... ......+.+|..+++.+..+--+.+++.    ....++..
T Consensus        16 ~~~~~~~~G~s~~~v~rv~~~--~----~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~----~~~~~~~~   85 (263)
T d1j7la_          16 YRCVKDTEGMSPAKVYKLVGE--N----ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLH----FERHDGWS   85 (263)
T ss_dssp             SEEEECSCCCSSSEEEEEECS--S----CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEE----EEEETTEE
T ss_pred             eEEEEcCCCCCCCcEEEEEeC--C----CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEE----EEecCCce
Confidence            333333333344689988632  2    24677776542 2344568899999998875422344443    11122345


Q ss_pred             EEEeecCCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 017746           82 NLLLEYASRGSLADRVKKQNNGRLQESDVKRYTRSMLKGLRHIHS-----------------------------------  126 (366)
Q Consensus        82 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-----------------------------------  126 (366)
                      ++||++++|.++.+....       ......++.++...|..||+                                   
T Consensus        86 ~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            599999999888654321       11122233444444444442                                   


Q ss_pred             ------------------C------CcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          127 ------------------K------GFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       127 ------------------~------givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                                        .      .++|+|+.|.|||+++++.+-|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                              1      279999999999998776667999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.07  E-value=6.9e-06  Score=75.86  Aligned_cols=77  Identities=19%  Similarity=0.159  Sum_probs=46.8

Q ss_pred             cCeeeecCCeeEEEEEECCCCCCCCceeEEeeecC-----C---CCchhhHHHHHHHHHHcCCC-C-ceeEeecceeecc
Q 017746            6 GDVIGHGSFGSVNLAKASKVSSEFPSLMAVKSCAD-----C---PPSSVTLKNEKEALDQIGIC-P-QIVRCFGDDYSFE   75 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~avK~~~~-----~---~~~~~~~~~E~~~l~~l~~~-p-~Iv~~~g~~~~~~   75 (366)
                      .+.||.|....||++.....++    .+++|....     .   .....+...|.++|+.+..+ | .+.+++.    +.
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~----svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~----~d  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDR----ALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY----SD  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----C----EEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE----EE
T ss_pred             EEEeCCCceEeEEEEEeCCCCe----EEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE----Ec
Confidence            4578999999999998655433    677786542     0   11234566799999888643 2 3445543    22


Q ss_pred             CCeeEEEEEeecCCCCC
Q 017746           76 KGERFYNLLLEYASRGS   92 (366)
Q Consensus        76 ~~~~~~~lv~E~~~~g~   92 (366)
                      ....  .+|||++.+..
T Consensus       103 ~~~~--~lvmE~L~~~~  117 (392)
T d2pula1         103 TEMA--VTVMEDLSHLK  117 (392)
T ss_dssp             TTTT--EEEECCCTTSE
T ss_pred             CCCC--EEEEeccCCcc
Confidence            2222  38999998754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.00  E-value=5.6e-06  Score=71.25  Aligned_cols=75  Identities=16%  Similarity=0.036  Sum_probs=45.9

Q ss_pred             eeeecCC-eeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCC-ceeEeecceeeccCCeeEEEEEe
Q 017746            8 VIGHGSF-GSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICP-QIVRCFGDDYSFEKGERFYNLLL   85 (366)
Q Consensus         8 ~lG~G~f-g~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p-~Iv~~~g~~~~~~~~~~~~~lv~   85 (366)
                      .+..|.. +.||+..... +    ..+++|....  .....+..|...++.+..+. .+.++++.    ..+....++||
T Consensus        17 ~~~~G~s~~~v~r~~~~~-~----~~~vlK~~~~--~~~~~l~~E~~~l~~L~~~gvpvP~v~~~----~~~~~~~~~v~   85 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG-R----PVLFVKTDLS--GALNELQDEAARLSWLATTGVPCAAVLDV----VTEAGRDWLLL   85 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT-S----CCEEEEEECS--CTTSCHHHHHHHHHHHHTTTCCBCCEEEE----EECSSCEEEEE
T ss_pred             EcCCcccCCeEEEEEeCC-C----CEEEEEeCCc--cCHhHHHHHHHHHHHHHhcCCCCCceeee----cccccceEEEE
Confidence            3445554 5789887533 2    2577787655  33456889999998886431 13444431    12233456999


Q ss_pred             ecCCCCCH
Q 017746           86 EYASRGSL   93 (366)
Q Consensus        86 E~~~~g~L   93 (366)
                      |+++|.++
T Consensus        86 ~~i~G~~~   93 (255)
T d1nd4a_          86 GEVPGQDL   93 (255)
T ss_dssp             ECCSSEET
T ss_pred             Eeeecccc
Confidence            99998655

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.39  E-value=0.00028  Score=64.64  Aligned_cols=79  Identities=19%  Similarity=0.165  Sum_probs=51.0

Q ss_pred             cCeeeecCCeeEEEEEECCCC---CCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCCCceeEeecceeeccCCeeEEE
Q 017746            6 GDVIGHGSFGSVNLAKASKVS---SEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGICPQIVRCFGDDYSFEKGERFYN   82 (366)
Q Consensus         6 ~~~lG~G~fg~Vy~a~~~~~~---~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~p~Iv~~~g~~~~~~~~~~~~~   82 (366)
                      ++.|+-|-.-.+|++......   +.....++++.... ........+|..+++.+..+.-..++++.    ..+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~----~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGI----FSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEE----ETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEE----cCC----c
Confidence            456777778899999875432   22334677777663 34455678899999998754333455552    222    2


Q ss_pred             EEeecCCCCCH
Q 017746           83 LLLEYASRGSL   93 (366)
Q Consensus        83 lv~E~~~~g~L   93 (366)
                      +||||++|.+|
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            78999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.10  E-value=0.0012  Score=58.47  Aligned_cols=70  Identities=13%  Similarity=0.019  Sum_probs=43.1

Q ss_pred             eeEEEEEECCCCCCCCceeEEeeecCCCCchhhHHHHHHHHHHcCCC----CceeEeecceeeccCCeeEEEEEeecCCC
Q 017746           15 GSVNLAKASKVSSEFPSLMAVKSCADCPPSSVTLKNEKEALDQIGIC----PQIVRCFGDDYSFEKGERFYNLLLEYASR   90 (366)
Q Consensus        15 g~Vy~a~~~~~~~~~~~~~avK~~~~~~~~~~~~~~E~~~l~~l~~~----p~Iv~~~g~~~~~~~~~~~~~lv~E~~~~   90 (366)
                      -.||+++..+ +    ..+++|...........+..|...+..|..+    +..+..-|.  .....+..++.++++++|
T Consensus        36 N~vy~v~~~d-g----~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~--~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQDED-R----RRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQ--TLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECCTT-C----CCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTB--SCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEcCC-C----CEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCC--eeeeeeeEEEEEEeecCC
Confidence            4799997643 2    3688998765445667788899999888632    222222221  111223456689999987


Q ss_pred             C
Q 017746           91 G   91 (366)
Q Consensus        91 g   91 (366)
                      .
T Consensus       109 ~  109 (325)
T d1zyla1         109 R  109 (325)
T ss_dssp             E
T ss_pred             c
Confidence            4

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.68  E-value=0.0053  Score=53.73  Aligned_cols=31  Identities=26%  Similarity=0.485  Sum_probs=27.1

Q ss_pred             CCcEecCCCCCcEEeccCCceEEEecCCccc
Q 017746          127 KGFVHCDIKLQNVLVFDNDEAKIADFGLAKK  157 (366)
Q Consensus       127 ~givHrDlkp~NILl~~~~~vkl~DFG~a~~  157 (366)
                      .|+||+|+.++||+++++...-|.||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            3799999999999999887778999998753